FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Ng, DHL
   Ho, HJ
   Chow, A
   Wong, JH
   Kyaw, WM
   Tan, A
   Chia, PY
   Choy, CY
   Tan, G
   Yeo, TW
   Leo, YS
AF Ng, Deborah H. L.
   Ho, Hanley J.
   Chow, Angela
   Wong, Joshua
   Kyaw, Win Mar
   Tan, Adriana
   Chia, Po Ying
   Choy, Chiaw Yee
   Tan, Glorijoy
   Yeo, Tsin Wen
   Leo, Yee Sin
TI Correlation of clinical illness with viremia in Zika virus disease
   during an outbreak in Singapore
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Viremia; Zika; Outbreak; Singapore
AB Background: The first autochthonous Zika virus (ZIKV) outbreak in Singapore was detected in August 2016. We report an analysis of the correlation of clinical illness with viremia and laboratory parameters in this Asian cohort.
   Methods: We conducted a prospective longitudinal cohort study of patients with a positive blood ZIKV polymerase chain reaction (PCR) result who were admitted to Tan Tock Seng Hospital, Singapore, for isolation and management.
   Results: We included 40 patients in our study. Rash was present in all patients, while 80% (32/40) had fever, 62.5% (25/40) myalgia, 60% (24/40) conjunctivitis and 38% (15/40) arthralgia. The median duration of viremia was 3.5 days (IQR: 3-5 days). Patients with viremia of days were more likely to have prolonged fever compared to those with viremia of less than >= 4 days (95% versus 63%, p = 0.01), but had no significant correlation with other clinical signs and symptoms, or laboratory investigations. However, 21 patients (53%) had hypokalemia despite the absence of gastrointestinal symptoms.
   Conclusion: Although fever correlated with duration of viremia, 30% of patients remained viremic despite defervescence. Laboratory abnormalities such as leukopenia or thrombocytopenia were not prominent in this cohort but about half the patients were noted to have hypokalemia.
C1 [Ng, Deborah H. L.; Chia, Po Ying; Choy, Chiaw Yee; Tan, Glorijoy; Yeo, Tsin Wen; Leo, Yee Sin] Natl Ctr Infect Dis, Moulmein Rd, Singapore 308433, Singapore.
   [Ho, Hanley J.; Chow, Angela; Wong, Joshua; Kyaw, Win Mar; Tan, Adriana] Tan Tock Seng Hosp, Dept Clin Epidemiol, Off Clin Epidemiol Analyt & Knowledge, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
   [Chow, Angela; Leo, Yee Sin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, 12 Sci Dr 2, Singapore 117549, Singapore.
   [Chow, Angela; Yeo, Tsin Wen; Leo, Yee Sin] Nanyang Technol Univ, Lee Kong Chian Sch Med, 11 Mandalay Rd, Singapore 308232, Singapore.
RP Ho, HJ (corresponding author), Tan Tock Seng Hosp, Dept Clin Epidemiol, Off Clin Epidemiol Analyt & Knowledge, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore.
EM hanleyho@gmail.com
RI Chia, Po Ying/AAN-9657-2020
OI Chia, Po Ying/0000-0002-8797-9527; Wong, Joshua/0000-0001-8268-5610
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leo YS, 2016, LANCET INFECT DIS, V16, P1317, DOI 10.1016/S1473-3099(16)30448-0
   Lizarraga Karlo J, 2014, J Nephropathol, V3, P57, DOI 10.12860/jnp.2014.13
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048
   World Health Organisation, WHO DIR GEN SUM OUTC
NR 12
TC 3
Z9 3
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUL 4
PY 2018
VL 18
AR 301
DI 10.1186/s12879-018-3211-9
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GL7BP
UT WOS:000437350300003
PM 29973158
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yang, S
   Onigman, P
   Wu, WW
   Sjogren, J
   Nyhlen, H
   Shen, RF
   Cipollo, J
AF Yang, Shuang
   Onigman, Philip
   Wu, Wells W.
   Sjogren, Jonathan
   Nyhlen, Helen
   Shen, Rong-Fong
   Cipollo, John
TI Deciphering Protein O-Glycosylation: Solid-Phase Chemoenzymatic Cleavage
   and Enrichment
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MASS-SPECTROMETRY; GLYCOPROTEIN IMMOBILIZATION; GLYCANS; SITES;
   GLYCOPEPTIDE; ROLES; IDENTIFICATION; RELEASE; INTACT; CANCER
AB Glycosylation plays a critical role in the biosynthetic-secretory pathway in the endoplasmic reticulum (ER) and Golgi apparatus. Over 50% of mammalian cellular proteins are typically glycosylated; this modification is involved in a wide range of biological functions such as barrier formation against intestinal microbes and serves as signaling molecules for selectins and galectins in the innate immune system. N-linked glycosylation analysis has been greatly facilitated owing to a range of specific enzymes available for their release. However, system-wide analysis on O-linked glycosylation remains a challenge due to the lack of equivalent enzymes and the inherent structural heterogeneity of O-glycans. Although O-glycosidase can catalyze the removal of core 1 and core 3 O-linked disaccharides from glycoproteins, analysis of other types of O-glycans remains difficult, particularly when residing on glycopeptides. Here, we describe a novel chemoenzymatic approach driven by a newly available O-protease and solid phase platform. This method enables the assignment of O-glycosylated peptides, N-glycan profile, sialyl O-glycopeptides linkage, and mapping of heterogeneous O-glycosylation. For the first time, we can analyze intact O-glycopeptides generated by O-protease and enriched using a solid-phase platform. We establish the method on standard glycoproteins, confirming known O-glycosites with high accuracy and confidence, and reveal up to 8-fold more glycosites than previously reported with concomitant increased heterogeneity. This technique is further applied for analysis of Zika virus recombinant glycoproteins, revealing their dominant O-glycosites and setting a basis set of O-glycosylation tracts in these important viral antigens. Our approach can serve as a benchmark for the investigation of protein O-glycosylation in diseases and other biomedical contexts. This method should become an indispensable tool for investigations where O-glycosylation is central.
C1 [Yang, Shuang; Cipollo, John] US FDA, Lab Bacterial Polysaccharides, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
   [Onigman, Philip; Sjogren, Jonathan] Genovis Inc, Cambridge, MA 02142 USA.
   [Wu, Wells W.; Shen, Rong-Fong] US FDA, Facil Biotechnol Resources, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
   [Nyhlen, Helen] Genovis AB, Box 790, SE-22007 Lund, Sweden.
RP Yang, S (corresponding author), G614,Bldg 75,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.; Cipollo, J (corresponding author), G637,Bldg 52-72,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM shuang.yang@fda.hhs.gov; john.cipollo@fad.hhs.gov
CR An YM, 2015, J PROTEOME RES, V14, P3957, DOI 10.1021/acs.jproteome.5b00416
   An YM, 2011, ANAL BIOCHEM, V415, P67, DOI 10.1016/j.ab.2011.04.018
   Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Brockhausen I, 2006, EMBO REP, V7, P599, DOI 10.1038/sj.embor.7400705
   Christiansen MN, 2010, ANAL CHEM, V82, P3500, DOI 10.1021/ac901717n
   Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7
   Fujita K, 2005, J BIOL CHEM, V280, P37415, DOI 10.1074/jbc.M506874200
   Fukuda M, 2002, BBA-GEN SUBJECTS, V1573, P394, DOI 10.1016/S0304-4165(02)00409-9
   Go EP, 2009, J PROTEOME RES, V8, P4231, DOI 10.1021/pr9002728
   HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913
   Hanisch FG, 2001, ANAL BIOCHEM, V290, P47, DOI 10.1006/abio.2000.4955
   Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440
   Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752
   Iwase H., 1993, GLYCOPROTEIN ANAL BI, V1, P151
   Kaji H, 2003, NAT BIOTECHNOL, V21, P667, DOI 10.1038/nbt829
   Koutsioulis D, 2008, GLYCOBIOLOGY, V18, P799, DOI 10.1093/glycob/cwn069
   Levery SB, 2015, BBA-GEN SUBJECTS, V1850, P33, DOI 10.1016/j.bbagen.2014.09.026
   Mancera-Arteu M, 2017, J PROTEOME RES, V16, P4166, DOI 10.1021/acs.jproteome.7b00524
   Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383
   Nath S, 2014, TRENDS MOL MED, V20, P332, DOI 10.1016/j.molmed.2014.02.007
   OSHANNESSY DJ, 1987, BIOTECHNOL APPL BIOC, V9, P488, DOI 10.1111/j.1470-8744.1987.tb00492.x
   PATEL T, 1993, BIOCHEMISTRY-US, V32, P679, DOI 10.1021/bi00053a037
   Rademaker GJ, 1998, ANAL BIOCHEM, V257, P149, DOI 10.1006/abio.1997.2548
   RADEMAKER GJ, 1993, ORG MASS SPECTROM, V28, P1536, DOI 10.1002/oms.1210281228
   Song XZ, 2016, NAT METHODS, V13, P528, DOI [10.1038/NMETH.3861, 10.1038/nmeth.3861]
   Stanley P., 2017, ESSENTIALS GLYCOBIOL
   Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79
   TAKAHASHI N, 1977, BIOCHEM BIOPH RES CO, V76, P1194, DOI 10.1016/0006-291X(77)90982-2
   Vakhrushev SY, 2013, MOL CELL PROTEOMICS, V12, P932, DOI 10.1074/mcp.O112.021972
   Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086
   Wells L, 2002, MOL CELL PROTEOMICS, V1, P791, DOI 10.1074/mcp.M200048-MCP200
   Woo CM, 2015, NAT METHODS, V12, P561, DOI 10.1038/nmeth.3366
   Yang S, 2017, ANAL CHEM, V89, P9508, DOI 10.1021/acs.analchem.7b02514
   Yang S, 2017, ANAL CHEM, V89, P6330, DOI 10.1021/acs.analchem.7b01048
   Yang S, 2017, NAT PROTOC, V12, P1229, DOI 10.1038/nprot.2017.034
   Yang S, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9137-1
   Yang S, 2015, ANAL CHEM, V87, P9671, DOI 10.1021/acs.analchem.5b01663
   Yang S, 2013, ANAL CHEM, V85, P5555, DOI 10.1021/ac400761e
   Zauner G, 2012, BIOL CHEM, V393, P687, DOI 10.1515/hsz-2012-0144
   Zheng YF, 2009, TALANTA, V78, P358, DOI 10.1016/j.talanta.2008.11.026
   Zhou HL, 2002, NAT BIOTECHNOL, V20, P512, DOI 10.1038/nbt0502-512
   Zhu ZK, 2015, ANNU REV ANAL CHEM, V8, P463, DOI 10.1146/annurev-anchem-071114-040240
NR 43
TC 13
Z9 12
U1 0
U2 20
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JUL 3
PY 2018
VL 90
IS 13
BP 8261
EP 8269
DI 10.1021/acs.analchem.8b01834
PG 9
WC Chemistry, Analytical
SC Chemistry
GA GM3ML
UT WOS:000438008600065
PM 29936827
OA Bronze
DA 2020-07-08
ER

PT J
AU Ding, Q
   Gaska, JM
   Douam, F
   Wei, L
   Kim, D
   Balev, M
   Heller, B
   Ploss, A
AF Ding, Qiang
   Gaska, Jenna M.
   Douam, Florian
   Wei, Lei
   Kim, David
   Balev, Metodi
   Heller, Brigitte
   Ploss, Alexander
TI Species-specific disruption of STING-dependent antiviral cellular
   defenses by the Zika virus NS2B3 protease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE flavivirus; Zika virus; antiviral immunity; viral evasion; species
   tropism
ID HEPATITIS-C VIRUS; ADAPTER PROTEIN; INNATE IMMUNITY; LIFE-CYCLE; WEST
   NILE; MICE; INFECTION; PATHWAY; VACCINE; IDENTIFICATION
AB The limited host tropism of numerous viruses causing disease in humans remains incompletely understood. One example is Zika virus (ZIKV), an RNA virus that has reemerged in recent years. Here, we demonstrate that ZIKV efficiently infects fibroblasts from humans, great apes, New and Old World monkeys, but not rodents. ZIKV infection in human-but not murine-cells impairs responses to agonists of the cGMP-AMP synthase/stimulator of IFN genes (cGAS/STING) signaling pathway, suggesting that viral mechanisms to evade antiviral defenses are less effective in rodent cells. Indeed, human, but not mouse, STING is subject to cleavage by proteases encoded by ZIKV, dengue virus, West Nile virus, and Japanese encephalitis virus, but not that of yellow fever virus. The protease cleavage site, located between positions 78/79 of human STING, is only partially conserved in nonhuman primates and rodents, rendering these orthologs resistant to degradation. Genetic disruption of STING increases the susceptibility of mouse-but not human-cells to ZIKV. Accordingly, expression of only mouse, not human, STING in murine STING knockout cells rescues the ZIKV suppression phenotype. STING-deficient mice, however, did not exhibit increased susceptibility, suggesting that other redundant antiviral pathways control ZIKV infection in vivo. Collectively, our data demonstrate that numerous RNA viruses evade cGAS/STING-dependent signaling and affirm the importance of this pathway in shaping the host range of ZIKV. Furthermore, our results explainat least in part-the decreased permissivity of rodent cells to ZIKV, which could aid in the development of mice model with inheritable susceptibility to ZIKV and other flaviviruses.
C1 [Ding, Qiang; Gaska, Jenna M.; Douam, Florian; Wei, Lei; Kim, David; Balev, Metodi; Heller, Brigitte; Ploss, Alexander] Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.
RP Ploss, A (corresponding author), Princeton Univ, Lewis Thomas Lab, Dept Mol Biol, Princeton, NJ 08544 USA.
EM aploss@princeton.edu
OI Ploss, Alexander/0000-0001-9322-7252
FU Cancer Institute of New Jersey Cancer Center Support Grant
   [P30CA072720]; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1
   A1107301, R21 A1117213]; Grand Health Challenge program from Princeton
   University; Investigator in Pathogenesis Award by the Burroughs Wellcome
   Fund; New Jersey Commission on Cancer Research Postdoctoral Fellowships
   [DHFS16PPC007, DFHS17PPC011]
FX We thank Drs. Tom Shenk (Princeton University) and Michael Diamond
   (Washington University in St. Louis) for sharing the Zika virus strains
   of MR766 and Dakar41671, respectively; Dr. Sergei Kotenko (Rutgers
   University) for providing the Ifnarl- mice; members of the A.P.
   laboratory for critical discussions and comments on the manuscript; and
   Christina DeCoste and Katherine Rittenbach and the Molecular Biology
   Flow Cytometry Resource Facility, which is partially supported by the
   Cancer Institute of New Jersey Cancer Center Support Grant P30CA072720.
   This work was supported by National Institutes of Health Grants RO1
   A1107301 and R21 A1117213 (to A.P.); and a grant from the Grand Health
   Challenge program from Princeton University and an Investigator in
   Pathogenesis Award by the Burroughs Wellcome Fund (to A.P.). Q.D. and
   L.W. are supported by New Jersey Commission on Cancer Research
   Postdoctoral Fellowships DHFS16PPC007 (to Q.D.) and DFHS17PPC011 (to
   LW.).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abecasis GR, 2010, NATURE, V473, P544
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   Dorner M, 2013, NATURE, V501, P237, DOI 10.1038/nature12427
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Douam F, 2015, ANNU REV GENET, V49, P21, DOI 10.1146/annurev-genet-112414-054823
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hercik K, 2017, ANTIVIR RES, V137, P131, DOI 10.1016/j.antiviral.2016.11.020
   Hirai-Yuki A, 2016, SCIENCE, V353, P1541, DOI 10.1126/science.aaf8325
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08
   Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liu BW, 2017, ANTIVIR RES, V147, P37, DOI 10.1016/j.antiviral.2017.10.001
   Liu H, 2017, J VIROL, V91, DOI [10.1128/JVI.02234-16, 10.1128/jvi.02234-16]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Ma Z, 2016, CELL HOST MICROBE, V19, P150, DOI 10.1016/j.chom.2016.01.010
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Piret J, 2018, J GEN VIROL, V99, P209, DOI 10.1099/jgv.0.000992
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Stabell AC, 2018, ELIFE, V7, DOI [10.7554/eLife.31919, 10.7554/elife.31919]
   Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vogt A, 2013, VIROLOGY, V444, P1, DOI 10.1016/j.virol.2013.05.036
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 59
TC 36
Z9 36
U1 1
U2 17
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 3
PY 2018
VL 115
IS 27
BP E6310
EP E6318
DI 10.1073/pnas.1803406115
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL4GH
UT WOS:000437107000027
PM 29915078
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Moore, EL
   Scott, MA
   Rodriguez, SD
   Mitra, S
   Vulcan, J
   Cordova, JJ
   Chung, HN
   de Souza, DLL
   Gonzales, KK
   Hansen, IA
AF Moore, Emily Lucille
   Scott, Mary Alice
   Rodriguez, Stacy Deadra
   Mitra, Soumi
   Vulcan, Julia
   Cordova, Joel Javierla
   Chung, Hae-Na
   Lino de Souza, Debora Linhares
   Gonzales, Kristina Kay
   Hansen, Immo Alex
TI An online survey of personal mosquito-repellent strategies
SO PEERJ
LA English
DT Article
DE Survey; Mosquito; Repellents
ID MEDICINAL-PLANT EXTRACTS; ODORANT RECEPTOR GENE; YELLOW-FEVER MOSQUITO;
   RED FLOUR BEETLE; ESSENTIAL OILS; AEDES-AEGYPTI; INSECT-REPELLENT;
   CHEMICAL-COMPOSITION; CULEX-TRITAENIORHYNCHUS; BOTANICAL INSECTICIDES
AB Background. Mosquito repellents can be an effective method for personal protection against mosquito bites that are a nuisance and carry the risk of transmission of mosquito-borne pathogens like plasmodia, dengue virus, chikungunya virus, and Zika virus. A multitude of commercially available products are currently on the market, some of them highly effective while others have low or no efficacy. Many home remedies of unknown efficacy are also widely used.
   Methods. We conducted a survey study to determine what kind of mosquito repellents and other mosquito control strategies people use. Our online survey was focused on unconventional methods and was answered by 5,209 participants.
   Results. The majority of participants resided in the United States, were female (67%), had higher education (81% had a university degree), and were 18 to 37 years old (50%). The most commonly used repellent was DEET spray (48%), followed closely by citronella candles (43%) and 'natural' repellent sprays (36%). We collected a plethora of home remedies and other strategies people use that warrant further research into their effectiveness.
   Discussion. Our study lays the foundation for future research in alternative, unconventional methods to repel mosquitoes that may be culturally acceptable and accessible for people.
C1 [Moore, Emily Lucille; Rodriguez, Stacy Deadra; Mitra, Soumi; Vulcan, Julia; Cordova, Joel Javierla; Chung, Hae-Na; Gonzales, Kristina Kay; Hansen, Immo Alex] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Scott, Mary Alice] New Mexico State Univ, Dept Anthropol, Las Cruces, NM 88003 USA.
   [Lino de Souza, Debora Linhares] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil.
   [Hansen, Immo Alex] New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA.
RP Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.; Hansen, IA (corresponding author), New Mexico State Univ, Inst Appl Biosci, Las Cruces, NM 88003 USA.
EM immoh@nmsu.edu
CR Abdel-Sattar E, 2010, NAT PROD RES, V24, P226, DOI 10.1080/14786410802346223
   Ahmad MS, 2016, RECENT ADV BIOL MED, V2, P57, DOI [10.18639/RABM.2016.02.293742, DOI 10.18639/RABM.2016.02.293742]
   Akbar V, 2005, J ECON ENTOMOL, V98, P683, DOI 10.1603/0022-0493-98.3.683
   Alankar S, 2009, ASIAN J PHARM CLIN R, V2, P27
   Alem MAS, 2004, ANTIMICROB AGENTS CH, V48, P41, DOI 10.1128/AAC.48.1.41-47.2004
   Alexander B, 1962, J CHEM ENGINEER DATA, V7, P263, DOI [10.1021/je60013a031, DOI 10.1021/JE60013A031]
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amusan A A S, 2005, Tanzan Health Res Bull, V7, P174
   Angradi T, 1987, P E WILDLIFE DAMAGE, V3, P102
   Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Arutselvi R., 2012, Journal of Biopesticides, V5, P77
   Aubernon C, 2015, FORENSIC SCI INT, V253, P125, DOI 10.1016/j.forsciint.2015.05.032
   Barone M, 1999, ANN APPL BIOL, V134, P341, DOI 10.1111/j.1744-7348.1999.tb05274.x
   Becker N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1180-z
   Beever R., 2006, BC MED J, V48, P226
   Belant JL, 1997, CROP PROT, V16, P439, DOI 10.1016/S0261-2194(97)00019-7
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Beresford RM, 1996, PROCEEDINGS OF THE FORTY NINTH NEW ZEALAND PLANT PROTECTION CONFERENCE, P106
   Bisseleua HBD, 2008, AFR J BIOTECHNOL, V7, P4635
   Bleeker PM, 2009, PLANT PHYSIOL, V151, P925, DOI 10.1104/pp.109.142661
   Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x
   Brower V, 2001, EMBO REP, V2, P755, DOI 10.1093/embo-reports/kve193
   Brown K, 2013, J ROY ANTHROPOL INST, V19, P319, DOI 10.1111/1467-9655.12035
   Bunescu H, 2012, P 47 CROAT 7 INT S A, P47
   BUNKER C. W. O., 1925, American Journal of Tropical Medicine, V5, P359
   Cantrell CL, 2005, J AGR FOOD CHEM, V53, P5948, DOI 10.1021/jf0509308
   Ceuppens B, 2015, ARTHROPOD-PLANT INTE, V9, P281, DOI 10.1007/s11829-015-9375-y
   Chen Sisi, 2014, F1000Res, V3, P84, DOI 10.12688/f1000research.3825.1
   Choochote W, 2005, J VECTOR ECOL, V30, P302
   Cilek J. E., 2010, Journal of Agricultural and Urban Entomology, V27, P54
   Clark S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154808
   Das N. G., 2003, Journal of Vector Borne Diseases, V40, P49
   Del Fabbro S, 2008, EXP APPL ACAROL, V45, P219, DOI 10.1007/s10493-008-9182-6
   Destoumieux-Garzon D, 2018, FRONT VET SCI, V5, DOI 10.3389/fvets.2018.00014
   Di Campli E, 2012, PARASITOL RES, V111, P1985, DOI 10.1007/s00436-012-3045-0
   Dong XL, 2013, J INSECT PHYSIOL, V59, P26, DOI 10.1016/j.jinsphys.2012.11.004
   Donnelly E, 2002, P UK ORG RES 2002 C, P255
   Douglas HD, 2008, NATURWISSENSCHAFTEN, V95, P45, DOI 10.1007/s00114-007-0294-3
   Dua VK, 2010, INDIAN J MED RES, V131, P434
   Effiom O, 2012, GLOBAL J SCI FRONTIE, V12, P5
   Fargione MJ, 1991, 5 E WILDLIFE DAMAGE, P42
   Ferraro DM., 1995, GREAT PLAINS WILDLIF, V432
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006
   Geetha R.V., 2014, INT J DRUG DEV RES, V6, P20, DOI DOI 10.1016/J.INDCROP.2013.04.011
   Gopal JV, 2013, INTERDISCIP SCI, V5, P280, DOI 10.1007/s12539-013-0152-2
   Gore JC, 2004, J ECON ENTOMOL, V97, P581, DOI 10.1603/0022-0493-97.2.581
   Govere J., 2000, Central African Journal of Medicine, V46, P213
   Gozan M, 2014, INT J APPL ENG RES, V9, P9739
   GREEN NATHAN, 1960, ADVANCES IN PEST CONTROL RES, V3, P129
   HAGLER JR, 1993, J KANSAS ENTOMOL SOC, V66, P223
   Hansen IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113692
   HARRIS MT, 1983, J WILDLIFE MANAGE, V47, P516, DOI 10.2307/3808526
   Ishii T., 2010, J TROP BIOL CONSERV, V7, P75
   Islam MS, 2010, J PEST SCI, V83, P105, DOI 10.1007/s10340-009-0276-7
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Jaenson TGT, 2006, J MED ENTOMOL, V43, P731, DOI 10.1603/0022-2585(2006)43[731:ROOOLE]2.0.CO;2
   Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304
   Jufri M, 2016, INT J PHARMTECHRESEA, V9, P140
   Kamaraj C, 2011, INDIAN J MED RES, V134, P101
   Karamaouna F, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.14201
   Kareru PG, 2010, AFR J PHARM PHARMACO, V4, P87
   Karunamoorthi K, 2008, PARASITOL RES, V103, P545, DOI 10.1007/s00436-008-1005-5
   Kettridge N, 2014, J HYDROL, V513, P335, DOI 10.1016/j.jhydrol.2014.03.019
   Krosnick J.A., 2015, FUTURE SURVEY RES CH
   Kruger T, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1005-8
   Kulkarni D. K., 2010, ASIAN AGR HIST, V14, P207
   Kulkarni SJ., 2017, INT J RES REV, V4, P10
   Kumar BN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070218
   Lefevre T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009546
   Leverkus AB, 2017, FORESTS, V8, DOI 10.3390/f8080276
   Licciardello F, 2013, INNOV FOOD SCI EMERG, V19, P173, DOI 10.1016/j.ifset.2013.05.002
   Lindqvist I, 2010, AGR FOOD SCI, V19, P1, DOI 10.2137/145960610791015050
   Liu XC, 2013, MOLECULES, V18, P10733, DOI 10.3390/molecules180910733
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Marquardt W. C, 2004, BIOL DIS VECTORS
   MATHIS W, 1953, AM J TROP MED HYG, V2, P318, DOI 10.4269/ajtmh.1953.2.318
   McPartland J. M., 1997, J INT HEMP ASS, V4, P87
   Miller G. D., 1983, INT C BEAR RES MANAG, V5, P275, DOI DOI 10.2307/3872549
   Mondal N.K., 2014, INT J SCI RES ENV SC, V3, DOI [10.12983/ijsres-2015-p0009-0015., DOI 10.12983/IJSRES-2015-P0009-0015]
   Moore Sarah J., 2007, P3
   Mugabe J., 1999, P INT C INT PROP HUM, P97
   Nakayama FS, 2010, IND CROP PROD, V31, P312, DOI 10.1016/j.indcrop.2009.11.009
   Newby G, 2016, LANCET, V387, P1775, DOI 10.1016/S0140-6736(16)00230-0
   Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053
   Pates HV, 2002, MED VET ENTOMOL, V16, P277, DOI 10.1046/j.1365-2915.2002.00375.x
   Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Peterson C., 2001, Pesticide Outlook, V12, P154, DOI 10.1039/b106296b
   Plarre R, 1997, ANZ SCHADLINGSKD PFL, V70, P45, DOI 10.1007/BF01996920
   Rahmat B, 2014, BIORESOURCES, V9, P6350
   Rawani A, 2012, J MOSQ RES, V2, P8, DOI [10.5376/jmr.2012.02.0002, DOI 10.5376/JMR.2012.02.0002]
   Rodriguez SD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew117
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   ROGERS LL, 1984, WILDLIFE SOC B, V12, P59
   Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029
   Sarwar M, 2017, AM J FOOD SCI HLTH, V3, P64
   Satho T, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0874-6
   Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870
   Scandurra L, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-504
   SCHEARER WR, 1984, J NAT PROD, V47, P964, DOI 10.1021/np50036a009
   Schueller R, 2016, MULTIFUNCTIONAL COSM, P1
   Sharma P. K., 2005, Indian Journal of Traditional Knowledge, V4, P403
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   Sritabutra D., 2013, Asian Pacific Journal of Tropical Disease, V3, P271
   Subramaniam J, 2012, SAUDI J BIOL SCI, V19, P503, DOI 10.1016/j.sjbs.2012.07.003
   Suh E, 2014, CURR OPIN INSECT SCI, V6, P86, DOI 10.1016/j.cois.2014.10.006
   Tabanca N, 2013, J AGR FOOD CHEM, V61, P8573, DOI 10.1021/jf402182h
   Tabanca N, 2010, NAT PROD COMMUN, V5, P1409
   Tavassoli M, 2011, IRAN J ARTHROPOD-BOR, V5, P10
   Taylor RW, 2012, ACS CHEM BIOL, V7, P1647, DOI 10.1021/cb300331z
   Thorsell W, 1998, PHYTOMEDICINE, V5, P311, DOI 10.1016/S0944-7113(98)80072-X
   Tibbets TM, 1999, OECOLOGIA, V118, P297, DOI 10.1007/s004420050730
   Tisgratog R, 2016, ACTA TROP, V157, P136, DOI 10.1016/j.actatropica.2016.01.024
   Tripathi AK, 2000, J ECON ENTOMOL, V93, P43, DOI 10.1603/0022-0493-93.1.43
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Turner RM, 2014, J BIOL CHEM, V289, P31837, DOI 10.1074/jbc.M114.603993
   Verhulst NO, 2016, SCI REP-UK, V6, DOI 10.1038/srep27141
   Wimalaratne PDC, 1996, J CHEM ECOL, V22, P49, DOI 10.1007/BF02040199
   Xu PX, 2014, P NATL ACAD SCI USA, V111, P16592, DOI 10.1073/pnas.1417244111
   Xue R., 2015, INSECT REPELLENTS HD
   Yaghoobi-Ershadi MR, 2006, IRAN J PUBLIC HEALTH, V35, P7
   Yang P, 2005, J VECTOR ECOL, V30, P231
   Yoon Changmann, 2007, Journal of Asia-Pacific Entomology, V10, P263, DOI 10.1016/S1226-8615(08)60361-1
   Yoon KS, 2015, J MED ENTOMOL, V52, P970, DOI 10.1093/jme/tjv069
   Zhang W, 2004, J ECON ENTOMOL, V97, P1310, DOI 10.1603/0022-0493-97.4.1310
   Zhu BCR, 2001, J CHEM ECOL, V27, P1617, DOI 10.1023/A:1010410325174
NR 128
TC 2
Z9 2
U1 1
U2 9
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD JUL 3
PY 2018
VL 6
AR e5151
DI 10.7717/peerj.5151
PG 25
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL6AI
UT WOS:000437258000008
PM 30002979
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hernandez-Triana, LM
   de Marco, MF
   Mansfield, KL
   Thorne, L
   Lumley, S
   Marston, D
   Fooks, AA
   Johnson, N
AF Hernandez-Triana, Luis M.
   de Marco, Maria Fernandez
   Mansfield, Karen L.
   Thorne, Leigh
   Lumley, Sarah
   Marston, Denise
   Fooks, Anthony A.
   Johnson, Nick
TI Assessment of vector competence of UK mosquitoes for Usutu virus of
   African origin
SO PARASITES & VECTORS
LA English
DT Article
DE Culex pipiens; Usutu virus; Vector competence; UK; Mosquito
ID WEST-NILE-VIRUS; CO-CIRCULATION; SURVEILLANCE; TRANSMISSION; CULICIDAE;
   DIPTERA; BIRDS; ZIKA; QUINQUEFASCIATUS; INFECTION
AB Background: Usutu virus (USUV) is an emerging zoonotic virus originally from sub-Saharan Africa. It has been introduced into Europe on multiple occasions, causing substantial mortality within the Eurasian blackbird (Turdus merula) population. It is transmitted by the mosquito species Culex pipiens in Europe and Africa. Vector competence studies indicate that European strains of USUV are readily transmitted by indigenous Cx. pipiens. However, there is limited information on the ability of an African strain to infect European mosquitoes.
   Methods: We evaluated the ability of African strain SAAR-1776 to infect two lines of Cx. pipiens colonised within the United Kingdom (UK). Mosquitoes were fed blood meals containing this virus and maintained at 25 degrees C for up to 21 days. Individual mosquitoes were tested for the presence of virus in the body, legs and an expectorate saliva sample. Changes to the consensus of the virus genome were monitored in samples derived from infected mosquitoes using amplicon based next generation sequencing.
   Results: Infection, dissemination and the presence of virus in saliva in one mosquito line was observed, but no evidence for dissemination in the second mosquito line. This suggests a strong barrier to infection in UK Cx. pipiens for this strain of USUV. When comparing the genome of input virus within the blood meal with USUV recovered from an infected mosquito, we observed limited changes in the consensus genome sequence.
   Conclusions: The evaluation of vector competence of UK populations of Cx. pipiens for Usutu virus suggests a limited susceptibility to infection with USUV strain SAAR-1776 of African origin. However, within a single mosquito there was complete dissemination and expectoration of USUV, indicating that infection, and potentially transmission, is possible. Sequence changes were observed that may represent early adaption to the mosquito host arid could reflect the early events of USUV establishment in European mosquito populations.
C1 [Hernandez-Triana, Luis M.; de Marco, Maria Fernandez; Mansfield, Karen L.; Thorne, Leigh; Lumley, Sarah; Marston, Denise; Fooks, Anthony A.; Johnson, Nick] Anim & Plant Hlth Agcy, Wildlife Zoonoses & Vector Borne Dis Res Grp, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
   [Lumley, Sarah; Johnson, Nick] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 XH, Surrey, England.
   [Lumley, Sarah] Publ Hlth England, Salisbury SP4 0JG, Wilts, England.
   [Fooks, Anthony A.] Univ Liverpool, Inst Infect & Global Hlth, Dept Clin Infect Microbiol & Immunol, Liverpool, Merseyside, England.
RP Hernandez-Triana, LM (corresponding author), Anim & Plant Hlth Agcy, Wildlife Zoonoses & Vector Borne Dis Res Grp, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
EM luis.hernandez-triana@apha.gsi.gov.uk
RI Marston, Denise A/D-7993-2011
OI Marston, Denise A/0000-0001-9215-088X
FU Department for Environment Food and Rural Affairs (DEFRA)Department for
   Environment, Food & Rural Affairs (DEFRA); Welsh Government [SV3045,
   SE4112, SE4113]; EU Framework Horizon 2020 Innovation Grant (EVAg)
   [653316]; Scottish Government [SV3045, SE4112, SE4113]
FX Funding was provided by the Department for Environment Food and Rural
   Affairs (DEFRA), Scottish Government and Welsh Government through grants
   SV3045, SE4112, and SE4113, and the EU Framework Horizon 2020 Innovation
   Grant (EVAg, No. 653316).
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Bakonyi T, 2004, VIROLOGY, V328, P301, DOI 10.1016/j.virol.2004.08.005
   Bakonyi T, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.41.17-00644
   Blagrove MSC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1739-3
   Buckley A, 2003, J GEN VIROL, V84, P2807, DOI 10.1099/vir.0.19341-0
   Buckley A, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-71
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Cadar D, 2014, EMERG INFECT DIS, V20, P1771, DOI 10.3201/eid2010.140909
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Dallimore T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2251-0
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Engler O, 2013, INT J ENV RES PUB HE, V10, P4869, DOI 10.3390/ijerph10104869
   Fonseca DM, 1998, MOL ECOL, V7, P1617
   Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991
   Fros JJ, 2015, ONE HEALTH, V1, P31, DOI 10.1016/j.onehlt.2015.08.002
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hubalek Z, 2008, PARASITOL RES, V103, pS29, DOI 10.1007/s00436-008-1064-7
   Jost H, 2011, AM J TROP MED HYG, V84, P241, DOI 10.4269/ajtmh.2011.10-0483
   Mackenzie-Impoinvil L, 2015, MED VET ENTOMOL, V29, P1, DOI 10.1111/mve.12083
   MANI P, 1998, SELEZIONE VET, V8, P749
   Manley R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134453
   Marston DA, 2015, MICROBIOL RESOUR ANN, V3, DOI 10.1128/genomeA.00157-15
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Ndiaye E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1383-y
   Nikolay B, 2015, T ROY SOC TROP MED H, V109, P609, DOI 10.1093/trstmh/trv066
   Nikolay B, 2012, AM J TROP MED HYG, V86, P993, DOI 10.4269/ajtmh.2012.11-0509
   O'Guinn ML, 2002, J MED ENTOMOL, V39, P806, DOI 10.1603/0022-2585-39.5.806
   Perez-Ramirez E, 2014, VIRUSES-BASEL, V6, P752, DOI 10.3390/v6020752
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ramsdale C.D., 2005, European Mosquito Bulletin, V20, P15
   Rijks J, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.45.30391
   Rudolf I, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1139-0
   Saiz J.C., 2017, VIRUS ADAPT TREAT, V9, P27, DOI [10.2147/VAAT.S123619, DOI 10.2147/VAAT.S123619]
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0705-9
   Vogels CBF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05185-4
   Vogels CBF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1677-0
   Weissenbock H, 2003, MICROBES INFECT, V5, P1132, DOI 10.1016/S1286-4579(03)00204-1
   WILLIAMS MC, 1964, ANN TROP MED PARASIT, V58, P367, DOI 10.1080/00034983.1964.11686258
NR 45
TC 7
Z9 7
U1 0
U2 7
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUL 3
PY 2018
VL 11
AR 381
DI 10.1186/s13071-018-2959-5
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GL8YZ
UT WOS:000437516500004
PM 29970149
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shoukat, A
   Vilches, T
   Moghadas, SM
AF Shoukat, Affan
   Vilches, Thomas
   Moghadas, Seyed M.
TI Cost-effectiveness of a potential Zika vaccine candidate: a case study
   for Colombia
SO BMC MEDICINE
LA English
DT Article
DE Zika; Microcephaly; Vaccination; Agent-based modeling;
   Cost-effectiveness
ID VIRUS OUTBREAK; BIRTH-DEFECTS; DENGUE; INFANTS; TRANSMISSION; DISEASE;
   UPDATE; TEXAS
AB Background: A number of Zika vaccine platforms are currently being investigated, some of which have entered clinical trials. We sought to evaluate the cost-effectiveness of a potential Zika vaccine candidate under the WHO Vaccine Target Product Profile for outbreak response, prioritizing women of reproductive age to prevent microcephaly and other neurological disorders.
   Methods: Using an agent-based simulation model of ZIKV transmission dynamics in a Colombian population setting, we conducted cost-effectiveness analysis with and without pre-existing herd immunity. The model was parameterized with estimates associated with ZIKV infection, risks of microcephaly in different trimesters, direct medical costs, and vaccination costs. We assumed that a single dose of vaccine provides a protection efficacy in the range 60% to 90% against infection. Cost-effectiveness analysis was conducted from a government perspective.
   Results: Under a favorable scenario when the reproduction number is relatively low (R-0 = 2.2) and the relative transmissibility of asymptomatic infection is 10% compared with symptomatic infection, a vaccine is cost-saving (with negative incremental cost-effective ratio; ICER) for vaccination costs up to US$6 per individual without herd immunity, and up to US$4 per individual with 8% herd immunity. For positive ICER values, vaccination is highly cost-effective for vaccination costs up to US$10 (US$7) in the respective scenarios with the willingness-to-pay of US$6610 per disability-adjusted life-year, corresponding to the average per capita GDP of Colombia between 2013 and 2017. Our results indicate that the effect of other control measures targeted to reduce ZIKV transmission decreases the range of vaccination costs for cost-effectiveness due to reduced returns of vaccine-induced herd immunity. In all scenarios investigated, the median reduction of microcephaly exceeded 64% with vaccination.
   Conclusions: Our study suggests that a Zika vaccine with protection efficacy as low as 60% could significantly reduce the incidence of microcephaly. From a government perspective, Zika vaccination is highly cost-effective, and even cost-saving in Colombia if vaccination costs per individual is sufficiently low. Efficacy data from clinical trials and number of vaccine doses will be important requirements in future studies to refine our estimates, and conduct similar studies in other at-risk populations.
C1 [Shoukat, Affan; Moghadas, Seyed M.] York Univ, Agent Based Modelling Lab, Toronto, ON M3J 1P3, Canada.
   [Vilches, Thomas] Sao Paulo State Univ, UNESP, Inst Biosci, Dept Biostat, BR-18618689 Botucatu, SP, Brazil.
RP Moghadas, SM (corresponding author), York Univ, Agent Based Modelling Lab, Toronto, ON M3J 1P3, Canada.
EM moghadas@yorku.ca
OI Nogueira Vilches, Thomas/0000-0002-4980-7564
FU Natural Sciences and Engineering Research Council of Canada
   (NSERC)Natural Sciences and Engineering Research Council of Canada;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   BrazilCAPES [88881.132327/2016-01]; Canadian Foundation for Innovation
   (CFI)Canada Foundation for Innovation
FX This study was in part supported by the Natural Sciences and Engineering
   Research Council of Canada (NSERC), and Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Brazil, grant number
   88881.132327/2016-01. The authors acknowledge the financial support of
   the Canadian Foundation for Innovation (CFI) for the establishment of
   "Areto Computational Cluster" at York University, which was used to
   perform simulations in this study.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Rodriguez RC, 2015, AM J TROP MED HYG, V92, P709, DOI 10.4269/ajtmh.14-0386
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chowell G., 2016, PLOS CURR, V8
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Murray CJL, 1996, GLOBAL BURDEN DIS CO
   Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Salomon JA, 2015, LANCET GLOB HEALTH, V3, pE712, DOI 10.1016/S2214-109X(15)00069-8
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   United Nations Development Programme, 2016, SOC IMP ASS ZIK VIR
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   WHO, 2016, MICR PAN
   WHO/ UNICEF Zika Virus Vaccine Target Product Profile for Emergency/, 2017, WHO UNICEF ZIKA VIRU
   World Health Organization, 2016, 5 M EM COMM INT HLTH
   World Health Organization (WHO), ZIK SIT REP
   Zeng W, 2018, VACCINE, V36, P413, DOI 10.1016/j.vaccine.2017.11.064
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 39
TC 5
Z9 5
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUL 3
PY 2018
VL 16
AR 100
DI 10.1186/s12916-018-1091-x
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA GL7FC
UT WOS:000437361500001
PM 29966516
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Muffat, J
   Li, Y
   Omer, A
   Durbin, A
   Bosch, I
   Bakiasi, G
   Richards, E
   Meyer, A
   Gehrke, L
   Jaenisch, R
AF Muffat, Julien
   Li, Yun
   Omer, Attya
   Durbin, Ann
   Bosch, Irene
   Bakiasi, Grisilda
   Richards, Edward
   Meyer, Aaron
   Gehrke, Lee
   Jaenisch, Rudolf
TI Human induced pluripotent stem cell-derived glial cells and neural
   progenitors display divergent responses to Zika and dengue infections
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika; microglia; organoids; interferon; iPS
ID VIRUS-INFECTION; BRAIN; ORGANOIDS; MODELS; PATHOGENESIS; MACROPHAGES;
   ANTIBODY; PROTEIN; MICE
AB Maternal Zika virus (ZIKV) infection during pregnancy is recognized as the cause of an epidemic of microcephaly and other neurological anomalies in human fetuses. It remains unclear how ZIKV accesses the highly vulnerable population of neural progenitors of the fetal central nervous system (CNS), and which cell types of the CNS may be viral reservoirs. In contrast, the related dengue virus (DENV) does not elicit teratogenicity. To model viral interaction with cells of the fetal CNS in vitro, we investigated the tropism of ZIKV and DENV for different induced pluripotent stem cell-derived human cells, with a particular focus on microglia-like cells. We show that ZIKV infected isogenic neural progenitors, astrocytes, and microglia-like cells (pMGLs), but was only cytotoxic to neural progenitors. Infected glial cells propagated ZIKV and maintained ZIKV load over time, leading to viral spread to susceptible cells. DENV triggered stronger immune responses and could be cleared by neural and glial cells more efficiently. pMGLs, when cocultured with neural spheroids, invaded the tissue and, when infected with ZIKV, initiated neural infection. Since microglia derive from primitive macrophages originating in proximity to the maternal vasculature, they may act as a viral reservoir for ZIKV and establish infection of the fetal brain. Infection of immature neural stem cells by invading microglia may occur in the early stages of pregnancy, before angiogenesis in the brain rudiments. Our data are also consistent with ZIKV and DENV affecting the integrity of the blood-brain barrier, thus allowing infection of the brain later in life.
C1 [Muffat, Julien; Li, Yun; Omer, Attya; Jaenisch, Rudolf] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.
   [Durbin, Ann; Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Durbin, Ann; Bosch, Irene; Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Durbin, Ann; Bosch, Irene; Gehrke, Lee] Harvard MIT Program Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Bakiasi, Grisilda] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.
   [Richards, Edward; Meyer, Aaron] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Jaenisch, Rudolf] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Muffat, Julien] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 1X8, Canada.
   [Muffat, Julien; Li, Yun] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 0A4, Canada.
   [Li, Yun] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada.
   [Meyer, Aaron] Univ Calif Los Angeles, Dept Bioengn, Los Angeles, CA 90095 USA.
RP Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Jaenisch, R (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM jaenisch@wi.mit.edu
RI Li, Yun/C-3367-2011
OI Li, Yun/0000-0002-5849-5910; Bosch, Irene/0000-0003-1352-5888
FU European Leukodystrophy Association; National Alliance for Research on
   Schizophrenia and Depression (NARSAD) Young Investigator Grant from the
   Brain AMP; Behavior Research (BBR) Foundation; Simons Postdoctoral
   Fellowship; International Rett Syndrome Foundation Postdoctoral
   Fellowship; NARSAD Young Investigator Grant from the BBR Foundation;
   Howard Hughes Medical InstituteHoward Hughes Medical Institute; Simons
   Foundation [SFARI 204106]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HD 045022,
   R37-CA084198, AI100190]; ELA Foundation; Emerald Foundation, Biogen
FX We thank Li-Huei Tsai for providing iPS-wt5 (affectionately referred to
   as LHT22); Dongdong Fu, Raaji Alagappan, Tenzin Lungjangwa, and Sarah
   Elmsaouri for technical support; and all members of the R.J. laboratory
   for helpful discussions. Confocal microscopy was performed at the Keck
   facility, with the precious help of Wendy Salmon. J.M. received funding
   from the European Leukodystrophy Association, and a National Alliance
   for Research on Schizophrenia and Depression (NARSAD) Young Investigator
   Grant from the Brain & Behavior Research (BBR) Foundation. Y.L. received
   funding from a Simons Postdoctoral Fellowship, an International Rett
   Syndrome Foundation Postdoctoral Fellowship, and a NARSAD Young
   Investigator Grant from the BBR Foundation. G.B. was supported by the
   Howard Hughes Medical Institute. Work for this project was supported by
   a grant from the Simons Foundation (SFARI 204106 to R.J.), NIH Grants HD
   045022 and R37-CA084198, the ELA Foundation, the Emerald Foundation,
   Biogen (to R.J.), and NIH AI100190 (to L.G.).
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DAS GD, 1976, VIRCHOWS ARCH B, V20, P299
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Durbin AP, 2016, TRENDS IMMUNOL, V37, P635, DOI 10.1016/j.it.2016.08.006
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024
   Halstead SB, 2015, MICROBIOL MOL BIOL R, V79, P281, DOI 10.1128/MMBR.00009-15
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li Y, 2016, CELL STEM CELL, V20
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martins SD, 2012, VIRUSES-BASEL, V4, P2736, DOI 10.3390/v4112736
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muffat J, 2016, CURR OPIN CELL BIOL, V43, P96, DOI 10.1016/j.ceb.2016.10.001
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7
   Olagnier D, 2016, J MOL BIOL, V428, P3429, DOI 10.1016/j.jmb.2016.04.024
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roberts DJ, 2016, LANCET, V388, P847, DOI 10.1016/S0140-6736(16)30930-8
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Sarathy VV, 2015, VACCINE, V33, P7051, DOI 10.1016/j.vaccine.2015.09.112
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Soldner F, 2012, SCIENCE, V338, P1155, DOI 10.1126/science.1227682
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 49
TC 24
Z9 24
U1 1
U2 19
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 3
PY 2018
VL 115
IS 27
BP 7117
EP 7122
DI 10.1073/pnas.1719266115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL4GH
UT WOS:000437107000083
PM 29915057
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ramirez, JL
   Muturi, EJ
   Dunlap, C
   Rooney, AP
AF Ramirez, Jose L.
   Muturi, Ephantus J.
   Dunlap, Christopher
   Rooney, Alejandro P.
TI Strain-specific pathogenicity and subversion of phenoloxidase activity
   in the mosquito Aedes aegypti by members of the fungal entomopathogenic
   genus Isaria
SO SCIENTIFIC REPORTS
LA English
DT Article
ID JAK-STAT PATHWAY; IMMUNE PATHWAY; GENES; DROSOPHILA; TOLL; DENGUE; PCR;
   ACTIVATION; INSIGHTS; DIPTERA
AB Development of alternative vector control strategies are becoming more pressing given the rapid evolution of insecticide resistance and the rise of vector borne pathogens affecting public health such as dengue, chikungunya and Zika. Fungal-based biopesticides are promising alternatives to synthetic insecticides because they are ecofriendly and are highly effective at infecting insects through contact. This study evaluated the susceptibility of the yellow fever mosquito Ae. aegypti to a range of entomopathogenic fungal strains from the genus Isaria. We observed a diverse variation in the virulence of the Isaria strains tested, with two strains showing high pathogenicity towards adult mosquitoes. Mosquito susceptibility to fungal infection was further corroborated through the molecular quantification of fungal loads and the transcript evaluation of a fungal-specific pathogen recognition molecule in the mosquito body. Moreover, quantitative analysis of transcript abundance coupled with enzymatic assays revealed strain-specific subversion of the melanization cascade, an important immune response component. Our study contributes critical insights for a better understanding of fungal-mosquito interactions.
C1 [Ramirez, Jose L.; Muturi, Ephantus J.; Dunlap, Christopher; Rooney, Alejandro P.] ARS, Crop Bioprotect Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 20250 USA.
RP Ramirez, JL (corresponding author), ARS, Crop Bioprotect Res Unit, Natl Ctr Agr Utilizat Res, USDA, Peoria, IL 20250 USA.
EM jose.ramirez@ars.usda.gov
RI Rooney, Alejandro P/S-1201-2018
OI Rooney, Alejandro P/0000-0001-5450-4122; Ramirez, Jose
   Luis/0000-0001-9607-1097
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Al-Abri SS, 2017, INT J INFECT DIS, V58, P82, DOI 10.1016/j.ijid.2017.02.018
   Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   Alout H, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006499
   Antonio-Nkondjio C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2417-9
   Araujo JPM, 2016, ADV GENET, V94, P1, DOI 10.1016/bs.adgen.2016.01.001
   Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411
   Bali G. K., 2013, J ENTOMOLOGY ZOOLOGY, V1
   BARSON G, 1994, J INVERTEBR PATHOL, V64, P107, DOI 10.1006/jipa.1994.1078
   Bell AS, 2009, J INVERTEBR PATHOL, V100, P160, DOI 10.1016/j.jip.2009.01.006
   Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102
   Blanford S, 2005, SCIENCE, V308, P1638, DOI 10.1126/science.1108423
   Blanford S, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-365
   Blanford S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023591
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Butt TM, 2016, ADV GENET, V94, P307, DOI 10.1016/bs.adgen.2016.01.006
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Cabanillas HE, 2013, MYCOSCIENCE, V54, P158, DOI 10.1016/j.myc.2012.09.009
   Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164
   D'Alessandro CP, 2014, J BASIC MICROB, V54, pS21, DOI 10.1002/jobm.201300499
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dunlap C. A., 2017, J INVERTEBR PATHOL
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910
   Feng P, 2015, P NATL ACAD SCI USA, V112, P11365, DOI 10.1073/pnas.1503200112
   Barletta ABF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-148
   Gallou A, 2016, FUNGAL BIOL-UK, V120, P414, DOI 10.1016/j.funbio.2015.11.009
   Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611
   GLASS NL, 1995, APPL ENVIRON MICROB, V61, P1323, DOI 10.1128/AEM.61.4.1323-1330.1995
   Hotez PJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005462
   Inglis G. D., 2012, MANUAL TECHNIQUES IN, P189, DOI DOI 10.1016/B978-0-12-386899-2.00007-5
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Leles RN, 2010, PARASITOL RES, V107, P1271, DOI 10.1007/s00436-010-1991-y
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lovett B, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0001-2016
   Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252
   Lu HL, 2016, ADV GENET, V94, P251, DOI 10.1016/bs.adgen.2015.11.002
   Luangsa-Ard JJ, 2005, MYCOL RES, V109, P581, DOI 10.1017/S0953756205002741
   Luz C, 2007, J MED ENTOMOL, V44, P799, DOI 10.1603/0022-2585(2007)44[799:OAOEHO]2.0.CO;2
   Matskevich AA, 2010, EUR J IMMUNOL, V40, P1244, DOI 10.1002/eji.200940164
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Pelizza SA, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.2201
   Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84
   Sadd B, 2006, J EVOLUTION BIOL, V19, P321, DOI 10.1111/j.1420-9101.2005.01062.x
   Santi L, 2011, WORLD J MICROB BIOT, V27, P2297, DOI 10.1007/s11274-011-0695-5
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Shin SW, 2011, EMBO REP, V12, P938, DOI 10.1038/embor.2011.130
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Valero-Jimenez CA, 2016, J INVERTEBR PATHOL, V133, P41, DOI 10.1016/j.jip.2015.11.011
   Wang Y, 2017, INSECT MOL BIOL, V26, P552, DOI 10.1111/imb.12318
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029
   Zakovic S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00258
NR 56
TC 4
Z9 4
U1 3
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 2
PY 2018
VL 8
AR 9896
DI 10.1038/s41598-018-28210-6
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL2LX
UT WOS:000436953900005
PM 29967469
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, JF
   Zhang, H
   Tan, QQ
   Zhou, HQ
   Guan, DW
   Zhang, X
   Duan, JH
   Cai, SW
   Peng, ZQ
   He, JF
   Ke, CW
   Lin, JY
   Liu, T
   Ma, WJ
   Wu, D
AF Sun, Jiufeng
   Zhang, Huan
   Tan, Qiqi
   Zhou, Huiqiong
   Guan, Dawei
   Zhang, Xin
   Duan, Jinhua
   Cai, Songwu
   Peng, Zhiqiang
   He, Jianfeng
   Ke, Changwen
   Lin, Jinyan
   Liu, Tao
   Ma, Wenjun
   Wu, De
TI The epidemiological characteristics and molecular phylogeny of the
   dengue virus in Guangdong, China, 2015
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ZIKA VIRUS; SPATIOTEMPORAL DYNAMICS; EVOLUTIONARY HISTORY;
   HEMORRHAGIC-FEVER; GENETIC DIVERSITY; SUBTYPE-III; SEROTYPE 4; OUTBREAK;
   TYPE-4; EMERGENCE
AB In 2015, an unexpected multiple outbreak of dengue occurred in Guangdong, China. In total, 1,699 cases were reported, of which 1,627 cases were verified to have DENV infections by nucleic acid or NS1 protein, including 44 DENV-1, 1126 DENV-2, 18 DENV-3 and 6 DENV-4, and the other cases were confirmed by NS1 ELISA. Phylogenetic analyses of DENV-1 isolates identified two genotypes (I and V). The predominant DENV-2 outbreak isolates were the Cosmopolitan genotypes, which likely originated from Malaysia. The DENV-3 isolates were assigned into genotype I and genotype III. All 6 DENV-4 isolates from imported cases were likely originally from Cambodia, Thailand and the Philippines. The entomological surveillance showed a moderate risk for the BI index in Chaozhou and Foshan and a low risk in Guangzhou. The imported cases were mostly detected in Guangzhou and Foshan. Surprisingly, the most serious outbreak occurred in Chaozhou, but not in Guangzhou or Foshan. A combined analyses demonstrated the multiple geographical origins of this outbreak, and highlight the detection of suspected cases after the alerting of imported cases, early implementation of control policies and reinforce the vector surveillance strategies were the key points in the chain of prevention and control of dengue epidemics.
C1 [Sun, Jiufeng; Liu, Tao; Ma, Wenjun] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Guangdong, Peoples R China.
   [Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Guan, Dawei; Zhang, Xin; Duan, Jinhua; Cai, Songwu; Peng, Zhiqiang; He, Jianfeng; Ke, Changwen; Lin, Jinyan; Wu, De] Guangdong Prov Ctr Dis Control & Prevent, Res Ctr Pathogens Detect Technol Emerging Infect, Key Lab Repository & Applicat Pathogen Microbiol, Guangzhou 511430, Guangdong, Peoples R China.
   [Zhang, Huan; Tan, Qiqi; Zhou, Huiqiong; Guan, Dawei; Zhang, Xin; Duan, Jinhua; Cai, Songwu; Peng, Zhiqiang; He, Jianfeng; Ke, Changwen; Lin, Jinyan; Wu, De] WHO Collaborating Ctr Surveillance Res & Training, Guangzhou 511430, Guangdong, Peoples R China.
RP Wu, D (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Res Ctr Pathogens Detect Technol Emerging Infect, Key Lab Repository & Applicat Pathogen Microbiol, Guangzhou 511430, Guangdong, Peoples R China.; Wu, D (corresponding author), WHO Collaborating Ctr Surveillance Res & Training, Guangzhou 511430, Guangdong, Peoples R China.
EM wude68@tom.com
RI Zhou, Huiqiong/S-1276-2016
OI Zhou, Huiqiong/0000-0003-2124-6563
FU Guangdong Provincial Science and Technology Program [2015A020213004,
   2016A020251001, 2013A020229004]; National Key Development Program
   [2016YFC1200201]; Guangdong provincial health innovation platform
   construction program
FX The present study was supported by grants from the Guangdong Provincial
   Science and Technology Program (2015A020213004, 2016A020251001,
   2013A020229004) and the National Key Development Program
   (2016YFC1200201) and Guangdong provincial health innovation platform
   construction program.
CR AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437
   Chen RB, 2016, AM J TROP MED HYG, V94, P198, DOI 10.4269/ajtmh.15-0546
   Chen SP, 2011, INFECT GENET EVOL, V11, P1183, DOI 10.1016/j.meegid.2011.03.025
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dash PK, 2011, EPIDEMIOL INFECT, V139, P857, DOI 10.1017/S0950268810001706
   de Melo FL, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000390
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   FAN WF, 1989, REV INFECT DIS, V11, pS847
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fernandez J, 2011, ARCH VIROL, V156, P1865, DOI 10.1007/s00705-011-1049-1
   Foster JE, 2003, VIROLOGY, V306, P126, DOI 10.1016/S0042-6822(02)00033-8
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   He Peng, 2011, Zhonghua Liu Xing Bing Xue Za Zhi, V32, P1051
   HENCHAL EA, 1990, CLIN MICROBIOL REV, V3, P376, DOI 10.1128/CMR.3.4.376-396.1990
   Jiang LY, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-4
   Jiang T, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-125
   Jing QL, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-87
   Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003
   Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051
   Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Li G, 2017, VIROL SIN, V32, P63, DOI 10.1007/s12250-016-3872-8
   Liang HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055353
   Liu T, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4616-x
   Luo L, 2013, INT J INFECT DIS, V17, pE498, DOI 10.1016/j.ijid.2012.12.017
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Massad E, 2011, LANCET, V377, P1630, DOI 10.1016/S0140-6736(11)60470-4
   Messer WB, 2003, EMERG INFECT DIS, V9, P800
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Pang Tikki, 2017, Lancet Infect Dis, V17, pe79, DOI 10.1016/S1473-3099(16)30471-6
   Peng HJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-83
   QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rather IA, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00336
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Sang SW, 2015, INFECT GENET EVOL, V32, P178, DOI 10.1016/j.meegid.2015.03.005
   Sun JM, 2011, EMERG INFECT DIS, V17, P321, DOI 10.3201/eid1702.100396
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Sun JF, 2016, J INFECTION, V72, P80, DOI 10.1016/j.jinf.2015.10.007
   Sun Y, 2013, INFECT GENET EVOL, V16, P19, DOI 10.1016/j.meegid.2013.01.013
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Temporao JG, 2011, EMERG INFECT DIS, V17, P938, DOI 10.3201/eid1705.101681
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   Wei KF, 2017, SCI REP-UK, V7, DOI 10.1038/srep45505
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Wu JY, 2010, AM J TROP MED HYG, V83, P664, DOI 10.4269/ajtmh.2010.09-0755
   Wu WL, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-322
   Xu GZ, 2007, AM J TROP MED HYG, V76, P1182, DOI 10.4269/ajtmh.2007.76.1182
   Zhang FC, 2014, INT J INFECT DIS, V27, P4, DOI 10.1016/j.ijid.2014.03.1392
   Zheng NX, 2002, MOD PREV MED, V29, P495
NR 59
TC 2
Z9 5
U1 1
U2 9
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUL 2
PY 2018
VL 8
AR 9976
DI 10.1038/s41598-018-28349-2
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GL2MG
UT WOS:000436955000031
PM 29967414
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gambhir, S
   Malik, SK
   Kumar, Y
AF Gambhir, Shalini
   Malik, Sanjay Kumar
   Kumar, Yugal
TI The Diagnosis of Dengue Disease: An Evaluation of Three Machine Learning
   Approaches
SO INTERNATIONAL JOURNAL OF HEALTHCARE INFORMATION SYSTEMS AND INFORMATICS
LA English
DT Article
DE ANN; Dengue Disease; Diagnosis; DT; Machine Learning; NB
ID EXPERT-SYSTEM; HEART-DISEASE; CLASSIFICATION; PREDICTION; REGRESSION;
   SELECTION; FAILURE
AB This article describes how Dengue fever is a fatal and hazardous disease resulting from the bite of several species of the female mosquito (principally, Aedesaegypti). Symptoms of the dengue fever mimic those of a number of other infectious and/or mosquito-borne tropical diseases such as Viral flu, Chikungunya, and Zika fever. Yet, with dengue fever, human life can be more at risk due to severe depletion of blood platelets. Thus, early detection of dengue disease can ensure saving lives; furthermore, it can help in making a preventive move before the disease progresses to epidemic proportion. Hence, the target of this article is to propose a model for an early detection and precise diagnosis of dengue disease. In this article, three prevalent machine learning methodologies, including, Artificial Neural Network (ANN), Decision Tree (DT) and Naive Bayes (NB) are evaluated for designing a diagnostic model. The performance of these models is assessed utilizing available dengue datasets. Results comparing and contrasting performance of diagnostic models utilizing accuracy, sensitivity, specificity and error rate parameters showed that ANN-based diagnostic model appears to yield better performance measures over both the DT and NB models.
C1 [Gambhir, Shalini; Kumar, Yugal] SRM Univ, Sonepat, Haryana, India.
   [Malik, Sanjay Kumar] Jaypee Univ Informat Technol, Solan, India.
RP Gambhir, S (corresponding author), SRM Univ, Sonepat, Haryana, India.
OI Kumar, Yugal/0000-0003-3451-4897
CR Albinati J, 2016, PROCEEDINGS OF 2016 5TH BRAZILIAN CONFERENCE ON INTELLIGENT SYSTEMS (BRACIS 2016), P43, DOI [10.1109/BRACIS.2016.63, 10.1109/BRACIS.2016.019]
   Althouse BM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001258
   Austin PC, 2013, J CLIN EPIDEMIOL, V66, P398, DOI 10.1016/j.jclinepi.2012.11.008
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   BREIMAN L, 1992, INT STAT REV, V60, P291, DOI 10.2307/1403680
   Breiman L., 1984, CLASSIFICATION REGRE
   Bujlow T., 2012, 2012 International Conference on Computing, Networking and Communications (ICNC), P237, DOI 10.1109/ICCNC.2012.6167418
   Cheong YL, 2014, SPAT SPATIO-TEMPORAL, V10, P75, DOI 10.1016/j.sste.2014.05.002
   Das R, 2009, EXPERT SYST APPL, V36, P7675, DOI 10.1016/j.eswa.2008.09.013
   Domingos P, 1997, MACH LEARN, V29, P103, DOI 10.1023/A:1007413511361
   Er O, 2012, EXPERT SYST APPL, V39, P1862, DOI 10.1016/j.eswa.2011.08.064
   Er O, 2010, J MED SYST, V34, P299, DOI 10.1007/s10916-008-9241-x
   Faisal T, 2010, EXPERT SYST APPL, V37, P2175, DOI 10.1016/j.eswa.2009.07.060
   Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199
   Gambhir S, 2017, NEW HORIZ TRANSL MED, V4, P1, DOI 10.1016/j.nhtm.2017.10.001
   Gambhir S, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0651-x
   Grzymala-Busse JW, 1992, HDB APPL ADV ROUGH S, V11, P3, DOI [DOI 10.1007/978-94-015-7975-9_1, DOI 10.1007/978-94-015-7579-5]
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gupta E, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-92
   Hati A K, 2006, J Commun Dis, V38, P124
   Hsieh CH, 2011, SURGERY, V149, P87, DOI 10.1016/j.surg.2010.03.023
   John G. H., 1995, Uncertainty in Artificial Intelligence. Proceedings of the Eleventh Conference (1995), P338
   Karabatak M, 2009, EXPERT SYST APPL, V36, P3465, DOI 10.1016/j.eswa.2008.02.064
   Kumar Y, 2013, TECHNOL HEALTH CARE, V21, P417, DOI 10.3233/THC-130742
   LANGLEY P, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P223
   Loh WY, 1997, STAT SINICA, V7, P815
   Mao Y, 2008, J ZHEJIANG UNIV-SC B, V9, P474, DOI 10.1631/jzus.B0820044
   Mulyani Y, 2016, PROCEEDINGS OF 2016 2ND INTERNATIONAL CONFERENCE ON SCIENCE IN INFORMATION TECHNOLOGY (ICSITECH) - INFORMATION SCIENCE FOR GREEN SOCIETY AND ENVIRONMENT, P367, DOI 10.1109/ICSITech.2016.7852664
   Ozcift A, 2011, COMPUT BIOL MED, V41, P265, DOI 10.1016/j.compbiomed.2011.03.001
   Quinlan J. R., 1986, Machine Learning, V1, P81, DOI 10.1007/BF00116251
   QUINLAN JR, 1995, C4 5 PROGRAMS MACHIN
   Rahmawati D, 2016, INT CONF SYST SCI EN
   Sahoo AJ, 2014, TECHNOL HEALTH CARE, V22, P531, DOI 10.3233/THC-140816
   SCHAFFER C, 1993, MACH LEARN, V13, P135, DOI 10.1007/BF00993106
   Sengur A, 2008, EXPERT SYST APPL, V35, P214, DOI 10.1016/j.eswa.2007.06.012
   Sengur A, 2008, COMPUT BIOL MED, V38, P329, DOI 10.1016/j.compbiomed.2007.11.004
   Shaukat K., 2015, J DATA MINING GENOMI
   Silverman B.W., 1986, DENSITY ESTIMATION S, DOI [10.1007/978-1-4899-3324-9, DOI 10.1007/978-1-4899-3324-9]
   Siriyasatien P, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1034-5
   Soman T., 2005, WSEAS Transactions on Computers, V4, P548
   Temurtas F, 2009, EXPERT SYST APPL, V36, P944, DOI 10.1016/j.eswa.2007.10.010
   Utgoff P. E., 1989, Machine Learning, V4, P161, DOI 10.1023/A:1022699900025
   UTGOFF PE, 1988, P 5 INT C MACH LEARN, P107
   Yadav G., 2012, COMP COMM SYST NCCCS, P1, DOI [DOI 10.1109/NCCCS.2012.6413034, 10.1109/NCCCS.2012.6413034]
   Yan HM, 2006, EXPERT SYST APPL, V30, P272, DOI 10.1016/j.eswa.2005.07.022
NR 46
TC 1
Z9 1
U1 1
U2 7
PU IGI GLOBAL
PI HERSHEY
PA 701 E CHOCOLATE AVE, STE 200, HERSHEY, PA 17033-1240 USA
SN 1555-3396
EI 1555-340X
J9 INT J HEALTHC INF SY
JI Int. J. Healthc. Inf. Syst. Inf.
PD JUL-SEP
PY 2018
VL 13
IS 3
BP 1
EP 19
DI 10.4018/IJHISI.2018070101
PG 19
WC Medical Informatics
SC Medical Informatics
GA HI0GY
UT WOS:000456121300001
DA 2020-07-08
ER

PT J
AU Foxi, C
   Puggioni, G
   Meloni, G
   Rossi, R
   Rocchigiani, AM
   Vento, L
   Collova, A
   Satta, G
AF Foxi, Cipriano
   Puggioni, Giantonella
   Meloni, Giorgio
   Rossi, Renata
   Rocchigiani, Angela Maria
   Vento, Luigi
   Collova, Antonio
   Satta, Giuseppe
TI Entomological surveillance of Zika virus in Sardinia, Italy, 2016
SO VETERINARIA ITALIANA
LA English
DT Article
DE Aedes albopictus; Culex pipiens; Entomological surveillance; Italy;
   Sardinia; Zika Virus
ID MOSQUITOS; CHIKUNGUNYA; EUROPE; DENGUE; FEVER
AB Zika Virus (ZIKV) is a RNA virus belonging to the genus Flavivirus, family Flaviviridae. This virus is transmitted through bite of Aedes mosquitoes, in particular Ae. aegypti. On February 1st 2016, the World Health Organization (WHO) has declared ZIKV a Public Health Emergency of International Concern. Successively, considering the establishment of Ae. albopictus, WHO has classified Italy as having a moderate likelihood of local transmission of ZIKV, preceded in Europe only by France. For this reason an entomological surveillance plan was been activated in Sardinia in 2016. BG Sentinel Mosquito Traps have been positioned in 29 sites, comprising urban areas and points of entry, as ports and airports. Mosquitoes were collected fortnightly from April to December. A total of 3,089 mosquitoes were collected belonging to 10 species. The most numerous species have been Cx. pipiens s.l. and Ae. albopictus. All mosquitoes sampled have been assayed by real time reverse transcriptase PCR for detection of ZIKV RNA. A total of 584 pool have been analyzed and have been reported no evidence of ZIKV. A permanent entomological surveillance should be implemented principally in the urban areas and points of entry, as ports and airports, because Ae. albopictus, susceptible to ZIKV, is established in Sardinia and also know the recent introduction of invasive mosquitoes species Ae. koericus and Ae. japonicus in Italy.
C1 [Foxi, Cipriano; Puggioni, Giantonella; Meloni, Giorgio; Rossi, Renata; Rocchigiani, Angela Maria; Vento, Luigi; Satta, Giuseppe] Ist Zooprofilatt Sperimentale Sardegna, Via Duca Abruzzi 8, I-07100 Sassari, Italy.
   [Collova, Antonio] Ufficio Sanita Marittima & Frontiera USMAF, Molo Teleferica, Porto Torres, Italy.
RP Meloni, G (corresponding author), Ist Zooprofilatt Sperimentale Sardegna, Via Duca Abruzzi 8, I-07100 Sassari, Italy.
EM giorgiomeloni82@gmail.com
RI Foxi, Cipriano/AAB-9578-2019
OI Foxi, Cipriano/0000-0002-1089-7574; Puggioni,
   Giantonella/0000-0001-9013-8203
CR Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Busquets N, 2008, EMERG INFECT DIS, V14, P861, DOI 10.3201/eid1405.071577
   Callot J, 1972, Ann Parasitol Hum Comp, V47, P665
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Capelli G, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-188
   Chessa P. A., 1997, IL CLIMA IN SARDEGNA
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cristo Benedetto, 2006, Bulletin of Insectology, V59, P161
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Di Luca M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146476
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   European Centre for Disease Prevention and Control (ECDC), 2016, EX MOS DISTR MAPS
   European Centre for Disease Prevention and Control (ECDC), 2017, SURV ATL INF DIS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Korba RA, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1725-9
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lundstrom JO, 1999, J VECTOR ECOL, V24, P1
   Maslov A. V, 1967, BLOODSUCKING MOSQUIT, V93, P48
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Ministero della salute. Direzione Generale della Prevenzione Sanitaria Ufficio V Malattie Infettive e Profilassi Internazionale., 2014, SORV CAS UM MAL TRAS
   Moussiegt O., 1988, 45 EID
   Moutailler S, 2008, VECTOR-BORNE ZOONOT, V8, P749, DOI 10.1089/vbz.2008.0009
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ndiaye E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1383-y
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Ravanini P, 2012, EUROSURVEILLANCE, V17, P2
   Romi R., 1995, Parassitologia (Rome), V37, P99
   Rossi R., 2016, INT M EM DIS SURV IM, P220
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Seidel B, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1566-6
   Severini Francesco, 2009, Fragmenta Entomologica, V41, P213
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   World Health Organization Regional Office for Europe (WHO/Europe), 2016, INT RISK ASS MAY 201
NR 37
TC 1
Z9 1
U1 0
U2 1
PU IST ZOOPROFILATTICO SPERIMENTALE ABRUZZO & MOLISE G CAPORALE-IZS A&M
PI TERAMO
PA CAMPO BOARIO, TERAMO, 64100, ITALY
SN 0505-401X
EI 1828-1427
J9 VET ITAL
JI Vet. Ital.
PD JUL-SEP
PY 2018
VL 54
IS 3
BP 243
EP 249
DI 10.12834/VetIt.1303.7208.2
PG 7
WC Veterinary Sciences
SC Veterinary Sciences
GA HG2UE
UT WOS:000454820000009
PM 30575002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Shaw, LP
   Sugden, NC
AF Shaw, Liam P.
   Sugden, Nicola C.
TI Portable sequencing, genomic data, and scale in global emerging
   infectious disease surveillance
SO GEO-GEOGRAPHY AND ENVIRONMENT
LA English
DT Article
DE emerging infectious disease surveillance; global health; human
   microbiome; more-than-human geography; portable sequencing
ID ZIKA VIRUS; REAL-TIME; PATHOGEN SURVEILLANCE; EBOLA-VIRUS; TRANSMISSION;
   MICROBIOMES; INTERNET; WORLD
AB Emerging infectious diseases (EIDs) occur when pathogens unpredictably spread into new contexts. EID surveillance systems seek to rapidly identify EID outbreaks to contain spread and improve public health outcomes. Sequencing data has historically not been integrated into real-time responses, but portable DNA sequencing technology has prompted optimism among epidemiologists. Specifically, attention has focused on the goal of a sequencing singularity: the integration of portable sequencers in a worldwide event-based surveillance network with other digital data (Gardy & Loman, Nature Reviews Genetics, 19, 2018, p. 9). The sequencing singularity vision is a powerful socio-technical imaginary, shaping the discourse around the future of portable sequencing. Ethical and practical issues are bound by the vision in two ways: they are framed only as obstacles, and they are formulated only at the scales made visible by its implicit geography. This geography privileges two extremes of scale - the genomic and the global - and leaves intermediate scales comparatively unmapped. We explore how widespread portable sequencing could challenge this geography. Portable sequencers put the ability to produce genomic data in the hands of the individual. The explicit assertion of rights over data may therefore become a matter disputed more at an interpersonal scale than an international one. Portable sequencers also promise ubiquitous, indiscriminate sequencing of the total metagenomic content of samples, raising the question of what (or who) is under surveillance and inviting consideration of the human microbiome and more-than-human geographies. We call into question a conception of a globally integrated stream of sequencing data as composed mostly of noise, within which signals of pathogen emergence are hidden, considering it instead from the perspective of recent work into more-than-human geographies. Our work highlights a practical need for researchers to consider both the alternative possibilities they foreclose as well as the exciting opportunities they move towards when they deploy their visions of the future.
C1 [Shaw, Liam P.] UCL, Genet Inst, London, England.
   [Shaw, Liam P.] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Sugden, Nicola C.] Univ Manchester, Ctr Hist Sci Technol & Med, Manchester, Lancs, England.
RP Shaw, LP (corresponding author), UCL, Genet Inst, London, England.; Shaw, LP (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.; Sugden, NC (corresponding author), Univ Manchester, Ctr Hist Sci Technol & Med, Manchester, Lancs, England.
EM liam.philip.shaw@gmail.com; nicola.sugden@manchester.ac.uk
RI Sugden, Nicola/AAE-5847-2019
OI Sugden, Nicola/0000-0002-3431-4652; Shaw, Liam/0000-0001-7332-0820
CR Abeysinghe S, 2013, SOC STUD SCI, V43, P905, DOI 10.1177/0306312713492559
   Alirol E, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0201-1
   Barboza P., 2017, 2 OIE GLOB C BIOL TH
   Barboza P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057252
   Bedford T., 2018, AUSPICE
   Bedford T., 2018, ABOUT NEXTSTRAIN
   Benezra A, 2012, P NATL ACAD SCI USA, V109, P6378, DOI 10.1073/pnas.1200515109
   Bowman AS, 2014, EMERG INFECT DIS, V20, P1472, DOI 10.3201/eid2009.131082
   Brookes VJ, 2015, EPIDEMIOL INFECT, V143, P2043, DOI 10.1017/S095026881400315X
   Butler D., 2013, NATURE NEWS
   Caduff C, 2014, CURR ANTHROPOL, V55, P296, DOI 10.1086/676124
   Cadwalladr C., 2018, GUARDIAN
   Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594
   Chiappinelli E., 2007, SEATTLE U LAW REV, V30, P959
   Clark L., 2015, OXFORD NANOPORE WE W
   COSGROVE D, 1994, ANN ASSOC AM GEOGR, V84, P270, DOI 10.1111/j.1467-8306.1994.tb01738.x
   Cosgrove D., 2008, GEOGRAPHY VISION SEE
   Daniels J, 2013, NEW MEDIA SOC, V15, P695, DOI 10.1177/1461444812462849
   David LA, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-7-r89
   Edelstein M, 2018, EMERG INFECT DIS, V24, P1324, DOI 10.3201/eid2407.151830
   Eden Amnon H., 2012, SINGULARITY HYPOTHES, P1
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Feehery GR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076096
   Franklin S., 2000, GLOBAL NATURE GLOBAL, P188
   Franzosa EA, 2015, P NATL ACAD SCI USA, V112, pE2930, DOI 10.1073/pnas.1423854112
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130
   Gardy J. L., 2017, NATURE MICROBIOLOGY
   Gardy J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0726-x
   Gardy JL, 2018, NAT REV GENET, V19, P9, DOI 10.1038/nrg.2017.88
   Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176
   Grady D., 2014, EBOLA CASES COULD RE
   Grevsmuhl S. V., 2017, GEO GEOGRAPHY ENV, V4, DOI 10. 1002/geo2. 35
   Hammond E., 2008, SOME INTELLECTUAL PR
   Hanson R, 2008, IEEE SPECTRUM, V45, P44, DOI 10.1109/MSPEC.2008.4531461
   Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15
   Helmreich S., 2014, THRESHOLDS, V42, P52, DOI DOI 10.1162/thld_a_00076
   Henry M., 2009, INT ENCY HUMAN GEOGR, V2009, P95, DOI 10. 1016/B978-008044910-4. 01008-7
   Hern Alex, 2018, GUARDIAN
   Hinchliffe S, 2014, GEOFORUM, V53, P136, DOI 10.1016/j.geoforum.2014.03.002
   Hinterberger A, 2015, PUBLIC CULTURE, V27, P361, DOI 10.1215/08992363-2841904
   Holbrooke Richard, 2008, WASHINGTON POST
   IDDO, 2018, IDDO INF DIS DAT OBS
   IFPMA, 2018, IFPMA STAT WHA71 IT
   IFPMA, 2016, LEAD PHARM CO PRES I
   Jasanoff S., 2015, DREAMSCAPES MODERNIT, P1, DOI DOI 10.7208/CHICAGO/9780226276663.001.0001
   Kramer J, 2013, TELECOMMUN POLICY, V37, P794, DOI 10.1016/j.telpol.2012.08.005
   Kupferschmidt K., 2017, SCI NEWS, DOI 10. 1126/science. aan6907
   Kurzweil R., 2005, SINGULARITY IS NEAR
   Lakoff A, 2015, DREAMSCAPES MODERNIT, P300, DOI DOI 10.7208/CHICAG0/9780226276663.003.0014
   Lassalle F, 2018, MOL ECOL, V27, P182, DOI 10.1111/mec.14435
   Leggett RM, 2017, J EXP BOT, V68, P5419, DOI 10.1093/jxb/erx289
   Leonelli S, 2016, DATA CENTRIC BIOL PH
   Loman N., 2018, SEQUENCE 1 ASK QUEST
   Loose MW, 2017, HUM MOL GENET, V26, pR202, DOI 10.1093/hmg/ddx287
   Lorimer J., 2017, GLOBAL HLTH GEOGRAPH
   Lorimer J, 2016, ENVIRON HUMANITIES, V8, P57, DOI 10.1215/22011919-3527722
   MacKenzie D., 2012, NEW SCI
   MacKenzie D., 2013, NEW SCI
   MacPhail T., 2014, VIRAL NETWORK PATHOG
   Mayer A., 2013, CAN YOU PATENT DIS C
   Meltzer M. I., 2014, MORBIDITY MORTALITY, V63
   Mirowski P, 2018, SOC STUD SCI, V48, P171, DOI 10.1177/0306312718772086
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   Morozov E., 2012, NET DELUSION NOT LIB
   Nelkin Dorothy und M. Susan Lindee, 2004, DNA MYSTIQUE GENE CU
   Noble Safiya Umoja, 2016, SCHOLAR FEMINIST ONL, V13, P1
   O'Shea J, 2017, INT J MED INFORM, V101, P15, DOI 10.1016/j.ijmedinf.2017.01.019
   ONeill J., 2016, TACKLING DRUG RESIST
   Open Science Prize, 2017, 28 FEBR 2017 NEXTSTR
   Oxford Nanopore, 2018, OXF NAN TECHN
   Paxson H, 2008, CULT ANTHROPOL, V23, P15, DOI 10.1111/j.1548-1360.2008.00002.x
   Physorg, 2014, IM SEQ LAPT COMP CAN
   Pinsent Mason, 2010, NOB READS TERMS COND
   Raven KE, 2017, CLIN INFECT DIS, V64, P886, DOI 10.1093/cid/ciw872
   Raymond E. S., 2003, SEPTEMBER NEVER ENDE
   Rohde H, 2011, NEW ENGL J MED, V365, P718, DOI 10.1056/NEJMoa1107643
   Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973
   Ruffino J., 2017, ARCHAEOLOGY CYBORGS
   Russ London, 2010, FIL WELLC GEN BOOKC
   Schatz MC, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-4
   Sender R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002533
   Shaw L, 2017, MBIO, V8, DOI 10.1128/mBio.01237-17
   Song SJ, 2013, ELIFE, V2, DOI 10.7554/eLife.00458
   Stephenson N, 2011, SCI TECHNOL HUM VAL, V36, P616, DOI 10.1177/0162243910388023
   Stone MJ, 2012, J CLIN MICROBIOL, V50, P164, DOI 10.1128/JCM.05692-11
   Struelens MJ, 2013, EUROSURVEILLANCE, V18, P3
   Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490
   Wellcome Images, 2014, FIL PENC SKETCH DNA
   Wellcome Trust, 2018, ANT RES SURV SHAR IN
   Whatmore S, 2006, CULT GEOGR, V13, P600, DOI 10.1191/1474474006cgj377oa
   WHO, 2017, SHAR BIOL SAMPL DAT
   World Bank, 2017, GDP CURR US WORLD BA
   World Health Organisation, 2016, EB DAT STAT
   World Health Organization Western Pacific Region, 2008, GUID EST EV BAS SURV
   World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
   Yong E., 2016, ATLANTIC
   Zibra Project, 2016, DATA
NR 101
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2054-4049
J9 GEO-GEOGR ENVIRON
JI Geo-Geogr. Environ.
PD JUL-DEC
PY 2018
VL 5
IS 2
AR UNSP e00066
DI 10.1002/geo2.66
PG 17
WC Geography
SC Geography
GA HG1CC
UT WOS:000454686500010
PM 32337052
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Makroo, RN
   Sardana, R
   Mediratta, L
   Butta, H
   Thakur, UK
   Agrawal, S
   Chowdhry, M
   Kumar, S
   Chokroborty, S
AF Makroo, Raj Nath
   Sardana, Raman
   Mediratta, Leena
   Butta, Hena
   Thakur, Uday Kumar
   Agrawal, Soma
   Chowdhry, Mohit
   Kumar, Satendra
   Chokroborty, Sourit
TI Evaluation of bacterial inactivation in random donor platelets and
   single-donor apheresis platelets by the INTERCEPT blood system
SO ASIAN JOURNAL OF TRANSFUSION SCIENCE
LA English
DT Article
DE Amotosalen; bacterial contamination; pathogen inactivation; random donor
   platelets; sepsis; single-donor platelets; transfusion; ultraviolet A
ID WAVELENGTH ULTRAVIOLET-LIGHT; ZIKA VIRUS; PHOTOCHEMICAL INACTIVATION;
   AMOTOSALEN; CONTAMINATION; COMPONENTS; PLASMA; SAFETY; DENGUE
AB BACKGROUND: Blood transfusion of contaminated components is a potential source of sepsis by a wide range of known and unknown pathogens. Collection mechanism and storage conditions of platelets make them vulnerable for bacterial contamination. Several interventions aim to reduce the transfusion of contaminated platelet units; however, data suggest that contaminated platelet transfusion remains very common.
   AIM: A pathogen inactivation system, "INTERCEPT', to inactivate bacteria in deliberately contaminated platelet units was implemented and evaluated.
   MATERIALS AND METHODS: Five single-donor platelets (SDP) and five random donor platelets (RDP) were prepared after prior consent of donors. Both SDP and RDP units were deliberately contaminated by stable stock ATCC Staphylococcus aureus and Escherichia coli, respectively, with a known concentration of stock culture. Control samples were taken from the infected units and bacterial concentrations were quantified. The units were treated for pathogen inactivation with the INTERCEPT (Cerus Corporation, Concord, CA) Blood system for platelets (Amotosalen/UVA), as per the manufacturer's instructions for use. Post illumination, test samples were analyzed for any bacterial growth.
   RESULTS: Post-illumination test samples did not result in any bacterial growth. A complete reduction of >6 log(10), S. aureus in SDP units and >6 log(10)) Escherichia coli in RDP units was achieved.
   CONCLUSION: The INTERCEPT system has been shown to be very effective in our study for bacterial inactivation. Implementation of INTERCEPT may be used as a mitigation against any potential bacterial contamination in platelet components.
C1 [Makroo, Raj Nath; Thakur, Uday Kumar; Agrawal, Soma; Chowdhry, Mohit] Indraprastha Apollo Hosp, Dept Transfus Med, New Delhi, India.
   [Sardana, Raman; Mediratta, Leena; Butta, Hena] Indraprastha Apollo Hosp, Dept Microbiol, New Delhi, India.
   [Kumar, Satendra; Chokroborty, Sourit] Hemogenomics Pvt Ltd, Bangalore, Karnataka, India.
RP Makroo, RN (corresponding author), Indraprastha Apollo Hosp, Delhi Mathura Rd, New Delhi 110076, India.
EM makroo@apollohospitalsdelhi.com
RI Agrawal, Soma/W-9176-2019
FU Hemogenomics Pvt. Ltd, Bengaluru, India; Cerus Corporation, CA, USA
FX This study was financially supported by Hemogenomics Pvt. Ltd,
   Bengaluru, India, and Cerus Corporation, CA, USA.
CR Amato M, 2017, VOX SANG, V112, P47, DOI 10.1111/vox.12456
   [Anonymous], NON TRADITIONAL REF
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bacterial Risk Control Strategies for Blood Collection, 2016, BACT RISK CONTR STRA
   Bashir S, 2014, J APPL HEMATOL, V5, P10
   Bhattacharya Prasun, 2011, Asian J Transfus Sci, V5, P164, DOI 10.4103/0973-6247.83245
   Brecher ME, 2005, CLIN MICROBIOL REV, V18, P195, DOI 10.1128/CMR.18.1.195-204.2005
   Cazenave JP, 2013, PLATELET TRANSFUSION, P119
   Ciaravino V, 2001, HUM EXP TOXICOL, V20, P533, DOI 10.1191/096032701718120319
   Ciaravino V, 2001, SEMIN HEMATOL, V38, P12, DOI 10.1016/S0037-1963(01)90119-2
   Dodd RY, 2003, TRANSFUS CLIN BIOL, V10, P6, DOI 10.1016/S1246-7820(02)00277-X
   Eder AF, 2009, TRANSFUSION, V49, P1554, DOI 10.1111/j.1537-2995.2009.02192.x
   French National Agency for Medicine and Health Product Safety/ANSM, HEM ACT REP
   Grellier P, 2008, TRANSFUSION, V48, P1676, DOI 10.1111/j.1537-2995.2007.01762.x
   Gupta N, 2012, INDIAN J MED RES, V136, P373
   Hong H, 2016, BLOOD, V127, P496, DOI 10.1182/blood-2015-07-655944
   Kleinman S, 2013, TRANSFUSION, V53, P1603, DOI 10.1111/j.1537-2995.2012.03928.x
   Kulkarni N, 2014, INDIAN J HEMATOL BLO, V30, P319, DOI 10.1007/s12288-013-0236-5
   Kumar Rajesh, 2015, Asian J Transfus Sci, V9, P199, DOI 10.4103/0973-6247.154250
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lin L, 2005, TRANSFUSION, V45, P1610, DOI 10.1111/j.1537-2995.2005.00554.x
   Lin L, 2004, TRANSFUSION, V44, P1496, DOI 10.1111/j.1537-2995.2004.04125.x
   Lin LL, 2005, TRANSFUSION, V45, P580, DOI 10.1111/j.0041-1132.2005.04316.x
   Maria FS, 2016, TRANSFUSION, V56, p11A
   Mittal Kshitija, 2015, Asian J Transfus Sci, V9, P1, DOI 10.4103/0973-6247.150933
   Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nagpal BN, 2012, INDIAN J MED RES, V135, P351
   Nussbaumer W, 2017, VOX SANG, V112, P249, DOI 10.1111/vox.12489
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Tice RR, 2007, MUTAT RES-GEN TOX EN, V630, P50, DOI 10.1016/j.mrgentox.2007.02.008
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   Vasconcelos E, 2004, TRANSFUS APHER SCI, V31, P155, DOI 10.1016/j.transci.2004.05.005
   Wagner SJ, 1996, TRANSFUSION, V36, P989, DOI 10.1046/j.1537-2995.1996.36111297091744.x
NR 34
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1998-3565
J9 ASIAN J TRANSF SCI
JI Asian J. Transf. Sci.
PD JUL-DEC
PY 2018
VL 12
IS 2
BP 146
EP 153
DI 10.4103/ajts.AJTS_87_17
PG 8
WC Hematology
SC Hematology
GA HF7QL
UT WOS:000454434300011
PM 30692800
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Romano, D
   Stefanini, C
   Canale, A
   Benelli, G
AF Romano, Donato
   Stefanini, Cesare
   Canale, Angelo
   Benelli, Giovanni
TI Artificial blood feeders for mosquito and ticks-Where from, where to?
SO ACTA TROPICA
LA English
DT Article
DE Anaplasmosis; Automation; Bio-hybrid systems; Bloodsucking insects;
   Chikungunya; Culicidae; Dengue; Ixodiidae; Malaria; Mass-rearing; West
   Nile virus; Tick-borne diseases; Vector biology; Yellow fever; Zika
   virus
ID MEMBRANE FEEDING TECHNIQUE; MAINTAINING AEDES-AEGYPTI; ONE HEALTH
   PERSPECTIVE; IN-VITRO BIOASSAY; RHIPICEPHALUS-APPENDICULATUS;
   BOOPHILUS-MICROPLUS; THEILERIA-PARVA; IXODES-RICINUS; BORNE DISEASES;
   DIPTERA-CULICIDAE
AB Mosquito and tick feeding activity represent a key threat for humans, livestock, pets and wildlife worldwide Rearing these vectors in laboratory conditions is extremely important to investigate basic facets of their biology, vector competence, new control strategies, as well as mechanisms of pesticide resistance However, the use of animals or humans to provide blood for hematophagous arthropod feeding poses a strict limit to these re searches, due to the accidental transmission of diseases, ethical problems concerning animal welfare, as well as expensive and time-consuming animal rearing procedures The use of devices to artificially feed arthropod vectors can importantly leverage progresses in parasitology and entomology The aim of this review is to summarize current knowledge about artificial feeding of mosquitoes and ticks, focusing on key concepts and case studies about the design and fabrication of blood feeding devices From a technical standpoint, the literature analyzed here showed little standardization of materials used for fabricating membrane interfaces, as well as in the strategy used to heat the "biomimetic host" In addition, a lack of uniform methods to design an architecture merging complex and realistic cues with an easy-to-assemble approach have been found Some commercial products are available, but they are quite expensive, thus hard to reach for many laboratories, especially in developing countries An important challenge for future research is represented by the introduction of automation and bioinspired engineered solutions in these devices, improving the effectiveness of blood-feeding systems by increasing their host-mimicking features Automation can reduce labor costs and provide interesting solutions - in line with the 3R principle "reduce, replace and refine" - aimed to minimize the employ of experimental animals in research.
C1 [Romano, Donato; Stefanini, Cesare; Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
   [Stefanini, Cesare] Khalifa Univ, Dept Biomed Engn, POB 127788, Abu Dhabi, U Arab Emirates.
   [Stefanini, Cesare] Khalifa Univ, Robot Inst, POB 127788, Abu Dhabi, U Arab Emirates.
   [Canale, Angelo; Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
OI Romano, Donato/0000-0003-4975-3495
CR Abbas RZ, 2014, VET PARASITOL, V203, P6, DOI 10.1016/j.vetpar.2014.03.006
   Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Adenubi OT, 2016, S AFR J BOT, V105, P178, DOI 10.1016/j.sajb.2016.03.010
   Ajelli M, 2017, ACTA TROP, V176, P332, DOI 10.1016/j.actatropica.2017.08.026
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Allen J., 1962, MOSQ NEWS, V22
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Aziz AT, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-258
   BAILEY DL, 1978, MOSQ NEWS, V38, P403
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Barnard DR, 2014, ACTA TROP, V136, P58, DOI 10.1016/j.actatropica.2014.04.019
   Barnard DR, 1998, MED VET ENTOMOL, V12, P39, DOI 10.1046/j.1365-2915.1998.00078.x
   Barre N, 1998, ANN NY ACAD SCI, V849, P384, DOI 10.1111/j.1749-6632.1998.tb11077.x
   BARZEEV M, 1959, J ECON ENTOMOL, V52, P263, DOI 10.1093/jee/52.2.263
   BAUER B, 1976, B ENTOMOL RES, V65, P563, DOI 10.1017/S0007485300006246
   BEHIN REZA, 1967, MOSQUITO NEWS, V27, P87
   Benelli G, 2018, TRENDS PARASITOL, V34, P351, DOI 10.1016/j.pt.2018.01.002
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10149, DOI 10.1007/s11356-017-9960-y
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ACTA TROP, V179, P88, DOI 10.1016/j.actatropica.2017.12.024
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2018, ACTA TROP, V178, P176, DOI 10.1016/j.actatropica.2017.11.024
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   BENYAKIR D, 1993, ISRAEL J ZOOL, V39, P169
   Bergquist R, 2017, ACTA TROP, V175, P1, DOI 10.1016/j.actatropica.2017.07.015
   Bertens J. M. P., 2013, THESIS
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BLACKWELL A, 1994, J MED ENTOMOL, V31, P302, DOI 10.1093/jmedent/31.2.302
   Bohme B, 2018, PARASITOL RES, V117, P565, DOI 10.1007/s00436-017-5648-y
   Bonnet S, 2000, T ROY SOC TROP MED H, V94, P103, DOI 10.1016/S0035-9203(00)90456-5
   BOORMAN J. P. T., 1956, Transactions of the Royal Society of Tropical Medicine and Hygiene, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   BOYD MARK F., 1935, AMER JOUR TROP MED, V15, P485
   Brake DK, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-103
   Buckingham SC, 2015, J INFECTION, V71, pS88, DOI 10.1016/j.jinf.2015.04.009
   Burkot TR, 2001, J MED ENTOMOL, V38, P167, DOI 10.1603/0022-2585-38.2.167
   CDC, 2017, LYM DIS
   Chabaud xC.G., 1950, Ann Parasit, V25, P42
   Chanda E, 2016, EMERG INFECT DIS, V22, P773, DOI 10.3201/eid2205.150984
   Cockcroft A, 1998, MED VET ENTOMOL, V12, P289, DOI 10.1046/j.1365-2915.1998.00121.x
   COLLINS DA, 1993, PHYTOTHER RES, V7, P17, DOI 10.1002/ptr.2650070106
   COSGROVE JB, 1994, J AM MOSQUITO CONTR, V10, P434
   Costa-da-Silva AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053816
   Crowell RL, 1940, AM J HYG, V32, P12, DOI 10.1093/oxfordjournals.aje.a118663
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   deMoura ST, 1997, MEM I OSWALDO CRUZ, V92, P545, DOI 10.1590/S0074-02761997000400019
   Deng L, 2012, TROP BIOMED, V29, P169
   Deplazes T., 2013, LEHRBUCH PARASITOLOG, P639
   Diehlmann H. E. I. K. O., 1999, LAB REARING MOSQUITO
   Ebani VV, 2017, ACTA TROP, V172, P197, DOI 10.1016/j.actatropica.2017.05.014
   Eckert J, 1997, VET PARASITOL, V71, P99, DOI 10.1016/S0304-4017(97)00027-7
   Ellse L, 2014, MED VET ENTOMOL, V28, P233, DOI 10.1111/mve.12033
   FAHRNER J, 1988, VET PARASITOL, V28, P307, DOI 10.1016/0304-4017(88)90078-7
   Finlayson C, 2015, ACTA TROP, V152, P245, DOI 10.1016/j.actatropica.2015.09.026
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   FRIEND W G, 1987, Memorias do Instituto Oswaldo Cruz, V82, P11, DOI 10.1590/S0074-02761987000700005
   GALUN R, 1967, B WORLD HEALTH ORGAN, V36, P590
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Gonzalez J, 2017, EXP APPL ACAROL, V72, P449, DOI 10.1007/s10493-017-0167-1
   Gosling R, 2016, PLOS MED, V13, P1, DOI DOI 10.1371/J0URNAL.PMED.1001994
   Gray J, 2005, INT J MED MICROBIOL, V295, P567, DOI 10.1016/j.ijmm.2005.05.008
   GREENBERG J., 1949, Mosquito News, V9, P48
   GUERIN PM, 2000, NOVA ACTA LEOPOLDINA, V83, P213
   Guglielmone A. A., 2014, HARD TICKS ACARI IXO
   HAGEN HE, 1990, J AM MOSQUITO CONTR, V6, P535
   Hemotek Ltd, 2018, START PACK 6 FEED 3
   HOKAMA Y, 1987, J MED ENTOMOL, V24, P319, DOI 10.1093/jmedent/24.3.319
   HOWARTH JA, 1983, J MED ENTOMOL, V20, P248, DOI 10.1093/jmedent/20.3.248
   Huang TH, 2015, MED VET ENTOMOL, V29, P238, DOI 10.1111/mve.12114
   Inci A, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005021
   Inokuma H, 1998, J VET MED SCI, V60, P509, DOI 10.1292/jvms.60.509
   Jambulingam P, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1768-y
   Kasap H, 2003, J AM MOSQUITO CONTR, V19, P367
   KEMP DH, 1975, PARASITOLOGY, V70, P243, DOI 10.1017/S0031182000049702
   Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9
   Klun JA, 2000, J MED ENTOMOL, V37, P177, DOI 10.1603/0022-2585-37.1.177
   Klun JA, 2005, J AM MOSQUITO CONTR, V21, P64, DOI 10.2987/8756-971X(2005)21[64:ANIVBS]2.0.CO;2
   Klun JA, 2003, J MED ENTOMOL, V40, P293, DOI 10.1603/0022-2585-40.3.293
   KOGAN PH, 1990, J MED ENTOMOL, V27, P709, DOI 10.1093/jmedent/27.4.709
   Krober T, 2007, TRENDS PARASITOL, V23, P445, DOI 10.1016/j.pt.2007.07.010
   Krober T, 2007, PEST MANAG SCI, V63, P17, DOI 10.1002/ps.1293
   Krull C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2000-4
   KUHNERT F, 1995, INT J PARASITOL, V25, P887, DOI 10.1016/0020-7519(95)00009-Q
   Kuhnert F., 1995, ALTEX, V13, P76
   Lani R, 2014, TICKS TICK-BORNE DIS, V5, P457, DOI 10.1016/j.ttbdis.2014.04.001
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Levin ML, 2016, EXP APPL ACAROL, V70, P343, DOI 10.1007/s10493-016-0084-8
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Luo YP, 2014, J VECTOR ECOL, V39, P271, DOI 10.1111/jvec.12101
   Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   MELLOR PS, 1971, T ROY SOC TROP MED H, V65, P199, DOI 10.1016/0035-9203(71)90218-5
   Mishra K, 2005, ANN TROP MED PARASIT, V99, P803, DOI 10.1179/136485905X65189
   Mitsui Yoshinori, 2010, Tropical Medicine and Health, V38, P97, DOI 10.2149/tmh.2010-07
   MOLOO SK, 1971, PARASITOLOGY, V63, P507, DOI 10.1017/S0031182000080021
   Montes C, 2002, J MED ENTOMOL, V39, P675, DOI 10.1603/0022-2585-39.4.675
   Musyoki JM, 2004, EXP APPL ACAROL, V32, P51, DOI 10.1023/B:APPA.0000018159.47700.e4
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nasirian H, 2006, J AM MOSQUITO CONTR, V22, P54, DOI 10.2987/8756-971X(2006)22[54:ABOASO]2.0.CO;2
   Nasirian H, 2008, BIMONTH J HORMOZGAN, V12, P137
   NOVAK MG, 1991, J AM MOSQUITO CONTR, V7, P327
   OSBORNE RW, 1985, TROP ANIM HEALTH PRO, V17, P31, DOI 10.1007/BF02356130
   Ouedraogo AL, 2013, MALAR WORLD J, V4, P1
   Pfaffle M, 2013, INT J PARASITOL, V43, P1059, DOI 10.1016/j.ijpara.2013.06.009
   Pitts RJ, 2014, ACTA TROP, V132, pS26, DOI 10.1016/j.actatropica.2013.09.005
   PURNELL RE, 1967, NATURE, V216, P484, DOI 10.1038/216484a0
   Rampersad J, 2007, J AM MOSQUITO CONTR, V23, P149, DOI 10.2987/8756-971X(2007)23[149:VBBFLF]2.0.CO;2
   Romano D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12941-z
   Romano D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04840-0
   Ross R. W, 1954, REP VIRUS RES I E AF, V1953, P19
   Rozeboom L. E., 1936, American Journal of Tropical Medicine, V16, P471
   Russell W.M.S., 1959, PRINCIPLES HUMANE EX
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   RUTLEDGE LC, 1976, MOSQ NEWS, V36, P283
   Rutledge LC, 2004, J AM MOSQUITO CONTR, V20, P150
   SCHRECK CE, 1989, J AM MOSQUITO CONTR, V5, P247
   STONE BF, 1983, INT J PARASITOL, V13, P447, DOI 10.1016/S0020-7519(83)80007-1
   Tajeri S, 2011, VET PARASITOL, V180, P332, DOI 10.1016/j.vetpar.2011.03.014
   Takano-Lee M, 2003, J MED ENTOMOL, V40, P628, DOI 10.1603/0022-2585-40.5.628
   Tseng M, 2003, J MED ENTOMOL, V40, P588, DOI 10.1603/0022-2585-40.4.588
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   Vanickova L, 2017, PARASITOL INT, V66, P190, DOI 10.1016/j.parint.2016.09.010
   Vega R. de la, 2004, Revista de Salud Animal, V26, P202
   VOIGT WP, 1993, PARASITOLOGY, V107, P257, DOI 10.1017/S0031182000079233
   WALADDE SM, 1995, PARASITOLOGY, V111, P463, DOI 10.1017/S0031182000065963
   Waladde SM, 1996, PARASITOL TODAY, V12, P272, DOI 10.1016/0169-4758(96)10027-2
   WALADDE SM, 1992, INSECT SCI APPL, V13, P579, DOI 10.1017/S1742758400016167
   WALADDE SM, 1979, INT J PARASITOL, V9, P89, DOI 10.1016/0020-7519(79)90096-1
   WALADDE SM, 1993, PARASITOLOGY, V107, P249, DOI 10.1017/S0031182000079221
   WALADDE SM, 1991, EXP APPL ACAROL, V11, P297, DOI 10.1007/BF01202876
   WETZEL H, 1979, ENTOMOL EXP APPL, V25, P117, DOI 10.1007/BF00421827
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Willadsen P, 2006, VET PARASITOL, V138, P161, DOI 10.1016/j.vetpar.2006.01.050
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Young AS, 1996, ANN NY ACAD SCI, V791, P211, DOI 10.1111/j.1749-6632.1996.tb53527.x
   Yu CY, 2001, VET PARASITOL, V99, P297, DOI 10.1016/S0304-4017(01)00491-5
NR 146
TC 7
Z9 7
U1 2
U2 55
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUL
PY 2018
VL 183
BP 43
EP 56
DI 10.1016/j.actatropica.2018.04.009
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GG5TE
UT WOS:000432757800008
PM 29625092
DA 2020-07-08
ER

PT J
AU de Oya, NJ
   Blazquez, AB
   Casas, J
   Saiz, UC
   Martin-Acebes, MA
AF Jimenez de Oya, Nereida
   Blazquez, Ana-Belen
   Casas, Josefina
   Saiz, Uan-Carlos
   Martin-Acebes, Miguel A.
TI Direct Activation of Adenosine Monophosphate-Activated Protein Kinase
   (AMPK) by PF-06409577 Inhibits Flavivirus Infection through Modification
   of Host Cell Lipid Metabolism
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE AMPK; West Nile virus; Zika virus; antiviral agents; dengue fever;
   flavivirus; lipid synthesis
ID WEST NILE VIRUS; ZIKA VIRUS; DENGUE; ENCEPHALITIS; REPLICATION;
   MECHANISMS; CERAMIDE; SYNTHASE; SITES; DRUGS
AB Mosquito-borne flaviviruses are a group of RNA viruses that constitute global threats for human and animal health. Replication of these pathogens is strictly dependent on cellular lipid metabolism. We have evaluated the effect of the pharmacological activation of AMP-activated protein kinase (AMPK), a master regulator of lipid metabolism, on the infection of three medically relevant flaviviruses, namely, West Nile virus (WNV),Zika virus (ZIKV), and dengue virus (DENV). WNV is responsible for recurrent outbreaks of meningitis and encephalitis, affecting humans and horses worldwide. ZIKV has caused a recent pandemic associated with birth defects (microcephaly), reproductive disorders, and severe neurological complications (Guillain-Barre syndrome). DENV is the etiological agent of the most prevalent mosquito-borne viral disease, which can induce a potentially lethal complication called severe dengue. Our results showed, for the first time, that activation of AMPK using the specific small molecule activator PF-06409577 reduced WNV, ZIKV, and DENV infection. This antiviral effect was associated with an impairment of viral replication due to the modulation of host cell lipid metabolism exerted by the compound. These results support that the pharmacological activation of AMPK, which currently constitutes an important pharmacological target for human diseases, could also provide a feasible approach for broad-spectrum host-directed antiviral discovery.
C1 [Jimenez de Oya, Nereida; Blazquez, Ana-Belen; Saiz, Uan-Carlos; Martin-Acebes, Miguel A.] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
   [Casas, Josefina] Inst Adv Chem Catalonia, IQAC CISC, Dept Biomed Chem, Barcelona, Spain.
RP Martin-Acebes, MA (corresponding author), Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Biotechnol, Madrid, Spain.
EM martin.mangel@nia.es
RI de Oya, Nereida Jimenez/T-6449-2019; Jimenez de Oya,
   Nereida/K-8470-2016; Blazquez, Ana/G-9791-2015; Martin-Acebes, Miguel
   A./L-2258-2014
OI de Oya, Nereida Jimenez/0000-0003-3129-813X; Jimenez de Oya,
   Nereida/0000-0003-3129-813X; Blazquez, Ana/0000-0002-0847-0977;
   Martin-Acebes, Miguel A./0000-0001-6015-3613; Saiz,
   Juan-Carlos/0000-0001-8269-5544
FU MINECO [AGL2014-56518-JIN]; INIAInstituto de Investigacion Agropecuaria
   (INIA) [RTA2015-00009]; Comunidad Autonoma de MadridComunidad de Madrid
   [S2013/ABI-2906]
FX This work was supported by grant AGL2014-56518-JIN from MINECO to
   M.A.M.-A and grants RTA2015-00009 from INIA and S2013/ABI-2906 (PLATESA)
   from the Comunidad Autonoma de Madrid to J.-C.S. The funders had no role
   in study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Aktepe TE, 2015, VIROLOGY, V484, P241, DOI 10.1016/j.virol.2015.06.015
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Burakoff A, 2018, MMWR-MORBID MORTAL W, V67, P13, DOI 10.15585/mmwr.mm6701a3
   Cameron KO, 2016, J MED CHEM, V59, P8068, DOI 10.1021/acs.jmedchem.6b00866
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Collins TJ, 2007, BIOTECHNIQUES, V43, P25
   Day EA, 2017, TRENDS ENDOCRIN MET, V28, P545, DOI 10.1016/j.tem.2017.05.004
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Garanto A, 2013, EXP EYE RES, V110, P96, DOI 10.1016/j.exer.2013.03.003
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gonzalez-Magaldi M, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106685, 10.]
   Gorrochategui E, 2014, ENVIRON SCI POLLUT R, V21, P11907, DOI 10.1007/s11356-014-3172-5
   Guigas B, 2009, IUBMB LIFE, V61, P18, DOI 10.1002/iub.135
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HA J, 1994, J BIOL CHEM, V269, P22162
   Hardie DG, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0774
   Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879
   Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kaufmann SHE, 2018, NAT REV DRUG DISCOV, V17, P35, DOI 10.1038/nrd.2017.162
   Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martin-Acebes Miguel A, 2012, World J Virol, V1, P51, DOI 10.5501/wjv.v1.i2.51
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Merino-Ramos T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108056
   Muller PY, 2012, NAT REV DRUG DISCOV, V11, P751, DOI 10.1038/nrd3801
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Rena G, 2017, DIABETOLOGIA, V60, P1577, DOI 10.1007/s00125-017-4342-z
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Salatto CT, 2017, J PHARMACOL EXP THER, V361, P303, DOI 10.1124/jpet.116.237925
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008
   Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200
   Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09
   Taniguchi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37829
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Villareal VA, 2015, ANTIVIR RES, V124, P110, DOI 10.1016/j.antiviral.2015.10.013
   Webster DP, 2015, LANCET, V385, P1124, DOI 10.1016/S0140-6736(14)62401-6
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
NR 53
TC 13
Z9 13
U1 1
U2 14
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUL
PY 2018
VL 62
IS 7
AR e00360-18
DI 10.1128/AAC.00360-18
PG 11
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA GK8HP
UT WOS:000436461100031
PM 29712653
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Zika Virus In Vitro Research
SO ATLA-ALTERNATIVES TO LABORATORY ANIMALS
LA English
DT News Item
CR Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
NR 1
TC 0
Z9 0
U1 0
U2 1
PU FRAME
PI NOTTINGHAM
PA RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE,
   NOTTS, ENGLAND
SN 0261-1929
J9 ATLA-ALTERN LAB ANIM
JI ATLA-Altern. Lab. Anim.
PD JUL
PY 2018
VL 46
IS 3
BP 110
EP 110
PG 1
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA HC4AU
UT WOS:000451745700006
DA 2020-07-08
ER

PT J
AU Contreras-Capetillo, SN
   Valadez-Gonzalez, N
   Manrique-Saide, P
   Carcano-Castillo, RE
   Pacheco-Tugores, F
   Barrera-Perez, HAM
   Pinto-Escalante, D
   Lliteras-Cardin, M
   Hoil-Parra, JA
   Caceres-Solis, JL
   Pavia-Ruz, N
AF Noemi Contreras-Capetillo, Silvina
   Valadez-Gonzalez, Nina
   Manrique-Saide, Pablo
   Eduardo Carcano-Castillo, Rafael
   Pacheco-Tugores, Freddy
   Moshe Barrera-Perez, Hirian Alonso
   Pinto-Escalante, Doris
   Lliteras-Cardin, Manuel
   Alfredo Hoil-Parra, Jose
   Luis Caceres-Solis, Jose
   Pavia-Ruz, Norma
TI Birth Defects Associated With Congenital Zika Virus Infection in Mexico
SO CLINICAL PEDIATRICS
LA English
DT Article
DE Zika virus; birth defects; pregnancy; congenital infection; clinical
   variation
ID NEURAL-TUBE DEFECTS; UPDATE INTERIM GUIDELINES; UNITED-STATES; MTHFR
   GENE; INFANTS; BRAZIL; BRAIN; PERSISTENCE; PREGNANCY; EXPOSURE
AB Part of the work agenda of international health authorities is to define the clinical spectrum of the congenital Zika syndrome (CZS) in different territories. We describe the clinical variability that gave rise to the suspicion of CZS in 3 newborn patients in the south of Mexico with active transmission of Zika. All of them presented Zika RNA by reverse transcription-polymerase chain reaction and positive antibodies for IgM by enzyme-linked immunosorbent assay. None of the mothers tested positive for active viremia, only one mother had Zika-symptoms and titers of Zika-positive IgM. Intrauterine growth restriction, brain disruption sequence, and intracranial calcifications are the clinical characteristics common in all. One patient had neural tube defect and other, arthrogryposis. Because the majority of pregnant women will be asymptomatic to Zika, we must be alert to the clinical variability of the birth defects associated to pregnancy Zika infection. Reports of clinical cases encourage the medical community to make diagnostic decisions.
C1 [Noemi Contreras-Capetillo, Silvina; Pacheco-Tugores, Freddy; Lliteras-Cardin, Manuel; Alfredo Hoil-Parra, Jose] Hosp Gen Agustin OHoran, Secretaria Salud Yucatan, Merida, Yucatan, Mexico.
   [Noemi Contreras-Capetillo, Silvina; Valadez-Gonzalez, Nina; Eduardo Carcano-Castillo, Rafael; Pinto-Escalante, Doris; Pavia-Ruz, Norma] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Calle 96 S-N X Av Jacinto Canek & Calle 47 Paseo, Merida 97225, Yucatan, Mexico.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Campus Ciencias Biol & Agr, Merida, Yucatan, Mexico.
   [Moshe Barrera-Perez, Hirian Alonso] ANAPAT, Serv Particulares Anatomopatol, Merida, Yucatan, Mexico.
   [Luis Caceres-Solis, Jose] ISSSTE Hosp Reg Merida, Merida, Yucatan, Mexico.
RP Contreras-Capetillo, SN (corresponding author), Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Calle 96 S-N X Av Jacinto Canek & Calle 47 Paseo, Merida 97225, Yucatan, Mexico.
EM silvina.contreras@correo.uady.mx
FU Office of Infectious Disease, Bureau for Global Health, US Agency for
   International DevelopmentUnited States Agency for International
   Development (USAID)
FX We would like to thank the families for their interest and collaboration
   in this report and for allowing us to share the findings. The RT-PCR
   studies were carried out in the Laboratory of Clinical Hematology of the
   CIR Hideyo Noguchi with support provided by the Office of Infectious
   Disease, Bureau for Global Health, US Agency for International
   Development, under the terms of an Interagency Agreement with CDC. We
   thank Margarita Elsa Villarino, MD, MPH, for her support and
   contribution to the logistics for the management and conclusion of this
   report. We thank Cynthia Moore, MD, PhD for her generous review of the
   manuscript. We also thank Lizbeth Gonzalez-Herrera, PhD and Gerardo
   Perez, MS for their contribution on the complementary studies.
CR Acosta-Reyes J, 2017, EMERG INFECT DIS, V23, P982, DOI 10.3201/eid2306.161702
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   [Anonymous], 2017, LIN EST VIG EP DIAGN
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, TRIOPL REALT RT PCR
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gonzalez-Herrera L, 2002, CLIN GENET, V62, P394, DOI 10.1034/j.1399-0004.2002.620507.x
   Gonzalez-Herrera L, 2012, NEURAL TUBE DEFECTSR, P179
   Gonzalez-Herrera L, 2007, BIRTH DEFECTS RES A, V79, P622, DOI 10.1002/bdra.20381
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hyde KJ, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023119
   InBios International Inc, FACTSH HEALTHC PROV
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Juranek J, 2010, DEV DISABIL RES REV, V16, P23, DOI 10.1002/ddrr.88
   Kulesz PA, 2015, NEUROIMAGE-CLIN, V8, P72, DOI 10.1016/j.nicl.2015.03.022
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Vahanian SA, 2015, AM J OBSTET GYNECOL, V213, pS78, DOI 10.1016/j.ajog.2015.05.058
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Viswanathan M, 2017, JAMA-J AM MED ASSOC, V317, P190, DOI 10.1001/jama.2016.19193
NR 42
TC 5
Z9 5
U1 0
U2 8
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0009-9228
EI 1938-2707
J9 CLIN PEDIATR
JI Clin. Pediatr.
PD JUL
PY 2018
VL 57
IS 8
BP 927
EP 936
DI 10.1177/0009922817738341
PG 10
WC Pediatrics
SC Pediatrics
GA GI5TQ
UT WOS:000434433900007
PM 29152996
DA 2020-07-08
ER

PT J
AU Tsai, WY
   Youn, HH
   Tyson, J
   Brites, C
   Tsai, JJ
   Pedroso, C
   Drexler, JF
   Balmaseda, A
   Harris, E
   Wang, WK
AF Tsai, Wen-Yang
   Youn, Han Ha
   Tyson, Jasmine
   Brites, Carlos
   Tsai, Jih-Jin
   Pedroso, Celia
   Drexler, Jan Felix
   Balmaseda, Angel
   Harris, Eva
   Wang, Wei-Kung
TI Use of Urea Wash ELISA to Distinguish Zika and Dengue Virus Infections
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID NEUTRALIZING ANTIBODIES; CROSS-REACTIVITY; ENHANCEMENT
AB Serologic testing remains crucial for Zika virus diagnosis. We found that urea wash in a Zika virus nonstructural protein 1 IgG ELISA distinguishes secondary dengue from Zika virus infection with previous dengue (sensitivity 87.5%, specificity 93.8%). This test will aid serodiagnosis, serosurveillance, and monitoring of Zika complications in dengue-endemic regions.
C1 [Tsai, Wen-Yang] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, 651 Ilalo St,BSB 325E, Honolulu, HI 96822 USA.
   [Youn, Han Ha; Tyson, Jasmine; Wang, Wei-Kung] Univ Hawaii Manoa, Honolulu, HI 96822 USA.
   [Brites, Carlos; Pedroso, Celia] Univ Fed Bahia, Salvador, BA, Brazil.
   [Tsai, Jih-Jin] Kaohsiung Med Univ, Kaohsiung, Taiwan.
   [Drexler, Jan Felix] Univ Bonn, Med Ctr, Bonn, Germany.
   [Balmaseda, Angel] Minist Hlth, Natl Ctr Diag & Reference, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RP Wang, WK (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, 651 Ilalo St,BSB 325E, Honolulu, HI 96822 USA.
EM wangwk@hawaii.edu
OI Drexler, Jan Felix/0000-0002-3509-0232
FU National Institutes of Health, National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI110769-01, R01 AI099631,
   U54AI065359, P01AI106695, U19 AI118610]; Molecular and Cellular
   Immunology Core from the National Institute of General Medical Sciences
   [5P30GM114737]; National Health Research Institutes, TaiwanNational
   Health Research Institutes - Taiwan [NHRI-106A1-MRCO-1017178]
FX This work was supported by grants R01AI110769-01 (W.-K.W.), R01 AI099631
   and U54AI065359 (A.B.), and P01AI106695 and U19 AI118610 (E.H.) from the
   National Institutes of Health, National Institute of Allergy and
   Infectious Diseases; Molecular and Cellular Immunology Core through
   grant 5P30GM114737 from the National Institute of General Medical
   Sciences; and grant NHRI-106A1-MRCO-1017178 (J.-J.T., W.-K.W.) from the
   National Health Research Institutes, Taiwan. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puschnik A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002274
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
NR 15
TC 4
Z9 6
U1 0
U2 7
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2018
VL 24
IS 7
BP 1355
EP 1359
DI 10.3201/eid2407.171170
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GJ8JP
UT WOS:000435635900025
PM 29912689
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moise, IK
   Kangmennaang, J
   Hutchings, TCSG
   Sheskin, IM
   Fuller, DO
AF Moise, Imelda K.
   Kangmennaang, Joseph
   Hutchings, Tricia Caroline S. G.
   Sheskin, Ira M.
   Fuller, Douglas O.
TI Perceptions of Zika Virus Risk during 2016 Outbreak, Miami-Dade County,
   Florida, USA
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
ID KNOWLEDGE
AB We conducted a survey on Zika virus perceptions and behaviors during the 2016 outbreak in Miami-Dade County, Florida, USA. Among women, Zika knowledge was associated with having a bachelor's degree. Among men, knowledge was associated with knowing someone at risk. Interventions during future outbreaks could be targeted by sex and education level.
C1 [Moise, Imelda K.; Hutchings, Tricia Caroline S. G.; Sheskin, Ira M.; Fuller, Douglas O.] Univ Miami, Coral Gables, FL 33146 USA.
   [Kangmennaang, Joseph] Univ Waterloo, Waterloo, ON, Canada.
RP Moise, IK (corresponding author), Univ Miami, Geog & Reg Studies, Publ Hlth Sci, 1300 Campo Sano Ave, Coral Gables, FL 33146 USA.
EM moise@miami.edu
RI Moise, Imelda K/AAL-7226-2020
OI Moise, Imelda K/0000-0003-0222-780X
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [U01CK000510]
FX This publication was supported by Cooperative Agreement no. U01CK000510
   funded by the Centers for Disease Control and Prevention.
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Annenberg Public Policy Center, 2016, MOR 4 10 MIST THINK
   Byron K, 2017, J MED ETHICS, V43, P334, DOI 10.1136/medethics-2016-103862
   Esposito DLA, 2018, IMMUNOLOGY, V153, P435, DOI 10.1111/imm.12878
   Moise IK, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160107
   Moore KJ, 2017, J OCCUP ENVIRON MED, V59, pE17, DOI 10.1097/JOM.0000000000000960
   Poletti P, 2012, MATH BIOSCI, V238, P80, DOI 10.1016/j.mbs.2012.04.003
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016460
   Rubsamen N, 2015, EMERG INFECT DIS, V21, P1012, DOI 10.3201/eid2106.150013
   Wong LP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002789
NR 10
TC 3
Z9 3
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUL
PY 2018
VL 24
IS 7
BP 1379
EP 1381
DI 10.3201/eid2407.171650
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GJ8JP
UT WOS:000435635900032
PM 29912705
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Abinaya, M
   Vaseeharan, B
   Divya, M
   Vijayakumar, S
   Govindarajan, M
   Alharbi, NS
   Khaled, JM
   Al-anbr, MN
   Benelli, G
AF Abinaya, Muthukumar
   Vaseeharan, Baskaralingam
   Divya, Mani
   Vijayakumar, Sekar
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Khaled, Jamal M.
   Al-anbr, Mohammed N.
   Benelli, Giovanni
TI Structural characterization of Bacillus licheniformis Dahb1
   exopolysaccharide-antimicrobial potential and larvicidal activity on
   malaria and Zika virus mosquito vectors
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Exopolysaccharide; H-1-NMR; Dengue fever; Insecticide; Drug development;
   Microbial pathogens; Pesticide; Yellow fever
ID ESSENTIAL OILS; IN-VITRO; SILVER NANOPARTICLES; ANTIBIOFILM ACTIVITY;
   GOLD NANOPARTICLES; BORNE COMPOUNDS; AEDES-AEGYPTI; ANTIOXIDANT;
   TOXICITY; CHALLENGES
AB Microbial polysaccharides produced by marine species play a key role in food and cosmetic industry, as they are nontoxic and biodegradable polymers. This investigation reports the isolation of exopolysaccharide from Bacillus licheniformis Dahbl and its biomedical applications. Bacillus licheniformis Dahbl exopolysaccharide (Bl-EPS) was extracted using the ethanol precipitation method and structurally characterized. FTIR and H-1-NMR pointed out the presence of various functional groups and primary aromatic compounds, respectively. Bl-EPS exhibited strong antioxidant potential confirmed via DPPH radical, reducing power and superoxide anion scavenging assays. Microscopic analysis revealed that the antibiofilm activity of Bl-EPS (75 mu g/ml) was higher against Gram-negative (Pseudomonas aeruginosa and Proteus vulgaris) bacteria over Gram-positive species (Bacillus subtilis and Bacillus pumilus). Bl-EPS led to biofilm inhibition against Candida albicans when tested at 75 mu g/ml. The hemolytic assay showed low cytotoxicity of Bl-EPS at 5 mg/ml. Besides, Bl-EPS achieved LC50 values < 80 mu g/ml against larvae of mosquito vectors Anopheles stephensi and Aedes aegypti. Overall, our findings pointed out the multipurpose bioactivity of Bl-EPS, which deserves further consideration for pharmaceutical, environmental and entomological applications.
C1 [Abinaya, Muthukumar; Vaseeharan, Baskaralingam; Divya, Mani; Vijayakumar, Sekar] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Govt Coll Women, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Khaled, Jamal M.; Al-anbr, Mohammed N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Pontedera, Italy.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI /L-2836-2013; Sekar/A-8600-2018; Alharbi, Naiyf S/B-9402-2019; Khaled,
   Jamal/D-8188-2017; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI /0000-0001-7018-5379; Sekar/0000-0001-8211-069X; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931; Muthukumar, Abinaya/0000-0002-9635-4852
FU Department of Biotechnology (DBT), Government of India, New Delhi,
   IndiaDepartment of Biotechnology (DBT) India [BT/PR7903/AAQ/3/638/2013];
   DST-INSPIRE fellowship, New Delhi, India [IF160623]; Deanship of
   Scientific Research at King Saud UniversityDeanship of Scientific
   Research at King Saud University [RG-1438-091]
FX The authors gratefully acknowledge the financial support of the
   Department of Biotechnology (DBT), Government of India, New Delhi,
   India, under the project grant code BT/PR7903/AAQ/3/638/2013. M.A.
   thanks the support of DST-INSPIRE fellowship [IF160623], New Delhi,
   India. The authors extend their appreciation to the Deanship of
   Scientific Research at King Saud University for funding this work
   through research group no. RG-1438-091.
CR Abdhul K, 2014, INT J BIOL MACROMOL, V70, P450, DOI 10.1016/j.ijbiomac.2014.07.026
   Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Peralta MA, 2015, PHYTOMEDICINE, V22, P975, DOI 10.1016/j.phymed.2015.07.003
   Arena A, 2006, INT IMMUNOPHARMACOL, V6, P8, DOI 10.1016/j.intimp.2005.07.004
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Benelli G, 2018, IND CROP PROD, V117, P382, DOI 10.1016/j.indcrop.2018.02.072
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4
   Bermudez J, 2004, WORLD J MICROB BIOT, V20, P179, DOI 10.1023/B:WIBI.0000021754.59894.4a
   BITTER T, 1962, ANAL BIOCHEM, V4, P330, DOI 10.1016/0003-2697(62)90095-7
   Bramhachari PV, 2007, J MICROBIOL BIOTECHN, V17, P44
   Dahech I, 2013, INT J BIOL MACROMOL, V59, P417, DOI 10.1016/j.ijbiomac.2013.04.036
   Del Re B, 2000, LETT APPL MICROBIOL, V31, P438, DOI 10.1046/j.1365-2672.2000.00845.x
   DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017
   Elshikh M, 2016, BIOTECHNOL LETT, V38, P1015, DOI 10.1007/s10529-016-2079-2
   Fang YW, 2013, CARBOHYD POLYM, V98, P1377, DOI 10.1016/j.carbpol.2013.07.076
   Fang YW, 2013, CARBOHYD POLYM, V92, P1172, DOI 10.1016/j.carbpol.2012.10.016
   [房耀维 Fang Yaowei], 2010, [食品科学, Food Science], V31, P276
   Ganesh Kumar C, 2004, ENZYME MICROB TECH, V34, P673, DOI 10.1016/j.enzmictec.2004.03.001
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ismail B, 2010, ARCH MICROBIOL, V192, P1049, DOI 10.1007/s00203-010-0636-y
   Jayaseelan BD, 2013, ANN MICROBIOL, V63, P1601, DOI 10.1007/s13213-013-0623-z
   Junter GA, 2016, ACTA BIOMATER, V30, P13, DOI 10.1016/j.actbio.2015.11.010
   Kanmani P, 2011, BIORESOURCE TECHNOL, V102, P4827, DOI 10.1016/j.biortech.2010.12.118
   Khaled JM, 2018, ENVIRON SCI POLLUT R, V25, P10447, DOI 10.1007/s11356-017-0071-6
   Khater H. F., 2012, Pharmacologia, V3, P641
   Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9
   Khater HF, 2018, INT J DERMATOL, V57, P449, DOI 10.1111/ijd.13828
   Khater HF, 2017, NATURAL REMEDIES FIG, P4
   Khater HF, 2013, RECENT PROGR MED PLA, V37, P151
   Kumar AS, 2007, B ENVIRON CONTAM TOX, V79, P617, DOI 10.1007/s00128-007-9283-7
   Larpin S, 2002, INT J FOOD MICROBIOL, V77, P1, DOI 10.1016/S0168-1605(02)00058-2
   Lee IY, 1997, BIOPROCESS ENG, V16, P71, DOI 10.1007/s004490050290
   Lima LFO, 2008, APPL BIOCHEM BIOTECH, V151, P283, DOI 10.1007/s12010-008-8187-2
   Lin ES, 2011, WORLD J MICROB BIOT, V27, P555, DOI 10.1007/s11274-010-0489-1
   Liu CH, 2010, BIORESOURCE TECHNOL, V101, P5528, DOI 10.1016/j.biortech.2010.01.151
   Liu J, 2010, CARBOHYD POLYM, V82, P1278, DOI 10.1016/j.carbpol.2010.07.008
   Mahendran S., 2013, INT J REC SCI RES, V4, P501
   Molyneux P., 2003, J SCI TECHNOL, V26, P211
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Nazzaro F, 2013, PHARMACEUTICALS, V6, P1451, DOI 10.3390/ph6121451
   Patel AK, 2009, FOOD RES INT, V42, P505, DOI 10.1016/j.foodres.2009.01.013
   Pavela R, 2018, ENVIRON SCI POLLUT R, V25, P10904, DOI 10.1007/s11356-018-1398-3
   Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779
   Prior RL, 2005, J AGR FOOD CHEM, V53, P4290, DOI 10.1021/jf0502698
   Rahman MM, 2008, WORLD J MICROB BIOT, V24, P1593, DOI 10.1007/s11274-007-9650-x
   Rani RP, 2017, INT J BIOL MACROMOL, V96, P1, DOI 10.1016/j.ijbiomac.2016.11.122
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Rosenberg M, 2006, FEMS MICROBIOL LETT, V262, P129, DOI 10.1111/j.1574-6968.2006.00291.x
   Sajna KV, 2013, INT J BIOL MACROMOL, V59, P84, DOI 10.1016/j.ijbiomac.2013.04.025
   Singh RP, 2011, CARBOHYD POLYM, V84, P1019, DOI 10.1016/j.carbpol.2010.12.061
   Sun HH, 2009, CARBOHYD POLYM, V78, P117, DOI 10.1016/j.carbpol.2009.04.017
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Surendra TV, 2016, J PHOTOCH PHOTOBIO B, V161, P463, DOI 10.1016/j.jphotobiol.2016.06.013
   Sutherland I W, 1972, Adv Microb Physiol, V8, P143, DOI 10.1016/S0065-2911(08)60190-3
   Tadhani MB, 2007, J FOOD COMPOS ANAL, V20, P323, DOI 10.1016/j.jfca.2006.08.004
   Velusamy P, 2015, IND CROP PROD, V66, P103, DOI 10.1016/j.indcrop.2014.12.042
   Vijayabaskar P, 2011, ADV BIOL RES, V5, p71 
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Vinoj G, 2014, MAR BIOTECHNOL, V16, P707, DOI 10.1007/s10126-014-9585-9
   Vinoj G, 2015, ANTIMICROB AGENTS CH, V59, P763, DOI 10.1128/AAC.03047-14
   Vu B, 2009, MOLECULES, V14, P2535, DOI 10.3390/molecules14072535
   Wang CL, 2011, NEW BIOTECHNOL, V28, P559, DOI 10.1016/j.nbt.2011.03.003
   Wang LQ, 2010, WORLD J MICROB BIOT, V26, P1999, DOI 10.1007/s11274-010-0384-9
   Wang YP, 2010, CARBOHYD POLYM, V82, P895, DOI 10.1016/j.carbpol.2010.06.013
   World Health Organization, 2005, WHOCDSHOPESGCDPP1, V3, P2005
   Ye SH, 2012, CARBOHYD POLYM, V87, P764, DOI 10.1016/j.carbpol.2011.08.057
   Yu KX, 2015, ASIAN PAC J TROP MED, V8, P981, DOI 10.1016/j.apjtm.2015.11.011
   Zhang J, 2016, CARBOHYD POLYM, V146, P368, DOI 10.1016/j.carbpol.2016.03.063
NR 80
TC 12
Z9 12
U1 4
U2 31
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JUL
PY 2018
VL 25
IS 19
BP 18604
EP 18619
DI 10.1007/s11356-018-2002-6
PG 16
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GL6CH
UT WOS:000437264700037
PM 29704178
DA 2020-07-08
ER

PT J
AU Massad, E
   Amaku, M
   Coutinho, FAB
   Struchiner, CJ
   Lopez, LF
   Coelho, G
   Wilder-Smith, A
   Burattini, MN
AF Massad, Eduardo
   Amaku, Marcos
   Bezerra Coutinho, Francisco Antonio
   Struchiner, Claudio Jose
   Lopez, Luis Fernandez
   Coelho, Giovanini
   Wilder-Smith, Annelies
   Burattini, Marcelo Nascimento
TI The risk of urban yellow fever resurgence in Aedes-infested American
   cities
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Article
DE Aedes aegypti; dengue; mathematical models; risk; yellow fever
ID RIO-DE-JANEIRO; DENGUE; VIRUS; VISITORS; OUTBREAK; AEGYPTI; SPREAD
AB Aedes aegypti, historically known as yellow fever (YF) mosquito, transmits a great number of other viruses such as Dengue, West Nile, Chikungunya, Zika, Mayaro and perhaps Oropouche, among others. Well established in Africa and Asia, Aedes mosquitoes are now increasingly invading large parts of the American continent, and hence the risk of urban YF resurgence in the American cities should because of great concern to public health authorities. Although no new urban cycle of YF was reported in the Americas since the end of an Aedes eradication programme in the late 1950s, the high number of non-vaccinated individuals that visit endemic areas, that is, South American jungles where the sylvatic cycle of YF is transmitted by canopy mosquitoes, and return to Aedes-infested urban areas, increases the risk of resurgence of the urban cycle of YF. We present a method to estimate the risk of urban YF resurgence in dengue-endemic cities. This method consists in (1) to estimate the number of Aedes mosquitoes that explains a given dengue outbreak in a given region; (2) calculate the force of infection caused by the introduction of one infective individual per unit area in the endemic area under study; (3) using the above estimates, calculate the probability of at least one autochthonous YF case per unit area produced by one single viraemic traveller per unit area arriving from a YF endemic or epidemic sylvatic region at the city studied. We demonstrate that, provided the relative vector competence, here defined as the capacity to being infected and disseminate the virus, of Ae. aegypti is greater than 0.7 (with respect to dengue), one infected traveller can introduce urban YF in a dengue endemic area.
C1 [Massad, Eduardo; Amaku, Marcos; Bezerra Coutinho, Francisco Antonio; Lopez, Luis Fernandez; Burattini, Marcelo Nascimento] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Massad, Eduardo; Wilder-Smith, Annelies] London Sch Hyg & Trop Med, London, England.
   [Massad, Eduardo] Univ Derby, Coll Life & Nat Sci, Derby, England.
   [Massad, Eduardo; Struchiner, Claudio Jose] Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
   [Struchiner, Claudio Jose] Fundacao Oswaldo Cruz, Programme Sci Computat, Rio De Janeiro, Brazil.
   [Lopez, Luis Fernandez] Florida Int Univ, Ctr Internet Augmented Res & Assessment, Miami, FL 33199 USA.
   [Coelho, Giovanini] CHA VT PAHO WHO, Neglected Trop & Vector Borne Dis Program, Washington, DC USA.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Burattini, Marcelo Nascimento] Univ Fed Sao Paulo, Escola Paulista Med, Hosp Sao Paulo, Sao Paulo, SP, Brazil.
RP Massad, E (corresponding author), Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.; Massad, E (corresponding author), London Sch Hyg & Trop Med, London, England.; Massad, E (corresponding author), Univ Derby, Coll Life & Nat Sci, Derby, England.; Massad, E (corresponding author), Fundacao Getulio Vargas, Sch Appl Math, Rio De Janeiro, Brazil.
EM edmassad@usp.br
RI Lopez, Luis F/C-4721-2012; Struchiner, Claudio J/M-9360-2013; Amaku,
   Marcos/D-5252-2012; Burattini, Marcelo N/J-9272-2014; Massad,
   Eduardo/B-1169-2012
OI Lopez, Luis F/0000-0003-4097-6887; Struchiner, Claudio
   J/0000-0003-2114-847X; Amaku, Marcos/0000-0003-4752-6774; Burattini,
   Marcelo N/0000-0002-5407-6890; Massad, Eduardo/0000-0002-7200-2916
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [LIM01-HCFMUSP]; Brazilian Ministry of Health [777588/2012]; ZikaPLAN
   through the European Union [734584]; Canadian Institutes of Health
   Research (CIHR)Canadian Institutes of Health Research (CIHR) [372512]
FX This work has been funded by LIM01-HCFMUSP, CNPq, by the Brazilian
   Ministry of Health (grant #777588/2012), by ZikaPLAN through the
   European Union's Horizon 2020 research and innovation programme under
   grant agreement No. 734584, and the Canadian Institutes of Health
   Research (CIHR), consortium Canada-Latin/America-Caribean Zika Virus
   Program (Grant no. 372512). Data used in this paper are available at
   http://portalsinan.saude.gov.br/dengue, accessed in January 2017.
CR Amaku M, 2016, EPIDEMIOLOGY INFECT, V19, P1
   Amaku M, 2011, BIOSYSTEMS, V106, P111, DOI 10.1016/j.biosystems.2011.07.004
   Bailey NT, 2006, ELEMENTS STOCHASTIC
   Bryan CS, 2004, INFECT DIS CLIN N AM, V18, P275, DOI 10.1016/j.idc.2004.01.007
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   CDC, 2016, ZIK VIR POT RANG US
   Chernick MR, 2008, BOOTSTRAP METHODS GU
   Coutinho FAB, 2006, B MATH BIOL, V68, P2263, DOI 10.1007/s11538-006-9108-6
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Johnson BW, 2002, T ROY SOC TROP MED H, V96, P611, DOI 10.1016/S0035-9203(02)90326-3
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   MAGALHAES Rodrigo Cesar da Silva, 2016, ERRADICACAO AEDES AE
   Massad E, 2005, VACCINE, V23, P3908, DOI 10.1016/j.vaccine.2005.03.002
   Massad E, 2001, T ROY SOC TROP MED H, V95, P370, DOI 10.1016/S0035-9203(01)90184-1
   Massad Eduardo, 2017, Infect Dis Model, V2, P441, DOI 10.1016/j.idm.2017.12.001
   Massad E, 2016, LANCET, V388, P25, DOI 10.1016/S0140-6736(16)30842-X
   PAHO, EP UPD YELL FEV
   Strode WK, 1951, YELLOW FEVER
   WHO, YELL FEV ANG
   Ximenes R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1517-z
NR 25
TC 8
Z9 8
U1 0
U2 16
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD JUL
PY 2018
VL 146
IS 10
BP 1219
EP 1225
DI 10.1017/S0950268818001334
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GO3YN
UT WOS:000439936400003
PM 29843824
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Hertzog, J
   Dias, AG
   Rigby, RE
   Donald, CL
   Mayer, A
   Sezgin, E
   Song, CJ
   Jin, BQ
   Hublitz, P
   Eggeling, C
   Kohl, A
   Rehwinkel, J
AF Hertzog, Jonny
   Dias, Antonio Gregorio, Jr.
   Rigby, Rachel E.
   Donald, Claire L.
   Mayer, Alice
   Sezgin, Erdinc
   Song, Chaojun
   Jin, Boquan
   Hublitz, Philip
   Eggeling, Christian
   Kohl, Alain
   Rehwinkel, Jan
TI Infection with a Brazilian isolate of Zika virus generates RIG-I
   stimulatory RNA and the viral NS5 protein blocks type I IFN induction
   and signaling
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE Interferon; MDA5; RIG-I; STAT; Zika virus
ID NUCLEAR-LOCALIZATION; ANTIVIRAL IMMUNITY; RECOGNITION; CELLS;
   TRANSMISSION; RESPONSES; BIOLOGY; DISEASE; TESTES; BRAIN
AB Zika virus (ZIKV) is a major public health concern in the Americas. We report that ZIKV infection and RNA extracted from ZIKV infected cells potently activated the induction of type I interferons (IFNs). This effect was fully dependent on the mitochondrial antiviral signaling protein (MAVS), implicating RIG-I-like receptors (RLRs) as upstream sensors of viral RNA. Indeed, RIG-I and the related RNA sensor MDA5 contributed to type I IFN induction in response to RNA from infected cells. We found that ZIKV NS5 from a recent Brazilian isolate blocked type I IFN induction downstream of RLRs and also inhibited type I IFN receptor (IFNAR) signaling. We defined the ZIKV NS5 nuclear localization signal and report that NS5 nuclear localization was not required for inhibition of signaling downstream of IFNAR. Mechanistically, NS5 blocked IFNAR signaling by both leading to reduced levels of STAT2 and by blocking phosphorylation of STAT1, two transcription factors activated by type I IFNs. Taken together, our observations suggest that ZIKV infection induces a type I IFN response via RLRs and that ZIKV interferes with this response by blocking signaling downstream of RLRs and IFNAR.
C1 [Hertzog, Jonny; Dias, Antonio Gregorio, Jr.; Rigby, Rachel E.; Mayer, Alice; Sezgin, Erdinc; Eggeling, Christian; Rehwinkel, Jan] Univ Oxford, MRC, Human Immunol Unit, Weatherall Inst Mol Med,Radcliffe Dept Med, Oxford, England.
   [Donald, Claire L.; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Hublitz, Philip] Univ Oxford, MRC, Genome Engn Facil, Weatherall Inst Mol Med,Radcliffe Dept Med, Oxford, England.
   [Song, Chaojun; Jin, Boquan] Fourth Mil Med Univ, Dept Immunol, Xian, Shaanxi, Peoples R China.
RP Rehwinkel, J (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Radcliffe Dept Med, JR Hosp, Headley Way, Oxford OX3 9DS, England.
EM jan.rehwinkel@imm.ox.ac.uk
RI Sezgin, Erdinc/R-1980-2018; Hublitz, Philip/AAM-5159-2020; Donald,
   Claire/AAC-7556-2019
OI Sezgin, Erdinc/0000-0002-4915-388X; Donald, Claire/0000-0002-4370-0707;
   Hertzog, Jonny/0000-0002-7089-982X; Rigby, Rachel/0000-0001-5201-9422;
   Rehwinkel, Jan/0000-0003-3841-835X
FU UK Medical Research Council [MRC of the MRC Human Immunology Unit]
   [MC_UU_12014, MR/N017552/1]; Wellcome TrustWellcome Trust [100954];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [211806/2013-7]; European CommissionEuropean Commission Joint Research
   Centre [MSCA-ITN GA 675278 EDGE]
FX This work was funded by the UK Medical Research Council [MRC core
   funding of the MRC Human Immunology Unit; J.R.], [MC_UU_12014,
   MR/N017552/1; A.K.] and by the Wellcome Trust [grant number 100954;
   J.R.]. A.G.D.J. is supported by CNPq [grant number 211806/2013-7]. J.H.
   is supported by the European Commission under the Horizon2020 program
   H2020 MSCA-ITN GA 675278 EDGE. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7
   Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632
   Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Brubaker SW, 2014, CELL, V156, P800, DOI 10.1016/j.cell.2014.01.021
   Cao XZ, 2015, J HEPATOL, V62, P771, DOI 10.1016/j.jhep.2014.11.007
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   DesMaio F. A., 2016, PLOS PATHOG, V12
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012
   Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hartmann G, 2017, ADV IMMUNOL, V133, P121, DOI 10.1016/bs.ai.2016.11.001
   Hato SV, 2007, CELL MICROBIOL, V9, P2921, DOI 10.1111/j.1462-5822.2007.01006.x
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Marzahn MR, 2016, EMBO J, V35, P1254, DOI 10.15252/embj.201593169
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Rehwinkel J, 2013, CURR OPIN MICROBIOL, V16, P485, DOI 10.1016/j.mib.2013.04.009
   Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020
   Saha S, 2016, CELL, V166, P1572, DOI 10.1016/j.cell.2016.08.006
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 63
TC 26
Z9 26
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD JUL
PY 2018
VL 48
IS 7
BP 1120
EP 1136
DI 10.1002/eji.201847483
PG 17
WC Immunology
SC Immunology
GA GL9TF
UT WOS:000437680700005
PM 29572905
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Kim, H
   Jun, S
   Park, EC
   Song, HS
   Kim, J
   Kim, SI
AF Kim, H.
   Jun, S.
   Park, E. C.
   Song, H. S.
   Kim, J.
   Kim, S. I.
TI Expression, purification and characterization of recombinant Zika viral
   proteins for antibody development and structural studies
SO FEBS OPEN BIO
LA English
DT Meeting Abstract
C1 [Kim, H.; Jun, S.; Park, E. C.; Song, H. S.; Kim, J.; Kim, S. I.] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea.
   [Kim, H.] Korea Basic Sci Inst, Prot Struct Grp, Ochang, South Korea.
   [Kim, H.; Jun, S.; Park, E. C.; Song, H. S.; Kim, S. I.] Univ Sci & Technol, Dept Bioanalyt Sci, Daejeon, South Korea.
   [Jun, S.; Park, E. C.; Song, H. S.; Kim, S. I.] Korea Basic Sci Inst, Drug & Dis Target Team, Ochang, South Korea.
   [Kim, J.] Korea Univ, Grad Sch, Seoul, South Korea.
RI Park, Eun-Cheol/O-5644-2019
OI Park, Eun-Cheol/0000-0002-2306-5398
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2211-5463
J9 FEBS OPEN BIO
JI FEBS Open Bio
PD JUL
PY 2018
VL 8
SU 1
MA P.18-093-W
BP 416
EP 416
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GL9RL
UT WOS:000437674105018
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Scott, RP
   de Lira, LC
   de Matos, SS
   Souza, FM
   Silva, ACR
   de Quadros, MT
AF Scott, Russell Parry
   de Lira, Luciana Campelo
   de Matos, Silvana Sobreira
   Souza, Fernanda Meira
   Rodrigues Silva, Ana Claudia
   de Quadros, Marion Teodosio
TI Therapeutic paths, care and assistance in the construction of ideas
   about maternity and childhood in the context of the Zika virus
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Article
DE Therapeutic paths; Care; Maternal-child images; Zika; Vital conjuncture
AB Based on an ethnographic field research, we followed the therapeutic paths of caregivers of children with the Zika congenital syndrome in order to understand the way different contexts (discovery, household, health units, social work, associations) contribute to creating notions about maternity and childhood. The concept of "vital conjunctures" in generational rites of passage singularizes experiences that lead to stabilization and/or inverted paths in the passage between stages. The practical and symbolic construction of maternity and childhood oscillates among a multiplicity of meanings marked by the obligatoriness of women to strive in the task of caring and experiencing suffering and care sacralization, in a daily reality that ties their lives to searches for causal explanations and diverse therapeutic answers without marked generational changes. Those who take these therapeutic paths build a multifaceted image of themselves in a direct or indirect relationship to maternity, childhood and their social and biological affiliation.
C1 [Scott, Russell Parry; de Lira, Luciana Campelo; Souza, Fernanda Meira; de Quadros, Marion Teodosio] Univ Fed Pernambuco UFPE, Dept Antropol & Museol, Av Acad Helio Ramos CFCH, BR-50670901 Recife, PE, Brazil.
   [de Matos, Silvana Sobreira] Univ Fed Pernambuco UFPE, Programa Posgrad Antropol, Recife, PE, Brazil.
RP Scott, RP (corresponding author), Univ Fed Pernambuco UFPE, Dept Antropol & Museol, Av Acad Helio Ramos CFCH, BR-50670901 Recife, PE, Brazil.
EM rparryscott@gmail.com; ludelira@gmail.com; silvanasmatos@gmail.com;
   fernanda.meira@gmail.com; acrodriguess@gmail.com;
   marionteodosio@yahoo.com
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPESCAPES; FACEPE; Newton Fund
FX Such a dynamic field of study offers many experiences of very important
   "collaboration" in the understanding of the subject; however, whether it
   be informality or excess of formality, may not be listed as
   collaborators, even when we recognize their contribution in the
   elaboration of our ideas and in access to research sites. For that
   reason we restrict the naming of our collaborators, beyond those who
   financed research and represent instituions cited in the text and
   footnotes, to researchers that collaborated more directly in our
   research despite even though they did not participate as authors in this
   text: At the University of Sussex, from the Institute of Development
   Studies (IDS) - Prof. Hayley MacGregor and Prof. Alexander Shankland;
   from the Centre for Cultures of Health, Reproduction and Technologies
   (CORTH), Prof. Maya Unnithan; at the Universidade de Brasilia,
   Departamento de Antropologia, Prof. Soraya Fleischer; at the Fundacao
   Osvaldo Cruz, Escola Nacional de Saude Publica, Prof. Jeni Vaitsman,
   Sandra Venancio Siqueira; at the Universidade Federal Fluminense, Prof.
   Lenaura Lobato e at the Universidade Federal de Pernambuco, the
   administrative assistants, Jeiza Saraiva and Rafael Acioly. We thank
   CNPq, CAPES, FACEPE and the Newton Fund for financial aupport for the
   work.
CR Alves PC, 2015, REV CIENC SOC, V42, P29
   Arruda P, 2016, HLTH POLICY EMERGING
   Badinter E, 1985, AMOR CONQUISTADO MIT
   CANESQUI Ana Maria, 2007, OLHARES SOCIOANTROPO
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diniz D, 2009, SUR, V6, P65, DOI DOI 10.1590/S1806-64452009000200004
   Diniz D., 2007, COLECAO 1 PASSOS
   dos Santos ET, 2008, SAUDE SOC-SAO PAULO, V17, P107, DOI 10.1590/S0104-12902008000200011
   Duarte LFD, 1998, DOENCA SOFRIMENTO PE, P9
   Farah Marta Ferreira Santos, 2004, Rev. Estud. Fem., V12, P47, DOI 10.1590/S0104-026X2004000100004
   Faya Robles A, 2011, THESIS
   Gerhardt Tatiana Engel, 2006, Cad. Saúde Pública, V22, P2449, DOI 10.1590/S0102-311X2006001100019
   HIRATA H., 2012, REV POLIT PUBLICAS U, P283
   Hirata Helena, 2016, Cad. Pagu, V0, P7, DOI 10.1590/18094449201600460007
   Johnson-Hanks J, 2002, AM ANTHROPOL, V104, P865, DOI 10.1525/aa.2002.104.3.865
   Organizacao Mundial da Saude, 2011, REL MUND DEF
   Pinho PA, 2012, INTERFACE-BOTUCATU, V16, P435
   Rohden Fabiola, 2009, CIENCIA DIFERENCA SE
   Scavone L., 2004, DAR VIDA CUIDAR VIDA
   Scott Parry, 2010, Soc. estado., V25, P251, DOI 10.1590/S0102-69922010000200006
   Scott RP, 2010, FAMILIA CONT SAUDE S, P243
   Scott RP, 2001, INTERFACE-BOTUCATU, V5, P61
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   Shankland A, 2007, DEVELOPMENT SUCCESS: STATECRAFT IN THE SOUTH, P163
   Vilela W, 2005, GENERO SAUDE PROGRAM
NR 25
TC 1
Z9 2
U1 0
U2 2
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PD JUL-SEP
PY 2018
VL 22
IS 66
BP 673
EP 684
DI 10.1590/1807-57622017.0425
PG 17
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GW1AU
UT WOS:000446602400002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Williamson, KE
AF Williamson, K. Eliza
TI Care in the time of Zika: notes on the 'afterlife' of the epidemic in
   Salvador (Bahia), Brazil
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Article
DE Zika; Time; Deficiency; Maternity; Anthropology
ID DISABILITY; MOTHERS; CHILDREN; KINSHIP
AB This article presents a reflection on the "afterlife" of the Zika virus epidemic, drawing on the narratives of mothers of children born with neurological malformations associated with the virus in Bahia. Based on eleven semi-structured interviews with mothers and fathers whose children are attended in a state rehabilitation center, and in dialogue with contemporary theorizations of time and disability in cultural anthropology, it proposes an approach to the temporality of Zika and its effects. Three narratives are highlighted, showing how their children's unpredictable condition, together with the precarities they already experience, make the future almost impossible to imagine. In the face of so much uncertainty, mothers create alternative forms of thinking about, interacting with, and appreciating the child in her or his own terms. This article suggests that hope may include, paradoxically, "expecting nothing".
C1 [Williamson, K. Eliza] Rice Univ, Dept Antropol, Sewell Hall,POB 1892,6100 Main St, Houston, TX 77005 USA.
RP Williamson, KE (corresponding author), Rice Univ, Dept Antropol, Sewell Hall,POB 1892,6100 Main St, Houston, TX 77005 USA.
EM eliza.williamson@rice.edu
FU Wenner-Gren Foundation; Fulbright-Hays Program; Brazilian Studies
   Association; Association for Feminist Anthropology; Rice University
FX I am indebted, first and foremost, to the women and men who have shared
   their stories with me, and who continue to teach me about disability and
   care. Additionally, I owe a great deal of gratitude to the Cepred staff,
   who welcomed this research project. I also want to thank Rosamaria
   Carneiro and Soraya Fleischer for inviting me to participate in this
   series, and Soraya and Lynn Morgan for reading and commenting on earlier
   versions of this manuscript. I would also like to thank the Wenner-Gren
   Foundation, the Fulbright-Hays Program, the Brazilian Studies
   Association, the Association for Feminist Anthropology, and Rice
   University for funding this project at various stages of research and
   writing.
CR [Anonymous], 2017, REV FORUM IDENTIDADE
   Bastos OM, 2008, CAD SAUDE PUBLICA, V24, P2141, DOI 10.1590/S0102-311X2008000900020
   Bear L, 2016, ANNU REV ANTHROPOL, V45, P487, DOI 10.1146/annurev-anthro-102313-030159
   Brodwin P, 2013, EVERYDAY ETHICS: VOICES FROM THE FRONT LINE OF COMMUNITY PSYCHIATRY, P1
   Bryant A, 2010, SAGE HDB GROUNDED TH
   Bryant R, 2016, HIST ANTHR
   Carvalho LP, 2017, CAD GENERO DIVERS, V3, P134
   Cerqueira D, 2017, ATLAS VIOLENCIA 2017
   Davis E, BAD SOULS MADNESS RE
   Diniz D, 2007, QUE DEFICIENCIA
   DINIZ D, 2017, ZIKA ALAGOAS URGENCI
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Falkenbach AP, 2008, CIENC SAUDE COLETIVA, V13, P2065, DOI 10.1590/S1413-81232008000900011
   Fisher P, 2007, SOCIOL HEALTH ILL, V29, P66, DOI 10.1111/j.1467-9566.2007.00518.x
   Gammeltoft Tine M., 2014, HAUNTING IMAGES CULT
   Garland-Thomson R, 2005, SIGNS, V30, P1557, DOI 10.1086/423352
   Ginsburg F, 2013, ANNU REV ANTHROPOL, V42, P53, DOI 10.1146/annurev-anthro-092412-155502
   Han C, LIFE DEBT CARE VIOLE
   HIRATA H., 2012, REV POLIT PUBLICAS U, P283
   LANDSMAN G, 2008, RECONSTRUCTING MOTHE
   Barbosa MAM, 2008, ACTA PAUL ENFERM, V21, P46, DOI 10.1590/S0103-21002008000100007
   Marcondes M.M, 2013, DOSSIE MULHERES NEGR
   Martins Alaerte Leandro, 2006, Cad. Saúde Pública, V22, P2473, DOI 10.1590/S0102-311X2006001100022
   Mattingly C, 2014, MORAL LABORATORIES: FAMILY PERIL AND THE STRUGGLE FOR A GOOD LIFE, P1
   Mattingly Cheryl., 2010, PARADOX HOPE JOURNEY
   Millar KM, 2014, CULT ANTHROPOL, V29, P32, DOI 10.14506/ca29.1.04
   Ministerio da Saude (BR), 2017, CAD CRIANC MEN
   Ministerio da Saude Brasil, 2016, DIR EST PREC CRIANC
   Mitchell LM, 1997, FEMINIST STUD, V23, P373, DOI 10.2307/3178405
   Morgan LM, 1997, FEMINIST STUD, V23, P323
   MUNN ND, 1992, ANNU REV ANTHROPOL, V21, P93, DOI 10.1146/annurev.an.21.100192.000521
   Organizacao Panamericana de Saude. Organizacao Mundial de Saude, ZIK CUM CAS
   Perpetuo IHO, 2000, AN 12 ENC NAC EST PO
   Pinheiro L, 2009, RETRATO DESIGUALDADE
   Rapp R, 1999, ANTHR EVERYDAY LIFE, P1
   Rapp R, 2001, PUBLIC CULTURE, V13, P533, DOI 10.1215/08992363-13-3-533
   Rapp R, 2011, ANTHROPOL QUART, V84, P379, DOI 10.1353/anq.2011.0030
   READ J, 2000, DISABILITY FAMILY SO
   Roberts Elizabeth, 2012, GODS LAB ASSISTED RE
   Samuels E, 2017, DISABIL STUD Q, V37
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   Secretaria Estadual de Saude da Bahia, 2017, B EPIDEMIOLOGICO MIC
   Shakespeare T, 1998, DISABILITY STUDIES R, P197
   Silva EM, 2014, AN EL 3 SEM NAC ED D
   Smith Christen A, 2016, AFROPARADISE BLACKNE
   Staples J, 2016, INT PERSPECT SOC POL, P35, DOI 10.1007/978-3-319-42488-0_3
   TRAUSTADOTTIR R, 1991, J FAM ISSUES, V12, P211, DOI 10.1177/019251391012002005
   Wool ZH, 2017, SOC TEXT, V35, P1, DOI 10.1215/01642472-3727960
   Wool Zoe H., 2015, WAR WEIGHT LIFE WALT
NR 49
TC 2
Z9 3
U1 0
U2 2
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PD JUL-SEP
PY 2018
VL 22
IS 66
BP 685
EP 696
DI 10.1590/1807-57622017.0856
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GW1AU
UT WOS:000446602400003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Carneiro, R
   Fleischer, SR
AF Carneiro, Rosamaria
   Fleischer, Soraya Resende
TI "I never expected this, it was a big shock": conception, pregnancy and
   birth in times of zika through the eyes of women in Recife, PE, Brazil
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Article
DE Reproductive health; Woman; Recife; Zika Virus
AB This article discusses conceptions of conception, gestation and childbirth shortly after the boom of the Zika epidemic in Brazil, from the narratives of female mothers of babies with microcephaly. His children were conceived and gestated in a sui generis context, quite chaotic and insecure, due to the deconditioning of the deficit, the roads of Recife and the neighborhoods of popular litters. Most were born in public hospitals in the state capital of Pernambuco. This way, trying to comprehend these sexual and reproductive experiences of these women, with her we were in 2016 and then in 2017, in this case, from the memory of your gestations and births. Try to be more of the particularity of sexual and reproductive life of Brazilian women, to be thought, for this reason we recover their ideals and practices, comparing them to others, a little wider, on the subject.
C1 [Carneiro, Rosamaria] Univ Brasilia, Fac Ceilandia, Ctr Metropolitano, Lote 01, BR-72220275 Brasilia, DF, Brazil.
   [Fleischer, Soraya Resende] Univ Brasilia, Dept Antropol, Brasilia, DF, Brazil.
RP Carneiro, R (corresponding author), Univ Brasilia, Fac Ceilandia, Ctr Metropolitano, Lote 01, BR-72220275 Brasilia, DF, Brazil.
EM rosacarneiro@yahoo.com.br; fleischer.soraya@gmail.com
CR Carvalho LP, 2017, CAD GENERO DIVERS, V3, P134
   Chazan LK, 2007, MEIO QUILO GENTE EST
   Corozacss V, 2009, O CORPO DA NACAO
   Dalsgaard AL, 2006, VIDA ESPERANCAS ESTE
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Foucault M, 2001, HIST SEXUALIDADE, V1
   Heritier F., 2001, MASCULINO E FEMININO
   Mattingly C, 2014, MORAL LABORATORIES: FAMILY PERIL AND THE STRUGGLE FOR A GOOD LIFE, P1
   Rezende Claudia Barcellos, 2016, Etnográfica, V20, P231
   Valim T, 2017, ELE SENTE TUDO QUE G
   Williamson KE, 2017, 2 REUN ANTR SAUD 201
   Woortmann k, 1999, RESPEITO DIFERENCA I
NR 12
TC 4
Z9 5
U1 0
U2 2
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PD JUL-SEP
PY 2018
VL 22
IS 66
BP 709
EP 719
DI 10.1590/1807-57622017.0857
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GW1AU
UT WOS:000446602400005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinez-Bello, DA
   Lopez-Quilez, A
   Prieto, AT
AF Adyro Martinez-Bello, Daniel
   Lopez-Quilez, Antonio
   Torres Prieto, Alexander
TI Spatio-Temporal Modeling of Zika and Dengue Infections within Colombia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE disease mapping; Bayesian modeling; integrated nested Laplace
   approximation; relative risk
ID PUBLIC-HEALTH; RELATIVE RISK; DISEASE; TRANSMISSION; OUTBREAK;
   MUNICIPALITIES
AB The aim of this study is to estimate the parallel relative risk of Zika virus disease (ZVD) and dengue using spatio-temporal interaction effects models for one department and one city of Colombia during the 2015-2016 ZVD outbreak. We apply the integrated nested Laplace approximation (INLA) for parameter estimation, using the epidemiological week (EW) as a time measure. At the departmental level, the best model showed that the dengue or ZVD risk in one municipality was highly associated with risk in the same municipality during the preceding EWs, while at the city level, the final model selected established that the high risk of dengue or ZVD in one census sector was highly associated not only with its neighboring census sectors in the same EW, but also with its neighboring sectors in the preceding EW. The spatio-temporal models provided smoothed risk estimates, credible risk intervals, and estimation of the probability of high risk of dengue and ZVD by area and time period. We explore the intricacies of the modeling process and interpretation of the results, advocating for the use of spatio-temporal models of the relative risk of dengue and ZVD in order to generate highly valuable epidemiological information for public health decision making.
C1 [Adyro Martinez-Bello, Daniel; Lopez-Quilez, Antonio] Univ Valencia, Fac Math, Dept Stat & Operat Res, E-46100 Valencia, Spain.
   [Torres Prieto, Alexander] Dept Santander, Secretary Hlth, Epidemiol Monitoring Off, Cl 45 11-52, Bucaramanga, Colombia.
RP Martinez-Bello, DA (corresponding author), Univ Valencia, Fac Math, Dept Stat & Operat Res, E-46100 Valencia, Spain.
EM danieladyro@gmail.com; antonio.lopez@uv.es; atorrespri@hotmail.com
RI Lopez-Quilez, Antonio/H-5945-2011
OI Lopez-Quilez, Antonio/0000-0002-7022-9260; Torres Prieto,
   Alexander/0000-0002-3926-8739; Martinez-Bello, Daniel
   Adyro/0000-0003-3219-0753
FU Colombian Department of Science and Technology COLCIENCIAS [646-2014];
   Ministerio de Economia y Competitividad (the Spanish Ministry of Economy
   and Finance) (European Regional Development Fund) [MTM2016-77501-P]
FX Daniel Martinez-Bello acknowledges the support of the Colombian
   Department of Science and Technology COLCIENCIAS under Grant 646-2014.
   Antonio Lopez-Quilez would like to thank the Ministerio de Economia y
   Competitividad (the Spanish Ministry of Economy and Finance) for its
   support in the form of the Research Grant MTM2016-77501-P (jointly
   financed by the European Regional Development Fund).
CR Abd Naeeim NS, 2017, MALAYS J FUNDAM APPL, V13, P721, DOI 10.11113/mjfas.v0n0.575
   Martinez-Bello DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005696
   Martinez-Bello DA, 2017, INT J HEALTH GEOGR, V16, DOI 10.1186/s12942-017-0104-x
   Aguiar BS, 2018, INT J INFECT DIS, V70, P20, DOI 10.1016/j.ijid.2018.02.007
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Arboleda S, 2009, INT J ENV RES PUB HE, V6, P3040, DOI 10.3390/ijerph6123040
   Banerjee S., 2015, HIERARCHICAL MODELIN, P529
   Chien LC, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3085-x
   Ugarte MD, 2016, STAT METHODS MED RES, V25, P1080, DOI 10.1177/0962280216660423
   Ugarte MD, 2014, STAT METHODS MED RES, V23, P507, DOI 10.1177/0962280214527528
   Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437
   Goicoa T, 2018, STOCH ENV RES RISK A, V32, P749, DOI 10.1007/s00477-017-1405-0
   Knorr-Held L, 2000, STAT MED, V19, P2555, DOI 10.1002/1097-0258(20000915/30)19:17/18<2555::AID-SIM587>3.0.CO;2-#
   Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208
   Lee D, 2011, SPAT SPATIO-TEMPORAL, V2, P79, DOI 10.1016/j.sste.2011.03.001
   Leroux Brian G., 2000, STAT MODELS EPIDEMIO, P179, DOI DOI 10.1007/978-1-4612-1284-34
   Lippi CA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040827
   Louis VR, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-50
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lowe R, 2016, STOCH ENV RES RISK A, V30, P2067, DOI 10.1007/s00477-015-1053-1
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Lowe R, 2013, STAT MED, V32, P864, DOI 10.1002/sim.5549
   Lowe R, 2011, COMPUT GEOSCI-UK, V37, P371, DOI 10.1016/j.cageo.2010.01.008
   Martinez-Bello D, 2018, STOCH ENV RES RISK A, V32, P1587, DOI 10.1007/s00477-017-1461-5
   National Administrative Department of Statistics (DANE), 2005, URB SECT LEV LAYER D
   National Administrative Department of Statistics (DANE), 2005, CENS 2005
   National Health Institute, 2016, WEEKL EP B EP WEEK 5
   National Health Institute, 2016, EV REP DENG 2016
   National Health Institute of Colombia, 2016, INF QUINC EPIDEMIOL, V21, P501
   National Health Institute of Colombia, 2018, METH ROUT SURV STAT
   Ospina J, 2017, TROP MED INT HEALTH, V22, P1249, DOI 10.1111/tmi.12924
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization/World Health Organization, 2017, ZIK SUSP CONF CAS RE
   Perkins T. A., 2015, PLOS CURR, V7, DOI 10.1371
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   R Core Team, 2018, R LANG ENV STAT COMP
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Rodriguez-Morales Alfonso J, 2017, Infez Med, V25, P241
   Rodriguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V18, P57, DOI 10.1016/j.tmaid.2017.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Romero-Vega Liliana, 2014, Rev. Saúde Pública, V48, P899, DOI [10.1590/S0034-8910.2014048005321, 10.1590/s0034-8910.2014048005321]
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Sallam MF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101230
   Sebrango-Rodriguez CR, 2017, EPIDEMIOL INFECT, V145, P2313, DOI [10.1017/S0950268817001078, 10.1017/s0950268817001078]
   Stewart-Ibarra AM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121516
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Watanabe S, 2010, J MACH LEARN RES, V11, P3571
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004500
NR 55
TC 6
Z9 6
U1 1
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUL
PY 2018
VL 15
IS 7
AR 1376
DI 10.3390/ijerph15071376
PG 18
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GU7XC
UT WOS:000445543500082
PM 29966348
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prata-Barbosa, A
   Cleto-Yamane, TL
   Robaina, JR
   Guastavino, AB
   de Magalhaes-Barbosa, MC
   Brindeiro, RD
   Medronho, RA
   da Cunha, AJLA
AF Prata-Barbosa, Arnaldo
   Cleto-Yamane, Thais Lira
   Robaina, Jaqueline Rodrigues
   Guastavino, Andrea Bittencourt
   de Magalhaes-Barbosa, Maria Clara
   Brindeiro, Rodrigo de Moraes
   Medronho, Roberto Andrade
   Ledo Alves da Cunha, Antonio Jose
TI Co-infection with Zika and Chikungunya viruses associated with fetal
   death-A case report
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Chikungunya; Dengue; Stillbirth; Arbovirus
ID INFECTION; PREGNANCY
AB We describe a case of fetal death associated with a recent infection by Chikungunya virus (CHIKV) in a Brazilian pregnant woman (positive RT-PCR in blood and placenta). Zika virus (ZIKV) infection during pregnancy was also identified, based on a positive RT-PCR in a fetal kidney specimen. The maternal infection caused by the ZIKV was asymptomatic and the CHIKV infection had a classical clinical presentation. The fetus had no apparent anomalies, but her weight was between the 3rd and 10th percentile for the gestational age. This is the second case report of congenital arboviral co-infection and the first followed by antepartum fetal death.
   (C) 2008 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license.
C1 [Prata-Barbosa, Arnaldo; Cleto-Yamane, Thais Lira; Robaina, Jaqueline Rodrigues; de Magalhaes-Barbosa, Maria Clara; Ledo Alves da Cunha, Antonio Jose] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, Brazil.
   [Prata-Barbosa, Arnaldo; Medronho, Roberto Andrade; Ledo Alves da Cunha, Antonio Jose] Fed Univ Rio de Janeiro UFRJ, Sch Med, Rio De Janeiro, Brazil.
   [Cleto-Yamane, Thais Lira] State Univ Rio de Janeiro UERJ, Rio De Janeiro, Brazil.
   [Guastavino, Andrea Bittencourt] Fed Univ Rio de Janeiro UFRJ, Matern Hosp, Rio De Janeiro, Brazil.
   [Brindeiro, Rodrigo de Moraes] Fed Univ Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil.
RP Prata-Barbosa, A (corresponding author), DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, Brazil.
EM arnaldoprata@globo.com
RI Yamane, Thais Cleto/AAG-4629-2020; Prata-Barbosa, Arnaldo/B-2212-2009;
   da Cunha, Antonio Jose Ledo Alves/O-5914-2019; amsalu,
   ribka/G-8780-2019; de Andrade Medronho, Roberto/B-6196-2013
OI Yamane, Thais Cleto/0000-0002-7890-5139; Prata-Barbosa,
   Arnaldo/0000-0002-4726-9782; da Cunha, Antonio Jose Ledo
   Alves/0000-0003-3592-1849; de Andrade Medronho,
   Roberto/0000-0003-4073-3930
FU Instituto D'Or de Pesquisa e Ensino (IDOR)
FX Instituto D'Or de Pesquisa e Ensino (IDOR)
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Euroimmun Medizinische Labordiagnostika AG, 2018, ANT DENG VIR ELISA
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Marinho PS, 2017, MATERN HLTH NEONATOL, P3
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pan American Health Association, 2015, EP AL NEUR SYNDR CON
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
NR 18
TC 5
Z9 5
U1 0
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2018
VL 72
BP 25
EP 27
DI 10.1016/j.ijid.2018.04.4320
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA GK5XG
UT WOS:000436252600010
PM 29738826
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vasquez, V
   Haddad, E
   Perignon, A
   Jaureguiberry, S
   Brichler, S
   Leparc-Goffart, I
   Caumes, E
AF Vasquez, Victor
   Haddad, Elie
   Perignon, Alice
   Jaureguiberry, Stephane
   Brichler, Segolene
   Leparc-Goffart, Isabelle
   Caumes, Eric
TI Dengue, chikungunya, and Zika virus infections imported to Paris between
   2009 and 2016: Characteristics and correlation with outbreaks in the
   French overseas territories of Guadeloupe and Martinique
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Dengue; Chikungunya; Traveller; Sentinel; Outbreaks; French
   territories
ID TRAVELERS; AMERICA
AB Background: Dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV) infections are rapidly expanding across countries and are being diagnosed in returned travellers who represent epidemiological sentinels. The French Territories of America (FTA) such as Guadeloupe and Martinique see high levels of tourism and have experienced three consecutive outbreaks by these viruses in the last decade.
   Objective: This study was performed to evaluate how ill returned travellers could have represented epidemiological sentinels for these three expanding arboviral diseases over eight consecutive years. The degree of correlation between the cases of ill returned travellers arriving at a French tertiary hospital in Paris and the three outbreaks that occurred in the FTA during the study period was estimated. Methods: All consecutive ill returned travellers diagnosed at the hospital in Paris with imported DENV, CHIKV, or ZIKV infections from January 2009 to December 2016 were included. Epidemiological and clinical variables were evaluated. Data concerning the incidence of arboviruses in the FTA, as well as the temporal relationship between the occurrence of imported cases and outbreaks in the FTA, were analyzed.
   Results: Overall, 320 cases of arboviral infection were reported: 216 DENV, 68 CHIKV, and 36 ZIKV. Most of the patients presented with fever and exanthema. One hundred and fifteen patients were exposed in Guadeloupe or Martinique, which were the at-risk destinations in 25% of patients with DENV, 59% of patients with CHIKV, and 58% of patients with ZIKV. The occurrence of cases diagnosed in returning travellers followed the same time pattern as the outbreaks in these areas.
   Conclusions: A temporal correlation was found between newly diagnosed imported cases of arboviruses and the three corresponding outbreaks that occurred in Martinique and Guadeloupe during 8 consecutive years. Thus, ill returned travellers act as epidemiological sentinels from the beginning up to the end of outbreaks occurring in touristic locations.
   (C) 2008 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license.
C1 [Vasquez, Victor; Haddad, Elie; Perignon, Alice; Jaureguiberry, Stephane; Caumes, Eric] Hop La Pitie Salpetriere, Infect Dis & Trop Med Dept, Paris, France.
   [Brichler, Segolene] Hop Avicenne, Lab Virol & Infect Dis, Bobigny, France.
   [Leparc-Goffart, Isabelle] Hop Instruct Armees Laveran, Natl Arbovirus Reference Ctr, Marseille, France.
   [Caumes, Eric] Sorbonne Univ, INSERM, IPLESP, AP HP,Hop Pitie Salpetriere,Serv Malad Infect & T, Paris, France.
RP Haddad, E (corresponding author), Hop La Pitie Salpetriere, Infect Dis & Trop Med Dept, Paris, France.
EM elie.haddad@aphp.fr
RI Haddad, Elie/L-3289-2019; BRICHLER, Segolene/R-7039-2018
OI Haddad, Elie/0000-0002-0271-0888; BRICHLER, Segolene/0000-0002-7336-7730
CR Anez G, 2013, BIOMED RES INT, DOI 10.1155/2013/678645
   Anon, 2016, ANON            0107
   [Anonymous], 2010, ANON            0106
   [Anonymous], 2016, ANON            1124
   [Anonymous], 2018, ANON            1215
   [Anonymous], 2010, ANON            1122
   [Anonymous], 2013, ANON            1219
   [Anonymous], 2007, BEH
   [Anonymous], 2010, ANON            0203, DOI DOI 10.2010/ANTILLES-GUYANE/T0US
   [Anonymous], 2015, ANON            0115
   Boggild AK, 2017, JAMMI, DOI [10.3138/jammi.1.3.02, DOI 10.3138/JAMMI.1.3.02]
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Frank C, 2013, EUROSURVEILLANCE, V18, P14, DOI 10.2807/1560-7917.ES2013.18.14.20446
   Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jelinek T, 2002, CLIN INFECT DIS, V35, P1047, DOI 10.1086/342906
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lestelle C, 2015, MED MALADIES INFECT, V45, P222, DOI 10.1016/j.medmal.2015.04.007
   Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604
   Neumayr A, 2017, EURO SURVEILL, V22
   PAHO WHO, 2018, CHIK
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Succo T, 2016, EURO SURVEILL, V21
   WHO, 2018, ZIK VIR
   Wilson ME, 2014, CLIN INFECT DIS, V58, P1347, DOI 10.1093/cid/ciu122
   World Health Organisation, 2008, GUID CLIN MAN CHIK F
NR 30
TC 7
Z9 7
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUL
PY 2018
VL 72
BP 34
EP 39
DI 10.1016/j.ijid.2018.05.007
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA GK5XG
UT WOS:000436252600012
PM 29782922
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Read, JS
   Torres-Velasquez, B
   Lorenzi, O
   Sanchez, AR
   Torres-Torres, S
   Rivera, LV
   Capre-Franceschi, SM
   Garcia-Gubern, C
   Munoz-Jordan, J
   Santiago, GA
   Alvarado, LI
AF Read, Jennifer S.
   Torres-Velasquez, Brenda
   Lorenzi, Olga
   Sanchez, Aidsa Rivera
   Torres-Torres, Sanet
   Rivera, Lillian V.
   Capre-Franceschi, Sheila M.
   Garcia-Gubern, Carlos
   Munoz-Jordan, Jorge
   Santiago, Gilberto A.
   Alvarado, Luisa I.
TI Symptomatic Zika Virus Infection in Infants, Children, and Adolescents
   Living in Puerto Rico
SO JAMA PEDIATRICS
LA English
DT Article
ID TRANSMISSION; OUTBREAK; NIGERIA; STATES; BRAZIL
AB IMPORTANCE Little information is available regarding Zika virus (ZIKV) infection in children.
   OBJECTIVE To describe patients younger than 18 years who were infected with ZIKV and were enrolled in the Sentinel Enhanced Dengue and Acute Febrile Illness Surveillance System (SEDSS).
   DESIGN, SETTING, AND PARTICIPANTS Children infected with ZIKV with 7 or fewer days of fever or emancipated minors aged 14 to 17 years with a generalized maculopapular rash, arthritis or arthralgia, or nonpurulent conjunctivitis were eligible for enrollment on or before December 31, 2016, in Puerto Rico. Patients were evaluated using ZIKV polymerase chain reaction testing at 7 or fewer days after the onset of symptoms. Available ZIKV polymerase chain reaction-positive specimens were evaluated to determine viral loads.
   EXPOSURES Confirmed polymerase chain reaction-positive ZIKV infection.
   MAIN OUTCOMES AND MEASURES Clinical characteristics and viral loads of symptomatic children with confirmed ZIKV infection.
   RESULTS Of 7191 children enrolled in SEDSS on or before December 31, 2016, only those with confirmed ZIKV infection (351 participants) were included in this study. Participants who had confirmed ZIKV infection included 25 infants (7.1%), 69 children (19.7%) aged 1 to 4 years, 95 (27.1%) aged 5 to 9 years, and 162 (46.1%) aged 10 to 17 years. Among these, 260 patients (74.1%) presented for evaluation of ZIKV infection at fewer than 3 days after the onset of symptoms, 340 (96.9%) were discharged to home after evaluation, and 349 (99.4%) had fever, 280 (79.8%) had a rash, 243 (69.2%) had facial or neck erythema, 234 (66.7%) had fatigue, 223 (63.5%) had headache, 212 (60.4%) had chills, 206 (58.7%) had pruritus, and 204 (58.1%) had conjunctival hyperemia. Of 480 specimens collected (317 serum and 163 urine specimens) from 349 children, the median number of days after the onset of symptoms was lower for children who had serum specimens (1day [interquartile range (IQR), 1-2 days]) than for children who had urine specimens (2 [1-3] days) (P < .001). Of 131 children who had both serum and urine specimens collected on the same day, the median viral load was higher in serum than in urine (median [IQR], 23 098 [8784-88 242] copies/mL for serum vs 9966 [2815-52 774] copies/mL for urine; P = .02). When a single serum sample from each of 317 patients was analyzed, there were no statistically significant differences in median viral loads according to age, sex, or disposition. However, the median serum viral load varied significantly according to the number of days after the onset of symptoms (0 days, 106 778 [IQR, 9772-1571718] copies/mL; 1day, 46 299 [10 663-255 030] copies/ml; 2 days, 20 678 [8763-42 458] copies/ml; and >= 3 days, 15 901 [5135-49 248] copies/ml; P = .001).
   CONCLUSIONS AND RELEVANCE This study represents the largest study to date of ZIKV infection in the pediatric population. Most children infected with ZIKV had fever, rash, and conjunctival hyperemia. The children usually presented for evaluation at fewer than 3 days after the onset of symptoms. Viral loads for ZIKV were higher in serum vs urine specimens. Median viral loads in serum specimens differed significantly according to the number of days after the onset of symptoms.
C1 [Read, Jennifer S.] Univ Vermont, Med Ctr, Dept Pediat, 108 Cherry St,Ste 304, Burlington, VT 05401 USA.
   [Read, Jennifer S.; Torres-Velasquez, Brenda; Lorenzi, Olga; Sanchez, Aidsa Rivera; Munoz-Jordan, Jorge; Santiago, Gilberto A.] Ctr Dis Control & Prevent, Dengue Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Dis,Off Infect Dis, San Juan, PR USA.
   [Torres-Torres, Sanet; Rivera, Lillian V.; Capre-Franceschi, Sheila M.; Alvarado, Luisa I.] St Lukes Episcopal Hosp, Ponce Hlth Sci Univ Consortium, Dept Pediat, Ponce, PR USA.
   [Rivera, Lillian V.] Ponce Hlth Sci Univ, Sch Med, Dept Pediat, Ponce, PR USA.
   [Garcia-Gubern, Carlos] St Lukes Episcopal Hosp, Ponce Hlth Sci Univ Consortium, Dept Emergency Med, Ponce, PR USA.
RP Read, JS (corresponding author), Univ Vermont, Med Ctr, Dept Pediat, 108 Cherry St,Ste 304, Burlington, VT 05401 USA.
EM jennifer.read@uvm.edu
FU Sentinal Enhanced Dengue and Acute Febrile Illness Surveillance System
   [5U01CK000437-02]
FX The Sentinal Enhanced Dengue and Acute Febrile Illness Surveillance
   System is funded through cooperative agreement 5U01CK000437-02 with the
   Centers for Disease Control and Prevention (CDC).
CR Berge T, 1975, INT CATALOG ARBOVIRU
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Charrad M, 2014, J STAT SOFTW, V61, P1
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Everitt BC, 2011, CLUSTER ANAL
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffin I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2044
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Puerto Rico Department of Health, WEEKL ARB INF REP
   Shirkhorshidi AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144059
   Simmonds P, 2011, VIRUS TAXONOMY, P1008
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Strauss T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168288
   WHO, 2017, ZIK SIT REP
NR 31
TC 8
Z9 8
U1 0
U2 3
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JUL
PY 2018
VL 172
IS 7
BP 686
EP 693
DI 10.1001/jamapediatrics.2018.0870
PG 8
WC Pediatrics
SC Pediatrics
GA GL5PE
UT WOS:000437219600018
PM 29813148
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Dean, CL
   Wade, J
   Roback, JD
AF Dean, Christina L.
   Wade, Jenna
   Roback, John D.
TI Transfusion-Transmitted Infections: an Update on Product Screening,
   Diagnostic Techniques, and the Path Ahead
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Review
DE infectious disease
ID HUMAN-IMMUNODEFICIENCY-VIRUS; RED-CROSS EXPERIENCE; STATES BLOOD-DONORS;
   WEST NILE VIRUS; UNITED-STATES; ZIKA VIRUS; POSTTRANSFUSION HEPATITIS;
   BABESIA-MICROTI; CHAGAS-DISEASE; RESIDUAL RISK
AB The mandated testing of blood components for infectious diseases, to prevent transfusion-transmitted infections (TTIs), began in the 1950s. Since then, changes in predonation questionnaires and advances in testing techniques have afforded more sensitive and specific tests for pathogens, in addition to allowing earlier detection. Given that these approaches have very low but detectable failure rates, the recent development and implementation of proactive pathogen reduction approaches is the new forefront of TTI prevention strategies. With globalization and the ability of pathogens to evolve rapidly, continuous redefining of testing standards and laboratory techniques is paramount for maintaining a safe blood supply.
C1 [Dean, Christina L.; Wade, Jenna; Roback, John D.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
RP Dean, CL (corresponding author), Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
EM cdean6@emory.edu
CR Alter HJ, 2008, BLOOD, V112, P2617, DOI 10.1182/blood-2008-07-077370
   ALTER HJ, 1981, JAMA-J AM MED ASSOC, V246, P630, DOI 10.1001/jama.246.6.630
   ALTER HJ, 1972, ANN INTERN MED, V77, P691, DOI 10.7326/0003-4819-77-5-691
   [Anonymous], 2009, GUID IND US NUCL AC
   [Anonymous], 2018, STANDARDS BLOOD BANK
   Burnouf T, 2007, TRANSFUS MED REV, V21, P101, DOI 10.1016/j.tmrv.2006.11.001
   Cantey PT, 2012, TRANSFUSION, V52, P1922, DOI 10.1111/j.1537-2995.2012.03581.x
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carr-Greer MA., 2015, COMMUNICATION   0513
   Crowder LA, 2017, TRANSFUSION, V57, P1875, DOI 10.1111/trf.14145
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Eder AF, 2007, TRANSFUSION, V47, P1134, DOI 10.1111/j.1537-2995.2007.01248.x
   FDA, 2016, DRAFT GUID IND BACT
   Food and Drug Administration, 2017, GUID IND US SER TEST
   Food and Drug Administration, 2017, GUID IND NUCL AC TES
   Food and Drug Administration, 2016, GUID IND REV REC RED
   Food and Drug Administration, 2017, DRAFT GUID IND AM RE
   Food and Drug Administration, 2012, FIN GUID IND US NUCL
   Food and Drug Administration, 2014, GUID IND REC SCREEN
   Food and Drug Administration, 2014, GUID IND REC DON QUE
   Food and Drug Administration, 1997, GUID IND DON SCREEN
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Heddle NM, 2016, TRANSFUSION, V56, P1581, DOI 10.1111/trf.13503
   KHABBAZ RF, 1993, ANN INTERN MED, V118, P448
   KOZIOL DE, 1986, ANN INTERN MED, V104, P488, DOI 10.7326/0003-4819-104-4-488
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lozano M, 2015, TRANSFUSION, V55, P690, DOI 10.1111/trf.12996
   Manne-Goehler J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005033
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Moritz ED, 2016, NEW ENGL J MED, V375, P2236, DOI 10.1056/NEJMoa1600897
   Mungai M, 2001, NEW ENGL J MED, V344, P1973, DOI 10.1056/NEJM200106283442603
   Murphy EL, 1996, J ACQ IMMUN DEF SYND, V13, pS215, DOI 10.1097/00042560-199600001-00032
   Pealer LN, 2003, NEW ENGL J MED, V349, P1236, DOI 10.1056/NEJMoa030969
   PETERMAN TA, 1987, TRANSFUSION, V27, P371, DOI 10.1046/j.1537-2995.1987.27587320525.x
   Snyder EL, 2015, NEW ENGL J MED, V373, P882, DOI 10.1056/NEJMc1507761
   Steele WR, 2014, TRANSFUSION, V54, P2092, DOI 10.1111/trf.12590
   Stramer SL, 2014, ISBT SCI SER, V9, P30, DOI 10.1111/voxs.12070
   Stramer SL, 2004, NEW ENGL J MED, V351, P760, DOI 10.1056/NEJMoa040085
   Stramer SL, 2013, TRANSFUSION, V53, P2449, DOI 10.1111/trf.12213
   Stramer SL, 2011, NEW ENGL J MED, V364, P236, DOI 10.1056/NEJMoa1007644
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   SULLIVAN MT, 1991, ARCH INTERN MED, V151, P2043, DOI 10.1001/archinte.151.10.2043
   Tonnetti L, 2017, TRANSFUSION, V57, P2404, DOI 10.1111/trf.14280
   WALSH JH, 1970, J AMER MED ASSOC, V211, P261, DOI 10.1001/jama.211.2.261
   Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x
NR 47
TC 7
Z9 6
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JUL
PY 2018
VL 56
IS 7
AR UNSP e00352
DI 10.1128/JCM.00352-18
PG 9
WC Microbiology
SC Microbiology
GA GK7VW
UT WOS:000436421200009
PM 29669792
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Zheng, ZF
   Yang, JY
   Jiang, X
   Liu, YL
   Zhang, XW
   Li, M
   Zhang, MD
   Fu, M
   Hu, K
   Wang, HZ
   Luo, MH
   Gong, P
   Hu, QX
AF Zheng, Zifeng
   Yang, Jieyu
   Jiang, Xuan
   Liu, Yalan
   Zhang, Xiaowei
   Li, Mei
   Zhang, Mudan
   Fu, Ming
   Hu, Kai
   Wang, Hanzhong
   Luo, Min-Hua
   Gong, Peng
   Hu, Qinxue
TI Tick-Borne Encephalitis Virus Nonstructural Protein NS5 Induces RANTES
   Expression Dependent on the RNA-Dependent RNA Polymerase Activity
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID INTERFERON REGULATORY FACTOR-3; DOUBLE-STRANDED-RNA; HUMAN
   CYTOMEGALOVIRUS-INFECTION; NEURAL PROGENITOR CELLS; NF-KAPPA-B;
   EPITHELIAL-CELLS; IMMUNE-RESPONSE; WEST-NILE; TRANSCRIPTION FACTORS;
   INFLAMED ENDOTHELIUM
AB Tick-borne encephalitis virus (TBEV) is one of the flaviviruses that targets the CNS and causes encephalitis in humans. The mechanism of TBEV that causes CNS destruction remains unclear. It has been reported that RANTES-mediated migration of human blood monocytes and T lymphocytes is specifically induced in the brain of mice infected with TBEV, which causes ensuing neuroinflammation and may contribute to brain destruction. However, the viral components responsible for RANTES induction and the underlying mechanisms remain to be fully addressed. In this study, we demonstrate that the NS5, but not other viral proteins of TBEV, induces RANTES production in human glioblastoma cell lines and primary astrocytes. TBEV NS5 appears to activate the IFN regulatory factor 3 (IRF-3) signaling pathway in a manner dependent on RIG-I/MDA5, which leads to the nuclear translocation of IRF-3 to bind with RANTES promoter. Further studies reveal that the activity of RNA-dependent RNA polymerase (RdRP) but not the RNA cap methyltransferase is critical for TBEV NS5-induced RANTES expression, and this is likely due to RdRP-mediated synthesis of dsRNA. Additional data indicate that the residues at K359, D361, and D664 of TBEV NS5 are critical for RdRP activity and RANTES induction. Of note, NS5s from other flaviviruses, including Japanese encephalitis virus, West Nile virus, Zika virus, and dengue virus, can also induce RANTES expression, suggesting the significance of NS5-induced RANTES expression in flavivirus pathogenesis. Our findings provide a foundation for further understanding how flaviviruses cause neuroinflammation and a potential viral target for intervention.
C1 [Zheng, Zifeng; Jiang, Xuan; Liu, Yalan; Zhang, Xiaowei; Li, Mei; Zhang, Mudan; Fu, Ming; Hu, Kai; Luo, Min-Hua; Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.
   [Zheng, Zifeng; Yang, Jieyu; Li, Mei; Fu, Ming; Luo, Min-Hua] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
   [Yang, Jieyu; Wang, Hanzhong; Gong, Peng] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Hubei, Peoples R China.
   [Zhang, Mudan] Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Pediat, Guangzhou 510623, Guangdong, Peoples R China.
   [Hu, Qinxue] St Georges Univ London, Inst Infect & Immun, London SW17 0RE, England.
RP Liu, YL; Hu, QX (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Hubei, Peoples R China.
EM liuyl@wh.iov.cn; qhu@wh.iov.cn
OI Hu, Qinxue/0000-0002-4594-9215; Liu, Yalan/0000-0003-0464-0964
FU National Key Research and Development Program of China [2016YFC1200400];
   National Mega-Projects for Infectious Diseases [2018ZX10301406-002,
   2018ZX10301405-003]; State Key Laboratory of Virology [klv-2016-02];
   Chinese Academy of SciencesChinese Academy of Sciences [CXJJ-16M120];
   Open Research Fund Program of Wuhan National Bio-Safety Level 4
   Laboratory of Chinese Academy of Sciences [NBL2017009]
FX This work was supported by the National Key Research and Development
   Program of China (2016YFC1200400 to Y.L.), the National Mega-Projects
   for Infectious Diseases (2018ZX10301406-002 and 2018ZX10301405-003 to
   Q.H.), the State Key Laboratory of Virology (klv-2016-02 to Q.H.), the
   Chinese Academy of Sciences (CXJJ-16M120 to Q.H.), and the Open Research
   Fund Program of Wuhan National Bio-Safety Level 4 Laboratory of Chinese
   Academy of Sciences (NBL2017009 to P.G.)
CR Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340
   Baltus T, 2005, J LEUKOCYTE BIOL, V78, P435, DOI 10.1189/jlb.0305141
   Baltus T, 2003, BLOOD, V102, P1985, DOI 10.1182/blood-2003-04-1175
   Bassi MR, 2015, J IMMUNOL, V194, P1141, DOI 10.4049/jimmunol.1402605
   BEESE LS, 1991, EMBO J, V10, P25, DOI 10.1002/j.1460-2075.1991.tb07917.x
   Best SM, 2016, CURR BIOL, V26, pR1258, DOI 10.1016/j.cub.2016.09.029
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001
   Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108
   Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414
   Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032
   Dorrbecker B, 2010, TRAVEL MED INFECT DI, V8, P213, DOI 10.1016/j.tmaid.2010.05.010
   Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069
   Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022
   Gelpi E, 2005, J NEUROPATH EXP NEUR, V64, P506, DOI 10.1093/jnen/64.6.506
   Gelpi E, 2006, J NEUROVIROL, V12, P322, DOI 10.1080/13550280600848746
   Genin P, 2000, J IMMUNOL, V164, P5352, DOI 10.4049/jimmunol.164.10.5352
   Gohara DW, 1999, PROTEIN EXPRES PURIF, V17, P128, DOI 10.1006/prep.1999.1100
   Golovljova I, 2004, J MED VIROL, V74, P580, DOI 10.1002/jmv.20224
   Gong P, 2010, P NATL ACAD SCI USA, V107, P22505, DOI 10.1073/pnas.1007626107
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003
   Grygorczuk Sambor, 2006, Neurol Neurochir Pol, V40, P106
   Heinz FX, 2003, ADV VIRUS RES, V59, P63, DOI 10.1016/S0065-3527(03)59003-0
   Holub M, 2002, ACTA NEUROL SCAND, V106, P302, DOI 10.1034/j.1600-0404.2002.01314.x
   Hudopisk N, 2013, EMERG INFECT DIS, V19, P806, DOI 10.3201/eid1905.121442
   Hughes HR, 2012, VIROLOGY, V424, P129, DOI 10.1016/j.virol.2011.12.012
   Ieki K, 2004, CLIN EXP ALLERGY, V34, P745, DOI 10.1111/j.1365-2222.2004.1941.x
   Imaizumi T, 2014, NEUROSCI RES, V84, P34, DOI 10.1016/j.neures.2014.03.001
   Jin ZN, 2011, J BIOL CHEM, V286, P2067, DOI 10.1074/jbc.M110.162685
   Kaiser R, 2012, WIEN MED WOCHENSCHR, V162, P239, DOI 10.1007/s10354-012-0105-0
   Kallio-Kokko H, 2005, FEMS MICROBIOL REV, V29, P1051, DOI 10.1016/j.femsre.2005.04.012
   Kerkvliet J, 2011, J VIROL, V85, P621, DOI 10.1128/JVI.01626-10
   Khunchai S, 2012, BIOCHEM BIOPH RES CO, V423, P398, DOI 10.1016/j.bbrc.2012.05.137
   Kindberg E, 2008, J INFECT DIS, V197, P266, DOI 10.1086/524709
   KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Kurhade C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0487-9
   Li HX, 2010, J GEN VIROL, V91, P2947, DOI 10.1099/vir.0.025205-0
   Li XD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002891
   Lin RT, 1999, MOL CELL BIOL, V19, P959
   Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lu HL, 2013, J IMMUNOL, V191, P3264, DOI 10.4049/jimmunol.1300512
   Luo MH, 2008, J VIROL, V82, P9994, DOI 10.1128/JVI.00943-08
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mandl CW, 2005, VIRUS RES, V111, P161, DOI 10.1016/j.virusres.2005.04.007
   Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0
   Miner JJ, 2016, CURR OPIN IMMUNOL, V38, P18, DOI 10.1016/j.coi.2015.10.008
   Nazmi A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021761
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nelson PJ, 1996, J IMMUNOL, V157, P1139
   Nikonov A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003610
   Nookala AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078855
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Ortiz BD, 1996, MOL CELL BIOL, V16, P202
   Painter MM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005311
   Palus M, 2014, J GEN VIROL, V95, P2411, DOI 10.1099/vir.0.068411-0
   Park GS, 2007, J VIROL, V81, P6936, DOI 10.1128/JVI.02830-06
   Parsons KS, 2014, CLIN EXP ALLERGY, V44, P91, DOI 10.1111/cea.12218
   Posadas I, 2016, NANOMEDICINE-UK, V11, P833, DOI 10.2217/nnm.16.15
   Ransohoff RM, 2007, INT REV NEUROBIOL, V82, P187, DOI 10.1016/S0074-7742(07)82010-1
   SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993
   Selinger M, 2017, J GEN VIROL, V98, P2043, DOI 10.1099/jgv.0.000853
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Subba-Reddy CV, 2011, J VIROL, V85, P13027, DOI 10.1128/JVI.06191-11
   Surasombatpattana P, 2011, INFECT GENET EVOL, V11, P1664, DOI 10.1016/j.meegid.2011.06.009
   Vegna S, 2016, J VIROL, V90, P6022, DOI 10.1128/JVI.03230-15
   Wu JQ, 2015, J VIROL, V89, P249, DOI 10.1128/JVI.02085-14
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yu GY, 2012, MOL CELL, V48, P313, DOI 10.1016/j.molcel.2012.07.032
   Zajkowska J, 2011, ADV MED SCI-POLAND, V56, P311, DOI 10.2478/v10039-011-0033-z
   Zellweger RM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003723
   Zhang LK, 2016, J VIROL, V90, P10259, DOI 10.1128/JVI.01292-16
   Zhang PF, 2014, J CELL SCI, V127, P2471, DOI 10.1242/jcs.139626
   Zhang XW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0665-9
   Zhang XW, 2016, VIRUS RES, V213, P6, DOI 10.1016/j.virusres.2015.11.006
   Zhang ZF, 2012, J IMMUNOL, V189, P1144, DOI 10.4049/jimmunol.1200096
NR 88
TC 7
Z9 7
U1 1
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JUL 1
PY 2018
VL 201
IS 1
BP 53
EP 68
DI 10.4049/jimmunol.1701507
PG 16
WC Immunology
SC Immunology
GA GR2HH
UT WOS:000442387100008
PM 29760190
OA Bronze
DA 2020-07-08
ER

PT J
AU Dinkar, A
   Singh, J
   Prakash, P
   Das, A
   Nath, G
AF Dinkar, Anju
   Singh, Jitendra
   Prakash, Pradyot
   Das, Arghya
   Nath, Gopal
TI Hidden burden of chikungunya in North India; A prospective study in a
   tertiary care centre
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Chikungunya; Dengue haemorrhagic fever; Co-infection; Vector borne
   diseases; Joint pain
ID DENGUE VIRUS; COINFECTION; INFECTION; FEVER; OUTBREAKS; EPIDEMIC;
   FEATURES; STRAINS; DELHI
AB Background: Arboviral diseases, such as chikungunya, dengue and now zika represent a public health problem, especially in tropical countries. Epidemiology of chikungunya and dengue is well known, including its social and climatic factors associated, but only few data and reports of chikungunya are available from North India. The clinical differentiation of chikungunya from dengue is no doubt challenging since both diseases can share clinical signs and symptoms leading to potential misdiagnosis of chikungunya in areas where dengue is endemic. The aim of this study was to know the seroprevalence, seasonal trends, clinical presentations of chikungunya and its co-infection with dengue virus.
   Methods: This was a prospective study conducted in Varanasi, from January to December 2016. All serum samples were tested for both chikungunya and dengue IgM antibodies by MAC ELISA test.
   Results: Total of 186 samples, out of which 108 (58%) samples were total seropositive, 23 (12.37%) samples positive for chikungunya IgM antibodies, 57 (30.65%) samples positive for dengue and 28 (15.05%) samples positive for both chikungunya and dengue. The most affected age group was 20-30 years and males were more affected than females. A seasonal peak for chikungunya and its co-infection with dengue were seen in November.
   Conclusion: In India, the seroprevalence of chikungunya is increasing. India is a rapidly developing country where adequate sanitation is required. More aggressive intervention and vigilance by health authorities is needed to decrease vector born diseases. (C) 2017 The Authors. Published by Elsevier Limited on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Dinkar, Anju; Prakash, Pradyot; Das, Arghya; Nath, Gopal] BHU, Inst Med Sci, Dept Microbiol, Varanasi, Uttar Pradesh, India.
   [Singh, Jitendra] Heritage Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India.
RP Singh, J (corresponding author), Heritage Inst Med Sci, Dept Med, Varanasi, Uttar Pradesh, India.
EM drjitengsvm@gmail.com
RI Prakash, Pradyot/AAD-7739-2020; Prakash, Pradyot/AAF-7411-2019; Dinkar,
   Anju/AAB-7473-2020
OI Prakash, Pradyot/0000-0003-3622-4295; Dinkar, Anju/0000-0003-2297-444X
CR Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209
   Balasubramaniam Sudharsanam M, 2011, Indian J Community Med, V36, P124, DOI 10.4103/0970-0218.84131
   Barraquer IR, 2015, PLOSNEGL TROP DIS, V9
   Bhooshan S, 2015, INT J HEALTHCARE BIO, V03, P117
   CAREY DE, 1969, T ROY SOC TROP MED H, V63, P434, DOI 10.1016/0035-9203(69)90030-3
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chipwaza B, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003335
   Dwibedi B, 2011, INDIAN J MED RES, V133, P316
   Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Hapuarachchi H. A. C., 2008, CEYLON MEDICAL JOURNAL, V53, P104
   Jitendra Singh, 2015, Advances in Bio Research, V6, P148
   Kalawat U, 2011, INDIAN J PATHOL MICR, V54, P844, DOI 10.4103/0377-4929.91518
   Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746
   Laoprasopwattana K, 2012, PEDIATR INFECT DIS J, V31, P459, DOI 10.1097/INF.0b013e31824bb06d
   Londhey Vikram, 2016, J Assoc Physicians India, V64, P36
   Mohanty Indrani, 2013, J Family Med Prim Care, V2, P33, DOI 10.4103/2249-4863.109939
   Omarjee R, 2013, EUROSURVEILLANCE, P19, DOI DOI 10.2807/1560-
   Ray P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030025
   Rezza G, 2014, EMERG INFECT DIS, V20, P1351, DOI 10.3201/eid2008.131615
   Saswat T, 2015, INFECT GENET EVOL, V35, P134, DOI 10.1016/j.meegid.2015.08.006
   SHAH KV, 1964, INDIAN J MED RES, V52, P676
   Singh J, 2014, INT J RES MED SCI, V2, P132
   Singh J, 2014, J MED SCI CLIN RES
   Singh J, 2014, INT J SCI RES, V3, P2251
   Singh Jitendra, 2017, J Assoc Physicians India, V65, P42
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   Tun MMN, 2014, EMERG INFECT DIS, V20, P1378, DOI 10.3201/eid2008.131431
   Velasco JM, 2015, AM J TROP MED HYG, V93, P1318, DOI 10.4269/ajtmh.15-0332
NR 31
TC 8
Z9 8
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD JUL-AUG
PY 2018
VL 11
IS 4
BP 586
EP 591
DI 10.1016/j.jiph.2017.09.008
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GK7JD
UT WOS:000436375300023
PM 28993172
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Manning, JE
   Morens, DM
   Kamhawi, S
   Valenzuela, JG
   Memoli, M
AF Manning, Jessica E.
   Morens, David M.
   Kamhawi, Shaden
   Valenzuela, Jesus G.
   Memoli, Matthew
TI Mosquito Saliva: The Hope for a Universal Arbovirus Vaccine?
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE arbovirus; mosquito; saliva; tick; vaccines
ID VIRUS-INFECTION; DENGUE VIRUS; LYME-DISEASE; SAND FLIES; VECTOR;
   PROTEIN; HOST; SKIN; BITES; CELLS
AB Arthropod-borne viruses (arboviruses) are taxonomically diverse causes of significant morbidity and mortality. In recent decades, important mosquito-borne viruses such as West Nile, chikungunya, dengue, and Zika have re-emerged and spread widely, in some cases pandemically, to cause serious public health emergencies. There are no licensed vaccines against most of these viruses, and vaccine development and use has been complicated by the number of different viruses to protect against, by subtype and strain variation, and by the inability to predict when and where outbreaks will occur. A new approach to preventing arboviral diseases is suggested by the observation that arthropod saliva facilitates transmission of pathogens, including leishmania parasites, Borrelia burgdorferi, and some arboviruses. Viruses carried within mosquito saliva may more easily initiate host infection by taking advantage of the host's innate and adaptive immune responses to saliva. This provides a rationale for creating vaccines against mosquito salivary proteins, rather than against only the virus proteins contained within the saliva. As proof of principle, immunization with sand fly salivary antigens to prevent leishmania infection has shown promising results in animal models. A similar approach using salivary proteins of important vector mosquitoes, such as Aedes aegypti, might protect against multiple mosquito-borne viral infections.
C1 [Manning, Jessica E.; Kamhawi, Shaden; Valenzuela, Jesus G.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Manning, Jessica E.; Memoli, Matthew] NIAID, Lab Infect Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Morens, David M.] NIAID, Off Director, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Manning, JE (corresponding author), NIAID, Lab Malaria & Vector Res, Infect Dis Lab, NIH, 12735 Twinbrook Pkwy,Room 2E22C, Rockville, MD 20852 USA.
EM jessica.manning@nih.gov
FU Intramural Research Program of the NIH, National Institute of Allergy
   and Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID)
FX This work was funded by the Intramural Research Program of the NIH,
   National Institute of Allergy and Infectious Diseases.
CR Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Collin N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000441
   Conway MJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004941
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Dai JF, 2009, CELL HOST MICROBE, V6, P482, DOI 10.1016/j.chom.2009.10.006
   Donovan MJ, 2007, INFECT IMMUN, V75, P2523, DOI 10.1128/IAI.01928-06
   Dorigatti I, 2017, EUROSURVEILLANCE, V22, P10, DOI 10.2807/1560-7917.ES.2017.22.28.30572
   Doucoure S, 2012, AM J TROP MED HYG, V87, P504, DOI 10.4269/ajtmh.2012.11-0477
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Gershman MD, 2017, MMWR-MORBID MORTAL W, V66, P457, DOI 10.15585/mmwr.mm6617e2
   Gomes R, 2008, P NATL ACAD SCI USA, V105, P7845, DOI 10.1073/pnas.0712153105
   Gomes R, 2012, J INVEST DERMATOL, V132, P2735, DOI 10.1038/jid.2012.205
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hopp CS, 2015, ANN NY ACAD SCI, V1342, P37, DOI 10.1111/nyas.12661
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Londono-Renteria B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081211
   McCracken MK, 2014, VIROLOGY, V468, P133, DOI 10.1016/j.virol.2014.07.019
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Moser LA, 2016, J VIROL, V90, P292, DOI 10.1128/JVI.02280-15
   Murfin KE, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00222
   Neelakanta G, 2015, ARCH IMMUNOL THER EX, V63, P169, DOI 10.1007/s00005-014-0324-8
   Odegaard F, 2000, BIOL J LINN SOC, V71, P583, DOI 10.1006/bijl.2000.0468
   Olds CL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1774-0
   Oliveira F, 2009, PARASITOL INT, V58, P1, DOI 10.1016/j.parint.2008.07.004
   Oliveira F, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3043
   Oliveira F, 2013, J INVEST DERMATOL, V133, P452, DOI 10.1038/jid.2012.315
   Peng ZK, 2004, INT ARCH ALLERGY IMM, V133, P198, DOI 10.1159/000076787
   Peters NC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000484
   Pingen M, 2017, TRENDS PARASITOL, V33, P645, DOI 10.1016/j.pt.2017.04.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Reagan KL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001935
   Reed SG, 2016, EXPERT REV VACCINES, V15, P81, DOI 10.1586/14760584.2016.1105135
   Sauerwein RW, 2011, NAT REV IMMUNOL, V11, P57, DOI 10.1038/nri2902
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schneider BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011704
   Schneider BS, 2006, VIRAL IMMUNOL, V19, P74, DOI 10.1089/vim.2006.19.74
   Scholl DC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1638-7
   Spring M, 2014, J INFECT DIS, V209, P540, DOI 10.1093/infdis/jiu063
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Sultana H, 2016, TICKS TICK-BORNE DIS, V7, P46, DOI 10.1016/j.ttbdis.2015.08.003
   Surasombatpattana P, 2014, J INVEST DERMATOL, V134, P281, DOI 10.1038/jid.2013.251
   Thangamani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012137
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, GLOB BRIEF VECT BORN
   World Health Organization, WHO ADV DENGV US ONL
   Zahedifard F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002751
   Zeidner NS, 1999, PARASITE IMMUNOL, V21, P35, DOI 10.1046/j.1365-3024.1999.00199.x
NR 56
TC 12
Z9 13
U1 0
U2 22
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUL 1
PY 2018
VL 218
IS 1
BP 7
EP 15
DI 10.1093/infdis/jiy179
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GJ0GQ
UT WOS:000434930900003
PM 29617849
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Hatala, AJ
   Harrington, LC
   Degner, EC
AF Hatala, A. J.
   Harrington, L. C.
   Degner, E. C.
TI Age and Body Size Influence Sperm Quantity in Male Aedes albopictus
   (Diptera: Culicidae) Mosquitoes
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE larval diet; spermatogenesis; modified male release; mating; male
   reproductive success
ID CHIKUNGUNYA VIRUS; AEGYPTI DIPTERA; REUNION ISLAND; VECTOR; DENGUE;
   POLYANDRY; FIELD; LONGEVITY; FECUNDITY; DEPLETION
AB Aedes albopictus (Skuse) (Diptera: Culicidae) is a vector of several arboviruses impacting human health, including dengue, chikungunya, and potentially Zika. Vector control strategies that deploy modified males into the field are in use or under development and require a solid understanding of male biology; unfortunately, there has been limited effort to understand male Ae. albopictus reproductive biology, including sperm production and capacity. We tested whether body size and age affect spermatogenesis in Ae. albopictus. In general, older and larger males produced more sperm than their younger or smaller counterparts. Large males continued spermatogenesis well after 10-d post-eclosion (dpe), augmenting their reserves by 39%. By contrast, small males stopped producing sperm at 10 dpe. These results contribute to a deeper understanding of Ae. albopictus reproductive physiology. We discuss the usefulness of these findings in the context of Ae. albopictus life history and their utility in optimizing male mosquito release strategies.
C1 [Hatala, A. J.; Harrington, L. C.; Degner, E. C.] Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.
RP Degner, EC (corresponding author), Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.
EM ecd77@cornell.edu
FU Cornell Graduate School fellowship; NIH/NIAIDUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI095491]
FX We thank Sylvie Pitcher for technical expertise and Dr. Alongkot
   Ponlawat for experimental guidance. This work was funded in part by a
   Cornell Graduate School fellowship (to E.C.D.) and NIH/NIAID grant
   R01AI095491.
CR Alfonso-Parra C, 2014, J INSECT PHYSIOL, V70, P117, DOI 10.1016/j.jinsphys.2014.07.004
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Bjork A, 2007, BIOL LETTERS, V3, P517, DOI 10.1098/rsbl.2007.0219
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040
   BULLINI L, 1976, B ENTOMOL RES, V65, P683, DOI 10.1017/S0007485300006374
   Clements A. N., 1992, BIOL MOSQUITOES DEV, V1
   CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499
   Degner EC, 2016, AM J TROP MED HYG, V94, P780, DOI 10.4269/ajtmh.15-0893
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   HAUSERMANN W, 1975, J MED ENTOMOL, V11, P707, DOI 10.1093/jmedent/11.6.707
   Helinski MEH, 2013, ECOL CONT VECTOR-BOR, V3, P221
   Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003
   Helinski MEH, 2012, AM J TROP MED HYG, V86, P635, DOI 10.4269/ajtmh.2012.11-0225
   Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071
   IBM, 2016, IBM SPSS STAT 24 COR
   Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P3, DOI 10.1007/1-4020-4051-2_1
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Macias VM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091006
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Moatt JP, 2014, PHYSIOL BEHAV, V131, P111, DOI 10.1016/j.physbeh.2014.04.027
   Mondet B, 1996, B SOC PATHOL EXOT, V89, P107
   Muller GC, 2011, ACTA TROP, V118, P45, DOI 10.1016/j.actatropica.2011.01.009
   O'Connor L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001797
   Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884
   Oliva CF, 2013, ACTA TROP, V125, P287, DOI 10.1016/j.actatropica.2012.11.010
   Oliva CF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049414
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2
   Reisen WK, 2003, WAG UR FRON, V2, P25
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Richardson JB, 2015, AM J TROP MED HYG, V93, P189, DOI 10.4269/ajtmh.14-0718
   Shaw WR, 2014, P NATL ACAD SCI USA, V111, P5854, DOI 10.1073/pnas.1401715111
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Tripet F, 2003, AM J TROP MED HYG, V68, P1
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121126
NR 46
TC 4
Z9 4
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD JUL
PY 2018
VL 55
IS 4
BP 1051
EP 1054
DI 10.1093/jme/tjy040
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GM5ZK
UT WOS:000438232000040
PM 29618076
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Nascimento, EJM
   George, JK
   Velasco, M
   Bonaparte, MI
   Zheng, LY
   DiazGranados, CA
   Marques, ETA
   Huleatt, JW
AF Nascimento, Eduardo J. M.
   George, James K.
   Velasco, Melissa
   Bonaparte, Matthew I.
   Zheng, Lingyi
   DiazGranados, Carlos A.
   Marques, Ernesto T. A.
   Huleatt, James W.
TI Development of an anti-dengue NS1 IgG ELISA to evaluate exposure to
   dengue virus
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Enzyme-Linked immunosorbent assay; Flavivirus; Neutralization assay;
   Non-Structural protein 1; Dengue virus; IgG; Seroprevalence
ID VACCINE; ANTIBODIES; ASSAY
AB Dengue virus infection elicits immune responses to multiple viral antigens including antibodies to dengue nonstructural protein 1 (NS1) which are rapidly induced and detected within days of infection. The recombinant, live, attenuated, tetravalent dengue vaccine (CYD-TDV; Sanofi Pasteur) uses the yellow fever vaccine virus as a back-bone but expresses dengue virus pre-membrane and envelop proteins. Since CYD-TDV does not express dengue NS1, we evaluated the utility of dengue NS1-specific IgG antibodies as biomarkers of dengue exposure in CYD-TDV recipients and controls. We optimized and evaluated a quantitative anti-dengue NS1 IgG enzyme linked immunosorbent assay (ELISA). Parameters assessed included: accuracy, dilutability/linearity, precision, limit of quantitation and specificity. The assay specificity was further evaluated using Japanese Encephalitis virus, West Nile virus, Yellow Fever virus or Zika virus positive sera samples collected following confirmed infection or vaccination. Receiver-operating-characteristics (ROC) curves as well as sensitivity and specificity for discriminating previous dengue exposure were assessed using 1250 reference samples. Overall, the anti-dengue NS1 IgG ELISA was able to discriminate previous dengue exposure from non-exposure before vaccination with CYD-TDV (ROC area under the curve > 0.9). Assessment of paired samples from 2511 vaccinated participants showed high overall agreement (93%) between pre-vaccination and post-vaccination dengue serostatus classification based on the anti-dengue NS1 IgG ELISA. However, misclassification of dengue serostatus was observed after vaccination likely due to a combination of asymptomatic dengue infections, assay variability and a modest effect of CYD-TDV on the anti-dengue NS1 IgG ELISA readout.
C1 [Nascimento, Eduardo J. M.; George, James K.; Velasco, Melissa; Bonaparte, Matthew I.; Zheng, Lingyi; DiazGranados, Carlos A.; Huleatt, James W.] Sanofi Pasteur, Discovery Dr, Swiftwater, PA 18370 USA.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Grad Sch Publ Hlth, Biomed Sci Tower 3,Room 9052,3501 5th Ave, Pittsburgh, PA 15261 USA.
   [Marques, Ernesto T. A.] Univ Pittsburgh, Ctr Vaccine Res, Biomed Sci Tower 3,Room 9052,3501 5th Ave, Pittsburgh, PA 15261 USA.
   [Marques, Ernesto T. A.] Oswaldo Cruz Fdn FIOCRUZ, Aggeu Magalhaes Inst, Av Prof Moraes Rego S-N,Campus UFPE, BR-50740465 Recife, PE, Brazil.
RP Huleatt, JW (corresponding author), Sanofi Pasteur, Discovery Dr, Swiftwater, PA 18370 USA.
EM Eduardo.Nascimento@sanofi.com; James.Huleatt@sanofi.com
RI Marques, Ernesto T. A/L-4967-2013
OI Marques, Ernesto T. A/0000-0003-3826-9358
FU Sanofi Pasteur
FX This study was funded by Sanofi Pasteur.
CR Arredondo-Garcia JL, 2018, CLIN MICROBIOL INFEC, V24, P755, DOI 10.1016/j.cmi.2018.01.018
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Hernandez-Avila M, 2016, SALUD PUBLICA MEXICO, V58, P71, DOI 10.21149/spm.v58i1.7670
   ICH Harmonised Tripartite Guideline, 2005, VAL AN PROC TEXT MET, VQ2
   Malisheni M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00863
   Moodie Z, 2017, J INFECT DIS
   *NAT COMM CLIN LAB, 2004, EP17A NCCLS
   OCONNELL MA, 1993, CHEMOMETR INTELL LAB, V20, P97, DOI 10.1016/0169-7439(93)80008-6
   Olivera-Botello G, 2016, J INFECT DIS, V214, P994, DOI 10.1093/infdis/jiw297
   Quinn CP, 2002, EMERG INFECT DIS, V8, P1103, DOI 10.3201/eid0810.020380
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
NR 21
TC 16
Z9 17
U1 3
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD JUL
PY 2018
VL 257
BP 48
EP 57
DI 10.1016/j.jviromet.2018.03.007
PG 10
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA GI8BA
UT WOS:000434745600009
PM 29567514
OA Other Gold
DA 2020-07-08
ER

PT J
AU Poland, GA
   Kennedy, RB
   Ovsyannikova, IG
   Palacios, R
   Ho, PL
   Kalil, J
AF Poland, Gregory A.
   Kennedy, Richard B.
   Ovsyannikova, Inna G.
   Palacios, Ricardo
   Ho, Paulo Lee
   Kalil, Jorge
TI Development of vaccines against Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID ORIGINAL ANTIGENIC SIN; YELLOW-FEVER; WESTERN-HEMISPHERE;
   INFLUENZA-VIRUSES; DENGUE VIRUS; GLIAL-CELLS; INFECTION; TRANSMISSION;
   VACCINATION; ANTIBODIES
AB Zika virus is an emerging pathogen of substantial public health concern to human beings. Although most infections are asymptomatic or present with benign, self-limited symptoms, a small percentage of patients have complications, such as congenital anomalies in the developing fetus of pregnant women infected with the virus and neurological complications (eg, Guillain-Barre syndrome). To date, there is no vaccine, antiviral drug, or other modality available to prevent or treat Zika virus infection. In this Review, we examine vaccine development efforts for Zika virus to date and research gaps in the development of candidate vaccines against Zika virus. Top research priorities should include development of a better understanding of immunity to Zika virus to establish clear correlates of protection; determination of what effect, if any, Zika vaccine-induced immune responses will have on subsequent dengue virus infection; evaluation of vaccine immunogenicity and efficacy in healthy adults and in the various subpopulations affected by Zika virus infection (children, pregnant women, women of childbearing age, and eldery people); and identification of the molecular mechanisms that underlie birth defects and neurological sequelae related to Zika virus.
C1 [Poland, Gregory A.; Kennedy, Richard B.; Ovsyannikova, Inna G.] Mayo Clin, Vaccine Res Grp, Rochester, MN USA.
   [Palacios, Ricardo; Ho, Paulo Lee] Inst Butantan, Sao Paulo, Brazil.
   [Kalil, Jorge] Univ Sao Paulo, Sch Med, Sao Paulo, Brazil.
   [Kalil, Jorge] Univ Sao Paulo, Inst Heart, Sao Paulo, Brazil.
RP Poland, GA (corresponding author), Mayo Clin, Mayo Vaccine Res Grp, Rochester, MN 55905 USA.
EM poland.gregory@mayo.edu
RI amsalu, ribka/G-8780-2019; Palacios, Ricardo/AAN-7606-2020
OI Palacios, Ricardo/0000-0002-1410-8579
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Barba-Spaeth G, NW16, V536, P48
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3588
   Favoretto S, 2016, BIORXIV
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Fulton TR, 2015, VACCINE, V33, P6453, DOI 10.1016/j.vaccine.2015.08.043
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gulati U, 2005, VACCINE, V23, P1414, DOI 10.1016/j.vaccine.2004.08.053
   Gulich GA, 2016, J INFECT DIS THER, V4, P278
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kim JH, 2012, P NATL ACAD SCI USA, V109, P13751, DOI 10.1073/pnas.0912458109
   Kim JH, 2009, J IMMUNOL, V183, P3294, DOI 10.4049/jimmunol.0900398
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   National Institute of Allergy and Infectious Diseases, 2016, NIH BEG TEST INV ZIK
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Omer SB, 2016, JAMA-J AM MED ASSOC, V315, P1227, DOI 10.1001/jama.2016.2237
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Palacios R, 2016, VACCINE, V34, P2291, DOI 10.1016/j.vaccine.2016.03.059
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Plotkin SA, 2015, NEW ENGL J MED, V373, P297, DOI 10.1056/NEJMp1506820
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   WHO, 2017, ZIK SIT REP ZIK VIR
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2016, CURR ZIK PROD PIP
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 81
TC 47
Z9 47
U1 6
U2 29
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD JUL
PY 2018
VL 18
IS 7
BP E211
EP E219
DI 10.1016/S1473-3099(18)30063-X
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA GL0QI
UT WOS:000436794600003
PM 29396004
OA Bronze
DA 2020-07-08
ER

PT J
AU Herrera, BB
   Tsai, WY
   Brites, C
   Luz, E
   Pedroso, C
   Drexler, JF
   Wang, WK
   Kanki, PJ
AF Herrera, Bobby Brooke
   Tsai, Wen-Yang
   Brites, Carlos
   Luz, Estela
   Pedroso, Celia
   Drexler, Jan Felix
   Wang, Wei-Kung
   Kanki, Phyllis J.
TI T Cell Responses to Nonstructural Protein 3 Distinguish Infections by
   Dengue and Zika Viruses
SO MBIO
LA English
DT Article
DE Brazil; dengue virus; T cell immunity; Zika virus; nonstructural protein
   3
ID MHC CLASS-I; ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN;
   CROSS-REACTIVITY; PEPTIDE; CYTOSOL; PATHOGENESIS; EPITOPES; IMMUNITY;
   BINDING
AB The 2015-2016 Zika virus (ZIKV) epidemic in the Americas and the Caribbean demonstrated that clinical assays to detect, distinguish, and characterize immune responses to flaviviral infections are needed. ZIKV and dengue virus (DENV) are mosquito-transmitted flaviviruses sharing overlapping geographic distributions and have significant sequence similarities that can increase the potential for antibody and T cell cross-reaction. Using nonstructural protein 1-based enzyme-linked immunosorbent assays (ELISA5), we determined the serostatus of individuals living in a region of DENV and ZIKV endemicity in Brazil, identifying individuals with primary DENV (pDENV) and primary ZIKV (pZIKV), ZIKV with primary DENV (ZIKVwpDENV), and secondary DENV (sDENV) infections; the presence of pDENV and pZIKV was further confirmed by neutralization tests. Development of an enzyme-linked immunosorbent spot (ELISPOT) assay for DENV and ZIKV structural and nonstructural (NS) protein antigens enabled us to distinguish infections by these viruses based on T cell responses and to characterize those responses. We found that gamma interferon (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) T cell responses to NS3 differentiated DENV and ZIKV infections with 94% sensitivity and 92% specificity. In general, we also showed that pDENV and sDENV cases and pZIKV and ZIKVwpDENV cases elicit similar T cell response patterns and that HIV-infected individuals show T cell responses that are lower than those shown by HIV-negative individuals. These results have important implications for DENV and ZIKV diagnostic and vaccine development and provide critical insights into the T cell response in individuals with multiple flaviviral infections.
   IMPORTANCE The potential for antibody and T cell cross-reactions to DENV and ZIKV, flaviviruses that cocirculate and can sequentially infect individuals, has complicated diagnostic and vaccine development. Our serological data show that antibodies to nonstructural protein 1 can distinguish sequential human infections by DENV and ZIKV. The development of a simple and inexpensive assay also enables the differentiation of DENV and ZIKV infections based on characterization of T cell responses. Our T cell data reveal strong response patterns that are similar in nature to those seen with individuals with one or multiple DENV infections and with individuals with only primary ZIKV infection and ZIKV-infected individuals with previous DENV exposure. The characterization of T cell responses in a serologically validated group of individuals is of relevance to the development of vaccines and immunotherapeutics against these global threats.
C1 [Herrera, Bobby Brooke; Kanki, Phyllis J.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Tsai, Wen-Yang; Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Brites, Carlos; Luz, Estela; Pedroso, Celia] Univ Fed Bahia, Sch Med, Lab Infect Res, Salvador, BA, Brazil.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Drexler, Jan Felix] German Ctr Infect Res, Braunschweig, Germany.
RP Kanki, PJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Wang, WK (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
EM wkwang@hawaii.edu; pkanki@hsph.harvard.edu
OI Drexler, Jan Felix/0000-0002-3509-0232
FU Harvard University David Rockefeller Center for Latin American Studies;
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI110769-01]; National Institute of General Medical Sciences,
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P20GM103516]
FX This work was funded by a Harvard University David Rockefeller Center
   for Latin American Studies grant to B.B.H. and by grants R01AI110769-01
   from the National Institute of Allergy and Infectious Diseases and
   P20GM103516 from the National Institute of General Medical Sciences,
   NIH, to W.-K.W. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cao HY, 2002, J INFECT DIS, V185, P244, DOI 10.1086/338448
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Horig H, 1999, J IMMUNOL, V163, P4434
   Johnson BW, 2005, VECTOR-BORNE ZOONOT, V5, P137, DOI 10.1089/vbz.2005.5.137
   Karlsson RK, 2004, J IMMUNOL METHODS, V285, P89, DOI 10.1016/j.jim.2003.11.013
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kushner N, 2003, P NATL ACAD SCI USA, V100, P6652, DOI 10.1073/pnas.1131930100
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liao Q, 2012, VACCINE, V30, P1601, DOI 10.1016/j.vaccine.2011.12.117
   Lu YC, 2000, P NATL ACAD SCI USA, V97, P8027, DOI 10.1073/pnas.97.14.8027
   MADDEN DR, 1995, ANNU REV IMMUNOL, V13, P587, DOI 10.1146/annurev.iy.13.040195.003103
   McEvers K, 2005, VACCINE, V23, P4128, DOI 10.1016/j.vaccine.2005.03.022
   McLinden JH, 2008, J INFECT DIS, V198, P860, DOI 10.1086/591254
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Peirson TC, 2013, FIELDS VIROLOGY
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Sarr AD, 2001, AIDS RES HUM RETROV, V17, P1257, DOI 10.1089/088922201750461311
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stryhn A, 2000, EUR J IMMUNOL, V30, P3089, DOI 10.1002/1521-4141(200011)30:11<3089::AID-IMMU3089>3.0.CO;2-5
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Watt G, 2003, CLIN INFECT DIS, V36, P1067, DOI 10.1086/374600
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 48
TC 3
Z9 3
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD JUL-AUG
PY 2018
VL 9
IS 4
AR e00755-18
DI 10.1128/mBio.00755-18
PG 15
WC Microbiology
SC Microbiology
GA GS7MC
UT WOS:000443884300010
PM 30087165
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Volkova, E
   Grinev, A
   Fares-Gusmao, R
   Chancey, C
   Rios, M
AF Volkova, Evgeniya
   Grinev, Andriyan
   Fares-Gusmao, Rafaelle
   Chancey, Caren
   Rios, Maria
TI Complete Genome Sequences of Zika Virus Strains Used for the Formulation
   of CBER/FDA RNA Reference Reagents and Lot Release Panels for Nucleic
   Acid Technology Testing
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID INFECTION; TRANSMISSION; OUTBREAK; BRAZIL; EMERGENCE; INFANTS; ISLAND
AB We report here the complete genome sequences of two Zika virus strains (FSS13025 and PRVABC59) used for formulation of CBER/FDA RNA reference reagents and lot release panels for use with nucleic acid technology (NAT) testing.
C1 [Volkova, Evgeniya; Grinev, Andriyan; Fares-Gusmao, Rafaelle; Chancey, Caren; Rios, Maria] US FDA, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
RP Rios, M (corresponding author), US FDA, Div Emerging & Transfus Transmitted Dis, Lab Emerging Pathogens, Off Blood Res & Review,Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.
EM Maria.Rios@fda.hhs.gov
OI Fares Gusmao, Rafaelle/0000-0002-2186-4145
FU FDA Medical Countermeasure Initiative Funding (MCMi) Intramural Research
   Program; U.S. Department of EnergyUnited States Department of Energy
   (DOE); FDAUnited States Department of Health & Human Services
FX This work was supported by the FDA Medical Countermeasure Initiative
   Funding (MCMi) Intramural Research Program. This project was supported
   in part by an appointment to the Research Participation Program at the
   OBRR/CBER, U.S. Food and Drug Administration, administered by the Oak
   Ridge Institute for Science and Education (ORISE) through an interagency
   agreement between the U.S. Department of Energy and the FDA.
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Centers for Disease Control and Prevention, 2016, 2016 CAS COUNTS US
   Centers for Disease Control and Prevention, 2016, HLTH ADV REC MAN REP
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   U.S. Food and Drug Administration, 2017, FDA APPR 1 TEST SCRE
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 35
TC 0
Z9 0
U1 5
U2 21
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JUL
PY 2018
VL 6
IS 27
AR UNSP e00572-18
DI 10.1128/genomeA.00572-18
PG 3
WC Microbiology
SC Microbiology
GA HD2WF
UT WOS:000452372000006
PM 29976606
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Mann, TZ
   Haddad, LB
   Williams, TR
   Hills, SL
   Read, JS
   Dee, DL
   Dziuban, EJ
   Perez-Padilla, J
   Jamieson, DJ
   Honein, MA
   Shapiro-Mendoza, CK
AF Mann, Taylor Z.
   Haddad, Lisa B.
   Williams, Tonya R.
   Hills, Susan L.
   Read, Jennifer S.
   Dee, Deborah L.
   Dziuban, Eric J.
   Perez-Padilla, Janice
   Jamieson, Denise J.
   Honein, Margaret A.
   Shapiro-Mendoza, Carrie K.
TI Breast milk transmission of flaviviruses in the context of Zika virus: A
   systematic review
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Review
DE breast feeding transmission; breast milk; flavivirus; Zika virus
ID WEST-NILE-VIRUS; FEVER VACCINE VIRUS; BORNE TRANSMISSION; BRAZIL;
   INFECTION; LACTATION; HAMSTERS
AB BackgroundSince the Zika virus epidemic in the Americas began in 2015, Zika virus transmission has occurred throughout the Americas. However, limited information exists regarding possible risks of transmission of Zika virus and other flaviviruses through breast feeding and human milk. We conducted a systematic review of the evidence regarding flaviviruses detection in and transmission through milk, specifically regarding Zika virus, Japanese encephalitis virus, tick-borne encephalitis virus, Powassan virus, West Nile virus, dengue virus, and yellow fever virus.
   MethodsMedline, Embase, Global Health, CINAHL, Cochrane Library, Scopus, Popline, Virtual Health Library, and WorldCat were searched through June 2017. Two authors independently screened potential studies for inclusion and extracted data. Human and nonhuman (animal) studies describing: 1) confirmed or suspected cases of mother-to-child transmission through milk; or 2) the presence of flavivirus genomic material in milk.
   ResultsSeventeen studies were included, four animal models and thirteen observational studies. Dengue virus, West Nile virus, and Zika virus viral ribonucleic acid was detected in human milk, including infectious Zika virus and dengue virus viral particles. Human breast-feeding transmission was confirmed for only yellow fever virus. There was evidence of milk-related transmission of dengue virus, Powassan virus, and West Nile virus in animal studies.
   ConclusionsBecause the health advantages of breast feeding are considered greater than the potential risk of transmission, the World Health Organization recommends that mothers with possible or confirmed Zika virus infection or exposure continue to breast feed. This review did not identify any data that might alter this recommendation.
C1 [Mann, Taylor Z.; Honein, Margaret A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
   [Mann, Taylor Z.] ORISE, Res Participat Program, Atlanta, GA USA.
   [Haddad, Lisa B.; Dee, Deborah L.; Jamieson, Denise J.; Shapiro-Mendoza, Carrie K.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA USA.
   [Haddad, Lisa B.; Jamieson, Denise J.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
   [Williams, Tonya R.] Ctr Dis Control & Prevent, Div Human Dev & Disabil, Atlanta, GA USA.
   [Hills, Susan L.; Read, Jennifer S.; Perez-Padilla, Janice] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Dee, Deborah L.; Dziuban, Eric J.] United States Publ Hlth Serv, Commissioned Corps, Rockville, MD USA.
RP Mann, TZ (corresponding author), Ctr Dis Control & Prevent, Div Congenital & Dev Disabilities, Atlanta, GA 30329 USA.
EM mov8@cdc.gov
RI Shapiro-Mendoza, Carrie/H-3596-2019
OI Shapiro-Mendoza, Carrie/0000-0002-8204-8782; Jamieson,
   Denise/0000-0003-2597-1201; Mann, Taylor/0000-0002-9648-2520
FU National Institute of Child Health and Human DevelopmentUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [1K23HD078153-01A1]
FX Mr. Mann's effort was supported in part by an appointment to the
   Research Participation Program at the CDC administered by the Oak Ridge
   Institute for Science and Education through an interagency agreement
   between the U.S. Department of Energy and CDC/ATSDR. Dr. Haddad's effort
   was supported by the National Institute of Child Health and Human
   Development (1K23HD078153-01A1).
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Arragain L, 2017, J PEDIAT INF DIS SOC, V6, P324, DOI 10.1093/jpids/piw058
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Besnard M, 2014, EUROSURVEILLANCE, V19, P61
   Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009
   Blohm G.M., 2017, GENOME ANNOUNC, V5
   Bracken MB, 2008, JLL B COMMENTARIES H
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Centers for Disease Control and Prevention, BREASTF REP CARD PRO
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P877
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Couto A. Mallmann, 2010, Morbidity and Mortality Weekly Report, V59, P130
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Freitas AR, 2016, REV INST MED TROP SP, V58, pe24
   Gartner LM, 2005, PEDIATRICS, V115, P496, DOI [10.1542/peds.2011-3552, 10.1542/peds.2004-2491]
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hinckley AF, 2007, PEDIATRICS, V119, pE666, DOI 10.1542/peds.2006-2107
   Ip Stanley, 2007, Evid Rep Technol Assess (Full Rep), P1
   Kuhn S, 2011, CAN MED ASSOC J, V183, pE243, DOI 10.1503/cmaj.100619
   Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REAGAN RL, 1956, J IMMUNOL, V76, P243
   REAGAN RL, 1956, AM J TROP MED HYG, V5, P809, DOI 10.4269/ajtmh.1956.5.809
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Traiber C, 2011, J PEDIAT-BRAZIL, V87, P269, DOI [10.2223/JPED.2067, 10.1590/S0021-75572011000300015]
   WOODALL JP, 1977, AM J TROP MED HYG, V26, P190, DOI 10.4269/ajtmh.1977.26.190
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 33
TC 14
Z9 14
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
PD JUL
PY 2018
VL 32
IS 4
BP 358
EP 368
DI 10.1111/ppe.12478
PG 11
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA GO3BC
UT WOS:000439857600007
PM 29882971
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Meghani, Z
   Boete, C
AF Meghani, Zahra
   Boete, Christophe
TI Genetically engineered mosquitoes, Zika and other arboviruses, community
   engagement, costs, and patents: Ethical issues
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID LESSONS
C1 [Meghani, Zahra] Univ Rhode Isl, Dept Philosophy, Kingston, RI 02881 USA.
   [Boete, Christophe] Univ Montpellier, CNRS, Inst Sci Evolut Montpellier, IRD,EPHE, Montpellier, France.
RP Meghani, Z (corresponding author), Univ Rhode Isl, Dept Philosophy, Kingston, RI 02881 USA.
EM meghaniz@uri.edu
RI BOETE, Christophe/A-7926-2010
OI BOETE, Christophe/0000-0001-9043-8652
CR Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   [Anonymous], DRAFT ENV ASS INV US, P66
   Benhabib S., 2016, STRONG DEMOCRACY CRI, P79
   Boete C, 2016, LANCET GLOB HEALTH, V4, pE363, DOI 10.1016/S2214-109X(16)00084-X
   Burt A, 2003, P ROY SOC B-BIOL SCI, V270, P921, DOI 10.1098/rspb.2002.2319
   Courtier-Orgogozo V, 2017, EMBO REP, V18, P878, DOI 10.15252/embr.201744205
   de Campos AS, 2017, J RESPONSIBLE INNOV, V4, P5, DOI 10.1080/23299460.2017.1326257
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Gill S, 2017, INT J HEALTH POLICY, V6, P237, DOI 10.15171/ijhpm.2016.119
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   International Risk Governance Council, 2017, GOV EM RISKS
   Kolopack PA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003713
   Lwin KM, 2014, BMC MED ETHICS, V15, DOI 10.1186/1472-6939-15-12
   Macer D, 2006, GENETICALLY MODIFIED
   Meghani Z., 2017, REGULATION CONSUMER
   Meghani Z, 2018, J RESPONSIBLE INNOV, V5, pS203, DOI 10.1080/23299460.2017.1407912
   Neuhaus CP, 2017, NAT BIOTECHNOL, V35, P713, DOI 10.1038/nbt.3927
   Pechlaner G, 2010, RURAL SOCIOL, V75, P179, DOI 10.1111/j.1549-0831.2009.00006.x
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Regalado A., 2016, MIT TECHNOLOGY REV
   Rose DB, 2013, ENVIRON HUMANITIES, V3, P93, DOI 10.1215/22011919-3611248
   Servick K., 2016, WILL IT WORK
   Wilson Sabrina, 2014, EMORY LJ, V64, P169
NR 24
TC 9
Z9 9
U1 1
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006501
DI 10.1371/journal.pntd.0006501
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700008
PM 30048441
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, B
   Gao, SJ
AF Tan, Brandon
   Gao, Shou-Jiang
TI RNA epitranscriptomics: Regulation of infection of RNA and DNA viruses
   by N-6-methyladenosine (m(6)A)
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE hepatitis C virus; HCV; human immunodeficiency virus; HIV; influenza A
   virus; IAV; Kaposi sarcoma-associated herpesvirus; KSHV;
   N-6-methyladenosine; m(6)A; Zika virus; ZIKA
ID SARCOMA-ASSOCIATED HERPESVIRUS; BACTERIAL ARTIFICIAL CHROMOSOME;
   MESSENGER-RNA; KAPOSIS-SARCOMA; GENE-EXPRESSION; METHYLATED NUCLEOTIDES;
   GROWTH-FACTOR; NUCLEAR-RNA; CELL FATE; N6-METHYLADENOSINE
AB N-6-methyladenosine (m(6)A) was discovered 4 decades ago. However, the functions of m(6)A and the cellular machinery that regulates its changes have just been revealed in the last few years. m(6)A is an abundant internal mRNA modification on cellular RNA and is implicated in diverse cellular functions. Recent works have demonstrated the presence of m(6)A in the genomes of RNA viruses and transcripts of a DNA virus with either a proviral or antiviral role. Here, we first summarize what is known about the m(6)A writers, erasers, readers, and antireaders as well as the role of m(6)A in mRNA metabolism. We then review how the replications of numerous viruses are enhanced and restricted by m(6)A with emphasis on the oncogenic DNA virus, Kaposi sarcoma-associated herpesvirus (KSHV), whose m(6)A epitranscriptome was recently mapped. In the context of KSHV, m(6)A and the reader protein YTHDF2 acts as an antiviral mechanism during viral lytic replication. During viral latency, KSHV alters m(6)A on genes that are implicated in cellular transformation and viral latency. Lastly, we discuss future studies that are important to further delineate the functions of m(6)A in KSHV latent and lytic replication and KSHV-induced oncogenesis.
C1 [Tan, Brandon; Gao, Shou-Jiang] Univ Southern Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90007 USA.
   [Gao, Shou-Jiang] Shantou Univ, Coll Med, Lab Human Virol & Oncol, Shantou, Guangdong, Peoples R China.
   [Gao, Shou-Jiang] Nanjing Med Univ, Dept Microbiol, Nanjing, Jiangsu, Peoples R China.
RP Gao, SJ (corresponding author), Univ Southern Calif, Dept Mol Microbiol & Immunol, Keck Sch Med, Los Angeles, CA 90007 USA.
EM shoujiag@usc.edu
RI Gao, Shou-Jiang/B-8641-2012
OI Tan, Brandon/0000-0002-6326-202X; Gao, Shou-Jiang/0000-0001-6194-1742
FU National Cancer InstituteUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [CA096512, CA124332, CA132637, CA177377, CA197153,
   CA213275]; National Institute of Dental and Craniofacial ResearchUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Dental & Craniofacial
   Research (NIDCR) [DE025465]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [CA096512,
   CA124332, CA132637, CA177377, CA197153, CA213275, DE025465]
FX National Cancer Institute, Grant/Award Numbers: CA096512, CA124332,
   CA132637, CA177377, CA197153 and CA213275; National Institute of Dental
   and Craniofacial Research, Grant/Award Number: DE025465; NIH, Grant/
   Award Numbers: CA197153, DE025465, CA213275, CA177377, CA132637,
   CA124332 and CA096512
CR ABRAHAM G, 1975, CELL, V5, P51, DOI 10.1016/0092-8674(75)90091-4
   ADAMS JM, 1975, NATURE, V255, P28, DOI 10.1038/255028a0
   Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281
   ALONI Y, 1979, J VIROL, V32, P52, DOI 10.1128/JVI.32.1.52-60.1979
   Arguello AE, 2017, J AM CHEM SOC, V139, P17249, DOI 10.1021/jacs.7b09213
   BADER JP, 1978, VIROLOGY, V89, P494, DOI 10.1016/0042-6822(78)90191-5
   Bais C, 1998, NATURE, V391, P86
   Bartosovic M, 2017, NUCLEIC ACIDS RES, V45, P11356, DOI 10.1093/nar/gkx778
   Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019
   BEEMON K, 1977, J MOL BIOL, V113, P165, DOI 10.1016/0022-2836(77)90047-X
   Boccaletto P., 2017, NUCL ACIDS RES
   Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002
   Bokar JA, 1997, RNA, V3, P1233
   BOKAR JA, 1994, J BIOL CHEM, V269, P17697
   Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12
   Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102
   CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879
   Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879
   Chen K, 2015, ANGEW CHEM INT EDIT, V54, P1587, DOI 10.1002/anie.201410647
   Chen T, 2015, CELL STEM CELL, V16, P289, DOI 10.1016/j.stem.2015.01.016
   Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004
   DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971
   DESROSIERS RC, 1975, BIOCHEMISTRY-US, V14, P4367, DOI 10.1021/bi00691a004
   DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021
   DIMOCK K, 1978, BIOCHEMISTRY-US, V17, P3627, DOI 10.1021/bi00610a032
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626
   Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462
   Ensoli B, 1998, CYTOKINE GROWTH F R, V9, P63, DOI 10.1016/S1359-6101(97)00037-3
   FINKEL D, 1983, VIROLOGY, V131, P409, DOI 10.1016/0042-6822(83)90508-1
   Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848
   FURUICHI Y, 1975, NATURE, V257, P618, DOI 10.1038/257618a0
   FURUICHI Y, 1975, P NATL ACAD SCI USA, V72, P362, DOI 10.1073/pnas.72.1.362
   Fustin JM, 2013, CELL, V155, P793, DOI 10.1016/j.cell.2013.10.026
   Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Grundhoff A, 2004, J CLIN INVEST, V113, P124, DOI 10.1172/JCI200417803
   HASHIMOTO S, 1976, J VIROL, V20, P425, DOI 10.1128/JVI.20.2.425-435.1976
   Hess ME, 2013, NAT NEUROSCI, V16, P1042, DOI 10.1038/nn.3449
   Hong YK, 2004, NAT GENET, V36, P683, DOI 10.1038/ng1383
   HOROWITZ S, 1984, P NATL ACAD SCI-BIOL, V81, P5667, DOI 10.1073/pnas.81.18.5667
   Hsu PJ, 2017, CELL RES, V27, P1115, DOI 10.1038/cr.2017.99
   HSUCHEN CC, 1977, NUCLEIC ACIDS RES, V4, P2671, DOI 10.1093/nar/4.8.2671
   Ivanova I, 2017, MOL CELL, V67, P1059, DOI 10.1016/j.molcel.2017.08.003
   Jenner RG, 2001, J VIROL, V75, P891, DOI 10.1128/JVI.75.2.891-902.2001
   Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]
   Jones T, 2012, J CLIN INVEST, V122, P1076, DOI 10.1172/JCI58530
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012
   LAVI U, 1977, NUCLEIC ACIDS RES, V4, P63, DOI 10.1093/nar/4.1.63
   Lee MS, 2016, MBIO, V7, DOI 10.1128/mBio.02109-15
   Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10
   Li Y, 2017, CANC RES
   Li Y, 2015, RNA, V21, P1511, DOI 10.1261/rna.051474.115
   Li YL, 2014, RNA BIOL, V11, P1180, DOI 10.4161/rna.36281
   Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508
   Liu CQ, 2001, J VIROL, V75, P10933, DOI 10.1128/JVI.75.22.10933-10940.2001
   Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Loos RJF, 2014, NAT REV ENDOCRINOL, V10, P51, DOI 10.1038/nrendo.2013.227
   Luo GZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6630
   Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885
   Masood R, 1997, P NATL ACAD SCI USA, V94, P979, DOI 10.1073/pnas.94.3.979
   Massimelli MJ, 2015, VIRUSES-BASEL, V7, P496, DOI 10.3390/v7020496
   Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   MILES SA, 1992, SCIENCE, V255, P1432, DOI 10.1126/science.1542793
   Molinie B, 2016, NAT METHODS, V13, P692, DOI 10.1038/nmeth.3898
   Moody R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003857
   MOSS B, 1976, J VIROL, V17, P385, DOI 10.1128/JVI.17.2.385-392.1976
   MOSS B, 1977, J VIROL, V23, P234, DOI 10.1128/JVI.23.2.234-239.1977
   NARAYAN P, 1994, NUCLEIC ACIDS RES, V22, P419, DOI 10.1093/nar/22.3.419
   NARAYAN P, 1987, MOL CELL BIOL, V7, P1572, DOI 10.1128/MCB.7.4.1572
   Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3
   Qi ST, 2016, J BIOL CHEM, V291, P23020, DOI 10.1074/jbc.M116.748889
   Renne R, 1996, NAT MED, V2, P342, DOI 10.1038/nm0396-342
   Roundtree IA, 2017, ELIFE, V6, DOI 10.7554/eLife.31311
   Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175
   Sarid R, 1998, J VIROL, V72, P1005, DOI 10.1128/JVI.72.2.1005-1012.1998
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Schwartz S, 2013, CELL, V155, P1409, DOI 10.1016/j.cell.2013.10.047
   Sei E, 2011, VIROLOGY, V419, P107, DOI 10.1016/j.virol.2011.08.006
   Shen LS, 2016, DEV CELL, V38, P186, DOI 10.1016/j.devcel.2016.06.008
   Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15
   Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031
   Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138
   SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Staskus KA, 1997, J VIROL, V71, P715, DOI 10.1128/JVI.71.1.715-719.1997
   STOLTZFUS CM, 1976, J VIROL, V18, P586, DOI 10.1128/JVI.18.2.586-595.1976
   STOLTZFUS CM, 1981, J VIROL, V38, P173, DOI 10.1128/JVI.38.1.173-183.1981
   Sun R, 1999, J VIROL, V73, P2232, DOI 10.1128/JVI.73.3.2232-2242.1999
   Tang C, 2017, P NATL ACAD SCI US
   THOMASON AR, 1976, J VIROL, V20, P123, DOI 10.1128/JVI.20.1.123-132.1976
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Uldrick TS, 2010, CLIN INFECT DIS, V51, P350, DOI 10.1086/654798
   Wang HW, 2004, NAT GENET, V36, P687, DOI 10.1038/ng1384
   Wang P, 2016, MOL CELL, V63, P306, DOI 10.1016/j.molcel.2016.05.041
   Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Wang Y, 2014, NAT CELL BIOL, V16, P191, DOI 10.1038/ncb2902
   WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023
   WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0
   WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318
   WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024
   Wojtas MN, 2017, MOL CELL, V68, P374, DOI 10.1016/j.molcel.2017.09.021
   Xiang Y, 2017, NATURE, V543, P573, DOI 10.1038/nature21671
   Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012
   Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100
   Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17
   Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003
   Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113
   Zhang S, 2017, CANCER CELL, V31, pe596
   Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013
   Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151
   Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015
   Zhong WD, 1996, P NATL ACAD SCI USA, V93, P6641, DOI 10.1073/pnas.93.13.6641
   Zhou FC, 2002, J VIROL, V76, P6185, DOI 10.1128/JVI.76.12.6185-6196.2002
   Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377
   Zhu Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005648
NR 134
TC 11
Z9 11
U1 4
U2 16
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD JUL
PY 2018
VL 28
IS 4
AR e1983
DI 10.1002/rmv.1983
PG 11
WC Virology
SC Virology
GA GM5XD
UT WOS:000438220400005
PM 29698584
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Mota, VMR
   Cavalcanti, LPD
   Delfino, AD
   Lopes, TECF
   Pessoa, ALS
   Ribeiro, EM
AF Ribeiro Mota, Vivian Maria
   de Goes Cavalcanti, Luciano Pamplona
   Delfino, Alanna dos Santos
   Costa Figueiredo Lopes, Thayse Elaine
   Santos Pessoa, Andre Luiz
   Ribeiro, Erlane Marques
TI Abortion in Cases of Zika Virus Congenital Infection
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE zika virus infection; abortion; bioethics
ID REPRODUCTIVE RIGHTS; WOMEN; PROFESSIONALS; HEALTH
AB The emergency in international public health caused by the Zika virus gave rise to the discussion about abortion in cases of congenital Zika virus syndrome (CZS). Therefore, we propose to carry out a bibliographic review on abortion in these cases. Five databases were searched using the following terms: abortion , miscarriage , and zika , with the interposition of the Boolean operator AND. In the selected literature, we found references to the lack of information concerning the risks and severity of CZS, to the great psychological distress suffered by pregnant women, and to the risk of unsafe abortions as a justification for abortion in cases of CZS. However, it is necessary to have available tests that could diagnose, in the first trimester of pregnancy, that the fetus has been affected by the virus, and that it may have important limitations, in order to subsidize the qualified discussion about abortion in these cases.
   Resumo
   A emergencia provocada na saude publica internacional por causa do virus Zika trouxe a tona a discussAo do aborto em casos de sindrome congenita de Zika. Portanto, propomos a realizacAo de uma revisAo bibliografica sobre o aborto nesses casos. Foram pesquisados cinco bancos de dados utilizando os seguintes termos: aborto , aborto espontaneo , e zika , com interposicAo do operador booleano E. Na literatura selecionada, encontramos referencias a falta de informacoes sobre os riscos e a gravidade da sindrome congenita de Zika, bem como ao grande sofrimento psicologico de mulheres gravidas e ao risco de aborto inseguro como justificativa para o aborto em casos de sindrome congenita de Zika. No entanto, e necessario ter testes disponiveis que possam diagnosticar, no primeiro trimestre da gravidez, que o feto foi afetada pelo virus, e que ele pode ter limitacoes importantes, para subsidiar a discussAo qualificada sobre o aborto nesses casos.
C1 [Ribeiro Mota, Vivian Maria] Univ Fortaleza, Med Sch, Fortaleza, Ceara, Brazil.
   [de Goes Cavalcanti, Luciano Pamplona] Univ Fed Ceara, Communitary Hlth Dept, Fortaleza, Ceara, Brazil.
   [Delfino, Alanna dos Santos] Univ Estadual Ceara, Sch Med, Fortaleza, Ceara, Brazil.
   [Costa Figueiredo Lopes, Thayse Elaine; Ribeiro, Erlane Marques] Ctr Univ Christus Unichristus, Fac Med, Fortaleza, Ceara, Brazil.
   [Santos Pessoa, Andre Luiz] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
RP Mota, VMR (corresponding author), Univ Fortaleza, Rua Vasco de Ataide 895, BR-60841395 Fortaleza, CE, Brazil.
EM vivianmariaribeiromota@gmail.com
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Ali M, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0282-9
   Bitencourt C R, 2016, TRATADO DIREITO PENA, P183
   Blanchard K, 2017, LANCET, V389, P1603, DOI 10.1016/S0140-6736(17)31010-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burke A, 2016, SEMIN REPROD MED, V34, P305, DOI 10.1055/s-0036-1592068
   Cecatti JG, 2010, REV BRAS GINECOL OBS, V32, P105, DOI 10.1590/S0100-72032010000300002
   de Camargo TMCR, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00071516
   Collucci C, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4657
   de Campos TC, 2017, MED HEALTH CARE PHIL, V20, P443, DOI 10.1007/s11019-016-9739-9
   Freitas A, 2011, ABORTO GUIA PROFISSI
   Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Borsari CMG, 2013, REV BRAS GINECOL OBS, V35, P27, DOI 10.1590/S0100-72032013000100006
   Gollop T R, 2009, REV BIOET, V2, P1
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Benute GRG, 2012, REV BRAS GINECOL OBS, V34, P69, DOI 10.1590/S0100-72032012000200005
   Guttmacher Institute, 2012, MAK AB SERV ACC WAK
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Mayor S, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3492
   Milanez Núbia, 2016, Sex., Salud Soc. (Rio J.), V0, P129, DOI 10.1590/1984-6487.sess.2016.22.06.a
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Perry C Nicolás, 2017, Rev. chil. obstet. ginecol., V82, P89
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pitanguy J, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00066016
   Rego Sergio, 2016, Rev. Bioét., V24, P430, DOI 10.1590/1983-80422016243141
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Sheridan MA, 2017, P NATL ACAD SCI USA, V114, pE1587, DOI 10.1073/pnas.1616097114
   Silva V., 2013, THESIS
   Ventura M, 2016, DIREITO PRAX, V7, P622, DOI 10.12957/dep.2016.25168
   dos Santos APV, 2016, REV BRAS GINECOL OBS, V38, P273, DOI 10.1055/s-0036-1584940
   Vieira EM, 2012, REV BRAS GINECOL OBS, V34, P1, DOI 10.1590/S0100-72032012000100001
   Vieira EM, 2010, REV BRAS GINECOL OBS, V32, P103, DOI 10.1590/S0100-72032010000300001
NR 32
TC 4
Z9 4
U1 0
U2 9
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD JUL
PY 2018
VL 40
IS 7
BP 417
EP 424
DI 10.1055/s-0038-1648219
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GP1XO
UT WOS:000440611800008
PM 29959761
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU dos Santos, GRB
   Aragao, FBA
   Lobao, WJD
   Lima, FR
   de Andrade, LMRL
   Furtado, QR
   Batista, JE
AF Bastos dos Santos, Gerusinete Rodrigues
   Arruda Aragao, Francisca Bruna
   de Mello Lobao, Walder Jansen
   Lima, Fabiano Rosario
   Ramos Lacerda de Andrade, Luisa Marillac
   Furtado, Quesia Rodrigues
   Batista, Jose Eduardo
TI Relationship between microcephaly and Zika virus during pregnancy: a
   review
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Review
DE Epidemics; Zika virus; Microcephaly; Pregnancy
ID FETAL-BRAIN ABNORMALITY; INFECTION; BRAZIL; TRANSMISSION; STANDARDS;
   ICEBERG; CELL; TIP
AB AIM: the present study analysed the association between Zika-virus and microcephaly during the gestational period of women in Brazil. Methodology: Systematic reviews of intervention research, current publications of clinical investigations were used systematic search strategies in three electronic databases PubMed, SciELO and Google academic. The following keywords were used: Microcephaly, gestation, Zika-virus to perform the search, and 1020 articles were obtained after exclusion, 45 were left and 35 were eligible. The collection period was from 2004 to 2017. Results: Epidemiological data suggest a temporal association between the quantitative increase and the Zika-virus epidemic, especially in Northeast Brazil. It is not consensual to measure the cephalic perimeter curve to be considered. Conclusion: Given this, the application of techniques to accurately diagnose the relationship between causes and effects in the pathogenesis of Zika virus infection in the central nervous system should be prioritized.
C1 [Bastos dos Santos, Gerusinete Rodrigues; Arruda Aragao, Francisca Bruna] Fed Univ Maranhao UFMA, Adult & Child Hlth, Sao Luis, MA, Brazil.
   [de Mello Lobao, Walder Jansen] Univ Fed Maranhao, Pathol Dept, Sao Luis, MA, Brazil.
   [Lima, Fabiano Rosario] Family Hlth Strategy Municipal Turilandia, Turilandia, MA, Brazil.
   [Ramos Lacerda de Andrade, Luisa Marillac; Batista, Jose Eduardo] Fed Univ Maranhao UFMA, Sao Luis, MA, Brazil.
   [Ramos Lacerda de Andrade, Luisa Marillac] Univ Fed Maranhao, Family Hlth MS, Sao Luis, MA, Brazil.
   [Furtado, Quesia Rodrigues] Latin Amer Private Univ Upal, Med, Cochabamba, Bolivia.
   [Batista, Jose Eduardo] Pathol Dept, Sao Luis, MA, Brazil.
RP Aragao, FBA (corresponding author), Univ Fed Maranhao, Programa Posgrad Saude Adulto & Crianca, Av Portugueses 1996, BR-65080805 Sao Luis, MA, Brazil.
EM gerusinete@hotmail.com; aragao_bruna@hotmail.com;
   walderjansen@hotmail.com; fabianorosariolima@hotmail.com;
   luisa.marillac.andrade@hotmail.com; quesiamed21@gmail.com;
   jbatistaufma@gmail.com
RI Aragao, Francisca Bruna Arruda/S-2711-2019
OI Aragao, Francisca Bruna Arruda/0000-0002-1191-0988
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2014, EURO SURVEILL, V19
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caveiao C., 2016, SAUDE, V1, P3
   Cofre F, 2016, REV CHIL INFECTOL, V33, P96, DOI 10.4067/S0716-10182016000100018
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Golden JA, 2001, NEUROPATH APPL NEURO, V27, P22, DOI 10.1046/j.0305-1846.2001.00307.x
   Greig LC, 2013, NAT REV NEUROSCI, V14, P755, DOI 10.1038/nrn3586
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Herling JD, 2016, REV CIENCIA ESTUDOS, V5, P59
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   JACKSON AS, 1978, BRIT J NUTR, V40, P497, DOI 10.1079/BJN19780152
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lucey DR, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i781
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martin-Loeches I, 2015, J INFECTION, V70, P213, DOI 10.1016/j.jinf.2014.10.004
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Negras L, 2016, LETRAS, V26
   Passemard S, 2016, CORTEX, V74, P158, DOI 10.1016/j.cortex.2015.10.010
   RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Viral Volpe J., 2001, NEUROLOGY NEWBORN, P737
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 37
TC 3
Z9 3
U1 0
U2 0
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JUL
PY 2018
VL 64
IS 7
BP 635
EP 642
DI 10.1590/1806-9282.64.07.635
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA GX3XC
UT WOS:000447659600014
PM 30365666
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU da Silva, CJ
   Pereira, SV
   Apolinario, EJ
   dos Santos, GL
   Melo-Santos, MAV
   da Silva, AF
   Wallau, GL
   de Oliveira, CMF
AF da Silva, Claudio Julio
   Pereira, Sonia Valeria
   Apolinario, Edivaldo Jose
   dos Santos, Gilvan Leite
   Varjal Melo-Santos, Maria Alice
   da Silva, Alexandre Freitas
   Wallau, Gabriel Luz
   Fontes de Oliveira, Claudia Maria
TI Culicidae fauna (Diptera: Culicidae) survey in urban ecotonal and
   forested areas, from the Moreno municipality - Pernambuco State, Brazil
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Culicidae species; Enviromnental changes; Mosquitoes; Urbanization;
   Sylvatic mosquitoes
ID VECTOR; VIRUS; ZIKA
AB Introduction: Mosquitoes are vectors of several pathogens in tropical regions. However, information on Culicidae in the northeast region of Brazil is scarce despite many municipalities having environmental conditions favorable for these insects. Methods: We collected mosquitoes monthly for one year from urban, ecotonal, and ecological reserve areas in Moreno, Brazil, by using CDC Miniature light traps, aspiration, ovitraps, and liquid suction. Results: We collected 1,401 insects in the Culicidae family. Fifteen species of seven genera of Culicidae were identified and five specimens were identified only at the genus level. Conclusions: There is a wide diversity of mosquito species in the sampled areas, some of which are important for human health.
C1 [da Silva, Claudio Julio; Apolinario, Edivaldo Jose; dos Santos, Gilvan Leite] Nucleo Vigilancia Saude & Meio Ambiente, Moreno, PE, Brazil.
   [Pereira, Sonia Valeria] Inst Tecnol Pernambuco, Recife, PE, Brazil.
   [Varjal Melo-Santos, Maria Alice; da Silva, Alexandre Freitas; Wallau, Gabriel Luz; Fontes de Oliveira, Claudia Maria] Fundacao Oswald Cruz, Inst Aggeu Magalhaes, Posgrad Biociencias & Biotecnol Saude, Recife, PE, Brazil.
   [Varjal Melo-Santos, Maria Alice; da Silva, Alexandre Freitas; Wallau, Gabriel Luz; Fontes de Oliveira, Claudia Maria] Fundacao Oswald Cruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
RP de Oliveira, CMF (corresponding author), Fundacao Oswald Cruz, Inst Aggeu Magalhaes, Posgrad Biociencias & Biotecnol Saude, Recife, PE, Brazil.; de Oliveira, CMF (corresponding author), Fundacao Oswald Cruz, Inst Aggeu Magalhaes, Dept Entomol, Recife, PE, Brazil.
EM claudia@cpqam.fiocruz.br
RI Wallau, Gabriel Luz/B-5911-2008
OI Wallau, Gabriel Luz/0000-0002-1419-5713
CR de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Aragao NC, 2010, REV SOC BRAS MED TRO, V43, P458, DOI 10.1590/S0037-86822010000400024
   Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   de Albuquerque C M, 2000, Rev Saude Publica, V34, P314
   Despommier D, 2006, ECOHEALTH, V3, P281, DOI 10.1007/s10393-006-0063-3
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Petersen V, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0740-6
   RACHOU RENE G., 1956, REV BRASIL MALARIOL E DOENC AS TROP, V8, P267
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888
   Weaver SC, 2005, ARCH VIROL, P33
   Wilcox B. A., 2006, Unasylva (English ed.), V57, P11
   Wilson ME, 2016, TRAVEL MED INFECT DI, V14, P1, DOI 10.1016/j.tmaid.2016.01.010
NR 15
TC 2
Z9 2
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD JUL-AUG
PY 2018
VL 51
IS 4
BP 523
EP 527
DI 10.1590/0037-8682-0249-2017
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GR0BJ
UT WOS:000442171900018
PM 30133638
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zirbel, K
   Eastmond, B
   Alto, BW
AF Zirbel, Kylie
   Eastmond, Bradley
   Alto, Barry W.
TI Parental and offspring larval diets interact to influence life-history
   traits and infection with dengue virus in Aedes aegypti
SO ROYAL SOCIETY OPEN SCIENCE
LA English
DT Article
DE Aedes aegypti; parental effects; dengue virus infection; life-history
   traits; larval nutrition
ID ALBOPICTUS DIPTERA-CULICIDAE; NUTRITIONAL STRESS; VECTOR COMPETENCE;
   HOST-SEEKING; BODY-SIZE; EGG-PRODUCTION; PUERTO-RICO; MOSQUITOS;
   TRANSMISSION; SUSCEPTIBILITY
AB The environmental conditions experienced by parents can influence offspring phenotype along with the conditions experienced by offspring. These parental effects are clear in organisms that display parental care and are less clear in other organisms. Here, we consider effects of parental and offspring larval nutrition on offspring development time, survivorship and infection with dengue virus in Aedes aegypti, the mosquito vector of dengue, chikungunya, yellow fever and Zika. Parents were raised on either high or low larval detritus inputs with subsequent offspring being divided into two groups, one receiving high nutrients and the other low. Low nutrient females from low nutrient parents (LL) developed significantly slower than those from high nutrient parents (HL). Females from all parent by offspring nutrient treatment groups were equally likely to become infected with dengue virus at 24h, 3 days and 14 days. After 14 days, high nutrient females from low nutrient parents (LH) had 11 times higher viral titres and more disseminated infections than high nutrient females from high nutrient parents (HH). These results suggest that carry-over environmental stress from the parental generation can influence life histories and arbovirus infection in Ae. aegypti females. We found males to be robust to the life-history parameters measured, suggesting sex-specific differences which may relate to their lower nutrient requirements for metamorphosis.
C1 [Zirbel, Kylie; Eastmond, Bradley; Alto, Barry W.] Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Florida Med Entomol Lab, Vero Beach, FL 32962 USA.
RP Zirbel, K (corresponding author), Univ Florida, Inst Food & Agr Sci, Entomol & Nematol Dept, Florida Med Entomol Lab, Vero Beach, FL 32962 USA.
EM zirbelke@ufl.edu
FU University of Florida, Graduate School
FX This research was, in part, supported by a Graduate Fellowship from the
   University of Florida, Graduate School.
CR Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Alto BW, 2014, J VECTOR ECOL, V39, P406, DOI 10.1111/jvec.12116
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209
   Armbruster P, 2002, J MED ENTOMOL, V39, P699, DOI 10.1603/0022-2585-39.4.699
   Barrera R, 1996, J NAT HIST, V30, P447, DOI 10.1080/00222939600770231
   Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boggs CL, 2009, FUNCT ECOL, V23, P27, DOI 10.1111/j.1365-2435.2009.01527.x
   Bonduriansky R, 2007, J EVOLUTION BIOL, V20, P2379, DOI 10.1111/j.1420-9101.2007.01419.x
   Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441
   Bongiorni S, 1999, GENETICS, V151, P1471
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   CARRIERE Y, 1994, HEREDITY, V72, P420, DOI 10.1038/hdy.1994.58
   CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103
   CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394
   Daugherty MP, 2000, J MED ENTOMOL, V37, P364, DOI 10.1603/0022-2585(2000)037[0364:ICAARF]2.0.CO;2
   Dodson BL, 2011, VECTOR-BORNE ZOONOT, V11, P1493, DOI 10.1089/vbz.2011.0662
   Farjana T, 2013, J MED ENTOMOL, V50, P838, DOI 10.1603/ME12146
   Franzke A, 2013, BEHAV ECOL, V24, P734, DOI 10.1093/beheco/ars205
   Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323
   Grech K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-130
   GRIMSTAD PR, 1991, J MED ENTOMOL, V28, P378, DOI 10.1093/jmedent/28.3.378
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   HAWLEY WA, 1985, J MED ENTOMOL, V22, P220, DOI 10.1093/jmedent/22.2.220
   Jones TM, 2005, ECOL ENTOMOL, V30, P397, DOI 10.1111/j.0307-6946.2005.00705.x
   KLOWDEN MJ, 1978, AM J TROP MED HYG, V27, P827, DOI 10.4269/ajtmh.1978.27.827
   Kyneb A, 2006, ECOL ENTOMOL, V31, P322, DOI 10.1111/j.1365-2311.2006.00775.x
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lorenz LM, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-382
   LYIMO EO, 1993, MED VET ENTOMOL, V7, P328, DOI 10.1111/j.1365-2915.1993.tb00700.x
   MacDonald WA, 2012, GENET RES INT, DOI 10.1155/2012/585024
   Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x
   Mousseau TA, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P219
   Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4
   Murrell EG, 2011, ANN ENTOMOL SOC AM, V104, P688, DOI 10.1603/AN10158
   Muturi EJ, 2011, TROP MED INT HEALTH, V16, P955, DOI 10.1111/j.1365-3156.2011.02796.x
   NASCI RS, 1994, J MED ENTOMOL, V31, P123, DOI 10.1093/jmedent/31.1.123
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Otti O, 2008, TRENDS PARASITOL, V24, P197, DOI 10.1016/j.pt.2008.02.004
   Pigeault R, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1136
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Rauw Wendy M., 2012, Frontiers in Genetics, V3, P267, DOI 10.3389/fgene.2012.00267
   RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x
   Richards SL, 2012, J MED ENTOMOL, V49, P942, DOI 10.1603/ME11293
   Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451
   Saastamoinen M, 2013, OECOLOGIA, V171, P93, DOI 10.1007/s00442-012-2412-y
   Scheiner M., 2001, DESIGN ANAL ECOLOGIC, P99
   Scott TW, 2012, TRENDS PARASITOL, V28, P114, DOI 10.1016/j.pt.2012.01.001
   Shikano I, 2015, FUNCT ECOL, V29, P1156, DOI 10.1111/1365-2435.12422
   Stjernman M, 2011, J EVOLUTION BIOL, V24, P2357, DOI 10.1111/j.1420-9101.2011.02363.x
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   TAKAHASHI M, 1976, J MED ENTOMOL, V13, P275, DOI 10.1093/jmedent/13.3.275
   Takken W, 1998, J MED ENTOMOL, V35, P639, DOI 10.1093/jmedent/35.5.639
   Telang A, 2004, J INSECT PHYSIOL, V50, P677, DOI 10.1016/j.jinsphys.2004.05.001
   Telang A, 2012, MED VET ENTOMOL, V26, P271, DOI 10.1111/j.1365-2915.2011.00993.x
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Triggs AM, 2012, FUNCT ECOL, V26, P1409, DOI 10.1111/j.1365-2435.2012.02051.x
   Trout A., 2010, Morbidity and Mortality Weekly Report, V59, P577
   TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176
   Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005
   Valtonen TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031611
   Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754
   WASHBURN JO, 1995, J AM MOSQUITO CONTR, V11, P279
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Zhang S., 1993, ARBOVIRUS RES AUST, V6, P44
   Zirbel K, 2018, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.6c78sn1, DOI 10.5061/DRYAD.6C78SN1]
   Zizzari ZV, 2016, J EVOLUTION BIOL, V29, P1317, DOI 10.1111/jeb.12872
NR 71
TC 7
Z9 7
U1 2
U2 9
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2054-5703
J9 ROY SOC OPEN SCI
JI R. Soc. Open Sci.
PD JUL
PY 2018
VL 5
IS 7
DI 10.1098/rsos.180539;180539
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO6IM
UT WOS:000440143500069
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Araujo, IF
   de Araujo, PHF
   Ferreira, RMA
   Sena, IDS
   Lima, AL
   Carvalho, JCT
   Ferreira, IM
   Souto, RNP
AF de Araujo, I. F.
   de Araujo, P. H. F.
   Ferreira, R. M. A.
   Sena, I. D. S.
   Lima, A. L.
   Carvalho, J. C. T.
   Ferreira, I. M.
   Souto, R. N. P.
TI Larvicidal effect of hydroethanolic extract from the leaves of Acmella
   oleracea L. R. K. Jansen in Aedes aegypti and Culex quinquefasciatus
SO SOUTH AFRICAN JOURNAL OF BOTANY
LA English
DT Article
DE Acmella oleracea; Jambu; Amazon biodiversity; Larvicidal activity
ID ANTIOXIDANT ACTIVITY; ANOPHELES-STEPHENSI; TOXICITY; SPILANTHOL
AB Mosquitoes, such as Aedes uegypti and Culex quiaquefasciatus, are important vectors of diseases, such as dengue fever, chikungunya fever, Zika virus, and filariasis, and these diseases are public health problems. The present study was carried out to evaluate the larvicidal activity of the hydroethanolic extract from leaves of/lc:men oleracea leaves against 3rd instal- larvae of the Ae. uegypti dengue vector and the Cx. quinquefusciatus filariasis vector. The hydroethanolic extract caused significant mortality in Ae. aegypti and Cx. quinquefasciutus. After 24 h of exposure to the extract, it was possible to establish the LC50 values for the extract: 1141 ppm for Ae. aegypti and LC50 3240 ppm for Cx. quinquerasciatus. The hydroethanolic extract from leaves of A. oleracea showed very low ecotoxicity suggesting that it can be used without causing environmental damage. This is the first study that shows the use of hydroethanolic extract from leaves of A. oleracea as an alternative to synthetic larvicides to eliminate larvae of Ae aegypti and Cx. quinquefasciatus in an easy, cheap and sate way. (C) 2018 SAAB. Published by Elsevier B.V. All rights reserved.
C1 [de Araujo, I. F.; Ferreira, R. M. A.; Souto, R. N. P.] Univ Fed Amapa, Lab Artropodes, Collegiate Biol, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
   [de Araujo, I. F.; de Araujo, P. H. F.; Sena, I. D. S.; Ferreira, I. M.] Univ Fed Amapa, Biocatalysis & Biotransjormat Grp Organ Chem, Collegiate Chem, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
   [Lima, A. L.] Brazilian Agr Res Corp Embrapa, Rod JK,KM 02,2-600 Bairro Univ, BR-58428095 Macapa, Amapa, Brazil.
   [Carvalho, J. C. T.] Univ Fed Amapa, Lab Phannacera Res, Dept Biol Sci & Hlth, Collegiate Pharm, Macapa, Amapa, Brazil.
RP Ferreira, IM (corresponding author), Univ Fed Amapa, Biocatalysis & Biotransjormat Grp Organ Chem, Collegiate Chem, Rod JK,KM 02, BR-68902280 Macapa, Amapa, Brazil.
EM irlon.ferreira@gmail.com
RI Ferreira, Irlon M./K-3300-2014
OI Souto, Raimundo/0000-0002-8795-1217; Fauro de Araujo,
   Inana/0000-0002-3168-3137
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Fundacao de Amparo a Pesquisa do Amapa (FAPEAP); Federal
   University of Amapa (UNIFAP); UNIFAP
FX WA thanks the Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior (CAPES), PHFA thanks the Fundacao de Amparo a Pesquisa do Amapa
   (FAPEAP) for scholarships, and PHSB thanks the Federal University of
   Amapa (UNIFAP) for scholarships. The authors thank UNIFAP and Fundacao
   de Amparo a Pesquisa do Amapa (FAPEAP) for the financial support.
CR Abeysiri GRPI, 2013, IND CROP PROD, V50, P852, DOI 10.1016/j.indcrop.2013.08.043
   Al-Mekhlafi FA, 2017, SAUDI J BIOL SCI, V24, P817, DOI 10.1016/j.sjbs.2016.07.003
   Barbosa AF, 2016, REV BRAS FARMACOGN, V26, P128, DOI 10.1016/j.bjp.2015.07.024
   Belinato TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130719
   Borges L. S., 2015, BIOL AGR HORTICULTUR, V32, P149
   Borges RS, 2015, BIOORG MED CHEM LETT, V25, P4808, DOI 10.1016/j.bmcl.2015.07.001
   Brasil. Guia de vigilancia do Culex quinquefasciatus, 2011, GUIA VIG CUL QUINQ
   Brazil, 2017, B EPIDEMIOLOGICO, V51, P48
   Cardoso MO, 1997, HORTALICAS NAO CONVE, P133
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Dastogeer KMG, 2017, ENVIRON EXP BOT, V143, P59, DOI 10.1016/j.envexpbot.2017.08.008
   Dias AMA, 2012, J SUPERCRIT FLUID, V61, P62, DOI 10.1016/j.supflu.2011.09.020
   Gams W, 1998, TRICHODERMA GLIOCLAD, V1, P3, DOI DOI 10.4324/9780203483558
   Gilberto B., 2010, REV FITOS, V5, P83
   Gobbo-Neto L, 2007, QUIM NOVA, V30, P374, DOI 10.1590/S0100-40422007000200026
   Guissoni A.C.P., 2013, Rev. bras. plantas med., V15, P363, DOI 10.1590/S1516-05722013000300008
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hiserodt RD, 2004, J AM SOC MASS SPECTR, V15, P1462, DOI 10.1016/j.jasms.2004.06.009
   JACOBSON W, 1954, J PHYSIOL-LONDON, V123, P603, DOI 10.1113/jphysiol.1954.sp005073
   KADIR HA, 1989, PESTIC SCI, V25, P329, DOI 10.1002/ps.2780250402
   Maciel M.V, 2010, Rev. bras. plantas med., V12, P105, DOI 10.1590/S1516-05722010000100015
   Mastouri F, 2010, PHYTOPATHOLOGY, V100, P1213, DOI 10.1094/PHYTO-03-10-0091
   Melagraki G, 2009, EUR J MED CHEM, V44, P3020, DOI 10.1016/j.ejmech.2008.12.027
   Menezes E. L., 2005, INSETICIDAS BOTANICO
   Moreno SC, 2012, PEST MANAG SCI, V68, P386, DOI 10.1002/ps.2274
   Moulay S., 2017, J ANAL PHARM RES, V5, P1
   Mukandiwa L, 2015, S AFR J BOT, V100, P169, DOI 10.1016/j.sajb.2015.05.016
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Oliveira AC, 2018, J PUBLIC HEALTH-UK, V40, P163, DOI 10.1093/pubmed/fdx035
   Pandey V, 2007, PARASITOL RES, V102, P171, DOI 10.1007/s00436-007-0763-9
   Pandey V, 2009, IN VITRO CELL DEV-PL, V45, P491, DOI 10.1007/s11627-008-9184-4
   Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026
   SHARMA A, 2012, AM J PLANT SCI, V3, P1568, DOI DOI 10.4236/ajps.2012.311189
   Simas NK, 2013, PHYTOCHEM LETT, V6, P67, DOI 10.1016/j.phytol.2012.10.016
   Soonwera M, 2016, PARASITOL RES, V115, P1691, DOI 10.1007/s00436-016-4910-z
   Souza Antonia Queiroz Lima de, 2004, Acta Amaz., V34, P185, DOI 10.1590/S0044-59672004000200006
   Uquiche E, 2016, J SUPERCRIT FLUID, V110, P257, DOI 10.1016/j.supflu.2015.12.003
   Vale MD, 2011, ENG SANIT AMBIENT, V16, P237, DOI 10.1590/S1413-41522011000300006
   Valoto C. F. B., 2010, REV PATOLOGIA TROPIC, V39, P309
   Veni T, 2016, INT J PURE APPL ZOOL, V4, P149
   WHO, 1997, VECTOR CONTROL METHO
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Yasmeen R, 2017, ACTA BOT CROAT, V76, P154, DOI 10.1515/botcro-2016-0054
NR 43
TC 2
Z9 2
U1 0
U2 13
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0254-6299
EI 1727-9321
J9 S AFR J BOT
JI S. Afr. J. Bot.
PD JUL
PY 2018
VL 117
BP 134
EP 140
DI 10.1016/j.sajb.2018.05.008
PG 7
WC Plant Sciences
SC Plant Sciences
GA GM8HI
UT WOS:000438463700016
OA Green Published
DA 2020-07-08
ER

PT J
AU Petkova, MS
   Elabor, ZB
   Djarova-Daniels, T
   Pavlova, EG
   Omole, OB
AF Petkova, Magdelena S.
   Elabor, Zuberu B.
   Djarova-Daniels, Trayana
   Pavlova, Emilia G.
   Omole, Olufemi B.
TI Nurses' knowledge of and willingness to promote female condom use in
   Johannesburg Health District
SO SOUTH AFRICAN JOURNAL OF SCIENCE
LA English
DT Article
DE health professional; prevention; women; cognition; compliance
ID SOUTH-AFRICA; INTERVENTION TRIAL; CARE PROVIDERS; ZIKA VIRUS; WOMEN;
   ACCEPTABILITY; EXPERIENCES; TANZANIA; KENYA; CITY
AB The female condom is the only current method for female partners to simultaneously prevent both pregnancy and sexually transmitted infections. Studies of various contraceptive methods suggest that providers acceptance and endorsement may be a key factor in their clients' uptake and continued use of a method. Our aim in this study was to assess the relationship between nurses' knowledge of and their willingness to promote female condom use in 18 public healthcare facilities within the Johannesburg District. The mean score of correct answers of 398 nurses completing an anonymous, self-administered, six-item questionnaire was 4 out of a maximum of 6. Data analysis included the use of descriptive statistics and a chi-square test. It was found that 79% of participants were knowledgeable but only 59% were willing to promote female condom use. There was no association between knowledge of and willingness to promote female condom use. The following significant associations with knowledge and willingness to promote female condom use were found: family planning experience, being employed by a local government authority, working in a primary care clinic and having had informal training on female condom use. Informal training of nurses within the family planning unit in the clinics has the potential to improve nurses' knowledge and willingness to promote female condom use.
C1 [Petkova, Magdelena S.; Omole, Olufemi B.] Univ Witwatersrand, Dept Family Med, Johannesburg, South Africa.
   [Elabor, Zuberu B.] Eastern Cape Dist Clin Specialist Team, Port Elizabeth, South Africa.
   [Djarova-Daniels, Trayana] Univ Zululand, Dept Biochem & Microbiol, Kwa Dlangezwa, South Africa.
   [Pavlova, Emilia G.] Natl Sports Acad, Dept Physiol & Biochem, Sofia, Bulgaria.
RP Petkova, MS (corresponding author), Univ Witwatersrand, Dept Family Med, Johannesburg, South Africa.
EM dr_meggdim@yahoo.com
RI Petkova, Magdelena/S-3507-2019
OI OMOLE, OLUFEMI BABATUNDE/0000-0002-4621-1378
CR Agha S, 2002, INT FAM PLAN PERSPEC, V28, P151, DOI 10.2307/3088258
   Bachmann MO, 1997, SOC SCI MED, V45, P723, DOI 10.1016/S0277-9536(96)00406-6
   Beksinska M, 2016, EVALUATION NATL S AF
   Beksinska ME, 2012, SEX HEALTH, V9, P51, DOI 10.1071/SH11011
   Bookshelf, 2014, REPROD HEALTH MATTER, V22, P200, DOI [10.1016/S0968-8080(14)43764-9, DOI 10.1016/S0968-8080(14)43764-9]
   Cook J, 2004, COMPUT EDUC, V43, P35, DOI 10.1016/j.compedu.2003.12.003
   Andrade SSD, 2015, REV ESC ENFERM USP, V49, P364, DOI 10.1590/S0080-623420150000300002
   Eraut M, 2000, BRIT J EDUC PSYCHOL, V70, P113, DOI 10.1348/000709900158001
   Feldblum PJ, 2001, AIDS, V15, P1037, DOI 10.1097/00002030-200105250-00012
   Godhelp K., 2015, ADVOCATING FEMALE CO
   Hayford SR, 2010, STUD FAMILY PLANN, V41, P291, DOI 10.1111/j.1728-4465.2010.00254.x
   Hoffman S, 2004, PERSPECT SEX REPRO H, V36, P120, DOI 10.1363/3612004
   Holmes L, 2008, AIDS CARE, V20, P470, DOI 10.1080/09540120701867016
   Holt K, 2013, NATIONALLY REPRESENT, V3, P1, DOI [10.1136/bmjopen-2012-002208, DOI 10.1136/BMJOPEN-2012-002208]
   Holtgrave DR, 2012, AIDS BEHAV, V16, P1115, DOI 10.1007/s10461-012-0174-5
   Joanis C, 2011, CONTRACEPTION, V83, P248, DOI 10.1016/j.contraception.2010.08.002
   Kerrigan D, 2000, HRNA00970001200 USAI
   Maksut JL, 2015, WOMEN HEALTH ISS, V25, P366, DOI 10.1016/j.whi.2015.03.015
   Mantel JE, 2011, AIDS EDUC PREV, V23, P65, DOI 10.1521/aeap.2011.23.1.65
   Mantell JE, 2000, AIDS CARE, V12, P589, DOI 10.1080/095401200750003770
   Mantell JE, 2001, J URBAN HEALTH, V78, P658, DOI 10.1093/jurban/78.4.658
   Mantell JE, 2015, AIDS BEHAV, V19, P1129, DOI 10.1007/s10461-014-0860-6
   Mashanda-Tafaune B, 2016, HEALTH SA GESONDHEID, V21, DOI 10.1016/j.hsag.2015.12.002
   Masvawure TB, 2014, J SEX RES, V51, P841, DOI 10.1080/00224499.2013.814043
   MatCH Research Unit (Maternal Adolescent and Child Health), 2011, P EXP M 2011 NOV 23
   MatCH Research Unit University of the Witwatersrand; HIV Center for Clinical and Behavioral Studies New York State Psychiatric Institute and Columbia University Medical Center, 2017, USAID PROJ SOAR EV S
   Matseke G, 2012, GENDER BEHAV, V10, P1
   Moore L, 2015, KNOWLEDGE ATTITUDES, V2015, P125, DOI [10.2147/OAJC.S55041, DOI 10.2147/OAJC.S55041]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ng C, 2012, INTRAHEALTH INT INTE
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oliveira ND, 2008, SAUDE SOC-SAO PAULO, V17, P107, DOI 10.1590/S0104-12902008000100010
   Ramkissoon A, 2010, SEXUAL REPROD HLTH R
   Ruminjo JK, 1996, E AFR MED J, V73, P101
   South African National AIDS Council, 2015, S AFR GLOB AIDS RESP
   Speizer IS, 2000, INT FAM PLAN PERSPEC, V26, P13, DOI 10.2307/2648285
   Spizzichino Laura, 2007, Ann Ist Super Sanita, V43, P419
   Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859
   Weeks MR, 2015, AIDS BEHAV, V19, P1642, DOI 10.1007/s10461-015-1052-8
   Weeks MR, 2013, J WOMENS HEALTH, V22, P26, DOI 10.1089/jwh.2011.3430
NR 40
TC 0
Z9 0
U1 0
U2 2
PU ACAD SCIENCE SOUTH AFRICA A S S AF
PI LYNWOOD RIDGE
PA PO BOX 72135, LYNWOOD RIDGE 0040, SOUTH AFRICA
SN 0038-2353
EI 1996-7489
J9 S AFR J SCI
JI S. Afr. J. Sci.
PD JUL-AUG
PY 2018
VL 114
IS 7-8
BP 41
EP 47
DI 10.17159/sajs.2018/20170174
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GO6QD
UT WOS:000440172900012
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU De Ory, F
   Sanchez-Seco, MP
   Vazquez, A
   Montero, MD
   Sulleiro, E
   Martinez, MJ
   Matas, L
   Merino, FJ
AF De Ory, Fernando
   Paz Sanchez-Seco, Maria
   Vazquez, Ana
   Dolores Montero, Maria
   Sulleiro, Elena
   Martinez, Miguel J.
   Matas, Lurdes
   Merino, Francisco J.
CA Working Grp Study Zika Virus Infec
TI Comparative Evaluation of Indirect Immunofluorescence and NS-1-Based
   ELISA to Determine Zika Virus-Specific IgM
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; dengue viruses; flavivirus; ELISA; indirect
   immunofluorescence; plaque reduction neutralization test; polymerase
   chain reaction; cross-reactions
ID INFECTION; IMMUNOASSAYS; ANTIBODIES
AB Differential diagnosis of the Zika virus (ZIKV) is hampered by cross-reactivity with other flaviviruses, mainly dengue viruses. The aim of this study was to compare two commercial methods for detecting ZIKV immunoglobulin M (IgM), an indirect immunofluorescence (IIF) and an enzyme immunoassay (ELISA), using the non-structural (NS) 1 protein as an antigen, both from EuroImmun, Germany. In total, 255 serum samples were analyzed, 203 of which showed laboratory markers of ZIKV infections (PCR-positive in serum and/or in urine and/or positive or indeterminate specific IgM). When tested with IIF, 163 samples were IgM-positive, while 13 samples were indeterminate and 78 were negative. When IIF-positive samples were tested using ELISA, we found 61 positive results, 14 indeterminate results, and 88 negative results. Among the indeterminate cases tested with IIF, ELISA analysis found two positive, two indeterminate, and nine negative results. Finally, 74 of the 78 IIF-negative samples proved also to be negative using ELISA. For the calculations, all indeterminate results were considered to be positive. The agreement, sensitivity, and specificity between ELISA and IIF were 60.2%, 44.9%, and 94.9%, respectively. Overall, 101 samples showed discrepant results; these samples were finally classified on the basis of other ZIKV diagnostic approaches (PCR-positive in serum and/or in urine, IgG determinations using IIF or ELISA, and ZIKV Plaque Reduction Neutralization test-positive), when available. A final classification of 228 samples was possible; 126 of them were positive and 102 were negative. The corresponding values of agreement, sensitivity, and specificity of IIF were 86.0%, 96.8%, and 72.5%, respectively. The corresponding figures for ELISA were 81.1%, 65.9%, and 100%, respectively. The ELISA and IIF methods are both adequate approaches for detecting ZIKV-specific IgM. However, considering their respective weaknesses (low sensitivity in ELISA and low specificity in IIF), serological results must be considered jointly with other laboratory results.
C1 [De Ory, Fernando; Paz Sanchez-Seco, Maria; Vazquez, Ana] Inst Salud Carlos III, Ctr Nacl Microbiol, Lab Serol & Arbovirus, Majadahonda 28220, Spain.
   [De Ory, Fernando; Vazquez, Ana; Matas, Lurdes] Inst Salud Carlos III, Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid 28029, Spain.
   [Dolores Montero, Maria] Hosp Univ La Paz, Madrid 28046, Spain.
   [Sulleiro, Elena] Hosp Valle De Hebron, Barcelona 08035, Spain.
   [Martinez, Miguel J.] Hosp Clin Barcelona, Barcelona 08036, Spain.
   [Matas, Lurdes] Hosp Univ Germans Trias i Pujol, Badalona 08916, Spain.
   [Merino, Francisco J.] Hosp Severo Ochoa, Leganes 28911, Spain.
RP De Ory, F (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Lab Serol & Arbovirus, Majadahonda 28220, Spain.; De Ory, F (corresponding author), Inst Salud Carlos III, Ctr Invest Biomed Red Epidemiol & Salud Publ, Madrid 28029, Spain.
EM fory@isciii.es; paz.sanchez@isciii.es; a.vazquez@isciii.es;
   mdolores.montero@salud.madrid.org; esulleir@vhebron.net;
   myoldi@clinic.cat; lmatas.germanstrias@gencat.cat;
   franciscojesus.merino@salud.madrid.org
RI Vazquez, Ana/H-4911-2013
OI Vazquez, Ana/0000-0002-9872-3316; Sulleiro, Elena/0000-0002-9783-6060;
   SANCHEZ-SECO, MARIA PAZ/0000-0001-9033-7704; Cabrera Alvargonzalez,
   Jorge J./0000-0002-0397-0868; Martinez, Miguel
   Julian/0000-0002-0682-1075; Merino Fernandez, Francisco
   Jesus/0000-0001-9180-2479
FU ISCIIIInstituto de Salud Carlos III [MVP216/17, RD16CIII/0003/0003];
   Euroimmun Diagnostics Espana SLU [MVP216/17]; FEDEREuropean Union (EU); 
   [PI16CIII/00037]
FX The study was partially financed by a contract between the ISCIII and
   Euroimmun Diagnostics Espana SLU (MVP216/17), and by ISCIII, project
   RD16CIII/0003/0003, "Red de Enfermedades Tropicales", Subprogram RETICS
   Plan Estatal de I+D+I 2013-2016, and co-funded by FEDER "Una manera de
   hacer Europa" and project PI16CIII/00037.
CR Bachiller-Luque P, 2016, ENFERM INFEC MICR CL, V34, P243, DOI 10.1016/j.eimc.2016.02.012
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Domingo C, 2009, DIAGN MICR INFEC DIS, V65, P42, DOI 10.1016/j.diagmicrobio.2009.05.004
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Huzly D, 2016, EURO SURVEILL, V21
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 15
TC 3
Z9 3
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2018
VL 10
IS 7
AR 379
DI 10.3390/v10070379
PG 9
WC Virology
SC Virology
GA GU3CV
UT WOS:000445153200041
PM 30029548
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Agumadu, VC
   Ramphul, K
AF Agumadu, Vivian C.
   Ramphul, Kamleshun
TI Zika Virus: A Review of Literature
SO CUREUS
LA English
DT Review
DE zika virus; microcephaly; aedes mosquito
ID TRANSMISSION; AMERICA
AB Zika virus (ZIKV) is an arthropod-borne virus that was first isolated in 1947. Since then, multiple outbreaks of ZIKV have been reported in different countries. It is transmitted mostly by Aedes mosquitoes, and the symptoms of fever, joint pain, red eyes, headache, and maculopapular rash closely resemble chikungunya and dengue. The most severe complications of ZIKV infection include the risk of microcephaly and other congenital brain anomalies in infected pregnant women. It is a condition that can be easily prevented with proper education. In this review, we focussed on different aspects of the recent outbreaks of Zika virus disease, including its epidemiological background, transmission routes, presentation, as well as diagnosis and prevention.
C1 [Agumadu, Vivian C.] Int Univ Hlth Sci Sch Med, Med, Basseterre, St Kitts & Nevi.
   [Ramphul, Kamleshun] Shanghai Jiao Tong Univ, Shanghai Xin Hua Hosp, Dept Pediat, Sch Med, Shanghai, Peoples R China.
RP Ramphul, K (corresponding author), Shanghai Jiao Tong Univ, Shanghai Xin Hua Hosp, Dept Pediat, Sch Med, Shanghai, Peoples R China.
EM adramphul@hotmail.com
RI amsalu, ribka/G-8780-2019
CR Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2018, FACT SHEETS POST ZIK
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 25
TC 4
Z9 4
U1 3
U2 5
PU CUREUS INC
PI PALO ALTO
PA PO BOX 61002, PALO ALTO, CA 94306 USA
SN 2168-8184
J9 CUREUS
JI Cureus
PD JUL
PY 2018
VL 10
IS 7
AR UNSP e3025
DI 10.7759/cureus.3025
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA HB3HX
UT WOS:000450942900123
PM 30254814
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Hage, DS
AF Hage, David S.
TI Development of Immunochromatographic Assays for the Selective Detection
   of Zika Virus or Dengue Virus Serotypes in Serum
SO CLINICAL CHEMISTRY
LA English
DT Editorial Material
C1 [Hage, David S.] Univ Nebraska, Dept Chem, 704 Hamilton Hall, Lincoln, NE 68588 USA.
RP Hage, DS (corresponding author), Univ Nebraska, Dept Chem, 704 Hamilton Hall, Lincoln, NE 68588 USA.
EM dhage1@unl.edu
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Wild D., 2013, IMMUNOASSAY HDB
NR 5
TC 3
Z9 3
U1 1
U2 5
PU AMER ASSOC CLINICAL CHEMISTRY
PI WASHINGTON
PA 2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA
SN 0009-9147
EI 1530-8561
J9 CLIN CHEM
JI Clin. Chem.
PD JUL
PY 2018
VL 64
IS 7
BP 991
EP 993
DI 10.1373/clinchem.2017.282699
PG 3
WC Medical Laboratory Technology
SC Medical Laboratory Technology
GA GY1MI
UT WOS:000448294200002
PM 29632126
OA Bronze
DA 2020-07-08
ER

PT J
AU Moreira, MCN
   Mendes, CHF
   Nascimento, M
AF Nunes Moreira, Martha Cristina
   Figueira Mendes, Corina Helena
   Nascimento, Marcos
TI Zika, women's prominent role and care: rehearsing contact zones
SO INTERFACE-COMUNICACAO SAUDE EDUCACAO
LA English
DT Article
DE Disability; Women; Children; Care; Zika
ID HEALTH
AB In this essay, we dialogue with themes launched in the post-epidemic debate of Zika Virus (ZIKAV), on the lives of women and children. We analyzed 23 Brazilian papers published between 2016 and 2017, selected in Brazilian journals, in the fields of Social and Human Sciences. There is a mixed speech of claiming for rights grand narratives of social appeal and explanation by the social forces of a negligent State - associated with minor narratives of caring for a disabled child. We tentatively conclude that the contact zone is the movement of retrieval of the minor narratives in the translation of the iniquities produced by the State in the life of ordinary people.
C1 [Nunes Moreira, Martha Cristina; Figueira Mendes, Corina Helena; Nascimento, Marcos] Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Ensino, Ave Rui Barbosa 716,2 Andar, BR-22250020 Rio De Janeiro, RJ, Brazil.
RP Moreira, MCN (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Dept Ensino, Ave Rui Barbosa 716,2 Andar, BR-22250020 Rio De Janeiro, RJ, Brazil.
EM moreira@iff.fiocruz.br; corimendes@gmail.com;
   marcos.nascimento@iff.fiocruz.br
RI Moreira, Martha Cristina Nunes/AAQ-5567-2020
OI Nascimento, Marcos/0000-0002-3363-4232
CR Aguiar R, 2016, REV ELETRON COMUN IN, V10, P1
   Alanen L., 2001, CRIANCAS JOVENS CONS, P69
   Antunes MN, 2016, RECIIS REV ELETRON C, V10, P1
   AVILA MB, 1993, ESTUD FEM, V1, P382
   Baum P, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064416
   Carneiro RG, 2017, INTERFACE-BOTUCATU, V21, P753, DOI 10.1590/1807-57622017.0404
   Carvalho LP, 2017, CAD GENERO DIVERS, V3, P134
   Carvalho MS, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311XED010516
   Carvalho MS, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311XED010416
   DINIZ D., 2016, 5 CLICHES ABORTO ZIK
   Diniz D, 2007, FEMINISMO DEFICIENCI
   Diniz D, 2016, RECIIS ONLINE, V10, P1
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   FASSIN D, 2004, UNHEALTHY HLTH POLIC, P203
   FLEISCHER S., 2017, CADERNOS GENERO DIVE, V3, P93
   Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Goffman E., 1988, ESTIGMA NOTAS CONSTR
   González Sebastián, 2016, Arch. Pediatr. Urug., V87, P53
   Gonzalez-Velez AC, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311XCO070516
   Helleiner J., 1999, ATLANTIS, V24, P27
   Lara Netto MM, 2016, RECIIS REV ELETRON C, V10, P1
   LARROSA Jorge, 2004, EDUC REAL, V29, P27
   Latour B., 2000, CIENCIA ACAO COMO SE
   Latour B, 2012, REAGREGANDO SOCIAL
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   Ventura DDL, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00033316
   Luna F, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311XCO080516
   Mello Anahi Guedes de, 2012, Rev. Estud. Fem., V20, P635, DOI 10.1590/S0104-026X2012000300003
   Moreira MCN, 2016, REDE PESQUISA MANGUI, P175
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Petryna A., 2002, LIFE EXPOSED BIOL CI
   Castellanos MEP, 2014, CIENC SAUDE COLETIVA, V19, P1065, DOI 10.1590/1413-81232014194.12052013
   Pinheiro DAJP, 2017, CAD GENERO DIVERS, V3, P113
   Pitanguy J, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00066016
   PORTO R., 2017, CAD GENERO DIVERS, V3, P158
   Rego Sergio, 2016, Rev. Bioét., V24, P430, DOI 10.1590/1983-80422016243141
   Ribeiro Djamila, 2017, QUE LUGAR FALA
   Santos B. de S., 2007, RENOVAR TEORIA CRITI
   Santos Boaventura de S., 2002, REV CRITICA CIENCIAS, V63, P237, DOI DOI 10.4000/RCCS.1285
   Santos BS, 2010, EPISTEMOLOGIAS
   Santos DN, 2016, DOCUMENTO POSICAO TR
   Scott RP, 2017, CADERNOS GENERO DIVE, V3, P73
   SERRES Michel, 1993, FILOSOFIA MESTICA
   Shum TT, 2016, DISCUSSION ZIKA EPID
   Stanley L, 2009, SOCIOL RES ONLINE, V14, DOI 10.5153/sro.2068
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Vianna Adriana, 2011, Cad. Pagu, V0, P79, DOI 10.1590/S0104-83332011000200004
NR 48
TC 2
Z9 4
U1 0
U2 0
PU UNIV ESTADUAL PAULISTA-UNESP
PI BOTUCATU
PA CAMPUS DE BOTUCATU, DIST RUBIAO JR S N, CAIXA POSTAL 592, BOTUCATU, SP
   18618-000, BRAZIL
SN 1414-3283
EI 1807-5762
J9 INTERFACE-BOTUCATU
JI Interface-Comun. Saude Educ.
PD JUL-SEP
PY 2018
VL 22
IS 66
BP 697
EP 708
DI 10.1590/1807-57622017.0930
PG 14
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GW1AU
UT WOS:000446602400004
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Singh, PK
   Giri, S
   Kumar, A
AF Singh, Pawan Kumar
   Giri, Shailendra
   Kumar, Ashok
TI AMP-activated Kinase (AMPK) Promotes Innate immunity and Antiviral
   Defense against Zika Virus Induced Ocular Infection
SO INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE
LA English
DT Meeting Abstract
CT Annual Meeting of the
   Association-for-Research-in-Vision-and-Ophthalmology (ARVO)
CY APR 29-MAY 03, 2018
CL Honolulu, HI
SP Assoc Res Vis & Ophthalmol
C1 [Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Sch Med, Kresge Eye Inst, Detroit, MI 48201 USA.
   [Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Sch Med, Anat & Cell Biol, Detroit, MI USA.
   [Giri, Shailendra] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI USA.
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [EY026964, EY027381]
FX NIH Grant EY026964, EY027381
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ASSOC RESEARCH VISION OPHTHALMOLOGY INC
PI ROCKVILLE
PA 12300 TWINBROOK PARKWAY, ROCKVILLE, MD 20852-1606 USA
SN 0146-0404
EI 1552-5783
J9 INVEST OPHTH VIS SCI
JI Invest. Ophthalmol. Vis. Sci.
PD JUL
PY 2018
VL 59
IS 9
MA 4935
PG 2
WC Ophthalmology
SC Ophthalmology
GA GR8CB
UT WOS:000442932804397
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dai, SY
   Zhang, YF
   Zhang, T
   Zhang, B
   Wang, HL
   Deng, F
AF Dai, Shiyu
   Zhang, Yanfang
   Zhang, Tao
   Zhang, Bo
   Wang, Hualin
   Deng, Fei
TI Establishment of Baculovirus-Expressed VLPs Induced Syncytial Formation
   Assay for Flavivirus Antiviral Screening
SO VIRUSES-BASEL
LA English
DT Article
DE baculovirus expression system; virus like particle; flavivirus; zika
   virus; syncytia
ID VIRUS-LIKE PARTICLES; INSECT-CELL LINE; ZIKA VIRUS; PERSISTENT
   INFECTION; CYSTEINE RESIDUES; ENVELOPE PROTEIN; SF9 CELLS; VACCINE;
   FUSION; ENTRY
AB The baculovirus-insect cell expression system has been widely used for heterologous protein expression and virus-like particles (VLPs) expression. In this study, we established a new method for antiviral screening targeting to glycoprotein E of flaviviruses based on the baculovirus expression system. ZIKV is a mosquito-borne flavivirus and has posed great threat to the public health. It has been reported that ZIKV infection was associated with microcephaly and serious neurological complications. Our study showed that either ZIKV E or prME protein expressed in insect cells can form VLPs and induce membrane fusion between insect cells. Therefore, the E protein, which is responsible for receptor binding, attachment, and virus fusion during viral entry, achieved proper folding and retained its fusogenic ability in VLPs when expressed in this system. The syncytia in insect cells were significantly reduced by the anti-ZIKV-E specific polyclonal antibody in a dose-dependent manner. AMS, a thiol-conjugating reagent, was also shown to have an inhibitory effect on the E protein induced syncytia and inhibited ZIKV infection by blocking viral entry. Indeed the phenomenon of syncytial formation induced by E protein expressed VLPs in insect cells is common among flaviviruses, including Japanese encephalitis virus (JEV), Dengue virus type 2 (DENV-2), and tick-borne encephalitis virus (TBEV). This inhibition effect on syncytial formation can be developed as a novel, safe, and simple antiviral screening approach for inhibitory antibodies, peptides, or small molecules targeting to E protein of ZIKV and other flaviviruses.
C1 [Dai, Shiyu; Zhang, Yanfang; Zhang, Tao; Zhang, Bo; Wang, Hualin; Deng, Fei] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
   [Dai, Shiyu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Wang, HL; Deng, F (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
EM 15629039156@163.com; Zhangyf@wh.iov.cn; tzhang@wh.iov.cn;
   zhangbo@wh.iov.cn; h.wang@wh.iov.cn; df@wh.iov.cn
OI deng, fei/0000-0002-5385-083X
FU National Key R&D Program of China [2017YFD0200400]; Science and
   Technology Basic Work Program from the Ministry of Science and
   Technology of China [2013FY113500]; strategic priority research program
   of the Chinese Academy of SciencesChinese Academy of Sciences
   [ZDRW-ZS-2016-4]
FX This work was supported by the National Key R&D Program of China
   (2017YFD0200400), the Science and Technology Basic Work Program
   (2013FY113500) from the Ministry of Science and Technology of China, and
   the strategic priority research program of the Chinese Academy of
   Sciences (ZDRW-ZS-2016-4).
CR Abou-Jaoude G, 2007, J VIROL, V81, P13057, DOI 10.1128/JVI.01495-07
   Barros MCES, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-261
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Dong SC, 2010, J VIROL, V84, P5351, DOI 10.1128/JVI.02517-09
   Du RK, 2015, J GEN VIROL, V96, P1006, DOI 10.1099/vir.0.000052
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fraser J, 2011, J BIOL CHEM, V286, P31984, DOI 10.1074/jbc.M111.269605
   Fu DW, 1996, BIOLOGICALS, V24, P225, DOI 10.1006/biol.1996.0031
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Harper DM, 2004, LANCET, V364, P1757, DOI 10.1016/S0140-6736(04)17398-4
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kielian M, 2006, NAT REV MICROBIOL, V4, P67, DOI 10.1038/nrmicro1326
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lin YJ, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-39
   Liu FX, 2013, PROTEIN EXPRES PURIF, V90, P104, DOI 10.1016/j.pep.2013.05.009
   RYSER HJP, 1994, P NATL ACAD SCI USA, V91, P4559, DOI 10.1073/pnas.91.10.4559
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Strandin T, 2011, J GEN VIROL, V92, P1189, DOI 10.1099/vir.0.027896-0
   van Oers MM, 2011, J INVERTEBR PATHOL, V107, pS3, DOI 10.1016/j.jip.2011.05.001
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wang ML, 2008, J VIROL, V82, P9800, DOI 10.1128/JVI.00759-08
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yamaji H, 2014, APPL MICROBIOL BIOT, V98, P1963, DOI 10.1007/s00253-013-5474-9
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   ZHANG PF, 1993, J GEN VIROL, V74, P1703, DOI 10.1099/0022-1317-74-8-1703
   ZHANG PF, 1994, BIOLOGICALS, V22, P205, DOI 10.1006/biol.1994.1030
NR 34
TC 2
Z9 2
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2018
VL 10
IS 7
AR 365
DI 10.3390/v10070365
PG 19
WC Virology
SC Virology
GA GU3CV
UT WOS:000445153200027
PM 29997331
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Munster, M
   Plaszczyca, A
   Cortese, M
   Neufeldt, CJ
   Goellner, S
   Long, G
   Bartenschlager, R
AF Muenster, Maximilian
   Plaszczyca, Anna
   Cortese, Mirko
   Neufeldt, Christopher John
   Goellner, Sarah
   Long, Gang
   Bartenschlager, Ralf
TI A Reverse Genetics System for Zika Virus Based on a Simple Molecular
   Cloning Strategy
SO VIRUSES-BASEL
LA English
DT Article
DE ZIKV; reporter virus; cryptic promoter silencing; full-length molecular
   clone; subgenomic replicon; plasmid toxicity
ID NUCLEAR-LOCALIZATION; REPLICATION; EFFICIENT; PROTEIN; RNAS
AB The Zika virus (ZIKV) has recently attracted major research interest as infection was unexpectedly associated with neurological manifestations in developing foetuses and with Guillain-Barre syndrome in infected adults. Understanding the underlying molecular mechanisms requires reverse genetic systems, which allow manipulation of infectious cDNA clones at will. In the case of flaviviruses, to which ZIKV belongs, several reports have indicated that the construction of full-length cDNA clones is difficult due to toxicity during plasmid amplification in Escherichia coli. Toxicity of flaviviral cDNAs has been linked to the activity of cryptic prokaryotic promoters within the region encoding the structural proteins leading to spurious transcription and expression of toxic viral proteins. Here, we employ an approach based on in silico prediction and mutational silencing of putative promoters to generate full-length cDNA clones of the historical MR766 strain and the contemporary French Polynesian strain H/PF/2013 of ZIKV. While for both strains construction of full-length cDNA clones has failed in the past, we show that our approach generates cDNA clones that are stable on single bacterial plasmids and give rise to infectious viruses with properties similar to those generated by other more complex assembly strategies. Further, we generate luciferase and fluorescent reporter viruses as well as sub-genomic replicons that are fully functional and suitable for various research and drug screening applications. Taken together, this study confirms that in silico prediction and silencing of cryptic prokaryotic promoters is an efficient strategy to generate full-length cDNA clones of flaviviruses and reports novel tools that will facilitate research on ZIKV biology and development of antiviral strategies.
C1 [Muenster, Maximilian; Plaszczyca, Anna; Cortese, Mirko; Neufeldt, Christopher John; Goellner, Sarah; Bartenschlager, Ralf] Heidelberg Univ, Dept Infect Dis, Ctr Integrat Infect Dis Res, Mol Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.
   [Long, Gang] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Bartenschlager, Ralf] Heidelberg Partner Site, German Ctr Infect Res, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.
RP Bartenschlager, R (corresponding author), Heidelberg Univ, Dept Infect Dis, Ctr Integrat Infect Dis Res, Mol Virol, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.; Bartenschlager, R (corresponding author), Heidelberg Partner Site, German Ctr Infect Res, Neuenheimer Feld 344, D-69120 Heidelberg, Germany.
EM max.muenster1991@googlemail.com; anna.plaszczyca@med.uni-heidelberg.de;
   mirko.cortese@med.uni-heidelberg.de;
   Christopher.Neufeldt@med.uni-heidelberg.de;
   sarah.goellner@med.uni-heidelberg.de; glong@ips.ac.cn;
   ralf.bartenschlager@med.uni-heidelberg.de
RI Neufeldt, Christopher/AAD-1702-2019; Bartenschlager, Ralf/L-2582-2015
OI Neufeldt, Christopher/0000-0002-4551-1811; Bartenschlager,
   Ralf/0000-0001-5601-9307; Goellner, Sarah/0000-0002-3300-4273; Cortese,
   Mirko/0000-0003-1786-4211
FU Bundesministerium fur Bildung und ForschungFederal Ministry of Education
   & Research (BMBF) [TTU 01.911]; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [Ba1505/8-1]; European UnionEuropean Union
   (EU) [642434]; European Molecular Biology Organization (EMBO) Long-Term
   FellowshipEuropean Molecular Biology Organization (EMBO) [ALTF 466-2016]
FX This research was funded by the Bundesministerium fur Bildung und
   Forschung (project TTU 01.911) and the Deutsche Forschungsgemeinschaft
   (Ba1505/8-1). A. P. was funded via the European Union's Horizon 2020
   research and innovation programme under the Marie Sklodowska-Curie grant
   agreement No 642434 (to R.B.). C.J.N was funded by a European Molecular
   Biology Organization (EMBO) Long-Term Fellowship (ALTF 466-2016). The
   funding institutions had no role in the design of the study; in the
   collection, analyses, or interpretation of data; in the writing of the
   manuscript and in the decision to publish the results.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Aubry F, 2015, ANTIVIR RES, V114, P67, DOI 10.1016/j.antiviral.2014.12.007
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Diamond MS, 2018, NAT REV IMMUNOL, V18, P89, DOI 10.1038/nri.2017.132
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Kitamura A, 2015, BIOCHEM BIOPH RES CO, V463, P401, DOI 10.1016/j.bbrc.2015.05.084
   Kumar A, 2013, J VIROL, V87, P4545, DOI 10.1128/JVI.03083-12
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munster M., 2017, TITRATION SYNZ UNPUB
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   Plaszczyca A., 2018, REPLICATION KI UNPUB
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7
   Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Schwarz MC, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00246-16
   Setoh YX, 2017, MSPHERE, V2, DOI [10.1128/mSphereDirect.00190-17, 10.1128/mspheredirect.00190-17]
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Steinmann E, 2008, J VIROL, V82, P7034, DOI 10.1128/JVI.00118-08
   Tischer BK, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/472537
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388
   Weger-Lucarelli J., 2017, J VIROL, V91
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Xue KS, 2016, ELIFE, V5, DOI 10.7554/eLife.13974
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 40
TC 9
Z9 9
U1 2
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUL
PY 2018
VL 10
IS 7
AR 368
DI 10.3390/v10070368
PG 17
WC Virology
SC Virology
GA GU3CV
UT WOS:000445153200030
PM 30002313
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kothandan, S
   Purushothaman, I
   George, SP
   Purushothaman, SR
   Sulochana, MK
AF Kothandan, Sangeetha
   Purushothaman, Indu
   George, Stella Puthur
   Purushothaman, Sasikala Reddy
   Sulochana, Meena Karunakaran
TI Molecular Docking and Density Function Theory Studies of Compounds from
   Euphorbia hirta and Bacopa monnieri to Zika Virus Structural and
   Nonstructural Proteins
SO PHARMACOGNOSY MAGAZINE
LA English
DT Article
DE Absorption, distribution, metabolism, and excretion-toxicity; density
   function theory; molecular docking; Zika virus
ID GUILLAIN-BARRE-SYNDROME; HEPATITIS-B; PHYLLANTHUS; PREDICTION;
   INHIBITION; CLASSIFICATION; GLYCYRRHIZIN; INFECTION; SITES
AB Background: Zika virus is an arbovirus belongs to the genus flavivirus and pose a serious global threat. The recent 2015 outbreak in Brazil was associated with a significant increase in microcephaly cases and other neurological complications in newborn babies and WHO declared Zika to be an international public health emergency. Currently, there is no specific treatment or Vaccine available for the Zika virus, and thus due to the unavailability of the antiviral drugs, the need for the identification of novel drugs is paramount. Materials and Methods: The compounds from two medicinal plants (Bacopa monnieri and Euphorbia hirta) were selected for the in silico molecular docking studies against the structural and nonstructural proteins of Zika virus. Quantum-chemical parameters density functional theory and absorption, distribution, metabolism, and excretion-toxicity (ADMET) was performed to identify the drug-likeliness properties. Results: Among the tested compounds, galloylquinic acid, Bacopaside III, and Bacopaside A were identified as leads against multiple targets of Zika virus. The identified compounds also exhibited desirable quantum chemical and ADMET properties. Conclusion: Hence, the compounds hampering the active site of the three different proteins playing a prime role in replication and fusion with desirable pharmacokinetic properties could be suggested for further in vitro and in vivo analysis of Zika virus.
C1 [Kothandan, Sangeetha; George, Stella Puthur; Purushothaman, Sasikala Reddy; Sulochana, Meena Karunakaran] Queen Marys Coll Autonomous, Bioinformat Infrastruct Facil Ctr DBT, Madras, Tamil Nadu, India.
   [Purushothaman, Indu] Presidency Coll Autonomous, Dept Microbiol & Biotechnol, Madras, Tamil Nadu, India.
   [Sulochana, Meena Karunakaran] Queen Marys Coll Autonomous, Dept Chem, Madras, Tamil Nadu, India.
RP Sulochana, MK (corresponding author), Queen Marys Coll Autonomous, Madras, Tamil Nadu, India.
EM journal171191@gmail.com
FU Bioinformatics Infrastructure Facility Centre of Department of
   Biotechnology, Ministry of Science and Technology, Govt. of India
   [BT/BI/25/068/2012/2015]
FX This work was supported by Bioinformatics Infrastructure Facility Centre
   of Department of Biotechnology, Ministry of Science and Technology,
   Govt. of India vide Grant No. BT/BI/25/068/2012/2015.
CR Aguiar S, 2013, REJUV RES, V16, P313, DOI 10.1089/rej.2013.1431
   Atlam FM, 2014, J MOL STRUCT, V1075, P311, DOI 10.1016/j.molstruc.2014.06.045
   BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913
   Besnard M, 2016, EUROSURVEILLANCE, V21, P1560
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cheng AL, 2003, J MED CHEM, V46, P3572, DOI 10.1021/jm020266b
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Egan WJ, 2000, J MED CHEM, V43, P3867, DOI 10.1021/jm000292e
   Ertl P, 2000, J MED CHEM, V43, P3714, DOI 10.1021/jm000942e
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m
   Jadhav P, 2012, N AM J MED SCI, V4, P641, DOI 10.4103/1947-2714.104316
   Kim YH, 2015, INT IMMUNOPHARMACOL, V26, P30, DOI 10.1016/j.intimp.2015.02.025
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kurokawa M, 1998, J PHARMACOL EXP THER, V284, P728
   LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785
   Liu Q, 2009, J NAT PROD, V72, P969, DOI 10.1021/np800792d
   Mishra KP, 2013, VIROL ANTIVIR RES, V2, P1
   Nagao Y, 1996, J GASTROENTEROL, V31, P691, DOI 10.1007/BF02347618
   Naik A D, 2003, Indian J Med Sci, V57, P387
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pengsuparp T, 1996, J NAT PROD, V59, P839, DOI 10.1021/np960399y
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Spino C, 1998, BIOORG MED CHEM LETT, V8, P3475, DOI 10.1016/S0960-894X(98)00628-3
   Susnow RG, 2003, J CHEM INF COMP SCI, V43, P1308, DOI 10.1021/ci030283p
   TAYLOR PB, 1994, J BIOL CHEM, V269, P6325
   THYAGARAJAN SP, 1988, LANCET, V2, P764
   van de Waterbeemd H, 2001, J COMPUT AID MOL DES, V15, P273, DOI 10.1023/A:1008192010023
   van Rossum TGJ, 2001, AM J GASTROENTEROL, V96, P2432, DOI 10.1111/j.1572-0241.2001.04049.x
   VENKATESWARAN PS, 1987, P NATL ACAD SCI USA, V84, P274, DOI 10.1073/pnas.84.1.274
   WANG MX, 1995, J LAB CLIN MED, V126, P350
   Xia XY, 2004, J MED CHEM, V47, P4463, DOI 10.1021/jm0303195
NR 36
TC 1
Z9 1
U1 0
U2 5
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 0973-1296
EI 0976-4062
J9 PHARMACOGN MAG
JI Pharmacogn. Mag.
PD JUL-SEP
PY 2018
VL 14
IS 57
SU 2
BP S481
EP S487
DI 10.4103/pm.pm_89_17
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GT8FI
UT WOS:000444771700029
DA 2020-07-08
ER

PT J
AU Wahid, B
   Ali, A
   Rafique, S
   Idrees, M
AF Wahid, Braira
   Ali, Amjad
   Rafique, Shazia
   Idrees, Muhammad
TI Zika virus: Is Pakistan next?
SO ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE
LA English
DT Article
C1 [Wahid, Braira; Idrees, Muhammad] Genome Ctr Mol Based Diagnost & Res, Cl 25 Block B Al Sudais Plaza Abdalian Cooperat S, Lahore, Pakistan.
   [Wahid, Braira; Ali, Amjad; Idrees, Muhammad] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
   [Idrees, Muhammad] Ha ra Univ, Mansehra, Pakistan.
   [Rafique, Shazia; Idrees, Muhammad] Univ Punjab, Div Mol Virol, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
   [Rafique, Shazia; Idrees, Muhammad] Univ Punjab, Diagnost Ctr Excellence Mol Biol CEMB, 87 West Canal Bank Rd Thokar Niaz Baig, Lahore, Pakistan.
RP Wahid, B (corresponding author), Genome Ctr Mol Based Diagnost & Res, Cl 25 Block B Al Sudais Plaza Abdalian Cooperat S, Lahore, Pakistan.
EM idrees.khan96@yahoo.com
RI Idrees, Muhammad/K-6032-2012
OI Idrees, Muhammad/0000-0002-3081-7631
CR Ali A, 2013, INT J INFECT DIS, V17, pE518, DOI 10.1016/j.ijid.2013.01.007
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Rauf M, 2017, LANCET INFECT DIS, V17, P258, DOI 10.1016/S1473-3099(17)30074-9
   World Health Organization, 2017, SIT REP ZIK VIR MICR
NR 5
TC 0
Z9 0
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 1995-7645
EI 2352-4146
J9 ASIAN PAC J TROP MED
JI Asian Pac. J. Trop. Med.
PD JUL
PY 2018
VL 11
IS 7
BP 451
EP 452
DI 10.4103/1995-7645.237190
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA GS7HM
UT WOS:000443871600007
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Colombo, TE
   Estofolete, CF
   Terzian, ACB
   Nogueira, ML
AF Colombo, Tatiana E.
   Estofolete, Cassia F.
   Terzian, Ana C. B.
   Nogueira, Mauricio L.
TI Viruria in Zika-infected pregnant women: implications for the newborn
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE pregnant women; viruria; Zika virus
ID HUMAN PLACENTAL TROPHOBLASTS; WEST-NILE-VIRUS; DISEASE; BRAZIL; URINE;
   BRAIN; OUTBREAK; TISSUES; DENGUE
C1 [Colombo, Tatiana E.; Estofolete, Cassia F.; Terzian, Ana C. B.; Nogueira, Mauricio L.] Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
   [Colombo, Tatiana E.] Univ Paulista UNIP, Ave Presidente Juscelino Kubitscheck de Oliveira, BR-15091450 Sao Jose Do Rio Preto, SP, Brazil.
   [Estofolete, Cassia F.; Nogueira, Mauricio L.] Hosp Base Sao Jose do Rio Preto FUNFARME, Ave Brigadeiro Faria Lima,5544 Vila Sao Jose, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, Ave Brigadeiro Faria Lima,5416 Vila Sao Pedro, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.; Nogueira, ML (corresponding author), Hosp Base Sao Jose do Rio Preto FUNFARME, Ave Brigadeiro Faria Lima,5544 Vila Sao Jose, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI amsalu, ribka/G-8780-2019; Estofolete, Cassia/N-6673-2019; Nogueira,
   Mauricio L/B-7599-2012
OI Estofolete, Cassia/0000-0001-7324-1591; Nogueira, Mauricio
   L/0000-0003-1102-2419
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1, 2015/12295-0];
   FAPESP Zika Network
FX This work is supported by the Sao Paulo Research Foundation (FAPESP) via
   grant numbers 2013/21719-3 and 2016/15021-1 (FAPESP - DECIT/PPSUS) for
   ML Nogueira, the fellowship 2015/12295-0 for ACB Terzian. This work was
   supported by the FAPESP Zika Network. ML Nogueira is a CNPq Research
   Fellow. The authors have no other relevant affiliations or financial
   involvement with any organization or entity with a financial interest in
   or financial conflict with the subject matter or materials discussed in
   the manuscript apart from those disclosed.
CR Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599
   Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Appler KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010649
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2013, EURO SURVEILL, V19
   Bhatnagar J, 2007, J CLIN VIROL, V38, P106, DOI 10.1016/j.jcv.2006.11.003
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Giugliano S, 2015, J IMMUNOL, V195, P3737, DOI 10.4049/jimmunol.1500409
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lan Nguyen Thi Phuong, 2011, Trop Med Health, V39, P73, DOI 10.2149/tmh.2011-S08
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Maidji E, 2007, J VIROL, V81, P4701, DOI 10.1128/JVI.02748-06
   Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pessoa R, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.30.30302
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Terzian ACB, 2017, EMERG INFECT DIS, V23, P1891, DOI 10.3201/eid2311.170078
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 35
TC 0
Z9 0
U1 0
U2 0
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUL
PY 2018
VL 13
IS 7
BP 449
EP 451
DI 10.2217/fvl-2018-0034
PG 3
WC Virology
SC Virology
GA GS0FP
UT WOS:000443164000002
DA 2020-07-08
ER

PT J
AU Greenway, A
   Schimmer, R
AF Greenway, Alice
   Schimmer, Ralph
TI Advancements in diagnostic solutions for complex viruses: an interview
   with Ralph Schimmer
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE complex viruses; diagnostics; immunoassay; infectious diseases; zika
ID MICRONESIA; TRAVELERS
AB Ralph has been Chief Medical Officer and Head Global Medical & Scientific Affairs for Centralized and Point of Care Solutions within the Roche Diagnostics division since May 2014. Between 2012 and 2016, Ralph was the Roche coordinator of the Innovative Medicines Initiative's (IMI) project Eu2P, a public-private partnership with a consortium of seven European universities, 15 pharmaceutical companies and the European and French Medicines Agencies. The Commissioning Editor of Future Virology, Alice Greenway, talks to Schimmer about the role that Roche Diagnostics plays in the development of tailored diagnostic solutions for complex viruses as well as the launch of the new Elecsys (R) Zika IgG assay.
C1 [Greenway, Alice] Future Med, London, England.
   [Schimmer, Ralph] Roche Diagnost Int Ltd, Risch Rotkreuz, Switzerland.
RP Greenway, A (corresponding author), Future Med, London, England.
EM alicee.greenway@googlemail.com
CR Centers for Disease Control and Prevention, 2017, ZIK VIR TYP TESTS
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Jeong YE, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0740-6
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   World Health Organization Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
NR 9
TC 0
Z9 0
U1 0
U2 1
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUL
PY 2018
VL 13
IS 7
BP 453
EP 456
DI 10.2217/fvl-2018-0074
PG 4
WC Virology
SC Virology
GA GS0FP
UT WOS:000443164000003
OA Bronze
DA 2020-07-08
ER

PT J
AU Kuang, LD
   Lei, M
   Li, CY
   Zhang, XY
   Ren, YJ
   Zheng, J
   Guo, ZQ
   Zhang, CX
   Yang, C
   Mei, XL
   Fu, M
   Xie, XH
AF Kuang, Liangde
   Lei, Min
   Li, Congyan
   Zhang, Xiangyu
   Ren, Yongjun
   Zheng, Jie
   Guo, Zhiqiang
   Zhang, Cuixia
   Yang, Chao
   Mei, Xiuli
   Fu, Min
   Xie, Xiaohong
TI Identification of Long Non-Coding RNAs Related to Skeletal Muscle
   Development in Two Rabbit Breeds with Different Growth Rate
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE rabbit; lncRNA; skeletal muscle development; RNA-Sequencing
ID EXTRACELLULAR-MATRIX; MYOGENIN EXPRESSION; MEAT; CAVEOLIN-3; COFACTOR;
   COLLAGEN; TENDON; CELLS; HISAT
AB Skeletal muscle development plays an important role in muscle quality and yield, which decides the economic value of livestock. Long non-coding RNAs (lncRNAs) have been reported to be associated with skeletal muscle development. However, little is revealed about the function of lncRNAs in rabbits' muscle development. LncRNAs and mRNAs in two rabbit breeds (ZIKA rabbits (ZKR) and Qixin rabbits (QXR)) with different growth rates at three developmental stages (0 day, 35 days, and 84 days after birth) were researched by transcriptome sequencing. Differentially expressed lncRNAs and mRNAs were identified for two rabbit breeds at the same stages by DESeq package. Co-expression correlation analysis of differentially expressed lncRNAs and mRNAs were performed to construct lncRNA-mRNA pairs. To explore the function of lncRNAs, Gene Ontology (GO) analysis of co-expression mRNAs in lncRNA-mRNA pairs were performed. In three comparisons, there were 128, 109, and 115 differentially expressed lncRNAs, respectively. LncRNAs TCONS_00013557 and XR_518424.2 differentially expressed in the two rabbit breeds might play important roles in skeletal muscle development, for their co-expressed mRNAs were significantly enriched in skeletal muscle development related GO terms. This study provides potentially functional lncRNAs in skeletal muscle development of two rabbit breeds and might be beneficial to the production of rabbits.
C1 [Kuang, Liangde; Lei, Min; Li, Congyan; Zhang, Xiangyu; Ren, Yongjun; Zheng, Jie; Guo, Zhiqiang; Zhang, Cuixia; Yang, Chao; Mei, Xiuli; Fu, Min; Xie, Xiaohong] Sichuan Anim Sci Acad, Chengdu 610066, Sichuan, Peoples R China.
   [Kuang, Liangde; Lei, Min; Li, Congyan; Zhang, Xiangyu; Ren, Yongjun; Zheng, Jie; Guo, Zhiqiang; Zhang, Cuixia; Yang, Chao; Mei, Xiuli; Fu, Min; Xie, Xiaohong] Anim Breeding & Genet Key Lab Sichuan Prov, Chengdu 610066, Sichuan, Peoples R China.
RP Xie, XH (corresponding author), Sichuan Anim Sci Acad, Chengdu 610066, Sichuan, Peoples R China.; Xie, XH (corresponding author), Anim Breeding & Genet Key Lab Sichuan Prov, Chengdu 610066, Sichuan, Peoples R China.
EM happyboy5851258@163.com; meets888@163.com; licongyan0311@163.com;
   chadance33@163.com; swees2@126.com; laolang1188@163.com; ygzhiq@126.com;
   dawn713@163.com; yc20040736@163.com; mxl038@126.com; safm2017@126.com;
   swin258@163.com
OI Xie, Xiaohong/0000-0003-3697-0845
FU Sichuan Province Fundamental Research Project [2018JY0265]; Livestock
   Breeding Project of Sichuan Province [2016NYZ0046]; special financial
   operation of Sichuan Province [SASA2014CZYX005]; National modern
   agricultural industrial technology system of China [CARS-43-D-3];
   Fundamental Research Funds for the Sichuan Province Institute of Animal
   Husbandry Research [SASA2017A04]
FX This work was supported by Sichuan Province Fundamental Research Project
   (2018JY0265), the Livestock Breeding Project of Sichuan Province
   (2016NYZ0046), the special financial operation of Sichuan Province
   (SASA2014CZYX005), National modern agricultural industrial technology
   system of China (CARS-43-D-3) and the Fundamental Research Funds for the
   Sichuan Province Institute of Animal Husbandry Research (SASA2017A04).
CR Baguma-Nibasheka M, 2016, HISTOL HISTOPATHOL, V31, P699, DOI 10.14670/HH-11-742
   Billerey C, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-499
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonnet A, 2010, MECH DEVELOP, V127, P120, DOI 10.1016/j.mod.2009.10.001
   Chen HH, 2004, GENESIS, V39, P273, DOI 10.1002/gene.20055
   Dalle Zotte A, 2011, MEAT SCI, V88, P319, DOI 10.1016/j.meatsci.2011.02.017
   Hagiwara Y, 2002, CELL STRUCT FUNCT, V27, P375, DOI 10.1247/csf.27.375
   Hermida M, 2006, MEAT SCI, V73, P635, DOI 10.1016/j.meatsci.2006.03.004
   Honda M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07149-0
   Kawai S, 2005, BIOCHEM BIOPH RES CO, V328, P306, DOI 10.1016/j.bbrc.2004.12.173
   Kawai S, 2013, GENE EXPR PATTERNS, V13, P372, DOI 10.1016/j.gep.2013.06.007
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kinoshita A, 1997, J BIOL CHEM, V272, P31777, DOI 10.1074/jbc.272.50.31777
   Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003
   Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391
   Kunert-Keil C, 2011, FOLIA HISTOCHEM CYTO, V49, P291, DOI 10.5603/FHC.2011.0041
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Li AM, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-311
   Li TT, 2012, GENOMICS, V99, P292, DOI 10.1016/j.ygeno.2012.02.003
   Maeda T, 2002, J BIOL CHEM, V277, P48889, DOI 10.1074/jbc.M206858200
   Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034
   Melo F, 1996, J CELL BIOCHEM, V62, P227, DOI 10.1002/(SICI)1097-4644(199608)62:2<227::AID-JCB11>3.3.CO;2-F
   NANDAN D, 1990, J CELL BIOL, V110, P1673, DOI 10.1083/jcb.110.5.1673
   Nishimura T, 2015, MEAT SCI, V109, P48, DOI 10.1016/j.meatsci.2015.05.015
   Okada K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115169
   Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095
   Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547
   Ren CF, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080191
   Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]
   Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22
   SAITOH O, 1992, EXP CELL RES, V200, P70, DOI 10.1016/S0014-4827(05)80072-2
   Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320
   Sun L, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt646
   Tsai CC, 2013, CELL TRANSPLANT, V22, P413, DOI 10.3727/096368912X656090
   Velleman SG, 1999, POULTRY SCI, V78, P778, DOI 10.1093/ps/78.5.778
NR 35
TC 3
Z9 3
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD JUL
PY 2018
VL 19
IS 7
AR 2046
DI 10.3390/ijms19072046
PG 14
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA GR6UX
UT WOS:000442807400225
PM 30011879
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kollars, TM
AF Kollars, Thomas M., Jr.
TI Potential for the Invasive Species Aedes Albopictus and Arboviral
   Transmission through the Chabahar Port in Iran
SO IRANIAN JOURNAL OF MEDICAL SCIENCES
LA English
DT Article
DE Integrated mosquito management; Vector control; Disease management; Iran
ID ZIKA VIRUS OUTBREAK; DIPTERA-CULICIDAE; MOSQUITOS; DISEASE; ECOLOGY;
   STATES; ISLAND; SKUSE
AB Background: Dengue, chikungunya, and Zika viruses are emerging infectious disease threats wherever suitable vectors, hosts, and habitat are present. The aim of the present study was to use the bioagent transport and environmental modeling system (BioTEMS) to identify the potential for arbovirus-infected Aedes species to invade the Chabahar area in southeastern Iran.
   Methods: ArcGIS geospatial analysis software, Statistica software, and BioTEMS were used to analyze geographic information and conduct data analysis. BioTEMS utilizes up to several hundred abiotic and biotic factors to produce risk and vulnerability assessments for biological agents and infectious diseases. The output of BioTEMS was validated using published predictive models, and most importantly published collection data of Aedes species in Iran.
   Results: There appears to have been two separate invasion events by Ae. albopictus into the southern region of Iran, first preceding 2009 and then again in 2013. BioTEMS identified two probable areas of introduction during the 2009 time frame, either through one or both the Chabahar ports or the Iranshahr airport with subsequent spread through vehicular transport. BioTEMS identified the port as an introduction zone for ZIKAV with high-risk zones and identifies gap zones during the 2013 time frame. Recommended surveillance sites are provided.
   Conclusion: The air and maritime ports of Iran serve international customers, and are therefore vulnerable to import and invasion of mosquito vectors and arboviruses. Based on comparisons with other published low-resolution models, BioTEMS provides information for medical and public health professionals conducting integrated mosquito management, preventive medicine, and epidemiological surveillance.
C1 [Kollars, Thomas M., Jr.] Liberty Univ, Coll Hlth Sci, Lynchburg, VA USA.
RP Kollars, TM (corresponding author), 1971 Univ Blvd, Lynchburg, VA 24515 USA.
EM tkollars@liberty.edu
CR Aghaie A, 2016, INDIAN J HEMATOL BLO, V32, P343, DOI 10.1007/s12288-015-0567-5
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Azari-Hamidian S, 2009, MED VET ENTOMOL, V23, P111, DOI 10.1111/j.1365-2915.2009.00802.x
   Azari-Hamidian S, 2007, J VECTOR ECOL, V32, P235, DOI 10.3376/1081-1710(2007)32[235:COIMDC]2.0.CO;2
   Baca-Carrasco D, 2016, B MATH BIOL, V78, P2228, DOI 10.1007/s11538-016-0219-4
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Chinikar S, 2013, ALL RES J BIOL, V4, P16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doosti S, 2016, IRAN J PUBLIC HEALTH, V45, P1064
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control Rapid Risk Assessment, ZIK VIR EP AM POT AS
   Futami K, 2015, J ECON ENTOMOL, V108, P761, DOI 10.1093/jee/tou028
   Gardner L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072129
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heusel JL, PEATY LFAW
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kampango A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1361-4
   Kollars Jr TM, 2016, ANN COMMUNITY MED PR, V2, P1015
   Kollars Jr TM, 2016, ASIAN J SCI TECHNOLO, V7, P3833
   Kollars Jr TM, 2016, INT J MED, V4, P70, DOI DOI 10.14419/IJM.V4I2.5922
   Kollars TM, 2017, RES REP TROP MED, V8, P1, DOI [10.2147/RRTM.S123456, 10.2147/rrtm.s123456]
   Kollars TM, 2008, CHEM BIOL WEAPONS DE
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   LaPook J, 2016, WHATS BEING DONE FIG
   Lindsay MDA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004114
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Meyerson LA, 2007, FRONT ECOL ENVIRON, V5, P199, DOI 10.1890/1540-9295(2007)5[199:IASIAE]2.0.CO;2
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Moosa-Kazemi SH, 2009, IRAN J ARTHROPOD-BOR, V3, P29
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Peterson A. T., 2006, BIODIVERSITY INFORM, V3, P59, DOI DOI 10.17161/BI.V3I0.29
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Thuiller W, 2006, GLOBAL CHANGE BIOL, V12, P759, DOI 10.1111/j.1365-2486.2006.01140.x
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
   World Health Organization, 2017, REG OFF E REG
   World Health Organization (WHO), 5 M EM COMM INT HLTH
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yalwala S, 2016, J MED ENTOMOL, V53, P1242, DOI 10.1093/jme/tjw075
   ZAIM M, 1987, J AM MOSQUITO CONTR, V3, P568
NR 50
TC 1
Z9 1
U1 0
U2 7
PU SHIRAZ UNIV MEDICAL SCIENCES
PI SHIRAZ
PA ZAND ST, SHIRAZ, FARS 00000, IRAN
SN 0253-0716
EI 1735-3688
J9 IRAN J MED SCI
JI Iran. J. Med. Sci.
PD JUL
PY 2018
VL 43
IS 4
BP 393
EP 400
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA GQ6WH
UT WOS:000441868500007
PM 30046208
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Shameer, K
   Glicksberg, BS
   Hodos, R
   Johnson, KW
   Badgeley, MA
   Readhead, B
   Tomlinson, MS
   O'Connor, T
   Miotto, R
   Kidd, BA
   Chen, R
   Ma'ayan, A
   Dudley, JT
AF Shameer, Khader
   Glicksberg, Benjamin S.
   Hodos, Rachel
   Johnson, Kipp W.
   Badgeley, Marcus A.
   Readhead, Ben
   Tomlinson, Max S.
   O'Connor, Timothy
   Miotto, Riccardo
   Kidd, Brian A.
   Chen, Rong
   Ma'ayan, Avi
   Dudley, Joel T.
TI Systematic analyses of drugs and disease indications in RepurposeDB
   reveal pharmacological, biological and epidemiological factors
   influencing drug repositioning
SO BRIEFINGS IN BIOINFORMATICS
LA English
DT Article
DE precision medicine; drug repositioning; translational bioinformatics;
   drug development; drug discovery; precision pharmacology; systems
   pharmacology
ID GENOME-WIDE ASSOCIATION; SEMANTIC SIMILARITY; ENRICHMENT ANALYSIS;
   DATABASE; PREDICTION; LIBRARY; GENES; PROMISCUITY; INFORMATION;
   COMORBIDITY
AB Increase in global population and growing disease burden due to the emergence of infectious diseases (Zika virus), multidrug-resistant pathogens, drug-resistant cancers (cisplatin-resistant ovarian cancer) and chronic diseases (arterial hypertension) necessitate effective therapies to improve health outcomes. However, the rapid increase in drug development cost demands innovative and sustainable drug discovery approaches. Drug repositioning, the discovery of new or improved therapies by reevaluation of approved or investigational compounds, solves a significant gap in the public health setting and improves the productivity of drug development. As the number of drug repurposing investigations increases, a new opportunity has emerged to understand factors driving drug repositioning through systematic analyses of drugs, drug targets and associated disease indications. However, such analyses have so far been hampered by the lack of a centralized knowledgebase, benchmarking data sets and reporting standards. To address these knowledge and clinical needs, here, we present RepurposeDB, a collection of repurposed drugs, drug targets and diseases, which was assembled, indexed and annotated from public data. RepurposeDB combines information on 253 drugs [small molecules (74.30%) and protein drugs 25.29%)] and 1125 diseases. Using RepurposeDB data, we identified pharmacological (chemical descriptors, physicochemical features and absorption, distribution, metabolism, excretion and toxicity properties), biological (protein domains, functional process, molecular mechanisms and pathway cross talks) and epidemiological (shared genetic architectures, disease comorbidities and clinical phenotype similarities) factors mediating drug repositioning. Collectively, RepurposeDB is developed as the reference database for drug repositioning investigations. The pharmacological, biological and epidemiological principles of drug repositioning identified from the meta-analyses could augment therapeutic development.
C1 [Shameer, Khader; Readhead, Ben] Mt Sinai Hlth Syst, Inst Next Generat Healthcare, Dudley Lab, New York, NY USA.
   [Glicksberg, Benjamin S.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Dudley & Chen Labs, New York, NY USA.
   [Hodos, Rachel] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Dudley & Sontag Labs, New York, NY USA.
   [Hodos, Rachel] NYU, New York, NY USA.
   [Johnson, Kipp W.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Dudley Lab, New York, NY USA.
   [Badgeley, Marcus A.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, New York, NY USA.
   [Tomlinson, Max S.; O'Connor, Timothy; Miotto, Riccardo; Kidd, Brian A.] Dudley Lab, Boston, MA USA.
   [Tomlinson, Max S.] Boston Coll, Boston, MA USA.
   [Miotto, Riccardo; Kidd, Brian A.] Mt Sinai Hlth Syst, Inst Next Generat Healthcare, New York, NY USA.
   [Chen, Rong] Mt Sinai Hlth Syst, Icahn Inst Genet & Multiscale Biol, Clin Genome Informat, New York, NY USA.
   [Ma'ayan, Avi] Mt Sinai Hlth Syst, Mt Sinai Ctr Bioinformat, New York, NY USA.
   [Dudley, Joel T.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Inst Next Generat Healthcare, New York, NY USA.
   [Dudley, Joel T.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY USA.
   [Dudley, Joel T.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY USA.
   [Dudley, Joel T.] Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Biomed Informat, New York, NY USA.
RP Dudley, JT (corresponding author), Mt Sinai Hlth Syst, Icahn Sch Med Mt Sinai, Inst Next Generat Healthcare, Dept Genet & Genom Sci,Icahn Inst Genom & Multisc, New York, NY 10019 USA.
EM joel.dudley@mssm.edu
RI Johnson, Kipp/I-1260-2019; Khader, Shameer/J-2564-2016; Glicksberg,
   Benjamin/I-9500-2019; Ma'ayan, Avi/AAG-3131-2019
OI Johnson, Kipp/0000-0002-5102-741X; Glicksberg,
   Benjamin/0000-0003-4515-8090; Ma'ayan, Avi/0000-0002-6904-1017; Miotto,
   Riccardo/0000-0002-7815-6000
FU National Institutes of Health: National Institute of Diabetes and
   Digestive and Kidney Diseases (NIDDK)United States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R01-DK098242-03]; National Cancer Institute (NCI)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [U54-CA189201-02]; Illuminating
   the Druggable Genome (IDG); Knowledge Management Center - NIH Common
   Fund; National Center for Advancing Translational Sciences (NCATS)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [UL1TR000067]; Clinical and Translational Science
   Awards (CTSA) grant
FX This study was funded by the following grants from the National
   Institutes of Health: National Institute of Diabetes and Digestive and
   Kidney Diseases (NIDDK, grant number R01-DK098242-03); National Cancer
   Institute (NCI, grant number U54-CA189201-02); Illuminating the
   Druggable Genome (IDG); Knowledge Management Center sponsored by NIH
   Common Fund; National Center for Advancing Translational Sciences
   (NCATS, grant number UL1TR000067); and Clinical and Translational
   Science Awards (CTSA) grant.
CR Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159
   Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205
   Amelio I, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.9
   [Anonymous], 2007, Expert Rev Pharmacoecon Outcomes Res, V7, P315, DOI 10.1586/14737167.7.4.315
   Arain FA, 2012, J AM COLL CARDIOL, V59, P400, DOI 10.1016/j.jacc.2011.09.055
   Arnott IDR, 2003, PHARMACOL RES, V47, P1, DOI 10.1016/S1043-6618(02)00264-5
   Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175
   Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691
   Blackwell AD, 2015, DRUG DISCOV TODAY, V20, P391, DOI 10.1016/j.drudis.2014.12.005
   Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317
   Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307
   Cao YQ, 2008, BIOINFORMATICS, V24, pI366, DOI 10.1093/bioinformatics/btn186
   Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen X, 2002, J CHEM INF COMP SCI, V42, P1407, DOI 10.1021/ci025531g
   Chute CG, 2014, AM J EPIDEMIOL, V179, P759, DOI 10.1093/aje/kwt443
   Collins FS, 2015, NEW ENGL J MED, V372, P793, DOI 10.1056/NEJMp1500523
   Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102
   Das S, 2016, BIOINFORMATICS, V32, P2889, DOI 10.1093/bioinformatics/btw473
   Dudley JT, 2011, BRIEF BIOINFORM, V12, P303, DOI 10.1093/bib/bbr013
   Edwards DP, 2000, J MAMMARY GLAND BIOL, V5, P307, DOI 10.1023/A:1009503029176
   Fox NK, 2014, NUCLEIC ACIDS RES, V42, pD304, DOI 10.1093/nar/gkt1240
   Glicksberg BS, 2016, BIOINFORMATICS, V32, P101, DOI 10.1093/bioinformatics/btw282
   GLICKSBERG BSL, 2015, PAC S BIO, V20, P407
   Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551
   Guha R, 2006, J CHEM INF MODEL, V46, P991, DOI 10.1021/ci050400b
   Hahn U, 2012, BRIEF BIOINFORM, V13, P460, DOI 10.1093/bib/bbs018
   HAMMER B, 1968, GUT, V9, P17, DOI 10.1136/gut.9.1.17
   Hann MM, 2012, NAT REV DRUG DISCOV, V11, P355, DOI 10.1038/nrd3701
   Harispe S, 2014, J BIOMED INFORM, V48, P38, DOI 10.1016/j.jbi.2013.11.006
   Harispe S, 2014, BIOINFORMATICS, V30, P740, DOI 10.1093/bioinformatics/btt581
   Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146
   Hidalgo CA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000353
   Hodos RA, 2016, WILEY INTERDISCIP RE
   Hu Ye, 2014, F1000Res, V3, P218, DOI 10.12688/f1000research.5250.2
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/1471-2105-16-S13-S4
   Irie H, 2016, ONCOL LETT, V11, P1287, DOI 10.3892/ol.2016.4075
   Jahchan NS, 2013, CANCER DISCOV, V3, P1364, DOI 10.1158/2159-8290.CD-13-0183
   Jewison T, 2014, NUCLEIC ACIDS RES, V42, pD478, DOI 10.1093/nar/gkt1067
   Ji WDR, 1998, FASEB J, V12, P1731
   Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652
   Kamburov A, 2013, NUCLEIC ACIDS RES, V41, pD793, DOI 10.1093/nar/gks1055
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284
   Keiser MJ, 2010, BIOCHEMISTRY-US, V49, P10267, DOI 10.1021/bi101540g
   Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506
   Kelder T, 2012, NUCLEIC ACIDS RES, V40, pD1301, DOI 10.1093/nar/gkr1074
   Kersten S, 2000, NATURE, V405, P421
   Kesselheim AS, 2015, HEALTH AFFAIR, V34, P286, DOI 10.1377/hlthaff.2014.1038
   Kidd BA, 2015, PERS MED, V12, P245, DOI 10.2217/PME.14.87
   Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939
   Lang CC, 2007, HEART, V93, P665, DOI 10.1136/hrt.2005.068296
   Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320
   Lau QY, 2015, ANTIBIOTICS-BASEL, V4, P424, DOI 10.3390/antibiotics4040424
   Law V, 2014, NUCLEIC ACIDS RES, V42, pD1091, DOI 10.1093/nar/gkt1068
   Li Li, 2013, Pac Symp Biocomput, P224
   Li L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007191
   Li MJ, 2016, NUCLEIC ACIDS RES, V44, pD869, DOI 10.1093/nar/gkv1317
   Li MLJ, 2012, NUCLEIC ACIDS RES, V40, pD1047, DOI 10.1093/nar/gkr1182
   Li Y, 2008, BIOINFORMATICS, V24, P1442, DOI 10.1093/bioinformatics/btn200
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Liu X, 2013, CURR MED CHEM, V20, P1646
   Loging W, 2007, NAT REV DRUG DISCOV, V6, P220, DOI 10.1038/nrd2265
   Lyman GH, 2016, NEW ENGL J MED, V375, P4, DOI 10.1056/NEJMp1604033
   MAY ACW, 1994, PHILOS T ROY SOC B, V344, P373, DOI 10.1098/rstb.1994.0076
   McCabe BJ, 2004, CURR OPIN CLIN NUTR, V7, P21, DOI 10.1097/00075197-200401000-00005
   Menche J, 2015, SCIENCE, V347, DOI 10.1126/science.1257601
   Mendez-Lucio O, 2014, CHEMMEDCHEM, V9, P560, DOI 10.1002/cmdc.201300555
   Mirnezami R, 2012, NEW ENGL J MED, V366, P489, DOI 10.1056/NEJMp1114866
   Montojo J, 2010, BIOINFORMATICS, V26, P2927, DOI 10.1093/bioinformatics/btq562
   Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006
   Moreno P, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0486-3
   Murteira Susana, 2013, J Mark Access Health Policy, V1, DOI 10.3402/jmahp.v1i0.21131
   Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418
   Nelson MR, 2016, NAT REV GENET, V17, P197, DOI 10.1038/nrg.2016.12
   Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314
   Neves M, 2014, BRIEF BIOINFORM, V15, P327, DOI 10.1093/bib/bbs084
   NIEDELMAN M L, 1954, Pa Med J, V57, P333
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   OBOYLE NM, 2008, CHEM CENT J, V2, DOI DOI 10.1186/1752-153X-2-5
   Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199
   Pan YM, 2014, J CHEM INF MODEL, V54, P407, DOI 10.1021/ci4005354
   Piccirillo JF, 2008, CRIT REV ONCOL HEMAT, V67, P124, DOI 10.1016/j.critrevonc.2008.01.013
   Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078
   Power A, 2014, JAMA-J AM MED ASSOC, V311, P2063, DOI 10.1001/jama.2014.3002
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Rastegar-Mojarad M, 2015, NAT BIOTECHNOL, V33, DOI 10.1038/nbt.3183
   Readhead B, 2013, ADV WOUND CARE, V2, P470, DOI 10.1089/wound.2012.0422
   Robbins AS, 2002, ANN EPIDEMIOL, V12, P452, DOI 10.1016/S1047-2797(01)00278-2
   Romero P, 2005, GENOME BIOL, V6
   Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151
   Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653
   Shameer K, 2015, CURR TOP MED CHEM, V15, P5, DOI 10.2174/1568026615666150112103510
   Shameer Khader, 2012, J Clin Bioinforma, V2, P8, DOI 10.1186/2043-9113-2-8
   Sirota M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001318
   Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1
   Steinbeck C, 2003, J CHEM INF COMP SCI, V43, P493, DOI 10.1021/ci025584y
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tarcsay A, 2013, J MED CHEM, V56, P1789, DOI 10.1021/jm301514n
   Tetko IV, 2005, J COMPUT AID MOL DES, V19, P453, DOI 10.1007/s10822-005-8694-y
   van de Waterbeemd H, 2003, NAT REV DRUG DISCOV, V2, P192, DOI 10.1038/nrd1032
   van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1
   Varin T, 2010, J CHEM INF MODEL, V50, P2067, DOI 10.1021/ci100203e
   Vilar S, 2014, NAT PROTOC, V9, P2147, DOI 10.1038/nprot.2014.151
   Vogt I, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0052-z
   von Eichborn J, 2011, NUCLEIC ACIDS RES, V39, pD1060, DOI 10.1093/nar/gkq1037
   Wang WH, 2014, BIOINFORMATICS, V30, P2923, DOI 10.1093/bioinformatics/btu403
   Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537
   Waring MJ, 2015, NAT REV DRUG DISCOV, V14, P475, DOI 10.1038/nrd4609
   Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229
   Whirl-Carrillo M, 2012, CLIN PHARMACOL THER, V92, P414, DOI 10.1038/clpt.2012.96
   Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329
   Xie L, 2016, ANN REV PHARM TOXICO
   Xu K, 2011, BRIEF BIOINFORM, V12, P341, DOI 10.1093/bib/bbr006
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yu W, 2008, NAT GENET, V40, P124, DOI 10.1038/ng0208-124
NR 121
TC 18
Z9 18
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1467-5463
EI 1477-4054
J9 BRIEF BIOINFORM
JI Brief. Bioinform.
PD JUL
PY 2018
VL 19
IS 4
BP 656
EP 678
DI 10.1093/bib/bbw136
PG 23
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA GP9NI
UT WOS:000441243300012
PM 28200013
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Redmond, SN
   MacInnis, BM
   Bopp, S
   Bei, AK
   Ndiaye, D
   Hartl, DL
   Wirth, DF
   Volkman, SK
   Neafsey, DE
AF Redmond, Seth N.
   MacInnis, Bronwyn M.
   Bopp, Selina
   Bei, Amy K.
   Ndiaye, Daouda
   Hartl, Daniel L.
   Wirth, Dyann F.
   Volkman, Sarah K.
   Neafsey, Daniel E.
TI De Novo Mutations Resolve Disease Transmission Pathways in Clonal
   Malaria
SO MOLECULAR BIOLOGY AND EVOLUTION
LA English
DT Article
DE genomic epidemiology; de novo mutation; malaria; transmission networks
ID BURROWS-WHEELER TRANSFORM; LOW-COMPLEXITY REGIONS;
   PLASMODIUM-FALCIPARUM; PHYLOGENETIC ANALYSIS; GENOMIC EPIDEMIOLOGY;
   VARIATION DISCOVERY; HOSPITAL OUTBREAK; VIRUS EVOLUTION; READ ALIGNMENT;
   ZIKA VIRUS
AB Detecting de novo mutations in viral and bacterial pathogens enables researchers to reconstruct detailed networks of disease transmission and is a key technique in genomic epidemiology. However, these techniques have not yet been applied to the malaria parasite, Plasmodium falciparum, in which a larger genome, slower generation times, and a complex life cycle make them difficult to implement. Here, we demonstrate the viability of de novo mutation studies in P. falciparum for the first time. Using a combination of sequencing, library preparation, and genotyping methods that have been optimized for accuracy in low-complexity genomic regions, we have detected de novo mutations that distinguish nominally identical parasites from clonal lineages. Despite its slower evolutionary rate compared with bacterial or viral species, de novo mutation can be detected in P. falciparum across timescales of just 1-2 years and evolutionary rates in low-complexity regions of the genome can be up to twice that detected in the rest of the genome. The increased mutation rate allows the identification of separate Glade expansions that cannot be found using previous genomic epidemiology approaches and could be a crucial tool for mapping residual transmission patterns in disease elimination campaigns and reintroduction scenarios.
C1 [Redmond, Seth N.; MacInnis, Bronwyn M.; Bopp, Selina; Hartl, Daniel L.; Wirth, Dyann F.; Volkman, Sarah K.; Neafsey, Daniel E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
   [Redmond, Seth N.; MacInnis, Bronwyn M.; Bopp, Selina; Bei, Amy K.; Ndiaye, Daouda; Wirth, Dyann F.; Volkman, Sarah K.; Neafsey, Daniel E.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Bei, Amy K.; Ndiaye, Daouda] Cheikh Anta Diop Univ, Fac Med & Pharm, Dept Parasitol, Dakar, Senegal.
   [Hartl, Daniel L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.
   [Volkman, Sarah K.] Simmons Coll, Dept Nursing, Sch Nursing & Hlth Sci, Boston, MA 02115 USA.
RP Redmond, SN (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Redmond, SN (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
EM sredmond@broadinstitute.org
OI redmond, seth/0000-0003-2653-760X; Bopp, Selina/0000-0002-9412-9766
FU Global Health Program at the Bill and Melinda Gates Foundation
   [OPP1053604]; NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI099105]; Chronos system;
   ExxonMobil Foundation
FX We are grateful for the assistance of Thomas D. Otto (Sanger Institute)
   for providing the Dd2_v1 reference genome for validation. BEI resources,
   David Fidock (Columbia University), and Daniel Goldberg (Washington
   University in St. Louis) for supplying their Plasmodium stocks for
   sequencing. We thank the UCAD/LeDantec laboratory and SLAP clinic team,
   particularly Dr. Ngayo Sy, and the patients for clinical samples. We
   thank Sinead Chapman, Caroline Cusick, and Jim Bochicchio for project
   management, and Steve Schaffner and Angela Early for their insightful
   comments on the manuscript. Funding for this work at the Harvard T.H.
   Chan School of Public Health and the Broad Institute was provided by a
   grant to D.F. Wirth from the Global Health Program at the Bill and
   Melinda Gates Foundation (OPP1053604, "Genomic-Based Diagnostics for
   Elimination and Eradication of Plasmodium"); publication was paid for
   via the Chronos system. Senegal sample collection was funded by the
   NIAID (R01AI099105: "Genetic Variation and Evolution of Artemisinin
   Resistance."). This work was carried out with support from the
   ExxonMobil Foundation.
CR Azarian T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164397
   Biek R, 2015, TRENDS ECOL EVOL, V30, P306, DOI 10.1016/j.tree.2015.03.009
   Blum MGB, 2005, MATH BIOSCI, V195, P141, DOI 10.1016/j.mbs.2005.03.003
   Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293
   Chenet SM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0887-9
   Cleary JG, 2015, BIORXIV, DOI [10.1101/023754., DOI 10.1101/023754]
   Colijn Caroline, 2014, Evolution Medicine and Public Health, P96, DOI 10.1093/emph/eou018
   Cowell AN, 2018, SCIENCE, V359, P191, DOI 10.1126/science.aan4472
   Daniels R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060780
   Daniels RF, 2015, P NATL ACAD SCI USA, V112, P7067, DOI 10.1073/pnas.1505691112
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7
   Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569
   Galinsky K, 2015, MALARIA J, V14, DOI 10.1186/1475-2875-14-4
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Halachev MR, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0070-x
   Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395
   Hatherell HA, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000060
   Jombart T, 2011, HEREDITY, V106, P383, DOI 10.1038/hdy.2010.78
   Lemieux J., 2015, THESIS
   LENTO GM, 1995, MOL BIOL EVOL, V12, P28, DOI 10.1093/oxfordjournals.molbev.a040189
   Lenz C, 2014, GENOME BIOL EVOL, V6, P655, DOI 10.1093/gbe/evu042
   Li H, 2014, BIOINFORMATICS, V30, P2843, DOI 10.1093/bioinformatics/btu356
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   LI WH, 1988, MOL BIOL EVOL, V5, P313
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miles A, 2016, GENOME RES, V26, P1288, DOI 10.1101/gr.203711.115
   Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028
   Narzisi G, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00008
   Neher RA, 2015, BIOINFORMATICS, V31, P3546, DOI 10.1093/bioinformatics/btv381
   Nkhoma SC, 2013, MOL ECOL, V22, P273, DOI 10.1111/mec.12099
   Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412
   Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007
   Popovich KJ, 2016, CLIN INFECT DIS, V62, P37, DOI 10.1093/cid/civ794
   Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Reiner RC, 2015, ELIFE, V4, DOI 10.7554/eLife.09520
   Schliep KP, 2011, BIOINFORMATICS, V27, P592, DOI 10.1093/bioinformatics/btq706
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Strimmer K, 1996, MOL BIOL EVOL, V13, P964, DOI 10.1093/oxfordjournals.molbev.a025664
   Weisenfeld NI, 2014, NAT GENET, V46, P1350, DOI 10.1038/ng.3121
   WHO, 2016, WHO J WORLD MAL REP
   Worby CJ, 2017, AM J EPIDEMIOL, V186, P1209, DOI 10.1093/aje/kwx182
   Zilversmit MM, 2010, MOL BIOL EVOL, V27, P2198, DOI 10.1093/molbev/msq108
NR 48
TC 4
Z9 4
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0737-4038
EI 1537-1719
J9 MOL BIOL EVOL
JI Mol. Biol. Evol.
PD JUL
PY 2018
VL 35
IS 7
BP 1678
EP 1689
DI 10.1093/molbev/msy059
PG 12
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA GP8DY
UT WOS:000441141400010
PM 29722884
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Moreira-Soto, A
   Cabral, R
   Pedroso, C
   Eschbach-Bludau, M
   Rockstroh, A
   Vargas, LA
   Postigo-Hidalgo, I
   Luz, E
   Sampaio, GS
   Drosten, C
   Netto, EM
   Jaenisch, T
   Ulbert, S
   Sarno, M
   Brites, C
   Drexler, JF
AF Moreira-Soto, Andres
   Cabral, Renata
   Pedroso, Celia
   Eschbach-Bludau, Monika
   Rockstroh, Alexandra
   Vargas, Ludy Alexandra
   Postigo-Hidalgo, Ignacio
   Luz, Estela
   Sampaio, Gilmara Souza
   Drosten, Christian
   Netto, Eduardo Martins
   Jaenisch, Thomas
   Ulbert, Sebastian
   Sarno, Manoel
   Brites, Carlos
   Drexler, Jan Felix
TI Exhaustive TORCH Pathogen Diagnostics Corroborate Zika Virus Etiology of
   Congenital Malformations in Northeastern Brazil
SO MSPHERE
LA English
DT Article
DE Brazil; TORCH; Zika virus; microcephaly; parturient
ID INFECTION; RISK
AB The Latin American 2015-2016 Zika virus (ZIKV) outbreak was associ- ated with an increase in microcephaly predominantly in northeastern Brazil. To comparatively investigate infectious causes of congenital malformations, we performed a nested case-control study in 32 mothers of cases of suspected congenital Zika syndrome (CZS) and 160 age-matched controls from Bahia, northeastern Brazil. We collected clinical and imaging data and assessed past exposure to ZIKV, Chikungunya virus (CHIKV), dengue virus, and 8 established TORCH (Toxoplasma gondii, Treponema pallidum, rubella virus, cytomegalovirus, herpes simplex virus 1 [HSV-1] and HSV-2, varicella-zoster virus, parvovirus B19) pathogens using multiple serological tests. Heterogeneous symptoms prevented unequivocal diagnosis of CZS on clinical grounds. Only ZIKV and CHIKV seroprevalence rates differed significantly between cases and controls (93.8% versus 67.8% for ZIKV [Fisher's exact text, P = 0.0021 and 20.7% versus 8.2% for CHIKV [chi(2), P = 0.0391]). High ZIKV seroprevalence rates in cases could not be explained by previous dengue virus infections potentially eliciting cross-reactive antibody responses affecting ZIKV serological tests. In conditional logistic regression analyses, only ZIKV was significantly associated with congenital malformations (P = 0.030; odds ratio, 4.0 [95% confidence interval, 1.1 to 14.1]). Our data support an association between maternal ZIKV exposure and congenital malformations. Parallels between the discrepant ZIKV and CHIKV seroprevalence rates between cases and controls and similar seroprevalence rates between cases and controls for the sexually transmitted T. pallidum and HSV-2 may suggest the occurrence of predominantly vector-borne transmission in our study population. High seroprevalence of TORCH pathogens suggests that exhaustive diagnostics will be necessary in the aftermath of the ZIKV outbreak and provides baseline data for longitudinal studies on ZIKV pathogenesis.
   IMPORTANCE The Latin American Zika virus (ZIKV) outbreak had a major impact on reproductive health worldwide. The reasons for the massively increased reports of neonatal microcephaly in northeastern Brazil are still unclear. Beyond the technical limitations of laboratory diagnostics, unambiguous diagnosis of ZIKV as the cause of congenital malformations is hampered by similar clinical pictures elicited by other pathogens known as TORCH pathogens. We performed a case-control study comparing mothers of children with congenital malformations to age-matched controls from Salvador, Brazil, one of the areas most extensively affected by the ZIKV outbreak. The ZIKV and Chikungunya virus seroprevalence rates differed significantly, whereas the levels of maternal exposure to TORCH pathogens were similar between cases and controls. Our data support a link between maternal ZIKV infection and congenital malformations and suggest the occurrence of predominantly vector-borne ZIKV transmission in these cases. In addition, some highly prevalent TORCH pathogens may be misinterpreted as representative of ongoing ZIKV activity in the absence of exhaustive diagnostics in northeastern Brazil.
C1 [Moreira-Soto, Andres; Eschbach-Bludau, Monika] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany.
   [Moreira-Soto, Andres; Postigo-Hidalgo, Ignacio; Drosten, Christian; Drexler, Jan Felix] Charite Univ Med Berlin, Berlin, Germany.
   [Moreira-Soto, Andres; Postigo-Hidalgo, Ignacio; Drosten, Christian; Drexler, Jan Felix] Free Univ Berlin, Berlin, Germany.
   [Moreira-Soto, Andres; Postigo-Hidalgo, Ignacio; Drosten, Christian; Drexler, Jan Felix] Humboldt Univ, Berlin, Germany.
   [Moreira-Soto, Andres; Postigo-Hidalgo, Ignacio; Drosten, Christian; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [Cabral, Renata; Sarno, Manoel] Univ Fed Bahia, Maternidade Climerio de Oliveira, Salvador, BA, Brazil.
   [Pedroso, Celia; Vargas, Ludy Alexandra; Luz, Estela; Sampaio, Gilmara Souza; Netto, Eduardo Martins; Sarno, Manoel; Brites, Carlos] Univ Fed Bahia, Complexo Hosp Univ Prof Edgard Santos, Salvador, BA, Brazil.
   [Rockstroh, Alexandra; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany.
   [Drosten, Christian; Jaenisch, Thomas; Drexler, Jan Felix] German Ctr Infect Res DZIF, Braunschweig, Germany.
   [Jaenisch, Thomas] Heidelberg Univ Hosp, Dept Infect Dis, Sect Clin Trop Med, Heidelberg, Germany.
RP Drexler, JF (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Free Univ Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Humboldt Univ, Berlin, Germany.; Drexler, JF (corresponding author), Berlin Inst Hlth, Inst Virol, Berlin, Germany.; Drexler, JF (corresponding author), German Ctr Infect Res DZIF, Braunschweig, Germany.
EM felix.drexler@charite.de
RI Netto, Eduardo/D-1432-2013
OI Netto, Eduardo/0000-0003-1691-6761; Drexler, Jan
   Felix/0000-0002-3509-0232; Postigo-Hidalgo, Ignacio/0000-0001-9083-4102
FU German Centre for Infection Research (DZIF) through the ZIKApath
   project; European Union's Horizon 2020 research and innovation program
   through the ZIKAlliance project [734548]; German Research Foundation
   (DFG)German Research Foundation (DFG); Charite-Universitatsmedizin
   Berlin
FX This work was supported by the German Centre for Infection Research
   (DZIF) through the ZIKApath project, the European Union's Horizon 2020
   research and innovation program through the ZIKAlliance project (grant
   agreement no. 734548), the German Research Foundation (DFG), and the
   Open Access Publication Fund of Charite-Universitatsmedizin Berlin. We
   declare that we have no competing financial interests.
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Clemens S A, 1999, J Pediatr (Rio J), V75, P433
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Levine D, 2017, RADIOLOGY, V285, P744, DOI 10.1148/radiol.2017171238
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mitsuka-Bregano R, 2010, EPIDEMIOLOGIA IMPACT, P5
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Moura AA, 2015, INT J INFECT DIS, V39, P10, DOI 10.1016/j.ijid.2015.07.022
   Mower WR, 1999, ANN EMERG MED, V33, P85, DOI 10.1016/S0196-0644(99)70422-1
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rockstroh A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.87
   Rodrigues LC, 2017, LANCET, V390, P824, DOI 10.1016/S0140-6736(17)31478-2
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Secretaria-de-Vigilancia-em-Saude, 2015, B EP PROGR NAC IM AS, P46
   SHEPARD TH, 1982, J PEDIATR-US, V101, P810, DOI 10.1016/S0022-3476(82)80338-7
   Souza AI, 2018, PUBLIC HEALTH REP, V133, P461, DOI 10.1177/0033354918777256
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 25
TC 1
Z9 1
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD JUL-AUG
PY 2018
VL 3
IS 4
AR e00278-18
DI 10.1128/mSphere.00278-18
PG 6
WC Microbiology
SC Microbiology
GA GP7FE
UT WOS:000441058200023
PM 30089647
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Valiant, WG
   Lalani, T
   Yun, HC
   Kunz, A
   Burgess, TH
   Mattapallil, JJ
AF Valiant, William G.
   Lalani, Tahaniyat
   Yun, Heather C.
   Kunz, Anjali
   Burgess, Timothy H.
   Mattapallil, Joseph J.
TI Human Serum With High Neutralizing Antibody Titers Against Both Zika and
   Dengue Virus Shows Delayed In Vitro Antibody-Dependent Enhancement of
   Dengue Virus Infection
SO OPEN FORUM INFECTIOUS DISEASES
LA English
DT Article
DE antibody-dependent enhancement; cross-neutralization; dengue virus; Zika
   virus
ID CROSS-REACTIVITY; MACROPHAGES; DISEASE
AB Zika virus infection in a dengue virus-naive subject was associated with the induction of high levels of cross-reactive binding antibodies. These responses were, however, largely non-neutralizing and displayed a capacity to enhance dengue infection in vitro at significantly low dilution (1:10). In contrast, a subject who had high levels of neutralizing antibodies against both dengue and Zika viruses enhanced infection at a dilution of 1:10 000. These results suggest that high levels of dengue cross-neutralizing antibodies could potentially prevent the enhancement of dengue infection in Zika virus-convalescent individuals.
C1 [Valiant, William G.; Mattapallil, Joseph J.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD USA.
   [Lalani, Tahaniyat; Burgess, Timothy H.] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Infect Dis Clin Res Program, Rockville, MD USA.
   [Lalani, Tahaniyat] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA.
   [Lalani, Tahaniyat] Naval Med Ctr, Div Infect Dis, Portsmouth, VA USA.
   [Yun, Heather C.] San Antonio Mil Med Ctr, San Antonio, TX USA.
   [Kunz, Anjali] Madigan Army Med Ctr, Tacoma, WA 98431 USA.
RP Mattapallil, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.
EM joseph.mattapallil@usuhs.edu
OI Mattapallil, Joseph/0000-0002-7412-9507
FU Uniformed Services University; Infectious Disease Clinical Research
   Program (IDCRP), a Department of Defense (DoD) program through the
   Uniformed Services University of the Health Sciences, the National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health (NIH) [Y1-AI-5072]
FX The described project was supported by funds from the Uniformed Services
   University to J.J.M. The serum samples were derived from the Deployment
   and Travel Related Infectious Disease Risk Assessment, Outcomes, and
   Prevention Strategies among Department of Defense Beneficiaries
   (TravMil) study, supported by the Infectious Disease Clinical Research
   Program (IDCRP), a Department of Defense (DoD) program executed through
   the Uniformed Services University of the Health Sciences, the National
   Institute of Allergy and Infectious Diseases, National Institutes of
   Health (NIH), under the Inter-Agency Agreement Y1-AI-5072.
CR Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Montoya M, J INFECT DIS
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Valiant WG, 2018, JOVE-J VIS EXP, DOI 10.3791/57371
NR 15
TC 9
Z9 9
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 2328-8957
J9 OPEN FORUM INFECT DI
JI Open Forum Infect. Dis.
PD JUL
PY 2018
VL 5
IS 7
AR UNSP ofy151
DI 10.1093/ofid/ofy151
PG 4
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GP5YK
UT WOS:000440953400018
PM 30019003
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiu, HP
   Chiu, H
   Yang, CF
   Lee, YL
   Chiu, FL
   Kuo, HC
   Lin, RJ
   Lin, YL
AF Chiu, Hsin-Ping
   Chiu, Han
   Yang, Chao-Fu
   Lee, Yi-Ling
   Chiu, Feng-Lan
   Kuo, Hung-Chih
   Lin, Ren-Jye
   Lin, Yi-Ling
TI Inhibition of Japanese encephalitis virus infection by the host
   zinc-finger antiviral protein
SO PLOS PATHOGENS
LA English
DT Article
ID VIRAL MESSENGER-RNAS; CEREBROSPINAL-FLUID; IN-VIVO; RIG-I; REPLICATION;
   ZAP; EXPRESSION; INTERFERON; FLAVIVIRUS; CELLS
AB CCCH-type zinc-finger antiviral protein (ZAP) is a host factor that restricts the infection of many viruses mainly through RNA degradation, translation inhibition and innate immune responses. So far, only one flavivirus, yellow fever virus, has been reported to be ZAP-resistant. Here, we investigated the antiviral potential of human ZAP (isoform ZAP-L and ZAP-S) against three flaviviruses, Japanese encephalitis virus (JEV), dengue virus (DENV) and Zika virus (ZIKV). Infection of JEV but not DENV or ZIKV was blocked by ZAP overexpression, and depletion of endogenous ZAP enhanced JEV replication. ZAP hampered JEV translation and targeted viral RNA for 3'-5' RNA exosome-mediated degradation. The zinc-finger motifs of ZAP were essential for RNA targeting and anti-JEV activity. JEV 3'-UTR, especially in the region with dumbbell structures and high content of CG dinucleotide, was mapped to bind ZAP and confer sensitivity to ZAP. In summary, we identified JEV as the first ZAP-sensitive flavivirus. ZAP may act as an intrinsic antiviral factor through specific RNA binding to fight against JEV infection.
C1 [Chiu, Hsin-Ping; Chiu, Han; Lin, Yi-Ling] Natl Taiwan Univ, Grad Inst Microbiol, Taipei, Taiwan.
   [Chiu, Hsin-Ping; Chiu, Han; Yang, Chao-Fu; Lee, Yi-Ling; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Chiu, Feng-Lan; Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei, Taiwan.
   [Lin, Ren-Jye] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Taipei, Taiwan.
   [Lin, Yi-Ling] Acad Sinica, Genom Res Ctr, Taipei, Taiwan.
RP Lin, YL (corresponding author), Natl Taiwan Univ, Grad Inst Microbiol, Taipei, Taiwan.; Lin, YL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.; Lin, RJ (corresponding author), Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Taipei, Taiwan.; Lin, YL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei, Taiwan.
EM 040925@nhri.org.tw; yll@ibms.sinica.edu.tw
RI Lin, Yi-Ling/N-7128-2018
OI Lin, Yi-Ling/0000-0002-1838-6410; Lee, Yi-Ling/0000-0002-0220-1119
FU Academia SinicaAcademia Sinica - Taiwan [106-2101-01-11-01,
   107-2101-01-18-03]; Ministry of Science and Technology, TaiwanMinistry
   of Science and Technology, Taiwan [MOST 106-0210-01-15-02,
   107-021001-19-01]
FX This work was supported by Academia Sinica (106-2101-01-11-01 &
   107-2101-01-18-03) and the Ministry of Science and Technology, Taiwan
   (MOST 106-0210-01-15-02 & 107-021001-19-01). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bick MJ, 2003, J VIROL, V77, P11555, DOI 10.1128/JVI.77.21.11555-11562.2003
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   BURKE DS, 1987, J INFECT DIS, V155, P797, DOI 10.1093/infdis/155.4.797
   Chen GF, 2008, P NATL ACAD SCI USA, V105, P4352, DOI 10.1073/pnas.0712276105
   Chen LK, 1996, VIROLOGY, V223, P79, DOI 10.1006/viro.1996.0457
   Chen LK, 1996, VIROLOGY, V217, P220, DOI 10.1006/viro.1996.0109
   Chen SD, 2012, NAT STRUCT MOL BIOL, V19, P430, DOI 10.1038/nsmb.2243
   Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10
   Chiu FL, 2015, HUM MOL GENET, V24, P6066, DOI 10.1093/hmg/ddv318
   Clements MO, 2006, TISSUE ENG, V12, P1741, DOI 10.1089/ten.2006.12.1741
   Darnell Robert, 2012, Cold Spring Harb Protoc, V2012, P1146, DOI 10.1101/pdb.prot072132
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276
   Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004
   Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104
   Hayakawa S, 2011, NAT IMMUNOL, V12, P37, DOI 10.1038/ni.1963
   Huang PY, 2012, MOL THER, V20, P298, DOI 10.1038/mt.2011.245
   Huang Z, 2010, PROTEIN CELL, V1, P752, DOI 10.1007/s13238-010-0096-9
   Kao YT, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004750
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kerns JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040021
   Li M, 2015, ANTIVIR RES, V123, P50, DOI 10.1016/j.antiviral.2015.09.001
   Lin KC, 2004, J VIROL, V78, P5133, DOI 10.1128/JVI.78.10.5133-5138.2004
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lin RJ, 2004, J VIROL, V78, P9285, DOI 10.1128/JVI.78.17.9285-9294.2004
   Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998
   Liu LX, 2004, BIOCHEM BIOPH RES CO, V321, P517, DOI 10.1016/j.bbrc.2004.06.174
   Makarova O, 2000, BIOTECHNIQUES, V29, P970, DOI 10.2144/00295bm08
   Mao RC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003494
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Muller S, 2007, J VIROL, V81, P2391, DOI 10.1128/JVI.01601-06
   Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Olsthoorn RCL, 2001, RNA, V7, P1370
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Ravi V, 1997, J MED VIROL, V51, P132, DOI 10.1002/(SICI)1096-9071(199702)51:2&lt;132::AID-JMV8&gt;3.0.CO;2-8
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Su CH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0433-y
   Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039
   Tang QN, 2017, J VIROL, V91, DOI 10.1128/JVI.01909-16
   Todorova T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6362
   Wang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039159
   Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
   Xie L, 2018, J GEN VIROL, V99, P73, DOI 10.1099/jgv.0.000982
   Xuan YF, 2013, J VIROL, V87, P2735, DOI 10.1128/JVI.03015-12
   Zhu YP, 2012, EMBO J, V31, P4236, DOI 10.1038/emboj.2012.271
   Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108
NR 49
TC 18
Z9 18
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2018
VL 14
IS 7
AR e1007166
DI 10.1371/journal.ppat.1007166
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GO8OS
UT WOS:000440351300018
PM 30016363
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Counotte, MJ
   Kim, CR
   Wang, JY
   Bernstein, K
   Deal, CD
   Broutet, NJN
   Low, N
AF Counotte, Michel Jacques
   Kim, Caron Rahn
   Wang, Jingying
   Bernstein, Kyle
   Deal, Carolyn D.
   Broutet, Nathalie Jeanne Nicole
   Low, Nicola
TI Sexual transmission of Zika virus and other flaviviruses: A living
   systematic review
SO PLOS MEDICINE
LA English
DT Article
ID VECTOR-BORNE TRANSMISSION; CENTRAL-NERVOUS-SYSTEM; LOCAL TRANSMISSION;
   UNITED-STATES; DENGUE VIRUS; MOSQUITO-BORNE; MOUSE MODEL; VIRAL LOAD;
   INFECTION; SEMEN
AB Background
   Health authorities in the United States and Europe reported an increasing number of travel-associated episodes of sexual transmission of Zika virus (ZIKV) following the 2015-2017 ZIKV outbreak. This, and other scientific evidence, suggests that ZIKV is sexually transmissible in addition to having its primary mosquito-borne route. The objective of this systematic review and evidence synthesis was to clarify the epidemiology of sexually transmitted ZIKV.
   Methods and findings
   We performed a living (i.e., continually updated) systematic review of evidence published up to 15 April 2018 about sexual transmission of ZIKV and other arthropod-borne flaviviruses in humans and other animals. We defined 7 key elements of ZIKV sexual transmission for which we extracted data: (1) rectal and vaginal susceptibility to infection, (2) incubation period following sexual transmission, (3) serial interval between the onset of symptoms in a primary and secondary infected individuals, (4) duration of infectiousness, (5) reproduction number, (6) probability of transmission per sex act, and (7) transmission rate. We identified 1,227 unique publications and included 128, of which 77 presented data on humans and 51 presented data on animals. Laboratory experiments confirm that rectal and vaginal mucosae are susceptible to infection with ZIKV and that the testis serves as a reservoir for the virus in animal models. Sexual transmission was reported in 36 human couples: 34/36 of these involved male-to-female sexual transmission. The median serial symptom onset interval in 15 couples was 12 days (interquartile range: 10-14.5); the maximum was 44 days. We found evidence from 2 prospective cohorts that ZIKV RNA is present in human semen with a median duration of 34 days (95% CI: 28-41 days) and 35 days (no CI given) (low certainty of evidence, according to GRADE). Aggregated data about detection of ZIKV RNA from 37 case reports and case series indicate a median duration of detection of ZIKV of 40 days (95% CI: 30-49 days) and maximum duration of 370 days in semen. In human vaginal fluid, median duration was 14 days (95% CI: 7-20 days) and maximum duration was 37 days (very low certainty). Infectious virus in human semen was detected for a median duration of 12 days (95% CI: 1-21 days) and maximum of 69 days. Modelling studies indicate that the reproduction number is below 1 (very low certainty). Evidence was lacking to estimate the incubation period or the transmission rate. Evidence on sexual transmission of other flaviviruses was scarce. The certainty of the evidence is limited because of uncontrolled residual bias.
   Conclusions
   The living systematic review and sexual transmission framework allowed us to assess evidence about the risk of sexual transmission of ZIKV. ZIKV is more likely transmitted from men to women than from women to men. For other flaviviruses, evidence of sexual transmissibility is still absent. Taking into account all available data about the duration of detection of ZIKV in culture and from the serial interval, our findings suggest that the infectious period for sexual transmission of ZIKV is shorter than estimates from the earliest post-outbreak studies, which were based on reverse transcription PCR alone.
C1 [Counotte, Michel Jacques; Wang, Jingying; Low, Nicola] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
   [Kim, Caron Rahn; Broutet, Nathalie Jeanne Nicole] World Hlth Org, Dept Reprod Hlth & Res, Geneva, Switzerland.
   [Bernstein, Kyle] Ctr Dis Control & Prevent, Div Sexually Transmitted Dis Prevent, Atlanta, GA USA.
   [Deal, Carolyn D.] NIAID, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Low, N (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.
EM nicola.low@ispm.unibe.ch
RI Counotte, Michel Jacques/K-6735-2019
OI Counotte, Michel Jacques/0000-0003-1039-6873; Bernstein,
   Kyle/0000-0001-8455-899X
FU Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen
   ForschungAustrian Science Fund (FWF) [320030_170069, 320030_176233];
   World Health OrganizationWorld Health Organization [2017/725385-0,
   2017/733494-0]
FX MJC and JW received salary support from Schweizerischer Nationalfonds
   zur Forderung der Wissenschaftlichen Forschung (CH) http://www.snf.ch/
   Award Number: 320030_170069 & 320030_176233. MJC received salary support
   from World Health Organization contracts 2017/725385-0 and
   2017/733494-0. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Althouse GC, 2011, REPROD DOMEST ANIM, V46, P64, DOI 10.1111/j.1439-0531.2011.01863.x
   Armah HB, 2007, BRAIN PATHOL, V17, P354, DOI 10.1111/j.1750-3639.2007.00080.x
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Balshem H, 2011, J CLIN EPIDEMIOL, V64, P401, DOI 10.1016/j.jclinepi.2010.07.015
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   BARZON L, 2016, EUROSURVEILLANCE, V21, P2
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Biava M, 2018, NEW MICROBIOL, V41, P30
   Boggild AK, 2017, CAN MED ASSOC J, V189, pE334, DOI 10.1503/cmaj.161241
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Burke SA, 2004, IMMUNOL CELL BIOL, V82, P174, DOI 10.1046/j.0818-9641.2004.01239.x
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Caro JJ, 2014, VALUE HEALTH, V17, P174, DOI 10.1016/j.jval.2014.01.003
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Cassuto NG, 2018, J GYNECOL OBSTET HUM, V47, P211, DOI 10.1016/j.jogoh.2018.02.004
   Centers for Disease Control and Prevention, 2015, ZIK CAS UN STAT CUM
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JF, 2016, EMERG MICROBES INFEC, V5
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   Dudley DM, 2016, BIORXIV, DOI [10.1101/046334, DOI 10.1101/046334]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Duijster JW, 2017, NED TIJDSCHR GENEES, V161, pD1622
   Egger Matthias, 2017, F1000Res, V6, P1584, DOI 10.12688/f1000research.12367.2
   Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Fujita N, 1972, Kobe J Med Sci, V18, P143
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gerlinskaia L A, 1997, Biull Eksp Biol Med, V123, P327
   Giesecke J, 2017, MODERN INFECT DIS EP
   Gomez G, 2009, STAT MODEL, V9, P259, DOI 10.1177/1471082X0900900402
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Grossi PA, 2018, NEW MICROBIOL, V41, P80
   Gu XD, 2014, R J, V6, P31
   Guerin B, 2005, THERIOGENOLOGY, V63, P556, DOI 10.1016/j.theriogenology.2004.09.030
   Gulland A, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i6500
   Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI 10.1016/j.jclinepi.2011.06.004
   Habu A, 1977, Uirusu, V27, P21
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hearn P, 2014, AM J TROP MED HYG S1, V91, P62
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Huits RMHG, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.181370, DOI 10.2471/BLT.16.181370, 10.2471/blt.16.181370]
   Iannetta M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.34.30600
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Jia HM, 2018, TRAVEL MED INFECT DI, V21, P56, DOI 10.1016/j.tmaid.2017.11.012
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kelley Roger E, 2016, J La State Med Soc, V168, P21
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   KUMAR A, 2018, SCI REP UK, V8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Liu WJ, 2013, VIRUS RES, V178, P547, DOI 10.1016/j.virusres.2013.09.002
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Majumder MS, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171009, DOI 10.2471/BLT.16.171009]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Martinez LE, 2017, BIORXIV, DOI [10.1101/128876, DOI 10.1101/128876]
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mizuno Y, 2007, T ROY SOC TROP MED H, V101, P738, DOI 10.1016/j.trstmh.2007.02.007
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   National Heart Lung and Blood Institute, 2014, STUD QUAL ASS TOOLS
   National Institute for Health and Care Excellence, 2012, GUID MAN PROC METH P
   NEWMAN CM, 2017, NAT COMMUN, V8
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Panina-Bordignon P, 2017, REPROD SCI, V24, p85A
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Prabandari SA, 2015, EXP ANIM, V64, pS27
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rasinhas AD, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170208
   Reusken C, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.23.30251
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   Sriprapun M, 2012, CLIN MICROBIOL INFEC, V18, P28
   Sriprapun M, 2015, ASIAN BIOMED, V9, P197, DOI 10.5372/1905-7415.0902.387
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Torres JR, 2000, CLIN INFECT DIS, V31, P315
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Borrego BV, 2017, EMERGENCIAS, V29, P290
   Vandenbroucke JP, 1999, J ROY SOC MED, V92, P159, DOI 10.1177/014107689909200401
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Vink MA, 2014, AM J EPIDEMIOL, V180, P865, DOI 10.1093/aje/kwu209
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   WHO, 2016, PREV SEX TRANSM ZIK
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   World Health Organization, 2016, ZIKA SITUATION REPOR
   World Health Organization, 2016, SAUDI MED J, V37, P332
   World Health Organization, 2016, ZIK VIR INF D ARG FR
   World Health Organization, 2016, ZIK VIR INF D CHIL
   World Health Organization, 2016, ZIK VIR INF D PER
   World Health Organization, 2017, SEX TRANSM ZIK VIR M
   Wu D, 2016, J INFECTION, V73, P300, DOI 10.1016/j.jinf.2016.06.008
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zhang YP, 2015, INFECT GENET EVOL, V32, P342, DOI 10.1016/j.meegid.2015.03.037
   Zheng N C, 2016, Zhonghua Yi Xue Za Zhi, V96, P3666, DOI 10.3760/cma.j.issn.0376-2491.2016.45.012
NR 167
TC 27
Z9 27
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1676
J9 PLOS MED
JI PLos Med.
PD JUL
PY 2018
VL 15
IS 7
AR e1002611
DI 10.1371/journal.pmed.1002611
PG 25
WC Medicine, General & Internal
SC General & Internal Medicine
GA GO8KY
UT WOS:000440339700018
PM 30040845
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lowe, R
   Gasparrini, A
   Van Meerbeeck, CJ
   Lippi, CA
   Mahon, R
   Trotman, AR
   Rollock, L
   Hinds, AQJ
   Ryan, SJ
   Stewart-Ibarra, AM
AF Lowe, Rachel
   Gasparrini, Antonio
   Van Meerbeeck, Cedric J.
   Lippi, Catherine A.
   Mahon, Roche
   Trotman, Adrian R.
   Rollock, Leslie
   Hinds, Avery Q. J.
   Ryan, Sadie J.
   Stewart-Ibarra, Anna M.
TI Nonlinear and delayed impacts of climate on dengue risk in Barbados: A
   modelling study
SO PLOS MEDICINE
LA English
DT Article
ID METEOROLOGICAL FACTORS; CARIBBEAN RAINFALL; AEDES-AEGYPTI; FEVER;
   VARIABILITY; HEALTH; PREDICTION; EPIDEMICS; ATLANTIC
AB Background
   Over the last 5 years (2013-2017), the Caribbean region has faced an unprecedented crisis of co-occurring epidemics of febrile illness due to arboviruses transmitted by the Aedes sp. mosquito (dengue, chikungunya, and Zika). Since 2013, the Caribbean island of Barbados has experienced 3 dengue outbreaks, 1 chikungunya outbreak, and 1 Zika fever outbreak. Prior studies have demonstrated that climate variability influences arbovirus transmission and vector population dynamics in the region, indicating the potential to develop public health interventions using climate information. The aim of this study is to quantify the nonlinear and delayed effects of climate indicators, such as drought and extreme rainfall, on dengue risk in Barbados from 1999 to 2016.
   Methods and findings
   Distributed lag nonlinear models (DLNMs) coupled with a hierarchal mixed-model framework were used to understand the exposure-lag-response association between dengue relative risk and key climate indicators, including the standardised precipitation index (SPI) and minimum temperature (Tmin). The model parameters were estimated in a Bayesian framework to produce probabilistic predictions of exceeding an island-specific outbreak threshold. The ability of the model to successfully detect outbreaks was assessed and compared to a baseline model, representative of standard dengue surveillance practice. Drought conditions were found to positively influence dengue relative risk at long lead times of up to 5 months, while excess rainfall increased the risk at shorter lead times between 1 and 2 months. The SPI averaged over a 6-month period (SPI-6), designed to monitor drought and extreme rainfall, better explained variations in dengue risk than monthly precipitation data measured in millimetres. Tmin was found to be a better predictor than mean and maximum temperature. Furthermore, including bidimensional exposure-lag-response functions of these indicators-rather than linear effects for individual lags-more appropriately described the climate-disease associations than traditional modelling approaches. In prediction mode, the model was successfully able to distinguish outbreaks from nonoutbreaks for most years, with an overall proportion of correct predictions (hits and correct rejections) of 86% (81%: 91%) compared with 64% (58%: 71%) for the baseline model. The ability of the model to predict dengue outbreaks in recent years was complicated by the lack of data on the emergence of new arboviruses, including chikungunya and Zika.
   Conclusion
   We present a modelling approach to infer the risk of dengue outbreaks given the cumulative effect of climate variations in the months leading up to an outbreak. By combining the dengue prediction model with climate indicators, which are routinely monitored and forecasted by the Regional Climate Centre (RCC) at the Caribbean Institute for Meteorology and Hydrology (CIMH), probabilistic dengue outlooks could be included in the Caribbean Health-Climatic Bulletin, issued on a quarterly basis to provide climate-smart decision-making guidance for Caribbean health practitioners. This flexible modelling approach could be extended to model the risk of dengue and other arboviruses in the Caribbean region.
C1 [Lowe, Rachel] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
   [Lowe, Rachel] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.
   [Lowe, Rachel] Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain.
   [Gasparrini, Antonio] London Sch Hyg & Trop Med, Dept Publ Hlth Environm & Soc, London, England.
   [Gasparrini, Antonio] London Sch Hyg & Trop Med, Ctr Stat Methodol, London, England.
   [Van Meerbeeck, Cedric J.; Mahon, Roche; Trotman, Adrian R.] Caribbean Inst Meteorol & Hydrol, St James, Barbados.
   [Lippi, Catherine A.; Ryan, Sadie J.] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab Grp, Gainesville, FL 32611 USA.
   [Lippi, Catherine A.; Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Rollock, Leslie] Minist Hlth, St Michael, Barbados.
   [Hinds, Avery Q. J.] Caribbean Publ Hlth Agcy, Port Of Spain, Trinidad Tobago.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Publ Hlth & Preventat Med, Syracuse, NY 13210 USA.
RP Lowe, R (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.; Lowe, R (corresponding author), London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London, England.; Lowe, R (corresponding author), Barcelona Inst Global Hlth ISGLOBAL, Barcelona, Spain.
EM rachel.lowe@lshtm.ac.uk
RI Gasparrini, Antonio/F-7627-2012; Ryan, Sadie Jane/H-7488-2019
OI Gasparrini, Antonio/0000-0002-2271-3568; Ryan, Sadie
   Jane/0000-0002-4308-6321; Mahon, Roche/0000-0001-9621-7033; Lippi,
   Catherine/0000-0002-7988-0324; Lowe, Rachel/0000-0003-3939-7343;
   Trotman, Adrian/0000-0002-3099-8671; Stewart-Ibarra,
   Anna/0000-0002-3383-4672
FU Caribbean Institute for Meteorology and Hydrology (CIMH) through the
   United States Agency for International Development's (USAID)United
   States Agency for International Development (USAID)
   [AID-538-10-14-00001]; American people; Royal Society Dorothy Hodgkin
   FellowshipRoyal Society of London; Medical Research Council UKMedical
   Research Council UK (MRC) [MR/M022625/1]
FX This study was solicited by the Caribbean Institute for Meteorology and
   Hydrology (CIMH) through the United States Agency for International
   Development's (USAID, Grant ID: AID-538-10-14-00001) Programme for
   Building Regional Climate Capacity in the Caribbean (BRCCC Programme:
   rcc.cimh.edu.bb/brccc) with funding made possible by the generous
   support of the American people. RL was supported by a Royal Society
   Dorothy Hodgkin Fellowship. AG was supported by a grant from the Medical
   Research Council UK (Grant ID: MR/M022625/1). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amarakoon D, 2008, MITIG ADAPT STRAT GL, V13, P341, DOI 10.1007/s11027-007-9114-5
   Banu S, 2014, ENVIRON INT, V63, P137, DOI 10.1016/j.envint.2013.11.002
   Caribbean Development Bank, 2016, 2015 EC REV 2016 FOR
   CARPHA, 2013, STAT PUBL HLTH CAR R
   CARPHA PAHO CIMH, 2017, CAR HLTH CLIM B
   Cashman A, 2010, J ENVIRON DEV, V19, P42, DOI 10.1177/1070496509347088
   Cheong YL, 2013, INT J ENV RES PUB HE, V10, P6319, DOI 10.3390/ijerph10126319
   Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018
   Chowell G, 2008, EPIDEMIOL INFECT, V136, P1667, DOI 10.1017/S0950268808000290
   Colon-Gonzalez FJ, 2011, AM J TROP MED HYG, V84, P757, DOI 10.4269/ajtmh.2011.10-0609
   Depradine CA, 2004, INT J ENVIRON HEAL R, V14, P429, DOI 10.1080/09603120400012868
   Diaz-Quijano FA, 2012, AM J TROP MED HYG, V86, P328, DOI 10.4269/ajtmh.2012.11-0074
   Ebi KL, 2006, ENVIRON HEALTH PERSP, V114, P1957, DOI 10.1289/ehp.8429
   Enfield DB, 1999, J CLIMATE, V12, P2093, DOI 10.1175/1520-0442(1999)012<2093:TDOCRO>2.0.CO;2
   ESRI, 2016, ARCGIS 10 3 1
   Gasparrini A, 2014, STAT MED, V33, P881, DOI 10.1002/sim.5963
   Gelman A, 1996, STAT SINICA, V6, P733
   Giannini A, 2000, J CLIMATE, V13, P297, DOI 10.1175/1520-0442(2000)013<0297:IVOCRE>2.0.CO;2
   Global Administrative Areas, 2015, GADM DAT GLOB AR VER
   Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437
   Government of Barbados, 2013, 2010 POP HOUS CENS
   Hambleton I, 2014, ANAL DENGUE CASES BA
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   Held L, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P91, DOI 10.1007/978-3-7908-2413-1_6
   Hurtado-Diaz M, 2007, TROP MED INT HEALTH, V12, P1327, DOI 10.1111/j.1365-3156.2007.01930.x
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   International Monetary Fund, 2013, CAR SMALL STAT CHALL
   Jolliffe I. T., 2012, FORECAST VERIFICATIO
   Jury MR, 2008, INT J ENVIRON HEAL R, V18, P323, DOI 10.1080/09603120701849836
   Kramer Matthew, 2005, P C APPL STAT AGR, V17, P148
   Krishnamurti TN, 2006, J CLIMATE, V19, P6069, DOI 10.1175/JCLI3938.1
   Kumar A, 2018, ENVIRON CHEM LETT, V16, P797, DOI 10.1007/s10311-018-0723-x
   Liyanage P, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13111087
   Lowe R, 2017, LANCET PLANET HEALTH, V1, pE142, DOI 10.1016/S2542-5196(17)30064-5
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Lowe R, 2016, STOCH ENV RES RISK A, V30, P2067, DOI 10.1007/s00477-015-1053-1
   Lowe R, 2014, LANCET INFECT DIS, V14, P619, DOI 10.1016/S1473-3099(14)70781-9
   Macpherson CC, 2015, PUBLIC HEALTH ETH-UK, V8, P196, DOI 10.1093/phe/phv008
   McKee T. B., 1993, C APPL CLIMATOLOGY, P179
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Ortiz PL, 2015, MEDICC REV, V17, P20
   PAHO/WHO, 2017, PLISA HLTH INF PLATF
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688
   RAWLINS SC, 1995, J AM MOSQUITO CONTR, V11, P59
   Reig P., 2013, WORLDS 36 MOST WATER
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Ryan SJ, 2018, AM J TROP MED HYG, V98, P1587
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stephenson TS, 2014, INT J CLIMATOL, V34, P2957, DOI 10.1002/joc.3889
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Taylor MA, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015580
   Trotman A, 2017, DROUGHT RISK MANAGEM, P592
   United Nations Framework Convention on Climate Change [UNFCCC], 2005, CLIM CHANG SMALL ISL
   WHO, 2004, FILED GUID MAL EP AS
   Xiang JJ, 2017, ENVIRON RES, V153, P17, DOI 10.1016/j.envres.2016.11.009
   Xu HY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002805
NR 58
TC 19
Z9 19
U1 0
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1549-1277
EI 1549-1676
J9 PLOS MED
JI PLos Med.
PD JUL
PY 2018
VL 15
IS 7
AR e1002613
DI 10.1371/journal.pmed.1002613
PG 24
WC Medicine, General & Internal
SC General & Internal Medicine
GA GO8KY
UT WOS:000440339700020
PM 30016319
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Calvez, E
   Mousson, L
   Vazeille, M
   O'Connor, O
   Cao-Lormeau, VM
   Mathieu-Daude, F
   Pocquet, N
   Failloux, AB
   Dupont-Rouzeyrol, M
AF Calvez, Elodie
   Mousson, Laurence
   Vazeille, Marie
   O'Connor, Olivia
   Cao-Lormeau, Van-Mai
   Mathieu-Daude, Francoise
   Pocquet, Nicolas
   Failloux, Anna-Bella
   Dupont-Rouzeyrol, Myrielle
TI Zika virus outbreak in the Pacific: Vector competence of regional
   vectors
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; NEW-CALEDONIA; ALBOPICTUS; INFECTION; PHYLOGENY
AB Background
   In 2013, Zika virus (ZIKV) emerged in French Polynesia and spread through the Pacific region between 2013 and 2017. Several potential Aedes mosquitoes may have contributed to the ZIKV transmission including Aedes aegypti, the main arbovirus vector in the region, and Aedes polynesiensis, vector of lymphatic filariasis and secondary vector of dengue virus. The aim of this study was to analyze the ability of these two Pacific vectors to transmit ZIKV at a regional scale, through the evaluation and comparison of the vector competence of wild Ae. aegypti and Ae. polynesiensis populations from different Pacific islands for a ZIKV strain which circulated in this region during the 2013-2017 outbreak.
   Methodology/principal findings
   Field Ae. aegypti (three populations) and Ae. polynesiensis (two populations) from the Pacific region were collected for this study. Female mosquitoes were orally exposed to ZIKV (10 7 TCID50/mL) isolated in the region in 2014. At 6, 9, 14 and 21 days post-infection, mosquito bodies (thorax and abdomen), heads and saliva were analyzed to measure infection, dissemination, transmission rates and transmission efficiency, respectively. According to our results, ZIKV infection rates were heterogeneous between the Ae. aegypti populations, but the dissemination rates were moderate and more homogenous between these populations. For Ae. polynesiensis, infection rates were less heterogeneous between the two populations tested. The transmission rate and efficiency results revealed a low vector competence for ZIKV of the different Aedes vector populations under study.
   Conclusion/significance
   Our results indicated a low ZIKV transmission by Ae. aegypti and Ae. polynesiensis tested from the Pacific region. These results were unexpected and suggest the importance of other factors especially the vector density, the mosquito lifespan or the large immunologically naive fraction of the population that may have contributed to the rapid spread of the ZIKV in the Pacific region during the 2013-2017 outbreak.
C1 [Calvez, Elodie; O'Connor, Olivia; Dupont-Rouzeyrol, Myrielle] Inst Pasteur Nouvelle Caledonie, URE Dengue & Autres Arboviroses, Noumea, New Caledonia.
   [Mousson, Laurence; Vazeille, Marie; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors Lab, Paris, France.
   [Cao-Lormeau, Van-Mai] Inst Louis Malarde, Unit Emerging Infect Dis, Papette, French Polynesi, France.
   [Cao-Lormeau, Van-Mai] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterrane Infect, Marseille, France.
   [Mathieu-Daude, Francoise] UM, CNRS, UMR MIVEGEC IRD, Inst Rech Dev, Montpellier, France.
   [Pocquet, Nicolas] URE Entomol Med, Inst Pasteur Nouvelle Caledonie, Noumea, New Caledonia.
RP Dupont-Rouzeyrol, M (corresponding author), Inst Pasteur Nouvelle Caledonie, URE Dengue & Autres Arboviroses, Noumea, New Caledonia.
EM mdupont@pasteur.nc
RI Cao-Lormeau, Van-Mai/H-4879-2018
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Mathieu-Daude,
   Francoise/0000-0003-2994-3697; O'CONNOR, Olivia/0000-0002-8108-8408
FU Actions Concertees Inter Pasteuriennes [ACIP A-15-2014]; European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   Grant [734548]; Ministere des Outre-mer (SEOM)
FX This work was supported by the Actions Concertees Inter Pasteuriennes
   (ZikAe Project, ACIP A-15-2014). This work was partly funded by the
   European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant Agreement No. 734548 and by the Ministere des
   Outre-mer (SEOM). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Apte-Deshpande A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040401
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Boyer S, 2018, MICROBES INFECT, V23
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, P1
   Calvez E, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2319-x
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2016, TROPICAL ISLANDS NEW
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2011, PLOS ONE, V9
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Faye O, 2014, PLOS NEGL TROP DIS, V8
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guillaumot L., 2013, 412013IPNCUREEMLGDG
   Guillaumot L, 2012, PARASITE VECTOR, V5, P1756
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Igor ADP, 2016, EMERG INFECT DIS, V22, P1438, DOI [10.3201/eid2208.160496, DOI 10.3201/EID2208.160496]
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, P28
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Molko N, 2017, NEUROLOGY, V88, P1097, DOI 10.1212/WNL.0000000000003697
   Moore PR, 2007, J AM MOSQUITO CONTR, V23, P383, DOI 10.2987/5598.1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   R Foundation for Statistical Computing V, 2016, R A LANGUAGE AND ENV
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Tabachnick Walter J., 1994, Advances in Disease Vector Research, V10, P93
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 55
TC 6
Z9 7
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006637
DI 10.1371/journal.pntd.0006637
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700038
PM 30016372
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Costa, CF
   da Silva, AV
   do Nascimento, VA
   de Souza, VC
   Monteiro, DCD
   Terrazas, WCM
   dos Passos, RA
   Nascimento, S
   Lima, JBP
   Naveca, FG
AF da Costa, Cristiano Fernandes
   da Silva, Arlesson Viana
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   da Silva Monteiro, Dana Cristina
   Morhy Terrazas, Wagner Cosme
   dos Passos, Ricardo Augusto
   Nascimento, Suzete
   Pereira Lima, Jose Bento
   Naveca, Felipe Gomes
TI Evidence of vertical transmission of Zika virus in field- collected eggs
   of Aedes aegypti in the Brazilian Amazon
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; REAL-TIME PCR; DENGUE VIRUS; TRANSOVARIAL
   TRANSMISSION; CHIKUNGUNYA VIRUS; RNA; INFECTION; MOSQUITOS; CELLS; INDIA
AB Background
   Arboviruses are viruses transmitted to humans and other animals by the bite of hematophagous arthropods. Infections caused by chikungunya virus (CHIKV), dengue virus (DENV), Zika virus (ZIKV), and the deadlier yellow fever virus (YFV) are current public health problems in several countries, mainly those located in tropical and subtropical regions. One of the main prevention strategies continues to be vector control, with the elimination of breeding sites and surveillance of infested areas. The use of ovitraps for Aedes mosquitos monitoring has already demonstrated promising results, and maybe be also useful for arboviral surveillance.
   Methods
   This work aimed to detect natural vertical transmission of arboviruses in Aedes aegypti and Aedes albopictus. Mosquito egg collection was carried out using ovitraps in Itacoatiara, a mid-size city in Amazonas state, Brazil. Collected eggs were allowed to hatch and larvae were tested for CHIKV, DENV, and ZIKV RNA by RT-qPCR.
   Results
   A total of 2,057 specimens (1,793 Ae. aegypti and 264 Ae. albopictus), in 154 larvae pools were processed. Results showed one positive pool for CHIKV and one positive pool for ZIKV. The active ZIKV infection was further confirmed by the detection of the negative-strand viral RNA and nucleotide sequencing which confirmed the Asian genotype. The Infection Rate per 1,000 mosquitoes tested was assessed by Maximum Likelihood Estimation (MLE) with 0.45 and 0.44 for CHIKV and ZIKV, respectively, and by Minimum Infection Rate (MIR) with 0.45 for both viruses.
   Conclusion
   To our knowledge, this is the first detection of ZIKV in natural vertical transmission in the Ae. aegypti, a fact that may contribute to ZIKV maintenance in nature during epidemics periods. Furthermore, our results highlight that the use of ovitraps and the molecular detection of arbovirus may contribute to health surveillance, directing the efforts to more efficient transmission blockade.
C1 [da Costa, Cristiano Fernandes; Morhy Terrazas, Wagner Cosme; dos Passos, Ricardo Augusto; Nascimento, Suzete] Hlth Surveillance Fdn Amazonas State FVS, Dept Environm Surveillance, Manaus, Amazonas, Brazil.
   [da Silva, Arlesson Viana; do Nascimento, Valdinete Alves; de Souza, Victor Costa; da Silva Monteiro, Dana Cristina; Naveca, Felipe Gomes] Fiocruz Amazonia, Lab Ecol Doencas Transmiss Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [da Silva, Arlesson Viana] Fiocruz Amazonia, Programa Iniciacao Cient, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.
   [da Silva Monteiro, Dana Cristina] Univ Fed Amazonas, Programa Posgrad Imunol Basica & Aplicada, Manaus, Amazonas, Brazil.
   [dos Passos, Ricardo Augusto; Pereira Lima, Jose Bento] Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.
   [Naveca, Felipe Gomes] Fiocruz Amazonia, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.
RP Naveca, FG (corresponding author), Fiocruz Amazonia, Lab Ecol Doencas Transmiss Amazonia, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil.; Naveca, FG (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Programa Posgrad Biol Celular & Mol, Rio De Janeiro, Brazil.; Lima, JBP (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab Physiol & Control Arthropod Vectors, Rio De Janeiro, Brazil.; Naveca, FG (corresponding author), Fiocruz Amazonia, Inst Leonidas & Maria Deane, Programa Posgrad Biol Interacao Patogenohospedeir, Manaus, Amazonas, Brazil.
EM jbento@ioc.fiocruz.br; felipe.naveca@fiocruz.br
RI Naveca, Felipe/H-1130-2012
OI Naveca, Felipe/0000-0002-2888-1060; Souza, Victor Costa
   de/0000-0002-3869-1519; Lima, Jose/0000-0002-5015-3019; Dos
   Passos/0000-0002-2155-9351; Nascimento, Valdinete/0000-0002-7786-4718
FU Fundacao de Amparo a Pesquisa do Estado do Amazonas - FAPEAM [001/2013 -
   PPSUS / 062.00656/2014, 001/2014 - PROEP / 062.01939/2014]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [440856/2016-7];
   Coordenaca o de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES
   [88881.130825/2016-01, 88887.130823/2016-00]
FX JBPL has a visiting senior researcher fellow PVS PECTI-SAUDE (Amazonas
   State Research Support Foundation - FAPEAM). FGN is funded by Fundacao
   de Amparo a Pesquisa do Estado do Amazonas - FAPEAM
   (www.fapeam.am.gov.br, call 001/2013 - PPSUS / 062.00656/2014 and call
   001/2014 - PROEP / 062.01939/2014); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (http://www.cnpq.br, grant 440856/2016-7) and
   Coordenaca o de Aperfeicoamento de Pessoal de Nivel Superior
   (http://www.capes.gov.br, grants 88881.130825/2016-01 and
   88887.130823/2016-00) call MCTIC/FNDCT-CNPq / MEC-CAPES/ MS-Decit
   14/2016 - Prevencao e Combate ao virus Zika. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Agarwal A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002990
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Martins VDA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100535
   Angel A, 2016, ACTA TROP, V155, P20, DOI 10.1016/j.actatropica.2015.11.018
   Arunachalam N, 2008, INDIAN J MED RES, V127, P395
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil. Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Chivero ET, 2014, J GEN VIROL, V95, P1307, DOI 10.1099/vir.0.063016-0
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   de Figueiredo RMP, 2011, REV INST MED TROP SP, V53, P321, DOI 10.1590/S0036-46652011000600004
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   Diaz LA, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00493
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gullberg RC, 2015, VIROLOGY, V475, P219, DOI 10.1016/j.virol.2014.10.037
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Gutierrez-Bugallo G, 2017, ACTA TROP, V174, P146, DOI 10.1016/j.actatropica.2017.07.012
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Jain J, 2016, ACTA TROP, V162, P46, DOI 10.1016/j.actatropica.2016.06.004
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14
   Ministerio da Saude, 2017, B EPIDEMIOLOGICO, V48
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Niyas KP, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-189
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Pfeffer M, 1997, AM J TROP MED HYG, V57, P709, DOI 10.4269/ajtmh.1997.57.709
   de Figueiredo RMP, 2008, EMERG INFECT DIS, V14, P667, DOI 10.3201/eid1404.071185
   Raquin V, 2017, VIROLOGY, V507, P75, DOI 10.1016/j.virol.2017.04.009
   Rio DC, 2010, COLD SPRING HARB PRO, V2010, P5439, DOI DOI 10.1101/PDB.PROT5439
   Saeedi BJ, 2013, WIRES RNA, V4, P723, DOI 10.1002/wrna.1191
   Sahadeo N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004199
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Undurraga EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003547
   Vaughan G, 2002, CLIN DIAGN LAB IMMUN, V9, P198, DOI 10.1128/CDLI.9.1.198-200.2002
NR 46
TC 9
Z9 9
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006594
DI 10.1371/journal.pntd.0006594
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700017
PM 30011278
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fritzell, C
   Rousset, D
   Adde, A
   Kazanji, M
   Van Kerkhove, MD
   Flamand, C
AF Fritzell, Camille
   Rousset, Dominique
   Adde, Antoine
   Kazanji, Mirdad
   Van Kerkhove, Maria D.
   Flamand, Claude
TI Current challenges and implications for dengue, chikungunya and Zika
   seroprevalence studies worldwide: A scoping review
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID TEXAS-MEXICO BORDER; VIRUS-INFECTION; RISK-FACTORS; PREGNANT-WOMEN;
   BLOOD-DONORS; ARBOVIRAL INFECTIONS; FRENCH-POLYNESIA; IMMUNOGLOBULIN-G;
   SERO-PREVALENCE; PUERTO-RICO
AB Background
   Arboviral infections are a public health concern and an escalating problem worldwide. Estimating the burden of these diseases represents a major challenge that is complicated by the large number of unapparent infections, especially those of dengue fever. Serological surveys are thus required to identify the distribution of these diseases and measure their impact. Therefore, we undertook a scoping review of the literature to describe and summarize epidemiological practices, findings and insights related to seroprevalence studies of dengue, chikungunya and Zika virus, which have rapidly expanded across the globe in recent years.
   Methodology/Principal findings
   Relevant studies were retrieved through a literature search of MEDLINE, WHOLIS, Lilacs, SciELO and Scopus (2000 to 2018). In total, 1389 publications were identified. Studies addressing the seroprevalence of dengue, chikungunya and/or Zika written in English or French and meeting the inclusion and exclusion criteria were included. In total, 147 studies were included, from which 185 data points were retrieved, as some studies used several different samples. Most of the studies were exclusively conducted on dengue (66.5%), but 16% were exclusively conducted on chikungunya, and 7 were exclusively conducted on Zika; the remainder were conducted on multiple arboviruses. A wide range of designs were applied, but most studies were conducted in the general population (39%) and in households (41%). Although several assays were used, enzyme-linked immunosorbent assays (ELISAs) were the predominant test used (77%). The temporal distribution of chikungunya studies followed the virus during its rapid expansion since 2004. The results revealed heterogeneity of arboviruses seroprevalence between continents and within a given country for dengue, chikungunya and Zika viruses, ranging from 0 to 100%, 76% and 73% respectively.
   Conclusions/Significance
   Serological surveys provide the most direct measurement for defining the immunity landscape for infectious diseases, but the methodology remains difficult to implement. Overall, dengue, chikungunya and Zika serosurveys followed the expansion of these arboviruses, but there remain gaps in their geographic distribution. This review addresses the challenges for researchers regarding study design biases. Moreover, the development of reliable, rapid and affordable diagnosis tools represents a significant issue concerning the ability of sero-prevalence surveys to differentiate infections when multiple viruses co-circulate.
C1 [Fritzell, Camille; Adde, Antoine; Kazanji, Mirdad; Flamand, Claude] Inst Pasteur, Epidemiol Unit, Cayenne, French Guiana.
   [Rousset, Dominique] Inst Pasteur, Natl Reference Lab Arboviruses, Cayenne, French Guiana.
   [Van Kerkhove, Maria D.] Inst Pasteur Paris, Ctr Global Hlth, Paris, France.
   [Van Kerkhove, Maria D.] WHO, Hlth Emergencies Programme, Geneva, Switzerland.
RP Flamand, C (corresponding author), Inst Pasteur, Epidemiol Unit, Cayenne, French Guiana.
EM cflamand@pasteur-cayenne.fr
RI amsalu, ribka/G-8780-2019; Rousset, Dominique/S-5400-2019
OI Rousset, Dominique/0000-0002-1473-3147; Van Kerkhove,
   Maria/0000-0002-6135-0018; Flamand, Claude/0000-0002-8064-445X
FU 2014-2020 European Regional Development Fund under EPI-ARBO
   grantEuropean Union (EU) [GY0008695]
FX This study was supported by the 2014-2020 European Regional Development
   Fund under EPI-ARBO grant agreement (GY0008695). Camille Fritzell
   acknowledges funding from Calmette and Yersin allocated by the Pasteur
   Institut Department of International Affairs. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adler NE, 1999, ANN NY ACAD SCI, V896, P3, DOI 10.1111/j.1749-6632.1999.tb08101.x
   Alera MT, 2016, PLOS NEGLECT TROP D, V02, P10
   Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Amaya-Larios IY, 2014, AM J TROP MED HYG, V91, P1057, DOI 10.4269/ajtmh.14-0145
   Andayi F, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003299
   Ang LW, 2015, EPIDEMIOL INFECT, V143, P1585, DOI 10.1017/S0950268814002507
   Ang LW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006163
   Arguello DF, 2015, AM J TROP MED HYG, V92, P486, DOI 10.4269/ajtmh.14-0231
   Atalay T, 2017, TURK J MED SCI, V47, P1161, DOI 10.3906/sag-1604-36
   Aubry M, 2015, 64 ANN M AM SOC TRON
   Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Azami NAM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-67
   Babaniyi OA, 2015, INT J PUBLIC HLTH EP, V4, P110
   Babaniyi OA, 2015, J GLOB INFECT DIS, V7, P11, DOI 10.4103/0974-777X.150884
   Bacci A, 2015, AM J TROP MED HYG, V92, P1133, DOI 10.4269/ajtmh.14-0092
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Barakat AM, 2016, AM J TROP MED HYG, V94, P794, DOI 10.4269/ajtmh.15-0622
   Beatty ME, 2011, AM J TROP MED HYG, V84, P473, DOI 10.4269/ajtmh.2011.10-0521
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blaylock JM, 2011, TRAVEL MED INFECT DI, V9, P246, DOI 10.1016/j.tmaid.2011.06.005
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brown Michelle G., 2009, Human Antibodies, V18, P123, DOI 10.3233/HAB-2009-0207
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Campbell CA, 2007, ACTA TROP, V101, P153, DOI 10.1016/j.actatropica.2006.11.009
   Capeding RZ, 2010, AM J TROP MED HYG, V82, P330, DOI 10.4269/ajtmh.2010.09-0542
   Carabali M, 2017, INT J INFECT DIS, V58, P27, DOI 10.1016/j.ijid.2017.02.016
   Center for Disease Control and Prevention, 2012, MMWR-MORBID MORTAL W, P172
   Charrel RN, 2016, TRAVEL MED INFECT DI, V14, P11, DOI 10.1016/j.tmaid.2016.01.006
   Collenberg E, 2006, J MED VIROL, V78, P683, DOI 10.1002/jmv.20593
   Comach G, 2009, VECTOR-BORNE ZOONOT, V9, P87, DOI 10.1089/vbz.2007.0213
   Conlan JV, 2015, AM J TROP MED HYG, V93, P1010, DOI 10.4269/ajtmh.15-0072
   Cunha RV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005319
   Cutts FT, 2016, TROP MED INT HEALTH, V21, P1086, DOI 10.1111/tmi.12737
   da Silva-Nunes M, 2008, AM J TROP MED HYG, V79, P485, DOI 10.4269/ajtmh.2008.79.485
   Darcy Andrew, 2001, Papua New Guinea Medical Journal, V44, P43
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   De Carvalho IL, 2011, IN VIVO, V25, P625
   Dellagi K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004840
   Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950
   Demanou Maurice, 2010, BMC Res Notes, V3, P128, DOI 10.1186/1756-0500-3-128
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duncombe J, 2013, EMERG INFECT DIS, V19, P324, DOI 10.3201/eid1902.120464
   Espino C., 2010, THESIS
   Faddy HM, 2013, EMERG INFECT DIS, V19, P787, DOI 10.3201/eid1905.121664
   Farnon EC, 2010, AM J TROP MED HYG, V82, P1146, DOI 10.4269/ajtmh.2010.09-0105
   Ferguson NM, 1999, PHILOS T R SOC B, V354, P757, DOI 10.1098/rstb.1999.0428
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Fox A, 2014, AM J TROP MED HYG, V90, P892, DOI 10.4269/ajtmh.13-0077
   Gabor JJ, 2016, TRAVEL MED INFECT DI, V14, P26, DOI 10.1016/j.tmaid.2016.01.005
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005254
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garg S, 2017, INT J INFECT DIS, V54, P25, DOI 10.1016/j.ijid.2016.10.030
   Gay N, 2013, AM J TROP MED HYG, V2016, P393, DOI DOI 10.4269/AJTMH.15-0308
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Groen J, 2000, CLIN DIAGN LAB IMMUN, V7, P867, DOI 10.1128/CDLI.7.6.867-871.2000
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guo RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085596
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P804, DOI 10.1093/aje/152.9.804
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Halstead SB, 2001, AM J TROP MED HYG, V65, P180, DOI 10.4269/ajtmh.2001.65.180
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   HAYES J.M., 2003, AM J TROP MED HYG, V69, P629
   Himatt S, 2015, J INFECT PUBLIC HEAL, V8, P487, DOI 10.1016/j.jiph.2015.04.023
   Hiscox A, 2010, AM J TROP MED HYG, V83, P1166, DOI 10.4269/ajtmh.2010.09-0480
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Iturrino-Monge R, 2006, REV PANAM SALUD PUBL, V20, P39, DOI 10.1590/S1020-49892006000700005
   Jamjoom Ghazi A, 2016, Virology (Auckl), V7, P1, DOI [10.4137/VRT.S34187, 10.4137/vrt.s34187]
   Jeewandara C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144799
   Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000
   Kabilan L, 2004, AM J INFECT CONTROL, V32, P391, DOI 10.1016/j.ajic.2004.07.002
   Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuan G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004773
   Kumar NP, 2011, MEM I OSWALDO CRUZ, V106, P912, DOI 10.1590/S0074-02762011000800003
   Kuniholm MH, 2006, AM J TROP MED HYG, V74, P1078, DOI 10.4269/ajtmh.2006.74.1078
   L'Azou M, 2015, AM J TROP MED HYG, V92, P1137, DOI 10.4269/ajtmh.14-0211
   LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436
   Lam SK, 1996, CLIN DIAGN VIROL, V7, P93, DOI 10.1016/S0928-0197(96)00257-7
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Larrieu S, 2014, T ROY SOC TROP MED H, V108, P57, DOI 10.1093/trstmh/trt110
   Lo CLH, 2013, TROP MED INT HEALTH, V18, P1097, DOI 10.1111/tmi.12136
   Low SL, 2015, AM J TROP MED HYG, V93, P40, DOI 10.4269/ajtmh.14-0671
   Ly Sowath, 2012, Morbidity and Mortality Weekly Report, V61, P737
   Mahmood S, 2013, INT SCH RES NOT INT, V2013, DOI [10.1155/2013/521396, DOI 10.1155/2013/521396]
   Malavige GN, 2006, SERO PREVALENCE ANTI
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Mantke OD, 2004, J CLIN VIROL, V29, P105, DOI 10.1016/S1386-6532(03)00110-0
   Martins Antonio Camargo, 2014, Interdiscip Perspect Infect Dis, V2014, P703875, DOI 10.1155/2014/703875
   Mazaba-Liwewe ML, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-135
   Mease LE, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-371
   Mendez F, 2006, AM J TROP MED HYG, V74, P678, DOI 10.4269/ajtmh.2006.74.678
   Messenger AM, 2014, VECTOR-BORNE ZOONOT, V14, P783, DOI 10.1089/vbz.2014.1665
   Meynard J., 2006, STUDY SEROPREVALENCE, P357
   Mohamed Ismail Nor Azlin, 2014, ScientificWorldJournal, V2014, P436975, DOI 10.1155/2014/436975
   Mohammed H, 2012, TRANSFUSION, V52, P1652, DOI 10.1111/j.1537-2995.2011.03492.x
   Mohsin SN, 2016, EPIDEMIOL INFECT, V144, P2276, DOI 10.1017/S0950268816000522
   Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322
   Morrison AC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000670
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Muhammad Azami Nor Azila, 2011, BMC Res Notes, V4, P216, DOI 10.1186/1756-0500-4-216
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Niedrig M, 2009, CLIN MICROBIOL INFEC, V15, P880, DOI 10.1111/j.1469-0691.2009.02851.x
   Noden BH, 2014, ACTA TROP, V137, P123, DOI 10.1016/j.actatropica.2014.05.010
   Ochieng C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132645
   Ooi EE, 2001, LANCET, V357, P685, DOI 10.1016/S0140-6736(00)04137-4
   Ooi EE, 2009, CAD SAUDE PUBLICA, V25, pS115, DOI 10.1590/S0102-311X2009001300011
   Organization WH, 2017, INF VACC PROGR GUID
   Padbidri V. S., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P794
   Panagos A, 2005, REV PANAM SALUD PUBL, V17, P225
   Pem-Novosel I, 2015, NEW MICROBIOL, V38, P97
   Pengsaa K, 2008, PEDIATR INFECT DIS J, V27, P461, DOI 10.1097/INF.0b013e3181646d45
   Perret C, 2005, J INFECTION, V51, P287, DOI 10.1016/j.jinf.2004.10.003
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Poirier MJ, 2016, DETECTION IMMUNOGLOB
   Pourrut X, 2011, EMERG INFECT DIS, V17, P1568, DOI 10.3201/eid1708.110153
   Prayitno A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005621
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Ranjan P, 2016, J CLIN DIAGN RES, V10, pDC8, DOI 10.7860/JCDR/2016/21262.8711
   Reiskind MH, 2001, TROP MED INT HEALTH, V6, P212, DOI 10.1046/j.1365-3156.2001.00703.x
   Rioth M, 2011, AM J TROP MED HYG, V84, P630, DOI 10.4269/ajtmh.2011.10-0323
   Rodríguez G. Hernán, 2005, Rev. salud pública, V7, P1, DOI 10.1590/s0124-00642005000100001
   Rodriguez-Barraquer I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003906
   Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Schwarz NG, 2012, EMERG INFECT DIS, V18, P1780, DOI 10.3201/eid1811.111036
   Seidahmed OME, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001821
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Sergon K, 2007, AM J TROP MED HYG, V76, P1189, DOI 10.4269/ajtmh.2007.76.1189
   Shah PS, 2017, J VECTOR DIS, V54, P172
   Sharp TM, 2015, EMERG INFECT DIS, V21, P1311, DOI 10.3201/eid2108.150368
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shu PY, 2002, J CLIN MICROBIOL, V40, P1840, DOI 10.1128/JCM.40.5.1840-1844.2002
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Siqueira JB, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-361
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Sissoko D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014141
   Sissoko D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003066
   Smith JP, 2007, J HUM RESOUR, V42, P739
   Soghaier MA, 2014, J INFECT PUBLIC HEAL, V7, P54, DOI 10.1016/j.jiph.2013.07.008
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Sun JM, 2012, VIRAL IMMUNOL, V25, P456, DOI 10.1089/vim.2012.0039
   Sutherland LJ, 2011, AM J TROP MED HYG, V85, P158, DOI 10.4269/ajtmh.2011.10-0203
   Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Tiong V, 2015, TROP BIOMED, V32, P587
   Tissera HA, 2010, PROCEDIA VACCINOL, V2, P109, DOI 10.1016/j.provac.2010.03.020
   Quan TM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006246
   Tuntaprasart Walairut, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P564
   Undurraga EA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002056
   Vairo F, 2014, EMERG INFECT DIS, V20, P465, DOI 10.3201/eid2003.130150
   Vallee J, 2009, TROP MED INT HEALTH, V14, P1134, DOI 10.1111/j.1365-3156.2009.02319.x
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   Velasco-Salas ZI, 2014, AM J TROP MED HYG, V91, P1039, DOI 10.4269/ajtmh.14-0127
   Venturi G, 2016, EUROSURVEILLANCE, V21, P29, DOI 10.2807/1560-7917.ES.2016.21.10.30163
   VERBRUGGE LM, 1985, J HEALTH SOC BEHAV, V26, P156, DOI 10.2307/2136750
   Vilibic-Cavlek T, 2015, ACTA MICROBIOL IMM H, V62, P199, DOI 10.1556/030.62.2015.2.9
   Arenas CJV, 2012, REV ASSOC MED BRAS, V58, P477, DOI 10.1590/S0104-42302012000400020
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
   Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560
   Wahyono TYM, 2017, EPIDEMIOL INFECT, V145, P2324, DOI 10.1017/S0950268817001030
   Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1
   Weller N, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002979
   Weppelmann TA, 2017, AM J TROP MED HYG, V96, P135, DOI 10.4269/ajtmh.16-0422
   Wilder-Smith A, 2005, EPIDEMIOL INFECT, V133, P667, DOI 10.1017/S0950268805003821
   Wilder-Smith A, 2004, TROP MED INT HEALTH, V9, P305, DOI 10.1046/j.1365-3156.2003.01177.x
   Wood H, 2014, AM J TROP MED HYG, V91, P642, DOI 10.4269/ajtmh.14-0107
   Wu KM, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-505
   Yamashiro T, 2004, AM J TROP MED HYG, V71, P138, DOI 10.4269/ajtmh.2004.71.138
   Yap G, 2013, AM J TROP MED HYG, V88, P1065, DOI 10.4269/ajtmh.12-0150
   Yen TY, 2016, ACTA TROP, V155, P58, DOI 10.1016/j.actatropica.2015.12.012
   Yew YW, 2009, ANN ACAD MED SINGAP, V38, P667
NR 184
TC 20
Z9 21
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006533
DI 10.1371/journal.pntd.0006533
PG 29
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700010
PM 30011271
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Garcia-Luna, SM
   Weger-Lucarelli, J
   Ruckert, C
   Murrieta, RA
   Young, MC
   Byas, AD
   Fauver, JR
   Perera, R
   Flores-Suarez, AE
   Ponce-Garcia, G
   Rodriguez, AD
   Ebel, GD
   Black, WC
AF Garcia-Luna, Selene M.
   Weger-Lucarelli, James
   Ruckert, Claudia
   Murrieta, Reyes A.
   Young, Michael C.
   Byas, Alex D.
   Fauver, Joseph R.
   Perera, Rushika
   Flores-Suarez, Adriana E.
   Ponce-Garcia, Gustavo
   Rodriguez, Americo D.
   Ebel, Gregory D.
   Black, William C.
TI Variation in competence for ZIKV transmission by Aedes aegypti and Aedes
   albopictus in Mexico
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VALLEY FEVER VIRUS; MOSQUITOS DIPTERA-CULICIDAE; VECTOR COMPETENCE;
   SALIVARY-GLANDS; DENGUE-2 VIRUS; INFECTION; SUSCEPTIBILITY; MICRONESIA;
   OUTBREAK; BARRIER
AB Background
   ZIKV is a new addition to the arboviruses circulating in the New World, with more than 1 million cases since its introduction in 2015. A growing number of studies have reported vector competence (VC) of Aedes mosquitoes from several areas of the world for ZIKV transmission. Some studies have used New World mosquitoes from disparate regions and concluded that these have a variable but relatively low competence for the Asian lineage of ZIKV.
   Methodology/Principal findings
   Ten Aedes aegypti (L) and three Ae. albopictus (Skuse) collections made in 2016 from throughout Mexico were analyzed for ZIKV (PRVABC59-Asian lineage) VC. Mexican Ae. aegypti had high rates of midgut infection (MIR), dissemination (DIR) and salivary gland infection (SGIR) but low to moderate transmission rates (TR). It is unclear whether this low TR was due to heritable salivary gland escape barriers or to underestimating the amount of virus in saliva due to the loss of virus during filtering and random losses on surfaces when working with small volumes. VC varied among collections, geographic regions and whether the collection was made north or south of the Neovolcanic axis (NVA). The four rates were consistently lower in northeastern Mexico, highest in collections along the Pacific coast and intermediate in the Yucatan. All rates were lowest north of the NVA. It was difficult to assess VC in Ae. albopictus because rates varied depending upon the number of generations in the laboratory.
   Conclusions/Significance
   Mexican Ae. aegypti and Ae. albopictus are competent vectors of ZIKV. There is however large variance in vector competence among geographic sites and regions. At 14 days post infection, TR varied from 8-51% in Ae. aegypti and from 2-26% in Ae. albopictus.
C1 [Garcia-Luna, Selene M.; Weger-Lucarelli, James; Ruckert, Claudia; Murrieta, Reyes A.; Young, Michael C.; Byas, Alex D.; Fauver, Joseph R.; Perera, Rushika; Rodriguez, Americo D.; Ebel, Gregory D.; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Flores-Suarez, Adriana E.; Ponce-Garcia, Gustavo] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza, Nuevo Leon, Mexico.
   [Rodriguez, Americo D.] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.
   [Weger-Lucarelli, James] Pasteur Inst, Paris, France.
RP Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM William.black@colostate.edu
RI Flores, Adriana E./AAM-4478-2020
OI Flores, Adriana E./0000-0001-8554-8865; Weger-Lucarelli,
   James/0000-0002-9483-1694; Ponce-Garcia, Gustavo/0000-0003-0654-006X;
   Garcia-Luna, Selene M./0000-0001-8420-5078; Ruckert,
   Claudia/0000-0003-3732-6752; Byas, Alexandria/0000-0002-0762-7389
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI067380, AI125996]; National
   Institutes of Health/National Institute of Allergy and Infectious
   Diseases International Collaborations in Infectious Disease Research
   Program [U01-AI-088647]; Insecticide Resistance Management to Preserve
   Pyrethroid Resistance in Aedes aegypti [1R01AI121211-01A1]; Fogarty
   Training Grant "Training in Dengue Prevention and Control"
   [2D43TW001130-08]
FX NIH AI067380 and AI125996 grants supported people in the Ebel lab who
   helped SMGL and were used to purchase some of the reagents that were
   used for this work. This study was funded by the National Institutes of
   Health/National Institute of Allergy and Infectious Diseases
   International Collaborations in Infectious Disease Research Program
   (U01-AI-088647) and "Insecticide Resistance Management to Preserve
   Pyrethroid Resistance in Aedes aegypti" (1R01AI121211-01A1). SMGL was
   supported by the Fogarty Training Grant "Training in Dengue Prevention
   and Control" (2D43TW001130-08). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anderson JF, 2012, AM J TROP MED HYG, V86, P134, DOI 10.4269/ajtmh.2012.11-0473
   BEATY BJ, 1981, SCIENCE, V211, P1433, DOI 10.1126/science.6781068
   Beerntsen BT, 2000, MICROBIOL MOL BIOL R, V64, P115, DOI 10.1128/MMBR.64.1.115-137.2000
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Gorrochotegui-Escalante N, 2002, AM J TROP MED HYG, V66, P213, DOI 10.4269/ajtmh.2002.66.213
   GRIMSTAD PR, 1985, J MED ENTOMOL, V22, P447, DOI 10.1093/jmedent/22.4.447
   Grubaugh ND, 2017, CELL REP, V19, P709, DOI 10.1016/j.celrep.2017.03.076
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1
   JUPP PG, 1985, J AM MOSQUITO CONTR, V1, P374
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lozano-Fuentes S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000468
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   P. E. M. F, 1981, EP PRINC VECT MED TR
   PAHO, ZIK EP UPD 2016
   Phillips Aaron, 2010, J Vis Exp, DOI 10.3791/2363
   Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132
   Romoser S, 2005, ARCH VIROL, P89
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   SSA, 2017, PRIM CAS MICR AS INF
   TAKAHASHI M, 1980, JPN J MED SCI BIOL, V33, P321, DOI 10.7883/yoken1952.33.321
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Turell MJ, 2013, J MED ENTOMOL, V50, P1111, DOI 10.1603/ME13049
   Turell MJ, 2010, J MED ENTOMOL, V47, P884, DOI 10.1603/ME10007
   Vega-Rua A, 2015, VIRUSES-BASEL, V7, P5902, DOI 10.3390/v7112917
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, SIT REP
   WHO, 2016, ZIK SIT REP 2016
   WHO P, 2017, ZIK SUSP CONF CAS RE
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 45
TC 10
Z9 10
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006599
DI 10.1371/journal.pntd.0006599
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700020
PM 29965958
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Mathieu-Daude, F
   Claverie, A
   Plichart, C
   Boulanger, D
   Mphande, FA
   Bossin, HC
AF Mathieu-Daude, Francoise
   Claverie, Aurore
   Plichart, Catherine
   Boulanger, Denis
   Mphande, Fingani A.
   Bossin, Herve C.
TI Specific human antibody responses to Aedes aegypti and Aedes
   polynesiensis saliva: a new epidemiological tool to assess human
   exposure to disease vectors in the Pacific
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ROSS RIVER VIRUS; FRENCH-POLYNESIA; WUCHERERIA-BANCROFTI;
   ANOPHELES-GAMBIAE; FILTER-PAPER; ZIKA VIRUS; DENGUE; MOSQUITOS;
   POPULATION; RISK
AB Background
   Aedes mosquitoes severely affect the health and wellbeing of human populations by transmitting infectious diseases. In French Polynesia, Aedes aegypti is the main vector of dengue, chikungunya and Zika, and Aedes polynesiensis the primary vector of Bancroftian filariasis and a secondary vector of arboviruses. Tools for assessing the risk of disease transmission or for measuring the efficacy of vector control programmes are scarce. A promising approach to quantify the human-vector contact relies on the detection and the quantification of antibodies directed against mosquito salivary proteins.
   Methodology/Principal findings
   An ELISA test was developed to detect and quantify the presence of immunoglobulin G (IgG) directed against proteins from salivary gland extracts (SGE) of Ae. aegypti and Ae. polynesiensis in human populations exposed to either species, through a cross-sectional study. In Tahiti and Moorea islands where Ae. aegypti and Ae. polynesiensis are present, the test revealed that 98% and 68% of individuals have developed IgG directed against Ae. aegypti and Ae. polynesiensis SGE, respectively. By comparison, ELISA tests conducted on a cohort of people from metropolitan France, not exposed to these Aedes mosquitoes, indicated that 97% of individuals had no IgG directed against SGE of either mosquito species. The analysis of additional cohorts representing different entomological Aedes contexts showed no ELISA IgG cross-reactivity between Ae. aegypti and Ae. polynesiensis SGE.
   Conclusions/Significance
   The IgG response to salivary gland extracts seems to be a valid and specific biomarker of human exposure to the bites of Ae. aegypti and Ae. polynesiensis. This new immunoepidemiological tool will enhance our understanding of people exposure to mosquito bites, facilitate the identification of areas where disease transmission risk is high and permit to evaluate the efficacy of novel vector control strategies in Pacific islands and other tropical settings.
C1 [Mathieu-Daude, Francoise; Mphande, Fingani A.] UM, CNRS, IRD, UMR MIVEGEC, Noumea, New Caledonia.
   [Mathieu-Daude, Francoise; Boulanger, Denis] UM, CNRS, IRD, UMR MIVEGEC, Montpellier, France.
   [Claverie, Aurore; Plichart, Catherine] Inst Louis Malarde, Pole Rech & Veille Malad Iinfect Emergentes, Tahiti, French Polynesi, France.
   [Claverie, Aurore; Bossin, Herve C.] Inst Louis Malarde, Lab Entomol Med, Tahiti, French Polynesi, France.
RP Mathieu-Daude, F (corresponding author), UM, CNRS, IRD, UMR MIVEGEC, Noumea, New Caledonia.; Mathieu-Daude, F (corresponding author), UM, CNRS, IRD, UMR MIVEGEC, Montpellier, France.; Bossin, HC (corresponding author), Inst Louis Malarde, Lab Entomol Med, Tahiti, French Polynesi, France.
EM francoise.mathieu-daude@ird.fr; hbossin@ilm.pf
OI Mathieu-Daude, Francoise/0000-0003-2994-3697
FU French Polynesian government [34312/MEE/REC]; Grand Observatoire du
   Pacifique Sud grant [2011-2]; Infectiopole Sud Foundation fellowship
FX This study was supported in part by the French Polynesian government
   grant #34312/MEE/REC (recipient HCB), and the Grand Observatoire du
   Pacifique Sud grant #2011-2 (recipient FMD)
   (http://www.observatoire-gops.org/en/accueil). FAM was a recipient of a
   Infectiopole Sud Foundation fellowship. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Aubry M, 2012, J CLIN VIROL, V55, P23, DOI 10.1016/j.jcv.2012.05.010
   Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644
   Boyer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091170
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1034, DOI 10.3201/eid2006.131413
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chungue E., 1998, Pacific Health Dialog, V5, P154
   Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195
   Daudens E., 2009, Bulletin Epidemiologique Hebdomadaire, P499
   Demirev PA, 2013, ANAL CHEM, V85, P779, DOI 10.1021/ac303205m
   Descloux E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000493
   DOUCOURE S, 2012, PLOS NEGLECT TROP D, V6, P36569
   Doucoure S, 2015, INSECTS, V6, P961, DOI 10.3390/insects6040961
   Doucoure S, 2012, AM J TROP MED HYG, V87, P504, DOI 10.4269/ajtmh.2012.11-0477
   Drame PM, 2010, AM J TROP MED HYG, V83, P115, DOI 10.4269/ajtmh.2010.09-0684
   Drame PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015596
   Farraudiere L, 2017, REV PANAM SALUD PUBL, V41
   FOCKS DA, 2003, TDRIDEDEN031 WHO
   Fontaine A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029107
   Hogrefe WR, 2002, CLIN DIAGN LAB IMMUN, V9, P1338, DOI 10.1128/CDLI.9.6.1338-1342.2002
   Ichimori K, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0075-4
   ISPF, 2017, POP LEG POL FRANC 17
   Kimura Eisaku, 2011, Trop Med Health, V39, P57, DOI [10.2149/tmh.2010-18, 10.2149/tmh.39-1-suppl_2-57]
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   Logan JG, 2008, J CHEM ECOL, V34, P308, DOI 10.1007/s10886-008-9436-0
   Londono-Renteria B, 2015, BIOMEDICA, V35, P572, DOI 10.7705/biomedica.v35i4.2530
   Londono-Renteria B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081211
   Machain-Williams C, 2012, PARASITE IMMUNOL, V34, P15, DOI 10.1111/j.1365-3024.2011.01339.x
   Marris E, 2017, NATURE, V548, P17, DOI 10.1038/548017a
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   MITCHELL CJ, 1987, J AM MOSQUITO CONTR, V3, P142
   Mou Y, 2009, B EPIDEMIOL HEBDOMAD, V48-49-50, P497
   Musso D, 2017, LANCET INFECT DIS
   Ndille EE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005109
   Ndille EE, 2014, TROP MED INT HEALTH, V19, P576, DOI 10.1111/tmi.12280
   Ndille EE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001905
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Orlandi-Pradines E, 2007, MICROBES INFECT, V9, P1454, DOI 10.1016/j.micinf.2007.07.012
   Remoue F, 2006, T ROY SOC TROP MED H, V100, P363, DOI 10.1016/j.trstmh.2005.06.032
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004694
   Riviere F., 1988, ECOLOGIE AEDES STEGO
   Ruangturakit Sudarat, 1994, Southeast Asian Journal of Tropical Medicine and Public Health, V25, P560
   Russell RC, 2005, J MED ENTOMOL, V42, P1045, DOI 10.1603/0022-2585(2005)042[1045:AALAAP]2.0.CO;2
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005
   Ya-Umphan P, 2018, AM J TROP MED HYG, V99, P350, DOI 10.4269/ajtmh.18-0081
   Zhang XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143950
NR 57
TC 1
Z9 1
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006660
DI 10.1371/journal.pntd.0006660
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700050
PM 30040826
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moretti, R
   Yen, PS
   Houe, V
   Lampazzi, E
   Desiderio, A
   Failloux, AB
   Calvitti, M
AF Moretti, Riccardo
   Yen, Pei-Shi
   Houe, Vincent
   Lampazzi, Elena
   Desiderio, Angiola
   Failloux, Anna-Bella
   Calvitti, Maurizio
TI Combining Wolbachia-induced sterility and virus protection to fight
   Aedes albopictus-borne viruses
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CYTOPLASMIC INCOMPATIBILITY; CHIKUNGUNYA VIRUS; DIPTERA-CULICIDAE;
   BLOCKS DENGUE; MOSQUITOS; AEGYPTI; STRAIN; ZIKA; PERFORMANCE; INHIBITION
AB Among the strategies targeting vector control, the exploitation of the endosymbiont Wolbachia to produce sterile males and/or invasive females with reduced vector competence seems to be promising. A new Aedes albopictus transinfection (ARwP-M) was generated by introducing wMel Wolbachia in the ARwP line which had been established previously by replacing wAlbA and wAlbB Wolbachia with the wPip strain. Various infection and fitness parameters were studied by comparing ARwP-M, ARwP and wild-type (SANG population) Ae. albopictus sharing the same genetic background. Moreover, the vector competence of ARwP-M related to chikungunya, dengue and zika viruses was evaluated in comparison with ARwP. ARwP-M showed a 100% rate of maternal inheritance of wMel and wPip Wolbachia. Survival, female fecundity and egg fertility did not show to differ between the three Ae. albopictus lines. Crosses between ARwP-M males and SANG females were fully unfertile regardless of male age while egg hatch in reverse crosses increased from 0 to about 17% with SANG males aging from 3 to 17 days. When competing with SANG males for SANG females, ARwP-M males induced a level of sterility significantly higher than that expected for an equal mating competitiveness (mean Fried index of 1.71 instead of 1). The overall Wolbachia density in ARwP-M females was about 15 fold higher than in ARwP, mostly due to the wMel infection. This feature corresponded to a strongly reduced vector competence for chikungunya and dengue viruses (in both cases, 5 and 0% rates of transmission at 14 and 21 days post infection) with respect to ARwP females. Results regarding Zika virus did not highlight significant differences between ARwP-M and ARwP. However, none of the tested ARwP-M females was capable at transmitting ZIKV. These findings are expected to promote the exploitation of Wolbachia to suppress the wild-type Ae. albopictus populations.
C1 [Moretti, Riccardo; Lampazzi, Elena; Desiderio, Angiola; Calvitti, Maurizio] ENEA Italian Natl Agcy New Technol Energy & Susta, Biotechnol & Agroind Div, Casaccia Res Ctr, Rome, Italy.
   [Yen, Pei-Shi; Houe, Vincent; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Arboviruses & Insect Vectors Unit, Paris, France.
RP Moretti, R (corresponding author), ENEA Italian Natl Agcy New Technol Energy & Susta, Biotechnol & Agroind Div, Casaccia Res Ctr, Rome, Italy.
EM riccardo.moretti@enea.it
OI Moretti, Riccardo/0000-0003-1654-9383; Yen, Pei-Shi/0000-0002-2113-7394
FU European Union's Horizon 2020 research and innovation programme [731060]
FX This project has received resources funded by the European Union's
   Horizon 2020 research and innovation programme under grant agreement No
   731060 (Infravec2, Research Infrastructures for the control of
   vector-borne diseases; http://infravec2.eu/). Funding followed the
   positive evaluation of a formal request describing the research project
   which was prepared and submitted to Infravec2 by RM. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Atyame CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146834
   Atyame CM, 2011, MOL BIOL EVOL, V28, P2761, DOI 10.1093/molbev/msr083
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Balestrino F, 2010, J MED ENTOMOL, V47, P581, DOI 10.1603/ME09272
   Bellini R., 2007, P505, DOI 10.1007/978-1-4020-6059-5_47
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bordi L, 2008, CLIN INFECT DIS, V47, P428, DOI 10.1086/589925
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brelsfoard C.L., 2009, ASIA PAC J MOL BIOL, V17, P55
   Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Dobson SL, 2002, P ROY SOC B-BIOL SCI, V269, P437, DOI 10.1098/rspb.2001.1876
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   European Centre for Disease Prevention and Control, 2017, CLUST AUT CHIK CAS I
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Gibbons RV, 2010, INT J ANTIMICROB AG, V36, pS36, DOI 10.1016/j.ijantimicag.2010.06.019
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould F, 2004, ANNU REV ENTOMOL, V49, P193, DOI 10.1146/annurev.ento.49.061802.123344
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Jeffries Claire L, 2016, Curr Trop Med Rep, V3, P20
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kress A, 2016, J VECTOR ECOL, V41, P142, DOI 10.1111/jvec.12206
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Mains JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep33846
   Manica M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.44.17-00685
   Marcondes CB, 2017, ARTHROPOD BORNE DIS, P723, DOI [10.1016/S1473-3099(16)00026-8, DOI 10.1016/S1473-3099(16)00026-8]
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   Massonnet-Bruneel B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062711
   Moretti R, 2013, MED VET ENTOMOL, V27, P377, DOI 10.1111/j.1365-2915.2012.01061.x
   Moretti R, 2007, 30 C NAZ IT ENT CAMP, P380
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   O'Neill SL, 2017, NATURE, V543, P182, DOI 10.1038/nature21509
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Puggioli A, 2016, ACTA TROP, V164, P473, DOI 10.1016/j.actatropica.2016.10.014
   Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Sinkins SP, 2000, INSECT TRANSGENESIS, P271
   Sinkins SP, 2013, FUTURE MICROBIOL, V8, P1249, DOI 10.2217/fmb.13.95
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Tortosa P, 2008, INSECT MOL BIOL, V17, P677, DOI 10.1111/j.1365-2583.2008.00842.x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Xi ZY, 2006, P R SOC B, V273, P1317, DOI 10.1098/rspb.2005.3405
   Xi ZY, 2005, APPL ENVIRON MICROB, V71, P3199, DOI 10.1128/AEM.71.6.3199-3204.2005
   Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223
   Zeller H, 2018, CHIKUNGUNYA ITS HIST, V214, P2014, DOI [10.1093/infdis/jiw391, DOI 10.1093/INFDIS/JIW391]
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 87
TC 7
Z9 7
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006626
DI 10.1371/journal.pntd.0006626
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700031
PM 30020933
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vasconcellos, AG
   Fonseca, BDFE
   Morel, CM
AF Vasconcellos, Alexandre Guimaraes
   Fonseca e Fonseca, Bruna de Paula
   Morel, Carlos Medicis
TI Revisiting the concept of Innovative Developing Countries (IDCs) for its
   relevance to health innovation and neglected tropical diseases and for
   the prevention and control of epidemics
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIO-DE-JANEIRO; ZIKA VIRUS; SCIENTIFIC COLLABORATION; NETWORKS; BRAZIL;
   INFECTION; TRANSMISSION
AB Introduction
   Countries have traditionally been split into two major groups: developed or industrialized (<"the North) and developing or underdeveloped ("the South"). Several authors and organizations have challenged this classification to recognize countries that have reached an intermediate stage of social and economic development. As proposed by Morel and collaborators in 2005, the concept of Innovative Developing Countries (IDCs) defines a group of nations with impactful scientific programs. Here, IDCs are reexamined by a variety of metrics to highlight their role in health innovation through research and development (R&D) programs on neglected tropical diseases (NTDs) that also positively impact epidemic preparedness.
   Results
   To address the global changes due to expanding globalization we updated the original indicator of the number of USPTO patents deposited by individual countries per GDP and per capita to the number of international patents applications, related to applicant residence and deposited under the Patent Cooperation Treaty (PCT) per GNI (or GDP) and per capita. A comparison of the originally described ranking of top innovative countries to those in the present study revealed new members that updated the list of IDCs and showed a prominent role now played by China.
   Analyzing scientific publications in international journals since the introduction of the IDC concept in 2005 we found that IDCs do prioritize Neglected Tropical Diseases (NTDs) as an area of research.
   Finally we investigated the role of IDCs in two major public health emergencies between 2012 and 2016, the outbreaks of Ebola in West Africa and Zika in South America. An analysis of the co-authorship country networks demonstrated an important role for IDC infrastructure and personnel in the prevention and control of these epidemics.
   Discussion and conclusions
   Different techniques can be used to evaluate and measure innovative performance of countries. Country rankings published by traditional indexes, such as the Bloomberg Innovation Index (BII) and the Global Innovation Index (GII), only include high income economies among the top 20 performers. This is in sharp contrast to our approach, which identified 8-9 IDCs among the first 25 with China occupying the top position. Through an analysis of the pros and cons of the different methodologies, the IDC concept challenges more conventional approaches to address and estimate the innovative capacity of countries.
C1 [Vasconcellos, Alexandre Guimaraes] Natl Inst Ind Property INPI, Postgrad & Res Div, Rio De Janeiro, RJ, Brazil.
   [Fonseca e Fonseca, Bruna de Paula; Morel, Carlos Medicis] Oswaldo Cruz Fdn Fiocruz, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
RP Vasconcellos, AG (corresponding author), Natl Inst Ind Property INPI, Postgrad & Res Div, Rio De Janeiro, RJ, Brazil.; Morel, CM (corresponding author), Oswaldo Cruz Fdn Fiocruz, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, Brazil.
EM alexguim@inpi.gov.br; morel@cdts.fiocruz.br
RI Morel, Carlos M/B-4079-2009; Morel, Carlos/Q-9657-2019
OI Morel, Carlos M/0000-0003-2752-0009; Morel, Carlos/0000-0003-2752-0009;
   Fonseca, Bruna de Paula/0000-0002-8795-2578
FU Oswaldo Cruz Foundation (Fiocruz); National Council for Scientific and
   Technological Development (CNPq), Ministry of Science and
   TechnologyNational Council for Scientific and Technological Development
   (CNPq) [573642/2008-7, 465313/2014-0]; National Council for Scientific
   and Technological Development (CNPq), Ministry of Science and Technology
   (Productivity II Fellowship)National Council for Scientific and
   Technological Development (CNPq); Ministry of Education/CAPESCAPES
   [465313/2014-0]; Research Foundation of the State of Rio de Janeiro
   (FAPERJ)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [465313/2014-0]; CNPq postdoctoral fellowship
   at WIPO [202109/2015-1]
FX Funding was provided by the Oswaldo Cruz Foundation (Fiocruz); National
   Council for Scientific and Technological Development (CNPq), Ministry of
   Science and Technology (no. 573642/2008-7, 465313/2014-0 and
   Productivity II Fellowship to CMM); Ministry of Education/CAPES (no.
   465313/2014-0); Research Foundation of the State of Rio de Janeiro
   (FAPERJ) (no. 465313/2014-0) and CNPq postdoctoral fellowship at WIPO to
   AGV (202109/2015-1). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Access to Essential Medicines Campaign and the Drugs for Neglected Diseases Working Group, 2001, FAT IMB CRIS RES DEV
   [Anonymous], 2017, ECONOMIST
   Attaran A., 2016, HARVARD PUBLIC HLTH
   Baldwin R., 2016, GREAT CONVERGENCE IN
   Bastian M., 2009, 3 INT AAAI C WEBL SO
   Batallas DA, 2006, IEEE T ENG MANAGE, V53, P570, DOI 10.1109/TEM.2006.883706
   Bender ME, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004182
   Benoit Battistelli, 2017, EPO BLOG
   Bornmann L, 2015, J ASSOC INF SCI TECH, V66, P1507, DOI 10.1002/asi.23333
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burhan M, 2016, TECHNOLOGICAL FORECA
   Butler D., 2016, NATURE NEWS, V540, P507
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carroll D, 2018, SCIENCE, V359, P872, DOI 10.1126/science.aap7463
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chan M., 2014, WHO DIRECTOR GEN BRI
   Codeco C, 2016, MEM I OSWALDO CRUZ, V111, P414, DOI 10.1590/0074-02760160003
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cornell University INSEAD and WIPO, 2017, GLOB INN IND 2017 IN
   Costa G, 2016, RIO 2016 FIC R 400 M
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   European Centre for Disease Prevention and Control, 2017, ZIK EP 2014 ONW
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fonseca BDFE, 2016, HEALTH RES POLICY SY, V14, DOI 10.1186/s12961-016-0151-y
   FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gay B, 2005, RES POLICY, V34, P1457, DOI 10.1016/j.respol.2005.07.001
   Global Innovation Index, 2016, WINN GLOB INN
   Hidalgo CA, 2007, SCIENCE, V317, P482, DOI 10.1126/science.1144581
   HOTEZ PJ, 2008, FORGOTTEN PEOPLE FOR
   Jamrisko M, 2017, THESE ARE WORLDS MOS
   Keating Conrad, 2017, K WARREN GREAT NEGLE
   LONG JC, 2013, BMC HEALTH SERV RES, V13, P36569
   Ltd IC, 2017, BLOOMB INN IND REP
   Mahoney R., 2005, INNOVATION STRATEGY, V1, P33
   Mahoney RT, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-33
   Mahoney RT, 2006, INNOVATION STRATEGY, V2, P1
   MAHONEY RT, 2006, GLOBAL FORUM UPDATE, V3, P149
   MASHELKAR RA, 2005, INNOVATION STRATEGY, V1, P16
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Morel C, 2005, INNOVATION STRATEGY, V1, P1
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Morel CM, 2005, SCIENCE, V309, P401, DOI 10.1126/science.1115538
   Morel CM, 2003, EMBO REP, V4, pS35, DOI 10.1038/sj.embor.embor851
   Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100
   Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898
   Nilsson A., 2013, THESIS
   Organization for Economic Co-Operation and Development (OECD), 2005, OSL MAN GUID COLL IN
   Phillips K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002568
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Scott JP, 2000, SOCIAL NETWORK ANALY, DOI [10.2307/3033543, DOI 10.2307/3033543]
   Tavernise S., 2016, NO ZIKA CASES REPORT
   Uniting to Combat Neglected Tropical Diseases, 2012, LOND DECL
   Vasconcellos AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045569
   Vollmer S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057624
   Warren K. S., 1986, ORPHAN DIS ORPHAN DR, P169
   WHO, 2016, WHO PUBL HLTH ADV RE
   WHO-World Health Organization, 2001, MACROECONOMICS HLTH
   Wike R, 2017, MORE NAME US CHINA W
   WIPO, 2017, INT PAT CLASS FREQ A
   WIPO, 2017, INT PAT CLASS IPC
   WIPO, 2016, WIPO FACTS FIG TOT A
   World Bank Group, 2016, WORLD DEV IND 2016
   World Health Organization, 2012, WHOHTMNTD20121
   World Health Organization, 2013, NEGLECTED TROPICAL D
   World Health Organization, 2005, WHOCDSCPECEE200554
   World Health Organization, 2014, STAT 1 M IHRE EM COM
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 72
TC 3
Z9 3
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006469
DI 10.1371/journal.pntd.0006469
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700003
PM 30001318
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xue, L
   Fang, X
   Hyman, JM
AF Xue, Ling
   Fang, Xin
   Hyman, James M.
TI Comparing the effectiveness of different strains of Wolbachia for
   controlling chikungunya, dengue fever, and zika
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI; MATHEMATICAL-MODEL; BORNE DISEASES; VIRUS; ALBOPICTUS;
   TRANSMISSION; POPULATION; CULICIDAE; DIPTERA; VECTOR
AB Once Aedes aegypti and Aedes albopictus mosquitoes that spread Chikungunya virus, dengue virus, and Zika virus are infected with Wolbachia, they have reduced egg laying rates, reduced transmission abilities, and shorter lifespans. Since most infected mosquitoes are only infectious in the last few days of their lives, shortening a mosquito's lifespan by a day or two can greatly reduce their abilities to spread mosquito-borne viral diseases, such as Chikungunya, dengue fever, and Zika. We developed a mathematical model to compare the effectiveness of the wMel and wAlbB strains of Wolbachia for controlling the spread of these viruses. The differences among the diseases, mosquitoes, and Wolbachia strains are captured by the model parameters for the mosquito-human transmission cycle. Moreover, the model accounts for the behavior changes of infectious population created by differences in the malaise caused by these viruses. We derived the effective and basic reproduction numbers for the model that are used to estimate the number of secondary infections from the infectious populations. In the same density of Wolbachia-free Aedes aegypti or Aedes albopictus mosquitoes, we observed that wMel and wAlbB strains of Wolbachia can reduce the transmission rates of these diseases effectively.
C1 [Xue, Ling; Fang, Xin] Harbin Engn Univ, Dept Math, Harbin, Heilongjiang, Peoples R China.
   [Xue, Ling] Univ Manitoba, Dept Math, Winnipeg, MB, Canada.
   [Hyman, James M.] Tulane Univ, Dept Math, New Orleans, LA 70118 USA.
RP Xue, L (corresponding author), Harbin Engn Univ, Dept Math, Harbin, Heilongjiang, Peoples R China.; Xue, L (corresponding author), Univ Manitoba, Dept Math, Winnipeg, MB, Canada.
EM lxue@hrbeu.edu.cn
RI Hyman, James M/AAF-7389-2020
OI Hyman, James M/0000-0001-5247-5794
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11501145]; Fundamental Research funds for the
   Central Universities of ChinaFundamental Research Funds for the Central
   Universities [HEUCFM181101]; endowment for the Evelyn and John G.
   Phillips Distinguished Chair in Mathematics at Tulane University;
   National Science FoundationNational Science Foundation (NSF)
   [MPS-DMS-1122666, MPS-DMS-156353]; NIH/NIGMSUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U01GM097661];
   DEB-RAPID [1641130]
FX This work is funded by National Natural Science Foundation of China
   11501145, the Fundamental Research funds for the Central Universities of
   China HEUCFM181101, the endowment for the Evelyn and John G. Phillips
   Distinguished Chair in Mathematics at Tulane University, the National
   Science Foundation awards MPS-DMS-1122666, MPS-DMS-156353, DEB-RAPID
   1641130, and the NIH/NIGMS program for Models of Infectious Disease
   Agent Study award U01GM097661. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Bloch D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005075
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   Costanzo KS, 2005, J MED ENTOMOL, V42, P559, DOI 10.1603/0022-2585(2005)042[0559:ACAPOA]2.0.CO;2
   Costero A, 1998, J MED ENTOMOL, V35, P809, DOI 10.1093/jmedent/35.5.809
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   GUBLER DJ, 1981, B WORLD HEALTH ORGAN, V59, P623
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gupta D, 2016, INDAN J COMMUNITY HE, V28, P398
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes H, 2013, B MATH BIOL, V75, P796, DOI 10.1007/s11538-013-9835-4
   Jiggins FM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002780
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kozek WJ, 2007, ISSUES INFECT DIS, V5, P1, DOI [10.1159/000104228, DOI 10.1159/000104228]
   Lahariya Chandrakant, 2006, Journal of Vector Borne Diseases, V43, P151
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li YZ, 2017, NONLINEAR ANAL-REAL, V37, P412, DOI 10.1016/j.nonrwa.2017.03.003
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Moulay D, 2011, MATH BIOSCI, V229, P50, DOI 10.1016/j.mbs.2010.10.008
   Ndii MZ, 2015, MATH BIOSCI, V262, P157, DOI 10.1016/j.mbs.2014.12.011
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Nur AH, 2008, TROP BIOMED, V25, P117
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Pesko K, 2009, J MED ENTOMOL, V46, P395, DOI 10.1603/033.046.0228
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   PUTNAM JL, 1995, AM J TROP MED HYG, V52, P225, DOI 10.4269/ajtmh.1995.52.225
   Qu Z, 2017, SIAM J APPL MATH
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Sebastian MR, 2009, INDIAN J PEDIATR, V76, P185, DOI 10.1007/s12098-009-0049-6
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   SILER J. F., 1926, PHILIPPINE JOUR SCI, V29, P1
   Sivanathan MM, 2006, THE ECOLOGY AND BIOL
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   TRPIS M, 1995, J MED ENTOMOL, V32, P27, DOI 10.1093/jmedent/32.1.27
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Xue L., 2016, J BIOL DYNAM, P1
   Zhang XH, 2016, B MATH BIOL, V78, P1968, DOI 10.1007/s11538-016-0208-7
   Zhang XH, 2015, MATH BIOSCI, V269, P164, DOI 10.1016/j.mbs.2015.09.004
NR 69
TC 5
Z9 5
U1 0
U2 18
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUL
PY 2018
VL 12
IS 7
AR e0006666
DI 10.1371/journal.pntd.0006666
PG 24
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GP0JP
UT WOS:000440495700054
PM 30059498
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chimelli, L
   Wiley, CA
   Vasconcelos, ZFM
   Moreira, MEL
   Pone, SM
   Pone, MVD
AF Chimelli, Leila
   Wiley, Clayton A.
   Meira Vasconcelos, Zilton Farias
   Lopes Moreira, Maria Elisabeth
   Pone, Sheila Moura
   da Silva Pone, Marcos Vinicius
TI Persistence of Zika Virus After Birth Response
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Letter
C1 [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
   [Wiley, Clayton A.] UPMC Presbyterian Hosp, Div Neuropathol, Pittsburgh, PA USA.
   [Meira Vasconcelos, Zilton Farias; Lopes Moreira, Maria Elisabeth] Oswaldo Cruz Fdn Fiocruz, Hlth Fernandes Figueira IFF, Natl Inst Women Children & Adolescents, Clin Res Unit, Rio De Janeiro, Brazil.
   [Pone, Sheila Moura; da Silva Pone, Marcos Vinicius] Oswaldo Cruz Fdn Fiocruz, Hlth Fernandes Figueira IFF, Natl Inst Women Children & Adolescents, Pediat Infect Dis Unit, Rio De Janeiro, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rio de Janeiro, Brazil.
EM chimelli@hucff.ufrj.br
RI da Silva Pone, Marcos Vinicius/N-1285-2019; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020
OI Moreira, Maria Elisabeth Lopes/0000-0002-2034-0294; da Silva Pone,
   Marcos Vinicius/0000-0002-5152-2242; Moura Pone,
   Sheila/0000-0002-6246-8915; Vasconcelos, Zilton/0000-0002-2193-2224
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
NR 7
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUL
PY 2018
VL 77
IS 7
BP 656
EP 657
PG 2
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GO1KC
UT WOS:000439709000012
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Persistence of Zika Virus After Birth
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Kolikonda Murali K, 2017, Innov Clin Neurosci, V14, P11
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 6
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-3069
EI 1554-6578
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD JUL
PY 2018
VL 77
IS 7
BP 656
EP 656
DI 10.1093/jnen/nly023
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA GO1KC
UT WOS:000439709000011
PM 29659939
OA Bronze
DA 2020-07-08
ER

PT J
AU Hilgenfeld, R
   Lei, J
   Zhang, L
AF Hilgenfeld, R.
   Lei, J.
   Zhang, L.
TI Zika virus protease as a target for antivirals
SO FEBS OPEN BIO
LA English
DT Meeting Abstract
C1 [Hilgenfeld, R.; Lei, J.; Zhang, L.] Univ Lubeck, Lubeck, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2211-5463
J9 FEBS OPEN BIO
JI FEBS Open Bio
PD JUL
PY 2018
VL 8
SU 1
MA S.18-1
BP 32
EP 32
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GL9RL
UT WOS:000437674100093
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Pereira, L
AF Pereira, L.
TI Replication of Cytomegalovirus and Zika virus in first-trimester human
   placentas, mechanisms of viral pathogenesis and host cell defense
SO HUMAN REPRODUCTION
LA English
DT Meeting Abstract
CT 34th Annual Meeting of the
   European-Society-of-Human-Reproduction-and-Embryology (ESHRE)
CY JUN 01-04, 2018
CL Barcelona, SPAIN
SP European Soc Human Reprod & Embryol
C1 [Pereira, L.] UCSF, Sch Dent, Cell & Tissue Biol, San Francisco, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD JUL
PY 2018
VL 33
SU 1
MA O-160
BP 72
EP 72
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA GM8WX
UT WOS:000438519900145
DA 2020-07-08
ER

PT J
AU Rodriguez-Morales, AJ
   Villamil-Gomez, WE
   Loaiza-Maya, EH
   Ramirez-Vallejo, E
AF Rodriguez-Morales, Alfonso J.
   Villamil-Gomez, Wilmer E.
   Hernel Loaiza-Maya, Edier
   Ramirez-Vallejo, Eduardo
TI In Reply-Electrocardiographic Finding in Zika Virus Infection
SO MAYO CLINIC PROCEEDINGS
LA English
DT Letter
ID CARDIAC COMPROMISE
C1 [Rodriguez-Morales, Alfonso J.; Hernel Loaiza-Maya, Edier; Ramirez-Vallejo, Eduardo] Univ Tecnol Pereira, Pereira, Risaralda, Colombia.
   [Villamil-Gomez, Wilmer E.] Hosp Univ Sincelejo, Sinceleje, Sucre, Colombia.
   [Villamil-Gomez, Wilmer E.] Univ Cartagena, Cartagena Univ Atlantico, Barranquilla, Colombia.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Pereira, Risaralda, Colombia.
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192
CR Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Schwartzmann PV, 2018, MAYO CLIN PROC, V93, P394, DOI 10.1016/j.mayocp.2017.12.007
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Villamil-Gomez WE, 2018, MAYO CLIN PROC, V93, P393, DOI 10.1016/j.mayocp.2017.12.006
   Villamil-Gomez WE, 2017, J CLIN VIROL, V95, P52, DOI 10.1016/j.jcv.2017.08.010
NR 5
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD JUL
PY 2018
VL 93
IS 7
BP 956
EP 957
DI 10.1016/j.mayocp.2018.03.024
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA GN2AK
UT WOS:000438797000026
PM 29907401
OA Bronze
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Electrocardiographic Finding in Zika Virus Infection
SO MAYO CLINIC PROCEEDINGS
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Hainan Med Univ, Haikou, Hainan, Peoples R China.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
CR Joob B, 2016, ANATOL J CARDIOL, V16, P455, DOI 10.14744/AnatolJCardiol.2016.7140
   Villamil-Gomez WE, 2018, MAYO CLIN PROC, V93, P393, DOI 10.1016/j.mayocp.2017.12.006
   Wiwanitkit Viroj, 2016, Indian Heart J, V68, P380, DOI 10.1016/j.ihj.2016.03.031
NR 3
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-6196
EI 1942-5546
J9 MAYO CLIN PROC
JI Mayo Clin. Proc.
PD JUL
PY 2018
VL 93
IS 7
BP 956
EP 956
DI 10.1016/j.mayocp.2018.03.023
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA GN2AK
UT WOS:000438797000025
PM 29907402
OA Bronze
DA 2020-07-08
ER

PT J
AU Marzinek, JK
   Bag, N
   Huber, RG
   Holdbrook, DA
   Wohland, T
   Verma, CS
   Bond, PJ
AF Marzinek, Jan K.
   Bag, Nirmalya
   Huber, Roland G.
   Holdbrook, Daniel A.
   Wohland, Thorsten
   Verma, Chandra S.
   Bond, Peter J.
TI A Funneled Conformational Landscape Governs Flavivirus Fusion Peptide
   Interaction with Lipid Membranes
SO JOURNAL OF CHEMICAL THEORY AND COMPUTATION
LA English
DT Article
ID VIRUS ENVELOPE PROTEIN; FLUORESCENCE CORRELATION SPECTROSCOPY;
   MOLECULAR-DYNAMICS SIMULATIONS; DENGUE VIRUS; FORCE-FIELD;
   LIGAND-BINDING; BILAYERS; SWITCH; CELLS; MODEL
AB During host cell infection by flaviviruses such as dengue and Zika, acidic pH within the endosome triggers a conformational change in the envelope protein on the outer surface of the virion. This results in exposure of the similar to 15 residue fusion peptide (FP) region, freeing it to induce fusion between the viral and endosomal membranes. A better understanding of the conformational dynamics of the FP in the presence of membranes, and the basis for its selectivity for anionic lipid species present within the endosome, would facilitate its therapeutic targeting with antiviral drugs and antibodies. In this work, multiscale modeling, simulations, and free energy calculations (including a total of similar to 75 mu s of atomic-resolution sampling), combined with imaging total internal reflection fluorescence correlation spectroscopy experiments, were employed to investigate the mechanisms of interaction of FP variants with lipid bilayers. Wild-type FPs (in the presence or absence of a fluorescein isothiocyanate tag) were shown to possess a funneled conformational landscape governing their exit from solvent and penetration into the lipid phase and to exhibit an electrostatically favored >2-fold affinity for membranes containing anionic species over purely zwitterionic ones. Conversely, the landscape was abolished in a nonfunctional point mutant, leading to a 2-fold drop in host membrane affinity. Collectively, our data reveal how the highly conserved flavivirus FP has evolved to funnel its conformational space toward a maximally fusogenic state anchored within the endosomal membrane. Therapeutically targeting the accessible ensemble of FP conformations may represent a new, rational strategy for blocking viral infection.
C1 [Marzinek, Jan K.; Bag, Nirmalya; Wohland, Thorsten; Verma, Chandra S.; Bond, Peter J.] Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.
   [Wohland, Thorsten] Natl Univ Singapore, Dept Chem, 14 Sci Dr 4, Singapore 117543, Singapore.
   [Marzinek, Jan K.; Huber, Roland G.; Holdbrook, Daniel A.; Verma, Chandra S.; Bond, Peter J.] ASTAR, Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.
   [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 63755, Singapore.
RP Wohland, T; Verma, CS; Bond, PJ (corresponding author), Natl Univ Singapore, Dept Biol Sci, 14 Sci Dr 4, Singapore 117543, Singapore.; Wohland, T (corresponding author), Natl Univ Singapore, Dept Chem, 14 Sci Dr 4, Singapore 117543, Singapore.; Verma, CS; Bond, PJ (corresponding author), ASTAR, Bioinformat Inst, 30 Biopolis St,07-01 Matrix, Singapore 138671, Singapore.; Verma, CS (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 63755, Singapore.
EM twohland@nus.edu.sg; chandra@bii.a-star.edu.sg;
   peterjb@bii.a-star.edu.sg
RI WOHLAND, THORSTEN/R-6404-2019; Huber, Roland/AAG-6353-2019; Wohland,
   Thorsten/H-8285-2012
OI Huber, Roland/0000-0001-5093-5988; Marzinek, Jan/0000-0002-5493-8753;
   Wohland, Thorsten/0000-0002-0148-4321; verma,
   chandra/0000-0003-0733-9798; Bag, Nirmalya/0000-0001-6752-9142; Bond,
   Peter/0000-0003-2900-098X
FU Ministry of Education in Singapore (MOE AcRF) [MOE2012-T3-1-008]
FX The research leading to these results was supported by funding from the
   Ministry of Education in Singapore (MOE AcRF Tier 3 Grant Number
   MOE2012-T3-1-008).
CR Apellaniz B, 2014, CHEM PHYS LIPIDS, V181, P40, DOI 10.1016/j.chemphyslip.2014.03.003
   Bag N, 2012, CHEMPHYSCHEM, V13, P2784, DOI 10.1002/cphc.201200032
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Batista MRB, 2013, BIOPHYS J, V105, P1670, DOI 10.1016/j.bpj.2013.07.032
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x
   Bond PJ, 2007, J STRUCT BIOL, V157, P593, DOI 10.1016/j.jsb.2006.10.004
   BRIAN AA, 1984, P NATL ACAD SCI-BIOL, V81, P6159, DOI 10.1073/pnas.81.19.6159
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Carvalho A, 2016, EXPERT REV VACCINES, V15, P539, DOI 10.1586/14760584.2016.1152187
   Christian EA, 2013, P NATL ACAD SCI USA, V110, P18662, DOI 10.1073/pnas.1310962110
   Domanski J, 2018, J CHEM THEORY COMPUT, V14, P1706, DOI 10.1021/acs.jctc.7b00983
   Domanski J, 2017, J PHYS CHEM B, V121, P3364, DOI 10.1021/acs.jpcb.6b08445
   Elahi M, 2014, BBA-PROTEINS PROTEOM, V1844, P585, DOI 10.1016/j.bbapap.2013.12.013
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Guo SM, 2014, BIOPHYS J, V106, P190, DOI 10.1016/j.bpj.2013.11.4458
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695
   Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027
   Huber R. G., 2018, STRUCTURE
   Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Krieger JW, 2015, NAT PROTOC, V10, P1948, DOI 10.1038/nprot.2015.100
   KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f
   Marzinek JK, 2016, STRUCTURE, V24, P1410, DOI 10.1016/j.str.2016.05.014
   Marzinek JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19160
   Marzinek JK, 2014, J CHEM INF MODEL, V54, P2093, DOI 10.1021/ci500164q
   Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035
   Mendes YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047596
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x
   Mori T, 2016, BBA-BIOMEMBRANES, V1858, P1635, DOI 10.1016/j.bbamem.2015.12.032
   Murray CJL, 2013, NEW ENGL J MED, V369, P448, DOI 10.1056/NEJMra1201534
   Nayak V, 2009, J VIROL, V83, P4338, DOI 10.1128/JVI.02574-08
   NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334
   Onuchic JN, 2004, CURR OPIN STRUC BIOL, V14, P70, DOI 10.1016/j.sbi.2004.01.009
   PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pronk S, 2015, J AM CHEM SOC, V137, P708, DOI 10.1021/ja508803d
   Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513
   Rogers DM, 2015, BBA-BIOMEMBRANES, V1848, P1041, DOI 10.1016/j.bbamem.2014.12.018
   RUBIN DB, 1981, ANN STAT, V9, P130, DOI 10.1214/aos/1176345338
   Sankaran J, 2010, OPT EXPRESS, V18, P25468, DOI 10.1364/OE.18.025468
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Seligman SJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-27
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stauffer F, 2008, MOL MEMBR BIOL, V25, P128, DOI 10.1080/09687680701633091
   Ulmschneider JP, 2018, ACCOUNTS CHEM RES, V51, P1106, DOI 10.1021/acs.accounts.7b00613
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330
   Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 61
TC 4
Z9 4
U1 4
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1549-9618
EI 1549-9626
J9 J CHEM THEORY COMPUT
JI J. Chem. Theory Comput.
PD JUL
PY 2018
VL 14
IS 7
BP 3920
EP 3932
DI 10.1021/acs.jctc.8b00438
PG 13
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA GN0KN
UT WOS:000438654500046
PM 29874075
DA 2020-07-08
ER

PT J
AU Souza, AI
   de Siqueira, MT
   Ferreira, ALCG
   de Freitas, CU
   Bezerra, ACV
   Ribeiro, AG
   Nardocci, AC
AF Souza, Ariani Impieri
   de Siqueira, Marilia Teixeira
   Gomes Ferreira, Ana Laura Carneiro
   de Freitas, Clarice Umbelino
   Vasconcelos Bezerra, Anselmo Cesar
   Ribeiro, Adeylson Guimaraes
   Nardocci, Adelaide Cassia
TI Geography of Microcephaly in the Zika Era: A Study of Newborn
   Distribution and Socio-environmental Indicators in Recife, Brazil,
   2015-2016
SO PUBLIC HEALTH REPORTS
LA English
DT Article
DE ecological studies; environmental indicators; health inequalities;
   microcephaly; social indicators; Zika
ID VIRUS
AB Objectives: We assessed sociodemographic and health care factors of mothers and newborns during a 2015-2016 outbreak of microcephaly in Recife, Brazil, and we analyzed the spatial distribution and incidence risk of newborns with microcephaly in relation to socio-environmental indicators.
   Methods: We collected data from August 2015 through May 2016 from Brazil's Live Birth Information System and Bulletin of Microcephaly Notification, and we geocoded the data by maternal residence. We constructed thematic maps of districts, according to socio-environmental and vector indicators. We identified spatial aggregates of newborns with microcephaly by using the Bernoulli model. We performed logistic regression analyses to compare the incidence risk of microcephaly within socio-environmental indicator groups.
   Results: We geocoded 17990 of 19 554 (92.0%) live births in Recife, of which 202 (1.1%) newborns were classified as having microcephaly, based on a head circumference of >= 2 standard deviations below the mean. Larger proportions of newborns with microcephaly (compared with newborns without microcephaly) were born to mothers who delivered in a public hospital, did not attend college, were aged <= 19, or were black or mixed race. A higher risk of microcephaly (incidence rate ratio [IRR] = 3.90; 95% confidence interval [CI], 1.88-8.06) occurred in districts with the lowest (vs highest) Municipal Human Development Index (ie, an index that assesses longevity, education, and income). The risk of microcephaly was significantly higher where rates of larvae density (IRR = 2.31; 95% CI, 1.19-4.50) and larvae detection (IRR = 2.04; 95% CI, 1.05-4.00) were higher and rates of sewage system (IRR = 2.20; 95% CI, 1.16-4.18) and garbage collection (IRR = 1.96; 95% CI, 0.99-3.88) were lower. Newborns with microcephaly lived predominantly in the poorest areas and in a high-risk cluster (relative risk = 1.89, P = .01) in the north.
   Conclusions: The disproportionate incidence of microcephaly in newborns in poor areas of Recife reinforces the need for government and public health authorities to formulate policies that promote social equity and support for families and their children with microcephaly.
C1 [Souza, Ariani Impieri; Gomes Ferreira, Ana Laura Carneiro] Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
   [de Siqueira, Marilia Teixeira] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.
   [Vasconcelos Bezerra, Anselmo Cesar] Inst Fed Pernambuco, Recife, PE, Brazil.
   [Ribeiro, Adeylson Guimaraes; Nardocci, Adelaide Cassia] Univ Sao Paulo, Fac Saude Publ, Sao Paulo, Brazil.
RP Souza, AI (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM ariani@imip.org.br
RI Nardocci, Adelaide C/H-5003-2012; Souza, Ariani I/C-1568-2015; de Souza,
   Ariani Impieri/AAR-6884-2020; Ribeiro, Adeylson G/T-9430-2018
OI Souza, Ariani I/0000-0002-7917-5983; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Ribeiro, Adeylson G/0000-0001-8447-8463
FU Foundation for Support of Science and Technology of Pernambuco (FACEPE),
   Brazil [APQ-0051-4.06/16]
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   supported by grants from the Foundation for Support of Science and
   Technology of Pernambuco (FACEPE), Brazil (grant No. APQ-0051-4.06/16).
CR Bivand R. S., 2013, APPL SPATIAL DATA AN
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   CIEVSPE Centro de Informacoes Estrategicas de Vigilancia em Saude de Pernambuco, CTR INF ESTR VIG SAU
   COMPESA . Companhia Pernambucana de Saneamento, 2016, COMP PERN SAN IND AT
   Costa AM, 2016, DETERMINACAO SOCIAL
   COSTA Glaucio Jose Ferreira da, 2008, THESIS
   deOLIVEIRA D. S. C, 2009, THESIS
   Environmental Systems Research Institute, 2009, ARCGIS REL 9 3
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Guimarães Maria José Bezerra, 2003, Cad. Saúde Pública, V19, P1413, DOI 10.1590/S0102-311X2003000500020
   Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995
   Kulldorff M, 2015, SATSCAN VERSION 9 4
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   McNeil D., 2016, ZIKA EMERGING EPIDEM
   Ministerio da Saude, SINASC SIST INF NASC
   Ministerio da Saude Brasil, 2016, MON CAS MICR BRAS
   Ministerio da Saude Departamento de Informatica do SUS, DATASUS INF SAUD
   Mondini Adriano, 2007, Rev. Saúde Pública, V41, P923, DOI 10.1590/S0034-89102007000600006
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Poletta FA, 2014, PUBLIC HEALTH GENOM, V17, P61, DOI 10.1159/000356568
   Profeitura do Recife Secretaria Municipal de Saude, 2014, PLAN MUN SAUD 2014 2
   R Development Core Team, 2016, R STAT SOFTW
   RECIFE, 2017, SECRETARIA SAUDE INF
   Rego Sergio, 2016, Rev. Bioét., V24, P430, DOI 10.1590/1983-80422016243141
   SANEARSanitation Authority of Recife, 2014, MAP SOCIAL INTEREST
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   StataCorp, 2013, STAT REL 13
   Teurlai M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004211
   United Nations Development Program, 2013, ATL HUM DEV BRAZ
   Vargas WP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2097-3
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, MON EV DENG CONTR SU
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
NR 37
TC 4
Z9 4
U1 1
U2 3
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD JUL-AUG
PY 2018
VL 133
IS 4
BP 461
EP 471
DI 10.1177/0033354918777256
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GM9XT
UT WOS:000438610300013
PM 29920225
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ahn, S
   Ke, ZQ
   Vikalo, H
AF Ahn, Soyeon
   Ke, Ziqi
   Vikalo, Haris
TI Viral quasispecies reconstruction via tensor factorization with
   successive read removal
SO BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 26th Annual Conference on Intelligent Systems for Molecular Biology
   (ISMB)
CY JUL 06-10, 2018
CL Chicago, IL
ID SEQUENCING DATA; HAPLOTYPE RECONSTRUCTION; INFERENCE
AB Motivation: As RNA viruses mutate and adapt to environmental changes, often developing resistance to anti-viral vaccines and drugs, they form an ensemble of viral strains-a viral quasispecies. While high-throughput sequencing (HTS) has enabled in-depth studies of viral quasispecies, sequencing errors and limited read lengths render the problem of reconstructing the strains and estimating their spectrum challenging. Inference of viral quasispecies is difficult due to generally non-uniform frequencies of the strains, and is further exacerbated when the genetic distances between the strains are small. Results: This paper presents TenSQR, an algorithm that utilizes tensor factorization framework to analyze HTS data and reconstruct viral quasispecies characterized by highly uneven frequencies of its components. Fundamentally, TenSQR performs clustering with successive data removal to infer strains in a quasispecies in order from the most to the least abundant one; every time a strain is inferred, sequencing reads generated from that strain are removed from the dataset. The proposed successive strain reconstruction and data removal enables discovery of rare strains in a population and facilitates detection of deletions in such strains.
   Results on simulated datasets demonstrate that TenSQR can reconstruct full-length strains having widely different abundances, generally outperforming state-of-the-art methods at diversities 1-10% and detecting long deletions even in rare strains. A study on a real HIV-1 dataset demonstrates that TenSQR outperforms competing methods in experimental settings as well. Finally, we apply TenSQR to analyze a Zika virus sample and reconstruct the full-length strains it contains.
C1 [Ahn, Soyeon; Ke, Ziqi; Vikalo, Haris] Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.
RP Ahn, S (corresponding author), Univ Texas Austin, Dept Elect & Comp Engn, Austin, TX 78712 USA.
EM soyeon.ahn@utexas.edu
FU National Science FoundationNational Science Foundation (NSF) [CCF
   1320273, CCF 1618427]
FX This work was supported by the National Science Foundation under grants
   CCF 1320273 and CCF 1618427.
CR Ahn S, 2017, LECT N BIOINFORMAT, V10229, P353, DOI 10.1007/978-3-319-56970-3_22
   Astrovskaya I, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S6-S1
   Baaijens JA, 2017, GENOME RES, V27, P835, DOI 10.1101/gr.215038.116
   Beerenwinkel N, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00329
   Cai CX, 2016, IEEE J-STSP, V10, P647, DOI 10.1109/JSTSP.2016.2547860
   Carroll SA, 2013, J VIROL, V87, P2608, DOI 10.1128/JVI.03118-12
   Chaisson MJ, 2017, LECT N BIOINFORMAT, V10229, P117, DOI 10.1007/978-3-319-56970-3_8
   Di Giallonardo F, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku537
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Eriksson N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000074
   Hashemi A., 2017, BIORXIV
   Jain P, 2013, STOC'13: PROCEEDINGS OF THE 2013 ACM SYMPOSIUM ON THEORY OF COMPUTING, P665
   Jayasundara D, 2015, BIOINFORMATICS, V31, P886, DOI 10.1093/bioinformatics/btu754
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Le T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006079
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lippert Ross, 2002, Brief Bioinform, V3, P23, DOI 10.1093/bib/3.1.23
   Malhotra R, 2015, ARXIV150204239
   Mangul S, 2014, BIOINFORMATICS, V30, P329, DOI 10.1093/bioinformatics/btu295
   Posada-Cespedes S, 2017, VIRUS RES, V239, P17, DOI 10.1016/j.virusres.2016.09.016
   Prabhakaran S, 2014, IEEE ACM T COMPUT BI, V11, P182, DOI 10.1109/TCBB.2013.145
   Prosperi MCF, 2012, BIOINFORMATICS, V28, P132, DOI 10.1093/bioinformatics/btr627
   Schirmer M, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0976-y
   Schirmer M, 2014, BRIEF BIOINFORM, V15, P431, DOI 10.1093/bib/bbs081
   Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736
   Topfer A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003515
   Topfer A, 2013, J COMPUT BIOL, V20, P113, DOI 10.1089/cmb.2012.0232
   Zagordi O, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-119
   Zagordi O, 2010, J COMPUT BIOL, V17, P417, DOI 10.1089/cmb.2009.0164
NR 29
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1367-4803
EI 1460-2059
J9 BIOINFORMATICS
JI Bioinformatics
PD JUL 1
PY 2018
VL 34
IS 13
BP 23
EP 31
DI 10.1093/bioinformatics/bty291
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Computer Science, Interdisciplinary Applications; Mathematical &
   Computational Biology; Statistics & Probability
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Computer Science; Mathematical & Computational Biology; Mathematics
GA GM6DA
UT WOS:000438247800004
PM 29949976
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Rapid Zika Detection: A Game-Changer in Disease Surveillance
SO CHEMICAL ENGINEERING PROGRESS
LA English
DT News Item
CR Fernandes JN, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat0496
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER INST CHEMICAL ENGINEERS
PI NEW YORK
PA 3 PARK AVE, NEW YORK, NY 10016-5901 USA
SN 0360-7275
EI 1945-0710
J9 CHEM ENG PROG
JI Chem. Eng. Prog.
PD JUL
PY 2018
VL 114
IS 7
BP 7
EP 8
PG 2
WC Engineering, Chemical
SC Engineering
GA GN2OC
UT WOS:000438836400005
DA 2020-07-08
ER

PT J
AU Imad, HA
   Atsawawaranunt, K
   Sharma, C
   Poonam, T
   Piyaphanee, W
AF Imad, Hisham Ahmed
   Atsawawaranunt, Kamolthip
   Sharma, Chollasap
   Poonam, Thitiya
   Piyaphanee, Watcharapong
TI Fever, rash, and red eyes in Thailand: A diagnostic challenge
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Editorial Material
DE Zika virus infection; Zika virus; Flavivirus; Travel destinations;
   Thailand
C1 [Imad, Hisham Ahmed; Atsawawaranunt, Kamolthip; Sharma, Chollasap; Poonam, Thitiya; Piyaphanee, Watcharapong] Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Bangkok, Thailand.
RP Imad, HA (corresponding author), Mahidol Univ, Fac Trop Med, Dept Clin Trop Med, Thai Travel Clin,Hosp Trop Dis, Rajanagarinda Bldg,420-6 Ratchawithi Rd, Bangkok 10400, Thailand.
EM hisham.a.imad@gmail.com
OI Imad, Hisham/0000-0003-4812-6334
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD JUL-AUG
PY 2018
VL 24
BP 15
EP 15
DI 10.1016/j.tmaid.2018.05.010
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GN2II
UT WOS:000438821200008
PM 29803863
DA 2020-07-08
ER

PT J
AU Ncube, NB
   Ramharack, P
   Soliman, MES
AF Ncube, Nomagugu B.
   Ramharack, Pritika
   Soliman, Mahmoud E. S.
TI An "All-In-One" Pharmacophoric Architecture for the Discovery of
   Potential Broad-Spectrum Anti-Flavivirus Drugs
SO APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY
LA English
DT Article
DE Flaviviridae; Pharmacophore model; Free-binding energy; Binding
   landscape; NITD008; RdRp
ID ADENOSINE NUCLEOSIDE INHIBITOR; ZIKA; IDENTIFICATION; NITD008; DESIGN
AB A precipitous increase in the number of flaviviral infections has been noted over the last 5 years. Despite these outbreaks, treatment protocols for infected individuals remain ambiguous. Numerous studies have identified NITD008 as a potent flavivirus inhibitor; however, clinical testing was dismissed due to undesirable toxic effects. The binding landscape of NITD008 in complex with five detrimental flaviviruses at the RNA-dependent RNA polymerase active sites was explored. An "all-in-one" pharmacophore model was created for the design of small molecules that may inhibit a broad spectrum of flaviviruses. This pharmacophore model approach serves as a robust cornerstone, thus assisting medicinal experts in the composition of multifunctional inhibitors that will eliminate cross-resistance and toxicity and enhance patient adherence.
C1 [Ncube, Nomagugu B.; Ramharack, Pritika; Soliman, Mahmoud E. S.] Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, Westville Campus, ZA-4001 Durban, South Africa.
RP Soliman, MES (corresponding author), Univ KwaZulu Natal, Sch Hlth Sci, Mol Biocomputat & Drug Design Lab, Westville Campus, ZA-4001 Durban, South Africa.
EM soliman@ukzn.ac.za
RI Soliman, Mahmoud E S/M-8724-2013
OI Soliman, Mahmoud E S/0000-0002-8711-7783; Ramharack,
   Pritika/0000-0001-5850-6782
FU National Research Foundation (NRF) of South AfricaNational Research
   Foundation - South Africa; School of Health Sciences, UKZN
FX The authors would like to thank the Centre of High Performance Computing
   in Cape Town (www.chpc.ac.za) for the computational facility and the
   National Research Foundation (NRF) of South Africa and the School of
   Health Sciences, UKZN, for the scholarships and financial support.
CR Ahmed SSSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040654
   Awasthi S., 2016, J ANTIVIRALS ANTIRET, V8, P8
   Baharuddin A, 2014, CURR PHARM DESIGN, V20, P3428, DOI 10.2174/13816128113199990635
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Best SM, 2016, CURR BIOL, V26, pR1258, DOI 10.1016/j.cub.2016.09.029
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Case D, 2014, AMBER, V14, P29
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Cele FN, 2016, DRUG DES DEV THER, V10, P1365, DOI 10.2147/DDDT.S95533
   Daina A, 2016, CHEMMEDCHEM, V11, P1117, DOI 10.1002/cmdc.201600182
   Deng CL, 2014, J VIROL, V88, P11915, DOI 10.1128/JVI.01207-14
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Diosa-Toro M, 2013, ADV VIRUS RES, V85, P91, DOI 10.1016/B978-0-12-408116-1.00004-5
   Duan W., 2017, EMBO J, V36, P1
   Edwards T. E., 2014, J VIROL, V88, P1
   Harris E., 2008, NORVATIS FDN S, P277
   Heaps C., 2008, INTRO LEAP, P1
   Homeyer N, 2012, MOL INFORM, V31, P114, DOI 10.1002/minf.201100135
   Huang HJ, 2010, J TAIWAN INST CHEM E, V41, P623, DOI 10.1016/j.jtice.2010.03.017
   Hung CL, 2014, DRUG DEVELOP RES, V75, P412, DOI 10.1002/ddr.21222
   Katz LM, 2017, ARCH PATHOL LAB MED, V141, P85, DOI 10.5858/arpa.2016-0430-RA
   Koes DR, 2012, NUCLEIC ACIDS RES, V40, pW409, DOI 10.1093/nar/gks378
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kore P., 2012, OPEN J MED CHEM, V2, P139, DOI [10.4236/ojmc.2012.24017, DOI 10.4236/OJMC.2012.24017]
   Kumalo HM, 2016, CELL MOL BIOENG, V9, P175, DOI 10.1007/s12195-015-0421-8
   Kumar Rajnish, 2011, J Nat Sci Biol Med, V2, P168, DOI 10.4103/0976-9668.92325
   Kusumaningrum S., 2014, J APP SCI, V4, P47, DOI [10.7324/JAPS.2014.4119, DOI 10.7324/JAPS.2014.4119]
   Lequime S, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vew035
   Lill MA, 2011, J COMPUT AID MOL DES, V25, P13, DOI 10.1007/s10822-010-9395-8
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Nelson J, 2015, ANTIVIR RES, V122, P39, DOI 10.1016/j.antiviral.2015.07.008
   Noble CG, 2013, J VIROL, V87, P5291, DOI 10.1128/JVI.00045-13
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Pijlman GP, 2014, CURR OPIN VIROL, V7, P55, DOI 10.1016/j.coviro.2014.04.002
   Ramharack P, 2016, RSC ADV, V6, P68719, DOI 10.1039/c6ra12142j
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336
   Solomon T., 2001, J INFECTION, V5, P1
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   WHO, 2016, WHO HIST ZIK VIR
   WHO, 2016, ZIK VIR MICR GUILL B, P1
   Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
NR 51
TC 4
Z9 4
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0273-2289
EI 1559-0291
J9 APPL BIOCHEM BIOTECH
JI Appl. Biochem. Biotechnol.
PD JUL
PY 2018
VL 185
IS 3
BP 799
EP 814
DI 10.1007/s12010-017-2690-2
PG 16
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA GM6NI
UT WOS:000438285900017
PM 29349531
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Untitled
SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
LA English
DT Letter
ID ZIKA VIRUS; TRANSMISSION
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok 10150, Thailand.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok 10150, Thailand.
EM beuyjoob@hotmail.com
CR Pohl L, 2018, J DTSCH DERMATOL GES, V16, P599, DOI 10.1111/ddg.13503
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
   Wiwanitkit V, 2016, J FORMOS MED ASSOC, V115, P684, DOI 10.1016/j.jfma.2016.03.008
NR 3
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1610-0379
EI 1610-0387
J9 J DTSCH DERMATOL GES
JI J. Dtsch. Dermatol. Ges.
PD JUL
PY 2018
VL 16
IS 7
BP 923
EP 923
DI 10.1111/ddg.13560
PG 1
WC Dermatology
SC Dermatology
GA GM3SV
UT WOS:000438030200016
PM 29989358
DA 2020-07-08
ER

PT J
AU Pohl, L
   Raulin, C
   Raulin, S
AF Pohl, Laura
   Raulin, Christian
   Raulin, Sabine
TI Untitled Reply
SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
LA English
DT Letter
ID ZIKA VIRUS
C1 [Pohl, Laura] MVZ Dres Raulin & Kollegen GbR, Kaiserstr 104, D-76133 Karlsruhe, Germany.
RP Pohl, L (corresponding author), MVZ Dres Raulin & Kollegen GbR, Kaiserstr 104, D-76133 Karlsruhe, Germany.
EM info@raulin.de
CR Joob B, 2018, J FR OPHTALMOL, V41, pE89, DOI 10.1016/j.jfo.2017.03.029
   Joob B, 2018, ARQ NEURO-PSIQUIAT, V76, P63, DOI 10.1590/0004-282X20170173
   Joob B, 2016, INT MARIT HEALTH, V67, P260, DOI 10.5603/IMH.2016.0046
   Joob B, 2016, ANATOL J CARDIOL, V16, P455, DOI 10.14744/AnatolJCardiol.2016.7140
NR 4
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1610-0379
EI 1610-0387
J9 J DTSCH DERMATOL GES
JI J. Dtsch. Dermatol. Ges.
PD JUL
PY 2018
VL 16
IS 7
BP 923
EP 923
PG 1
WC Dermatology
SC Dermatology
GA GM3SV
UT WOS:000438030200017
DA 2020-07-08
ER

PT J
AU Evans, MV
   Murdock, CC
   Drake, JM
AF Evans, Michelle V.
   Murdock, Courtney C.
   Drake, John M.
TI Anticipating Emerging Mosquito-borne Flaviviruses in the USA: What Comes
   after Zika?
SO TRENDS IN PARASITOLOGY
LA English
DT Editorial Material
ID JAPANESE ENCEPHALITIS; WESSELSBRON-DISEASE; VIRUS; HISTORY; VACCINE
AB New mosquito-borne diseases have emerged on multiple occasions over the last several decades, raising fears that there are yet more poorly understood viruses that may emerge in the USA. Here, we provide a data-driven 'watch list' of virusesinthe [95TD$DIF] Flaviviridae family with high potential to emerge in the USA, identified using statistical techniques, to enable the public health community to better target surveillance. We suggest that public health authorities further incorporate predictive modeling techniques into disease-prevention strategies.
C1 [Evans, Michelle V.; Murdock, Courtney C.; Drake, John M.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.
   [Evans, Michelle V.; Murdock, Courtney C.; Drake, John M.] Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.
   [Evans, Michelle V.; Murdock, Courtney C.] Univ Georgia, Ctr Trop Emerging Global Dis, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Dept Infect Dis, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, Ctr Vaccines & Immunol, Athens, GA 30602 USA.
   [Murdock, Courtney C.] Univ Georgia, River Basin Ctr, Athens, GA 30602 USA.
RP Evans, MV (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.; Evans, MV (corresponding author), Univ Georgia, Ctr Ecol Infect Dis, Athens, GA 30602 USA.; Evans, MV (corresponding author), Univ Georgia, Ctr Trop Emerging Global Dis, Athens, GA 30602 USA.
EM mvevans@uga.edu
RI Evans, Michelle V./S-1027-2019
OI Evans, Michelle V./0000-0002-5628-0502
FU University of Georgia (Presidential Fellowship); National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U01GM110744]; National Science
   FoundationNational Science Foundation (NSF) [DEB1640780]
FX We would like to thank Barbara Han and Tad Dallas, who provided support
   in the creation and analysis of the predictive model [9TD$DIF], as well
   as the three anonymous reviewers whose comments helped improve and
   clarify this manuscript. MVE was supported by The University of Georgia
   (Presidential Fellowship). JMD was funded by the National Institutes of
   Health (Grant No. U01GM110744). CCM was funded by the National Science
   Foundation (Grant No. DEB1640780). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Butler D, 2017, NATURE, V541, P444, DOI 10.1038/nature.2017.21329
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   COETZER JAW, 1979, ONDERSTEPOORT J VET, V46, P165
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Frierson J. Gordon, 2010, Yale Journal of Biology and Medicine, V83, P77
   Hamer GL, 2016, J MED ENTOMOL, V53, P485, DOI 10.1093/jme/tjw020
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000256
   Kaur R, 2003, J NEUROVIROL, V9, P421, DOI 10.1080/13550280390218454
   Mackenzie J., 2012, JAPANESE ENCEPHALITI
   Mushi EZ, 1998, J VET DIAGN INVEST, V10, P191, DOI 10.1177/104063879801000216
   Nemeth N, 2012, AM J TROP MED HYG, V87, P760, DOI 10.4269/ajtmh.2012.12-0141
   Souza L.O, 2017, HDB ZOONOSES, P205
   Van Regenmortel M.H.V, 2000, VIRUS TAXONOMY CLASS
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 16
TC 4
Z9 4
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JUL
PY 2018
VL 34
IS 7
BP 544
EP 547
DI 10.1016/j.pt.2018.02.010
PG 5
WC Parasitology
SC Parasitology
GA GM0SA
UT WOS:000437764800002
PM 29551358
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Simoes, ML
   Caragata, EP
   Dimopoulos, G
AF Simoes, Maria L.
   Caragata, Eric P.
   Dimopoulos, George
TI Diverse Host and Restriction Factors Regulate Mosquito-Pathogen
   Interactions
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID DENGUE VIRUS-REPLICATION; MALARIA PARASITE CHITINASE; ANOPHELES-GAMBIAE
   IMMUNITY; NITRIC-OXIDE SYNTHASE; JAK-STAT PATHWAY; AEDES-AEGYPTI; WEST
   NILE; PLASMODIUM-FALCIPARUM; SALIVARY-GLANDS; RNA INTERFERENCE
AB Mosquitoes transmit diseases that seriously impact global human health. Despite extensive knowledge of the life cycles of mosquito-borne parasites and viruses within their hosts, control strategies have proven insufficient to halt their spread. An understanding of the relationships established between such pathogens and the host tissues they inhabit is therefore paramount for the development of new strategies that specifically target these interactions, to prevent the pathogens' maturation and transmission. Here we present an updated account of the antagonists and host factors that affect the development of Plasmodium, the parasite causing malaria, and mosquito-borne viruses, such as dengue virus and Zika virus, within their mosquito vectors, and we discuss the similarities and differences between Plasmodium and viral systems, looking toward the elucidation of new targets for disease control.
C1 [Simoes, Maria L.; Caragata, Eric P.; Dimopoulos, George] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Malaria Res Inst, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Malaria Res Inst, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.
EM gdimopo1@jhu.edu
FU Johns Hopkins Malaria Research Institute Postdoctoral Fellowship
FX This work was supported by a Johns Hopkins Malaria Research Institute
   Postdoctoral Fellowship (to M.L.S.). We also thank Dr Deborah McClellan
   for editorial assistance.
CR Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Akman-Anderson L, 2007, INFECT IMMUN, V75, P4012, DOI 10.1128/IAI.00645-07
   Anglero-Rodriguez YI, 2017, ELIFE, V6, DOI 10.7554/eLife.28844
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Anglero-Rodriguez YI, 2016, SCI REP-UK, V6, DOI 10.1038/srep34084
   Apte-Deshpande AD, 2014, INDIAN J MED RES, V139, P762
   Attardo GM, 2006, J EXP BIOL, V209, P3071, DOI 10.1242/jeb.02349
   Bahia AC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001317
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Baton LA, 2005, TRENDS PARASITOL, V21, P22, DOI 10.1016/j.pt.2004.11.001
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bhatnagar RK, 2003, BIOCHEM BIOPH RES CO, V304, P783, DOI 10.1016/S0006-291X(03)00682-X
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   BILLINGSLEY PF, 1992, J PARASITOL, V78, P430, DOI 10.2307/3283640
   Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   BRIEGEL H, 1985, J INSECT PHYSIOL, V31, P15, DOI 10.1016/0022-1910(85)90036-8
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x
   Chertemps T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011538
   Chevillon C, 2008, TRENDS MICROBIOL, V16, P80, DOI 10.1016/j.tim.2007.12.003
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Munoz MD, 2013, BIOMED RES INT, DOI 10.1155/2013/875958
   Dennison NJ, 2015, DEV COMP IMMUNOL, V49, P170, DOI 10.1016/j.dci.2014.10.016
   Dessens JT, 2001, INFECT IMMUN, V69, P4041, DOI 10.1128/IAI.69.6.4041-4047.2001
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052
   Dong YM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006898
   Dong YM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002458
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dong YM, 2009, J BIOL CHEM, V284, P9835, DOI 10.1074/jbc.M807084200
   Dubey SK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18043-0
   Dutra H. L., 2016, BIOESSAYS, DOI 10.1002/bies.201600175
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Barletta ABF, 2016, SCI REP-UK, V6, DOI 10.1038/srep19928
   Fraiture M, 2009, CELL HOST MICROBE, V5, P273, DOI 10.1016/j.chom.2009.01.005
   Frolet C, 2006, IMMUNITY, V25, P677, DOI 10.1016/j.immuni.2006.08.019
   Fu Q, 2015, J MED ENTOMOL, V52, P1124, DOI 10.1093/jme/tjv101
   Garver LS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003622
   Garver LS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002737
   Garver LS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000335
   Ghosh AK, 2001, P NATL ACAD SCI USA, V98, P13278, DOI 10.1073/pnas.241491198
   Ghosh AK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000265
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Gupta L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015410
   Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Hillyer JF, 2010, ADV EXP MED BIOL, V708, P218
   HUBER M, 1991, P NATL ACAD SCI USA, V88, P2807, DOI 10.1073/pnas.88.7.2807
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Jupatanakul N, 2014, DEV COMP IMMUNOL, V43, P1, DOI 10.1016/j.dci.2013.10.002
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kato N, 2008, VECTOR-BORNE ZOONOT, V8, P701, DOI 10.1089/vbz.2007.0270
   Kelly EM, 2012, J GEN VIROL, V93, P2419, DOI 10.1099/vir.0.042846-0
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015
   Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lambrechts L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2437
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005
   Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Maharaj PD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003386
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069
   Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478
   Miesen P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004452
   Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576
   Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Moon AE, 2011, INSECT BIOCHEM MOLEC, V41, P628, DOI 10.1016/j.ibmb.2011.04.001
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moreno-Garcia M, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00451
   Mueller AK, 2010, INT J PARASITOL, V40, P1229, DOI 10.1016/j.ijpara.2010.05.005
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Myung JM, 2004, MOL BIOCHEM PARASIT, V133, P53, DOI 10.1016/j.molbiopara.2003.09.002
   Niu GD, 2015, SCI REP-UK, V5, DOI 10.1038/srep14694
   Nunes RD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005034
   Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037
   Pike A, 2017, SCIENCE, V357, P1396, DOI 10.1126/science.aak9691
   Pinheiro-Silva R, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1079-8
   Pinto SB, 2008, CELL MICROBIOL, V10, P891, DOI 10.1111/j.1462-5822.2007.01091.x
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Povelones M, 2009, SCIENCE, V324, P258, DOI 10.1126/science.1171400
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ramirez JL, 2014, J INNATE IMMUN, V6, P119, DOI 10.1159/000353765
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Ramos-Castaneda J, 2008, INTERVIROLOGY, V51, P335, DOI 10.1159/000175639
   Ramphul UN, 2015, P NATL ACAD SCI USA, V112, P1273, DOI 10.1073/pnas.1423586112
   Rodrigues J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035210
   Rono MK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000434
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Schlegelmilch T, 2013, PATHOG GLOB HEALTH, V107, P480, DOI 10.1179/2047772413Z.000000000180
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   SHAHABUDDIN M, 1994, EXP PARASITOL, V79, P85, DOI 10.1006/expr.1994.1066
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Simoes ML, 2017, MBIO, V8, DOI 10.1128/mBio.01631-17
   Simoes ML, 2017, DEV COMP IMMUNOL, V67, P257, DOI 10.1016/j.dci.2016.09.012
   Simoes ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0619-y
   Smith RC, 2014, MEM I OSWALDO CRUZ, V109, P644, DOI 10.1590/0074-0276130597
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tsai YL, 2001, INFECT IMMUN, V69, P4048, DOI 10.1128/IAI.69.6.4048-4054.2001
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   Vega-Rodriguez J, 2014, P NATL ACAD SCI USA, V111, pE492, DOI 10.1073/pnas.1315517111
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044
   Waldock J, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001565
   Wang JL, 2013, J INFECT DIS, V208, P1161, DOI 10.1093/infdis/jit284
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WHO, 2017, WORLD MAL REP 2017, P196
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xiao XP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004848
   Xiao XP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004027
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang GW, 2015, J BIOL CHEM, V290, P16490, DOI 10.1074/jbc.M114.623165
   Zhou YH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0488-4
   Zieler H, 2000, P NATL ACAD SCI USA, V97, P11516, DOI 10.1073/pnas.97.21.11516
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 145
TC 13
Z9 13
U1 2
U2 11
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JUL
PY 2018
VL 34
IS 7
BP 603
EP 616
DI 10.1016/j.pt.2018.04.011
PG 14
WC Parasitology
SC Parasitology
GA GM0SA
UT WOS:000437764800009
PM 29793806
DA 2020-07-08
ER

PT J
AU Alam, MK
   Arshad, AI
AF Alam, M. K.
   Arshad, A., I
TI Zika virus: raising awareness to prevent a pandemic
SO BANGLADESH JOURNAL OF MEDICAL SCIENCE
LA English
DT Editorial Material
DE Zika virus; Pandemic; ZIKV
AB Zika virus is a flavivirus which is transmitted through Aedes female mosquito species or sexually. "Mild dengue" like symptoms are noticed which usually subside shortly and uneventfully. In 1969 ZIKV was isolated in West Malaysia for the first time. Since then no case has been reported in Malaysia. WHO has declared a global threat of an epidemic spread after the outbreak in Brazil. Rain forest climate regions are at a constant state of emergency as pools of water are abundantly formed as a result of rain showers throughout the year which provides a habitat for mosquitos. We try to raise awareness and alert health governing bodies and institutions to take necessary steps to prevent and eradicate the potential pandemic threat. Counselling of females who are planning to conceive is required to minimize the threat to newborn babies. Travellers visiting the equatorial regions should be screened and counselled to detect and prevent viral infection transfer and to avoid complications on a larger scale.
   Zika virus (ZIKV), a form of flavivirus, is commonly thought to be transmitted through Aedes female mosquito species. Sexual transmission has also been documented. Symptoms of the viral infection are similar to those of dengue infection. Common symptoms are maculopapular rashes, arthralgia and abnormal lymphocytic activity. Symptomatic treatment and rest usually leads to a full recovery. However recently, congenital microcephaly has been ambiguously linked to infections during pregnancy. During 1969, ZIKV was isolated in West-Malaysia(1). Since then, no case in Malaysia has been documented as being affected directly or congenitally by ZIKV. In mid-2015, an epidemic outbreak originating from Brazil has been documented(2). Coincidentally, outbreaks in Cambodia, Indonesia, French Polynesia, Malaysia and Philippines have also been reported(3). Equatorial regions are at a constant risk of widespread infection attributing mainly to the rain forest climate. Malaysia has rain forest climate throughout the year. Increased risk of human-mosquito-human has been previously documented.
   As it is a cultural melting pot of Asian continent and one of the favourite travelling destinations, peaks of tourism are noted in mid-year. World Health Organization has declared a state of emergency to control this epidemic from spreading across the globe. We request global health organizations such as UNICEF, WHO, etc. to join hands with Governments, Social Media, local NGOs, advertising agencies, and Health professionals to battle against the upcoming potential viral Pandemic. Serological testing and Polymerase Chain Reaction methods have been used for diagnosis of infection in early stages(4).
   Affected cases should be reported and studied to assess the risks of further spread. Females who plan to conceive or are pregnant should be closely monitored and counselled to avoid congenital transmission. Congenitally affected children should be assessed and provided necessary mental and health care facilities. The formulation of a vaccination is way down the lane and currently we should focus all efforts for preventing the spread of infection through minimizing the risk of exposure and controlling any further transmission of cases that have already been detected.
   Within this context, the global model based on season as presented by Bogoch and colleagues(2), predicts higher risks of local transmission of infection in equatorial regions throughout the year as well as travelers can worsen the global situation out of proportions. The potentiality of rapid spread of ZIKV requires an urgent notice and necessary preventive measures, viz., mosquito nets, repellent sprays, proper water sanitation, eradication of water pools, fumigation etc.
C1 [Alam, M. K.] Aljouf Univ, Coll Dent, Dept Orthodont, Sakaka, Saudi Arabia.
   [Arshad, A., I] Univ Sains Malaysia, Sch Dent Sci, Kota Bharu, Kelantan, Saudi Arabia.
RP Alam, MK (corresponding author), Aljouf Univ, Coll Dent, Dept Orthodont, Sakaka, Saudi Arabia.
EM dralam@gmail.com
RI Alam, Mohammad/D-3062-2012; amsalu, ribka/G-8780-2019; Arshad, Anas
   Imran/G-2151-2019
OI Alam, Mohammad/0000-0001-7131-1752; Arshad, Anas
   Imran/0000-0001-8318-5546
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017
NR 4
TC 0
Z9 0
U1 1
U2 12
PU IBN SINA TRUST
PI DHAKA
PA 1-1B KALLYANPUR, MIRPUR RD, DHAKA, 1216, BANGLADESH
SN 2223-4721
EI 2076-0299
J9 BANGLADESH J MED SCI
JI Bangladesh J. Med. Sci.
PD JUL
PY 2018
VL 17
IS 3
BP 327
EP 328
DI 10.3329/bjms.v17i3.36984
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GL8MU
UT WOS:000437476300001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Asturias, EJ
AF Asturias, Edwin J.
TI Uncovering the Spectrum of Postnatal Zika Infection in Children
SO JAMA PEDIATRICS
LA English
DT Editorial Material
ID VIRUS-INFECTION; PREGNANCY; OUTBREAK; DISEASE; INFANTS
C1 [Asturias, Edwin J.] Univ Colorado, Sch Med, Dept Pediat, 13199 E Montview Blvd, Aurora, CO 80045 USA.
   [Asturias, Edwin J.] Childrens Hosp Colorado, Aurora, CO USA.
   [Asturias, Edwin J.] Colorado Sch Publ Hlth, Dept Epidemiol, Ctr Global Hlth, Aurora, CO USA.
RP Asturias, EJ (corresponding author), Univ Colorado, Sch Med, Dept Pediat, 13199 E Montview Blvd, Aurora, CO 80045 USA.
EM edwin.asturias@ucdenver.edu
RI Asturias, Edwin/D-9842-2016
OI Asturias, Edwin/0000-0002-1275-0787
FU National Institutes of Health (Division of Microbiology and Infectious
   Diseases)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [16-0057]
FX Dr Asturias reported receiving a grant from the National Institutes of
   Health (Division of Microbiology and Infectious Diseases; grant 16-0057)
   to study postnatal effects of Zika infection in children. No other
   disclosures were reported.
CR Centers for Disease Control and Prevention, 2018, ZIK CAS US
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
NR 12
TC 3
Z9 3
U1 0
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD JUL
PY 2018
VL 172
IS 7
BP 624
EP 625
DI 10.1001/jamapediatrics.2018.0921
PG 2
WC Pediatrics
SC Pediatrics
GA GL5PE
UT WOS:000437219600010
PM 29813163
DA 2020-07-08
ER

PT J
AU Delatorre, E
   Miranda, M
   Tschoeke, DA
   de Sequeira, PC
   Sampaio, SA
   Barbosa-Lima, G
   Vieira, YR
   Leomil, L
   Bozza, FA
   Cerbino-Neto, J
   Bozza, PT
   Nogueira, RMR
   Brasil, P
   Thompson, FL
   de Filippis, AMB
   Souza, TML
AF Delatorre, Edson
   Miranda, Milene
   Tschoeke, Diogo A.
   de Sequeira, Patricia Carvalho
   Sampaio, Simone Alves
   Barbosa-Lima, Giselle
   Vieira, Yasmine Rangel
   Leomil, Luciana
   Bozza, Fernando A.
   Cerbino-Neto, Jose
   Bozza, Patricia T.
   Ribeiro Nogueira, Rita Maria
   Brasil, Patricia
   Thompson, Fabiano L.
   de Filippis, Ana M. B.
   Souza, Thiago Moreno L.
TI An observational clinical case of Zika virus-associated neurological
   disease is associated with primary IgG response and enhanced TNF levels
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE Zika virus; zika; neurological disease; neurotropism; Brazil; Rio de
   Janeiro
ID ANTIBODY-DEPENDENT ENHANCEMENT; GUILLAIN-BARRE-SYNDROME; PATHOGENESIS;
   INFECTION
AB Descriptive clinical data help to reveal factors that may provoke Zika virus (ZIKV) neuropathology. The case of a 24-year-old female with a ZIKV-associated severe acute neurological disorder was studied. The levels of ZIKV in the cerebrospinal fluid (CSF) were 50 times higher than the levels in other compartments. An acute anti-flavivirus IgG, together with enhanced TNFalpha levels, may have contributed to ZIKV invasion in the CSF, whereas the unbiased genome sequencing [obtained by next-generation sequencing (NGS)] of the CSF revealed that no virus mutations were associated with the anatomic compartments (CSF, serum, saliva and urine).
C1 [Delatorre, Edson] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, Brazil.
   [Miranda, Milene] Fiocruz MS, IOC, Lab Virus Resp & Sarampo, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene; Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, RJ, Brazil.
   [Miranda, Milene; Tschoeke, Diogo A.; Leomil, Luciana; Thompson, Fabiano L.] Univ Fed Rio de Janeiro, SAGE COPPE, Rio de Janeiro, RJ, Brazil.
   [Tschoeke, Diogo A.] Univ Fed Rio de Janeiro, Nucleo Ecol & Desenvolvimento Socioambiental Maca, Macae, RJ, Brazil.
   [de Sequeira, Patricia Carvalho; Sampaio, Simone Alves; Ribeiro Nogueira, Rita Maria; de Filippis, Ana M. B.] Fiocruz MS, IOC, Lab Flavivirus, Rio De Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Bozza, Fernando A.; Cerbino-Neto, Jose; Brasil, Patricia; Souza, Thiago Moreno L.] Fiocruz MS, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Bozza, Fernando A.; Souza, Thiago Moreno L.] Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.
   [Barbosa-Lima, Giselle; Vieira, Yasmine Rangel; Souza, Thiago Moreno L.] Fiocruz MS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
RP Souza, TML (corresponding author), Fiocruz MS, Inst Nacl Infectol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fundacao Oswaldo Cruz Fiocruz, Inst Oswaldo Cruz, Lab Imunofarmacol, Rio De Janeiro, RJ, Brazil.; Souza, TML (corresponding author), Fiocruz MS, Natl Inst Sci & Technol Innovat Dis Neglected Pop, Ctr Technol Dev Hlth CDTS, Rio De Janeiro, RJ, Brazil.
EM tmoreno@cdts.fiocruz.br
RI Leomil, Luciana/O-4860-2019; Tschoeke, Diogo A/F-9913-2019; Bozza,
   Fernando A/A-2618-2013; Delatorre, Edson/J-8330-2015; Neto, Jose
   Cerbino/P-3713-2018
OI Tschoeke, Diogo A/0000-0001-8134-4259; Bozza, Fernando
   A/0000-0003-4878-0256; Delatorre, Edson/0000-0002-5746-0820; Neto, Jose
   Cerbino/0000-0001-9254-917X; Souza, Thiago/0000-0003-2212-3899; Bozza,
   Patricia/0000-0001-8349-9529
FU Brazilian Ministry of Health; Fundacao Carlos Chagas Filho de Amparo a
   Pesquisa no Estado do Rio de Janeiro (FAPERJ)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX Thanks are due to the Brazilian Ministry of Health, Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa no Estado do Rio de Janeiro (FAPERJ),
   and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq) for providing the funding to conduct this research.
CR Abbott NJ, 2005, CELL MOL NEUROBIOL, V25, P5, DOI 10.1007/s10571-004-1374-y
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
NR 21
TC 2
Z9 2
U1 0
U2 1
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUL
PY 2018
VL 99
IS 7
BP 913
EP 916
DI 10.1099/jgv.0.001080
PG 4
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GL5TT
UT WOS:000437234800008
PM 29771234
OA Bronze
DA 2020-07-08
ER

PT J
AU Le-Trilling, VTK
   Wohlgemuth, K
   Ruckborn, MU
   Jagnjic, A
   Maassen, F
   Timmer, L
   Katschinski, B
   Trilling, M
AF Le-Trilling, Vu Thuy Khanh
   Wohlgemuth, Kerstin
   Rueckborn, Meike U.
   Jagnjic, Andreja
   Maassen, Fabienne
   Timmer, Lejla
   Katschinski, Benjamin
   Trilling, Mirko
TI STAT2-Dependent Immune Responses Ensure Host Survival despite the
   Presence of a Potent Viral Antagonist
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE STAT transcription factors; cytomegalovirus; immune antagonists; in
   vivo; interferons
ID MURINE CYTOMEGALOVIRUS REPLICATION; LONG-TERM DEPLETION; MOUSE
   CYTOMEGALOVIRUS; SIGNAL-TRANSDUCER; INTERFERON RESPONSES;
   VIRUS-REPLICATION; STAT2 DEFICIENCY; CELL ACTIVATION; IFN-GAMMA;
   INFECTION
AB A pathogen encounter induces interferons, which signal via Janus kinases and STAT transcription factors to establish an antiviral state. However, the host and pathogens are situated in a continuous arms race which shapes host evolution toward optimized immune responses and the pathogens toward enhanced immune-evasive properties. Mouse cytomegalovirus (MCMV) counteracts interferon responses by pM27-mediated degradation of STAT2, which directly affects the signaling of type I as well as type III interferons. Using MCMV mutants lacking M27 and mice lacking STAT2, we studied the opposing relationship between antiviral activities and viral antagonism in a natural host-pathogen pair in vitro and in vivo. In contrast to wild-type (wt) MCMV, Delta M27 mutant MCMV was efficiently cleared from all organs within a few days in BALB/c, C57BL/6, and 129 mice, highlighting the general importance of STAT2 antagonism for MCMV replication. Despite this effective and relevant STAT2 antagonism, wt and STAT2-deficient mice exhibited fundamentally different susceptibilities to MCMV infections. MCMV replication was increased in all assessed organs (e.g., liver, spleen, lungs, and salivary glands) of STAT2-deficient mice, resulting in mortality during the first week after infection. Taken together, the results of our study reveal the importance of cytomegaloviral interferon antagonism for viral replication as well as a pivotal role of the remaining STAT2 activity for host survival. This mutual influence establishes a stable evolutionary standoff situation with fatal consequences when the equilibrium is disturbed.
   IMPORTANCE The host limits viral replication by the use of interferons (IFNs), which signal via STAT proteins. Several viruses evolved antagonists targeting STATs to antagonize IFNs (e.g., cytomegaloviruses, Zika virus, dengue virus, and several paramyxoviruses). We analyzed infections caused by MCMV expressing or lacking the STAT2 antagonist pM27 in STAT2-deficient and control mice to evaluate its importance for the host and the virus in vitro and in vivo. The inability to counteract STAT2 directly translates into exaggerated IFN susceptibility in vitro and pronounced attenuation in vivo. Thus, the antiviral activity mediated by IFNs via STAT2-dependent signaling drove the development of a potent MCMV-encoded STAT2 antagonist which became indispensable for efficient virus replication and spread to organs required for dissemination. Despite this clear impact of viral STAT2 antagonism, the host critically required the remaining STAT2 activity to prevent overt disease and mortality upon MCMV infection. Our findings highlight a remarkably delicate balance between host and virus.
C1 [Le-Trilling, Vu Thuy Khanh; Wohlgemuth, Kerstin; Rueckborn, Meike U.; Jagnjic, Andreja; Maassen, Fabienne; Timmer, Lejla; Katschinski, Benjamin; Trilling, Mirko] Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.
RP Le-Trilling, VTK; Trilling, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Virol, Essen, Germany.
EM Khanh.Le@uk-essen.de; Mirko.Trilling@uk-essen.de
OI Le-Trilling, Vu Thuy Khanh/0000-0002-2733-3732; Trilling,
   Mirko/0000-0003-3659-3541
FU Deutsche Forschungsgemeinschaft (DFG)German Research Foundation (DFG)
   [TRR60, GRK1949]; (IFORES Sonderprogramm fur Innovative Forschung) from
   the Medical Faculty of the University Hospital Essen
FX V.T.K.L.-T. and M.T. received funding from the Deutsche
   Forschungsgemeinschaft (DFG) through TRR60 project A7N and GRK1949
   project 13. M.T. also received intramural support (IFORES Sonderprogramm
   fur Innovative Forschung) from the Medical Faculty of the University
   Hospital Essen.
CR Abenes G, 2001, J VIROL, V75, P1697, DOI 10.1128/JVI.75.4.1697-1707.2001
   Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640
   ALLAN JE, 1984, ARCH VIROL, V81, P139, DOI 10.1007/BF01309303
   Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002
   Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Atalay R, 2002, J VIROL, V76, P8596, DOI 10.1128/JVI.76.17.8596-8608.2002
   Becker SD, 2007, LAB ANIM-UK, V41, P229, DOI 10.1258/002367707780378203
   Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016
   Brune W, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1907s43
   Chan B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006382
   Crawford LB, 2015, CURR OPIN VIROL, V13, P86, DOI 10.1016/j.coviro.2015.06.006
   Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29
   Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522
   Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714
   Egli A, 2014, J INFECT DIS, V210, P717, DOI 10.1093/infdis/jiu144
   Fodil N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004511
   GLASGOW LA, 1967, P SOC EXP BIOL MED, V125, P843, DOI 10.3181/00379727-125-32220
   Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011
   Gough DJ, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000361
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GRUNDY JE, 1981, INFECT IMMUN, V32, P277, DOI 10.1128/IAI.32.1.277-286.1981
   Hambleton S, 2013, P NATL ACAD SCI USA, V110, P3053, DOI 10.1073/pnas.1220098110
   Hemann EA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01707
   Hsu KM, 2009, J GEN VIROL, V90, P33, DOI 10.1099/vir.0.006668-0
   JONJIC S, 1994, J EXP MED, V179, P1713, DOI 10.1084/jem.179.5.1713
   JONJIC S, 1990, J VIROL, V64, P5457
   JONJIC S, 1989, J EXP MED, V169, P1199, DOI 10.1084/jem.169.4.1199
   Jordan S, 2011, J VIROL, V85, P10346, DOI 10.1128/JVI.00545-11
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Kropp KA, 2011, J VIROL, V85, P10286, DOI 10.1128/JVI.00373-11
   Le VTK, 2008, J GEN VIROL, V89, P2416, DOI 10.1099/vir.0.2008/001669-0
   Le VTK, 2008, J GEN VIROL, V89, P1131, DOI 10.1099/vir.0.83538-0
   Le-Trilling VTK, 2015, TISSUE ANTIGENS, V86, P1, DOI 10.1111/tan.12594
   Le-Trilling VTK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19977
   Lee SH, 2001, NAT GENET, V28, P42, DOI 10.1038/ng0501-42
   Matsumoto M, 1999, BIOL CHEM, V380, P699, DOI 10.1515/BC.1999.087
   Moens L, 2017, J ALLERGY CLIN IMMUN, V139, P1995, DOI 10.1016/j.jaci.2016.10.033
   Noda S, 2006, BLOOD, V107, P30, DOI 10.1182/blood-2005-05-1833
   Parisien JP, 2002, J VIROL, V76, P6435, DOI 10.1128/JVI.76.13.6435-6441.2002
   Parisien JP, 2001, VIROLOGY, V283, P230, DOI 10.1006/viro.2001.0856
   Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7
   Pott J, 2011, P NATL ACAD SCI USA, V108, P7944, DOI 10.1073/pnas.1100552108
   Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10
   Rattay S, 2015, J VIROL, V89, P8590, DOI 10.1128/JVI.01234-15
   Saederup N, 1999, P NATL ACAD SCI USA, V96, P10881, DOI 10.1073/pnas.96.19.10881
   SCALZO AA, 1990, J EXP MED, V171, P1469, DOI 10.1084/jem.171.5.1469
   Shahni R, 2015, BRAIN, V138, P2834, DOI 10.1093/brain/awv182
   Shingai M, 2007, J IMMUNOL, V179, P6123, DOI 10.4049/jimmunol.179.9.6123
   Sinzger C, 1996, J INFECT DIS, V173, P240, DOI 10.1093/infdis/173.1.240
   Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599
   Smith MS, 2010, CELL HOST MICROBE, V8, P284, DOI 10.1016/j.chom.2010.08.001
   Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884
   Tam A, 2003, J VIROL, V77, P7746, DOI 10.1128/JVI.77.14.7746-7755.2003
   Thomas S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005049
   Toth K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005084
   Trilling M, 2014, J IMMUNOL, V192, P447, DOI 10.4049/jimmunol.1203516
   Trilling M, 2013, NUCLEIC ACIDS RES, V41, P8107, DOI 10.1093/nar/gkt589
   Trilling M, 2012, FUTURE MICROBIOL, V7, P1269, DOI 10.2217/fmb.12.109
   Trilling M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002069
   Trilling M, 2009, J VIROL, V83, P3684, DOI 10.1128/JVI.02042-08
   Valchanova RS, 2006, J VIROL, V80, P10181, DOI 10.1128/JVI.00908-06
   Le-Trilling VTK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174695
   Waggoner SN, 2012, NATURE, V481, P394, DOI 10.1038/nature10624
   Wagner FM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003493
   Wagner M, 2002, J EXP MED, V196, P805, DOI 10.1084/jem.20020811
   Weekes MP, 2014, CELL, V157, P1460, DOI 10.1016/j.cell.2014.04.028
   Zimmermann A, 2005, J EXP MED, V201, P1543, DOI 10.1084/jem.20041401
NR 68
TC 7
Z9 7
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUL
PY 2018
VL 92
IS 14
AR e00296-18
DI 10.1128/JVI.00296-18
PG 17
WC Virology
SC Virology
GA GL7JN
UT WOS:000437375800013
PM 29743368
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Virtual Zika transmission and spread on Twitter
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Navi Mumbai, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Barata G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190482
   Chandrasekaran N, 2017, CUREUS, V9, DOI 10.7759/cureus.1792
   Joob B, 2016, AM J INFECT CONTROL, V44, P1756, DOI 10.1016/j.ajic.2016.08.019
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015
NR 5
TC 0
Z9 0
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD JUL
PY 2018
VL 46
IS 7
BP 850
EP 850
DI 10.1016/j.ajic.2018.01.030
PG 1
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GL2MR
UT WOS:000436956200030
PM 29661628
OA Bronze
DA 2020-07-08
ER

PT J
AU Rivera-Correa, J
   Rodriguez, A
AF Rivera-Correa, Juan
   Rodriguez, Ana
TI Divergent Roles of Antiself Antibodies during Infection
SO TRENDS IN IMMUNOLOGY
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; B-CELL ACTIVATION; C VIRUS-INFECTION; FACTOR
   T-BET; ZIKA VIRUS; ANTIPHOSPHOLIPID ANTIBODIES; RHEUMATOID-ARTHRITIS;
   NATURAL ANTIBODIES; CHIKUNGUNYA VIRUS; AUTOANTIBODIES
AB Antiself antibodies are most commonly associated with autoimmune disorders, but a large body of evidence indicates that they are also present in numerous infectious diseases. These autoimmune antibodies appear transiently during infection with a number of viruses, bacteria, and parasites and in some cases have been associated with the development of autoimmune disorders that develop after infection has been cleared. Traditionally these infection-associated autoantibodies are considered an erroneous byproduct of a legitimate immune response, but their possible role in the clearance of microbes and infected cells or inhibition of host-cell invasion suggests that they may be present because of their beneficial protective role against various infections.
C1 [Rivera-Correa, Juan; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
RP Rodriguez, A (corresponding author), NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA.
EM ana.rodriguez@nyumc.org
OI Rivera-Correa, Juan/0000-0003-4822-0005; Rodriguez,
   Ana/0000-0002-0060-3405
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI007180, T32 AI100853]
CR Abdel-Wahab N, 2018, LUPUS, V27, P572, DOI 10.1177/0961203317731532
   Agrawal S, 2007, CLIN RHEUMATOL, V26, P201, DOI 10.1007/s10067-006-0275-5
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Arroyo-Avila M, 2017, AM J TROP MED HYG, V96, P916, DOI 10.4269/ajtmh.16-0890
   BARNETT LA, 1992, INFECT IMMUN, V60, P3932, DOI 10.1128/IAI.60.9.3932-3936.1992
   Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901
   Berlin T, 2007, ANN NY ACAD SCI, V1108, P584, DOI 10.1196/annals.1422.061
   Callahan MK, 2003, J IMMUNOL, V170, P4840, DOI 10.4049/jimmunol.170.9.4840
   Clark SE, 2013, INFECT IMMUN, V81, P392, DOI 10.1128/IAI.01168-12
   CUNHANETO E, 1995, P NATL ACAD SCI USA, V92, P3541, DOI 10.1073/pnas.92.8.3541
   Daniel-Ribeiro CT, 2000, ACTA TROP, V76, P205, DOI 10.1016/S0001-706X(00)00099-1
   Dowall SD, 2015, J IMMUNOL RES, DOI 10.1155/2015/347903
   Draborg A, 2016, CURR OPIN RHEUMATOL, V28, P398, DOI 10.1097/BOR.0000000000000289
   Elkington P, 2016, TRENDS IMMUNOL, V37, P815, DOI 10.1016/j.it.2016.09.007
   Elkon KB, 2012, ADV EXP MED BIOL, V750, P14, DOI 10.1007/978-1-4614-3461-0_2
   Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x
   FAABER P, 1984, CLIN EXP IMMUNOL, V55, P502
   Fernandez-Arias C, 2016, CELL HOST MICROBE, V19, P194, DOI 10.1016/j.chom.2016.01.009
   Flodstrom-Tullberg M, 2003, MICROBES INFECT, V5, P911, DOI 10.1016/S1286-4579(03)00161-8
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   GARZELLI C, 1989, CLIN EXP IMMUNOL, V76, P412
   Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Gronwall C, 2014, J CLIN IMMUNOL, V34, pS12, DOI 10.1007/s10875-014-0025-4
   Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530
   Kivity S, 2009, TRENDS IMMUNOL, V30, P409, DOI 10.1016/j.it.2009.05.005
   Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Litwin Christine M, 2016, J Immunoassay Immunochem, V37, P439, DOI 10.1080/15321819.2016.1174136
   Lobo PI, 2017, CURR TOP MICROBIOL, V408, P89, DOI 10.1007/82_2017_37
   Manimunda SP, 2010, T ROY SOC TROP MED H, V104, P392, DOI 10.1016/j.trstmh.2010.01.011
   Mannoor K, 2013, IMMUNOBIOLOGY, V218, P10, DOI 10.1016/j.imbio.2012.01.018
   Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   MATSUDA J, 1995, AM J GASTROENTEROL, V90, P1138
   Mercer J, 2010, ANN NY ACAD SCI, V1209, P49, DOI 10.1111/j.1749-6632.2010.05772.x
   Miloudi M, 2017, ANN BIOL CLIN-PARIS, V75, P569, DOI 10.1684/abc.2017.1280
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Mourao LC, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1449-5
   Nico D, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed.2018.00025, 10.3389/fmed2018.00025]
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Radon K, 2003, EUR J MED RES, V8, P147
   Ringrose JH, 2001, J MED MICROBIOL, V50, P385, DOI 10.1099/0022-1317-50-4-385
   Rivera-Correa J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01476-6
   Rivera-Correa J. R. A., 2016, MALARIA IMMUNE RESPO, P81
   ROSENBERG YJ, 1978, NATURE, V274, P170, DOI 10.1038/274170a0
   Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250
   Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110
   Schwartz-Albiez R, 2009, CLIN EXP IMMUNOL, V158, P43, DOI [10.1111/j.1365-2249.2009.04026.x, 10.1111/j.1365-2249.2009.04026.X]
   Sene D, 2008, AUTOIMMUN REV, V7, P272, DOI 10.1016/j.autrev.2007.10.001
   Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472
   SHOENFELD Y, 1986, CLIN EXP IMMUNOL, V66, P255
   Soares MM, 2008, NAT MED, V14, P1357, DOI 10.1038/nm.1885
   Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165
   Stratton R, 2009, CURR OPIN INFECT DIS, V22, P49, DOI 10.1097/QCO.0b013e3283210006
   Tanay A, 2017, CURR OPIN RHEUMATOL, V29, P389, DOI 10.1097/BOR.0000000000000396
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tsunoda Ikuo, 2016, Acta Med Kinki Univ, V41, P37
   Venuti A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01358
   Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13
   Wan SW, 2013, J FORMOS MED ASSOC, V112, P3, DOI 10.1016/j.jfma.2012.11.006
   World Health Organization, 2018, Vaccine, V36, P3576, DOI 10.1016/j.vaccine.2016.10.047
   WOZENCRAFT AO, 1990, INFECT IMMUN, V58, P2156, DOI 10.1128/IAI.58.7.2156-2164.1990
   Yee LJ, 2004, J VIRAL HEPATITIS, V11, P459, DOI 10.1111/j.1365-2893.2004.00530.x
   Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053
   Zaccone P, 2008, TRENDS PARASITOL, V24, P35, DOI 10.1016/j.pt.2007.10.006
NR 66
TC 6
Z9 6
U1 1
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4906
EI 1471-4981
J9 TRENDS IMMUNOL
JI Trends Immunol.
PD JUL
PY 2018
VL 39
IS 7
BP 515
EP 522
DI 10.1016/j.it.2018.04.003
PG 8
WC Immunology
SC Immunology
GA GL0GB
UT WOS:000436643200001
PM 29724608
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Villarreal, SM
   Pitcher, S
   Helinski, MEH
   Johnson, L
   Wolfner, MF
   Harrington, LC
AF Villarreal, Susan M.
   Pitcher, Sylvie
   Helinski, Michelle E. H.
   Johnson, Lynn
   Wolfner, Mariana F.
   Harrington, Laura C.
TI Male contributions during mating increase female survival in the disease
   vector mosquito Aedes aegypti
SO JOURNAL OF INSECT PHYSIOLOGY
LA English
DT Article
DE Post-mating; Seminal fluid; Blood feeding; Fecundity; Survival; R-0;
   Life table analysis
ID ACCESSORY-GLAND SUBSTANCES; SEMINAL FLUID PROTEINS; ANOPHELES-GAMBIAE;
   DENGUE VECTOR; DROSOPHILA-MELANOGASTER; JUVENILE-HORMONE; SEXUAL
   CONFLICT; NUPTIAL GIFTS; BLOOD INTAKE; CULICIDAE
AB Aedes aegypti is a vector of medically important viruses including those causing Zika, dengue, and chikungunya. During mating, males transfer a number of proteins and other molecules to the female and these components of the male ejaculate are essential in shifting female post-mating behaviors in a number of insect species. Because these molecules are highly variable by species, and female post-mating behavior by species is also varied, behavioral assays testing the function of the ejaculate are necessary before we can develop control strategies targeting the mating system to reduce mosquito populations. Because increased survival in mosquitoes strongly increases vectorial capacity and can influence population sizes and potential risk we tested the effect of mating on female survival. The ejaculate can either promote or reduce female survival, as both have been shown in multiple insect species, yet this effect has not been directly assessed in mosquitoes. We compared survival of females in four treatment groups: mated females, virgin females, and virgin females injected with either an extract from the male reproductive glands or a saline control. Survival, blood feeding frequency, fecundity and cumulative net reproductive rate (R-0) were determined after multiple feedings from a human host. Our results confirm that male reproductive gland substances increase female fecundity and blood feeding frequency, resulting in dramatic increases in fitness (R-0). We also demonstrate, for the first time, an effect of male reproductive gland extracts alone on female survival, regardless of whether or not the female ingested a vertebrate blood meal. Thus, the effects of MAG extract on survival are not secondary effects from altered blood feeding. Collectively, we demonstrate a direct role for Ae. aegypti male-derived molecules on increasing female fitness, reproductive success and, ultimately, transmission potential for vector borne pathogens.
C1 [Villarreal, Susan M.; Pitcher, Sylvie; Helinski, Michelle E. H.; Harrington, Laura C.] Cornell Univ, Dept Entomol, 3131 Comstock Hall, Ithaca, NY 14853 USA.
   [Johnson, Lynn] Cornell Univ, Cornell Stat Consulting Unit, B-11 Savage Hall, Ithaca, NY 14853 USA.
   [Wolfner, Mariana F.] Cornell Univ, Dept Mol Biol & Genet, 423 Biotechnol Bldg, Ithaca, NY 14853 USA.
   [Villarreal, Susan M.] Grinnell Coll, Dept Biol, 1116 8th Ave, Grinnell, IA 50112 USA.
   [Helinski, Michelle E. H.] European & Dev Countries Clin Trials Partnership, Anna van Saksenlaan 51, NL-2593 HW The Hague, Netherlands.
RP Harrington, LC (corresponding author), Cornell Univ, Dept Entomol, 3131 Comstock Hall, Ithaca, NY 14853 USA.
EM lch27@cornell.edu
OI Villarreal, Susan/0000-0002-5280-329X
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI095491]; USDA National Institute of
   Food and AgricultureUnited States Department of Agriculture (USDA)
   [2011-12-19, 139487]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32-HD052471]
FX This material is based upon work that is supported by NIH/NIAID Grant
   R01AI095491 to LCH and MFW, and by the USDA National Institute of Food
   and Agriculture, grants 2011-12-19 to LCH, and 139487 to LCH and MFW,
   respectively. For part of these studies, SMV was supported by NIH
   Training Grant T32-HD052471. Any opinions, findings, conclusions, or
   recommendations expressed in this publication are those of the authors
   and do not necessarily reflect the views of the NIH/NIAID, the National
   Institute of Food and Agriculture (NIFA) or the United States Department
   of Agriculture (USDA). We thank Julian Montijo and Sam Henson for their
   assistance with aspects of this study.
CR ADLAKHA V, 1976, J INSECT PHYSIOL, V22, P1441, DOI 10.1016/0022-1910(76)90206-7
   Alto BW, 2013, AM J TROP MED HYG, V88, P497, DOI 10.4269/ajtmh.12-0421
   Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446
   Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823
   Baldini F, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001695
   Baldini F, 2012, PATHOG GLOB HEALTH, V106, P82, DOI 10.1179/2047773212Y.0000000016
   BEGON M, 1996, ECOLOGY INDIVIDUALS
   Boes KE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002946
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   CHAPMAN T, 1995, NATURE, V373, P241, DOI 10.1038/373241a0
   Clements A.N., 1992, BIOL MOSQUITOES, V1
   Clements AN, 1999, BIOL MOSQUITOES, VII
   Clifton ME, 2014, J INSECT PHYSIOL, V64, P40, DOI 10.1016/j.jinsphys.2014.03.006
   Clifton ME, 2012, J INSECT PHYSIOL, V58, P1007, DOI 10.1016/j.jinsphys.2012.05.005
   COLLESS D H, 1960, Ann Trop Med Parasitol, V54, P475
   Costero A, 1998, J AM MOSQUITO CONTR, V14, P234
   COX DR, 1972, J R STAT SOC B, V34, P187
   Dottorini T, 2007, P NATL ACAD SCI USA, V104, P16215, DOI 10.1073/pnas.0703904104
   DOWNE AER, 1975, J INSECT PHYSIOL, V21, P1835, DOI 10.1016/0022-1910(75)90250-4
   DYE C, 1986, Parasitology Today, V2, P203
   EDMAN JD, 1992, J MED ENTOMOL, V29, P1033
   Ferguson HM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000303
   Fernandez-Salas I., 2016, CURR OPIN INFECT DIS, V1, DOI [10.1097/QC0.0000000000000304, DOI 10.1097/QC0.0000000000000304]
   FUCHS MS, 1968, LIFE SCI PT 1 PHYSI, V7, P835, DOI 10.1016/0024-3205(68)90114-8
   FUCHS MS, 1970, J INSECT PHYSIOL, V16, P931, DOI 10.1016/0022-1910(70)90223-4
   Gabrieli P, 2014, P NATL ACAD SCI USA, V111, P16353, DOI 10.1073/pnas.1410488111
   GARRETTJONES C, 1969, B WORLD HEALTH ORGAN, V40, P531
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gwynne DT, 2008, ANNU REV ENTOMOL, V53, P83, DOI 10.1146/annurev.ento.53.103106.093423
   Harrington LC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003048
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   HAYES RO, 1953, J ECON ENTOMOL, V46, P624, DOI 10.1093/jee/46.4.624
   Helinski MEH, 2013, ECOL CONT VECTOR-BOR, V3, P221
   Helinski MEH, 2012, J INSECT PHYSIOL, V58, P1307, DOI 10.1016/j.jinsphys.2012.07.003
   Helinski MEH, 2011, J MED ENTOMOL, V48, P202, DOI 10.1603/ME10071
   HISS EA, 1972, J INSECT PHYSIOL, V18, P2217, DOI 10.1016/0022-1910(72)90250-8
   HOUSEMAN JG, 1986, CAN ENTOMOL, V118, P241, DOI 10.4039/Ent118241-3
   JUDSON CL, 1968, J MED ENTOMOL, V5, P21, DOI 10.1093/jmedent/5.1.21
   Kalbfleisch J. D., 2002, WILEY SERIES PROBABI
   KELLY TJ, 1981, INT J INVER REP DEV, V3, P101
   KLOWDEN MJ, 1979, J INSECT PHYSIOL, V25, P349, DOI 10.1016/0022-1910(79)90023-4
   KLOWDEN MJ, 1991, J INSECT PHYSIOL, V37, P721, DOI 10.1016/0022-1910(91)90105-9
   KLOWDEN MJ, 1993, J AM MOSQUITO CONTR, V9, P169
   KLOWDEN MJ, 1992, J MED ENTOMOL, V29, P467, DOI 10.1093/jmedent/29.3.467
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   LAVOIPIERRE MMJ, 1958, NATURE, V182, P1567, DOI 10.1038/1821567a0
   LEA AO, 1978, PHYSIOL ENTOMOL, V3, P309, DOI 10.1111/j.1365-3032.1978.tb00164.x
   LEAHY M. G., 1965, MOSQUITO NEWS, V25, P448
   Levy-Blitchtein S, 2016, ASIAN PAC J TROP MED, V9, P997, DOI 10.1016/j.apjtm.2016.07.030
   Lewis S, 2012, ADV STUD BEHAV, V44, P53, DOI 10.1016/B978-0-12-394288-3.00002-2
   Lewis SM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0336
   Liles J. N., 1960, ANN ENTOMOL SOC AM, V53, P227
   LILES JAMES N., 1965, MOSQUITO NEWS, V25, P434
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Montero A, 2015, MED CLIN-BARCELONA, V145, P118, DOI [10.1016/j.medcle.2014.05.013, 10.1016/j.medcli.2014.05.031]
   NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716
   Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005
   RAMALINGAM S, 1976, CAN ENTOMOL, V108, P955, DOI 10.4039/Ent108955-9
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   SCOTT TW, 1993, J MED ENTOMOL, V30, P94, DOI 10.1093/jmedent/30.1.94
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Sirot LK, 2008, INSECT BIOCHEM MOLEC, V38, P176, DOI 10.1016/j.ibmb.2007.10.007
   Sirot LK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000989
   Southwood T. R. E., 1978, ECOLOGICAL METHODS P, P1, DOI 10.1007/978-94-009-1225-0_1
   Spencer CY, 2005, J AM MOSQUITO CONTR, V21, P177, DOI 10.2987/8756-971X(2005)21[177:FVITDV]2.0.CO;2
   Vahed K, 2007, ETHOLOGY, V113, P105, DOI 10.1111/j.1439-0310.2006.01312.x
   Wagner WE, 2001, EVOLUTION, V55, P994, DOI 10.1554/0014-3820(2001)055[0994:FRALSB]2.0.CO;2
   Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051
   YEH CC, 1990, J INSECT PHYSIOL, V36, P799, DOI 10.1016/0022-1910(90)90165-C
NR 71
TC 14
Z9 14
U1 1
U2 19
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0022-1910
EI 1879-1611
J9 J INSECT PHYSIOL
JI J. Insect Physiol.
PD JUL
PY 2018
VL 108
BP 1
EP 9
DI 10.1016/j.jinsphys.2018.05.001
PG 9
WC Entomology; Physiology; Zoology
SC Entomology; Physiology; Zoology
GA GK5LX
UT WOS:000436217700001
PM 29729859
OA Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Theillet, G
   Rubens, A
   Foucault, F
   Dalbon, P
   Rozand, C
   Leparc-Goffart, I
   Bedin, F
AF Theillet, G.
   Rubens, A.
   Foucault, F.
   Dalbon, P.
   Rozand, C.
   Leparc-Goffart, I.
   Bedin, F.
TI Laser-cut paper-based device for the detection of dengue non-structural
   NS1 protein and specific IgM in human samples
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID DOMAIN III PROTEIN; ZIKA VIRUS; POINT; ANTIGEN; CIRCULATION; DISEASE;
   BLOOD; COINFECTION; CHIKUNGUNYA; DIAGNOSTICS
AB The incidence of flavivirus infections has increased dramatically in recent decades in tropical and sub-tropical areas worldwide, affecting hundreds of millions of people each year. Dengue viruses are typically transmitted by mosquitoes and can cause a wide range of symptoms from flu-like fever to organ impairment and death. Although conventional diagnostic tests can provide early diagnosis of acute dengue infections, access to these tests is often limited in developing countries. Consequently, there is an urgent need to develop affordable, simple, rapid, and robust diagnostic tools that can be used at 'Point of Care' settings. Early diagnosis is crucial to improve patient management and reduce the risk of complications. In the present study, a novel laser-cut device made of glass-fiber paper was designed and tested for the detection of the dengue Non Structural 1 (NS1) viral protein and specific IgM in blood and plasma. The device, called PAD, was able to detect around 25 ng/mL of NS1 protein in various sample types in 8 minutes, following a few simple steps. The PAD was also able to detect specific IgM in human plasmas in less than 10 minutes. The PAD appears to have all the potential to assist health workers in early diagnosis of dengue fever or other tropical fevers caused by flaviviruses.
C1 [Theillet, G.; Rubens, A.; Foucault, F.; Dalbon, P.; Rozand, C.; Bedin, F.] BioMerieux, Innovat New Immuno Concepts, Chemin Orme, F-69280 Marcy Letoile, France.
   [Theillet, G.; Leparc-Goffart, I.] ERRIT, HIA Laveran, 34 Blvd Laveran, F-13013 Marseille, France.
RP Bedin, F (corresponding author), BioMerieux, Innovat New Immuno Concepts, Chemin Orme, F-69280 Marcy Letoile, France.
EM gerald.theillet@biomerieux.com; agnes.rubens@biomerieux.com;
   frederic.foucault@biomerieux.com; pascal.dalbon@biomerieux.com;
   christine.rozand@biomerieux.com; isabelle.leparcgoffart@gmail.com;
   frederic.bedin@biomerieux.com
OI Theillet, Gerald/0000-0002-8747-9071
FU BioMerieux SA; Agence Nationale de la Recherche et de la Technologie (G.
   Theillet's grant CIFRE) [2015/0514]
FX This study was funded by BioMerieux SA and Agence Nationale de la
   Recherche et de la Technologie (G. Theillet's grant CIFRE no 2015/0514).
CR Ahmed S, 2016, BIOSENS BIOELECTRON, V77, P249, DOI 10.1016/j.bios.2015.09.038
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Apilux A, 2013, LAB CHIP, V13, P126, DOI 10.1039/c2lc40690j
   Batra G, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-64
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p
   Cate DM, 2015, ANAL CHEM, V87, P19, DOI 10.1021/ac503968p
   Cedillo-Barron L, 2014, MICROBES INFECT, V16, P711, DOI 10.1016/j.micinf.2014.07.011
   Chen J, 2016, MOL MED REP, V14, P1799, DOI 10.3892/mmr.2016.5454
   Cheung SF, 2015, JALA-J LAB AUTOM, V20, P316, DOI 10.1177/2211068215577197
   Chin CD, 2013, POINT OF CARE DIAGNO, P3
   Choi JR, 2016, LAB CHIP, V16, P611, DOI 10.1039/c5lc01388g
   Combe M, 2017, PROTEIN EXPRES PURIF, V133, P57, DOI 10.1016/j.pep.2017.03.004
   Cucunawangsih, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1022-9
   de la Cruz-Hernandez SI, 2013, AM J TROP MED HYG, V88, P446, DOI 10.4269/ajtmh.12-0023
   Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280
   Fang XE, 2014, LAB CHIP, V14, P911, DOI 10.1039/c3lc51246k
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Fu E, 2012, ANAL CHEM, V84, P4574, DOI 10.1021/ac300689s
   Fu E, 2011, ANAL CHEM, V83, P7941, DOI 10.1021/ac201950g
   Gan WP, 2014, LAB CHIP, V14, P3719, DOI 10.1039/c4lc00686k
   Granger D, SERODIAGNOSIS DENGUE
   Mahato K, 2017, BIOSENS BIOELECTRON, V96, P246, DOI 10.1016/j.bios.2017.05.001
   Mahmud MA, 2016, ANALYST, V141, P6449, DOI 10.1039/c6an02208a
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   Martinez AW, 2008, P NATL ACAD SCI USA, V105, P19606, DOI 10.1073/pnas.0810903105
   Mathengtheng L, 2014, VECTOR-BORNE ZOONOT, V14, P261, DOI 10.1089/vbz.2013.1407
   Niu GY, 2015, VIRUS RES, V201, P73, DOI 10.1016/j.virusres.2015.02.008
   Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   PRYOR MJ, 1993, VIROLOGY, V194, P769, DOI 10.1006/viro.1993.1318
   PS-M, 2013, J MICROMECH MICROENG, V23
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Saswat T, 2015, INFECT GENET EVOL, V35, P134, DOI 10.1016/j.meegid.2015.08.006
   Shah P, 2013, EXPERT REV MOL DIAGN, V13, P83, DOI [10.1586/ERM.12.130, 10.1586/erm.12.130]
   Shukla J, 2009, DIAGN MICR INFEC DIS, V65, P142, DOI 10.1016/j.diagmicrobio.2009.06.017
   Songjaroen T, 2012, LAB CHIP, V12, P3392, DOI 10.1039/c2lc21299d
   Soni A, 2015, BIOSENS BIOELECTRON, V67, P763, DOI 10.1016/j.bios.2014.09.042
   Soo KM, 2017, PEERJ, V5, DOI 10.7717/peerj.3589
   Steidel M, 2012, J MED VIROL, V84, P490, DOI 10.1002/jmv.23204
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Vazquez S, 2010, DIAGN MICR INFEC DIS, V68, P46, DOI 10.1016/j.diagmicrobio.2010.04.006
   Vella SJ, 2012, ANAL CHEM, V84, P2883, DOI 10.1021/ac203434x
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Zhang B, 2015, NANOMED-NANOTECHNOL, V11, P1745, DOI 10.1016/j.nano.2015.05.009
NR 50
TC 5
Z9 6
U1 3
U2 16
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUL
PY 2018
VL 163
IS 7
BP 1757
EP 1767
DI 10.1007/s00705-018-3776-z
PG 11
WC Virology
SC Virology
GA GJ5DK
UT WOS:000435401300005
PM 29525973
DA 2020-07-08
ER

PT J
AU Saavedra, LM
   Romanelli, GP
   Duchowicz, PR
AF Saavedra, Laura M.
   Romanelli, Gustavo P.
   Duchowicz, Pablo R.
TI Quantitative structure-activity relationship (QSAR) analysis of
   plant-derived compounds with larvicidal activity against Zika Aedes
   aegypti (Diptera: Culicidae) vector using freely available descriptors
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE Aedes aegypti; larvicidal activity; quantitative structure-activity
   relationship (QSAR) theory; PaDEL open-source softwares; EPI Suite
   program
ID STRUCTURE-TOXICITY RELATIONSHIPS; STRUCTURE-PROPERTY RELATIONSHIP;
   MULTIPLE LINEAR-REGRESSION; MOLECULAR DESCRIPTORS; RETENTION INDEX;
   QSPR; DERIVATIVES; INHIBITORS; ALGORITHM; LARVAE
AB BACKGROUNDWe have developed a quantitative structure-activity relationship (QSAR) model for predicting the larvicidal activity of 60 plant-derived molecules against Aedes aegypti L. (Diptera: Culicidae), a vector of several diseases such as dengue, yellow fever, chikungunya and Zika. The balanced subsets method (BSM) based on k-means cluster analysis (k-MCA) was employed to split the data set. The replacement method (RM) variable subset selection technique coupled with multivariable linear regression (MLR) proved to be successful for exploring 18326 molecular descriptors and fingerprints calculated with PaDEL, Mold(2) and EPI Suite open-source softwares.
   RESULTSA robust QSAR model (=0.84, S-train=0.20 and =0.92, S-test=0.23) involving five non-conformational descriptors was established. The model was validated and tested through the use of an external test set of compounds, the leave-one-out (LOO) and leave-more-out (LMO) cross-validation methods, Y-randomization and applicability domain (AD) analysis.
   CONCLUSIONThe QSAR model surpasses previously published models based on geometrical descriptors, thereby representing a suitable tool for predicting larvicidal activity against the vector A. aegypti using a conformation-independent approach. (c) 2018 Society of Chemical Industry
C1 [Saavedra, Laura M.; Duchowicz, Pablo R.] Univ Nacl La Plata, CONICET, Inst Invest Fis Quim Teor & Aplicadas INIFTA, Diag 113 & 64,CC 16,Sucursal 4, RA-1900 La Plata, Buenos Aires, Argentina.
   [Romanelli, Gustavo P.] Univ Nacl La Plata, CONICET, Ctr Invest & Desarrollo Ciencias Aplicadas Dr JJ, Fac Ciencias Exactas,Dept Quim, La Plata, Buenos Aires, Argentina.
   [Romanelli, Gustavo P.] Univ Nacl La Plata, Fac Ciencias Agr & Forestales, Catedra Quim Organ, Ctr Invest Sanidad Vegetal CISaV, La Plata, Buenos Aires, Argentina.
RP Saavedra, LM; Duchowicz, PR (corresponding author), Univ Nacl La Plata, CONICET, Inst Invest Fis Quim Teor & Aplicadas INIFTA, Diag 113 & 64,CC 16,Sucursal 4, RA-1900 La Plata, Buenos Aires, Argentina.
EM laurasaa0913@gmail.com; pabloducho@gmail.com
FU National Scientific and Technical Research Council (CONICET)Consejo
   Nacional de Investigaciones Cientificas y Tecnicas (CONICET)
   [PIP11220130100311]
FX PRD acknowledges financial support from the National Scientific and
   Technical Research Council (CONICET) PIP11220130100311 project, and
   thanks Ministerio de Ciencia, Tecnologia e Innovacion Productiva for
   providing electronic library facilities. PRD and GPR are members of the
   scientific researcher career of CONICET.
CR Alencar EB, 2016, MED CHEM RES, V25, P2171, DOI 10.1007/s00044-016-1650-7
   [Anonymous], 2015, ACD CHEMSKETCH
   [Anonymous], 2015, MATL 7 0
   Aranda JF, 2017, SAR QSAR ENVIRON RES, V28, P749, DOI [10.1080/1062936X.2017.1377765, 10.1080/1062936x.2017.1377765]
   Aranda JF, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081247
   Bandyopadhyay P, 2014, BIOORG MED CHEM LETT, V24, P2934, DOI 10.1016/j.bmcl.2014.04.082
   Barbosa JDF, 2012, PEST MANAG SCI, V68, P1478, DOI 10.1002/ps.3331
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   Draper NR, 1998, APPL REGRESSION ANAL, P230
   Duchowicz PR, 2017, CHEMISTRYSELECT, V2, P3725, DOI 10.1002/slct.201700436
   Duchowicz PR, 2014, EUR J MED CHEM, V77, P176, DOI 10.1016/j.ejmech.2014.02.057
   Duchowicz PR, 2006, MATCH-COMMUN MATH CO, V55, P179
   Duchowicz PR, 2005, CHEM PHYS LETT, V412, P376, DOI 10.1016/j.cplett.2005.07.016
   Eriksson L, 2003, ENVIRON HEALTH PERSP, V111, P1361, DOI 10.1289/ehp.5758
   Golbraikh A, 2003, J COMPUT AID MOL DES, V17, P241, DOI 10.1023/A:1025386326946
   Gramatica P, 2007, QSAR COMB SCI, V26, P694, DOI 10.1002/qsar.200610151
   Hansch C, 1979, SUBSTITUENT CONSTANT, P187
   Hansch C, 1995, HYDROPHOBIC ELECT ST, P280
   Hansch C, 1995, FUNDAMENTALS APPL CH, P139
   Hansch C, 2009, EUR J MED CHEM, V44, P260, DOI 10.1016/j.ejmech.2008.02.040
   Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i
   Hong HX, 2008, J CHEM INF MODEL, V48, P1337, DOI 10.1021/ci800038f
   Ibezim E, 2012, CHEMOMETR INTELL LAB, V110, P81, DOI 10.1016/j.chemolab.2011.10.002
   Kaiser KLE, 1989, AQUATIC TOXICOLOGY E, P424
   KATRITZKY AR, 1993, J CHEM INF COMP SCI, V33, P835, DOI 10.1021/ci00016a005
   Khosrokhavar R, 2010, INT J MOL SCI, V11, P3052, DOI 10.3390/ijms11093052
   Kier LB, 1976, MOL CONNECTIVITY CHE, P123
   Kim MG, 2013, J AGR FOOD CHEM, V61, P10741, DOI 10.1021/jf403679h
   Mullen LMA, 2011, CHEMOMETR INTELL LAB, V107, P269, DOI 10.1016/j.chemolab.2011.04.011
   Paluch G, 2009, J AGR FOOD CHEM, V57, P7618, DOI 10.1021/jf900964e
   Rafiei H, 2016, EXCLI J, V15, P38, DOI 10.17179/excli2015-731
   Rojas C., 2016, INT J QUANT STRUCT P, V1, P78, DOI DOI 10.4018/IJQSPR.2016010104
   Rojas C, 2015, J CHROMATOGR A, V1422, P277, DOI 10.1016/j.chroma.2015.10.028
   Rojas C, 2015, CHEMOMETR INTELL LAB, V140, P126, DOI 10.1016/j.chemolab.2014.09.020
   Roy K., 2015, UNDERSTANDING BASICS
   Rucker C, 2007, J CHEM INF MODEL, V47, P2345, DOI 10.1021/ci700157b
   Saavedra LM, 2018, SCI TOTAL ENVIRON, V610, P937, DOI 10.1016/j.scitotenv.2017.08.119
   Santos SRL, 2011, CHEMOSPHERE, V84, P150, DOI 10.1016/j.chemosphere.2011.02.018
   Santos SRL, 2010, VECTOR-BORNE ZOONOT, V10, P1049, DOI 10.1089/vbz.2009.0158
   Scotti L, 2014, MED CHEM, V10, P201, DOI 10.2174/15734064113099990005
   STANTON DT, 1993, QUANT STRUCT-ACT REL, V12, P239, DOI 10.1002/qsar.19930120304
   Todeschini R, 2009, MOL DESCRIPTORS CHEM, P158
   US EPA, 2016, EST PROGR INT SUIT M
   *WHO, 2009, UN ACC SCAL PRIOR HI, P1
   WOLD S, 1995, CHEMOMETRICS METHODS
   World Health Organization, 1992, WHO TECHN REP SER
   World Health Organization (WHO), 2016, NUMB REP CAS CHIK FE
   World Health Organization (WHO), 2012, HDB INT VECT MAN, P29
   World Health Organization (WHO), 2016, ZIK STRAT RESP FRAM
   Xiao Y, 2012, WIRES DATA MIN KNOWL, V2, P209, DOI 10.1002/widm.1049
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
NR 51
TC 8
Z9 8
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUL
PY 2018
VL 74
IS 7
BP 1608
EP 1615
DI 10.1002/ps.4850
PG 8
WC Agronomy; Entomology
SC Agriculture; Entomology
GA GJ2IT
UT WOS:000435094600010
PM 29314584
OA Bronze
DA 2020-07-08
ER

PT J
AU Tonsing, C
   Timmer, J
   Kreutz, C
AF Toensing, Christian
   Timmer, Jens
   Kreutz, Clemens
TI Profile likelihood-based analyses of infectious disease models
SO STATISTICAL METHODS IN MEDICAL RESEARCH
LA English
DT Article
DE Modeling; dynamical systems; ordinary differential equations; parameter
   estimation; uncertainty analysis; profile likelihood; identifiability
   analysis; model reduction; vector-borne disease models; Zika virus
   disease
ID ZIKA VIRUS; STRUCTURAL IDENTIFIABILITY; SENSITIVITY-ANALYSIS;
   PARAMETER-ESTIMATION; TRANSMISSION; PREVENTION; INFLUENZA; EPIDEMIC;
   SPREAD
AB Ordinary differential equation models are frequently applied to describe the temporal evolution of epidemics. However, ordinary differential equation models are also utilized in other scientific fields. We summarize and transfer state-of-the art approaches from other fields like Systems Biology to infectious disease models. For this purpose, we use a simple SIR model with data from an influenza outbreak at an English boarding school in 1978 and a more complex model of a vector-borne disease with data from the Zika virus outbreak in Colombia in 2015-2016. Besides parameter estimation using a deterministic multistart optimization approach, a multitude of analyses based on the profile likelihood are presented comprising identifiability analysis and model reduction. The analyses were performed using the freely available modeling framework Data2Dynamics (data2dynamics.org) which has been awarded as best performing within the DREAM6 parameter estimation challenge and in the DREAM7 network reconstruction challenge.
C1 [Toensing, Christian; Timmer, Jens; Kreutz, Clemens] Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.
   [Timmer, Jens; Kreutz, Clemens] Univ Freiburg, Ctr Biosyst Anal ZBSA, Freiburg, Germany.
   [Timmer, Jens] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany.
RP Tonsing, C (corresponding author), Univ Freiburg, Inst Phys, Hermann Herder Str 3, D-79104 Freiburg, Germany.
EM christian.toensing@fdm.uni-freiburg.de
OI Tonsing, Christian/0000-0003-2822-5191; Kreutz,
   Clemens/0000-0002-8796-5766
FU German Federal Ministry of Education and Research (BMBF)Federal Ministry
   of Education & Research (BMBF) [031L0080, 0316042A, 031L0042]
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: The
   authors acknowledge funding of the projects EA:sys (031L0080), LungSysII
   (0316042A) and LiSyM (031L0042) by the German Federal Ministry of
   Education and Research (BMBF).
CR [Anonymous], 1978, BMJ-BRIT MED J, V1, P587
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bachmann J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.50
   Barnes B, 2002, MATH MODELING CASE S
   Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913
   Beer R, 2014, MOL BIOSYST, V10, P1709, DOI 10.1039/c3mb70594c
   Birrell PJ, 2011, P NATL ACAD SCI USA, V108, P18238, DOI 10.1073/pnas.1103002108
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090126
   Chis O, 2011, BIOINFORMATICS, V27, P2610, DOI 10.1093/bioinformatics/btr431
   Chis OT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027755
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Chretien JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094130
   COBELLI C, 1980, AM J PHYSIOL, V239, pR7
   Cox DR, 2000, THEORETICAL STATISTI
   D2D development team, 2016, DATA2DYNAMICS SOFTWA
   Daley D., 1999, EPIDEMIC MODELLING I
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8
   ECDC (European Centre for Disease Control and Prevention, FACTSH HLTH PROF
   Farah M, 2014, J AM STAT ASSOC, V109, P1398, DOI 10.1080/01621459.2014.934453
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fiore Anthony E., 2008, Morbidity and Mortality Weekly Report, V57, P1
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Held L, 2012, BIOMETRICAL J, V54, P824, DOI 10.1002/bimj.201200037
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020
   Inc. M, 2016, MATLAB R2016B
   Instituto Nacional de Salud Colombia, 2016, B EPIDEMIOLOGICO SEM, P106
   Keeling M. J., 2011, MODELING INFECT DIS
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   King AA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0347
   Kreutz C, 2016, IFAC PAPERSONLINE, V49, P63, DOI 10.1016/j.ifacol.2016.12.104
   Kreutz C, 2013, FEBS J, V280, P2564, DOI 10.1111/febs.12276
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   LEIS JR, 1988, ACM T MATH SOFTWARE, V14, P45, DOI 10.1145/42288.46156
   LJUNG L, 1994, AUTOMATICA, V30, P265, DOI 10.1016/0005-1098(94)90029-9
   MACDONALD G, 1950, Trop Dis Bull, V47, P907
   Maiwald T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162366
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Margaria G, 2001, MATH BIOSCI, V174, P1, DOI 10.1016/S0025-5564(01)00079-7
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Martcheva M, 2015, INTRO MATH EPIDEMIOL
   MEEKER WQ, 1995, AM STAT, V49, P48, DOI 10.2307/2684811
   Merkt B, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.012920
   MEYER P, 2014, BMC SYST BIOL, V8
   Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063
   Ming RX, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0199-5
   Murphy SA, 2000, J AM STAT ASSOC, V95, P449, DOI 10.2307/2669386
   Murray JD, 2004, MATH BIOL INTRO INTE, V17
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009
   Nsoesie E, 2013, PLOS CURR, V5, P1, DOI [10.1371/currents.outbreaks.bb1e879a23137022ea79a8c508b030bc, DOI 10.1371/CURRENTS.OUTBREAKS.BB1E879A23137022EA79A8C508B030BC]]
   Raia V, 2011, CANCER RES, V71, P693, DOI 10.1158/0008-5472.CAN-10-2987
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Raue A, 2015, BIOINFORMATICS, V31, P3558, DOI 10.1093/bioinformatics/btv405
   Raue A, 2010, CHAOS, V20, DOI 10.1063/1.3528102
   Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358
   Raue A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074335
   Rodriguez-Fernandez M, 2007, J FOOD ENG, V83, P374, DOI 10.1016/j.jfoodeng.2007.03.023
   Rohatgi A., WEBPLOTDIGITIZER
   Ross R, 1915, BRIT MED J, V1915, P546, DOI 10.1136/bmj.1.2830.546
   Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837
   Steiert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040052
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   VENZON DJ, 1988, J R STAT SOC C-APPL, V37, P87, DOI 10.2307/2347496
   Weidemann F, 2014, STAT MED, V33, P1580, DOI 10.1002/sim.6041
   White LJ, 2001, MATH BIOSCI, V174, P77, DOI 10.1016/S0025-5564(01)00080-3
   Wu JT, 2014, PLOS PATH, V10
   Xing ZM, 2014, J APPL STAT, V41, P1358, DOI 10.1080/02664763.2013.870138
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zimmer C, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005257
NR 78
TC 1
Z9 1
U1 1
U2 13
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 0962-2802
EI 1477-0334
J9 STAT METHODS MED RES
JI Stat. Methods Med. Res.
PD JUL
PY 2018
VL 27
IS 7
BP 1979
EP 1998
DI 10.1177/0962280217746444
PG 20
WC Health Care Sciences & Services; Mathematical & Computational Biology;
   Medical Informatics; Statistics & Probability
SC Health Care Sciences & Services; Mathematical & Computational Biology;
   Medical Informatics; Mathematics
GA GH7IL
UT WOS:000433616600005
PM 29512437
DA 2020-07-08
ER

PT J
AU Yates, JF
   Troester, MM
   Ingram, DG
AF Yates, Jacqueline F.
   Troester, Matthew M.
   Ingram, David G.
TI Sleep in Children with Congenital Malformations of the Central Nervous
   System
SO CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS
LA English
DT Review
DE Sleep disorders; Corpus callosum; Septo-optic dysplasia; Chiari
   malformation; Joubert syndrome; Zika; Achondroplasia; Aicardi; Fetal
   alcohol spectrum disorder
ID ALCOHOL SPECTRUM DISORDERS; FORAMEN MAGNUM STENOSIS; CORPUS-CALLOSUM;
   JOUBERT-SYNDROME; NEURODEVELOPMENTAL DISORDERS; LIGHT PERCEPTION;
   AICARDI-SYNDROME; ZIKA VIRUS; AGENESIS; ACHONDROPLASIA
AB Congenital malformations of the central nervous system may be seen in isolation or in association with syndromes that have multiorgan involvement. Among the potential health challenges these children may face, sleep concerns are frequent and may include chronic insomnia, sleep-related breathing disorders, and circadian rhythm disorders.
   In this review, we describe recent research into sleep disorders affecting children with congenital malformations of the CNS including visual impairment, septo-optic dysplasia, agenesis of the corpus callosum, Aicardi syndrome, Chiari malformation, spina bifida, achondroplasia, Joubert syndrome, fetal alcohol spectrum disorders, and congenital Zika syndrome. In many cases, the sleep disturbance can be directly related to observed anatomical differences in the brain (such as in apnea due to Chiari malformation), but in most syndromes, a complete understanding of the underlying pathophysiology connecting the malformation with sleep problem is still being elucidated.
   Our review provides a synthesis of available evidence for clinicians who treat this patient population, in whom appropriate diagnosis and management of sleep problems may improve the quality of life for both patient and caregiver.
C1 [Yates, Jacqueline F.] Truman Med Ctr, Kansas City, MO USA.
   [Troester, Matthew M.] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ USA.
   [Ingram, David G.] Childrens Mercy Hosp, Dept Pediat, 2401 Gillham Rd, Kansas City, MO 64108 USA.
RP Ingram, DG (corresponding author), Childrens Mercy Hosp, Dept Pediat, 2401 Gillham Rd, Kansas City, MO 64108 USA.
EM dgingram@cmh.edu
CR Aicardi J, 2005, BRAIN DEV-JPN, V27, P164, DOI 10.1016/j.braindev.2003.11.011
   Anderson LB, 2017, ARCH CLIN NEUROPSYCH, V32, P267, DOI 10.1093/arclin/acx001
   Aubin S, 2017, BEHAV BRAIN RES, V317, P515, DOI 10.1016/j.bbr.2016.09.060
   Aubin S, 2016, SLEEP MED, V23, P100, DOI 10.1016/j.sleep.2016.07.021
   Aubin S, 2018, J SLEEP RES, V27, P120, DOI 10.1111/jsr.12548
   Aviezer D, 2003, CURR DRUG TARGETS, V4, P353, DOI 10.2174/1389450033490993
   Badaruddin DH, 2007, CHILD PSYCHIAT HUM D, V38, P287, DOI 10.1007/s10578-007-0065-6
   Borniger JC, 2014, PHYSIOL BEHAV, V133, P99, DOI 10.1016/j.physbeh.2014.05.012
   Castriotta R, 2017, SLEEP MED, V40, pE47, DOI 10.1016/j.sleep.2017.11.132
   Cesmebasi A, 2015, CLIN ANAT, V28, P184, DOI 10.1002/ca.22442
   Charng J, 2017, INVEST OPHTH VIS SCI, V58, P3215, DOI 10.1167/iovs.17-21909
   Chen ML, 2012, J CLIN SLEEP MED, V8, P421, DOI 10.5664/jcsm.2038
   Corkum P, 2014, SLEEP MED CLIN, V9, P149, DOI 10.1016/j.jsmc.2014.02.006
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Davitt B V, 1997, J AAPOS, V1, P151, DOI 10.1016/S1091-8531(97)90057-4
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Doherty D, 2006, CHILD CARE HLTH DEV, V32, P333, DOI 10.1111/j.1365-2214.2006.00602.x
   Emens J, 2010, J BIOL RHYTHM, V25, P381, DOI 10.1177/0748730410379080
   Esbensen AJ, 2016, INT REV RES DEV DISA, V51, P153, DOI 10.1016/bs.irrdd.2016.07.005
   Fard M A, 2010, Pediatr Endocrinol Rev, V8, P18
   Ferre A, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx069
   Flynn-Evans EE, 2014, J BIOL RHYTHM, V29, P215, DOI 10.1177/0748730414536852
   Gleeson J, 2018, RECOMMENDATIONS EVAL
   Goril Shery, 2016, Sleep Med, V23, P59, DOI 10.1016/j.sleep.2016.06.002
   Ingram DG, 2017, PEDIATR NEUROL, V67, P85, DOI 10.1016/j.pediatrneurol.2016.10.002
   Ipsiroglu OS, 2013, SOC SCI MED, V79, P76, DOI 10.1016/j.socscimed.2012.10.027
   Jan JE, 2010, INT J PEDIAT, DOI 10.1155/2010/639048
   Jernigan SC, 2012, J NEUROSURG-PEDIATR, V9, P149, DOI 10.3171/2011.11.PEDS11269
   Joseph D, 2015, ARCH DIS CHILD-FETAL, V100, pF50, DOI 10.1136/archdischild-2014-306104
   Kamdar BB, 2011, PEDIATR NEUROL, V45, P395, DOI 10.1016/j.pediatrneurol.2011.09.005
   Khanzada NS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030527
   Kirk VG, 2000, PEDIATR PULM, V30, P445, DOI 10.1002/1099-0496(200012)30:6<445::AID-PPUL2>3.0.CO;2-C
   Kurugundla N, 2010, J PULMONARY MED, V11
   Lewis P, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00044
   Losurdo A, 2013, J CLIN SLEEP MED, V9, P371, DOI 10.5664/jcsm.2592
   Lunn RM, 2017, SCI TOTAL ENVIRON, V607, P1073, DOI 10.1016/j.scitotenv.2017.07.056
   May Philip A, 2018, JAMA, V319, P474, DOI 10.1001/jama.2017.21896
   Messing-Junger M, 2013, CHILD NERV SYST, V29, P1553, DOI 10.1007/s00381-013-2134-4
   Mizuguchi Koichi, 2016, No To Hattatsu, V48, P25
   Mogayzel PJ, 1998, J PEDIATR-US, V132, P667, DOI 10.1016/S0022-3476(98)70358-0
   Moore RY, 2007, SLEEP MED, V8, pS27, DOI 10.1016/j.sleep.2007.10.003
   Morris CJ, 2012, MOL CELL ENDOCRINOL, V349, P91, DOI 10.1016/j.mce.2011.09.003
   Murray CB, 2018, J PEDIATR PSYCHOL, V43, P601, DOI 10.1093/jpepsy/jsx150
   NIELSEN T, 1992, J SLEEP RES, V1, P197, DOI 10.1111/j.1365-2869.1992.tb00038.x
   NIELSEN T, 1993, EUR NEUROL, V33, P173, DOI 10.1159/000116928
   NIELSEN T, 1993, J SLEEP RES, V2, P82, DOI 10.1111/j.1365-2869.1993.tb00066.x
   Norman AL, 2009, DEV DISABIL RES REV, V15, P209, DOI 10.1002/ddrr.72
   Olateju OI, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00110
   Owens J, 2008, PRIMARY CARE, V35, P533, DOI 10.1016/j.pop.2008.06.003
   Parisi M., 1993, GENEREVIEWS
   Parisi MA, 2007, EUR J HUM GENET, V15, P511, DOI 10.1038/sj.ejhg.5201648
   PASTERKAMP H, 1989, CHEST, V95, P1064, DOI 10.1378/chest.95.5.1064
   Patel DM, 2015, J NEUROSURG-PEDIATR, V16, P30, DOI 10.3171/2014.11.PEDS14314
   Paul LK, 2007, NAT REV NEUROSCI, V8, P287, DOI 10.1038/nrn2107
   Pelidou SH, 2009, SLEEP MED, V10, P256, DOI 10.1016/j.sleep.2007.10.018
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000
   Rivkees SA, 2001, J PEDIATR-US, V139, P463, DOI 10.1067/mpd.2001.117074
   Rivkees SA, 2007, SLEEP MED CLIN, V2, P331, DOI 10.1016/j.jsmc.2007.05.010
   Romaniello R, 2017, J CHILD NEUROL, V32, P60, DOI 10.1177/0883073816664668
   Rosser TL, 2002, PEDIATR NEUROL, V27, P343, DOI 10.1016/S0887-8994(02)00450-2
   Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032
   Sato Kieko, 2007, J Oral Sci, V49, P173, DOI 10.2334/josnusd.49.173
   Shellhaas RA, 2018, J PEDIATR-US, V194, P244, DOI 10.1016/j.jpeds.2017.10.070
   Siffredi V, 2018, J INT NEUROPSYCH SOC, V24, P445, DOI 10.1017/S1355617717001357
   Sisk EA, 1999, OTOLARYNG HEAD NECK, V120, P248, DOI 10.1016/S0194-5998(99)70414-6
   Skene DJ, 2007, SLEEP MED, V8, P651, DOI 10.1016/j.sleep.2006.11.013
   Speer Marcy C, 2003, J Genet Couns, V12, P297, DOI 10.1023/A:1023948921381
   Steinhausen HC, 1998, ALCOHOL CLIN EXP RES, V22, P334, DOI 10.1111/j.1530-0277.1998.tb03657.x
   Tenconi R, 2017, AM J MED GENET A, V173, P868, DOI 10.1002/ajmg.a.38130
   Tsai SY, 2012, J ADV NURS, V68, P1738, DOI 10.1111/j.1365-2648.2011.05857.x
   Uchiyama M, 2015, SLEEP MED CLIN, V10, P495, DOI 10.1016/j.jsmc.2015.07.006
   Van Gelder RN, 2016, ANNU REV VIS SCI, V2, P153, DOI 10.1146/annurev-vision-111815-114558
   Vartanian GV, 2015, J BIOL RHYTHM, V30, P351, DOI 10.1177/0748730415585413
   Vervloed MPJ, 2003, J VISUAL IMPAIR BLIN, V97, P28, DOI 10.1177/0145482X0309700104
   Webb EA, 2010, J CLIN ENDOCR METAB, V95, pE198, DOI 10.1210/jc.2010-0027
   Wengel T, 2011, J DEV BEHAV PEDIATR, V32, P384, DOI 10.1097/DBP.0b013e3182199694
   White KK, 2016, AM J MED GENET A, V170, P42, DOI 10.1002/ajmg.a.37394
   White KK, 2016, AM J MED GENET A, V170, P32, DOI 10.1002/ajmg.a.37385
   Wolfe L, 2010, J CLIN SLEEP MED, V6, P384
   Yildirim SV, 2006, EUR ARCH OTO-RHINO-L, V263, P775, DOI 10.1007/s00405-006-0042-x
   Zaffanello M, 2017, WORLD J PEDIATR, V13, P8, DOI 10.1007/s12519-016-0051-9
NR 82
TC 2
Z9 2
U1 0
U2 11
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1528-4042
EI 1534-6293
J9 CURR NEUROL NEUROSCI
JI Curr. Neurol. Neurosci. Rep.
PD JUL
PY 2018
VL 18
IS 7
AR 38
DI 10.1007/s11910-018-0850-6
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GH0JG
UT WOS:000433087700003
PM 29789951
DA 2020-07-08
ER

PT J
AU Gizzi, AS
   Grove, TL
   Arnold, JJ
   Jose, J
   Jangra, RK
   Garforth, SJ
   Du, Q
   Cahill, SM
   Dulyaninova, NG
   Love, JD
   Chandran, K
   Bresnick, AR
   Cameron, CE
   Almo, SC
AF Gizzi, Anthony S.
   Grove, Tyler L.
   Arnold, Jamie J.
   Jose, Joyce
   Jangra, Rohit K.
   Garforth, Scott J.
   Du, Quan
   Cahill, Sean M.
   Dulyaninova, Natalya G.
   Love, James D.
   Chandran, Kartik
   Bresnick, Anne R.
   Cameron, Craig E.
   Almo, Steven C.
TI A naturally occurring antiviral ribonucleotide encoded by the human
   genome
SO NATURE
LA English
DT Article
ID WEST NILE VIRUS; ZIKA VIRUS; VIPERIN; REPLICATION; PROTEIN;
   IDENTIFICATION; BIOSYNTHESIS; INTERMEDIATE; NUCLEOTIDE
AB Viral infections continue to represent major challenges to public health, and an enhanced mechanistic understanding of the processes that contribute to viral life cycles is necessary for the development of new therapeutic strategies(1). Viperin, a member of the radical S-adenosyl-l-methionine (SAM) superfamily of enzymes, is an interferon-inducible protein implicated in the inhibition of replication of a broad range of RNA and DNA viruses, including dengue virus, West Nile virus, hepatitis C virus, influenza A virus, rabies virus(2) and HIV3,4. Viperin has been suggested to elicit these broad antiviral activities through interactions with a large number of functionally unrelated host and viral proteins(3,4). Here we demonstrate that viperin catalyses the conversion of cytidine triphosphate (CTP) to 3'-deoxy-3', 4'-didehydro-CTP (ddhCTP), a previously undescribed biologically relevant molecule, via a SAM-dependent radical mechanism. We show that mammalian cells expressing viperin and macrophages stimulated with IFN alpha produce substantial quantities of ddhCTP. We also establish that ddhCTP acts as a chain terminator for the RNA-dependent RNA polymerases from multiple members of the Flavivirus genus, and show that ddhCTP directly inhibits replication of Zika virus in vivo. These findings suggest a partially unifying mechanism for the broad antiviral effects of viperin that is based on the intrinsic enzymatic properties of the protein and involves the generation of a naturally occurring replication-chain terminator encoded by mammalian genomes.
C1 [Gizzi, Anthony S.; Grove, Tyler L.; Garforth, Scott J.; Du, Quan; Cahill, Sean M.; Dulyaninova, Natalya G.; Bresnick, Anne R.; Almo, Steven C.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.
   [Arnold, Jamie J.; Jose, Joyce; Cameron, Craig E.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.
   [Jangra, Rohit K.; Chandran, Kartik] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.
   [Love, James D.; Almo, Steven C.] Inst Prot Innovat, Boston, MA 02115 USA.
RP Grove, TL; Almo, SC (corresponding author), Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA.; Almo, SC (corresponding author), Inst Prot Innovat, Boston, MA 02115 USA.
EM tyler.grove@einstein.yu.edu; steve.almo@einstein.yu.edu
OI Jangra, Rohit K/0000-0002-3119-0869
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R21-A1133329,
   P01-GM118303-01, U54-GM093342, U54-GM094662, R01-A1045818]; Pennsylvania
   State University Start-Up Funds; Price Family Foundation
FX We thank S. J. Booker for helpful discussions, L. Nordstroem (Chemical
   Synthesis & Biology Core Facility) for synthesis of ddhC and R. Sharma
   and J. Perryman for assistance with construction of RdRp expression
   plasmids and purification of RdRp enzymes. This work was supported by
   National Institutes of Health (NIH) Grants R21-A1133329 (T.L.G. and
   S.C.A.), P01-GM118303-01 (J. A. Gerlt and S.C.A.), U54-GM093342 (J. A.
   Gerlt and S.C.A.), U54-GM094662 (S.C.A.), R01-A1045818 (C.E.C.),
   Pennsylvania State University Start-Up Funds (J.J.), and the Price
   Family Foundation (S.C.A.). We acknowledge the Albert Einstein Anaerobic
   Structural and Functional Genomics Resource
   (http://www.nysgxrc.org/psi3/anaerobic.html).
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ebrahimi KH, 2017, FEBS LETT, V591, P2394, DOI 10.1002/1873-3468.12769
   Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114
   GIESE B, 1995, CHEM BIOL, V2, P367, DOI 10.1016/1074-5521(95)90217-1
   Grove TL, 2013, NAT CHEM BIOL, V9, P422, DOI [10.1038/NCHEMBIO.1251, 10.1038/nchembio.1251]
   Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019
   Hover BM, 2013, J AM CHEM SOC, V135, P7019, DOI 10.1021/ja401781t
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kambara H, 2014, NUCLEIC ACIDS RES, V42, P10668, DOI 10.1093/nar/gku713
   Kennedy AD, 2010, J CLIN MICROBIOL, V48, P4504, DOI 10.1128/JCM.01050-10
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lee H.M., 2017, THESIS
   Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Proud D, 2008, AM J RESP CRIT CARE, V178, P962, DOI 10.1164/rccm.200805-670OC
   Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497
   Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Tang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep30529
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Van Slyke GA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005009
   Wang B, 2015, PLACENTA, V36, P667, DOI 10.1016/j.placenta.2015.03.002
   Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0
   Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200
   Yokoyama K, 2007, J AM CHEM SOC, V129, P15147, DOI 10.1021/ja072481t
NR 25
TC 44
Z9 45
U1 17
U2 89
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 28
PY 2018
VL 558
IS 7711
BP 610
EP +
DI 10.1038/s41586-018-0238-4
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK9SN
UT WOS:000436594300065
PM 29925952
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Neris, RLS
   Figueiredo, CM
   Higa, LM
   Araujo, DF
   Carvalho, CAM
   Vercoza, BRF
   Silva, MOL
   Carneiro, FA
   Tanuri, A
   Gomes, AMO
   Bozza, MT
   Da Poian, AT
   Cruz-Oliveira, C
   Assuncao-Miranda, I
AF Neris, Romulo L. S.
   Figueiredo, Camila M.
   Higa, Luiza M.
   Araujo, Daniel F.
   Carvalho, Carlos A. M.
   Vercoza, Brunno R. F.
   Silva, Mariana O. L.
   Carneiro, Fabiana A.
   Tanuri, Amilcar
   Gomes, Andre M. O.
   Bozza, Marcelo T.
   Da Poian, Andrea T.
   Cruz-Oliveira, Christine
   Assuncao-Miranda, Iranaia
TI Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika,
   Chikungunya and other arboviruses by targeting the viral envelope
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TIN-PROTOPORPHYRIN; ANTIVIRAL ACTIVITY; HEME OXYGENASE-1; VIRUSES;
   FUSION; DENGUE; MONOXIDE; AMERICA; COINFECTION; COLOMBIA
AB The global situation of diseases transmitted by arthropod-borne viruses such as Dengue (DENV), Yellow Fever (YFV), Chikungunya (CHIKV) and Zika (ZIKV) viruses is alarming and treatment of human infection by these arboviruses faces several challenges. The discovery of broad-spectrum antiviral molecules, able to inactivate different groups of viruses, is an interesting approach. The viral envelope is a common structure among arboviruses, being a potential target for antivirals. Porphyrins are amphipathic molecules able to interact with membranes and absorb light, being widely used in photodynamic therapy. Previously, we showed that heme, Co-protoporphyrin IX (CoPPIX) and Sn-protoporphyrin IX (SnPPIX) directly inactivate DENV and YFV infectious particles. Here we demonstrate that the antiviral activity of these porphyrins can be broadened to CHIKV, ZIKV, Mayaro virus, Sindbis virus and Vesicular Stomatitis virus. Porphyrin treatment causes viral envelope protein loss, affecting viral morphology, adsorption and entry into target cells. Also, light-stimulation enhanced the SnPPIX activity against all tested arboviruses. In summary, CoPPIX and SnPPIX were shown to be efficient broad-spectrum compounds to inactivate medically and veterinary important viruses.
C1 [Neris, Romulo L. S.; Figueiredo, Camila M.; Araujo, Daniel F.; Silva, Mariana O. L.; Bozza, Marcelo T.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.
   [Carvalho, Carlos A. M.; Gomes, Andre M. O.; Da Poian, Andrea T.; Cruz-Oliveira, Christine] Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
   [Higa, Luiza M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro UFRJ, Inst Biol, Rio De Janeiro, Brazil.
   [Vercoza, Brunno R. F.; Carneiro, Fabiana A.] Univ Fed Rio de Janeiro UFRJ, Polo Avancado Xerem, NUMPEX Nucleo Multidisciplinar Pesquisas, Duque De Caxias, RJ, Brazil.
   [Carvalho, Carlos A. M.] Inst Evandro Chagas IEC, Secao Arbovirol & Febres Hemorrag, Ananindeua, PA, Brazil.
   [Carvalho, Carlos A. M.] Univ Estado Para UEPA, Ctr Ciencias Biol & Saude, Dept Morfol & Ciencias Fisiol, Belem, Para, Brazil.
RP Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Microbiol Paulo de Goes, Rio De Janeiro, Brazil.; Cruz-Oliveira, C (corresponding author), Univ Fed Rio de Janeiro UFRJ, Ctr Ciencias Saude, Inst Bioquim Med Leopoldo de Meis, Rio De Janeiro, Brazil.
EM ccruz@bioqmed.ufrj.br; iranaiamiranda@micro.ufrj.br
RI Higa, Luiza/W-2698-2019; Da Poian, Andrea T./V-1699-2019; Vercoza,
   Brunno Renato Farias/AAB-4725-2019; Gomes, Andre/C-4009-2014; CARNEIRO,
   FABIANA A/S-4525-2018
OI Vercoza, Brunno Renato Farias/0000-0001-6117-7879; Gomes,
   Andre/0000-0003-1052-8004; Cruz-Oliveira, Christine/0000-0003-4838-0703;
   Carvalho, Carlos/0000-0001-6615-1387; Carneiro,
   Fabiana/0000-0002-6584-4875
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX This work was supported by grants from Brazilian funding agencies:
   Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior and Financiadora de Estudos
   e Projetos.
CR Akamatsu Y, 2004, FASEB J, V18, P771, DOI 10.1096/fj.03-0921fje
   ANDERSON KE, 1986, CLIN PHARMACOL THER, V39, P510, DOI 10.1038/clpt.1986.88
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Bonnett R, 1989, CIBA F SYMP, V146, P40
   Bonnett R, 1989, AM J HYG, V146, P40
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Cruz-Oliveira C, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00053-17
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DRUMMOND GS, 1986, J CLIN INVEST, V77, P971, DOI 10.1172/JCI112398
   Espinoza JA, 2017, AM J PATHOL, V187, P487, DOI 10.1016/j.ajpath.2016.11.011
   de Figueiredo MLG, 2014, REV SOC BRAS MED TRO, V47, P677, DOI 10.1590/0037-8682-0246-2014
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Man D, 2011, J BIOL INORG CHEM, V16, P173, DOI 10.1007/s00775-010-0715-1
   Mardekian SK, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/834371
   Matanic VCA, 2004, INT J ANTIMICROB AG, V23, P382, DOI 10.1016/j.ijantimicag.2003.07.022
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Notario-Perez F, 2017, DRUG DES DEV THER, V11, P1767, DOI 10.2147/DDDT.S133170
   Olivia Lwande Wesula, 2015, Infection Ecology & Epidemiology, V5, P29853, DOI 10.3402/iee.v5.29853
   Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586
   Pushpan S. K., 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P187, DOI 10.2174/1568011023354137
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005
   Sample CJ, 2013, PEPTIDES, V48, P96, DOI 10.1016/j.peptides.2013.07.014
   Silva P, 2010, PHOTOCHEM PHOTOBIOL, V86, P1147, DOI 10.1111/j.1751-1097.2010.00764.x
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Sousa IP, 2011, J BIOL CHEM, V286, P1730, DOI 10.1074/jbc.M110.198002
   St Vincent MR, 2010, P NATL ACAD SCI USA, V107, P17339, DOI 10.1073/pnas.1010026107
   Stojiljkovic I, 2001, EXPERT OPIN INV DRUG, V10, P309, DOI 10.1517/13543784.10.2.309
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Vigant F, 2014, J VIROL, V88, P1849, DOI 10.1128/JVI.02907-13
   Vigant F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003297
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WHO, 2017, DENG CONTR EP
   Wolf MC, 2010, P NATL ACAD SCI USA, V107, P3157, DOI 10.1073/pnas.0909587107
   World Health Organization, 2017, EM ZIK SIT REP
   Zhao HJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22008
   Zhu JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00517
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 44
TC 5
Z9 5
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 28
PY 2018
VL 8
AR 9805
DI 10.1038/s41598-018-27855-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK9FC
UT WOS:000436546200026
PM 29955082
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Draz, MS
   Moazeni, M
   Venkataramani, M
   Lakshminarayanan, H
   Saygili, E
   Lakshminaraasimulu, NK
   Kochehbyoki, KM
   Kanakasabapathy, MK
   Shabahang, S
   Vasan, A
   Bijarchi, MA
   Memic, A
   Shafiee, H
AF Draz, Mohamed Shehata
   Moazeni, Maryam
   Venkataramani, Manasa
   Lakshminarayanan, Harini
   Saygili, Ecem
   Lakshminaraasimulu, Nivethitha Kota
   Kochehbyoki, Kamyar Mehrabi
   Kanakasabapathy, Manoj Kumar
   Shabahang, Shirin
   Vasan, Anish
   Bijarchi, Mohamad Ali
   Memic, Adnan
   Shafiee, Hadi
TI Hybrid Paper-Plastic Microchip for Flexible and High-Performance
   Point-of-Care Diagnostics
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
DE electrical sensing; flexible electronics; paper microfluidics; plastic
   microfluidics; point-of-care diagnostics
ID LIGHT MANAGEMENT; ZIKA VIRUS; GRAPHENE; HEALTH
AB A low-cost and easy-to-fabricate microchip remains a key challenge for the development of true point-of-care (POC) diagnostics. Cellulose paper and plastic are thin, light, flexible, and abundant raw materials, which make them excellent substrates for mass production of POC devices. Herein, a hybrid paper-plastic microchip (PPMC) is developed, which can be used for both single and multiplexed detection of different targets, providing flexibility in the design and fabrication of the microchip. The developed PPMC with printed electronics is evaluated for sensitive and reliable detection of a broad range of targets, such as liver and colon cancer protein biomarkers, intact Zika virus, and human papillomavirus nucleic acid amplicons. The presented approach allows a highly specific detection of the tested targets with detection limits as low as 10(2) ng mL(-1) for protein biomarkers, 10(3) particle per milliliter for virus particles, and 10(2) copies per microliter for a target nucleic acid. This approach can potentially be considered for the development of inexpensive and stable POC microchip diagnostics and is suitable for the detection of a wide range of microbial infections and cancer biomarkers.
C1 [Draz, Mohamed Shehata; Moazeni, Maryam; Venkataramani, Manasa; Lakshminarayanan, Harini; Saygili, Ecem; Lakshminaraasimulu, Nivethitha Kota; Kochehbyoki, Kamyar Mehrabi; Kanakasabapathy, Manoj Kumar; Shabahang, Shirin; Vasan, Anish; Bijarchi, Mohamad Ali; Shafiee, Hadi] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Engn Med, Boston, MA 02115 USA.
   [Draz, Mohamed Shehata; Shafiee, Hadi] Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
   [Draz, Mohamed Shehata] Tanta Univ, Fac Sci, Tanta 31527, Egypt.
   [Memic, Adnan] King Abdulaziz Univ, Ctr Nanotechnol, Jeddah 21589, Saudi Arabia.
RP Shafiee, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Engn Med, Boston, MA 02115 USA.; Shafiee, H (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
EM hshafiee@bwh.harvard.edu
RI Memic, Adnan/I-6138-2013; Memic, Adnan/AAP-7997-2020; Bijarchi, Mohamad
   Ali/AAC-2730-2020; Memic, Adnan/AAQ-1154-2020; Kanakasabapathy,
   Manoj/L-3760-2017
OI Memic, Adnan/0000-0003-4639-8168; Memic, Adnan/0000-0003-4639-8168;
   Bijarchi, Mohamad Ali/0000-0003-0601-2988; Kanakasabapathy,
   Manoj/0000-0002-0756-8585
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI118502,
   R21HD092828, P30ES000002]; King Abdulaziz University, Saudi Arabia
   [17/1436]; Harvard T.H. Chan School of Public Health, Harvard Center for
   Environmental Health through Harvard NIEHS; American Board of Obstetrics
   and Gynecology; American College of Obstetricians and Gynecologists;
   American Society for Reproductive Medicine; Society for Reproductive
   Endocrinology and Infertility through ASRM; Harvard University Center
   for AIDS Research (CFAR) [5P30AI060354-14]
FX The authors would like to thank Donald Coen and Seamus McCarron Xu Yu,
   Behzad Etemad, Stephane Hua, Francoise Giguel, Mohammadali Safavieh, and
   Shantanu Kallakuri. Research reported in this publication was partially
   supported by the National Institute of Health under award numbers
   R01AI118502, R21HD092828, and P30ES000002; King Abdulaziz University,
   Saudi Arabia through Scientific WAQF Fund under grant number 17/1436;
   Harvard T.H. Chan School of Public Health, Harvard Center for
   Environmental Health through Harvard NIEHS Grant; American Board of
   Obstetrics and Gynecology, American College of Obstetricians and
   Gynecologists, American Society for Reproductive Medicine, Society for
   Reproductive Endocrinology and Infertility through ASRM Award; and
   Harvard University Center for AIDS Research (CFAR) under award number
   5P30AI060354-14.
CR Ahmed MU, 2016, CRIT REV BIOTECHNOL, V36, P495, DOI 10.3109/07388551.2014.992387
   [Anonymous], 2015, SCI REPORTS, V5, pe9919
   Becker H, 2002, TALANTA, V56, P267, DOI 10.1016/S0039-9140(01)00594-X
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Belder D, 2003, ELECTROPHORESIS, V24, P3595, DOI 10.1002/elps.200305648
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003
   Chin CD, 2013, POINT OF CARE DIAGNO, P3
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   Cui Z, 2015, J MATER RES, V30, P79, DOI 10.1557/jmr.2014.347
   Daar AS, 2002, NAT GENET, V32, P229, DOI 10.1038/ng1002-229
   Das A, 2014, IMMUNOL LETT, V162, P132, DOI 10.1016/j.imlet.2014.08.004
   Draz MS, 2018, THERANOSTICS, V8, P1985, DOI 10.7150/thno.23856
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   da Silva ETSG, 2014, ANAL CHEM, V86, P10531, DOI 10.1021/ac503029q
   Gervais L, 2011, ADV MATER, V23, pH151, DOI 10.1002/adma.201100464
   Gillison ML, 2008, CANCER-AM CANCER SOC, V113, P3036, DOI 10.1002/cncr.23764
   Guo JX, 2017, SENSOR ACTUAT B-CHEM, V250, P250, DOI 10.1016/j.snb.2017.04.123
   Jung YH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8170
   Kim J, 2015, ADV MATER, V27, P3292, DOI 10.1002/adma.201500710
   Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587
   Lan WJ, 2013, LAB CHIP, V13, P4103, DOI 10.1039/c3lc50771h
   Lebiga E, 2015, ANALYST, V140, P5006, DOI 10.1039/c5an00720h
   Li X, 2013, MOL CLIN ONCOL, V1, P153, DOI 10.3892/mco.2012.23
   Li X, 2010, CELLULOSE, V17, P649, DOI 10.1007/s10570-010-9401-2
   Liana DD, 2012, SENSORS-BASEL, V12, P11505, DOI 10.3390/s120911505
   Low N, 2006, LANCET, V368, P2001, DOI 10.1016/S0140-6736(06)69482-8
   McDonald JC, 2002, ACCOUNTS CHEM RES, V35, P491, DOI 10.1021/ar010110q
   Miller JR, 2010, SCIENCE, V329, P1637, DOI 10.1126/science.1194372
   Pasricha R, 2009, SMALL, V5, P2253, DOI 10.1002/smll.200900726
   Pumera M, 2011, MATER TODAY, V14, P308, DOI 10.1016/S1369-7021(11)70160-2
   Saetiew C, 2011, J VIROL METHODS, V178, P22, DOI 10.1016/j.jviromet.2011.08.007
   Safavieh M, 2017, NANOSCALE, V9, P1852, DOI 10.1039/c6nr06417e
   Shafiee H, 2015, SCI REP-UK, V5, DOI 10.1038/srep08719
   Sher M, 2017, EXPERT REV MOL DIAGN, V17, P351, DOI 10.1080/14737159.2017.1285228
   Silverstein R. M., 1974, SPECTROMETRIC IDENTI
   Syedmoradi L, 2017, BIOSENS BIOELECTRON, V87, P373, DOI 10.1016/j.bios.2016.08.084
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Tobjork D, 2011, ADV MATER, V23, P1935, DOI 10.1002/adma.201004692
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Xia YY, 2016, BIOSENS BIOELECTRON, V77, P774, DOI 10.1016/j.bios.2015.10.032
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep22090
   Yao YG, 2016, ENERG ENVIRON SCI, V9, P2278, DOI 10.1039/c6ee01011c
   Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h
   Zhu HL, 2016, ACS NANO, V10, P1369, DOI 10.1021/acsnano.5b06781
NR 46
TC 13
Z9 13
U1 11
U2 59
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD JUN 27
PY 2018
VL 28
IS 26
AR 1707161
DI 10.1002/adfm.201707161
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA GK4DG
UT WOS:000436104800005
PM 30416415
OA Green Accepted
DA 2020-07-08
ER

PT J
AU ten Bosch, QA
   Castro-Llanos, F
   Manda, H
   Morrison, AC
   Grieco, JP
   Achee, NL
   Perkins, TA
AF ten Bosch, Quirine A.
   Castro-Llanos, Fanny
   Manda, Hortance
   Morrison, Amy C.
   Grieco, John P.
   Achee, Nicole L.
   Perkins, T. Alex
TI Model-based analysis of experimental data from interconnected,
   row-configured huts elucidates multifaceted effects of a volatile
   chemical on Aedes aegypti mosquitoes
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Bayesian parameter estimation; Continuous-time
   Markov-chain models; Dengue; Spatial repellent; Transfluthrin; Vector
   control; Zika
ID RELEASE-RECAPTURE; ANOPHELES-GAMBIAE; MALARIA CONTROL; HOUSE-ENTRY;
   CULICIDAE; DIPTERA; BEHAVIOR; PARAMETERS; HISTORIES; REPELLENT
AB Background: Insecticides used against Aedes aegypti and other disease vectors can elicit a multitude of dose-dependent effects on behavioral and bionomic traits. Estimating the potential epidemiological impact of a product requires thorough understanding of these effects and their interplay at different dosages. Volatile spatial repellent (SR) products come with an additional layer of complexity due to the potential for altered movement of affected mosquitoes and diffusion of volatile particles of the product beyond the treated Huse Here, we propose a paired experimental design and statistical inference framework for estimating these nuanced effects of volatile SRs.
   Method: We fitted a continuous-time Markov chain model in a Bayesian framework to data on marked mosquitoes released in interconnected experimental huts conducted in Iquitos, Peru. We estimated the effects of two dosages of transfluthrin on Ae. aegypti behaviors associated with human-vector contact: repellency, exiting and knockdown in the treated space and in connected, adjacent huts. We validated the framework using simulated data.
   Results: The odds of a female Ae. aegypti being repelled, and thus prevented from entering a treated hut (H-T), increased at both dosages (low dosage: odds = 1.64, 95% highest density interval (HDI) = 1.30-2.09; high dosage: odds = 1.35, HDI = 1.04-1.67). The relative risk of exiting from the treated hut was reduced (low: RR = 0.70, HDI = 0.62-1.09; high: RR = 0.70, HDI = 0.40-1.06), with this effect carrying over to untreated spaces two huts away from the treated hut (H-2) (low: RR = 0.79, HDI = 0.59-1.01; high: RR = 0.66, HDI = 0.50-0.87). Knockdown rates were increased in both treated and downstream huts, particularly under high dosage (H-T: RR = 8.37, HDI = 2.11-17.35; H-1: RR = 1.39, HDI = 0.52-2.69; H-2: RR = 2.22, HDI = 0.96-3.86).
   Conclusions: Our framework is effective at elucidating multiple effects of volatile chemicals used in SR products, as well as their downstream effects. For the examined formulations of transfluthrin, we found notable dose-dependent effects on repellency, movement and knockdown that carry over to adjacent, untreated spaces.
C1 [ten Bosch, Quirine A.; Grieco, John P.; Achee, Nicole L.; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [ten Bosch, Quirine A.; Grieco, John P.; Achee, Nicole L.; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [ten Bosch, Quirine A.] Inst Pasteur, Mathemat Modelling Infect Dis Unit, Paris, France.
   [Castro-Llanos, Fanny; Morrison, Amy C.] US Naval Med Res Unit 6, Callao, Peru.
   [Manda, Hortance] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biometr, Bethesda, MD 20814 USA.
   [Morrison, Amy C.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
RP ten Bosch, QA; Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; ten Bosch, QA; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.; ten Bosch, QA (corresponding author), Inst Pasteur, Mathemat Modelling Infect Dis Unit, Paris, France.
EM qtenbosc@pasteur.fr; taperkins@nd.edu
RI Bosch, Quirine ten/H-6734-2019
OI Bosch, Quirine ten/0000-0002-5227-1406
FU Bill & Melinda Gates FoundationGates Foundation [48513]; Eck Institute
   for Global Health at the University of Notre Dame
FX This work was supported and funded by the Bill & Melinda Gates
   Foundation (Grant #48513): "A push-pull strategy for Aedes aegypti
   control." The funders had no role in study design, data collection and
   analysis, decision to publish or preparation of the manuscript. QAtB was
   supported by a graduate student fellowship from the Eck Institute for
   Global Health at the University of Notre Dame.
CR Achee N, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-300
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Achee NL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-164
   Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1
   Achee NL, 2005, J AM MOSQUITO CONTR, V21, P366, DOI 10.2987/8756-971X(2006)21[366:AMSUAN]2.0.CO;2
   ARNASON A N, 1973, Researches on Population Ecology (Tokyo), V15, P1
   ARNASON A N, 1972, Researches on Population Ecology (Tokyo), V13, P97
   Bibbs CS, 2017, J INTEGR PEST MANAG, V8, DOI 10.1093/jipm/pmx016
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brady OJ, 2016, T ROY SOC TROP MED H, V110, P107, DOI 10.1093/trstmh/trv113
   Briet OJT, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-77
   Briet OJT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-256
   Buhagiar TS, 2017, PARASITE VECTOR, V10, DOI [10.1186/s13071-017-2220-7, 10.1186/s13071-017-2219-0]
   CHAPMAN DG, 1956, ANN MATH STAT, V27, P375, DOI 10.1214/aoms/1177728264
   Chareonviriyaphap T, 2010, J VECTOR ECOL, V35, P428, DOI 10.1111/j.1948-7134.2010.00102.x
   Chitnis N, 2010, AM J TROP MED HYG, V83, P230, DOI 10.4269/ajtmh.2010.09-0179
   Choi DB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004850
   Corbel V, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P579, DOI 10.5772/56117
   Darbro JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2004-0
   Eldridge BF, 2012, MED ENTOMOLOGY TXB P
   Ergon T, 2014, METHODS ECOL EVOL, V5, P1327, DOI 10.1111/2041-210X.12133
   Fanello C, 2003, MED VET ENTOMOL, V17, P333, DOI 10.1046/j.1365-2915.2003.00450.x
   Gatton ML, 2013, EVOLUTION, V67, P1218, DOI 10.1111/evo.12063
   Gelman A, 1992, STAT SCI, V7, P457, DOI DOI 10.1214/SS/1177011136
   Gilks W. R., 2005, ENCY BIOSTATISTICS, DOI [10.1002/0470011815.b2a14021, DOI 10.1002/0470011815.B2A14021]
   Govella NJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0937-8
   Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716
   Grieco JP, 2000, J VECTOR ECOL, V25, P62
   Hoffmann EJ, 2002, J MED ENTOMOL, V39, P935, DOI 10.1603/0022-2585-39.6.935
   JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.1093/biomet/52.1-2.225
   Kendall WL, 2002, ECOLOGY, V83, P3276
   Killeen GF, 2007, T ROY SOC TROP MED H, V101, P867, DOI 10.1016/j.trstmh.2007.04.022
   Kiware SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037661
   Lebreton JD, 2002, J APPL STAT, V29, P353, DOI 10.1080/02664760120108638
   Lebreton JD, 2009, ADV ECOL RES, V41, P87, DOI 10.1016/S0065-2504(09)00403-6
   LINDSAY SW, 1992, B ENTOMOL RES, V82, P49, DOI 10.1017/S0007485300051488
   Maia MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084875
   Manda H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002074
   Martin NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071884
   Martin NJ, 2012, PEST MANAG SCI, V68, P1360, DOI 10.1002/ps.3313
   McLean-Cooper N, 2008, J AM MOSQUITO CONTR, V24, P460, DOI 10.2987/5649.1
   McPhatter Lee P, 2017, US Army Med Dep J, P13
   Nentwig G, 2017, J MED ENTOMOL, V54, P150, DOI 10.1093/jme/tjw129
   Ogoma SB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005455
   Ogoma SB, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-131
   Ogoma SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-54
   Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706
   PLEASS RJ, 1993, B ENTOMOL RES, V83, P133, DOI 10.1017/S0007485300041870
   Randriamaherijaona S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0836-7
   Restif O, 2012, ECOL LETT, V15, P1083, DOI 10.1111/j.1461-0248.2012.01836.x
   Ritchie SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-262
   Russell TL, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-80
   SEBER GAF, 1965, BIOMETRIKA, V52, P249
   Sobol I. M., 1967, USSR COMP MATH MATH, V7, P86, DOI [10.1016/0041-5553(67)90144-9, DOI 10.1016/0041-5553(67)90144-9]
   Sugiharto VA, 2016, J MED ENTOMOL, V53, P1100, DOI 10.1093/jme/tjw066
   Taylor H.M., 2014, INTRO STOCHASTIC MOD
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Villela DAM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123794
   WHO, 2013, GUID EFF TEST SPAT R
NR 59
TC 1
Z9 1
U1 2
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 26
PY 2018
VL 11
AR 365
DI 10.1186/s13071-018-2919-0
PG 15
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GK9WD
UT WOS:000436607400003
PM 29941038
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barrett, ADT
AF Barrett, Alan D. T.
TI Developing Zika vaccines: the lessons for disease X
SO GENOME MEDICINE
LA English
DT Editorial Material
ID CLINICAL-TRIALS; VIRUS; IMMUNOGENICITY; PHASE-1; SAFETY
C1 [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Barrett, ADT (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM abarrett@utmb.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI 129844]; Gillson Longenbaugh
   Foundation
FX ADTB is support by grants from the NIH (R21 AI 129844) and the Gillson
   Longenbaugh Foundation. The funders did not contribute to the design of
   the study, to the collection, analysis, and interpretation of data, or
   to writing the manuscript.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Frantz PN, 2018, MICROBES INFECT, V20, P493, DOI 10.1016/j.micinf.2018.01.005
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   World Health Organisation, 2018, RES DEV BLUEPR ACT P
   World Health Organization, 2018, LIST BLUEPR PRIOR DI
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 11
TC 1
Z9 1
U1 1
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-994X
J9 GENOME MED
JI Genome Med.
PD JUN 26
PY 2018
VL 10
AR 47
DI 10.1186/s13073-018-0561-2
PG 3
WC Genetics & Heredity
SC Genetics & Heredity
GA GL0UY
UT WOS:000436808900001
PM 29945653
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaushik, A
   Yndart, A
   Kumar, S
   Jayant, RD
   Vashist, A
   Brown, AN
   Li, CZ
   Nair, M
AF Kaushik, Ajeet
   Yndart, Adriana
   Kumar, Sanjeev
   Jayant, Rahul Dev
   Vashist, Arti
   Brown, Ashley N.
   Li, Chen-Zhong
   Nair, Madhavan
TI A sensitive electrochemical immunosensor for label-free detection of
   Zika-virus protein
SO SCIENTIFIC REPORTS
LA English
DT Article
ID BIOSENSORS; DISEASE
AB This work, as a proof of principle, presents a sensitive and selective electrochemical immunosensor for Zika-virus (ZIKV)-protein detection using a functionalized interdigitated micro-electrode of gold (IDE-Au) array. A miniaturized IDE-Au immunosensing chip was prepared via immobilization of ZIKV specific envelop protein antibody (Zev-Abs) onto dithiobis(succinimidyl propionate) i.e., (DTSP) functionalized IDE-Au (electrode gap/width of 10 mu m). Electrochemical impedance spectroscopy (EIS) was performed to measure the electrical response of developed sensing chip as a function of ZIKV-protein concentrations. The results of EIS studies confirmed that sensing chip detected ZIKV-protein selectively and exhibited a detection range from 10 pM to 1 nM and a detection limit of 10 pM along with a high sensitivity of 12 k Omega M<b>(-1). Such developed ZIKV immune-sensing chip can be integrated with a miniaturized potentiostat (MP)-interfaced with a smartphone for rapid ZIKV-infection detection required for early stage diagnostics at point-of-care application.
C1 [Kaushik, Ajeet; Yndart, Adriana; Jayant, Rahul Dev; Vashist, Arti; Nair, Madhavan] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Ctr Personalized Nanomed,Inst NeuroImmune Pharmac, Miami, FL 33199 USA.
   [Kumar, Sanjeev] CSIR, Cent Sci Instruments Org, Biomed Instrumentat, Sect 30-C, Chandigarh 160030, India.
   [Brown, Ashley N.] Univ Florida, Coll Med, Dept Med, Inst Therapeut Innovat, Orlando, FL 32827 USA.
   [Li, Chen-Zhong] Florida Int Univ, Dept Biomed Engn, Nanobioengn Bioelect Lab, 10555 West Flagler St, Miami, FL 33174 USA.
RP Kaushik, A; Nair, M (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Ctr Personalized Nanomed,Inst NeuroImmune Pharmac, Miami, FL 33199 USA.
EM ajeet.npl@gmail.com; naimm@fiu.edu
RI Vashist, Arti/O-5204-2019; Kaushik, Ajeet/K-1289-2018; Vashist,
   Arti/AAH-5926-2020; Jayant, Rahul/K-7934-2019
OI Kaushik, Ajeet/0000-0003-4206-1541; Vashist, Arti/0000-0002-7519-1863;
   Jayant, Rahul Dev/0000-0002-2584-3878
FU Institute for NeuroImmune Pharmacology [FDOH-7ZK09, FIU 800008106];
   Engineering Research Centers Program of NSF projects [EEC-1647837,
   EEC-1648451]; NSF's Independent Research/Development (IR/D) Program
FX We acknowledge financial support and research facilities of Institute
   for NeuroImmune Pharmacology along with grants namely FDOH-7ZK09, and
   FIU 800008106. This work was partially supported by the Engineering
   Research Centers Program of NSF projects No. EEC-1647837 and
   EEC-1648451. Dr. Li also thanks the support of the NSF's Independent
   Research/Development (IR/D) Program.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Ahmadivand A, 2018, BIOMED OPT EXPRESS, V9, P373, DOI 10.1364/BOE.9.000373
   Ahmadivand A, 2017, ACS SENSORS, V2, P1359, DOI 10.1021/acssensors.7b00478
   Cheng C, 2017, CHEMELECTROCHEM, V4, P485, DOI 10.1002/celc.201600831
   Cruz AFD, 2014, BIOSENS BIOELECTRON, V62, P249, DOI 10.1016/j.bios.2014.06.053
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Jiang QS, 2017, ADV BIOSYST, V1, DOI 10.1002/adbi.201700096
   Kaushik A., 2018, US Patent, Patent No. [US20180059099A1, 20180059099A1]
   Kaushik A, 2017, TRENDS BIOTECHNOL, V35, P308, DOI 10.1016/j.tibtech.2016.10.001
   Kaushik A, 2016, ANAL METHODS-UK, V8, P6115, DOI 10.1039/c6ay01910b
   Kaushik A, 2016, BIOSENS BIOELECTRON, V86, P426, DOI 10.1016/j.bios.2016.06.086
   Kaushik A, 2016, BIOSENS BIOELECTRON, V80, P273, DOI 10.1016/j.bios.2016.01.065
   Kaushik A, 2016, BIOSENS BIOELECTRON, V75, P254, DOI 10.1016/j.bios.2015.08.040
   Kaushik A, 2015, INT J NANOMED, V10, P677, DOI 10.2147/IJN.S75514
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Meagher RJ, 2016, TRENDS MOL MED, V22, P529, DOI 10.1016/j.molmed.2016.05.009
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pasha SK, 2014, J ELECTROCHEM SOC, V161, pB3077, DOI 10.1149/2.017402jes
   Pawitwar S. S., 2017, J NEUROIMMUNE PHARM, P1
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
NR 21
TC 27
Z9 27
U1 5
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 26
PY 2018
VL 8
AR 9700
DI 10.1038/s41598-018-28035-3
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK5RH
UT WOS:000436233600028
PM 29946074
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ma, JZ
   Ketkar, H
   Geng, TT
   Lo, E
   Wang, LL
   Xi, JM
   Sun, QM
   Zhu, ZB
   Cui, Y
   Yang, L
   Wang, PH
AF Ma, Jinzhu
   Ketkar, Harshada
   Geng, Tingting
   Lo, Emily
   Wang, Leilei
   Xi, Juemin
   Sun, Qiangming
   Zhu, Zhanbo
   Cui, Yudong
   Yang, Long
   Wang, Penghua
TI Zika Virus Non-structural Protein 4A Blocks the RLR-MAVS Signaling
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE flavivirus; Zika; non-structural protein 4A; NS4A; RIG-I like receptors;
   RLR
ID HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; ANTIVIRAL INNATE IMMUNITY; RIG-I;
   DENGUE VIRUS; ADAPTER PROTEIN; NS5 PROTEIN; INTERFERON; NS4B; ANTAGONIST
AB Flaviviruses have evolved complex mechanisms to evade the mammalian host immune systems including the RIG-I (retinoic acid-inducible gene I) like receptor (RLR) signaling. Zika virus (ZIKV) is a re-emerging flavivirus that is associated with severe neonatal microcephaly and adult Guillain-Barre syndrome. However, the molecular mechanisms underlying ZIKV pathogenesis remain poorly defined. Here we report that ZIKV nonstructural protein 4A (NS4A) impairs the RLR-mitochondrial antiviral-signaling protein (MAVS) interaction and subsequent induction of antiviral immune responses. In human trophoblasts, both RIG-I and melanoma differentiation-associated protein 5 (MDA5) contribute to type I interferon (IFN) induction and control ZIKV replication. Type I IFN induction by ZIKV is almost completely abolished in MAVS(-/-) cells. NS4A represses RLR-, but not Toll-like receptor-mediated immune responses. NS4A specifically binds the N-terminal caspase activation and recruitment domain (CARD) of MAVS and thus blocks its accessibility by RLRs. Our study provides in-depth understanding of the molecular mechanisms of immune evasion by ZIKV and its pathogenesis.
C1 [Ma, Jinzhu; Zhu, Zhanbo; Cui, Yudong] Heilongjiang Bayi Agr Univ, Coll Life Sci & Technol, Daqing, Peoples R China.
   [Ma, Jinzhu; Ketkar, Harshada; Geng, Tingting; Lo, Emily; Wang, Leilei; Yang, Long; Wang, Penghua] New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
   [Wang, Leilei] China Med Univ, Shengjing Hosp, Dept Obstet & Gynecol, Shenyang, Liaoning, Peoples R China.
   [Xi, Juemin; Sun, Qiangming] Peking Union Med Coll, Chinese Acad Med Sci, Inst Med Biol, Kunming, Yunnan, Peoples R China.
   [Yang, Long] McGill Univ, Lady Davis Inst Med Res, Dept Med, Montreal, PQ, Canada.
RP Wang, PH (corresponding author), New York Med Coll, Dept Microbiol & Immunol, Valhalla, NY 10595 USA.
EM Penghua_wang@nymc.edu
RI wang, Penghua/AAL-4011-2020
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI132526]
FX This work was supported by a National Institutes of Health award
   R01AI132526 to PW.
CR Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harvey TJ, 2004, J VIROL, V78, P531, DOI 10.1128/JVI.78.22.12225-12235.2004
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kaukinen P, 2013, J MED VIROL, V85, P71, DOI 10.1002/jmv.23442
   Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Otsuka M, 2005, HEPATOLOGY, V41, P1004, DOI 10.1002/hep.20666
   Perry H, 2017, BRIT MED BULL, V124, P157, DOI 10.1093/bmb/ldx038v1
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Seth RB, 2006, CELL RES, V16, P141, DOI 10.1038/sj.cr.7310019
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Sun LJ, 2010, CELL, V140, P436, DOI 10.1016/j.cell.2010.01.041
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08
   Wang PH, 2013, CELL REP, V3, P1057, DOI 10.1016/j.celrep.2013.02.027
   Wang PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044153
   Wang PH, 2010, NAT IMMUNOL, V11, P912, DOI 10.1038/ni.1933
   Werme K, 2008, CELL MICROBIOL, V10, P696, DOI 10.1111/j.1462-5822.2007.01076.x
   Wilkins C, 2010, CURR OPIN IMMUNOL, V22, P41, DOI 10.1016/j.coi.2009.12.003
   Yi GH, 2016, J VIROL, V90, P254, DOI 10.1128/JVI.01720-15
   You FP, 2013, NAT IMMUNOL, V14, P1237, DOI 10.1038/ni.2756
NR 52
TC 7
Z9 7
U1 1
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 25
PY 2018
VL 9
AR 1350
DI 10.3389/fmicb.2018.01350
PG 10
WC Microbiology
SC Microbiology
GA GK4DA
UT WOS:000436104100001
PM 29988497
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chattopadhyay, A
   Aguilar, PV
   Bopp, NE
   Yarovinsky, TO
   Weaver, SC
   Rose, JK
AF Chattopadhyay, Anasuya
   Aguilar, Patricia V.
   Bopp, Nathen E.
   Yarovinsky, Timur O.
   Weaver, Scott C.
   Rose, John K.
TI A recombinant virus vaccine that protects against both Chikungunya and
   Zika virus infections
SO VACCINE
LA English
DT Article
DE Vesicular stomatitis virus; Arbovirus; Microcephaly
ID VESICULAR STOMATITIS VIRUSES; TRANSMISSION; GENE; GLYCOPROTEIN;
   REEMERGENCE; EXPRESSION
AB Chikungunya virus (CHIKV) and Zika virus (ZIKV) have recently expanded their range in the world and caused serious and widespread outbreaks of near pandemic proportions. There are no licensed vaccines that protect against these co-circulating viruses that are transmitted by invasive mosquito vectors. We report here on the development of a single-dose, bivalent experimental vaccine for CHIKV and ZIKV. This vaccine is based on a chimeric vesicular stomatitis virus (VSV) that expresses the CHIKV envelope polyprotein (E3-E2-6K-E1) in place of the VSV glycoprotein (G) and also expresses the membrane-envelope (ME) glycoproteins of ZIKV. This vaccine induced neutralizing antibody responses to both CHIKV and ZIKV in wild-type mice and in interferon receptor-deficient A129 mice, animal models for CHIKV and ZIKV infection. A single vaccination of A129 mice with the vector protected these mice against infection with both CHIKV and ZIKV. Our single-dose vaccine could provide durable, low-cost protection against both CHIKV and ZIKV for people traveling to or living in areas where both viruses are circulating, which include most tropical regions in the world. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Chattopadhyay, Anasuya; Yarovinsky, Timur O.; Rose, John K.] Yale Univ, Sch Med, Dept Pathol, 310 Cedar St LH315, New Haven, CT 06510 USA.
   [Aguilar, Patricia V.; Bopp, Nathen E.; Weaver, Scott C.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77550 USA.
   [Aguilar, Patricia V.; Bopp, Nathen E.; Weaver, Scott C.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Aguilar, Patricia V.; Weaver, Scott C.] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
RP Rose, JK (corresponding author), Yale Univ, Sch Med, Dept Pathol, 310 Cedar St LH315, New Haven, CT 06510 USA.
EM john.rose@yale.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI119119, R24 AI120942]
FX This work was supported by NIH grant R21 AI119119 to J.K.R. P.V.A. and
   S.C.W. were supported by NIH grant R24 AI120942. We thank Dr. Brett
   Lindenbach, Yale University, for providing Zika virus and BHK clone 15
   cells.
CR Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chattopadhyay A, 2013, J VIROL, V87, P395, DOI 10.1128/JVI.01860-12
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Cooper D, 2008, J VIROL, V82, P207, DOI 10.1128/JVI.01515-07
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fuchs JD, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv082
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Langsjoen RM, 2018, MBIO, V9, DOI 10.1128/mBio.02449-17
   LAWSON ND, 1995, P NATL ACAD SCI USA, V92, P4477, DOI 10.1073/pnas.92.10.4477
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LEFRANCOIS L, 1982, VIROLOGY, V121, P157, DOI 10.1016/0042-6822(82)90125-8
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moron AF, 2016, BJOG INT J OBSTET GY, V6
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Musso D, 2016, LANCET
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Poland GA, 2018, LANCET INFECT DIS
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Powers AM, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00104-16
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Ryder AB, 2015, J VIROL, V89, P2820, DOI 10.1128/JVI.03246-14
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Schnell MJ, 1996, J VIROL, V70, P2318, DOI 10.1128/JVI.70.4.2318-2323.1996
   Schnell MJ, 1996, P NATL ACAD SCI USA, V93, P11359, DOI 10.1073/pnas.93.21.11359
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Thomas DL, 2015, LOCAL TRANSMISSION Z
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   van den Pol AN, 2017, J VIROL, V91, DOI 10.1128/JVI.02154-16
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
NR 47
TC 14
Z9 14
U1 1
U2 13
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 22
PY 2018
VL 36
IS 27
BP 3894
EP 3900
DI 10.1016/j.vaccine.2018.05.095
PG 7
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GM3KI
UT WOS:000438003100006
PM 29807712
DA 2020-07-08
ER

PT J
AU Lopez-Camacho, C
   Abbink, P
   Larocca, RA
   Dejnirattisai, W
   Boyd, M
   Badamchi-Zadeh, A
   Wallace, ZR
   Doig, J
   Velazquez, RS
   Neto, RDL
   Coelho, DF
   Kim, YC
   Donald, CL
   Owsianka, A
   De Lorenzo, G
   Kohl, A
   Gilbert, SC
   Dorrell, L
   Mongkolsapaya, J
   Patel, AH
   Screaton, GR
   Barouch, DH
   Hill, AV
   Reyes-Sandovakl, A
AF Lopez-Camacho, Cesar
   Abbink, Peter
   Larocca, Rafael A.
   Dejnirattisai, Wanwisa
   Boyd, Michael
   Badamchi-Zadeh, Alex
   Wallace, Zoe R.
   Doig, Jennifer
   Velazquez, Ricardo Sanchez
   Neto, Roberto Dias Lins
   Coelho, Danilo F.
   Kim, Young Chan
   Donald, Claire L.
   Owsianka, Ania
   De Lorenzo, Giuditta
   Kohl, Alain
   Gilbert, Sarah C.
   Dorrell, Lucy
   Mongkolsapaya, Juthathip
   Patel, Arvind H.
   Screaton, Gavin R.
   Barouch, Dan H.
   Hill, Adrian Vs
   Reyes-Sandovakl, Arturo
TI Rational Zika vaccine design via the modulation of antigen membrane
   anchors in chimpanzee adenoviral vectors
SO NATURE COMMUNICATIONS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; CROSS-REACTIVITY;
   HEALTHY-ADULTS; DNA VACCINE; INFECTION; PROTECTION; IMMUNOGENICITY;
   IMMUNIZATION; SPECIFICITY
AB Zika virus (ZIKV) emerged on a global scale and no licensed vaccine ensures long-lasting anti-ZIKV immunity. Here we report the design and comparative evaluation of four replication-deficient chimpanzee adenoviral (ChAdOx1) ZIKV vaccine candidates comprising the addition or deletion of precursor membrane (prM) and envelope, with or without its transmembrane domain (TM). A single, non-adjuvanted vaccination of ChAdOx1 ZIKV vaccines elicits suitable levels of protective responses in mice challenged with ZIKV. ChAdOx1 prME Delta TM encoding prM and envelope without TM provides 100% protection, as well as long-lasting anti-envelope immune responses and no evidence of in vitro antibody-dependent enhancement to dengue virus. Deletion of prM and addition of TM reduces protective efficacy and yields lower anti-envelope responses. Our finding that immunity against ZIKV can be enhanced by modulating antigen membrane anchoring highlights important parameters in the design of viral vectored ZIKV vaccines to support further clinical assessments.
C1 [Lopez-Camacho, Cesar; Kim, Young Chan; Reyes-Sandovakl, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.
   [Abbink, Peter; Larocca, Rafael A.; Boyd, Michael; Badamchi-Zadeh, Alex; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Dejnirattisai, Wanwisa; Mongkolsapaya, Juthathip] Imperial Coll London, Dept Med, Div Immunol & Inflammat, Hammersmith Campus, London W12 0NN, England.
   [Wallace, Zoe R.; Dorrell, Lucy] Univ Oxford, Nuffield Dept Med, Oxford OX3 7FZ, England.
   [Wallace, Zoe R.; Dorrell, Lucy] Univ Oxford, Oxford NIHR Biomed Res Ctr, Oxford OX3 7FZ, England.
   [Doig, Jennifer; Velazquez, Ricardo Sanchez; Donald, Claire L.; Owsianka, Ania; De Lorenzo, Giuditta; Kohl, Alain; Patel, Arvind H.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Neto, Roberto Dias Lins; Coelho, Danilo F.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, BR-50670465 Recife, PE, Brazil.
   [Gilbert, Sarah C.; Hill, Adrian Vs] Univ Oxford, Jenner Inst, Nuffield Dept Med, Old Rd Campus Res Bldg,Roosevelt Dr, Oxford OX3 7DQ, England.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med Siriraj Hosp, Dengue Hemorrhag Fever Res Unit, Off Res & Dev, Bangkok 10700, Thailand.
   [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Div Med Sci, Oxford OX3 9DU, England.
RP Reyes-Sandovakl, A (corresponding author), Univ Oxford, Jenner Inst, Nuffield Dept Med, Henry Wellcome Bldg Mol Physiol,Roosevelt Dr, Oxford OX3 7BN, England.
EM arturo.reyes@ndm.ox.ac.uk
RI Gilbert, Sarah C./H-2857-2019; Barouch, Dan/Y-3918-2019; Coelho, Danilo
   Fernandes/AAC-9206-2020; Lins, Roberto D/J-7511-2012; Donald,
   Claire/AAC-7556-2019; Assumpcao Larocca, Rafael/H-1655-2015
OI Gilbert, Sarah C./0000-0002-6823-9750; Coelho, Danilo
   Fernandes/0000-0002-1111-0825; Lins, Roberto D/0000-0002-3983-8025;
   Donald, Claire/0000-0002-4370-0707; Abbink, Peter/0000-0003-1978-088X;
   LOPEZ-CAMACHO, CESAR/0000-0001-7932-2341; De Lorenzo,
   Giuditta/0000-0002-2736-8740; Kim, Young Chan/0000-0003-2847-9407;
   Assumpcao Larocca, Rafael/0000-0002-9995-1804; Screaton,
   Gavin/0000-0002-3549-4309
FU CapesCAPES; Facepe; CNPqNational Council for Scientific and
   Technological Development (CNPq); LNCC; UK Department of Health and
   Social Care through Innovate UK "New vaccines for global epidemics:
   development and manufacture" [972216]; ODA budget (Global Health (ODA))
   [16/107/05]; UK Medical Research CouncilMedical Research Council UK
   (MRC) [MC_UU_12014, MR/N017552/1]; MRC-Newton Fund
FX We would like to thank the Jenner Institute's Vector Core Facility for
   producing and supplying the recombinant viral vectors. A.R.-S., A.V.S.H.
   and S.C.G. are Jenner Investigators and an Oxford Martin Fellows.
   R.D.L.N. and D.F.C. were supported by Capes, Facepe, CNPq and LNCC. This
   report is independent research funded by the UK Department of Health and
   Social Care through Innovate UK "New vaccines for global epidemics:
   development and manufacture" grant No. 972216 (A.R.-S.), and also funded
   from an ODA budget (Global Health (ODA), 16/107/05-Design, development
   and GMP manufacture of a Zika vaccine) (A.H.P. and A.R-S). The views
   expressed in this publication are those of the author(s) and not
   necessarily those of the Department of Health and Social Care. We also
   acknowledge funding by the UK Medical Research Council [MC_UU_12014
   (A.H.P. and A.K.) and MR/N017552/1 (A.K.)]. Juthathip Mongkolsapaya is
   supported by an MRC-Newton Fund grant, Gavin Screaton is a Wellcome
   Trust Senior Investigator.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Antrobus RD, 2014, MOL THER, V22, P668, DOI 10.1038/mt.2013.284
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Borthwick N, 2014, MOL THER, V22, P464, DOI 10.1038/mt.2013.248
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diamond MS, 2018, NAT REV IMMUNOL, V18, P89, DOI 10.1038/nri.2017.132
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627
   Ewer KJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3836
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Golden A, 1998, PROTEIN EXPRES PURIF, V14, P8, DOI 10.1006/prep.1998.0926
   Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Satti I, 2014, LANCET INFECT DIS, V14, P939, DOI 10.1016/S1473-3099(14)70845-X
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 42
TC 16
Z9 16
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 22
PY 2018
VL 9
AR 2441
DI 10.1038/s41467-018-04859-5
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GK3MI
UT WOS:000436049400001
PM 29934593
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Eiras, AE
   Pires, SF
   Staunton, KM
   Paixao, KS
   Resende, MC
   Silva, HA
   Rocha, IG
   Oliveira, BA
   Peres, AM
   Drumond, BP
   Ritchie, SA
AF Eiras, Alvaro E.
   Pires, Simone F.
   Staunton, Kyran M.
   Paixao, Kelly S.
   Resende, Marcelo C.
   Silva, Hilcielly A.
   Rocha, Isadora G.
   Oliveira, Bruna A.
   Peres, Anderson M.
   Drumond, Betania P.
   Ritchie, Scott A.
TI A high-risk Zika and dengue transmission hub: virus detections in
   mosquitoes at a Brazilian university campus
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Dengue virus; Zika virus; GAT; Dissemination premises
ID GRAVID AEDES TRAP; ANTIGEN
AB Background: Zika virus (ZIKV) and dengue virus (DENV) are mosquito-borne flaviviruses prevalent throughout tropical regions. Currently, management of ZIKV and DENV centers on control of the primary vector Aedes aegypti. This vector is highly anthropophilic and is therefore prevalent throughout densely urbanised landscapes. A new passive trap for gravid Ae. aegypti (Gravid Aedes Trap - GAT) was developed for mosquito surveillance. Here the different killing agents and the level of transmission of arboviruses that may occur in mosquitoes sampled by GATs are assessed for the first time.
   Methods: Gravid Aedes traps (GATs) were deployed at the Federal University of Minas Gerais campus, in Belo Horizonte, Brazil to sample Ae. aegypti. Three different killing agents were evaluated within the GATs: sticky cards, long-lasting insecticide-impregnated nets (LLINs) and canola oil. Traps were monitored weekly for 14 weeks then mosquito specimens were identified to the species level and Ae. aegypti catches were pooled and submitted to qRT-PCR assays for to DENV and ZIKV virus detection, followed by Bayesian phylogenetic analysis of the ZIKV. Additionally, comparisons of means were performed on transformed weekly catch data (P = 0.05, t-tests) with the stats package of the R statistical software.
   Results: In total, 1506 female Ae. aegypti were captured using GATs, with traps using sticky cards catching more mosquito than those using either LLINs or canola oil. Both ZIKV and DENV were detected in Ae. aegypti females captured over several weeks suggesting that this highly populated university campus may have served as a significant transmission hub. The infection rate for ZIKV was present in seven (8.5%) pools from four weeks while DENV was detected in four (4.9%) pools from four weeks. Phylogenetic analysis of ZIKV classified the strain as Asian genotype.
   Conclusions: The Federal University of Minas Gerais and similar organizations must strongly consider monitoring Ae. aegypti populations and reinforcing personal protection of staff and students during seasons of high mosquito activity.
C1 [Eiras, Alvaro E.; Pires, Simone F.; Paixao, Kelly S.; Resende, Marcelo C.; Silva, Hilcielly A.; Rocha, Isadora G.; Oliveira, Bruna A.; Peres, Anderson M.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.
   [Staunton, Kyran M.; Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Australia.
   [Staunton, Kyran M.; Ritchie, Scott A.] James Cook Univ, Australian Inst Trop Hlth & Med, Cairns, Australia.
   [Drumond, Betania P.] Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
RP Eiras, AE (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Parasitol, Belo Horizonte, MG, Brazil.
EM alvaro@icb.ufmg.br
RI Staunton, Kyran/W-2263-2019; Eiras, Alvaro/Z-6023-2019
OI Staunton, Kyran/0000-0001-6812-3320; Eiras, Alvaro/0000-0002-3045-0673
FU CAPES/MEC-CNPq/MCTI-DECIT/SCTIE/MS [440358/2016-7]; FAPEMIGMinas Gerais
   State Research Foundation (FAPEMIG) [23129-02/2015]; National Health and
   Medical Research Council of AustraliaNational Health and Medical
   Research Council of Australia [1044698]
FX The research received funding support from the
   CAPES/MEC-CNPq/MCTI-DECIT/SCTIE/MS (Grant #440358/2016-7) and FAPEMIG
   (Grant# 23129-02/2015) and National Health and Medical Research Council
   of Australia (Senior Research Fellowship 1044698).
CR Andrade Filho A, 2016, EXPERIENCIA BELO HOR
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Benson DA, 2013, NUCLEIC ACIDS RES, V41, pD36, DOI 10.1093/nar/gks1195
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Christophers R, 1960, AEDES AEGYPTI L YELL
   de Resende MC, 2012, MEM I OSWALDO CRUZ, V107, P294, DOI 10.1590/S0074-02762012000300002
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Drummond AJ, BAYESIAN EVOLUTIONAR
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grange L, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00280
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0000
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hanna JN, 2001, MED J AUSTRALIA, V174, P178, DOI 10.5694/j.1326-5377.2001.tb143213.x
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Heringer L, 2016, J MED ENTOMOL, V53, P873, DOI 10.1093/jme/tjw051
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kollars TM, 2017, RES REP TROP MED, V8, P1, DOI [10.2147/RRTM.S123456, 10.2147/rrtm.s123456]
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rajapakse Senaka, 2011, J Emerg Trauma Shock, V4, P120, DOI 10.4103/0974-2700.76835
   Rambaut A., TREE FIGURE DRAWING
   Reiter P, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P481, DOI 10.1079/9781845939649.0481
   Ritchie SA, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P455, DOI 10.1079/9781845939649.0455
   Ritchie SA, 2014, J MED ENTOMOL, V51, P210, DOI 10.1603/ME13105
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tan CH, 2011, VECTOR-BORNE ZOONOT, V11, P789, DOI 10.1089/vbz.2010.0028
   Voge NV, 2013, AM J TROP MED HYG, V88, P260, DOI 10.4269/ajtmh.2012.12-0477
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 40
TC 2
Z9 3
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 22
PY 2018
VL 11
AR 359
DI 10.1186/s13071-018-2883-8
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GK1WS
UT WOS:000435914600001
PM 29929561
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Ratto-Kim, S
   Yoon, IK
   Paris, RM
   Excler, JL
   Kim, JH
   O'Connell, RJ
AF Ratto-Kim, Silvia
   Yoon, In-Kyu
   Paris, Robert M.
   Excler, Jean-Louis
   Kim, Jerome H.
   O'Connell, Robert J.
TI The US Military Commitment to vaccine Development: A Century of
   Successes and Challenges
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE vaccines; military medicine; army; development; history
ID TETRAVALENT DENGUE VACCINE; RESEARCH-AND-DEVELOPMENT; PHASE-1
   CLINICAL-TRIAL; YELLOW-FEVER VACCINE; PLASMODIUM-FALCIPARUM;
   CIRCUMSPOROZOITE-PROTEIN; HUMAN IMMUNITY; JAPANESE ENCEPHALITIS;
   VIRUS-VACCINE; SUBTYPE-E
AB The US military has been a leading proponent of vaccine development since its founding. General George Washington ordered the entire American army to be variolated against smallpox after recognizing the serious threat that it posed to military operations. He did this on the recommendation from Dr. John Morgan, the physician-in-chief of the American army, who wrote a treatise on variolation in 1776. Although cases of smallpox still occurred, they were far fewer than expected, and it is believed that the vaccination program contributed to victory in the War of Independence. Effective military force requires personnel who are healthy and combat ready for worldwide deployment. Given the geography of US military operations, military personnel should also be protected against diseases that are endemic in potential areas of conflict. For this reason, and unknown to many, the US military has strongly supported vaccine research and development. Four categories of communicable infectious diseases threaten military personnel: (1) diseases that spread easily in densely populated areas (respiratory and dysenteric diseases); (2) vector-borne diseases (disease carried by mosquitoes and other insects); (3) sexually transmitted diseases (hepatitis, HIV, and gonorrhea); and (4) diseases associated with biological warfare. For each category, the US military has supported research that has provided the basis for many of the vaccines available today. Although preventive measures and the development of drugs have provided some relief from the burden of malaria, dengue, and HIV, the US military continues to fund research and development of prophylactic vaccines that will contribute to force health protection and global health. In the past few years, newly recognized infections with Zika, severe acute respiratory syndrome, Middle East respiratory syndrome viruses have pushed the US military to fund research and fast track clinical trials to quickly and effectively develop vaccines for emerging diseases. With US military personnel present in every region of the globe, one of the most cost-effective ways to maintain military effectiveness is to develop vaccines against prioritized threats to military members' health.
C1 [Ratto-Kim, Silvia; Yoon, In-Kyu; Excler, Jean-Louis; Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea.
   [Paris, Robert M.] GSK Vaccines, Rockville, MD USA.
   [O'Connell, Robert J.] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
RP Ratto-Kim, S (corresponding author), Int Vaccine Inst, Seoul, South Korea.
EM silvia.kim@ivi.int
CR Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Ahuka-Mundeke S, 2018, NEW ENGL J MED, DOI [10.1056/NEJMoa1710430, DOI 10.1056/NEJMOA1710430]
   Ake JA, 2017, J INFECT DIS, V216, P1080, DOI 10.1093/infdis/jix456
   [Anonymous], 2002, NATL SECURITY STRATE
   Appaiahgari MB, 2010, EXPERT REV VACCINES, V9, P1371, DOI [10.1586/erv.10.139, 10.1586/ERV.10.139]
   Artenstein AW, 2008, EXPERT REV VACCINES, V7, P1225, DOI 10.1586/14760584.7.8.1225
   Artenstein Andrew W, 2005, Mil Med, V170, P3
   Artenstein AW, 2009, VACCINE, V27, pD16, DOI 10.1016/j.vaccine.2009.07.044
   Barnett ED, 2007, CLIN INFECT DIS, V44, P850, DOI 10.1086/511869
   Bauer K, 2015, AM J TROP MED HYG, V93, P441, DOI 10.4269/ajtmh.14-0625
   Belshe RB, 2001, J INFECT DIS, V183, P1343, DOI 10.1086/319863
   Birkett AJ, 2016, VACCINE, V34, P2915, DOI 10.1016/j.vaccine.2015.12.074
   Bonten MJM, 2015, NEW ENGL J MED, V372, P1114, DOI 10.1056/NEJMoa1408544
   Boudreau EF, 2012, VACCINE, V30, P1951, DOI 10.1016/j.vaccine.2012.01.024
   Brown AE, 2004, MIL MED, V169, P588, DOI 10.7205/MILMED.169.8.588
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Christenson S, 2003, LACKLAND GETS SHOT S
   Currier JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013983
   Danko JR, 2018, AM J TROP MED HYG, V98, P849, DOI 10.4269/ajtmh.17-0416
   DeFraites Robert F, 2014, MSMR, V21, P10
   Diaz C, 2018, AM J TROP MED HYG, V98, P1435, DOI 10.4269/ajtmh.17-0627
   Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426
   ELLIS J, 1983, NATURE, V302, P536, DOI 10.1038/302536a0
   Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939
   Evans TG, 1999, J INFECT DIS, V180, P290, DOI 10.1086/314895
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Findlow J, 2013, HUM VACC IMMUNOTHER, V9, P1387, DOI 10.4161/hv.24689
   Freedman DO, 2008, NEW ENGL J MED, V359, P603, DOI 10.1056/NEJMcp0803572
   Gershman MD, 2017, MMWR-MORBID MORTAL W, V66, P457, DOI 10.15585/mmwr.mm6617e2
   Gibbons RV, 2013, VACCINE, V31, P4487, DOI 10.1016/j.vaccine.2013.07.082
   Gibbons RV, 2012, EMERG INFECT DIS, V18, P623, DOI 10.3201/eid1804.110134
   Golden JW, 2011, EXPERT REV VACCINES, V10, P1021, DOI [10.1586/ERV.11.46, 10.1586/erv.11.46]
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1307, DOI 10.1084/jem.129.6.1307
   GOLDSCHNEIDER I, 1969, J EXP MED, V129, P1327, DOI 10.1084/jem.129.6.1327
   GOOD MF, 1988, P NATL ACAD SCI USA, V85, P1199, DOI 10.1073/pnas.85.4.1199
   GORDON DM, 1995, J INFECT DIS, V171, P1576, DOI 10.1093/infdis/171.6.1576
   Gordon JE, 1958, PREVENTIVE MED WORLD
   GOTSCHLICH EC, 1969, J EXP MED, V129, P1385, DOI 10.1084/jem.129.6.1385
   GOTSCHLICH EC, 1969, J EXP MED, V129, P1367, DOI 10.1084/jem.129.6.1367
   Grabenstein JD, 2006, EPIDEMIOL REV, V28, P3, DOI 10.1093/epirev/mxj003
   GREMILLION DH, 1983, J INFECT DIS, V147, P1099, DOI 10.1093/infdis/147.6.1099
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gupta K, 2002, J ACQ IMMUN DEF SYND, V29, P254, DOI 10.1097/00126334-200203010-00005
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409
   HOFFMAN SL, 1986, NEW ENGL J MED, V315, P601, DOI 10.1056/NEJM198609043151001
   Hoffman SL, 2015, AM J PREV MED, V49, pS319, DOI 10.1016/j.amepre.2015.09.011
   HOKE CH, 1979, REV INFECT DIS, V1, P946
   Hoke CH, 2012, VACCINE, V30, P6713, DOI 10.1016/j.vaccine.2012.08.025
   Honigsbaum Mark, 2002, FEVER TRAIL SEARCH C
   Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110
   Jelinek T, 2013, EXPERT REV VACCINES, V12, P859, DOI 10.1586/14760584.2013.835638
   Kelly DJ, 2002, CLIN INFECT DIS, V34, pS145, DOI 10.1086/339908
   Kimmel Sanford R, 2003, J Fam Pract, V52, pS56
   Kitchen LW, 2007, VACCINE, V25, P7017, DOI 10.1016/j.vaccine.2007.07.030
   Leca M, 2015, PATHOL BIOL, V63, P144, DOI 10.1016/j.patbio.2015.04.003
   LEMON SM, 2002, PROTECTING OUR FORCE
   Lutwick LI, 2002, EXPERT OPIN BIOL TH, V2, P883, DOI 10.1517/14712598.2.8.883
   MASON CJ, 1995, AIDS, V9, P1061, DOI 10.1097/00002030-199509000-00012
   Masterson KM., 2014, THE MALARIA PROJECT
   McClain DJ, 2000, J MED VIROL, V60, P77, DOI 10.1002/(SICI)1096-9071(200001)60:1&lt;77::AID-JMV13&gt;3.0.CO;2-S
   MEIKLEJOHN G, 1977, J INFECT DIS, V136, pS456, DOI 10.1093/infdis/136.Supplement_3.S456
   MEIKLEJOHN G, 1978, J INFECT DIS, V138, P618, DOI 10.1093/infdis/138.5.618
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Moore MR, 2016, LANCET RESP MED, V4, P399, DOI 10.1016/S2213-2600(16)00052-7
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   Nitayaphan S, 2000, VACCINE, V18, P1448, DOI 10.1016/S0264-410X(99)00421-1
   Nitayaphan S, 2004, J INFECT DIS, V190, P702, DOI 10.1086/422258
   Ockenhouse Christian F, 2005, Mil Med, V170, P12
   Olotu A, 2013, NEW ENGL J MED, V368, P1111, DOI 10.1056/NEJMoa1207564
   Ottolini Martin G, 2005, Mil Med, V170, P66
   Paulke-Korinek Maria, 2008, Wien Klin Wochenschr, V120, P15, DOI 10.1007/s00508-008-1071-9
   Petersen BW, 2016, MMWR-MORBID MORTAL W, V65, P257, DOI 10.15585/mmwr.mm6510a2
   Pilishvili T, 2015, AM J PREV MED, V49, pS383, DOI 10.1016/j.amepre.2015.09.008
   Pitisuttithum P, 2003, J INFECT DIS, V188, P219, DOI 10.1086/376506
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Poland GA, 2005, VACCINE, V23, P2078, DOI 10.1016/j.vaccine.2005.01.012
   Radin JM, 2014, CLIN INFECT DIS, V59, P962, DOI 10.1093/cid/ciu507
   Regules JA, 2016, J INFECT DIS, V214, P762, DOI 10.1093/infdis/jiw237
   Reilly L, 2010, MIL MED, V175, P42, DOI 10.7205/MILMED-D-10-00168
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Riddle MS, 2008, VACCINE, V26, P2490, DOI 10.1016/j.vaccine.2008.03.008
   RIECKMANN KH, 1990, B WORLD HEALTH ORGAN, V68, P13
   Riedel Stefan, 2004, Proc (Bayl Univ Med Cent), V17, P400
   Roukens AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001993
   Russell PK, 1999, EMERG INFECT DIS, V5, P531, DOI 10.3201/eid0504.990413
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Schmaljohn CS, 2012, HUM VACC IMMUNOTHER, V8, P1126, DOI 10.4161/hv.20503
   Schmaljohn CS, 2012, EXPERT REV VACCINES, V11, P511, DOI [10.1586/erv.12.15, 10.1586/ERV.12.15]
   Schmidt AC, 2017, AM J TROP MED HYG, V96, P1325, DOI 10.4269/ajtmh.16-0634
   Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Sissoko MS, 2017, LANCET INFECT DIS, V17, P498, DOI [10.1016/S1473-3099(17)30104-4, 10.1016/s1473-3099(17)30104-4]
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Stanhope B-J, EVOLUTION PREVENTIVE
   Steele AD, 2016, CLIN INFECT DIS, V62, pS4, DOI 10.1093/cid/civ976
   Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202
   Tallant A, 2014, VACCINE, V32, P5156, DOI 10.1016/j.vaccine.2014.07.070
   Thomas SJ, 2013, CURR OPIN INFECT DIS, V26, P429, DOI 10.1097/01.qco.0000433310.28771.cc
   Thomas SJ, 2011, HUM VACCINES, V7, P674, DOI 10.4161/hv.7.6.14985
   Thongcharoen P, 2007, JAIDS-J ACQ IMM DEF, V46, P48
   Thornton SA, 2005, CLIN INFECT DIS, V40, P519, DOI 10.1086/427501
   TIGERTT WD, 1969, ANN INTERN MED, V70, P150, DOI 10.7326/0003-4819-70-1-150
   Tomaras GD, 2017, IMMUNOL REV, V275, P245, DOI 10.1111/imr.12514
   Tschanz DW, 1995, COMMAND MILITARY HIS, P33
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Viputtijul K, 2002, AIDS RES HUM RETROV, V18, P1235, DOI 10.1089/08892220260387986
   Walker RI, 2015, VACCINE, V33, P954, DOI 10.1016/j.vaccine.2014.11.049
   WATSON DA, 1993, CLIN INFECT DIS, V17, P913, DOI 10.1093/clinids/17.5.913
   Watson J C, 1998, MMWR Recomm Rep, V47, P1
   WHO, 2016, MAL VACC WHO POS PAP, P33
   World Health Organization, 2016, DENG VACC WHO POS PA, V91, P349
   World Health Organization (WHO), 2017, TOP 10 CAUS DEATH
   YOUNG MD, 1961, AM J TROP MED HYG, V10, P317, DOI 10.4269/ajtmh.1961.10.317
NR 117
TC 5
Z9 5
U1 1
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD JUN 21
PY 2018
VL 9
AR 1397
DI 10.3389/fimmu.2018.01397
PG 14
WC Immunology
SC Immunology
GA GK0BZ
UT WOS:000435772300001
PM 29977239
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McIntyre, W
   Netzband, R
   Bonenfant, G
   Biegel, JM
   Miller, C
   Fuchs, G
   Henderson, E
   Arra, M
   Canki, M
   Fabris, D
   Pager, CT
AF McIntyre, Will
   Netzband, Rachel
   Bonenfant, Gaston
   Biegel, Jason M.
   Miller, Clare
   Fuchs, Gabriele
   Henderson, Eric
   Arra, Manoj
   Canki, Mario
   Fabris, Daniele
   Pager, Cara T.
TI Positive-sense RNA viruses reveal the complexity and dynamics of the
   cellular and viral epitranscriptomes during infection
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID HEPATITIS-C-VIRUS; MASS-SPECTROMETRY; OXIDATIVE STRESS; FORM
   PSEUDOURIDINES; ACTIVATES STAT-3; RIBOSOMAL-RNA; NUCLEIC-ACIDS;
   METHYLATION; HIV-1; HELICASE
AB More than 140 post-transcriptional modifications (PTMs) are known to decorate cellular RNAs, but their incidence, identity and significance in viral RNA are still largely unknown. We have developed an agnostic analytical approach to comprehensively survey PTMs on viral and cellular RNAs. Specifically, we used mass spectrometry to analyze PTMs on total RNA isolated from cells infected with Zika virus, Dengue virus, hepatitis C virus (HCV), poliovirus and human immunodeficiency virus type 1. All five RNA viruses significantly altered global PTM landscapes. Examination of PTM profiles of individual viral genomes isolated by affinity capture revealed a plethora of PTMs on viral RNAs, which far exceeds the handful of well-characterized modifications. Direct comparison of viral epitranscriptomes identified common and virus-specific PTMs. In particular, specific dimethylcytosine modifications were only present in total RNA from virus-infected cells, and in intracellular HCV RNA, and viral RNA from Zika and HCV virions. Moreover, dimethylcytosine abundance during viral infection was modulated by the cellular DEAD-box RNA helicase DDX6. By opening the Pandora's box on viral PTMs, this report presents numerous questions and hypotheses on PTM function and strongly supports PTMs as a new tier of regulation by which RNA viruses subvert the host and evade cellular surveillance systems.
C1 [McIntyre, Will; Netzband, Rachel; Bonenfant, Gaston; Biegel, Jason M.; Miller, Clare; Fuchs, Gabriele; Henderson, Eric; Fabris, Daniele; Pager, Cara T.] SUNY Albany, RNA Inst, Albany, NY 12222 USA.
   [Arra, Manoj; Canki, Mario] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA.
RP Fabris, D; Pager, CT (corresponding author), SUNY Albany, RNA Inst, Albany, NY 12222 USA.
EM dfabris@albany.edu; ctpager@albany.edu
OI Fuchs, Gabriele/0000-0002-6838-2100; Bonenfant,
   Gaston/0000-0002-0081-7470
FU University at Albany-SUNY and New York State Start-up Funds;
   Presidential Initiatives Fund for Research and Scholarship (PIFRS);
   American Association for the Study of Liver Diseases; National Institute
   of Allergy and Infectious Diseases (NIAID)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R21
   AI133617-01]; National Institute of General Medical SciencesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [R01 GM121844-01]
FX University at Albany-SUNY and New York State Start-up Funds (to C.T.P.);
   Presidential Initiatives Fund for Research and Scholarship (PIFRS) (to
   C.T.P.); American Association for the Study of Liver Diseases (to
   C.T.P.); National Institute of Allergy and Infectious Diseases (NIAID)
   [R21 AI133617-01 to C.T.P., D.F.]; National Institute of General Medical
   Sciences [R01 GM121844-01 to D.F.]. Funding for open access charge:
   NIAID [R21 AI133617-01].
CR Ansmant I, 2001, J BIOL CHEM, V276, P34934, DOI 10.1074/jbc.M103131200
   Bakin AV, 1998, METH MOL B, V77, P297
   Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015
   Biegel JM, 2017, VIROLOGY, V507, P231, DOI 10.1016/j.virol.2017.04.014
   Bisaillon M, 1997, VIROLOGY, V236, P1, DOI 10.1006/viro.1997.8698
   Bouvet M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000863
   CANAANI D, 1979, NUCLEIC ACIDS RES, V6, P2879, DOI 10.1093/nar/6.8.2879
   Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028
   Carell T, 2012, ANGEW CHEM INT EDIT, V51, P7110, DOI 10.1002/anie.201201193
   Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938
   Chang KY, 1997, NAT STRUCT BIOL, V4, P854
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chen K, 2016, CELL CHEM BIOL, V23, P74, DOI 10.1016/j.chembiol.2015.11.007
   Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324
   Collings BA, 2001, RAPID COMMUN MASS SP, V15, P1777, DOI 10.1002/rcm.440
   Crain PF, 1998, CURR OPIN BIOTECH, V9, P25, DOI 10.1016/S0958-1669(98)80080-3
   CRAIN PF, 1990, METHOD ENZYMOL, V193, P782, DOI 10.1016/0076-6879(90)93450-Y
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   DAVIS FF, 1957, J BIOL CHEM, V227, P907
   Ding Y, 2004, NUCLEIC ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449
   Dominissini D, 2016, NATURE, V530, P441, DOI 10.1038/nature16998
   Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong ZW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks698
   Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084
   Durbin AF, 2016, MBIO, V7, DOI 10.1128/mBio.00833-16
   Endres L, 2015, RNA BIOL, V12, P603, DOI 10.1080/15476286.2015.1031947
   Fabris D, 2011, ANAL CHEM, V83, P5810, DOI 10.1021/ac200374y
   Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102
   Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017
   Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711
   Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gong GZ, 2001, P NATL ACAD SCI USA, V98, P9599, DOI 10.1073/pnas.171311298
   Gong YD, 2012, INT CONF INFRA MILLI
   Gonzales-van Horn SR, 2017, CELL HOST MICROBE, V21, P661, DOI 10.1016/j.chom.2017.05.008
   Groppelli E, 2015, J VIROL, V89, P14, DOI 10.1128/JVI.02425-14
   GROSJEAN H, 2005, TOPICS CURRENT GENET, V12
   Gutgsell NS, 2001, RNA, V7, P990, DOI 10.1017/S1355838201000243
   Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471
   Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144
   Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657
   Hyde JL, 2015, VIROLOGY, V479, P66, DOI 10.1016/j.virol.2015.01.019
   Iglesias NG, 2011, RNA BIOL, V8, P249, DOI 10.4161/rna.8.2.14992
   Jackman JE, 2003, RNA, V9, P574, DOI 10.1261/rna.5070303
   KANE SE, 1985, MOL CELL BIOL, V5, P2298, DOI 10.1128/MCB.5.9.2298
   Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285
   Kimura S, 2010, NUCLEIC ACIDS RES, V38, P1341, DOI 10.1093/nar/gkp1073
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   King TH, 2003, MOL CELL, V11, P425, DOI 10.1016/S1097-2765(03)00040-6
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   KIRKEGAARD K, 1986, CELL, V47, P433, DOI 10.1016/0092-8674(86)90600-8
   Kleiman L, 2004, INT J BIOCHEM CELL B, V36, P1776, DOI 10.1016/j.biocel.2004.02.022
   KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014
   KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976
   Lee KW, 2014, J BIOL CHEM, V289, P24936, DOI 10.1074/jbc.C114.581868
   Li JJ, 2005, CURR BIOL, V15, P1501, DOI 10.1016/j.cub.2005.07.029
   Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200
   Li MMH, 2015, TRENDS CELL BIOL, V25, P320, DOI 10.1016/j.tcb.2015.02.001
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Limbach PA, 1996, MASS SPECTROM REV, V15, P297, DOI 10.1002/(SICI)1098-2787(1996)15:5<297::AID-MAS2>3.0.CO;2-D
   LIMBACH PA, 1994, NUCLEIC ACIDS RES, V22, P2183, DOI 10.1093/nar/22.12.2183
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24
   Lohmann V, 2001, J VIROL, V75, P1437, DOI 10.1128/JVI.75.3.1437-1449.2001
   Lumb JH, 2017, CELL REP, V20, P819, DOI 10.1016/j.celrep.2017.06.085
   Ma YM, 2014, J VIROL, V88, P2913, DOI 10.1128/JVI.03420-13
   Machnicka MA, 2013, NUCLEIC ACIDS RES, V41, pD262, DOI 10.1093/nar/gks1007
   Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022
   McCloskey J A, 1979, Nucleic Acids Symp Ser, ps109
   McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   NARAYAN P, 1987, MOL CELL BIOL, V7, P1572, DOI 10.1128/MCB.7.4.1572
   Nordhoff E, 1996, MASS SPECTROM REV, V15, P67, DOI 10.1002/(SICI)1098-2787(1996)15:2<67::AID-MAS1>3.0.CO;2-8
   Onafuwa-Nuga AA, 2006, RNA, V12, P542, DOI 10.1261/rna.2306306
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Park IW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099545
   Piccoli C, 2007, HEPATOLOGY, V46, P58, DOI 10.1002/hep.21679
   Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914
   Presnyak V, 2013, BBA-GENE REGUL MECH, V1829, P817, DOI 10.1016/j.bbagrm.2013.03.006
   Reed JC, 2012, J CELL BIOL, V198, P439, DOI 10.1083/jcb.201111012
   Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017
   Rose RE, 2016, MOL CELL PROTEOMICS, V15, P932, DOI 10.1074/mcp.M115.054718
   Rose RE, 2015, RNA, V21, P1361, DOI 10.1261/rna.049429.114
   Sainz B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006561
   Schaefer M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn954
   Shafik A., 2015, BIOCHIM BIOPHYS ACTA, V1859, P59
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   TOMER KB, 1988, ANAL CHEM, V60, P2232, DOI 10.1021/ac00171a014
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Waris G, 2005, J VIROL, V79, P9725, DOI 10.1128/JVI.79.15.9725-9734.2005
   Waris G, 2005, J VIROL, V79, P1569, DOI 10.1128/JVI.79.3.1569-1580.2005
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Wei Y, 2012, J STRUCT BIOL, V179, P29, DOI 10.1016/j.jsb.2012.04.011
   Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127
   Wilm M, 1996, ANAL CHEM, V68, P1, DOI 10.1021/ac9509519
   YAMASHITA M, 1984, J PHYS CHEM-US, V88, P4451, DOI 10.1021/j150664a002
   Yasuda-Inoue M, 2013, BIOCHEM BIOPH RES CO, V434, P803, DOI 10.1016/j.bbrc.2013.04.016
   YIH LH, 1991, CELL BIOL INT REP, V15, P253, DOI 10.1016/0309-1651(91)90157-E
   Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132
   Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zhu J, 2007, P NATL ACAD SCI USA, V104, P3129, DOI 10.1073/pnas.0611617104
NR 109
TC 19
Z9 19
U1 2
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 20
PY 2018
VL 46
IS 11
BP 5776
EP 5791
DI 10.1093/nar/gky029
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GM7JW
UT WOS:000438362400036
PM 29373715
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Coffey, LL
   Keesler, RI
   Pesavento, PA
   Woolard, K
   Singapuri, A
   Watanabe, J
   Cruzen, C
   Christe, KL
   Usachenko, J
   Yee, J
   Heng, VA
   Bliss-Moreau, E
   Reader, JR
   von Morgenland, W
   Gibbons, AM
   Jackson, K
   Ardeshir, A
   Heimsath, H
   Permar, S
   Senthamaraikannan, P
   Presicce, P
   Kallapur, SG
   Linnen, JM
   Gao, K
   Orr, R
   MacGill, T
   McClure, M
   McFarland, R
   Morrison, JH
   Van Rompay, KKA
AF Coffey, Lark L.
   Keesler, Rebekah I.
   Pesavento, Patricia A.
   Woolard, Kevin
   Singapuri, Anil
   Watanabe, Jennifer
   Cruzen, Christina
   Christe, Kari L.
   Usachenko, Jodie
   Yee, JoAnn
   Heng, Victoria A.
   Bliss-Moreau, Eliza
   Reader, J. Rachel
   von Morgenland, Wilhelm
   Gibbons, Anne M.
   Jackson, Kenneth
   Ardeshir, Amir
   Heimsath, Holly
   Permar, Sallie
   Senthamaraikannan, Paranthaman
   Presicce, Pietro
   Kallapur, Suhas G.
   Linnen, Jeffrey M.
   Gao, Kui
   Orr, Robert
   MacGill, Tracy
   McClure, Michelle
   McFarland, Richard
   Morrison, John H.
   Van Rompay, Koen K. A.
TI Intraamniotic Zika virus inoculation of pregnant rhesus macaques
   produces fetal neurologic disease
SO NATURE COMMUNICATIONS
LA English
DT Article
ID BRAIN ABNORMALITY; NONHUMAN PRIMATE; MACACA-MULATTA; CASE SERIES;
   INFECTION; BRAZIL; TRANSMISSION; PLACENTA; MONKEYS; VACCINE
AB Zika virus (ZIKV) infection of pregnant women can cause fetal microcephaly and other neurologic defects. We describe the development of a non-human primate model to better understand fetal pathogenesis. To reliably induce fetal infection at defined times, four pregnant rhesus macaques are inoculated intravenously and intraamniotically with ZIKV at gestational day (GD) 41, 50, 64, or 90, corresponding to first and second trimester of gestation. The GD41-inoculated animal, experiencing fetal death 7 days later, has high virus levels in fetal and placental tissues, implicating ZIKV as cause of death. The other three fetuses are carried to near term and euthanized; while none display gross microcephaly, all show ZIKV RNA in many tissues, especially in the brain, which exhibits calcifications and reduced neural precursor cells. Given that this model consistently recapitulates neurologic defects of human congenital Zika syndrome, it is highly relevant to unravel determinants of fetal neuropathogenesis and to explore interventions.
C1 [Coffey, Lark L.; Pesavento, Patricia A.; Woolard, Kevin; Singapuri, Anil; Jackson, Kenneth] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.
   [Keesler, Rebekah I.; Watanabe, Jennifer; Cruzen, Christina; Christe, Kari L.; Usachenko, Jodie; Yee, JoAnn; Heng, Victoria A.; Bliss-Moreau, Eliza; Reader, J. Rachel; von Morgenland, Wilhelm; Gibbons, Anne M.; Ardeshir, Amir; Morrison, John H.; Van Rompay, Koen K. A.] Univ Calif Davis, Calif Natl Primate Res Ctr, 1 Shields Ave, Davis, CA 95616 USA.
   [Heng, Victoria A.] Radboud Univ Nijmegen, Donders Inst, Montessorilaan 3, NL-6525 HR Nijmegen, Netherlands.
   [Bliss-Moreau, Eliza] Univ Calif Davis, Dept Psychol, 1 Shields Ave, Davis, CA 95616 USA.
   [Heimsath, Holly; Permar, Sallie] Duke Univ, Med Ctr, Duke Human Vaccine Inst, 103020,2 Genome Court MSRBII, Durham, NC 27710 USA.
   [Senthamaraikannan, Paranthaman] Cincinnati Childrens Hosp Res Fdn, Div Neonatol & Pulm Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.
   [Presicce, Pietro; Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Presicce, Pietro; Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Dev Biol, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.
   [Linnen, Jeffrey M.; Gao, Kui] Grifols Diagnost Solut Inc, 10808 Willow Court, San Diego, CA 92127 USA.
   [Orr, Robert; MacGill, Tracy] US FDA, Off Counterterrorism & Emerging Threats, Off Chief Scientist, 25 New Hampshire Ave, Silver Spring, MD 20903 USA.
   [McClure, Michelle] US FDA, Off Tissues & Adv Therapies, Ctr Biol Evaluat & Res, 10903 New Hampshire Ave, Silver Spring, MD 20903 USA.
   [McFarland, Richard] Adv Regenerat Mfg Inst, 400 Commercial St, Manchester, NH 03101 USA.
RP Coffey, LL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, 1 Shields Ave, Davis, CA 95616 USA.; Van Rompay, KKA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, 1 Shields Ave, Davis, CA 95616 USA.
EM lcoffey@ucdavis.edu; kkvanrompay@ucdavis.edu
RI Senthamaraikannan, Paranthaman/H-3992-2018; Presicce,
   Pietro/AAN-8719-2020; Ardeshir, Amir/Q-1258-2017
OI Senthamaraikannan, Paranthaman/0000-0002-3333-3720; Presicce,
   Pietro/0000-0002-2690-1814; Ardeshir, Amir/0000-0002-4330-4659
FU CNPRC pilot research grant; Office of Research Infrastructure
   Programs/OD [P51OD011107]; Pathology, Microbiology and Immunology
   Department [1R21AI129479-01]; United States Food and Drug Administration
   (FDA) [HHSF223201610542P]
FX We acknowledge the research and support staff at CNPRC for their
   assistance with all aspects of the study, as well as the UC Davis IACUC
   and Environmental Health and Safety Offices for expedited approval for
   work on this project. Sarah Mills, Abigail Spinner, and the staff of the
   Pathogen Detection Laboratory, Clinical Laboratories and Colony Research
   Services at CNPRC helped with procedures, necropsies and biospecimen
   processing, and analysis. Kathy West provided illustrations. The Zika
   research team at the Wisconsin National Primate Research Center provided
   ongoing advice and data sharing. This study was supported by a CNPRC
   pilot research grant to L.L.C. and K.K.A. v.R., the Office of Research
   Infrastructure Programs/OD (P51OD011107), start up funds from the
   Pathology, Microbiology and Immunology Department, and 1R21AI129479-01
   to K.K.A.v.R. This effort was partially funded by the United States Food
   and Drug Administration (FDA), via contract #HHSF223201610542P
   "Companion Studies to Define the Distribution and Duration of Zika virus
   Infection in Non-Human Primates". The views, opinions, and/or findings
   contained in this report are those of the authors and not necessarily
   those of the FDA.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Barry PA, 2006, ILAR J, V47, P49, DOI 10.1093/ilar.47.1.49
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   FAZELY F, 1993, J ACQ IMMUN DEF SYND, V6, P107
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hopper KJ, 2008, COMPARATIVE MED, V58, P597
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Makori N, 2003, CLIN DIAGN LAB IMMUN, V10, P140, DOI 10.1128/CDLI.10.1.140-153.2003
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Presicce P, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124420
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Schmidt AF, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0706-4
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Smith DR, 2006, EMERG INFECT DIS, V12, P1190, DOI 10.3201/eid1708.050841
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   TARANTAL AF, 1988, J MED PRIMATOL, V17, P105
   Tarantal Alice F., 2005, P317, DOI 10.1016/B978-012080261-6/50020-9
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Wiwanitkit V, 2016, AM J REPROD IMMUNOL, V76, P97, DOI 10.1111/aji.12521
   Xavier-Neto J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005363
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 62
TC 22
Z9 23
U1 2
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 20
PY 2018
VL 9
AR 2414
DI 10.1038/s41467-018-04777-6
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ8PA
UT WOS:000435650800005
PM 29925843
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Julander, JG
   Siddharthan, V
   Park, AH
   Preston, E
   Mathur, P
   Bertolio, M
   Wang, H
   Zukor, K
   Van Wettere, AJ
   Sinex, DG
   Morrey, JD
AF Julander, Justin G.
   Siddharthan, Venkatraman
   Park, Albert H.
   Preston, Elizabeth
   Mathur, Pranav
   Bertolio, Michael
   Wang, Hong
   Zukor, Katherine
   Van Wettere, Arnaud J.
   Sinex, Donal G.
   Morrey, John D.
TI Consequences of in utero exposure to Zika virus in offspring of AG129
   mice
SO SCIENTIFIC REPORTS
LA English
DT Article
ID WEST-NILE-VIRUS; HEARING-LOSS; SPINAL-CORD; INFECTION; MODELS;
   PATHOGENESIS; BRAZIL
AB Zika virus (ZIKV) can cause various diseases in offspring after congenital infection. The purpose of this study was to identify disease phenotypes in pups exposed to ZIKV in utero. Female interferon-alpha/ss, -gamma receptor knockout mice (AG129) were infected intraperitoneally with ZIKV 7.5 days' post coitus (dpc). Viral RNA, antigen and infectious virus were detected in some, but not all, maternal and fetal tissues at various times during gestation. Fetuses of infected dams had significant intrauterine growth restriction (IUGR), which was more pronounced as females neared parturition. Pups born to infected dams were significantly smaller and had significantly shortened skull lengths, as determined by measurement with a caliper and by micro-CT analysis, as compared with age-matched controls. Growth rates of exposed pups after birth, however, was similar to sham-exposed offspring. Viral RNA was detected in pups of infected dams after birth. A lower survival rate was observed in neonates exposed to ZIKV in utero. A mortality rate of over 50%, attributed to consequences of ZIKV infection, occurred after birth in pups born to infected dams. A transient hearing loss was observed in some animals exposed to virus in utero. No motor deficits or cognitive deficits were detected using running wheel or viral paresis scoring assays. Abnormalities in offspring included smaller size, shorter skull length and increased neonatal mortality, while the only functional deficit we could detect was a low incidence of transient hearing loss.
C1 [Julander, Justin G.; Siddharthan, Venkatraman; Bertolio, Michael; Wang, Hong; Zukor, Katherine; Morrey, John D.] Utah State Univ, Anim Dairy & Vet Sci Dept, Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Park, Albert H.] Univ Utah, Div Otolaryngol Head & Neck Surg, 50 N Med Dr, Salt Lake City, UT USA.
   [Preston, Elizabeth] Utah State Univ, Dept Commun Disorders & Deaf Educ, Audiol Div, 2620 Old Main Hill, Logan, UT 84322 USA.
   [Mathur, Pranav] Univ Utah, Dept Neurobiol & Anat, 1795 E South Campus Dr, Salt Lake City, UT 84112 USA.
   [Van Wettere, Arnaud J.] Utah State Univ, Utah Vet Diagnost Lab, 950 E 1400 N, Logan, UT 84341 USA.
   [Sinex, Donal G.] Utah State Univ, Dept Biol, 5305 Old Main Hill, Logan, UT 84322 USA.
RP Julander, JG (corresponding author), Utah State Univ, Anim Dairy & Vet Sci Dept, Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.
EM justin.julander@usu.edu
RI Mathur, Pranav/Y-1529-2019
OI Ditton, Thomas/0000-0003-4622-2613; Sinex, Donal/0000-0002-0673-7252;
   Van Wettere, Arnaud/0000-0002-9611-1316
FU NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [5R33AI101483-05]; Virology Branch, NIAID,
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [HHSN272201000039I]
FX We thank the following individuals from the Institute for Antiviral
   Research at Utah State University for their excellent technical
   assistance: Heidi Julander for maintenance of transgenic mouse colonies
   and providing timed-pregnant animals for studies. Neil Motter for
   designing and building the in-house ABR instrument. Skot Neilson, Jason
   Fairbourn, Jean Maxwell, Jared Bennet, John McClatchy, Devin Pfister,
   Rachelle Stanton and Trevor Truex for monitoring of females for births
   and assisting with animal studies. Preston Collins, Mitch Stevens and
   Jason Stewart for help with immunohistochemistry and infectious assays.
   Thomas Ditton, and Christian Morrill for RT-PCR. We also thank Samar
   Sarfaraz Merchant (Department of Bio-engineering, University of Utah)
   for performing Micro CT and Gobalakrishnan Sundaresan (Department of
   Radiology, Virginia Commonwealth University) for helpful suggestions
   with micro-CT. This work was supported in part by the R33 grant
   5R33AI101483-05, NIAID, NIH and by contract HHSN272201000039I from the
   Virology Branch, NIAID, NIH.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Cugola F. R., 2016, BRAZILIAN ZIKA VIRUS
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Hatzipetros T, 2015, JOVE-J VIS EXP, DOI 10.3791/53257
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Julander JG, 2006, VIROLOGY, V347, P175, DOI 10.1016/j.virol.2005.11.040
   Julander JG, 2005, ANTIVIR RES, V65, P79, DOI 10.1016/j.antiviral.2004.10.005
   Julander JG, 2017, J INFECT DIS, V216, pS919, DOI 10.1093/infdis/jix465
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Wang Y, 2013, LARYNGOSCOPE, V123, P2801, DOI 10.1002/lary.24090
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu JH, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9070165
NR 42
TC 8
Z9 8
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 20
PY 2018
VL 8
AR 9384
DI 10.1038/s41598-018-27611-x
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ8HM
UT WOS:000435630000010
PM 29925850
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Channon, RB
   Yang, YY
   Feibelman, KM
   Geiss, BJ
   Dandy, DS
   Henry, CS
AF Channon, Robert B.
   Yang, Yuanyuan
   Feibelman, Kristen M.
   Geiss, Brian J.
   Dandy, David S.
   Henry, Charles S.
TI Development of an Electrochemical Paper-Based Analytical Device for
   Trace Detection of Virus Particles
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID WEST-NILE-VIRUS; LATERAL-FLOW ASSAY; APTAMER-BASED SENSORS; LABEL-FREE
   DETECTION; IMPEDANCE SPECTROSCOPY; ZIKA VIRUS; IMPEDIMETRIC
   IMMUNOSENSORS; JAPANESE ENCEPHALITIS; INFLUENZA-VIRUS; RAPID DETECTION
AB Viral pathogens are a serious health threat around the world, particularly in resource limited settings, where current sensing approaches are often insufficient and slow, compounding the spread and burden of these pathogens. Here, we describe a label-free, point-of-care approach toward detection of virus particles, based on a microfluidic paper-based analytical device with integrated microwire Au electrodes. The device is initially characterized through capturing of streptavidin modified nanoparticles by biotin-modified microwires. An order of magnitude improvement in detection limits is achieved through use of a microfluidic device over a classical static paper-based device, due to enhanced mass transport and capturing of particles on the modified electrodes. Electrochemical impedance spectroscopy detection of West Nile virus particles was carried out using antibody functionalized Au microwires, achieving a detection limit of 10.2 particles in 50 mu L of cell culture media. No increase in signal is found on addition of an excess of a nonspecific target (Sindbis). This detection motif is significantly cheaper (similar to$1 per test) and faster (similar to 30 min) than current methods, while achieving the desired selectivity and sensitivity. This sensing motif represents a general platform for trace detection of a wide range of biological pathogens.
C1 [Channon, Robert B.; Yang, Yuanyuan; Henry, Charles S.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Feibelman, Kristen M.; Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Dandy, David S.; Henry, Charles S.] Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.; Dandy, David S.; Henry, Charles S.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP Henry, CS (corresponding author), Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.; Henry, CS (corresponding author), Colorado State Univ, Dept Chem & Biol Engn, Ft Collins, CO 80523 USA.; Henry, CS (corresponding author), Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
EM Chuck.Henry@colostate.edu
RI Dandy, David/G-6984-2012; Henry, Charles S/AAG-8084-2019
OI Dandy, David/0000-0003-3254-0717; Henry, Charles S/0000-0002-8671-7728
FU CSU through the Catalyst for Innovative Partnerships program; USDA
   through the National Wildlife Research Center (NWRC) [AP17WSNWRC00C027];
   NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI114675]; NIOSHUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USANational Institute for Occupational Safety & Health
   (NIOSH) [R01 OH010662]
FX R.B.C., Y.Y., and C.S.H. thank CSU through the Catalyst for Innovative
   Partnerships program and the USDA through the National Wildlife Research
   Center (NWRC, AP17WSNWRC00C027) for project support. K.M.F. and B.J.G.
   are grateful for partial support from NIH/NIAID R01 AI114675. R.B.C. is
   grateful for partial support from NIOSH R01 OH010662.
CR Adelman ZN, 2001, INSECT MOL BIOL, V10, P265, DOI 10.1046/j.1365-2583.2001.00267.x
   Adkins JA, 2016, ANAL CHEM, V88, P10639, DOI 10.1021/acs.analchem.6b03010
   Adkins JA, 2015, ANAL CHIM ACTA, V891, P247, DOI 10.1016/j.aca.2015.07.019
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Bogomolova A, 2009, ANAL CHEM, V81, P3944, DOI 10.1021/ac9002358
   Burkhalter KL, 2014, J AM MOSQUITO CONTR, V30, P21, DOI 10.2987/13-6386.1
   Chang BY, 2010, ANNU REV ANAL CHEM, V3, P207, DOI 10.1146/annurev.anchem.012809.102211
   Channon RB, 2018, LAB CHIP, V18, P793, DOI 10.1039/c7lc01300k
   Daniels JS, 2007, ELECTROANAL, V19, P1239, DOI 10.1002/elan.200603855
   Devarakonda S, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17112597
   Fall G, 2016, VECTOR-BORNE ZOONOT, V16, P781, DOI 10.1089/vbz.2016.1967
   Feng QM, 2015, SENSOR ACTUAT B-CHEM, V209, P870, DOI 10.1016/j.snb.2014.12.062
   Foord AJ, 2014, J VIROL METHODS, V203, P65, DOI 10.1016/j.jviromet.2014.03.018
   Fros JJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003956
   Galula JU, 2016, J CLIN MICROBIOL, V54, P412, DOI 10.1128/JCM.02469-15
   Glavan AC, 2014, ANAL CHEM, V86, P11999, DOI 10.1021/ac5020782
   Gong MM, 2017, CHEM REV, V117, P8447, DOI 10.1021/acs.chemrev.7b00024
   Gupta RK, 2014, BIOSENS BIOELECTRON, V59, P112, DOI 10.1016/j.bios.2014.03.027
   HARVEY JD, 1973, VIROLOGY, V56, P365, DOI 10.1016/0042-6822(73)90313-9
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Herrmann S, 2005, TALANTA, V66, P6, DOI 10.1016/j.talanta.2004.10.013
   Jiang J, 2014, SENSOR ACTUAT B-CHEM, V193, P653, DOI 10.1016/j.snb.2013.11.103
   Katz E, 2003, ELECTROANAL, V15, P913, DOI 10.1002/elan.200390114
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Kelley SO, 2017, ACS SENSORS, V2, P193, DOI 10.1021/acssensors.6b00691
   Kramer LD, 2007, LANCET NEUROL, V6, P171, DOI 10.1016/S1474-4422(07)70030-3
   Lasia A, 2002, ELECTROCHEMICAL IMPE, DOI [10.1007/0-306-46916-2_2, DOI 10.1007/0-306-46916-2_2]
   Lazar J, 2016, ANAL CHEM, V88, P682, DOI 10.1021/acs.analchem.5b02367
   Le TT, 2017, ANAL CHEM, V89, P6781, DOI 10.1021/acs.analchem.7b01149
   Li ZM, 2017, ANAL METHODS-UK, V9, P5238, DOI 10.1039/c7ay01585b
   Ma C, 2015, BIOSENS BIOELECTRON, V63, P7, DOI 10.1016/j.bios.2014.07.014
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Otte K., 1992, TRANSPL P, P449
   Palomar Q, 2017, BIOSENS BIOELECTRON, V97, P177, DOI 10.1016/j.bios.2017.05.052
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Peeling RW, 2010, CLIN MICROBIOL INFEC, V16, P1062, DOI 10.1111/j.1469-0691.2010.03279.x
   Plaxco KW, 2011, TRENDS BIOTECHNOL, V29, P1, DOI 10.1016/j.tibtech.2010.10.005
   Putzbach W, 2013, SENSORS-BASEL, V13, P4811, DOI 10.3390/s130404811
   Ricci F, 2009, ANAL CHEM, V81, P1608, DOI 10.1021/ac802365x
   Ryan J, 2003, J MED ENTOMOL, V40, P95, DOI 10.1603/0022-2585-40.1.95
   Safaei TS, 2015, ACS APPL MATER INTER, V7, P14165, DOI 10.1021/acsami.5b02404
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Schoukroun-Barnes LR, 2016, ANNU REV ANAL CHEM, V9, P163, DOI 10.1146/annurev-anchem-071015-041446
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Songjaroen Temsiri, 2016, Sensing and Bio-Sensing Research, V8, P14, DOI 10.1016/j.sbsr.2016.03.003
   Srisombat L, 2011, COLLOID SURFACE A, V390, P1, DOI 10.1016/j.colsurfa.2011.09.020
   Tang RH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01558-x
   Vogels CBF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05185-4
   White RJ, 2008, LANGMUIR, V24, P10513, DOI 10.1021/la800801v
   Wu SJL, 2001, J CLIN MICROBIOL, V39, P2794, DOI 10.1128/JCM.39.8.2794-2798.2001
   Yang YY, 2017, ANAL CHEM, V89, P71, DOI 10.1021/acs.analchem.6b04581
   Yu CM, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/32/325501
   Zhao W, 2012, ANAL CHEM, V84, P2358, DOI 10.1021/ac203102u
   Zhu M, 2016, J VIROL METHODS, V235, P51, DOI 10.1016/j.jviromet.2016.05.011
NR 55
TC 17
Z9 17
U1 27
U2 94
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD JUN 19
PY 2018
VL 90
IS 12
BP 7777
EP 7783
DI 10.1021/acs.analchem.8b02042
PG 7
WC Chemistry, Analytical
SC Chemistry
GA GK3FZ
UT WOS:000436028800092
PM 29790331
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Vicenzi, E
   Pagani, I
   Ghezzi, S
   Taylor, SL
   Rudd, TR
   Lima, MA
   Skidmore, MA
   Yates, EA
AF Vicenzi, Elisa
   Pagani, Isabel
   Ghezzi, Silvia
   Taylor, Sarah L.
   Rudd, Timothy R.
   Lima, Marcelo A.
   Skidmore, Mark A.
   Yates, Edwin A.
TI Subverting the mechanisms of cell death: flavivirus manipulation of host
   cell responses to infection
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Review
ID WEST-NILE-VIRUS; HUMAN ENDOTHELIAL-CELLS; BORNE ENCEPHALITIS-VIRUS;
   HEPARAN-SULFATE PROTEOGLYCANS; UNFOLDED PROTEIN RESPONSE; YELLOW-FEVER
   VIRUS; DENGUE-VIRUS; ZIKA VIRUS; ENVELOPE PROTEIN; CULTURED-CELLS
AB Viruses exploit host metabolic and defence machinery for their own replication. The flaviviruses, which include Dengue (DENV), Yellow Fever (YFV), Japanese Encephalitis (JEV), West Nile (WNV) and Zika (ZIKV) viruses, infect a broad range of hosts, cells and tissues. Flaviviruses are largely transmitted by mosquito bites and humans are usually incidental, dead-end hosts, with the notable exceptions of YFV, DENV and ZIKV. Infection by flaviviruses elicits cellular responses including cell death via necrosis, pyroptosis (involving inflammation) or apoptosis (which avoids inflammation). Flaviviruses exploit these mechanisms and subvert them to prolong viral replication. The different effects induced by DENV, WNV, JEV and ZIKV are reviewed. Host cell surface proteoglycans (PGs) bearing glycosaminoglycan (GAG) polysaccharides -heparan/chondroitin sulfate (HS/CS)-are involved in initial flavivirus attachment and during the expression of non-structural viral proteins play a role in disease aetiology. Recent work has shown that ZIKVinfected cells are protected from cell death by exogenous heparin (a GAG structurally similar to host cell surface HS), raising the possibility of further subtle involvement of HS PGs in flavivirus disease processes. The aim of this review is to synthesize information regarding DENV, WNV, JEV and ZIKV from two areas that are usually treated separately: the response of host cells to infection by flaviviruses and the involvement of cell surface GAGs in response to those infections.
C1 [Vicenzi, Elisa; Pagani, Isabel; Ghezzi, Silvia] Osped San Raffaele, Viral Pathogens & Biosafety Unit, Via Olgettina 60, I-20132 Milan, Italy.
   [Taylor, Sarah L.; Rudd, Timothy R.; Yates, Edwin A.] Univ Liverpool, IIB, Dept Biochem, Crown St, Liverpool L69 7ZB, Merseyside, England.
   [Rudd, Timothy R.] NIBSC, Blanche Lane,South Mimms, Potters Bar EN6 3QG, Herts, England.
   [Lima, Marcelo A.; Skidmore, Mark A.; Yates, Edwin A.] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil.
   [Lima, Marcelo A.; Skidmore, Mark A.; Yates, Edwin A.] Keele Univ, Sch Life Sci, Keele ST5 5BG, Staffs, England.
RP Vicenzi, E (corresponding author), Osped San Raffaele, Viral Pathogens & Biosafety Unit, Via Olgettina 60, I-20132 Milan, Italy.
EM vicenzi.elisa@hsr.it
RI ghezzi, silvia/AAN-4092-2020; Pagani, Isabel/AAB-3301-2019; Vicenzi,
   Elisa/AAL-3980-2020; Rudd, Tim/M-6129-2019
OI Pagani, Isabel/0000-0001-5396-0740; Rudd, Tim/0000-0003-4434-0333;
   Skidmore, Mark/0000-0002-0287-5594; Ghezzi, Silvia/0000-0002-7586-663X
FU Italian Ministry of HealthMinistry of Health, Italy; BBSRCBiotechnology
   and Biological Sciences Research Council (BBSRC); FAPESPFundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); CNPqNational Council
   for Scientific and Technological Development (CNPq)
FX The authors acknowledge funding from the Italian Ministry of Health
   (E.V.), BBSRC (E.A.Y., M.A.S. and S.L.T.), FAPESP and CNPq (M.A.L. and
   E.A.Y.).
CR Avirutnan P, 1998, J IMMUNOL, V161, P6338
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Beatman E, 2012, VIROLOGY, V433, P262, DOI 10.1016/j.virol.2012.08.016
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Blair CD, 2000, CLIN MICROBIOL REV, V13, P651, DOI 10.1128/CMR.13.4.651-661.2000
   Brinton MA, 2001, ANN NY ACAD SCI, V951, P207
   Bussini S., 2005, AGEING, V2, P11, DOI [10.1186/1742-4933-2-11, DOI 10.1186/1742-4933-2-11]
   Carvalho-Leandro D, 2012, ACTA TROP, V124, P113, DOI 10.1016/j.actatropica.2012.07.006
   Catteau A, 2003, J GEN VIROL, V84, P2781, DOI 10.1099/vir.0.19163-0
   Chen HL, 2010, BIOPOLYMERS, V94, P331, DOI 10.1002/bip.21371
   Chen SO, 2006, INTERVIROLOGY, V49, P346, DOI 10.1159/000095154
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chu JJH, 2003, J GEN VIROL, V84, P3305, DOI 10.1099/vir.0.19447-0
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Couvelard A, 1999, HUM PATHOL, V30, P1106, DOI 10.1016/S0046-8177(99)90230-7
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Despres P, 1998, J VIROL, V72, P823
   Despres P, 1996, J VIROL, V70, P4090
   Donadieu E, 2013, VIRUSES-BASEL, V5, P2856, DOI 10.3390/v5112856
   Elhadj S, 2002, J CELL BIOCHEM, V86, P239, DOI 10.1002/jcb.10226
   Erb SM, 2010, VIROLOGY, V406, P328, DOI 10.1016/j.virol.2010.07.024
   Fouillet A, 2012, AUTOPHAGY, V8, P915, DOI 10.4161/auto.19716
   Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Gill S, 2010, ANAT REC, V293, P968, DOI 10.1002/ar.21094
   Haynes A, 2005, INFECT IMMUN, V73, P7914, DOI 10.1128/IAI.73.12.7914-7921.2005
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hills FA, 2006, MOL HUM REPROD, V12, P237, DOI 10.1093/molehr/gal026
   Ho CY, 2017, ANN NEUROL, V82, P121, DOI 10.1002/ana.24968
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004
   Jin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052909
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   KANER RJ, 1990, AM J RESP CELL MOL, V2, P423, DOI 10.1165/ajrcmb/2.5.423
   Kenig M, 2008, J CHROMATOGR B, V867, P119, DOI 10.1016/j.jchromb.2008.03.023
   KHANNA N, 1991, CLIN EXP IMMUNOL, V86, P299, DOI 10.1111/j.1365-2249.1991.tb05813.x
   Kozlovskaya LI, 2010, VIROLOGY, V398, P262, DOI 10.1016/j.virol.2009.12.012
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Lee E, 2008, J VIROL, V82, P6024, DOI 10.1128/JVI.02509-07
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Li JK, 2012, MICROBES INFECT, V14, P159, DOI 10.1016/j.micinf.2011.09.001
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liao CL, 1997, J VIROL, V71, P5963, DOI 10.1128/JVI.71.8.5963-5971.1997
   Liao CL, 1998, J VIROL, V72, P9844, DOI 10.1128/JVI.72.12.9844-9854.1998
   Lin RJ, 2004, J GEN VIROL, V85, P521, DOI 10.1099/vir.0.19496-0
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296
   Mandl CW, 2001, J VIROL, V75, P5627, DOI 10.1128/JVI.75.12.5627-5637.2001
   Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x
   Marianneau P, 1997, J VIROL, V71, P3244, DOI 10.1128/JVI.71.4.3244-3249.1997
   Marianneau P, 1998, CLIN DIAGN VIROL, V10, P113, DOI 10.1016/S0928-0197(98)00031-2
   McLean JE, 2008, CURR PHARM DESIGN, V14, P198
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Oliveira ERA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16197-5
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005
   Panyasrivanit M, 2011, VIROLOGY, V418, P74, DOI 10.1016/j.virol.2011.07.010
   Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100
   Pekosz A, 1996, J VIROL, V70, P5329, DOI 10.1128/JVI.70.8.5329-5335.1996
   Porcionatto MA, 1998, J CELL BIOCHEM, V70, P563, DOI 10.1002/(SICI)1097-4644(19980915)70:4<563::AID-JCB12>3.0.CO;2-I
   Raucci A, 2007, AUTOIMMUNITY, V40, P285, DOI 10.1080/08916930701356978
   Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x
   Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06
   Salas-Benito JS, 2015, J IMMUNOL RES, DOI 10.1155/2015/873404
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shen J, 1997, J VIROL, V71, P9323, DOI 10.1128/JVI.71.12.9323-9332.1997
   Shin SJ, 2003, J APPL PHYSIOL, V95, P308, DOI 10.1152/japplphysiol.00131.2003
   Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Su HL, 2002, J VIROL, V76, P4162, DOI 10.1128/JVI.76.9.4162-4171.2002
   Suwanmanee S, 2017, VIRAL IMMUNOL, V30, P13, DOI 10.1089/vim.2016.0092
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tschopp J, 1998, CURR OPIN GENET DEV, V8, P82, DOI 10.1016/S0959-437X(98)80066-X
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Venereau E, 2012, J EXP MED, V209, P1519, DOI 10.1084/jem.20120189
   Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351
   Wang T, 2004, NAT MED, V10, P1366, DOI 10.1038/nm1140
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yang JS, 2002, EMERG INFECT DIS, V8, P1379, DOI 10.3201/eid0812.020224
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   Yang TC, 2009, VIRUS RES, V143, P77, DOI 10.1016/j.virusres.2009.03.007
   Yiang GT, 2013, MOL MED REP, V7, P826, DOI 10.3892/mmr.2013.1261
   Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042
   Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765
NR 92
TC 8
Z9 8
U1 3
U2 15
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0300-5127
EI 1470-8752
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD JUN 19
PY 2018
VL 46
BP 609
EP 617
DI 10.1042/BST20170399
PN 3
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GN4PQ
UT WOS:000439013000012
PM 29678952
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Li, LL
   Zhao, H
   Liu, P
   Li, CF
   Quanquin, N
   Ji, X
   Sun, NN
   Du, PS
   Qin, CF
   Lu, N
   Cheng, GH
AF Li, Lili
   Zhao, Hui
   Liu, Ping
   Li, Chunfeng
   Quanquin, Natalie
   Ji, Xue
   Sun, Nina
   Du, Peishuang
   Qin, Cheng-Feng
   Lu, Ning
   Cheng, Genhong
TI PARP12 suppresses Zika virus infection through PARP-dependent
   degradation of NS1 and NS3 viral proteins
SO SCIENCE SIGNALING
LA English
DT Article
ID POLY(ADP-RIBOSE) POLYMERASE; MESSENGER-RNA; ANTIVIRAL RESPONSE;
   ADP-RIBOSYLATION; DNA-REPAIR; REPLICATION; GENE; UBIQUITINATION;
   IDENTIFICATION; TRANSLATION
AB Zika virus infection stimulates a type I interferon (IFN) response in host cells, which suppresses viral replication. Type I IFNs exert antiviral effects by inducing the expression of hundreds of IFN-stimulated genes (ISGs). To screen for antiviral ISGs that restricted Zika virus replication, we individually knocked out 21 ISGs in A549 lung cancer cells and identified PARP12 as a strong inhibitor of Zika virus replication. Our findings suggest that PARP12 mediated the ADP-ribosylation of NS1 and NS3, nonstructural viral proteins that are involved in viral replication and modulating host defense responses. This modification of NS1 and NS3 triggered their proteasome-mediated degradation. These data increase our understanding of the antiviral activity of PARP12 and suggest a molecular basis for the potential development of therapeutics against Zika virus.
C1 [Li, Lili; Liu, Ping; Sun, Nina; Du, Peishuang; Lu, Ning] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China.
   [Li, Lili; Sun, Nina] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Zhao, Hui; Ji, Xue; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 10071, Peoples R China.
   [Li, Chunfeng; Cheng, Genhong] Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Cheng, Genhong] Peking Union Med Coll, Beijing 100005, Peoples R China.
   [Li, Chunfeng; Cheng, Genhong] Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.
   [Quanquin, Natalie; Cheng, Genhong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
RP Lu, N (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China.; Cheng, GH (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Ctr Syst Med, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Peking Union Med Coll, Beijing 100005, Peoples R China.; Cheng, GH (corresponding author), Suzhou Inst Syst Med, Suzhou 215123, Jiangsu, Peoples R China.; Cheng, GH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.
EM ninglu@ibp.ac.cn; gcheng@mednet.ucla.edu
RI Li, Chunfeng/S-3185-2019; Qin, Cheng-Feng/I-6839-2019
OI Li, Chunfeng/0000-0001-8883-9078; Qin, Cheng-Feng/0000-0002-0632-2807;
   Li, Lili/0000-0002-0895-244X
FU Chinese Academy of Medical Sciences (CAMS) Initiative for Innovative
   Medicine [2016-I2M-1-005]; National Science and Technology Major Project
   for "Significant New Drugs Innovation and Development" [2015ZX09102023];
   National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [91542201, 81590765]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01AI069120, AI056154, AI078389]; Non-profit Central Research
   Institute Fund of CAMS [2016ZX310194, 2017NL31002]; Ministry of Science
   and Technology (China)Ministry of Science and Technology, China
   [2016YFD0500304]; State Key Laboratory of Pathogen and Biosecurity
   [SKLPBS1601]; NSFC Excellent Young Scientist Award [81522025];
   Innovative Research Group [81621005]; Newton Advanced Fellowship from
   the UK Academy of Medical Sciences [NAF003/1003]; NSFCNational Natural
   Science Foundation of China [81661130162]
FX This work was supported by grants from the Chinese Academy of Medical
   Sciences (CAMS) Initiative for Innovative Medicine (no. 2016-I2M-1-005),
   the National Science and Technology Major Project for "Significant New
   Drugs Innovation and Development" (2015ZX09102023), the National Natural
   Science Foundation of China (NSFC; 91542201 and 81590765), the NIH
   (grants R01AI069120, AI056154, and AI078389), the Non-profit Central
   Research Institute Fund of CAMS (2016ZX310194 and 2017NL31002) to G.C.;
   and the Ministry of Science and Technology (China; 2016YFD0500304), the
   State Key Laboratory of Pathogen and Biosecurity (SKLPBS1601), the NSFC
   Excellent Young Scientist Award (81522025), the Innovative Research
   Group (81621005), the Newton Advanced Fellowship from the UK Academy of
   Medical Sciences (NAF003/1003), and the NSFC (81661130162) to C.-F.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aravind L, 2015, CURR TOP MICROBIOL, V384, P3, DOI 10.1007/82_2014_414
   Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P273, DOI 10.1016/S0968-0004(01)01787-X
   Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13
   Atasheva S, 2012, J VIROL, V86, P8147, DOI 10.1128/JVI.00733-12
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Bock FJ, 2016, FEBS J, V283, P4017, DOI 10.1111/febs.13737
   Campos GC, 2016, BRAZ J INFECT DIS, V20, P227, DOI 10.1016/j.bjid.2016.05.001
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ximenes ASFC, 2019, J MATERN-FETAL NEO M, V32, P493, DOI 10.1080/14767058.2017.1384459
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276
   Gibson BA, 2012, NAT REV MOL CELL BIO, V13, P411, DOI 10.1038/nrm3376
   Grady SL, 2012, J VIROL, V86, P8259, DOI 10.1128/JVI.00495-12
   Guo XM, 2004, J VIROL, V78, P12781, DOI 10.1128/JVI.78.23.12781-12787.2004
   Guo XM, 2007, P NATL ACAD SCI USA, V104, P151, DOI 10.1073/pnas.0607063104
   Guzyk MM, 2016, NEUROCHEM RES, V41, P2526, DOI 10.1007/s11064-016-1964-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hottiger MO, 2010, TRENDS BIOCHEM SCI, V35, P208, DOI 10.1016/j.tibs.2009.12.003
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuny CV, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005453
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li MMH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006145
   Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005
   Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723
   MENDOZAALVAREZ H, 1993, J BIOL CHEM, V268, P22575
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ong CW, 2016, INTERN MED J, V46, P525, DOI 10.1111/imj.13059
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Smulson ME, 2000, ADV ENZYME REGUL, V40, P183, DOI 10.1016/S0065-2571(99)00024-2
   Todorova T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6362
   Wang SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep32336
   Wang ZZ, 2012, GENE DEV, V26, P235, DOI 10.1101/gad.182618.111
   Welsby I, 2014, J BIOL CHEM, V289, P26642, DOI 10.1074/jbc.M114.589515
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yu MB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-546
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222
   Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339
   Zhu YP, 2012, EMBO J, V31, P4236, DOI 10.1038/emboj.2012.271
NR 56
TC 19
Z9 19
U1 0
U2 8
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 19
PY 2018
VL 11
IS 535
AR eaas9332
DI 10.1126/scisignal.aas9332
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GJ7XU
UT WOS:000435604300003
PM 29921658
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Zhang, BY
   He, YZG
   Xu, YP
   Mo, F
   Mi, TW
   Shen, QS
   Li, CF
   Li, YL
   Liu, J
   Wu, YH
   Chen, GL
   Zhu, WL
   Qin, CF
   Hu, BY
   Zhou, GM
AF Zhang, Boya
   He, Yangzhige
   Xu, Yanpeng
   Mo, Fan
   Mi, Tingwei
   Shen, Qing Sunny
   Li, Chunfeng
   Li, Yali
   Liu, Jing
   Wu, Yihui
   Chen, Guilai
   Zhu, Wenliang
   Qin, Chengfeng
   Hu, Baoyang
   Zhou, Guomin
TI Differential antiviral immunity to Japanese encephalitis virus in
   developing cortical organoids
SO CELL DEATH & DISEASE
LA English
DT Article
ID EMBRYONIC STEM-CELLS; OUTER RADIAL GLIA; IN-VITRO; 3-DIMENSIONAL
   CULTURE; WEST-NILE; REPLICATION; EXPRESSION; RNA; INFECTIONS; EXPANSION
AB Japanese encephalitis (JE) caused by Japanese encephalitis virus (JEV) poses a serious threat to the world's public health yet without a cure. Certain JEV-infected neural cells express a subset of previously identified intrinsic antiviral interferon stimulated genes (ISGs), indicating brain cells retain autonomous antiviral immunity. However, whether this happens in composited brain remains unclear. Human pluripotent stem cell (hPSC)-derived organoids can model disorders caused by human endemic pathogens such as Zika virus, which may potentially address this question and facilitate the discovery of a cure for JE. We thus generated telencephalon organoid and infected them with JEV. We found JEV infection caused significant decline of cell proliferation and increase of cell death in brain organoid, resulting in smaller organoid spheres. JEV tended to infect astrocytes and neural progenitors, especially the population representing outer radial glial cells (oRGCs) of developing human brain. In addition, we revealed variable antiviral immunity in brain organoids of different stages of culture. In organoids of longer culture (older than 8 weeks), but not of early ones (less than 4 weeks), JEV infection caused typical activation of interferon signaling pathway. Preferential infection of oRGCs and differential antiviral response at various stages might explain the much more severe outcomes of JEV infection in the younger, which also provide clues to develop effective therapeutics of such diseases.
C1 [Zhang, Boya; Zhou, Guomin] Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Anat, Shanghai 200032, Peoples R China.
   [Zhang, Boya; Zhou, Guomin] Key Lab Med Imaging Comp & Comp Assisted Interven, Shanghai 200032, Peoples R China.
   [Zhang, Boya; Mo, Fan; Mi, Tingwei; Liu, Jing; Wu, Yihui; Chen, Guilai; Zhu, Wenliang; Hu, Baoyang] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.
   [He, Yangzhige] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.
   [Xu, Yanpeng; Li, Chunfeng; Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Shen, Qing Sunny; Li, Yali] Peking Univ, Beijing Key Lab Cardiometabol Mol Med, Inst Mol Med, Beijing 100871, Peoples R China.
RP Zhou, GM (corresponding author), Fudan Univ, Shanghai Med Coll, Sch Basic Med Sci, Dept Anat, Shanghai 200032, Peoples R China.; Zhou, GM (corresponding author), Key Lab Med Imaging Comp & Comp Assisted Interven, Shanghai 200032, Peoples R China.; Hu, BY (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing 100101, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM chengfeng_qin@126.com; byhu@ioz.ac.cn; gmzhou@shmu.edu.cn
RI Qin, Cheng-Feng/I-6839-2019; Li, Chunfeng/S-3185-2019; Hu,
   Baoyang/R-8374-2016
OI Qin, Cheng-Feng/0000-0002-0632-2807; Li, Chunfeng/0000-0001-8883-9078;
   Hu, Baoyang/0000-0003-3993-4014
FU Chinese Academy of SciencesChinese Academy of Sciences [XDA16020604,
   XDA16030401]; CASDefence Research & Development Organisation
   (DRDO)Chinese Academy of Sciences [ZDRW-ZS-2017-5]; National Key
   Research and Development [2014CB964604]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [31571238, 31471394, 31621004]
FX This project was funded by Research Program of Chinese Academy of
   Sciences (XDA16020604 and XDA16030401), the Key Research Program of CAS
   (ZDRW-ZS-2017-5), the National Key Research and Development
   (2014CB964604), and Program of National Natural Science Foundation of
   China (31571238, 31471394, and 31621004). We thank Da Zhang, Mengqi Li,
   Jianhuan Qi, and Dongmei Wang for comments on the manuscript. We also
   thank Lin Yang, Shiwen Li, Lixiang Ma, and Yan Sun for their help with
   technical assistance.
CR Au-Yeung Nancy, 2013, JAKSTAT, V2, pe23931, DOI 10.4161/jkst.23931
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042
   D'Angelo W, 2016, STEM CELLS DEV, V25, P648, DOI 10.1089/scd.2015.0377
   Das S, 2008, J NEUROCHEM, V106, P1624, DOI 10.1111/j.1471-4159.2008.05511.x
   Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941
   Endy TP, 2002, CURR TOP MICROBIOL, V267, P11
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gu Q, 2017, STEM CELL REP, V9, P366, DOI 10.1016/j.stemcr.2017.04.017
   Hegde NR, 2017, HUM VACC IMMUNOTHER, V13, P1320, DOI 10.1080/21645515.2017.1285472
   Hsiao NW, 2010, ANTIVIR RES, V85, P504, DOI 10.1016/j.antiviral.2009.12.007
   JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Li XF, 2013, J VIROL, V87, P13694, DOI 10.1128/JVI.00931-13
   Liu J, 2017, CELL STEM CELL, V21, P635, DOI 10.1016/j.stem.2017.08.013
   Liu K, 2013, RES VET SCI, V95, P950, DOI 10.1016/j.rvsc.2013.08.008
   Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Roost MS, 2015, STEM CELL REP, V4, P1112, DOI 10.1016/j.stemcr.2015.05.002
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Shen SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114990
   Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37
   Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263
   Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637
   Suprunenko T, 2016, CYTOKINE GROWTH F R, V29, P35, DOI 10.1016/j.cytogfr.2016.03.002
   Takamatsu Y, 2015, J GEN VIROL, V96, P2194, DOI 10.1099/vir.0.000168
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thomsen ER, 2016, NAT METHODS, V13, P87, DOI [10.1038/nmeth.3629, 10.1038/NMETH.3629]
   van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510
   Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438
   Wang WS, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4248
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
NR 47
TC 6
Z9 6
U1 2
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-4889
J9 CELL DEATH DIS
JI Cell Death Dis.
PD JUN 18
PY 2018
VL 9
AR 719
DI 10.1038/s41419-018-0763-y
PG 10
WC Cell Biology
SC Cell Biology
GA GK9NZ
UT WOS:000436579800007
PM 29915260
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kaid, C
   Goulart, E
   Caires, LC
   Araujo, BHS
   Soares-Schanoski, A
   Bueno, HMS
   Telles-Silva, KA
   Astray, RM
   Assoni, AF
   Junior, AFR
   Ventini, DC
   Puglia, ALP
   Gomes, RP
   Zatz, M
   Okamoto, OK
AF Kaid, Carolini
   Goulart, Ernesto
   Caires-Junior, Luiz C.
   Araujo, Bruno H. S.
   Soares-Schanoski, Alessandra
   Bueno, Heloisa M. S.
   Telles-Silva, Kayque A.
   Astray, Renato M.
   Assoni, Amanda F.
   Junior, Antonio F. R.
   Ventini, Daniella C.
   Puglia, Ana L. P.
   Gomes, Roselane P.
   Zatz, Mayana
   Okamoto, Oswaldo K.
TI Zika Virus Selectively Kills Aggressive Human Embryonal CNS Tumor Cells
   In Vitro and In Vivo
SO CANCER RESEARCH
LA English
DT Article
ID NEURAL PROGENITORS; BRAIN; MEDULLOBLASTOMA
AB Zika virus (ZIKV) is largely known for causing brain abnormalities due to its ability to infect neural progenitor stem cells during early development. Here, we show that ZIKV is also capable of infecting and destroying stem-like cancer cells from aggressive human embryonal tumors of the central nervous system (CNS). When evaluating the oncolytic properties of Brazilian Zika virus strain (ZIKV(BR)) against human breast, prostate, colorectal, and embryonal CNS tumor cell lines, we verified a selective infection of CNS tumor cells followed by massive tumor cell death. ZIKV(BR) was more efficient in destroying embryonal CNS tumorspheres than normal stem cell neurospheres. A single intracerebroventricular injection of ZIKV(BR) in BALB/c nude mice bearing orthotopic human embryonal CNS tumor xenografts resulted in a significantly longer survival, decreased tumor burden, fewer metastasis, and complete remission in some animals. Tumor cells closely resembling neural stem cells at the molecular level with activated Wnt signaling were more susceptible to the oncolytic effects of ZIKV(BR). furthermore, modulation of Wnt signaling pathway significantly affected ZIKV(BR)-induced tumor cell death and viral shedding. Altogether, these preclinical findings indicate that ZIKV(BR) could be an efficient agent to treat aggressive forms of embryonal CNS tumors and could provide mechanistic insights regarding its oncolytic effects.
   Significance: Brazilian Zika virus strain kills aggressive metastatic forms of human CNS tumors and could be a potential oncolytic agent for cancer therapy. (C) 2018 AACR
C1 [Kaid, Carolini; Goulart, Ernesto; Caires-Junior, Luiz C.; Bueno, Heloisa M. S.; Telles-Silva, Kayque A.; Assoni, Amanda F.; Junior, Antonio F. R.; Zatz, Mayana; Okamoto, Oswaldo K.] Univ Sao Paulo, Human Genome & Stem Cell Res Ctr, Biosci Inst, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil.
   [Araujo, Bruno H. S.] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.
   [Soares-Schanoski, Alessandra; Astray, Renato M.; Ventini, Daniella C.; Puglia, Ana L. P.; Gomes, Roselane P.] Butantan Inst, Sao Paulo, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Human Genome & Stem Cell Res Ctr, Biosci Inst, Dept Genet & Evolutionary Biol, Sao Paulo, SP, Brazil.; Okamoto, OK (corresponding author), Univ Sao Paulo, BR-05508900 Sao Paulo, SP, Brazil.
EM mayazatz@usp.br; keith.okamoto@usp.br
RI Kaid, Carolini/AAQ-9294-2020; Goulart, Ernesto/AAC-3713-2020; Astray,
   Renato Mancini/N-6627-2013; Schanoski, Alessandra/H-8144-2014; Okamoto,
   Oswaldo Keith/C-5593-2013; Zatz, Mayana/M-5338-2015; Bueno,
   Hector/I-3910-2015; Araujo, Bruno/P-9975-2019; Araujo,
   Bruno/B-8741-2013; Kaid, Carolini/O-8523-2018
OI Kaid, Carolini/0000-0002-1852-6997; Astray, Renato
   Mancini/0000-0002-6983-5298; Schanoski, Alessandra/0000-0002-6514-8458;
   Zatz, Mayana/0000-0003-3970-8025; Bueno, Hector/0000-0003-0277-7596;
   Araujo, Bruno/0000-0003-0012-4217; Araujo, Bruno/0000-0003-0012-4217;
   Goulart, Ernesto/0000-0001-9526-8701; Alves Telles Silva,
   Kayque/0000-0002-2994-609X; Okamoto, Oswaldo Keith/0000-0002-8528-6225;
   de Caires Junior, Luiz Carlos/0000-0002-1735-2008
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/08028-1, 2015/14821-1, 2016/09707-8, 2014/08049-1, 2017/16283-2];
   FAPESP (INCT); CAPESCAPES [1379594]
FX The authors thank Drs. Patricia Semedo-Kuriki and Vivek Kumar for
   helping with cytometry assay and neuron differentiation, respectively.
   This study was supported by grants from FAPESP (CEPID number
   2013/08028-1 and INCT to M. Zatz and O.K. Okamoto); C. Kaid is a fellow
   of CAPES (1379594); E. Goulart, A.F. Assoni, B.H.S. Araujo, and L.C.
   Caires-Junior are fellows of FAPESP (2015/14821-1; 2016/09707-8;
   2014/08049-1; 2017/16283-2).
CR BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chakravadhanula M, 2015, NEURO-ONCOLOGY, V17, P526, DOI 10.1093/neuonc/nou229
   Cho YJ, 2011, J CLIN ONCOL, V29, P1424, DOI 10.1200/JCO.2010.28.5148
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   da Silva PBG, 2016, CYTOTECHNOLOGY, V68, P1545, DOI 10.1007/s10616-015-9914-5
   Han ZY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10421
   Ho DMT, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0103-3
   Kass DE, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Kaufman HL, 2015, NAT REV DRUG DISCOV, V14, P642, DOI 10.1038/nrd4663
   Lawler SE, 2017, JAMA ONCOL, V3, P841, DOI 10.1001/jamaoncol.2016.2064
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McCord M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00318
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moreno N, 2014, J NEUROSCI, V34, P13486, DOI 10.1523/JNEUROSCI.2560-14.2014
   Northcott PA, 2017, NATURE, V547, P311, DOI 10.1038/nature22973
   Panosyan EH, 2010, PEDIATR BLOOD CANCER, V55, P644, DOI 10.1002/pbc.22627
   Pfister SM, 2010, ACTA NEUROPATHOL, V120, P553, DOI 10.1007/s00401-010-0751-5
   Rocha CRR, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.465
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Studebaker AW, 2012, NEURO-ONCOLOGY, V14, P459, DOI 10.1093/neuonc/nor231
   Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027
   Xie ZG, 2009, NEUROCHEM RES, V34, P2055, DOI 10.1007/s11064-009-0079-5
   Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 33
TC 12
Z9 12
U1 0
U2 8
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 0008-5472
EI 1538-7445
J9 CANCER RES
JI Cancer Res.
PD JUN 15
PY 2018
VL 78
IS 12
BP 3363
EP 3374
DI 10.1158/0008-5472.CAN-17-3201
PG 12
WC Oncology
SC Oncology
GA GJ5ZJ
UT WOS:000435462000021
PM 29700002
OA Bronze
DA 2020-07-08
ER

PT J
AU Brainard, J
AF Brainard, Jeffrey
TI Zika's fake news epidemic
SO SCIENCE
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 3
U2 9
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD JUN 15
PY 2018
VL 360
IS 6394
BP 1155
EP 1155
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ4OM
UT WOS:000435360400009
DA 2020-07-08
ER

PT J
AU He, ZJ
   Chen, JH
   Zhu, X
   An, S
   Dong, XH
   Yu, JC
   Zhang, SH
   Wu, Y
   Li, G
   Zhang, Y
   Wu, JH
   Li, MF
AF He, Zhenjian
   Chen, Jiahui
   Zhu, Xun
   An, Shu
   Dong, Xinhuai
   Yu, Jianchen
   Zhang, Shihao
   Wu, Yun
   Li, Ge
   Zhang, Yu
   Wu, Jueheng
   Li, Mengfeng
TI NLRP3 Inflammasome Activation Mediates Zika Virus-Associated
   Inflammation
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; NS5; NLRP3 inflammasome; interleukin-1 beta
ID ENCEPHALITIS; INFECTION; INTERLEUKIN-1; MECHANISMS; MICROGLIA; CELLS
AB Zika virus (ZIKV) is a mosquito-borne virus that has been identified as a cause of several severe disease manifestations, including congenital microcephaly and Guillain-Barre syndrome, meningoencephalitis, and myelitis. Previous studies showed that ZIKVinfected patients exhibited elevated plasma levels of interleukin 1 beta (IL-1 beta), indicating that ZIKV may activate inflammasomes. However, the molecular basis for its viral pathogenesis remains poorly understood. In this current study, we found that ZIKV infection caused severe inflammatory pathological changes and promoted IL-1 beta production in vitro and in vivo. We here demonstrate that the maturation and secretion of IL-1 beta during ZIKV infection was mediated by NLRP3 inflammasome activation and that ZIKV nonstructural protein 5 (NS5) facilitated the assembly of the NLRP3 inflammasome complex, leading to IL-1 beta activation through interaction with NLRP3 and induction of reactive oxygen species production. Collectively, our data identify NLRP3 inflammasomederived IL-1 beta production as a critical feature of inflammation during ZIKV infection. These findings offer new insights into inflammasome-mediated diseases and may provide new therapeutic options for ZIKV-associated diseases.
C1 [He, Zhenjian] Sch Publ Hlth, Guangzhou, Guangdong, Peoples R China.
   [He, Zhenjian] Sun Yat Sen Univ, Guangzhou, Guangdong, Peoples R China.
   [Chen, Jiahui; Zhu, Xun; An, Shu; Dong, Xinhuai; Yu, Jianchen; Wu, Yun; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Guangdong, Peoples R China.
   [Zhang, Shihao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Basic Med, Guangzhou, Guangdong, Peoples R China.
   [He, Zhenjian; Chen, Jiahui; Zhu, Xun; An, Shu; Dong, Xinhuai; Yu, Jianchen; Wu, Yun; Wu, Jueheng; Li, Mengfeng] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Guangdong, Peoples R China.
   [Li, Ge; Zhang, Yu] Guangdong Lab Anim Monitoring Inst, Guangdong Prov Key Lab Lab Anim, Guangzhou, Guangdong, Peoples R China.
RP Li, MF (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, 4 Zhongshan Rd 2, Guangzhou 510080, Guangdong, Peoples R China.
EM limf@mail.sysu.edu.cn
FU National Mega Project on Major Infectious Disease Prevention
   [2017ZX10103011]; Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81501744, 81571992, 81330058]; Guangdong
   Natural Science Funds for Distinguished Young Scholars [2014A030306023];
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [16ykzd16]; Young Talent of
   Science and Technology Project of the Guangdong Te Zhi Program
   [2015TQ01R281]
FX This work was supported by the National Mega Project on Major Infectious
   Disease Prevention (2017ZX10103011), the Natural Science Foundation of
   China (81501744, 81571992, and 81330058), Guangdong Natural Science
   Funds for Distinguished Young Scholars (2014A030306023), Fundamental
   Research Funds for the Central Universities (16ykzd16), and the Young
   Talent of Science and Technology Project of the Guangdong Te Zhi Program
   (2015TQ01R281).
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375
   Das S, 2008, J NEUROIMMUNOL, V195, P60, DOI 10.1016/j.jneuroim.2008.01.009
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005
   Guo S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005155
   Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636
   Ito M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002857
   Jo EK, 2016, CELL MOL IMMUNOL, V13, P148, DOI 10.1038/cmi.2015.95
   Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270
   Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007
   Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745
   Lum FM, 2017, CLIN INFECT DIS, V64, P914, DOI 10.1093/cid/ciw878
   Mamik MK, 2017, J NEUROIMMUNE PHARM, V12, P233, DOI 10.1007/s11481-016-9708-3
   Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Schmitz N, 2005, J VIROL, V79, P6441, DOI 10.1128/JVI.79.10.6441-6448.2005
   Shrivastava G, 2016, IMMUNOL RES, V64, P1101, DOI 10.1007/s12026-016-8873-z
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Trouplin V, 2013, JOVE-J VIS EXP, DOI 10.3791/50966
   Tsai TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep27670
   Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638
   Wang WB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006123
   Zhao ML, 2001, J NEUROIMMUNOL, V115, P182, DOI 10.1016/S0165-5728(00)00463-X
   Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831
NR 27
TC 19
Z9 21
U1 0
U2 9
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 15
PY 2018
VL 217
IS 12
BP 1942
EP 1951
DI 10.1093/infdis/jiy129
PG 10
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GI0TI
UT WOS:000434082000015
PM 29518228
OA Bronze
DA 2020-07-08
ER

PT J
AU Gao, XJ
   Wen, YF
   Wang, J
   Hong, WX
   Li, CL
   Zhao, LZ
   Yin, CB
   Jin, X
   Zhang, FC
   Yu, L
AF Gao, Xiujie
   Wen, Yingfen
   Wang, Jian
   Hong, Wenxin
   Li, Chunlin
   Zhao, Lingzhai
   Yin, Chibiao
   Jin, Xia
   Zhang, Fuchun
   Yu, Lei
TI Delayed and highly specific antibody response to nonstructural protein 1
   (NS1) revealed during natural human ZIKV infection by NS1-based capture
   ELISA
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Dengue virus; Non-structural protein 1; Antibody response;
   Cross-reactivity
ID DENGUE VIRUS-INFECTION; LINKED-IMMUNOSORBENT-ASSAY; CROSS-REACTIVITY;
   CHINA; DIAGNOSIS; GUANGDONG; KINETICS; HIV-1; CELL
AB Background: Zika virus (ZIKV) had spread rapidly in the past few years in southern hemisphere where dengue virus (DENV) had caused epidemic problems for over half a century. The high degree of cross-reactivity of Envelope (E) protein specific antibody responses between ZIKV and DENV made it challenging to perform differential diagnosis between the two infections using standard ELISA method for E protein.
   Methods: Using an IgG capture ELISA, we investigated the kinetics of nonstructural protein 1 (NS1) antibody response during natural ZIKV infection and the cross-reactivity to NS1 proteins using convalescent sera obtained from patients infected by either DENV or ZIKV.
   Results: The analyses of the sequential serum samples from ZIKV infected individuals showed NS1 specific Abs appeared 2 weeks later than E specific Abs. Notably, human sera from ZIKV infected individuals did not contain cross-reactivity to NS1 proteins of any of the four DENV serotypes. Furthermore, four out of five NS1-specific monoclonal antibodies (mAbs) isolated from ZIKV infected individuals did not bind to DENV NS1 proteins. Only limited amount of cross-reactivity to ZIKV NS1 was displayed in 108 DENV1 immune sera at 1: 100 dilution.
   Conclusions: The high degree of NS1-specific Abs in both ZIKV and DENV infection revealed here suggest that NS1-based diagnostics would significantly improve the differential diagnosis between DENV and ZIKV infections.
C1 [Gao, Xiujie; Wen, Yingfen; Wang, Jian; Hong, Wenxin; Li, Chunlin; Zhao, Lingzhai; Yin, Chibiao; Zhang, Fuchun; Yu, Lei] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, 627 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.
   [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, CAS Key Lab Mol Virol & Immunol, Shanghai 200025, Peoples R China.
RP Zhang, FC; Yu, L (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, 627 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China.
EM gz8hzfc@126.com; leiyu11393@126.com
FU 2017 Guangzhou major projects of collaborative innovation in health care
   [201704020229]; 2016 Guangdong provincial science and technology program
   on emergency preparedness of Zika [2016A020248001]; Ministry of Science
   and Technology of ChinaMinistry of Science and Technology, China
   [2017ZX10305501-003]; Municipal Science and Technology Bureau Foundation
   of Guangzhou [201508020106]
FX This project was supported by funds from 2017 Guangzhou major projects
   of collaborative innovation in health care [201704020229], 2016
   Guangdong provincial science and technology program on emergency
   preparedness of Zika [2016A020248001], Ministry of Science and
   Technology of China[2017ZX10305501-003] and the Municipal Science and
   Technology Bureau Foundation of Guangzhou [201508020106].
CR Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Chao DY, 2015, J CLIN MICROBIOL, V53, P557, DOI 10.1128/JCM.02735-14
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Guan YJ, 2009, P NATL ACAD SCI USA, V106, P3952, DOI 10.1073/pnas.0813392106
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Hong WX, 2013, J CLIN VIROL, V57, P184, DOI 10.1016/j.jcv.2013.02.012
   Liu L, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00291-16
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   MOORE JP, 1989, AIDS, V3, P155, DOI 10.1097/00002030-198903000-00006
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Pasquier C, 2018, DIAGN MICR INFEC DIS, V90, P26, DOI 10.1016/j.diagmicrobio.2017.09.001
   Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Roehrig JT, 2003, ADV VIRUS RES, V59, P141, DOI 10.1016/S0065-3527(03)59005-4
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Tsai WY, 2017, CLIN INFECT DIS, V65, P1829, DOI 10.1093/cid/cix672
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Yin YX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.100
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548
   Zhao H, 2014, SCI CHINA LIFE SCI, V57, P1149, DOI 10.1007/s11427-014-4782-3
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
NR 32
TC 8
Z9 10
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUN 14
PY 2018
VL 18
AR 275
DI 10.1186/s12879-018-3173-y
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GK4QU
UT WOS:000436149100003
PM 29898684
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Donate-Macian, P
   Jungfleisch, J
   Perez-Vilaro, G
   Rubio-Moscardo, F
   Peralvarez-Marin, A
   Diez, J
   Valverde, MA
AF Donate-Macian, P.
   Jungfleisch, J.
   Perez-Vilaro, G.
   Rubio-Moscardo, F.
   Peralvarez-Marin, A.
   Diez, J.
   Valverde, M. A.
TI The TRPV4 channel links calcium influx to DDX3X activity and viral
   infectivity
SO NATURE COMMUNICATIONS
LA English
DT Article
ID HEPATITIS-C VIRUS; BOX RNA HELICASE; TRANSLATION INITIATION;
   GENE-EXPRESSION; MESSENGER-RNA; BREAST-CANCER; REPLICATION; PROTEINS;
   ACTIVATION; BINDING
AB Ion channels are well placed to transduce environmental cues into signals used by cells to generate a wide range of responses, but little is known about their role in the regulation of RNA metabolism. Here we show that the TRPV4 cation channel binds the DEAD-box RNA helicase DDX3X and regulates its function. TRPV4-mediated Ca2+ influx releases DDX3X from the channel and drives DDX3X nuclear translocation, a process that involves calmodulin (CaM) and the CaM-dependent kinase II. Genetic depletion or pharmacological inhibition of TRPV4 diminishes DDX3X-dependent functions, including nuclear viral export and translation. Furthermore, TRPV4 mediates Ca2+ influx and nuclear accumulation of DDX3X in cells exposed to the Zika virus or the purified viral envelope protein. Consequently, targeting of TRPV4 reduces infectivity of dengue, hepatitis C and Zika viruses. Together, our results highlight the role of TRPV4 in the regulation of DDX3X-dependent control of RNA metabolism and viral infectivity.
C1 [Donate-Macian, P.; Rubio-Moscardo, F.; Valverde, M. A.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol, Barcelona 08003, Spain.
   [Donate-Macian, P.; Peralvarez-Marin, A.] Univ Autonoma Barcelona, Unitat Biofis, Dept Bioquim & Biol Mol, Bellaterra 08193, Spain.
   [Jungfleisch, J.; Perez-Vilaro, G.; Diez, J.] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Mol Virol Grp, Barcelona 08003, Spain.
RP Valverde, MA (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Lab Mol Physiol, Barcelona 08003, Spain.
EM miguel.valverde@upf.edu
RI Donate-Macian, Pablo/L-3106-2014; Peralvarez-Marin, Alex/AAH-4305-2020;
   Perez-Vilaro, Gemma/AAA-1244-2019; Rubio-Moscardo, Francisca/L-6247-2014
OI Donate-Macian, Pablo/0000-0002-8297-2035; Peralvarez-Marin,
   Alex/0000-0002-3457-0875; Rubio-Moscardo, Francisca/0000-0002-3609-9992;
   Valverde, Miguel A./0000-0002-6961-3361
FU Spanish Ministry of Economy and Competitiveness [SAF2015-69762R,
   BFU2016-80039-R, BFU2017-87843-R]; institutional "Maria de Maeztu"
   Programme for Units of Excellence in RD [MDM-2014-0370]; FEDER
   fundsEuropean Union (EU); Marie Curie International Outgoing Fellowship
   within the 7th European Community Framework ProgrammeEuropean Union (EU)
   [PIOF-GA-2009-237120]; Generalitat de Catalunya research program (AGAUR)
   [2014-SGR-1628, FI-2013FIB00251]
FX We thank Dr. Andres Merits (University of Tartu, Estonia) for kindly
   providing the plasmid encoding the ZIKV with NanoLuc, Dr. Hiroshi
   Yoshizawa (Niigata University) for kindly providing the plasmid encoding
   DDX3X with Myc tag; and Dr. Dr. Ming-Chih Lai (Chang Gung University)
   for kindly providing the plasmid encoding DDX3X with GFP. This work was
   supported by the Spanish Ministry of Economy and Competitiveness through
   grants SAF2015-69762R, BFU2016-80039-R, BFU2017-87843-R, an
   institutional "Maria de Maeztu" Programme for Units of Excellence in R&D
   (MDM-2014-0370) and FEDER funds; Marie Curie International Outgoing
   Fellowship within the 7th European Community Framework Programme
   (PIOF-GA-2009-237120) and the Generalitat de Catalunya research program
   (AGAUR, 2014-SGR-1628 and FI-2013FIB00251).
CR Abdullah H, 2014, THORAX, V69, P46, DOI 10.1136/thoraxjnl-2013-203894
   Alpizar YA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01201-3
   Andrade YN, 2005, J CELL BIOL, V168, P869, DOI 10.1083/jcb.200409070
   Ariumi Y, 2007, J VIROL, V81, P13922, DOI 10.1128/JVI.01517-07
   Ariumi Y, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00423
   Arniges M, 2006, J BIOL CHEM, V281, P1580, DOI 10.1074/jbc.M511456200
   Arniges M, 2004, J BIOL CHEM, V279, P54062, DOI 10.1074/jbc.M409708200
   Bautista-Carbajal P, 2017, VIROLOGY, V501, P188, DOI 10.1016/j.virol.2016.12.004
   Berna-Erro A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11274-1
   Bolinger C, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-8
   Botlagunta M, 2008, ONCOGENE, V27, P3912, DOI 10.1038/onc.2008.33
   Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113
   Chami M, 2006, BBA-MOL CELL RES, V1763, P1344, DOI 10.1016/j.bbamcr.2006.09.025
   Chen JB, 2001, J VIROL, V75, P3207, DOI 10.1128/JVI.75.7.3207-3219.2001
   Cheshenko N, 2003, J CELL BIOL, V163, P283, DOI 10.1083/jcb.200301084
   Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028
   de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055
   Everaerts W, 2010, P NATL ACAD SCI USA, V107, P19084, DOI 10.1073/pnas.1005333107
   Fernandes J, 2008, J CELL BIOL, V181, P143, DOI 10.1083/jcb.200712058
   Fernandez-Fernandez JM, 2008, PFLUG ARCH EUR J PHY, V457, P149, DOI 10.1007/s00424-008-0516-3
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Frohlich A, 2016, BBA-GENE REGUL MECH, V1859, P719, DOI 10.1016/j.bbagrm.2016.03.009
   Fujioka Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3763
   Fullam A, 2013, BBA-GENE REGUL MECH, V1829, P854, DOI 10.1016/j.bbagrm.2013.03.012
   Galindo-Villegas J, 2016, J IMMUNOL, V196, P738, DOI 10.4049/jimmunol.1501729
   Garcia-Elias A, 2014, HANDB EXP PHARMACOL, V222, P293, DOI 10.1007/978-3-642-54215-2_12
   Garcia-Elias A, 2013, P NATL ACAD SCI USA, V110, P9553, DOI 10.1073/pnas.1220231110
   Hanover JA, 2009, J BIOL CHEM, V284, P12593, DOI 10.1074/jbc.R800076200
   Hou WH, 2017, GENE, V628, P117, DOI 10.1016/j.gene.2017.07.049
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.14
   Ibba M, 1999, SCIENCE, V286, P1893, DOI 10.1126/science.286.5446.1893
   Jang DL, 2007, J PROTEOME RES, V6, P3718, DOI 10.1021/pr0703268
   Jungfleisch J, 2017, GENOME RES, V27, P95, DOI 10.1101/gr.209015.116
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   King HA, 2014, CELL DEATH DIFFER, V21, P161, DOI 10.1038/cdd.2013.135
   Kolokoltsov AA, 2009, DRUG DEVELOP RES, V70, P255, DOI 10.1002/ddr.20303
   Koutsoudakis G, 2015, J HEPATOL, V63, P813, DOI 10.1016/j.jhep.2015.06.002
   MALIM MH, 1989, CELL, V58, P205, DOI 10.1016/0092-8674(89)90416-9
   Manninen A, 2002, J EXP MED, V195, P1023, DOI 10.1084/jem.20012039
   Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005
   Moore C, 2013, P NATL ACAD SCI USA, V110, pE3225, DOI 10.1073/pnas.1312933110
   Nilius B, 2013, EMBO REP, V14, P152, DOI 10.1038/embor.2012.219
   Noueiry AO, 2000, P NATL ACAD SCI USA, V97, P12985, DOI 10.1073/pnas.240460897
   Omar S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171681
   Park SH, 1998, CYTOGENET CELL GENET, V81, P178, DOI 10.1159/000015022
   Phelps CB, 2010, J BIOL CHEM, V285, P731, DOI 10.1074/jbc.M109.052548
   Pocock GM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005565
   Proud CG, 2007, BIOCHEM J, V403, P217, DOI 10.1042/BJ20070024
   Ranji A, 2010, RNA BIOL, V7, P775, DOI 10.4161/rna.7.6.14249
   RestrepoHartwig MA, 1996, J VIROL, V70, P8908, DOI 10.1128/JVI.70.12.8908-8916.1996
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Snider J, 2010, NAT PROTOC, V5, P1281, DOI 10.1038/nprot.2010.83
   Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306
   Soto-Rifo R, 2012, EMBO J, V31, P3745, DOI 10.1038/emboj.2012.220
   Strotmann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010580
   Syeda R, 2015, ELIFE, V4, DOI 10.7554/eLife.07369
   Thorneloe K. S., 2008, PHARM EXP THER, V326, P432
   Valiente-Echeverria F, 2015, REV MED VIROL, V25, P286, DOI 10.1002/rmv.1845
   van Voss MRH, 2017, ONCOTARGETS THER, V10, P3501, DOI 10.2147/OTT.S140639
   Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007
   Voets T, 2005, NAT CHEM BIOL, V1, P85, DOI 10.1038/nchembio0705-85
   Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200
   von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014
   Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268
   White JPM, 2016, PHYSIOL REV, V96, P911, DOI 10.1152/physrev.00016.2015
   Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029
   Zhou YB, 2009, CELL CALCIUM, V46, P1, DOI 10.1016/j.ceca.2009.05.005
NR 67
TC 5
Z9 5
U1 1
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 13
PY 2018
VL 9
AR 2307
DI 10.1038/s41467-018-04776-7
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ2EC
UT WOS:000435081300006
PM 29899501
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiu, C
AF Chiu, Charles
TI Cutting-Edge Infectious Disease Diagnostics with CRISPR
SO CELL HOST & MICROBE
LA English
DT Editorial Material
ID ZIKA VIRUS
AB Three recent Science articles (Chen et al., 2018; Gootenberg et al., 2018; Myhrvold et al., 2018) describe the use of CRISPR-Cas technology to develop point-of-care diagnostics that directly detect viruses from clinical samples. These tests could radically transform approaches to diagnosing infectious diseases at the bedside and in the field.
C1 [Chiu, Charles] Univ Calif San Francisco, Div Infect Dis, Dept Lab Med & Med, San Francisco, CA 94107 USA.
   [Chiu, Charles] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.
RP Chiu, C (corresponding author), Univ Calif San Francisco, Div Infect Dis, Dept Lab Med & Med, San Francisco, CA 94107 USA.; Chiu, C (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 91407 USA.
EM charles.chiu@ucsf.edu
CR Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245
   Chung RT, 2015, HEPATOLOGY, V62, P932, DOI 10.1002/hep.27950
   Drancourt M, 2016, CLIN MICROBIOL REV, V29, P429, DOI 10.1128/CMR.00090-15
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179
   Hille F, 2018, CELL, V172, P1239, DOI 10.1016/j.cell.2017.11.032
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Ramanan P, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00024-17
   Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA
   Somasekar S, 2017, CLIN INFECT DIS, V65, P1477, DOI 10.1093/cid/cix596
   Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 12
TC 3
Z9 3
U1 2
U2 15
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 13
PY 2018
VL 23
IS 6
BP 702
EP 704
DI 10.1016/j.chom.2018.05.016
PG 3
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7WT
UT WOS:000438408600008
PM 29902435
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Zhang, JS
   Lan, Y
   Li, MY
   Lamers, MM
   Fusade-Boyer, M
   Klemm, E
   Thiele, C
   Ashour, J
   Sanyal, S
AF Zhang, Jingshu
   Lan, Yun
   Li, Ming Yuan
   Lamers, Mart Matthias
   Fusade-Boyer, Maxime
   Klemm, Elizabeth
   Thiele, Christoph
   Ashour, Joseph
   Sanyal, Sumana
TI Flaviviruses Exploit the Lipid Droplet Protein AUP1 to Trigger Lipophagy
   and Drive Virus Production
SO CELL HOST & MICROBE
LA English
DT Article
ID HEPATITIS-C VIRUS; DENGUE VIRUS; ENDOPLASMIC-RETICULUM; HOST FACTORS;
   ZIKA VIRUS; REPLICATION; CELLS; INFECTION; AUTOPHAGY; ORGANELLES
AB Ubiquitylation is one of the most versatile protein post-translational modifications and is frequently altered during virus infections. Here we employed a functional proteomics screen to identify host proteins that are differentially ubiquitylated upon dengue virus (DENV) infection. Among the several differentially modified proteins identified in infected cells was AUP1, a lipid droplet-localized type-III membrane protein, which exists predominantly in the mono-ubiquitylated form. AUP1 associated with DENV NS4A and relocalized from lipid droplets to autophagosomes upon infection. Virus production was abolished in cells deleted for AUP1 or expressing an AUP1 acyltransferase domain mutant. Ubiquitylation disrupted the AUP1-NS4A interaction, resulting in inhibited acyltransferase activity, defective lipophagy, and attenuated virus production. Our results show that DENV-NS4A exploits the acyltransferase activity of AUP1 to trigger lipophagy, a process regulated by ubiquitylation. This mechanism appears to be a general phenomenon in biogenesis of flaviviruses and underscores the critical role of post-translational modifications in virus infections.
C1 [Zhang, Jingshu; Lan, Yun; Li, Ming Yuan; Lamers, Mart Matthias; Fusade-Boyer, Maxime; Sanyal, Sumana] Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China.
   [Sanyal, Sumana] Univ Hong Kong, Sch Biomed Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.
   [Ashour, Joseph] Icahn Sch Med Mt Sinai, New York, NY 10029 USA.
   [Thiele, Christoph] Univ Bonn, Life & Med Sci Inst LIMES, Bonn, Germany.
   [Klemm, Elizabeth] Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge, England.
RP Sanyal, S (corresponding author), Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China.; Sanyal, S (corresponding author), Univ Hong Kong, Sch Biomed Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China.
EM sanyal@hku.hk
RI Sanyal, Sumana/AAF-5155-2020; Sanyal, Sumana/I-7975-2013
OI Sanyal, Sumana/0000-0002-6230-5366
FU Research Grants Council (GRF) [17117914, 17113915]; Health and Medical
   Research funds [16150592]; Research Grants CouncilHong Kong Research
   Grants Council [T11-705/14N]; PTR from Institut Pasteur [546]; BNP
   Paribas; Croucher Foundation
FX This work was funded by Research Grants Council (GRF grants 17117914 and
   17113915) and partially supported by Health and Medical Research funds
   (16150592), a theme-based research grant from the Research Grants
   Council (project no. T11-705/14N), PTR (546) from Institut Pasteur, and
   contributions from BNP Paribas. S.S. is supported by the Croucher
   Foundation. The authors acknowledge Christopher Bachran for help with
   generation of the ubiquitin plasmid, Eric Spooner for help with mass
   spectrometry analyses, and Roberto Bruzzone for critical comments on the
   manuscript.
CR Alvisi G, 2011, RNA BIOL, V8, P258, DOI 10.4161/rna.8.2.15011
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Budt M, 2011, J VIROL, V85, P10415, DOI 10.1128/JVI.05071-11
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Duran A, 2015, ARCH VIROL, V160, P1687, DOI 10.1007/s00705-015-2433-z
   EJERCITO PM, 1968, J GEN VIROL, V2, P357, DOI 10.1099/0022-1317-2-3-357
   Filipe A, 2015, TRENDS MOL MED, V21, P34, DOI 10.1016/j.molmed.2014.11.003
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564
   Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y
   Klemm EJ, 2011, J BIOL CHEM, V286, P37602, DOI 10.1074/jbc.M111.284794
   Kudelko M, 2012, J BIOL CHEM, V287, P767, DOI 10.1074/jbc.M111.270579
   Li MY, 2015, CELL REP, V10, P1496, DOI 10.1016/j.celrep.2015.02.021
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin YP, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1379-4
   Lohmann D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072453
   Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105
   Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Olivo-Marin JC, 2002, PATTERN RECOGN, V35, P1989, DOI 10.1016/S0031-3203(01)00127-3
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Ramage H, 2015, ANNU REV VIROL, V2, P497, DOI 10.1146/annurev-virology-100114-055238
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098
   Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047
   Sanyal S, 2013, CELL HOST MICROBE, V14, P510, DOI 10.1016/j.chom.2013.10.011
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Spandl J, 2011, J BIOL CHEM, V286, P5599, DOI 10.1074/jbc.M110.190785
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32243
   Zhang JS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02286
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 49
TC 18
Z9 18
U1 1
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 13
PY 2018
VL 23
IS 6
BP 819
EP +
DI 10.1016/j.chom.2018.05.005
PG 18
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7WT
UT WOS:000438408600020
PM 29902443
OA Bronze
DA 2020-07-08
ER

PT J
AU Theze, J
   Li, T
   du Plessis, L
   Bouquet, J
   Kraemer, MUG
   Somasekar, S
   Yu, GX
   de Cesare, M
   Balmaseda, A
   Kuan, G
   Harris, E
   Wu, CH
   Ansari, MA
   Bowden, R
   Faria, NR
   Yagi, S
   Messenger, S
   Brooks, T
   Stone, M
   Bloch, EM
   Busch, M
   Munoz-Medina, JE
   Gonzalez-Bonilla, CR
   Wolinsky, S
   Lopez, S
   Arias, CF
   Bonsall, D
   Chiu, CY
   Pybus, OG
AF Theze, Julien
   Li, Tony
   du Plessis, Louis
   Bouquet, Jerome
   Kraemer, Moritz U. G.
   Somasekar, Sneha
   Yu, Guixia
   de Cesare, Mariateresa
   Balmaseda, Angel
   Kuan, Guillermina
   Harris, Eva
   Wu, Chieh-hsi
   Ansari, M. Azim
   Bowden, Rory
   Faria, Nuno R.
   Yagi, Shigeo
   Messenger, Sharon
   Brooks, Trevor
   Stone, Mars
   Bloch, Evan M.
   Busch, Michael
   Munoz-Medina, Jose E.
   Gonzalez-Bonilla, Cesar R.
   Wolinsky, Steven
   Lopez, Susana
   Arias, Carlos F.
   Bonsall, David
   Chiu, Charles Y.
   Pybus, Oliver G.
TI Genomic Epidemiology Reconstructs the Introduction and Spread of Zika
   Virus in Central America and Mexico
SO CELL HOST & MICROBE
LA English
DT Article
ID SEXUAL TRANSMISSION; MOLECULAR SEQUENCES; CLINICAL-SAMPLES; GENERATION;
   DENGUE; CHIKUNGUNYA; ACCURATE; PROTEIN; BRAZIL; EVOLUTION
AB The Zika virus (ZIKV) epidemic in the Americas established ZIKV as a major public health threat and uncovered its association with severe diseases, including microcephaly. However, genetic epidemiology in some at-risk regions, particularly Central America and Mexico, remains limited. We report 61 ZIKV genomes from this region, generated using metagenomic sequencing with ZIKV-specific enrichment, and combine phylogenetic, epidemiological, and environmental data to reconstruct ZIKV transmission. These analyses revealed multiple independent ZIKV introductions to Central America and Mexico. One introduction, likely from Brazil via Honduras, led to most infections and the undetected spread of ZIKV through the region from late 2014. Multiple lines of evidence indicate biannual peaks of ZIKV transmission in the region, likely driven by varying local environmental conditions for mosquito vectors and herd immunity. The spatial and temporal heterogeneity of ZIKV transmission in Central America and Mexico challenges arbovirus surveillance and disease control measures.
C1 [Theze, Julien; du Plessis, Louis; Kraemer, Moritz U. G.; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Li, Tony; Bouquet, Jerome; Somasekar, Sneha; Yu, Guixia; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Li, Tony; Bouquet, Jerome; Somasekar, Sneha; Yu, Guixia; Chiu, Charles Y.] UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, Boston, MA USA.
   [Kraemer, Moritz U. G.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA.
   [de Cesare, Mariateresa; Bowden, Rory] Univ Oxford, Oxford Genom Ctr, Wellcome Trust Ctr Human Genet, Oxford, England.
   [Balmaseda, Angel] Minist Salud, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Salud, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Wu, Chieh-hsi] Univ Oxford, Dept Stat, Oxford, England.
   [Ansari, M. Azim; Bonsall, David] Univ Oxford, Nuffield Dept Med, Oxford, England.
   [Yagi, Shigeo; Messenger, Sharon] Calif Dept Publ Hlth, Richmond, CA USA.
   [Brooks, Trevor; Stone, Mars; Busch, Michael] Blood Syst Res Inst, San Francisco, CA USA.
   [Bloch, Evan M.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA.
   [Munoz-Medina, Jose E.; Gonzalez-Bonilla, Cesar R.] Inst Mexicano Seguro Social, Div Labs Vigilancia & Invest Epidemiol, Mexico City, DF, Mexico.
   [Wolinsky, Steven] Northwestern Univ, Feinberg Sch Med, Div Infect Dis, Chicago, IL 60611 USA.
   [Lopez, Susana; Arias, Carlos F.] Univ Nacl Autonoma Mexico, Inst Biotecnol, Cuernavaca, Morelos, Mexico.
   [Chiu, Charles Y.] Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), UCSF Abbott Viral Diagnost & Discovery Ctr, San Francisco, CA 94143 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Div Infect Dis, Dept Med, San Francisco, CA 94143 USA.
EM charles.chiu@ucsf.edu; oliver.pybus@zoo.ox.ac.uk
RI Arias, Carlos/O-4036-2019; Wolinsky, Steven/B-2893-2012; Esteban, Munoz
   Medina Jose/B-6186-2015; Faria, Nuno/I-2975-2012; Pybus, Oliver
   g/B-2640-2012; Lopez, Susana/H-6661-2017; du Plessis, Louis/K-1667-2013
OI Arias, Carlos/0000-0003-3130-4501; Esteban, Munoz Medina
   Jose/0000-0002-1289-4457; Faria, Nuno/0000-0001-8839-2798; Pybus, Oliver
   g/0000-0002-8797-2667; Lopez, Susana/0000-0001-6336-9209; bonsall,
   david/0000-0003-2187-0550; Bowden, Rory/0000-0001-8596-0366; du Plessis,
   Louis/0000-0003-0352-6289; Wu, Chieh-Hsi/0000-0001-9386-725X; Gonzalez
   Bonilla, Cesar/0000-0002-2225-5069; Ansari, M. Azim/0000-0003-2790-8353;
   Bouquet, Jerome/0000-0001-8077-6025
FU European Research Council under the European Commission Seventh
   Framework Program (FP7)/European Research Council grant
   [614725-PATHPHYLODYN]; Oxford Martin School; Society in Science Branco
   Weiss Fellowship; National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [T32HD040128];
   National Library of Medicine of the NIH [R01LM010812, R01LM011965];
   Wellcome TrustWellcome Trust; Royal SocietyRoyal Society of London
   [204311/Z/16/Z]; Abbott LaboratoriesAbbott Laboratories; NIH from the
   National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI099631, P01AI106695, U19 AI118610, R21AI129455]; NIH from the
   National Heart, Lung, and Blood InstituteUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [R01 HL105704]; Wellcome
   Trust core awardWellcome Trust [203141/Z/16/Z]
FX We thank Marco A. Espinoza for processing the Mexican ZIKV serum
   samples. We thank Magelda Montoya and Juan Carlos Mercado for their
   invaluable assistance in providing samples from Nicaragua. Wealso thank
   Prof. Nicholas Loman and Joshua Quick for their feedback on the
   manuscript. We are grateful to past and present members of the team at
   the Centro de Salud Socrates Flores Vivas, the National Virology
   Laboratory in the Centro Nacional de Diagnostico y Referencia, and the
   Sustainable Sciences Institute in Nicaragua for their dedication and
   high-quality work, as well as the children who participated in the
   studies and their families. We thank Philippe Lemey for providing the
   script to analyze viral transmissions among locations. We thank Paul
   Klenerman, who supported sequencing of the Nicaragua samples through the
   Oxford Viromics initiative. This work was supported by the European
   Research Council under the European Commission Seventh Framework Program
   (FP7/2007-2013)/European Research Council grant agreement
   614725-PATHPHYLODYN and by the Oxford Martin School. M.U.G.K. is
   supported by the Society in Science Branco Weiss Fellowship,
   administered by the ETH Zurich, and acknowledges funding from a training
   grant from the National Institute of Child Health and Human Development
   (T32HD040128) and the National Library of Medicine of the NIH
   (R01LM010812, R01LM011965). N.R.F. is supported by the Wellcome Trust
   and the Royal Society (204311/Z/16/Z). This work was also funded in part
   by Abbott Laboratories (C.Y.C.), NIH grants R01AI099631 (A.B.),
   P01AI106695 (E.H.), U19 AI118610 (S.W. and E.H.), and R21AI129455
   (C.Y.C.) from the National Institute of Allergy and Infectious Diseases,
   and NIH grant R01 HL105704 (C.Y.C.) from the National Heart, Lung, and
   Blood Institute. This work was also supported by the Wellcome Trust core
   award (203141/Z/16/Z).
CR Diaz-Quionez JA, 2016, VIRUS GENES, V52, P855, DOI 10.1007/s11262-016-1384-0
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonsall David, 2015, F1000Res, V4, P1062, DOI 10.12688/f1000research.7111.1
   Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537
   Briese T, 2015, MBIO, V6, DOI 10.1128/mBio.01491-15
   Brooks T, 2017, EMERG INFECT DIS, V23, P1360, DOI 10.3201/eid2308.161944
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Koehler JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107007
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Li H, 2013, ARXIVQBIOGN13033997
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Luk KC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141723
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Minin VN, 2008, PHILOS T R SOC B, V363, P3985, DOI 10.1098/rstb.2008.0176
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Naccache SN, 2016, EMERG INFECT DIS, V22, P1788, DOI 10.3201/eid2210.160663
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   O'Brien JD, 2009, MOL BIOL EVOL, V26, P801, DOI 10.1093/molbev/msp003
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stadler T, 2013, P NATL ACAD SCI USA, V110, P228, DOI 10.1073/pnas.1207965110
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wylie TN, 2015, GENOME RES, V25, P1910, DOI 10.1101/gr.191049.115
   Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628
   Zambrano LI, 2017, J INFECT PUBLIC HEAL, V10, P446, DOI 10.1016/j.jiph.2016.08.003
NR 67
TC 28
Z9 29
U1 1
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN 13
PY 2018
VL 23
IS 6
BP 855
EP +
DI 10.1016/j.chom.2018.04.017
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GM7WT
UT WOS:000438408600023
PM 29805095
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Fink, SL
   Vojtech, L
   Wagoner, J
   Slivinski, NSJ
   Jackson, KJ
   Wang, RF
   Khadka, S
   Luthra, P
   Basler, CF
   Polyak, SJ
AF Fink, Susan L.
   Vojtech, Lucia
   Wagoner, Jessica
   Slivinski, Natalie S. J.
   Jackson, Konner J.
   Wang, Ruofan
   Khadka, Sudip
   Luthra, Priya
   Basler, Christopher F.
   Polyak, Stephen J.
TI The Antiviral Drug Arbidol Inhibits Zika Virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID IN-VITRO; COXSACKIE-VIRUS; PHARMACOKINETICS; COMBINATION; INFECTIONS;
   MECHANISM; EFFICACY; SINGLE; ENTRY; ASSAY
AB There are many emerging and re-emerging globally prevalent viruses for which there are no licensed vaccines or antiviral medicines. Arbidol (ARB, umifenovir), used clinically for decades in several countries as an anti-influenza virus drug, inhibits many other viruses. In the current study, we show that ARB inhibits six different isolates of Zika virus (ZIKV), including African and Asian lineage viruses in multiple cell lines and primary human vaginal and cervical epithelial cells. ARB protects against ZIKV-induced cytopathic effects. Time of addition studies indicate that ARB is most effective at suppressing ZIKV when added to cells prior to infection. Moreover, ARB inhibits pseudoviruses expressing the ZIKV Envelope glycoprotein. Thus, ARB, a broadly acting anti-viral agent with a well-established safety profile, inhibits ZIKV, likely by blocking viral entry.
C1 [Fink, Susan L.; Wagoner, Jessica; Slivinski, Natalie S. J.; Jackson, Konner J.; Polyak, Stephen J.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Vojtech, Lucia; Wang, Ruofan] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Khadka, Sudip; Luthra, Priya; Basler, Christopher F.] Georgia State Univ, Inst Biomed Sci, Ctr Microbial Pathogenesis, Atlanta, GA 30303 USA.
RP Polyak, SJ (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
EM polyak@uw.edu
OI Fink, Susan/0000-0003-1705-0103; Vojtech, Lucia/0000-0003-2343-0719;
   khadka, sudip/0000-0002-5551-0417; Basler,
   Christopher/0000-0003-4195-425X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [A1095023]; UW STI Developmental Award
   [U19 AI113173];  [K08AI119142];  [R21AI130281];  [U19 AI109664]
FX We thank Robert Tesh, Justin Roby, and Michael Gale Jr. for ZIKV stocks;
   Theodore Pierson, Oscar Burrone and Jose Luis Slon Campos for plasmids.
   S.L.F. is partially supported by K08AI119142 and R21AI130281. L.V. is
   partially supported by NIH A1095023 and a UW STI Developmental Award
   from U19 AI113173. C.F.B. is partially supported by U19 AI109664. C.F.B.
   is a Georgia Research Alliance Eminent Scholar in Microbial
   Pathogenesis.
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Belokrinitskaya T. E., 2012, QUESTIONS GYNECOLOGY, V11, pS31
   Blaising J, 2014, ANTIVIR RES, V107, P84, DOI 10.1016/j.antiviral.2014.04.006
   Blaising J, 2013, ANTIVIR RES, V100, P215, DOI 10.1016/j.antiviral.2013.08.008
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56
   Brooks MJ, 2012, J MED VIROL, V84, P170, DOI 10.1002/jmv.22234
   Chapman S, 2010, J CLIN INVEST, V120, P2619, DOI 10.1172/JCI42297
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Delogu I, 2011, ANTIVIR RES, V90, P99, DOI 10.1016/j.antiviral.2011.03.182
   Deng HY, 2009, ACTA PHARMACOL SIN, V30, P1015, DOI 10.1038/aps.2009.53
   Deng P, 2013, ANTIMICROB AGENTS CH, V57, P1743, DOI 10.1128/AAC.02282-12
   Guskova T., ARBIDOL NEW ANTIVIRA, P63
   Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647
   Hladik F, 2015, ELIFE, V4, DOI 10.7554/eLife.04525
   Kadam RU, 2017, P NATL ACAD SCI USA, V114, P206, DOI 10.1073/pnas.1617020114
   Leneva IA, 2005, TERAPEVT ARKH, V77, P84
   Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009
   LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110
   Liu MY, 2009, CLIN THER, V31, P784, DOI 10.1016/j.clinthera.2009.04.016
   Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1075, DOI 10.1038/aps.2013.54
   Liu X, 2007, J PHARMACEUT BIOMED, V43, P371, DOI 10.1016/j.jpba.2006.06.039
   Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036
   Luthra P, 2018, ANTIVIR RES, V150, P193, DOI 10.1016/j.antiviral.2017.12.019
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nasser ZH, 2013, ANTIVIR RES, V100, P399, DOI 10.1016/j.antiviral.2013.08.021
   Nayak S, 2016, SEMIN REPROD MED, V34, P266, DOI 10.1055/s-0036-1592071
   Oehler E, 2014, EURO SURVEILL, V19
   Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804
   Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j
   Pecheur EI, 2016, J VIROL, V90, P3086, DOI 10.1128/JVI.02077-15
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Polyak SJ, 2010, P NATL ACAD SCI USA, V107, P5995, DOI 10.1073/pnas.0914009107
   Ren JS, 2018, J MED CHEM, V61, P724, DOI 10.1021/acs.jmedchem.7b01249
   Sharma V, 2009, BRIT J PHARMACOL, V157, P907, DOI 10.1111/j.1476-5381.2009.00267.x
   Shi L, 2007, ARCH VIROL, V152, P1447, DOI 10.1007/s00705-007-0974-5
   SIMIZU B, 1967, P SOC EXP BIOL MED, V125, P119, DOI 10.3181/00379727-125-32029
   Sun YX, 2013, INT J CLIN PHARM TH, V51, P423, DOI 10.5414/CP201843
   Teissier E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015874
   Teissier E, 2011, MOLECULES, V16, P221, DOI 10.3390/molecules16010221
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang M, 2010, DRUG CHEM TOXICOL, V33, P244, DOI 10.3109/01480540903311050
   Wright ZVF, 2017, BIOORG MED CHEM LETT, V27, P3744, DOI 10.1016/j.bmcl.2017.06.074
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhao CS, 2006, BIOORGAN MED CHEM, V14, P2552, DOI 10.1016/j.bmc.2005.11.033
   Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102
   Zhong Q, 2009, ARCH VIROL, V154, P601, DOI 10.1007/s00705-009-0346-4
NR 55
TC 18
Z9 20
U1 4
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 12
PY 2018
VL 8
AR 8989
DI 10.1038/s41598-018-27224-4
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ0EI
UT WOS:000434920800033
PM 29895962
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castro, MC
   Han, QYC
   Carvalho, LR
   Victora, CG
   Franca, GVA
AF Castro, Marcia C.
   Han, Qiuyi C.
   Carvalho, Lucas R.
   Victora, Cesar G.
   Franca, Giovanny V. A.
TI Implications of Zika virus and congenital Zika syndrome for the number
   of live births in Brazil
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika virus; congenital Zika syndrome; Brazil; births; abortion
ID ABORTION; SURVEILLANCE; FERTILITY; RECESSION; INFECTION; OUTBREAKS;
   EPIDEMIC; SAFETY
AB An increase in microcephaly, associated with an epidemic of Zika virus (ZIKV) in Brazil, prompted the World Health Organization to declare a Public Health Emergency of International Concern in February 2016. While knowledge on biological and epidemiological aspects of ZIKV has advanced, demographic impacts remain poorly understood. This study uses time-series analysis to assess the impact of ZIKV on births. Data on births, fetal deaths, and hospitalizations due to abortion complications for Brazilian states, from 2010 to 2016, were used. Forecasts for September 2015 to December 2016 showed that 119,095 fewer births than expected were observed, particularly after April 2016 (a reduction significant at 0.05), demonstrating a link between publicity associated with the ZIKV epidemic and the decline in births. No significant changes were observed in fetal death rates. Although no significant increases in hospitalizations were forecasted, after the ZIKV outbreak hospitalizations happened earlier in the gestational period in most states. We argue that postponement of pregnancy and an increase in abortions may have contributed to the decline in births. Also, it is likely that an increase in safe abortions happened, albeit selective by socioeconomic status. Thus, the ZIKV epidemic resulted in a generation of congenital Zika syndrome (CZS) babies that reflect and exacerbate regional and social inequalities. Since ZIKV transmission has declined, it is unlikely that reductions in births will continue. However, the possibility of a new epidemic is real. There is a need to address gaps in reproductive health and rights, and to understand CZS risk to better inform conception decisions.
C1 [Castro, Marcia C.] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
   [Han, Qiuyi C.] Harvard Univ, Stat Dept, Cambridge, MA 02138 USA.
   [Carvalho, Lucas R.] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, BR-31270901 Belo Horizonte, MG, Brazil.
   [Victora, Cesar G.] Univ Fed Pelotas, Programa Posgrad Epidemiol, BR-96020220 Pelotas, RS, Brazil.
   [Franca, Giovanny V. A.] Brazilian Minist Hlth, Secretariat Hlth Surveillance, BR-70719040 Brasilia, DF, Brazil.
RP Castro, MC (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA.
EM mcastro@hsph.harvard.edu
RI Victora, Cesar Gomes/Y-2455-2019; de Franca, Giovanny Vinicius
   Araujo/L-7385-2018; Castro, Marcia/S-2681-2019; de Carvalho, Lucas
   Resende/AAB-7031-2019
OI Victora, Cesar Gomes/0000-0002-2465-2180; de Franca, Giovanny Vinicius
   Araujo/0000-0002-7530-2017; Castro, Marcia/0000-0003-4606-2795; de
   Carvalho, Lucas Resende/0000-0002-3618-3967
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alfenas Amorim F, 2008, POBLACION SALUD SEXU, P101
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Bongaarts J, 2008, HOW LONG DO WE LIVE? DEMOGRAPHIC MODELS AND REFLECTIONS ON TEMPO EFFECTS, P29, DOI 10.1007/978-3-540-78520-0_3
   Brasil Ministerio da Saude, 2013, SIST INF MORT SIM CO
   Brasil Ministerio da Saude Secretaria da Vigilancia em Saude, 2015, SAUD BRAS 2014 AN SI
   Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Secretaria de Atencao a Saude, 2009, SURV HDB CHILD FET D
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carvalho JR, 2017, IZA DISCUSSION PAPER
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   CONDON RG, 1982, HUM ECOL, V10, P495, DOI 10.1007/BF01531169
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cummings DR, 2014, AM J HUM BIOL, V26, P424, DOI 10.1002/ajhb.22534
   de Oliveira CS, 2016, J PEDIAT-BRAZIL, V92, P103, DOI 10.1016/j.jped.2016.02.003
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Dias TZ, 2015, INT J GYNECOL OBSTET, V128, P224, DOI 10.1016/j.ijgo.2014.09.031
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   Barbeiro FMD, 2015, REV SAUDE PUBL, V49, DOI 10.1590/S0034-8910.2015049005568
   Duarte HHP, 2006, REV SAUDE PUBL, V40, P134, DOI 10.1590/S0034-89102006000100021
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Ganatra B, 2017, LANCET, V390, P2372, DOI 10.1016/S0140-6736(17)31794-4
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goldstein JR, 2013, DEMOGR RES, V29, P85, DOI 10.4054/DemRes.2013.29.4
   Henderson JT, 2005, CONTRACEPTION, V72, P175, DOI 10.1016/j.contraception.2005.03.011
   IBGE, 2010, CENS DEM 2010 NUPC F
   IBGE, 2017, PESQ MENS EMPR
   IBGE, 2013, PESQ NAC SAUD 2013 C, V3
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2009, IND SOC SAUD BRAS 20
   Krug EG, 2002, WORLD REPORT VIOLENC, P89
   LAM DA, 1994, ANN NY ACAD SCI, V709, P9, DOI 10.1111/j.1749-6632.1994.tb30385.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leite Iuri C, 2007, Reprod Health, V4, P6, DOI 10.1186/1742-4755-4-6
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Moreira MM, 2013, 19 C AS LAT SOC
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Neri Marcelo, 2002, Cad. Saúde Pública, V18, pS77, DOI 10.1590/S0102-311X2002000700009
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Orlandi DP, 2016, 9 C CONSAD GEST PUBL
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sedgh G, 2016, LANCET, V388, P258, DOI 10.1016/S0140-6736(16)30380-4
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Singh S, 2010, METHODOLOGIES ESTIMA, P71
   Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x
   Szwarcwald CL, 2011, SAUDE BRASIL 2010 AN, P79
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vrachnis N, 2014, LANCET, V383, P692, DOI 10.1016/S0140-6736(14)60252-X
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, R D BLUEPR ACT PREV
   World Health Organization, 1993, INT STAT CLASS DIS R, V2
NR 65
TC 19
Z9 20
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 12
PY 2018
VL 115
IS 24
BP 6177
EP 6182
DI 10.1073/pnas.1718476115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GJ0HJ
UT WOS:000434933400042
PM 29844186
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barrett, ADT
AF Barrett, Alan D. T.
TI Current status of Zika vaccine development: Zika vaccines advance into
   clinical evaluation
SO NPJ VACCINES
LA English
DT Article
ID VIRUS; PROTECTION; DISEASE
AB Zika virus (ZIKV), a mosquito-borne flavivirus, was first identified in the 1940s in Uganda in Africa and emerged in the Americas in Brazil in May 2015. In the 30 months since ZIKV emerged as a major public health problem, spectacular progress has been made with vaccine development cumulating with the publication of three reports of phase 1 clinical trials in the 4th quarter of 2017. Clinical trials involving candidate DNA and purified inactivated virus vaccines showed all were safe and well-tolerated in the small number of volunteers and all induced neutralizing antibodies, although these varied by vaccine candidate and dosing regimen. These results suggest that a Zika vaccine can be developed and that phase 2 clinical trials are warranted. However, it is difficult to compare the results from the different phase 1 studies or with neutralizing antibodies induced by licensed flavivirus vaccines (Japanese encephalitis, tick-borne encephalitis, and yellow fever) as neutralizing antibody assays vary and, unfortunately, there are no standards for Zika virus neutralizing antibodies. In addition to clinical studies, substantial progress continues to be made in nonclinical development, particularly in terms of the ability of candidate vaccines to protect reproductive tissues, and the potential use of monoclonal antibodies for passive prophylaxis.
C1 [Barrett, Alan D. T.] Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.
   [Barrett, Alan D. T.] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Barrett, ADT (corresponding author), Univ Texas Med Branch, Sealy Inst Vaccine Sci, Galveston, TX 77555 USA.; Barrett, ADT (corresponding author), Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
EM abarrett@utmb.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI 129844]; Gillson Longenbaugh
   Foundation
FX ADTB is supported by NIH R21 AI 129844 and a grant from the Gillson
   Longenbaugh Foundation.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
NR 19
TC 30
Z9 31
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD JUN 11
PY 2018
VL 3
AR 24
DI 10.1038/s41541-018-0061-9
PG 4
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GK4WY
UT WOS:000436169500001
PM 29900012
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, H
AF Wang, Hansen
TI Modeling Neurological Diseases With Human Brain Organoids
SO FRONTIERS IN SYNAPTIC NEUROSCIENCE
LA English
DT Review
DE brain organoids; pluripotent stem cells; neurological diseases;
   neurodevelopmental disorders; neurodegenerative diseases; iPSCs; autism;
   Alzheimer disease
ID PLURIPOTENT STEM-CELLS; AUTISM SPECTRUM DISORDERS; ZIKA-VIRUS; CEREBRAL
   ORGANOIDS; CORTICAL DEVELOPMENT; SELF-ORGANIZATION; NEURAL PROGENITORS;
   MINI-BRAINS; MUTATIONS; DIFFERENTIATION
AB The complexity and delicacy of human brain make it challenging to recapitulate its development, function and disorders. Brain organoids derived from human pluripotent stem cells (PSCs) provide a new tool to model both normal and pathological human brain, and greatly enhance our ability to study brain biology and diseases. Currently, human brain organoids are increasingly used in modeling neurological disorders and relative therapeutic discovery. This review article focuses on recent advances in human brain organoid system and its application in disease modeling. It also discusses the limitations and future perspective of human brain organoids in modeling neurological diseases.
C1 [Wang, Hansen] Univ Toronto, Fac Med, Toronto, ON, Canada.
RP Wang, H (corresponding author), Univ Toronto, Fac Med, Toronto, ON, Canada.
EM hansen.wang@utoronto.ca
RI Wang, Hansen/H-7703-2014
OI Wang, Hansen/0000-0003-4414-3372
CR Allende ML, 2018, J LIPID RES, V59, P550, DOI 10.1194/jlr.M081323
   Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Bradshaw NJ, 2012, NEUROPHARMACOLOGY, V62, P1230, DOI 10.1016/j.neuropharm.2010.12.027
   Bredenoord AL, 2017, SCIENCE, V355, DOI 10.1126/science.aaf9414
   Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036
   Butler MG, 2005, J MED GENET, V42, P318, DOI 10.1136/jmg.2004.024646
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Castro J, 2013, CURR OPIN NEUROL, V26, P154, DOI 10.1097/WCO.0b013e32835f19a7
   Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800
   Clevers H, 2016, CELL, V165, P1586, DOI 10.1016/j.cell.2016.05.082
   Cordeiro P, 2000, GENET MED, V2, P319, DOI 10.1097/00125817-200011000-00003
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dezonne RS, 2017, SCI REP-UK, V7, DOI 10.1038/srep45091
   Di Lullo E, 2017, NAT REV NEUROSCI, V18, P573, DOI 10.1038/nrn.2017.107
   Dyer MA, 2016, CELL STEM CELL, V18, P425, DOI 10.1016/j.stem.2016.03.017
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Ferreira Carlos R, 2017, Transl Sci Rare Dis, V2, P1, DOI 10.3233/TRD-160005
   Forsberg SL, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-017-0062-x
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcez PP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7474
   Giandomenico SL, 2017, CURR OPIN CELL BIOL, V44, P36, DOI 10.1016/j.ceb.2017.01.001
   Hagerman RJ, 2014, J CLIN PSYCHIAT, V75, pE294, DOI 10.4088/JCP.13r08714
   Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994
   Hartley BJ, 2017, NEUROCHEM INT, V106, P85, DOI 10.1016/j.neuint.2016.10.004
   Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047
   Janssens Sylvie, 2018, mSystems, V3, DOI [10.1128/msystems.00219-17, 10.1128/mSystems.00219-17]
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kelava I, 2016, DEV BIOL, V420, P199, DOI 10.1016/j.ydbio.2016.06.037
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Koch P, 2017, CELL STEM CELL, V21, P157, DOI 10.1016/j.stem.2017.07.001
   Krumm N, 2014, TRENDS NEUROSCI, V37, P95, DOI 10.1016/j.tins.2013.11.005
   Lancaster MA, 2018, NAT BIOTECHNOL, V36, P407, DOI 10.1038/nbt.4133
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee CT, 2017, NEUROPSYCHOPHARMACOL, V42, P774, DOI 10.1038/npp.2016.156
   Lee CT, 2011, SYNAPSE, V65, P21, DOI 10.1002/syn.20814
   Lee CT, 2008, PLOS MED, V5, P987, DOI 10.1371/journal.pmed.0050117
   Lee HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163072
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lipina TV, 2014, NEUROSCI BIOBEHAV R, V45, P271, DOI 10.1016/j.neubiorev.2014.07.001
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Marchese M, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-26
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mason JO, 2016, NEUROSCIENCE, V334, P105, DOI 10.1016/j.neuroscience.2016.07.048
   Matarese CA, 2009, PEDIATR NEUROL, V40, P324, DOI 10.1016/j.pediatrneurol.2008.11.008
   McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29
   McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mellios N, 2018, Mol Psychiatry, V23, P791, DOI 10.1038/mp.2018.5
   Mellios N, 2018, MOL PSYCHIATR, V23, P1051, DOI 10.1038/mp.2017.86
   Mich JK, 2017, CELL STEM CELL, V21, P289, DOI 10.1016/j.stem.2017.08.017
   Micu I, 2018, NAT REV NEUROSCI, V19, P49, DOI 10.1038/nrn.2017.128
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mirzaa GM, 2013, AM J MED GENET C, V163C, P122, DOI 10.1002/ajmg.c.31361
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muffat J, 2016, CURR OPIN CELL BIOL, V43, P96, DOI 10.1016/j.ceb.2016.10.001
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Mullins C, 2016, NEURON, V89, P1131, DOI 10.1016/j.neuron.2016.02.017
   Nagamani SCS, 2009, J MED GENET, V46, P825, DOI 10.1136/jmg.2009.067637
   Narayan S, 2013, NEUROSCIENTIST, V19, P451, DOI 10.1177/1073858412470168
   Nasr B, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8010014
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003
   Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032
   Porteous DJ, 2011, TRENDS MOL MED, V17, P699, DOI 10.1016/j.molmed.2011.09.002
   Prytkova I, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00360
   Qian XY, 2018, NAT PROTOC, V13, P565, DOI 10.1038/nprot.2017.152
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, CURR OPIN CELL BIOL, V49, P47, DOI 10.1016/j.ceb.2017.11.010
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rubenstein JLR, 2010, CURR OPIN NEUROL, V23, P118, DOI 10.1097/WCO.0b013e328336eb13
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112
   Seo J, 2017, J NEUROSCI, V37, P9917, DOI 10.1523/JNEUROSCI.0621-17.2017
   Shi Y, 2017, NAT REV DRUG DISCOV, V16, P115, DOI 10.1038/nrd.2016.245
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Sutcliffe Magdalena, 2019, Methods Mol Biol, V1576, P1, DOI 10.1007/7651_2017_2
   Sztainberg Y, 2016, NAT NEUROSCI, V19, P1408, DOI 10.1038/nn.4420
   Szulwach KE, 2010, J CELL BIOL, V189, P127, DOI 10.1083/jcb.200908151
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Takebe T, 2015, CELL STEM CELL, V16, P556, DOI 10.1016/j.stem.2015.03.004
   van der Zee J, 2008, NEUROLOGY, V71, P1191, DOI 10.1212/01.wnl.0000327523.52537.86
   Wan ACA, 2016, TRENDS BIOTECHNOL, V34, P711, DOI 10.1016/j.tibtech.2016.02.015
   Wang H, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00183
   Wang HS, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00055
   Wang HS, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/346053
   Wang P, 2017, MOL AUTISM, V8, DOI 10.1186/s13229-017-0124-1
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wen ZX, 2016, CURR OPIN NEUROBIOL, V36, P118, DOI 10.1016/j.conb.2015.11.003
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Wu H, 2010, P NATL ACAD SCI USA, V107, P18161, DOI 10.1073/pnas.1005595107
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Ye F, 2017, NEURON, V96, P1204, DOI 10.1016/j.neuron.2017.11.034
   Yin XL, 2016, CELL STEM CELL, V18, P25, DOI 10.1016/j.stem.2015.12.005
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526
   Zhong SJ, 2018, NATURE, V555, P524, DOI 10.1038/nature25980
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 122
TC 24
Z9 24
U1 6
U2 14
PU FRONTIERS RESEARCH FOUNDATION
PI LAUSANNE
PA EPFL SCIENCE PARK, BLDG D, LAUSANNE, 1015, SWITZERLAND
SN 1663-3563
J9 FRONT SYNAPTIC NEURO
JI Front. Synaptic Neurosci.
PD JUN 8
PY 2018
VL 10
AR UNSP 15
DI 10.3389/fnsyn.2018.00015
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA HG6YM
UT WOS:000455134400001
PM 29937727
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kudlacek, ST
   Premkumar, L
   Metz, SW
   Tripathy, A
   Bobkov, AA
   Payne, AM
   Graham, S
   Brackbill, JA
   Miley, MJ
   de Silva, AM
   Kuhlman, B
AF Kudlacek, Stephan T.
   Premkumar, Lakshmanane
   Metz, Stefan W.
   Tripathy, Ashutosh
   Bobkov, Andrey A.
   Payne, Alexander Matthew
   Graham, Stephen
   Brackbill, James A.
   Miley, Michael J.
   de Silva, Aravinda M.
   Kuhlman, Brian
TI Physiological temperatures reduce dimerization of dengue and Zika virus
   recombinant envelope proteins
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HUMAN-ANTIBODY; NEUTRALIZING ANTIBODIES; CONFORMATIONAL-CHANGES;
   PROTECTIVE EFFICACY; CRYSTAL-STRUCTURE; HIGHLY POTENT; EPITOPES; DOMAIN;
   IMMUNOGENICITY; STABILITY
AB The spread of dengue (DENV) and Zika virus (ZIKV) is a major public health concern. The primary target of antibodies that neutralize DENV and ZIKV is the envelope (E) glycoprotein, and there is interest in using soluble recombinant E (sRecE) proteins as subunit vaccines. However, the most potent neutralizing antibodies against DENV and ZIKV recognize epitopes on the virion surface that span two or more E proteins. Therefore, to create effective DENV and ZIKV vaccines, presentation of these quaternary epitopes may be necessary. The sRecE proteins fromDENVand ZIKV crystallize as native-like dimers, but studies in solution suggest that these dimers are marginally stable. To better understand the challenges associated with creating stable sRecE dimers, we characterized the thermostability of sRecE proteins from ZIKV and three DENV serotypes, DENV2-4. All four proteins irreversibly unfolded at moderate temperatures (46-53 degrees C). At 23 degrees C and low micromolar concentrations, DENV2 and ZIKV were primarily dimeric, and DENV3-4 were primarily monomeric, whereas at 37 degrees C, all four proteins were predominantly monomeric. We further show that the dissociation constant for DENV2 dimerization is very temperature-sensitive, ranging from < 1 mu M at 25 degrees C to 50 mu M at 41 degrees C, due to a large exothermic enthalpy of binding of similar to 79 kcal/mol. We also found that quaternary epitope antibody binding to DENV2-4 and ZIKV sRecE is reduced at 37 degrees C. Our observation of reduced sRecE dimerization at physiological temperature highlights the need for stabilizing the dimer as part of its development as a subunit vaccine.
C1 [Kudlacek, Stephan T.; Tripathy, Ashutosh; Payne, Alexander Matthew; Kuhlman, Brian] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.
   [Premkumar, Lakshmanane; Metz, Stefan W.; Graham, Stephen; de Silva, Aravinda M.] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Bobkov, Andrey A.] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
   [Brackbill, James A.; Miley, Michael J.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA.
   [Kuhlman, Brian] Univ N Carolina, Lineburger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.
RP Kuhlman, B (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.
EM bkuhlman@email.unc.edu
RI Metz, Stefan/J-1974-2019
OI Metz, Stefan/0000-0002-9249-2844; Payne, Alex/0000-0003-0947-0191
FU NIGMS, National Institutes of Health (NIH)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM073960];
   NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19 AI09784]; Centers for Disease Control
   and PreventionUnited States Department of Health & Human ServicesCenters
   for Disease Control & Prevention - USA [00HVELJB-2017-04191]
FX This work was supported by NIGMS, National Institutes of Health (NIH),
   Grant R01GM073960; NIAID, NIH Grant U19 AI09784; and Centers for Disease
   Control and Prevention Grant 00HVELJB-2017-04191. The authors declare
   that they have no conflicts of interest with the contents of this
   article. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of the National
   Institutes of Health.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   COHEN J, 2017, SCIENCE, V80
   Coller BAG, 2011, VACCINE, V29, P7267, DOI 10.1016/j.vaccine.2011.07.021
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DELENDA C, 1994, ARCH VIROL, V139, P197, DOI 10.1007/BF01309465
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hsieh SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100641
   KOSLYUCHENKO VA, 2016, NATURE, V533, P425
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kuhlman B, 1998, BIOCHEMISTRY-US, V37, P1025, DOI 10.1021/bi972352x
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017
   Lim XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14339
   Liu Y, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.74
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Manoff SB, 2015, VACCINE, V33, P7126, DOI 10.1016/j.vaccine.2015.09.101
   MCDIS Y, 2004, NATURE, V427, P313
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Metz SW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005071
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Scheiblhofer S, 2017, EXPERT REV VACCINES, V16, P479, DOI 10.1080/14760584.2017.1306441
   Sergeev YV, 2004, BIOCHEMISTRY-US, V43, P415, DOI 10.1021/bi034617f
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661
   WHO, 2016, J WKLY EPIDEMIOL REC, V91, P349
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2015, CURR OPIN VIROL, V12, P109, DOI 10.1016/j.coviro.2015.04.006
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019
NR 55
TC 6
Z9 6
U1 1
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 8
PY 2018
VL 293
IS 23
BP 8922
EP 8933
DI 10.1074/jbc.RA118.002658
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GJ0JZ
UT WOS:000434941900016
PM 29678884
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Bottino-Rojas, V
   Talyuli, OAC
   Carrara, L
   Martins, AJ
   James, AA
   Oliveira, PL
   Paiva-Silva, GO
AF Bottino-Rojas, Vanessa
   Talyuli, Octavio A. C.
   Carrara, Luana
   Martins, Ademir J.
   James, Anthony A.
   Oliveira, Pedro L.
   Paiva-Silva, Gabriela O.
TI The redox-sensing gene Nrf2 affects intestinal homeostasis, insecticide
   resistance, and Zika virus susceptibility in the mosquito Aedes aegypti
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID DENGUE VIRUS; ANOPHELES-GAMBIAE; TRANSCRIPTION FACTORS; OXIDATIVE
   STRESS; DROSOPHILA GUT; PYRETHROID RESISTANCE; CONSENSUS SEQUENCE;
   TISSUE HOMEOSTASIS; DUAL OXIDASE; BLOOD MEAL
AB Production and degradation of reactive oxygen species (ROS) are extensively regulated to ensure proper cellular responses to various environmental stimuli and stresses. Moreover, physiologically generated ROS function as secondary messengers that can influence tissue homeostasis. The cap'n'collar transcription factor known as nuclear factor erythroid-derived factor 2 (Nrf2) coordinates an evolutionarily conserved transcriptional activation pathway that mediates antioxidant and detoxification responses in many animal species, including insects and mammals. Here, we show that Nrf2-mediated signaling affects embryo survival, midgut homeostasis, and redox biology in Aedes aegypti, a mosquito species vector of dengue, Zika, and other disease-causing viruses. We observed that AeNrf2 silencing increases ROS levels and stimulates intestinal stem cell proliferation. Because ROS production is a major aspect of innate immunity in mosquito gut, we found that a decrease in Nrf2 signaling results in reduced microbiota growth and Zika virus infection. Moreover, we provide evidence that AeNrf2 signaling also controls transcriptional adaptation of A. aegypti to insecticide challenge. Therefore, we conclude that Nrf2-mediated response regulates assorted gene clusters in A. aegypti that determine cellular and midgut redox balance, affecting overall xenobiotic resistance and vectorial adaptation of the mosquito.
C1 [Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Carrara, Luana; Martins, Ademir J.] Fundacao Oswaldo Cruz, Laficave, Inst Oswaldo Cruz, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Martins, Ademir J.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Inst Nacl Ciencia & Tecnol Entomol Mol, Rio De Janeiro, RJ, Brazil.
   [James, Anthony A.] Univ Calif Irvine, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.
   [James, Anthony A.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA.
RP Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Predio CCS Rm DSS05,Cid Univ Ilha Fundao, BR-21902 Rio De Janeiro, RJ, Brazil.
EM gosilva@bioqmed.ufrj.br
RI Martins, Ademir J./B-4117-2009; Martins, Ademir/W-3251-2019
OI Martins, Ademir/0000-0001-5739-1215; James, Anthony/0000-0001-5577-3308;
   Bottino-Rojas, Vanessa/0000-0001-8019-9942
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoarnento de Pessoal de Nivel SuperiorCAPES; Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ);
   National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI115595, AI29746]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico; Coordenacao de Aperfeicoarnento de Pessoal de
   Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro; and National Institute of Health Grants AI115595 (to A. J. M.)
   and AI29746 (to A. A. J.). The authors declare that they have no
   conflicts of interest with the contents of this article. The content is
   solely the responsibility of the authors and does not necessarily
   represent the official views of the National Institutes of Health.
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024
   Biteau B, 2011, CELL STEM CELL, V9, P402, DOI 10.1016/j.stem.2011.10.004
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Blank V, 2008, J MOL BIOL, V376, P913, DOI 10.1016/j.jmb.2007.11.074
   Bottino-Rojas V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135985
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Carter JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139899
   Chan KM, 1996, P NATL ACAD SCI USA, V93, P13943, DOI 10.1073/pnas.93.24.13943
   Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000
   Chowdhry S, 2013, ONCOGENE, V32, P3765, DOI 10.1038/onc.2012.388
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   David JP, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-174
   Faucon F, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005526
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645
   Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311
   Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007
   Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002
   Heiss EH, 2013, REDOX BIOL, V1, P359, DOI 10.1016/j.redox.2013.06.001
   Hochmuth CE, 2011, CELL STEM CELL, V8, P188, DOI 10.1016/j.stem.2010.12.006
   Huang HX, 2017, VIROLOGY, V503, P1, DOI 10.1016/j.virol.2016.12.019
   Ingham VA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4086-7
   Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943
   Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634
   Jones RM, 2015, CELL REP, V12, P1217, DOI 10.1016/j.celrep.2015.07.042
   Jones RM, 2013, EMBO J, V32, P3017, DOI 10.1038/emboj.2013.224
   Kalsi M, 2017, INSECT BIOCHEM MOLEC, V83, P1, DOI 10.1016/j.ibmb.2017.02.002
   Kalsi M, 2015, INSECT BIOCHEM MOLEC, V65, P47, DOI 10.1016/j.ibmb.2015.08.002
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Kramer LD, 2016, CURR OPIN VIROL, V21, P81, DOI 10.1016/j.coviro.2016.08.008
   Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100
   Lacher SE, 2015, FREE RADICAL BIO MED, V88, P452, DOI 10.1016/j.freeradbiomed.2015.06.044
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238
   Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997
   Misra JR, 2013, INSECT BIOCHEM MOLEC, V43, P1116, DOI 10.1016/j.ibmb.2013.09.005
   Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200
   Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003
   Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257
   Nioi P, 2003, BIOCHEM J, V374, P337, DOI 10.1042/BJ20030754
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313
   Paes MC, 2001, ARCH INSECT BIOCHEM, V48, P63, DOI 10.1002/arch.1058
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Peng T, 2016, INSECT MOL BIOL, V25, P450, DOI 10.1111/imb.12230
   Pitoniak A, 2015, FREE RADICAL BIO MED, V88, P302, DOI 10.1016/j.freeradbiomed.2015.06.020
   Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x
   Poupardin R, 2012, AQUAT TOXICOL, V114, P49, DOI 10.1016/j.aquatox.2012.02.001
   Rahman MM, 2013, AGING CELL, V12, P554, DOI 10.1111/acel.12078
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010
   RUSHMORE TH, 1991, J BIOL CHEM, V266, P11632
   SAMPSON JR, 1988, P NATL ACAD SCI USA, V85, P1033, DOI 10.1073/pnas.85.4.1033
   Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Singh A, 2009, FREE RADICAL BIO MED, V46, P376, DOI 10.1016/j.freeradbiomed.2008.10.026
   Sterkel M, 2017, TRENDS PARASITOL, V33, P633, DOI 10.1016/j.pt.2017.04.008
   Stevenson BJ, 2011, INSECT BIOCHEM MOLEC, V41, P492, DOI 10.1016/j.ibmb.2011.02.003
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401
   Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002
   Sykiotis GP, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3112re3
   Tebay LE, 2015, FREE RADICAL BIO MED, V88, P108, DOI 10.1016/j.freeradbiomed.2015.06.021
   Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006
   Tromp N, 2016, LANCET, V387, P1053, DOI 10.1016/S0140-6736(16)00659-0
   Tsai JJ, 2013, NAT CELL BIOL, V15, P309, DOI 10.1038/ncb2699
   Wan H, 2014, PEST MANAG SCI, V70, P1048, DOI 10.1002/ps.3645
   Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003
   Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004
NR 88
TC 10
Z9 10
U1 0
U2 19
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 8
PY 2018
VL 293
IS 23
BP 9053
EP 9063
DI 10.1074/jbc.RA117.001589
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GJ0JZ
UT WOS:000434941900027
PM 29685890
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Muller, JA
   Harms, M
   Kruger, F
   Gross, R
   Joas, S
   Hayn, M
   Dietz, AN
   Lippold, S
   von Einem, J
   Schubert, A
   Michel, M
   Mayer, B
   Cortese, M
   Jang, KS
   Sandi-Monroy, N
   Deniz, M
   Ebner, F
   Vapalahti, O
   Otto, M
   Bartenschlager, R
   Herbeuval, JP
   Schmidt-Chanasit, J
   Roan, NR
   Munch, J
AF Mueller, Janis A.
   Harms, Mirja
   Krueger, Franziska
   Gross, Ruediger
   Joas, Simone
   Hayn, Manuel
   Dietz, Andrea N.
   Lippold, Sina
   von Einem, Jens
   Schubert, Axel
   Michel, Manuela
   Mayer, Benjamin
   Cortese, Mirko
   Jang, Karen S.
   Sandi-Monroy, Nathallie
   Deniz, Miriam
   Ebner, Florian
   Vapalahti, Olli
   Otto, Markus
   Bartenschlager, Ralf
   Herbeuval, Jean-Philippe
   Schmidt-Chanasit, Jonas
   Roan, Nadia R.
   Muench, Jan
TI Semen inhibits Zika virus infection of cells and tissues from the
   anogenital region
SO NATURE COMMUNICATIONS
LA English
DT Article
ID WEST NILE VIRUS; SEXUAL TRANSMISSION; SEMINAL PLASMA; AMYLOID FIBRILS;
   PREVENTION; DIAGNOSIS; OUTBREAK; BIOLOGY; BORNE
AB Zika virus (ZIKV) causes severe birth defects and can be transmitted via sexual intercourse. Semen from ZIKV-infected individuals contains high viral loads and may therefore serve as an important vector for virus transmission. Here we analyze the effect of semen on ZIKV infection of cells and tissues derived from the anogenital region. ZIKV replicates in all analyzed cell lines, primary cells, and endometrial or vaginal tissues. However, in the presence of semen, infection by ZIKV and other flaviviruses is potently inhibited. We show that semen prevents ZIKV attachment to target cells, and that an extracellular vesicle preparation from semen is responsible for this anti-ZIKV activity. Our findings suggest that ZIKV transmission is limited by semen. As such, semen appears to serve as a protector against sexual ZIKV transmission, despite the availability of highly susceptible cells in the anogenital tract and high viral loads in this bodily fluid.
C1 [Mueller, Janis A.; Harms, Mirja; Krueger, Franziska; Gross, Ruediger; Joas, Simone; Hayn, Manuel; Sandi-Monroy, Nathallie; Muench, Jan] Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.
   [Dietz, Andrea N.; Lippold, Sina; von Einem, Jens; Schubert, Axel; Michel, Manuela] Ulm Univ, Inst Virol, Med Ctr, D-89081 Ulm, Germany.
   [Mayer, Benjamin] Ulm Univ, Inst Epidemiol & Med Biometry, D-89075 Ulm, Germany.
   [Cortese, Mirko; Bartenschlager, Ralf] Heidelberg Univ, Fac Med, Dept Infect Dis, Mol Virol, D-69120 Heidelberg, Germany.
   [Jang, Karen S.; Roan, Nadia R.] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.
   [Jang, Karen S.; Roan, Nadia R.] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94158 USA.
   [Deniz, Miriam; Ebner, Florian] Ulm Univ, Klin Frauenheilkunde & Geburtshilfe, Med Ctr, D-89081 Ulm, Germany.
   [Ebner, Florian] Helios Amper Klin, Frauenklin, D-85221 Dachau, Germany.
   [Vapalahti, Olli] Univ Helsinki, Dept Virol & Immunol, FIN-00014 Helsinki, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki 00014, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland.
   [Otto, Markus] Ulm Univ, Dept Neurol, D-89081 Ulm, Germany.
   [Bartenschlager, Ralf] Heidelberg Univ, German Ctr Infect Res DZIF, Heidelberg Partner Site, D-69120 Heidelberg, Germany.
   [Herbeuval, Jean-Philippe] Univ Paris 05, Lab Chim & Biochim Pharmacol & Toxicol, Chem Biol Modeling & Immunotherapy CBMIT, CNRS,UMR8601,CICB Paris, F-75006 Paris, France.
   [Schmidt-Chanasit, Jonas] World Hlth Org Collaborating Ctr Arbovirus & Hemo, Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, D-20359 Hamburg, Germany.
   [Muench, Jan] Ulm Univ, Med Ctr, Core Facil Funct Peptid, D-89081 Ulm, Germany.
RP Munch, J (corresponding author), Ulm Univ, Inst Mol Virol, Med Ctr, D-89081 Ulm, Germany.; Munch, J (corresponding author), Ulm Univ, Med Ctr, Core Facil Funct Peptid, D-89081 Ulm, Germany.
EM jan.muench@uni-ulm.de
RI Otto, Markus/F-4304-2015
OI Otto, Markus/0000-0003-4273-4267; Gross, Rudiger/0000-0003-0355-7915; ,
   Nathallie/0000-0001-5457-1448; Cortese, Mirko/0000-0003-1786-4211; Jan,
   Munch/0000-0001-7316-7141; Vapalahti, Olli/0000-0003-2270-6824
FU Baden-Wurttemberg Stiftung; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R21 AI122821,
   R01 AI127219]; DFGGerman Research Foundation (DFG) [CRC1279]
FX We thank Martha Mayer for helping with tissue preparations and Stephanie
   Kallis for helping with the Dengue virus experiments. We thank the
   Kinderwunsch-Zentrum Ulm for providing semen samples and acknowledge the
   NIH Specialized Cooperative Centers Program in Reproduction and
   Infertility Research Human Endometrial Tissue and DNA Bank for
   endometrial tissues. Mirja Harms, Simone Joas, Rudiger Gross, Manuel
   Hayn, Andrea Dietz, and Sina Lippold are part of the International
   Graduate School in Molecular Medicine Ulm. Anogenital cell lines were
   provided by Kerstin Otte (Institute of Applied Biotechnology, Biberach
   University of Applied Sciences, Biberach, Germany), Ninel Azoitei
   (Center for Internal Medicine I, University of Ulm, Ulm, Germany), or
   Markus Huber-Lang (Department of Orthopaedic Trauma, Hand-, Plastic- and
   Reconstructive Surgery, University Hospital of Ulm, Ulm Germany). J.A.M.
   is indebted to the Baden-Wurttemberg Stiftung for the financial support
   of this research project by the Eliteprogramme for Postdocs. N.R.R.
   acknowledges funding from the NIH (R21 AI122821 and R01 AI127219). J.M.
   acknowledges funding by the DFG (CRC1279).
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Arakelyan A, 2014, METHODS MOL BIOL, V1087, P233, DOI 10.1007/978-1-62703-670-2_19
   Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B., 2016, GENOME ANNOUNC, V4
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bergman P, 2016, J INTERN MED, V280, P139, DOI 10.1111/joim.12479
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bryson Y, 2017, CURR OPIN PEDIATR, V29, P94, DOI 10.1097/MOP.0000000000000453
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Castellano Laura M, 2012, Biology (Basel), V1, P58, DOI 10.3390/biology1010058
   Chen JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116549
   Chen Lin H, 2016, Trop Dis Travel Med Vaccines, V2, P15, DOI 10.1186/s40794-016-0032-y
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Danesh A, 2014, BLOOD, V123, P687, DOI 10.1182/blood-2013-10-530469
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   GLUSHAKOVA S, 1995, NAT MED, V1, P1320, DOI 10.1038/nm1295-1320
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Grivel JC, 2009, NAT PROTOC, V4, P256, DOI 10.1038/nprot.2008.245
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Heigele A, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-13
   Hoog JL, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.28680
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Kim KA, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-55
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Muller J. A., 2016, BIO PROTOC, V6, pe1871
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Owen DH, 2005, J ANDROL, V26, P459, DOI 10.2164/jandrol.04104
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Purpura LJ, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30330-9
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roan NR, 2014, J VIROL, V88, P7221, DOI 10.1128/JVI.00269-14
   Roan NR, 2011, CELL HOST MICROBE, V10, P541, DOI 10.1016/j.chom.2011.10.010
   Roan NR, 2009, J VIROL, V83, P73, DOI 10.1128/JVI.01366-08
   RONQUIST G, 1985, BIOCHIM BIOPHYS ACTA, V822, P203, DOI 10.1016/0304-4157(85)90008-5
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Southern PJ, 2013, TRENDS MICROBIOL, V21, P245, DOI 10.1016/j.tim.2013.02.002
   Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tang QY, 2013, J VIROL, V87, P12583, DOI 10.1128/JVI.02083-13
   Terrault NA, 2002, HEPATOLOGY, V36, pS99, DOI 10.1053/jhep.2002.36797
   Torres L, 2015, VIRUSES-BASEL, V7, P2057, DOI 10.3390/v7042057
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508
   VALLELY PJ, 1986, CLIN EXP IMMUNOL, V66, P181
   Vojtech L, 2014, NUCLEIC ACIDS RES, V42, P7290, DOI 10.1093/nar/gku347
   Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002
   WHO, 2016, PREV SEX TRANSM ZIK
   WHO, 2017, ZIK VIR SIT REP
   Winkler CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07099-7
   World Health Organization, 2016, ZIK VIR SIT REP
   Yanez-Mo M, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27066
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817
   Zirafi O, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009634
NR 80
TC 11
Z9 11
U1 0
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 7
PY 2018
VL 9
AR 2207
DI 10.1038/s41467-018-04442-y
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI4ZL
UT WOS:000434379800004
PM 29880824
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, R
   Liao, XZ
   Fan, DY
   Wang, L
   Song, J
   Feng, KH
   Li, MY
   Wang, PG
   Chen, H
   An, J
AF Wang, Ran
   Liao, Xianzheng
   Fan, Dongying
   Wang, Lei
   Song, Ji
   Feng, Kaihao
   Li, Mingyuan
   Wang, Peigang
   Chen, Hui
   An, Jing
TI Maternal immunization with a DNA vaccine candidate elicits specific
   passive protection against post-natal Zika virus infection in
   immunocompetent BALB/c mice
SO VACCINE
LA English
DT Article
ID ENCEPHALITIS; EFFICACY
AB Zika virus (ZIKV) infection is closely associated in the fetus with microcephaly and in the adults with Guillain-Barre syndrome and even male infertility. It is an urgent international priority to develop a safe and effective vaccine that offers protection to both women of childbearing age and their children. In this study, female immunocompetent BALB/c mice were immunized with a DNA-based vaccine candidate, pVAX1-ZME, expressing the prM/E protein of ZIKV, and the immunogenicity for maternal mice and the post-natal protection for suckling mice were evaluated. It was found that administration with three doses of 5014 pVAX1-ZME via in vivo electroporation induced robust ZIKV-specific cellular and long-term humoral immune responses with high and sustained neutralizing activity in adult mice. Moreover, using a maternal immunization protocol, neutralizing antibodies provided specific passive protection against ZIKV infection in neonatal mice and effectively inhibited the growth delay. This vaccine candidate is expected to be further evaluated in higher animals, and maternal vaccination shows great promise for protecting both women of childbearing age and their offspring against post-natal ZIKV infection. The vaccinated mothers and ZIKV-challenged pups provide key insight into Zika vaccine evaluation in an available fully immunocompetent animal model. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Wang, Ran; Liao, Xianzheng; Fan, Dongying; Song, Ji; Feng, Kaihao; Wang, Peigang; Chen, Hui; An, Jing] Chinese Capital Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100069, Peoples R China.
   [Wang, Lei] Cangzhou Med Coll, Dept Basic Med Sci, Fac Pathogen Biol & Immunol, Cangzhou 061001, Hebei, Peoples R China.
   [Li, Mingyuan] Univ Hong Kong, LKS Fac Med, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Hong Kong, Peoples R China.
   [An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100069, Peoples R China.
RP Chen, H; An, J (corresponding author), Chinese Capital Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100069, Peoples R China.
EM chenhuicxh@ccmu.edu.cn; anjing@ccmu.edu.cn
RI Wang, Ran/O-9878-2019
OI Wang, Ran/0000-0002-0243-8538; Wang, Peigang/0000-0001-6045-2007
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81772172, 81471957, 81671971, U1602223]
FX This work was supported by National Natural Science Foundation of China
   (Grant numbers 81772172, 81471957, 81671971 and U1602223). These funding
   sources played no part in the decision to publish, data analysis, or the
   writing of the manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Brasil P, 2016, LANCET INFECT DIS, V16, P1307, DOI 10.1016/S1473-3099(16)30372-3
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Chen H, 2016, CLIN IMMUNOL, V171, P41, DOI 10.1016/j.clim.2016.08.021
   Chen H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034602
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Hagmann SHF, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0584-7
   Hannaman D, 2016, VACCINE, V34, P3607, DOI 10.1016/j.vaccine.2016.04.077
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   PALMER EL, 1980, J MED VIROL, V5, P123, DOI 10.1002/jmv.1890050205
   Pawitwar SS, 2017, J NEUROIMMUNE PHARM, V12, P371, DOI 10.1007/s11481-017-9743-8
   Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Sheng ZY, 2016, VACCINE, V34, P5751, DOI 10.1016/j.vaccine.2016.10.001
   Silaeva YY, 2013, BIOCHEMISTRY-MOSCOW+, V78, P549, DOI 10.1134/S0006297913050143
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tebas P, 2017, N ENGL J MED
   Wang ZY, 2016, VIROL SIN, V31, P103, DOI 10.1007/s12250-016-3780-y
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Yang YJ, 2017, EBIOMEDICINE, V17, P145, DOI 10.1016/j.ebiom.2017.02.003
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zheng XY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00175
NR 40
TC 9
Z9 10
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD JUN 7
PY 2018
VL 36
IS 24
BP 3522
EP 3532
DI 10.1016/j.vaccine.2018.04.051
PG 11
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GJ1XG
UT WOS:000435060600020
PM 29753607
DA 2020-07-08
ER

PT J
AU Rodrigues, NCP
   Daumas, RP
   de Almeida, AS
   dos Santos, RS
   Koster, I
   Rodrigues, PP
   Gomes, MD
   Macedo, AD
   Gerardi, A
   Lett, ID
AF Pinheiro Rodrigues, Nadia Cristina
   Daumas, Regina Paiva
   de Almeida, Andrea Sobral
   dos Santos, Reinaldo Souza
   Koster, Isabella
   Rodrigues, Pedro Pinheiro
   Gomes, Marcelly de Freitas
   Macedo, Auriane de Fatima
   Gerardi, Alyssa
   Lett, Iuri da Costa
TI Risk factors for arbovirus infections in a low-income community of Rio
   de Janeiro, Brazil, 2015-2016
SO PLOS ONE
LA English
DT Article
ID ZIKA VIRUS; DENGUE
AB Background
   Dengue epidemics have occurred in the city of Rio de Janeiro (Brazil) since 1986. In the year 2015, Zika and chikungunya viruses were introduced in the city, causing sequential and simultaneous epidemics. Poor socioeconomic conditions have been suggested as contributing factors of arboviral infection.
   Objective
   To describe the spatial distribution of human cases of symptomatic arboviral infections and to identify risk factors for infection in a poor community of Rio de Janeiro in the years 2015 and 2016.
   Methods
   We built thematic maps of incidence rates for 78 micro-areas in the Manguinhos neighborhood. The micro-areas congregate about 600 inhabitants. Simple and multiple multilevel logistic regression models were used to evaluate the association between the incidence of arboviral diseases and socio-demographic factors at both the individual and micro-area levels.
   Results
   From 2015 to 2016, 370 human cases of arbovirus infection were reported in the Manguinhos community: 123 in 2015 and 247 in 2016. There was a significant difference in the risk of arbovirus diseases among different micro-areas, but this was not explained by water and sanitation indicators. The cumulative incidence rate was 849/100,000 in two years. The incidence was greater in those individuals with familiar vulnerability (1,156/100,000 vs. 794/100,000). The multilevel adjusted model showed that the odds of acquiring an arbovirus infection was 55% greater in those with familiar vulnerability.
   Conclusion
   Arbovirus infections cause a high burden of disease in Brazilian urban centers. Our results suggest that even in poor neighborhoods, there is a high spatial variability in the risk of acquiring an arbovirus infection. The conditions that favor vector proliferation and infection by arboviruses are complex and involve both individual and environmental characteristics that vary from place to place. To reduce the burden of arboviral diseases, continued public health policies and basic services should be provided to the communities at risk that consider specific local needs.
C1 [Pinheiro Rodrigues, Nadia Cristina; Daumas, Regina Paiva; de Almeida, Andrea Sobral; dos Santos, Reinaldo Souza; Koster, Isabella; Rodrigues, Pedro Pinheiro; Gomes, Marcelly de Freitas; Macedo, Auriane de Fatima; Lett, Iuri da Costa] Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.
   [Pinheiro Rodrigues, Nadia Cristina] Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.
   [Rodrigues, Pedro Pinheiro; Gomes, Marcelly de Freitas] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Gerardi, Alyssa] Georgetown Univ, Washington, DC USA.
RP Rodrigues, NCP (corresponding author), Fundacao Oswaldo Cruz, Natl Sch Publ Hlth Sergio Arouca, Rio De Janeiro, Brazil.; Rodrigues, NCP (corresponding author), Univ Estado Rio De Janeiro, Sch Med Sci, Rio De Janeiro, Brazil.
EM nadiacristinapr@gmail.com
RI Sobral, Andrea/K-2319-2016; DAUMAS, REGINA/M-9387-2013
OI Sobral, Andrea/0000-0003-0552-771X; DAUMAS, REGINA/0000-0002-8923-7711;
   Koster, Isabella/0000-0001-6061-2824; Rodrigues,
   Nadia/0000-0002-2613-5283; Souza dos Santos,
   Reinaldo/0000-0003-2387-6999
FU Territorio Integrado de Atencao a Sakle (Teias) - Escola Manguinhos
   Project
FX We received funding from Territorio Integrado de Atencao a Sakle (Teias)
   - Escola Manguinhos Project, which only covered recruitment costs.
CR [Anonymous], 2012, GLOB STRAT DENG PREV
   Aquino Junior J., 2014, DENGUE INT BORDER AR
   Barcellos C, 2005, REV SOC BRAS MED TRO, V38, P246, DOI 10.1590/S0037-86822005000300008
   Barcellos C, 2009, EPIDEMIOL SERV SAUDE, V18, P285
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Coelho F, 2004, APPL FAMILY RISK SCA
   Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Fernandes TM, 2013, TEMPO-NITEROI, V19, P117, DOI [10.5533/TEM-1980-542X-2013173410, 10.5533/TEM-1980-542X-2013173410eng]
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   FONSECA A. F., 2007, TERRITORIO PROCESSO
   FUNASA BHM, 2011, HIST PUBL HLTH CHR
   Garcia-Betancourt T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129054
   Heringer M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2488-4
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   IBGE, 2010, SUBN CLUST TERR INF
   IIED, 2008, ACH MILL DEV GOALS L
   Jacobi P., 2004, URBAN ENV IMPACTS RI, P169
   Kikuti M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003937
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   Little E, 2017, J MED ENTOMOL, V54, P1183, DOI 10.1093/jme/tjx103
   Matysiak A, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8947067
   Mendonça Francisco de Assis, 2009, Soc. nat., V21, P257, DOI 10.1590/S1982-45132009000300003
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Rodrigues NCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165945
   PMRJ, 2018, STORY MAP J RIO DE J
   PMRJ, 2018, ARM RIO DE JAN
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Schutz G, 2012, INTEGRATED AREA HLTH, P25
   Silverman B. W., 1986, DENSITY ESTIMATION S
   SMS-RJ SMdS-R, 2017, VIG SAUD RIO DE JAN
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Torres EM, 2005, DENGUE
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zoonoses GdDTpVe, 2016, B EPIDEMIOLOGICO ABR
NR 40
TC 3
Z9 3
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 7
PY 2018
VL 13
IS 6
AR e0198357
DI 10.1371/journal.pone.0198357
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI5BF
UT WOS:000434384900034
PM 29879155
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Strange, DP
   Green, R
   Siemann, DN
   Gale, M
   Verma, S
AF Strange, Daniel P.
   Green, Richard
   Siemann, David N.
   Gale, Michael, Jr.
   Verma, Saguna
TI Immunoprofiles of human Sertoli cells infected with Zika virus reveals
   unique insights into host-pathogen crosstalk
SO SCIENTIFIC REPORTS
LA English
DT Article
ID TOLL-LIKE RECEPTORS; RIG-I; NEURAL PROGENITORS; CEREBRAL ORGANOIDS;
   ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; GENE-EXPRESSION; INTERFERON;
   ACTIVATION; AXL
AB Confirmed reports of Zika virus (ZIKV) in seminal fluid months after clearance of viremia suggests that ZIKV can establish persistent infection in the seminiferous tubules, an immune privileged site of the testis. The seminiferous tubule epithelium is mainly composed of Sertoli cells that function to nourish and protect developing germ cells. We recently demonstrated that primary human Sertoli cells (hSeC) were highly susceptible to ZIKV as compared to dengue virus without causing cell death and thus may act as a reservoir for ZIKV in the testes. However, the cellular and immune responses of hSeC to infection with ZIKV or any other virus are not yet characterized. Using genome-wide RNA-seq to compare immunoprofiles of hSeC, we show that the most prominent response to ZIKV at early stage of infection was suppression of cell growth and proliferation functional pathways. Peak virus replication was associated with induction of multiple antiviral defense pathways. Unique ZIKV-associated signatures included dysregulation of germ cell-Sertoli cell junction signaling. This study demonstrates that hSeC are capable of signaling through canonical pro-inflammatory pathways and provides insights into unique cell-type-specific response induced by ZIKV in association with viral persistence in the testes.
C1 [Strange, Daniel P.; Siemann, David N.; Verma, Saguna] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Green, Richard; Gale, Michael, Jr.] Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98195 USA.
RP Verma, S (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.; Gale, M (corresponding author), Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98195 USA.
EM mgale@uw.edu; saguna@hawaii.edu
FU Centers of Biomedical Research Excellence-National Institutes of Health
   (NIH) [P30GM114737]; Hawaii Community Foundation (HCF);  [21AI129465-01]
FX This work was partially supported by grants from the R21AI129465-01 and
   Centers of Biomedical Research Excellence (P30GM114737)-National
   Institutes of Health (NIH), Hawaii Community Foundation (HCF), and
   institutional funds. We thank Dr. Vivek R. Nerurkar for providing ZIKV
   stock and critical inputs during scientific discussion. We also thank
   Seattle Genomics (University of Washington) for providing RNA sequencing
   service.
CR Aslani F, 2015, HUM REPROD, V30, P417, DOI 10.1093/humrep/deu320
   Atasheva S, 2014, J VIROL, V88, P2116, DOI 10.1128/JVI.03443-13
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bagga S, 2014, METHODS MOL BIOL, V1170, P165, DOI 10.1007/978-1-4939-0888-2_10
   Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Carty M, 2010, CLIN EXP IMMUNOL, V161, P397, DOI 10.1111/j.1365-2249.2010.04196.x
   CDC, 2018, ZIK VIR CAS COUNTS U
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019
   Chui K, 2011, CELL TRANSPLANT, V20, P619, DOI 10.3727/096368910X536563
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Daffis S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000607
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Diamond MS, 2012, TRENDS IMMUNOL, V33, P522, DOI 10.1016/j.it.2012.05.008
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Errett JS, 2013, J VIROL, V87, P11416, DOI 10.1128/JVI.01488-13
   Gack MU, 2014, J VIROL, V88, P5213, DOI 10.1128/JVI.03370-13
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hedger MP, 2011, J REPROD IMMUNOL, V88, P130, DOI 10.1016/j.jri.2011.01.010
   Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Ikushima Hiroaki, 2013, Cold Spring Harb Symp Quant Biol, V78, P105, DOI 10.1101/sqb.2013.78.020321
   Kamau E, 2009, J GEN VIROL, V90, P1827, DOI 10.1099/vir.0.009027-0
   Kannan RP, 2011, J VIROL, V85, P7989, DOI 10.1128/JVI.00280-11
   Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Luo C, 2013, EXP EYE RES, V112, P93, DOI 10.1016/j.exer.2013.04.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022
   Naghavi MH, 2017, J VIROL, V91, DOI 10.1128/JVI.00538-17
   Paz-Bailey G, 2017, N ENGL J MED
   Petry S, 2015, NAT CELL BIOL, V17, P1089, DOI 10.1038/ncb3220
   Rawlinson SM, 2015, CELL MICROBIOL, V17, P1108, DOI 10.1111/cmi.12465
   Riccioli A, 2006, J IMMUNOL, V177, P7122, DOI 10.4049/jimmunol.177.10.7122
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Ryan EL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010002
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Senturk Emir, 2013, Methods Mol Biol, V962, P49, DOI 10.1007/978-1-62703-236-0_4
   Sharpe RM, 2003, REPRODUCTION, V125, P769, DOI 10.1530/rep.0.1250769
   Shaw PH, 1996, PATHOL RES PRACT, V192, P669, DOI 10.1016/S0344-0338(96)80088-4
   Shin EC, 2006, J CLIN INVEST, V116, P3006, DOI 10.1172/JCI29832
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Starace D, 2008, BIOL REPROD, V79, P766, DOI 10.1095/biolreprod.108.068619
   Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120
   Sun B, 2010, ENDOCRINOLOGY, V151, P2886, DOI 10.1210/en.2009-1498
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wong MT, 2016, CELL MOL IMMUNOL, V13, P11, DOI 10.1038/cmi.2014.127
   Wu H, 2016, SCI REP, V6
   Zainal N, 2017, SCI REP-UK, V7, DOI 10.1038/srep42998
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhou BR, 2013, P NATL ACAD SCI USA, V110, P19390, DOI 10.1073/pnas.1314905110
NR 72
TC 8
Z9 8
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 7
PY 2018
VL 8
AR 8702
DI 10.1038/s41598-018-27027-7
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI4YG
UT WOS:000434376700004
PM 29880853
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Powell, L
   Wiederkehr, RS
   Damascus, P
   Fauvart, M
   Buja, F
   Stakenborg, T
   Ray, SC
   Fiorini, P
   Osburn, WO
AF Powell, Laura
   Wiederkehr, Rodrigo Sergio
   Damascus, Paige
   Fauvart, Maarten
   Buja, Federico
   Stakenborg, Tim
   Ray, Stuart C.
   Fiorini, Paolo
   Osburn, William O.
TI Rapid and sensitive detection of viral nucleic acids using silicon
   microchips
SO ANALYST
LA English
DT Article
ID POLYMERASE-CHAIN-REACTION; CHIP; HEPATITIS; PCR; VIRUS; DNA;
   DIAGNOSTICS; LOAD; RNA
AB Clinical laboratory-based nucleic acid amplification tests (NAT) play an important role in diagnosing viral infections. However, laboratory infrastructure requirements and their failure to diagnose at the point-of-need (PON) limit their clinical utility in both resource-rich and -limited clinical settings. The development of fast and sensitive PON viral NAT may overcome these limitations. The scalability of silicon microchip manufacturing combined with advances in silicon microfluidics present an opportunity for development of rapid and sensitive PON NAT on silicon microchips. In the present study, we present rapid and sensitive NAT for a number of RNA and DNA viruses on the same silicon microchip platform. We first developed sensitive (4 copies per reaction) one-step RT-qPCR and qPCR assays detecting HCV, HIV, Zika, HPV 16, and HPV 18 on a benchtop real-time PCR instrument. A silicon microchip was designed with an etched 1.3 mu L meandering microreactor, integrated aluminum heaters, thermal insulation trenches and microfluidic channels; this chip was used in all on-chip experiments. Melting curve analysis confirmed precise and localized heating of the microreactor. Following minimal optimization of reaction conditions, the benchscale assays were successfully transferred to 1.3 mu L silicon microreactors with reaction times of 25 min with no reduction in sensitivity, reproducibility, or reaction efficiencies. Taken together, these results demonstrate that rapid and sensitive detection of multiple viruses on the same silicon microchip platform is feasible. Further development of this technology, coupled with silicon microchip-based nucleic acid extraction solutions, could potentially shift viral nucleic acid detection and diagnosis from centralized clinical laboratories to the PON.
C1 [Powell, Laura; Damascus, Paige; Ray, Stuart C.; Osburn, William O.] Johns Hopkins Univ, Sch Med, Lab Integrated Nanodiagnost, Baltimore, MD 21218 USA.
   [Wiederkehr, Rodrigo Sergio; Fauvart, Maarten; Buja, Federico; Stakenborg, Tim; Fiorini, Paolo] IMEC, Dept Life Sci & Imaging, Leuven, Belgium.
RP Osburn, WO (corresponding author), Johns Hopkins Univ, Sch Med, Lab Integrated Nanodiagnost, Baltimore, MD 21218 USA.
EM wosburn1@jhmi.edu
RI Fauvart, Maarten/B-1612-2010; Wiederkehr, Rodrigo Sergio/L-3739-2013;
   Ray, Stuart C./B-7527-2008; Wiederkehr, Rodrigo Sergio/N-1114-2018
OI Fauvart, Maarten/0000-0002-6256-9193; Ray, Stuart
   C./0000-0002-1051-7260; Wiederkehr, Rodrigo Sergio/0000-0002-1383-2776
FU miDiagnostics
FX Funding for the study described in this publication was provided by
   miDiagnostics.
CR Ahn CH, 2004, P IEEE, V92, P154, DOI 10.1109/JPROC.2003.820548
   Ahrberg CD, 2016, LAB CHIP, V16, P3866, DOI 10.1039/c6lc00984k
   Al Olaby RR, 2011, EXPERT REV MOL DIAGN, V11, P53, DOI 10.1586/ERM.10.101
   Bu MQ, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/7/074002
   BURKS C, 1985, COMPUT APPL BIOSCI, V1, P225
   Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578
   Cho YK, 2006, BIOSENS BIOELECTRON, V21, P2161, DOI 10.1016/j.bios.2005.10.005
   Cobb BR, 2011, J CLIN VIROL, V52, pS77, DOI 10.1016/j.jcv.2011.09.015
   Consolandi C, 2006, ANAL BIOCHEM, V353, P191, DOI 10.1016/j.ab.2006.03.019
   Del Rio-Ospina L, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1126-z
   Erill I, 2003, SENSOR ACTUAT B-CHEM, V96, P685, DOI 10.1016/S0925-4005(03)00522-7
   Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104
   Legendre LA, 2006, ANAL CHEM, V78, P1444, DOI 10.1021/ac0516988
   Luo L, 2010, ANAL LETT, V43, P12, DOI 10.1080/00032710802677167
   Majeed B, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.04DL01
   McGowan CE, 2012, LIVER INT, V32, P151, DOI 10.1111/j.1478-3231.2011.02706.x
   Nabatiyan A, 2011, J VIROL METHODS, V173, P37, DOI 10.1016/j.jviromet.2011.01.003
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306
   Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227
   Song HO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053325
   Sposito A, 2016, LAB CHIP, V16, P3524, DOI 10.1039/c6lc00711b
   Ticehurst JR, 2007, J CLIN MICROBIOL, V45, P2426, DOI 10.1128/JCM.02448-06
   World Health Organization, 2014, ANT RES GLOB REP SUR
   Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134
NR 25
TC 5
Z9 5
U1 6
U2 27
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD JUN 7
PY 2018
VL 143
IS 11
BP 2596
EP 2603
DI 10.1039/c8an00552d
PG 8
WC Chemistry, Analytical
SC Chemistry
GA GH5WZ
UT WOS:000433509800017
PM 29741175
DA 2020-07-08
ER

PT J
AU Ferreira, RN
   Holanda, GM
   Silva, EVP
   Casseb, SMM
   Melo, KFL
   Carvalho, CAM
   Lima, JA
   Vasconcelos, PFC
   Cruz, ACR
AF Ferreira, Rafaella Nascimento
   Holanda, Gustavo Moraes
   Pinto Silva, Eliana Vieira
   Moraes Casseb, Samir Mansour
   Lopes Melo, Karla Fabiane
   Marques Carvalho, Carlos Alberto
   Lima, Juliana Abreu
   Costa Vasconcelos, Pedro Fernando
   Ribeiro Cruz, Ana Cecilia
TI Zika Virus Alters the Expression Profile of microRNA-Related Genes in
   Liver, Lung, and Kidney Cell Lineages
SO VIRAL IMMUNOLOGY
LA English
DT Article
DE Zika virus; microRNAs; flavivirus
ID HEPATITIS-B-VIRUS; MESSENGER-RNA; REPLICATION; INFECTION; HEPG2;
   INHIBITION; ROTAVIRUS; MACHINERY; APOPTOSIS; EPIDEMIC
AB Zika virus (ZIKV) is an arbovirus belonging to the genus Flavivirus (Flaviviridae). ZIKV infection is associated with alterations in various organs, including the liver, lungs, and kidneys. Studies on the influence of posttranscriptional control on viral infections have demonstrated that microRNAs (miRNAs) interfere with different stages of the replicative cycle of several viruses and may influence the disease outcome. To shed light on ZIKV-induced regulation of host miRNA-processing machinery in the above organs, we analyzed the expression of genes encoding key proteins of the miRNA pathway in different ZIKV-infected continuous primate cell lineages (HepG2, A549, and MA104) by reverse-transcription quantitative polymerase chain reaction (RT-qPCR). Expression of the genes encoding the miRNA-related proteins DGCR8, Ago1, and Ago3 in HepG2 cells and Drosha, Dicer, Ago2, and Ago3 in A549 and MA104 cells was significantly altered in the presence of ZIKV. Our results suggest that ZIKV modulates miRNA levels during infection in liver, lung, and kidney cells, which may be an additional mechanism of host cell subversion in these organs.
C1 [Ferreira, Rafaella Nascimento; Holanda, Gustavo Moraes; Pinto Silva, Eliana Vieira; Moraes Casseb, Samir Mansour; Lopes Melo, Karla Fabiane; Marques Carvalho, Carlos Alberto; Lima, Juliana Abreu; Costa Vasconcelos, Pedro Fernando; Ribeiro Cruz, Ana Cecilia] Evandro Chagas Inst, Sect Arbovirol & Hemorrhag Fevers, BR-67030000 Ananindeua, Para, Brazil.
   [Marques Carvalho, Carlos Alberto] State Univ Para, Dept Morphol & Physiol Sci, Belem, Para, Brazil.
   [Costa Vasconcelos, Pedro Fernando; Ribeiro Cruz, Ana Cecilia] State Univ Para, Dept Pathol, Belem, Para, Brazil.
RP Cruz, ACR (corresponding author), Evandro Chagas Inst, Sect Arbovirol & Hemorrhag Fevers, BR-67030000 Ananindeua, Para, Brazil.
EM anacecilia@iec.pa.gov.br
RI Holanda, Gustavo/M-6442-2019; Vasconcelos, Pedro/AAH-3142-2019; Cruz,
   Ana Cecilia Ribeiro/V-9276-2019
OI Carvalho, Carlos/0000-0001-6615-1387; Casseb, Samir/0000-0002-7419-3381
FU Postgraduate Program in Biology of Infectious and Parasitic Agents
   (BAIP/UFPA); Evandro Chagas Institute (IEC); Pro-Rectory of Research and
   Postgraduate Studies (PROPESP) of Federal University of Para (UFPA);
   National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [CNPq-439971/2016-0, 303999/2016-0, 440405/2016-5]; Coordination of
   Improvement of Higher Level Personnel (CAPES-Zika Fast-Track)
FX We thank the Postgraduate Program in Biology of Infectious and Parasitic
   Agents (BAIP/UFPA) and the Evandro Chagas Institute (IEC) for their
   support to this study. This work was supported by Pro-Rectory of
   Research and Postgraduate Studies (PROPESP) of Federal University of
   Para (UFPA), and by grants from the National Council for Scientific and
   Technological Development (CNPq-439971/2016-0; 303999/2016-0;
   440405/2016-5) and Coordination of Improvement of Higher Level Personnel
   (CAPES-Zika Fast-Track). Those who provided funding had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the article.
CR Castillo JA, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1364-y
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Casseb SMM, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027891
   Chiu HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093305
   Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FILIPE AR, 1973, ARCH GES VIRUSFORSCH, V43, P315, DOI 10.1007/BF01556147
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Holanda GM, 2017, VIRAL IMMUNOL, V30, P336, DOI 10.1089/vim.2016.0149
   Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Jafari N, 2013, INT J CLIN EXP MED, V6, P269
   Jiang X, 2014, WORLD J GASTROENTERO, V20, P7197, DOI 10.3748/wjg.v20.i23.7197
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kumari B, 2016, SCI REP-UK, V6, DOI 10.1038/srep20263
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11
   Ospina-Bedoya M, 2014, BIOINFORM BIOL INSIG, V8, P169, DOI 10.4137/BBI.S13649
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Seo GJ, 2013, CELL HOST MICROBE, V14, P435, DOI 10.1016/j.chom.2013.09.002
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243
   Smith JL, 2012, J VIROL, V86, P5278, DOI 10.1128/JVI.06883-11
   Teterina NL, 2014, VIROLOGY, V456, P247, DOI 10.1016/j.virol.2014.04.001
   Thongtan T, 2004, J MED VIROL, V72, P436, DOI 10.1002/jmv.20004
   TSUNEMITSU H, 1991, J CLIN MICROBIOL, V29, P2609, DOI 10.1128/JCM.29.11.2609-2613.1991
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang ZZ, 2011, WORLD J GASTROENTERO, V17, P3353, DOI 10.3748/wjg.v17.i28.3353
   Zheng QL, 2016, J IMMUNOL, V196, P1317, DOI 10.4049/jimmunol.1502134
   Zhou Y, 2016, J MED VIROL, V88, P1497, DOI 10.1002/jmv.24500
NR 41
TC 5
Z9 5
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD OCT
PY 2018
VL 31
IS 8
BP 583
EP 588
DI 10.1089/vim.2017.0186
EA JUN 2018
PG 6
WC Immunology; Virology
SC Immunology; Virology
GA GW7SS
UT WOS:000434863300001
PM 29878881
DA 2020-07-08
ER

PT J
AU Wilder-Smith, A
   Vannice, K
   Durbin, A
   Hombach, J
   Thomas, SJ
   Thevarjan, I
   Simmons, CP
AF Wilder-Smith, Annelies
   Vannice, Kirsten
   Durbin, Anna
   Hombach, Joachim
   Thomas, Stephen J.
   Thevarjan, Irani
   Simmons, Cameron P.
TI Zika vaccines and therapeutics: landscape analysis and challenges ahead
SO BMC MEDICINE
LA English
DT Article
DE Zika; Zika vaccines; Flavivirus; Anti-virals; Prophylaxis; Therapeutics;
   Efficacy trials; Zika diagnostics; Monoclonal antibodies; Immune
   correlates; Immune surrogates; Human controlled infections; Clinical
   endpoints
ID MESSENGER-RNA VACCINES; VIRUS-INFECTION; PROTECTIVE EFFICACY;
   CROSS-REACTIVITY; DOUBLE-BLIND; DNA VACCINE; DENGUE; ANTIBODIES;
   INHIBITORS; DISEASE
AB Background: Various Zika virus (ZIKV) vaccine candidates are currently in development. Nevertheless, unique challenges in clinical development and regulatory pathways may hinder the licensure of high-quality, safe, and effective ZIKV vaccines.
   Discussion: Implementing phase 3 efficacy trials will be difficult given the challenges of the spatio-temporal heterogeneity of ZIKV transmission, the unpredictability of ZIKV epidemics, the broad spectrum of clinical manifestations making a single definite endpoint difficult, a lack of sensitive and specific diagnostic assays, and the need for inclusion of vulnerable target populations. In addition to a vaccine, drugs for primary prophylaxis, post-exposure prophylaxis, or treatment should also be developed to prevent or mitigate the severity of congenital Zika syndrome.
   Conclusion: Establishing the feasibility of immune correlates and/or surrogates are a priority. Given the challenges in conducting phase 3 trials at a time of waning incidence, human challenge trials should be considered to evaluate efficacy. Continued financial support and engagement of industry partners will be essential to the successful development, licensure, and accessibility of Zika vaccines or therapeutics.
C1 [Wilder-Smith, Annelies; Vannice, Kirsten; Hombach, Joachim] WHO, Immunizat Vaccines & Biol, Geneva, Switzerland.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
   [Wilder-Smith, Annelies] Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
   [Durbin, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Immunizat Res, Baltimore, MD USA.
   [Thomas, Stephen J.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA.
   [Thevarjan, Irani] Doherty Inst Infect & Immun, Parkville, Vic 3010, Australia.
   [Thevarjan, Irani] Royal Melbourne Hosp, Parkville, Vic 3010, Australia.
   [Simmons, Cameron P.] Univ Oxford, Clin Res Unit, 764 Vo Kiet St,Dist 5, Minh City, Vietnam.
   [Simmons, Cameron P.] Monash Univ, Inst Vector borne Dis, Melbourne, Vic, Australia.
RP Wilder-Smith, A (corresponding author), WHO, Immunizat Vaccines & Biol, Geneva, Switzerland.; Wilder-Smith, A (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.; Wilder-Smith, A (corresponding author), Umea Univ, Dept Epidemiol & Global Hlth, Umea, Sweden.
EM wildersmitha@who.int
OI Simmons, Cameron P./0000-0002-9039-7392
FU World Health OrganizationWorld Health Organization; USAIDUnited States
   Agency for International Development (USAID); European Union's Horizon
   2020 research and innovation programme under ZikaPLAN [734584]; Lee Kong
   Chian School of Medicine start up grant
FX This work was supported by the World Health Organization, with partial
   funding by USAID, the European Union's Horizon 2020 research and
   innovation programme under ZikaPLAN (Grant Agreement No. 734584), and
   the Lee Kong Chian School of Medicine start up grant.
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   CEPI, NEW VACC SAF WORLD O
   ClinicalTrials.gov, VRC 705 ZIK VIR DNA
   Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Global Advisory Committee on Vaccine Safety, 2014, SAF IMM PREGN REV EV
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Huff A, 2016, PLOS CURR, V8
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Martinez-Palomo A, 2016, J PUBLIC HEALTH POL, V37, P273, DOI 10.1057/s41271-016-0001-8
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mortimer PP, 2016, REV MED VIROL, V26, P219, DOI 10.1002/rmv.1886
   PAHO, ZIK RES CAS DEF
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tatsis N, 2004, MOL THER, V10, P616, DOI 10.1016/j.ymthe.2004.07.013
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Vannice KS, 2019, VACCINE, V37, P7443, DOI 10.1016/j.vaccine.2016.10.034
   Vannice KS, 2018, VACCINE
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   WHO, 2014, SAF IMM PREGN REV EV
   WHO, 2016, WHO GLOB CONS RES RE
   World Health Organization, 2016, WHO ZIK VIR ZIKV VAC
   World Health Organization, WHO EXP PRIOR VACC D
   World Health Organization, 2016, WHO R D BLUEPR
   World Health Organization, 2017, WHO NIH SCI CONS ZIK
   World Health Organization, WHO VACC PIP TRACK
   World Health Organization, WHO ZIK VIR COMPL 20
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Young MK, 2015, COCHRANE DB SYST REV, V9
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 80
TC 28
Z9 28
U1 2
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD JUN 6
PY 2018
VL 16
AR 84
DI 10.1186/s12916-018-1067-x
PG 15
WC Medicine, General & Internal
SC General & Internal Medicine
GA GJ1JQ
UT WOS:000435012000001
PM 29871628
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Souza, IND
   Frost, PS
   Franca, JV
   Nascimento-Viana, JB
   Neris, RLS
   Freitas, L
   Pinheiro, DJLL
   Nogueira, CO
   Neves, G
   Chimelli, L
   De Felice, FG
   Cavalheiro, EA
   Ferreira, ST
   Assuncao-Miranda, I
   Figueiredo, CP
   Da Poian, AT
   Clarke, JR
AF de Oliveira Souza, Isis Nem
   Frost, Paula S.
   Franca, Julia V.
   Nascimento-Viana, Jessica B.
   Neris, Romulo L. S.
   Freitas, Leandro
   Pinheiro, Daniel J. L. L.
   Nogueira, Clara O.
   Neves, Gilda
   Chimelli, Leila
   De Felice, Fernanda G.
   Cavalheiro, Esper A.
   Ferreira, Sergio T.
   Assuncao-Miranda, Iranaia
   Figueiredo, Claudia P.
   Da Poian, Andrea T.
   Clarke, Julia R.
TI Acute and chronic neurological consequences of early-life Zika virus
   infection in mice
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID NEUROPSYCHIATRIC DISORDERS; OXIDATIVE STRESS; CASE SERIES; BRAZIL;
   BRAIN; SEIZURES; INFANTS; GROWTH; HIPPOCAMPUS; INDUCTION
AB Although congenital Zika virus (ZIKV) exposure has been associated with microcephaly and other neurodevelopmental disorders, long-term consequences of perinatal infection are largely unknown. We evaluated short-and long-term neuropathological and behavioral consequences of neonatal ZIKV infection in mice. ZIKV showed brain tropism, causing postnatal-onset microcephaly and several behavioral deficits in adulthood. During the acute phase of infection, mice developed frequent seizures, which were reduced by tumor necrosis factor-alpha (TNF-alpha) inhibition. During adulthood, ZIKV replication persisted in neonatally infected mice, and the animals showed increased susceptibility to chemically induced seizures, neurodegeneration, and brain calcifications. Altogether, the results show that neonatal ZIKV infection has long-term neuropathological and behavioral complications in mice and suggest that early inhibition of TNF-alpha-mediated neuroinflammation might be an effective therapeutic strategy to prevent the development of chronic neurological abnormalities.
C1 [de Oliveira Souza, Isis Nem; Frost, Paula S.; Nascimento-Viana, Jessica B.; Nogueira, Clara O.; Figueiredo, Claudia P.; Clarke, Julia R.] Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Frost, Paula S.; Franca, Julia V.; Neves, Gilda] Univ Fed Rio de Janeiro, Inst Biomed Sci, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Neris, Romulo L. S.; Assuncao-Miranda, Iranaia] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [Freitas, Leandro; Pinheiro, Daniel J. L. L.; Cavalheiro, Esper A.] Univ Fed Sao Paulo, Escola Paulista Med, Dept Neurol & Neurosurg, BR-04023062 Sao Paulo, SP, Brazil.
   [Chimelli, Leila] State Inst Brain Paulo Niemeyer, Lab Neuropathol, Rio De Janeiro, Brazil.
   [De Felice, Fernanda G.; Ferreira, Sergio T.; Da Poian, Andrea T.] Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
   [De Felice, Fernanda G.] Queens Univ, Dept Biomed & Mol Sci, Ctr Neurosci Studies, Kingston, ON, Canada.
   [Ferreira, Sergio T.] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, BR-21944590 Rio De Janeiro, RJ, Brazil.
RP Figueiredo, CP; Clarke, JR (corresponding author), Univ Fed Rio de Janeiro, Sch Pharm, BR-21944590 Rio De Janeiro, RJ, Brazil.; Assuncao-Miranda, I (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, BR-21944590 Rio De Janeiro, RJ, Brazil.; Da Poian, AT (corresponding author), Univ Fed Rio de Janeiro, Inst Med Biochem Leopoldo de Meis, BR-21944590 Rio De Janeiro, RJ, Brazil.
EM iranaiamiranda@micro.ufrj.br; claufig@gmail.com;
   dapoian@bioqmed.ufrj.br; juliaclarke@pharma.ufrj.br
RI Figueiredo, Claudia P/F-8424-2012; de Oliveira Souza, Isis
   Nem/AAA-3423-2019; Cavalheiro, Esper A/I-3084-2016; Clarke,
   Julia/AAF-9434-2019; Neves, Gilda A./K-7573-2012; Cavalheiro,
   Esper/N-3985-2019; Da Poian, Andrea T./V-1699-2019
OI de Oliveira Souza, Isis Nem/0000-0002-0335-2541; Cavalheiro, Esper
   A/0000-0002-0854-3582; Neves, Gilda A./0000-0002-7027-3851; Cavalheiro,
   Esper/0000-0002-0854-3582; da Silva Frost, Paula/0000-0002-3814-999X;
   Freitas, Leandro/0000-0002-0249-2948; Neris, Romulo/0000-0002-7436-1680;
   Pinheiro, Daniel/0000-0003-0078-993X; Figueiredo,
   Claudia/0000-0001-9467-9891
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao
   de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Institutos
   Nacionais de Pesquisa-Instituto Nacional de Neurociencia Translacional;
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Institutos
   Nacionais de Pesquisa-Inovacao em Medicamentos e Identificacao de Novos
   Alvos Terapeuticos; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   SuperiorCAPES; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP)
FX Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (to F.G.D.F.,
   S.T.F., A.T.D.P., I.A.-M., C.P.F., and J.R.C.), Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (to E.A.C.), Institutos Nacionais de
   Pesquisa-Instituto Nacional de Neurociencia Translacional (to F.G.D.F.,
   E.A.C., and S.T.F.), Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (to P.S.F., G.N., F.G.D.F., E.A.C., S.T.F., A.T.D.P.,
   C.P.F., I.A.-M., and J.R.C.), Institutos Nacionais de Pesquisa-Inovacao
   em Medicamentos e Identificacao de Novos Alvos Terapeuticos (to C.P.F.),
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (to
   I.N.O.S., J.V.F., L.F., and D.J.L.L.P.), and Financiadora de Estudos e
   Projetos (to A.T.D.P.).
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Assuncao-Miranda I, 2016, J APPL MICROBIOL, V120, P790, DOI 10.1111/jam.13038
   Balosso S, 2013, EXP NEUROL, V247, P267, DOI 10.1016/j.expneurol.2013.05.010
   Bao AM, 2010, NEUROSCIENTIST, V16, P550, DOI 10.1177/1073858410377005
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Chakrabarti B, 2009, AUTISM RES, V2, P157, DOI 10.1002/aur.80
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   Dalman C, 2008, AM J PSYCHIAT, V165, P59, DOI 10.1176/appi.ajp.2007.07050740
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Edwards MJJ, 2002, NEUROLOGY, V59, P1447, DOI 10.1212/WNL.59.9.1447
   Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Ho YH, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0157-8
   Jiang PF, 2012, BRAIN RES, V1459, P1, DOI 10.1016/j.brainres.2012.03.058
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kirkman NJ, 2010, EPILEPSIA, V51, P454, DOI 10.1111/j.1528-1167.2009.02390.x
   Kovac S, 2016, REACT OXYGEN SPECIES, V1, P38, DOI DOI 10.20455/ROS.2016.807
   Kramer AH, 2008, CURR TREAT OPTION NE, V10, P201, DOI 10.1007/s11940-008-0022-0
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Libbey JE, 2008, EPILEPSIA, V49, P1066, DOI 10.1111/j.1528-1167.2008.01535.x
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pauletti A, 2017, BRAIN, V140, P1885, DOI 10.1093/brain/awx117
   RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Smith R, 2006, PEDIATRICS, V117, P851, DOI 10.1542/peds.2005-0804
   Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Zhao K, 2010, BIOSCIENCE REP, V30, P233, DOI 10.1042/BSR20090048
NR 51
TC 27
Z9 27
U1 0
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD JUN 6
PY 2018
VL 10
IS 444
AR eaar2749
DI 10.1126/scitranslmed.aar2749
PG 10
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GI5IG
UT WOS:000434403600003
PM 29875203
OA Bronze
DA 2020-07-08
ER

PT J
AU Yang, S
   Xu, M
   Lee, EM
   Gorshkov, K
   Shiryaev, SA
   He, SH
   Sun, W
   Cheng, YS
   Hu, X
   Tharappel, AM
   Lu, BL
   Pinto, A
   Farhy, C
   Huang, CT
   Zhang, ZR
   Zhu, WJ
   Wu, YY
   Zhou, Y
   Song, G
   Zhu, H
   Shamim, K
   Martinez-Romero, C
   Garcia-Sastre, A
   Preston, RA
   Jayaweera, DT
   Huang, RL
   Huang, WW
   Xia, MH
   Simeonov, A
   Ming, GL
   Qiu, XG
   Terskikh, AV
   Tang, HL
   Song, HJ
   Zheng, W
AF Yang, Shu
   Xu, Miao
   Lee, Emily M.
   Gorshkov, Kirill
   Shiryaev, Sergey A.
   He, Shihua
   Sun, Wei
   Cheng, Yu-Shan
   Hu, Xin
   Tharappel, Anil Mathew
   Lu, Billy
   Pinto, Antonella
   Farhy, Chen
   Huang, Chun-Teng
   Zhang, Zirui
   Zhu, Wenjun
   Wu, Yuying
   Zhou, Yi
   Song, Guang
   Zhu, Heng
   Shamim, Khalida
   Martinez-Romero, Carles
   Garcia-Sastre, Adolfo
   Preston, Richard A.
   Jayaweera, Dushyantha T.
   Huang, Ruili
   Huang, Wenwei
   Xia, Menghang
   Simeonov, Anton
   Ming, Guoli
   Qiu, Xiangguo
   Terskikh, Alexey, V
   Tang, Hengli
   Song, Hongjun
   Zheng, Wei
TI Emetine inhibits Zika and Ebola virus infections through two molecular
   mechanisms: inhibiting viral replication and decreasing viral entry
SO CELL DISCOVERY
LA English
DT Article
ID NIEMANN-PICK C1; REPURPOSING SCREEN; IDENTIFICATION; CARDIOTOXICITY;
   MODELS; SYSTEM; DENGUE; ASSAY; RNA
AB The re-emergence of Zika virus (ZIKV) and Ebola virus (EBOV) poses serious and continued threats to the global public health. Effective therapeutics for these maladies is an unmet need. Here, we show that emetine, an anti-protozoal agent, potently inhibits ZIKV and EBOV infection with a low nanomolar half maximal inhibitory concentration (IC50) in vitro and potent activity in vivo. Two mechanisms of action for emetine are identified: the inhibition of ZIKV NS5 polymerase activity and disruption of lysosomal function. Emetine also inhibits EBOV entry. Cephaeline, a desmethyl analog of emetine, which may be better tolerated in patients than emetine, exhibits a similar efficacy against both ZIKV and EBOV infections. Hence, emetine and cephaeline offer pharmaceutical therapies against both ZIKV and EBOV infection.
C1 [Yang, Shu; Xu, Miao; Gorshkov, Kirill; Sun, Wei; Cheng, Yu-Shan; Hu, Xin; Lu, Billy; Shamim, Khalida; Huang, Ruili; Huang, Wenwei; Xia, Menghang; Simeonov, Anton; Zheng, Wei] NIH, Natl Ctr Advancing Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.
   [Lee, Emily M.; Tharappel, Anil Mathew; Tang, Hengli] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.
   [Shiryaev, Sergey A.; Pinto, Antonella; Farhy, Chen; Huang, Chun-Teng; Terskikh, Alexey, V] Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.
   [He, Shihua; Zhang, Zirui; Zhu, Wenjun; Qiu, Xiangguo] Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada.
   [Wu, Yuying; Zhou, Yi] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA.
   [Song, Guang; Zhu, Heng] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA.
   [Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Martinez-Romero, Carles; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Preston, Richard A.; Jayaweera, Dushyantha T.] Univ Miami, Miller Sch Med, Dept Med, Miami, FL 33136 USA.
   [Ming, Guoli; Song, Hongjun] Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Ming, Guoli; Song, Hongjun] Univ Penn, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.
   [Qiu, Xiangguo] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.
RP Zheng, W (corresponding author), NIH, Natl Ctr Advancing Translat Sci, 9800 Med Ctr Dr, Bethesda, MD 20892 USA.; Tang, HL (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.; Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Dev Aging & Regenerat Program, La Jolla, CA 92037 USA.; Qiu, XG (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Special Pathogens Program, Winnipeg, MB R3E 3R2, Canada.; Song, HJ (corresponding author), Univ Penn, Dept Neurosci, Philadelphia, PA 19104 USA.; Song, HJ (corresponding author), Univ Penn, Mahoney Inst Neurosci, Philadelphia, PA 19104 USA.; Qiu, XG (corresponding author), Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada.
EM Xiangguo.qiu@canada.ca; terskikh@sbpdiscovery.org; tang@bio.fsu.edu;
   shongju1@jhmi.edu; wzhang@mail.nih.gov
RI Gorshkov, Kirill/AAQ-7272-2020; Gorshkov, Kirill/W-2188-2019; Terskikh,
   Alexey/U-8407-2019
OI Gorshkov, Kirill/0000-0002-4652-8818; Yang, Shu/0000-0001-8909-1962;
   Ming, Guo-li/0000-0002-2517-6075; Martinez-Romero,
   Carles/0000-0001-8888-7715; Huang, Chun-Teng/0000-0003-3737-7875
FU Intramural Research Programs of the National Center for Advancing
   Translational Sciences; National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); Public Health Agency of Canada; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [U19 AI109762-1, R01AI079110, R01AI089539,
   R35NS097370, U19AI131130, R37NS047344, R21NS100477]; CIHRCanadian
   Institutes of Health Research (CIHR) [IER-143487]; Spotlight Innovation
   Inc, IA, USA
FX We thank Egan Sanchez and Jennifer Jallo from the Tang lab for technical
   assistance. We also thank DeeAnn Visk for careful editing of this
   mansucript. This work was supported by the Intramural Research Programs
   of the National Center for Advancing Translational Sciences and the
   National Institute of Allergy and Infectious Diseases (W.Z.), Public
   Health Agency of Canada (X.Q.), NIH grant U19 AI109762-1(X.Q.), CIHR
   IER-143487 (X.Q), NIH grants of R01AI079110 and R01AI089539 (A.G.), NIH
   grants R35NS097370 (G.M.), U19AI131130 (G.M. and H.T.), and R37NS047344
   (H.S.), R21NS100477 (A.V.T.). The study is also partially supported by
   Spotlight Innovation Inc, IA, USA. (H.T.)
CR Bansal Devendra, 2004, Ann Clin Microbiol Antimicrob, V3, P27, DOI 10.1186/1476-0711-3-27
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348
   Valadao ALC, 2015, MOLECULES, V20, P11474, DOI 10.3390/molecules200611474
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   CHINTANA T, 1986, Southeast Asian Journal of Tropical Medicine and Public Health, V17, P591
   Coleman EM, 2012, VIROL J, V9, P31
   Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai S, 2017, AUTOPHAGY, V13, P1435, DOI 10.1080/15548627.2017.1329081
   Edwards MR, 2015, ACS INFECT DIS, V1, P380, DOI 10.1021/acsinfecdis.5b00053
   Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005
   Guarner V., 1986, TREATMENT AMEBIASIS, P197
   GUPTA RS, 1977, CELL, V10, P61, DOI 10.1016/0092-8674(77)90140-4
   Hawkins D, 2005, HIV MED, V6, P107, DOI 10.1111/j.1468-1293.2005.00302.x
   Jasenosky LD, 2010, ANTIMICROB AGENTS CH, V54, P3007, DOI 10.1128/AAC.00138-10
   JIMENEZ A, 1977, BIOCHEMISTRY-US, V16, P4727, DOI 10.1021/bi00640a030
   Khandelwal N, 2017, ANTIVIR RES, V144, P196, DOI 10.1016/j.antiviral.2017.06.006
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Krstin S, 2016, PHYTOMEDICINE, V23, P1771, DOI 10.1016/j.phymed.2016.10.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee E., 2017, P NATL ACAD SCI US
   LemmensGruber R, 1996, BRIT J PHARMACOL, V117, P377, DOI 10.1111/j.1476-5381.1996.tb15202.x
   Li Y, 2016, PHARMACOL RES, V110, P35, DOI 10.1016/j.phrs.2016.05.004
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Matthews H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-359
   Mehrotra PK, 2004, CONTRACEPTION, V69, P379, DOI 10.1016/j.contraception.2003.12.011
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mukhopadhyay R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005717
   Organization W. H, EB OUTBR 2014 2015
   Qiu XG, 2016, ANTIMICROB AGENTS CH, V60, P5182, DOI 10.1128/AAC.00307-16
   Rojo M, 2002, J CELL SCI, V115, P1663
   Rough K, 2017, AIDS, V31, P1733, DOI [10.1097/qad.0000000000001549, 10.1097/QAD.0000000000001549]
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Sun W, 2017, ANTIVIR RES, V137, P165, DOI 10.1016/j.antiviral.2016.11.017
   Sweiti H, 2017, CURR THER RES CLIN E, V84, P10, DOI 10.1016/j.curtheres.2017.01.007
   Tscherne DM, 2010, J VIROL METHODS, V163, P336, DOI 10.1016/j.jviromet.2009.10.020
   WAGNER VP, 1975, OBSTET GYNECOL, V45, P562
   Wang Yuhong, 2010, Curr Chem Genomics, V4, P57, DOI 10.2174/1875397301004010057
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu M, 2014, J BIOMOL SCREEN, V19, P168, DOI 10.1177/1087057113501197
   Xu M, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.357707
   YANG WCT, 1980, PHARMACOL THERAPEUT, V10, P15, DOI 10.1016/0163-7258(80)90007-8
   Yin Low JS, 2009, J ANTIVIR ANTIRETROV, V1, P062
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zheng W, 2007, P NATL ACAD SCI USA, V104, P13192, DOI 10.1073/pnas.0705637104
NR 51
TC 21
Z9 21
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD JUN 5
PY 2018
VL 4
AR 31
DI 10.1038/s41421-018-0034-1
PG 14
WC Cell Biology
SC Cell Biology
GA GI2VX
UT WOS:000434231100001
PM 29872540
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mesci, P
   Macia, A
   Moore, SM
   Shiryaev, SA
   Pinto, A
   Huang, CT
   Tejwani, L
   Fernandes, IR
   Suarez, NA
   Kolar, MJ
   Montefusco, S
   Rosenberg, SC
   Herai, RH
   Cugola, FR
   Russo, FB
   Sheets, N
   Saghatelian, A
   Shresta, S
   Momper, JD
   Siqueira-Neto, JL
   Corbett, KD
   Beltrao-Braga, PCB
   Terskikh, AV
   Muotri, AR
AF Mesci, Pinar
   Macia, Angela
   Moore, Spencer M.
   Shiryaev, Sergey A.
   Pinto, Antonella
   Huang, Chun-Teng
   Tejwani, Leon
   Fernandes, Isabella R.
   Suarez, Nicole A.
   Kolar, Matthew J.
   Montefusco, Sandro
   Rosenberg, Scott C.
   Herai, Roberto H.
   Cugola, Fernanda R.
   Russo, Fabiele B.
   Sheets, Nicholas
   Saghatelian, Alan
   Shresta, Sujan
   Momper, Jeremiah D.
   Siqueira-Neto, Jair L.
   Corbett, Kevin D.
   Beltrao-Braga, Patricia C. B.
   Terskikh, Alexey V.
   Muotri, Alysson R.
TI Blocking Zika virus vertical transmission (vol 8, pg 1218, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Correction
C1 [Mesci, Pinar; Macia, Angela; Moore, Spencer M.; Tejwani, Leon; Fernandes, Isabella R.; Suarez, Nicole A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego Dept Cellular & Mol, Rady Childrens Hosp San Diego,Stem Cell Program, La Jolla, CA 92037 USA.
   [Shiryaev, Sergey A.; Pinto, Antonella; Huang, Chun-Teng; Terskikh, Alexey V.] Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, Helmsley Ctr Genom Med, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Montefusco, Sandro; Siqueira-Neto, Jair L.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Ctr Discovery & Innovat Parasit Dis, 9500 Gilman Dr,MC 0755, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.; Corbett, Kevin D.] Ludwig Inst Canc Res, San Diego Branch, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Rosenberg, Scott C.] Univ Calif San Diego, Dept Cellular & Mol Med, 9500 Gilman Dr,MC 2385, La Jolla, CA 92093 USA.
   [Herai, Roberto H.] Pontificia Univ Catolica Parana PUCPR, Sch Med, Grad Program Hlth Sci, Curitiba, Parana, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.
   [Cugola, Fernanda R.; Russo, Fabiele B.; Beltrao-Braga, Patricia C. B.] Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
   [Sheets, Nicholas; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Momper, Jeremiah D.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.
RP Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego Dept Cellular & Mol, Rady Childrens Hosp San Diego,Stem Cell Program, La Jolla, CA 92037 USA.; Terskikh, AV (corresponding author), Sanford Burnham Prebys Med Discovery Inst, 10901N Torrey Pines Rd, La Jolla, CA 92037 USA.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Stem Cell & Dis Modeling, BR-05508000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Arts Sci & Humanities, Dept Obstet, BR-03828000 Sao Paulo, SP, Brazil.; Beltrao-Braga, PCB (corresponding author), Univ Sao Paulo, Sch Med, Ctr Cellular & Mol Therapy NETCEM, BR-01246903 Sao Paulo, SP, Brazil.
EM patriciacbbbraga@usp.br; terskikh@sbpdiscovery.org; muotri@ucsd.edu
RI Siqueira-Neto, Jair L/D-6040-2012; Beltrao-Braga, Patricia C
   B/D-6450-2013
OI Siqueira-Neto, Jair L/0000-0001-9574-8174; Beltrao-Braga, Patricia C
   B/0000-0003-0004-1091; Kolar, Matthew/0000-0001-8054-9121; herai,
   roberto/0000-0001-9885-2735; Huang, Chun-Teng/0000-0003-3737-7875;
   Mesci, Pinar/0000-0003-3402-5671
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [F30 DK112604]
CR Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
NR 1
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD JUN 5
PY 2018
VL 8
AR 8794
DI 10.1038/s41598-018-26959-4
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GI1IH
UT WOS:000434123400001
PM 29867187
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jiang, X
   Dong, X
   Li, SH
   Zhou, YP
   Rayner, S
   Xia, HM
   Gao, GF
   Yuan, H
   Tang, YP
   Luo, MH
AF Jiang, Xuan
   Dong, Xiao
   Li, Shi-Hua
   Zhou, Yue-Peng
   Rayner, Simon
   Xia, Hui-Min
   Gao, George F.
   Yuan, Hui
   Tang, Ya-Ping
   Luo, Min-Hua
TI Proteomic Analysis of Zika Virus Infected Primary Human Fetal Neura
   Progenitors Suggests a Role for Doublecortin in the Pathological
   Consequences of Infection in the Cortex
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; human fetal neural progenitor cells (NPCs); doublecortin
   (DCX); cortex structure; proteomic analysis
ID HUMAN CYTOMEGALOVIRUS-INFECTION; STEM-CELLS; NEURONAL MIGRATION; BRAIN;
   NEUROGENESIS; DIFFERENTIATION; MUTATIONS; PROTEINS; RENEWAL; LEADS
AB Zika virus (ZIKV) infection is associated with severe neurological defects in fetuses and newborns, such as microcephaly. However, the underlying mechanisms remain to be elucidated. In this study, proteomic analysis on ZIKV-infected primary human fetal neural progenitor cells (NPCs) revealed that virus infection altered levels of cellular proteins involved in NPC proliferation, differentiation and migration. The transcriptional levels of some of the altered targets were also confirmed by qRT-PCR. Among the altered proteins, doublecortin (DCX) plays an important role in NPC differentiation and migration. Results showed that ZIKV infection downregulated DCX, at both mRNA and protein levels, as early as 1 day post infection (1 dpi), and lasted throughout the virus replication cycle (4 days). The downregulation of DCX was also observed in a ZIKV-infected fetal mouse brain model, which displayed decreased body weight, brain size and weight, as well as defective cortex structure. By screening the ten viral proteins of ZIKV, we found that both the expression of NS4A and NS5 were correlated with the downregulation of both mRNA and protein levels of DCX in NPCs. These data suggest that DCX is modulated following infection of the brain by ZIKV. How these observed changes of DCX expression translate in the pathological consequences of ZIKV infection and if other cellular proteins are equally involved remains to be investigated.
C1 [Jiang, Xuan; Xia, Hui-Min; Tang, Ya-Ping; Luo, Min-Hua] Guangzhou Women & Children Med Ctr, Guangzhou Inst Pediat, Joint Ctr Translat Precis Med, Guangzhou, Guangdong, Peoples R China.
   [Jiang, Xuan; Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, Joint Ctr Translat Precis Med, Wuhan, Hubei, Peoples R China.
   [Dong, Xiao; Zhou, Yue-Peng; Luo, Min-Hua] Chinese Acad Sci, Wuhan Inst Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Virol, Wuhan, Hubei, Peoples R China.
   [Li, Shi-Hua; Gao, George F.] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Rayner, Simon] Univ Oslo, Oslo Univ Hosp, Dept Med Genet, Oslo, Norway.
   [Gao, George F.] Natl Inst Viral Dis Control & Prevent, Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China.
   [Gao, George F.; Luo, Min-Hua] Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.
   [Gao, George F.] Chinese Acad Sci, Beijing Inst Life Sci, Res Network Immun & Hlth, Beijing, Peoples R China.
   [Yuan, Hui] Jianghan Univ, Med Coll, Dept Med, Wuhan, Hubei, Peoples R China.
RP Tang, YP; Luo, MH (corresponding author), Guangzhou Women & Children Med Ctr, Guangzhou Inst Pediat, Joint Ctr Translat Precis Med, Guangzhou, Guangdong, Peoples R China.; Luo, MH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Joint Ctr Translat Precis Med, Wuhan, Hubei, Peoples R China.; Luo, MH (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Virol, Wuhan, Hubei, Peoples R China.; Luo, MH (corresponding author), Univ Chinese Acad Sci, Savaid Med Sch, Beijing, Peoples R China.; Yuan, H (corresponding author), Jianghan Univ, Med Coll, Dept Med, Wuhan, Hubei, Peoples R China.
EM yuanhui06@126.com; yptang12@126.com; luomh@wh.iov.cn
OI Jiang, Xuan/0000-0003-2749-7304
FU National Key Research and Development Program of China [2016YFC1200400];
   Major Program of Guangzhou healthcare collaborative innovation
   foundation [201704020229]; Sino-Africa joint research center, Chinese
   Academy of Sciences [SAJC201605]; National Nature Science Foundation of
   ChinaNational Natural Science Foundation of China [81571355,
   81620108021]
FX We thank the Center for Instrumental Analysis and Metrology of Wuhan
   Institute of Virology, Chinese Academy of Sciences for technical support
   on virus stocks ultracentrifugation and two-photon microscopy. The study
   was supported by the National Key Research and Development Program of
   China (2016YFC1200400) and the Major Program of Guangzhou healthcare
   collaborative innovation foundation (201704020229) the Sino-Africa joint
   research center, Chinese Academy of Sciences (SAJC201605) and the
   National Nature Science Foundation of China (81571355, 81620108021).
CR Bai JL, 2003, NAT NEUROSCI, V6, P1277, DOI 10.1038/nn1153
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chen YY, 2017, J PROTEOMICS, V157, P10, DOI 10.1016/j.jprot.2017.01.017
   Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   des Portes V, 1998, CELL, V92, P51
   Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936
   El Ghouzzi V, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.266
   Francis F, 1999, NEURON, V23, P247, DOI 10.1016/S0896-6273(00)80777-1
   Fu YR, 2015, J VIROL, V89, P1070, DOI 10.1128/JVI.01740-14
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gleeson JG, 1999, ANN NEUROL, V45, P146, DOI 10.1002/1531-8249(199902)45:2<146::AID-ANA3>3.0.CO;2-N
   Gleeson JG, 1998, CELL, V92, P63, DOI 10.1016/S0092-8674(00)80899-5
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li XJ, 2015, J VIROL, V89, P6792, DOI 10.1128/JVI.00351-15
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108
   Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277
   Luo MH, 2008, J VIROL, V82, P9994, DOI 10.1128/JVI.00943-08
   Luo MH, 2010, J VIROL, V84, P3528, DOI 10.1128/JVI.02161-09
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pan X, 2013, J VIROL, V87, P10968, DOI 10.1128/JVI.01120-13
   Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pilz DT, 1998, HUM MOL GENET, V7, P2029, DOI 10.1093/hmg/7.13.2029
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tang G, 2015, NEUROSCIENCE, V303, P389, DOI 10.1016/j.neuroscience.2015.07.019
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443
NR 47
TC 5
Z9 6
U1 0
U2 22
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD JUN 5
PY 2018
VL 9
AR 1067
DI 10.3389/fmicb.2018.01067
PG 15
WC Microbiology
SC Microbiology
GA GI1NH
UT WOS:000434136800001
PM 29922247
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ophir, Y
AF Ophir, Yotam
TI COVERAGE OF EPIDEMICS IN AMERICAN NEWSPAPERS THROUGH THE LENS OF THE
   CRISIS AND EMERGENCY RISK COMMUNICATION FRAMEWORK
SO HEALTH SECURITY
LA English
DT Article
DE Risk communication; Epidemic management/response
ID MEDIA; NEWS
AB The Centers for Disease Control and Prevention (CDC) Crisis and Emergency Risk Communication (CERC) framework has been used by the organization during recent outbreaks of infectious diseases. However, the dissemination of the organization's crisis messages depends largely on mass media coverage. This study analyzed 5,006 articles from leading American newspapers covering 3 epidemics: H1N1, Ebola, and Zika. Using a mixed method of automated and manual content analysis, it identified 3 distinct themes used to cover the diseases: pandemic, scientific, and social. Analysis of the themes based on CERC guidelines demonstrated substantial discrepancies between what CDC aims to communicate during epidemics and what the media actually disseminated to the public. Implications for public health organizations and communicators are discussed.
C1 [Ophir, Yotam] Univ Penn, Annenberg Sch Commun, 3620 Walnut St, Philadelphia, PA 19104 USA.
RP Ophir, Y (corresponding author), Univ Penn, Annenberg Sch Commun, 3620 Walnut St, Philadelphia, PA 19104 USA.
EM yophir@asc.upenn.edu
RI Ophir, Yotam/J-8397-2019
OI Ophir, Yotam/0000-0001-5049-7906
CR Ajzen I, 1985, ACTION CONTROL COGNI, DOI DOI 10.1007/978-3-642-69746-3_2
   Althaus SL, 2002, COMMUN RES, V29, P180, DOI 10.1177/0093650202029002004
   BANDURA A, 1990, EVAL PROGRAM PLANN, V13, P9, DOI 10.1016/0149-7189(90)90004-G
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Coombs W.T., 2009, HDB RISK CRISIS COMM, P99
   Coombs WT, 2018, SOCIAL MEDIA AND CRISIS COMMUNICATION, P21
   Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802
   Covello VT, 2003, J HLTH COMMUN S1, V8, P148, DOI DOI 10.1080/713851971
   David CC, 2011, COMMUN METHODS MEAS, V5, P329, DOI 10.1080/19312458.2011.624873
   De Meo P., 2011, Proceedings of the 2011 11th International Conference on Intelligent Systems Design and Applications (ISDA), P88, DOI 10.1109/ISDA.2011.6121636
   DiMaggio P, 2013, POETICS, V41, P570, DOI 10.1016/j.poetic.2013.08.004
   Djerf-Pierre M, 2017, J COMMUN, V67, P733, DOI 10.1111/jcom.12327
   FISCHER HW, 1998, RESPONSE DISASTER FA
   GALTUNG J, 1965, J PEACE RES, P64
   Gans H. J., 1979, DECIDING WHATS NEWS
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Grimmer J, 2013, POLIT ANAL, V21, P267, DOI 10.1093/pan/mps028
   Herek GM, 2003, HEALTH PSYCHOL, V22, P533, DOI 10.1037/0278-6133.22.5.533
   Hindman M. S., 2008, MYTH DIGITAL DEMOCRA
   Hornik RC, 2002, SOCIAL MARKETING Q, V8, P30, DOI DOI 10.1080/15245000214135
   Iyengar S, 1994, IS ANYONE RESPONSIBL
   Jamieson K. H., 2000, INTERPLAY INFLUENCE
   Jamieson KH, 1996, PS, V29, P13, DOI 10.2307/420183
   Jockers M, 2014, TEXT ANAL R STUDENTS
   Jockers ML, 2013, TOP DIGIT HUM, P1
   LEE ST, 2014, INT J STRATEGIC COMM, V8, P294, DOI DOI 10.1080/1553118X.2014.913596
   Lewis N, 2012, HEALTH COMMUN, V27, P380, DOI 10.1080/10410236.2011.586990
   Lundgren R.E., 2013, RISK COMMUNICATION H
   Matthes J, 2008, J COMMUN, V58, P258, DOI 10.1111/j.1460-2466.2008.00384.x
   Mimno D, 2011, P C EMP METH NAT LAN, P262
   Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104
   Powers JH, 2008, DIS APPL POL SOC CUL, V30, P1
   Quinones Sergio Alberto Rojas, 2008, CRISIS COMMUNICATION, P23
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Reynolds B, 2007, CRISIS EMERGENCY RIS
   Reynolds B., 2014, CRISIS EMERGENCY RIS
   Reynolds B., 2016, ZIKA CRISIS EMERGENC
   Roberts ME, 2014, AM J POLIT SCI, V58, P1064, DOI 10.1111/ajps.12103
   ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P328, DOI 10.1177/109019817400200403
   Seeger MW, 2003, COMMUNICATION ORG CR, P21
   Seeger MW, 2008, CRISIS COMMUNICATION
   Sellnow T.L., 2013, THEORIZING CRISIS CO
   Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106
   Shehata A, 2013, INT J PRESS/POLIT, V18, P234, DOI 10.1177/1940161212473831
   Shih TJ, 2008, MASS COMMUN SOC, V11, P141, DOI 10.1080/15205430701668121
   Sinclair J. M., 2004, TRUST TEXT LANGUAGE
   Singer E., 2003, REPORTING RISK MASS
   Taddy MA, 2012, P 15 INT C ART INT S
   Tankard JW, 2001, LEA COMMUN SER, P95
   Veil S, 2008, HEALTH PROMOT PRACT, V9, p26S, DOI 10.1177/1524839908322113
   Veil SR, 2010, COMMUN STUD, V61, P412, DOI 10.1080/10510974.2010.491336
   Wallach H. M., 2006, ICML, V23, P977, DOI DOI 10.1145/1143844.1143967
   Wallach Hanna M., 2009, P 26 ANN INT C MACH, P1105, DOI DOI 10.1145/1553374.1553515
   Walter D., 2018, THESIS
   WEICK KE, 1988, J MANAGE STUD, V25, P305, DOI 10.1111/j.1467-6486.1988.tb00039.x
NR 55
TC 5
Z9 5
U1 7
U2 8
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JUN
PY 2018
VL 16
IS 3
BP 147
EP 157
DI 10.1089/hs.2017.0106
EA JUN 2018
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GK0UG
UT WOS:000434227900001
PM 29870279
DA 2020-07-08
ER

PT J
AU Amelia-Yap, ZH
   Chen, CD
   Sofian-Azirun, M
   Low, VL
AF Amelia-Yap, Zheng Hua
   Chen, Chee Dhang
   Sofian-Azirun, Mohd
   Low, Van Lun
TI Pyrethroid resistance in the dengue vector Aedes aegypti in Southeast
   Asia: present situation and prospects for management
SO PARASITES & VECTORS
LA English
DT Review
DE Pyrethroids; Insecticide resistance; Knockdown resistance; kdr;
   Metabolic-mediated resistance
ID SODIUM-CHANNEL GENE; STEGOMYIA ALBOPICTUS DIPTERA; TROPICAL
   INFECTIOUS-DISEASES; THROUGHPUT SCREENING SYSTEM; IN-FIELD POPULATIONS;
   INSECTICIDE RESISTANCE; KNOCKDOWN RESISTANCE; HEMORRHAGIC-FEVER;
   MOSQUITO VECTORS; CULEX-QUINQUEFASCIATUS
AB Human arboviral diseases transmitted by Aedes aegypti such as dengue, Zika, chikungunya and yellow fever remain global public health threats to date. Of these diseases, dengue fever is particularly prevalent in Southeast Asia. Relentless vector control efforts are performed to curtail disease transmissions through which pyrethroid insecticides are broadly used as the first line of defense to control Ae. aegypti, especially in the course of disease outbreaks. Here, we compile the largest contemporary database for susceptibility profiles and underlying mechanisms involved in Ae. aegypti resistant to pyrethroids in Southeast Asia. The extensive use of pyrethroids inevitably elicit different levels of resistance to numerous populations despite the presence of geographical isolation. The most common mechanisms of pyrethroid resistance that have been identified in Ae. aegypti includes mutations in the voltage sensitive sodium channel gene (Vssc gene) and metabolic-mediated insecticide resistance. Aedes aegypti develops resistance to pyrethroids by acquisition of one or several amino acid substitution(s) in this Vssc gene. Enzymes involved in metabolic-mediated detoxification (i.e. monooxygenases, glutathione-S-transferases and esterases) have been reported to be related to pyrethroid resistance but many specific contributory enzymes are not completely studied. An inadequate amount of data from some countries indicates an urgent need for further study to fill the knowledge gaps. Perspectives and future research needs are also discussed.
C1 [Amelia-Yap, Zheng Hua; Low, Van Lun] Univ Malaya, TIDREC, Kuala Lumpur 50603, Malaysia.
   [Chen, Chee Dhang; Sofian-Azirun, Mohd] Univ Malaya, Inst Biol Sci, Fac Sci, Kuala Lumpur 50603, Malaysia.
RP Amelia-Yap, ZH; Low, VL (corresponding author), Univ Malaya, TIDREC, Kuala Lumpur 50603, Malaysia.
EM ame_lia1031@hotmail.com; vanlun_low@um.edu.my
RI , Van Lun Low/C-8045-2013; Yap, Amelia/AAG-4098-2019; AZIRUN, MOHD
   SOFIAN/B-9127-2010
FU University of Malaya research grant [RP021D-16SUS]
FX This study was funded by University of Malaya research grant
   (RP021D-16SUS).
CR Ahmad Intan, 2007, Pakistan Journal of Biological Sciences, V10, P3688, DOI 10.3923/pjbs.2007.3688.3692
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   [Anonymous], 2017, SIT SEM DEM DENGG ZI
   Astari S, 2005, BUL PENELIT KESEHAT, V33, P73
   ASTUTI E, 2014, ASPIRATOR, V6, P7
   Aung T. T., 1996, Dengue Bulletin, V20, P41
   Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Lazcano JAB, 2009, REV PANAM SALUD PUBL, V26, P229
   Boyer S, 2016, WHOPES METHODS TEST
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   CHADWICK PR, 1975, B ENTOMOL RES, V65, P97, DOI 10.1017/S0007485300005800
   CHADWICK PR, 1977, PESTIC SCI, V8, P618, DOI 10.1002/ps.2780080605
   Chareonviriyahpap Theeraphap, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P184
   Chareonviriyaphap T, 2006, J VECTOR ECOL, V31, P89, DOI 10.3376/1081-1710(2006)31[89:IONAPS]2.0.CO;2
   Chareonviriyaphap T, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-280
   Chin AC, 2017, J ECON ENTOMOL, V110, P2247, DOI 10.1093/jee/tox183
   Choovattanapakorn N., 2017, Medical Entomology and Zoology, V68, P19
   Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x
   David JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-216
   Djouaka RF, BMC GENOMICS
   Dolabella SS, 2016, J MED ENTOMOL, V53, P967, DOI 10.1093/jme/tjw053
   El-garj FMA, 2015, ASIAN BIOMED, V9, P313, DOI 10.5372/1905-7415.0903.399
   Enayati AA, 2003, MED VET ENTOMOL, V17, P138, DOI 10.1046/j.1365-2915.2003.00418.x
   Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507
   Frances SP, 2016, AUSTRAL ENTOMOL, V55, P303, DOI 10.1111/aen.12186
   Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2
   HALSTEAD SB, 1965, AM J TROP MED HYG, V14, P819, DOI 10.4269/ajtmh.1965.14.819
   Hamdan Hidayati, 2005, Trop Biomed, V22, P45
   Hamid PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189680
   Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4
   Hasan H.A., 2016, INT J ENTOMOL RES, V3, P91
   Hemingway J, 2010, ANNU REV ENTOMOL, V45, P371
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hiscox A, 2013, AM J TROP MED HYG, V88, P1070, DOI 10.4269/ajtmh.12-0623
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Housset P., 2009, Bayer CropScience Journal, V62, P135
   Huber Karine, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P81
   Huong V. D., 1999, DENGUE B, V23, P85
   Huong VD, 2004, DENGUE B, V28, P179
   Ishak IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005302
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   JENNINGS CD, 1995, AM J TROP MED HYG, V53, P324, DOI 10.4269/ajtmh.1995.53.324
   Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x
   Jirakanjanakit N, 2007, J ECON ENTOMOL, V100, P545, DOI 10.1603/0022-0493(2007)100[545:IRSIAS]2.0.CO;2
   JOHNSEN RICHARD E., 1967, MOSQUITO NEWS, V27, P22
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Katsuda Yoshio, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P229
   Katsuda Yoshio, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P48
   Katsuda Y, 2009, SE ASIAN J TROP MED, V40, P929
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000391
   Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059
   Koou SY, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0471-0
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Lau KW, J MED ENTOMOL
   Lau SM, 2015, TROP MED INT HEALTH, V20, P1271, DOI 10.1111/tmi.12555
   Lazaro A, 2015, TROP MED INT HEALTH, V20, P685, DOI 10.1111/tmi.12485
   Lee C, 2013, AM J TROP MED HYG, V88, P888, DOI 10.4269/ajtmh.12-0329
   LEE CY, 2003, URBAN PEST CONTROL M
   Lee HL, 1999, SE ASIAN J TROP MED, V26, P164
   Lee RML, 2014, TROP BIOMED, V31, P670
   LIM K. A., 1961, SINGAPORE MED JOUR, V2, P158
   Low VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079928
   Lumjuan N, 2005, INSECT BIOCHEM MOLEC, V35, P861, DOI 10.1016/j.ibmb.2005.03.008
   Lumjuan N, 2007, INSECT BIOCHEM MOLEC, V37, P1026, DOI 10.1016/j.ibmb.2007.05.018
   Madarieta S. K., 1999, Dengue Bulletin, V23, P51
   Marcombe S, 2017, VECTOR MAPPING CHARA
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5
   Mihov C, 1959, FOLIA MED, V1, P169
   Ministry of Health of the Lao People's Democratic Republic, 2010, NAT STRAT MAL CONTR
   Ministry of Health Republic of Indonesia, 2015, DEM BERD BIAS MUL ME
   Mulla MS, 2001, J AM MOSQUITO CONTR, V17, P153
   Narahashi T, 2002, MINI-REV MED CHEM, V2, P419, DOI 10.2174/1389557023405927
   Nazni W A, 2005, Trop Biomed, V22, P63
   Nkya TE, 2013, INSECT BIOCHEM MOLEC, V43, P407, DOI 10.1016/j.ibmb.2012.10.006
   Oo TT, 2011, TROP BIOMED, V28, P302
   Paeporn P., 2007, Dengue Bulletin, V31, P153
   Paeporn Pungasem, 2004, Tropical Biomedicine, V21, P145
   Pang SC, 2015, TROP BIOMED, V32, P140
   Pasteur Institute, 2008, EP VIR VECT SURV DEN
   Pavlidi N, 2012, PESTIC BIOCHEM PHYS, V104, P132, DOI 10.1016/j.pestbp.2012.07.003
   Pethuan S, 2007, TROP BIOMED, V24, P7
   Ping LT, 2001, J AM MOSQUITO CONTR, V17, P144
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   POLSON KA, 2001, DENGUE B, V25, P79
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ponlawat A, 2005, J MED ENTOMOL, V42, P821, DOI 10.1603/0022-2585(2005)042[0821:ISOAAA]2.0.CO;2
   Ponlawat A, 2013, SE ASIAN J TROP MED, V44, P167
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Prapanthadara L., 2002, Dengue Bulletin, V26, P185
   Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004
   Rasic G, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1230-6
   Rohani A., 2001, Tropical Biomedicine, V18, P29
   Rohani A, 2011, TROP BIOMED, V28, P237
   Rong LS, 2012, SE ASIAN J TROP MED, V43, P34
   Rosilawati R, 2017, INT MED J MALAYS, V16, P73
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saiful A. N., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P315, DOI 10.1016/S2221-1691(12)60031-8
   Saingamsook J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2416-x
   Sathantriphop S, 2006, TROP BIOMED, V23, P97
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   SCOTT JG, 1988, ISI ATLAS-PHARMACOL, V2, P125
   Seng CM, 2008, J VECTOR ECOL, V33, P333, DOI 10.3376/1081-1710-33.2.333
   SHEPPARD PM, 1969, J ANIM ECOL, V38, P661, DOI 10.2307/3042
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Somboon Pradya, 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P87
   Somwang P, 2011, PARASITOL RES, V109, P531, DOI 10.1007/s00436-011-2280-0
   Srisawat R, 2012, SE ASIAN J TROP MED, V43, P1380
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stanton A. T., 1920, Bulletin of Entomological Research London, V10, DOI 10.1017/S0007485300044205
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Stevenson BJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001595
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Tan B. T., 1998, Dengue in Singapore., P124
   Thanispong K, 2008, J PESTIC SCI, V33, P351, DOI 10.1584/jpestics.G08-12
   Thanispong K, 2010, J MED ENTOMOL, V47, P833, DOI 10.1603/ME09246
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Tsuda Yoshio, 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P63
   Tun-Lin W, 2009, TROP MED INT HEALTH, V14, P1143, DOI 10.1111/j.1365-3156.2009.02341.x
   Verhaeghen K, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-59
   Vythilingam I, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01452
   Wan-Norafikah O, 2010, J ASIA-PAC ENTOMOL, V13, P175, DOI 10.1016/j.aspen.2010.03.003
   Whelan P, 2007, ASSESSMENT AUSAID TI
   WHO, 2017, DENG SEV DENG
   WHO, 2016, MON MAN INS RES AED
   WHO (World Health Organization), 1992, VECT RES PEST
   Wood OR, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-67
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1981, INSTR DET SUSC RES A
   World Health Organization, 2009, GUID EFF TEST HOUS I
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090
   Yaicharoen R, 2005, J VECTOR ECOL, V30, P144
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
   Yap H.H, 1996, P 2 INT C INS PESTS, P177
   Yap H. H., 2003, URBAN PEST CONTROL M, P43
   Zhu F, 2008, INSECT MOL BIOL, V17, P27, DOI 10.1111/j.1365-2583.2008.00777.x
NR 144
TC 21
Z9 21
U1 0
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 4
PY 2018
VL 11
AR 332
DI 10.1186/s13071-018-2899-0
PG 17
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GI2XQ
UT WOS:000434235600001
PM 29866193
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lai, WT
   Chen, CH
   Hung, H
   Chen, RB
   Shete, S
   Wu, CC
AF Lai, Wei-Ting
   Chen, Chien-Hsiun
   Hung, Hsin
   Chen, Ray-Bing
   Shete, Sanjay
   Wu, Chih-Chieh
TI Recognizing spatial and temporal clustering patterns of dengue outbreaks
   in Taiwan
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Hierarchical; Spatial clustering; Temporal clustering; Zika
AB Background: Dengue fever is the most common arbovira ! infection in humans, with viral transmissions occurring in more than 100 countries in tropical regions. A global strategy for dengue prevention and control was established more than 10 years ago. However, the factors that drive the transmission of the dengue virus and subsequent viral infection continue unabated. The largest dengue outbreaks in Taiwan since World War II occurred in two recent successive years: 2014 and 2015.
   Methods: We performed a systematic analysis to detect and recognize spatial and temporal clustering patterns of dengue incidence in geographical areas of Taiwan, using the map-based pattern recognition procedure and scan test. Our aim was to recognize geographical heterogeneity patterns of varying dengue incidence intensity and detect hierarchical incidence intensity clusters.
   Results: Using the map based pattern recognition procedure, we identified and delineated two separate hierarchical dengue incidence intensity clusters that comprise multiple mutually adjacent geographical units with high dengue incidence rates. We also found that that dengue incidence tends to peak simultaneously and homogeneously among the neighboring geographic units with high rates in the same cluster.
   Conclusion: Beyond significance testing, this study is particularly desired by and useful for health authorities who require optimal characteristics of disease incidence patterns on maps and over time. Among the integrated components for effective prevention and control of dengue and dengue hemorrhagic fever are active surveillance and community based integrated mosquito control, for which this study provides valuable inferences. Effective dengue prevention and control programs in Taiwan are critical, and have the added benefit of controlling the potential emergence of Zika.
C1 [Lai, Wei-Ting; Chen, Ray-Bing] Natl Cheng Kung Univ, Coll Management, Dept Stat, Tainan, Taiwan.
   [Chen, Chien-Hsiun] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Chen, Chien-Hsiun] China Med Univ, Sch Chinese Med, Taichung, Taiwan.
   [Hung, Hsin; Wu, Chih-Chieh] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, 1 Univ Rd Tainan, Tainan 701, Taiwan.
   [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA.
   [Shete, Sanjay] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA.
RP Wu, CC (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, 1 Univ Rd Tainan, Tainan 701, Taiwan.
EM cc_wu@mail.ncku.edu.tw
RI Chen, Ray-Bing/AAC-2159-2020
OI Wu, Chih-Chieh/0000-0002-9846-4086
FU Taiwan Ministry of Science and Technology [MOST 104-2118-M-006-006,
   105-2118-M-006-008]
FX The research presented in this manuscript was partially supported by the
   Taiwan Ministry of Science and Technology grants MOST 104-2118-M-006-006
   and 105-2118-M-006-008 to C.C.W.
CR Ad C, 1973, SPATIAL AUTOCORRELAT
   Akashi K., 1932, TAIWAN J MED, V31, P767
   [Anonymous], 1990, MMWR Recomm Rep, V39, P1
   [Anonymous], 2016, R LANG ENV STAT COMP
   Banu S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16105
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cliff A. D, 1981, SPATIAL PROCESSES MO
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0000
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Koizumi M., 1916, NISSHIN IGAKU, V6, P955
   Kulldorff M, 2001, J ROY STAT SOC A STA, V164, P61, DOI 10.1111/1467-985X.00186
   MANTEL N, 1967, CANCER RES, V27, P209
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rc G, 1981, SOC SCI MED, V15, P287
   St John AL, 2013, NAT REV MICROBIOL, V11, P420, DOI 10.1038/nrmicro3030
   Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Thomas SJ, 2015, NEW ENGL J MED, V372, P172, DOI 10.1056/NEJMe1413146
   WALLENSTEIN S, 1987, STAT MED, V6, P197, DOI 10.1002/sim.4780060212
   Wilder-Smith A, 2015, SCIENCE, V350, P626, DOI 10.1126/science.aab4047
NR 21
TC 3
Z9 3
U1 0
U2 6
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD JUN 4
PY 2018
VL 18
AR 256
DI 10.1186/s12879-018-3159-9
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA GI0LV
UT WOS:000434062400005
PM 29866173
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Draz, MS
   Lakshminaraasimulu, NK
   Krishnakumar, S
   Battalapalli, D
   Vasan, A
   Kanakasabaathy, MK
   Sreeram, A
   Kallakuri, S
   Thirumalaraju, P
   Li, YD
   Hua, S
   Yu, XG
   Kuritzkes, DR
   Shafiee, H
AF Draz, Mohamed Shehata
   Lakshminaraasimulu, Nivethitha Kota
   Krishnakumar, Sanchana
   Battalapalli, Dheerendranath
   Vasan, Anish
   Kanakasabaathy, Manoj Kumar
   Sreeram, Aparna
   Kallakuri, Shantanu
   Thirumalaraju, Prudhvi
   Li, Yudong
   Hua, Stephane
   Yu, Xu G.
   Kuritzkes, Daniel R.
   Shafiee, Hadi
TI Motion-Based Immunological Detection of Zika Virus Using Pt-Nanomotors
   and a Cellphone
SO ACS NANO
LA English
DT Article
DE motion sensing; nanomotors; platinum nanoparticles; cellphone; Zika
   virus
ID DRUG-DELIVERY; DIAGNOSTICS; MICROMOTORS; NANOPARTICLES
AB Zika virus (ZIKV) infection is an emerging pandemic threat to humans that can be fatal in newborns. Advances in digital health systems and nanoparticles can facilitate the development of sensitive and portable detection technologies for timely management of emerging viral infections. Here we report a nanomotor-based bead motion cellphone (NBC) system for the immunological detection of ZIKV. The presence of virus in a testing sample results in the accumulation of platinum (Pt)-nanomotors on the surface of beads, causing their motion in H2O2 solution. Then the virus concentration is detected in correlation with the change in beads motion. The developed NBC system was capable of detecting ZIKV in samples with virus concentrations as low as 1 particle/mu L. The NBC system allowed a highly specific detection of ZIKV in the presence of the closely related dengue virus and other neurotropic viruses, such as herpes simplex virus type 1 and human cytomegalovirus. The NBC platform technology has the potential to be used in the development of point-of-care diagnostics for pathogen detection and disease management in developed and developing countries.
C1 [Draz, Mohamed Shehata; Lakshminaraasimulu, Nivethitha Kota; Krishnakumar, Sanchana; Battalapalli, Dheerendranath; Vasan, Anish; Kanakasabaathy, Manoj Kumar; Sreeram, Aparna; Kallakuri, Shantanu; Thirumalaraju, Prudhvi; Li, Yudong; Shafiee, Hadi] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Engn Med, Boston, MA 02139 USA.
   [Draz, Mohamed Shehata; Shafiee, Hadi] Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
   [Draz, Mohamed Shehata] Tanta Univ, Fac Sci, Tanta 31527, Egypt.
   [Yu, Xu G.; Kuritzkes, Daniel R.] Harvard Med Sch, Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02139 USA.
   [Hua, Stephane; Yu, Xu G.] MIT, Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02129 USA.
   [Hua, Stephane; Yu, Xu G.] Harvard Univ, Boston, MA 02129 USA.
RP Shafiee, H (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Engn Med, Boston, MA 02139 USA.; Shafiee, H (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.
EM hshafiee@bwh.harvard.edu
RI Thirumalaraju, Prudhvi/AAO-7932-2020; tirumalaraju,
   Prudhvi/AAA-3214-2020; Kanakasabapathy, Manoj/L-3760-2017
OI Kanakasabapathy, Manoj/0000-0002-0756-8585; Kallakuri,
   Shantanu/0000-0002-9809-6690
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01Al118502,
   R21HD092828, P30ES000002]; American Board of Obstetrics and Gynecology;
   American College of Obstetricians and Gynecologists, American Society
   for Reproductive Medicine; Society for Reproductive Endocrinology and
   Infertility through ASRM award; Harvard University Center for AIDS
   Research (CFAR) [5P30AI060354-14]; Harvard T.H. Chan School of Public
   Health, Harvard Center for Environmental Health through Harvard NIEHS
   grant
FX We would like to thank Donald Coen, Seamus McCarron, Sambeeta Das, and
   Francoise Giguel. Research reported in this publication was partially
   supported by the National Institute of Health under award numbers
   R01Al118502, R21HD092828, and P30ES000002; Harvard T.H. Chan School of
   Public Health, Harvard Center for Environmental Health through Harvard
   NIEHS grant; American Board of Obstetrics and Gynecology; American
   College of Obstetricians and Gynecologists, American Society for
   Reproductive Medicine, Society for Reproductive Endocrinology and
   Infertility through ASRM award; and Harvard University Center for AIDS
   Research (CFAR) under award number 5P30AI060354-14.
CR Balasubramanian S, 2011, ANGEW CHEM INT EDIT, V50, P4161, DOI 10.1002/anie.201100115
   Bhardwaj SK, 2015, ACS APPL MATER INTER, V7, P26124, DOI 10.1021/acsami.5b07692
   Bigall NC, 2008, NANO LETT, V8, P4588, DOI 10.1021/nl802901t
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Campuzano S, 2011, ANALYST, V136, P4621, DOI 10.1039/c1an15599g
   Campuzano S, 2012, NANO LETT, V12, P396, DOI 10.1021/nl203717q
   Ceylan H, 2017, LAB CHIP, V17, P1705, DOI 10.1039/c7lc00064b
   Chalupniak A, 2015, ADV DRUG DELIVER REV, V95, P104, DOI 10.1016/j.addr.2015.09.004
   Chandra S, 2005, SPECTROCHIM ACTA A, V61, P269, DOI 10.1016/j.saa.2004.03.040
   Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dong B, 2013, ACS NANO, V7, P5192, DOI 10.1021/nn400925q
   Draz MS, 2018, THERANOSTICS, V8, P1985, DOI 10.7150/thno.23856
   Draz MS, 2014, THERANOSTICS, V4, P872, DOI 10.7150/thno.9404
   Draz MS, 2012, ACS NANO, V6, P7634, DOI 10.1021/nn3034056
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fu XW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701160
   Gao W, 2014, NANOSCALE, V6, P10486, DOI 10.1039/c4nr03124e
   Gao W, 2012, SMALL, V8, P460, DOI 10.1002/smll.201101909
   Garcia M, 2013, NANOSCALE, V5, P1325, DOI 10.1039/c2nr32400h
   He QJ, 2011, J MATER CHEM, V21, P5845, DOI 10.1039/c0jm03851b
   Illien P, 2017, CHEM SOC REV, V46, P5508, DOI 10.1039/c7cs00087a
   Ismagilov RF, 2002, ANGEW CHEM INT EDIT, V41, P652, DOI 10.1002/1521-3773(20020215)41:4<652::AID-ANIE652>3.0.CO;2-U
   Kagan D, 2011, NANO LETT, V11, P2083, DOI 10.1021/nl2005687
   Kanakasabapathy MK, 2017, LAB CHIP, V17, P2910, DOI 10.1039/c7lc00273d
   Kanakasabapathy MK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7863
   Nguyen KV, 2015, CHEM COMMUN, V51, P4782, DOI 10.1039/c4cc10250a
   Laksanasopin T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0056
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lavrentovich OD, 2010, NATURE, V467, P947, DOI 10.1038/nature09427
   Ma X, 2015, J AM CHEM SOC, V137, P4976, DOI 10.1021/jacs.5b02700
   Ma X, 2013, CHEM-EUR J, V19, P15593, DOI 10.1002/chem.201302736
   Medina F, 2012, CURR PROTOC MICROBIO, V27
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morales-Narvaez E, 2014, SMALL, V10, P2542, DOI 10.1002/smll.201303068
   Mudanyali O, 2013, NAT PHOTONICS, V7, P247, DOI [10.1038/nphoton.2012.337, 10.1038/NPHOTON.2012.337]
   Orozco J, 2013, J AM CHEM SOC, V135, P5336, DOI 10.1021/ja4018545
   Patra D, 2013, NANOSCALE, V5, P1273, DOI 10.1039/c2nr32600k
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585
   Romeo A, 2016, LAB CHIP, V16, P1957, DOI 10.1039/c6lc90046a
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Solovev AA, 2009, SMALL, V5, P1688, DOI 10.1002/smll.200900021
   Vilela D, 2014, LAB CHIP, V14, P3505, DOI 10.1039/c4lc00596a
   Wang H, 2014, J AM CHEM SOC, V136, P2719, DOI 10.1021/ja411705d
   Wang J., 2013, NANOMACHINES FUNDAME
   Wang W, 2013, NANO TODAY, V8, P531, DOI 10.1016/j.nantod.2013.08.009
   Wong F, 2016, ANNU REV MATER RES, V46, P407, DOI 10.1146/annurev-matsci-070115-032047
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wu J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1035
   Xu TL, 2015, J AM CHEM SOC, V137, P2163, DOI 10.1021/ja511012v
   Yu XP, 2014, ANAL CHEM, V86, P4501, DOI 10.1021/ac500912c
   Zhang H, 2014, ACS NANO, V8, P8537, DOI 10.1021/nn503170c
NR 53
TC 16
Z9 16
U1 18
U2 88
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD JUN
PY 2018
VL 12
IS 6
BP 5709
EP 5718
DI 10.1021/acsnano.8b01515
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA GL1YM
UT WOS:000436910200066
PM 29767504
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Benelli, G
   Duggan, MF
AF Benelli, Giovanni
   Duggan, Mary Frances
TI Management of arthropod vector data - Social and ecological dynamics
   facing the One Health perspective
SO ACTA TROPICA
LA English
DT Review
DE Dengue; Emerging infectious diseases; Filariasis; Lyme disease; Malaria;
   Mosquitoes; Ticks; Vector-borne diseases; West Nile virus; Zika virus;
   Zoonosis
ID ASIAN TIGER MOSQUITO; RIFT-VALLEY FEVER; BORNE DISEASES; PUBLIC-HEALTH;
   POPULATION-DYNAMICS; INFECTIOUS-DISEASE; MALARIA INFECTION;
   AEDES-ALBOPICTUS; ONE MEDICINE; ZIKA VIRUS
AB Emerging infectious diseases (EIDs) are spread by direct and/or indirect contacts between a pathogen or parasite and their hosts. Arthropod vectors have evolved as excellent bloodsuckers, providing an elegant transportation mode for a wide number of infectious agents. The nature of pathogen and parasite transfer and the models used to predict how a disease might spread are magnified in complexity when an arthropod vector is part of the disease cycle. One Health is a worldwide strategy for expanding interdisciplinary collaborations and communications in all aspects of health care for humans, animals and the environment. It would benefit from a structured analysis to address vectoring of arthropod-borne diseases as a dynamic transactional process. This review focused on how arthropod vector data can be used to better model and predict zoonotic disease outbreaks. With enhanced knowledge to describe arthropod vector disease transfer, researchers will have a better understanding about how to model disease outbreaks. As public health research evolves to include more social-ecological systems, the roles of society, ecology, epidemiology, pathogen/parasite evolution and animal behavior can be better captured in the research design. Overall, because of more collaborative data collection processes on arthropod vectors, disease modeling can better predict conditions where EIDs will occur.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
   [Duggan, Mary Frances] Benjamin Franklin Inst Technol, Boston, MA USA.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Benelli, Giovanni/A-9100-2013
OI Benelli, Giovanni/0000-0001-8971-6010
CR Agnew P, 1999, EVOL ECOL, V13, P67, DOI 10.1023/A:1006586131235
   Ajelli M, 2017, ACTA TROP, V176, P332, DOI 10.1016/j.actatropica.2017.08.026
   Almas R, 2012, RES RURAL SOCIOL DEV, V18, P1, DOI 10.1108/S1057-1922(2012)0000018003
   Atlas RM, 2013, CURR TOP MICROBIOL, V365, P1, DOI 10.1007/82_2012_223
   Baltussen Rob, 2006, Cost Eff Resour Alloc, V4, P14, DOI 10.1186/1478-7547-4-14
   Beasley V, 2009, VET ITAL, V45, P97
   Belay ED, 2014, EMERG INFECT DIS, V20, P319, DOI 10.3201/eid2002.131748
   Benelli G, 2018, ENVIRON SCI POLLUT R, DOI [10.1007/x11356-017-9960-y, DOI 10.1007/X11356-017-9960-Y]
   Benelli G., 2018, TRENDS PARASITOL, DOI [10.1016/j.pt2018.01.002, DOI 10.1016/J.PT2018.01.002]
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2018, ACTA TROP, V178, P176, DOI 10.1016/j.actatropica.2017.11.024
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bichara D, 2015, B MATH BIOL, V77, P2004, DOI 10.1007/s11538-015-0113-5
   Bird BH, 2016, ANTIVIR RES, V132, P274, DOI 10.1016/j.antiviral.2016.07.005
   Bopp M., 2004, ECOHEALTH, V1, pSU24, DOI [10.1007/s10393-004-0044-3, DOI 10.1007/S10393-004-0044-3]
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brouqui P, 2006, ANN NY ACAD SCI, V1078, P223, DOI 10.1196/annals.1374.041
   Brown TM, 2006, AM J PUBLIC HEALTH, V96, P62, DOI 10.2105/AJPH.2004.050831
   Cantas L, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00144
   Casadevall A, 1999, INFECT IMMUN, V67, P3703, DOI 10.1128/IAI.67.8.3703-3713.1999
   CDC, 2016, RIFT VALL FEV
   CDC, 2017, LYM OTH TICKB DIS
   Charron DF, 2012, INSIGHT INNOV INT DE, P1, DOI 10.1007/978-1-4614-0517-7_1
   Ciota AT, 2017, CURR OPIN INSECT SCI, V22, P28, DOI 10.1016/j.cois.2017.05.002
   Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85
   Cleaveland S., 2017, PHIL PHIL T R SOC B, V372
   Coker R, 2011, LANCET INFECT DIS, V11, P326, DOI 10.1016/S1473-3099(10)70312-1
   Colwell DD, 2011, VET PARASITOL, V182, P14, DOI 10.1016/j.vetpar.2011.07.012
   CRAIG GB, 1965, AM J TROP MED HYG, V14, P904, DOI 10.4269/ajtmh.1965.14.904
   d'Onofrio A, 2007, THEOR POPUL BIOL, V71, P301, DOI 10.1016/j.tpb.2007.01.001
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Davis MF, 2017, ONE HEALTH-AMSTERDAM, V4, P14, DOI 10.1016/j.onehlt.2017.07.001
   De Plaen R, 2004, ECOHEALTH, V1, pSU8
   Dicker R., 2011, PRINCIPLES EPIDEMIOL, P84
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681
   EcoHealth Alliance, 2017, ECOHEALTH ALL AB
   Eisen L, 2011, ANNU REV ENTOMOL, V56, P41, DOI 10.1146/annurev-ento-120709-144847
   Eisler MC, 2003, TRENDS PARASITOL, V19, P341, DOI 10.1016/S1471-4922(03)00164-8
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   EWALD PW, 1994, EVOLUTION INFECT DIS
   EWALD PW, 1994, EVOLUTION INFECT DIS, P298
   Fidler D. P., 1999, U KAN L REV, V48, P1
   Fine P.E, 1975, TROPICAL DIS CHALLEN
   Freifeld CC, 2008, J AM MED INFORM ASSN, V15, P150, DOI 10.1197/jamia.M2544
   Galea S, 2010, INT J EPIDEMIOL, V39, P97, DOI 10.1093/ije/dyp296
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Geoghegan JL, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170189
   Gibbs EPJ, 2014, VET REC, V174, P85, DOI 10.1136/vr.g143
   Godfroid J, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0207-7
   Grace D, 2014, ONDERSTEPOORT J VET, V81, DOI 10.4102/ojvr.v81i2.725
   Grzywacz JG, 2000, BEHAV MED, V26, P101, DOI 10.1080/08964280009595758
   Gubler D, 2005, REV PANAM SALUD PUBL, V17, P221
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Halbach R, 2017, CURR OPIN INSECT SCI, V22, P16, DOI 10.1016/j.cois.2017.05.004
   Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767
   Hardy M.C., 2017, INFECT DIS, V2, P1, DOI [10.3390/tropicalmed2010001, DOI 10.3390/TROPICALMED2010001]
   Heesterbeek H., 2015, SCIENCE, DOI [10.1126/science.aaa4339, DOI 10.1126/SCIENCE.SAA4339]
   Hemingway J, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002380
   Holling CS, 2001, ECOSYSTEMS, V4, P390, DOI 10.1007/s10021-001-0101-5
   Hongoh V, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040419
   Jana S., 2015, COMPLEX DYNAMICS SIR, V64, DOI [10.1007/s10441-015-9273-9, DOI 10.1007/S10441-015-9273-9]
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kahn RE, 2009, ZOONOSES PUBLIC HLTH, V56, P407, DOI 10.1111/j.1863-2378.2009.01255.x
   Keeling MJ, 2008, J R SOC INTERFACE, V5, P171, DOI 10.1098/rsif.2007.1106
   Kenawy MA, 2018, ACTA TROP, V181, P40, DOI 10.1016/j.actatropica.2018.01.015
   Khan AS, 2010, AM J PUBLIC HEALTH, V100, P1237, DOI 10.2105/AJPH.2009.180489
   Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   KNUDSEN AB, 1992, B WORLD HEALTH ORGAN, V70, P1
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Lazer D, 2014, SCIENCE, V343, P1203, DOI 10.1126/science.1248506
   LEBEL J, 2004, ECOHEALTH, V1, P325, DOI DOI 10.1007/510393-004-0142-2
   Leboeuf A, 2011, MAKING SENSE ONE HLT
   Lebov J, 2017, ONE HEALTH-AMSTERDAM, V3, P44, DOI 10.1016/j.onehlt.2017.03.004
   Lefevre T, 2007, PROTEOMICS, V7, P1908, DOI 10.1002/pmic.200601021
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Lessler J, 2016, AM J EPIDEMIOL, V183, P415, DOI 10.1093/aje/kww021
   LI MY, 1995, MATH BIOSCI, V125, P155, DOI 10.1016/0025-5564(95)92756-5
   Lindsey NP, 2012, PUBLIC HEALTH REP, V127, P383, DOI 10.1177/003335491212700406
   Lipsitch M, 1996, EVOLUTION, V50, P1729, DOI 10.1111/j.1558-5646.1996.tb03560.x
   Lord CC, 2004, PHYSIOL ENTOMOL, V29, P214, DOI 10.1111/j.0307-6962.2004.00411.x
   Lord CC, 2010, ISR J ECOL EVOL, V56, P371, DOI 10.1560/IJEE.55.3-4.371
   Luz PM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000761
   Lysaght T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170967
   MACDONALD G, 1961, PUBLIC HEALTH REP, V76, P753, DOI 10.2307/4591271
   Malaney P, 2004, AM J TROP MED HYG, V71, P141, DOI 10.4269/ajtmh.2004.71.141
   Martcheva M, 2013, DYNAMIC MODELS INFEC, P43, DOI DOI 10.1007/978-1-4614-3961-5
   McMichael AJ, 1999, AM J EPIDEMIOL, V149, P887
   Mobasheri A, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00002
   MORRIS M, 1993, SOCIOL METHOD RES, V22, P99, DOI 10.1177/0049124193022001005
   Murdock CC, 2017, CURR OPIN INSECT SCI, V20, P28, DOI 10.1016/j.cois.2017.03.001
   Myers SS, 2009, ANNU REV ENV RESOUR, V34, P223, DOI 10.1146/annurev.environ.033108.102650
   Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9
   Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406
   Niu TC, 2012, COMPUT MATH METHOD M, DOI 10.1155/2012/138757
   Nuttall G.H.F, 1899, ROLE INSECTS ARACHNI, V8
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Osburn B, 2009, REV SCI TECH OIE, V28, P481, DOI 10.20506/rst.28.2.1884
   Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133
   Otranto D., 2015, HUMAN EMERGING REEME, P505, DOI [10.1002/9781118644843.ch26, DOI 10.1002/9781118644843.CH26]
   Paternoster G., 2017, 8 INT C EM ZOON FOC
   Patz JA, 2006, ECOHEALTH, V3, P66, DOI 10.1007/s10393-005-0011-7
   Paull SH, 2012, FRONT ECOL ENVIRON, V10, P75, DOI 10.1890/110111
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petric M, 2017, CLIMATIC CHANGE, V142, P361, DOI 10.1007/s10584-017-1946-8
   Possas  C A, 2001, Cad Saude Publica, V17, P31
   Pulliam JRC, 2008, ECOHEALTH, V5, P80, DOI 10.1007/s10393-007-0149-6
   Racaniello VR, 2004, J CLIN INVEST, V113, P796, DOI [10.1172/JCI21370, 10.1172/JCI200421370]
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Richards CL, 2017, PUBLIC HEALTH REP, V132, P403, DOI 10.1177/0033354917709542
   Ross Ronald, 1911, PREVENTION MALARIA
   Satsuma J, 2004, PHYSICA A, V336, P369, DOI 10.1016/j.physa.2003.12.035
   Schaffner F., 2016, VBORNET GAP ANAL MOS, DOI [10.6084/m9.figshare.3426068, DOI 10.6084/M9.FIGSHARE.3426068]
   Sharakhov IV, 2015, CURR OPIN INSECT SCI, V10, P110, DOI 10.1016/j.cois.2015.05.003
   Smith DL, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-13
   Smith T, 1893, INVESTIGATIONS NATUR
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   Stanczyk NM, 2017, CURR OPIN INSECT SCI, V20, P7, DOI 10.1016/j.cois.2017.02.002
   STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6
   TAKKEN W, 2003, ECOLOGICAL ASPECTS A
   Thomas JJ, 2006, IEEE COMPUT GRAPH, V26, P10, DOI 10.1109/MCG.2006.5
   Uttal DH, 2008, MODEL MODEL SCI EDUC, V3, P53
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Vogels CBF, 2017, J EXP BIOL, V220, P3598, DOI 10.1242/jeb.164186
   Walker B, 2002, CONSERV ECOL, V6
   Waltner-Toews D, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0171
   Wang RA, 2017, GENES DIS, V4, P154, DOI 10.1016/j.gendis.2017.07.004
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   Wonham MJ, 2006, ECOL LETT, V9, P706, DOI 10.1111/j.1461-0248.2006.00912.x
   Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569
   Xie T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184430
   Zinsstag J, 2012, ECOHEALTH, V9, P107, DOI 10.1007/s10393-012-0772-8
   Zouache K, 2015, CURR OPIN INSECT SCI, V10, P14, DOI 10.1016/j.cois.2015.04.010
NR 147
TC 52
Z9 52
U1 9
U2 85
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2018
VL 182
BP 80
EP 91
DI 10.1016/j.actatropica.2018.02.015
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GD5BT
UT WOS:000430520700012
PM 29454734
DA 2020-07-08
ER

PT J
AU Cortes, F
   Martelli, CMT
   Ximenes, RAD
   Montarroyos, UR
   Siqueira, JB
   Cruz, OG
   Alexander, N
   de Souza, WV
AF Cortes, Fanny
   Turchi Martelli, Celina Maria
   de Alencar Ximenes, Ricardo Arraes
   Montarroyos, Ulisses Ramos
   Siqueira Junior, Joao Bosco
   Cruz, Oswaldo Gonsalves
   Alexander, Neal
   de Souza, Wayner Vieira
TI Time series analysis of dengue surveillance data in two Brazilian cities
SO ACTA TROPICA
LA English
DT Article
DE Dengue; Time series analysis; Anima; Brazil; Forecasting; America region
ID HEMORRHAGIC-FEVER; SAO-PAULO; INFECTION; OUTBREAKS; DISEASE; SARIMA;
   STATE; MODEL; PERNAMBUCO; FORECAST
AB The aim of the study was to evaluate the temporal patterns of dengue incidence from 2001 to 2014 and forecast for 2015 in two Brazilian cities. We analysed dengue surveillance data (SINAN) from Recife, 1.6 million population, and Goiania, 1.4 million population. We used Auto-Regressive Integrated Moving Average (ARIMA) modelling of monthly notified dengue incidence (2001-2014). Forecasting models (95% prediction interval) were developed to predict numbers of dengue cases for 2015. During the study period, 73,479 dengue cases were reported in Recife varying from 11 cases/100,000 inhab (2004) to 2418 cases/100,000 inhab (2002). In Goiania, 253,008 dengue cases were reported and the yearly incidence varied from 293 cases/100,000 inhab (2004) to 3927 cases/100,000 inhab (2013). Trend was the most important component for Recife, while seasonality was the most important one in Goiania. For Recife, the best fitted model was ARIMA (1,1,3)(12) and for Goiania Seasonal ARIMA (1,0,2) (1,1,2)(12). The model predicted 4254 dengue cases for Recife in 2015; SINAN registered 35,724 cases. For Goiania the model predicted 33,757 cases for 2015; the reported number of cases by SINAN was 74,095, within the 95% prediction interval. The difference between notified and forecasted dengue cases in Recife can be explained by the co-circulation of dengue and Zika virus in 2015. In this year, all cases with rash were notified as "dengue-like" illness. The ARIMA models may be considered a baseline for the time series analysis of dengue incidence before the Zika epidemic.
C1 [Cortes, Fanny; de Alencar Ximenes, Ricardo Arraes; Montarroyos, Ulisses Ramos] Univ Pernambuco, Recife, PE, Brazil.
   [Turchi Martelli, Celina Maria; de Souza, Wayner Vieira] Aggeu Magalhaes Inst, Fiocrus Recife, Brazil.
   [de Alencar Ximenes, Ricardo Arraes] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Siqueira Junior, Joao Bosco] Univ Fed Goias, Goiania, Go, Brazil.
   [Cruz, Oswaldo Gonsalves] Oswaldo Cruz Inst, Fiocrus Rio De Janerio, Brazil.
   [Alexander, Neal] London Sch Hyg & Trop Med, London, England.
RP Cortes, F (corresponding author), Nucleo Pos Grad Prof Ruy Joao Marques, Rua Arnobio Marques 310, BR-50100901 Recife, PE, Brazil.
EM fannycortes2508@gmail.com; turchicm@gmail.com; raaximenes@uol.com.br;
   ulisses.montarroyos@upe.br; siqueirajb2@gmail.com;
   oswaldo.cruz@fiocruz.br; Neal.Alexander@lishtim.ac.uk;
   wayner@cpqam.fiocruz.br
RI Souza, Wayner V/H-3798-2013; Montarroyos, Ulisses/AAJ-7527-2020
OI Souza, Wayner/0000-0002-0939-9332; Alexander, Neal/0000-0002-6707-7876
FU National Council for Scientific and Technological Development (Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq])National
   Council for Scientific and Technological Development (CNPq)
   [306708/2014-0, 308818/2013-0, 306222/2013-2]; CAPESCAPES
FX FC received CAPES scholar for MSc. Brazilian Ministry of Education.
   Partial support from the National Council for Scientific and
   Technological Development (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico [CNPq]; scholarship 306708/2014-0 to CMTM,
   308818/2013-0 to RAAX, and 306222/2013-2 to WVS).
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Amaku M, 2016, EPIDEMIOL INFECT, V144, P3435, DOI 10.1017/S0950268816001448
   Amaku M, 2015, EPIDEMIOL INFECT, V143, P1803, DOI 10.1017/S0950268814002660
   [Anonymous], 2012, GLOB STRAT DENG PREV
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P553, DOI 10.1590/0037-8682-0245-2016
   Barcellos C, 2014, TROP MED INT HEALTH, V19, P159, DOI 10.1111/tmi.12227
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Box G. E., 1976, TIME SERIES ANAL FOR
   BOX G.E.P., 1970, J AM STAT ASSOC, V65, P1509, DOI DOI 10.1080/01621459.1970.10481180
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brasil M. S, 2016, B EPIDEMIOLOGICO MON, P52
   Brasil M. S, 2013, NOVA CLASSIFICACAO C
   Brasil M. S, 2009, DIRETRIZES NACIONAIS
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Chatfield C., 2000, TIME SERIES FORECAST
   Chen YR, 2015, EMERG INFECT DIS, V21, P1651, DOI 10.3201/eid2109.141030
   Cleveland RC, 1990, J OFF STAT, V6, P3, DOI DOI 10.1016/J.SOILBIO.2009.09.001
   ClinicalTrials. gov, 2016, PHAS 3 TRIAL EV EFF
   Coelho GE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004705
   Cordeiro MT, 2007, REV SOC BRAS MED TRO, V40, P605, DOI 10.1590/S0037-86822007000600001
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Trung DT, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P115
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   HAMILTON DC, 1978, BIOMETRIKA, V65, P135, DOI 10.1093/biomet/65.1.135
   Hyndman R. J., 2013, FORECASTING PRINCIPL
   Hyndman RJ, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i03
   Johansson MA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33707
   Ljung G. M., 1978, BIOMETRIKA, V66, P67, DOI DOI 10.1093/BIOMET/65.2.297
   Luz PM, 2008, AM J TROP MED HYG, V79, P933, DOI 10.4269/ajtmh.2008.79.933
   Martinez EZ, 2011, CAD SAUDE PUBLICA, V27, P1809, DOI 10.1590/S0102-311X2011000900014
   Martinez EZ, 2011, REV SOC BRAS MED TRO, V44, P436, DOI 10.1590/S0037-86822011000400007
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Morato DG, 2015, MEM I OSWALDO CRUZ, V110, P528, DOI 10.1590/0074-0276140388
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nobre FF, 2001, STAT MED, V20, P3051, DOI 10.1002/sim.963
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Porta M, 2014, DICT EPIDEMIOLOGY
   Ruberto I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003511
   Runge-Ranzinger S, 2008, TROP MED INT HEALTH, V13, P1022, DOI 10.1111/j.1365-3156.2008.02112.x
   Silawan Tassanee, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P90
   Silva MMO, 2016, EMERG INFECT DIS, V22, P336, DOI 10.3201/eid2202.150495
   Siqueira JB, 2005, EMERG INFECT DIS, V11, P48, DOI 10.3201/eid1101.031091
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Teixeira M. G., 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/jounial.pntd.0002520, DOI 10.1371/JOUNIAL.PNTD.0002520]
   Tukey JW, 1977, EXPLORATORY DATA ANA
   Martelli CMT, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004042
   WHO, 2016, WEEKL EP REP DENG VA, DOI DOI 10.1371/J0UR
   (WHO). World Health Organization, 2009, DENG GUID DIAGN TREA, P147
   Wilder-Smith A., 2016, LANCET INFECT DIS, V3099, P1, DOI [10.1016/S1473-3099(16)305111-7, DOI 10.1016/S1473-3099(16)305111-7]
   World Health Organization (WHO), 2016, DENG SEV DENG
NR 54
TC 12
Z9 12
U1 2
U2 24
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2018
VL 182
BP 190
EP 197
DI 10.1016/j.actatropica.2018.03.006
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GD5BT
UT WOS:000430520700028
PM 29545150
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Silva, JVJ
   Lopes, TRR
   de Oliveira, EF
   Oliveira, RAS
   Durdes-Carvalho, R
   Gil, LHVG
AF Silva, Jose V. J., Jr.
   Lopes, Thaisa R. R.
   de Oliveira-Filho, Edmilson F.
   Oliveira, Renato A. S.
   Durdes-Carvalho, Ricardo
   Gil, Laura H. V. G.
TI Current status, challenges and perspectives in the development of
   vaccines against yellow fever, dengue, Zika and chikungunya viruses
SO ACTA TROPICA
LA English
DT Review
DE Arboviruses; Disease control; Vaccination; Public health
ID DNA VACCINE; PROTECTIVE EFFICACY; CROSS-REACTIVITY; PROTEIN NS1;
   IN-VITRO; ANTIBODIES; STRAIN; IMMUNOGENICITY; ATTENUATION; STRATEGIES
AB Emerging and re-emerging viral infections transmitted by insect vectors (arthopode-borne viruses, arbovirus) are a serious threat to global public health. Among them, yellow fever (YFV), dengue (DENV), chikungunya (CHIKV) and Zika (ZIKV) viruses are particularly important in tropical and subtropical regions. Although vector control is one of the most used prophylactic measures against arboviruses, it often faces obstacles, such as vector diversity, uncontrolled urbanization and increasing resistance to insecticides. In this context, vaccines may be the best control strategy for arboviral diseases. Here, we provide a general overview about licensed vaccines and the most advanced vaccine candidates against YFV, DENV, CHIKV and ZIKV. In particular, we highlight vaccine difficulties, the current status of the most advanced strategies and discuss how the molecular characteristics of each virus can influence the choice of the different vaccine formulations.
C1 [Silva, Jose V. J., Jr.; de Oliveira-Filho, Edmilson F.; Oliveira, Renato A. S.; Durdes-Carvalho, Ricardo; Gil, Laura H. V. G.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Virol & Expt Therapy, BR-50670420 Recife, PE, Brazil.
   [Lopes, Thaisa R. R.] Univ Fed Pernambuco, Lab Immunopathol Keizo Asami, Virol Sect, Recife, PE, Brazil.
   [Oliveira, Renato A. S.] Univ Fed Pernambuco, Dept Pharmaceut Sci, Recife, PE, Brazil.
RP Gil, LHVG (corresponding author), Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Dept Virol & Expt Therapy, BR-50670420 Recife, PE, Brazil.
EM laura@cpqam.fiocruz.br
RI Oliveira, Renato/A-2863-2013; Oliveira, Renato/AAN-9394-2020;
   Oliveira-Filho, Edmilson F/A-6305-2012; Oliveira, Renato/AAN-9879-2020;
   Duraes-Carvalho, Ricardo/X-3065-2018
OI Oliveira, Renato/0000-0002-4044-0794; Oliveira-Filho, Edmilson
   F/0000-0002-3771-1565; Oliveira, Renato/0000-0002-4044-0794;
   Duraes-Carvalho, Ricardo/0000-0001-5734-7601
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (FACEPE); MCT/CNPq DCR grants; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES)CAPES; Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico (CNPq)National Council for Scientific and
   Technological Development (CNPq)
FX E.F. Oliveira-Filho and R. Durales-Carvalho are supported by Fundacao de
   Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE) and
   MCT/CNPq DCR grants. J.V.J. Silva Junior is supported by Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES). T.R.R. Lopes is
   supported by Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq). We thank Dr. Rodolfo Garcia and Dr. Awanish Kumar
   for the English correction and critics of the manuscript.
CR Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Blitvich B, 2016, AM J TROP MED HYG, V95, P488, DOI DOI 10.4269/AJTMH.16-0281
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Butrapet S, 2000, J VIROL, V74, P3011, DOI 10.1128/JVI.74.7.3011-3019.2000
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CDC, 2017, YELL FEV MAPS
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Chotiwan N, 2014, VIROLOGY, V456, P238, DOI 10.1016/j.virol.2014.03.031
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Costa SM, 2006, VACCINE, V24, P4562, DOI 10.1016/j.vaccine.2005.08.022
   Dawes BE, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.7
   Zara ALDA, 2016, EPIDEMIOL SERV SAUDE, V25, P391, DOI 10.5123/S1679-49742016000200017
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Galler R, 1997, BRAZ J MED BIOL RES, V30, P157, DOI 10.1590/S0100-879X1997000200002
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Gosling R, 2016, PLOS MED, V13, P1, DOI DOI 10.1371/J0URNAL.PMED.1001994
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HAHN CS, 1987, P NATL ACAD SCI USA, V84, P2019, DOI 10.1073/pnas.84.7.2019
   Halstead SB, 2016, AM J TROP MED HYG, V95, P741, DOI 10.4269/ajtmh.16-0222
   *ICTV, 2016, TAX
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Silva JVJ, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759021, 10.1590/s1678-9946201759021]
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Lanciotti R. R. J., 2016, MANUAL MOL CLIN LAB, P648
   LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4
   Li Y, 2017, AM J TROP MED HYG, V96, P727, DOI 10.4269/ajtmh.16-0698
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lin CF, 2003, J MED VIROL, V69, P82, DOI 10.1002/jmv.10261
   LLOYD Wray, 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P481, DOI 10.1016/S0035-9203(36)90002-0
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Maciel M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003693
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Monath TP, 2011, NEW ENGL J MED, V364, P1326, DOI 10.1056/NEJMoa1009303
   Monath TP, 2005, EXPERT REV VACCINES, V4, P553, DOI 10.1586/14760584.4.4.553
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   NIH, 2017, PHAS 2 ZIK VACC TRIA
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parashar D, 2014, BIOMED RES INT, V2014, P1
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Resnik DB, 2014, DEV WORLD BIOETH, V14, P37, DOI 10.1111/dewb.12011
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Sahadeo NSD, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex010
   Schafer B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024505
   Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Smith SA, 2016, J VIROL, V90, P780, DOI 10.1128/JVI.01805-15
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stokes A, 2001, REV MED VIROL, V11, P141, DOI 10.1002/rmv.311
   Talceda, 2016, TAK DENG VACC CAND A
   Theiler M, 1937, J EXP MED, V65, P767, DOI 10.1084/jem.65.6.767
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Thomas RE, 2016, DRUG DES DEV THER, V10, P3345, DOI 10.2147/DDDT.S99600
   Vicente CR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1668-y
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   WHO, 2017, DIS OUTBREAK NE 0208
   WHO, 2017, YELLOW FEVER
   WHO, 2017, DENG FEV
   WHO, 2016, MON MAN INS RES AED
   World Health Organization, 2017, UPD QUEST ANSW REL D
   World Health Organization, 2017, CHIK
   Wu SF, 2003, VACCINE, V21, P3919, DOI 10.1016/S0264-410X(03)00310-4
NR 83
TC 15
Z9 15
U1 2
U2 46
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2018
VL 182
BP 257
EP 263
DI 10.1016/j.actatropica.2018.03.009
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GD5BT
UT WOS:000430520700039
PM 29551394
DA 2020-07-08
ER

PT J
AU Bido-Medina, R
   Wirsich, J
   Rodriguez, M
   Oviedo, J
   Miches, I
   Bido, P
   Tusen, L
   Stoeter, P
   Sadaghiani, S
AF Bido-Medina, Richard
   Wirsich, Jonathan
   Rodriguez, Minelly
   Oviedo, Jairo
   Miches, Isidro
   Bido, Pamela
   Tusen, Luis
   Stoeter, Peter
   Sadaghiani, Sepideh
TI Impact of Zika Virus on adult human brain structure and functional
   organization
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; GUILLAIN-BARRE-SYNDROME;
   ELECTRODIAGNOSTIC FINDINGS; ENCEPHALITIS; NETWORKS; INFECTION;
   COMMUNICATION; CONNECTIVITY; ASSOCIATION
AB ObjectiveTo determine the impact of Zika virus (ZIKV) infection on brain structure and functional organization of severely affected adult patients with neurological complications that extend beyond Guillain-Barre Syndrome (GBS)-like manifestations and include symptoms of the central nervous system (CNS).
   MethodsIn this first case-control neuroimaging study, we obtained structural and functional magnetic resonance images in nine rare adult patients in the subacute phase, and healthy age- and sex-matched controls. ZIKV patients showed atypical descending and rapidly progressing peripheral nervous system (PNS) manifestations, and importantly, additional CNS presentations such as perceptual deficits. Voxel-based morphometry was utilized to evaluate gray matter volume, and resting state functional connectivity and Network Based Statistics were applied to assess the functional organization of the brain.
   ResultsGray matter volume was decreased bilaterally in motor areas (supplementary motor cortex, specifically Frontal Eye Fields) and beyond (left inferior frontal sulcus). Additionally, gray matter volume increased in right middle frontal gyrus. Functional connectivity increased in a widespread network within and across temporal lobes.
   InterpretationWe provide preliminary evidence for a link between ZIKV neurological complications and changes in adult human brain structure and functional organization, comprising both motor-related regions potentially secondary to prolonged PNS weakness, and nonsomatomotor regions indicative of PNS-independent alternations. The latter included the temporal lobes, particularly vulnerable in a range of neurological conditions. While future studies into the ZIKV-related neuroinflammatory mechanisms in adults are urgently needed, this study indicates that ZIKV infection can lead to an impact on the brain.
C1 [Bido-Medina, Richard; Wirsich, Jonathan; Sadaghiani, Sepideh] Univ Illinois, Beckman Inst Adv Sci & Technol, 405 N Mathews Ave, Urbana, IL 61801 USA.
   [Bido-Medina, Richard; Miches, Isidro] Univ Illinois, Neurosci Program, Urbana, IL 61801 USA.
   [Rodriguez, Minelly; Bido, Pamela; Tusen, Luis] Hosp Salvador B Gautier, Santo Domingo, Dominican Rep.
   [Oviedo, Jairo; Stoeter, Peter] Ctr Diagnost Med Avanzada & Telemed CEDIMAT, Santo Domingo, Dominican Rep.
   [Sadaghiani, Sepideh] Univ Illinois, Psychol Dept, Urbana, IL 61801 USA.
RP Bido-Medina, R (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, 405 N Mathews Ave, Urbana, IL 61801 USA.
EM bidomed2@illinois.edu
RI Wirsich, Jonathan/AAC-5021-2019
OI Wirsich, Jonathan/0000-0003-0588-9710
CR Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006
   Anderson BJ, 2011, DEV PSYCHOBIOL, V53, P456, DOI 10.1002/dev.20563
   Ann HW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153493
   Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Barttfeld P, 2015, P NATL ACAD SCI USA, V112, P887, DOI 10.1073/pnas.1418031112
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Brier MR, 2016, J NEUROL, V263, P1083, DOI 10.1007/s00415-016-8083-6
   Brito-Ferreira ML, 2016, AM ACAD NEUROL, V95, P1405, DOI 10. 4269/ajtmh. 17-0106
   Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Corbetta M, 1998, P NATL ACAD SCI USA, V95, P831, DOI 10.1073/pnas.95.3.831
   Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017
   DEMAEREL P, 1992, NEURORADIOLOGY, V34, P490, DOI 10.1007/BF00598957
   Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dickie DA, 2015, MAGN RESON IMAGING, V33, P1299, DOI 10.1016/j.mri.2015.07.014
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Machado-Alba JE, 2016, INT J INFECT DIS, V51, P133, DOI 10.1016/j.ijid.2016.09.010
   Eran A, 2016, INSIGHTS IMAGING, V7, P265, DOI 10.1007/s13244-016-0481-x
   Finke C, 2013, ANN NEUROL, V74, P284, DOI 10.1002/ana.23932
   Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X
   Fornito A, 2015, NAT REV NEUROSCI, V16, P159, DOI 10.1038/nrn3901
   Frisch S, 2015, J NEUROL, V262, P563, DOI 10.1007/s00415-014-7604-4
   Frontera JA, 2016, NEW ENGL J MED, V375, P1581, DOI 10.1056/NEJMe1611840
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Gitelman DR, 2001, NEUROIMAGE, V13, P623, DOI 10.1006/nimg.2000.0734
   Gordon PH, 2001, ARCH NEUROL-CHICAGO, V58, P913, DOI 10.1001/archneur.58.6.913
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   He BJ, 2007, CURR OPIN NEUROL, V20, P655, DOI 10.1097/WCO.0b013e3282f1c720
   He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013
   Jacobs BC, 1997, MUSCLE NERVE, V20, P446
   Japee S, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00023
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Kuper M, 2011, J NEUROL, V258, P1066, DOI 10.1007/s00415-010-5883-y
   Lu YC, 2016, NEUROL SCI, V37, P51, DOI 10.1007/s10072-015-2356-1
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018
   Puri BK, 2012, BRIT J RADIOL, V85, pE270, DOI 10.1259/bjr/93889091
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   ROPPER AH, 1991, GUILLAIN BARRE SYNDR
   Sadaghiani S, 2015, CEREB CORTEX, V25, P2763, DOI 10.1093/cercor/bhu072
   Selvarajah D, 2014, DIABETES CARE, V37, P1681, DOI 10.2337/dc13-2610
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Sureka J, 2012, BRIT J RADIOL, V85, pE782, DOI 10.1259/bjr/30039090
   Susuki K, 2009, J NEUROL, V256, P1899, DOI 10.1007/s00415-009-5254-8
   Tagliazucchi E, 2014, NEURON, V82, P695, DOI 10.1016/j.neuron.2014.03.020
   Teutsch S, 2008, NEUROIMAGE, V42, P845, DOI 10.1016/j.neuroimage.2008.05.044
   van de Beek D, 2017, NAT REV NEUROL, V13, P69, DOI 10.1038/nrneurol.2016.202
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Wagner J, 2015, EPILEPSIA, V56, P754, DOI 10.1111/epi.12968
   Wang JH, 2013, BIOL PSYCHIAT, V73, P472, DOI 10.1016/j.biopsych.2012.03.026
   WHO, 2017, WHO ZIK SIT REP
   WHO/PAHO, 2017, ZIK EP UPD
   Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060
   Wirsich J, 2016, NEUROIMAGE-CLIN, V11, P707, DOI 10.1016/j.nicl.2016.05.010
   Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041
   Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004
NR 61
TC 2
Z9 2
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD JUN
PY 2018
VL 5
IS 6
BP 752
EP 762
DI 10.1002/acn3.575
PG 11
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GI4NY
UT WOS:000434349700009
PM 29928658
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ianevski, A
   Zusinaite, E
   Kuivanen, S
   Strand, M
   Lysvand, H
   Teppor, M
   Kakkola, L
   Paavilainen, H
   Laajala, M
   Kallio-Kokko, H
   Valkonen, M
   Kantele, A
   Telling, K
   Lutsar, I
   Letjuka, P
   Metelitsa, N
   Oksenych, V
   Bjoras, M
   Nordbo, SA
   Dumpis, U
   Vitkauskiene, A
   Ohrmalm, C
   Bondeson, K
   Bergqvist, A
   Aittokallio, T
   Cox, RJ
   Evander, M
   Hukkanen, V
   Marjomaki, V
   Julkunen, I
   Vapalahti, O
   Tenson, T
   Merits, A
   Kainov, D
AF Ianevski, Aleksandr
   Zusinaite, Eva
   Kuivanen, Suvi
   Strand, Marten
   Lysvand, Hilde
   Teppor, Mona
   Kakkola, Laura
   Paavilainen, Henrik
   Laajala, Mira
   Kallio-Kokko, Hannimari
   Valkonen, Miia
   Kantele, Anu
   Telling, Kaidi
   Lutsar, Irja
   Letjuka, Pille
   Metelitsa, Natalja
   Oksenych, Valentyn
   Bjoras, Magnar
   Nordbo, Svein Arne
   Dumpis, Uga
   Vitkauskiene, Astra
   Ohrmalm, Christina
   Bondeson, Kare
   Bergqvist, Anders
   Aittokallio, Tero
   Cox, Rebecca J.
   Evander, Magnus
   Hukkanen, Veijo
   Marjomaki, Varpu
   Julkunen, Ilkka
   Vapalahti, Olli
   Tenson, Tanel
   Merits, Andres
   Kainov, Denis
TI Novel activities of safe-in-human broad-spectrum antiviral agents
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID ZIKA VIRUS-INFECTION; INFLUENZA-A VIRUS; APPROVED DRUGS; CELL-CULTURE;
   INHIBITORS; SALIPHENYLHALAMIDE; REPLICATION; CHOLESTEROL; EZETIMIBE;
   OBATOCLAX
AB According to the WHO, there is an urgent need for better control of viral diseases. Re-positioning existing safe-inhuman antiviral agents from one viral disease to another could play a pivotal role in this process. Here, we reviewed all approved, investigational and experimental antiviral agents, which are safe in man, and identified 59 compounds that target at least three viral diseases. We tested 55 of these compounds against eight different RNA and DNA viruses. We found novel activities for dalbavancin against echovirus 1, ezetimibe against human immunodeficiency virus 1 and Zika virus, as well as azacitidine, cyclosporine, minocycline, oritavancin and ritonavir against Rift valley fever virus. Thus, the spectrum of antiviral activities of existing antiviral agents could be expanded towards other viral diseases.
C1 [Ianevski, Aleksandr; Kainov, Denis] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7028 Trondheim, Norway.
   [Zusinaite, Eva; Teppor, Mona; Tenson, Tanel; Merits, Andres; Kainov, Denis] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia.
   [Kuivanen, Suvi; Vapalahti, Olli] Univ Helsinki, Dept Virol, FIN-00014 Helsinki, Finland.
   [Strand, Marten; Evander, Magnus] Umea Univ, Dept Clin Microbiol, S-90185 Umea, Sweden.
   [Lysvand, Hilde; Bjoras, Magnar; Nordbo, Svein Arne] Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7491 Trondheim, Norway.
   [Kakkola, Laura; Paavilainen, Henrik; Hukkanen, Veijo; Julkunen, Ilkka] Univ Turku, Inst Biomed, FIN-20520 Turku, Finland.
   [Laajala, Mira; Marjomaki, Varpu] Univ Jyvaskyla, Dept Biol & Environm Sci, Jyvaskyla 40500, Finland.
   [Kallio-Kokko, Hannimari] Univ Helsinki, Helsinki Univ Hosp, Dept Virol & Immunol, FIN-00014 Helsinki, Finland.
   [Valkonen, Miia; Kantele, Anu; Vapalahti, Olli] Helsinki Univ Hosp, Helsinki 00014, Finland.
   [Telling, Kaidi; Lutsar, Irja] Univ Tartu, Inst Med Microbiol, EE-50411 Tartu, Estonia.
   [Letjuka, Pille; Metelitsa, Natalja] Narva Haigla, EE-20104 Narva, Estonia.
   [Oksenych, Valentyn] Trondheim Reg & Univ Hosp, St Olays Hosp, Clin Med, N-7006 Trondheim, Norway.
   [Nordbo, Svein Arne] Trondheim Reg & Univ Hosp, St Olays Hosp, Dept Med Microbiol, N-7006 Trondheim, Norway.
   [Dumpis, Uga] Pouls Stradins Clin Univ Hosp, LV-1002 Riga, Latvia.
   [Vitkauskiene, Astra] Lithuanian Univ Hlth Sci, Dept Lab Med, LT-44307 Kaunas, Lithuania.
   [Ohrmalm, Christina; Bondeson, Kare; Bergqvist, Anders] Uppsala Univ, Dept Med Sci, S-75309 Uppsala, Sweden.
   [Aittokallio, Tero] Univ Helsinki, Inst Mol Med Finland, FIMM, FIN-00290 Helsinki, Finland.
   [Aittokallio, Tero] Univ Turku, Dept Math & Stat, Turku 20014, Finland.
   [Cox, Rebecca J.] Univ Bergen, Influenza Ctr, Dept Clin Sci, N-5021 Bergen, Norway.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, FIN-00014 Helsinki, Finland.
RP Kainov, D (corresponding author), Norwegian Univ Sci & Technol, Dept Clin & Mol Med, N-7028 Trondheim, Norway.
EM aleksandr.ianevski@helsinki.fi; eva.zusinaite@gmail.com;
   suvi.kuivanen@helsinki.fi; marten.strand@umu.se; hilde.lysvand@ntnu.no;
   mona.teppor@gmail.com; laura.kakkola@utu.fi; hojpaa@utu.fi;
   mira.a.laajala@jyu.fi; hannimari.kallio-kokko@hus.fi;
   miia.valkonen@hus.fi; anu.kantele@helsinki.fi; kaidi.telling@ut.ee;
   irja.lutsar@ut.ee; ellipellip@mail.ru; nmetelitsa@gmail.com;
   valentyn.oksenych@ntnu.no; magnar.bjoras@ntnu.no;
   svein.a.nordbo@ntnu.no; uga.dumpis@gmail.com;
   astra.vitkauskiene@kaunoklinikos.lt; christina.ohrmalm@akademiska.se;
   kare.bondeson@akademiska.se; anders.bergqvist@akademiska.se;
   tero.aittokallio@fimm.fi; rebecca.cox@uib.no; magnus.evander@umu.se;
   veijo.hukkanen@utu.fi; varpu.s.marjomaki@jyu.fi; ilkka.julkunen@utu.fi;
   olli.vapalahti@helsinki.fi; tanel.tenson@ut.ee; andres.merits@ut.ee;
   denis.kainov@helsinki.fi
RI Bjoras, Magnar/N-9286-2017; Evander, Magnus/AAF-5665-2019; Aittokallio,
   Tero/B-6583-2009; Oksenych, Valentyn/J-6216-2019; Merits,
   Andres/H-3125-2015; Kainov, Denis/I-5526-2019; Teppor, Mona/G-5445-2019;
   Tenson, Tanel/I-6431-2015
OI Evander, Magnus/0000-0001-6034-4807; Aittokallio,
   Tero/0000-0002-0886-9769; Oksenych, Valentyn/0000-0002-5088-3791;
   Merits, Andres/0000-0001-8193-0071; Kainov, Denis/0000-0001-7716-6955;
   Teppor, Mona/0000-0001-6477-8063; Marjomaki, Varpu/0000-0002-4592-5926;
   Kakkola, Laura/0000-0001-9271-4059; Vapalahti, Olli/0000-0003-2270-6824;
   Ohrmalm, Christina/0000-0002-3287-3549; Tenson,
   Tanel/0000-0002-0260-3601; Bondeson, Kare/0000-0001-9684-7887
FU European Regional Development Fund, the Mobilitas Pluss Project
   MOBTT39European Union (EU); Jane and Aatos Erkko Foundation [170046]
FX This study was supported by the European Regional Development Fund, the
   Mobilitas Pluss Project MOBTT39 (to Denis E. Kainov), Jane and Aatos
   Erkko Foundation grant #170046 (to the Vejo Hukkanen). We thank Qiuwei
   Abdullah Pan from the Department of Gastroenterology and Hepatology,
   Erasmus MC, University Medical Center Rotterdam for advice. We thank
   Ritva Kajander for the HSV-1 culture.
CR De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Wilde AH, 2017, VIRUS RES, V228, P7, DOI 10.1016/j.virusres.2016.11.011
   Debing Y, 2015, CURR OPIN INFECT DIS, V28, P596, DOI 10.1097/QCO.0000000000000212
   Delogu I, 2011, J MED VIROL, V83, P1058, DOI 10.1002/jmv.22019
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Disease G. B. D., 2017, GLOBAL REGIONAL NATL
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Enserink M, 2005, SCIENCE, V309, P1976
   Firpi RJ, 2006, LIVER TRANSPLANT, V12, P51, DOI 10.1002/lt.20532
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heredia A, 2015, P NATL ACAD SCI USA, V112, P9412, DOI 10.1073/pnas.1511144112
   Hodge RAV, 2013, ADV PHARMACOL, V67, P1, DOI 10.1016/B978-0-12-405880-4.00001-9
   Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697
   Hong Zhi, 2002, Prog Drug Res, V59, P41
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Islam MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20362-9
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jupille HJ, 2011, VIROLOGY, V410, P216, DOI 10.1016/j.virol.2010.11.012
   Kang H, 2015, ANTIVIR RES, V124, P1, DOI 10.1016/j.antiviral.2015.10.011
   Keck F, 2015, ANTIVIR RES, V120, P48, DOI 10.1016/j.antiviral.2015.05.004
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   Krieger SE, 2013, J VIROL, V87, P8884, DOI 10.1128/JVI.03415-12
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Laube I, 2004, INFECTION, V32, P51, DOI 10.1007/s15010-003-3094-5
   Lee K., 2017, ONCOTARGET, V8
   Leela SL, 2016, BIOCHEM BIOPH RES CO, V478, P410, DOI 10.1016/j.bbrc.2016.07.029
   Lempp FA, 2014, INTERVIROLOGY, V57, P151, DOI 10.1159/000360948
   Marjomaki V, 2002, J VIROL, V76, P1856, DOI 10.1128/JVI.76.4.1856-1865.2002
   McKimm-Breschkin JL, 2018, ANTIVIR RES, V149, P118, DOI 10.1016/j.antiviral.2017.11.013
   Monrroy-Bravo H, 2016, ANN HEPATOL, V15, P803, DOI 10.5604/16652681.1212626
   Myllynen M, 2016, J VIROL, V90, P6759, DOI 10.1128/JVI.00342-16
   Nygardas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064200
   Oo A, 2018, ANTIVIR RES, V150, P101, DOI 10.1016/j.antiviral.2017.12.012
   Paavilainen H, 2016, J MED VIROL, V88, P2196, DOI 10.1002/jmv.24578
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Quick ED, 2017, J VIROL, V91, DOI 10.1128/JVI.00569-17
   Ravikumar B, 2017, NUCLEIC ACIDS RES, V45, pW495, DOI 10.1093/nar/gkx384
   Rawson JMO, 2016, BIOORGAN MED CHEM, V24, P2410, DOI 10.1016/j.bmc.2016.03.052
   Saeedi R, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0054-x
   Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581
   Schor S, 2018, DNA CELL BIOL, V37, P63, DOI 10.1089/dna.2017.4033
   Singh M, 2014, IMMUNOLOGY, V142, P562, DOI 10.1111/imm.12246
   Soderholm S, 2016, ANTIVIR RES, V126, P69, DOI 10.1016/j.antiviral.2015.12.011
   Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215
   Taylor A, 2016, J VIROL, V90, P4150, DOI 10.1128/JVI.03192-15
   Ulferts R, 2016, ANTIMICROB AGENTS CH, V60, P2627, DOI 10.1128/AAC.02182-15
   Utt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151616
   Viira B, 2016, BIOORGAN MED CHEM, V24, P2519, DOI 10.1016/j.bmc.2016.04.018
   WHO, 2015, WHO PUBL LIST TOP EM
   Wilen CB, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006866
   Wohl DA, 2008, CLIN INFECT DIS, V47, P1105, DOI 10.1086/592116
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhou N, 2016, J BIOL CHEM, V291, P9218, DOI 10.1074/jbc.M116.716100
NR 54
TC 10
Z9 11
U1 1
U2 10
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2018
VL 154
BP 174
EP 182
DI 10.1016/j.antiviral.2018.04.016
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GH7RO
UT WOS:000433651300021
PM 29698664
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Raekiansyah, M
   Buerano, CC
   Luz, MAD
   Morita, K
AF Raekiansyah, Muhareva
   Buerano, Corazon C.
   Luz, Mark Anthony D.
   Morita, Kouichi
TI Inhibitory effect of the green tea molecule EGCG against dengue virus
   infection
SO ARCHIVES OF VIROLOGY
LA English
DT Article
ID EPIGALLOCATECHIN GALLATE; LUNG-CANCER; POLYPHENOLS
AB Dengue virus (DENV) infection is a major public health problem worldwide; however, specific antiviral drugs against it are not available. Hence, identifying effective antiviral agents for the prevention of DENV infection is important. In this study, we showed that the reportedly highly biologically active green-tea component epigallocatechin gallate (EGCG) inhibited dengue virus infection regardless of infecting serotype, but no or minimal inhibition was observed with other flaviviruses, including Japanese encephalitis virus, yellow fever virus, and Zika virus. EGCG exerted its antiviral effect mainly at the early stage of infection, probably by interacting directly with virions to prevent virus infection. Our results suggest that EGCG specifically targets DENV and might be used as a lead structure to develop an antiviral drug for use against the virus.
C1 [Raekiansyah, Muhareva; Buerano, Corazon C.; Luz, Mark Anthony D.; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
   [Buerano, Corazon C.] St Lukes Med Ctr, Res & Biotechnol, Quezon City, Philippines.
RP Morita, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, 1-12-4 Sakamoto, Nagasaki 8528523, Japan.
EM moritak@nagasaki-u.ac.jp
FU Japan Initiative for Global Research Network on Infectious Diseases
   (J-GRID) of Japan Agency for Medical Research and Development
   (AMED)Japan Agency for Medical Research and Development (AMED)
FX The authors are grateful to members of the Department of Virology,
   Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki,
   Japan, for their support. This research was supported by the Japan
   Initiative for Global Research Network on Infectious Diseases (J-GRID)
   of Japan Agency for Medical Research and Development (AMED).
CR Adungo F, 2016, CLIN VACCINE IMMUNOL, V23, P689, DOI 10.1128/CVI.00209-16
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1429, DOI 10.2174/138955708786369564
   Chow HHS, 2003, CLIN CANCER RES, V9, P3312
   Clark J, 2006, MOL NUTR FOOD RES, V50, P144, DOI 10.1002/mnfr.200500135
   Colpitts CC, 2014, J VIROL, V88, P7806, DOI 10.1128/JVI.00896-14
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Ismail NA, 2017, INTERDISCIP SCI, V9, P499, DOI 10.1007/s12539-016-0157-8
   Kim M, 2013, ANTIVIR RES, V100, P460, DOI 10.1016/j.antiviral.2013.08.002
   Kinghorn AD, 2011, J NAT PROD, V74, P1539, DOI 10.1021/np200391c
   Lipson SM, 2017, FOOD ENVIRON VIROL, V9, P434, DOI 10.1007/s12560-017-9299-z
   Liu G, 2011, ARCH VIROL, V156, P1359, DOI 10.1007/s00705-011-0989-9
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Munin Aude, 2011, Pharmaceutics, V3, P793, DOI 10.3390/pharmaceutics3040793
   O'Shea D, 2016, LIVER TRANSPLANT, V22, P324, DOI 10.1002/lt.24344
   Raekiansyah M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0072-7
   Raekiansyah M, 2014, JPN J INFECT DIS, V67, P86, DOI 10.7883/yoken.67.86
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   Sullivan NJ, 2001, CURR TOP MICROBIOL, V260, P145
   Uchida L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07395
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Yamaguchi K, 2002, ANTIVIR RES, V53, P19, DOI 10.1016/S0166-3542(01)00189-9
   Yamauchi R, 2009, TOXICOL IN VITRO, V23, P834, DOI 10.1016/j.tiv.2009.04.011
   Zandi K, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-214
NR 27
TC 5
Z9 5
U1 3
U2 14
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
PD JUN
PY 2018
VL 163
IS 6
BP 1649
EP 1655
DI 10.1007/s00705-018-3769-y
PG 7
WC Virology
SC Virology
GA GG3NV
UT WOS:000432599500026
PM 29429035
DA 2020-07-08
ER

PT J
AU Musso, D
   Cao-Lormeau, VM
AF Musso, D.
   Cao-Lormeau, V. M.
TI Is the Zika threat over?
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Editorial Material
ID VIRUS-INFECTION
C1 [Musso, D.; Cao-Lormeau, V. M.] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Musso, D.; Cao-Lormeau, V. M.] Aix Marseille Univ, AP HM, IRD, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
RP Musso, D (corresponding author), Inst Louis Malarde, POB 30, F-98713 Tahiti, French Polynesi, France.
EM dmusso@ilm.pf
RI Cao-Lormeau, Van-Mai/H-4879-2018; Musso, Didier/AAO-8178-2020; Musso,
   Didier/P-7809-2016
OI Cao-Lormeau, Van-Mai/0000-0001-5606-7480; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Cohen J, 2017, SCIENCE, V357, P631, DOI 10.1126/science.357.6352.631
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Siraj AS, 2017, BMJ GLOB HEAL, V2
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
NR 8
TC 6
Z9 6
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2018
VL 24
IS 6
BP 566
EP 567
DI 10.1016/j.cmi.2018.03.007
PG 2
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GG1KS
UT WOS:000432446500002
PM 29549059
OA Bronze
DA 2020-07-08
ER

PT J
AU Nogueira, ML
   Nery, NRR
   Estofolete, CF
   Terzian, ACB
   Guimaraes, GF
   Zini, N
   da Silva, RA
   Silva, GCD
   Franco, LCJ
   Rahal, P
   Bittar, C
   Carneiro, B
   Vasconcelos, PFC
   Henriques, DF
   Barbosa, DMU
   Rombola, PL
   de Grande, L
   Reis, AFN
   Palomares, SA
   Catelan, MW
   Cruz, LEAA
   Necchi, SH
   Mendonca, RCV
   dos Santos, INP
   Caron, SBA
   Costa, F
   Bozza, FA
   de Souza, AS
   de Mattos, CCB
   de Mattos, LC
   Vasilakis, N
   Oliani, AH
   Oliani, DCMV
   Ko, AI
AF Nogueira, M. L.
   Nery Junior, N. R. R.
   Estofolete, C. F.
   Bernardes Terzian, A. C.
   Guimaraes, G. F.
   Zini, N.
   Alves da Silva, R.
   Dutra Silva, G. C.
   Junqueira Franco, L. C.
   Rahal, P.
   Bittar, C.
   Carneiro, B.
   Vasconcelos, P. F. C.
   Freitas Henriques, D.
   Barbosa, D. M. U.
   Lopes Rombola, P.
   de Grande, L.
   Negri Reis, A. F.
   Palomares, S. A.
   Wakai Catelan, M.
   Cruz, L. E. A. A.
   Necchi, S. H.
   Mendonca, R. C. V.
   Penha dos Santos, I. N.
   Alavarse Caron, S. B.
   Costa, F.
   Bozza, F. A.
   Soares de Souza, A.
   Brandao de Mattos, C. C.
   de Mattos, L. C.
   Vasilakis, N.
   Oliani, A. H.
   Vaz Oliani, D. C. M.
   Ko, A. I.
TI Adverse birth outcomes associated with Zika virus exposure during
   pregnancy in Sao Jose do Rio Preto, Brazil
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Adverse outcome; Arbovirus; Birth; Pregnancy; Zika virus
ID INFECTION; RUBELLA
AB Objectives: We aimed to report the first 54 cases of pregnant women infected by Zika virus (ZIKV) and their virologic and clinical outcomes, as well as their newborns' outcomes, in 2016, after the emergence of ZIKV in dengue-endemic areas of Sao Paulo, Brazil.
   Methods: This descriptive study was performed from February to October 2016 on 54 quantitative realtime PCR ZIKV-positive pregnant women identified by the public health authority of Sao Jose do Rio Preto, Sao Paulo, Brazil. The women were followed and had clinical and epidemiologic data collected before and after birth. Adverse outcomes in newborns were analysed and reported. Urine or blood samples from newborns were collected to identify ZIKV infection by reverse transcription PCR (RT-PCR).
   Results: A total of 216 acute Zika-suspected pregnant women were identified, and 54 had the diagnosis confirmed by RT-PCR. None of the 54 women miscarried. Among the 54 newborns, 15 exhibited adverse outcomes at birth. The highest number of ZIKV infections occurred during the second and third trimesters. No cases of microcephaly were reported, though a broad clinical spectrum of outcomes, including lenticulostriate vasculopathy, subependymal cysts, and auditory and ophthalmologic disorders, were identified. ZIKV RNA was detected in 18 of 51 newborns tested and in eight of 15 newborns with adverse outcomes.
   Conclusions: Although other studies have associated many newborn outcomes to ZIKV infection during pregnancy, these same adverse outcomes were rare or nonexistent in this study. The clinical presentation the newborns we studied was mild compared to other reports, suggesting that there is significant heterogeneity in congenital Zika infection. (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Nogueira, M. L.; Estofolete, C. F.; Bernardes Terzian, A. C.; Guimaraes, G. F.; Zini, N.; Alves da Silva, R.; Dutra Silva, G. C.; Junqueira Franco, L. C.; Soares de Souza, A.; Brandao de Mattos, C. C.; de Mattos, L. C.; Oliani, A. H.; Vaz Oliani, D. C. M.] Sao Jose do Rio Preto Sch Med, Sao Jose Do Rio Preto, SP, Brazil.
   [Rahal, P.; Bittar, C.; Carneiro, B.] Sao Paulo State Univ, Sao Jose Do Rio Preto, SP, Brazil.
   [Barbosa, D. M. U.; Lopes Rombola, P.; de Grande, L.; Negri Reis, A. F.; Palomares, S. A.; Wakai Catelan, M.; Cruz, L. E. A. A.; Necchi, S. H.; Mendonca, R. C. V.; Penha dos Santos, I. N.; Alavarse Caron, S. B.] Hlth Secretariat, Sao Jose Do Rio Preto, SP, Brazil.
   [Nery Junior, N. R. R.; Costa, F.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil.
   [Vasconcelos, P. F. C.; Freitas Henriques, D.] Evandro Chagas Inst, Ananindeua, Para, Brazil.
   [Costa, F.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Bozza, F. A.] Fundacao Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Vasilakis, N.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Costa, F.; Ko, A. I.] Yale Sch Publ Hlth, New Haven, CT USA.
RP Nogueira, ML (corresponding author), Sao Jose do Rio Preto Sch Med FAMERP, 5416 Brigadeiro Faria Lima Ave, BR-15090000 Sao Jose Do Rio Preto, SP, Brazil.
EM mnogueira@famerp.br
RI Vasconcelos, Pedro/AAH-3142-2019; Carneiro, Bruno/P-2415-2019; de
   Mattos, Luiz Carlos/P-3574-2019; Rahal, Paula/D-3871-2012; de Mattos,
   Cinara Brandao/B-3650-2008; Estofolete, Cassia/N-6673-2019; Costa,
   Federico/G-1838-2015; de Mattos, Luiz Carlos/P-4005-2019; OLIANI,
   ANTONIO/O-1673-2019; Bittar, Cintia/A-5042-2015; Ko, Albert
   Icksang/P-2343-2015; Nogueira, Mauricio L/B-7599-2012; amsalu,
   ribka/G-8780-2019; Bozza, Fernando A/A-2618-2013
OI Rahal, Paula/0000-0001-5693-6148; de Mattos, Cinara
   Brandao/0000-0002-4836-3113; Estofolete, Cassia/0000-0001-7324-1591;
   Costa, Federico/0000-0001-6951-2336; de Mattos, Luiz
   Carlos/0000-0002-8572-8177; Bittar, Cintia/0000-0002-2048-4589; Ko,
   Albert Icksang/0000-0001-9023-2339; Nogueira, Mauricio
   L/0000-0003-1102-2419; Bozza, Fernando A/0000-0003-4878-0256; Rocha Nery
   Junior, Nivison Ruy/0000-0002-8164-0602; Oliani, Antonio
   Helio/0000-0003-1242-4364; Carneiro, Bruno/0000-0002-2355-7907;
   Spegiorin, Ligia Cosentino Junqueira Franco/0000-0003-4405-8098
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2013/21719-3, 2016/15021-1, 2015/12295-0,
   2016/05115-9]; Zika Virus Fast Track program by the Coordination for the
   Improvement of Higher Level Education Personnel; Brazilian National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [303999/2016-0, 440405/2016-5, 457664/2013-4]
FX Supported by the Sao Paulo Research Foundation (FAPESP) via grants
   2013/21719-3 and 2016/15021-1 to MLN, grant 2015/12295-0 to ACBT and
   grant 2016/05115-9 to LCM. The opinions, assumptions and conclusions or
   recommendations expressed in this material are the responsibility of the
   authors and do not necessarily reflect the views of FAPESP. PFCV was
   supported by the Zika Virus Fast Track program provided by the
   Coordination for the Improvement of Higher Level Education Personnel and
   the Brazilian National Council for Scientific and Technological
   Development (CNPq) by grants 303999/2016-0, 440405/2016-5 and
   457664/2013-4. MLM is a CNPq research fellow. All authors report no
   conflicts of interest relevant to this article.
CR [Anonymous], 2000, ASS PREN MAN TECN, P66
   [Anonymous], 2016, PROC SER AD VIG FEBR
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Terzian ACB, 2011, VECTOR-BORNE ZOONOT, V11, P291, DOI 10.1089/vbz.2009.0200
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2015, MMWR RECOMM REP, V64, P138
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   Enright Andrea M, 2002, Semin Neonatol, V7, P283, DOI 10.1053/siny.2002.0115
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MILLER E, 1982, LANCET, V2, P781
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mondini A, 2005, REV SAUDE PUBL, V39, P444, DOI [10.1590/S0034-89102005000300016, 10.1590/s0034-89102005000300016]
   Mondini A, 2007, J CLIN VIROL, V40, P84, DOI 10.1016/j.jcv.2007.06.007
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nei M, 2000, MOL EVOLUTION PHYLOG, P333
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   RORKE LB, 1973, ARCH OTOLARYNGOL, V98, P249
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   SHOPE RE, 1979, DIAGNOSTIC PROCEDURE, P767
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Singh Sarman, 2016, Trop Parasitol, V6, P113
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   World Health Organization, 2016, ASS INF MICR CONT ZI, P2
NR 28
TC 20
Z9 20
U1 0
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD JUN
PY 2018
VL 24
IS 6
BP 646
EP 652
DI 10.1016/j.cmi.2017.11.004
PG 7
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GG1KS
UT WOS:000432446500017
PM 29133154
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Wood, AM
   Hughes, BL
AF Wood, Amber M.
   Hughes, Brenna L.
TI Detection and Prevention of Perinatal Infection Cytomegalovirus and Zika
   Virus
SO CLINICS IN PERINATOLOGY
LA English
DT Article
DE Congenital cytomegalovirus infection; Congenital Zika virus syndrome;
   Perinatal infections; Ultrasound diagnosis
ID PRENATAL-DIAGNOSIS; INTERIM GUIDANCE; PROGNOSTIC VALUE; AMNIOTIC-FLUID;
   PREGNANT-WOMEN; BIRTH-DEFECTS; ANTIBODY; INFANTS; FETUSES; BLOOD
AB Congenital cytomegalovirus is the most common viral congenital infection and affects up to 2% of neonates. Significant sequelae may develop after congenital cytomegalovirus, including hearing loss, cognitive defects, seizures, and death. Zika virus is an emerging virus with perinatal implications; a congenital Zika virus syndrome has been identified and includes findings such as microcephaly, fetal nervous system abnormalities, and neurologic sequelae after birth. Screening, diagnosis, prevention, and treatment of these perinatal infections are reviewed in this article.
C1 [Wood, Amber M.; Hughes, Brenna L.] Duke Univ, Med Ctr, Dept Obstet & Gynecol, Div Maternal Fetal Med, Durham, NC 27710 USA.
RP Wood, AM (corresponding author), Duke Univ, DUMC 3967, Durham, NC 27710 USA.
EM amber.wood@duke.edu
CR Adhikari E. H., 2017, AM J OBSTET GYNECOL, V216, pe1
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   American College of Obstetricians and Gynecologists, 2014, Obstet Gynecol, V123, P372, DOI 10.1097/01.AOG.0000443276.68274.cc
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Benoist G, 2008, BJOG-INT J OBSTET GY, V115, P823, DOI 10.1111/j.1471-0528.2008.01714.x
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Cannon MJ, 2012, PREV MED, V54, P351, DOI 10.1016/j.ypmed.2012.03.009
   Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention (CDC), ZIK VIR PREV
   Centers for Disease Control and Prevention (CDC), 2017, AR ZIK
   Centers for Disease Control and Prevention (CDC), 2017, CYT CMV CONG CMV INF
   Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   De Carolis S, 2010, LUPUS, V19, P844, DOI 10.1177/0961203310361350
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   De Paschale M, 2010, J VIROL METHODS, V168, P121, DOI 10.1016/j.jviromet.2010.05.001
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   DONNER C, 1993, OBSTET GYNECOL, V82, P481
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552
   Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Gouarin S, 2002, J CLIN MICROBIOL, V40, P1767, DOI 10.1128/JCM.40.5.1767-1772.2002
   Guerra B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.052
   HOHLFELD P, 1991, OBSTET GYNECOL, V78, P615
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hughes BL, 2017, OBSTET GYNECOL, V130, P726, DOI 10.1097/AOG.0000000000002216
   Hughes BL, 2016, AM J OBSTET GYNECOL, V214, pB5, DOI 10.1016/j.ajog.2016.02.042
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson J, 2014, OBSTET GYN CLIN N AM, V41, P593, DOI 10.1016/j.ogc.2014.08.005
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042
   LAMY ME, 1992, AM J OBSTET GYNECOL, V166, P91, DOI 10.1016/0002-9378(92)91836-Y
   Lazzarotto T, 2011, CLIN MICROBIOL INFEC, V17, P1285, DOI 10.1111/j.1469-0691.2011.03564.x
   Lazzarotto T, 2008, J CLIN VIROL, V41, P192, DOI 10.1016/j.jcv.2007.10.015
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.052
   Liesnard C, 2000, OBSTET GYNECOL, V95, P881, DOI 10.1016/S0029-7844(99)00657-2
   Lipitz S, 1997, OBSTET GYNECOL, V89, P763, DOI 10.1016/S0029-7844(97)00084-7
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   NICOLINI U, 1994, PRENATAL DIAG, V14, P903, DOI 10.1002/pd.1970141002
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   Paz-Bailey G, 2017, N ENGL J MED
   Picone O, 2004, PRENATAL DIAG, V24, P1001, DOI 10.1002/pd.942
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Prince HE, 2007, CLIN VACCINE IMMUNOL, V14, P1228, DOI 10.1128/CVI.00233-07
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Revello MG, 2015, EBIOMEDICINE, V2, P1205, DOI 10.1016/j.ebiom.2015.08.003
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   REVELLO MG, 1995, J MED VIROL, V47, P462, DOI 10.1002/jmv.1890470428
   Revello MG, 1999, J CLIN VIROL, V14, P57, DOI 10.1016/S1386-6532(99)00016-5
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Ross DS, 2009, J WOMENS HEALTH, V18, P1187, DOI 10.1089/jwh.2008.1288
   Saldan A, 2017, J CLIN MICROBIOL, V55, P693, DOI 10.1128/JCM.01868-16
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
NR 86
TC 2
Z9 2
U1 0
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0095-5108
EI 1557-9840
J9 CLIN PERINATOL
JI Clin. Perinatol.
PD JUN
PY 2018
VL 45
IS 2
BP 307
EP +
DI 10.1016/j.clp.2018.01.005
PG 19
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA GI6QJ
UT WOS:000434495100013
PM 29747890
DA 2020-07-08
ER

PT J
AU Screaton, G
   Mongkolsapaya, J
AF Screaton, Gavin
   Mongkolsapaya, Juthathip
TI Which Dengue Vaccine Approach Is the Most Promising, and Should We Be
   Concerned about Enhanced Disease after Vaccination? The Challenges of a
   Dengue Vaccine
SO COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY
LA English
DT Article
ID NEUTRALIZING HUMAN-ANTIBODIES; ZIKA VIRUS-INFECTION; CROSS-REACTIVITY;
   STRUCTURAL BASIS; HIGHLY POTENT; FLAVIVIRUSES; RECOGNITION; MATURATION;
   EFFICACY; FUSION
AB A dengue vaccine has been pursued for more than 50 years and, unlike other flaviviral vaccines such as that against yellow fever, progress has been slow. In this review, we describe progress toward the first licensed dengue vaccine Dengvaxia, which does not give complete protection against disease. The antibody response to the dengue virion is reviewed, highlighting immunodominant yet poorly neutralizing responses in the context of a highly dynamic structurally flexible dengue virus particle. Finally, we review recent evidence for cross-reactivity between antibody responses to Zika and dengue viruses, which may further complicate the development of broadly protective dengue virus vaccines.
C1 [Screaton, Gavin; Mongkolsapaya, Juthathip] Imperial Coll London, Fac Med, London SW7 2AZ, England.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok 10700, Thailand.
RP Screaton, G (corresponding author), Imperial Coll London, Fac Med, London SW7 2AZ, England.
EM g.screaton@imperial.ac.uk
OI Screaton, Gavin/0000-0002-3549-4309
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Guzman MG, 2007, EMERG INFECT DIS, V13, P282, DOI 10.3201/eid1302.060539
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Junjhon J, 2008, J VIROL, V82, P10776, DOI 10.1128/JVI.01180-08
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
NR 47
TC 6
Z9 7
U1 0
U2 2
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1943-0264
J9 CSH PERSPECT BIOL
JI Cold Spring Harbor Perspect. Biol.
PD JUN
PY 2018
VL 10
IS 6
AR a029520
DI 10.1101/cshperspect.a029520
PG 10
WC Cell Biology
SC Cell Biology
GA GK3RU
UT WOS:000436063800008
PM 28716884
OA Green Published
DA 2020-07-08
ER

PT J
AU Johnson, TP
   Nath, A
AF Johnson, Tory P.
   Nath, Avindra
TI Neurological syndromes driven by postinfectious processes or
   unrecognized persistent infections
SO CURRENT OPINION IN NEUROLOGY
LA English
DT Review
DE autoimmunty; CNS; persistent infection; postinfection
ID WEST-NILE-VIRUS; GUILLAIN-BARRE-SYNDROME; CENTRAL-NERVOUS-SYSTEM; ACUTE
   DISSEMINATED ENCEPHALOMYELITIS; HERPES-SIMPLEX ENCEPHALITIS;
   MYCOPLASMA-PNEUMONIAE INFECTION; D-ASPARTATE RECEPTOR;
   T-CELL-ACTIVATION; EBOLA-VIRUS; ZIKA VIRUS
AB Purpose of review
   The immune system serves a critical role in protecting the host against various pathogens. However, under circumstances, once triggered by the infectious process, it may be detrimental to the host. This may be as a result of nonspecific immune activation or due to a targeted immune response to a specific host antigen. In this opinion piece, we discuss the underlying mechanisms that lead to such an inflammatory or autoimmune syndrome affecting the nervous system. We examine these hypotheses in the context of recent emerging infections to provide mechanistic insight into the clinical manifestations and rationale for immunomodulatory therapy.
   Recent findings
   Some pathogens endure longer than previously thought. Persistent infections may continue to drive immune responses resulting in chronic inflammation or development of autoimmune processes, resulting in damage to the nervous system. Patients with genetic susceptibilities in immune regulation may be particularly vulnerable to pathogen driven autoimmune responses.
   Summary
   The presence of prolonged pathogens may result in chronic immune stimulations that drives immune-mediated neurologic complications. Understanding the burden and mechanisms of these processes is challenging but important.
C1 [Johnson, Tory P.] Johns Hopkins Univ, Dept Neurol, Richard T Johnson Div Neuroimmunol & Neurol Infec, Baltimore, MD 21218 USA.
   [Nath, Avindra] NINDS, Sect Infect Nervous Syst, NIH, Bethesda, MD 20892 USA.
RP Nath, A (corresponding author), NINDS, OCD, CNP, NIH, 10 Ctr Dr MSC 1430, Bethesda, MD 20892 USA.
EM avindra.nath@nih.gov
FU National Institutes of Health, Bethesda, MarylandUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA; Department of Neurology at Johns Hopkins University
FX Supported by intramural funds from the National Institutes of Health,
   Bethesda, Maryland and the Department of Neurology at Johns Hopkins
   University.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   Bangs SC, 2006, TRENDS IMMUNOL, V27, P518, DOI 10.1016/j.it.2006.09.006
   Barzon L., 2016, EURO SURVEILL, V21
   Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545
   Billioux BJ, 2017, JAMA NEUROL, V74, P1141, DOI 10.1001/jamaneurol.2017.1460
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Buchbinder D, 2017, J PEDIAT HEMATOL ONC
   Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889
   Burakoff A, 2018, MMWR-MORBID MORTAL W, V67, P13, DOI 10.15585/mmwr.mm6701a3
   Cao NJY, 2005, J NEUROL SCI, V236, P73, DOI 10.1016/j.jns.2005.05.007
   Carson PJ, 2006, CLIN INFECT DIS, V43, P723, DOI 10.1086/506939
   Chertow DS, 2016, ANN INTERN MED, V165, P301, DOI 10.7326/M15-3066
   Choi SY, 2017, NEUROL SCI, V38, P1323, DOI 10.1007/s10072-017-2922-9
   Colebunders R, 2017, TRENDS PARASITOL
   Colebunders Robert, 2016, BMC Res Notes, V9, P182, DOI 10.1186/s13104-016-1993-7
   Cook RL, 2010, AM J TROP MED HYG, V83, P1133, DOI 10.4269/ajtmh.2010.09-0717
   Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8294-7, 10.1007/s12016-011-8293-8]
   Darrah E, 2017, J PROTEOME RES, V16, P355, DOI 10.1021/acs.jproteome.6b00617
   Dauvilliers Y, 2013, BRAIN, V136, P2486, DOI 10.1093/brain/awt187
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy J, 2014, NEUROLOGY, V83, P1823, DOI 10.1212/WNL.0000000000000987
   Elkhayat HA, 2017, ACTA NEUROL BELG
   Garcia MN, 2014, VIRAL IMMUNOL, V27, P327, DOI 10.1089/vim.2014.0035
   Gardon J, 2002, LANCET, V360, P203, DOI 10.1016/S0140-6736(02)09456-4
   GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Howlett P, 2016, EMERG INFECT DIS, V22, P150, DOI 10.3201/eid2201.151212
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jagadesh S, 2018, CLIN INFECT DIS, V66, P131, DOI 10.1093/cid/cix705
   Johnson TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6953
   Johnson TP, 2014, CURR OPIN HIV AIDS, V9, P572, DOI 10.1097/COH.0000000000000107
   Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110
   Joseph CG, 2014, SCIENCE, V343, P152, DOI 10.1126/science.1246886
   Keegan M, 2002, NEUROLOGY, V58, P143, DOI 10.1212/WNL.58.1.143
   Klager SL, 1996, TROP MED INT HEALTH, V1, P581
   Laubli H, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0249-y
   Liao B, 2014, NEURO-ONCOLOGY, V16, P589, DOI 10.1093/neuonc/nou001
   Liewluck T, 2017, J IMMUNOTHER
   Linnoila JJ, 2016, NEUROL-NEUROIMMUNOL, V3, DOI 10.1212/NXI.0000000000000245
   Llufriu S, 2009, NEUROLOGY, V73, P949, DOI 10.1212/WNL.0b013e3181b879be
   Lopez PH, 2010, J NEUROSCI, V30, P9533, DOI 10.1523/JNEUROSCI.2281-10.2010
   Loshaj-Shala A, 2018, J NEUROIMMUNOL
   Lotsch F, 2017, TRAVEL MED INFECT DI, V18, P18, DOI 10.1016/j.tmaid.2017.05.001
   Mammen AL, 2009, ARTHRITIS RHEUM, V60, P3784, DOI 10.1002/art.24977
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Menge T, 2005, ARCH NEUROL-CHICAGO, V62, P1673, DOI 10.1001/archneur.62.11.1673
   Miller SD, 2001, ADV VIRUS RES, V56, P199, DOI 10.1016/S0065-3527(01)56008-X
   Miravalle Augusto A, 2014, Handb Clin Neurol, V121, P1549, DOI 10.1016/B978-0-7020-4088-7.00103-6
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohammad SS, 2014, MOVEMENT DISORD, V29, P117, DOI 10.1002/mds.25623
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray KO, 2017, AM J TROP MED HYG, V97, P1913, DOI 10.4269/ajtmh.17-0405
   Nana-Djeunga HC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002824
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Nishikawa M, 1999, PEDIATR NEUROL, V21, P583, DOI 10.1016/S0887-8994(99)00042-9
   Nolan MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040374
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patel RJ, 2017, BMJ CASE REP, V2017
   Paz-Bailey G, 2017, N ENGL J MED
   Pion SDS, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000461
   PLAISIER AP, 1991, ACTA TROP, V48, P271, DOI 10.1016/0001-706X(91)90015-C
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   Pruss H, 2012, ANN NEUROL, V72, P902, DOI 10.1002/ana.23689
   Qiu XG, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006605
   Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rowe AK, 1999, J INFECT DIS, V179, pS28, DOI 10.1086/514318
   Salam Sharfaraz, 2016, BMJ Case Rep, V2016, DOI 10.1136/bcr-2016-215012
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Sheikh KA, 2004, ANN NEUROL, V56, P228, DOI 10.1002/ana.20173
   Skoldenberg B, 2006, J NEUROL, V253, P163, DOI 10.1007/s00415-005-0941-6
   Spatola M, 2017, NEUROLOGY, V88, P1012, DOI 10.1212/WNL.0000000000003713
   Supakornnumporn Songkit, 2017, J Clin Neuromuscul Dis, V19, P80, DOI 10.1097/CND.0000000000000193
   Tan K, 2009, NEUROLOGY, V72, P1458, DOI 10.1212/01.wnl.0000343510.08643.74
   TAYLOR HR, 1986, ARCH OPHTHALMOL-CHIC, V104, P863, DOI 10.1001/archopht.1986.01050180097039
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   Touat M, 2017, CURR OPIN NEUROL, V30, P659, DOI 10.1097/WCO.0000000000000503
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Winkler AS, 2013, AFR HEALTH SCI, V13, P529, DOI 10.4314/ahs.v13i2.51
   WOLPERT E, 1995, INT IMMUNOL, V7, P919, DOI 10.1093/intimm/7.6.919
   Wong G, 2016, J INFECT DIS, V214, pS294, DOI 10.1093/infdis/jiw257
   Wykes MN, 2018, NAT REV IMMUNOL, V18, P91, DOI 10.1038/nri.2017.112
   Yimenicioglu S, 2014, IRAN J PEDIATR, V24, P647
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yshii LM, 2016, BRAIN, V139, P2923, DOI 10.1093/brain/aww225
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
NR 93
TC 3
Z9 3
U1 1
U2 11
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1350-7540
EI 1473-6551
J9 CURR OPIN NEUROL
JI Curr. Opin. Neurol.
PD JUN
PY 2018
VL 31
IS 3
BP 318
EP 324
DI 10.1097/WCO.0000000000000553
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GE8WM
UT WOS:000431511900015
PM 29547402
DA 2020-07-08
ER

PT J
AU Amuzu, HE
   Tsyganov, K
   Koh, C
   Herbert, RI
   Powell, DR
   McGraw, EA
AF Amuzu, Hilaria E.
   Tsyganov, Kirill
   Koh, Cassandra
   Herbert, Rosemarie I.
   Powell, David R.
   McGraw, Elizabeth A.
TI Wolbachia enhances insect-specific flavivirus infection in Aedes aegypti
   mosquitoes
SO ECOLOGY AND EVOLUTION
LA English
DT Article
DE biocontrol; dengue; flavivirus; insect-specific flavivirus; mosquitoes;
   virome; Wolbachia
ID WEST NILE VIRUS; DENGUE VIRUS; ZIKA VIRUS; SUPERINFECTION EXCLUSION;
   CULEX-QUINQUEFASCIATUS; JAPANESE ENCEPHALITIS; VERTICAL TRANSMISSION;
   VECTOR COMPETENCE; SINDBIS VIRUS; UNITED-STATES
AB Mosquitoes transmit a diverse group of human flaviviruses including West Nile, dengue, yellow fever, and Zika viruses. Mosquitoes are also naturally infected with insect-specific flaviviruses (ISFs), a subgroup of the family not capable of infecting vertebrates. Although ISFs are not medically important, they are capable of altering the mosquito's susceptibility to flaviviruses and may alter host fitness. Wolbachia is an endosymbiotic bacterium of insects that when present in mosquitoes limits the replication of co-infecting pathogens, including flaviviruses. Artificially created Wolbachia-infected Aedes aegypti mosquitoes are being released into the wild in a series of trials around the globe with the hope of interrupting dengue and Zika virus transmission from mosquitoes to humans. Our work investigated the effect of Wolbachia on ISF infection in wild-caught Ae.aegypti mosquitoes from field release zones. All field mosquitoes were screened for the presence of ISFs using general degenerate flavivirus primers and their PCR amplicons sequenced. ISFs were found to be common and widely distributed in Ae.aegypti populations. Field mosquitoes consistently had higher ISF infection rates and viral loads compared to laboratory colony material indicating that environmental conditions may modulate ISF infection in Ae.aegypti. Surprisingly, higher ISF infection rates and loads were found in Wolbachia-infected mosquitoes compared to the Wolbachia-free mosquitoes. Our findings demonstrate that the symbiont is capable of manipulating the mosquito virome and that Wolbachia-mediated viral inhibition is not universal for flaviviruses. This may have implications for the Wolbachia-based DENV control strategy if ISFs confer fitness effects or alter mosquito susceptibility to other flaviviruses.
C1 [Amuzu, Hilaria E.; Koh, Cassandra; Herbert, Rosemarie I.; McGraw, Elizabeth A.] Monash Univ, Sch Biol Sci, Clayton, Vic, Australia.
   [Tsyganov, Kirill; Powell, David R.] Monash Univ, Monash Bioinformat Platform, Clayton, Vic, Australia.
   [McGraw, Elizabeth A.] Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
RP McGraw, EA (corresponding author), Penn State Univ, Dept Entomol, University Pk, PA 16802 USA.
EM eam7@psu.edu
RI McGraw, Elizabeth/A-6658-2012
OI McGraw, Elizabeth/0000-0001-7973-088X; Powell, David
   Richard/0000-0002-6639-6250
FU Australian Research CouncilAustralian Research Council [DP160100588]
FX Australian Research Council, Grant/Award Number: DP160100588
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Alto BW, 2008, P ROY SOC B-BIOL SCI, V275, P463, DOI 10.1098/rspb.2007.1497
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Amuzu HE, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0853-y
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Audsley MD, 2018, MOL ECOL, V27, P297, DOI 10.1111/mec.14436
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   BAQAR S, 1980, MOSQ NEWS, V40, P165
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125, DOI 10.4269/ajtmh.1980.29.125
   Berry D, 2011, APPL ENVIRON MICROB, V77, P7846, DOI 10.1128/AEM.05220-11
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Billecocq A, 2000, J GEN VIROL, V81, P2161, DOI 10.1099/0022-1317-81-9-2161
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   BOSIO CF, 1992, J MED ENTOMOL, V29, P985, DOI 10.1093/jmedent/29.6.985
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   CHAMBERS GM, 1990, J AM MOSQUITO CONTR, V6, P394
   Chevenet F, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-439
   Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180
   Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Fauquet C.M., 2005, VIRUS TAXONOMY
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Geib T, 2003, J VIROL, V77, P4283, DOI 10.1128/JVI.77.7.4283-4290.2003
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gomes FM, 2017, P NATL ACAD SCI USA, V114, P12566, DOI 10.1073/pnas.1716181114
   Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x
   GRIMSTAD PR, 1984, J MED ENTOMOL, V21, P249, DOI 10.1093/jmedent/21.3.249
   Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039
   Huber K, 2002, HEREDITY, V89, P7, DOI 10.1038/sj.hdy.6800086
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   KARABATSOS N, 1978, AM J TROP MED HYG, V27, P372
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   KAY BH, 1984, AUST J EXP BIOL MED, V62, P641, DOI 10.1038/icb.1984.61
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kho EA, 2016, J MED ENTOMOL, V53, P894, DOI 10.1093/jme/tjw029
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Lorenz L., 1980, AM J TROP MED HYG, V29, P125
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999
   Lutomiah JJL, 2007, J INSECT SCI, V7
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MACKENZIE JS, 1994, ARCH VIROL, V136, P447, DOI 10.1007/BF01321074
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   MCALLISTER WT, 1977, J VIROL, V24, P709, DOI 10.1128/JVI.24.2.709-711.1977
   McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   MUNSTERMANN LE, 1980, ANN ENTOMOL SOC AM, V73, P699, DOI 10.1093/aesa/73.6.699
   MUNSTERMANN LE, 1994, ANN ENTOMOL SOC AM, V87, P157, DOI 10.1093/aesa/87.2.157
   Murdock CC, 2012, P ROY SOC B-BIOL SCI, V279, P3357, DOI 10.1098/rspb.2012.0638
   Murdock CC, 2014, SCI REP-UK, V4, DOI 10.1038/srep03932
   Murdock CC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.2030
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Nethe M, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-52
   Newman CM, 2011, VECTOR-BORNE ZOONOT, V11, P1099, DOI 10.1089/vbz.2010.0144
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Pesko K, 2009, VECTOR-BORNE ZOONOT, V9, P281, DOI 10.1089/vbz.2007.0281
   Pujhari S., 2016, PEERJ PREPRINTS, V4, pe1781
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Richardson MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003129
   Ritchie S, 2014, AUSTRAL ENTOMOL, V53, P363, DOI 10.1111/aen.12127
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Sanchez-Seco MP, 2005, J VIROL METHODS, V126, P101, DOI 10.1016/j.jviromet.2005.01.025
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Shaw WR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11772
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Webster CL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002210
   Weinert LA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0249
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
   Zele F, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2837
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
NR 109
TC 11
Z9 11
U1 2
U2 17
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2045-7758
J9 ECOL EVOL
JI Ecol. Evol.
PD JUN
PY 2018
VL 8
IS 11
BP 5441
EP 5454
DI 10.1002/ece3.4066
PG 14
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA GK0DI
UT WOS:000435776600021
PM 29938064
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Piltch-Loeb, R
   Merdjanoff, AA
   Abramson, DM
AF Piltch-Loeb, Rachael
   Merdjanoff, Alexis A.
   Abramson, David M.
TI HOW THE US POPULATION ENGAGED WITH AND PRIORITIZED SOURCES OF
   INFORMATION ABOUT THE EMERGING ZIKA VIRUS IN 2016
SO HEALTH SECURITY
LA English
DT Article
DE Risk communication; Public health preparedness/response; Epidemic
   management/response
ID SOCIAL MEDIA; RISK COMMUNICATION; INFLUENZA; OUTBREAK; BEHAVIORS;
   EPIDEMIC; CARE; NEED
AB Emerging disease threats like Zika pose a risk to naive populations. In comparison to chronic diseases, there is scientific uncertainty surrounding emerging diseases because of the lack of medical and public health information available as the threat emerges. Further complicating this are the multiple, diverse channels through which people get information. This article used bivariate and multivariate analysis to first describe the breadth of information sources individuals accessed about the Zika virus, and then describe individuals' primary sources of information for Zika using a nationally representative pooled cross-sectional data set collected at 3 time points in 2016 (N = 3,698). The analysis also highlights how 3 subgroupshigh-education, high-income adults; Hispanic women of childbearing age; and retirees over the age of 65 with less than a high school educationvaried in their use of information. Results suggest individuals accessed multiple sources, but TV and radio were the primary sources of Zika information for the public, followed by print news. Demographic variation in primary source of information means public health officials should consider alternative channels to reach target groups in an emerging event. Without an understanding of how information has reached people, and who individuals engaged with regarding that information, public health practitioners are missing a key piece of the puzzle to improving public health campaigns during a future event like Zika. This analysis aims to inform the public health community about the message channels the US population uses during an emerging disease event and the most prevalent channels for different demographic groups, who can be targeted with particular messaging.
C1 [Piltch-Loeb, Rachael; Merdjanoff, Alexis A.; Abramson, David M.] NYU, Coll Global Publ Hlth, 715 Broadway,Rm 1229, New York, NY 10003 USA.
RP Piltch-Loeb, R (corresponding author), NYU, Coll Global Publ Hlth, 715 Broadway,Rm 1229, New York, NY 10003 USA.
EM rpl5@nyu.edu
CR Al-Surimi K, 2017, EMERGING REEMERGING
   AUSTIN EW, 1994, JOURNALISM QUART, V71, P973, DOI 10.1177/107769909407100420
   Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Bernier S, 2013, AM RED CROSS DISASTE
   Bosslet GT, 2011, ACAD EMERG MED, V18, P1221, DOI 10.1111/j.1553-2712.2011.01197.x
   Branswell H., 2017, STAT NEWS       0501
   CDC, 2016, ZIK VIR GUID CLIN 20
   Dutwin D., 2016, SURV PRACT, V9
   Fox S., 2011, SOCIAL LIFE HLTH INF
   Goldfarb IT, 2017, JAMA-J AM MED ASSOC, V318, P2075, DOI 10.1001/jama.2017.15680
   Houston JB, 2015, DISASTERS, V39, P1, DOI 10.1111/disa.12092
   HUCKFELDT R, 1995, AM J POLIT SCI, V39, P1025, DOI 10.2307/2111668
   Hughes A. L., 2012, J HOMEL SECUR EMERG, V9, P1, DOI DOI 10.1515/1547-7355.1976
   Igbinosa Irogue I, 2017, Am Fam Physician, V95, P507
   Johnson TJ, 2000, JOURNALISM MASS COMM, V77, P865, DOI 10.1177/107769900007700409
   Kapucu N, 2010, DISASTER PREV MANAG, V19, P452, DOI 10.1108/09653561011070376
   Kohut A., 2012, ASSESSING REPRESENTA
   Lau JTF, 2010, AM J INFECT CONTROL, V38, P374, DOI 10.1016/j.ajic.2010.03.002
   Lehnert JD, 2017, J PUBLIC HEALTH MAN, V23, P608, DOI 10.1097/PHH.0000000000000537
   Meaney-Delman D, 2016, OBSTET GYNECOL, V127, P642, DOI 10.1097/AOG.0000000000001378
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Mergel I, 2013, SOCIAL MEDIA PUBLIC
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oussayef NL, 2017, MMWR-MORBID MORTAL W, V65, P1482, DOI 10.15585/mmwr.mm6552e1
   Palen L., 2007, P SIGCHI C HUM FACT
   Pechta L. E., 2010, J HOMEL SECUR EMERG, V7, P1, DOI DOI 10.2202/1547-7355.1671
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Raphael M, 2017, NACCHO PUBLIC HLTH P
   Reynolds B, 2008, HEALTH PROMOT PRACT, V9, p13S, DOI 10.1177/1524839908325267
   Sastry S, 2017, HEALTH COMMUN, V32, P329, DOI 10.1080/10410236.2016.1138380
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Steelman TA, 2014, ADMIN SOC, V46, P707, DOI 10.1177/0095399712469198
   Suri VR, 2016, PATIENT EDUC COUNS, V99, P1038, DOI 10.1016/j.pec.2015.12.017
   Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537
   Velasco E, 2014, MILBANK Q, V92, P7, DOI 10.1111/1468-0009.12038
   Vraga EK, 2018, INFORM COMMUN SOC, V21, P1337, DOI 10.1080/1369118X.2017.1313883
   WHO, 2016, ZIK SIT REP NEUR SYN
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 38
TC 1
Z9 1
U1 1
U2 3
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JUN
PY 2018
VL 16
IS 3
BP 165
EP 177
DI 10.1089/hs.2017.0107
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GK0UG
UT WOS:000435826900004
PM 29927341
DA 2020-07-08
ER

PT J
AU Islam, F
   Gopalan, V
   Lam, AKY
AF Islam, Farhadul
   Gopalan, Vinod
   Lam, Alfred King-yin
TI RETREG1 (FAM134B): A new player in human diseases: 15 years after the
   discovery in cancer
SO JOURNAL OF CELLULAR PHYSIOLOGY
LA English
DT Review
DE cancer; endoplasmic reticulum; FAM134B; JK1; neuronal disorder; RETREG1
ID ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; SQUAMOUS-CELL
   CARCINOMA; AUTONOMIC NEUROPATHY; COLORECTAL-CANCER; COLON-CANCER;
   CLINICOPATHOLOGICAL SIGNIFICANCE; 3-DIMENSIONAL ARCHITECTURE; SELECTIVE
   AUTOPHAGY; MUTATIONS
AB FAM134B (family with sequence similarity 134, member B)/RETREG1 and its functional roles are relatively new in human diseases. This review aimed to summarize various functions of FAM134B since our first discovery of the gene in 2001. The protein encoded by FAM134B is a reticulophagy receptor that regulates turnover of the endoplasmic reticulum (ER) by selective phagocytosis. Absence or non-functional expression of FAM134B protein impairs ER-turnover and thereby is involved in the pathogenesis of some human diseases. FAM134B inhibition contributes to impair proteostasis in the ER due to the accumulation of misfolded or aggregated proteins, which in turn leads to compromised neuronal survival and progressive neuronal degenerative diseases. Mutations in FAM134B associated with hereditary sensory and autonomic neuropathy type IIB (HSAN IIB). Selective cleavage of FAM134B by Dengue, Zika, and West Nile virus encoded protease NS2B3 leads to the increased production of infection units, whereas upregulation of FAM134B inhibits viral replication. In cancer, FAM134B acts as a tumor suppressor and inhibit cancer growth both in-vitro and in-vivo. Pharmacological upregulation of FAM134B resulted in reduced cancer cell growth and proliferation. In addition, FAM134B mutations are common in patients with colorectal adenocarcinoma, and oesophageal squamous cell carcinoma. These mutations and expression changes of FAM134B were associated with the biological aggressiveness of these cancers. FAM134B also plays a role in allergic rhinitis, vascular dementia, and identification of stem cells. Taken together, information available in the literature suggests that FAM134B plays critical roles in human diseases, by interacting with different biological and chemical mediators, which are primarily regulated by ER turnover.
C1 [Islam, Farhadul; Gopalan, Vinod; Lam, Alfred King-yin] Griffith Univ, Sch Med, Canc Mol Pathol, Gold Coast, Qld, Australia.
   [Islam, Farhadul; Gopalan, Vinod; Lam, Alfred King-yin] Griffith Univ, Griffith Hlth Inst, Gold Coast, Qld, Australia.
   [Islam, Farhadul] Rajshahi Univ, Dept Biochem & Mol Biol, Rajshahi, Bangladesh.
RP Lam, AKY (corresponding author), Griffith Med Sch, Pathol, Gold Coast Campus, Gold Coast, Qld 4222, Australia.
EM a.lam@griffith.edu.au
RI Lam, Alfred/C-1652-2008; Islam, Farhadul/R-5643-2017
OI Lam, Alfred/0000-0003-2771-564X; Islam, Farhadul/0000-0001-5262-4702
FU Griffith UniversityGriffith University; Menzies Health Institute
   Queensland
FX Griffith University; Menzies Health Institute Queensland
CR Bernales S, 2006, PLOS BIOL, V4, P2311, DOI 10.1371/journal.pbio.0040423
   Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008
   Chiramel AI, 2016, J INFECT DIS, V214, pS319, DOI 10.1093/infdis/jiw270
   Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367
   Cybulsky AV, 2017, NAT REV NEPHROL, V13, P681, DOI 10.1038/nrneph.2017.129
   Dai XF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07189-6
   Davidson GL, 2012, J NEUROL, V259, P1673, DOI 10.1007/s00415-011-6397-y
   Duret C, 2014, MUSCLE NERVE, V49, P774, DOI 10.1002/mus.24145
   Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x
   Haque MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep29173
   Houlden H, 2004, CURR OPIN NEUROL, V17, P569, DOI 10.1097/00019052-200410000-00007
   Islam F, 2017, EXP CELL RES, V357, P260, DOI 10.1016/j.yexcr.2017.05.021
   Islam F, 2017, HUM GENET, V136, P321, DOI 10.1007/s00439-017-1760-4
   Islam F, 2017, MOL CARCINOGEN, V56, P238, DOI 10.1002/mc.22488
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kasem K, 2014, EXP MOL PATHOL, V97, P99, DOI 10.1016/j.yexmp.2014.06.002
   Kasem K, 2014, EXP MOL PATHOL, V97, P31, DOI 10.1016/j.yexmp.2014.05.001
   Kasem K, 2014, EXP CELL RES, V326, P166, DOI 10.1016/j.yexcr.2014.06.013
   Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Klionsky DJ, 2008, AUTOPHAGY, V4, P740, DOI 10.4161/auto.6398
   Knudson AG, 2001, NAT REV CANCER, V1, P157, DOI 10.1038/35101031
   Kobayashi S, 2015, BIOL PHARM BULL, V38, P1098, DOI 10.1248/bpb.b15-00096
   Kong M, 2011, PSYCHIAT GENET, V21, P37, DOI 10.1097/YPG.0b013e3283413496
   Kurth I., 2015, GENEREVIEWS, P1993
   Kurth I, 2009, NAT GENET, V41, P1179, DOI 10.1038/ng.464
   Lam AKY, 2012, INT J COLORECTAL DIS, V27, P1303, DOI 10.1007/s00384-012-1474-y
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.pathmechdis.3.121806.151434
   Lipatova Z, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005390
   Melchiotti R, 2014, BMC MED GENET, V15, DOI 10.1186/1471-2350-15-73
   Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026
   Murphy SM, 2012, J NEUROL NEUROSUR PS, V83, P119, DOI 10.1136/jnnp.2010.228965
   Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8
   Rao RV, 2006, CELL DEATH DIFFER, V13, P415, DOI 10.1038/sj.cdd.4401761
   Riviere JB, 2011, AM J HUM GENET, V89, P219, DOI 10.1016/j.ajhg.2011.06.013
   Rubinsztein DC, 2015, NATURE, V522, P291, DOI 10.1038/nature14532
   Scheubert L, 2011, DNA RES, V18, P233, DOI 10.1093/dnares/dsr016
   Schneider-Brachert W, 2004, IMMUNITY, V21, P415, DOI 10.1016/j.immuni.2004.08.017
   Schuchman EH, 2010, FEBS LETT, V584, P1895, DOI 10.1016/j.febslet.2009.11.083
   Schuck S, 2009, J CELL BIOL, V187, P525, DOI 10.1083/jcb.200907074
   Schwarz DS, 2016, CELL MOL LIFE SCI, V73, P79, DOI 10.1007/s00018-015-2052-6
   Song S., 2017, J CELLULAR PHYSL
   Tang JCO, 2001, CLIN CANCER RES, V7, P1539
   Tang WK, 2007, INT J MOL MED, V19, P915
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Yadav Raj Kumar, 2014, J Cancer Prev, V19, P75, DOI 10.15430/JCP.2014.19.2.75
   Yorimitsu T, 2007, TRENDS CELL BIOL, V17, P279, DOI 10.1016/j.tcb.2007.04.005
NR 50
TC 13
Z9 13
U1 3
U2 200
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9541
EI 1097-4652
J9 J CELL PHYSIOL
JI J. Cell. Physiol.
PD JUN
PY 2018
VL 233
IS 6
BP 4479
EP 4489
DI 10.1002/jcp.26384
PG 11
WC Cell Biology; Physiology
SC Cell Biology; Physiology
GA FX6JP
UT WOS:000426190900009
PM 29226326
OA Green Published
DA 2020-07-08
ER

PT J
AU Koppolu, V
   Raju, TS
AF Koppolu, Veerendra
   Raju, T. Shantha
TI Zika virus outbreak: a review of neurological complications, diagnosis,
   and treatment options
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Review
DE Zika virus; Microcephaly; Zika vaccine; Aedes mosquito; Antiviral
   chemotherapy; Neuropathogen; Flavivirus; Guillain-Barre syndrome
ID MALE SEXUAL TRANSMISSION; SMALL-MOLECULE INHIBITOR; NEURAL STEM-CELLS;
   DENGUE VIRUS; CEREBRAL ORGANOIDS; CROSS-REACTIVITY; INTERIM GUIDANCE;
   UNITED-STATES; GLIAL-CELLS; INFECTION
AB Zika virus (ZIKV) is an arbovirus transmitted mainly by mosquitos of Aedes species. The virus has emerged in recent years and spread throughout North and South Americas. The recent outbreak of ZIKV started in Brazil (2015) has resulted in infections surpassing a million mark. Contrary to the previous beliefs that Zika causes mildly symptomatic infections fever, headache, rash, arthralgia, and conjunctivitis, the recent outbreak associated ZIKV to serious neurological complications such as microcephaly, Guillain-Barr, syndrome, and eye infections. The recent outbreak has resulted in an astonishing number of microcephaly cases in fetus and infants. Consequently, numerous studies were conducted using in vitro cell and in vivo animal models. These studies showed clear links between ZIKV infections and neurological abnormalities. Diagnosis methods based on nucleic acid and serological detection facilitated rapid and accurate identification of ZIKV infections. New transmission modalities such as sexual and transplacental transmission were uncovered. Given the seriousness of ZIKV infections, WHO declared the development of safe and effective vaccines and new antiviral drugs as an urgent global health priority. Rapid work in this direction has led to the identification of several vaccine and antiviral drug candidates. Here, we review the remarkable progress made in understanding the molecular links between ZIKV infections and neurological irregularities, new diagnosis methods, potential targets for antiviral drugs, and the current state of vaccine development.
C1 [Koppolu, Veerendra; Raju, T. Shantha] MedImmune, Global Bioassay Dev & Qual, Biopharmaceut Dev, Gaithersburg, MD 20878 USA.
RP Raju, TS (corresponding author), MedImmune, Global Bioassay Dev & Qual, Biopharmaceut Dev, Gaithersburg, MD 20878 USA.
EM tshantharaju@yahoo.com
RI Koppolu, Veerendra/N-1366-2017
OI Koppolu, Veerendra/0000-0001-9141-9058; Raju,
   Shantha/0000-0002-6698-2508
CR ABBASI J, 2016, JAMA J AM MED ASSOC, V316, P1249
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   [Anonymous], 2016, ZIK VIR INF
   [Anonymous], 2016, EM PREP RESP
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bahia SDS, 2015, DENGUE CHIKUNGUNYA Z
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bauer T, 2012, J EXP MED, V209, P2033, DOI 10.1084/jem.20120493
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benzekri R, 2017, J FR OPHTALMOL
   Besnard M, 2014, EURO SURVEILL, V19
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PM, 2016, J INFECT DIS
   Cavalcanti MG, 2017, INT J INFECT DIS
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR DIS
   Centers for Infectious Disease Research Policy, 2016, BRAZ CONF BLOOD TRAN
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan JF, 2017, ANTIVIRAL RES
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   De Clercq E., 2009, V189, P53, DOI 10.1007/978-3-540-79086-0_3
   de Valdez MRW, 2011, P NATL ACAD SCI USA, V108, P4772, DOI 10.1073/pnas.1019295108
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   desPaula Freitas B, 2016, JAMA OPHTHALMOL
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2016, ZIK VIR DIS EP RAP R
   European Centre for Disease Prevention and Control, 2015, ZIK VIR EP AM POT AS
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandes NC, 2016, EXP TOXICOL PATHOL
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   He SS, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010286
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huzly D, 2016, EURO SURVEILL, V21
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kim SY, 2017, BIOCHEMISTRY
   Koppolu V, 2013, INFECT IMMUN, V81, P4220, DOI 10.1128/IAI.00919-13
   Kouznetsova J, 2014, EMERG MICROBES INFEC, V3, DOI 10.1038/emi.2014.88
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Lu G., 2016, ANTIMICROB AGENTS CH
   Mallet H, 2015, B INF SANIT EPIDEMIO, V2015
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MCCARTHY M, 2016, BMJ-BRIT MED J, V354
   McCarthy M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4235
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J., 2017, CLIN MICROBIOL INFEC
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Patino-Barbosa AM, 2015, SEX TRANSM INFECT, V91, P359, DOI 10.1136/sextrans-2015-052189
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Ritchie SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105846
   Ritchie SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003930
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Sacramento CQ, 2016, BIORXIV061671
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Santora M., 2016, TWIST ZIKA OUTBREAK
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Singh MV, 2017, J NEUROVIROL
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Skredenske JM, 2013, J BIOMOL SCREEN, V18, P588, DOI 10.1177/1087057112474690
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03743
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2013, EURO SURVEILL, V19
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Venturi G, 2016, EURO SURVEILL, V21
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHO, 2016, DIS OUTBR NEWS ZIK V
   WHO, 2016, ZIK SIT REP NEUR SYN
   World Health Organization, 2016, SIT REP ZIK VIR
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zammarchi L, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.056
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang XA, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.134
   Zhou K, 2017, J NEUROVIROL, V23, P341, DOI 10.1007/s13365-017-0514-3
NR 152
TC 8
Z9 9
U1 2
U2 15
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2018
VL 24
IS 3
BP 255
EP 272
DI 10.1007/s13365-018-0614-8
PG 18
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ET
UT WOS:000434755500001
PM 29441490
DA 2020-07-08
ER

PT J
AU Ishwarya, R
   Vaseeharan, B
   Subbaiah, S
   Nazar, AK
   Govindarajan, M
   Alharbi, NS
   Kadaikunnan, S
   Khaled, JM
   Al-anbr, MN
AF Ishwarya, Ramachandran
   Vaseeharan, Baskaralingam
   Subbaiah, Suganya
   Nazar, Abdul Khudus
   Govindarajan, Marimuthu
   Alharbi, Naiyf S.
   Kadaikunnan, Shine
   Khaled, Jamal M.
   Al-anbr, Mohammed N.
TI Sargassum wightii-synthesized ZnO nanoparticles - from antibacterial and
   insecticidal activity to immunostimulatory effects on the green tiger
   shrimp Penaeus semisulcatus
SO JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY
LA English
DT Article
DE Crustaceans; Antibiofilm activity; Dengue; Larvicides; Microbial
   pathogens; Zika virus
ID HOT-WATER EXTRACT; SILVER NANOPARTICLES; LITOPENAEUS-VANNAMEI;
   AEDES-AEGYPTI; CULEX-QUINQUEFASCIATUS; ANOPHELES-STEPHENSI; LARVICIDAL
   ACTIVITY; IMMUNE-RESPONSE; PLANT-EXTRACTS; VECTOR CONTROL
AB The green synthesis of metal nanoparticles using phytochemical from marine seaweeds is a fast-growing research field in nanotechnology. Here, the biosynthesis of zinc oxide nanoparticles was achieved using the hot water extract of Sargassum wightii. The hot water extract prepared from S. wightii (H Sw) and ZnO NPs were studied by UV-visible and FTIR spectroscopy, SEM and XRD. Then, both products were evaluated for antibiofilm activity towards aquatic pathogens. The nanoparticles' immunostimulating potential on green tiger prawns, Penaeus semisulcatus was studied through immersion and dietary administration. Shrimp immune parameters (i.e., total hemocytes count (THC), respiratory bursts (RBs), phenoloxidase (PO) and superoxide dismutase (SOD) activity) were significantly affected by exposure or ingestion of ZnO nanoparticles. In addition, the hot water extract and ZnO nanoparticles had high antibiofilm activity against Gram-positive (B. subtilis, S. aureus) and Gram-negative (S. sonnei, P. aeruginosa) microbial pathogens. It was accomplished that the ZnO nanoparticles can be used as the bacteriostatic and immunostimulant agents through immersion and dietary administration enhancing immunity of green tiger shrimp. Furthermore, the toxicity effects of ZnO nanoparticles were 100% at 24 h on Aedes aegypti 3rd instar larvae at the concentration of 100 mu g/mL and the greatest efficacy was accomplished by H Sw ZnO NPs against the Ae. aegypti after 24 h (LC50 49.22; LC90 86.96 mg/mL), if compared to the seaweed extract alone. Morphological and histological damages triggered by nanoexposure were investigated.
C1 [Ishwarya, Ramachandran; Vaseeharan, Baskaralingam; Subbaiah, Suganya] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Nanobiosci & Nanopharmacol Div, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
   [Nazar, Abdul Khudus] Cent Marine Fisheries Res Inst, Mandapam Reg Ctr, Mandapam, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Govt Coll Women, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
   [Alharbi, Naiyf S.; Kadaikunnan, Shine; Khaled, Jamal M.; Al-anbr, Mohammed N.] King Saud Univ, Coll Sci, Dept Bot & Microbiol, Riyadh 11451, Saudi Arabia.
RP Vaseeharan, B (corresponding author), Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Nanobiosci & Nanopharmacol Div, Sci Block,6th Floor, Karaikkudi 630004, Tamil Nadu, India.
EM vaseeharanb@gmail.com
RI Alharbi, Naiyf S/B-9402-2019; GOVINDARAJAN, MARIMUTHU/A-8070-2019;
   /L-2836-2013; Khaled, Jamal/D-8188-2017
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; /0000-0001-7018-5379; 
FU Council of Scientific and Indutrial Research (CSIR), New Delhi, India
   [9/688 (0030)/18 EMR - I]; Department of Biotechnology (DBT), New Delhi,
   IndiaDepartment of Biotechnology (DBT) India [BT/PR7903/AAQ/3/638/
   2013]; Deanship of Scientific Research at King Saud UniversityDeanship
   of Scientific Research at King Saud University [RG-1438-074]
FX The authors would like to extend their thanks to the Council of
   Scientific and Indutrial Research (CSIR), New Delhi, India for the
   financial assistance Rendered [Ref: 9/688 (0030)/18 EMR - I] and this
   work was partly carried by Department of Biotechnology (DBT), New Delhi,
   India, below the Project grants code: BT/PR7903/AAQ/3/638/ 2013. The
   authors extend their appreciation to the Deanship of Scientific Research
   at King Saud University for funding this work through research group No.
   RG-1438-074.
CR Ali M. Y. S., 2013, Asian Pacific Journal of Tropical Disease, V3, P196
   Balasubramanian G, 2008, FISH SHELLFISH IMMUN, V25, P820, DOI 10.1016/j.fsi.2008.09.002
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Barman D, 2013, J MAR SCI RES DEV, V3, P134, DOI DOI 10.4172/2155-9910.1000134
   BELL KL, 1993, DEV COMP IMMUNOL, V17, P211, DOI 10.1016/0145-305X(93)90040-W
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10149, DOI 10.1007/s11356-017-9960-y
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2018, IND CROP PROD, V112, P668, DOI 10.1016/j.indcrop.2017.12.062
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bilal H, 2012, AFR ENTOMOL, V20, P8, DOI 10.4001/003.020.0102
   Chand R.K., 2008, FISH SHELLFISH IMMUN, V25, P820
   Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390
   Chang CC, 2013, FISH SHELLFISH IMMUN, V35, P92, DOI 10.1016/j.fsi.2013.04.008
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Deepak P, 2018, PARTICUL SCI TECHNOL, V36, P974, DOI 10.1080/02726351.2017.1331286
   Deepak P, 2017, ARTIF CELL NANOMED B, V45, P990, DOI 10.1080/21691401.2016.1198365
   Dubey N. K., 2008, Journal of Biopesticides, V1, P182
   Fitton J., 2006, ADV APPL PHYCOLOGY U
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   Folmer F, 2010, PHYTOCHEM REV, V9, P557, DOI 10.1007/s11101-010-9200-2
   [Food and Agriculture Organization (FAO) FAO Fisheries and Aquaculture Department], FISHSTATJ SOFTW FISH
   Fu YW, 2007, FISH SHELLFISH IMMUN, V22, P673, DOI 10.1016/j.fsi.2006.08.014
   Fujiki K., 1992, Science Bulletin of the Faculty of Agriculture, Kyushu University, V47, P137
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, PARASITOL RES, V115, P2685, DOI 10.1007/s00436-016-5038-x
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Harikrishnan R, 2011, AQUACULTURE, V317, P1, DOI 10.1016/j.aquaculture.2011.03.039
   HernandezLopez J, 1996, COMP BIOCHEM PHYS C, V113, P61, DOI 10.1016/0742-8413(95)02033-0
   Holmblad T, 1999, AQUACULTURE, V172, P111, DOI 10.1016/S0044-8486(98)00446-3
   Hou WY, 2005, FISH SHELLFISH IMMUN, V19, P127, DOI 10.1016/j.fsi.2004.11.009
   Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Ivase T. J. P., 2017, Acta Universitatis Sapientiae: Agriculture and Environment, V9, P95, DOI 10.1515/ausae-2017-0009
   Johansson MW, 2000, AQUACULTURE, V191, P45, DOI 10.1016/S0044-8486(00)00418-X
   Lakshmi B, 2013, J PATHOG, V2013, P1
   Le TX, 2005, SCI TOTAL ENVIRON, V349, P95, DOI 10.1016/j.scitotenv.2005.01.006
   Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288
   Liu CH, 2004, FISH SHELLFISH IMMUN, V16, P321, DOI 10.1016/S1050-4648(03)00113-X
   Manilal A, 2009, J MAR SCI TECH-TAIW, V17, P67
   MARTIN GG, 1991, COMP BIOCHEM PHYS B, V100, P517, DOI 10.1016/0305-0491(91)90213-W
   MCCLINTOCK JB, 2001, MARINE CHEM ECOLOGY
   Mizukoshi S, 1993, B FAC BIORESOURCE MI, V8, P27
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   OURTH DD, 1993, COMP BIOCHEM PHYS B, V105, P719, DOI 10.1016/0305-0491(93)90111-H
   Pino Oriela, 2013, Rev. Protección Veg., V28, P81
   RATCLIFFE NA, 1985, INT REV CYTOL, V97, P183, DOI 10.1016/S0074-7696(08)62351-7
   Reverter M, 2014, AQUACULTURE, V433, P50, DOI 10.1016/j.aquaculture.2014.05.048
   Rico A, 2013, AQUACULTURE, V412, P231, DOI 10.1016/j.aquaculture.2013.07.028
   Ringo E., 2011, J MARINE SCI RES DEV, V2, P1, DOI DOI 10.4172/2155-9910.1000104
   Rodriguez J, 2000, AQUACULTURE, V191, P109, DOI 10.1016/S0044-8486(00)00421-X
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Sakai M, 1999, AQUACULTURE, V172, P63, DOI 10.1016/S0044-8486(98)00436-0
   Saravi S. S. Saeedi, 2011, ROLE PESTICIDES HUMA
   Shankar R, 2012, AQUACULT INT, V20, P1, DOI 10.1007/s10499-011-9430-3
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Su BK, 2008, FISH SHELLFISH IMMUN, V24, P74, DOI 10.1016/j.fsi.2007.09.002
   Suphantharika M, 2003, BIORESOURCE TECHNOL, V88, P55, DOI 10.1016/S0960-8524(02)00257-2
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Xian JA, 2009, AQUACULTURE, V298, P139, DOI 10.1016/j.aquaculture.2009.10.008
   Yeh ST, 2006, FISH SHELLFISH IMMUN, V20, P332, DOI 10.1016/j.fsi.2005.05.008
   Yu KX, 2015, ASIAN PAC J TROP MED, V8, P981, DOI 10.1016/j.apjtm.2015.11.011
NR 74
TC 9
Z9 9
U1 5
U2 12
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1011-1344
J9 J PHOTOCH PHOTOBIO B
JI J. Photochem. Photobiol. B-Biol.
PD JUN
PY 2018
VL 183
BP 318
EP 330
DI 10.1016/j.jphotobiol.2018.04.049
PG 13
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA GJ1SV
UT WOS:000435049000037
PM 29754050
DA 2020-07-08
ER

PT J
AU Oldfield, LM
   Fedorova, N
   Puri, V
   Shrivastava, S
   Amedeo, P
   Durbin, A
   Rocchi, I
   Williams, T
   Shabman, RS
   Tan, GS
   Balmaseda, A
   Kuan, G
   Saborio, S
   Gordon, A
   Harris, E
   Pickett, BE
AF Oldfield, Lauren M.
   Fedorova, Nadia
   Puri, Vinita
   Shrivastava, Susmita
   Amedeo, Paolo
   Durbin, Alan
   Rocchi, Iara
   Williams, Torrey
   Shabman, Reed S.
   Tan, Gene S.
   Balmaseda, Angel
   Kuan, Guillermina
   Saborio, Saira
   Gordon, Aubree
   Harris, Eva
   Pickett, Brett E.
TI Sequences of Zika Virus Genomes from a Pediatric Cohort in Nicaragua
SO MICROBIOLOGY RESOURCE ANNOUNCEMENTS
LA English
DT Article
ID OUTBREAK
AB We report here the whole-genome sequence of 11 Zika virus (ZIKV) samples from six pediatric patients in Nicaragua. Serum samples were collected, and ZIKV was isolated in tissue culture. Both serum and virus isolates were sequenced. The consensus ZIKV genomes are greater than 99% identical to each other.
C1 [Oldfield, Lauren M.; Fedorova, Nadia; Puri, Vinita; Shrivastava, Susmita; Amedeo, Paolo; Shabman, Reed S.; Pickett, Brett E.] J Craig Venter Inst, Rockville, MD 20850 USA.
   [Durbin, Alan; Rocchi, Iara; Williams, Torrey; Tan, Gene S.] J Craig Venter Inst, La Jolla, CA USA.
   [Balmaseda, Angel; Saborio, Saira] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Puri, Vinita] GlaxoSmithKline, Rockville, MD USA.
   [Shabman, Reed S.] Amer Type Culture Collect, Gaithersburg, MD USA.
RP Pickett, BE (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.
EM bpickett@jcvi.org
RI Gordon, Aubree/X-1113-2019; Pickett, Brett/AAE-3582-2020
OI Gordon, Aubree/0000-0002-9352-7877; Pickett, Brett/0000-0001-7930-8160
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110819, P01AI106695]
FX This project has been funded in whole or in part with federal funds from
   the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, under
   award numbers U19AI110819 and P01AI106695 (E.H.).
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Djikeng A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-5
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Moser LA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00039-15
   Wang SL, 2012, NUCLEIC ACIDS RES, V40, pW186, DOI 10.1093/nar/gks528
NR 6
TC 0
Z9 0
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2576-098X
J9 MICROBIOL RESOUR ANN
JI Microbiol. Resour. Ann.
PD JUN
PY 2018
VL 6
IS 24
AR e00498-18
DI 10.1128/genomeA.00498-18
PG 2
WC Microbiology
SC Microbiology
GA HD2VT
UT WOS:000452370700011
PM 29903816
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Stower, H
AF Stower, Hannah
TI Zika virus shedding in semen
SO NATURE MEDICINE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JUN
PY 2018
VL 24
IS 6
BP 702
EP 702
DI 10.1038/s41591-018-0075-x
PG 1
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA GI3OQ
UT WOS:000434281300007
PM 29875461
DA 2020-07-08
ER

PT J
AU Fleith, RC
   Mears, HV
   Leong, XY
   Sanford, TJ
   Emmott, E
   Graham, SC
   Mansur, DS
   Sweeney, TR
AF Fleith, Renata C.
   Mears, Harriet V.
   Leong, Xin Yun
   Sanford, Thomas J.
   Emmott, Edward
   Graham, Stephen C.
   Mansur, Daniel S.
   Sweeney, Trevor R.
TI IFIT3 and IFIT2/3 promote IFIT1-mediated translation inhibition by
   enhancing binding to non-self RNA
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID MESSENGER-RNA; CRYSTAL-STRUCTURE; VIRUS; PROTEIN; ELECTROSTATICS;
   RECOGNITION; INTERFERONS; REVEALS; PDB2PQR; MEMBERS
AB Interferon-induced proteins with tetratricopeptide repeats (IFITs) are highly expressed during the cell-intrinsic immune response to viral infection. IFIT1 inhibits translation by binding directly to the 5 ' end of foreign RNAs, particularly those with non-self cap structures, precluding the recruitment of the cap-binding eukaryotic translation initiation factor 4F and ribosome recruitment. The presence of IFIT1 imposes a requirement on viruses that replicate in the cytoplasm to maintain mechanisms to avoid its restrictive effects. Interaction of different IFIT family members is well described, but little is known of the molecular basis of IFIT association or its impact on function. Here, we reconstituted different complexes of IFIT1, IFIT2 and IFIT3 in vitro, which enabled us to reveal critical aspects of IFIT complex assembly. IFIT1 and IFIT3 interact via a YxxxL motif present in the C-terminus of each protein. IFIT2 and IFIT3 homodimers dissociate to form a more stable heterodimer that also associates with IFIT1. We show for the first time that IFIT3 stabilizes IFIT1 protein expression, promotes IFIT1 binding to a cap0 Zika virus reporter mRNA and enhances IFIT1 translation inhibition. This work reveals molecular aspects of IFIT interaction and provides an important missing link between IFIT assembly and function.
C1 [Fleith, Renata C.; Mears, Harriet V.; Leong, Xin Yun; Sanford, Thomas J.; Emmott, Edward; Graham, Stephen C.; Sweeney, Trevor R.] Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Hills Rd, Cambridge, England.
   [Fleith, Renata C.; Mansur, Daniel S.] Univ Fed Santa Catarina, Dept Microbiol Immunol & Parasitol, Lab Immunobiol, Florianopolis, SC, Brazil.
   [Fleith, Renata C.] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil.
   [Emmott, Edward] Northeastern Univ, Coll Engn, Dept Bioengn, 360 Huntington Ave, Boston, MA 02115 USA.
RP Sweeney, TR (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Virol, Dept Pathol, Hills Rd, Cambridge, England.
EM ts629@cam.ac.uk
RI Mansur, Daniel/AAQ-8062-2020
OI Mansur, Daniel/0000-0001-6773-9334; Mears, Harriet/0000-0003-0300-0885;
   Sweeney, Trevor/0000-0003-4016-7326; Graham,
   Stephen/0000-0003-4547-4034; Sanford, Thomas/0000-0002-5091-1457
FU Royal Society/Wellcome Trust Sir Henry Dale Fellowship [202471/Z/16/Z];
   Royal Society Research GrantRoyal Society of London [RG140708];
   University of Cambridge, Department of Pathology PhD studentship; King's
   Scholarship from the Malaysian government; Wellcome Trust PhD
   studentshipWellcome Trust [105389/Z/14/Z]; CAPES Computational Biology
   [23038.010048/2013-27]; Academy of Medical Sciences/UK [NAF004/1005];
   Wellcome TrustWellcome Trust [098406/Z/12/Z]; Royal SocietyRoyal Society
   of London [098406/Z/12/Z]; Wellcome Trust Sir Henry Dale Fellowship
   [202471/Z/16/Z]
FX Royal Society/Wellcome Trust Sir Henry Dale Fellowship [202471/Z/16/Z];
   Royal Society Research Grant [RG140708 to T.R.S.]; University of
   Cambridge, Department of Pathology PhD studentship (to H.V.M.); King's
   Scholarship from the Malaysian government (to X.Y.L.); Wellcome Trust
   PhD studentship [105389/Z/14/Z to T.J.S.]; CAPES Computational Biology
   [23038.010048/2013-27 to R.C.F. and D.S.M.]; Academy of Medical
   Sciences/UK [NAF004/1005 to D.S.M.]; SCG is a Sir Henry Dale Fellow
   [098406/Z/12/Z] co-funded by the Wellcome Trust and Royal Society.
   Funding for open access charge: Wellcome Trust Sir Henry Dale Fellowship
   [202471/Z/16/Z to T.S.].
CR Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114
   Abbas YM, 2013, NATURE, V494, P60, DOI 10.1038/nature11783
   Allan RK, 2011, CELL STRESS CHAPERON, V16, P353, DOI 10.1007/s12192-010-0248-0
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Daugherty MD, 2016, ELIFE, V5, DOI 10.7554/eLife.14228
   Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381
   Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276
   DUBIN DT, 1977, VIROLOGY, V77, P457, DOI 10.1016/0042-6822(77)90471-8
   Emmott E, 2014, JOVE-J VIS EXP, DOI 10.3791/51656
   Feng F, 2013, CELL RES, V23, P1055, DOI 10.1038/cr.2013.80
   Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002
   Guo JJ, 2000, EMBO J, V19, P6891, DOI 10.1093/emboj/19.24.6891
   Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663
   Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518
   Hyde JL, 2014, SCIENCE, V343, P783, DOI 10.1126/science.1248465
   Katibah GE, 2013, MOL CELL, V49, P743, DOI 10.1016/j.molcel.2012.12.015
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Liu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066859
   Menachery VD, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00346-17
   Menachery VD, 2014, J VIROL, V88, P4251, DOI 10.1128/JVI.03571-13
   Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321
   Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048
   Rabbani MAG, 2016, J VIROL, V90, P11145, DOI 10.1128/JVI.01551-16
   Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0
   Reich NC, 2013, J INTERF CYTOK RES, V33, P199, DOI 10.1089/jir.2012.0159
   Reynaud JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004863
   Saikia P, 2010, J VIROL, V84, P13036, DOI 10.1128/JVI.01194-10
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Soto Rifo R, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm682
   Stawowczyk M, 2011, J BIOL CHEM, V286, P7257, DOI 10.1074/jbc.M110.207068
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449
   Yang ZL, 2012, CELL RES, V22, P1328, DOI 10.1038/cr.2012.111
   Young DF, 2016, J VIROL, V90, P9446, DOI 10.1128/JVI.01056-16
   Zhao L, 2008, NMR BIOMED, V21, P159, DOI 10.1002/nbm.1173
   Zhou X, 2013, INT J BIOL SCI, V9, P200, DOI 10.7150/ijbs.5613
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 44
TC 12
Z9 12
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN 1
PY 2018
VL 46
IS 10
BP 5269
EP 5285
DI 10.1093/nar/gky191
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GM7AB
UT WOS:000438329100037
PM 29554348
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Almeida, LCP
   Tabosa, PMS
   Hissa, DC
   Vasconcelos, IM
   Carvalho, AFU
AF Almeida Filho, Luiz C. P.
   Tabosa, Pedroms M. S.
   Hissa, Denise C.
   Vasconcelos, Ilka M.
   Carvalho, Ana F. U.
TI First insights into insecticidal activity against Aedes aegypti and
   partial biochemical characterization of a novel low molecular mass
   chymotrypsin-trypsin inhibitor purified from Lonchocarpus sericeus seeds
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE chymotrypsin inhibitor; Lonchocarpus; legume seeds; dengue; zika; midgut
   enzymes
ID BOWMAN-BIRK INHIBITOR; KUNITZ-TYPE INHIBITOR; PROTEINASE-INHIBITOR;
   BIOINSECTICIDAL ACTIVITY; TOXIC PROTEINS; L. SEEDS; PURIFICATION;
   LARVAE; IDENTIFICATION; PROTEASES
AB BACKGROUNDArboviroses such as dengue, Zika and chikungunya represent a serious public health issue as a consequence of the absence of approved vaccines or specific antiviral drugs against the arboviruses that cause them. One way to prevent these diseases is by combating the vector mosquito, Aedes aegypti (Diptera), which has serine proteases in the midgut. Protease inhibitors are molecules that can block enzyme activity, impairing digestion and nutrition, which can lead to death. Thus, we purified and characterized a novel chymotrypsin-trypsin inhibitor (LsCTI) from Lonchocarpus sericeus seeds and investigated its effect upon Ae. aegypti egg hatching, larval development and digestive proteases.
   RESULTSLsCTI showed a single protein band in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and the molecular mass determined by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF-MS) was 8870.45 Da. Kinetics analyses revealed a noncompetitive type of inhibition and low inhibition constant (K-i) for chymotrypsin (8.24 x 10(-8) m). The thermal resistance was remarkable, even at 100 degrees C for 180 min. The inhibitor concentration required for 50-percent enzyme inhibition (IC50) of LsCTI was 4.7 x 10(-7) m for Ae. aegypti midgut larval enzymes. LsCTI did not affect egg hatchability at 0.3 mg mL(-1), but caused a high larval mortality rate (77%) and delayed development (37%).
   CONCLUSIONSLsCTI is a novel protease inhibitor with remarkable biochemical characteristics and is a potential tool to control Ae. aegypti development. (c) 2017 Society of Chemical Industry
C1 [Hissa, Denise C.; Carvalho, Ana F. U.] Univ Fed Ceara, Biol Dept, Pici Campus, BR-60440900 Fortaleza, Ceara, Brazil.
   [Almeida Filho, Luiz C. P.; Tabosa, Pedroms M. S.; Vasconcelos, Ilka M.] Univ Fed Ceara, Biochem & Mol Biol Dept, Pici Campus, Fortaleza, Ceara, Brazil.
RP Carvalho, AFU (corresponding author), Univ Fed Ceara, Biol Dept, Pici Campus, BR-60440900 Fortaleza, Ceara, Brazil.
EM aurano@ufc.br
RI Carvalho, Ana/K-7344-2018; Almeida Filho, Luiz/K-7313-2018; Hissa,
   Denise/X-3314-2019
OI Carvalho, Ana/0000-0001-5293-9317; Almeida Filho,
   Luiz/0000-0001-6234-2418; 
FU Brazilian Agency Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [448150/2014-0]; MCT-INSA/CNPq/CT [35/2010];
   Coordenacao de Aperfeicoamento de Pessoal do Ensino Superior
   (CAPES)CAPES
FX The authors thank The Brazilian Agency Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) for a research grant
   provided to DCH (Process N. 448150/2014-0) and are also grateful to
   MCT-INSA/CNPq/CT for financial support of this research through
   Hidro/Acao Tranversal No 35/2010-Desenvolvimento Sustentavel do
   Semiarido Brasileiro and Coordenacao de Aperfeicoamento de Pessoal do
   Ensino Superior (CAPES).
CR ABE M, 1992, EUR J BIOCHEM, V209, P933, DOI 10.1111/j.1432-1033.1992.tb17365.x
   Alencar NMN, 2005, J PHARM PHARMACOL, V57, P919, DOI 10.1211/0022357056352
   Almeida LCP, 2017, PEST MANAG SCI, V73, P181, DOI 10.1002/ps.4284
   Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694
   Araujo CL, 2005, J AGR FOOD CHEM, V53, P4381, DOI 10.1021/jf0502505
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bezerra CD, 2016, PROCESS BIOCHEM, V51, P792, DOI 10.1016/j.procbio.2016.03.008
   Bhattacharyya A, 2009, PHYTOCHEMISTRY, V70, P703, DOI 10.1016/j.phytochem.2009.04.001
   BIRK Y, 1961, BIOCHIM BIOPHYS ACTA, V54, P378, DOI 10.1016/0006-3002(61)90387-0
   Brand GD, 2017, ARCH BIOCHEM BIOPHYS, V618, P9, DOI 10.1016/j.abb.2017.01.009
   Carlini CR, 2002, TOXICON, V40, P1515, DOI 10.1016/S0041-0101(02)00240-4
   Cruz ACB, 2013, PLANT PHYSIOL BIOCH, V70, P61, DOI 10.1016/j.plaphy.2013.04.023
   Cunha GMD, 2003, PHYTOTHER RES, V17, P155, DOI 10.1002/ptr.1096
   Dang LY, 2015, PHYTOCHEMISTRY, V117, P51, DOI 10.1016/j.phytochem.2015.05.020
   Dantzger M, 2015, PHYTOCHEMISTRY, V118, P224, DOI 10.1016/j.phytochem.2015.08.013
   Santos NDD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044840
   Dias LP, 2017, PROCESS BIOCHEM, V57, P228, DOI 10.1016/j.procbio.2017.03.015
   DIXON M, 1953, BIOCHEM J, V55, P170, DOI 10.1042/bj0550170
   DOMONEY C, 1995, FEBS LETT, V360, P15, DOI 10.1016/0014-5793(95)00070-P
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Ee KY, 2009, J AGR FOOD CHEM, V57, P7022, DOI 10.1021/jf900923t
   Fang EF, 2011, PROTEIN PEPTIDE LETT, V18, P64
   Fontenele JB, 2005, PHARM BIOL, V43, P726, DOI 10.1080/13880200500387406
   Guimaraes LC, 2015, PESTIC BIOCHEM PHYS, V118, P1, DOI 10.1016/j.pestbp.2014.12.001
   Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142
   Jamal F, 2015, PROCESS BIOCHEM, V50, P311, DOI 10.1016/j.procbio.2014.12.003
   Jamal F, 2013, PHYTOCHEM REV, V12, P1, DOI 10.1007/s11101-012-9231-y
   Johansson S, 2002, J NAT PROD, V65, P32, DOI 10.1021/np010323o
   Klomklao S, 2011, FOOD CHEM, V129, P1348, DOI 10.1016/j.foodchem.2011.05.029
   Koodalingam A, 2013, ACTA TROP, V126, P249, DOI 10.1016/j.actatropica.2013.02.021
   Krishnan V.G.M., 2015, FOOD SCI HUM WELL, V4, P97, DOI DOI 10.1016/j.fshw.2015.06.003
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lannoo N, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00397
   Lingaraju MH, 2008, BBA-PROTEINS PROTEOM, V1784, P850, DOI 10.1016/j.bbapap.2008.02.013
   Lyu JC, 2015, ACTA BIOCH BIOPH SIN, V47, P376, DOI 10.1093/abbs/gmv022
   Maag D, 2015, BIOESSAYS, V37, P167, DOI 10.1002/bies.201400124
   Macedo MLR, 2004, J AGR FOOD CHEM, V52, P2533, DOI 10.1021/jf035389z
   Macedo MLR, 2002, PLANT PHYSIOL BIOCH, V40, P891, DOI 10.1016/S0981-9428(02)01441-9
   MAZID S, 2011, INT J SC ADV TECHNOL, V1, P169, DOI DOI 10.1007/S10886-005-4244-2
   Migliolo L, 2010, J MOL GRAPH MODEL, V29, P148, DOI 10.1016/j.jmgm.2010.05.006
   Morrison SC, 2007, FOOD CHEM, V100, P1, DOI 10.1016/j.foodchem.2005.07.062
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nakahata AM, 2006, INT J BIOL MACROMOL, V40, P22, DOI 10.1016/j.ijbiomac.2006.05.008
   Oyedeji OA, 2015, AFR J FOOD SCI TECHN, V6, P131
   Paiva PMG, 2013, LECTINS TRYPSIN INHI, P17
   Pilon AM, 2006, PESTIC BIOCHEM PHYS, V86, P23, DOI 10.1016/j.pestbp.2005.11.005
   Pontual EV, 2014, PARASITOL RES, V113, P727, DOI 10.1007/s00436-013-3702-y
   Pontual EV, 2012, ARCH INSECT BIOCHEM, V79, P135, DOI 10.1002/arch.21012
   Prasad ER, 2010, PHYTOCHEMISTRY, V71, P363, DOI 10.1016/j.phytochem.2009.11.006
   Prasad ER, 2010, J AGR FOOD CHEM, V58, P2838, DOI 10.1021/jf903675d
   Ragg EM, 2006, FEBS J, V273, P4024, DOI 10.1111/j.1742-4658.2006.05406.x
   de Oliveira CFR, 2012, PROCESS BIOCHEM, V47, P929, DOI 10.1016/j.procbio.2012.02.022
   Ramos MV, 2009, MEM I OSWALDO CRUZ, V104, P805, DOI 10.1590/S0074-02762009000600001
   Macedo MLR, 2007, PHYTOCHEMISTRY, V68, P1104, DOI 10.1016/j.phytochem.2007.01.024
   Ruan JJ, 2017, PESTIC BIOCHEM PHYS, V142, P141, DOI 10.1016/j.pestbp.2017.06.013
   Rufino FPS, 2013, PLANT PHYSIOL BIOCH, V63, P70, DOI 10.1016/j.plaphy.2012.11.013
   Sarwar M., 2014, J ECOL ENV SCI, V2, P24
   Sarwar M, 2015, BIOMED ENG, V3, P311
   Sasaki NY, 2015, BIOCHIMIE, V112, P172, DOI 10.1016/j.biochi.2015.03.011
   Senthil-Nathan S., 2015, ENV SUSTAINABILITY, P49, DOI 10.1007/978-81-322-2056-5_3.
   Senthilkumar R, 2010, PLANT BIOTECHNOL J, V8, P65, DOI 10.1111/j.1467-7652.2009.00466.x
   Silva RGG, 2015, IND CROP PROD, V70, P48, DOI 10.1016/j.indcrop.2015.02.058
   Singh RR, 2002, BBA-PROTEIN STRUCT M, V1597, P280, DOI 10.1016/S0167-4838(02)00301-1
   Soares TS, 2011, GENE, V489, P70, DOI 10.1016/j.gene.2011.08.018
   Souza TM, 2011, J MED ENTOMOL, V48, P846, DOI 10.1603/ME10205
   Carvalho AFU, 2011, J FOOD COMPOS ANAL, V24, P487, DOI 10.1016/j.jfca.2011.01.013
   Venancio TM, 2009, INSECT MOL BIOL, V18, P33, DOI 10.1111/j.1365-2583.2008.00845.x
   WHO, 2017, DENG SEV DENG
   World Health Organization, 2017, VECT BORN DIS
NR 69
TC 3
Z9 3
U1 0
U2 14
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUN
PY 2018
VL 74
IS 6
BP 1362
EP 1373
DI 10.1002/ps.4812
PG 12
WC Agronomy; Entomology
SC Agriculture; Entomology
GA GF1CP
UT WOS:000431670200018
PM 29193604
OA Bronze
DA 2020-07-08
ER

PT J
AU Kumar, AA
AF Kumar, Ashok A.
TI Creating novel medical diagnostics with a design for manufacturing
SO TRANSLATIONAL MATERIALS RESEARCH
LA English
DT Article
DE point-of-care; diagnostics; manufacturing; paper diagnostics;
   microfluidics; translational technology
ID FABRICATION
AB When research is undertaken with the aim of creating a product to address real-world problems, incorporating considerations for manufacturing early in the creative process is important to reduce the barriers to translation later in development. A general description of the product development process is provided within the context of design for manufacturing. Building technologies on existing infrastructure for manufacturing can dramatically reduce the cost and time to create a product. The trade off of such an approach is that the work may not be deemed novel and may, thus, be harder to publish. A brief overview of recent work by several groups to develop a point-of-care test for Zika virus illustrates the repercussions of different approaches to novelty versus manufacturability. Actionable guidance is given for both researchers and those that support the research endeavor, such as funders and editors of peer-reviewed journals, on how to incorporate manufacturing into early research.
C1 [Kumar, Ashok A.] Jana Care Inc, 8 St Marys St, Boston, MA 02215 USA.
RP Kumar, AA (corresponding author), Jana Care Inc, 8 St Marys St, Boston, MA 02215 USA.
EM akumar@janacare.com
OI Kumar, Ashok/0000-0002-9345-2481
CR [Anonymous], 2017, ECONOMIST
   Au AK, 2014, LAB CHIP, V14, P1294, DOI 10.1039/c3lc51360b
   Becker H, 2000, SENSOR ACTUAT A-PHYS, V83, P130, DOI 10.1016/S0924-4247(00)00296-X
   Carreyrou J, 2016, WSJ
   Carrilho E, 2009, ANAL CHEM, V81, P7091, DOI 10.1021/ac901071p
   Comstock J, 2017, MOBIHEALTHNEWS
   Cross R, 2016, MIT TECHNOL REV
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Kumar AA, 2015, ANGEW CHEM INT EDIT, V54, P5835, DOI 10.1002/anie.201411741
   Lee GB, 2001, SENSOR ACTUAT B-CHEM, V75, P142, DOI 10.1016/S0925-4005(00)00745-0
   Lee LJ, 2001, BIOMED MICRODEVICES, V3, P339, DOI 10.1023/A:1012469017354
   Mace CR, 2014, MICROFLUID NANOFLUID, V16, P801, DOI 10.1007/s10404-013-1314-6
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   O'Farrell B, 2009, LATERAL FLOW IMMUNOASSAY, P1, DOI 10.1007/978-1-59745-240-3_1
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Waldbaur A, 2011, ANAL METHODS-UK, V3, P2681, DOI 10.1039/c1ay05253e
   Weigl B, 2008, LAB CHIP, V8, P1999, DOI 10.1039/b811314a
   Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058
   Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524
NR 19
TC 2
Z9 2
U1 0
U2 16
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 2053-1613
J9 TRANSL MATER RES
JI Transl. Mater. Res.
PD JUN
PY 2018
VL 5
IS 2
AR 024001
DI 10.1088/2053-1613/aab86b
PG 6
WC Materials Science, Multidisciplinary
SC Materials Science
GA GD3BA
UT WOS:000430376400001
DA 2020-07-08
ER

PT J
AU Rua, R
   McGavern, DB
AF Rua, Rejane
   McGavern, Dorian B.
TI Advances in Meningeal Immunity
SO TRENDS IN MOLECULAR MEDICINE
LA English
DT Review
ID CENTRAL-NERVOUS-SYSTEM; CD4(+) T-CELLS; TRAUMATIC BRAIN-INJURY; ZIKA
   VIRUS-INFECTION; MAST-CELLS; CEREBROSPINAL-FLUID; MULTIPLE-SCLEROSIS;
   DURA-MATER; NEUTROPHIL RECRUITMENT; PERIVASCULAR MACROPHAGES
AB The central nervous system (CNS) is an immunologically specialized tissue protected by a blood-brain barrier. The CNS parenchyma is enveloped by a series of overlapping membranes that are collectively referred to as the meninges. The meninges provide an additional CNS barrier, harbor a diverse array of resident immune cells, and serve as a crucial interface with the periphery. Recent studies have significantly advanced our understanding of meningeal immunity, demonstrating how a complex immune landscape influences CNS functions under steady-state and inflammatory conditions. The location and activation state of meningeal immune cells can profoundly influence CNS homeostasis and contribute to neurological disorders, but these cells are also well equipped to protect the CNS from pathogens. In this review, we discuss advances in our understanding of the meningeal immune repertoire and provide insights into how this CNS barrier operates immunologically under conditions ranging from neurocognition to inflammatory diseases.
C1 [Rua, Rejane; McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
RP McGavern, DB (corresponding author), NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.
EM mcgavernd@mail.nih.gov
FU National Institute of Neurological Disorders & Stroke (NINDS), National
   Institutes of Health (NIH)
FX This work was supported by the intramural program at the National
   Institute of Neurological Disorders & Stroke (NINDS), National
   Institutes of Health (NIH). We thank Alan Hoofring and Ethan Tyler in
   the NIH Medical Arts Design Section for their help with the
   illustrations.
CR Absinta M, 2017, ELIFE, V6, DOI 10.7554/eLife.29738
   Akerman S, 2002, BRAIN RES, V956, P96, DOI 10.1016/S0006-8993(02)03485-6
   ANDRES KH, 1987, ANAT EMBRYOL, V175, P289, DOI 10.1007/BF00309843
   Arac A, 2014, AM J PATHOL, V184, P2493, DOI 10.1016/j.ajpath.2014.06.003
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Azevedo RSS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-17765-5
   BALIN BJ, 1986, J COMP NEUROL, V251, P260, DOI 10.1002/cne.902510209
   Bartholomaus I, 2009, NATURE, V462, P94, DOI 10.1038/nature08478
   Bedussi B, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/s12987-015-0019-5
   Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068
   Bhaskar S, 2018, BMC NEUROL, V18, DOI 10.1186/s12883-017-1007-y
   Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005
   Bove GM, 1997, J NEUROPHYSIOL, V77, P299
   Brown DA, 2007, J COMP NEUROL, V502, P236, DOI 10.1002/cne.21307
   Brynskikh A, 2008, BRAIN BEHAV IMMUN, V22, P861, DOI 10.1016/j.bbi.2007.12.008
   Burgos-Vega C, 2015, PROG MOL BIOL TRANSL, V131, P537, DOI 10.1016/bs.pmbts.2015.01.001
   Carare RO, 2014, BRAIN BEHAV IMMUN, V36, P9, DOI 10.1016/j.bbi.2013.10.012
   Cassella JP, 1997, J NEUROCYTOL, V26, P567, DOI 10.1023/A:1015438624949
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003
   Cipolla MJ, 2009, CEREBRAL CIRCULATION, P3
   Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027
   Coles JA, 2017, PROG NEUROBIOL, V156, P107, DOI 10.1016/j.pneurobio.2017.05.002
   Coles JA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003714
   Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558
   Cushman J, 2003, CLIN DIAGN LAB IMMUN, V10, P13, DOI 10.1128/CDLI.10.1.13-18.2003
   de Graaf MT, 2011, CYTOM PART B-CLIN CY, V80B, P43, DOI 10.1002/cyto.b.20542
   Deen M, 2017, J HEADACHE PAIN, V18, DOI 10.1186/s10194-017-0807-1
   Derecki NC, 2011, BRAIN BEHAV IMMUN, V25, P379, DOI 10.1016/j.bbi.2010.11.009
   Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419
   Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004
   Enzmann G, 2013, ACTA NEUROPATHOL, V125, P395, DOI 10.1007/s00401-012-1076-3
   Faraco G, 2017, J MOL MED, V95, P1143, DOI 10.1007/s00109-017-1573-x
   Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39
   Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626
   Filiano AJ, 2015, BRAIN RES, V1617, P18, DOI 10.1016/j.brainres.2014.07.050
   Fontaine D, 2018, BRAIN, V141, P1040, DOI 10.1093/brain/awy005
   Fricke B, 1997, CELL TISSUE RES, V287, P11
   Gadani SP, 2017, J EXP MED, V214, P285, DOI 10.1084/jem.20161982
   Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124
   Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004
   Gardner C, 2013, BRAIN, V136, P3596, DOI 10.1093/brain/awt279
   Gelderblom M, 2012, BLOOD, V120, P3793, DOI 10.1182/blood-2012-02-412726
   Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503
   Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423
   Grande G, 2014, J HEADACHE PAIN, V15, DOI 10.1186/1129-2377-15-22
   Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197
   Hagan CE, 2011, COMPARATIVE ANATOMY AND HISTOLOGY: A MOUSE AND HUMAN ATLAS, P339
   Hannocks MJ, 2018, J CEREBR BLOOD F MET, V38, P669, DOI 10.1177/0271678X17749689
   Hartman A. L, 2009, CAPE TIMES      1124, P5, DOI DOI 10.1016/B978-141602908-3.50005-4
   Hatfield JK, 2015, CELL IMMUNOL, V297, P69, DOI 10.1016/j.cellimm.2015.06.006
   Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748
   Jacobs B, 2016, NEUROSCIENCE, V338, P130, DOI 10.1016/j.neuroscience.2016.06.012
   Jeon SG, 2016, MOL CELLS, V39, P603, DOI 10.14348/molcells.2016.0072
   Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45
   Kambayashi T, 2009, J IMMUNOL, V182, P4686, DOI 10.4049/jimmunol.0803180
   Kang SS, 2008, FRONT BIOSCI-LANDMRK, V13, P4529, DOI 10.2741/3021
   Kang SS, 2011, J EXP MED, V208, P747, DOI 10.1084/jem.20101295
   Kang SS, 2010, J NEUROIMMUNE PHARM, V5, P370, DOI 10.1007/s11481-010-9208-9
   KELLER JT, 1991, J COMP NEUROL, V309, P515, DOI 10.1002/cne.903090408
   Kemp WJ, 2012, WORLD NEUROSURG, V78, P505, DOI 10.1016/j.wneu.2011.10.045
   Kim JV, 2009, NATURE, V457, P191, DOI 10.1038/nature07591
   Kipnis J, 2004, P NATL ACAD SCI USA, V101, P8180, DOI 10.1073/pnas.0402268101
   Kivisakk P, 2003, P NATL ACAD SCI USA, V100, P8389, DOI 10.1073/pnas.1433000100
   Kivisakk P, 2009, ANN NEUROL, V65, P457, DOI 10.1002/ana.21379
   Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610
   Kosaras B, 2009, J COMP NEUROL, V515, P331, DOI 10.1002/cne.22049
   Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816
   Lamers SL, 2011, INFECT GENET EVOL, V11, P31, DOI 10.1016/j.meegid.2010.10.016
   Levy D, 2007, PAIN, V130, P166, DOI 10.1016/j.pain.2007.03.012
   Levy D, 2009, CURR PAIN HEADACHE R, V13, P237, DOI 10.1007/s11916-009-0040-y
   Livingston WS, 2017, J NEUROTRAUM, V34, P853, DOI 10.1089/neu.2016.4479
   Lodygin D, 2013, NAT MED, V19, P784, DOI 10.1038/nm.3182
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Ma QL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01484-6
   Magliozzi R, 2007, BRAIN, V130, P1089, DOI 10.1093/brain/awm038
   MARKOWITZ S, 1987, J NEUROSCI, V7, P4129, DOI 10.1523/jneurosci.07-12-04129.1987
   Mascagni P., 1787, VASORUM LYMPHATICORU
   McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491
   Mogk S, 2017, BIOL REV, V92, P1675, DOI 10.1111/brv.12301
   Moretti R, 2016, J NEUROSCI RES, V94, P1546, DOI 10.1002/jnr.23911
   MORSE DE, 1972, ANAT RECORD, V174, P469, DOI 10.1002/ar.1091740406
   Mrdjen D, 2018, IMMUNITY, V48, P599, DOI 10.1016/j.immuni.2018.02.014
   Nag Sukriti, 2003, Methods Mol Med, V89, P97
   Nakae S, 2006, J IMMUNOL, V176, P2238, DOI 10.4049/jimmunol.176.4.2238
   Nakae S, 2007, BLOOD, V109, P3640, DOI 10.1182/blood-2006-09-046128
   Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240
   Nayak Debasis, 2012, Intravital, V1, P95, DOI 10.4161/intv.22823
   OCONNOR TP, 1986, J NEUROSCI, V6, P2200
   Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010
   POLTERA AA, 1980, CLIN EXP IMMUNOL, V40, P496
   Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703
   Protasoni M, 2011, J NEUROSURG, V114, P1723, DOI 10.3171/2010.12.JNS101732
   Quan N, 1999, J COMP NEUROL, V414, P114, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;114::AID-CNE9&gt;3.0.CO;2-G
   Radjavi A, 2014, MOL PSYCHIATR, V19, P531, DOI 10.1038/mp.2013.79
   Radjavi A, 2014, BRAIN BEHAV IMMUN, V35, P58, DOI 10.1016/j.bbi.2013.08.013
   Ransohoff RM, 2012, NAT NEUROSCI, V15, P1074, DOI 10.1038/nn.3168
   Ransohoff RM, 2003, NAT REV IMMUNOL, V3, P569, DOI 10.1038/nri1130
   Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808
   Russi AE, 2016, J AUTOIMMUN, V73, P100, DOI 10.1016/j.jaut.2016.06.015
   Russi AE, 2015, TRANSL RES, V165, P255, DOI 10.1016/j.trsl.2014.08.005
   Sayed BA, 2010, J IMMUNOL, V184, P6891, DOI 10.4049/jimmunol.1000126
   Schain AJ, 2018, ANN NEUROL, V83, P508, DOI 10.1002/ana.25169
   Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939
   SCHMIDT H, 1983, VIRCHOWS ARCH A, V399, P333, DOI 10.1007/BF00612951
   Schmuck K, 1996, EUR J NEUROSCI, V8, P959, DOI 10.1111/j.1460-9568.1996.tb01583.x
   Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012
   Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999
   Simon MJ, 2016, BBA-MOL BASIS DIS, V1862, P442, DOI 10.1016/j.bbadis.2015.10.014
   Smith AJ, 2017, ELIFE, V6, DOI [10.7554/eLife.27679, 10.7554/elife.27679]
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Spector R, 2015, EXP NEUROL, V273, P57, DOI 10.1016/j.expneurol.2015.07.027
   Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009
   Stokely ME, 2008, J NEUROTRAUM, V25, P52, DOI 10.1089/neu.2007.0397
   Strassman AM, 1996, NATURE, V384, P560, DOI 10.1038/384560a0
   Szmydynger-Chodobska J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167677
   Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x
   Terron JA, 2007, EUR J PHARMACOL, V560, P56, DOI 10.1016/j.ejphar.2007.01.019
   WAGGENER JD, 1967, J NEUROPATH EXP NEUR, V26, P412, DOI 10.1097/00005072-196707000-00005
   Walsh JT, 2015, J CLIN INVEST, V125, P699, DOI [10.1172/JCI176210, 10.1172/JCI76210]
   Wang XJ, 2014, J MOL NEUROSCI, V54, P164, DOI 10.1007/s12031-014-0268-9
   Watanabe R, 2016, NEUROPATHOLOGY, V36, P513, DOI 10.1111/neup.12302
   Wilson EH, 2009, IMMUNITY, V30, P300, DOI 10.1016/j.immuni.2008.12.013
   WIRTH FP, 1971, J NEUROSURG, V34, P630, DOI 10.3171/jns.1971.34.5.0630
   Wolburg H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034304
   Wolf SA, 2009, J IMMUNOL, V182, P3979, DOI 10.4049/jimmunol.0801218
   Yasuda K, 2013, DRUG METAB DISPOS, V41, P923, DOI 10.1124/dmd.112.050344
   Zarif H, 2018, BRAIN BEHAV IMMUN, V69, P235, DOI 10.1016/j.bbi.2017.11.016
   Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010
NR 129
TC 24
Z9 24
U1 1
U2 15
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4914
EI 1471-499X
J9 TRENDS MOL MED
JI Trends Mol. Med
PD JUN
PY 2018
VL 24
IS 6
BP 542
EP 559
DI 10.1016/j.molmed.2018.04.003
PG 18
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA GH2ND
UT WOS:000433237700005
PM 29731353
OA Green Published
DA 2020-07-08
ER

PT J
AU Alfonso-Parra, C
   Avila, FW
AF Alfonso-Parra, Catalina
   Avila, Frank W.
TI Molecular Responses to the Zika Virus in Mosquitoes
SO PATHOGENS
LA English
DT Review
DE Flavivirus; ZIKV; Aedes aegypti; Aedes albopictus
ID CULEX-QUINQUEFASCIATUS MOSQUITOS; AEDES-AEGYPTI MOSQUITOS; VECTOR
   COMPETENCE; DIPTERA-CULICIDAE; EXPERIMENTAL-MODELS; GENETIC DIVERSITY;
   YELLOW-FEVER; ALBOPICTUS; INFECTION; TRANSMISSION
AB The Zika virus (ZIKV), originally discovered in 1947, did not become a major concern until the virus swept across the Pacific and into the Americas in the last decade, bringing with it news of neurological complications and birth defects in ZIKV affected areas. This prompted researchers to dissect the molecular interactions between ZIKV and the mosquito vector in an attempt to better understand not only the changes that occur upon infection, but to also identify molecules that may potentially enhance or suppress a mosquito's ability to become infected and/or transmit the virus. Here, we review what is currently known regarding ZIKV-mosquito molecular interactions, focusing on ZIKV infection of Aedes aegypti and Aedes albopictus, the primary species implicated in transmitting ZIKV during the recent outbreaks.
C1 [Alfonso-Parra, Catalina; Avila, Frank W.] Univ Antioquia, Max Planck Tandem Grp Mosquito Reprod Biol, Calle 67 53-108, Medellin 050010, Colombia.
   [Alfonso-Parra, Catalina] Inst Colombiano Med Trop, Carerra 43A 52 Sur 99, Sabaneta 055450, Colombia.
RP Avila, FW (corresponding author), Univ Antioquia, Max Planck Tandem Grp Mosquito Reprod Biol, Calle 67 53-108, Medellin 050010, Colombia.
EM calfonso@ces.edu.co; grupotandem.mosquito@udea.edu.co
FU COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [CD 325671250804, CT 409-2016]; Universidad de
   Antioquia; Max Planck SocietyMax Planck Society [566-1]
FX The authors would like to thank Carolina Arias for the invitation to
   write this review, Carolina Camargo, Ethan Degner, and the Reviewers for
   their helpful comments on the manuscript. This research was funded by
   COLCIENCIAS, Universidad de Antioquia and the Max Planck Society
   Cooperation agreement 566-1 (February 2014) (to FWA) and COLCIENCIAS
   grant CD 325671250804 (CT 409-2016) (to CA).
CR Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Asgari S, 2014, VIRUSES-BASEL, V6, P3514, DOI 10.3390/v6093514
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Effler PV, 2005, EMERG INFECT DIS, V11, P742
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Etebari K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005069
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gaio Analiz de O, 2011, Parasit Vectors, V4, P105, DOI 10.1186/1756-3305-4-105
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guegan M, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0435-2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hoornweg TE, 2016, J VIROL, V90, P4745, DOI 10.1128/JVI.03184-15
   Huang YR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168725
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu YX, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0009-y
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Londono-Renteria B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005202
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146
   Mulyatno KC, 2018, JPN J INFECT DIS, V71, P58, DOI 10.7883/yoken.JJID.2017.117
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ransohoff JD, 2018, NAT REV MOL CELL BIO, V19, P143, DOI 10.1038/nrm.2017.104
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Saldana MA, 2017, MEM I OSWALDO CRUZ, V112, P81, DOI 10.1590/0074-02760160373
   Schmidt TL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006009
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sherpa S, 2018, INFECT GENET EVOL, V58, P145, DOI 10.1016/j.meegid.2017.12.018
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   SMITHBURN KC, 1954, J IMMUNOL, V72, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Spahn TW, 2005, INFECT IMMUN, V73, P7077, DOI 10.1128/IAI.73.11.7077-7088.2005
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Uraki R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006350
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Varjak M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006010
   Vazeille M, 2018, MED VET ENTOMOL, V32, P251, DOI 10.1111/mve.12284
   Villegas LEM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190352
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang YH, 2018, DEV COMP IMMUNOL, V83, P12, DOI 10.1016/j.dci.2017.12.001
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
NR 106
TC 4
Z9 4
U1 1
U2 8
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-0817
J9 PATHOGENS
JI Pathogens
PD JUN
PY 2018
VL 7
IS 2
AR 49
DI 10.3390/pathogens7020049
PG 14
WC Microbiology
SC Microbiology
GA GR1CZ
UT WOS:000442266900017
PM 29751526
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, LRC
AF Cangussu da Silva, Lucia Regina
TI Zika Virus Trafficking and Interactions in the Human Male Reproductive
   Tract
SO PATHOGENS
LA English
DT Review
DE Zika virus; sexual transmission; male reproductive tract; human
   reproduction
ID FEMALE GENITAL-TRACT; VECTOR-BORNE TRANSMISSION; MALE SEXUAL
   TRANSMISSION; WHOLE-BLOOD; VERTICAL TRANSMISSION; IMMUNE-RESPONSES;
   UNITED-STATES; HIV-INFECTION; SEMEN; CELLS
AB Sexual transmission of Zika virus (ZIKV) is a matter of great concern. Infectious viral particles can be shed in semen for as long as six months after infection and can be transferred to male and female sexual partners during unprotected sexual intercourse. The virus can be found inside spermatozoa and could be directly transferred to the oocyte during fertilization. Sexual transmission of ZIKV can contribute to the rise in number of infected individuals in endemic areas as well as in countries where the mosquito vector does not thrive. There is also the possibility, as has been demonstrated in mouse models, that the vaginal deposition of ZIKV particles present in semen could lead to congenital syndrome. In this paper, we review the current literature to understand ZIKV trafficking from the bloodstream to the human male reproductive tract and viral interactions with host cells in interstitial spaces, tubule walls, annexed glands and semen. We hope to highlight gaps to be filled by future research and potential routes for vaccine and antiviral development.
C1 [Cangussu da Silva, Lucia Regina] Univ Salgado de Oliveira, Dept Ciencias Saude, BR-36036 Juiz De Fora, MG, Brazil.
RP da Silva, LRC (corresponding author), Univ Salgado de Oliveira, Dept Ciencias Saude, BR-36036 Juiz De Fora, MG, Brazil.
EM prof.luciacangussu@gmail.com
OI Cangussu da Silva, Lucia Regina/0000-0002-1546-7573
CR Adefuye AO, 2016, J IMMUNOL RES, DOI 10.1155/2016/9707252
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.01116-16
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Barr KL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004931
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007
   Biava M, 2018, NEW MICROBIOL, V41, P30
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brazilian Ministry of Health, 2018, EPIDEMIOL B, V49, P1
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019
   Chen SR, 2017, NATL SCI REV, V4, P157, DOI 10.1093/nsr/nww096
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalrymple NA, 2014, CURR OPIN VIROL, V7, P134, DOI 10.1016/j.coviro.2014.06.006
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Dejucq-Rainsford N, 2004, CURR PHARM DESIGN, V10, P557, DOI 10.2174/1381612043453225
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Doncel GF, 2014, AM J REPROD IMMUNOL, V71, P564, DOI 10.1111/aji.12231
   Duan YG, 2016, ANDROLOGIA, V48, P431, DOI 10.1111/and.12463
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Huits RMHG, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.181370, DOI 10.2471/BLT.16.181370, 10.2471/blt.16.181370]
   Jenabian MA, 2016, AIDS, V30, P2777, DOI 10.1097/QAD.0000000000001282
   Jiang Q, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.560
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kalkeri Raj, 2017, F1000Res, V6, P1850, DOI 10.12688/f1000research.12695.1
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Li N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00152
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Loveland KL, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00307
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Lustig Y, 2016, J CLIN MICROBIOL, V54, P2294, DOI 10.1128/JCM.01283-16
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Meachem SJ, 2001, EUR J ENDOCRINOL, V145, P561, DOI 10.1530/eje.0.1450561
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray K, 2010, J INFECT DIS, V201, P2, DOI 10.1086/648731
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, CLIN MICROBIOL, V4, P222, DOI [10.4172/2327-5073.1000222, DOI 10.4172/2327-5073.1000222]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen PV, 2014, CELL MOL IMMUNOL, V11, P410, DOI 10.1038/cmi.2014.41
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nielsen DG, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-211
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Salam AP, 2018, LANCET INFECT DIS, V18, P144, DOI 10.1016/S1473-3099(18)30020-3
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969
   Stekler J, 2008, AIDS RES HUM RETROV, V24, P1269, DOI 10.1089/aid.2008.0014
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003168
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tappe D., 2015, EUROSURVEILLANCE, V20, P21153
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Tyler KL, 2017, JAMA NEUROL, V74, P1169, DOI 10.1001/jamaneurol.2017.1471
   Valadao ALC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01233
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Wang P, 2016, AM J REPROD IMMUNOL, V76, P186, DOI 10.1111/aji.12536
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wu H, 2016, SCI REP-UK, V6, DOI 10.1038/srep19507
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
   Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38
NR 123
TC 4
Z9 4
U1 0
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2076-0817
J9 PATHOGENS
JI Pathogens
PD JUN
PY 2018
VL 7
IS 2
AR 51
DI 10.3390/pathogens7020051
PG 19
WC Microbiology
SC Microbiology
GA GR1CZ
UT WOS:000442266900019
PM 29751638
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rodriguez, Y
   Rojas, M
   Pacheco, Y
   Acosta-Ampudia, Y
   Ramirez-Santana, C
   Monsalve, DM
   Gershwin, ME
   Anaya, JM
AF Rodriguez, Yhojan
   Rojas, Manuel
   Pacheco, Yovana
   Acosta-Ampudia, Yeny
   Ramirez-Santana, Carolina
   Monsalve, Diana M.
   Gershwin, M. Eric
   Anaya, Juan-Manuel
TI Guillain-Barre syndrome, transverse myelitis and infectious diseases
SO CELLULAR & MOLECULAR IMMUNOLOGY
LA English
DT Review
DE bacterial infections; disease outbreaks; Guillain-Barre syndrome;
   transverse myelitis; virus diseases; Zika virus
ID MOTOR AXONAL NEUROPATHY; CAMPYLOBACTER-JEJUNI LIPOOLIGOSACCHARIDE;
   PRIMARY CYTOMEGALOVIRUS-INFECTION; POSSIBLE TARGET MOLECULE;
   MILLER-FISHER-SYNDROME; CENTRAL-NERVOUS-SYSTEM; DNA-BINDING PROTEIN;
   HEPATITIS-E VIRUS; CLASS-II ALLELES; MYCOPLASMA-PNEUMONIAE
AB Guillain-Barre syndrome (GBS) and transverse myelitis (TM) both represent immunologically mediated polyneuropathies of major clinical importance. Both are thought to have a genetic predisposition, but as of yet no specific genetic risk loci have been clearly defined. Both are considered autoimmune, but again the etiologies remain enigmatic. Both may be induced via molecular mimicry, particularly from infectious agents and vaccines, but clearly host factor and co-founding host responses will modulate disease susceptibility and natural history. GBS is an acute inflammatory immune-mediated polyradiculoneuropathy characterized by tingling, progressive weakness, autonomic dysfunction, and pain. Immune injury specifically takes place at the myelin sheath and related Schwann-cell components in acute inflammatory demyelinating polyneuropathy, whereas in acute motor axonal neuropathy membranes on the nerve axon (the axolemma) are the primary target for immune-related injury. Outbreaks of GBS have been reported, most frequently related to Campylobacter jejuni infection, however, other agents such as Zika Virus have been strongly associated. Patients with GBS related to infections frequently produce antibodies against human peripheral nerve gangliosides. In contrast, TM is an inflammatory disorder characterized by acute or subacute motor, sensory, and autonomic spinal cord dysfunction. There is interruption of ascending and descending neuroanatomical pathways on the transverse plane of the spinal cord similar to GBS. It has been suggested to be triggered by infectious agents and molecular mimicry. In this review, we will focus on the putative role of infectious agents as triggering factors of GBS and TM.
C1 [Rodriguez, Yhojan; Rojas, Manuel; Pacheco, Yovana; Acosta-Ampudia, Yeny; Ramirez-Santana, Carolina; Monsalve, Diana M.; Anaya, Juan-Manuel] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Cra 26-63-B-51, Bogota 110231, Colombia.
   [Gershwin, M. Eric] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.
RP Anaya, JM (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res CREA, Cra 26-63-B-51, Bogota 110231, Colombia.
EM juan.anaya@urosario.edu.co
RI Anaya, Juan-Manuel/J-1960-2016; Monsalve, Diana M./J-2374-2016; Pacheco
   Nieva, Yovana/J-2932-2018; Ramirez-Santana, Carolina/J-2363-2016
OI Anaya, Juan-Manuel/0000-0002-6444-1249; Monsalve, Diana
   M./0000-0002-1145-1312; Pacheco Nieva, Yovana/0000-0002-0722-546X;
   Rojas, Manuel/0000-0002-8604-4658; Ramirez-Santana,
   Carolina/0000-0003-2137-4899
FU Universidad del Rosario [ABN011]; Colciencias, Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX We express our gratitude to Julian Barahona-Correa for his help in the
   earliest stages of the preparation of the manuscript. This work was
   supported by Universidad del Rosario (ABN011), and Colciencias
   (747-2016), Bogota, Colombia.
CR ADELMANN M, 1992, NEUROCHEM RES, V17, P887, DOI 10.1007/BF00993264
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alvarez LAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075534
   Anandan C, 2017, MUSCLE NERVE, V56, P331, DOI 10.1002/mus.25551
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Ang CW, 2000, NEUROLOGY, V54, P1453, DOI 10.1212/WNL.54.7.1453
   Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002
   Ang CW, 2002, J NEUROIMMUNOL, V130, P179, DOI 10.1016/S0165-5728(02)00209-6
   Arias-Murillo YR, 2016, BIOMEDICA, V36, p[187, 2010]
   ASPINALL GO, 1994, INFECT IMMUN, V62, P2122, DOI 10.1128/IAI.62.5.2122-2125.1994
   ASPINALL GO, 1994, BIOCHEMISTRY-US, V33, P241, DOI 10.1021/bi00167a032
   Avril T, 2004, J IMMUNOL, V173, P6841, DOI 10.4049/jimmunol.173.11.6841
   Avril T, 2006, INFECT IMMUN, V74, P4133, DOI 10.1128/IAI.02094-05
   Baar I, 2007, SPINAL CORD, V45, P690, DOI 10.1038/sj.sc.3102012
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   BenSmith A, 1997, CLIN EXP IMMUNOL, V109, P121, DOI 10.1046/j.1365-2249.1997.4221318.x
   BenSmith A, 1996, J NEUROL NEUROSUR PS, V61, P362, DOI 10.1136/jnnp.61.4.362
   Blum S, 2014, J NEUROIMMUNOL, V267, P92, DOI 10.1016/j.jneuroim.2013.12.007
   Borchers AT, 2012, AUTOIMMUN REV, V11, P231, DOI 10.1016/j.autrev.2011.05.018
   Born W, 1999, Adv Immunol, V71, P77
   Bowes T, 2002, INFECT IMMUN, V70, P5008, DOI 10.1128/IAI.70.9.5008-5018.2002
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   Britt W., 2007, VIRUS ENTRY HOST EST
   Caporale CM, 2006, J NEUROIMMUNOL, V177, P112, DOI 10.1016/j.jneuroim.2006.05.018
   Caudie C, 2011, J NEUROL, V258, P1958, DOI 10.1007/s00415-011-6042-9
   Chatzipanagiotou S, 2005, CLIN MICROBIOL INFEC, V11, P63, DOI 10.1111/j.1469-0691.2004.01038.x
   Chen TY, 2007, ANN EMERG MED, V50, P94, DOI 10.1016/j.annemergmed.2007.02.026
   Cooper JC, 2002, J NEUROL NEUROSUR PS, V72, P413, DOI 10.1136/jnnp.72.3.413
   Corssmit EPM, 1997, J NEUROVIROL, V3, P460, DOI 10.3109/13550289709031193
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cronin S, 2011, IRISH J MED SCI, V180, P255, DOI 10.1007/s11845-010-0635-7
   Csabi G, 2009, PEDIATR NEUROL, V41, P312, DOI 10.1016/j.pediatrneurol.2009.04.029
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Vieira MADES, 2017, REV INST MED TROP SP, V59, DOI [10.1590/s1678-9946201759022, 10.1590/S1678-9946201759022]
   Dalton HR, 2016, NAT REV NEUROL, V12, P77, DOI 10.1038/nrneurol.2015.234
   de Castro G, 2006, ARQ NEURO-PSIQUIAT, V64, P606, DOI 10.1590/S0004-282X2006000400016
   Mota MTDO, 2017, AM J TROP MED HYG, V96, P380, DOI 10.4269/ajtmh.16-0284
   Dilena R, 2016, MUSCLE NERVE, V53, P140, DOI 10.1002/mus.24908
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Drulovic J, 2000, J NEUROL NEUROSUR PS, V68, P249, DOI 10.1136/jnnp.68.2.249
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Fekih-Mrissa N, 2014, CLIN NEUROL NEUROSUR, V121, P19, DOI 10.1016/j.clineuro.2014.03.014
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Frohman EM, 2010, NEW ENGL J MED, V363, P564, DOI 10.1056/NEJMcp1001112
   Fry BN, 2000, INFECT IMMUN, V68, P2594, DOI 10.1128/IAI.68.5.2594-2601.2000
   FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848
   Galvan M, 2007, J CLIN VIROL, V38, P271, DOI 10.1016/j.jcv.2006.12.003
   Gardner SP, 2017, GENOME ANNOUNC, V5, P1
   Gatto CL, 2003, J CELL BIOL, V162, P489, DOI 10.1083/jcb.200303039
   Geleijns K, 2005, J NEUROIMMUNOL, V161, P183, DOI 10.1016/j.jneuroim.2004.12.001
   Geleijns K, 2005, NEUROLOGY, V64, P44, DOI 10.1212/01.WNL.0000148727.02732.01
   GERKEN G, 1985, KLIN WOCHENSCHR, V63, P468, DOI 10.1007/BF01731495
   Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200
   Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707
   Godschalk PCR, 2007, J CLIN MICROBIOL, V45, P2316, DOI 10.1128/JCM.00203-07
   Goodfellow JA, 2005, J NEUROSCI, V25, P1620, DOI 10.1523/JNEUROSCI.4279-04.2005
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   GORODEZKY C, 1983, J NEUROIMMUNOL, V4, P1, DOI 10.1016/0165-5728(83)90058-9
   GOUST JM, 1978, NEUROLOGY, V28, P421, DOI 10.1212/WNL.28.5.421
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002
   Guleria R, 2005, J LAB CLIN MED, V146, P55, DOI 10.1016/j.lab.2005.04.006
   Guo Li, 2002, Zhonghua Nei Ke Za Zhi, V41, P381
   Gustafsson R, 2014, J MICROBIOL IMMUNOL, V47, P418, DOI 10.1016/j.jmii.2013.03.009
   Haase CG, 2001, NEUROSCI LETT, V307, P131, DOI 10.1016/S0304-3940(01)01949-8
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   HAFEZ M, 1985, J NEUROGENET, V2, P285, DOI 10.3109/01677068509102324
   HART IK, 1987, POSTGRAD MED J, V63, P1087, DOI 10.1136/pgmj.63.746.1087
   Hasan ZN, 2014, NEUROSCIENCES, V19, P301
   Heikema AP, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.05.031
   Heikema AP, 2010, INFECT IMMUN, V78, P3237, DOI 10.1128/IAI.01273-09
   Hong SC, 1996, J EXP MED, V183, P1437, DOI 10.1084/jem.183.4.1437
   Houliston RS, 2007, BIOCHEMISTRY-US, V46, P8164, DOI 10.1021/bi700685s
   Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200
   HUGHES R, 1992, MUSCLE NERVE, V15, P568, DOI 10.1002/mus.880150506
   Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793
   Iontcheva I, 2004, INFECT IMMUN, V72, P2312, DOI 10.1128/IAI.72.4.2312-2320.2004
   Irie S, 1996, J NEUROIMMUNOL, V68, P19, DOI 10.1016/0165-5728(96)00059-8
   Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Jaffar-Bandjee MC, 2010, EXPERT REV ANTI-INFE, V8, P987, DOI [10.1586/eri.10.92, 10.1586/ERI.10.92]
   Jahan I, 2017, J NEUROIMMUNOL, V310, P46, DOI 10.1016/j.jneuroim.2017.06.005
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jiao H, 2012, MOL BIOL REP, V39, P1537, DOI 10.1007/s11033-011-0892-1
   Jung SF, 2005, NEUROSCI LETT, V381, P175, DOI 10.1016/j.neulet.2005.02.028
   Kaida K, 2001, J NEUROIMMUNOL, V113, P260, DOI 10.1016/S0165-5728(00)00451-3
   Kang JH, 2010, CLIN INFECT DIS, V51, P525, DOI 10.1086/655136
   Kaplin AI, 2005, NEUROLOGIST, V11, P2, DOI 10.1097/01.nrl.0000149975.39201.0b
   KASLOW RA, 1984, NEUROLOGY, V34, P240, DOI 10.1212/WNL.34.2.240
   Kawamura N, 2011, J NEUROIMMUNOL, V240, P74, DOI 10.1016/j.jneuroim.2011.09.004
   Keswani SC, 2003, ANN NEUROL, V54, P287, DOI 10.1002/ana.10645
   KHALILISHIRAZI A, 1992, J NEUROL SCI, V111, P200, DOI 10.1016/0022-510X(92)90069-W
   Kharwar NK, 2017, INT J NEUROSCI, V127, P680, DOI 10.1080/00207454.2016.1231186
   Kirkpatrick BD, 2011, CURR OPIN GASTROEN, V27, P1, DOI 10.1097/MOG.0b013e3283413763
   KLEMOLA E, 1967, ACTA MED SCAND, V181, P603
   Kobori S, 2017, J EPIDEMIOL, V27, P311, DOI 10.1016/j.je.2016.07.003
   Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14
   Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C
   Koga M, 2003, J NEUROIMMUNOL, V141, P112, DOI 10.1016/S0165-5728(03)00212-1
   Koga M, 2003, NEUROLOGY, V60, P1514, DOI 10.1212/01.WNL.0000061615.77865.83
   Koga M, 2001, NEUROLOGY, V57, P686, DOI 10.1212/WNL.57.4.686
   Koga M, 2007, NEUROLOGY, V69, P1727, DOI 10.1212/01.wnl.0000285517.52448.e8
   Koga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124004
   Komagamine Tomoko, 2006, CNS & Neurological Disorders-Drug Targets, V5, P391, DOI 10.2174/187152706777950765
   KUSUNOKI S, 1995, MUSCLE NERVE, V18, P409, DOI 10.1002/mus.880180407
   Kusunoki S, 1996, MUSCLE NERVE, V19, P257
   Kusunoki S, 2001, NEUROLOGY, V57, P736, DOI 10.1212/WNL.57.4.736
   Kuwahara M, 2017, J NEUROL, V264, P467, DOI 10.1007/s00415-016-8371-1
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413
   Linton D, 2000, MOL MICROBIOL, V37, P501, DOI 10.1046/j.1365-2958.2000.02020.x
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Lum LCS, 1996, AM J TROP MED HYG, V54, P256, DOI 10.4269/ajtmh.1996.54.256
   Lunn M, 2011, CLIN INFECT DIS, V52, P845, DOI 10.1093/cid/cir082
   Ma JJ, 1998, NEUROLOGY, V51, P379, DOI 10.1212/WNL.51.2.379
   Magira EE, 2003, J IMMUNOL, V170, P3074, DOI 10.4049/jimmunol.170.6.3074
   Matsui M, 1996, J NEUROL SCI, V139, P235
   Maurissen I, 2012, INFECTION, V40, P323, DOI 10.1007/s15010-011-0185-6
   McCombe PA, 2006, J NEUROIMMUNOL, V180, P172, DOI 10.1016/j.jneuroim.2006.07.017
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   MERELLI E, 1992, ACTA NEUROL SCAND, V85, P334
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   MILNER P, 1987, J NEUROL SCI, V79, P275, DOI 10.1016/0022-510X(87)90235-8
   Miyaji K, 2016, CARBOHYD RES, V434, P37, DOI 10.1016/j.carres.2016.08.004
   Miyaji K, 2014, NEUROLOGY, V83, P2314, DOI 10.1212/WNL.0000000000001090
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786
   Moran AP, 2001, J AUTOIMMUN, V16, P241, DOI 10.1006/jaut.2000.0490
   Mori M, 1999, NEUROLOGY, V52, P1282, DOI 10.1212/WNL.52.6.1282
   Morris G, 2018, MOL NEUROBIOL, V55, P4160, DOI 10.1007/s12035-017-0635-y
   Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002
   Nakamura K, 1998, ANN NY ACAD SCI, V845, P423, DOI 10.1111/j.1749-6632.1998.tb09710.x
   NIKKELS AF, 1993, VIRCHOWS ARCH A, V422, P121, DOI 10.1007/BF01607163
   Nishijima T, 2011, INTERNAL MED, V50, P2427, DOI 10.2169/internalmedicine.50.5883
   Nishimura M, 1996, J NEUROL SCI, V140, P91, DOI 10.1016/0022-510X(96)00106-2
   Notturno F, 2009, INT J IMMUNOPATH PH, V22, P437, DOI 10.1177/039463200902200220
   Ntziora Fotinie, 2011, J Med Case Rep, V5, P563, DOI 10.1186/1752-1947-5-563
   Nyati KK, 2013, BIOMED RES INT, DOI 10.1155/2013/852195
   Nyati KK, 2010, J NEUROIMMUNOL, V218, P116, DOI 10.1016/j.jneuroim.2009.10.018
   Oishi Kazunori, 2007, Journal of Infection and Chemotherapy, V13, P125, DOI 10.1007/s10156-007-0516-9
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   Orr SJ, 2007, J BIOL CHEM, V282, P3418, DOI 10.1074/jbc.C600216200
   Pangault C, 2004, VIRAL IMMUNOL, V17, P123, DOI 10.1089/088282404322875520
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   PENNER E, 1982, GASTROENTEROLOGY, V82, P576
   PERSEGHIN P, 1985, ITAL J NEUROL SCI, V6, P447, DOI 10.1007/BF02331037
   Phongsisay V, 2006, INFECT IMMUN, V74, P1368, DOI 10.1128/IAI.74.2.1368-1372.2006
   Phongsisay V, 2016, IMMUNOBIOLOGY, V221, P535, DOI 10.1016/j.imbio.2015.12.005
   Piao H, 2011, NEUROCHEM RES, V36, P58, DOI 10.1007/s11064-010-0263-7
   Puccioni-Sohler M, 2009, NEUROLOGY, V73, P1413, DOI 10.1212/WNL.0b013e3181bd8258
   RABBANI MU, 1990, JPN J MED, V29, P397
   Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08
   REES JH, 1995, J NEUROIMMUNOL, V62, P53, DOI 10.1016/0165-5728(95)00102-8
   Reindl M, 1999, BRAIN, V122, P2047, DOI 10.1093/brain/122.11.2047
   Renard JL, 1999, PRESSE MED, V28, P1290
   Sa MJ, 2009, AUTOIMMUN REV, V9, P128, DOI 10.1016/j.autrev.2009.04.005
   SANDERS EACM, 1987, J NEUROL, V234, P437, DOI 10.1007/BF00314094
   Sauteur PMM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003983
   Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566
   Scelsa SN, 2004, MUSCLE NERVE, V30, P423, DOI 10.1002/mus.20105
   Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138
   Schirmer L, 2016, J NEUROL, V263, P2105, DOI 10.1007/s00415-016-8237-6
   Schnorf H, 1998, EUR NEUROL, V40, P177
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shu XM, 2006, MUSCLE NERVE, V33, P225, DOI 10.1002/mus.20457
   Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12
   Sindern E, 1997, J NEUROL SCI, V151, P29, DOI 10.1016/S0022-510X(97)00082-8
   Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x
   Steininger C, 2007, J NEUROIMMUNOL, V183, P214, DOI 10.1016/j.jneuroim.2006.11.006
   Susuki K, 2004, NEUROLOGY, V62, P949, DOI 10.1212/01.WNL.0000115123.42929.FD
   Susuki K, 2007, J NEUROSCI, V27, P3956, DOI 10.1523/JNEUROSCI.4401-06.2007
   SVENNERHOLM L, 1990, ANN NEUROL, V27, pS36, DOI 10.1002/ana.410270710
   Taboada EN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-359
   TABOR E, 1987, J MED VIROL, V21, P207, DOI 10.1002/jmv.1890210303
   Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tsukaguchi M, 1998, J NEUROL NEUROSUR PS, V65, P407
   Tsukita S, 1999, J BIOL CHEM, V274, P34507, DOI 10.1074/jbc.274.49.34507
   Van Rhijn I, 2003, NEUROLOGY, V61, P994, DOI 10.1212/01.WNL.0000083986.53792.90
   Vanderlugt CL, 1998, IMMUNOL REV, V164, P63, DOI 10.1111/j.1600-065X.1998.tb01208.x
   VARKI A, 2009, ESSENTIALS GLYCOBIOL, P1
   Verma R, 2014, J NEUROL SCI, V346, P26, DOI 10.1016/j.jns.2014.08.044
   Visser LH, 1996, NEUROLOGY, V47, P668, DOI 10.1212/WNL.47.3.668
   von Gunten S, 2008, ANN NY ACAD SCI, V1143, P61, DOI 10.1196/annals.1443.011
   Wang Q, 2017, J NEUROIMMUNOL, V305, P1, DOI 10.1016/j.jneuroim.2017.01.004
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Willison HJ, 2005, NAT CLIN PRACT NEURO, V1, P2, DOI 10.1038/ncpneuro0001
   Willison H, 2014, NEUROLOGY, V83, P106, DOI 10.1212/WNL.0000000000000581
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Xiang SL, 2006, J NEUROIMMUNOL, V174, P126, DOI 10.1016/j.jneuroim.2006.02.009
   YOSHINO H, 1992, EUR NEUROL, V32, P28, DOI 10.1159/000116872
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   YUKI N, 1995, J NEUROIMMUNOL, V60, P161, DOI 10.1016/0165-5728(95)00052-4
   Yuki N, 1998, J NEUROL SCI, V154, P14, DOI 10.1016/S0022-510X(97)00174-3
   YUKI N, 1993, ANN NEUROL, V33, P655, DOI 10.1002/ana.410330617
   Yuki N, 2001, ACTA NEUROL SCAND, V104, P57, DOI 10.1034/j.1600-0404.2001.00288.x
   YUKI N, 1991, NEUROLOGY, V41, P1561, DOI 10.1212/WNL.41.10.1561
   YUKI N, 1990, NEUROLOGY, V40, P1900, DOI 10.1212/WNL.40.12.1900
   Yuki N, 2007, MUSCLE NERVE, V35, P691, DOI 10.1002/mus.20762
   Yuki N, 2011, J NEUROL SCI, V302, P1, DOI 10.1016/j.jns.2010.12.010
   ZHANG JW, 1995, J AUTOIMMUN, V8, P615, DOI 10.1016/0896-8411(95)90012-8
   Zhou X, 2017, J INFECT DIS, V215, P1197, DOI 10.1093/infdis/jix079
NR 208
TC 21
Z9 22
U1 0
U2 11
PU CHIN SOCIETY IMMUNOLOGY
PI BEING
PA 5 DONGDAN SANTIAO, DONGCHEN DISTRICT, BEING, 100005, PEOPLES R CHINA
SN 1672-7681
EI 2042-0226
J9 CELL MOL IMMUNOL
JI Cell. Mol. Immunol.
PD JUN
PY 2018
VL 15
IS 6
BP 547
EP 562
DI 10.1038/cmi.2017.142
PG 16
WC Immunology
SC Immunology
GA GP4OW
UT WOS:000440848000002
PM 29375121
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU van der Linden, V
   Rasmussen, SA
   Moore, CA
AF van der Linden, Vanessa
   Rasmussen, Sonja A.
   Moore, Cynthia A.
TI CONGENITAL ZIKA VIRUS INFECTION WITH ARTHROGRYPOSIS AND PARALYSIS OF THE
   DIAPHRAGM
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Meeting Abstract
CT 38th Annual David W. Smith Workshop on Malformations and Morphogenesis
CY AUG 26-29, 2017
CL Stowe, VT
SP Ctr Dis Control & Prevent, Natl Inst Child Hlth & Dev, March Dimes
C1 [van der Linden, Vanessa] Assoc Assistance Disabled Children, Recife, PE, Brazil.
   [van der Linden, Vanessa] Barao de Lucena Hosp, Recife, PE, Brazil.
   [Rasmussen, Sonja A.; Moore, Cynthia A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD JUN
PY 2018
VL 176
IS 6
BP 1518
EP 1518
PG 1
WC Genetics & Heredity
SC Genetics & Heredity
GA GI0DW
UT WOS:000434040600140
DA 2020-07-08
ER

PT J
AU Sarwar, MR
   Saqib, A
   Iftikhar, S
AF Sarwar, Muhammad Rehan
   Saqib, Anum
   Iftikhar, Sadia
TI Zika Virus Infection during Pregnancy; Maternofetal Risk Assessment,
   Transmission, Complications, and Management: A Review of the Literature
SO ARCHIVES OF CLINICAL INFECTIOUS DISEASES
LA English
DT Review
DE Zika Virus; Pregnancy; Microcephaly; Transmission; Management
ID BIRTH-DEFECTS; INFANTS; DISEASE
AB Zika virus (ZIKV) is a vector transmitted, arthropod-borne viral disease. People around the globe, especially pregnant females are more prone to it. Various neurological and ophthalmological congenital abnormalities make it an epidemic in Central and South Americas as well as Pacific regions. Therefore, the present review, by considering available literature, aims to evaluate the link between ZIKV infection and maternofetal damage. We used a number of electronic databases (PubMed, Google Scholar, Scopus, and Science Direct) to identify the relevant published studies. Of 200 articles found initially, 144 were selected for additional review. Subsequently, 69 articles were finally selected. ZIKV is a life threatening fetal infection. It can easily encounter developing fetus through maternal circulation. Large numbers of fetal mortalities and adult morbidities have been reported till date. WHO has reported cases of ZIKV associated fetus neural damage from 29 countries in its recent report of 2017. Though the exact mechanism of maternofetal ZIKV transmission is still inconspicuous, it is evident that in the 1st trimester the risk of developing microcephaly is at its peak, thus, maximizing the risk of various congenital anomalies. The lack of proper therapeutic and preventive measurements makes it more deleterious.
C1 [Sarwar, Muhammad Rehan; Saqib, Anum] Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.
   [Iftikhar, Sadia] Akhtar Saeed Coll Pharmaceut Sci, Lahore, Pakistan.
RP Sarwar, MR (corresponding author), Islamia Univ Bahawalpur, Dept Pharm, Bahawalpur, Punjab, Pakistan.
EM rehansarwaralvi@gmail.com
OI Sarwar, Muhammad Rehan/0000-0003-4312-9157
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   American Society for Reproductive Medicine, 2017, AM SOC REP MED GUID
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   [Anonymous], 2016, TERRITORIES ACTIVE Z
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Besnard M, 2014, EURO SURVEILL, V19
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Delorme-Axford E, 2013, AUTOPHAGY, V9, P2173, DOI 10.4161/auto.26558
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dogan AC, 2017, J MATERN-FETAL NEO M, V30, P386, DOI 10.3109/14767058.2016.1174210
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Center for Disease Prevention and Control, 2017, RAP RISK ASS ZIK VIR
   Faheem M, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S1-S4
   Feldman HS, 2012, ALCOHOL CLIN EXP RES, V36, P670, DOI 10.1111/j.1530-0277.2011.01664.x
   Fiorentino DG, 2016, CURR OBSTET GYNECOL, V5, P234, DOI 10.1007/s13669-016-0171-1
   Gilboa SM, 2017, BIRTH DEFECTS RES, V109, P372, DOI 10.1002/bdr2.1007
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Igbinosa Irogue I, 2017, Am Fam Physician, V95, P507
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rather IA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00305
   Relich RF, 2017, CLIN LAB MED, V37, P253, DOI 10.1016/j.cll.2017.01.002
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruddiman WF, 2015, SCIENCE, V348, P38, DOI 10.1126/science.aaa7297
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sarwar MR, 2017, J MOL PATHOL EPIDEMI, V2, pS1
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Stagg Denise, 2016, Nurs Womens Health, V20, P299, DOI 10.1016/j.nwh.2016.03.001
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van Well Gijs T J, 2017, Mol Cell Pediatr, V4, P4, DOI 10.1186/s40348-017-0070-1
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura LO, 2017, J AAPOS OFFICIAL PUB
   Weisblum Y, 2016, J VIROL
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Women's Health Care Physicians, 2016, PERINATOLOGIYA PEDIA, V1, P8
   World Health Organization, 2016, PREGN MEN CONT ZIK V
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00062
NR 66
TC 0
Z9 0
U1 0
U2 4
PU SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED
PI TEHRAN
PA SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN
SN 2345-2641
EI 2008-1081
J9 ARCH CLIN INFECT DIS
JI Arch. Clin. Infect. Dis.
PD JUN
PY 2018
VL 13
IS 3
AR UNSP e12848
DI 10.5812/archcid.12848
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GO8WU
UT WOS:000440381700002
OA Other Gold
DA 2020-07-08
ER

PT J
AU Ortega-Morales, AI
   Bond, G
   Mendez-Lopez, R
   Garza-Hernandez, JA
   Hernandez-Triana, LM
   Casas-Martinet, M
AF Ortega-Morales, Aldo, I
   Bond, Guillermo
   Mendez-Lopez, Ramon
   Garza-Hernandez, Javier A.
   Hernandez-Triana, Luis M.
   Casas-Martinet, Mauricio
TI FIRST RECORD OF INVASIVE MOSQUITO AEDES ALBOPICTUS IN TABASCO AND
   YUCATAN, MEXICO
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes albopictus; first record; Mexico; Quintana Roo; Tabasco; Yucatan
ID UNITED-STATES; AMERICA; TIRES; SKUSE; ASIA
AB The invasive mosquito Aedes albopictus is currently distributed in most of the southern Mexican region. Since the species was first recorded in the state of Tamaulipas, in northeastern Mexico in 1988, it has expanded its distribution throughout the Sierra Madre Oriental and Gulf of Mexico to the Neotropical region of the country. Currently the species occurs in the states of Tamaulipas, Coahuila, Nuevo Leon, Veracruz, Chiapas, Morelos, Quintana Roo, Sinaloa, San Luis Potosi, and Hidalgo. This is the first report of the mosquito in the states of Tabasco and Yucatan and the confirmation of its presence in Quintana Roo state. Aedes albopictus has been incriminated as a secondary vector of diseases such as those caused by dengue, chikungunya, and Zika viruses, which have caused epidemic outbreaks in most tropical and subtropical regions of Mexico; therefore, surveillance for the detection of Ae. albopictus is paramount so that targeted control strategies can be implemented for its control throughout Mexico.
C1 [Ortega-Morales, Aldo, I; Mendez-Lopez, Ramon] Univ Autonoma Agr Antonio Narro, Dept Parasitol, Unidad Laguna, Torreon 27084, Coahuila, Mexico.
   [Bond, Guillermo; Casas-Martinet, Mauricio] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula 30700, Chiapas, Mexico.
   [Garza-Hernandez, Javier A.] Univ Autonoma Ciudad Juarez, Inst Ciencias Biomed, Lab Biotecnol, Chihuahua 32310, Mexico.
   [Hernandez-Triana, Luis M.] Anim & Plant Hlth Agcy, Dept Virol, Wildlife Zoonoses & Vector Borne Dis Res Grp, Woodham Lane, Addlestone KT15 3NB, Surrey, England.
RP Casas-Martinet, M (corresponding author), Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula 30700, Chiapas, Mexico.
FU Secretary of Public Education (SEP-PRODEP); National Commission for the
   Knowledge and Use of Biodiversity (CONABIO) [CUAC1414, LI040]
FX We thank Salvador Morales-Avitia and Martha Ortega-Lozano for their
   valuable collaboration during field collections trips in Tabasco state
   and Miguel Munoz-Reyes, Jose L. Aguilar-Rodriguez, and Martin
   Vazquez-Castillo for their support on collection trips in the Yucatan
   Peninsula. We also thank the Secretary of Public Education (SEP-PRODEP)
   and the National Commission for the Knowledge and Use of Biodiversity
   (CONABIO) for providing funds to carry out the field trips of this study
   project: "Taxonomic inventory of some groups of haematophagous
   nematoceroids (Lower Diptera) in the state of Tabasco, Mexico'' (Grant
   No. CUAC1414) and "Diagnosis of the current status of biological
   invasion of Aedes albopictus in the main protected natural areas of the
   Yucatan Peninsula'' (Grant No. LI040).
CR Casas-Martinez M, 2003, EMERG INFECT DIS, V9, P606
   CRAVEN RB, 1988, J AM MOSQUITO CONTR, V4, P138
   Flisser A, 2002, ARCH MED RES, V33, P343, DOI 10.1016/S0188-4409(02)00381-8
   FRANCY DB, 1990, J AM MOSQUITO CONTR, V6, P127
   GISD [Global Invasive Species Database], 2017, SPEC PROF AED ALB
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Ibanez-Bernal S, 1997, MED VET ENTOMOL, V11, P305, DOI 10.1111/j.1365-2915.1997.tb00413.x
   IBANEZBERNAL S, 1994, J AM MOSQUITO CONTR, V10, P231
   Orta-Pesina H, 2005, SALUD PUBLICA MEXICO, V47, P163, DOI 10.1590/s0036-36342005000200010
   Ortega-Morales AI, 2016, J VECTOR ECOL, V41, P314, DOI 10.1111/jvec.12229
   Ortega-Morales AI, 2016, J AM MOSQUITO CONTR, V32, P234, DOI 10.2987/16-6576.1
   Ortega-Morales AI, 2015, J MED ENTOMOL, V52, P171, DOI 10.1093/jme/tju008
   Pesina HO, 2001, J AM MOSQUITO CONTR, V17, P260
   Reiter P, 1987, J AM MOSQUITO CONTR, V44, P396
   Reyes-Villanueva F, 2013, J VECTOR DIS, V50, P202
   Salomon-Grajales J, 2012, EMERG INFECT DIS, V18, P525, DOI 10.3201/eid1803.111626
   SEGOB [ Secretaria de Gobernacion], 2015, NOM032SSA22014 SEGOB
   SPRENGER D, 1986, J AM MOSQUITO CONTR, V2, P217
   Torres-Avendano JI, 2015, J AM MOSQUITO CONTR, V31, P164, DOI 10.2987/14-6461R
   TOVAR MLR, 1994, J AM MOSQUITO CONTR, V10, P587
   Villegas-Trejo A, 2010, J AM MOSQUITO CONTR, V26, P321, DOI 10.2987/10-6014.1
   WRBU [Walter Reed Biosystematics Unit], 2005, SYST CAT CUL
NR 22
TC 4
Z9 4
U1 1
U2 3
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD JUN
PY 2018
VL 34
IS 2
BP 120
EP 123
DI 10.2987/18-6736.1
PG 4
WC Entomology
SC Entomology
GA GO6KM
UT WOS:000440151100006
PM 31442162
OA Bronze
DA 2020-07-08
ER

PT J
AU Rose, DA
   Godsey, MS
   Faraji, A
   Ostrum, EM
   Savage, HM
AF Rose, Dominic A.
   Godsey, Marvin S., Jr.
   Faraji, Ary
   Ostrum, Erik M.
   Savage, Harry M.
TI A SURVEY OF THE MOSQUITOES OF KOSRAE STATE, FEDERATED STATES OF
   MICRONESIA, 2016
SO JOURNAL OF THE AMERICAN MOSQUITO CONTROL ASSOCIATION
LA English
DT Article
DE Aedes; arbovirus; Culicidae; Stegomyia; surveillance
ID YAP STATE; VIRUS; EPIDEMIC
AB In response to an outbreak of Zika virus that started in February 2016 on Kosrae Island, Kosrae State, Federated States of Micronesia, we conducted entomological investigations, including a survey to characterize the mosquito fauna on Kosrae, from November 29 to December 8, 2016. Mosquitoes were collected using several surveillance methods in order to sample all stages of the mosquito life cycle. Eggs were collected using ovicups, larvae and pupae were sampled using standard dippers, and adults were collected using aspirators and Biogents-2 Sentinel traps. All species previously recorded from Kosrae State were found in the current survey, confirming their continued presence on the island. Aedes aegypti was detected on Lelu Island, representing a new municipal record. The collection of Ae. vexans nocturnus represents a new species record for Kosrae, increasing the number of known taxa on this island from 6 to 7. The report herein provides updated knowledge of the mosquitoes that occur on Kosrae State, Federated States of Micronesia.
C1 [Rose, Dominic A.; Godsey, Marvin S., Jr.; Ostrum, Erik M.; Savage, Harry M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Arbovirus Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Faraji, Ary] Salt Lake City Mosquito Abatement Dist, 2020 North Redwood Rd, Salt Lake City, UT 84116 USA.
RP Rose, DA (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Arbovirus Dis Branch, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
FU Intramural CDC HHS [CC999999]
CR Bohart R. M., 1946, MOSQUITOES OKINAWA I
   Bohart RM, 1956, INSECTS MICRONESIA, V12
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Falanruw MC, 2002, TERRESTRIAL BIODIVER
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Harbach R, 2015, STEGOMYIA
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Marano N, 2007, EMERG INFECT DIS, V13, P1807, DOI 10.3201/eid1312.071276
   Noda Shinichi, 2013, Tropical Medicine and Health, V41, P157, DOI 10.2149/tmh.2013-08
   Pacific RISA [Pacific Regional Integrated Sciences and Assessments], 2017, FED STAT MICR
   Pastula DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005410
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pecor J, 1997, LAB FIELD PROTOCOLS
   Rueda LM, 2004, PICTORIAL KEYS IDENT
   Savage HM, 2015, AM J TROP MED HYG, V92, P429, DOI 10.4269/ajtmh.14-0374
   Savage HM, 1998, AM J TROP MED HYG, V58, P519, DOI 10.4269/ajtmh.1998.58.519
   WHO [World Health Organization], 2017, WORLD HLTH ASS APPR
NR 19
TC 0
Z9 0
U1 0
U2 1
PU AMER MOSQUITO CONTROL ASSOC
PI MOUNT LAUREL
PA 15000 COMMERCE PARKWAY, SUITE C, MOUNT LAUREL, NJ 08054 USA
SN 8756-971X
EI 1943-6270
J9 J AM MOSQUITO CONTR
JI J. Am. Mosq. Control Assoc.
PD JUN
PY 2018
VL 34
IS 2
BP 143
EP 146
DI 10.2987/18-6728.1
PG 4
WC Entomology
SC Entomology
GA GO6KM
UT WOS:000440151100012
PM 31414080
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Jurgens, I
   Rey, A
AF Jurgens, Ignasi
   Rey, Amanda
TI Ocular findings in patients with microcephaly can suggest presumed
   congenital zika virus infection
SO ACTA OPHTHALMOLOGICA
LA English
DT Editorial Material
C1 [Jurgens, Ignasi; Rey, Amanda] Inst Catala Retina, C Ganduxer 117, Barcelona 08022, Spain.
RP Jurgens, I (corresponding author), Inst Catala Retina, C Ganduxer 117, Barcelona 08022, Spain.
EM jurgens@comb.cat
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
NR 5
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1755-375X
EI 1755-3768
J9 ACTA OPHTHALMOL
JI Acta Ophthalmol.
PD JUN
PY 2018
VL 96
IS 4
BP 423
EP 424
PG 2
WC Ophthalmology
SC Ophthalmology
GA GO1SU
UT WOS:000439737000041
PM 28834250
OA Bronze
DA 2020-07-08
ER

PT J
AU Rutschman, AS
AF Rutschman, Ana Santos
TI IP Preparedness for Outbreak Diseases
SO UCLA LAW REVIEW
LA English
DT Article
ID RESEARCH-AND-DEVELOPMENT; ZIKA VIRUS; DNA VACCINES; INTELLECTUAL
   PROPERTY; MALARIA VACCINE; EBOLA; PATENTS; PROTECTION; INNOVATION;
   PHASE-1
AB Outbreaks of infectious diseases will worsen in the coming decades, as illustrated by the recent back-to-back Ebola and Zika epidemics. The development of innovative drugs, especially in the form of vaccines, is key to minimizing the scale and impact of future outbreaks, yet current intellectual property (IP) regimes are ineffective in supporting this goal.
   Scholarship has not adequately addressed the role of IP in the development of vaccines for outbreak diseases. This Article fills that void. Through case studies on the recent Ebola and Zika outbreaks, it provides the first descriptive analysis of the role of IP from the pre- to the post-outbreak stages, specifically identifying IP inefficiencies.
   The Article concludes that these inefficiencies result in a lack of "IP preparedness" that ultimately weakens our ability to respond effectively to outbreaks. To solve the problem, we need a blend of new and existing legal tools. This Article surveys existing solutions and proposes a new legal mechanism: a dormant license, agreed upon in the pre-outbreak period, that would become active once a public health emergency is declared. This solution addresses transactional IP inefficiencies during the early stages of an outbreak and helps get vaccines to the market more efficiently to save lives.
C1 [Rutschman, Ana Santos] Depaul Univ, Coll Law, Hlth Law & Intellectual Property, Chicago, IL 60604 USA.
   [Rutschman, Ana Santos] Univ Chicago, Legal Scholarship Workshop, Chicago, IL 60637 USA.
   [Rutschman, Ana Santos] Stanford Univ, Stanford, CA 94305 USA.
   [Rutschman, Ana Santos] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Rutschman, Ana Santos] Indianapolis McKinney Sch Law, Duke Law Sch, Indianapolis, IN USA.
   [Rutschman, Ana Santos] Syracuse Univ, Coll Law, Syracuse, NY 13244 USA.
RP Rutschman, AS (corresponding author), Depaul Univ, Coll Law, Hlth Law & Intellectual Property, Chicago, IL 60604 USA.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P1249, DOI 10.1001/jama.2016.12760
   Alsever Jennifer, 2016, FORTUNE
   [Anonymous], 2016, TEST INV IN ZIK VACC
   [Anonymous], 2017, CF ZIK VIR SPREAD UN
   [Anonymous], 2016, FED REGISTER, V81, P89087
   [Anonymous], TIM US ARM SAN ZIK V
   [Anonymous], 2016, HIGH LEVEL PANEL GLO, P18
   [Anonymous], 2016 CAS COUNTS US
   [Anonymous], DEV PROF RAR DIS CON
   [Anonymous], 2016, UND PAT EXCL
   [Anonymous], OFF ASS SECR PREP RE
   [Anonymous], DNDIS INT PROP POL
   [Anonymous], CANC MOONSH
   [Anonymous], 2011, HIGH RES FUND LEADS
   [Anonymous], SUPPL PROC IMM PROD
   [Anonymous], ZIK CUM CAS 16 NOV 2
   [Anonymous], SOL LIC AGREEM REC V
   [Anonymous], VACC SUPP
   [Anonymous], 2017, EB NEW TRIAL LAUNCH
   [Anonymous], EB DAT STAT
   [Anonymous], 2016, CONS GUID USE ANT DR, P5
   [Anonymous], IMI MISS OBJ
   [Anonymous], 2017, NATURE MICROBIOLOGY, V2, P1
   [Anonymous], WHAT AR MED COUNT
   [Anonymous], MAL VENT MMV NONPR P
   [Anonymous], 2017, KEI COMM RE ARM INT
   [Anonymous], HAEM FEV VIR
   [Anonymous], 2003, Patent, Patent No. [WO 2004/011488 A2, 2004011488]
   [Anonymous], 2014, EB VIR DIS OUTBR W A
   [Anonymous], FUND
   [Anonymous], BIOM ADV RES DEV AUT
   [Anonymous], 2002, GLOB PUBL GOODS HLTH
   Arrow K.J., 1962, RATE DIRECTION INVEN, P609, DOI DOI 10.1515/9781400879762-024
   Attaran A, 2014, LANCET, V384, pE61, DOI 10.1016/S0140-6736(14)62044-4
   Barnes-Weise Julia, 2015, HUFFINOTON POST 0407
   Barrett Man D. T., 2016, NPJ VACCINES    1110
   Belluz Julia, 2016, VOX             0531
   Ben Hirschler, 2013, REUTERS
   Bennett DA, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002256
   Berg S., 1988, NATURAL MONOPOLY REG
   Biden J., 2016, INSPIRING NEW GENERA
   Black Christopher, 2015, WHO PUBLISHES LIST T
   Boyle Annette M., 2016, ARMY RES PRODUCES ZI
   Branswell H, 2017, STAT
   Branswell H., 2016, STAT
   Branswell H., 2018, STAT
   Braswell Helen, 2014, TORONTO STAR
   Burk DL, 2003, VA LAW REV, V89, P1575, DOI 10.2307/3202360
   BURK DL, 2003, VA LAW REV, V89, P1581
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, OUTBR CHRON EB VIR D
   CENTERS FOR DISEASE CONTROL & PREVENTION, 2017, US VACC
   CENTERS FOR DISEASE CONTROL & PREVENTION, ZIK VIR PREG
   Chappell Keith J., 2017, PLOS PATHOG, V13, P1
   Choi Annette, 2017, 1 MALARIA VACCINE 30
   Christaki E, 2015, VIRULENCE, V6, P554, DOI 10.1080/21505594.2015.1040975
   Cohen J., 2016, SCIENCE
   Cohn D'Vera, 1989, WASH POST
   CTR. FOR DISEASE CONTROL AND PREVENTION, 2009, BIOSAFETY MICROBIOLO, P251
   CTR. FOR INFECTIOUS DISEASE RESEARCH & POLICY, 2017, COMPL DEV EBOL VACC, P29
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Curthoys Kathleen, 2016, ARMYTIMES       1108
   Daszak P, 2012, LANCET, V380, P1883, DOI 10.1016/S0140-6736(12)61887-X
   Donnelly JJ, 2005, J IMMUNOL, V175, P633, DOI 10.4049/jimmunol.175.2.633
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Drake JM, 2006, PLOS MED, V3, P57, DOI 10.1371/journal.pmed.0030003
   Eisenberg Rebecca S., 2007, MICH TELECOMM TECH L, V13, P359
   Eisenberg Rebecca S., 2007, MICH TELECOMM TECH L, V13, P345
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   FDA, GUID IND CONS PLASM
   Ferraro B, 2011, CLIN INFECT DIS, V53, P296, DOI 10.1093/cid/cir334
   Fisher III William W, 2015, LEARNING EBOLA DRUG
   Gates B, 2015, NEXT OUTBREAK WERE N
   GATTER R, 2015, U MIAMI BUS L REV, V23, P375
   Geisbert TW, 2011, J INFECT DIS, V204, pS1075, DOI 10.1093/infdis/jir349
   Gholipour B, 2013, SCI AM
   GLOBAL RESEARCH COLLABORATION FOR INFECTIOUS DISEASE PREPAREDNESS, 2016, ZIK VACC WORK GROUP, P1
   Goo Leslie, 2017, PLOS PATHOG, V13, P1
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grady D., 2014, NY TIMES
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Harris Richard, 2016, TESTING BEGINS EXPT
   Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698
   Hemel DJ, 2013, TEX LAW REV, V92, P301
   Howard E., 2015, GUARDIAN
   Jaffe Adam B., 2002, INNOVATION POLICY EC, V2, p[51, 53], DOI DOI 10.1162/153134602753396976
   Jiang X, 2010, J AM MED INFORM ASSN, V17, P462, DOI 10.1136/jamia.2009.000356
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Jones SM, 2005, NAT MED, V11, P786, DOI 10.1038/nm1258
   Joseph A., 2016, STAT
   Kalil Jorge, 2014, PLOS NEGLECT TROP D, V8, P1
   Kapczynski Amy, 2011, CONTAGION PROPERTY C
   Kaslow DC, 2015, VACCINE, V33, P7425, DOI 10.1016/j.vaccine.2015.09.061
   Katz IT, 2017, NEW ENGL J MED, V376, P1701, DOI 10.1056/NEJMp1703734
   Keaten Jamey, 2016, AP NEWS         1223
   Keshwara R, 2017, ANNU REV MED, V68, P371, DOI 10.1146/annurev-med-051215-030919
   Kesselheim Aaron S, 2011, Yale J Health Policy Law Ethics, V11, P101
   Kieny MP, 2016, LANCET, V388, P460, DOI 10.1016/S0140-6736(16)31152-7
   Kitch EW, 2000, VANDERBILT LAW REV, V53, P1727
   Knox Richard, 2005, SCI RACE FIND VACCIN
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Largeron Nathalie, 2015, J MKT ACCESS HLTH PO, V3, P1
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lett D, 2005, CAN MED ASSOC J, V173, P472, DOI 10.1503/cmaj.050938
   Lichtman D, 2018, UCLA LAW REV, V65, P1268
   Lietzan Erika F., 2017, U MO SCH LAW LEGAL S
   Lovas TO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108069
   Lucey D, 2016, JAMA-J AM MED ASSOC, V315, P2661, DOI 10.1001/jama.2016.6606
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Lucey Daniel R., 2016, JAMA-J AM MED ASSOC, V315, P866
   Lyon GM, 2014, NEW ENGL J MED, V371, P2402, DOI 10.1056/NEJMoa1409838
   Lyon J, 2016, JAMA-J AM MED ASSOC, V316, P1246, DOI 10.1001/jama.2016.11054
   Lyon Jeff, 2016, JAMA-J AM MED ASSOC, V316, P1248
   MACAULAY THOMAS BABINGTON, 1877, SPEECHES LORD MACAUL, P112
   Magill Alan J., 2017, RECORD HIST MALARIA
   Mahoney Richard T., 2011, HLTH RES POLY SYS, V9, P2
   Mahoney Richard T., 2011, HLTH RES POLY SYS, V9, P1
   Maron Dina Fine, 2014, SCI AM
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   Martins KA, 2016, EXPERT REV VACCINES, V15, P1101, DOI 10.1080/14760584.2016.1187566
   Marzi A, 2011, J INFECT DIS, V204, pS1066, DOI 10.1093/infdis/jir348
   McNeil Jr Donald G., 2016, NY TIMES
   MERGES RP, 1990, COLUMBIA LAW REV, V90, P839, DOI 10.2307/1122920
   MERGES RP, 1990, COLUMBIA LAW REV, V90, P843
   Mervis J, 2017, SCIENCE, V355, P1005, DOI 10.1126/science.355.6329.1005
   Meurer Michael J., 2008, LEWIS CLARK L REV, V12, P547
   MEURER MJ, 2008, LEWIS CLARK L REV, V12, P558
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Moser P, 2016, ANNU REV ECON, V8, P241, DOI 10.1146/annurev-economics-080315-015136
   Nicholson W., 2015, HARV JL TECH, V28, P421
   Nicholson W., 2015, HARV JL TECH, V28, P419
   NIH, EB VACC
   Outterson K, 2007, LANCET INFECT DIS, V7, P559, DOI 10.1016/S1473-3099(07)70188-3
   Outterson Kevin, 2010, CARDOZO L REV, V31, P613
   PATH, 2011, STAY COURS MAL RES D, P13
   PAVOT V, 2016, VACCIN RES OPEN J, V1, P1
   Payne Elizabeth, 2016, OTTAWA CITIZEN
   Pellerin Cheryl, 2016, WALTER REED SCI TEST
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   POLICY CURES RESEARCH, 2016, NEGL DIS RES DEV PIV, P5
   Powell K, 2004, NAT BIOTECHNOL, V22, P799, DOI 10.1038/nbt0704-799
   Prasad Vinay, 2016, WASH POST
   Price II W. Nicholson, PRECISION MED INITIA
   Price WN, 2016, IOWA LAW REV, V101, P1023
   Rai AK, 2012, NAT BIOTECHNOL, V30, P953, DOI 10.1038/nbt.2382
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   Ridley DB, 2006, HEALTH AFFAIR, V25, P313, DOI 10.1377/hlthaff.25.2.313
   Ridley RG, 2003, EMBO REP, V4, pS43, DOI 10.1038/sj.embor.embor858
   Rimer Sara, 2016, BU TODAY        0728
   Roberts A, 1999, J VIROL, V73, P3723, DOI 10.1128/JVI.73.5.3723-3732.1999
   Rodriguez Carmen Heredia, 2017, TEST ZIKA VACCINES S
   Roin BN, 2014, U CHICAGO LAW REV, V81, P999
   Roland D, 2015, WALL STREET J
   Roldao A, 2010, EXPERT REV VACCINES, V9, P1149, DOI [10.1586/erv.10.115, 10.1586/ERV.10.115]
   Rottingen JA, 2017, NEW ENGL J MED, V376, P610, DOI 10.1056/NEJMp1613577
   Rutschman Ana Santos, 2017, ANN HLTH L, V26, P71
   Rutschman Ana Santos, 2017, ANN HLTH L, V26, P83
   Sachs Rachel E., 2018, MICH L REV, V116
   Sanders B., 2017, NY TIMES
   Scherer FM, 2015, J TECHNOL TRANSFER, V40, P559, DOI 10.1007/s10961-015-9394-y
   Schneider AD, 2017, CLADISTICS, V33, P1, DOI 10.1111/cla.12178
   Schnirring Lisa, 2014, NEWLINK MERCK DEAL B
   SCOTCHMER S, 1991, J ECON PERSPECT, V5, P29, DOI 10.1257/jep.5.1.29
   Scotchmer Suzanne, 1991, J EC PERSP, V5, P30
   Scott D, 2016, STAT
   Senthilingam M., 2017, CNN
   Shavell S, 2001, J LAW ECON, V44, P525, DOI 10.1086/322811
   Shavell Steven, 2001, J LAW ECON, V44, P529
   Sheridan Cormac, JOHNSON JOHNSON BAV
   Sherkow Jacob S., 2018, NC L REV, V96, P297
   Sifferlin A, 2015, TIME
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   Smith Katherine F., 2014, J ROYAL SOC INTERFAC, V11, P3
   Smith Tara C., 2015, SLATE
   Soucheray Stephanie, 2016, TRIAL OFFERS MIXED V
   TANG DC, 1992, NATURE, V356, P152, DOI 10.1038/356152a0
   Tapia MD, 2016, LANCET INFECT DIS, V16, P31, DOI 10.1016/S1473-3099(15)00362-X
   THE HISTORY OF VACCINES, DIFF TYP VACC
   Thomas Katie, 2016, NY TIMES
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   U. S. DEP'T OF HEALTH & HUMAN SERVS, 2015, 2015 PUBL HLTH EM ME, P15
   U.S. NAT'L LIBR. OF MED, ZIK VIR PUR IN VACC
   ULMER JB, 1993, SCIENCE, V259, P1745, DOI 10.1126/science.8456302
   Vitoria M, 2009, AM J CLIN PATHOL, V131, P844, DOI 10.1309/AJCP5XHDB1PNAEYT
   Wadman M., 2017, VACCINE RACE SCI POL
   Wagner M M, 2001, J Public Health Manag Pract, V7, P51
   Wang YX, 2017, HUM VACC IMMUNOTHER, V13, P153, DOI 10.1080/21645515.2016.1225637
   WHO, ZIK VIR
   WHO, HIST ZIK VIR
   WHO, CARDIOVASCULAR DIS
   WHO, 2016, EB OUTBR 2014 2015
   WORLD HEALTH ORG, 2016, 5 M EM REG ZIK VIR
   WORLD HEALTH ORG, 2005, INT HLTH REG, P10
   WORLD HEALTH ORG, OR 2014 EB
   WORLD HEALTH ORG, DNA VACC
   WORLD HEALTH ORG, 2016, ZIK STRAT RESP PLAN, P8
   WORLD HEALTH ORG, 2016, R D BLUEPR ACT PREV, P22
   World Health Organization, NEGLECTED TROPICAL D
   World Health Organization, DIS OUTBR
   World Health Organization, INFECT DIS
   World Health Organization, 2014, EB VIR DIS UPD W AFR
   World Health Organization, 2009, WHOL OF SOC PAND REA
   World Health Organization (WHO), WHO UNICEF ZIK VIR Z
   2011, NEW ENG J MED, V365, P1863
NR 205
TC 1
Z9 1
U1 1
U2 3
PU UNIV CALIF
PI LOS ANGELES
PA SCH LAW 405 HILGARD AVE, LOS ANGELES, CA 90024 USA
SN 0041-5650
J9 UCLA LAW REV
JI UCLA Law Rev.
PD JUN
PY 2018
VL 65
IS 5
BP 1200
EP 1266
PG 67
WC Law
SC Government & Law
GA GN0MQ
UT WOS:000438663100004
DA 2020-07-08
ER

PT J
AU Lichtman, D
AF Lichtman, Doug
TI The Central Assumptions of Patent Law: A Response to Ana Santos
   Rutschman's IP Preparedness for Outbreak Diseases
SO UCLA LAW REVIEW
LA English
DT Article
AB Professor Rutschman is right to question whether the patent system is prepared to address the unique challenges posed by outbreak diseases like Ebola and Zika. But her proposed dormant license and her call for increased "preparedness" both imply an optimism that regrettably I cannot share. The patent system's failures in this setting are foundational. The solution is not to make small, thoughtful improvements at the edges; the solution instead is to recognize that, in this setting, government funding, prize systems, and other innovation-producing mechanisms should fully displace the normally attractive market-based patent regime.
C1 [Lichtman, Doug] Univ Calif Los Angeles, Sch Law, Law, Los Angeles, CA 90024 USA.
RP Lichtman, D (corresponding author), Univ Calif Los Angeles, Sch Law, Law, Los Angeles, CA 90024 USA.
CR Abramowicz M, 2003, VANDERBILT LAW REV, V56, P115
   Chiang Tun-Jen, 2017, HARV JL TECH, V30, p[9, 9]
   FISHER III WILLIAM W, 2017, INFECT HLTH CRISIS I
   Kremer M, 1998, Q J ECON, V113, P1137, DOI 10.1162/003355398555865
   Kremer Michael, 1998, Q J ECON, P1140
   Lichtman Douglas Gary, 1997, HARV JL TECH, V11, P123
   Nossiter A., 2014, NY TIMES
   Rich Giles S., 1960, GEORGE WASH LAW REV, V28, P402
   RICH GS, 1960, GEORGE WASH LAW REV, V28, P393
   Roin BN, 2014, U CHICAGO LAW REV, V81, P999
   Rutschman AS, 2018, UCLA LAW REV, V65, P1200
   Scotchmer S, 1999, RAND J ECON, V30, P181, DOI 10.2307/2556076
   SOBEL D, 1995, LONGITUDE TRUE STORY
NR 13
TC 1
Z9 1
U1 0
U2 0
PU UNIV CALIF
PI LOS ANGELES
PA SCH LAW 405 HILGARD AVE, LOS ANGELES, CA 90024 USA
SN 0041-5650
J9 UCLA LAW REV
JI UCLA Law Rev.
PD JUN
PY 2018
VL 65
IS 5
BP 1268
EP 1275
PG 8
WC Law
SC Government & Law
GA GN0MQ
UT WOS:000438663100005
DA 2020-07-08
ER

PT J
AU Fried, I
AF Fried, Istvan
TI Souvenir and avenir: Multilingualism in Andrzej Kusniewicz's novel
   Lesson in a dead language
SO NEOHELICON
LA English
DT Article
DE Kusniewicz; Lesson in a dead language; Austro-Hungarian Empire; World
   War I; Multilingualism
AB Andrzej Kusniewicz's novel Lekcja martwego jA (TM) zika is set during the last days of the Austro-Hungarian Empire, depicted as a sort of end of times. A military officer tries to collect artifacts and to reconstruct the cultural picture of the good old days but the icons, the china fragments, and the cutlery are only witnesses to a world that has irrevocably passed. While the tubercular officer perseveres with his collection project till his last breath, World War I is drawing to an end and so is the empire, displaying signs of complete disintegration. The decay of the state unfolds in parallel to the officer's private deterioration. The death of the individual and of the whole system is gradually terminating the language of the era as well. The era itself is ending and turning into past by the end of World War I.
C1 [Fried, Istvan] Univ Szeged, Szeged, Hungary.
RP Fried, I (corresponding author), Univ Szeged, Szeged, Hungary.
EM oaniko@arts.u-szeged.hu
CR Bachmann-Medick Doris, 2006, CULTURAL TURNS NEUOR
   Becker S, 2007, LIT KULTURWISSENSCHA
   Bohme Hartmut, 2000, ORIENTIERUNG KULTURW
   Brodzka A., 1993, SLOWNIK LIT POLSKIEJ
   Daviau D. G, 1984, MANN UBERMORGEN HERM
   Fried I, 2011, LEBEN POESIE FESTSCH, P311
   Kaszynski S. H, 1987, GALIZIEN LIT HEIMAT
   Muller-Funk Wolfgang, 1989, J ROTH
   Sontag Susan, 1978, ILLNESS METAPHOR
   Sproede A, 2008, MIEDZY GALICJA WIEDN, P149
   Strelka J, 1994, TAKTE RADETZKYMARSCH
   Wojda D, 2008, MIEDZY GALICJA WIEDN, P21
   Woldan A, 2006, ZEIT ORT ERINNERUNG, P323
   Woldan A, 1998, GALIZIEN
   Woldan A, 1996, OSTERREICH MYTHOS PO
NR 15
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0324-4652
EI 1588-2810
J9 NEOHELICON
JI Neohelicon
PD JUN
PY 2018
VL 45
IS 1
BP 123
EP 132
DI 10.1007/s11059-018-0429-x
PG 10
WC Literature
SC Literature
GA GM9BF
UT WOS:000438535400009
DA 2020-07-08
ER

PT J
AU Earl, LA
   Falconieri, V
   Subramaniam, S
AF Earl, Lesley A.
   Falconieri, Veronica
   Subramaniam, Sriram
TI Microbiology catches the cryo-EM bug
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID III SECRETION SYSTEMS; ZIKA VIRUS; MOLECULAR ARCHITECTURE; SURVEILLANCE
   COMPLEX; ATOMIC-STRUCTURE; STRUCTURAL BASIS; DRUG DISCOVERY;
   HUMAN-ANTIBODY; E PROTEIN; IN-SITU
AB Over the past few years, the advances in technology and methods that have revolutionized cryo-EM are allowing for key insights in a variety of areas in biology, and microbiology is no exception. A wide range of important macromolecular assemblies in prokaryotic and eukaryotic cells, as well as intact viruses, have now become accessible to investigation by new methods in 3D electron microscopy. We focus here on selected examples that illustrate this breadth, and review the application of methods in single particle cryo-EM and cryo-electron tomography to progress in the structural biology of CRISPR systems, visualization of small molecule drugs in membrane proteins, in situ visualization of bacterial nanomachines, and the analysis of antigen-antibody interactions to drive vaccine design.
C1 [Earl, Lesley A.; Falconieri, Veronica; Subramaniam, Sriram] NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.
RP Subramaniam, S (corresponding author), NCI, Cell Biol Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.
EM ss1@nih.gov
OI Subramaniam, Sriram/0000-0003-4231-4115
FU Intramural program of the National Cancer Institute, NIH, Bethesda, MD
FX This work was supported by the Intramural program of the National Cancer
   Institute, NIH, Bethesda, MD.
CR Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576
   Boland A, 2017, ESSAYS BIOCHEM, V61, P543, DOI 10.1042/EBC20170032
   Chowdhury S, 2017, CELL, V169, P47, DOI 10.1016/j.cell.2017.03.012
   Deng WY, 2017, NAT REV MICROBIOL, V15, P323, DOI 10.1038/nrmicro.2017.20
   Fan C, 2017, J VIROL, V91, DOI 10.1128/JVI.00038-17
   Farley MM, 2016, J BACTERIOL, V198, P1186, DOI 10.1128/JB.00901-15
   Fibriansah G, 2015, SCIENCE, V349, P88, DOI 10.1126/science.aaa8651
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fitzpatrick AWP, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.70
   Gold V, 2016, CURR OPIN STRUC BIOL, V39, P1, DOI 10.1016/j.sbi.2016.03.001
   Guo TW, 2017, CELL, V171, P414, DOI 10.1016/j.cell.2017.09.006
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hochstrasser ML, 2016, MOL CELL, V63, P840, DOI 10.1016/j.molcel.2016.07.027
   Hu B, 2017, CELL, V168, P1065, DOI 10.1016/j.cell.2017.02.022
   Hu B, 2015, P NATL ACAD SCI USA, V112, P1047, DOI 10.1073/pnas.1411610112
   Johnson ZL, 2017, CELL, V168, P1075, DOI 10.1016/j.cell.2017.01.041
   Kawamoto A, 2013, SCI REP-UK, V3, DOI 10.1038/srep03369
   Kim Y, 2018, SCIENCE, V359, P915, DOI 10.1126/science.aar7389
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kudryashev M, 2013, ELIFE, V2, DOI 10.7554/eLife.00792
   Lee H, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501929
   Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159
   Liu Y, 2016, P NATL ACAD SCI USA, V113, P8997, DOI 10.1073/pnas.1606595113
   Makino F, 2016, SCI REP-UK, V6, DOI 10.1038/srep33341
   Marsian J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00090-w
   Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040
   Meyerson JR, 2016, NATURE, V537, P567, DOI 10.1038/nature19352
   Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117
   Mohanraju P, 2016, SCIENCE, V353, DOI 10.1126/science.aad5147
   Nans A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10114
   Oikonomou CM, 2017, ANNU REV BIOCHEM, V86, P873, DOI 10.1146/annurev-biochem-061516-044741
   Oldham ML, 2016, ELIFE, V5, DOI 10.7554/eLife.21829
   Pallesen J, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.128, 10.1038/nmicrobiol.2016.128]
   Qian HW, 2017, CELL, V169, P1228, DOI 10.1016/j.cell.2017.05.020
   Shin J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701620
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Subramaniam S, 2016, CURR OPIN STRUC BIOL, V41, P194, DOI 10.1016/j.sbi.2016.07.009
   Sun J, 2017, CELL, V169, P1042, DOI 10.1016/j.cell.2017.05.019
   Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535
   Taylor NMI, 2017, NATURE, V546, P504, DOI 10.1038/nature22345
   Tran EEH, 2016, J VIROL, V90, P7618, DOI 10.1128/JVI.00406-16
   Tran EEH, 2016, MBIO, V7, DOI 10.1128/mBio.00257-16
   Twomey EC, 2017, NATURE, V549, P60, DOI 10.1038/nature23479
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Xiao YB, 2017, CELL, V170, P48, DOI 10.1016/j.cell.2017.06.012
   Ye XH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005454
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Z, 2017, CELL, V170, P483, DOI 10.1016/j.cell.2017.06.041
   Zhang Z, 2016, CELL, V167, P1586, DOI 10.1016/j.cell.2016.11.014
NR 49
TC 2
Z9 2
U1 0
U2 10
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD JUN
PY 2018
VL 43
BP 199
EP 207
DI 10.1016/j.mib.2018.02.012
PG 9
WC Microbiology
SC Microbiology
GA GM3JM
UT WOS:000438000900027
PM 29656089
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Merle, H
   Donnio, A
   Jean-Charles, A
   Guyomarch, J
   Hage, R
   Najioullah, F
   Cesaire, R
   Cabie, A
AF Merle, H.
   Donnio, A.
   Jean-Charles, A.
   Guyomarch, J.
   Hage, R.
   Najioullah, F.
   Cesaire, R.
   Cabie, A.
TI Ocular manifestations of emerging arboviruses: Dengue fever,
   Chikungunya, Zika virus, West Nile virus, and yellow fever
SO JOURNAL FRANCAIS D OPHTALMOLOGIE
LA English
DT Review
DE Arboviruses; Dengue fever; Chikungunya virus; Zika virus; West Nile
   virus; Yellow fever; Eye; Uveitis; Choroiditis; Optic neuritis; Retinal
   vasculitis; Neuroretinitis; Retinopathy; Maculopathy
ID SIMULTANEOUS HEPATITIS-A; INFECTION; TRANSMISSION; MACULOPATHY;
   MARTINIQUE; CHALLENGES; EMERGENCE; NEURITIS; INFANTS; BRAZIL
AB Arboviruses are viral diseases transmitted by mosquitoes and tick bites. They are a major cause of morbidity and sometimes mortality. Their expansion is constant and due in part to climate change and globalization. Mostly found in tropical regions, arboviruses are sometimes the source of epidemics in Europe. Recently, the Chikungunya virus and the Zika virus were responsible for very large epidemics impacting populations that had never been in contact with those viruses. There are currently no effective antiviral treatments or vaccines. Ocular manifestations due to those infections are thus more frequent and increasingly better described. They are sometimes, as with Zika, complicated by a congenital ocular syndrome. The goal of this review is to describe the ophthalmological manifestations of Dengue fever, Chikungunya virus, Zika virus, West Nile virus, and yellow fever. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Merle, H.; Donnio, A.; Jean-Charles, A.; Guyomarch, J.; Hage, R.] Ctr Hosp Univ Martinique, Hop Pierre Zobda Quitman, Ophthalmol Serv, BP 632, F-97261 Fort De France, Martinique, France.
   [Najioullah, F.; Cesaire, R.] Hop Pierre Zobda Quitman, Virol Lab, BP 632, F-97261 Fort De France, Martinique, France.
   [Cabie, A.] Univ Antilles, Ctr Hosp Univ Martinique, Hop Pierre Zobda Quitman, INSERM,Trop & Infect Dis Serv,EA4537,CIC 1424, BP 632, F-97261 Fort De France, Martinique, France.
RP Merle, H (corresponding author), Ctr Hosp Univ Martinique, Hop Pierre Zobda Quitman, Ophthalmol Serv, BP 632, F-97261 Fort De France, Martinique, France.
EM harold.merle@chu-martinique.fr
OI Cabie, Andre/0000-0003-0117-3061
CR [Anonymous], 2017, B EPIDEMIOL HEBD
   Antlanger M, 2011, CAN J OPHTHALMOL, V46, P92, DOI 10.3129/i10-071
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bacsal KE, 2007, ARCH OPHTHALMOL-CHIC, V125, P501, DOI 10.1001/archopht.125.4.501
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Benzekri R, 2017, J FR OPHTALMOL, V40, P138, DOI 10.1016/j.jfo.2017.01.002
   Benzekri R, 2016, AM J TROP MED HYG, V95, P180, DOI 10.4269/ajtmh.15-0547
   Beral L, 2008, OPHTHALMOLOGY, V115, P1524
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cerbino-Neto J, 2016, EMERG INFECT DIS, V22, P1318, DOI 10.3201/eid2207.160375
   Chaskopoulou A, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1736-6
   Chee E, 2009, AM J OPHTHALMOL, V148, P910, DOI 10.1016/j.ajo.2009.06.030
   Chuah K H, 2017, Med J Malaysia, V72, P73
   Couderc T, 2012, J INFECT DIS, V206, P851, DOI 10.1093/infdis/jis296
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Daudens-Vaysse E, 2016, EUROSURVEILLANCE, V21, P11, DOI 10.2807/1560-7917.ES.2016.21.28.30285
   Garcia CAD, 2006, EYE, V20, P1382, DOI 10.1038/sj.eye.6702219
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   de Sousa Adriano Miranda, 2006, Journal of Infection and Chemotherapy, V12, P396, DOI 10.1007/s10156-006-0475-6
   Donnio A, 2010, CAN J OPHTHALMOL, V45, P183, DOI 10.1139/i09-207
   Escott S, 2013, CLIN OPHTHALMOL, V7, P363, DOI 10.2147/OPTH.S37443
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garg S, 2005, SURV OPHTHALMOL, V50, P3, DOI 10.1016/j.survophthal.2004.10.001
   Gerardin P, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-99
   Gossner C. M., 2017, EURO SURVEILL, V22
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Groves JA, 2017, TRANSFUSION, V57, P850, DOI 10.1111/trf.14018
   Gupta A, 2009, EYE, V23, P873, DOI 10.1038/eye.2008.124
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Haritoglou C, 2002, LANCET, V360, P1070, DOI 10.1016/S0140-6736(02)11145-7
   Hayek S, 2015, JAMA OPHTHALMOL, V133, P849, DOI 10.1001/jamaophthalmol.2015.0698
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Kapoor HK, 2006, CAN J OPHTHALMOL, V41, P741, DOI 10.1139/I06-069
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Learned D, 2014, RETINA-J RET VIT DIS, V34, P2269, DOI 10.1097/IAE.0000000000000213
   Lederman E., 2010, Morbidity and Mortality Weekly Report, V59, P34
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Loh BK, 2008, OPHTHALMOLOGICA, V222, P317, DOI 10.1159/000144074
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-35
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   Martinez-Pulgarin DF, 2016, TRAVEL MED INFECT DI, V14, P451, DOI 10.1016/j.tmaid.2016.05.008
   Merle H, 2017, JAMA OPHTHALMOL, V135, P284, DOI 10.1001/jamaophthalmol.2016.5689
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Monath TP, 2007, NEW ENGL J MED, V357, P2222, DOI 10.1056/NEJMp0707161
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Moysidis Stavros N, 2017, Retin Cases Brief Rep, V11 Suppl 1, pS18, DOI 10.1097/ICB.0000000000000391
   Ng AW, 2015, SURV OPHTHALMOL, V60, P106, DOI 10.1016/j.survophthal.2014.07.003
   Nouvelle-Aquitaine CIRE, 2017, B VEILLE SANITAIRE, P12
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Parke DW, 2016, OPHTHALMOLOGY, V123, P2432, DOI 10.1016/j.ophtha.2016.06.039
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Rhee Taek Kwan, 2014, Korean J Ophthalmol, V28, P96, DOI 10.3341/kjo.2014.28.1.96
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Scripsema Nicole K, 2015, Retin Cases Brief Rep, V9, P352, DOI 10.1097/ICB.0000000000000232
   Shaller A, 2016, REV MED SUISSE, V12, P889
   Shivanthan MC, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-156
   Sivakumar RR, 2013, OPHTHALMOLOGY, V120, P1820, DOI 10.1016/j.ophtha.2013.02.006
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stangos A, 2006, OCUL IMMUNOL INFLAMM, V14, P301, DOI 10.1080/09273940600932311
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Su DHW, 2007, OPHTHALMOLOGY, V114, P1743, DOI 10.1016/j.ophtha.2007.03.054
   Tabbara K, 2012, ANN SAUDI MED, V32, P530, DOI 10.5144/0256-4947.2012.30.4.1105
   Tan CSH, 2007, EYE, V21, P875, DOI 10.1038/sj.eye.6702748
   Teixeira MG, 2009, BMJ-BRIT MED J, V339, P1189
   Teoh SC, 2010, RETINA-J RET VIT DIS, V30, P390, DOI 10.1097/IAE.0b013e3181bd2fc6
   Veloso CE, 2015, CASE REP OPHTHALM, V6, P18, DOI 10.1159/000371791
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Voigt U, 2001, KLIN MONATSBL AUGENH, V218, P688, DOI 10.1055/s-2001-18392
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wong CW, 2017, RETIN CASES BRIEF RE, V2, P1
   Yadav HM, 2017, J OPHTHALMIC INFLAMM, V7, DOI 10.1186/s12348-017-0132-5
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
NR 88
TC 6
Z9 7
U1 0
U2 4
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 0181-5512
EI 1773-0597
J9 J FR OPHTALMOL
JI J. Fr. Ophthamol.
PD JUN
PY 2018
VL 41
IS 6
BP E235
EP E243
DI 10.1016/j.jfo.2018.05.002
PG 9
WC Ophthalmology
SC Ophthalmology
GA GM4AB
UT WOS:000438053600001
PM 29929827
DA 2020-07-08
ER

PT J
AU Ferreira, HNC
   Schiariti, V
   Regalado, ICR
   Sousa, KG
   Pereira, SA
   Fechine, CPND
   Longo, E
AF Confessor Ferreira, Haryelle Naryma
   Schiariti, Veronica
   Rodrigues Regalado, Isabelly Cristina
   Sousa, Klayton Galante
   Pereira, Silvana Alves
   Novaes dos Santos Fechine, Carla Patricia
   Longo, Egmar
TI Functioning and Disability Profile of Children with Microcephaly
   Associated with Congenital Zika Virus Infection
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE ICF; public health; Zika virus infection; microcephaly; children
ID FAMILY-CENTERED CARE; CEREBRAL-PALSY; PEDIATRIC REHABILITATION;
   YOUNG-CHILDREN; CONTEXT; BRAZIL; PARTICIPATION; FRAMEWORK; ATTITUDES;
   BORN
AB Introduction: The increase in the number of cases of microcephaly in Brazil and its association with the Zika virus (ZIKV) is a global public health problem. The International Classification of Functioning Disability and Health (ICF) model is a powerful tool and extremely relevant in managing disability. Objective: Describe the functioning profile of children with microcephaly associated with ZIKV in two states of northeastern Brazil. Methods: This is a descriptive cross-sectional study. The sociodemographic characteristics, head circumference, and other clinical data were collected from medical charts, physical examinations, measuring instruments, and interviews with the children and their parents. The Brazilian Portuguese version of the Brief Common ICF Core Set for cerebral palsy (CP) was used. Each ICF category was assigned a qualifier, which ranged from 0 to 4 (no problem, mild problem, moderate problem, severe problem, complete problem). For environmental factors, 0 represents no barrier and 4 represents complete barrier; +0, no facilitator and +4, complete facilitator. Results: A total of 34 children with microcephaly caused by ZIKV were recruited (18 girls and 16 boys) at four rehabilitation facilities in Rio Grande do Norte and Paraiba states, Brazil. The average age of the participants was 21 months, monthly income was approximate to USD 300.00, and head circumference z-scores ranged between 0.92 and -5.51. The functioning profile revealed complete disability in most of the body function categories (b). The activity and participation areas (d) were highly impacted, particularly in mobility-related categories. With respect to environmental factors (e), most of the sample reported a complete facilitator for the immediate family, friends, and health services, systems, and policies, as well as a complete barrier to societal attitudes. Conclusion: This is the first study that describes the functioning profile of children with microcephaly associated with ZIKV, using a tool based on the ICF in Brazil. Our findings reinforce the need to maximize health care and access to information, based on the ICF, for multiprofessional teams, administrators, family members, and children.
C1 [Confessor Ferreira, Haryelle Naryma; Sousa, Klayton Galante; Pereira, Silvana Alves; Longo, Egmar] Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi UFRN FACISA, Postgrad Program Collect Hlth, BR-59200000 Santa Cruz, Brazil.
   [Schiariti, Veronica] Univ Victoria, Div Med Sci, Victoria, BC V8W 2Y2, Canada.
   [Rodrigues Regalado, Isabelly Cristina] Univ Fed Rio Grande do Norte, Postgrad Program Phys Therapy, BR-59078970 Natal, RN, Brazil.
   [Novaes dos Santos Fechine, Carla Patricia] UNIPE, Undegrad Program Phys Therapy, BR-58053000 Joao Pessoa, Paraiba, Brazil.
RP Longo, E (corresponding author), Univ Fed Rio Grande do Norte, Fac Hlth Sci Trairi UFRN FACISA, Postgrad Program Collect Hlth, BR-59200000 Santa Cruz, Brazil.
EM haryelle_naryma@yahoo.com.br; vschiariti@cw.bc.ca;
   isabellyrodrigues_@hotmail.com; galante@facisa.ufrn.br;
   apsilvana@gmail.com; carla.novaes@unipe.br; egmarlongo@yahoo.es
RI Pereira, Silvana Alves/O-7243-2019; Longo, Elson/B-9395-2012
OI Pereira, Silvana Alves/0000-0002-6226-2837; Longo,
   Elson/0000-0001-8062-7791
CR Almasri NA, 2018, PHYS OCCUP THER PEDI, V38, P427, DOI 10.1080/01942638.2017.1337664
   Alsem MW, 2017, RES DEV DISABIL, V60, P125, DOI 10.1016/j.ridd.2016.11.015
   Anaby D, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14091005
   Anaby D, 2015, INT J ENV RES PUB HE, V12, P13388, DOI 10.3390/ijerph121013388
   [Anonymous], 2001, INT CLASS FUNCT DIS
   Armstrong M, 2017, DISABIL HEALTH J, V10, P11, DOI 10.1016/j.dhjo.2016.10.003
   Badia M, 2016, RES DEV DISABIL, V49-50, P312, DOI 10.1016/j.ridd.2015.12.011
   Banks LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189996
   Bastos M., 2016, REV BRAS MED FAM COM, V11, P1
   Di Marino E, 2018, DISABIL HEALTH J, V11, P36, DOI 10.1016/j.dhjo.2017.05.005
   Gladstone M, 2017, LANCET CHILD ADOLESC, V1, P258, DOI 10.1016/S2352-4642(17)30117-7
   Granlund M, 2013, CHILD CARE HLTH DEV, V39, P470, DOI 10.1111/cch.12080
   Guerette P, 2013, ASSIST TECHNOL, V25, P39, DOI 10.1080/10400435.2012.685824
   ICF Research Branch, ICF BAS DOC FORM
   Jerome E., 2016, INT J ENV RES PUB HE, V13, P123
   Jones MA, 2012, PEDIATR PHYS THER, V24, P131, DOI 10.1097/PEP.0b013e31824c5fdc
   Ketelaar M, 2017, DEV MED CHILD NEUROL, V59, P259, DOI 10.1111/dmcn.13287
   King G, 2017, CHILD CARE HLTH DEV, V43, P334, DOI 10.1111/cch.12435
   King GA, 1997, CHILD CARE HLTH DEV, V23, P47, DOI 10.1046/j.1365-2214.1997.840840.x
   King G, 2014, J CHILD NEUROL, V29, P1046, DOI 10.1177/0883073814533009
   Kleber de Oliveira W, 2015, MMWR-MORBID MORTAL W, V2016, P242
   Leyser M, 2016, EUR J PAEDIATR NEURO, V20, P946, DOI 10.1016/j.ejpn.2016.08.001
   Longo E, 2017, BRAZ J PHYS THER, V21, P389, DOI 10.1016/j.bjpt.2017.10.003
   Maenpaa H, 2017, DEV MED CHILD NEUROL, V59, P322, DOI 10.1111/dmcn.13289
   Barbosa MAM, 2012, TEXTO CONTEXTO ENFER, V21, P194, DOI 10.1590/S0104-07072012000100022
   McAnuff J, 2015, TRIALS, V16, DOI 10.1186/1745-6215-16-S2-P1
   Ministerio da Saude, 2016, NOV TECHN BRAS AD RE
   Ministerio da Saude, 2016, SECR AT SAUD PROT AT
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oliveira R., 2016, ACTA FISIATR, V23, P46, DOI [10.5935/0104-7795.20160010, DOI 10.5935/0104-7795.20160010]
   Poirot I, 2017, ANN PHYS REHABIL MED, V60, P371, DOI 10.1016/j.rehab.2017.03.011
   Rosenbaum P, 2015, DEV MED CHILD NEUROL, V57, P1084, DOI 10.1111/dmcn.12956
   Rosenbaum P, 2011, DEV MED CHILD NEUROL, V53, P99, DOI 10.1111/j.1469-8749.2010.03871.x
   Rosenbaum P, 2010, DEV MED CHILD NEUROL, V52, P889, DOI 10.1111/j.1469-8749.2010.03723.x
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schiarit V., ICF ED E TOOL
   Schiariti V, 2017, EUR J PAEDIATR NEURO, V21, P252, DOI 10.1016/j.ejpn.2016.10.007
   Schiariti V, 2015, DEV MED CHILD NEUROL, V57, P149, DOI 10.1111/dmcn.12551
   Secretaria de Vigilancia em Saude/Ministerio da Saude, 2017, INF EP 29 SEM EP SE
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Trabacca A, 2012, J CHILD NEUROL, V27, P183, DOI 10.1177/0883073811415852
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Warlow TA, 2018, CHILDREN-BASEL, V5, DOI 10.3390/children5010013
NR 43
TC 14
Z9 14
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2018
VL 15
IS 6
AR 1107
DI 10.3390/ijerph15061107
PG 14
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GK8SE
UT WOS:000436496900058
PM 29844290
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thomas, SM
   Tjaden, NB
   Frank, C
   Jaeschke, A
   Zipfel, L
   Wagner-Wiening, C
   Faber, M
   Beierkuhnlein, C
   Stark, K
AF Thomas, Stephanie Margarete
   Tjaden, Nils Benjamin
   Frank, Christina
   Jaeschke, Anja
   Zipfel, Lukas
   Wagner-Wiening, Christiane
   Faber, Mirko
   Beierkuhnlein, Carl
   Stark, Klaus
TI Areas with High Hazard Potential for Autochthonous Transmission of Aedes
   albopictus-Associated Arboviruses in Germany
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Aedes albopictus; Asian tiger mosquito; species distribution model;
   global change; vector-borne diseases; mosquito-borne diseases;
   chikungunya; dengue; Europe
ID ASIAN TIGER MOSQUITO; CLIMATE-CHANGE IMPACTS; CHIKUNGUNYA VIRUS;
   DISTRIBUTION MODELS; DIPTERA-CULICIDAE; GLOBAL SPREAD; ZIKA VIRUS;
   SEPTEMBER; DENGUE; FRANCE
AB The intensity and extent of transmission of arboviruses such as dengue, chikungunya, and Zika virus have increased markedly over the last decades. Autochthonous transmission of dengue and chikungunya by Aedes albopictus has been recorded in Southern Europe where the invasive mosquito was already established and viraemic travelers had imported the virus. Ae. albopictus populations are spreading northward into Germany. Here, we model the current and future climatically suitable regions for Ae. albopictus establishment in Germany, using climate data of spatially high resolution. To highlight areas where vectors and viraemic travellers are most likely to come into contact, reported dengue and chikungunya incidences are integrated at the county level. German cities with the highest likelihood of autochthonous transmission of Aedes albopictus-borne arboviruses are currently located in the western parts of the country: Freiburg im Breisgau, Speyer, and Karlsruhe, affecting about 0.5 million people. In addition, 8.8 million people live in regions considered to show elevated hazard potential assuming further spread of the mosquito: Baden-Wurttemberg (Upper Rhine, Lake Constance regions), southern parts of Hesse, and North Rhine-Westphalia (Lower Rhine). Overall, a more targeted and thus cost-efficient implementation of vector control measures and health surveillance will be supported by the detailed maps provided here.
C1 [Thomas, Stephanie Margarete; Tjaden, Nils Benjamin; Jaeschke, Anja; Zipfel, Lukas; Beierkuhnlein, Carl] Univ Bayreuth, Dept Biogeog, D-95447 Bayreuth, Germany.
   [Frank, Christina; Faber, Mirko; Stark, Klaus] Robert Koch Inst, D-13353 Berlin, Germany.
   [Wagner-Wiening, Christiane] Baden Wurttemberg Hlth Author, D-70565 Stuttgart, Germany.
RP Thomas, SM (corresponding author), Univ Bayreuth, Dept Biogeog, D-95447 Bayreuth, Germany.
EM Stephanie.Thomas@uni-bayreuth.de; Nils.Tjaden@uni-bayreuth.de;
   FrankC@rki.de; Anja.Jaeschke@uni-bayreuth.de;
   Lukas.Zipfel@uni-bayreuth.de; christiane.wagner-wiening@rps.bwl.de;
   FaberM@rki.de; Carl.Beierkuhnlein@uni-bayreuth.de; StarkK@rki.de
RI Faber, MIrko/O-1191-2018
OI Faber, MIrko/0000-0002-9196-570X; Frank, Christina/0000-0001-6776-8450;
   Thomas, Stephanie Margarete/0000-0003-0507-2006
FU Robert Koch Institute (the national public health institution in Germany
   located in Berlin, Germany); Ministry of Social Affairs and Integration
   Baden-Wurttemberg; German Research Platform for Zoonoses; Federal
   Ministry of Education and Research (Interdisciplinary cross-sectional
   project "Spatial, Temporal and Economic Risk Assessment of Vector-borne
   Zoonoses") [FKZ: 01KI1601]; German Research Foundation (DFG)German
   Research Foundation (DFG); University of Bayreuth
FX The study was funded by the Robert Koch Institute (the national public
   health institution in Germany located in Berlin, Germany), the Ministry
   of Social Affairs and Integration Baden-Wurttemberg, the German Research
   Platform for Zoonoses, and the Federal Ministry of Education and
   Research (Interdisciplinary cross-sectional project "Spatial, Temporal
   and Economic Risk Assessment of Vector-borne Zoonoses" FKZ: 01KI1601).
   Ruth Klopstein supported the data collection and processing. This
   publication was funded by the German Research Foundation (DFG) and the
   University of Bayreuth in the funding program for publishing in Open
   Access.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Ahola T, 2015, VECTOR-BORNE ZOONOT, V15, P250, DOI 10.1089/vbz.2014.1681
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   [Anonymous], 2016, BUNDESGESETZBLATT 1
   [Anonymous], AED ALB
   Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x
   Becker N, 2017, PARASITOL RES, V116, P847, DOI 10.1007/s00436-016-5356-z
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bittner T, 2011, J VEG SCI, V22, P699, DOI 10.1111/j.1654-1103.2011.01266.x
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dormann CF, 2008, ECOLOGY, V89, P3371, DOI 10.1890/07-1772.1
   European Centre for Disease Prevention and Control, CLUST AUT CHIK CAS I
   European Centre for Disease Prevention and Control, MOSQ MAPS
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Kampen H, 2017, PARASITOL RES, V116, P3253, DOI 10.1007/s00436-017-5619-3
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Morens DM, 2014, NEW ENGL J MED, V371, P885, DOI 10.1056/NEJMp1408509
   Oxley D., GLOBAL AIR PASSENGER
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1
   R Core Team, 2017, R LANG ENV STAT COMP
   Riahi K, 2011, CLIMATIC CHANGE, V109, P33, DOI 10.1007/s10584-011-0149-y
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sebesta O, 2012, EUROSURVEILLANCE, V17, P6
   Seidel Bernhard, 2015, Beitrage zur Entomofaunistik, V16, P83
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Stocker T.F., 2013, CLIMATE CHANGE 2013
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x
   Tjaden NB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03566-3
   Tjaden NB, 2018, TRENDS PARASITOL, V34, P227, DOI 10.1016/j.pt.2017.11.006
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   VanDerWal J, 2009, ECOL MODEL, V220, P589, DOI 10.1016/j.ecolmodel.2008.11.010
   Walsh C, 2013, R PACKAGE VERSION 1
   Walther D, 2017, ACTA TROP, V166, P186, DOI 10.1016/j.actatropica.2016.11.024
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Werner D, 2012, EUROSURVEILLANCE, V17, P14
   Werner D, 2015, PARASITOL RES, V114, P831, DOI 10.1007/s00436-014-4244-7
NR 53
TC 5
Z9 5
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD JUN
PY 2018
VL 15
IS 6
AR 1270
DI 10.3390/ijerph15061270
PG 12
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GK8SE
UT WOS:000436496900221
PM 29914102
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Glitscher, M
   Himmelsbach, K
   Woytinek, K
   Johne, R
   Reuter, A
   Spiric, J
   Schwaben, L
   Grunweller, A
   Hildt, E
AF Glitscher, Mirco
   Himmelsbach, Kiyoshi
   Woytinek, Kathrin
   Johne, Reimar
   Reuter, Andreas
   Spiric, Jelena
   Schwaben, Luisa
   Gruenweller, Arnold
   Hildt, Eberhard
TI Inhibition of Hepatitis E Virus Spread by the Natural Compound
   Silvestrol
SO VIRUSES-BASEL
LA English
DT Article
DE HEV; silvestrol; antiviral; eIF4A; MVP
ID MAJOR VAULT PROTEIN; CAPSID PROTEIN; CELL-CULTURE; CANCER CELLS; ORF3
   PROTEIN; LIFE-CYCLE; INFECTION; RNA; REPLICATION; INTERFERON
AB Every year, there are about 20 Mio hepatitis E virus (HEV) infections and 60,000 deaths that are associated with HEV worldwide. At the present, there exists no specific therapy for HEV. The natural compound silvestrol has a potent antiviral effect against the (-)-strand RNA-virus Ebola virus, and also against the (+)-strand RNA viruses Corona-, Picorna-, and Zika virus. The inhibitory effect on virus spread is due to an inhibition of the DEAD-box RNA helicase eIF4A, which is required to unwind structured 5-untranslated regions (UTRs). This leads to an impaired translation of viral RNA. The HEV (+)-strand RNA genome contains a 5-capped, short 5-UTR. This study aims to analyze the impact of silvestrol on the HEV life cycle. Persistently infected A549 cells were instrumental. This study identifies silvestrol as a potent inhibitor of the release of HEV infectious viral particles. This goes along with a strongly reduced HEV capsid protein translation, retention of viral RNA inside the cytoplasm, and without major cytotoxic effects. Interestingly, in parallel silvestrol affects the activity of the antiviral major vault protein (MVP) by translocation from the cytoplasm to the perinuclear membrane. These data further characterize the complex antiviral activity of silvestrol and show silvestrol's broad spectrum of function, since HEV is a virus without complex secondary structures in its genome, but it is still affected.
C1 [Glitscher, Mirco; Himmelsbach, Kiyoshi; Woytinek, Kathrin; Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Johne, Reimar] Fed Inst Risk Assessment, D-10589 Berlin, Germany.
   [Reuter, Andreas; Spiric, Jelena; Schwaben, Luisa] Paul Ehrlich Inst, Dept Allergol, D-63225 Langen, Germany.
   [Gruenweller, Arnold] Philipps Univ Marburg, Inst Pharmaceut Chem, D-35037 Marburg, Germany.
   [Hildt, Eberhard] German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
RP Hildt, E (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.; Hildt, E (corresponding author), German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
EM mirco.glitscher@pei.de; kiyoshi.himmelsbach@pei.de;
   kathrin.woytinek@pei.de; Reimar.Johne@bfr.bund.de;
   Andreas.Reuter@pei.de; Jelena.Spiric@pei.de; Luisa.schwaben@pei.de;
   arnold.gruenweller@staff.uni-marburg.de; eberhard.hildt@pei.de
RI Hildt, Eberhard/A-1040-2015
OI Grunweller, Arnold/0000-0003-1508-3016; Reuter,
   Andreas/0000-0002-6082-9000; Glitscher, Mirco/0000-0002-8799-7565
FU German One Health Initiative (GOHI); German center for infection
   research (DZIF); LOEWE Center DRUID (Novel Drug Targets against
   Poverty-Related and Neglected Tropical Infectious Diseases)
FX The authors thank Gert Carra for his excellent technical support and
   Jihong Meng (Southeast University Nanjing, China), Rainer Ulrich
   (Friedrich-Loeffler-Institute, Federal Research Institute for Animal
   Health, Grifswald, Germany) and Suzanne Emerson (National Institutes of
   Health, Bethesda, MD, USA) for antibodies and reporter genome. R.J.
   obtained a grant to from the German One Health Initiative (GOHI). E.H.
   obtained a grant from the German center for infection research (DZIF).
   E.H. and A.G. obtained funding by the LOEWE Center DRUID (Novel Drug
   Targets against Poverty-Related and Neglected Tropical Infectious
   Diseases).
CR Aspinall EJ, 2017, EUROSURVEILLANCE, V22, P13, DOI 10.2807/1560-7917.ES.2017.22.26.30561
   Balan S, 2013, GENE, V526, P449, DOI 10.1016/j.gene.2013.05.067
   Biedenkopf N, 2017, ANTIVIR RES, V137, P76, DOI 10.1016/j.antiviral.2016.11.011
   Boxall E, 2006, TRANSFUSION MED, V16, P79, DOI 10.1111/j.1365-3148.2006.00652.x
   Brunelle JL, 2014, METHOD ENZYMOL, V541, P151, DOI 10.1016/B978-0-12-420119-4.00012-4
   Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424
   Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223
   Chandra V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022412
   Chen GB, 2004, WORLD J GASTROENTERO, V10, P2045, DOI 10.3748/wjg.v10.i14.2045
   Chen YL, 2016, CHINESE J PHYSIOL, V59, P331, DOI 10.4077/CJP.2016.BAF426
   De Winter BCM, 2018, PHARMACOL RES, V130, P308, DOI 10.1016/j.phrs.2018.02.030
   Debing Y, 2014, ANTIMICROB AGENTS CH, V58, P267, DOI 10.1128/AAC.01795-13
   Distler U, 2014, NAT METHODS, V11, P167, DOI [10.1038/NMETH.2767, 10.1038/nmeth.2767]
   Echevarria JM, 2013, J MED VIROL, V85, P1037, DOI 10.1002/jmv.23526
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029
   Graff J, 2006, J VIROL, V80, P5919, DOI 10.1128/JVI.00046-06
   Hafner A, 2003, EMBO REP, V4, P767, DOI 10.1038/sj.embor.embor903
   Johne R, 2014, J VIRAL HEPATITIS, V21, P447, DOI 10.1111/jvh.12157
   Kamar N, 2013, J CLIN EXP HEPATOL, V3, P134, DOI 10.1016/j.jceh.2013.05.003
   Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7
   KEDERSHA NL, 1986, J CELL BIOL, V103, P699, DOI 10.1083/jcb.103.3.699
   Kenney SP, 2015, VIROLOGY, V486, P198, DOI 10.1016/j.virol.2015.09.012
   Khuroo MS, 2016, WORLD J GASTROENTERO, V22, P7030, DOI 10.3748/wjg.v22.i31.7030
   Kim KM, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1413
   Kogure T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076136
   KOONIN EV, 1992, P NATL ACAD SCI USA, V89, P8259, DOI 10.1073/pnas.89.17.8259
   Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642
   McPherson S, 2018, TRANSPLANTATION, V102, P15, DOI 10.1097/TP.0000000000001908
   Minuk GY, 2007, CAN J GASTROENTEROL, V21, P439, DOI 10.1155/2007/289059
   Montpellier C, 2018, GASTROENTEROLOGY, V154, P211, DOI 10.1053/j.gastro.2017.09.020
   Muller C, 2018, ANTIVIR RES, V150, P123, DOI 10.1016/j.antiviral.2017.12.010
   Nagashima S, 2017, J VIROL, V91, DOI 10.1128/JVI.00822-17
   Nagashima S, 2014, J GEN VIROL, V95, P2166, DOI 10.1099/vir.0.066910-0
   Pan L, 2014, NAT PROD REP, V31, P924, DOI 10.1039/c4np00006d
   Peng NF, 2016, J IMMUNOL, V196, P2753, DOI 10.4049/jimmunol.1501481
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Ramakrishnan Muthannan Andavar, 2016, World J Virol, V5, P85, DOI 10.5501/wjv.v5.i2.85
   Ratajczak J, 2006, LEUKEMIA, V20, P1487, DOI 10.1038/sj.leu.2404296
   Ricci A., 2017, EFS2, V15, P42
   Schemmerer M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100267
   Sehgal D, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-38
   Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12
   Slesina M, 2005, CELL TISSUE RES, V321, P97, DOI 10.1007/s00441-005-1086-8
   Steiner E, 2006, J CELL SCI, V119, P459, DOI 10.1242/jcs.02773
   Tajitsu Y, 2013, INT J MOL MED, V32, P703, DOI 10.3892/ijmm.2013.1428
   TAM AW, 1991, VIROLOGY, V185, P120, DOI 10.1016/0042-6822(91)90760-9
   TSEGA E, 1993, ETHIOPIAN MED J, V31, P173
   Tyagi S, 2002, J BIOL CHEM, V277, P22759, DOI 10.1074/jbc.M200185200
   Ursitti J A, 2001, Curr Protoc Protein Sci, VChapter 10, DOI 10.1002/0471140864.ps1007s00
   Yin X, 2018, P NATL ACAD SCI USA, V115, P4773, DOI 10.1073/pnas.1721345115
   Yin X, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8080229
NR 52
TC 13
Z9 13
U1 4
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD JUN
PY 2018
VL 10
IS 6
AR 301
DI 10.3390/v10060301
PG 19
WC Virology
SC Virology
GA GK4QE
UT WOS:000436146700024
PM 29865243
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Contopoulos-Ioannidis, D
   Newman-Lindsay, S
   Chow, C
   LaBeaud, AD
AF Contopoulos-Ioannidis, Despina
   Newman-Lindsay, Shoshana
   Chow, Camille
   LaBeaud, A. Desiree
TI Mother-to-child transmission of Chikungunya virus: A systematic review
   and meta-analysis
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Review
ID MATERNAL-FETAL TRANSMISSION; REUNION ISLAND; MOLECULAR CHARACTERIZATION;
   VERTICAL TRANSMISSION; PHYLOGENETIC ANALYSIS; ANTIBODY KINETICS;
   AEDES-AEGYPTI; RISK-FACTORS; ZIKA VIRUS; OUTBREAK
AB Background
   Chikungunya virus (CHIKV) is an emerging arboviral infection with a global distribution and may cause fetal and neonatal infections after maternal CHIKV-infections during gestation.
   Methodology
   We performed a systematic review to evaluate the risk for: a) mother-to-child transmission (MTCT), b) antepartum fetal deaths (APFD), c) symptomatic neonatal disease, and d) neonatal deaths from maternal CHIKV-infections during gestation. We also recorded the neonatal clinical manifestations after such maternal infections (qualitative data synthesis). We searched PubMed (last search 3/2017) for articles, of any study design, with any of the above outcomes. We calculated the overall risk of MTCT, APFDs and risk of symptomatic neonatal disease by simple pooling. For endpoints with >= 5 events in more than one study, we also synthesized the data by random-effect-model (REM) meta-analysis.
   Principal findings
   Among 563 identified articles, 13 articles from 8 cohorts were included in the quantitative data synthesis and 33 articles in the qualitative data synthesis. Most cohorts reported data only on symptomatic rather than on all neonatal infections. By extrapolation also of these data, the overall pooled-MTCT-risk across cohorts was at least 15.5% (206/1331), (12.6% by REMs). The pooled APFD-risk was 1.7% (20/1203); while the risk of CHIKV-confirmed-APFDs was 0.3% (3/1203). Overall, the pooled-risk of symptomatic neonatal disease was 15.3% (203/1331), (11.9% by REMs). The pooled risk of symptomatic disease was 50.0% (23/46) among intrapartum vs 0% (0/712) among antepartum/peripartum maternal infections. Infected newborns, from maternal infections during gestation were either asymptomatic or presented within their first week of life, but not at birth, with fever, irritability, hyperalgesia, diffuse limb edema, rashes and occasionally sepsis-like illness and meningoencephalitis. The pooled-risk of neonatal death was 0.6% (5/832) among maternal infections and 2.8% (5/182) among neonatal infections; long-term neurodevelopmental delays occurred in 50% of symptomatic neonatal infections.
   Conclusions/Significance
   Published cohorts with data on the risk to the fetus and/or newborn from maternal CHIKV-infections during gestation were sparse compared to the number of recently reported CHIKV-infection outbreaks worldwide; however perinatal infections do occur, at high rates during intrapartum period, and can be related to neonatal death and long-term disabilities.
C1 [Contopoulos-Ioannidis, Despina; LaBeaud, A. Desiree] Stanford Univ, Dept Pediat, Div Infect Dis, Sch Med, Stanford, CA 94305 USA.
   [Newman-Lindsay, Shoshana] Virginia Commonwealth Univ, Childrens Hosp Richmond, Dept Pediat, Richmond, VA USA.
   [Chow, Camille] St Agnes Med Ctr, Dept Internal Med, Fresno, CA USA.
RP Contopoulos-Ioannidis, D (corresponding author), Stanford Univ, Dept Pediat, Div Infect Dis, Sch Med, Stanford, CA 94305 USA.
EM dcontop@stanford.edu
OI Chow, Camille/0000-0002-4859-0957
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21TW010536]; Neurodevelopment and
   Vector-borne Diseases: Building Research Capacity in the Tropics
FX This project was partially supported by NIH, R21TW010536;
   Neurodevelopment and Vector-borne Diseases: Building Research Capacity
   in the Tropics. The funder had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR AbuBakar S, 2007, EMERG INFECT DIS, V13, P147, DOI 10.3201/eid1301.060617
   Afreen N, 2014, MICROBIOL IMMUNOL, V58, P688, DOI 10.1111/1348-0421.12209
   Alvarado-Socarras JL, 2016, J PEDIAT INF DIS SOC, V5, pE17, DOI 10.1093/jpids/piw021
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Armstrong PM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005623
   Ayu SM, 2010, AM J TROP MED HYG, V83, P1245, DOI 10.4269/ajtmh.2010.10-0279
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Bessaud M, 2006, EMERG INFECT DIS, V12, P1604, DOI 10.3201/eid1210.060596
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Boumahni B, 2012, Med Trop (Mars), V72 Spec No, P94
   Boumahni B, 2011, ARCH PEDIATRIE, V18, P272, DOI 10.1016/j.arcped.2010.12.002
   Bustos F, 2018, 67 ANN M ASTMH AM SO
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Chattopadhyay S, 2016, INDIAN J MED MICROBI, V34, P213, DOI 10.4103/0255-0857.176839
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2
   Directorate of National Vector Borne Disease Control Programme, 2010, STAT REP DENG CHIK 3
   Dotters-Katz SK, 2015, OBSTET GYNECOL SURV, V70, P453, DOI 10.1097/OGX.0000000000000184
   Doughty CT, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0724-3
   Enserink M, 2007, SCIENCE, V318, P1860, DOI 10.1126/science.318.5858.1860
   Escobar M, 2017, EMERG INFECT DIS, V23, P1777, DOI 10.3201/eid2311.170480
   Evans-Gilbert T, 2017, AM J TROP MED HYG, V96, P913, DOI 10.4269/ajtmh.16-0491
   FRIEDRICH MJ, 2014, JAMA-J AM MED ASSOC, V312, P222
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Gerardin P, 2016, NEUROLOGY, V86, P2025
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gilbert RE, 2007, J MED SCREEN, V14, P8, DOI 10.1258/096914107780154440
   Gopakumar H, 2012, J CLIN NEONATOL, V1, P155, DOI 10.4103/2249-4847.101704
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hartling L, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0347-z
   Hopperstad KA, 2016, J MED ENTOMOL, V53, P836, DOI 10.1093/jme/tjw050
   Hortion J, 2017, AM J TROP MED HYG, V95, P223
   Hussain R, 2013, E MEDITERR HEALTH J, V19, P506
   Jain J, 2017, CLIN INFECT DIS, V65, P133, DOI 10.1093/cid/cix283
   Karthiga V, 2016, J PEDIATR NEUROSCI, V11, P223, DOI 10.4103/1817-1745.193369
   Kawle AP, 2017, J VECTOR DIS, V54, P35
   Khandelwal K, 2012, J PAEDIATR CHILD H, V48, P542, DOI 10.1111/j.1440-1754.2012.02484.x
   Khatun S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003907
   Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483
   Kumar CVMN, 2016, ACTA VIROL, V60, P114, DOI 10.4149/av_2016_01_114
   Kumar CVMN, 2010, INDIAN J VIROL, V21, P8, DOI 10.1007/s13337-010-0012-1
   Kumar NP, 2011, MEM I OSWALDO CRUZ, V106, P912, DOI 10.1590/S0074-02762011000800003
   Kumar N, 2014, INDIAN PEDIATR, V51, P419, DOI 10.1007/s13312-014-0408-x
   LaBeaud AD, 2015, AM J TROP MED HYG, V93, P322
   LaBeaud AD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003436
   Lanciotti RS, 2016, AM J TROP MED HYG, V94, P800, DOI 10.4269/ajtmh.15-0375
   Lane KR, 2017, INTEGR COMP BIOL, V57, pE93
   Laoprasopwattana K, 2016, EPIDEMIOL INFECT, V144, P381, DOI 10.1017/S0950268815001065
   Lenglet Y, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P578
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Macpherson C, 2016, AM J TROP MED HYG, V95, P890, DOI 10.4269/ajtmh.16-0122
   Manica M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.44.17-00685
   Manimunda SP, 2010, AM J TROP MED HYG, V83, P751, DOI 10.4269/ajtmh.2010.09-0433
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   McNerney R, 2015, DIAGNOSTICS, V5, P200, DOI 10.3390/diagnostics5020200
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mudurangaplar B, 2016, J CLIN DIAGN RES, V10, pDC14, DOI 10.7860/JCDR/2016/18370.7509
   Mukherjee S, 2017, EUR J CLIN MICROBIOL, V36, P2273, DOI 10.1007/s10096-017-3061-1
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Olajiga OM, 2017, IMMUNOL INVEST, V46, P552, DOI 10.1080/08820139.2017.1319383
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Passi GR, 2008, INDIAN PEDIATR, V45, P240
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paulman P M, 1990, J Am Board Fam Pract, V3, P121
   Peper SM, 2016, J GEN INTERN MED, V31, P576, DOI 10.1007/s11606-015-3459-3
   Pinzon-Redondo H, 2016, PEDIATR INFECT DIS J, V35, P702, DOI 10.1097/INF.0000000000001135
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Raghavendhar BS, 2016, J MED VIROL, V88, P923, DOI 10.1002/jmv.24433
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramful D, 2014, J INFECT DIS, V209, P1726, DOI 10.1093/infdis/jit814
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   Rodrigues Faria Nuno, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.c97507e3e48efb946401755d468c28b2
   Rodriguez-Nieves Melanie, 2016, Pediatr Infect Dis J, V35, P1163, DOI 10.1097/INF.0000000000001261
   Ruckert C, 2017, AM J TROP MED HYG, V95, P191
   Senanayake M. P., 2009, CEYLON MEDICAL JOURNAL, V54, P47
   Shenoy S, 2012, INDIAN PEDIATR, V49, P238
   Shrivastava A, 2011, INDIAN J PEDIATR, V78, P1008, DOI 10.1007/s12098-011-0371-7
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Souza Thiara Manuele Alves, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.4200119978d62ccaa454599cd2735727
   Tan KK, 2015, SCI REP-UK, V5, DOI 10.1038/srep12279
   Teo TH, 2015, J VIROL, V89, P7955, DOI 10.1128/JVI.00909-15
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Touret Y, 2006, PRESSE MED, V35, P1656, DOI 10.1016/S0755-4982(06)74874-6
   Valamparampil JJ, 2009, INDIAN J PEDIATR, V76, P151, DOI 10.1007/s12098-009-0045-x
   van Aalst M, 2017, TRAVEL MED INFECT DI, V15, P8, DOI 10.1016/j.tmaid.2017.01.004
   Vasani R, 2016, PEDIATR DERMATOL, V33, P209, DOI 10.1111/pde.12650
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Watanaveeradej V, 2006, EMERG INFECT DIS, V12, P1770, DOI 10.3201/eid1211.051560
   Wu D, 2012, EMERG INFECT DIS, V18, P493, DOI 10.3201/eid1803.110034
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
NR 102
TC 17
Z9 17
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006510
DI 10.1371/journal.pntd.0006510
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000019
PM 29897898
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Elliott, R
   Banerjee, T
   Santra, S
AF Elliott, Rebekah
   Banerjee, Tuhina
   Santra, Santimukul
TI Zika: An emerging disease requiring prevention and awareness
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID DIAGNOSTIC-TEST; VIRUS; BIOSENSORS
C1 [Elliott, Rebekah; Banerjee, Tuhina; Santra, Santimukul] Pittsburg State Univ, Dept Chem, Pittsburg, KS 66762 USA.
RP Santra, S (corresponding author), Pittsburg State Univ, Dept Chem, Pittsburg, KS 66762 USA.
EM ssantra@pittstate.edu
OI Santra, Santimukul/0000-0002-5047-5245
FU National Institute of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1 R03
   AI132832-01]; Kansas INBRE Bridging grants [K-INBRE P20 GM103418]
FX This project was supported by the National Institute of Health (NIH: 1
   R03 AI132832-01) and Kansas INBRE Bridging grants (K-INBRE P20
   GM103418), all to SS. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bhalla N, 2016, ESSAYS BIOCHEM, V60, P1, DOI 10.1042/EBC20150001
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Das S, 2009, VIROLOGY, V385, P47, DOI 10.1016/j.virol.2008.10.025
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Kennedy RB, 2016, EBIOMEDICINE, V13, P29, DOI 10.1016/j.ebiom.2016.10.016
   Naiyer MM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5296
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pan American Health Organization (PAHO) / World Health Organization (WHO), 2016, ZIK EP UPD D 15 DEC
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Shelby T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07620-y
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   World Health Organization, 10 WHO
NR 19
TC 2
Z9 4
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006486
DI 10.1371/journal.pntd.0006486
PG 4
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000016
PM 29927941
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hladish, TJ
   Pearson, CAB
   Rojas, DP
   Gomez-Dantes, H
   Halloran, ME
   Vazquez-Prokopec, GM
   Longini, IM
AF Hladish, Thomas J.
   Pearson, Carl A. B.
   Rojas, Diana Patricia
   Gomez-Dantes, Hector
   Halloran, M. Elizabeth
   Vazquez-Prokopec, Gonzalo M.
   Longini, Ira M.
TI Forecasting the effectiveness of indoor residual spraying for reducing
   dengue burden
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; VACCINE; IMPACT; TRANSMISSION; EPIDEMIC; IMMUNITY
AB Background
   Historically, mosquito control programs successfully helped contain malaria and yellow fever, but recent efforts have been unable to halt the spread of dengue, chikungunya, or Zika, all transmitted by Aedes mosquitoes. Using a dengue transmission model and results from indoor residual spraying (IRS) field experiments, we investigated how IRS-like campaign scenarios could effectively control dengue in an endemic setting.
   Methods and findings
   In our model, we found that high levels of household coverage (75% treated once per year), applied proactively before the typical dengue season could reduce symptomatic infections by 89.7% (median of 1000 simulations; interquartile range [IQR]:[83.0%, 94.8%]) in year one and 78.2% (IQR: [71.2%, 88.0%]) cumulatively over the first five years of an annual program. Lower coverage had correspondingly lower effectiveness, as did reactive campaigns. Though less effective than preventative campaigns, reactive and even post-epidemic interventions retain some effectiveness; these campaigns disrupt inter-seasonal transmission, highlighting an off-season control opportunity. Regardless, none of the campaign scenarios maintain their initial effectiveness beyond two seasons, instead stabilizing at much lower levels of benefit: in year 20, median effectiveness was only 27.3% (IQR: [-21.3%, 56.6%]). Furthermore, simply ceasing an initially successful program exposes a population with lowered herd immunity to the same historical threat, and we observed outbreaks more than four-fold larger than pre-intervention outbreaks. These results do not take into account evolving insecticide resistance, thus long-term effectiveness may be lower if new, efficacious insecticides are not developed.
   Conclusions
   Using a detailed agent-based dengue transmission model for Yucata An State, Mexico, we predict that high coverage indoor residual spraying (IRS) interventions can largely eliminate transmission for a few years, when applied a few months before the typical seasonal epidemic peak. However, vector control succeeds by preventing infections, which precludes natural immunization. Thus, as a population benefits from mosquito control, it gradually loses naturally acquired herd immunity, and the control effectiveness declines; this occurs across all of our modeled scenarios, and is consistent with other empirical work. Long term control that maintains early effectiveness would require some combination of increasing investment, complementary interventions such as vaccination, and control programs across a broad region to diminish risk of importation.
C1 [Hladish, Thomas J.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Hladish, Thomas J.; Rojas, Diana Patricia; Longini, Ira M.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Pearson, Carl A. B.] Very Good Res & Dev LLC, Gainesville, FL USA.
   [Rojas, Diana Patricia] Univ Florida, Dept Epidemiol, Gainesville, FL USA.
   [Gomez-Dantes, Hector] Natl Inst Publ Hlth, Hlth Syst Res Ctr, Cuernavaca, Morelos, Mexico.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Halloran, M. Elizabeth; Longini, Ira M.] Ctr Inference & Dynam Infect Dis, Seattle, WA USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Longini, Ira M.] Univ Florida, Dept Biostat, Gainesville, FL USA.
RP Hladish, TJ (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Hladish, TJ (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM tjhladish@gmail.com
RI Pearson, Carl/AAH-8892-2019; Rojas, Diana Patricia/AAC-2469-2019
OI Pearson, Carl/0000-0003-0701-7860; Rojas, Diana
   Patricia/0000-0003-0241-6416; Hladish, Thomas/0000-0003-1819-6235;
   Halloran, M Elizabeth/0000-0002-3127-1757
FU National Institutes of Health/National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U54 GM111274]; National Science
   FoundationNational Science Foundation (NSF) [DEB/EEID: 1640698];
   Fulbright - Colciencias doctoral scholarship from the Colombian
   Department of Science and Technology
FX This project was funded by a National Institutes of Health/National
   Institute of General Medical Sciences Grant (https://www.nih.gov/; U54
   GM111274) to MEH, a National Science Foundation Grant (https://nsf.gov;
   DEB/EEID: 1640698) to GMVP, and a Fulbright - Colciencias doctoral
   scholarship (http://www.fulbright.edu.co) to DPR from the Colombian
   Department of Science and Technology. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, P3, DOI DOI 10.1371/J0URNAL.PNTD.0004551
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Direccion General de Epidemiologia SINAVE Ministry of Health Mexico, 2015, DENG MORB REP
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Farfan-Ale J A, 1991, Bol Med Hosp Infant Mex, V48, P780
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   GCC Collaboration, 2016, GNU COMP COLL GCC
   GIGLIOLI G, 1948, AM J TROP MED, V28, P43
   GSL Collaboration, 2015, GNU SCI LIB GSL
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hladish T., 2015, SEQUENTIAL MONTE CAR
   Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lorono-Pino MA, 1989, REV LATINOAM MICROBI, V31, P259
   MCLEAN AR, 1988, EPIDEMIOL INFECT, V100, P419, DOI 10.1017/S0950268800067170
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Nathan M B, 1982, Bull Pan Am Health Organ, V16, P28
   Nishiura H., 2006, DENGUE B, V30
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Okamoto KW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004695
   Oki M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001367
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Oxborough RM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-37
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   R Core Team, 2016, R LANG ENV STAT COMP
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Rowland M, 2013, PLOS ONE, V8, P1, DOI DOI 10.HTTPS://D0I.0RG/10.1371/J0URNAL.P0NE.0069516
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sanofi Media Relations, 2017, SAN UPD INF DENG VAC
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Scott TW, 2010, CURR TOP MICROBIOL, V338, P115, DOI 10.1007/978-3-642-02215-9_9
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   SOPER FL, 1965, AM J TROP MED HYG, V14, P887, DOI 10.4269/ajtmh.1965.14.887
   Uragayala S, 2018, VILLAGE SCALE PHASE
   Vazquez-Prokopec GM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005656
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   WHO, 2012, GLOB PLAN INS RES MA
   World Health Organization, 2016, WKLY EPIDEMIOL REC, V30, P349
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2006, PEAT THEIR APPL CONT
   Worrall E, 2007, TROP MED INT HEALTH, V12, P75, DOI 10.1111/j.1365-3156.2006.01772.x
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 55
TC 8
Z9 8
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006570
DI 10.1371/journal.pntd.0006570
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000045
PM 29939983
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Main, BJ
   Nicholson, J
   Winokur, OC
   Steiner, C
   Riemersma, KK
   Stuart, J
   Takeshita, R
   Krasnec, M
   Barker, CM
   Coffey, LL
AF Main, Bradley J.
   Nicholson, Jay
   Winokur, Olivia C.
   Steiner, Cody
   Riemersma, Kasen K.
   Stuart, Jackson
   Takeshita, Ryan
   Krasnec, Michelle
   Barker, Christopher M.
   Coffey, Lark L.
TI Vector competence of Aedes aegypti, Culex tarsalis, and Culex
   quinquefasciatus from California for Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID TRANSMISSION; MOSQUITOS; AMERICA; STRAIN; MODEL
AB Zika virus (ZIKV) has emerged since 2013 as a significant global human health threat following outbreaks in the Pacific Islands and rapid spread throughout South and Central America. Severe congenital and neurological sequelae have been linked to ZIKV infections. Assessing the ability of common mosquito species to transmit ZIKV and characterizing variation in mosquito transmission of different ZIKV strains is important for estimating regional outbreak potential and for prioritizing local mosquito control strategies for Aedes and Culex species. In this study, we evaluated the laboratory vector competence of Aedes aegypti, Culex quinquefasciatus, and Culex tarsalis that originated in areas of California where ZIKV cases in travelers since 2015 were frequent. We compared infection, dissemination, and transmission rates by measuring ZIKV RNA levels in cohorts of mosquitoes that ingested blood meals from type I interferon-deficient mice infected with either a Puerto Rican ZIKV strain from 2015 (PR15), a Brazilian ZIKV strain from 2015 (BR15), or an ancestral Asian-lineage Malaysian ZIKV strain from 1966 (MA66). With PR15, Cx. quinquefasciatus was refractory to infection (0%, N = 42) and Cx. tarsalis was infected at 4% (N = 46). No ZIKV RNA was detected in saliva from either Culex species 14 or 21 days post feeding (dpf). In contrast, Ae. aegypti developed infection rates of 85% (PR15; N = 46), 90% (BR15; N = 20), and 81% (MA66; N = 85) 14 or 15 dpf. Although MA66-infected Ae. aegypti showed higher levels of ZIKV RNA in mosquito bodies and legs, transmission rates were not significantly different across virus strains (P = 0.13, Fisher's exact test). To confirm infectivity and measure the transmitted ZIKV dose, we enumerated infectious ZIKV in Ae. aegypti saliva using Vero cell plaque assays. The expectorated plaque forming units PFU varied by viral strain: MA66infected expectorated 13 +/- 4 PFU (mean +/- SE, N = 13) compared to 29 +/- 6 PFU for PR15infected (N = 13) and 35 +/- 8 PFU for BR15-infected (N = 6; ANOVA, df = 2, F = 3.8, P = 0.035). These laboratory vector competence results support an emerging consensus that Cx. tarsalis and Cx. quinquefasciatus are not vectors of ZIKV. These results also indicate that Ae. aegypti from California are efficient laboratory vectors of ancestral and contemporary Asian lineage ZIKV.
C1 [Main, Bradley J.; Nicholson, Jay; Winokur, Olivia C.; Steiner, Cody; Riemersma, Kasen K.; Stuart, Jackson; Barker, Christopher M.; Coffey, Lark L.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Takeshita, Ryan; Krasnec, Michelle] ABT Associates Inc, Boulder, CO USA.
   [Takeshita, Ryan] Natl Marine Mammal Fdn, San Diego, CA USA.
RP Coffey, LL (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
EM lcoffey@ucdavis.edu
OI Stuart, Jackson/0000-0001-9577-1737; Riemersma,
   Kasen/0000-0002-5819-4720
FU NASA Health and Air Quality grant [NNX15AF36G]; Pacific Southwest
   Regional Center of Excellence for Vector-Borne Diseases - U.S. Centers
   for Disease Control and Prevention [1U01CK000516]; National Institutes
   of Health Ruth L. Kirschstein National Research Service AwardUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [T32 OD O11147]; Pathology, Microbiology and
   Immunology Department in the School of Veterinary Medicine at UC Davis;
   Abt Associates
FX Primary funding for this work was provided by Abt Associates and a
   consortium of vector control districts in California: Coachella Valley,
   Orange County, Greater Los Angeles County, San Gabriel Valley, West
   Valley, Kern, Butte County, Tulare, Sacramento-Yolo, Placer, and
   Turlock. OCW and CMB also acknowledge financial support from NASA Health
   and Air Quality grant NNX15AF36G, and CMB and LLC acknowledge funding
   support from the Pacific Southwest Regional Center of Excellence for
   Vector-Borne Diseases funded by the U.S. Centers for Disease Control and
   Prevention (Cooperative Agreement 1U01CK000516). KKR was supported by a
   National Institutes of Health Ruth L. Kirschstein National Research
   Service Award T32 OD O11147. Part of this work was supported by start-up
   funds provided to LLC by the Pathology, Microbiology and Immunology
   Department in the School of Veterinary Medicine at UC Davis. The funders
   had no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript. One funder, Abt Associates,
   provided support in the form of salaries for authors [MK and RT], but
   did not have any additional role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. The
   specific roles of these authors are articulated in the author
   contributions section.
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Curtis CF, 2001, MED VET ENTOMOL, V15, P231, DOI 10.1046/j.1365-2915.2001.00293.x
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Gloria-Soria A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003029
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee Y, 2017, BIORXIV
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Pless E, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005718
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   REITER P, 1983, MOSQ NEWS, V43, P496
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Ritchie SA, 2003, J AM MOSQUITO CONTR, V19, P235
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sanchez JD, 2017, PAHO WHO REGIONAL Z
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Thiemann TC, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001452
   TURELL MJ, 1984, AM J TROP MED HYG, V33, P176, DOI 10.4269/ajtmh.1984.33.176
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2017, WHO ZIK SIT REP
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 48
TC 24
Z9 24
U1 3
U2 5
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006524
DI 10.1371/journal.pntd.0006524
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000024
PM 29927940
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Riou, J
   Poletto, C
   Boelle, PY
AF Riou, Julien
   Poletto, Chiara
   Boelle, Pierre-Yves
TI Improving early epidemiological assessment of emerging Aedes-transmitted
   epidemics using historical data
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID ZIKA VIRUS; REAL-TIME; INFECTIOUS-DISEASES; TRANSMISSION; CHIKUNGUNYA;
   FORECASTS; AMERICA; SPREAD; MODELS; RISK
AB Model-based epidemiological assessment is useful to support decision-making at the beginning of an emerging Aedes-transmitted outbreak. However, early forecasts are generally unreliable as little information is available in the first few incidence data points. Here, we show how past Aedes-transmitted epidemics help improve these predictions. The approach was applied to the 2015 - 2017 Zika virus epidemics in three islands of the French West Indies, with historical data including other Aedes-transmitted diseases (chikungunya and Zika) in the same and other locations. Hierarchical models were used to build informative a priori distributions on the reproduction ratio and the reporting rates. The accuracy and sharpness of forecasts improved substantially when these a priori distributions were used in models for prediction. For example, early forecasts of final epidemic size obtained without historical information were 3.3 times too high on average (range: 0.2 to 5.8) with respect to the eventual size, but were far closer (1.1 times the real value on average, range: 0.4 to 1.5) using information on past CHIKV epidemics in the same places. Likewise, the 97.5% upper bound for maximal incidence was 15.3 times (range: 2.0 to 63.1) the actual peak incidence, and became much sharper at 2.4 times (range: 1.3 to 3.9) the actual peak incidence with informative a priori distributions. Improvements were more limited for the date of peak incidence and the total duration of the epidemic. The framework can adapt to all forecasting models at the early stages of emerging Aedes-transmitted outbreaks.
C1 [Riou, Julien; Poletto, Chiara; Boelle, Pierre-Yves] Sorbonne Univ, INSERM, IPLESP, UMR S1136, F-75012 Paris, France.
   [Riou, Julien] EHESP Sch Publ Hlth, Rennes, France.
RP Riou, J (corresponding author), Sorbonne Univ, INSERM, IPLESP, UMR S1136, F-75012 Paris, France.; Riou, J (corresponding author), EHESP Sch Publ Hlth, Rennes, France.
EM julien.riou@iplesp.upmc.fr
CR Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Althaus Christian L, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.91afb5e0f279e7f29e7056095255b288
   Andronico A, 2017, AM J EPIDEMIOL, V186, P1194, DOI 10.1093/aje/kwx008
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Breban R, 2013, LANCET, V382, P694, DOI 10.1016/S0140-6736(13)61492-0
   Calzolari M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038058
   Camacho Anton, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.406ae55e83ec0b5193e30856b9235ed2
   Carpenter B., 2015, J STAT SOFTWARE
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Cauchemez S, 2006, J AM STAT ASSOC, V101, P946, DOI 10.1198/016214506000000230
   Cauchemez S, 2014, LANCET INFECT DIS, V14, P50, DOI 10.1016/S1473-3099(13)70304-9
   CDC National Center for Immunization and Respiratory Diseases (NCIRD), 2016, CDC NAM MOST ACC FOR
   Centre d'hygiene et de salubrite publique de Polynesie francaise, 2014, SURV DENG ZIK POL FR
   Charu V, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005382
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Chowell G, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0811-y
   Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005
   Chretien JP, 2015, ELIFE, V4, DOI 10.7554/eLife.09186
   CIRE Antilles Guyane, 2015, POINT EPIDEMIOLOGIQU
   CIRE Antilles Guyane, 2017, POINT EPIDEMIOLOGIQU
   DARPA, 2014, FOR CHIK CHALL CHALL
   Direction de la sante Bureau de veille sanitaire, 2015, SURV VEILL SANIT POL
   Elderd BD, 2013, EPIDEMICS-NETH, V5, P146, DOI 10.1016/j.epidem.2013.07.001
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gelman A., 2014, BAYESIAN DATA ANAL, V2
   Gelman A, 2006, TECHNOMETRICS, V48, P432, DOI 10.1198/004017005000000661
   Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191
   Gneiting T, 2007, J R STAT SOC B, V69, P243, DOI 10.1111/j.1467-9868.2007.00587.x
   Gomes Marcelo F C, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.cd818f63d40e24aef769dda7df9e0da5
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Hsieh YH, 2006, EMERG INFECT DIS, V12, P122, DOI 10.3201/eid1201.050396
   Kolsrud D, 2007, J FORECASTING, V26, P171, DOI 10.1002/for.1020
   Ledrans M, 2016, B VEILLE SANTAIRE AN, V4, p23 
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   Marcombe S, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001202
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Meltzer MI, 2016, MMWR-MORBID MORTAL W, V65, P85, DOI 10.15585/mmwr.su6503a12
   Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Osthus D, 2017, ARXIV1708094812017
   Pearl J, 2014, STAT SCI, V29, P579, DOI 10.1214/14-STS486
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Poletto C., 2014, Eurosurveillance, V19, P20824, DOI 10.2807/1560-7917.ES2014.19.23.20824
   R Core Team, 2017, R LANG ENV STAT COMP
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Stan Development Team, 2016, RSTAN R INT STAN
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Valleron AJ, 2010, P NATL ACAD SCI USA, V107, P8778, DOI 10.1073/pnas.1000886107
   van Panhuis WG, 2013, NEW ENGL J MED, V369, P2152, DOI 10.1056/NEJMms1215400
   Viboud C., 2017, EPIDEMICS
   Vink MA, 2014, AM J EPIDEMIOL, V180, P865, DOI 10.1093/aje/kwu209
   Wesolowski A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02064-4
   Willem L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2699-8
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 62
TC 1
Z9 1
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD JUN
PY 2018
VL 12
IS 6
AR e0006526
DI 10.1371/journal.pntd.0006526
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GL8CX
UT WOS:000437442000025
PM 29864129
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tian, B
   Liao, XQ
   Svedlindh, P
   Stromberg, M
   Wetterskog, E
AF Tian, Bo
   Liao, Xiaoqi
   Svedlindh, Peter
   Stromberg, Mattias
   Wetterskog, Erik
TI Ferromagnetic Resonance Biosensor for Homogeneous and Volumetric
   Detection of DNA
SO ACS SENSORS
LA English
DT Article
DE ferromagnetic resonance; magnetic nanoparticles; homogeneous detection;
   volumetric detection; rolling circle amplification; loop-mediated
   isothermal amplification
ID MAGNETIC-RESONANCE; ONE-STEP; NANOPARTICLES; AMPLIFICATION; DIAGNOSTICS;
   SUSPENSION; ANISOTROPY; MOLECULES; SIZE
AB The ability to detect and analyze the state of magnetic labels with high sensitivity is of crucial importance for developing magnetic biosensors. In this work, we demonstrate, for the first time, a ferromagnetic resonance (FMR) based homogeneous and volumetric biosensor for magnetic label detection. Two different isothermal amplification methods, i.e., rolling circle amplification (RCA) and loop-mediated isothermal amplification (LAMP), are adopted and combined with a standard electron paramagnetic resonance (EPR) spectrometer for FMR biosensing. For the RCA-based FMR biosensor, binding of RCA products of a synthetic Vibrio cholerae target DNA sequence gives rise to the formation of aggregates of magnetic nanoparticles. Immobilization of nanoparticles within the aggregates leads to a decrease of the net anisotropy of the system and a concomitant increase of the resonance field. A limit of detection of 1 pM is obtained with a linear detection range between 7.8 and 250 pM. For the LAMP-based sensing, a synthetic Zika virus target oligonucleotide is amplified and detected in 20% serum samples. Immobilization of magnetic nanoparticles is induced by their coprecipitation with Mg2P2O7 (a byproduct of LAMP) and provides a detection sensitivity of 100 aM. The fast measurement, high sensitivity, and miniaturization potential of the proposed FMR biosensing technology makes it a promising candidate for designing future point-of-care devices.
C1 [Tian, Bo; Liao, Xiaoqi; Svedlindh, Peter; Stromberg, Mattias; Wetterskog, Erik] Uppsala Univ, Dept Engn Sci, Angstrom Lab, Box 534, SE-75121 Uppsala, Sweden.
RP Stromberg, M; Wetterskog, E (corresponding author), Uppsala Univ, Dept Engn Sci, Angstrom Lab, Box 534, SE-75121 Uppsala, Sweden.
EM mattias.stromberg@angstrom.uu.se; erik.wetterskog@angstrom.uu.se
RI Tian, Bo/K-1774-2019; Svedlindh, Peter/K-2702-2012; Wetterskog,
   Erik/S-8750-2016; Liao, Xiaoqi/K-2810-2017
OI Tian, Bo/0000-0002-5249-4415; Svedlindh, Peter/0000-0002-3049-6831;
   Wetterskog, Erik/0000-0002-6681-4803; Liao, Xiaoqi/0000-0003-2607-7527
FU Swedish Research Council FormasSwedish Research CouncilSwedish Research
   Council Formas [221-2012-444, 2011-1692]; EU FP7 GrantEuropean Union
   (EU) [FP7-NMP-601118]
FX The authors acknowledge financial support from Swedish Research Council
   Formas (Project no. 221-2012-444 and 2011-1692) and EU FP7 Grant No.
   FP7-NMP-601118. Fikret Mamedov is kindly acknowledged for technical
   support during the FMR measurements. Stefan Gustafsson at Chalmers
   University of Technology is acknowledged for acquisition of the TEM
   micrograph in Figure <SUP>1</SUP>. Cordula Gruttner at micromod
   Partikeltechnologie GmbH is acknowledged for the kind provision of the
   Synomag-D samples.
CR Ahrentorp F, 2015, J MAGN MAGN MATER, V380, P221, DOI 10.1016/j.jmmm.2014.09.070
   Ali MM, 2014, CHEM SOC REV, V43, P3324, DOI 10.1039/c3cs60439j
   Banholzer A, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/29/295713
   Bender P, 2018, J PHYS CHEM C, V122, P3068, DOI 10.1021/acs.jpcc.7b11255
   Charilaou M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3581103
   Chatterjee E, 2011, SENSOR ACTUAT B-CHEM, V156, P651, DOI 10.1016/j.snb.2011.02.012
   Chemla YR, 2000, P NATL ACAD SCI USA, V97, P14268, DOI 10.1073/pnas.97.26.14268
   Chen YP, 2015, ACS NANO, V9, P3184, DOI 10.1021/acsnano.5b00240
   de la Torre TZG, 2011, BIOSENS BIOELECTRON, V29, P195, DOI 10.1016/j.bios.2011.08.019
   Donolato M, 2015, ANAL CHEM, V87, P1622, DOI 10.1021/ac503191v
   Faraudo J, 2016, ADV FUNCT MATER, V26, P3837, DOI 10.1002/adfm.201504839
   Farle M, 1998, REP PROG PHYS, V61, P755, DOI 10.1088/0034-4885/61/7/001
   Fock J, 2017, PHYS CHEM CHEM PHYS, V19, P8802, DOI 10.1039/c6cp08749c
   Fornara A, 2008, NANO LETT, V8, P3423, DOI 10.1021/nl8022498
   Foy CA, 2001, CLIN CHEM, V47, P990
   Gavilan H, 2017, PART PART SYST CHAR, V34, DOI 10.1002/ppsc.201700094
   Gazeau F, 1998, J MAGN MAGN MATER, V186, P175, DOI 10.1016/S0304-8853(98)00080-8
   Ghionea S, 2008, IEEE SENS J, V8, P896, DOI 10.1109/JSEN.2008.923904
   Goodwill PW, 2012, ADV MATER, V24, P3870, DOI 10.1002/adma.201200221
   Grossman HL, 2004, P NATL ACAD SCI USA, V101, P129, DOI 10.1073/pnas.0307128101
   Huang J, 2016, ADV FUNCT MATER, V26, P3818, DOI 10.1002/adfm.201504185
   Huang XL, 2017, ACS NANO, V11, P5238, DOI 10.1021/acsnano.7b02618
   Issadore D, 2014, LAB CHIP, V14, P2385, DOI 10.1039/c4lc00314d
   Kaittanis C, 2007, NANO LETT, V7, P380, DOI 10.1021/nl062553z
   KITTEL C, 1948, PHYS REV, V73, P155, DOI 10.1103/PhysRev.73.155
   Lee H, 2015, CHEM REV, V115, P10690, DOI 10.1021/cr500698d
   Lee I, 2010, NATURE, V466, P845, DOI 10.1038/nature09279
   Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c
   Little CE, 2015, J MAGN MAGN MATER, V393, P15, DOI 10.1016/j.jmmm.2015.05.025
   Liu DY, 1996, J AM CHEM SOC, V118, P1587, DOI 10.1021/ja952786k
   Metaxas PJ, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4922392
   Obukhov Y, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.197601
   OSBORN JA, 1945, PHYS REV, V67, P351, DOI 10.1103/PhysRev.67.351
   Osterberg FW, 2014, SMALL, V10, P2877, DOI 10.1002/smll.201303325
   Park SY, 2010, NANO LETT, V10, P446, DOI 10.1021/nl9030488
   Pavuluri SK, 2009, J PHYS CONF SER, V178, DOI 10.1088/1742-6596/178/1/012009
   Puzic A, 2005, J APPL PHYS, V97, DOI 10.1063/1.1860971
   Raikher Y. L., 1992, SOV PHYS JETP, V102, P1409
   RAIKHER YL, 1983, J MAGN MAGN MATER, V39, P11, DOI 10.1016/0304-8853(83)90385-2
   RAIKHER YL, 1994, PHYS REV B, V50, P6250, DOI 10.1103/PhysRevB.50.6250
   Reynolds RA, 2000, J AM CHEM SOC, V122, P3795, DOI 10.1021/ja000133k
   Saville SL, 2014, J COLLOID INTERF SCI, V424, P141, DOI 10.1016/j.jcis.2014.03.007
   Schoeppner C, 2014, J APPL PHYS, V116, DOI 10.1063/1.4890515
   Schrittwieser S, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16060828
   Smit J., 1955, PHILIPS RES REP, V10, P31
   Stromberg M, 2008, NANO LETT, V8, P816, DOI 10.1021/nl072760e
   Sushruth M, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.044005
   Tian B, 2017, BIOSENS BIOELECTRON, V98, P285, DOI 10.1016/j.bios.2017.06.062
   Tian B, 2017, ACS NANO, V11, P1798, DOI 10.1021/acsnano.6b07763
   Tian B, 2016, ACS SENSORS, V1, P1228, DOI 10.1021/acssensors.6b00379
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tong S, 2017, ACS NANO, V11, P6808, DOI 10.1021/acsnano.7b01762
   Usselman RJ, 2012, J APPL PHYS, V112, DOI 10.1063/1.4757964
   Usselman RJ, 2010, J APPL PHYS, V107, DOI 10.1063/1.3400033
   Wago K, 1998, APPL PHYS LETT, V72, P2757, DOI 10.1063/1.121081
   Wetterskog E, 2017, NANOSCALE, V9, P4227, DOI 10.1039/c7nr00023e
   Winklhofer M, 2014, GEOCHEM GEOPHY GEOSY, V15, P1558, DOI 10.1002/2013GC005121
NR 57
TC 11
Z9 11
U1 2
U2 26
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2379-3694
J9 ACS SENSORS
JI ACS Sens.
PD JUN
PY 2018
VL 3
IS 6
BP 1093
EP 101
DI 10.1021/acssensors.8b00048
PG 17
WC Chemistry, Multidisciplinary; Chemistry, Analytical; Nanoscience &
   Nanotechnology
SC Chemistry; Science & Technology - Other Topics
GA GK8ZR
UT WOS:000436525800005
PM 29847920
OA Bronze
DA 2020-07-08
ER

PT J
AU Lappala, A
   Nishima, W
   Miner, J
   Fenimore, P
   Fischer, W
   Hraber, P
   Zhang, M
   McMahon, B
   Tung, CS
AF Lappala, Anna
   Nishima, Wataru
   Miner, Jacob
   Fenimore, Paul
   Fischer, Will
   Hraber, Peter
   Zhang, Ming
   McMahon, Benjamin
   Tung, Chang-Shung
TI Structural Transition and Antibody Binding of EBOV GP and ZIKV E
   Proteins from Pre-Fusion to Fusion-Initiation State
SO BIOMOLECULES
LA English
DT Article
DE EBOV GP; ZIKV E; pre-fusion-to-fusion transition; antibody binding
ID VIRAL MEMBRANE-FUSION; VIRUS GLYCOPROTEIN; EBOLAVIRUS GLYCOPROTEIN;
   CONFORMATIONAL-CHANGE; ENVELOPE PROTEIN; MECHANISMS; ENTRY;
   NEUTRALIZATION; DOMAIN
AB Membrane fusion proteins are responsible for viral entry into host cellsa crucial first step in viral infection. These proteins undergo large conformational changes from pre-fusion to fusion-initiation structures, and, despite differences in viral genomes and disease etiology, many fusion proteins are arranged as trimers. Structural information for both pre-fusion and fusion-initiation states is critical for understanding virus neutralization by the host immune system. In the case of Ebola virus glycoprotein (EBOV GP) and Zika virus envelope protein (ZIKV E), pre-fusion state structures have been identified experimentally, but only partial structures of fusion-initiation states have been described. While the fusion-initiation structure is in an energetically unfavorable state that is difficult to solve experimentally, the existing structural information combined with computational approaches enabled the modeling of fusion-initiation state structures of both proteins. These structural models provide an improved understanding of four different neutralizing antibodies in the prevention of viral host entry.
C1 [Lappala, Anna; Nishima, Wataru; Miner, Jacob; Fenimore, Paul; Fischer, Will; Hraber, Peter; McMahon, Benjamin; Tung, Chang-Shung] Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
   [Nishima, Wataru] New Mexico Consortium, Los Alamos, NM 87545 USA.
   [Zhang, Ming] Univ Georgia, Coll Publ Hlth, Athens, GA 30602 USA.
RP Tung, CS (corresponding author), Los Alamos Natl Lab, Los Alamos, NM 87545 USA.
EM vernon.anna@cantab.net; w.nishima@lanl.gov; jcminer@lanl.gov;
   paulf@lanl.gov; wfischer@lanl.gov; phraber@lanl.gov; mzhang01@uga.edu;
   mcmahon@lanl.gov; ct@lanl.gov
RI Lappala, Anna/K-9100-2019; Fischer, Will/AAD-2807-2019
OI Lappala, Anna/0000-0001-9926-2972; Fischer, Will/0000-0003-4579-4062;
   Hraber, Peter/0000-0002-2920-4897; Miner, Jacob/0000-0002-5600-5252
FU U.S. Department of Energy through the LANL/LDRD ProgramUnited States
   Department of Energy (DOE) [20170509DR]; NIAID Centers of Excellence for
   Influenza Research and Surveillance (CEIRS) [HHSN272201400004C]
FX We gratefully acknowledge the support of the U.S. Department of Energy
   through the LANL/LDRD Program, Project No. 20170509DR, for this work.
   C.-S.T. is a LANL retired scientist and worked on this project on a pro
   bono basis. M.Z. acknowledges the funding of NIAID Centers of Excellence
   for Influenza Research and Surveillance (CEIRS), Contract No.
   HHSN272201400004C.
CR Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326
   [Anonymous], 2015, EBOLA DATA STAT
   [Anonymous], 2017, ZIKA DATA STAT
   Bale S, 2012, VIRUSES-BASEL, V4, P447, DOI 10.3390/v4040447
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Brister JR, 2014, NUCLEIC ACIDS RES, V42, pD660, DOI 10.1093/nar/gkt1268
   Carr CM, 1997, P NATL ACAD SCI USA, V94, P14306, DOI 10.1073/pnas.94.26.14306
   CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dias JM, 2011, NAT STRUCT MOL BIOL, V18, P1424, DOI 10.1038/nsmb.2150
   Dimitrov DS, 2004, NAT REV MICROBIOL, V2, P109, DOI 10.1038/nrmicro817
   Dube D, 2010, P NATL ACAD SCI USA, V107, P16637, DOI 10.1073/pnas.1008509107
   Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777
   Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gregory SM, 2011, P NATL ACAD SCI USA, V108, P11211, DOI 10.1073/pnas.1104760108
   Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   KIELIAN M, 1990, MOL BIOL MED, V7, P17
   Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malashkevich VN, 1999, P NATL ACAD SCI USA, V96, P2662, DOI 10.1073/pnas.96.6.2662
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manicassamy B, 2005, J VIROL, V79, P4793, DOI 10.1128/JVI.79.8.4793-4805.2005
   Mas V., 2013, ENTRY ENVELOPED VIRU
   Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339
   Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moller-Tank S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004731
   Murin CD, 2014, P NATL ACAD SCI USA, V111, P17182, DOI 10.1073/pnas.1414164111
   Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riedel C, 2017, J STRUCT BIOL, V197, P172, DOI 10.1016/j.jsb.2016.06.017
   Sikic Kresimir, 2010, Open Biochem J, V4, P83, DOI 10.2174/1874091X01004010083
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Sullivan N, 1998, J VIROL, V72, P4694, DOI 10.1128/JVI.72.6.4694-4703.1998
   Tran EEH, 2014, J VIROL, V88, P10958, DOI 10.1128/JVI.00870-14
   Tran EEH, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002797
   Tung CS, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-3
   Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762
   Wang H, 2016, CELL, V164, P258, DOI 10.1016/j.cell.2015.12.044
   Wang Jizhen, 2011, Virologica Sinica, V26, P156, DOI 10.1007/s12250-011-3194-9
   Weissenhorn W, 1998, MOL CELL, V2, P605, DOI 10.1016/S1097-2765(00)80159-8
   White JM, 2008, CRIT REV BIOCHEM MOL, V43, P189, DOI [10.1080/10409230802058320, 10.1080/10409230802058320 ]
   Wilen C.B., 2012, CSH PERSPECT MED, V2, P8, DOI DOI 10.1101/CSHPERSPECT.A006866
NR 51
TC 4
Z9 5
U1 3
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 2218-273X
J9 BIOMOLECULES
JI Biomolecules
PD JUN
PY 2018
VL 8
IS 2
AR 25
DI 10.3390/biom8020025
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GK8PO
UT WOS:000436489100012
PM 29748487
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Aloni-Grinstein, R
   Charni-Natan, M
   Solomon, H
   Rotter, V
AF Aloni-Grinstein, Ronit
   Charni-Natan, Meital
   Solomon, Hilla
   Rotter, Varda
TI p53 and the Viral Connection: Back into the Future
SO CANCERS
LA English
DT Review
DE virus; p53; cancer; SV40; papilloma; zika; influenza; HIV-1; HSV-1;
   vaccinia
ID INFLUENZA-A VIRUS; LARGE-T-ANTIGEN; LARGE TUMOR-ANTIGEN; CELL-CYCLE
   ARREST; HUMAN-PAPILLOMAVIRUS; SV40-TRANSFORMED CELLS; P53-MEDIATED
   APOPTOSIS; ZIKA VIRUS; PROTEIN; REPLICATION
AB The discovery of the tumor suppressor p53, through its interactions with proteins of tumor-promoting viruses, paved the way to the understanding of p53 roles in tumor virology. Over the years, accumulating data suggest that WTp53 is involved in the viral life cycle of non-tumor-promoting viruses as well. These include the influenza virus, smallpox and vaccinia viruses, the Zika virus, West Nile virus, Japanese encephalitis virus, Human Immunodeficiency Virus Type 1, Human herpes simplex virus-1, and more. Viruses have learned to manipulate WTp53 through different strategies to improve their replication and spreading in a stage-specific, bidirectional way. While some viruses require active WTp53 for efficient viral replication, others require reduction/inhibition of WTp53 activity. A better understanding of WTp53 functionality in viral life may offer new future clinical approaches, based on WTp53 manipulation, for viral infections.
C1 [Aloni-Grinstein, Ronit; Charni-Natan, Meital; Solomon, Hilla; Rotter, Varda] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
   [Aloni-Grinstein, Ronit] Israel Inst Biol Res, Dept Biochem & Mol Genet, Box 19, IL-74100 Ness Ziona, Israel.
RP Rotter, V (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.
EM ronitag@iidr.gov.il; meital.charni@weizmann.ac.il;
   hilla.besserglick@weizmann.ac.il; varda.rotter@weizmann.ac.il
OI Charni-Natan, Meital/0000-0003-0221-1664
FU Center of Excellence from Flight Attendant Medical Research Institute
   (FAMRI); Israel Science Foundation (ISF)Israel Science Foundation
FX This publication was funded by the Center of Excellence from Flight
   Attendant Medical Research Institute (FAMRI) and from the Israel Science
   Foundation (ISF). This publication reflects the authors' views and not
   necessarily those of the European Community.
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Biktasova A, 2017, CLIN CANCER RES, V23, P7276, DOI 10.1158/1078-0432.CCR-17-1438
   Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347
   Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CROOK T, 1991, CELL, V67, P547, DOI 10.1016/0092-8674(91)90529-8
   DECAPRIO JA, 1988, CELL, V54, P275, DOI 10.1016/0092-8674(88)90559-4
   DEVILLIERS EM, 1989, J VIROL, V63, P4898, DOI 10.1128/JVI.63.11.4898-4903.1989
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DOWNIE AW, 1971, BRIT MED J, V1, P363, DOI 10.1136/bmj.1.5745.363
   Drayman N, 2016, ONCOTARGET, V7, P52643, DOI 10.18632/oncotarget.10769
   DUAN LX, 1994, J VIROL, V68, P4302, DOI 10.1128/JVI.68.7.4302-4313.1994
   Elbel M, 1997, VIROLOGY, V239, P132, DOI 10.1006/viro.1997.8860
   Engeland K, 2018, CELL DEATH DIFFER, V25, P114, DOI 10.1038/cdd.2017.172
   FAUCI AS, 1993, SCIENCE, V262, P1011, DOI 10.1126/science.8235617
   Fischer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02831-9
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Ghouzzi Vincent El, 2017, Cell Death Dis, V8, pe2567, DOI 10.1038/cddis.2016.446
   Gordon-Shaag A, 2002, J VIROL, V76, P5915, DOI 10.1128/JVI.76.12.5915-5924.2002
   Greenway AL, 2002, J VIROL, V76, P2692, DOI 10.1128/JVI.76.6.2692-2702.2002
   Hermannstadter A, 2009, J VIROL, V83, P10106, DOI 10.1128/JVI.00174-09
   Hewitt EW, 2003, IMMUNOLOGY, V110, P163, DOI 10.1046/j.1365-2567.2003.01738.x
   Hsieh JC, 2014, VIROLOGY, V460, P45, DOI 10.1016/j.virol.2014.04.019
   Izumi T, 2010, P NATL ACAD SCI USA, V107, P20798, DOI 10.1073/pnas.1008076107
   Kaminskyy V, 2010, J INTERN MED, V267, P473, DOI 10.1111/j.1365-2796.2010.02222.x
   Koromilas AE, 2001, CYTOKINE GROWTH F R, V12, P157, DOI 10.1016/S1359-6101(00)00023-X
   KRESS M, 1979, J VIROL, V31, P472, DOI 10.1128/JVI.31.2.472-483.1979
   LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0
   LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0
   Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723
   LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9
   Liu X, 2006, GENE DEV, V20, P2332, DOI 10.1101/gad.1471706
   Maruzuru Y, 2016, J VIROL, V90, P6738, DOI 10.1128/JVI.00846-16
   Maruzuru Y, 2013, J VIROL, V87, P9323, DOI 10.1128/JVI.01581-13
   MAY E, 1971, P NATL ACAD SCI USA, V68, P1208, DOI 10.1073/pnas.68.6.1208
   McLean JE, 2009, J VIROL, V83, P8233, DOI 10.1128/JVI.02672-08
   MEISTELMAN C, 1986, ANESTH ANALG, V65, P1319
   MELERO JA, 1979, VIROLOGY, V93, P466, DOI 10.1016/0042-6822(79)90250-2
   MOSS B, 1990, ANNU REV BIOCHEM, V59, P661, DOI 10.1146/annurev.bi.59.070190.003305
   Mukerjee R, 2010, CELL CYCLE, V9, P4569, DOI 10.4161/cc.9.22.13836
   Munoz-Fontela C, 2005, ONCOGENE, V24, P3059, DOI 10.1038/sj.onc.1208477
   Munoz-Fontela C, 2016, NAT REV IMMUNOL, V16, P741, DOI 10.1038/nri.2016.99
   Munoz-Fontela C, 2011, J IMMUNOL, V187, P6428, DOI 10.4049/jimmunol.1101459
   Nailwal H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.131
   Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107
   Park IU, 2015, CLIN INFECT DIS, V61, pS849, DOI 10.1093/cid/civ813
   PEEPER DS, 1993, MOL BIOL REP, V17, P197, DOI 10.1007/BF00986728
   Rajcani J, 2000, FOLIA MICROBIOL, V45, P7, DOI 10.1007/BF02817445
   Rivas C, 2010, VIRUSES-BASEL, V2, P298, DOI 10.3390/v2010298
   ROTTER V, 1980, J VIROL, V36, P547, DOI 10.1128/JVI.36.2.547-555.1980
   Sampson BA, 2000, HUM PATHOL, V31, P527, DOI 10.1053/hp.2000.8047
   Santos CR, 2004, VIROLOGY, V328, P254, DOI 10.1016/j.virol.2004.08.013
   SARNOW P, 1982, CELL, V28, P387, DOI 10.1016/0092-8674(82)90356-7
   Sato Y, 2013, REV MED VIROL, V23, P213, DOI 10.1002/rmv.1738
   Sawaya BE, 1998, J BIOL CHEM, V273, P20052, DOI 10.1074/jbc.273.32.20052
   SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3
   Seibert Krystal N, 2013, Open Virol J, V7, P1, DOI 10.2174/1874357901307010001
   Shen Y, 2009, BIOCHEM BIOPH RES CO, V382, P331, DOI 10.1016/j.bbrc.2009.03.018
   Shin Y, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0595-2
   SHIRODKAR S, 1992, CELL, V68, P157, DOI 10.1016/0092-8674(92)90214-W
   SMITH AE, 1979, CELL, V18, P335, DOI 10.1016/0092-8674(79)90053-9
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Thakur BK, 2012, BIOCHEM BIOPH RES CO, V424, P245, DOI 10.1016/j.bbrc.2012.06.084
   Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005
   Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675
   Wali A, 1999, DNA CELL BIOL, V18, P837, DOI 10.1089/104454999314836
   Wang B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3359
   Wang XD, 2012, J BIOL CHEM, V287, P18366, DOI 10.1074/jbc.M111.335422
   WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2
   WHYTE P, 1988, NATURE, V334, P124, DOI 10.1038/334124a0
   Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279
   Yan WJ, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0127-8
   Yang MR, 2008, CELL MICROBIOL, V10, P165, DOI 10.1111/j.1462-5822.2007.01027.x
   ZHU JY, 1991, J VIROL, V65, P6872, DOI 10.1128/JVI.65.12.6872-6880.1991
   Zhu ZX, 2014, BIOCHEM BIOPH RES CO, V454, P189, DOI 10.1016/j.bbrc.2014.10.067
   zur Hausen H, 1998, NATURE, V393, P217, DOI 10.1038/30363
NR 77
TC 12
Z9 12
U1 0
U2 12
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD JUN
PY 2018
VL 10
IS 6
AR 178
DI 10.3390/cancers10060178
PG 11
WC Oncology
SC Oncology
GA GK4KQ
UT WOS:000436128700025
PM 29866997
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diaz, A
   Stewart-Ibarra, AM
AF Diaz, Avriel
   Stewart-Ibarra, Anna M.
TI Zika virus infections and psychological distress following natural
   disasters
SO FUTURE VIROLOGY
LA English
DT Editorial Material
DE natural disasters; psychological morbidity; Zika virus
ID HEALTH; EARTHQUAKE; STRESS; CARE; RISK
C1 [Diaz, Avriel] Columbia Univ, Dept Evolut Ecol & Environm Biol, New York, NY 10027 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
RP Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.; Stewart-Ibarra, AM (corresponding author), SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
EM stewarta@upstate.edu
OI Stewart-Ibarra, Anna/0000-0002-3383-4672
CR [Anonymous], 2018, US CDC
   Borowsky SJ, 2000, J GEN INTERN MED, V15, P381, DOI 10.1046/j.1525-1497.2000.12088.x
   Chen CC, 2001, PSYCHIAT RES, V105, P13, DOI 10.1016/S0165-1781(01)00334-1
   COHEN S, 1991, PSYCHOL BULL, V109, P5, DOI 10.1037/0033-2909.109.1.5
   Dickerson C., 2017, NY TIMES
   Glaser R, 2005, NAT REV IMMUNOL, V5, P243, DOI 10.1038/nri1571
   HARDING TW, 1980, PSYCHOL MED, V10, P231, DOI 10.1017/S0033291700043993
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   National Hurricane Center, 2017, ATL HURR SEAS
   PAHO/WHO, 2018, ZIK CUM CAS
   Ortiz MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15706-w
   Sorensen CJ, 2017, GEOHEALTH, V1, P298, DOI 10.1002/2017GH000104
   Stewart-Ibarra AM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121516
   US Department of Health and Human Services, 2017, US CDC
   van Aalst MK, 2006, DISASTERS, V30, P5, DOI 10.1111/j.1467-9523.2006.00303.x
   Vasquez D, 2017, AM J PUBLIC HEALTH, V107, P1137, DOI 10.2105/AJPH.2017.303769
   Weather Underground, 2017, HURR TROP CYCL
   WHO WHO, 2008, INT MENT HLTH PRIM C
   World Health Organization, 2017, ZIK VIR
   Zhang WQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088263
NR 22
TC 0
Z9 0
U1 2
U2 6
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD JUN
PY 2018
VL 13
IS 6
BP 379
EP 383
DI 10.2217/fvl-2018-0022
PG 5
WC Virology
SC Virology
GA GL3PD
UT WOS:000437048800003
DA 2020-07-08
ER

PT J
AU Cisneros, IE
   Erdenizmenli, M
   Cunningham, KA
   Paessler, S
   Dineley, KT
AF Cisneros, Irma E.
   Erdenizmenli, Mert
   Cunningham, Kathryn A.
   Paessler, Slobodan
   Dineley, Kelly T.
TI Cocaine evokes a profile of oxidative stress and impacts innate
   antiviral response pathways in astrocytes
SO NEUROPHARMACOLOGY
LA English
DT Article
DE Astrocytes; Cocaine; Type I interferon; Oxidative stress; HIV-1; Zika
   virus
ID NF-KAPPA-B; IMMUNODEFICIENCY-VIRUS-INFECTION; I INTERFERON RESPONSE;
   NECROSIS-FACTOR-ALPHA; CGAS-STING PATHWAY; SIGNALING PROTEIN; SIGMA-1
   RECEPTORS; NUCLEAR-FACTOR; HIV-1; EXPRESSION
AB HIV-1 and Zika virus (ZIKV) represent RNA viruses with neurotropic characteristics. Infected individuals suffer neurocognitive disorders aggravated by environmental toxins, including drugs of abuse such as cocaine, exacerbating HIV-associated neurocognitive disorders through a combination of astrogliosis, oxidative stress and innate immune signaling; however, little is known about how cocaine impacts the progression of ZIKV neural perturbations. Impaired innate immune signaling is characterized by weakened antiviral activation of interferon signaling and alterations in inflammatory signaling, factors contributing to cognitive sequela associated with cocaine in HIV-1/ZIKV infection. We employed cellular/molecular biology techniques to test if cocaine suppresses the efficacy of astrocytes to initiate a Type 1 interferon response to HIV-1/ZIKV, in vitro. We found cocaine activated antiviral signaling pathways and type I interferon in the absence of inflammation. Cocaine pre-exposure suppressed antiviral responses to HIV-1/Z1KV, triggering antiviral signaling and phosphorylation of interferon regulatory transcription factor 3 to stimulate type I interferon gene transcription. Our data indicate that oxidative stress is a major driver of cocaine-mediated astrocyte antiviral immune responses. Although astrocyte antiviral signaling is activated following detection of foreign pathogenic material, oxidative stress and increased cytosolic double-stranded DNA (dsDNA) can drive antiviral signaling via stimulation of pattern recognition receptors. Pretreatment with the glial modulators propentofylline (PPF) or pioglitazone (PIO) reversed cocaine-mediated attenuation of astrocyte responses to HIV-1/ZIKV. Both PPF/PIO protected against cocaine-mediated generation of reactive oxygen species (ROS), increased dsDNA, antiviral signaling pathways and increased type I interferon, indicating that cocaine induces astrocyte type I interferon signaling in the absence of virus and oxidative stress is a major driver of cocaine-mediated astrocyte antiviral immunity. Lastly, PPF and PIO have therapeutic potential to ameliorate cocaine-mediated dysregulation of astrocyte antiviral immunity possibly via a myriad of protective actions including decreases in reactive phenotype and damaging immune factors. Published by Elsevier Ltd.
C1 [Cisneros, Irma E.; Cunningham, Kathryn A.; Dineley, Kelly T.] Univ Texas Med Branch, Addict Res Ctr, 301 Univ Blvd, Galveston, TX 77550 USA.
   [Cisneros, Irma E.; Dineley, Kelly T.] Univ Texas Med Branch, Dept Neurol, 301 Univ Blvd, Galveston, TX 77550 USA.
   [Cisneros, Irma E.; Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77550 USA.
   [Cisneros, Irma E.; Paessler, Slobodan] Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77550 USA.
   [Erdenizmenli, Mert] Univ Texas Med Branch, Sch Med, 301 Univ Blvd, Galveston, TX 77550 USA.
   [Cunningham, Kathryn A.] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77550 USA.
   [Dineley, Kelly T.] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, 301 Univ Blvd, Galveston, TX 77550 USA.
RP Dineley, KT (corresponding author), Univ Texas Med Branch, Addict Res Ctr, 301 Univ Blvd, Galveston, TX 77550 USA.; Paessler, S (corresponding author), Univ Texas Med Branch, Dept Pathol, 301 Univ Blvd, Galveston, TX 77550 USA.
EM ircisner@utmb.edu; meerdeni@utmb.edu; kcunning@utmb.edu;
   slpaessl@utmb.edu; ktdinele@utmb.edu
FU National Institute on Drug AbuseUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA) [NIDA T32 DA07287]; NIDAUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute on Drug Abuse (NIDA) [F32 DA045445, P50
   DA033935]; McManus Charitable Trust; UTMB Institute for Human Infection
   and Immunity (IHII)
FX This research was supported by a postdoctoral fellowship from the
   National Institute on Drug Abuse (IEC; NIDA T32 DA07287), NIDA F32
   DA045445 (IEC), NIDA P50 DA033935 (KAC), the McManus Charitable Trust
   (KTD) and the UTMB Institute for Human Infection and Immunity (IHII).
   The authors declare no conflicts of interest to report.
CR Ambuhl LMM, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030040
   Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54
   Baker PJ, 2017, PHYSIOL REV, V97, P1165, DOI 10.1152/physrev.00026.2016
   BANATI RB, 1994, J CEREBR BLOOD F MET, V14, P145, DOI 10.1038/jcbfm.1994.19
   Bik W, 2008, NEUROENDOCRINOL LETT, V29, P359
   Bondan EF, 2014, MICROSC RES TECHNIQ, V77, P23, DOI 10.1002/jemt.22308
   Borgmann K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01143
   Brawand P, 2002, J IMMUNOL, V169, P6711, DOI 10.4049/jimmunol.169.12.6711
   Brown KT, 2018, BRAIN BEHAV IMMUN, V67, P130, DOI 10.1016/j.bbi.2017.08.012
   Buch S, 2012, CURR HIV RES, V10, P425, DOI 10.2174/157016212802138823
   Burns SA, 2012, BRAIN RES, V1473, P236, DOI 10.1016/j.brainres.2012.07.054
   Cai Y, 2017, ADV EXP MED BIOL, V964, P163, DOI 10.1007/978-3-319-50174-1_12
   Cao L, 2016, MOL NEUROBIOL, V53, P4417, DOI 10.1007/s12035-015-9377-x
   Cearley CN, 2011, NEUROCHEM RES, V36, P686, DOI 10.1007/s11064-011-0410-9
   Chandrasekar V, 2011, NEUROPSYCHOPHARMACOL, V36, P1149, DOI 10.1038/npp.2010.250
   Chauhan A, 2015, MICROB PATHOGENESIS, V78, P1, DOI 10.1016/j.micpath.2014.11.003
   Chen CL, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-96
   Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558
   Cheng JB, 2017, CELL DEATH DIFFER, V24, P276, DOI 10.1038/cdd.2016.121
   Cisneros IE, 2014, NEUROPHARMACOLOGY, V85, P499, DOI 10.1016/j.neuropharm.2014.06.011
   Cisneros IE, 2012, CURR HIV RES, V10, P392, DOI 10.2174/157016212802138832
   Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08
   Cocka LJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002931
   Cohen KW, 2015, J IMMUNOL, V194, P2769, DOI 10.4049/jimmunol.1400952
   Cooper ZD, 2012, EXPERT OPIN INV DRUG, V21, P169, DOI 10.1517/13543784.2012.651123
   Cui CH, 2014, INT REV NEUROBIOL, V118, P1, DOI 10.1016/B978-0-12-801284-0.00001-4
   Cunningham KA, 2014, NEUROPHARMACOLOGY, V76, P460, DOI 10.1016/j.neuropharm.2013.06.030
   Da Costa A, 2017, SCI REP-UK, V7, DOI 10.1038/srep40720
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Dietrich JB, 2005, NEUROPHARMACOLOGY, V48, P965, DOI 10.1016/j.neuropharm.2005.01.018
   Dominkus PP, 2017, J NEUROVIROL, V23, P713, DOI 10.1007/s13365-017-0552-x
   Doria M, 2011, J GEN VIROL, V92, P1228, DOI 10.1099/vir.0.028043-0
   Ersche KD, 2013, MOL PSYCHIATR, V18, P134, DOI 10.1038/mp.2012.31
   Eugenin EA, 2007, J NEUROSCI, V27, P12844, DOI 10.1523/JNEUROSCI.4154-07.2007
   Fiala M, 2005, J NEUROVIROL, V11, P281, DOI 10.1080/13550280590952835
   Fox HC, 2012, HUM PSYCHOPHARM CLIN, V27, P156, DOI 10.1002/hup.1251
   Gekker G, 2006, INT IMMUNOPHARMACOL, V6, P1029, DOI 10.1016/j.intimp.2005.12.005
   Giraldo DM, 2016, IMMUNOL RES, V64, P1185, DOI 10.1007/s12026-016-8876-9
   Gorina R, 2011, GLIA, V59, P242, DOI 10.1002/glia.21094
   Gray LR, 2014, CURR OPIN HIV AIDS, V9, P552, DOI 10.1097/COH.0000000000000108
   Guha P, 2016, P NATL ACAD SCI USA, V113, P1417, DOI 10.1073/pnas.1524860113
   Guo ML, 2015, AUTOPHAGY, V11, P995, DOI 10.1080/15548627.2015.1052205
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   HARADA H, 1989, CELL, V58, P729, DOI 10.1016/0092-8674(89)90107-4
   Hayase T, 2017, BEHAV PHARMACOL, V28, P493, DOI 10.1097/FBP.0000000000000326
   Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900
   Horner SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117963
   Horvath CM, 1996, MOL CELL BIOL, V16, P6957
   Jang EY, 2015, ADDICT BIOL, V20, P663, DOI 10.1111/adb.12159
   Jones CM, 2017, AM J PUBLIC HEALTH, V107, P430, DOI 10.2105/AJPH.2016.303627
   Jones JD, 2016, PHYSIOL BEHAV, V159, P33, DOI 10.1016/j.physbeh.2015.10.006
   Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813
   Kenny PJ, 2014, DIALOGUES CLIN NEURO, V16, P335
   Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106
   Koob GF, 2016, LANCET PSYCHIAT, V3, P760, DOI 10.1016/S2215-0366(16)00104-8
   Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147
   Krausgruber T, 2011, NAT IMMUNOL, V12, P231, DOI 10.1038/ni.1990
   Lacagnina MJ, 2017, NEUROPSYCHOPHARMACOL, V42, P156, DOI 10.1038/npp.2016.121
   Lee CT, 2016, RESTOR NEUROL NEUROS, V34, P965, DOI 10.3233/RNN-160676
   Lepsch LB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/750752
   Li Y, 2002, J INFECT DIS, V185, P118, DOI 10.1086/338011
   Liao K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0501-2
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Liu Yiliu, 2017, Inflamm Cell Signal, V4, pe1491, DOI 10.14800/ics.1491
   Lodolce J, 2002, MOL IMMUNOL, V39, P537, DOI 10.1016/S0161-5890(02)00211-0
   Mamik MK, 2016, CURR DRUG TARGETS, V17, P111, DOI 10.2174/1389450116666150626124544
   Marasco CC, 2014, EXP BIOL MED, V239, P1433, DOI 10.1177/1535370214537747
   Meeuwsen S, 2003, GLIA, V43, P243, DOI 10.1002/glia.10259
   Meulendyke KA, 2014, CURR OPIN HIV AIDS, V9, P565, DOI 10.1097/COH.0000000000000106
   Miller KD, 2016, NAT REV NEUROSCI, V17, P766, DOI 10.1038/nrn.2016.140
   MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Moreira FP, 2016, DRUG ALCOHOL DEPEN, V158, P181, DOI 10.1016/j.drugalcdep.2015.11.024
   Muriach M, 2010, J NEUROCHEM, V114, P675, DOI 10.1111/j.1471-4159.2010.06794.x
   Nguyen VT, 2002, J BIOL CHEM, V277, P13796, DOI 10.1074/jbc.M111906200
   Northcutt AL, 2015, MOL PSYCHIATR, V20, P1525, DOI 10.1038/mp.2014.177
   Periyasamy P, 2018, MOL NEUROBIOL, V55, P3196, DOI 10.1007/s12035-017-0584-5
   Periyasamy P, 2016, AUTOPHAGY, V12, P1310, DOI 10.1080/15548627.2016.1183844
   Pfeiffer D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179850
   Pilakka-Kanthikeel S, 2015, FRONT MICROBIOL, V6, DOI [10.3389/fmicb.2075.00967, 10.3389/fmicb.2015.00967]
   Planes R, 2016, J VIROL, V90, P5886, DOI 10.1128/JVI.00262-16
   RANSOHOFF RM, 1991, J NEUROIMMUNOL, V33, P103, DOI 10.1016/0165-5728(91)90054-B
   Rausch MP, 2015, MOL IMMUNOL, V68, P124, DOI 10.1016/j.molimm.2015.06.008
   Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348
   Rosati A, 2007, J CELL PHYSIOL, V210, P676, DOI 10.1002/jcp.20865
   Rosebeck S, 2008, APOPTOSIS, V13, P562, DOI 10.1007/s10495-008-0190-0
   Roth MD, 2005, J LEUKOCYTE BIOL, V78, P1198, DOI 10.1189/jlb.0405219
   Sajja RK, 2016, J CEREBR BLOOD F MET, V36, P539, DOI 10.1177/0271678X15616978
   Samikkannu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep31784
   Schiavone S, 2016, TOXICOL LETT, V258, P29, DOI 10.1016/j.toxlet.2016.06.002
   Schmitz JM, 2017, ADDICTION, V112, P1861, DOI 10.1111/add.13868
   Scofield MD, 2016, BIOL PSYCHIAT, V80, P207, DOI 10.1016/j.biopsych.2015.12.022
   Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012
   Shao WH, 2016, ARTHRITIS RHEUMATOL, V68, P2697, DOI 10.1002/art.39733
   SHARKEY J, 1988, J PHARMACOL EXP THER, V246, P1048
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Sunita S, 2015, J BIOL CHEM, V290, P28156, DOI 10.1074/jbc.M115.679738
   Swanson CR, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-91
   Sweitzer Sarah, 2011, Handb Exp Pharmacol, P235, DOI 10.1007/978-3-642-13443-2_8
   Swepson C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00823
   Tabernero A, 2006, J NEUROCHEM, V99, P1049, DOI 10.1111/j.1471-4159.2006.04088.x
   Tsetsarkin K. A., 2017, MBIO, V8
   Tyagi M, 2016, J NEUROVIROL, V22, P261, DOI 10.1007/s13365-015-0398-z
   Vazquez C, 2015, J VIROL, V89, P6974, DOI 10.1128/JVI.01918-14
   Vermeire J, 2016, CELL REP, V17, P413, DOI 10.1016/j.celrep.2016.09.023
   Vivarini AD, 2015, SCI REP-UK, V5, DOI 10.1038/srep16777
   Wan SF, 2016, ONCOTARGET, V7, P76667, DOI 10.18632/oncotarget.12395
   Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491
   Wang YM, 2017, J BIOL CHEM, V292, P10061, DOI 10.1074/jbc.M117.789800
   Womersley JS, 2016, PROG MOL BIOL TRANSL, V137, P87, DOI 10.1016/bs.pmbts.2015.10.001
   Yao HH, 2009, J NEUROVIROL, V15, P164, DOI 10.1080/13550280902755375
   Yasui Y, 2016, J DRUG ALCOHOL RES, V5
   Yoneyama K, 2002, HEPATOL RES, V24, P327, DOI 10.1016/S1386-6346(02)00137-7
   Yoneyama M, 2016, J BIOCHEM, V159, P279, DOI 10.1093/jb/mvv122
NR 114
TC 4
Z9 4
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3908
EI 1873-7064
J9 NEUROPHARMACOLOGY
JI Neuropharmacology
PD JUN
PY 2018
VL 135
BP 431
EP 443
DI 10.1016/j.neuropharm.2018.03.019
PG 13
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA GL2AO
UT WOS:000436915600038
PM 29578037
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Haby, MM
   Pinart, M
   Elias, V
   Reveiz, L
AF Haby, Michelle M.
   Pinart, Mariona
   Elias, Vanessa
   Reveiz, Ludovic
TI Prevalence of asymptomatic Zika virus infection: a systematic review
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; POPULATION PATIENT CHARACTERISTICS;
   PREGNANT-WOMEN; PUERTO-RICO; PROSPECTIVE COHORT; NOVEMBER 1; JANUARY;
   BRAZIL; SURVEILLANCE; TRANSMISSION
AB Objective To conduct a systematic review to estimate the prevalence of asymptomatic Zika virus infection in the general population and in specific population groups.
   Methods We searched PubMed (R), Embase (R) and LILACS online databases from inception to 26 January 2018. We included observational epidemiological studies where laboratory testing was used to confirm positive exposure of participants to Zika virus and in which Zika virus symptom status was also recorded. We excluded studies in which having symptoms of Zika virus was a criterion for inclusion. The main outcome assessed was percentage of all Zika virus-positive participants who were asymptomatic. We used a quality-effects approach and the double arcsine transformation for the meta-analysis.
   Findings We assessed 753 studies for inclusion, of which 23 were included in the meta-analysis, totalling 11 305 Zika virus-positive participants. The high degree of heterogeneity in the studies (I-2 = 99%) suggests that the pooled prevalence of asymptomatic Zika virus-positive participants was probably not a robust estimate. Analysis based on subgroups of the population (general population, returned travellers, blood donors, adults with Guillain-Barre syndrome, pregnant women and babies with microcephaly) was not able to explain the heterogeneity. Funnel and Doi plots showed major asymmetry, suggesting selection bias or true heterogeneity.
   Conclusion Better-quality research is needed, using standardized methods, to determine the true prevalence of asymptomatic Zika virus and whether it varies between populations or over time.
C1 [Haby, Michelle M.] Univ Sonora, Dept Chem & Biol Sci, Colonia Ctr, Blvd Encinas Rosales S-N, Hermosillo 83000, Sonora, Mexico.
   [Pinart, Mariona] Univ Nottingham, Cochrane Skin Grp, Nottingham, England.
   [Elias, Vanessa; Reveiz, Ludovic] Pan Amer Hlth Org, Washington, DC USA.
RP Haby, MM (corresponding author), Univ Sonora, Dept Chem & Biol Sci, Colonia Ctr, Blvd Encinas Rosales S-N, Hermosillo 83000, Sonora, Mexico.
EM haby@unimelb.edu.au
RI ; Pinart, Mariona/L-1931-2015
OI Haby, Michelle/0000-0001-6203-9195; Pinart, Mariona/0000-0002-8223-1325
FU Pan American Health Organization
FX Michelle Haby was contracted by the Pan American Health Organization to
   work on the Zika virus research platform and support Zika virus research
   efforts during the initial stages of this review, including study
   selection.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, pS345
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Alvim LB, 2016, CLIN CHEM S1, V62, pS144
   [Anonymous], 2016, STANDARDIZED PROTOCO
   [Anonymous], 2016, GUIDELINES SURVEILLA
   [Anonymous], 2016, REV DIAGN TEST ZIK C
   [Anonymous], 2017, PUBLISHED PRIMARY RE
   [Anonymous], 2016, CASE DEFINITIONS
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Barendregt JJ, 2013, J EPIDEMIOL COMMUN H, V67, P974, DOI 10.1136/jech-2013-203104
   Barendregt JJ, 2011, METAXL USER GUIDE VE
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chow A, 2017, EMERG INFECT DIS, V23, P677, DOI 10.3201/eid2304.161716
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Diaz-Menendez M., 2016, ENFERM INFECC MICROB
   Diaz-Menendez M, 2018, ENFERM INFEC MICR CL, V36, P4, DOI 10.1016/j.eimc.2016.08.003
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Doi SAR, 2015, CONTEMP CLIN TRIALS, V45, P123, DOI 10.1016/j.cct.2015.05.010
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, OBSTET GYNECOL, V129, p135S, DOI 10.1097/01.AOG.0000514683.06169.08
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Figueiredo GM, 2016, AM J TROP MED HYG S1, V95, P226
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Furuya-Kanamori L, 2016, EMERG INFECT DIS, V22, P1052, DOI 10.3201/eid2206.151080
   Gonzalez R, 2017, REV ESP SALUD PUBLIC, V91
   Griffin I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2044
   Haby M, 2017, PROSPERO 2017
   Hamer DH, 2017, AM J TROP MED HYG, V95, P218
   Hancock WT, 2017, MMWR-MORBID MORTAL W, V66, P299, DOI 10.15585/mmwr.mm6611a5
   Higgins JPT, 2011, COCHRANE COLLABORATI, DOI DOI 10.1002/9780470712184
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hoy D, 2012, J CLIN EPIDEMIOL, V65, P934, DOI 10.1016/j.jclinepi.2011.11.014
   Huits R, 2017, TROP MED INT HEALTH, V22, P29
   Joanna Briggs Institute reviewers' manual, 2014, SYST REV PREV INC DA
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee CT, 2018, J PUBLIC HEALTH MAN, V24, P533, DOI 10.1097/PHH.0000000000000684
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Mani RS, 2016, NATL MED J INDIA, V29, P339
   Marban-Castro E, 2017, TROP MED INT HEALTH, V22, P28
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2016, VOX SANG S1, V111, P73
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rac M, 2017, OBSTET GYNECOL, V129, p35S, DOI 10.1097/01.AOG.0000514332.47783.0f
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rodo C, 2017, TROP MED INT HEALTH, V22, P200
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sarno M, 2016, ULTRASOUND OBSTET GY
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979
   STERNE JAC, 2001, SYSTEMATIC REV HLTH, P189, DOI DOI 10.1002/9780470693926.CH11
   Stone M, 2017, TRANSFUSION, V57, p4A
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Torres FP, 2016, AM J TROP MED HYG S1, V95, P430
   Tse C, 2017, OBSTET GYNECOL, V129, p137S, DOI 10.1097/01.AOG.0000514691.21416.35
   Uncini A, 2018, EUR J NEUROL, V25, P644, DOI 10.1111/ene.13552
   Van Kerkhove MD, 2016, LANCET GLOB HEALTH, V4, pE911, DOI 10.1016/S2214-109X(16)30255-8
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Zambrano H, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12630
NR 83
TC 28
Z9 28
U1 0
U2 6
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD JUN
PY 2018
VL 96
IS 6
BP 402
EP +
DI 10.2471/BLT.17.201541
PG 16
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GK5VE
UT WOS:000436245900009
PM 29904223
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Dai, SY
   Zhang, T
   Zhang, YF
   Wang, HL
   Deng, F
AF Dai, Shiyu
   Zhang, Tao
   Zhang, Yanfang
   Wang, Hualin
   Deng, Fei
TI Zika Virus Baculovirus-Expressed Virus-Like Particles Induce
   Neutralizing Antibodies in Mice
SO VIROLOGICA SINICA
LA English
DT Article
DE ZIKV; Baculovirus expression system; Virus-like particles (VLPs);
   Neutralizing antibodies
ID VACCINE DEVELOPMENT; PROTEIN; PROTECTION; PLATFORMS; IMMUNITY; SYSTEMS;
   CELLS
AB The newly emerged mosquito-borne Zika virus (ZIKV) strains pose a global challenge owing to its ability to cause microcephaly and neurological disorders. Several ZIKV vaccine candidates have been proposed, including inactivated and live attenuated virus vaccines, vector-based vaccines, DNA and RNA vaccines. These have been shown to be efficacious in preclinical studies in mice and nonhuman primates, but their use will potentially be a threat to immunocompromised individuals and pregnant women. Virus-like particles (VLPs) are empty particles composed merely of viral proteins, which can serve as a safe and valuable tool for clinical prevention and treatment strategies. In this study, we used a new strategy to produce ZIKV VLPs based on the baculovirus expression system and demonstrated the feasibility of their use as a vaccine candidate. The pre-membrane (prM) and envelope (E) proteins were co-expressed in insect cells and self-assembled into particles similar to ZIKV. We found that the ZIKV VLPs could be quickly and easily prepared in large quantities using this system. The VLPs were shown to have good immunogenicity in immunized mice, as they stimulated high levels of virus neutralizing antibody titers, ZIKV-specific IgG titers and potent memory T cell responses. Thus, the baculovirus-based ZIKV VLP vaccine is a safe, effective and economical vaccine candidate for use against ZIKV.
C1 [Dai, Shiyu; Zhang, Tao; Zhang, Yanfang; Wang, Hualin; Deng, Fei] Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.
RP Wang, HL; Deng, F (corresponding author), Chinese Acad Sci, State Key Lab Virol, Wuhan Inst Virol, Wuhan 430071, Hubei, Peoples R China.
EM h.wang@wh.iov.cn; df@wh.iov.cn
FU Science and Technology Basic Work Program from the Ministry of Science
   and Technology of China [2013FY113500]; Chinese Academy of
   SciencesChinese Academy of Sciences [ZDRW-ZS-2016-4]
FX This work was supported by the Science and Technology Basic Work Program
   (2013FY113500) from the Ministry of Science and Technology of China, and
   the strategic priority research program of the Chinese Academy of
   Sciences (ZDRW-ZS-2016-4). We acknowledge the Core Facility and
   Technical Support of Wuhan Institute of Virology for technical
   assistance.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Ch'ng WC, 2011, ACTA VIROL, V55, P227, DOI 10.4149/av_2011_03_227
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Del Prete Gianfranco, 1994, Trends in Microbiology, V2, P4, DOI 10.1016/0966-842X(94)90336-0
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Deng F, 2007, J VIROL, V81, P9377, DOI 10.1128/JVI.00632-07
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Du RK, 2015, J GEN VIROL, V96, P1006, DOI 10.1099/vir.0.000052
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Liu JL, 2016, VIROL SIN, V31, P279, DOI 10.1007/s12250-016-3756-y
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Rodriguez-Limas WA, 2013, CURR OPIN BIOTECH, V24, P1089, DOI 10.1016/j.copbio.2013.02.008
   Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shang WL, 2012, APPL MICROBIOL BIOT, V94, P39, DOI 10.1007/s00253-012-3958-7
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   VANLENT JWM, 1990, ARCH VIROL, V111, P103, DOI 10.1007/BF01310508
   Wang ML, 2008, J VIROL, V82, P9800, DOI 10.1128/JVI.00759-08
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zeltins A, 2013, MOL BIOTECHNOL, V53, P92, DOI 10.1007/s12033-012-9598-4
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 38
TC 14
Z9 15
U1 0
U2 6
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD JUN
PY 2018
VL 33
IS 3
BP 213
EP 226
DI 10.1007/s12250-018-0030-5
PG 14
WC Virology
SC Virology
GA GK3AR
UT WOS:000436012100001
PM 29774519
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Hui, Y
   Wu, ZM
   Qin, ZR
   Zhu, L
   Liang, JH
   Li, XJ
   Fu, HM
   Feng, SY
   Yu, JH
   He, XE
   Lu, WZ
   Xiao, WW
   Wu, QH
   Zhang, B
   Zhao, W
AF Hui, Yuan
   Wu, Zhiming
   Qin, Zhiran
   Zhu, Li
   Liang, Junhe
   Li, Xujuan
   Fu, Hanmin
   Feng, Shiyu
   Yu, Jianhai
   He, Xiaoen
   Lu, Weizhi
   Xiao, Weiwei
   Wu, Qinghua
   Zhang, Bao
   Zhao, Wei
TI Micro-droplet Digital Polymerase Chain Reaction and Real-Time
   Quantitative Polymerase Chain Reaction Technologies Provide Highly
   Sensitive and Accurate Detection of Zika Virus
SO VIROLOGICA SINICA
LA English
DT Article
DE Zika virus; Nucleic acid detection; Micro-droplet digital polymerase
   chain reaction (ddPCR); Real-time fluorescence quantitative polymerase
   chain reaction (RT-qPCR)
ID DNA COPY NUMBER; WHOLE-BLOOD; PCR; QUANTIFICATION; URINE; RNA;
   IDENTIFICATION; INFECTION; PLASMA; SYSTEM
AB The establishment of highly sensitive diagnostic methods is critical in the early diagnosis and control of Zika virus (ZIKV) and in preventing serious neurological complications of ZIKV infection. In this study, we established micro-droplet digital polymerase chain reaction (ddPCR) and real-time quantitative PCR (RT-qPCR) protocols for the detection of ZIKV based on the amplification of the NS5 gene. For the ZIKV standard plasmid, the RT-qPCR results showed that the cycle threshold (Ct) value was linear from 10(1) to 10(8) copy/mu L, with a standard curve R-2 of 0.999 and amplification efficiency of 92.203%; however, a concentration as low as 1 copy/mu L could not be detected. In comparison with RT-qPCR, the ddPCR method resulted in a linear range of 10(1)-10(4) copy/mu L and was able to detect concentrations as low as 1 copy/mu L. Thus, for detecting ZIKV from clinical samples, RT-qPCR is a better choice for high-concentration samples (above 10(1) copy/mu L), while ddPCR has excellent accuracy and sensitivity for low-concentration samples. These results indicate that the ddPCR method should be of considerable use in the early diagnosis, laboratory study, and monitoring of ZIKV.
C1 [Hui, Yuan; Wu, Zhiming; Qin, Zhiran; Zhu, Li; Li, Xujuan; Fu, Hanmin; Feng, Shiyu; Yu, Jianhai; He, Xiaoen; Lu, Weizhi; Xiao, Weiwei; Wu, Qinghua; Zhang, Bao; Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.
   [Liang, Junhe] Jiangmen Ctr Dis Control & Prevent, Jiangmen 529085, Peoples R China.
   [Zhao, Wei] Southern Med Univ, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Sch Pharm, Guangzhou 510515, Guangdong, Peoples R China.
RP Zhang, B; Zhao, W (corresponding author), Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Guangdong, Peoples R China.; Zhao, W (corresponding author), Southern Med Univ, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Sch Pharm, Guangzhou 510515, Guangdong, Peoples R China.
EM zhangb@smu.edu.cn; zhaowei@smu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31470271, 81730110]; Guangzhou Science and
   Technology Program key projects [201803040006]
FX This study was supported by the National Natural Science Foundation of
   China (Nos. 31470271 and 81730110) and Guangzhou Science and Technology
   Program key projects (No. 201803040006). We thank Changwen Ke, De Wu,
   and Jiufeng Sun from the Guangdong Center for Disease Control and
   Prevention for providing the Asian ZIKV Z16006 strain. The authors would
   like to thank anonymous referees for their valuable suggestions, which
   have improved the paper immensely.
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bizouarn F, 2014, METHODS MOL BIOL, V1160, P27, DOI 10.1007/978-1-4939-0733-5_4
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Cao YP, 2015, WATER RES, V70, P337, DOI 10.1016/j.watres.2014.12.008
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Floren C, 2015, FOOD CHEM, V173, P1054, DOI 10.1016/j.foodchem.2014.10.138
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hayden RT, 2013, J CLIN MICROBIOL, V51, P540, DOI 10.1128/JCM.02620-12
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g
   Huang X, 2016, VIROL SIN, V31, P342, DOI 10.1007/s12250-016-3757-x
   Nakano M, 2005, J BIOSCI BIOENG, V99, P293, DOI 10.1263/jbb.99.293
   Nathan LM, 2014, ENVIRON SCI TECHNOL, V48, P12800, DOI 10.1021/es5034052
   Pinheiro LB, 2012, ANAL CHEM, V84, P1003, DOI 10.1021/ac202578x
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Rutsaert S, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0399-0
   Sedlak RH, 2013, DIAGN MICR INFEC DIS, V75, P1, DOI 10.1016/j.diagmicrobio.2012.10.009
   SIDRANSKY D, 1992, SCIENCE, V256, P102, DOI 10.1126/science.1566048
   Strain MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055943
   SYKES PJ, 1992, BIOTECHNIQUES, V13, P444
   Taylor SC, 2015, J VIROL METHODS, V224, P58, DOI 10.1016/j.jviromet.2015.08.014
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zhao H, 2013, J VIROL METHODS, V194, P229, DOI 10.1016/j.jviromet.2013.08.027
NR 31
TC 0
Z9 0
U1 0
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
PD JUN
PY 2018
VL 33
IS 3
BP 270
EP 277
DI 10.1007/s12250-018-0037-y
PG 8
WC Virology
SC Virology
GA GK3AR
UT WOS:000436012100007
PM 29931514
OA Green Published
DA 2020-07-08
ER

PT J
AU Ventura, LO
   Ventura, CV
   Dias, ND
   Vilar, IG
   Gois, AL
   Arantes, TE
   Fernandes, LC
   Chiang, MF
   Miller, MT
   Lawrence, L
AF Ventura, Liana O.
   Ventura, Camila V.
   Dias, Natalia de C.
   Vilar, Isabelle G.
   Gois, Adriana L.
   Arantes, Tiago E.
   Fernandes, Luciene C.
   Chiang, Michael F.
   Miller, Marilyn T.
   Lawrence, Linda
TI Visual impairment evaluation in 119 children with congenital Zika
   syndrome
SO JOURNAL OF AAPOS
LA English
DT Article
ID VIRUS-INFECTION; INFANTS; BRAZIL; AGE
AB PURPOSE To assess visual impairment in a large sample of infants with congenital Zika syndrome (CZS) and to compare with a control group using the same assessment protocol.
   METHODS The study group was composed of infants with confirmed diagnosis of CZS. Controls were healthy infants matched for age, sex, and socioeconomic status. All infants underwent comprehensive ophthalmologic evaluation including visual acuity, visual function assessment, and visual developmental milestones.
   RESULTS The CZS group included 119 infants; the control group, 85 infants. At examination, the mean age of the CZS group was 8.5 +/- 1.2 months (range, 6-13 months); of the controls, 8.4 +/- 1.8 months (range, 5-12 months; P = 0.598). Binocular Teller Acuity Card (TAC) testing was abnormal in 107 CZS infants and in 4 controls (89.9% versus 5% [P < 0.001]). In the study group, abnormal monocular TAC results were more frequent in eyes with funduscopic alterations (P = 0.008); however, 104 of 123 structurally normal eyes (84.6%) also presented abnormal TAC results. Binocular contrast sensitivity was reduced in 87 of 107 CZS infants and in 8 of 80 controls (81.3% versus 10% [P < 0.001]). The visual development milestones were less achieved by infants with CZS compared to controls (P < 0.001).
   CONCLUSIONS Infants with CZS present with severe visual impairment. A protocol for assessment of the ocular findings, visual acuity, and visual developmental milestones tested against age-matched controls is suggested.
C1 [Ventura, Liana O.; Ventura, Camila V.; Dias, Natalia de C.; Vilar, Isabelle G.; Gois, Adriana L.; Arantes, Tiago E.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Liana O.; Ventura, Camila V.; Gois, Adriana L.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Fernandes, Luciene C.] Univ Fed Minas Gerais, Dept Low Vis, Belo Horizonte, MG, Brazil.
   [Chiang, Michael F.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Casey Eye Inst, Portland, OR 97201 USA.
   [Miller, Marilyn T.] Univ Illinois, Dept Ophthalmol, Chicago, IL 60680 USA.
   [Lawrence, Linda] Univ Kansas, Dept Ophthalmol, Sch Med, Kansas City, KS USA.
RP Ventura, LO (corresponding author), Altino Ventura Fdn FAV, R Soledade 170, BR-50070040 Recife, PE, Brazil.
EM lianaventuramd@gmail.com
RI Ventura, Camila V/N-2654-2018; Arantes, Tiago EF/I-3093-2013; Ventura,
   Liana Vieira O/N-6151-2018
OI Ventura, Camila V/0000-0002-2927-4684; Arantes, Tiago
   EF/0000-0002-8122-3446; Ventura, Liana Vieira O/0000-0001-6529-6883;
   Gois, Adriana/0000-0001-5542-1097
CR Chen D, 2015, PARENTS AND THEIR IN
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Fazzi E, 2007, J CHILD NEUROL, V22, P294, DOI 10.1177/08830738070220030801
   Freitas BDP, 2017, OPHTHALMOLOGY, V124, P407, DOI 10.1016/j.ophtha.2016.10.004
   Hyvarinen L, DELAYED VISUAL DEV D
   Khetpal V, 2007, J AAPOS, V11, P235, DOI 10.1016/j.jaapos.2007.01.122
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lennartsson F, 2014, INVEST OPHTH VIS SCI, V55, P8278, DOI 10.1167/iovs.14-14913
   LEWIS TL, 1992, VISION RES, V32, P903, DOI 10.1016/0042-6989(92)90033-F
   Miller JM, 2012, PEDIATRICS, V130, P983, DOI 10.1542/peds.2012-2548
   Ministerio da Saude Secretaria de Vigilancia em Saude, PROT VIG RESP OC MIC
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prager TC, 1999, J AAPOS, V3, P275, DOI 10.1016/S1091-8531(99)70023-6
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teller DY, REFERENCE INSTRUCTIO
   Tychsen L., 2001, CRITICAL THINKING CR, P67
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   WHO, ZIK VIR CLASS TABL
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
NR 33
TC 8
Z9 8
U1 0
U2 7
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD JUN
PY 2018
VL 22
IS 3
BP 218
EP 222
DI 10.1016/j.jaapos.2018.01.009
PG 5
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA GK1PH
UT WOS:000435890200013
PM 29654909
DA 2020-07-08
ER

PT J
AU Boon, PLS
   Saw, WG
   Lim, XX
   Raghuvamsi, PV
   Huber, RG
   Marzinek, JK
   Holdbrook, DA
   Anand, GS
   Gruber, G
   Bond, PJ
AF Boon, Priscilla L. S.
   Saw, Wuan Geok
   Lim, Xin Xiang
   Raghuvamsi, Palur Venkata
   Huber, Roland G.
   Marzinek, Jan K.
   Holdbrook, Daniel A.
   Anand, Ganesh S.
   Grueber, Gerhard
   Bond, Peter J.
TI Partial Intrinsic Disorder Governs the Dengue Capsid Protein
   Conformational Ensemble
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID RAY SOLUTION SCATTERING; N-TERMINAL REGION; ZIKA VIRUS; MACROMOLECULES;
   ORGANIZATION; SIMULATIONS; BINDING
AB The 11 kDa, positively charged dengue capsid protein (C protein) exists stably as a homodimer and colocalizes with the viral genome within mature viral particles. Its core is composed of four alpha helices encompassing a small hydrophobic patch that may interact with lipids, but approximately 20% of the protein at the N-terminus is intrinsically disordered, making it challenging to elucidate its conformational landscape. Here, we combine small-angle X-ray scattering (SAXS), amide hydrogen-deuterium exchange mass spectrometry (HDXMS), and atomic-resolution molecular dynamics (MD) simulations to probe the dynamics of dengue C proteins. We show that the use of MD force fields (FFs) optimized for intrinsically disordered proteins (IDPs) is necessary to capture their conformational landscape and validate the computationally generated ensembles with reference to SAXS and HDXMS data. Representative ensembles of the C protein dimer are characterized by alternating, clamp-like exposure and occlusion of the internal hydrophobic patch, as well as by residual helical structure at the disordered N-terminus previously identified as a potential source of autoinhibition. Such dynamics are likely to determine the multifunctionality of the C protein during the flavivirus life cycle and hence impact the design of novel antiviral compounds.
C1 [Saw, Wuan Geok; Grueber, Gerhard] Nanyang Technol Univ, SBS, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Boon, Priscilla L. S.; Huber, Roland G.; Marzinek, Jan K.; Holdbrook, Daniel A.; Bond, Peter J.] ASTAR, Bioinformat Inst BII, 07-01 Matrix,30 Biopolis St, Singapore 138671, Singapore.
   [Boon, Priscilla L. S.; Lim, Xin Xiang; Raghuvamsi, Palur Venkata; Marzinek, Jan K.; Anand, Ganesh S.; Bond, Peter J.] NUS, DBS, 14 Sci Dr 4, Singapore 117543, Singapore.
   [Boon, Priscilla L. S.] Natl Univ Singapore, NUS Grad Sch Integrated Sci & Engn, 05-01,28 Med Dr, Singapore 117456, Singapore.
RP Gruber, G (corresponding author), Nanyang Technol Univ, SBS, 60 Nanyang Dr, Singapore 637551, Singapore.; Bond, PJ (corresponding author), ASTAR, Bioinformat Inst BII, 07-01 Matrix,30 Biopolis St, Singapore 138671, Singapore.; Bond, PJ (corresponding author), NUS, DBS, 14 Sci Dr 4, Singapore 117543, Singapore.
EM ggrueber@ntu.edu.sg; peterjb@bii.a-star.edu.sg
OI Huber, Roland/0000-0001-5093-5988; Marzinek, Jan/0000-0002-5493-8753;
   Bond, Peter/0000-0003-2900-098X
FU Ministry of Education in Singapore (MOE) [MOE2012-T3-1-008]
FX This research was supported by the Ministry of Education in Singapore
   (MOE AcRF Tier 3 Grant Number MOE2012-T3-1-008). The authors gratefully
   acknowledge computing resources provided by the National Supercomputing
   Center Singapore, www.nscc.sg.
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Balakrishna AM, 2015, J BIOL CHEM, V290, P3183, DOI 10.1074/jbc.M114.622688
   Best RB, 2017, CURR OPIN STRUC BIOL, V42, P147, DOI 10.1016/j.sbi.2017.01.006
   Best RB, 2014, J CHEM THEORY COMPUT, V10, P5113, DOI 10.1021/ct500569b
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Chong SH, 2017, ANNU REV PHYS CHEM, V68, P117, DOI 10.1146/annurev-physchem-052516-050843
   Dip PV, 2014, ACTA CRYSTALLOGR D, V70, P2848, DOI 10.1107/S1399004714019233
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Faustino AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10592
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Freire JM, 2015, FEBS J, V282, P2267, DOI 10.1111/febs.13274
   Huang J, 2018, CURR OPIN STRUC BIOL, V48, P40, DOI 10.1016/j.sbi.2017.10.008
   Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]
   Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Markoff L, 1997, VIROLOGY, V233, P105, DOI 10.1006/viro.1997.8608
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Paramo T, 2014, J CHEM THEORY COMPUT, V10, P2151, DOI 10.1021/ct401098b
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 34
TC 8
Z9 8
U1 2
U2 10
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD JUN
PY 2018
VL 13
IS 6
BP 1621
EP 1630
DI 10.1021/acschembio.8b00231
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GJ9SW
UT WOS:000435746200025
PM 29792674
DA 2020-07-08
ER

PT J
AU Popik, W
   Khatua, A
   Hildreth, JEK
   Lee, B
   Alcendor, DJ
AF Popik, Waldemar
   Khatua, Atanu
   Hildreth, James E. K.
   Lee, Benjamin
   Alcendor, Donald J.
TI Phosphorodiamidate morpholino targeting the 5 ' untranslated region of
   the ZIKV RNA inhibits virus replication
SO VIROLOGY
LA English
DT Article
DE Zika virus; Morpholino; Podocyte; Antiviral; Inflammation; Therapy
ID INFECTION
AB Background: Zika virus (ZIKV) infection has been associated with microcephaly in infants. Currently there is no treatment or vaccine. Here we explore the use of a morpholino oligonucleotide targeted to the 5' untranslated region (5'-UTR) of the ZIKV RNA to prevent ZIKV replication.
   Methods: Morpholino DWK-1 inhibition of ZIKV replication in human glomerular podocytes was examined by qRT-PCR, reduction in ZIKV genome copy number, western blot analysis, immunofluorescence and proinflammatory cytokine gene expression.
   Results: Podocytes pretreated with DWK-1 showed reduced levels of both viral mRNA and ZIKV E protein expression compared to controls. We observed suppression in proinflammatory gene expression for IFN-beta (interferon beta) RANTES (regulated on activation, normal T cell expressed and secreted), MIP-1 alpha (macrophage inflammatory protein-1 alpha), TNF-alpha (tumor necrosis factor-alpha) and IL1-alpha a (interleukin 1-alpha) in ZIKV-infected podocytes pretreated with DWK-1.
   Conclusions: Morpholino DWK-1 targeting the ZIKV 5'-UTR effectively inhibits ZIKV replication and suppresses ZIKV-induced proinflammatory gene expression.
C1 [Hildreth, James E. K.; Alcendor, Donald J.] Meharry Med Coll, Sch Med, Ctr AIDS Hlth Dispar Res, Dept Microbiol & Immunol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.
   [Popik, Waldemar; Khatua, Atanu; Hildreth, James E. K.] Meharry Med Coll, Sch Med, Dept Internal Med, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.
   [Lee, Benjamin] Meharry Med Coll, Sch Med, Dept Obstet & Gynecol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.
RP Alcendor, DJ (corresponding author), Meharry Med Coll, Sch Med, Ctr AIDS Hlth Dispar Res, Dept Microbiol & Immunol, 1005 Dr DB Todd Jr Blvd, Nashville, TN 37208 USA.
EM dalcendor@mmc.edu
OI Alcendor, Donald/0000-0002-4568-8158
FU Meharry Medical College
FX DJA and WP were supported by a Zika Virus Research Startup Award from
   the Meharry Medical College. WP and DJA made equal contributions to this
   manuscript.
CR Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Anantpadma M, 2010, J ANTIMICROB CHEMOTH, V65, P953, DOI 10.1093/jac/dkq074
   Blum M, 2015, DEV CELL, V35, P145, DOI 10.1016/j.devcel.2015.09.017
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2016, ZIK TRAV INF ZIK VIR
   Deas TS, 2007, ANTIMICROB AGENTS CH, V51, P2470, DOI 10.1128/AAC.00069-07
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565
   Khatua AK, 2010, VIROLOGY, V408, P119, DOI 10.1016/j.virol.2010.09.005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Maharajan MK, 2016, CLIN REV ALLERG IMMU, V51, P383, DOI 10.1007/s12016-016-8554-7
   Moulton J. D., 2017, CURR PROTOC NUCL ACI, V68, P4
   Mukherjee S, 2015, CELL BIOL INT, V39, P224, DOI 10.1002/cbin.10354
   Nazmi A, 2014, NEUROBIOL DIS, V69, P235, DOI 10.1016/j.nbd.2014.05.036
   Nazmi A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000892
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Stein DA, 2008, J ANTIMICROB CHEMOTH, V62, P555, DOI 10.1093/jac/dkn221
   Subbotina E, 2016, CLIN PHARMACOL THER, V99, P21, DOI 10.1002/cpt.276
   Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Vorou R, 2016, INT J INFECT DIS S, V1201-9712, P31057
   Wilkerson I, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0219-y
   Zhang B, 2008, VIROLOGY, V382, P98, DOI 10.1016/j.virol.2008.08.044
NR 28
TC 2
Z9 2
U1 1
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JUN
PY 2018
VL 519
BP 77
EP 85
DI 10.1016/j.virol.2018.04.001
PG 9
WC Virology
SC Virology
GA GJ3VX
UT WOS:000435228000010
PM 29679791
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Sola, L
   Gagni, P
   D'Annessa, I
   Capelli, R
   Bertino, C
   Romanato, A
   Damin, F
   Bergamaschi, G
   Marchisio, E
   Cuzzocrea, A
   Bombaci, M
   Grifantini, R
   Chiari, M
   Colombo, G
   Gori, A
   Cretich, M
AF Sola, Laura
   Gagni, Paola
   D'Annessa, Ilda
   Capelli, Riccardo
   Bertino, Camilla
   Romanato, Alessandro
   Damin, Francesco
   Bergamaschi, Greta
   Marchisio, Edoardo
   Cuzzocrea, Angela
   Bombaci, Mauro
   Grifantini, Renata
   Chiari, Marcella
   Colombo, Giorgio
   Gori, Alessandro
   Cretich, Marina
TI Enhancing Antibody Serodiagnosis Using a Controlled Peptide
   Coimmobilization Strategy
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE discontinuous epitopes; peptide bioprobes; peptide design; microarrays;
   serodiagnosis; arbovirus; clickable polymer; Zika virus
ID NONSTRUCTURAL PROTEIN NS1; ZIKA VIRUS; FLAVIVIRUS NS1; SILICON BIOCHIPS;
   LABEL-FREE; MICROARRAYS; EPITOPE; IMMOBILIZATION; VACCINE; BINDING
AB Antigen immunoreactivity is often determined by surface regions defined by the 3D juxtapositions of amino acids stretches that are not continuous in the linear sequence. As such, mimicking an antigen immunoreactivity by means of putative linear peptide epitopes for diagnostic purposes is not trivial. Here we present a straightforward and robust method to extend the reach of immune-diagnostic probes design by copresenting peptides belonging to the same antigenic surface. In this case study focused on a computationally predicted Zika virus NS1 protein putative antigenic region, we reached a diagnostic confidence by the oriented and spatially controlled coimmobilization of peptide sequences found adjacent within the protein fold, that cooperatively interacted to provide enhanced immunoreactivity with respect to single linear epitopes. Through our method, we were able to differentiate Zika infected individuals from healthy controls. Remarkably, our strategy fits well with the requirements to build high-throughput screening platforms of linear and mixed peptide libraries, and it could possibly facilitate the rapid identification of conformational immunoreactive regions.
C1 [Sola, Laura; Gagni, Paola; D'Annessa, Ilda; Capelli, Riccardo; Bertino, Camilla; Romanato, Alessandro; Damin, Francesco; Bergamaschi, Greta; Chiari, Marcella; Colombo, Giorgio; Gori, Alessandro; Cretich, Marina] CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy.
   [Bombaci, Mauro; Grifantini, Renata] Ist Nazl Genet Mol Romeo ed Enrica Invernizzi ING, Via Francesco Sforza 35, I-20122 Milan, Italy.
   [Colombo, Giorgio] Univ Pavia, Dipartimento Chim, Vle Taramelli 12, I-27100 Pavia, Italy.
   [Marchisio, Edoardo; Cuzzocrea, Angela] Diagnost Bioprobes Srl DiaPro, Via G Carducci 27, I-20090 Sesto San Giovanni, Italy.
RP Gori, A; Cretich, M (corresponding author), CNR, ICRM, Via Mario Bianco 9, I-20131 Milan, Italy.
EM alessandro.gori@icrm.cnr.it; marina.cretich@icrm.cnr.it
RI BERGAMASCHI, Greta/AAK-1164-2020; Gori, Alessandro/A-1357-2019; Capelli,
   Riccardo/N-7907-2018; Colombo, Giorgio/A-2730-2012
OI BERGAMASCHI, Greta/0000-0002-4501-4057; Gori,
   Alessandro/0000-0003-1640-7238; Capelli, Riccardo/0000-0001-9522-3132;
   Colombo, Giorgio/0000-0002-1318-668X; Gagni, Paola/0000-0002-3652-6173;
   Damin, Francesco/0000-0003-1780-7823
FU Regione Lombardia, project READY (Regional Network for developing
   diagnostic methods in rapid response to emerging epidemics and
   bioemergencies) [229472]
FX Work partially funded by Regione Lombardia, project READY (Regional
   Network for developing diagnostic methods in rapid response to emerging
   epidemics and bioemergencies) ID 229472.
CR Akey DL, 2014, ACTA CRYSTALLOGR D, V70, P2719, DOI 10.1107/S1399004714017556
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Case D. A, 2015, THESIS
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Cretich M, 2004, ANAL BIOCHEM, V332, P67, DOI 10.1016/j.ab.2004.05.041
   Cretich M, 2012, PROTEOMICS, V12, P2963, DOI 10.1002/pmic.201200202
   Cretich M, 2011, BIOSENS BIOELECTRON, V26, P3938, DOI 10.1016/j.bios.2011.03.016
   Dar H, 2016, ASIAN PAC J TROP MED, V9, P822, DOI 10.1016/j.apjtm.2016.07.004
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Genoni A, 2012, J PHYS CHEM B, V116, P3331, DOI 10.1021/jp210568a
   Gori A, 2017, ANAL CHIM ACTA, V983, P189, DOI 10.1016/j.aca.2017.06.027
   Gori A, 2016, BIOCONJUGATE CHEM, V27, P2669, DOI 10.1021/acs.bioconjchem.6b00426
   Gori A, 2016, ACS INFECT DIS, V2, P221, DOI 10.1021/acsinfecdis.5b00118
   Gori A, 2016, METHODS MOL BIOL, V1352, P145, DOI 10.1007/978-1-4939-3037-1_11
   Gori A, 2013, AMINO ACIDS, V45, P257, DOI 10.1007/s00726-013-1526-9
   Gourlay L, 2017, TRENDS BIOTECHNOL, V35, P1208, DOI 10.1016/j.tibtech.2017.06.018
   Grotzinger C, 2016, METHODS MOL BIOL, V1352, P213, DOI 10.1007/978-1-4939-3037-1_16
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Lassaux P, 2013, STRUCTURE, V21, P167, DOI 10.1016/j.str.2012.10.005
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Liskamp R.M.J., 2008, MODERN SUPRAMOLECULA, P1
   Mazzara S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45477
   Meuleman TJ, 2018, BIOCONJUGATE CHEM, V29, P1091, DOI 10.1021/acs.bioconjchem.7b00755
   Nithichanon A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003917
   Ozkumur E, 2009, BIOSENS BIOELECTRON, V25, P167, DOI 10.1016/j.bios.2009.06.033
   Peri C, 2013, ACS CHEM BIOL, V8, P397, DOI 10.1021/cb300487u
   Pirri G, 2004, ANAL CHEM, V76, P1352, DOI 10.1021/ac0352629
   Platt GW, 2014, BIOSENS BIOELECTRON, V52, P82, DOI 10.1016/j.bios.2013.08.019
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Scarabelli G, 2010, BIOPHYS J, V98, P1966, DOI 10.1016/j.bpj.2010.01.014
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shivatare SS, 2016, NAT CHEM, V8, P338, DOI [10.1038/NCHEM.2463, 10.1038/nchem.2463]
   Simkiss D, 2016, J TROP PEDIATRICS, V62, P1, DOI 10.1093/tropej/fmw006
   Sola L, 2016, LANGMUIR, V32, P10284, DOI 10.1021/acs.langmuir.6b02816
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Soriani M, 2010, J BIOL CHEM, V285, P30126, DOI 10.1074/jbc.M110.118513
   Timmerman P., 2009, OPEN VACCINE J, V2, P56, DOI DOI 10.2174/1875035400902010056
   Timmerman P, 2007, J MOL RECOGNIT, V20, P283, DOI 10.1002/jmr.846
   Tomizaki K, 2010, FEBS J, V277, P1996, DOI 10.1111/j.1742-4658.2010.07626.x
   Uttamchandani M, 2008, CURR PHARM DESIGN, V14, P2428, DOI 10.2174/138161208785777450
   van de Langemheen H, 2014, ORG BIOMOL CHEM, V12, P4471, DOI 10.1039/c4ob00190g
   Van Regenmortel MHV, 2009, OPEN VACCINE J, V2, P33, DOI DOI 10.2174/1875035401002010033
   Werkhoven PR, 2016, ORG BIOMOL CHEM, V14, P701, DOI 10.1039/c5ob02014j
   Xu X, 2016, PLOS CURR, DOI [10.1371/currents.out-breaks.9aa2e1fb61b0f632f58a098773008c4b, DOI 10.1371/CURRENTS.OUT-BREAKS.9AA2E1FB61B0F632F58A098773008C4B]
   Yalcin A, 2009, ANAL CHEM, V81, P625, DOI [10.1021/ac80101954x, 10.1021/ac801954x]
   Zilio C, 2014, BIOMED MICRODEVICES, V16, P107, DOI 10.1007/s10544-013-9810-8
NR 51
TC 7
Z9 7
U1 2
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD JUN
PY 2018
VL 4
IS 6
BP 998
EP 1006
DI 10.1021/acsinfecdis.8b00014
PG 17
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA GJ3DS
UT WOS:000435158700016
PM 29570266
DA 2020-07-08
ER

PT J
AU Adamski, A
   Bertolli, J
   Castaneda-Orjuela, C
   Devine, OJ
   Johansson, MA
   Duarte, MAG
   Farr, SL
   Tinker, SC
   Reyes, MMM
   Tong, V
   Garcia, OEP
   Valencia, D
   Ortiz, DAC
   Honein, MA
   Jamieson, DJ
   Martinez, MLO
   Gilboa, SM
AF Adamski, Alys
   Bertolli, Jeanne
   Castaneda-Orjuela, Carlos
   Devine, Owen J.
   Johansson, Michael A.
   Gonzalez Duarte, Maritza Adegnis
   Farr, Sherry L.
   Tinker, Sarah C.
   Mercado Reyes, Marcela Maria
   Tong, Van T.
   Pacheco Garcia, Oscar Eduardo
   Valencia, Diana
   Cuellar Ortiz, Diego Alberto
   Honein, Margaret A.
   Jamieson, Denise J.
   Ospina Martinez, Martha Lucia
   Gilboa, Suzanne M.
TI Estimating the numbers of pregnant women infected with Zika virus and
   infants with congenital microcephaly in Colombia, 2015-2017
SO JOURNAL OF INFECTION
LA English
DT Article
DE Zika virus; Colombia; Microcephaly; Modeling
ID BIRTH-DEFECTS; RISK
AB Background: Colombia experienced a Zika virus (ZIKV) outbreak in 2015-2016. To assist with planning Accepted 25 February 2018 for medical and supportive services for infants affected by prenatal ZIKV infection, we used a model to Available online 6 April 2018 estimate the number of pregnant women infected with ZIKV and the number of infants with congenital microcephaly from August 2015 to August 2017.
   Methods: We used nationally reported cases of symptomatic ZIKV disease among pregnant women and information from the literature on the percent of asymptomatic infections to estimate the number of pregnant women with ZIKV infection occurring August 2015-December 2016. We then estimated the Modeling number of infants with congenital microcephaly expected to occur August 2015-August 2017. To compare to the observed counts of infants with congenital microcephaly due to all causes reported through the national birth defects surveillance system, the model was time limited to produce estimates for February-November 2016.
   Findings: We estimated 1140-2160 (interquartile range [IQR]) infants with congenital microcephaly in Colombia, during August 2015-August 2017, whereas 340-540 infants with congenital microcephaly would be expected in the absence of ZIKV. Based on the time limited version of the model, for February-November 2016, we estimated 650-1410 infants with congenital microcephaly in Colombia. The 95% uncertainty interval for the latter estimate encompasses the 476 infants with congenital microcephaly reported during that approximate time frame based on national birth defects surveillance.
   Interpretation: Based on modeled estimates, ZIKV infection during pregnancy in Colombia could lead to 3-4 times as many infants with congenital microcephaly in 2015-2017 as would have been expected in the absence of the ZIKV outbreak.Published by Elsevier Ltd on behalf of The British Infection Association.
C1 [Adamski, Alys; Bertolli, Jeanne; Johansson, Michael A.; Farr, Sherry L.; Tinker, Sarah C.; Tong, Van T.; Valencia, Diana; Honein, Margaret A.; Gilboa, Suzanne M.] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA.
   [Castaneda-Orjuela, Carlos] Inst Nacl Salud, Colombian Natl Hlth Observ, Bogota, Colombia.
   [Devine, Owen J.] KARNA Inc, Atlanta, GA USA.
   [Gonzalez Duarte, Maritza Adegnis; Mercado Reyes, Marcela Maria; Pacheco Garcia, Oscar Eduardo; Ospina Martinez, Martha Lucia] Inst Nacl Salud, Bogota, Colombia.
   [Cuellar Ortiz, Diego Alberto] Minist Salud & Protect Social, Bogota, Colombia.
   [Jamieson, Denise J.] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
RP Adamski, A (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA.
EM ksf7@cdc.gov
OI Jamieson, Denise/0000-0003-2597-1201; Johansson,
   Michael/0000-0002-5090-7722; Pacheco Garcia, Oscar
   Eduardo/0000-0001-5939-6407; Farr, Sherry/0000-0002-9773-9009
CR Besnard M, 2014, EURO SURVEILL, V19
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Departamento Administrativo Nacional de Estadistica, 2015, POPULATION PROJECTIO
   Departamento Administrativo Nacional de Estadistica, BIRTHS AR SEX
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto Nacional de Salud, B EP SEM 2016 EP WEE
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization, CUM ZIK SUSP CONF CA
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ruiz-Lopez F, 2016, BIOMEDICA, V36, P303, DOI 10.7705/biomedica.v36i2.3301
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 28
TC 7
Z9 7
U1 0
U2 4
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUN
PY 2018
VL 76
IS 6
BP 529
EP 535
DI 10.1016/j.jinf.2018.02.010
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA GI0VL
UT WOS:000434088300005
PM 29627357
OA Bronze
DA 2020-07-08
ER

PT J
AU Ramos, CL
   Moreno-Carvalho, OA
   Nascimento-Carvalho, CM
AF Ramos, Clara L.
   Moreno-Carvalho, Otavio A.
   Nascimento-Carvalho, Cristiana M.
TI Cerebrospinal fluid aspects of neonates with or without microcephaly
   born to mothers with gestational Zika virus clinical symptoms
SO JOURNAL OF INFECTION
LA English
DT Letter
ID INFECTION
C1 [Ramos, Clara L.] Bahiana Sch Med, Bahiana Fdn Sci Dev, Ave Santa Luzia 400,Apt 2002, BR-40295050 Salvador, BA, Brazil.
   [Moreno-Carvalho, Otavio A.] Jose Silveira Fdn, Cerebrospinal Fluid Lab, BR-40170100 Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Postgrad Program Hlth Sci, BR-40025010 Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Dept Paediat, BR-40025010 Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Brazilian Council Sci & Technol Dev, Brasilia, Brazil.
RP Ramos, CL (corresponding author), Bahiana Sch Med, Bahiana Fdn Sci Dev, Ave Santa Luzia 400,Apt 2002, BR-40295050 Salvador, BA, Brazil.
EM ccclr1@gmail.com
CR BOPPANA SB, 1992, PEDIATR INFECT DIS J, V11, P93, DOI 10.1097/00006454-199202000-00007
   Center for Diseases Control and Prevention, 2016, ZIK VIR TEST TREATM
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Fernandes RCDC, 2016, LANCET INFECT DIS, V16, P772, DOI 10.1016/S1473-3099(16)30079-2
   Passemard S, 2013, HAND CLINIC, V111, P129, DOI 10.1016/B978-0-444-52891-9.00013-0
   Reiber H, 2003, RESTOR NEUROL NEUROS, V21, P79
   Shah SS, 2011, J HOSP MED, V6, P22, DOI 10.1002/jhm.711
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 9
TC 1
Z9 1
U1 0
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD JUN
PY 2018
VL 76
IS 6
BP 565
EP 567
DI 10.1016/j.jinf.2018.02.004
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA GI0VL
UT WOS:000434088300010
PM 29432825
DA 2020-07-08
ER

PT J
AU Zukor, K
   Wang, H
   Siddharthan, V
   Julander, JG
   Morrey, JD
AF Zukor, Katherine
   Wang, Hong
   Siddharthan, Venkatraman
   Julander, Justin G.
   Morrey, John D.
TI Zika virus-induced acute myelitis and motor deficits in adult interferon
   alpha beta/gamma receptor knockout mice
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Zika virus; Brain; Spinal cord; Motor; Guillian-Barre syndrome; Mouse
ID WEST-NILE-VIRUS; CENTRAL-NERVOUS-SYSTEM; ACUTE FLACCID PARALYSIS;
   GUILLAIN-BARRE-SYNDROME; SPINAL-CORD-INJURY; MOUSE MODEL;
   ENCEPHALITIS-VIRUS; INFECTION; PATHOGENESIS; HAMSTERS
AB Zika virus (ZIKV) has received widespread attention because of its effect on the developing fetus. It is becoming apparent, however, that severe neurological sequelae, such as Guillian-Barre syndrome (GBS), myelitis, encephalitis, and seizures can occur after infection of adults. This study demonstrates that a contemporary strain of ZIKV can widely infect astrocytes and neurons in the brain and spinal cord of adult, interferon ou alpha/beta receptor knockout mice (AG 129 strain) and cause progressive hindlimb paralysis, as well as severe seizurelike activity during the acute phase of disease. The severity of hindlimb motor deficits correlated with increased numbers of ZIKV-infected lumbosacral spinal motor neurons and decreased numbers of spinal motor neurons. Electrophysiological compound muscle action potential (CMAP) amplitudes in response to stimulation of the lumbosacral spinal cord were reduced when obvious motor deficits were present. ZIKV immunoreactivity was high, intense, and obvious in tissue sections of the brain and spinal cord. Infection in the brain and spinal cord was also associated with astrogliosis as well as T cell and neutrophil infiltration. CMAP and histological analysis indicated that peripheral nerve and muscle functions were intact. Consequently, motor deficits in these circumstances appear to be primarily due to myelitis and possibly encephalitis as opposed to a peripheral neuropathy or a GBS-like syndrome. Thus, acute ZIKV infection of adult AG 129 mice may be a useful model for ZlKV-induced myelitis, encephalitis, and seizure activity.
C1 [Zukor, Katherine; Wang, Hong; Siddharthan, Venkatraman; Julander, Justin G.; Morrey, John D.] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.
RP Morrey, JD (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.
EM john.morrey@usu.edu
FU Public Health Service (PHS) research grant from the National Institute
   of Neurological Disorders and Stroke (NINDS), National Institutes of
   Health (NIH) [1R21NS090133]; PHS grant from the Virology Branch,
   National Institute of Allergy and Infectious Diseases (NIAID), NIH
   [5R33AI101483, HHSN272201000039I/HHSN27200004]; Utah Agriculture
   Research Station research grant [UTA01176]
FX The work was supported by Public Health Service (PHS) research grant
   1R21NS090133 to J.D.M. from the National Institute of Neurological
   Disorders and Stroke (NINDS), National Institutes of Health (NIH), and
   PHS grant 5R33AI101483 and contract HHSN272201000039I/HHSN27200004 to
   J.D.M. from the Virology Branch, National Institute of Allergy and
   Infectious Diseases (NIAID), NIH, and Utah Agriculture Research Station
   research grant UTA01176 to J.D.M. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Asadi-Pooya AA, 2016, SEIZURE-EUR J EPILEP, V43, P13, DOI 10.1016/j.seizure.2016.10.011
   Bai FW, 2010, J INFECT DIS, V202, P1804, DOI 10.1086/657416
   Basoglu H, 2013, SPINAL CORD, V51, P616, DOI 10.1038/sc.2013.40
   Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Blakely PK, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00344
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brison E, 2011, J VIROL, V85, P12464, DOI 10.1128/JVI.05576-11
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Fernandes NCCA, 2017, EXP TOXICOL PATHOL, V69, P63, DOI 10.1016/j.etp.2016.11.004
   Harrison M, 2013, NEUROIMAGE, V68, P22, DOI 10.1016/j.neuroimage.2012.11.048
   Hatzipetros T, 2015, JOVE-J VIS EXP, V104, P53257
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Ireland DDC, 2017, CELL MOL IMMUNOL, V14, P90, DOI 10.1038/cmi.2016.41
   Itoh A, 2011, J NEUROSCI, V31, P7223, DOI 10.1523/JNEUROSCI.5947-10.2011
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Marques KB, 2006, EUR J NEUROSCI, V24, P3053, DOI 10.1111/j.1460-9568.2006.05184.x
   McCandless EE, 2008, P NATL ACAD SCI USA, V105, P11270, DOI 10.1073/pnas.0800898105
   MCHANWELL S, 1981, PHILOS T ROY SOC B, V293, P477, DOI 10.1098/rstb.1981.0082
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Morrey JD, 2004, ANTIVIR RES, V63, P41, DOI 10.1016/j.antiviral.2004.02.005
   Morrey JD, 2008, J NEUROVIROL, V14, P152, DOI 10.1080/13550280801958930
   Murphy-Royal C, 2017, J NEUROSCI RES, V95, P2140, DOI 10.1002/jnr.24029
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nakanishi ST, 2005, J NEUROSCI, V25, P2226, DOI 10.1523/JNEUROSCI.5065-04.2005
   National Research Council, 2011, GUIDE CARE USE LAB A
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Nordander C, 2003, EUR J APPL PHYSIOL, V89, P514, DOI 10.1007/s00421-003-0819-1
   Ousman SS, 2012, NAT NEUROSCI, V15, P1096, DOI 10.1038/nn.3161
   Pastula DM, 2017, NEUROCRIT CARE, V26, P457, DOI 10.1007/s12028-016-0333-z
   Paxinos G., 2004, MOUSE BRAIN STEREOTA
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Samuel MA, 2007, P NATL ACAD SCI USA, V104, P17140, DOI 10.1073/pnas.0705837104
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schulz KS, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00498
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Shrestha B, 2003, J VIROL, V77, P13203, DOI 10.1128/JVI.77.24.13203-13213.2003
   Shrestha B, 2012, J VIROL, V86, P8937, DOI 10.1128/JVI.00673-12
   Siddharthan V, 2009, J VIROL, V83, P4251, DOI 10.1128/JVI.00017-09
   Smith DE, 2016, NEUROL-CLIN PRACT, V6, P515, DOI 10.1212/CPJ.0000000000000307
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solomon I. H., 2016, J NEUROINFECT DIS, V7
   Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Taylor MP, 2015, TRENDS MICROBIOL, V23, P283, DOI 10.1016/j.tim.2015.01.002
   VANDENBROEK MF, 1995, J VIROL, V69, P4792, DOI 10.1128/JVI.69.8.4792-4796.1995
   Wang H, 2009, J NEUROVIROL, V15, P293, DOI 10.1080/13550280902973978
   Watson C, 2009, SPINAL CORD: A CHRISTOPHER AND DANA REEVE FOUNDATION TEXT AND ATLAS, P308, DOI 10.1016/B978-0-12-374247-6.50020-1
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Winkler CW, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0836-3
   Xiao SY, 2001, EMERG INFECT DIS, V7, P714
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zukor K, 2017, J NEUROVIROL, V23, P186, DOI 10.1007/s13365-016-0488-6
   Zukor KA, 2010, DEV DYNAM, V239, P3048, DOI 10.1002/dvdy.22441
NR 72
TC 7
Z9 8
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2018
VL 24
IS 3
BP 273
EP 290
DI 10.1007/s13365-017-0595-z
PG 18
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ET
UT WOS:000434755500002
PM 29476408
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Simon, O
   Acket, B
   Forfait, C
   Girault, D
   Gourinat, AC
   Millon, P
   Daures, M
   Vanhomwegen, J
   Billot, S
   Biron, A
   Hoinard, D
   Descloux, E
   Guyon, D
   Manuguerra, JC
   Laumond, S
   Molko, N
   Dupont-Rouzeyrol, M
AF Simon, Olivier
   Acket, Blandine
   Forfait, Carole
   Girault, Dominique
   Gourinat, Ann-Claire
   Millon, Pauline
   Daures, Maguy
   Vanhomwegen, Jessica
   Billot, Segolene
   Biron, Antoine
   Hoinard, Damien
   Descloux, Elodie
   Guyon, David
   Manuguerra, Jean Claude
   Laumond, Sylvie
   Molko, Nicolas
   Dupont-Rouzeyrol, Myrielle
TI Zika virus outbreak in New Caledonia and Guillain-Barre syndrome: a
   case-control study
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article
DE Guillain-Barre syndrome; Case control study; Zika virus; New Caledonia
AB Zika virus (ZIKV) infection has been associated with neurologic disorders including Guillain-Barre syndrome (GBS). In New Caledonia during the ZIKV outbreak (2014-2015), case-control and retrospective studies have been performed to assess the link between ZIKVand GBS. Among the 15 cases included, 33% had evidence of a recent ZIKV infection compared to only 3.3% in the 30 controls involved. All patients were Melanesian, had facial diplegia and similar neurophysiological pattern consistent with acute inflammatory demyelinating polyneuropathy, and recovered well. Furthermore, during the peak of ZIKV transmission, we observed a number ofGBS cases higherthanthe calculated upper limit, emphasizing the fact that ZIKV is now a major trigger of GBS.
C1 [Simon, Olivier; Millon, Pauline; Billot, Segolene; Guyon, David; Molko, Nicolas] Gaston Bourret Terr Hosp, Dept Neurol, Noumea, New Caledonia.
   [Acket, Blandine] CHU Toulouse, Dept Neurophysiol, Toulouse, France.
   [Forfait, Carole; Daures, Maguy; Laumond, Sylvie] New Caledonia Hlth Dept, Noumea, New Caledonia.
   [Girault, Dominique; Dupont-Rouzeyrol, Myrielle] Inst Pasteur New Caledonia, Inst Pasteur Int Network, Dengue & Arboviruses Expertise & Res Unit, Noumea, New Caledonia.
   [Gourinat, Ann-Claire; Biron, Antoine] Inst Pasteur New Caledonia, Inst Pasteur Int Network, Immunoserol & Mol Biol Lab, Noumea, New Caledonia.
   [Vanhomwegen, Jessica; Hoinard, Damien; Manuguerra, Jean Claude] Inst Pasteur, Environm & Infect Risks Unit, Paris, France.
   [Descloux, Elodie] Gaston Bourret Terr Hosp, Dept Infect Dis, Noumea, New Caledonia.
RP Simon, O (corresponding author), Gaston Bourret Terr Hosp, Dept Neurol, Noumea, New Caledonia.
EM olivier.simon@cht.nc
OI GIRAULT, Dominique/0000-0003-4402-9721
FU French Government's Investissement d'Avenir Programme (Labex Integrative
   Biology of Emerging Infectious Diseases, IBEID)French National Research
   Agency (ANR) [ANR-10-LABX-62-IBEID]; New Caledonia Government; Institut
   Pasteur in New Caledonia; Centre Hospitalier Territorial, New Caledonia;
   European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant [734548]
FX Study partly funded by French Government's Investissement d'Avenir
   Programme (Labex Integrative Biology of Emerging Infectious Diseases,
   IBEID, grant number ANR-10-LABX-62-IBEID), New Caledonia Government,
   Institut Pasteur in New Caledonia, Centre Hospitalier Territorial, New
   Caledonia and by the European Union's Horizon 2020 Research and
   Innovation Programme under ZIKAlliance Grant Agreement no. 734548.
CR Beck C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/678084
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   da Silva IRF, 2016, NEUROLOGY, V87, pE180, DOI 10.1212/WNL.0000000000003024
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kassavetis P, 2016, NEUROLOGY, V87, P336, DOI 10.1212/WNL.0000000000002759
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pastula DM, 2017, J NEUROL SCI, V372, P350, DOI 10.1016/j.jns.2016.08.064
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Styczynski Malta, 2017, PLOS NEGLECT TROP D, V11
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Van Den Bergh PYK, 2004, MUSCLE NERVE, V29, P565, DOI 10.1002/mus.20022
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 26
TC 13
Z9 13
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD JUN
PY 2018
VL 24
IS 3
BP 362
EP 368
DI 10.1007/s13365-018-0621-9
PG 7
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ET
UT WOS:000434755500011
PM 29594985
DA 2020-07-08
ER

PT J
AU Rossi, SL
   Estofolete, CF
   Nogueira, ML
   Vasilakis, N
AF Rossi, Shannan L.
   Estofolete, Cassia F.
   Nogueira, Mauricio Lacerda
   Vasilakis, Nikos
TI Age and Sex in the Zika Pandemic Era
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
ID VIRUS OUTBREAK; BRAZIL; TRANSMISSION; CHIKUNGUNYA; MICRONESIA; AMERICA;
   DENGUE
C1 [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Rossi, Shannan L.; Vasilakis, Nikos] Univ Texas Med Branch, Dept Pathol, Keiller 2-138D,301 Univ Blvd, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
   [Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Galveston, TX 77555 USA.
   [Estofolete, Cassia F.; Nogueira, Mauricio Lacerda] Fac Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, Brazil.
RP Vasilakis, N (corresponding author), Univ Texas Med Branch, Dept Pathol, Keiller 2-138D,301 Univ Blvd, Galveston, TX 77555 USA.
EM nivasila@utmb.edu
RI Estofolete, Cassia/N-6673-2019; Nogueira, Mauricio L/B-7599-2012
OI Estofolete, Cassia/0000-0001-7324-1591; Nogueira, Mauricio
   L/0000-0003-1102-2419
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R24AI120942,
   1U01AI115577]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2013/21719-3, 2016/15021-1]; Instituto Nacional de Ciencia e Tecnologia
   em Dengue (INCT-Dengue); Conselho Nacional de Desenvolvimento Cientifico
   e Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq)
FX This work was supported by the National Institutes of Health (grants
   R24AI120942 and 1U01AI115577 to N. V.), Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) (grants 2013/21719-3 and 2016/15021-1 to M.
   L. N.), Instituto Nacional de Ciencia e Tecnologia em Dengue
   (INCT-Dengue) (to M. L. N.), and the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (research fellowship to
   M. L. N.).
CR Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Vasilakis N, 2017, CURR OPIN VIROL, V22, P30, DOI 10.1016/j.coviro.2016.11.007
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 24
TC 1
Z9 1
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2018
VL 217
IS 11
BP 1675
EP 1677
DI 10.1093/infdis/jix631
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GI0TA
UT WOS:000434081100001
PM 29216367
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Fortner, KB
   Nieuwoudt, C
   Reeder, CF
   Swamy, GK
AF Fortner, Kimberly B.
   Nieuwoudt, Claudia
   Reeder, Callie F.
   Swamy, Geeta K.
TI Infections in Pregnancy and the Role of Vaccines
SO OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Influenza; Pertussis; Zika; Influenza vaccine; Tdap vaccine; Maternal
   vaccination
ID IMMUNIZATION PRACTICES ACIP; CONGENITAL CYTOMEGALOVIRUS-INFECTION;
   ACELLULAR PERTUSSIS-VACCINE; MATERNAL VIRUS DISEASES; UPDATE INTERIM
   GUIDANCE; ADVISORY-COMMITTEE; ZIKA VIRUS; UNITED-STATES; INFLUENZA
   IMMUNIZATION; BACTERIAL-MENINGITIS
AB Pregnant women are at risk for infection and may have significant morbidity or mortality. Influenza, pertussis, zika, and cytomegalovirus produce mild or asymptomatic illness in the mother but have profound implications for her fetus. Maternal immunization can prevent or mitigate infections in pregnant women and their infants. The Advisory Committee of Immunization Practices recommends 2 vaccines during pregnancy: inactivated influenza, and tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis during pregnancy. The benefits of MMR, varicella, and other vaccines are reviewed. Novel vaccine studies for use during pregnancy for prevention of illness are explored.
C1 [Fortner, Kimberly B.] Univ Tennessee, Med Ctr, Dept Obstet & Gynecol Maternal Fetal Med, 1924 Alcoa Highway,Box 96, Knoxville, TN 37919 USA.
   [Nieuwoudt, Claudia; Reeder, Callie F.] Univ Tennessee, Med Ctr, Dept Obstet & Gynecol, 1924 Alcoa Highway,Box U27, Knoxville, TN 37920 USA.
   [Swamy, Geeta K.] Duke Univ Med Syst, Dept Obstet & Gynecol, Obstet Clin Res, Durham, NC USA.
RP Fortner, KB (corresponding author), Univ Tennessee, Med Ctr, Dept Obstet & Gynecol Maternal Fetal Med, 1924 Alcoa Highway,Box 96, Knoxville, TN 37919 USA.
EM kfortner@utmck.edu
FU GlaxoSmithKlineGlaxoSmithKline; NovartisNovartis; Novavax; PfizerPfizer;
   Regeneron
FX G.K. Swamy is on a Data and Safety Monitoring Board for a
   GlaxoSmithKline-funded respiratory syncytial virus (RSV) vaccine study
   in pregnant women. She has received research funding for studies of
   group B streptococcus vaccine in pregnant women produced by Novartis and
   for RSV vaccine in pregnant women produced by Novavax. K.B. Fortner has
   received research funding for studies of group B streptococcus vaccine
   in pregnant women produced by Novartis and for RSV and cytomegalovirus
   surveillance among pregnant women and their infants by Pfizer and
   Regeneron. The remaining authors have no conflicts of interest to
   declare.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adriani KS, 2012, CLIN MICROBIOL INFEC, V18, P345, DOI 10.1111/j.1469-0691.2011.03465.x
   Advisory Committee on Immunization Practices (ACIP), 2012, UPD REC US TET TOX R
   American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P941
   [Anonymous], 2013, Obstet Gynecol, V121, P1411, DOI 10.1097/01.AOG.0000431054.33593.e3
   Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P13
   [Anonymous], 1997, MMWR Recomm Rep, V46, P1
   Arvin AM, 2004, CLIN INFECT DIS, V39, P233, DOI 10.1086/421999
   Beigi RH, 2014, CLIN INFECT DIS, V59, pS408, DOI 10.1093/cid/ciu708
   Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309
   Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027
   Bohlke K, 2003, OBSTET GYNECOL, V102, P970, DOI 10.1016/S0029-7844(03)00860-3
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Bratton KN, 2015, CLIN INFECT DIS, V60, pE11, DOI 10.1093/cid/ciu915
   BRUNELL PA, 1983, SEMIN PERINATOL, V7, P47
   Centers for Disease Control and Prevention, 2017, GUID VACC PREGN WOM
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention, 2017, REC IMM SCHED CHILDR
   Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P621
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P1117
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P73
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P616
   Centers for Disease Control and Prevention (CDC), 2013, 2012 FIN PERT SURV R
   Centers for Disease Control and Prevention (CDC), 2016, VACC PREV DIS VACC D
   Centers for Disease Control and Prevention (CDC), 2017, RESP SYNCYTIAL VIRUS
   Centers for Disease Control and Prevention (CDC), 2017, PERT WHOOP COUGH SUR
   Centers for Disease Control and Prevention (CDC), 2017, REC AD IMM SCHED
   Chaithongwongwatthana S, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004903.pub4
   Davis NL, 2017, BIRTH DEFECTS RES, V109, P336, DOI 10.1002/bdra.23601
   Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Fell DB, 2015, BJOG-INT J OBSTET GY, V122, P17, DOI 10.1111/1471-0528.12977
   Fiore Anthony E., 2006, Morbidity and Mortality Weekly Report, V55, P1
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8
   Fu TM, 2014, VACCINE, V32, P2525, DOI 10.1016/j.vaccine.2014.03.057
   Gall SA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.024
   Haberg SE, 2013, NEW ENGL J MED, V368, P333, DOI 10.1056/NEJMoa1207210
   Halasa NB, 2008, J PEDIATR-US, V153, P327, DOI 10.1016/j.jpeds.2008.03.011
   Hamborsky J., 2015, EPIDEMIOLOGY PREVENT
   Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002
   Heath PT, 2016, VACCINE, V34, P2876, DOI 10.1016/j.vaccine.2015.12.072
   Hughes BL, 2016, AM J OBSTET GYNECOL, V214, pB5, DOI 10.1016/j.ajog.2016.02.042
   Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0
   Kallen B, 2012, BJOG-INT J OBSTET GY, V119, P1583, DOI 10.1111/j.1471-0528.2012.03470.x
   Koppaka Ram, 2011, Morbidity and Mortality Weekly Report, V60, P814
   Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042
   Kretsinger Katrina, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Kroger AT, 2017, GEN BEST PRACTICE GU
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P1155, DOI 10.1111/j.1471-0528.2011.02983.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Louie JK, 2010, NEW ENGL J MED, V362, P27, DOI 10.1056/NEJMoa0910444
   Madhi SA, 2014, NEW ENGL J MED, V371, P918, DOI 10.1056/NEJMoa1401480
   Makris MC, 2012, DRUG SAFETY, V35, P1, DOI 10.2165/11595670-000000000-00000
   Malek A, 1996, AM J REPROD IMMUNOL, V36, P248
   Marin Mona, 2007, Morbidity and Mortality Weekly Report, V56, P1
   MAST EE, 2006, MMWR RECOMM REP, V55, pCE1
   Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1
   McLean HQ, 2013, MMWR RECOMM REP, V62, P1
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Moro PL, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.12.036
   Munoz FM, 2014, JAMA-J AM MED ASSOC, V311, P1760, DOI 10.1001/jama.2014.3633
   National Institute of Allergy and Infectious Diseases (NIAID), 2017, ZIK VIR VACC
   Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587
   Nieves DJ, 2011, J PEDIATR-US, V159, P1044, DOI 10.1016/j.jpeds.2011.08.010
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Orenstein WA, 2015, PUBLIC HEALTH REP, V130, P10
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Plotkin SA, 2017, VACCINES
   Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rasmussen SA, 2012, AM J OBSTET GYNECOL, V207, pS3, DOI 10.1016/j.ajog.2012.06.068
   Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807
   Sawyer M, 2013, MMWR-MORBID MORTAL W, V62, P131
   Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592
   Schleiss MR, 2016, J VIRUS ERAD, V2, P198
   Seetoo K, 2013, MMWR-MORBID MORTAL W, V62, P226
   Sheffield JS, 2009, OBSTET GYNECOL, V114, P915, DOI 10.1097/AOG.0b013e3181b8e76d
   SIEGEL M, 1966, NEW ENGL J MED, V274, P768, DOI 10.1056/NEJM196604072741404
   SIEGEL M, 1966, J AMER MED ASSOC, V197, P680, DOI 10.1001/jama.197.9.680
   Steiner B, 2014, AM J PERINAT, V31, P407, DOI 10.1055/s-0033-1352483
   Steinhoff MC, 2012, CAN MED ASSOC J, V184, P645, DOI 10.1503/cmaj.110754
   Swamy GK, 2015, VACCINE, V33, P6436, DOI 10.1016/j.vaccine.2015.08.035
   Swamy GK, 2015, OBSTET GYNECOL, V125, P212, DOI 10.1097/AOG.0000000000000581
   Thigpen MC, 2011, NEW ENGL J MED, V364, P2016, DOI 10.1056/NEJMoa1005384
   Toback SL, 2012, INFLUENZA OTHER RESP, V6, P44, DOI 10.1111/j.1750-2659.2011.00266.x
   U. S. Food and Drug Administration, 2016, TET TOX RED DIPHTH T
   US Food and Drug Administration (FDA), 2015, TET TOX RED DIPHTH T
   Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1
   Watson B, 2007, PUBLIC HEALTH REP, V122, P499, DOI 10.1177/003335490712200411
   Watson J C, 1998, MMWR Recomm Rep, V47, P1
   Winter K, 2017, CLIN INFECT DIS, V64, P3, DOI 10.1093/cid/ciw634
   Woods CR, 2013, J PEDIATR INFECT DIS, V2, P87, DOI 10.1093/jpids/pis133
   World Health Organization, 2017, MAT NEON TET EL MNTE
   Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630
   Zheteyeva Y, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2013.02.027
NR 97
TC 2
Z9 2
U1 2
U2 6
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0889-8545
EI 1558-0474
J9 OBSTET GYN CLIN N AM
JI Obstet. Gynecol. Clin. N. Am.
PD JUN
PY 2018
VL 45
IS 2
BP 369
EP +
DI 10.1016/j.ogc.2018.01.006
PG 21
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GI9ZX
UT WOS:000434905200015
PM 29747736
DA 2020-07-08
ER

PT J
AU Lozier, MJ
   Burke, RM
   Lopez, J
   Acevedo, V
   Amador, M
   Read, JS
   Jara, A
   Waterman, SH
   Barrera, R
   Munoz-Jordan, J
   Rivera-Garcia, B
   Sharp, TM
AF Lozier, Matthew J.
   Burke, Rachel M.
   Lopez, Juan
   Acevedo, Veronica
   Amador, Manuel
   Read, Jennifer S.
   Jara, Amanda
   Waterman, Stephen H.
   Barrera, Roberto
   Munoz-Jordan, Jorge
   Rivera-Garcia, Brenda
   Sharp, Tyler M.
TI Differences in Prevalence of Symptomatic Zika Virus Infection, by Age
   and Sex-Puerto Rico, 2016
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Editorial Material
DE Zika virus; cluster investigation; surveillance; Puerto Rico; Aedes
   aegypti; flavivirus
ID AEDES-AEGYPTI; DENGUE VIRUS; TRANSMISSION; PRODUCTIVITY; COMMUNITIES;
   MICRONESIA; EPIDEMIC
AB Background. During the outbreak of Zika virus (ZIKV) disease in Puerto Rico in 2016, nonpregnant women aged 20-39 years were disproportionately identified with ZIKV disease. We used household-based cluster investigations to determine whether this disparity was associated with age-or sex-dependent differences in the rate of ZIKV infection or reported symptoms.
   Methods. Participation was offered to residents of households within a 100-m radius of the residences of a convenience sample of 19 laboratory-confirmed ZIKV disease cases. Participants answered a questionnaire and provided specimens for diagnostic testing by reverse transcription-polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA).
   Results. Among 367 study participants, 114 (31.1%) were laboratory positive for ZIKV infection, of whom 30% reported a recent illness (defined as self-reported rash or arthralgia) attributable to ZIKV infection. Age and sex were not associated with ZIKV infection. Female sex (adjusted prevalence ratio [aPR], 2.28; 95% confidence interval [CI], 1.40, 3.67), age < 40 years (aPR, 2.39; 95% CI, 1.55, 3.70), and asthma (aPR, 1.63; 95% CI, 1.12, 2.37) were independently associated with symptomatic infection.
   Conclusions. Although neither female sex nor age were associated with an increased prevalence of ZIKV infection, both were associated with symptomatic infection. Further investigation to identify a potential mechanism of age- and sex-dependent differences in reporting symptomatic ZIKV infection is warranted.
C1 [Lozier, Matthew J.; Lopez, Juan; Acevedo, Veronica; Amador, Manuel; Read, Jennifer S.; Jara, Amanda; Waterman, Stephen H.; Barrera, Roberto; Munoz-Jordan, Jorge; Sharp, Tyler M.] Univ Georgia, Natl Ctr Emerging Zoonot & Infect Dis, Ctr Dis Control & Prevent CDC, Athens, GA 30602 USA.
   [Burke, Rachel M.] Univ Georgia, Natl Ctr Immunizat & Resp Dis, Ctr Dis Control & Prevent CDC, Athens, GA 30602 USA.
   [Jara, Amanda] Univ Georgia, Coll Vet Med, Athens, GA 30602 USA.
   [Lopez, Juan] Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.
   [Rivera-Garcia, Brenda] Puerto Rico Dept Hlth, Off Epidemiol & Res, San Juan, PR USA.
RP Lozier, MJ (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Emerging Zoonot & Infect Dis, 1324 Calle Canada, San Juan, PR 00920 USA.
EM mlozier@cdc.gov
RI Burke, Rachel/R-3683-2019
OI Burke, Rachel/0000-0002-5678-5826
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX This work was supported by the Centers for Disease Control and
   Prevention.
CR Anders KL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003528
   Aubry M, 2017, EMERG INFECT DIS, P23
   Barrera R, 2008, MED VET ENTOMOL, V22, P62, DOI 10.1111/j.1365-2915.2008.00720.x
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bloch D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005075
   Carey VJ, PACKAGE GEE GEN ESTI
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, ZIK MAC ELISA
   Centers for Disease Control and Prevention, TRIP REAL TIM RT PCR
   Centers for Disease Control and Prevention, 2016, TEST ZIK VIR
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Dechant EJ, 1999, AM J TROP MED HYG, V61, P574, DOI 10.4269/ajtmh.1999.61.574
   Demanou M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002950
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellis EM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003733
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003977
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Puerto Rico Department of Health, ARB DIS WEEKL REP WE
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Salje H, 2016, J INFECT DIS, V213, P604, DOI 10.1093/infdis/jiv470
   Sarker AR, 2016, GLOB PEDIAT HLTH, V3
   Sharp TM, 2016, J INFECT DIS, V214, pS475, DOI 10.1093/infdis/jiw245
   Sharp TM, 2015, EMERG INFECT DIS, V21, P1311, DOI 10.3201/eid2108.150368
   Sharp TM, 2014, AM J TROP MED HYG, V91, P235, DOI 10.4269/ajtmh.13-0742
   Sharp TM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002159
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   Thompson AE, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0440-0
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   WATERMAN SH, 1985, AM J TROP MED HYG, V34, P625, DOI 10.4269/ajtmh.1985.34.625
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
NR 45
TC 16
Z9 16
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2018
VL 217
IS 11
BP 1678
EP 1689
DI 10.1093/infdis/jix630
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GI0TA
UT WOS:000434081100002
PM 29216376
OA Bronze
DA 2020-07-08
ER

PT J
AU Bandyopadhyay, D
   Ashish, K
   Ghosh, S
   Hajra, A
   Modi, VA
AF Bandyopadhyay, Dhrubajyoti
   Ashish, Kumar
   Ghosh, Sudeshna
   Hajra, Adrija
   Modi, Vivek Amit
TI Cardiovascular implications of Zika virus infection
SO EUROPEAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
C1 [Bandyopadhyay, Dhrubajyoti; Modi, Vivek Amit] Mt Sinai St Lukes Roosevelt Hosp Ctr, New York, NY 10025 USA.
   [Ashish, Kumar] Crozer Chester Med Ctr, Philadelphia, PA USA.
   [Ghosh, Sudeshna] Univ Nebraska Med Ctr, Omaha, NE USA.
   [Hajra, Adrija] IPGMER, Kolkata, India.
RP Bandyopadhyay, D (corresponding author), Mt Sinai St Lukes Roosevelt Hosp Ctr, New York, NY 10025 USA.
EM dhrubajyoti.bandyopadhyay@mountsinai.org
RI Hajra, Adrija/AAM-5736-2020; Bandyopadhyay, Dhrubajyoti/AAQ-5622-2020
OI Bandyopadhyay, Dhrubajyoti/0000-0002-0709-4324
CR Abdalla LF, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0938-2
   Aletti M, 2017, CLIN INFECT DIS, V64, P678, DOI 10.1093/cid/ciw802
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Di Cavalcanti D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175065
   Carta KAG, 2017, J AM COLL CARDIOL, V69, P906
   Gulland A., ZIKA VIRUS IS GLOBAL
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Minhas AM, 2017, CUREUS, V9
   Resiere D, 2018, J CLIN VIROL, V98, P8, DOI 10.1016/j.jcv.2017.11.002
   Waggoner JJ, 2017, OPEN FOR INFECT DIS, V4
NR 10
TC 0
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0953-6205
EI 1879-0828
J9 EUR J INTERN MED
JI Eur. J. Intern. Med.
PD JUN
PY 2018
VL 52
BP E35
EP E36
DI 10.1016/j.ejim.2018.03.016
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GI3ZR
UT WOS:000434311200015
PM 29657107
DA 2020-07-08
ER

PT J
AU Singh, K
   Ahmad, Z
   Hasan, SM
   Mujahid, M
   Shakya, P
AF Singh, Kuldeep
   Ahmad, Zeeshan
   Hasan, Syed Misbahul
   Mujahid, Mohd
   Shakya, Pragati
TI ZIKA VIRUS: A CHALLENGE FOR HUMANS
SO INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES AND RESEARCH
LA English
DT Review
DE Zika virus; A. aegypti; A. albopictus; Guillain-Barre syndrome
ID FRENCH-POLYNESIA; TRANSMISSION; INFECTION; OUTBREAK; FEVER; ARBOVIRUSES;
   AMERICA; DENGUE; BRAZIL
AB Zika virus infection is caused by the bite of an infected Aedes mosquito, usually causing rash, mild fever, conjunctivitis, and muscle pain. First time the virus was isolated in 1947 in the Zika forest in Uganda. It is transmitted to people through the bite of an infected Aedes mosquito. Symptoms are similar to those of dengue and chikungunya, which are transmitted by the same type of mosquito. Autoimmune and Neurological complications are infrequent. Treatment consists of relieving pain, fever, and any other symptom that inconveniences the patient. To prevent dehydration, it is recommended to drink plenty of water, rest, and control the fever. Thus far, there is no vaccine for the virus. But since it is a self-remitting disease, a person can be hopeful of being cured within a week or two, and the treatment is usually symptomatic. This review covers about the Zika virus; epidemiology and guidelines issued by the health ministry for control and prevention of Zika infections.
C1 [Singh, Kuldeep; Ahmad, Zeeshan; Hasan, Syed Misbahul; Mujahid, Mohd] Integral Univ, Fac Pharm, Kursi Rd, Lucknow 226026, Uttar Pradesh, India.
   [Shakya, Pragati] Govt Publ Analyst Labs, Lucknow 226020, Uttar Pradesh, India.
RP Singh, K (corresponding author), Integral Univ, Fac Pharm, Kursi Rd, Lucknow 226026, Uttar Pradesh, India.
EM kuldeep@iul.ac.in
CR [Anonymous], 2016, ZIK VIR INF
   [Anonymous], 2015, IMM VACC BIOL
   Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Bagla Pallava, 2016, HUFFINGTON POST 0207
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Bennett John E., 2014, PRINCIPLES PRACTICE, P1881
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chhabra M, 2008, INDIAN J MED MICROBI, V26, P5, DOI 10.4103/0255-0857.38850
   Cook J., 2016, BBC NEWS
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Euroimmun UK, 1 COMM ANT TESTS FOR
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grenoble R, 2016, WHO DECLARES PUBLIC
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   ICTV, VIR TAX 201 REL 2015
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Maron D. F., 2016, SCI AM
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Oster AM, 2016, MMWR-MORBID MORTAL W, P65
   PAHO: Pan American Health Organization, 2016, CHIK
   PAHO: Pan American Health Organization, ZIK VIR 457 INF 2016
   Pan American Health Organization, ZIK EP AL UPD
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sagonowsky Eric, 2016, INOVIO SET 1 ZIKA VA
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Siddiqi Zeba, 2016, REUTERS
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sternberg S., 2016, US NEWS WORLD REPORT
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tognarelli J., 2015, ARCH VIROL, P1
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2016, ZIK SIT REP
   World Health Organization, 2016, WHO EXP PRIOR VACC D
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
NR 87
TC 0
Z9 0
U1 0
U2 14
PU INT JOURNAL PHARMACEUTICAL SCIENCES & RESEARCH
PI HARYANA
PA 1117, SECTOR 12 A, PANCHKULA, HARYANA, 00000, INDIA
SN 0975-8232
J9 INT J PHARM SCI RES
JI Int. J. Pharm.l Sci. Res.
PD JUN
PY 2018
VL 9
IS 6
BP 2149
EP 2161
DI 10.13040/IJPSR.0975-8232.9(6).2149-61
PG 13
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GI0MK
UT WOS:000434063900001
OA Other Gold
DA 2020-07-08
ER

PT J
AU Monsanto-Hearne, V
   Johnson, KN
AF Monsanto-Hearne, Verna
   Johnson, Karyn N.
TI Wolbachia-mediated protection of Drosophila melanogaster against
   systemic infection with its natural viral pathogen Drosophila C virus
   does not involve changes in levels of highly abundant miRNAs
SO JOURNAL OF GENERAL VIROLOGY
LA English
DT Article
DE insect virus; Wolbachia; miRNA; Dicistroviridae; dengue virus
ID VECTOR AEDES-AEGYPTI; ANTIVIRAL PROTECTION; BLOCKS DENGUE; ZIKA VIRUS;
   MICRORNAS; HOST; ALBOPICTUS; MOSQUITOS; STRAIN; TRANSMISSION
AB The presence of Wolbachia confers virus protection to insects. The molecular mechanism underlying Wolbachia-mediated protection in this tripartite host-endosymbiont-virus interaction is not yet fully understood. In the bipartite association between Drosophila melanogaster and Drosophila C virus (DCV), changes in the expression of microRNAs (miRNAs) influence the outcome of viral pathogenesis. Here we examined whether changes in miRNA expression are similarly involved in the Drosophila-Wolbachia-DCV association. The levels of highly abundant miRNAs in a melanogaster, Wolbachia-mono-infected D. melanogaster, and DCV- and Wolbachia-bi-infected a melanogaster were quantified using RT-qPCR and compared. The results show that the abundance of the 17 tested a melanogaster miRNAs is not affected by Wolbachia endosymbiosis or by bi-infection of Wolbachia and DCV. These results suggest that the in vivo protection conferred by Wolbachia to its native host against D. melanogaster's natural pathogen DCV is not likely to be dependent on or associated with changes in the levels of highly expressed miRNAs.
C1 [Monsanto-Hearne, Verna; Johnson, Karyn N.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4067, Australia.
RP Johnson, KN (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4067, Australia.
EM karynj@uq.edu.au
RI Johnson, Karyn N/B-7980-2008; Monsanto-Hearne, Verna Marie/V-4940-2018
OI Johnson, Karyn N/0000-0001-8647-8985; Monsanto-Hearne, Verna
   Marie/0000-0003-0630-4067
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Asgari S, 2015, CURR OPIN INSECT SCI, V8, P104, DOI 10.1016/j.cois.2014.12.008
   Asgari S, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00048
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Cai Yimei, 2009, Genomics Proteomics & Bioinformatics, V7, P147, DOI 10.1016/S1672-0229(08)60044-3
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chrostek E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099025
   Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793
   Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gottwein E, 2008, CELL HOST MICROBE, V3, P375, DOI 10.1016/j.chom.2008.05.002
   Grassmann R, 2008, BBA-GENE REGUL MECH, V1779, P706, DOI 10.1016/j.bbagrm.2008.05.005
   Gulyaeva LF, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0893-x
   Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0
   Hertig M, 1924, J MED RES, V44, P329
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Johnson KN, 1999, J INVERTEBR PATHOL, V73, P248, DOI 10.1006/jipa.1998.4830
   Jonas S, 2015, NAT REV GENET, V16, P421, DOI 10.1038/nrg3965
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   McGraw EA, 2004, CURR OPIN MICROBIOL, V7, P67, DOI 10.1016/j.mib.2003.12.003
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Monsanto-Hearne V, 2017, J GEN VIROL, V98, P1904, DOI 10.1099/jgv.0.000831
   Monsanto-Hearne V, 2017, VIROLOGY, V502, P20, DOI 10.1016/j.virol.2016.12.009
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Saucereau Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3985-y
   Stevanovic AL, 2015, APPL ENVIRON MICROB, V81, P8215, DOI 10.1128/AEM.02841-15
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Vidigal JA, 2015, BIOL FUNCTIONS MIRNA, P137
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 51
TC 2
Z9 2
U1 0
U2 13
PU MICROBIOLOGY SOC
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER ST, LONDON WC1N 2JU, ERKS, ENGLAND
SN 0022-1317
EI 1465-2099
J9 J GEN VIROL
JI J. Gen. Virol.
PD JUN
PY 2018
VL 99
IS 6
BP 827
EP 831
DI 10.1099/jgv.0.001064
PG 5
WC Biotechnology & Applied Microbiology; Virology
SC Biotechnology & Applied Microbiology; Virology
GA GI2HM
UT WOS:000434190600009
PM 29676724
OA Bronze
DA 2020-07-08
ER

PT J
AU Abbink, P
   Larocca, RA
   Dejnirattisai, W
   Peterson, R
   Nkolola, JP
   Borducchi, EN
   Supasa, P
   Mongkolsapaya, J
   Screaton, GR
   Barouch, DH
AF Abbink, Peter
   Larocca, Rafael A.
   Dejnirattisai, Wanwisa
   Peterson, Rebecca
   Nkolola, Joseph P.
   Borducchi, Erica N.
   Supasa, Piyada
   Mongkolsapaya, Juthathip
   Screaton, Gavin R.
   Barouch, Dan H.
TI Therapeutic and protective efficacy of a dengue antibody against Zika
   infection in rhesus monkeys
SO NATURE MEDICINE
LA English
DT Article
ID VIRUS-INFECTION; CROSS-REACTIVITY; VACCINE; POTENT; ENHANCEMENT;
   CHALLENGE
AB Strategies to treat Zika virus (ZIKV) infection in dengue virus (DENV)-endemic areas are urgently needed. Here we show that a DENV-specific antibody against the E-dimer epitope (EDE) potently cross-neutralizes ZIKV and provides robust therapeutic efficacy as well as prophylactic efficacy against ZIKV in rhesus monkeys. Viral escape was not detected, suggesting a relatively high bar to escape. These data demonstrate the potential for antibody-based therapy and prevention of ZIKV.
C1 [Abbink, Peter; Larocca, Rafael A.; Peterson, Rebecca; Nkolola, Joseph P.; Borducchi, Erica N.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.
   [Dejnirattisai, Wanwisa; Supasa, Piyada; Mongkolsapaya, Juthathip] Imperial Coll, Div Immunol & Inflammat, Dept Med, Hammersmith Campus, London, England.
   [Mongkolsapaya, Juthathip] Mahidol Univ, Fac Med, Dengue Hemorrhag Fever Res Unit, Off Res & Dev,Siriraj Hosp, Bangkok, Thailand.
   [Screaton, Gavin R.] Univ Oxford, John Radcliffe Hosp, Dept Med, Oxford, England.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02115 USA.; Screaton, GR (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Med, Oxford, England.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM gavin.screaton@medsci.ox.ac.uk; dbarouch@bidmc.harvard.edu
RI Barouch, Dan/Y-3918-2019
OI Screaton, Gavin/0000-0002-3549-4309; Abbink, Peter/0000-0003-1978-088X
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI124377,
   AI126603, AI128751, AI129797]; National Institute for Health Research
   Biomedical Research Centre funding scheme UK; MRC-Newton UK; Ragon
   Institute of MGH, MIT, and Harvard
FX We thank V. Cao-Lormeau (Unit of Emerging Infectious Diseases, Institut
   Louis Malarde; provided Zika virus strain PF-13), E. Moseley, K.
   McMahan, M. Boyd, M. Kirilova, O. Nanayakkara, Z. Li, N. Mercado, A.
   Badamchi-Zadeh, M. Iampietro, C. Bricault, P. Gandhi, S. Khatiwada, S.
   Mojta, B. Alimonti, A. Chandrashekar, A. Brinkman, M. Ferguson, and W.
   Rinaldi for generous advice, assistance, and reagents. We acknowledge
   support from the US National Institutes of Health (AI124377, AI126603,
   AI128751, AI129797) (D.H.B.), the National Institute for Health Research
   Biomedical Research Centre funding scheme UK (G.R.S), MRC-Newton UK
   (J.M.), and the Ragon Institute of MGH, MIT, and Harvard (D.H.B.).
   G.R.S. is a Wellcome Trust Senior Investigator.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liu JY, 2016, SCIENCE, V353, P1045, DOI 10.1126/science.aag0491
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
NR 20
TC 22
Z9 22
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD JUN
PY 2018
VL 24
IS 6
BP 721
EP +
DI 10.1038/s41591-018-0056-0
PG 4
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA GI3OQ
UT WOS:000434281300016
PM 29867228
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Qu, PK
   Zhang, W
   Li, DP
   Zhang, C
   Liu, QW
   Zhang, XY
   Wang, XS
   Dai, WL
   Xu, YF
   Leng, QB
   Zhong, J
   Jin, X
   Huang, Z
AF Qu, Panke
   Zhang, Wei
   Li, Dapeng
   Zhang, Chao
   Liu, Qingwei
   Zhang, Xueyang
   Wang, Xuesong
   Dai, Wenlong
   Xu, Yongfen
   Leng, Qibin
   Zhong, Jin
   Jin, Xia
   Huang, Zhong
TI Insect cell-produced recombinant protein subunit vaccines protect
   against Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Envelope protein; Drosophila S2 cell; Subunit vaccine;
   Neutralizing antibody; Viral challenge
ID NEUTRALIZING ANTIBODIES; STRUCTURAL BASIS; IMMUNIZATION; RESPONSES;
   EFFICACY
AB Infection with Zika virus (ZIKV) may lead to severe neurologic disorders. It is of significant importance and urgency to develop safe and effective vaccines to prevent ZIKV infection. Here we report the development of ZIKV subunit vaccines based on insect cell-produced recombinant proteins. The N-terminal approximately 80% region (designated as E80) and the domain III (designated as EDIII) of ZIKV envelope (E) protein were efficiently produced as secreted proteins in a Drosophila S2 cell expression system. Both E80 and EDIII could inhibit ZIKV infection in vitro, suggesting that they may have folded properly to display native conformations. Immunization studies demonstrated that both E80 and EDIII vaccines were able to trigger antigen-specific antibody and T-cell responses in mice. The resulting anti-E80 and anti-EDIII sera could potently neutralize ZIKV infection in vitro. More importantly, passive transfer of either anti-E80 or anti-EDIII sera protected recipient mice against lethal ZIKV challenge. It is worth noting that the anti-EDIII sera possessed higher neutralizing titers and conferred more complete protection than the anti-E80 sera, indicating that the S2 cell-produced EDIII is a superior ZIKV vaccine candidate compared with the E80. These data support further preclinical and clinical development of a ZIKV subunit vaccine based on S2 cell-produced EDIII.
C1 [Qu, Panke; Zhang, Wei; Li, Dapeng; Zhang, Chao; Liu, Qingwei; Zhang, Xueyang; Wang, Xuesong; Dai, Wenlong; Xu, Yongfen; Leng, Qibin; Zhong, Jin; Jin, Xia; Huang, Zhong] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
RP Jin, X; Huang, Z (corresponding author), Inst Pasteur Shanghai, 320 Yueyang Rd, Shanghai 200031, Peoples R China.
EM xjin@ips.ac.cn; huangzhong@ips.ac.cn
FU National Major R&D Program of China [2016YFC1201000, 2016YFE0133500];
   Chinese Academy of SciencesChinese Academy of Sciences [XDPB0301,
   GJHZ1880]; European Union Horizon 2020 Research and Innovation program
   [734548]
FX We thank the Microorganisms & Viruses Culture Collection Center, Wuhan
   Institute of Virology, Chinese Academy of Sciences, for providing the
   ZIKV strain SZ-WIV01. This study was supported in part by grants
   (2016YFC1201000 and 2016YFE0133500) from the National Major R&D Program
   of China, grants (XDPB0301 and GJHZ1880) from the Chinese Academy of
   Sciences, and a grant (ZIKAlliance Grant Agreement 734548) from the
   European Union Horizon 2020 Research and Innovation program.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Flipse J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003749
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Knipe D.M., 2013, FIELDS VIROLOGY
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li DP, 2017, J INFECT DIS, V215, P1824, DOI 10.1093/infdis/jix180
   Li DP, 2016, J VIROL, V90, P10486, DOI 10.1128/JVI.01462-16
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Liu JW, 2016, ADV COMPUT SCI TECH, P1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miller JL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040017
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang LL, 2012, MOL BIOTECHNOL, V52, P170, DOI 10.1007/s12033-011-9484-5
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 36
TC 13
Z9 14
U1 1
U2 16
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUN
PY 2018
VL 154
BP 97
EP 103
DI 10.1016/j.antiviral.2018.04.010
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GH7RO
UT WOS:000433651300011
PM 29665376
DA 2020-07-08
ER

PT J
AU Muellner, U
   Fournie, G
   Muellner, P
   Ahlstrom, C
   Pfeiffer, DU
AF Muellner, Ulrich
   Fournie, Guillaume
   Muellner, Petra
   Ahlstrom, Christina
   Pfeiffer, Dirk U.
TI epidemix-An interactive multi-model application for teaching and
   visualizing infectious disease transmission
SO EPIDEMICS
LA English
DT Article
DE Mathematical modelling; Epidemiology; Infectious disease; Application
   software; Disease dynamics; Teaching
AB Mathematical models of disease transmission are used to improve our understanding of patterns of infection and to identify factors influencing them. During recent public and animal health crises, such as pandemic influenza, Ebola, Zika, foot-and-mouth disease, models have made important contributions in addressing policy questions, especially through the assessment of the trajectory and scale of outbreaks, and the evaluation of control interventions. However, their mathematical formulation means that they may appear as a "black box" to those without the appropriate mathematical background. This may lead to a negative perception of their utility for guiding policy, and generate expectations, which are not in line with what these models can deliver. It is therefore important for policymakers, as well as public health and animal health professionals and researchers who collaborate with modelers and use results generated by these models for policy development or research purpose, to understand the key concepts and assumptions underlying these models.
   The software application epidemix (http://shinyapps.rvc.ac.uk) presented here aims to make mathematical models of disease transmission accessible to a wider audience of users. By developing a visual interface for a suite of eight models, users can develop an understanding of the impact of various modelling assumptions especially mixing patterns - on the trajectory of an epidemic and the impact of control interventions, without having to directly deal with the complexity of mathematical equations and programming languages. Models are compartmental or individual-based, deterministic or stochastic, and assume homogeneous or heterogeneous-mixing patterns (with the probability of transmission depending on the underlying structure of contact networks, or the spatial distribution of hosts). This application is intended to be used by scientists teaching mathematical modelling short courses to non-specialists - including policy makers, public and animal health professionals and students - and wishing to develop hands-on practicals illustrating key concepts of disease dynamics and control.
C1 [Muellner, Ulrich; Muellner, Petra; Ahlstrom, Christina] Epiinteractive, POB 15327, Wellington 6243, New Zealand.
   [Fournie, Guillaume; Pfeiffer, Dirk U.] Royal Vet Coll, Pathobiol & Populat Sci Dept, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield AL9 7TA, Herts, England.
   [Pfeiffer, Dirk U.] City Univ Hong Kong, Sch Vet Med, To Yuen Bldg,31 To Yuen St, Kowloon, Hong Kong, Peoples R China.
RP Fournie, G (corresponding author), Royal Vet Coll, Pathobiol & Populat Sci Dept, Vet Epidemiol Econ & Publ Hlth Grp, Hatfield AL9 7TA, Herts, England.
RI Pfeiffer, Dirk U/C-5002-2009
OI Pfeiffer, Dirk U/0000-0001-7000-0530; Fournie,
   Guillaume/0000-0002-6998-1201
CR Aleven V, 2003, REV EDUC RES, V73, P277, DOI 10.3102/00346543073003277
   Allaire J. J., 2017, NETWORKD3 D3 JAVASCR
   Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100
   Baddeley A., 2015, SPATIAL POINT PATTER, P2015
   Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509
   Butts C, 2010, SNA TOOLS SOCIAL NET
   Butts C. T., 2008, J STAT SOFTW, V24, P1, DOI DOI 10.18637/JSS.V024.I02
   Carroll LN, 2014, J BIOMED INFORM, V51, P287, DOI 10.1016/j.jbi.2014.04.006
   Cauchemez S, 2016, P NATL ACAD SCI USA, V113, P9081, DOI 10.1073/pnas.1519235113
   Chang W., 2015, SHINY WEB APPL FRAME
   Cheng CKY, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1658
   Csardi G., 2014, INT J COMPLEX SYST, DOI [10.3724/SP.J.1087.2009.02191., DOI 10.3724/SP.J.1087.2009.02191]
   Cunniffe NJ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004211
   Erdos P., 1960, PUBL MATH I HUNG, V5, P17, DOI DOI 10.2307/1999405
   Folorunso O, 2008, KYBERNETES, V37, P1530, DOI 10.1108/03684920810907841
   Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062
   Heesterbeek H, 2015, SCIENCE, V347, P1216, DOI 10.1126/science.aaa4339
   Houben RMGJ, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0608-4
   Johnson P, 2014, ADAPTIVETAU TAU LEAP
   Jombart T, 2014, EPIDEMICS-NETH, V7, P28, DOI 10.1016/j.epidem.2014.04.003
   Karlsson D, 2013, STUD HEALTH TECHNOL, V192, P697, DOI 10.3233/978-1-61499-289-9-697
   Keeling M.J., 2007, MODELING INFECT DIS
   Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973
   Muellner UJ, 2015, FRONT VET SCI, V2, DOI 10.3389/fvets.2015.00047
   Pfeiffer D., 2010, VET EPIDEMIOLOGY INT
   Schloerke B., 2016, GGALLY EXTENSION GGP
   Soetaert K, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i09
   Vynnycky E., 2010, INTRO INFECT DIS MOD
   Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1
NR 29
TC 1
Z9 1
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD JUN
PY 2018
VL 23
BP 49
EP 54
DI 10.1016/j.epidem.2017.12.003
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA GH3GT
UT WOS:000433291200006
PM 29273280
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Schwab, SR
   Stone, CM
   Fonseca, DM
   Fefferman, NH
AF Schwab, Samantha R.
   Stone, Chris M.
   Fonseca, Dina M.
   Fefferman, Nina H.
TI The importance of being urgent: The impact of surveillance target and
   scale on mosquito-borne disease control
SO EPIDEMICS
LA English
DT Article
DE Zika control; Epidemiological surveillance; Disease surveillance;
   Mosquito control; Vector-borne disease control; Epidemiological modeling
ID WEST-NILE-VIRUS; ASIAN TIGER MOSQUITO; AEDES-AEGYPTI; VECTOR CONTROL;
   ZIKA VIRUS; POPULATIONS; ALBOPICTUS; DENGUE; CULICIDAE; OUTBREAK
AB With the emergence or re-emergence of numerous mosquito-borne diseases in recent years, effective methods for emergency vector control responses are necessary to reduce human infections. Current vector control practices often vary significantly between different jurisdictions, and are executed independently and at different spatial scales. Various types of surveillance information (e.g. number of human infections or adult mosquitoes) trigger the implementation of control measures, though the target and scale of surveillance vary locally. This patchy implementation of control measures likely alters the efficacy of control.
   We modeled six different scenarios, with larval mosquito control occurring in response to surveillance data of different types and at different scales (e.g. across the landscape or in each patch). Our results indicate that: earlier application of larvicide after an escalation of disease risk achieves much greater reductions in human infections than later control implementation; uniform control across the landscape provides better outbreak mitigation than patchy control application; and different types of surveillance data require different levels of sensitivity in their collection to effectively inform control measures. Our simulations also demonstrate a potential logical fallacy of reactive, surveillance-driven vector control: measures stop being implemented as soon as they are deemed effective. This false sense of security leads to patchier control efforts that will do little to curb the size of future vector-borne disease outbreaks. More investment should be placed in collecting high quality information that can trigger early and uniform implementation, while researchers work to discover more informative metrics of human risk to trigger more effective control.
C1 [Schwab, Samantha R.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Grad Program Ecol & Evolut, New Brunswick, NJ USA.
   [Stone, Chris M.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL USA.
   [Fonseca, Dina M.] Rutgers State Univ, Ctr Vector Biol, New Brunswick, NJ USA.
   [Stone, Chris M.; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN USA.
RP Schwab, SR (corresponding author), 14 Coll Farm Rd,First Floor, New Brunswick, NJ 08901 USA.
EM samantharoseschwab@gmail.com
RI Fonseca, Dina/B-9951-2011
OI Fonseca, Dina/0000-0003-4726-7100; Schwab, Samantha/0000-0002-4338-4943
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1640951]
FX We thank two other members of our research team, Alin Coman and Agnesa
   Redere, for their input, as well as the editor and three anonymous
   reviewers for their helpful suggestions for improving the manuscript.
   This material is based upon work supported by the National Science
   Foundation under grant no. DEB-1640951.
CR Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763
   Agusto FB, 2012, MATH BIOSCI, V239, P154, DOI 10.1016/j.mbs.2012.05.001
   Arostegui J, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4296-6
   Bodine EN, 2012, J BIOL DYNAM, V6, P31, DOI 10.1080/17513758.2012.697197
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corbel V, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2224-3
   Dickinson K, 2012, VECTOR-BORNE ZOONOT, V12, P886, DOI 10.1089/vbz.2011.0810
   Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578
   Eisen L, 2009, J MED ENTOMOL, V46, P1245, DOI 10.1603/033.046.0601
   Erickson RA, 2010, ECOL MODEL, V221, P2899, DOI 10.1016/j.ecolmodel.2010.08.036
   Faraji A, 2016, J MED ENTOMOL, V53, P1029, DOI 10.1093/jme/tjw096
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gaffa HD, 2015, TICKS TICK-BORNE DIS, V6, P146, DOI 10.1016/j.ttbdis.2014.11.004
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5
   Kilpatrick AM, 2013, AM J EPIDEMIOL, V178, P829, DOI 10.1093/aje/kwt046
   LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237
   Lindsey NP, 2012, PUBLIC HEALTH REP, V127, P383, DOI 10.1177/003335491212700406
   Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Marfin AA, 2001, EMERG INFECT DIS, V7, P730
   Massaro T, 2013, J BIOL SYST, V21, DOI 10.1142/S021833901340010X
   McKenna M., 2016, ZIKA ADV CAN US COPE
   NACCHO [National Association of County and City Health Officials], 2016, MOSQ SURV CONTR ASS
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Regis L, 2008, MEM I OSWALDO CRUZ, V103, P50, DOI 10.1590/S0074-02762008000100008
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Reyes-Castro PA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005611
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Ryan SJ, 2015, APPL GEOGR, V58, P18, DOI 10.1016/j.apgeog.2015.01.005
   Shepard DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111014
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Silvertown J, 2009, TRENDS ECOL EVOL, V24, P467, DOI 10.1016/j.tree.2009.03.017
   Skovmand O, 2009, J MED ENTOMOL, V46, P67, DOI 10.1603/033.046.0109
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stone CM, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0336
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   Unlu I, 2016, PEST MANAG SCI, V72, P1427, DOI 10.1002/ps.4174
   Unlu I, 2014, T ROY SOC TROP MED H, V108, P699, DOI 10.1093/trstmh/tru139
   Unlu I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077999
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Vreysen MJB, 2007, AREA WIDE CONTROL IN
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 1997, DENG HAEM FEV DIAGN, P48
   Yakob Laith, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.45deb8e03a438c4d088afb4fafae8747
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhong H, 2010, ENVIRON ENTOMOL, V39, P1961, DOI 10.1603/EN10089
NR 54
TC 7
Z9 7
U1 0
U2 15
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD JUN
PY 2018
VL 23
BP 55
EP 63
DI 10.1016/j.epidem.2017.12.004
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA GH3GT
UT WOS:000433291200007
PM 29279187
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Calvert, AE
   Boroughs, KL
   Laven, J
   Stovall, JL
   Luy, BE
   Kosoy, OI
   Huang, CYH
AF Calvert, Amanda E.
   Boroughs, Karen L.
   Laven, Janeen
   Stovall, Janae L.
   Luy, Betty E.
   Kosoy, Olga, I
   Huang, Claire Y-H
TI Incorporation of IgG Depletion in a Neutralization Assay Facilitates
   Differential Diagnosis of Zika and Dengue in Secondary Flavivirus
   Infection Cases
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Article
DE Zika virus; confirmatory testing; dengue virus; flavivirus;
   immunoglobulin M; neutralization test; neutralizing antibodies;
   serological testing
ID WEST-NILE-VIRUS; IMMUNOGLOBULIN-M ANTIBODIES;
   LINKED-IMMUNOSORBENT-ASSAY; ST-LOUIS-ENCEPHALITIS; TRANSMISSION;
   SPECIFICITY; COMPLEMENT; BRAZIL; SERUM; IMMUNOASSAY
AB Zika virus (ZIKV) has emerged as a major global public health concern due to its link as a causative agent of human birth defects. Laboratory diagnosis of suspected ZIKV infections by serological testing of specimens collected a week or more after symptom onset primarily relies on detection of anti-ZIKV-specific IgM antibodies by enzyme-linked immunosorbent assay coupled with detection of ZIKV-specific neutralizing antibody by neutralization tests. A definitive diagnosis based on serological assays is possible during primary ZIKV infections; however, due to the cross-reactivity of antibodies elicited during flaviviral infections, a definitive diagnosis is not always possible, especially among individuals who have previously been exposed to closely related flaviviruses, such as dengue virus (DENV). Here, we investigated the neutralizing IgM antibody profiles of 33 diagnostic specimens collected from individuals with suspected primary and secondary flaviviral infections acquired when visiting areas experiencing active ZIKV transmission in 2015 and 2016. Specimens collected between 1 day and 3 months postexposure were tested for ZIKV and dengue virus type 1 (DENV1) and type 2 (DENV2) by the plaque reduction neutralization test (PRNT) before and after IgG depletion. We found that IgG depletion prior to neutralization testing had little effect in differentiating samples from individuals with secondary infections taken less than 3 weeks postexposure; however, IgG depletion significantly reduced the cross-reactive neutralizing antibody titers and increased the percentage of cases discernible by PRNT from 15.4% (95% confidence interval [Cl], 4.3 to 42.2%) to 76.9% (95% Cl, 49.7 to 91.8%) for samples collected between roughly 3 and 12 weeks postexposure. These results highlight the potential of IgG depletion to improve the specificity of PRNT for better confirmation and differential diagnosis of flavivirus infections.
C1 [Calvert, Amanda E.; Boroughs, Karen L.; Laven, Janeen; Stovall, Janae L.; Luy, Betty E.; Kosoy, Olga, I; Huang, Claire Y-H] US Ctr Dis Control & Prevent, Div Vector Borne Dis, Arboviral Dis Branch, Atlanta, GA 30333 USA.
   [Luy, Betty E.] Takeda Vaccines Inc, Cambridge, MA USA.
RP Calvert, AE (corresponding author), US Ctr Dis Control & Prevent, Div Vector Borne Dis, Arboviral Dis Branch, Atlanta, GA 30333 USA.
EM zpz0@cdc.gov
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   BEATY BJ, 1995, DIAGNOSTIC PROCEDURE
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BURKE DS, 1982, J CLIN MICROBIOL, V15, P353, DOI 10.1128/JCM.15.3.353-361.1982
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   CHAPPELL WA, 1971, APPL MICROBIOL, V21, P79, DOI 10.1128/AEM.21.1.79-83.1971
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   GREEN EM, 1992, J GEN VIROL, V73, P1995, DOI 10.1099/0022-1317-73-8-1995
   Heukelbach J, 2016, LANCET, V388, P846, DOI 10.1016/S0140-6736(16)30931-X
   Holmes DA, 2005, J CLIN MICROBIOL, V43, P3227, DOI 10.1128/JCM.43.7.3227-3236.2005
   Huang CYH, 2005, J VIROL, V79, P7300, DOI 10.1128/JVI.79.12.7300-7310.2005
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06
   Johnson AJ, 2005, CLIN DIAGN LAB IMMUN, V12, P566, DOI 10.1128/CDLI.12.5.566-574.2005
   KIMMAN TG, 1992, VET IMMUNOL IMMUNOP, V31, P95, DOI 10.1016/0165-2427(92)90089-9
   Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lin HE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001447
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   LINSCOTT WD, 1969, P NATL ACAD SCI USA, V64, P520, DOI 10.1073/pnas.64.2.520
   Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002
   MONATH TP, 1984, J CLIN MICROBIOL, V20, P784, DOI 10.1128/JCM.20.4.784-790.1984
   MONATH TP, 1984, AM J TROP MED HYG, V33, P151, DOI 10.4269/ajtmh.1984.33.151
   Musso D., 2014, EURO SURVEILL, V19
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tardei G, 2000, J CLIN MICROBIOL, V38, P2232
   Tesfay MZ, 2014, J VIROL, V88, P6148, DOI 10.1128/JVI.00074-14
   Tsai WY, 2015, J VIROL, V89, P7348, DOI 10.1128/JVI.00273-15
   Vazquez S, 2005, J CLIN VIROL, V33, P132, DOI 10.1016/j.jcv.2004.10.013
   Venturi G, 2016, EURO SURVEILL, V21
   WESTAWAY EG, 1968, NATURE, V219, P78, DOI 10.1038/219078a0
   Yoksan S, 1986, ARBOVIRUS RES AUSTR, P35
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 3
Z9 3
U1 0
U2 3
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD JUN
PY 2018
VL 56
IS 6
AR UNSP e00234-18
DI 10.1128/JCM.00234-18
PG 13
WC Microbiology
SC Microbiology
GA GH5WD
UT WOS:000433507300013
PM 29618505
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Panayiotou, C
   Lindqvist, R
   Kurhade, C
   Vonderstein, K
   Pasto, J
   Edlund, K
   Upadhyay, AS
   Overby, AK
AF Panayiotou, Christakis
   Lindqvist, Richard
   Kurhade, Chaitanya
   Vonderstein, Kirstin
   Pasto, Jenny
   Edlund, Karin
   Upadhyay, Arunkumar S.
   Overby, Anna K.
TI Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus
   Replication by Targeting NS3 for Proteasomal Degradation (vol 92, pg 7,
   2018)
SO JOURNAL OF VIROLOGY
LA English
DT Correction
C1 [Panayiotou, Christakis; Lindqvist, Richard; Kurhade, Chaitanya; Vonderstein, Kirstin; Pasto, Jenny; Edlund, Karin; Upadhyay, Arunkumar S.; Overby, Anna K.] Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.
   [Panayiotou, Christakis; Lindqvist, Richard; Kurhade, Chaitanya; Vonderstein, Kirstin; Pasto, Jenny; Edlund, Karin; Upadhyay, Arunkumar S.; Overby, Anna K.] Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.
RP Panayiotou, C (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, Umea, Sweden.; Panayiotou, C (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, Umea, Sweden.
OI Kurhade, Chaitanya/0000-0002-6139-2461
CR Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
NR 1
TC 5
Z9 5
U1 0
U2 7
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2018
VL 92
IS 12
AR e00501-18
DI 10.1128/JVI.00501-18
PG 1
WC Virology
SC Virology
GA GH4XS
UT WOS:000433416900020
PM 29844247
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ieraci, A
   Herrera, DG
AF Ieraci, Alessandro
   Herrera, Daniel G.
TI Nicotinamide Inhibits Ethanol-Induced Caspase-3 and PARP-1
   Over-activation and Subsequent Neurodegeneration in the Developing Mouse
   Cerebellum
SO CEREBELLUM
LA English
DT Article
DE Fetal alcohol syndrome; Apoptosis; Caspase-3; Poly(ADP-ribose)
   polymerase; Developing brain; Nicotinamide
ID INDUCED APOPTOTIC NEURODEGENERATION; ALCOHOL SPECTRUM DISORDERS;
   NEONATAL-RAT CEREBELLUM; HIGH-DOSE NICOTINAMIDE; CELL-DEATH;
   POLY(ADP-RIBOSE) POLYMERASE-1; RANDOMIZED-TRIAL; NEURONAL DEATH; BINGE
   ALCOHOL; ZIKA VIRUS
AB Fetal alcohol spectrum disorder (FASD) is the principal preventable cause of mental retardation in the western countries resulting from alcohol exposure during pregnancy. Ethanol-induced massive neuronal cell death occurs mainly in immature neurons during the brain growth spurt period. The cerebellum is one of the brain areas that are most sensitive to ethanol neurotoxicity. Currently, there is no effective treatment that targets the causes of these disorders and efficient treatments to counteract or reverse FASD are desirable. In this study, we investigated the effects of nicotinamide on ethanol-induced neuronal cell death in the developing cerebellum. Subcutaneous administration of ethanol in postnatal 4-day-old mice induced an over-activation of caspase-3 and PARP-1 followed by a massive neurodegeneration in the developing cerebellum. Interestingly, treatment with nicotinamide, immediately or 2 h after ethanol exposure, diminished caspase-3 and PARP-1 over-activation and reduced ethanol-induced neurodegeneration. Conversely, treatment with 3-aminobenzadine, a specific PARP-1 inhibitor, was able to completely block PARP-1 activation, but not caspase-3 activation or ethanol-induced neurodegeneration in the developing cerebellum. Our results showed that nicotinamide reduces ethanol-induced neuronal cell death and inhibits both caspase-3 and PARP-1 alcohol-induced activation in the developing cerebellum, suggesting that nicotinamide might be a promising and safe neuroprotective agent for treating FASD and other neurodegenerative disorders in the developing brain that shares similar cell death pathways.
C1 [Ieraci, Alessandro; Herrera, Daniel G.] Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10065 USA.
   [Ieraci, Alessandro] Univ Milan, Dipartimento Sci Farmacol & Biomol, Lab Neuropsychopharmacol & Funct Neurogen, Via Balzaretti 9, I-20133 Milan, Italy.
   [Ieraci, Alessandro] Univ Milan, Ctr Excellence Neurodegenerat Dis, Via Balzaretti 9, I-20133 Milan, Italy.
   [Herrera, Daniel G.] Harvard Med Sch, Cambridge Hlth Alliance, Dept Psychiat, Cambridge, MA USA.
RP Ieraci, A (corresponding author), Cornell Univ, Weill Med Coll, Dept Psychiat, New York, NY 10065 USA.; Ieraci, A (corresponding author), Univ Milan, Dipartimento Sci Farmacol & Biomol, Lab Neuropsychopharmacol & Funct Neurogen, Via Balzaretti 9, I-20133 Milan, Italy.; Ieraci, A (corresponding author), Univ Milan, Ctr Excellence Neurodegenerat Dis, Via Balzaretti 9, I-20133 Milan, Italy.
EM alessandro.ieraci@unimi.it
RI Ieraci, Alessandro/AAA-8738-2020
OI Ieraci, Alessandro/0000-0001-6737-7695
FU DeWitt-Reader's Digest Fellowship; National Alliance for Research on
   Schizophrenia and DepressionNARSAD; Reader's Digest Foundation
FX A.I. was supported by the DeWitt-Reader's Digest Fellowship, and D.G.H.
   was supported by grants from the National Alliance for Research on
   Schizophrenia and Depression and the Reader's Digest Foundation.
CR Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010
   Andrabi SA, 2011, NAT MED, V17, P692, DOI 10.1038/nm.2387
   Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014
   Bearer CF, 2015, CEREBELLUM, V14, P413, DOI 10.1007/s12311-015-0691-7
   Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443
   BONTHIUS DJ, 1990, ALCOHOL CLIN EXP RES, V14, P107, DOI 10.1111/j.1530-0277.1990.tb00455.x
   Burd L, 2003, NEUROTOXICOL TERATOL, V25, P697, DOI 10.1016/j.ntt.2003.07.014
   Cebolla AM, 2009, NEUROSCI LETT, V455, P4, DOI 10.1016/j.neulet.2009.03.034
   Chen AC, 2015, NEW ENGL J MED, V373, P1618, DOI 10.1056/NEJMoa1506197
   Cheng DT, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00155
   Cherian PP, 2008, ALCOHOL CLIN EXP RES, V32, P1884, DOI 10.1111/j.1530-0277.2008.00769.x
   Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107
   Crino A, 2004, EUR J ENDOCRINOL, V150, P719, DOI 10.1530/eje.0.1500719
   Diaz-Hernandez JI, 2007, CELL DEATH DIFFER, V14, P1211, DOI 10.1038/sj.cdd.4402117
   Dikranian K, 2005, DEV BRAIN RES, V155, P1, DOI 10.1016/j.devbrainres.2004.11.005
   Fatokun AA, 2014, BRIT J PHARMACOL, V171, P2000, DOI 10.1111/bph.12416
   Feng YZ, 2006, BRAIN RES BULL, V69, P117, DOI 10.1016/j.brainresbull.2005.11.011
   Goodlett CR, 2005, EXP BIOL MED, V230, P394, DOI 10.1177/15353702-0323006-07
   Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008
   Guerri C, 2009, ALCOHOL ALCOHOLISM, V44, P108, DOI 10.1093/alcalc/agn105
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hathorn T, 2011, NEUROBIOL DIS, V41, P43, DOI 10.1016/j.nbd.2010.08.017
   HOLMES GL, 1986, J CLIN NEUROPHYSIOL, V3, P209, DOI 10.1097/00004691-198607000-00002
   Idrus NM, 2011, NEUROTOXICOL TERATOL, V33, P444, DOI 10.1016/j.ntt.2011.04.004
   Ieraci A, 2007, NEUROBIOL DIS, V26, P597, DOI 10.1016/j.nbd.2007.02.011
   Ieraci A, 2006, PLOS MED, V3, P547, DOI 10.1371/journal.pmed.0030101
   Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056
   Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003
   Jirikowic TL, 2013, J POPUL THER CLIN PH, V20, pE212
   Kauppinen TM, 2007, NEUROSCIENCE, V145, P1267, DOI 10.1016/j.neuroscience.2006.09.034
   Kim MY, 2005, GENE DEV, V19, P1951, DOI 10.1101/gad.1331805
   Klintsova AY, 2000, NEUROTOXICOL TERATOL, V22, P125, DOI 10.1016/S0892-0362(99)00052-5
   Knip M, 2000, DIABETOLOGIA, V43, P1337, DOI 10.1007/s001250051536
   Libri V, 2014, LANCET, V384, P504, DOI 10.1016/S0140-6736(14)60382-2
   Light KE, 2002, NEUROSCIENCE, V114, P327, DOI 10.1016/S0306-4522(02)00344-5
   Lubetzky-Vilnai A, 2011, PEDIATR PHYS THER, V23, P268, DOI 10.1097/PEP.0b013e318227cd82
   Luo J, 2012, CEREBELLUM, V11, P145, DOI 10.1007/s12311-010-0219-0
   Maiese K, 2003, TRENDS PHARMACOL SCI, V24, P228, DOI 10.1016/S0165-6147(03)00078-6
   Maiese K, 2009, MOLECULES, V14, P3446, DOI 10.3390/molecules14093446
   Martire S, 2015, MECH AGEING DEV, V146, P53, DOI 10.1016/j.mad.2015.04.001
   May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68
   Mukherjee SK, 1997, EUR J PHARMACOL, V330, P27, DOI 10.1016/S0014-2999(97)00171-4
   Olmos PR, 2006, DIABETES RES CLIN PR, V71, P320, DOI 10.1016/j.diabres.2005.07.009
   Olney JW, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00081
   Olney JW, 2004, TRENDS PHARMACOL SCI, V25, P135, DOI 10.1016/j.tips.2004.01.002
   Outeiro TF, 2007, BIOCHEM BIOPH RES CO, V357, P596, DOI 10.1016/j.bbrc.2007.03.163
   Siler-Marsiglio KI, 2006, ALCOHOL CLIN EXP RES, V30, P1031, DOI 10.1111/j.1530-0277.2006.000126.x
   Siler-Marsiglio KI, 2005, J NEUROSCI RES, V81, P632, DOI 10.1002/jnr.20591
   Sowell ER, 1996, ALCOHOL CLIN EXP RES, V20, P31, DOI 10.1111/j.1530-0277.1996.tb01039.x
   Ullah N, 2012, J MOL NEUROSCI, V47, P67, DOI 10.1007/s12031-011-9685-1
   Ullah N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027093
   Walsh SRA, 2005, DRUGS, V65, P905, DOI 10.2165/00003495-200565070-00002
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang J, 2002, PHARMACOL BIOCHEM BE, V73, P901, DOI 10.1016/S0091-3057(02)00939-5
   Yokoyama H, 2010, J NEUROSCI RES, V88, P1522, DOI 10.1002/jnr.22310
   Young C, 2005, NEUROBIOL DIS, V20, P608, DOI 10.1016/j.nbd.2005.04.014
   Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221
   Yuan FQ, 2017, ARCH TOXICOL, V91, P775, DOI 10.1007/s00204-016-1746-3
NR 58
TC 6
Z9 6
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1473-4222
EI 1473-4230
J9 CEREBELLUM
JI Cerebellum
PD JUN
PY 2018
VL 17
IS 3
BP 326
EP 335
DI 10.1007/s12311-017-0916-z
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA GH0IB
UT WOS:000433084600010
PM 29327278
DA 2020-07-08
ER

PT J
AU Estes, JD
   Wong, SW
   Brenchley, JM
AF Estes, Jacob D.
   Wong, Scott W.
   Brenchley, Jason M.
TI Nonhuman primate models of human viral infections
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Review
ID SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; INTERFERON REGULATORY
   FACTORS; HIV-1/SIV CHIMERIC VIRUS; NON-B HEPATITIS; RHESUS MACAQUES; SIV
   INFECTION; ZIKA VIRUS; IMMUNE ACTIVATION; MICROBIAL TRANSLOCATION
AB Humans have a close phylogenetic relationship with nonhuman primates (NHPs) and share many physiological parallels, such as highly similar immune systems, with them. Importantly, NHPs can be infected with many human or related simian viruses. In many cases, viruses replicate in the same cell types as in humans, and infections are often associated with the same pathologies. In addition, many reagents that are used to study the human immune response cross-react with NHP molecules. As such, NHPs are often used as models to study viral vaccine efficacy and antiviral therapeutic safety and efficacy and to understand aspects of viral pathogenesis. With several emerging viral infections becoming epidemic, NHPs are proving to be a very beneficial benchmark for investigating human viral infections.
C1 [Estes, Jacob D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD USA.
   [Estes, Jacob D.; Wong, Scott W.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.
   [Brenchley, Jason M.] NIAID, Barrier Immun Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
RP Brenchley, JM (corresponding author), NIAID, Barrier Immun Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
EM jbrenchl@niaid.nih.gov
RI Brenchley, Jason/AAC-5085-2019
FU US Division of Intramural Research; National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); National Institutes of Health
   (NIH)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; National Cancer Institute, NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI)
   [HHSN261200800001E]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P51-OD011092,
   R01-CA75922, R01-CA206404]
FX Funding for this work was provided in part with federal funds from the
   US Division of Intramural Research, National Institute of Allergy and
   Infectious Diseases, National Institutes of Health (NIH) and the
   National Cancer Institute, NIH, under contract number HHSN261200800001E
   and NIH grants P51-OD011092 (S.W.W. and J.D.E.), R01-CA75922 (S.W.W.)
   and R01-CA206404 (S.W.W.). The content of this publication does not
   necessarily reflect the views or policies of the US Department of Health
   and Human Services, nor does the mention of trade names, commercial
   products or organizations imply endorsement by the US government.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Abel K, 2009, CURR HIV RES, V7, P2, DOI 10.2174/157016209787048528
   Aggarwal R, 2001, J INFECT DIS, V184, P1380, DOI 10.1086/324376
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andersson J, 2005, J IMMUNOL, V174, P3143, DOI 10.4049/jimmunol.174.6.3143
   Arankalle VA, 2006, J VIRAL HEPATITIS, V13, P742, DOI 10.1111/j.1365-2893.2006.00759.x
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021
   Baskin CR, 2004, J VIROL, V78, P10420, DOI 10.1128/JVI.78.19.10420-10432.2004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Belkaid Y, 2017, IMMUNITY, V46, P562, DOI 10.1016/j.immuni.2017.04.008
   BRADLEY DW, 1987, P NATL ACAD SCI USA, V84, P6277, DOI 10.1073/pnas.84.17.6277
   Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511
   Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001
   Bukh J, 2004, HEPATOLOGY, V39, P1469, DOI 10.1002/hep.20268
   Catanese MT, 2015, VIROLOGY, V479, P221, DOI 10.1016/j.virol.2015.03.014
   CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802
   CHALIFOUX LV, 1987, AM J PATHOL, V128, P104
   Chang H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000606
   Ciccone EJ, 2010, MUCOSAL IMMUNOL, V3, P172, DOI 10.1038/mi.2009.129
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   DANIEL MD, 1985, SCIENCE, V228, P1201, DOI 10.1126/science.3159089
   de Groot N, 2014, IMMUNOGENETICS, V66, P535, DOI 10.1007/s00251-014-0783-4
   de Groot NG, 2017, IMMUNOGENETICS, V69, P499, DOI 10.1007/s00251-017-1006-6
   Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333
   Desrosiers RC, 1997, J VIROL, V71, P9764, DOI 10.1128/JVI.71.12.9764-9769.1997
   Douek DC, 2009, ANNU REV MED, V60, P471, DOI 10.1146/annurev.med.60.041807.123549
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Doxiadis GGM, 2013, IMMUNOGENETICS, V65, P569, DOI 10.1007/s00251-013-0707-8
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Durbin AP, 2011, VACCINE, V29, P7242, DOI 10.1016/j.vaccine.2011.07.023
   Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331
   Edghill-Smith Y, 2005, NAT MED, V11, P740, DOI 10.1038/nm1261
   Ericsen AJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006048
   Ericsen AJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0478-z
   Estep RD, 2013, CURR OPIN VIROL, V3, P245, DOI 10.1016/j.coviro.2013.05.016
   Estes JD, 2013, IMMUNOL REV, V254, P65, DOI 10.1111/imr.12070
   Estes JD, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001052
   Evans DT, 2013, CURR OPIN HIV AIDS, V8, P255, DOI 10.1097/COH.0b013e328361cee8
   Farci P, 1999, J INFECT DIS, V179, P1007, DOI 10.1086/314653
   FARCI P, 1992, J INFECT DIS, V165, P1006, DOI 10.1093/infdis/165.6.1006
   Fennessey CM, 2013, CURR OPIN HIV AIDS, V8, P280, DOI 10.1097/COH.0b013e328361cfff
   Fox A, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000967
   Fruh K, 2017, CURR OPIN IMMUNOL, V47, P52, DOI 10.1016/j.coi.2017.06.010
   Gach JS, 2016, J VIROL, V90, P8487, DOI 10.1128/JVI.00812-16
   Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660
   Greene JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002384
   Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959
   Haberthur K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002367
   Hansen SG, 2016, SCIENCE, V351, P714, DOI 10.1126/science.aac9475
   Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003
   Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935
   Hao XP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9020
   Harris LD, 2010, J VIROL, V84, P7886, DOI 10.1128/JVI.02612-09
   Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425
   Herrman M, 2016, J VIROL, V90, P1222, DOI 10.1128/JVI.02531-15
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Hickman HD, 2017, CURR OPIN VIROL, V22, P59, DOI 10.1016/j.coviro.2016.11.010
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   HIRSCH VM, 1989, J MED PRIMATOL, V18, P279
   HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0
   Houghton M, 2005, NATURE, V436, P961, DOI 10.1038/nature04081
   Itell HL, 2017, CURR OPIN VIROL, V25, P126, DOI 10.1016/j.coviro.2017.08.005
   Jacquelin B, 2009, J CLIN INVEST, V119, P3544, DOI 10.1172/JCI40093
   Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476
   KANE MA, 1984, JAMA-J AM MED ASSOC, V252, P3140, DOI 10.1001/jama.252.22.3140
   Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7
   Keele BF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15740
   Keele BF, 2009, J EXP MED, V206, P1117, DOI 10.1084/jem.20082831
   Kelsoe G, 2017, IMMUNOL REV, V275, P79, DOI 10.1111/imr.12508
   KING NW, 1983, AM J PATHOL, V113, P382
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14
   Klatt NR, 2012, J VIROL, V86, P1203, DOI 10.1128/JVI.06033-11
   Klatt NR, 2011, BLOOD, V118, P5803, DOI 10.1182/blood-2011-07-365874
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar N, 2016, CURR OPIN HIV AIDS, V11, P432, DOI 10.1097/COH.0000000000000290
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lanford RE, 2017, ILAR J, V58, P172, DOI 10.1093/ilar/ilx028
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2
   Lee FH, 2015, J VIROL, V89, P12388, DOI 10.1128/JVI.01531-15
   Leskowitz R, 2014, J VIROL, V88, P4721, DOI 10.1128/JVI.03744-13
   Leskowitz RM, 2013, J VIROL, V87, P8351, DOI 10.1128/JVI.00852-13
   LETVIN NL, 1983, P NATL ACAD SCI-BIOL, V80, P2718, DOI 10.1073/pnas.80.9.2718
   Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831
   Li SW, 2005, VACCINE, V23, P2893, DOI 10.1016/j.vaccine.2004.11.064
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Liu JY, 2010, J VIROL, V84, P10406, DOI 10.1128/JVI.01155-10
   Locher CP, 2001, IMMUNOL REV, V183, P127, DOI 10.1034/j.1600-065x.2001.1830111.x
   Ma ZM, 2011, AIDS RES HUM RETROV, V27, P1259, DOI 10.1089/aid.2011.0090
   Major ME, 2004, HEPATOLOGY, V39, P1709, DOI 10.1002/hep.20239
   Makori N, 2003, CLIN DIAGN LAB IMMUN, V10, P140, DOI 10.1128/CDLI.10.1.140-153.2003
   Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928
   Manickam C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00690
   Mansfield KG, 1999, J VIROL, V73, P10320, DOI 10.1128/JVI.73.12.10320-10328.1999
   Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307
   Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318
   Matsuoka Y, 2014, J VIROL, V88, P8139, DOI 10.1128/JVI.00425-14
   Maximova OA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004980
   McCaustland KA, 2000, ARCH VIROL, V145, P1909, DOI 10.1007/s007050070065
   McMichael AJ, 2014, NAT IMMUNOL, V15, P319, DOI 10.1038/ni.2844
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Messaoudi I, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002343
   Miller CJ, 1998, J REPROD IMMUNOL, V41, P331, DOI 10.1016/S0165-0378(98)00069-2
   MILLER CJ, 1989, J VIROL, V63, P4277, DOI 10.1128/JVI.63.10.4277-4284.1989
   Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005
   Minang JT, 2008, VIROLOGY, V375, P307, DOI 10.1016/j.virol.2008.02.005
   Mire CE, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai8711
   Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Moutschen M, 2007, VACCINE, V25, P4697, DOI 10.1016/j.vaccine.2007.04.008
   Mudd PA, 2012, J IMMUNOL, V188, P3364, DOI 10.4049/jimmunol.1102470
   Muhe J, 2015, CURR TOP MICROBIOL, V391, P385, DOI 10.1007/978-3-319-22834-1_13
   Mueller SN, 2010, CURR OPIN IMMUNOL, V22, P293, DOI 10.1016/j.coi.2009.12.009
   Nakayama E, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00267
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nilsson J, 2006, BLOOD, V108, P3808, DOI 10.1182/blood-2006-05-021576
   Ohashi M, 2011, J VIROL, V85, P1330, DOI 10.1128/JVI.01411-10
   Orlova N, 2011, CLIN VACCINE IMMUNOL, V18, P1427, DOI 10.1128/CVI.05126-11
   Orzechowska BU, 2008, BLOOD, V112, P4227, DOI 10.1182/blood-2008-04-151498
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Otting N, 2017, IMMUNOGENETICS, V69, P87, DOI 10.1007/s00251-016-0954-6
   Ouwendijk WJD, 2015, J PATHOL, V235, P298, DOI 10.1002/path.4451
   Pandrea IV, 2007, J IMMUNOL, V179, P3035, DOI 10.4049/jimmunol.179.5.3035
   Pegu P, 2013, J VIROL, V87, P1708, DOI 10.1128/JVI.02544-12
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pitcher CJ, 2002, J IMMUNOL, V168, P29, DOI 10.4049/jimmunol.168.1.29
   Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127
   Purcell R H, 2001, ILAR J, V42, P161
   Purcell RH, 2003, VACCINE, V21, P2607, DOI 10.1016/S0264-410X(03)00100-2
   Purcell RH, 2013, EMERG MICROBES INFEC, V2, DOI [10.1038/emi2013.9, 10.1038/emi.2013.9]
   PUTKONEN P, 1991, NATURE, V352, P436, DOI 10.1038/352436a0
   Ramesh A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01407
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Rimmelzwaan GF, 1997, J GEN VIROL, V78, P757, DOI 10.1099/0022-1317-78-4-757
   Robinson BA, 2012, J VIROL, V86, P2769, DOI 10.1128/JVI.05657-11
   Robinson BA, 2012, J VIROL, V86, P2197, DOI 10.1128/JVI.05047-11
   Rockstroh JK, 2017, LANCET GASTROENTEROL, V2, P347, DOI 10.1016/S2468-1253(17)30003-1
   Roederer M, 2014, NATURE, V505, P502, DOI 10.1038/nature12893
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Russo JJ, 1996, P NATL ACAD SCI USA, V93, P14862, DOI 10.1073/pnas.93.25.14862
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Sariol CA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00452
   Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]
   SHARP PM, 1995, PHILOS T ROY SOC B, V349, P41, DOI 10.1098/rstb.1995.0089
   Shibata R, 1999, NAT MED, V5, P204, DOI 10.1038/5568
   Shiver JW, 2002, NATURE, V415, P331, DOI 10.1038/415331a
   Shrestha MP, 2007, NEW ENGL J MED, V356, P895, DOI 10.1056/NEJMoa061847
   Silvestri G, 2007, J CLIN INVEST, V117, P3148, DOI 10.1172/JCI33034
   Smith DB, 2016, J GEN VIROL, V97, P537, DOI 10.1099/jgv.0.000393
   Sodora DL, 1998, AIDS RES HUM RETROV, V14, pS119
   Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013
   Sokal EM, 2007, J INFECT DIS, V196, P1749, DOI 10.1086/523813
   SOULIER J, 1995, BLOOD, V86, P1276, DOI 10.1182/blood.V86.4.1276.bloodjournal8641276
   Stittelaar KJ, 2006, NATURE, V439, P745, DOI 10.1038/nature04295
   Sundling C, 2014, J IMMUNOL, V192, P3637, DOI 10.4049/jimmunol.1303334
   Traina-Dorge V, 2015, J VIROL, V89, P9817, DOI 10.1128/JVI.01324-15
   TSAREV SA, 1993, J INFECT DIS, V167, P1302, DOI 10.1093/infdis/167.6.1302
   TSAREV SA, 1994, P NATL ACAD SCI USA, V91, P10198, DOI 10.1073/pnas.91.21.10198
   TSAREV SA, 1995, J INFECT DIS, V172, P31, DOI 10.1093/infdis/172.1.31
   Tsarev SA, 1997, VACCINE, V15, P1834, DOI 10.1016/S0264-410X(97)00145-X
   van Cuyck-Gandre H, 1998, J MED VIROL, V55, P197, DOI 10.1002/(SICI)1096-9071(199807)55:3<197::AID-JMV3>3.0.CO;2-X
   Van Rompay KKA, 1998, J INFECT DIS, V177, P1247, DOI 10.1086/515270
   Verstrepen BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112568
   Verstrepen BE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002797
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Widman DG, 2010, AM J TROP MED HYG, V82, P1160, DOI 10.4269/ajtmh.2010.09-0310
   Wong SW, 1999, J EXP MED, V190, P827, DOI 10.1084/jem.190.6.827
   Wu F, 2015, J VIROL, V89, P2233, DOI 10.1128/JVI.02978-14
   Yeung MW, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2637-9
   Yu CQ, 2013, IMMUNOGENETICS, V65, P185, DOI 10.1007/s00251-012-0670-9
   Yu GY, 2016, IMMUNOGENETICS, V68, P417, DOI 10.1007/s00251-016-0921-2
   Zehn D, 2015, ADV EXP MED BIOL, V850, P137, DOI 10.1007/978-3-319-15774-0_10
   Zhang J, 2003, J MED VIROL, V71, P518, DOI 10.1002/jmv.10523
   Zhang MD, 2001, VACCINE, V20, P853, DOI 10.1016/S0264-410X(01)00399-1
   Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353
NR 181
TC 18
Z9 18
U1 2
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD JUN
PY 2018
VL 18
IS 6
BP 390
EP 404
DI 10.1038/s41577-018-0005-7
PG 15
WC Immunology
SC Immunology
GA GH2OH
UT WOS:000433240700011
PM 29556017
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Beier, JC
   Benelli, G
AF Wilke, Andre B. B.
   Beier, John C.
   Benelli, Giovanni
TI Transgenic Mosquitoes - Fact or Fiction?
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID CULEX-QUINQUEFASCIATUS DIPTERA; STERILE INSECT TECHNIQUE; AEDES-AEGYPTI;
   YELLOW-FEVER; ZIKA VIRUS; VECTOR; DENGUE; TRANSMISSION; POPULATION;
   FITNESS
AB Technologies for controlling mosquito vectors based on genetic manipulation and the release of genetically modified mosquitoes (GMMs) are gaining ground. However, concrete epidemiological evidence of their effectiveness, sustainability, and impact on the environment and nontarget species is lacking; no reliable ecological evidence on the potential interactions among GMMs, target populations, and other mosquito species populations exists; and no GMM technology has yet been approved by the WHO Vector Control Advisory Group. Our opinion is that, although GMMs may be considered a promising control tool, more studies are needed to assess their true effectiveness, risks, and benefits. Overall, several lines of evidence must be provided before GMM-based control strategies can be used under the integrated vector management framework.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [1U01CK000510-01]
FX This research was supported by CDC (https://www.cdc.gov/) Grant
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program. CDC had no role in the
   design of the study, the collection, analysis, and interpretation of
   data, or in writing the manuscript.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Allen ML, 2004, PARASITOL INT, V53, P307, DOI 10.1016/j.parint.2004.04.002
   Allen ML, 2001, J MED ENTOMOL, V38, P701, DOI 10.1603/0022-2585-38.5.701
   Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Badran AH, 2016, NATURE, V533, P58, DOI 10.1038/nature17938
   Barnes KG, 2017, P NATL ACAD SCI USA, V114, P286, DOI 10.1073/pnas.1615458114
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Chaves LF, 2012, GLOBAL CHANGE BIOL, V18, P457, DOI 10.1111/j.1365-2486.2011.02522.x
   Chen CH, 2007, SCIENCE, V316, P597, DOI 10.1126/science.1138595
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Etienne C, 2017, AM J TROP MED HYG, V97, P16, DOI 10.4269/ajtmh.17-0207
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fu GL, 2007, NAT BIOTECHNOL, V25, P353, DOI 10.1038/nbt1283
   Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Haghighat-Khah RE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121097
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   HENDRICHS J, 1995, J APPL ENTOMOL, V119, P371, DOI 10.1111/j.1439-0418.1995.tb01303.x
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Ito J, 2002, NATURE, V417, P452, DOI 10.1038/417452a
   Jasinskiene N, 1998, P NATL ACAD SCI USA, V95, P3743, DOI 10.1073/pnas.95.7.3743
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kightlinger Lon, 2017, S D Med, V70, P346
   Kisinza WN, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2087-2
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   KNIPLING EF, 1968, B WORLD HEALTH ORGAN, V38, P421
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Lander ES, 2016, CELL, V164, P18, DOI 10.1016/j.cell.2015.12.041
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   LINDQUIST DA, 1992, MED VET ENTOMOL, V6, P2, DOI 10.1111/j.1365-2915.1992.tb00027.x
   Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851
   Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Marrelli MT, 2007, P NATL ACAD SCI USA, V104, P5580, DOI 10.1073/pnas.0609809104
   Marrelli MT, 2006, TRENDS PARASITOL, V22, P197, DOI 10.1016/j.pt.2006.03.004
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Medica DL, 2005, INFECT IMMUN, V73, P4363, DOI 10.1128/IAI.73.7.4363-4369.2005
   Moreira LA, 2004, GENETICS, V166, P1337, DOI 10.1534/genetics.166.3.1337
   Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Multini LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162328
   Murray JV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00043
   Myers JH, 1998, ANNU REV ENTOMOL, V43, P471, DOI 10.1146/annurev.ento.43.1.471
   Nam VS, 1998, AM J TROP MED HYG, V59, P657, DOI 10.4269/ajtmh.1998.59.657
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Pocquet N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077855
   Robert V, 2003, AM J TROP MED HYG, V68, P169, DOI 10.4269/ajtmh.2003.68.169
   Robinson AS, 2002, GENETICA, V116, P5, DOI 10.1023/A:1020951407069
   ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P209, DOI 10.1016/0035-9203(90)90258-G
   Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a
   Shi QM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2213-6
   Sinka ME, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-72
   Siqueira AM, 2016, AM J TROP MED HYG, V95, P87, DOI 10.4269/ajtmh.16-0204
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Volohonsky G, 2015, G3-GENES GENOM GENET, V5, P1151, DOI 10.1534/g3.115.016808
   Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123
   WHO, 2017, DES EP TRIALS VECT C
   WHO [World Health Organization], 2009, PROGR PROSP US GEN M
   Wilke ABB, 2013, MEM I OSWALDO CRUZ, V108, P529, DOI 10.1590/S0074-02762013000400023
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   World Health Organization, 2014, GUID FRAM TEST GEN M
   Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 88
TC 25
Z9 25
U1 1
U2 31
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD JUN
PY 2018
VL 34
IS 6
BP 456
EP 465
DI 10.1016/j.pt.2018.02.003
PG 10
WC Parasitology
SC Parasitology
GA GH1AW
UT WOS:000433134600004
PM 29526402
DA 2020-07-08
ER

PT J
AU Kumar, S
AF Kumar, Sachin
TI Sexual transmission of Zika virus: more to explore
SO LANCET GLOBAL HEALTH
LA English
DT Letter
C1 [Kumar, Sachin] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Viral Immunol Grp, Gauhati 781039, Assam, India.
RP Kumar, S (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Viral Immunol Grp, Gauhati 781039, Assam, India.
EM sachinku@iitg.ernet.in
CR Carias AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005885
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Wang SH, 2009, HEPATOLOGY, V50, P1392, DOI 10.1002/hep.23163
NR 5
TC 1
Z9 1
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD JUN
PY 2018
VL 6
IS 6
BP E618
EP E618
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GG7WC
UT WOS:000432908100015
PM 29773118
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Javanian, M
   Babazadeh, A
   Ebrahimpour, S
AF Javanian, Mostafa
   Babazadeh, Arefeh
   Ebrahimpour, Soheil
TI The immunopathogenesis of Zika virus: an overview
SO ROMANIAN JOURNAL OF INTERNAL MEDICINE
LA English
DT Letter
C1 [Javanian, Mostafa; Babazadeh, Arefeh; Ebrahimpour, Soheil] Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol Sar, Iran.
RP Ebrahimpour, S (corresponding author), Babol Univ Med Sci, Hlth Res Inst, Infect Dis & Trop Med Res Ctr, Babol Sar, Iran.
EM drsoheil1503@yahoo.com
OI javanian, mostafa/0000-0002-2771-4578
CR Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
NR 4
TC 0
Z9 0
U1 0
U2 7
PU DE GRUYTER POLAND SP ZOO
PI WARSAW
PA BOGUMILA ZUGA 32A STR., 01-811 WARSAW, POLAND
SN 1582-3296
EI 2501-062X
J9 ROM J INTERN MED
JI Rom. J. Intern. Med.
PD JUN
PY 2018
VL 56
IS 2
BP 128
EP 129
DI 10.2478/rjim-2018-0001
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GG2AW
UT WOS:000432492900010
PM 29360629
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Kang, S
   Odom, OW
   Malone, CL
   Thangamani, S
   Herrin, DL
AF Kang, Seongjoon
   Odom, Obed W.
   Malone, Candice L.
   Thangamani, Saravanan
   Herrin, David L.
TI Expression of a Synthetic Gene for the Major Cytotoxin (Cyt1Aa) of
   Bacillus thuringiensis subsp israelensis in the Chloroplast of Wild-Type
   Chlamydomonas
SO BIOLOGY-BASEL
LA English
DT Article
DE biolarvacide; green alga; Bacillus thuringiensis subsp; israelensis;
   Chlamydomonas; Cyt1Aa; pest control; West Nile; Zika
AB Chlamydomonas reinhardtii (Chlamydomonas) strains that are toxic to mosquito larvae because they express chloroplast transgenes that are based on the mosquitocidal proteins of Bacillus thuringiensis subsp. israelensis (Bti) could be very useful in mosquito control. Chlamydomonas has several advantages for this approach, including genetic controls not generally available with industrial algae. The Bti toxin is produced by sporulating bacteria and has been used for mosquito control for >30 years without creating highly resistant mosquito populations. The suite of toxins is four main proteins: three Cry proteins and the cytotoxic Cyt1Aa (27 kDa). Cyt1Aa is not very toxic to mosquitoes by itself, but it prevents the development of resistance. The production of Cyt1Aa in other microbes, however, has been challenging due to its affinity for certain membrane phospholipids. Here we report on the production of recombinant Cyt1Aa (rCyt1A) in the chloroplast of photosynthetic Chlamydomonas at levels of at least 0.3% total protein. Live cell bioassays demonstrated toxicity of the rCyt1Aa Chlamydomonas to larvae of Aedes aegypti. We also expressed the chloroplast cyt1Aa gene in a wild-type Chlamydomonas strain (21 gr) that can grow on nitrate. These results have implications for developing a Chlamydomonas strain that will be toxic to mosquito larvae but will not induce strongly resistant populations.
C1 [Kang, Seongjoon; Herrin, David L.] Pond Life Technol LLC, Cedar Pk, TX 78613 USA.
   [Odom, Obed W.; Malone, Candice L.; Herrin, David L.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.
   [Thangamani, Saravanan] Univ Texas Med Branch, Dept Pathol, Galveston, TX 77555 USA.
RP Herrin, DL (corresponding author), Pond Life Technol LLC, Cedar Pk, TX 78613 USA.; Herrin, DL (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.
EM joonk@utexas.edu; owodom@utexas.edu; candicemal@gmail.com;
   sathanga@utmb.edu; herrin@utexas.edu
RI Thangamani, Saravanan/E-7371-2010
OI Thangamani, Saravanan/0000-0002-4269-5993
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R41-AI115854A]
FX This work was supported in part by a grant from the National Institutes
   of Health (R41-AI115854A).
CR Alyahyaee SAS, 1995, MICROBIOL-UK, V141, P3141, DOI 10.1099/13500872-141-12-3141
   ANGSUTHANASOMBAT C, 1989, APPL ENVIRON MICROB, V55, P2428, DOI 10.1128/AEM.55.9.2428-2430.1989
   Ben-Dov E, 2014, TOXINS, V6, P1222, DOI 10.3390/toxins6041222
   Borovsky D, 2016, ARCH INSECT BIOCHEM, V91, P17, DOI 10.1002/arch.21306
   BOYNTON JE, 1993, METHOD ENZYMOL, V217, P510
   Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006
   DEBARJAC H, 1990, BACTERIAL CONTROL MO
   Fargo DC, 1998, MOL GEN GENET, V257, P271
   Fischer N, 1996, MOL GEN GENET, V251, P373, DOI 10.1007/s004380050179
   GLARE TR, 2000, BACILLUS THURINGIENS
   Harris EH, 2009, CHLAMYDOMONAS SOURCE
   Ibrahim MA, 2013, EXP BIOL MED, V238, P350, DOI 10.1177/1535370213477973
   Kang S, 2017, J APPL PHYCOL, V29, P1377, DOI 10.1007/s10811-016-1008-z
   Kaufman MG, 2006, J MED ENTOMOL, V43, P669, DOI 10.1603/0022-2585(2006)43[669:IOABTG]2.0.CO;2
   Khasdan V, 2001, ENVIRON MICROBIOL, V3, P798, DOI 10.1046/j.1462-2920.2001.00253.x
   Khasdan V, 2003, FEMS MICROBIOL LETT, V227, P189, DOI 10.1016/S0378-1097(03)00679-7
   Kioulos I, 2014, PEST MANAG SCI, V70, P623, DOI 10.1002/ps.3595
   Koou SY, 2014, J MED ENTOMOL, V51, P170, DOI 10.1603/ME13113
   Kumar A, 2013, MALARIAWORLD J, V4, P6
   Kwon T, 2014, METHODS MOL BIOL, V1123, P77, DOI 10.1007/978-1-62703-968-0_6
   LAIRD M, 1988, NATURAL HIST LARVAL
   LIU YT, 1993, J INVERTEBR PATHOL, V62, P131, DOI 10.1006/jipa.1993.1088
   Manasherob R, 2001, CURR MICROBIOL, V43, P355, DOI 10.1007/s002840010316
   MARTEN GG, 1986, J TROP MED HYG, V89, P213
   MEMON AR, 1993, BIOCHIM BIOPHYS ACTA, V1179, P11, DOI 10.1016/0167-4889(93)90070-6
   Odom OW, 2001, MOL CELL BIOL, V21, P3472, DOI 10.1128/MCB.21.10.3472-3481.2001
   OHANA B, 1987, APPL ENVIRON MICROB, V53, P828, DOI 10.1128/AEM.53.4.828-831.1987
   Puigbo P, 2007, NUCLEIC ACIDS RES, V35, pW126, DOI 10.1093/nar/gkm219
   Purton S, 2013, RUSS J PLANT PHYSL+, V60, P491, DOI 10.1134/S1021443713040146
   Schroda M., 2009, CHLAMYDOMONAS SOURCE, VVolume 2, P671
   Schwarz C, 2007, PLANT CELL, V19, P3627, DOI 10.1105/tpc.107.051722
   SOLTESRAK E, 1995, MOL GEN GENET, V246, P301, DOI 10.1007/BF00288602
   STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747
   STEVENS SE, 1994, J APPL PHYCOL, V6, P187, DOI 10.1007/BF02186072
   Surzycki R, 2007, P NATL ACAD SCI USA, V104, P17548, DOI 10.1073/pnas.0704205104
   Tetreau G, 2012, APPL ENVIRON MICROB, V78, P5189, DOI 10.1128/AEM.00903-12
   THOMAS WE, 1983, FEBS LETT, V154, P362, DOI 10.1016/0014-5793(83)80183-5
   Vincken QJJP, 2003, PLANT MOL BIOL, V51, P789, DOI 10.1023/A:1022528705590
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Wu XQ, 1997, APPL ENVIRON MICROB, V63, P4971, DOI 10.1128/AEM.63.12.4971-4974.1997
   Zaritsky Arieh, 2010, Bioeng Bugs, V1, P341, DOI 10.4161/bbug.1.5.13087
NR 41
TC 3
Z9 3
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-7737
J9 BIOLOGY-BASEL
JI Biology-Basel
PD JUN
PY 2018
VL 7
IS 2
AR 29
DI 10.3390/biology7020029
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA GK8PB
UT WOS:000436487700008
PM 29738473
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, KI
   Watanabe, CM
   Kallas, EG
AF Carvalho, Karina I.
   Watanabe, Caroline Mitika
   Kallas, Esper G.
TI Challenger Treats Zika Virus
SO CURRENT TREATMENT OPTIONS IN INFECTIOUS DISEASES
LA English
DT Article
DE Flavivirus; Zika virus; Pregnancy; Treatment
AB Purpose of review Arthropod-borne viruses (arboviruses) are zoonotic, and the common vectors are ticks and hematophagous mosquitoes. Currently, dengue, chikungunya, yellow fever, West Nile, and Japanese encephalitis virus infections have been causing worldwide concerns. In 2015, a large outbreak was documented with another mosquito-borne flavivirus, the Zika virus (ZIKV), and ravaging South and Central Americas and the Caribbean. ZIKV was declaring a public health emergency, because of the clinical evidence neurological complications. Recent findings The flavivirus infection is difficult to differentiate only with clinical manifestation. It has been reported 2366 cases of microcephaly or congenital defects associated with ZIKV in Brazil, and the mechanism or processes that lead to these neurological complications are still under investigation. No antivirals are available to treat ZIKV infection, leading to no option to prevent the fetal infection during pregnancy which could avoid the congenital Zika syndrome. In this review, we will describe the drugs that are being tested in vitro and in animal models against ZIKV. We reviewed several publications that test the compounds for the treatment of ZIKV disease. We conclude that some of these compounds testing in vitro and in vivo have shown a therapeutic possibilities to consider and to be test in pregnancy and in individuals with high risk of infection.
C1 [Carvalho, Karina I.; Watanabe, Caroline Mitika] Hosp Israelita Albert Einstein, Ave Albert Einstein,627 Bloco A 2ss, BR-05652000 Morumbi, Brazil.
   [Kallas, Esper G.] Univ Sao Paulo, Disciplina Imunol Clin & Alergia, Sao Paulo, Brazil.
RP Carvalho, KI (corresponding author), Hosp Israelita Albert Einstein, Ave Albert Einstein,627 Bloco A 2ss, BR-05652000 Morumbi, Brazil.
EM karina.ladislau@einstein.br
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Adams J, 1999, CANCER RES, V59, P2615
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   [Anonymous], 1995, PARASITIC DIS
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Borges MC, 2013, MEM I OSWALDO CRUZ, V108, P596, DOI 10.1590/S0074-02762013000500010
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   CALNE DB, 1974, BMJ-BRIT MED J, V4, P442, DOI 10.1136/bmj.4.5942.442
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2017, MALARIA
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   CHEN LL, 1987, J BACTERIOL, V169, P2373, DOI 10.1128/jb.169.6.2373-2379.1987
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DRUG F-USF, 2017, FDA APPR 2 HEP C DRU
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ELIOPOULOS GM, 1986, ANTIMICROB AGENTS CH, V30, P532, DOI 10.1128/AAC.30.4.532
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   FRANKLIN TJ, 1969, BIOCHEM J, V113, P515, DOI 10.1042/bj1130515
   Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x
   Ginther OJ, 2012, THERIOGENOLOGY, V78, P1969, DOI 10.1016/j.theriogenology.2012.08.003
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Henss L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0607-2
   Hoglen NC, 2004, J PHARMACOL EXP THER, V309, P634, DOI 10.1124/jpet.103.062034
   Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johansen LM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5597
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   KIRBY WMM, 1956, ARCH INTERN MED, V98, P1, DOI 10.1001/archinte.1956.00250250007001
   Koe BK, 1983, J PHARMACOL EXP THER, V226, P686
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   LIEBERT M, 1983, TRANSPLANTATION, V36, P200, DOI 10.1097/00007890-198308000-00019
   Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   MOLANDER CW, 1964, J BACTERIOL, V88, P591, DOI 10.1128/JB.88.3.591-594.1964
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Organization W-WH, 2017, IVERMECTIN
   Perachon S, 1999, EUR J PHARMACOL, V366, P293, DOI 10.1016/S0014-2999(98)00896-6
   PERERA DR, 1970, AM J TROP MED HYG, V19, P610, DOI 10.4269/ajtmh.1970.19.610
   Qing M, 2009, ANTIMICROB AGENTS CH, V53, P3226, DOI 10.1128/AAC.00189-09
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rieckmann KH, 1974, B WORLD HEALTH ORGAN, V51, P375
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Solomon T, 2016, LANCET INFECT DIS, V16, P402, DOI 10.1016/S1473-3099(16)00125-0
   Sun YH, 2002, MICROBIOL-SGM, V148, P361, DOI 10.1099/00221287-148-2-361
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takhampunya R, 2006, J GEN VIROL, V87, P1947, DOI 10.1099/vir.0.81655-0
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   THORNER MO, 1974, BRIT MED J, V2, P419, DOI 10.1136/bmj.2.5916.419
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   WHO, 1995, MODEL
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Wu T, 2014, EPSTEIN BARR VIRUS, V107, P95, DOI [10.1016/j.antiviral.2014.05.003, DOI 10.1016/J.ANTIVIRAL.2014.05.003]
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang Y, 1999, METABOLISM, V48, P1033, DOI 10.1016/S0026-0495(99)90202-0
NR 70
TC 0
Z9 0
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
EI 1534-6250
J9 CURR TREAT OPT INFEC
JI Curr. Treat. Option Infect. Dis
PD JUN
PY 2018
VL 10
IS 2
BP 217
EP 228
DI 10.1007/s40506-018-0160-1
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA VJ0QL
UT WOS:000526795800008
DA 2020-07-08
ER

PT J
AU del Carpio-Orantes, L
   Gonzalez-Clemente, MD
   Lamothe-Aguilar, T
AF del Carpio-Orantes, Luis
   del Carmen Gonzalez-Clemente, Maria
   Lamothe-Aguilar, Teresa
TI Zika and its vector mosquitoes in Mexico
SO JOURNAL OF ASIA-PACIFIC BIODIVERSITY
LA English
DT Article
DE Aedes; Anopheles; Culex; Haemagogus; Zika
AB In the present study, we carried out a review on the potential vectors of the Zika virus in the Americas, specifically in Mexico. Being vectors of the Culicidae family, they have great predominance in those territories, which could facilitate viral dissemination. (C) 2018 National Science Museum of Korea (NSMK) and Korea National Arboretum (KNA), Publishing Services by Elsevier.
C1 [del Carpio-Orantes, Luis; del Carmen Gonzalez-Clemente, Maria; Lamothe-Aguilar, Teresa] Gen Hosp 71, Inst Mexicano Seguro Social, Dept Internal Med, Chalco De Diaz Covarrubi, Mex, Mexico.
RP del Carpio-Orantes, L (corresponding author), Gen Hosp 71, Inst Mexicano Seguro Social, Dept Internal Med, Chalco De Diaz Covarrubi, Mex, Mexico.
EM neurona23@hotmail.com
RI Del Carpio-Orantes, Luis/H-6745-2017
OI Del Carpio-Orantes, Luis/0000-0003-2436-5744
CR Casas-Martinez M, 2006, CONABIO BIODIVERSITA, V67, P12
   Del Carpio-Orantes Luis, 2017, Rev Med Inst Mex Seguro Soc, V55, P63
   Del Carpio-Orantes Luis, 2016, Rev Med Inst Mex Seguro Soc, V54, P540
   del Carpio-Orantes Luis, 2016, Rev Med Inst Mex Seguro Soc, V54, P278
   del Carpio-Orantes Luis, 2013, Rev Med Inst Mex Seguro Soc, V51, P8
   Espinoza-Gomez F, 2013, REV MEX BIODIVERS, V84, P685, DOI 10.7550/rmb.27184
   Reyes-Villanueva Filiberto, 2006, Veterinaria Mexico, V37, P407
   Sanchez-Trinidad A, 2014, J VECTOR ECOL, V39, P134, DOI 10.1111/j.1948-7134.2014.12079.x
   Torres-Olave ME, 2016, REV MEXICANA AGROECO, V3, P220
   Wilkerson RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133602
   Zapata-Peniche A., 2007, REV BIOMED, V18, P3
NR 11
TC 2
Z9 2
U1 0
U2 0
PU NATL SCIENCE MUSEUM & KOREAN NATL ARBORETUM
PI DAEJEON
PA 481 DAEDEOK-DAERO, YUSEONG-GU, DAEJEON, 34143, SOUTH KOREA
EI 2287-9544
J9 J ASIA-PAC BIODIVERS
JI J. Asia-Pac. Biodivers.
PD JUN 1
PY 2018
VL 11
IS 2
BP 317
EP 319
DI 10.1016/j.japb.2018.01.002
PG 3
WC Biodiversity Conservation; Biology
SC Biodiversity & Conservation; Life Sciences & Biomedicine - Other Topics
GA VI8AN
UT WOS:000514193200022
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Marina, CF
   Bond, JG
   Munoz, J
   Valle, J
   Quiroz-Martinez, H
   Torres-Monzon, JA
   Williams, T
AF Marina, Carlos F.
   Bond, J. Guillermo
   Munoz, Jose
   Valle, Javier
   Quiroz-Martinez, Humberto
   Torres-Monzon, Jorge A.
   Williams, Trevor
TI Efficacy of larvicides for the control of dengue, Zika, and chikungunya
   vectors in an urban cemetery in southern Mexico
SO PARASITOLOGY RESEARCH
LA English
DT Article
DE Insecticide toxicity; Larvicide; Field trails; Oviposition; Aedes spp.
ID NATURALLY DERIVED INSECTICIDE; AEDES-AEGYPTI DIPTERA; LATIN-AMERICAN
   COUNTRIES; FRENCH-WEST-INDIES; LAMBDA-CYHALOTHRIN; STEGOMYIA-AEGYPTI;
   MOSQUITO LARVAE; 1ST REPORT; CULEX-QUINQUEFASCIATUS; RESISTANCE
   MECHANISMS
AB Many countries in Latin America have recently experienced outbreaks of Zika and chikungunya fever, in additional to the usual burden imposed by dengue, all of which are transmitted by Aedes aegypti in this region. To identify potential larvicides, we determined the toxicity of eight modern insecticides to A. aegypti larvae from a colony that originated from field-collected insects in southern Mexico. The most toxic compounds were pyriproxyfen (which prevented adult emergence) and lambda-cyhalothrin, followed by spinetoram, imidacloprid, thiamethoxam, and acetamiprid, with chlorantraniliprole and spiromesifen the least toxic products. Field trails performed in an urban cemetery during a chikungunya epidemic revealed that insecticide-treated ovitraps were completely protected from the presence of Aedes larvae and pupae for 6 and 7 weeks in spinosad (Natular G30) and lambda-cyhalothrin-treated traps in both seasons, respectively, compared to 5-6 weeks for temephos granule-treated ovitraps, but was variable for pyriproxyfen-treated ovitraps with and 1 and 5 weeks of absolute control in the dry and rainy seasons, respectively. Insecticide treatments influenced the mean numbers of Aedes larvae + pupae in each ovitrap, mean numbers of eggs laid, and percentage of egg hatch over time in both trials. The dominant species was A. aegypti in both seasons, although the invasive vector Aedes albopictus was more prevalent in the rainy season (26.7%) compared to the dry season (10.2%). We conclude that the granular formulation of spinosad (Natular G30) and a suspension concentrate formulation of lambda-cyhalothrin proved highly effective against Aedes spp. in both the dry and rainy seasons in the cemetery habitat in this region.
C1 [Marina, Carlos F.; Bond, J. Guillermo; Munoz, Jose; Torres-Monzon, Jorge A.] Ctr Reg Invest Salud Publ INSP, Tapachula 30700, Chiapas, Mexico.
   [Valle, Javier] ECOSUR, Tapachula 30700, Chiapas, Mexico.
   [Quiroz-Martinez, Humberto] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, San Nicolas De Los Garza 66450, Nuevo Leon, Mexico.
   [Williams, Trevor] Inst Ecol AC INECOL, Xalapa 91070, Veracruz, Mexico.
RP Williams, T (corresponding author), Inst Ecol AC INECOL, Xalapa 91070, Veracruz, Mexico.
EM trevor.williams@inecol.mx
RI Williams, Trevor/F-1447-2011
OI Williams, Trevor/0000-0003-3414-3440; Marina Fernandez, Carlos
   Felix/0000-0002-4804-8949
FU CONACYT-FOSISSS project [2012-180201]
FX We thank Sergio R. Torreblanca (Coordinador de Control de Vectores,
   Jurisdiccion Sanitaria No. 7) for the permission to perform cemetery
   experiments. We also thank Eufronio Diaz, Magdali Agustin, Antonia
   Ramirez, and Surisaday Mejia for valuable technical assistance and
   Gabriel Mercado (INECOL) for logistical support to TW. The study was
   funded by the CONACYT-FOSISSS project number 2012-180201 awarded to CFM.
CR Shaalan EAS, 2006, TROP BIOMED, V23, P180
   Cardona-Ospina JA, 2015, INT J INFECT DIS, V38, P60, DOI 10.1016/j.ijid.2015.07.015
   Antwi FB, 2015, ENVIRON TOXICOL PHAR, V40, P915, DOI 10.1016/j.etap.2015.09.023
   Ardila-Roldan S, 2013, BIOMEDICA, V33, P446, DOI 10.7705/biomedica.v33i3.1534
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bond JG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187420
   Bond JG, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-41
   Bond JG, 2004, MED VET ENTOMOL, V18, P50, DOI 10.1111/j.0269-283X.2004.0480.x
   BOUABIDA H, 2017, J ENTOMOL ZOOL STU H, V5, P572
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Chino-Cantor A, 2014, SOUTHWEST ENTOMOL, V39, P601, DOI 10.3958/059.039.0319
   Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005
   Darriet F, 2005, J AM MOSQUITO CONTR, V21, P495, DOI 10.2987/8756-971X(2006)21[495:SANLAI]2.0.CO;2
   Darriet F, 2006, J MED ENTOMOL, V43, P1190, DOI 10.1603/0022-2585(2006)43[1190:LEOPAS]2.0.CO;2
   Darriet F, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-88
   Dennett JA, 2003, J AM MOSQUITO CONTR, V19, P172
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   dos Santos Dias L, 2017, PLOS ONE, V12
   Equihua M, 2017, ACTA TROP, V166, P316, DOI 10.1016/j.actatropica.2016.11.014
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   George L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004006
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Henry MC, 2005, AM J TROP MED HYG, V73, P859, DOI 10.4269/ajtmh.2005.73.859
   Hernandez-Amparan S, 2017, SOUTHWEST ENTOMOL, V42, P789, DOI 10.3958/059.042.0317
   Hertlein MB, 2010, J AM MOSQUITO CONTR, V26, P67, DOI 10.2987/09-5936.1
   Honorio NA, 2006, MEM I OSWALDO CRUZ, V101, P225, DOI 10.1590/S0074-02762006000200017
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Kautz TF, 2015, EMERG INFECT DIS, V21, P2070, DOI 10.3201/eid2111.150546
   Khan HAA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-146
   Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5
   Kuehn BM, 2014, JAMA-J AM MED ASSOC, V312, P776, DOI 10.1001/jama.2014.9916
   Kuri-Morales P, 2017, MED VET ENTOMOL, V31, P240, DOI 10.1111/mve.12225
   Lawler SP, 2007, PEST MANAG SCI, V63, P234, DOI 10.1002/ps.1279
   Li CX, 2010, J AM MOSQUITO CONTR, V26, P346, DOI 10.2987/10-6007.1
   Liu H, 2004, J MED ENTOMOL, V41, P946, DOI 10.1603/0022-2585-41.5.946
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Marina CF, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-55
   Marina CF, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-95
   Marina CF, 2011, PEST MANAG SCI, V67, P114, DOI [10.1002/ps.2043, 10.1002/pros.21278]
   Mashauri FM, 2013, AM J TROP MED HYG, V88, P841, DOI 10.4269/ajtmh.12-0412
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   MILLER JE, 1994, J MED ENTOMOL, V31, P114, DOI 10.1093/jmedent/31.1.114
   Mulla M. S., 1979, Residue Reviews, V71, P121
   Muzari OM, 2014, J MED ENTOMOL, V51, P444, DOI 10.1603/ME13141
   Pech-May A, 2016, ACTA TROP, V157, P30, DOI 10.1016/j.actatropica.2016.01.021
   Perez CM, 2007, J MED ENTOMOL, V44, P631, DOI 10.1603/0022-2585(2007)44[631:SANDIF]2.0.CO;2
   Pettit WJ, 2010, J AM MOSQUITO CONTR, V26, P387, DOI 10.2987/09-5962.1
   Reiskind MH, 2013, MED VET ENTOMOL, V27, P421, DOI 10.1111/mve.12000
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   Reiter Paul, 1997, P425
   Rodriguez MM, 2007, J AM MOSQUITO CONTR, V23, P420, DOI 10.2987/5588.1
   Roiz D, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003854
   Samuel M, 2017, PLOS NEGLECT TROP D, V11
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1044, DOI 10.1016/S1473-3099(14)70925-9
   Secretaria de Salud, 2015, B EPIDEMIOLOGICO, V32, P52
   Secretaria de Salud, 2014, B EPIDEMIOLOGICO, V31, P53
   Shah RM, 2016, PARASITOL RES, V115, P4345, DOI 10.1007/s00436-016-5218-8
   Shetty V, 2013, PEST MANAG SCI, V69, P257, DOI 10.1002/ps.3383
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Sulaiman S, 1999, J VECTOR ECOL, V24, P154
   Sullivan JJ, 2008, J PESTIC SCI, V33, P339, DOI 10.1584/jpestics.R08-02
   Thavara U, 2001, J VECTOR ECOL, V26, P172
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   *WHO, 2005, WHOCDSWHOPESGCDPP200
   WHO, 2017, WHOPES REC COMP FORM
   WHO, 2001, REP 4 WHOPES WORK GR
   Williams T, 2003, BIOCONTROL SCI TECHN, V13, P459, DOI 10.1080/0958315031000140956
   World Health Organization, 2008, WHOHSEAMR080310
NR 76
TC 3
Z9 3
U1 4
U2 29
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
EI 1432-1955
J9 PARASITOL RES
JI Parasitol. Res.
PD JUN
PY 2018
VL 117
IS 6
BP 1941
EP 1952
DI 10.1007/s00436-018-5891-x
PG 12
WC Parasitology
SC Parasitology
GA GF7DO
UT WOS:000432128400030
PM 29713901
DA 2020-07-08
ER

PT J
AU Badolato-Correa, J
   Sanchez-Arcila, JC
   de Souza, TMA
   Barbosa, LS
   Nunes, PCG
   Lima, MDQ
   Gandini, M
   de Filippis, AMB
   da Cunha, RV
   de Azeredo, EL
   de-Oliveira-Pinto, LM
AF Badolato-Correa, Jessica
   Sanchez-Arcila, Juan Camilo
   Alves de Souza, Thiara Manuele
   Barbosa, Luciana Santos
   Guerra Nunes, Priscila Conrado
   Queiroz Lima, Monique da Rocha
   Gandini, Mariana
   Bispo de Filippis, Ana Maria
   da Cunha, Rivaldo Venancio
   de Azeredo, Elzinandes Leal
   de-Oliveira-Pinto, Luzia Maria
TI Human T cell responses to Dengue and Zika virus infection compared to
   Dengue/Zika coinfection
SO IMMUNITY INFLAMMATION AND DISEASE
LA English
DT Article
DE Dengue; Zika: T lymphocytes
ID LYMPHOCYTES; IMMUNITY; MEMORY; HETEROGENEITY; ARBOVIRUSES; MICRONESIA;
   EXPRESSION; EPIDEMIC; OUTBREAK; ADULTS
AB Introduction: Zika virus (ZIKV) and dengue virus (DENV) co-circulated during latest outbreaks in Brazil, hence, it is important to evaluate the host cross-reactive immune responses to these viruses. So far, little is known about human T cell responses to ZIKV and no reports detail adaptive immune responses during DENV/ZIKV coinfection.
   Methods: Here, we studied T cells responses in well-characterized groups of DENV, ZIKV, or DENV/ZIKV infected patients and DENV-exposed healthy donors. We evaluated chemokine receptors expression and single/multifunctional frequencies of IFN gamma, TNF, and IL2-producing T cells during these infections. Even without antigenic stimulation, it was possible to detect chemokine receptors and IFN gamma, TNF, and IL2-producing T cells from all individuals by flow cytometry. Additionally, PBMCs' IFN gamma response to DENV NS1 protein and to polyclonal stimuli was evaluated by ELISPOT.
   Results: DENV and ZIKV infections and DENV/ZIKV coinfections similarly induced expression of CCR5, CX3CR1, and CXCR3 on CD4 and CD8 T cells. DENV/ZIKV coinfection decreased the ability of CD4(+) T cells to produce IFN gamma(+), TNF+, TNF+IFN gamma(+), and TNF(+)IL2(+), compared to DENV and ZIKV infections. A higher magnitude of IFN response to DENV NS1 was found in donors with a history of dengue infection, however, a hyporesponsiveness was found in acute DENV, ZIKV, or DENV/ZIKV infected patients, even previously infected with DENV.
   Conclusion: Therefore, we emphasize the potential impact of coinfection on the immune response from human hosts, mainly in areas where DENV and ZIKV cocirculate.
C1 [Badolato-Correa, Jessica; Sanchez-Arcila, Juan Camilo; Alves de Souza, Thiara Manuele; Barbosa, Luciana Santos; Guerra Nunes, Priscila Conrado; Queiroz Lima, Monique da Rocha; de Azeredo, Elzinandes Leal; de-Oliveira-Pinto, Luzia Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Viral Immunol, Sala B119,Pavilhao Helio & Peggy Pereira, BR-21045900 Rio De Janeiro, Brazil.
   [Barbosa, Luciana Santos] Univ Fed Rio de Janeiro, Lab Genet, IPPMG, UFRJ, Rio De Janeiro, Brazil.
   [Gandini, Mariana] Fundacao Oswaldo Cruz, Lab Cellular Microbiol, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Bispo de Filippis, Ana Maria] Fundacao Oswaldo Cruz, Lab Flavivirus, Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [da Cunha, Rivaldo Venancio] Univ Fed Mato Grosso do Sul, Dept Clin Med, Campo Grande, Brazil.
   [da Cunha, Rivaldo Venancio] Fundacao Oswaldo Cruz, Campo Grande, MS, Brazil.
RP de-Oliveira-Pinto, LM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Viral Immunol, Sala B119,Pavilhao Helio & Peggy Pereira, BR-21045900 Rio De Janeiro, Brazil.
EM lpinto@ioc.fiocruz.br
OI Gandini, Mariana/0000-0003-3603-6921
FU IOC/FIOCRUZ; FAPERJCarlos Chagas Filho Foundation for Research Support
   of the State of Rio de Janeiro (FAPERJ) [E-26/202.011/2016]
FX This work was financially supported by IOC/FIOCRUZ and FAPERJ. Juan
   Camilo Sanchez-Arcila is recipient of Post-doctoral fellowship FAPERJ
   E-26/202.011/2016.
CR Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Azeredo EL, 2001, IMMUNOBIOLOGY, V204, P494, DOI 10.1078/0171-2985-00058
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306
   BRASIL(d). Ministerio da Saude, 2015, FEBR CHIK MAN CLIN
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   CDC, REV DIAGN TEST ZIK C
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   de-Oliveira-Pinto LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038527
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Farber JM, 1997, J LEUKOCYTE BIOL, V61, P246
   Foo S.-S., 2017, NAT MICROBIOL, V1
   Fuentes-Miranda CJ, 2014, INTERVIROLOGY, V57, DOI 10.1159/000357180
   Gao P, 2003, J LEUKOCYTE BIOL, V73, P273, DOI 10.1189/jlb.0602269
   Gideon HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071351
   Guzman MG, 2002, LANCET INFECT DIS, V2, P33, DOI 10.1016/S1473-3099(01)00171-2
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Lichterfeld M, 2004, BLOOD, V104, P487, DOI 10.1182/blood-2003-12-4341
   Lindow JC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001742
   Loetscher M, 1996, J EXP MED, V184, P963, DOI 10.1084/jem.184.3.963
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rodrigues NCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165945
   Rivino L, 2016, EXPERT REV VACCINES, V15, P443, DOI 10.1586/14760584.2016.1116948
   Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507
   Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722
   Sandberg JK, 2001, J IMMUNOL, V167, P181, DOI 10.4049/jimmunol.167.1.181
   Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274
   Sierra B, 2014, MICROBES INFECT, V16, P40, DOI 10.1016/j.micinf.2013.10.011
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   WHO, 2017, DENG FACT SHEET
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 11
Z9 11
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-4527
J9 IMMUN INFLAMM DIS
JI IMMUN. INFLAMM. DIS.
PD JUN
PY 2018
VL 6
IS 2
BP 194
EP 206
DI 10.1002/iid3.203
PG 13
WC Immunology
SC Immunology
GA GF5GQ
UT WOS:000431995100001
PM 29282904
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vazeille, M
   Dehecq, JS
   Failloux, AB
AF Vazeille, M.
   Dehecq, J. -S.
   Failloux, A. -B.
TI Vectorial status of the Asian tiger mosquito Aedes albopictus of La
   Reunion Island for Zika virus
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; arboviral emergence; Zika; La Reunion Island
ID AEGYPTI; CULICIDAE; DIPTERA
AB La Reunion Island has been the scene of unusually large epidemics of dengue (DENV) and chikungunya (CHIKV) viruses with Aedes albopictus Diptera, Culicidae (Skuse, 1894) as the sole vector. The emergence of Zika virus (ZIKV) in 2007 and the spread of the epidemic strain of the Asian genotype through the Pacific region and the Americas, mainly via the vector Aedes aegypti (Linnaeus, 1762), has raised concern about its possible introduction to, and transmission in, Ae. albopictus-infested areas. We performed an experimental oral infection with the Asian genotype of ZIKV in Ae. albopictus from La Reunion and found a strong midgut barrier to dissemination. This result is discussed in the light of previous vector competence assays for DENV and CHIKV performed by our team on other Ae. albopictus populations from La Reunion.
C1 [Vazeille, M.; Failloux, A. -B.] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, 25 Rue Dr Roux, F-75015 Paris, France.
   [Dehecq, J. -S.] Lutte Antivectorielle, Agence Sante Ocean Indien, St Denis, Reunion, France.
RP Vazeille, M (corresponding author), Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, 25 Rue Dr Roux, F-75015 Paris, France.
EM marie.vazeille@pasteur.fr
FU European Union's Horizon Research and Innovation Programme under
   'ZIKALLIANCE' [734548]
FX This study was funded by the European Union's Horizon 2020 Research and
   Innovation Programme under 'ZIKALLIANCE' (grant agreement no 734548). We
   are grateful to Myrielle Dupont-Rouzeyrol and Olivia O'Connor for
   providing the ZIKV.
CR Bagny L, 2009, J MED ENTOMOL, V46, P1541, DOI 10.1603/033.046.0644
   Bousses P., 2013, Bulletin de la Societe de Pathologie Exotique, V106, P113, DOI 10.1007/s13149-013-0288-7
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Lambrechts L, 2009, P R SOC B, V276, P1369, DOI 10.1098/rspb.2008.1709
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Passi D, 2017, INT J PREVENTIVE MED, V8, DOI 10.4103/2008-7802.199641
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Vazeille-Falcoz M, 1999, AM J TROP MED HYG, V60, P292, DOI 10.4269/ajtmh.1999.60.292
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 15
TC 4
Z9 4
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD JUN
PY 2018
VL 32
IS 2
BP 251
EP 254
DI 10.1111/mve.12284
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GF5QH
UT WOS:000432022100013
PM 29194706
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yee, DA
   Dejesus-Crespo, R
   Hunter, FF
   Bai, F
AF Yee, D. A.
   Dejesus-Crespo, R.
   Hunter, F. F.
   Bai, F.
TI Assessing natural infection with Zika virus in the southern house
   mosquito, Culex quinquefasciatus, during 2016 in Puerto Rico
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Stegomyia aegypti (= Aedes aegypti); Stegomyia albopicta (= Aedes
   albopictus); arbovirus; Zika virus; San Juan
AB The epidemic of Zika in the Western hemisphere has led to intense investigations of all species important in the transmission of Zika virus (ZikV), including putative mosquito vectors. Although evidence points to Stegomyia (= Aedes) (Diptera: Culicidae) mosquitoes as the primary vectors in nature among humans, there remains the possibility that other common mosquito species may be implicated in the rapid spread of the virus. Herein, field-caught Culex quinquefasciatus (Diptera: Culicidae) collected during June 2016 in different neighbourhoods in San Juan, Puerto Rico were examined for the presence of natural infection with ZikV. Stegomyiaaegypti (= Aedes aegypti) from the same locations were also analysed. None of the Cx. quinquefasciatus tested showed natural infection for ZikV, whereas S. aegypti tested positive at seven sites. The present results suggest that Cx. quinquefasciatus was not involved in the transmission of ZikV in San Juan, Puerto Rico in 2016.
C1 [Yee, D. A.; Bai, F.] Univ Southern Mississippi, Dept Biol Sci, Johnson Sci Tower 720,118 Coll Dr,Box 5018, Hattiesburg, MS 39406 USA.
   [Dejesus-Crespo, R.] US EPA, Gulf Ecol Div, Natl Hlth & Environm Effects Res Lab, Off Res & Dev, Gulf Breeze, FL USA.
   [Hunter, F. F.] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada.
RP Yee, DA (corresponding author), Univ Southern Mississippi, Dept Biol Sci, Johnson Sci Tower 720,118 Coll Dr,Box 5018, Hattiesburg, MS 39406 USA.
EM donald.yee@usm.edu
FU Natural Sciences and Engineering Research Council of CanadaNatural
   Sciences and Engineering Research Council of Canada
FX The authors thank J. H. Deerman, for assistance in collecting mosquitoes
   in the field, and A. Thompson and B. Neupane, for assistance with
   infection studies in Stegomyia aegypti. Trapping in San Juan was
   facilitated by R. Barrera from the Centers for Disease Control, Dengue
   Branch, and by members of the Corporacion del Proyecto ENLACE del Cano
   Martin Pena. Space for specimen sorting and processing was made possible
   by A. Ramirez and the Aquatic Ecology Laboratory at the University of
   Puerto Rico. Funding from the Natural Sciences and Engineering Research
   Council of Canada for FFH is acknowledged.
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   CDC, 2017, CAS COUNT US
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Franca RFO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004760
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sharp TM, 2014, MMWR-MORBID MORTAL W, V63, P1121
NR 16
TC 2
Z9 2
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD JUN
PY 2018
VL 32
IS 2
BP 255
EP 258
DI 10.1111/mve.12289
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GF5QH
UT WOS:000432022100014
PM 29239003
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Bui, TC
   Huynh, XV
   Nguyen, H
   Nguyen, KT
   Nguyen, CD
   Pham, ND
AF Bui, Thuong C.
   Huynh, Xuan V.
   Hoang Nguyen
   Nguyen, KieuTho T.
   Nguyen, Chuong D.
   Pham, Nguyen D.
TI Zika virus outbreaks and treatment in pregnant women in Ho Chi Minh
   City, Vietnam
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Editorial Material
DE HCM City Vietnam; Outbreak; Pregnancy; Treatment; Women; Zika virus
C1 [Bui, Thuong C.; Huynh, Xuan V.; Hoang Nguyen] Univ Med & Pharm HCM City, Dept Obstet Gynecol, Ho Chi Minh City, Vietnam.
   [Hoang Nguyen] Ohio State Univ, Coll Med, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.
   [Nguyen, KieuTho T.; Nguyen, Chuong D.] Univ Med & Pharm HCM City, Dept Otolaryngol, Ho Chi Minh City, Vietnam.
   [Pham, Nguyen D.] Children Hosp 1, Dept Otolaryngol, Ho Chi Minh City, Vietnam.
RP Nguyen, H (corresponding author), Ohio State Univ, Coll Med, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.
EM hoang.nguyen@osumc.edu
CR DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
NR 3
TC 2
Z9 3
U1 1
U2 23
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JUN
PY 2018
VL 141
IS 3
BP 390
EP 391
DI 10.1002/ijgo.12456
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GF0WQ
UT WOS:000431652400020
PM 29388670
DA 2020-07-08
ER

PT J
AU Pichler, V
   Bellini, R
   Veronesi, R
   Arnoldi, D
   Rizzoli, A
   Lia, RP
   Otranto, D
   Montarsi, F
   Carlin, S
   Ballardini, M
   Antognini, E
   Salvemini, M
   Brianti, E
   Gaglio, G
   Manica, M
   Cobre, P
   Serini, P
   Velo, E
   Vontas, J
   Kioulos, I
   Pinto, J
   della Torrea, A
   Caputo, B
AF Pichler, Verena
   Bellini, Romeo
   Veronesi, Rodolfo
   Arnoldi, Daniele
   Rizzoli, Annapaola
   Lia, Riccardo Paolo
   Otranto, Domenico
   Montarsi, Fabrizio
   Carlin, Sara
   Ballardini, Marco
   Antognini, Elisa
   Salvemini, Marco
   Brianti, Emanuele
   Gaglio, Gabriella
   Manica, Mattia
   Cobre, Pietro
   Serini, Paola
   Velo, Enkelejda
   Vontas, John
   Kioulos, Ilias
   Pinto, Joao
   della Torrea, Alessandra
   Caputo, Beniamino
TI First evidence of resistance to pyrethroid insecticides in Italian Aedes
   albopictus populations 26years after invasion
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE insecticide resistance; Aedes albopictus; pyrethroids; Chikungunya
   vector; vector control
ID DIPTERA-CULICIDAE; CROSS-RESISTANCE; DENGUE VECTORS; AEGYPTI DIPTERA;
   SKUSE DIPTERA; SUSCEPTIBILITY; MOSQUITOS; TEMEPHOS; ESTABLISHMENT;
   CHIKUNGUNYA
AB BACKGROUNDAedes albopictus has spread during the last few decades all over the world. This has increased significantly the risk of exotic arbovirus transmission (e.g. chikungunya, dengue, and Zika) also in temperate areas, as demonstrated by the Chikungunya 2007 and 2017 outbreaks in northeastern and central Italy. Insecticides are an important tool for limiting the circulation of these mosquito-borne viruses. The aim of the present study was to address the gap in current knowledge of pyrethroid insecticide resistance of European Ae. albopictus populations, focusing on populations from Italy, Albania and Greece.
   RESULTSBioassays for resistance to permethrin (0.75%), -cypermethrin (0.05%) or deltamethrin (0.05%) were performed according to World Health Organization (WHO) protocols and showed reduced susceptibility (<90% mortality) of some Italian populations to permethrin and -cypermethrin, but not to deltamethrin.
   CONCLUSIONThis study reports the first evidence of resistance to pyrethroids in adult Italian Ae. albopictus populations. Results refer to the season preceding the Chikungunya 2017 outbreak in central Italy and highlight the need to increase efforts to monitor the spread of insecticide resistance and the need to develop strategies to limit the spread of insecticide resistance, particularly in areas where extensive treatments have been carried out to contain disease outbreaks. (c) 2017 Society of Chemical Industry
C1 [Pichler, Verena; Manica, Mattia; Cobre, Pietro; Serini, Paola; della Torrea, Alessandra; Caputo, Beniamino] Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
   [Bellini, Romeo; Veronesi, Rodolfo] Ctr Agr Ambiente G Nicoli, Dept Med & Vet Entomol, Crevalcore, Italy.
   [Arnoldi, Daniele; Rizzoli, Annapaola; Manica, Mattia] Fdn Edmund Mach, San Michele All Adige, Italy.
   [Lia, Riccardo Paolo; Otranto, Domenico] Univ Bari, Dept Vet Med, Valenzano, Italy.
   [Montarsi, Fabrizio; Carlin, Sara] Ist Zooprofilatt Sperimentale Venezie, Legnaro, Italy.
   [Ballardini, Marco] Ist Zooprofilatt Sperimentale Piemonte Liguria &, Turin, Italy.
   [Antognini, Elisa] Ist Zooprofilatt Sperimentale Umbria & Marche, Ancona, Italy.
   [Salvemini, Marco] Univ Naples Federico II, Dept Biol, Naples, Italy.
   [Brianti, Emanuele; Gaglio, Gabriella] Polo Univ Annunziata, Dipartimento Sci Vet, Messina, Italy.
   [Velo, Enkelejda] Inst Publ Hlth, Tirana, Albania.
   [Vontas, John; Kioulos, Ilias] Agr Univ Athens, Athens, Greece.
   [Vontas, John] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Iraklion, Greece.
   [Pinto, Joao] Univ Nova Lisboa, Inst Higiene & Med Trop, Global Hlth & Trop Med, Lisbon, Portugal.
RP Caputo, B (corresponding author), Sapienza Univ Rome, Dept Publ Hlth & Infect Dis, Piazzale Aldo Moro 5, I-00185 Rome, Italy.
EM beniamino.caputo@uniroma1.it
RI Pinto, Joao/C-2208-2012; antognini, elisa/H-1633-2019; Ballardini,
   Marco/P-6301-2019; Rizzoli, Annapaola/J-2439-2012; Otranto,
   Domenico/Y-3249-2019
OI Pinto, Joao/0000-0001-8572-7708; antognini, elisa/0000-0002-4598-5101;
   Rizzoli, Annapaola/0000-0003-3997-6783; SALVEMINI,
   Marco/0000-0003-2297-9267; Vontas, John/0000-0002-8704-2574; Ballardini,
   Marco/0000-0001-8403-466X; MANICA, MATTIA/0000-0003-3709-1199
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004664)
   Angelini R, 2007, EUROSURVEILLANCE, V12, P9
   Arslan A, 2016, J VECTOR DIS, V53, P136
   Bellini R., 1994, Atti XVII Congresso Nazionale Italiano di Entomologia, Udine, Italy, 13-18 Giugno 1994., P795
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bengoa M, 2017, J AM MOSQUITO CONTR, V33, P246, DOI 10.2987/17-6636R.1
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230
   Chuaycharoensuk T, 2011, J VECTOR ECOL, V36, P204, DOI 10.1111/j.1948-7134.2011.00158.x
   Corbel V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005054
   Di Luca Marco, 2001, Annali dell'Istituto Superiore di Sanita, V37, P249
   ECDC, 2012, GUID SURV INV MOSQ E
   European Centre for Disease Prevention and Control (ECDC), 2017, COMM DIS THREATS REP
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, P8
   Farajollahi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049181
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Fonseca DM, 2013, PEST MANAG SCI, V69, P1351, DOI 10.1002/ps.3511
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Grigoraki L, 2017, PLOS NEGLECT TROP D, V11, P1
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Ishak IH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24707
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Kamgang B, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-79
   Kasai S, 2007, J MED ENTOMOL, V44, P822, DOI 10.1603/0022-2585(2007)44[822:IRIPVM]2.0.CO;2
   Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Lee RML, 2014, TROP BIOMED, V31, P670
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Manica M, 2017, PEST MANAG SCI, V73, P138, DOI 10.1002/ps.4315
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Ngoagouni C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1887-5
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pocquet N, 2014, INSECTICIDE RESISTAN, P1
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Richards SL, 2017, J MED ENTOMOL, V54, P1
   Rodriguez MM, 2002, J MED ENTOMOL, V39, P882, DOI 10.1603/0022-2585-39.6.882
   Romi R, 2003, J AM MOSQUITO CONTR, V19, P419
   Romi R, 2011, LINEE GUIDA CONTROLL
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   Seixas G, 2017, PLOS NEGLECT TROP D, V11, P1
   Severini Francesco, 2009, Fragmenta Entomologica, V41, P213
   Sivan A, 2015, PARASITOL RES, V114, P4693, DOI 10.1007/s00436-015-4717-3
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Team RDC, 2011, R FDN STAT COMP, V1, P409
   Thanispong K, 2015, J AM MOSQUITO CONTR, V31, P346, DOI 10.2987/moco-31-04-346-352.1
   Tilston N, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-61
   Usmani KA, 2001, J ECON ENTOMOL, V94, P868, DOI 10.1603/0022-0493-94.4.868
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wan-Norafikah O, 2013, ASIAN BIOMED, V7, P51, DOI 10.5372/1905-7415.0701.150
   WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1
   WHO, 1998, TEST PROC INS RES MO
   WHO, 2012, GLOB PLAN INS RES MA
   WHO, 2013, TEST PROC INREMO
   WHO, 2016, MON MAN INS RES AED
   WHO EMCA, 2013, GUID CONTR MOSQ PUBL
   Wirth MC, 1999, J AM MOSQUITO CONTR, V15, P315
NR 70
TC 13
Z9 13
U1 1
U2 19
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUN
PY 2018
VL 74
IS 6
BP 1319
EP 1327
DI 10.1002/ps.4840
PG 9
WC Agronomy; Entomology
SC Agriculture; Entomology
GA GF1CP
UT WOS:000431670200013
PM 29278457
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Escutia, G
   McDonald, E
   Rodriguez-Lainz, A
   Healy, J
AF Escutia, Gabriela
   McDonald, Eric
   Rodriguez-Lainz, Alfonso
   Healy, Jessica
TI Demographic and Travel Characteristics of Travel-Associated Zika Virus
   Infection Case-Patients in San Diego County, California (January 1,
   2016-March 31, 2017)
SO JOURNAL OF COMMUNITY HEALTH
LA English
DT Article
DE Zika virus; Travel; Hispanics; Foreign-born
ID VISITING FRIENDS; SURVEILLANCE; RELATIVES; DISEASE; STATES
AB Most Zika disease cases diagnosed in the continental US have been associated with travel to areas with risk of Zika transmission, mainly the Caribbean and Latin America. Limited information has been published about the demographic and travel characteristics of Zika case-patients in the United States, besides their age and gender. During 2016-2017 the County of San Diego Health and Human Services Agency, California, expanded the scope and completeness of demographic and travel information collected from Zika case-patients for public health surveillance purposes. The majority (53.8%) of travel-related Zika virus infection case-patients (n = 78) in the county were Hispanic, significantly higher (p ae<currency> 0.05) than the 33.0% of Hispanics in the county. Foreign-born residents, mainly from Mexico, were also overrepresented among cases compared to their share in the county population (33.3 vs. 23.0%; p ae<currency> 0.05). Seventeen (21.8%) patients reported a primary language other than English (14 Spanish). Most case-patients traveled for tourism (54%) or to visit friends and relatives (36%). This surveillance information helps identify higher-risk populations and implement culturally targeted interventions for Zika prevention and control.
C1 [Escutia, Gabriela; McDonald, Eric; Healy, Jessica] Cty San Diego Hlth & Human Serv Agcy, 3851 Rosecrans St, San Diego, CA 92110 USA.
   [Rodriguez-Lainz, Alfonso] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 3851 Rosecrans St,MS P575, San Diego, CA 92110 USA.
   [Healy, Jessica] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA.
RP Rodriguez-Lainz, A (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, 3851 Rosecrans St,MS P575, San Diego, CA 92110 USA.
EM jqi3@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
   [1U38OT000143-04]
FX Funding was provided by Centers for Disease Control and Prevention
   (Cooperative Agreement No. 1U38OT000143-04)
CR Bacaner N, 2004, JAMA-J AM MED ASSOC, V291, P2856, DOI 10.1001/jama.291.23.2856
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1
   Diaz-Menendez M, 2018, ENFERM INFEC MICR CL, V36, P4, DOI 10.1016/j.eimc.2016.08.003
   Hagmann SHF, 2014, FAM PRACT, V31, P678, DOI 10.1093/fampra/cmu063
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460
   Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Matthews CE, 2015, FRONT PUBLIC HEALTH, V3, DOI 10.3389/fpubh.2015.00141
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP MEX
   U.S. CENSUS BUREAU, 2015, QUICK FACTS
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Wallace Steven P, 2009, Med Care, V47, P662, DOI 10.1097/MLR.0b013e318190cc95
NR 15
TC 1
Z9 1
U1 1
U2 9
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0094-5145
EI 1573-3610
J9 J COMMUN HEALTH
JI J. Community Health
PD JUN
PY 2018
VL 43
IS 3
BP 566
EP 569
DI 10.1007/s10900-017-0453-1
PG 4
WC Health Policy & Services; Public, Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA GE2IB
UT WOS:000431037700016
PM 29188465
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Wang, YH
   Chang, MM
   Wang, XL
   Zheng, AH
   Zou, Z
AF Wang, Yan-Hong
   Chang, Meng-Meng
   Wang, Xue-Li
   Zheng, Ai-Hua
   Zou, Zhen
TI The immune strategies of mosquito Aedes aegypti against microbial
   infection
SO DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
LA English
DT Article
DE Aedes aegypti; Innate immunity; Arbovirus; Entomopathogenic fungus
ID BOLLWORM HELICOVERPA-ARMIGERA; YELLOW-FEVER MOSQUITO; JAK-STAT PATHWAY;
   INNATE IMMUNITY; BOMBYX-MORI; GENE-EXPRESSION; MANDUCA-SEXTA;
   TOLL-PATHWAY; PROPHENOLOXIDASE ACTIVATION; CULEX-QUINQUEFASCIATUS
AB Yellow fever mosquito Aedes aegypti transmits many devastating arthropod-borne viruses (arboviruses), such as dengue virus, yellow fever virus, Chikungunya virus, and Zika virus, which cause great concern to human health. Mosquito control is an effective method to block the spread of infectious diseases. Ae. aegypti uses its innate immune system to fight against arboviruses, parasites, and fungi. In this review, we briefly summarize the recent findings in the immune response of Ae. aegypti against arboviral and entomopathogenic infections. This review enriches our understanding of the mosquito immune system and provides evidence to support the development of novel mosquito control strategies. (C) 2017 Elsevier Ltd. All rights reserved.
C1 [Wang, Yan-Hong; Chang, Meng-Meng; Wang, Xue-Li; Zheng, Ai-Hua; Zou, Zhen] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.
   [Chang, Meng-Meng; Zou, Zhen] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Zou, Z (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China.
EM zouzhen@ioz.ac.cn
RI zou, zhen/C-6134-2016
OI zou, zhen/0000-0003-3550-7656
FU National Key Plan for Scientific Research and Development of China
   [2017YFC1201004, 2016YFD0500300, 2016YFC1200603]; Strategic Priority
   Research Program of the CAS [XDB11030600]; National Science Foundation
   of ChinaNational Natural Science Foundation of China [31402013,
   31472008, 31672291]
FX This work was supported by the National Key Plan for Scientific Research
   and Development of China (No. 2017YFC1201004, 2016YFD0500300,
   2016YFC1200603), Strategic Priority Research Program of the CAS (No.
   XDB11030600), National Science Foundation of China (No. 31402013,
   31472008, 31672291).
CR Arensburger P, 2010, SCIENCE, V330, P86, DOI 10.1126/science.1191864
   Ashida Masaaki, 1998, P135
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Barletta ABF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2040-9
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Blair CD, 2000, CLIN MICROBIOL REV, V13, P651, DOI 10.1128/CMR.13.4.651-661.2000
   Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao XL, 2017, INSECT BIOCHEM MOLEC, V88, P48, DOI 10.1016/j.ibmb.2017.07.008
   Castillo JC, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal1505
   Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x
   Cerenius L, 2008, TRENDS IMMUNOL, V29, P263, DOI 10.1016/j.it.2008.02.009
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Chen XG, 2008, ADV GENET, V64, P19, DOI 10.1016/S0065-2660(08)00802-X
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   CHRISTENSEN BM, 1986, J PARASITOL, V72, P220, DOI 10.2307/3281595
   Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136
   Cirimotich CM, 2010, DEV COMP IMMUNOL, V34, P387, DOI 10.1016/j.dci.2009.12.005
   Clemons A., 2010, COLD SPRING HARBOR P, V2010
   Dimopoulos G, 2003, CELL MICROBIOL, V5, P3, DOI 10.1046/j.1462-5822.2003.00252.x
   Dimopoulos G, 1997, P NATL ACAD SCI USA, V94, P11508, DOI 10.1073/pnas.94.21.11508
   Dong YM, 2012, INSECT BIOCHEM MOLEC, V42, P126, DOI 10.1016/j.ibmb.2011.11.005
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Dudchenko O, 2017, SCIENCE, V356, P92, DOI 10.1126/science.aal3327
   Fang WG, 2012, CURR OPIN MICROBIOL, V15, P232, DOI 10.1016/j.mib.2011.12.012
   Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Fujita T, 2004, IMMUNOL REV, V198, P185, DOI 10.1111/j.0105-2896.2004.0123.x
   Garcia-Munguia AM, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-24
   Glare T, 2012, TRENDS BIOTECHNOL, V30, P250, DOI 10.1016/j.tibtech.2012.01.003
   Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046
   Hillyer JF, 2003, CELL TISSUE RES, V313, P117, DOI 10.1007/s00441-003-0744-y
   Hillyer JF, 2002, HISTOCHEM CELL BIOL, V117, P431, DOI 10.1007/s00418-002-0408-0
   Hillyer JF, 2003, J PARASITOL, V89, P62, DOI 10.1645/0022-3395(2003)089[0062:RPAMOB]2.0.CO;2
   Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Hou Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005309
   Huang LH, 2001, INSECT MOL BIOL, V10, P87, DOI 10.1046/j.1365-2583.2001.00241.x
   Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013
   Jiang HB, 1998, P NATL ACAD SCI USA, V95, P12220, DOI 10.1073/pnas.95.21.12220
   Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x
   Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003
   Kanost MR, 2004, IMMUNOL REV, V198, P97, DOI 10.1111/j.0105-2896.2004.0121.x
   Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   Kim MS, 2002, J BIOL CHEM, V277, P39999, DOI 10.1074/jbc.M205508200
   Koizumi N, 1999, J INSECT PHYSIOL, V45, P853, DOI 10.1016/S0022-1910(99)00069-4
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Kokoza V, 2010, P NATL ACAD SCI USA, V107, P8111, DOI 10.1073/pnas.1003056107
   Krem MM, 2002, TRENDS BIOCHEM SCI, V27, P67, DOI 10.1016/S0968-0004(01)02007-2
   Kumar S, 2010, SCIENCE, V327, P1644, DOI 10.1126/science.1184008
   Lavine MD, 2002, INSECT BIOCHEM MOLEC, V32, P1295, DOI 10.1016/S0965-1748(02)00092-9
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Ligoxygakis P, 2002, SCIENCE, V297, P114, DOI 10.1126/science.1072391
   Ling EJ, 2006, DEV COMP IMMUNOL, V30, P289, DOI 10.1016/j.dci.2005.05.005
   Matskevich AA, 2010, EUR J IMMUNOL, V40, P1244, DOI 10.1002/eji.200940164
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014
   Nene V, 2007, SCIENCE, V316, P1718, DOI 10.1126/science.1138878
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Ortiz-Urquiza A, 2015, APPL MICROBIOL BIOT, V99, P1057, DOI 10.1007/s00253-014-6270-x
   Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   PERONA JJ, 1995, PROTEIN SCI, V4, P337
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Read AF, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000058
   Roh KB, 2009, J BIOL CHEM, V284, P19474, DOI 10.1074/jbc.M109.007419
   Royet J, 2007, NAT REV MICROBIOL, V5, P264, DOI 10.1038/nrmicro1620
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Sanders HR, 2005, INSECT BIOCHEM MOLEC, V35, P1293, DOI 10.1016/j.ibmb.2005.07.006
   Satoh D, 1999, J BIOL CHEM, V274, P7441, DOI 10.1074/jbc.274.11.7441
   Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200
   Severson DW, 2004, INSECT BIOCHEM MOLEC, V34, P715, DOI 10.1016/j.ibmb.2004.03.024
   Severson DW, 2001, ANNU REV ENTOMOL, V46, P183, DOI 10.1146/annurev.ento.46.1.183
   Shin SW, 2006, J BIOL CHEM, V281, P39388, DOI 10.1074/jbc.M608912200
   Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200
   Shin SW, 2002, P NATL ACAD SCI USA, V99, P9978, DOI 10.1073/pnas.162345999
   Shin SW, 2003, P NATL ACAD SCI USA, V100, P2616, DOI 10.1073/pnas.0537347100
   SODERHALL K, 1982, J INVERTEBR PATHOL, V39, P105, DOI 10.1016/0022-2011(82)90164-1
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   STRAND MR, 1995, ANNU REV ENTOMOL, V40, P31, DOI 10.1146/annurev.en.40.010195.000335
   Sutthangkul J, 2015, J BIOL CHEM, V290, P6470, DOI 10.1074/jbc.M114.605568
   Takahashi D, 2014, J BIOL CHEM, V289, P28399, DOI 10.1074/jbc.M114.583971
   Tang HP, 2006, J BIOL CHEM, V281, P28097, DOI 10.1074/jbc.M601642200
   Wang S, 2015, INSECT MOL BIOL, V24, P293, DOI 10.1111/imb.12159
   Wang XL, 2017, P NATL ACAD SCI USA, V114, pE2709, DOI 10.1073/pnas.1619326114
   Wang Y, 2017, INSECT MOL BIOL, V26, P552, DOI 10.1111/imb.12318
   Wang YH, 2013, PESTIC BIOCHEM PHYS, V105, P13, DOI 10.1016/j.pestbp.2012.11.001
   Wang YH, 2011, PESTIC BIOCHEM PHYS, V101, P48, DOI 10.1016/j.pestbp.2011.07.003
   Wang YH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004931
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   WHO, 2016, MALARIA
   Wilson R, 1999, J IMMUNOL, V162, P1590
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xing LS, 2017, MOL CELL PROTEOMICS, V16, P1009, DOI [10.1074/mcp.M116.062547, 10.1074/mcp.m116.062547]
   Xiong GH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1509-1
   Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029
   Ye YXH, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002362
   Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854
   Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200
   Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012
   Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao PC, 2007, INSECT BIOCHEM MOLEC, V37, P952, DOI 10.1016/j.ibmb.2007.05.001
   Zou Z, 2008, P NATL ACAD SCI USA, V105, P18454, DOI 10.1073/pnas.0804658105
   Zou Z, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r177
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
   Zou Z, 2010, IMMUNITY, V32, P41, DOI 10.1016/j.immuni.2009.11.011
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 114
TC 8
Z9 9
U1 3
U2 72
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0145-305X
EI 1879-0089
J9 DEV COMP IMMUNOL
JI Dev. Comp. Immunol.
PD JUN
PY 2018
VL 83
SI SI
BP 12
EP 21
DI 10.1016/j.dci.2017.12.001
PG 10
WC Fisheries; Immunology; Zoology
SC Fisheries; Immunology; Zoology
GA GD5BQ
UT WOS:000430520400003
PM 29217264
DA 2020-07-08
ER

PT J
AU Sousa, L
   de Mello, R
   Cedrim, D
   Garcia, A
   Missier, P
   Uchoa, A
   Oliveira, A
   Romanovsky, A
AF Sousa, Leonardo
   de Mello, Rafael
   Cedrim, Diego
   Garcia, Alessandro
   Missier, Paolo
   Uchoa, Anderson
   Oliveira, Anderson
   Romanovsky, Alexander
TI VazaDengue: An information system for preventing and combating
   mosquito-borne diseases with social networks
SO INFORMATION SYSTEMS
LA English
DT Article
DE Dengue; Mosquito; Social media; Surveillance; Tweets
ID TWITTER
AB Dengue is a disease transmitted by the Aedes Aegypti mosquito, which also transmits the Zika virus and Chikungunya. Unfortunately, the population of different countries has been suffering from the diseases transmitted by this mosquito. The communities should play an important role in combating and preventing the mosquito-borne diseases. However, due to the limited engagement of the population, new solutions need to be used to strengthen the mosquito surveillance. VazaDengue is one of these solutions, which offers the users a web and mobile platform for preventing and combating mosquito-borne diseases. The system relies on social actions of citizens reporting mosquito breeding sites and dengue cases, in which the reports are made available to the community and health agencies. In order to address the limited population engagement, the system proactively monitors social media network as Twitter to enrich the information provided by the system. It processes the natural language text from the network to classify the tweets according to a set of predefined categories. After the classification, the relevant tweets are provided to the users as reports. In this paper, we describe the VazaDengue features including its ability to harvest and classify tweets. Since the VazaDengue system aims to strengthen the entomological surveillance of the mosquito that transmits Dengue, Zika, and Chikungunya by providing geolocated reports, we present here two studies to evaluate its potential contributions. The first evaluation uses a survey conducted in the Brazilian community of health agents. The goal is to evaluate the relevance of the classified tweets according to the health agents' perspective. The second study compares the official reports of the 2015-2016 epidemic waves in Brazil with the concentration of mosquito-related tweets found by VazaDengue. The goal is to verify if the concentration of tweets can be used for monitoring the mosquito manifestation in big cities. The results of these two evaluations are encouraging. For instance, we have found that the health agents tend to agree with the relevance of the classified tweets. Moreover, the concentration of tweets is likely to be effective for monitoring big cities. The results of these evaluations are helping us to improve the VazaDengue system further. These improvements will make the VazaDengue system even more useful for combating and preventing the mosquito-borne diseases. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Sousa, Leonardo; de Mello, Rafael; Cedrim, Diego; Garcia, Alessandro; Uchoa, Anderson; Oliveira, Anderson] Pontificia Univ Catolica Rio de Janeiro, Dept Informat, Rio de Janeiro, Brazil.
   [Missier, Paolo; Romanovsky, Alexander] Newcastle Univ, Sch Comp Sci, Newcastle, England.
RP Sousa, L (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Informat, Rio de Janeiro, Brazil.
EM lsousa@inf.puc-rio.br; rmaiani@inf.puc-rio.br; dcgrego@inf.puc-rio.br;
   afgarcia@inf.puc-rio.br; paolo.missier@newcastle.ac.uk;
   auchoa@inf.puc-rio.br; aoliveira@inf.puc-rio.br;
   alexander.romanovsky@newcastle.ac.uk
RI Sousa, Leonardo/AAG-3796-2020; Uchoa, Anderson/N-4331-2019; Missier,
   Paolo/AAF-1882-2020
OI Sousa, Leonardo/0000-0003-0397-8277; Uchoa,
   Anderson/0000-0002-6847-5569; Missier, Paolo/0000-0002-0978-2446
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ); PPSUS; MRC/UK Newton fund project; FAPERJ
   (Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Brazil)Carlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E26-102.166/2013]; FAPERJCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [102166/2013, 22520 7/2016]; FAPEAL (grant Institucional Links - Virus
   Zika); FAPEAL (PPGs) [14/2016]
FX This work is supported by the FAPERJ, PPSUS and MRC/UK Newton fund
   project entitled A Software Infrastructure for Promoting Efficient
   Entomological Monitoring of Dengue Fever. We are grateful to Alexandre
   Plastino from UFF (Brazil) for sharing with us the results of his work
   on tweet classification. We would like to thank Leonardo Frajhof
   (UNIRIO), Oswardo Cruz (Fiocruz, Brazil), Soeli Fiori (PUC-Rio, Brazil)
   and Wagner Meira (UFMG, Brazil) for their contribution. We are grateful
   to the following students of Newcastle University (UK) who contributed
   to the earlier work on the topics of the paper: Atinda Pal, Michael
   Daniilakis, Callum McClean and Jonathan Carlton. Also, we would like to
   thank PP SUS (Programa Pesquisa para o SUS, Brazil) and FAPERJ (Fundacao
   de Amparo a Pesquisa do Estado do Rio de Janeiro, Brazil)
   (E26-102.166/2013), FAPERJ (grant # 102166/2013 and 22520 7/2016) and
   FAPEAL (grant Institucional Links - Virus Zika and PPGs 14/2016).
CR Achrekar H., 2011, IEEE INFOCOM 2011 - IEEE Conference on Computer Communications Workshops, P702, DOI 10.1109/INFCOMW.2011.5928903
   Aggarwal C. C., 2012, MINING TEXT DATA, P77, DOI DOI 10.1007/978-1-4614-3223-4
   Ajao O, 2015, J INF SCI, V41, P855, DOI 10.1177/0165551515602847
   B. H. Department, 2017, EP REP 2015
   B. H. Department, 2017, EP REP 2016
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Brasil D., DENG BRAS APP
   Carvalho J, 2016, FRONT ARTIF INTEL AP, V285, P769, DOI 10.3233/978-1-61499-672-9-769
   Codeco C, 2016, BIORXIV, DOI [10.1101/046193, DOI 10.1101/046193]
   COHEN J, 1968, PSYCHOL BULL, V70, P213, DOI 10.1037/h0026256
   Gerber MS, 2014, DECIS SUPPORT SYST, V61, P115, DOI 10.1016/j.dss.2014.02.003
   Gomide J., 2011, P ACM WEBSCI 11 JUN, P1, DOI [10.1145/2527031.2527049, DOI 10.1145/2527031.2527049]
   Graham M, 2014, PROF GEOGR, V66, P568, DOI 10.1080/00330124.2014.907699
   Jiang Zhu, 2011, 2011 IEEE Global Humanitarian Technology Conference, P431, DOI 10.1109/GHTC.2011.48
   Kotsiantis S. B., 2007, SUPERVISED MACHINE L
   Lampos V, 2010, 2010 2nd International Workshop on Cognitive Information Processing (CIP 2010), P411, DOI 10.1109/CIP.2010.5604088
   Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540
   Linaker J., 2015, GUIDELINES CONDUCTIN
   McCallum A., 1998, AAAI 98 WORKSH LEARN, V752, P41
   Missier P., 2017, ARXIV170303928
   Missier P., TRACKING DENGUE EPID, P80, DOI [10.1007/978-3-319-46963-8_7, DOI 10.1007/978-3-319-46963-8_7]
   Morstatter Fred, 2013, ARXIV13065204
   Nagarajan M, 2009, LECT NOTES COMPUT SC, V5802, P539, DOI 10.1007/978-3-642-04409-0_52
   Rodrigues R., 2014, OASICS OPENACCESS SE, V38
   Rosa K. D., 2011, P ACM SIGIR SWSM
   ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7
   Torchiano M, 2017, IEEE-ACM INT WKSP CO, P33, DOI 10.1109/CESI.2017.5
   UFRN, OBS AED AEG
   UNA-SUS, UN SUS DENG
   Vieweg S, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1079, DOI 10.1145/1753326.1753486
   Weng J, 2010, P 3 ACM INT C WEB SE, P261, DOI DOI 10.1145/1718487.1718520
   Xinyu Chen, 2015, 2015 Systems and Information Engineering Design Symposium. proceedings, P63, DOI 10.1109/SIEDS.2015.7117012
   Zheng X., 2017, ARXIV170503172
NR 33
TC 3
Z9 3
U1 4
U2 26
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0306-4379
EI 1873-6076
J9 INFORM SYST
JI Inf. Syst.
PD JUN
PY 2018
VL 75
BP 26
EP 42
DI 10.1016/j.is.2018.02.003
PG 17
WC Computer Science, Information Systems
SC Computer Science
GA GD8RG
UT WOS:000430779200003
OA Green Published
DA 2020-07-08
ER

PT J
AU Anders, KL
   Indriani, C
   Ahmad, RA
   Tantowijoyo, W
   Arguni, E
   Andari, B
   Jewell, NP
   Rances, E
   O'Neill, SL
   Simmons, CP
   Utarini, A
AF Anders, Katherine L.
   Indriani, Citra
   Ahmad, Riris Andono
   Tantowijoyo, Warsito
   Arguni, Eggi
   Andari, Bekti
   Jewell, Nicholas P.
   Rances, Edwige
   O'Neill, Scott L.
   Simmons, Cameron P.
   Utarini, Adi
TI The AWED trial (Applying Wolbachia to Eliminate Dengue) to assess the
   efficacy of Wolbachia-infected mosquito deployments to reduce dengue
   incidence in Yogyakarta, Indonesia: study protocol for a cluster
   randomised controlled trial
SO TRIALS
LA English
DT Article
DE Wolbachia; dengue; chikungunya; Zika; vector-borne disease; cluster
   randomised trial; test-negative design; Indonesia
ID TEST-NEGATIVE DESIGN; INFLUENZA VACCINE EFFECTIVENESS; VIRUS;
   TRANSMISSION; IMPACT
AB Background: Dengue and other arboviruses transmitted by Aedes aegypti mosquitoes, including Zika and chikungunya, present an increasing public health challenge in tropical regions. Current vector control strategies have failed to curb disease transmission, but continue to be employed despite the absence of robust evidence for their effectiveness or optimal implementation. The World Mosquito Program has developed a novel approach to arbovirus control using Ae. aegypti stably transfected with Wolbachia bacterium, with a significantly reduced ability to transmit dengue, Zika and chikungunya in laboratory experiments. Modelling predicts this will translate to local elimination of dengue in most epidemiological settings. This study protocol describes the first trial to measure the efficacy of Wolbachia in reducing dengue virus transmission in the field.
   Methods/design: The study is a parallel, two-arm, non-blinded cluster randomised controlled trial conducted in a single site in Yogyakarta, Indonesia. The aim is to determine whether large-scale deployment of Wolbachia-infected Ae. aegypti mosquitoes leads to a measurable reduction in dengue incidence in treated versus untreated areas. The primary endpoint is symptomatic, virologically confirmed dengue virus infection of any severity. The 26 km(2) study area was subdivided into 24 contiguous clusters, allocated randomly 1:1 to receive Wolbachia deployments or no intervention. We use a novel epidemiological study design, the cluster-randomised test-negative design trial, in which dengue cases and arbovirus-negative controls are sampled concurrently from among febrile patients presenting to a network of primary care clinics, with case or control status classified retrospectively based on the results of laboratory diagnostic testing. Efficacy is estimated from the odds ratio of Wolbachia exposure distribution (probability of living in a Wolbachia-treated area) among virologically confirmed dengue cases compared to test-negative controls. A secondary per-protocol analysis allows for individual Wolbachia exposure levels to be assessed to account for movements outside the cluster and the heterogeneity in local Wolbachia prevalence among treated clusters.
   Discussion: The findings from this study will provide the first experimental evidence for the efficacy of Wolbachia in reducing dengue incidence. Together with observational evidence that is accumulating from pragmatic deployments of Wolbachia in other field sites, this will provide valuable data to estimate the effectiveness of this novel approach to arbovirus control, inform future cost-effectiveness estimates, and guide plans for large-scale deployments in other endemic settings.
C1 [Anders, Katherine L.; Rances, Edwige; O'Neill, Scott L.; Simmons, Cameron P.] Monash Univ, Inst Vector Borne Dis, World Mosquito Program, Melbourne, Vic, Australia.
   [Indriani, Citra; Ahmad, Riris Andono] Univ Gadjah Mada, Dept Biostat Epidemiol & Populat Hlth, Fac Med, Yogyakarta, Indonesia.
   [Indriani, Citra; Ahmad, Riris Andono; Tantowijoyo, Warsito; Arguni, Eggi; Andari, Bekti; Utarini, Adi] Univ Gadjah Mada, Ctr Trop Med, Eliminate Dengue Project, Fac Med, Yogyakarta, Indonesia.
   [Arguni, Eggi] Univ Gadjah Mada, Fac Med, Dept Pediat, Yogyakarta, Indonesia.
   [Jewell, Nicholas P.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.
   [Utarini, Adi] Univ Gadjah Mada, Fac Med, Dept Hlth Policy & Management, Yogyakarta, Indonesia.
RP Anders, KL (corresponding author), Monash Univ, Inst Vector Borne Dis, World Mosquito Program, Melbourne, Vic, Australia.
EM katie.anders@worldmosquito.org
RI O'Neill, Scott L/B-3568-2009; O'Neill, Scott/R-9560-2019
OI O'Neill, Scott L/0000-0002-4131-3615; O'Neill,
   Scott/0000-0002-4131-3615; Simmons, Cameron P./0000-0002-9039-7392;
   indriani, citra/0000-0002-2884-5916
FU Yayasan Tahija (The Tahija Foundation), Indonesia
FX This study is funded by Yayasan Tahija (The Tahija Foundation),
   Indonesia. The funders have not had a role in the design of the study,
   and will not be involved in the collection, analysis or interpretation
   of the data.
CR Anders KL, 2018, AM J EPIDEMIOL, V187, P2021, DOI 10.1093/aje/kwy099
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhoomiboonchoo P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003138
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   De Serres G, 2013, EUROSURVEILLANCE, V18, P37, DOI DOI 10.2807/1560-7917.ES2013.18.37.20585
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Foppa IM, 2013, VACCINE, V31, P3104, DOI 10.1016/j.vaccine.2013.04.026
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Haber M, 2015, EPIDEMIOL INFECT, V143, P1417, DOI 10.1017/S0950268814002179
   HAYBITTLE JL, 1971, BRIT J RADIOL, V44, P793, DOI 10.1259/0007-1285-44-526-793
   Hayes RJ, 2009, INTERD STAT, P3
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Jackson ML, 2013, VACCINE, V31, P2165, DOI 10.1016/j.vaccine.2013.02.053
   Jewell NP, 2019, BIOSTATISTICS, V20, P332, DOI 10.1093/biostatistics/kxy005
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Li F, 2016, STAT MED, V35, P1565, DOI 10.1002/sim.6813
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Moulton Lawrence H, 2004, Clin Trials, V1, P297, DOI 10.1191/1740774504cn024oa
   Orenstein EW, 2007, INT J EPIDEMIOL, V36, P623, DOI 10.1093/ije/dym021
   Pilger D, 2010, TROPIKA, V1
   Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0
   Ramadona AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152688
   Restrepo AC, 2014, TROP MED INT HEALTH, V19, P863, DOI 10.1111/tmi.12325
   Rolph MS, 2015, LANCET INFECT DIS, V15, P1007, DOI 10.1016/S1473-3099(15)00231-5
   Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019
   Small DS, 2008, J AM STAT ASSOC, V103, P271, DOI 10.1198/016214507000000897
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Sullivan SG, 2016, AM J EPIDEMIOL, V184, P345, DOI 10.1093/aje/kww064
   Sullivan SG, 2014, EXPERT REV VACCINES, V13, P1571, DOI 10.1586/14760584.2014.966695
   Teurlai M, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001957
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, OUTC EM COMM REG CLU
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Yogyakarta Statistical Office (BPS), POP MUN SPEC REG YOG
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 46
TC 12
Z9 12
U1 1
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1745-6215
J9 TRIALS
JI Trials
PD MAY 31
PY 2018
VL 19
AR 302
DI 10.1186/s13063-018-2670-z
PG 16
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA GI0WY
UT WOS:000434092300001
PM 29855331
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU [Anonymous]
AF [Anonymous]
TI Tracing Zika's uncharted spread
SO NATURE
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAY 31
PY 2018
VL 557
IS 7707
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH4WT
UT WOS:000433412900002
DA 2020-07-08
ER

PT J
AU Zarei, M
AF Zarei, Mohammad
TI Infectious pathogens meet point-of-care diagnostics
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Review
DE Point-of-care; Infectious disease; Diagnostics; Microfluidics;
   Smartphone
ID HEPATITIS-B-VIRUS; MOLECULAR DIAGNOSIS; GENOTYPING METHOD; PLATFORM;
   DEVICES; BIOSENSOR; DRONE; ZIKA; MICROFLUIDICS; TECHNOLOGIES
AB The field of point-of-care (POC) diagnostics provides the rapid diagnosis of infectious diseases which is essential and critical for improving the general public health in resource-limited settings. POC platforms offer many advantages for detection of various pathogens including portability, automation, speed, cost, and efficiency. In this review, we provide an overview of the recent trends for POC diagnostics of infectious diseases with focus on portable platforms. We review here the present status of POC platforms, emphasizing in period of the past three years, then extrapolate their advance into the future applications for diagnosis of infectious pathogens.
C1 [Zarei, Mohammad] Univ Kurdistan, Dept Chem & Civil Engn, POB 66177, Sanandaj 6661836336, Kurdistan Provi, Iran.
RP Zarei, M (corresponding author), Univ Kurdistan, Dept Chem & Civil Engn, POB 66177, Sanandaj 6661836336, Kurdistan Provi, Iran.
EM Mo.zarei@alumni.um.ac.ir
RI Zarei, Mohammad/V-1359-2017
OI Zarei, Mohammad/0000-0002-6351-5058
CR Ahrberg CD, 2016, ANAL CHEM, V88, P4803, DOI 10.1021/acs.analchem.6b00278
   Amukele T, 2017, TRANSFUSION, V57, P582, DOI 10.1111/trf.13900
   Amukele TK, 2016, J CLIN MICROBIOL, V54, P2622, DOI 10.1128/JCM.01204-16
   Aronoff-Spencer E, 2016, BIOSENS BIOELECTRON, V86, P690, DOI 10.1016/j.bios.2016.07.023
   Banerjee I, 2017, RSC ADV, V7, P35048, DOI 10.1039/c7ra05209j
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Bissonnette L, 2017, EXPERT REV MOL DIAGN, V17, P471, DOI 10.1080/14737159.2017.1310619
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chin CD, 2012, LAB CHIP, V12, P2118, DOI 10.1039/c2lc21204h
   Coskun AF, 2013, LAB CHIP, V13, P4231, DOI 10.1039/c3lc50785h
   Cui XK, 2017, CHEM SCI, V8, P3628, DOI 10.1039/c6sc03720h
   Dincer C, 2017, TRENDS BIOTECHNOL, V35, P728, DOI 10.1016/j.tibtech.2017.03.013
   Dirkzwager RM, 2016, ACS SENSORS, V1, P420, DOI 10.1021/acssensors.5b00175
   Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0
   Fan Y, 2017, BIOSENS BIOELECTRON, V95, P60, DOI 10.1016/j.bios.2017.04.003
   Fraser LA, 2018, BIOSENS BIOELECTRON, V100, P591, DOI 10.1016/j.bios.2017.10.001
   Fu QQ, 2016, LAB CHIP, V16, P1927, DOI 10.1039/c6lc00083e
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Guner H, 2017, SENSOR ACTUAT B-CHEM, V239, P571, DOI 10.1016/j.snb.2016.08.061
   Guo T, 2015, LAB CHIP, V15, P3514, DOI 10.1039/c5lc00609k
   Hannan MA, 2014, BIOMED ENG ONLINE, V13, DOI 10.1186/1475-925X-13-79
   Hossain MA, 2015, OPT LETT, V40, P1737, DOI 10.1364/OL.40.001737
   Hou YH, 2018, BIOSENS BIOELECTRON, V99, P186, DOI 10.1016/j.bios.2017.07.035
   Hu J., 2017, ANAL CHEM
   Inan H, 2017, CHEM SOC REV, V46, P366, DOI 10.1039/c6cs00206d
   Jiang HQ, 2017, SLAS TECHNOL, V22, P122, DOI 10.1177/2211068216680163
   Joh DY, 2017, P NATL ACAD SCI USA, V114, pE7054, DOI 10.1073/pnas.1703200114
   Kanakasabapathy MK, 2017, LAB CHIP, V17, P2910, DOI 10.1039/c7lc00273d
   Keating SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160624
   Kim DS, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16122154
   Knowlton S, 2017, LAB CHIP, V17, P2839, DOI 10.1039/c7lc00706j
   Kosaka PM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171899
   Laksanasopin T, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0056
   Lebedev V, 2017, ORG ELECTRON, V42, P146, DOI 10.1016/j.orgel.2016.12.034
   Li J, 2016, BIOSENS BIOELECTRON, V83, P177, DOI 10.1016/j.bios.2016.04.021
   Meng X, 2017, LAB CHIP, V17, P104, DOI 10.1039/c6lc01321j
   Modali A, 2016, ELECTROANAL, V28, P1276, DOI 10.1002/elan.201600041
   Morens DM, 2004, NATURE, V430, P242, DOI 10.1038/nature02759
   Murdock RC, 2017, LAB CHIP, V17, P332, DOI 10.1039/c6lc01074a
   Navruz I, 2013, LAB CHIP, V13, P4015, DOI 10.1039/c3lc50589h
   Nayak S, 2017, ANAL CHEM, V89, P102, DOI 10.1021/acs.analchem.6b04630
   Preechaburana P, 2012, ANGEW CHEM INT EDIT, V51, P11585, DOI 10.1002/anie.201206804
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Priye A, 2016, ANAL CHEM, V88, P4651, DOI 10.1021/acs.analchem.5b04153
   Qiu XB, 2017, SENSOR ACTUAT B-CHEM, V243, P738, DOI 10.1016/j.snb.2016.12.058
   Qiu XB, 2016, SCI REP-UK, V6, DOI 10.1038/srep28274
   Roda A, 2014, ANALYST, V139, P6494, DOI 10.1039/c4an01612b
   Shu BW, 2015, LAB CHIP, V15, P2597, DOI 10.1039/c5lc00139k
   Sia SK, 2008, LAB CHIP, V8, P1982, DOI 10.1039/b817915h
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Song LW, 2015, ANAL CHEM, V87, P5173, DOI 10.1021/ac504832c
   Tur-Garcia EL, 2017, SENSOR ACTUAT B-CHEM, V242, P502, DOI 10.1016/j.snb.2016.11.040
   Turbe V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11887-6
   Urrios A, 2016, LAB CHIP, V16, P2287, DOI 10.1039/c6lc00153j
   Vashist SK, 2015, TRENDS BIOTECHNOL, V33, P692, DOI 10.1016/j.tibtech.2015.09.001
   Walsh DI, 2017, TRENDS BIOTECHNOL, V35, P383, DOI 10.1016/j.tibtech.2017.01.001
   Wei QS, 2013, ACS NANO, V7, P9147, DOI 10.1021/nn4037706
   WHO, 2016, INT GUID CLIN CAR SU
   WHO, 2017, WORLD MAL REP 2016 S
   World Health O, 2016, ZIK VIR RES AG
   World Health Organization, 2017, HIV AIDS FACT SHEET
   World Health Organization, 2017, GLOB HEP REP 2017
   Wu D, 2017, MICROFLUID NANOFLUID, V21, DOI 10.1007/s10404-017-1879-6
   Yang J, 2015, LAB CHIP, V15, P3925, DOI 10.1039/c5lc00681c
   Zarei M, 2017, BIOSENS BIOELECTRON, V98, P494, DOI 10.1016/j.bios.2017.07.024
   Zarei M, 2017, TRAC-TREND ANAL CHEM, V91, P26, DOI 10.1016/j.trac.2017.04.001
   Zhang DH, 2017, ANALYST, V142, P815, DOI [10.1039/c6an02452a, 10.1039/C6AN02452A]
   Zhang H., 2017, T MED, V9, P381
   Zhang JL, 2018, BIOSENS BIOELECTRON, V99, P312, DOI 10.1016/j.bios.2017.07.048
   Zhang L, 2017, TRAC-TREND ANAL CHEM, V94, P106, DOI 10.1016/j.trac.2017.07.013
NR 71
TC 23
Z9 25
U1 20
U2 135
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAY 30
PY 2018
VL 106
BP 193
EP 203
DI 10.1016/j.bios.2018.02.007
PG 11
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA FY9TL
UT WOS:000427209700026
PM 29428589
DA 2020-07-08
ER

PT J
AU Koblischke, M
   Stiasny, K
   Aberle, SW
   Malafa, S
   Tschouchnikas, G
   Schwaiger, J
   Kundi, M
   Heinz, FX
   Aberle, JH
AF Koblischke, Maximilian
   Stiasny, Karin
   Aberle, Stephan W.
   Malafa, Stefan
   Tschouchnikas, Georgios
   Schwaiger, Julia
   Kundi, Michael
   Heinz, Franz X.
   Aberle, Judith H.
TI Structural Influence on the Dominance of Virus-Specific CD4 T Cell
   Epitopes in Zika Virus Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Zika virus; flavivirus; CD4 T cell; immunodominance; epitope; Zika
   patients
ID BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; RESPONSES; VACCINE;
   PROTEIN; IMMUNODOMINANCE; HEMAGGLUTININ; COMPONENTS; PROSPECTS; BINDING
AB Zika virus (ZIKV) has recently caused explosive outbreaks in Pacific islands, South- and Central America. Like with other flaviviruses, protective immunity is strongly dependent on potently neutralizing antibodies (Abs) directed against the viral envelope protein E. Such Ab formation is promoted by CD4 T cells through direct interaction with B cells that present epitopes derived from E or other structural proteins of the virus. Here, we examined the extent and epitope dominance of CD4 T cell responses to capsid (C) and envelope proteins in Zika patients. All patients developed ZIKV-specific CD4 T cell responses, with substantial contributions of C and E. In both proteins, immunodominant epitopes clustered at sites that are structurally conserved among flaviviruses but have highly variable sequences, suggesting a strong impact of protein structural features on immunodominant CD4 T cell responses. Our data are particularly relevant for designing flavivirus vaccines and their evaluation in T cell assays and provide insights into the importance of viral protein structure for epitope selection and antigenicity.
C1 [Koblischke, Maximilian; Stiasny, Karin; Aberle, Stephan W.; Malafa, Stefan; Tschouchnikas, Georgios; Schwaiger, Julia; Heinz, Franz X.; Aberle, Judith H.] Med Univ Vienna, Ctr Virol, Vienna, Austria.
   [Kundi, Michael] Med Univ Vienna, Ctr Publ Hlth, Vienna, Austria.
RP Aberle, JH (corresponding author), Med Univ Vienna, Ctr Virol, Vienna, Austria.
EM judith.aberle@meduniwien.ac.at
OI Koblischke, Maximilian/0000-0003-1223-4990; Malafa,
   Stefan/0000-0002-0222-9832; Aberle, Judith H/0000-0003-1197-3935;
   Stiasny, Karin/0000-0002-1902-8674
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P29881-B30,
   P29928-B30, P27501-B21]
FX This study was funded by research grants from the Austrian Science Fund
   FWF (JA: P29881-B30; KS: P29928-B30; FH: P27501-B21).
CR Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   ARBASPAETH GB, 2016, NATURE, V539, DOI DOI 10.1038/NATURE19780
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bonsmann MSG, 2015, J IMMUNOL, V195, P4861, DOI 10.4049/jimmunol.1501377
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14
   Kim A, 2015, CURR OPIN IMMUNOL, V34, P9, DOI 10.1016/j.coi.2014.12.005
   Kim A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6369
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Koblischke M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09331-w
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Landry SJ, 2017, VIRAL IMMUNOL, V30, P479, DOI 10.1089/vim.2017.0008
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   MILICH DR, 1987, NATURE, V329, P547, DOI 10.1038/329547a0
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Ong EZ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40923
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   RUSSELL SM, 1979, NATURE, V280, P147, DOI 10.1038/280147a0
   Sadegh-Nasseri Scheherazade, 2016, F1000Res, V5, DOI 10.12688/f1000research.7664.1
   Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517
   SCHERLE PA, 1986, J EXP MED, V164, P1114, DOI 10.1084/jem.164.4.1114
   Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14
   Sercarz EE, 2003, NAT REV IMMUNOL, V3, P621, DOI 10.1038/nri1149
   Shi PY, 2014, CELL HOST MICROBE, V16, P269, DOI 10.1016/j.chom.2014.08.011
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Stiasny K, 2009, VACCINE, V27, P7021, DOI 10.1016/j.vaccine.2009.09.069
   Surman S, 2001, P NATL ACAD SCI USA, V98, P4587, DOI 10.1073/pnas.071063898
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
NR 44
TC 10
Z9 10
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 30
PY 2018
VL 9
AR 1196
DI 10.3389/fimmu.2018.01196
PG 11
WC Immunology
SC Immunology
GA GH6RW
UT WOS:000433572700001
PM 29899743
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Del Valle, SY
   McMahon, BH
   Asher, J
   Hatchett, R
   Lega, JC
   Brown, HE
   Leany, ME
   Pantazis, Y
   Roberts, DJ
   Moore, S
   Peterson, AT
   Escobar, LE
   Qiao, HJ
   Hengartner, NW
   Mukundan, H
AF Del Valle, Sara Y.
   McMahon, Benjamin H.
   Asher, Jason
   Hatchett, Richard
   Lega, Joceline C.
   Brown, Heidi E.
   Leany, Mark E.
   Pantazis, Yannis
   Roberts, David J.
   Moore, Sean
   Peterson, A. Townsend
   Escobar, Luis E.
   Qiao, Huijie
   Hengartner, Nicholas W.
   Mukundan, Harshini
TI Summary results of the 2014-2015 DARPA Chikungunya challenge
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Chikungunya; Forecasting; Morphological models; Mechanistic models
ID NICHE CENTRALITY
AB Background: Emerging pathogens such as Zika, chikungunya, Ebola, and dengue viruses are serious threats to national and global health security. Accurate forecasts of emerging epidemics and their severity are critical to minimizing subsequent mortality, morbidity, and economic loss. The recent introduction of chikungunya and Zika virus to the Americas underscores the need for better methods for disease surveillance and forecasting.
   Methods: To explore the suitability of current approaches to forecasting emerging diseases, the Defense Advanced Research Projects Agency (DARPA) launched the 2014-2015 DARPA Chikungunya Challenge to forecast the number of cases and spread of chikungunya disease in the Americas. Challenge participants (n = 38 during final evaluation) provided predictions of chikungunya epidemics across the Americas for a six-month period, from September 1, 2014 to February 16, 2015, to be evaluated by comparison with incidence data reported to the Pan American Health Organization (PAHO). This manuscript presents an overview of the challenge and a summary of the approaches used by the winners.
   Results: Participant submissions were evaluated by a team of non-competing government subject matter experts based on numerical accuracy and methodology. Although this manuscript does not include in-depth analyses of the results, cursory analyses suggest that simpler models appear to outperform more complex approaches that included, for example, demographic information and transportation dynamics, due to the reporting biases, which can be implicitly captured in statistical models. Mosquito-dynamics, population specific information, and dengue-specific information correlated best with prediction accuracy.
   Conclusion: We conclude that with careful consideration and understanding of the relative advantages and disadvantages of particular methods, implementation of an effective prediction system is feasible. However, there is a need to improve the quality of the data in order to more accurately predict the course of epidemics.
C1 [Del Valle, Sara Y.; Hengartner, Nicholas W.] Los Alamos Natl Lab, Analyt Intelligence & Technol Div, POB 1663,Bikini Atoll Rd, Los Alamos, NM 87544 USA.
   [McMahon, Benjamin H.] Los Alamos Natl Lab, Theoret Div, POB 1663,Bikini Atoll Rd, Los Alamos, NM 87544 USA.
   [Asher, Jason] Leidos Supporting Biomed Adv Res & Dev Author, 200 Independence Ave SW, Washington, DC 20201 USA.
   [Hatchett, Richard] US Dept Hlth & Human Serv, Off Assistant Secretary Preparedness & Response, 200 Independence Ave SW, Washington, DC 20201 USA.
   [Lega, Joceline C.] Univ Arizona, Dept Math, 617 N Santa Rita Ave, Tucson, AZ 85721 USA.
   [Brown, Heidi E.] Univ Arizona, Epidemiol & Biostat Dept, 1295 N Martin Ave, Tucson, AZ 85724 USA.
   [Leany, Mark E.] Utah Valley Univ, 800 W Univ Pkwy, Orem, UT 84058 USA.
   [Pantazis, Yannis] Univ Massachusetts, Dept Math & Stat, 710 N Pleasant St, Amherst, MA 01003 USA.
   [Pantazis, Yannis] Fdn Res & Technol Hellas, Inst Appl & Computat Math, Iraklion, Greece.
   [Roberts, David J.] John Radcliffe Hosp, BRC Haematol Theme, NHS Blood & Transplant Oxford, Headley Way, Oxford OX3 9BQ, England.
   [Roberts, David J.] John Radcliffe Hosp, Radcliffe Dept Med, Headley Way, Oxford OX3 9BQ, England.
   [Moore, Sean] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Peterson, A. Townsend] Univ Kansas, Biodivers Inst, 1345 Jayhawk Blvd, Lawrence, KS 66045 USA.
   [Escobar, Luis E.] Virginia Tech, Dept Fish & Wildlife Conservat, Blacksburg, VA 24061 USA.
   [Qiao, Huijie] Chinese Acad Sci, Inst Zool, 1 Beichen West Rd, Beijing 100101, Peoples R China.
   [Mukundan, Harshini] Los Alamos Natl Lab, Chem Div, POB 1663,Bikini Atoll Rd, Los Alamos, NM 87544 USA.
RP Del Valle, SY (corresponding author), Los Alamos Natl Lab, Analyt Intelligence & Technol Div, POB 1663,Bikini Atoll Rd, Los Alamos, NM 87544 USA.
EM sdelvall@lanl.gov
OI Escobar, Luis E./0000-0001-5735-2750; Brown, Heidi/0000-0001-8578-5510;
   Lega, Joceline/0000-0003-2064-229X
FU DARPAUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA); Department of EnergyUnited States Department of
   Energy (DOE) [DE-AC52-06NA25396]
FX The LANL authors would like to thank DARPA for supporting the analysis
   of the Challenge, as well as for providing administrative assistance
   during the DARPA Chikungunya Challenge workshop. The challenge and the
   independent analysis performed by LANL were supported by DARPA. LANL is
   operated by Los Alamos National Security, LLC for the Department of
   Energy under contract DE-AC52-06NA25396.
CR ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0
   ANDERSON RM, 1991, NATURE, V352, P581, DOI 10.1038/352581a0
   Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8
   Biggerstaff M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1669-x
   Brooks LC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004382
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   CDC, EP PRED IN
   Center for Disease Control and Prevention, EP PRED IN
   Chan J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001005
   Chretien JP, 2015, ELIFE, V4, DOI 10.7554/eLife.09186
   Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013
   DARPA, DARPA FOR CHIK CHALL
   Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892
   Hamer WH, 1906, LANCET, V167, P665
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Holt RD, 2009, P NATL ACAD SCI USA, V106, P19659, DOI 10.1073/pnas.0905137106
   Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103
   Keeling M. J., 2008, MODELING INFECT DIS
   Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118
   Kucharski AJ, 2016, EMERG INFECT DIS, V22, P105, DOI 10.3201/eid2201.151410
   Lega J, 2016, EPIDEMICS-NETH, V17, P19, DOI 10.1016/j.epidem.2016.10.002
   Lira-Noriega A, 2014, EVOLUTION, V68, P1082, DOI 10.1111/evo.12343
   Manthey JD, 2015, ENDANGER SPECIES RES, V26, P201, DOI 10.3354/esr00646
   Martinez-Meyer E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.0637
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Moghadas SM, 2009, INFLUENZA OTHER RESP, V3, P75, DOI 10.1111/j.1750-2659.2009.00081.x
   Moran KR, 2016, J INFECT DIS, V214, pS404, DOI 10.1093/infdis/jiw375
   Pan American Health Organization (PAHO), CHIK INC DAT
   Pan American Health Organization (PAHO), CHIK
   Qiao HJ, 2016, ECOGRAPHY, V39, P805, DOI 10.1111/ecog.01961
   Romero-Alvarez D, 2017, REV CHIL INFECTOL, V34, P289, DOI 10.4067/S0716-10182017000300015
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Tarantola A, 1987, INVERSE PROBLEM THEO
   Tizzoni M, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-165
   Van Aelst S, 2009, WIRES COMPUT STAT, V1, DOI 10.1002/wics.19
   W.H.O, CHIK
   White House, NAT STRAT BIOS
   *WHO, GLOB DAT
   World Health Organization (WHO), EM PREP RESP CHIK FR
   Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
   Yanez-Arenas C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100957
NR 45
TC 7
Z9 7
U1 1
U2 8
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 30
PY 2018
VL 18
AR 245
DI 10.1186/s12879-018-3124-7
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA GI0LI
UT WOS:000434061100002
PM 29843621
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Robinson, CL
   Chong, ACN
   Ashbrook, AW
   Jeng, G
   Jin, JL
   Chen, HQ
   Tang, EI
   Martin, LA
   Kim, RS
   Kenyon, RM
   Do, E
   Luna, JM
   Saeed, M
   Zeltser, L
   Ralph, H
   Dudley, VL
   Goldstein, M
   Rice, CM
   Cheng, CY
   Seandel, M
   Chen, SB
AF Robinson, Christopher L.
   Chong, Angie C. N.
   Ashbrook, Alison W.
   Jeng, Ginnie
   Jin, Julia
   Chen, Haiqi
   Tang, Elizabeth I.
   Martin, Laura A.
   Kim, Rosa S.
   Kenyon, Reyn M.
   Do, Eileen
   Luna, Joseph M.
   Saeed, Mohsan
   Zeltser, Lori
   Ralph, Harold
   Dudley, Vanessa L.
   Goldstein, Marc
   Rice, Charles M.
   Cheng, C. Yan
   Seandel, Marco
   Chen, Shuibing
TI Male germ cells support long-term propagation of Zika virus
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SMALL-MOLECULE INHIBITORS; NEURAL PROGENITORS; STEM-CELLS; IN-VITRO;
   INFECTION; REPLICATION; DRUG; DISCOVERY; SCREEN; MICE
AB Evidence of male-to-female sexual transmission of Zika virus (ZIKV) and viral RNA in semen and sperm months after infection supports a potential role for testicular cells in ZIKV propagation. Here, we demonstrate that germ cells (GCs) are most susceptible to ZIKV. We found that only GCs infected by ZIKV, but not those infected by dengue virus and yellow fever virus, produce high levels of infectious virus. This observation coincides with decreased expression of interferon-stimulated gene Ifi44l in ZIKV-infected GCs, and overexpression of Ifi44l results in reduced ZIKV production. Using primary human testicular tissue, we demonstrate that human GCs are also permissive for ZIKV infection and production. Finally, we identified berberine chloride as a potent inhibitor of ZIKV infection in both murine and human testes. Together, these studies identify a potential cellular source for propagation of ZIKV in testes and a candidate drug for preventing sexual transmission of ZIKV.
C1 [Robinson, Christopher L.; Chong, Angie C. N.; Jeng, Ginnie; Jin, Julia; Martin, Laura A.; Kenyon, Reyn M.; Do, Eileen; Seandel, Marco] Weill Cornell Med Coll, Dept Surg, 1300 York Ave, New York, NY 10065 USA.
   [Ashbrook, Alison W.; Luna, Joseph M.; Saeed, Mohsan; Rice, Charles M.] Rockefeller Univ, Ctr Study Hepatitis C, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Chen, Haiqi; Tang, Elizabeth I.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.
   [Kim, Rosa S.] Penn State Coll Med, Hershey, PA 17033 USA.
   [Zeltser, Lori] Columbia Univ, Naomi Berrie Diabet Ctr, New York, NY 10032 USA.
   [Zeltser, Lori] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA.
   [Ralph, Harold] Weill Cornell Med Coll, Microscopy & Image Anal Core Facil, 1300 York Ave, New York, NY 10065 USA.
   [Dudley, Vanessa L.] New York Presbyterian Hosp, Weill Cornell Med, Inst Reprod Med Weill Cornell Med, New York, NY 10065 USA.
   [Goldstein, Marc] Cornell Univ, Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA.
   [Goldstein, Marc] Cornell Univ, Weill Cornell Med Coll, Inst Reprod Med, New York, NY 10065 USA.
   [Chen, Shuibing] Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.
RP Seandel, M (corresponding author), Weill Cornell Med Coll, Dept Surg, 1300 York Ave, New York, NY 10065 USA.; Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.; Chen, SB (corresponding author), Weill Cornell Med Coll, Dept Biochem, 1300 York Ave, New York, NY 10065 USA.
EM y-Cheng@popcbr.rockefeller.edu; mas9066@med.cornell.edu;
   shc2034@med.cornell.edu
RI Chen, Haiqi/J-7468-2019
OI Chen, Haiqi/0000-0001-7179-3229; Jeng, Ginnie/0000-0003-4341-2489;
   Cheng, C Yan/0000-0003-3117-3791; Ashbrook, Alison/0000-0003-1114-1426
FU New York Stem Cell Foundation [R-103]; Center for Advanced Digestive
   Care of New York Presbyterian Hospital; National Institute of General
   Medical Sciences of the National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [T32GM007739]; National Institute of Diabetes and Digestive and Kidney
   Diseases of the National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [DP2DK098093]; Eunice Kennedy Shriver National Institute of Child Health
   and Human Development of National Institutes of Health
   [1DP2HD080352-01]; New York State Stem Cell Science Board [C029156];
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   Eunice Kennedy Shriver National Institute of Child Health & Human
   Development (NICHD) [R01 HD056034]
FX S.C., a New York Stem Cell Foundation-Robertson Investigator, is funded
   by The New York Stem Cell Foundation (R-103), and a pilot award from the
   Center for Advanced Digestive Care of New York Presbyterian Hospital.
   C.L.R. is funded by the National Institute of General Medical Sciences
   of the National Institutes of Health under Award Number T32GM007739 and
   the National Institute of Diabetes and Digestive and Kidney Diseases of
   the National Institutes of Health under Award Number DP2DK098093. M.S.
   is supported by a grant from the Eunice Kennedy Shriver National
   Institute of Child Health and Human Development of National Institutes
   of Health (1DP2HD080352-01) and a grant from the New York State Stem
   Cell Science Board (C029156). C.Y.C. is supported by a grant from the
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development of the National Institutes of Health (R01 HD056034). L.A.M.
   is a New York Stem Cell Foundation-Druckenmiller Fellow. Generous
   donations to the Rockefeller University support ZIKV work of J.M.L.,
   A.W.A., and C.M.R. We would like to thank Peter Marzuk, Eva Robinson,
   Jordan Robinson, and Jason Hoo-Fatt for assistance and support.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Bergqvist M, 2017, ACTA ONCOL, V56, P441, DOI 10.1080/0284186X.2016.1253866
   Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Di Persio S, 2017, DEVELOPMENT, V144, P3430, DOI 10.1242/dev.150284
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fischer MA, 2013, J VIROL, V87, P9411, DOI 10.1128/JVI.00101-13
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lindqvist R, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0748-7
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Martin LA, 2014, STEM CELL REP, V3, P219, DOI 10.1016/j.stemcr.2014.06.007
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Okimoto RA, 2015, LUNG CANCER-TARGETS, V6, P27, DOI 10.2147/LCTT.S60438
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22
   Rocchietti-March M, 2000, INT J ANDROL, V23, P51, DOI 10.1046/j.1365-2605.2000.00207.x
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Varghese FS, 2016, J VIROL, V90, P9743, DOI 10.1128/JVI.01382-16
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wen SQ, 2016, BIOORG MED CHEM LETT, V26, P2768, DOI 10.1016/j.bmcl.2016.04.070
   Wu H, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00117
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zhou L, 2016, ONCOGENE, V35, P2687, DOI 10.1038/onc.2015.343
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 47
TC 17
Z9 18
U1 0
U2 10
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 29
PY 2018
VL 9
AR 2090
DI 10.1038/s41467-018-04444-w
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH3JE
UT WOS:000433297900001
PM 29844387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martins, P
   Machado, D
   Theizen, TH
   Guarnieri, JPO
   Bernardes, BG
   Gomide, GP
   Corat, MAF
   Abbehausen, C
   Modena, JLP
   Melo, CFOR
   Morishita, KN
   Catharino, RR
   Arns, CW
   Lancellotti, M
AF Martins, Paula
   Machado, Daisy
   Theizen, Thais Holtz
   Oliveira Guarnieri, Joao Paulo
   Bernardes, Bruno Gaia
   Gomide, Gabriel Piccirillo
   Finzi Corat, Marcus Alexandre
   Abbehausen, Camilla
   Proenca Modena, Jose Luiz
   Odir Rodrigues Melo, Carlos Fernando
   Morishita, Karen Noda
   Catharino, Rodrigo Ramos
   Arns, Clarice Weis
   Lancellotti, Marcelo
TI Outer Membrane Vesicles from Neisseria Meningitidis (Proteossome) Used
   for Nanostructured Zika Virus Vaccine Production
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PSEUDOMONAS-AERUGINOSA; RESISTANCE; INFECTION; EPIDEMIC; BACTERIA;
   SPREAD
AB The increase of Zika virus (ZIKV) infections in Brazil in the last two years leaves a prophylactic measures on alert for this new and emerging pathogen. Concerning of our positive experience, we developed a new prototype using Neisseria meningitidis outer membrane vesicles (OMV) on ZIKV cell growth in a fusion of OMV in the envelope of virus particles. The fusion of nanoparticles resulting from outer membrane vesicles of N. meningitidis with infected C6/36 cells line were analyzed by Nano tracking analysis (NTA), zeta potential, differential light scattering (DLS), scan and scanning transmission eletronic microscopy (SEM and STEM) and high resolution mass spectometry (HRMS) for nanostructure characterization. Also, the vaccination effects were viewed by immune response in mice protocols immunization (ELISA and inflammatory chemokines) confirmed by Zika virus soroneutralization test. The results of immunizations in mice showed that antibody production had a titer greater than 1: 160 as compared to unvaccinated mice. The immune response of the adjuvant and non-adjuvant formulation activated the cellular immune response TH1 and TH2. In addition, the serum neutralization was able to prevent infection of virus particles in the glial tumor cell model (M059J). This research shows efficient strategies without recombinant technology or DNA vaccines.
C1 [Martins, Paula; Oliveira Guarnieri, Joao Paulo; Bernardes, Bruno Gaia; Gomide, Gabriel Piccirillo; Lancellotti, Marcelo] Univ Campinas UNICAMP, Fac Pharmaceut Sci FCF, Campinas, SP, Brazil.
   [Machado, Daisy; Theizen, Thais Holtz; Lancellotti, Marcelo] Univ Campinas UNICAMP, Inst Biol, Biochem & Tissue Biol Dept, Biotechnol Lab,LABIOTEC, Campinas, SP, Brazil.
   [Finzi Corat, Marcus Alexandre] Univ Estadual Campinas, Multidisciplinary Ctr Biol Res, Campinas, SP, Brazil.
   [Proenca Modena, Jose Luiz; Arns, Clarice Weis] Univ Campinas UNICAMP, Inst Biol, Genet Mol Biol & Bioagents Dept, Campinas, SP, Brazil.
   [Abbehausen, Camilla] Univ Campinas UNICAMP, Inst Chem, Inorgan Dept, Campinas, SP, Brazil.
   [Odir Rodrigues Melo, Carlos Fernando; Morishita, Karen Noda; Catharino, Rodrigo Ramos] Univ Campinas UNICAMP, Fac Pharmaceut Sci FCF, INNOVARE Biomarkers Lab, Campinas, SP, Brazil.
RP Lancellotti, M (corresponding author), Univ Campinas UNICAMP, Fac Pharmaceut Sci FCF, Campinas, SP, Brazil.; Lancellotti, M (corresponding author), Univ Campinas UNICAMP, Inst Biol, Biochem & Tissue Biol Dept, Biotechnol Lab,LABIOTEC, Campinas, SP, Brazil.
EM marcelo.lancellotti@fcf.unicamp.br
RI Abbehausen, Camilla/X-9527-2019; Abbehausen, Camilla/AAA-7975-2019;
   Modena, Jose Luiz Proenca/C-8231-2014; Corat, Marcus/AAH-2882-2020;
   Abbehausen, Camilla/AAD-3050-2020; Machado, Daisy/A-4891-2013
OI Modena, Jose Luiz Proenca/0000-0002-4996-3153; Abbehausen,
   Camilla/0000-0002-8410-2252; Machado, Daisy/0000-0002-6435-6159; Melo,
   Carlos/0000-0003-0334-1065
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2014/14457-5, 2016/17066-2, 2017/12719-0]
FX Thanks for Beatriz Jacyntho Siqueira, Prof. Dr. Daniel F. Kawano for the
   moral support for develop this article. Special acknowledgements for
   Prof. Dr. Glaucia Maria Pastore from the initiative for ZIKA Task Force
   in UNICAMP. Thanks for Prof. Dr. Eneida de Paula for use of NTA
   equipment (FAPESP 2014/14457-5), Carlos Fernando Odir Rodrigues de Melo
   (fellowship FAPESP 2016/17066-2), Prof. Dr. Camila Abbehausen in the
   acquisition and STEM images interpretation (FAPESP 2017/12719-0).
   Special thanks for the technician Hugo Campos Loureiro for disponibility
   in perfomed in short time the electronic microscopy images.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Collins B. S., 2016, DISCOV MED, V12, P7
   da Silva SR, 2016, J MED VIROL, V88, P1657, DOI 10.1002/jmv.24582
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Ferreiros C M, 1991, FEMS Microbiol Lett, V67, P123
   Furuta N, 2009, INFECT IMMUN, V77, P4761, DOI 10.1128/IAI.00841-09
   GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987
   Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071
   Jung R, 2000, CLIN CHEM LAB MED, V38, P833, DOI 10.1515/CCLM.2000.120
   Kadurugamuwa JL, 1996, J BACTERIOL, V178, P2767, DOI 10.1128/jb.178.10.2767-2774.1996
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843
   Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lappann M, 2013, J BACTERIOL, V195, P4425, DOI 10.1128/JB.00625-13
   Lappann M, 2013, MOL MICROBIOL, V89, P433, DOI 10.1111/mmi.12288
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Mashburn-Warren L, 2008, GEOBIOLOGY, V6, P214, DOI 10.1111/j.1472-4669.2008.00157.x
   Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x
   MAYRAND D, 1989, CAN J MICROBIOL, V35, P607, DOI 10.1139/m89-097
   McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x
   McCaig WD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149132
   McCaig WD, 2013, J BACTERIOL, V195, P1120, DOI 10.1128/JB.02007-12
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nagaputra JC, 2014, CLIN VACCINE IMMUNOL, V21, P234, DOI 10.1128/CVI.00561-13
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   PARSONS NJ, 1985, J GEN MICROBIOL, V131, P601
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Renelli M, 2004, MICROBIOL-SGM, V150, P2161, DOI 10.1099/mic.0.26841-0
   Sahiner F, 2016, MIKROBIYOL BUL, V50, P333, DOI 10.5578/mb.24167
   Schooling SR, 2006, J BACTERIOL, V188, P5945, DOI 10.1128/JB.00257-06
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   THOMPSON BG, 1981, CAN J MICROBIOL, V27, P729, DOI 10.1139/m81-111
   van der Pol L, 2015, BIOTECHNOL J, V10, P1689, DOI 10.1002/biot.201400395
   Virginio VG, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2016.e00225
   Warner JM, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.178101
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J., 2016, J VIROL, V91
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Xia J., 2016, CURRENT PROTOCOLS BI, V14, P91
   Zollinger WD, 1997, INFECT IMMUN, V65, P1053, DOI 10.1128/IAI.65.3.1053-1060.1997
NR 47
TC 4
Z9 4
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 29
PY 2018
VL 8
AR 8290
DI 10.1038/s41598-018-26508-z
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GH3GQ
UT WOS:000433290900021
PM 29844457
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Manangeeswaran, M
   Kielczewski, JL
   Sen, HN
   Xu, BYC
   Ireland, DDC
   McWilliams, IL
   Chan, CC
   Caspi, RR
   Verthelyi, D
AF Manangeeswaran, Mohanraj
   Kielczewski, Jennifer L.
   Sen, H. Nida
   Xu, Biying C.
   Ireland, Derek. D. C.
   McWilliams, Ian L.
   Chan, Chi-Chao
   Caspi, Rachel R.
   Verthelyi, Daniela
TI ZIKA virus infection causes persistent chorioretinal lesions
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID EYE; UVEITIS; DISEASE; MOUSE; CELLS; MODEL; GENE; MICE
AB Zika-infected patients can have eye involvement ranging from mild conjunctivitis to severe chorioretinal lesions, however the possible long-term sequelae of infection and timeline to recovery remain unknown. Here we describe the partial recovery of chorioretinal lesions in an immunocompetent patient diagnosed with bilateral posterior uveitis associated with Zika infection and show that some lesions resolved with focal atrophy evident as pigmentary changes on funduscopy. To better understand the progression of the lesions and correlate the changes in fundus imaging with local viral load, immune responses, and retinal damage, we developed a symptomatic mouse model of ocular Zika virus infection. Imaging of the fundus revealed multiple hypopigmentary patches indicative of chorioretinal degeneration as well as thinning of the retina that mirror the lesions in patients. Microscopically, the virus primarily infected the optic nerve, retinal ganglion cells, and inner nuclear layer cells, showing thinning of the outer plexiform layer. During acute infection, the eyes showed retinal layer disorganization, retinitis, vitritis, and focal choroiditis, with mild cellular infiltration and increased expression of tumor necrosis factor, interferon-gamma, granzyme B, and perforin. Focal areas of gliosis and retinal degeneration persisted 60 dpi. The model recapitulates features of ZIKA infections in patients and should help elucidate the mechanisms underlying the damage to the eyes and aid in the development of effective therapeutics.
C1 [Manangeeswaran, Mohanraj; Ireland, Derek. D. C.; McWilliams, Ian L.; Verthelyi, Daniela] Food & Drug Adm, Ctr Drug Evaluat & Res, Div Biotechnol Review & Research 3, Off Biotechnol Prod, Silver Spring, MD 20993 USA.
   [Kielczewski, Jennifer L.; Sen, H. Nida; Xu, Biying C.; Chan, Chi-Chao; Caspi, Rachel R.] NEI, Lab Immunol, NIH, Bethesda, MD 20892 USA.
RP Verthelyi, D (corresponding author), Food & Drug Adm, Ctr Drug Evaluat & Res, Div Biotechnol Review & Research 3, Off Biotechnol Prod, Silver Spring, MD 20993 USA.
EM daniela.verthelyi@fda.hhs.gov
OI Caspi, Rachel/0000-0002-7140-7671; Chan, Chi-Chao/0000-0001-9460-8049
FU Oak Ridge Institute for Science and Education; FDA's Office of
   Counter-terrorism and Emergency Coordination; CDER's critical Path
FX We wish to thank Jill Ascher, Mary Belcher, and the personnel of the
   animal facility for care of the mice. We thank Anthony St Leger for help
   with collecting the lacrimal glands and Leia Novak for providing
   tissues. We thank Mercedes Campos, NEI histology core for help with
   histology imaging. We also thank Maria Rios for providing the virus and
   help with developing the real-time PCR for ZIKV. We thank Maiu
   Romano-Verthelyi for technical help. In addition, we thank Ethan Cohen,
   Estella Jones, Christian Sauder, Dino Feigelstock, and Amy Rosenberg for
   useful discussions and reviewing the manuscript. This study was
   supported in part by a Senior Postgraduate Research Fellowship Award to
   L.N. and I.M. from the Oak Ridge Institute for Science and Education
   through an interagency agreement between the US Department of Energy and
   the US Food and Drug Administration. At last, this work was supported by
   grants funded by the FDA's Office of Counter-terrorism and Emergency
   Coordination and CDER's critical Path.
CR Agrawal R, 2018, OCUL IMMUNOL INFLAMM, V26, P654, DOI 10.1080/09273948.2017.1294184
   Chen JC, 2007, INVEST OPHTH VIS SCI, V48, P2799, DOI 10.1167/iovs.06-0922
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Henry CR, 2017, JAMA OPHTHALMOL, V135, P386, DOI 10.1001/jamaophthalmol.2017.0098
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jampol LM, 2015, JAMA OPHTHALMOL, V133, P1105, DOI 10.1001/jamaophthalmol.2015.2400
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee JH, 2017, SURV OPHTHALMOL, V62, P404, DOI 10.1016/j.survophthal.2016.12.008
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662
   Mets MB, 2008, SURV OPHTHALMOL, V53, P95, DOI 10.1016/j.survophthal.2007.12.003
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miner Jonathan J., 2016, CELL REP, V135, P386
   Murphy D, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006256
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Perez VL, 2015, TRENDS IMMUNOL, V36, P354, DOI 10.1016/j.it.2015.04.003
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Taylor AW, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00037
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Zinkernagel MS, 2012, IMMUNOL CELL BIOL, V90, P330, DOI 10.1038/icb.2011.43
NR 36
TC 14
Z9 14
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAY 25
PY 2018
VL 7
AR 96
DI 10.1038/s41426-018-0096-z
PG 15
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GI4OO
UT WOS:000434351300002
PM 29802245
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nikolay, A
   Castilho, LR
   Reichl, U
   Genzel, Y
AF Nikolay, Alexander
   Castilho, Leda R.
   Reichl, Udo
   Genzel, Yvonne
TI Propagation of Brazilian Zika virus strains in static and suspension
   cultures using Vero and BHK cells
SO VACCINE
LA English
DT Article; Proceedings Paper
CT 6th Conference of Vaccine Technology
CY JUN, 2016
CL Albufeira, PORTUGAL
DE Brazilian Zika virus; BHK-21 Suspension cell line; High cell density;
   Perfusion process; Process intensification
ID RABIES VACCINE
AB The recent spread of Zika virus (ZIKV) in the Americas and the Pacific has reached alarming levels in more than 60 countries. However, relatively little is known about the disease on a virological and epidemiological level and its consequences for humans. Accordingly, a large demand for in vitro derived Brazilian ZIKV material to support in vitro and in vivo studies has arisen. However, a prompt supply of ZIKV and ZIKV antigens cannot be guaranteed as the production of this virus typically using Vero or C6/36 cell lines remains challenging.
   Here we present a production platform based on BHK-21 suspension (BHK-21(sus)) cells to propagate Brazilian ZIKV at larger quantities in perfusion bioreactors. Scouting experiments performed in tissue culture flasks using adherent BHK-21 and Vero cells have demonstrated similar permissivity and virus yields for four different Brazilian ZIKV isolates. The cell-specific yield of infectious virus particles varied between respective virus strains (1-48 PFU/cell), and the ZIKV isolate from the Brazilian state Pernambuco (ZIKV(PE)) showed to be a best performing isolate for both cell lines. However, infection studies of BHK-21sus cells with ZIKVPE in shake flasks resulted in poor virus replication, with a maximum titer of 8.9 x 10(3) PFU/mL. Additional RT-qPCR measurements of intracellular and extracellular viral RNA levels revealed high viral copy numbers within the cell, but poor virus release. Subsequent cultivation in a perfusion bioreactor using an alternating tangential flow filtration system (ATF) under controlled process conditions enabled cell concentrations of about 1.2 x 10(7) cells/mI, and virus titers of 3.9 x 10(7) PFU/mL. However, while the total number of infectious virus particles was increased, the cell-specific yield (3.3 PFU/cell) remained lower than determined in adherent cell lines. Nevertheless, the established perfusion process allows to provide large amounts of ZIKV material for research and is a first step towards process development for manufacturing inactivated or live-attenuated ZIKV vaccines. (C) 2017 The Author(s). Published by Elsevier Ltd.
C1 [Nikolay, Alexander; Reichl, Udo; Genzel, Yvonne] Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
   [Castilho, Leda R.] Univ Fed Rio de Janeiro, COPPE, Cell Culture Engn Lab, Cx Postal 68502, BR-21941972 Rio De Janeiro, RJ, Brazil.
   [Reichl, Udo] Otto von Guericke Univ, Bioproc Engn, Univ Pl 2, D-39106 Magdeburg, Germany.
RP Nikolay, A (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Bioproc Engn, Sandtorstr 1, D-39106 Magdeburg, Germany.
EM nikolay@mpi-magdeburg.mpg.de; leda@peq.coppe.ufrj.br;
   ureichl@mpi-magdeburg.mpg.de; genzel@mpi-magdeburg.mpg.de
OI Nikolay, Alexander/0000-0003-4475-9556
FU Brazilian funding agency CNPqNational Council for Scientific and
   Technological Development (CNPq); Brazilian funding agency CAPESCAPES;
   Brazilian funding agency FAPERJCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ)
FX Financial support from the Brazilian funding agencies CNPq, CAPES and
   FAPERJ are gratefully acknowledged.
CR Bae HG, 2003, J VIROL METHODS, V110, P185, DOI 10.1016/S0166-0934(03)00129-0
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frensing T, 2016, APPL MICROBIOL BIOT, V100, P7181, DOI 10.1007/s00253-016-7542-4
   Gallo-Ramirez LE, 2015, EXPERT REV VACCINES, V14, P1181, DOI 10.1586/14760584.2015.1067144
   Genzel Y, 2014, VACCINE, V32, P2770, DOI 10.1016/j.vaccine.2014.02.016
   Hierholzer J. C., 1996, P25, DOI 10.1016/B978-012465330-6/50003-8
   Janis A. M., 2016, EMERG INFECT DIS J, V22
   Kindhauser MK, 2016, B WHO
   Lalosevic D, 2008, DEV BIOLOGICALS, V131, P421
   Lalosevic D, 1998, Med Pregl, V51 Suppl 1, P17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   O'Doherty U, 2000, J VIROL, V74, P10074, DOI 10.1128/JVI.74.21.10074-10080.2000
   PAY TWF, 1985, DEV BIOL STAND, V60, P171
   RADLETT PJ, 1985, DEV BIOL STAND, V60, P163
   REID LM, 1979, J GEN VIROL, V42, P609, DOI 10.1099/0022-1317-42-3-609
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   WHO, 2013, WHO TECHN REP SER
   WHO, 2016, ON YEAR ZIK OUTBR OB
NR 21
TC 9
Z9 9
U1 1
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 24
PY 2018
VL 36
IS 22
SI SI
BP 3140
EP 3145
DI 10.1016/j.vaccine.2017.03.018
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA GH7QD
UT WOS:000433647600010
PM 28343780
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bautista, LE
   Herrera, VM
AF Bautista, Leonelo E.
   Herrera, Victor M.
TI An assessment of public health surveillance of Zika virus infection and
   potentially associated outcomes in Latin America
SO BMC PUBLIC HEALTH
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; CARPAL-TUNNEL SYNDROME; HEAD CIRCUMFERENCE;
   UNITED-STATES; BELLS-PALSY; MINNESOTA; ROCHESTER; EPIDEMIOLOGY;
   POPULATION; AGE
AB Background: We evaluated whether outbreaks of Zika virus (ZIKV) infection, newborn microcephaly, and Guillain-Barre syndrome (GBS) in Latin America may be detected through current surveillance systems, and how cases detected through surveillance may increase health care burden.
   Methods: We estimated the sensitivity and specificity of surveillance case definitions using published data. We assumed a 10% ZIKV infection risk during a non-outbreak period and hypothetical increases in risk during an outbreak period. We used sensitivity and specificity estimates to correct for non-differential misclassification, and calculated a misclassification-corrected relative risk comparing both periods. To identify the smallest hypothetical increase in risk resulting in a detectable outbreak we compared the misclassification-corrected relative risk to the relative risk corresponding to the upper limit of the endemic channel (mean + 2 SD). We also estimated the proportion of false positive cases detected during the outbreak. We followed the same approach for microcephaly and GBS, but assumed the risk of ZIKV infection doubled during the outbreak, and ZIKV infection increased the risk of both diseases.
   Results: ZIKV infection outbreaks were not detectable through non-serological surveillance. Outbreaks were detectable through serologic surveillance if infection risk increased by at least 10%, but more than 50% of all cases were false positive. Outbreaks of severe microcephaly were detected if ZIKV infection increased prevalence of this condition by at least 24.0 times. When ZIKV infection did not increase the prevalence of severe microcephaly, 34.7 to 82.5% of all cases were false positive, depending on diagnostic accuracy. GBS outbreaks were detected if ZIKV infection increased the GBS risk by at least seven times. For optimal GBS diagnosis accuracy, the proportion of false positive cases ranged from 29 to 54% and from 45 to 56% depending on the incidence of GBS mimics.
   Conclusions: Current surveillance systems have a low probability of detecting outbreaks of ZIKV infection, severe microcephaly, and GBS, and could result in significant increases in health care burden, due to the detection of large numbers of false positive cases. In view of these limitations, Latin American countries should consider alternative options for surveillance.
C1 [Bautista, Leonelo E.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut St,WARF 703, Madison, WI 53726 USA.
   [Herrera, Victor M.] Univ Autonoma Bucaramanga, Ctr Biomed Res, Bucaramanga, Colombia.
RP Bautista, LE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, 610 Walnut St,WARF 703, Madison, WI 53726 USA.
EM lebautista@wisc.edu
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   [Anonymous], 1978, Ann Neurol, V3, P565
   [Anonymous], 2012, MSMR, V19, P8
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Badurdeen S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-607
   Baldereschi M, 2007, NEUROLOGY, V68, P1460, DOI 10.1212/01.wnl.0000260606.36443.29
   Bautista LE, 2017, J PUBLIC HLTH EM JUL, V2017
   Bautista LE, 2017, ANN EPIDEMI IN PRESS
   Bautista LE, 2016, LANCET, V387, P2599, DOI 10.1016/S0140-6736(16)30844-3
   BEGHI E, 1985, ANN NEUROL, V18, P320, DOI 10.1002/ana.410180308
   BHUSHAN V, 1991, J CLIN EPIDEMIOL, V44, P1027, DOI 10.1016/0895-4356(91)90004-S
   BRANDENBURG NA, 1993, NEUROEPIDEMIOLOGY, V12, P313, DOI 10.1159/000110333
   Branswell H., ZIKA VIRUS SPREADING
   Brenner H, 1997, STAT MED, V16, P981, DOI 10.1002/(SICI)1097-0258(19970515)16:9<981::AID-SIM510>3.0.CO;2-N
   Broemeling L. D., 2007, BAYESIAN BIOSTATISTI
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castilla EE, 2004, COMMUNITY GENET, V7, P76, DOI 10.1159/000080776
   Choe YJ, 2011, VACCINE, V29, P2066, DOI 10.1016/j.vaccine.2011.01.007
   CHUMLEA WC, 1990, AM J CLIN NUTR, V51, pS902
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   DEKROM MCTFM, 1992, J CLIN EPIDEMIOL, V45, P373, DOI 10.1016/0895-4356(92)90038-O
   Dieleman J, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d3908
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Esposito S, 2016, AUTOIMMUNREV
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Gale CR, 2004, BRAIN, V127, P321, DOI 10.1093/brain/awh034
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hughes RAC, 1997, J INFECT DIS, V176, pS92, DOI 10.1086/513793
   Imdad A, 2013, J PEDIATR-US, V162, pS107, DOI 10.1016/j.jpeds.2012.11.060
   Islam MB, 2016, J PERIPHER NERV SYST, V21, P345, DOI 10.1111/jns.12189
   KATUSIC SK, 1986, ANN NEUROL, V20, P622, DOI 10.1002/ana.410200511
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lash T.L., 2009, APPL QUANTITATIVE BI, P79
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Levin KH, 2004, NEUROLOGIST, V10, P61, DOI 10.1097/01.nrl.0000117821.35196.0b
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lorenz JM, 2009, J DEV BEHAV PEDIATR, V30, P535, DOI 10.1097/DBP.0b013e3181c35ee4
   Malhotra VM, 2016, LANCET, V388, P561, DOI 10.1016/S0140-6736(16)31214-4
   Martnez MLO, PROTOCOLO VIGILANCIA
   Mattos SD, 2015, B WORLD HEALTH ORGAN, V93, P881, DOI 10.2471/BLT.14.148874
   Mighell AS, 2009, PRENATAL DIAG, V29, P442, DOI 10.1002/pd.2245
   Ministerio de Salud P, 2016, GUIA AT EMB REC NAC
   Ministerio de Salud Publica y Asistencia S, 2016, GUIA VIG MAN INF VIR
   Murakami S, 1996, ANN INTERN MED, V124, P27, DOI 10.7326/0003-4819-124-1_Part_1-199601010-00005
   Nickerson JP, 2012, J NEUROIMAGING, V22, pe52, DOI 10.1111/j.1552-6569.2011.00699.x
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   OKUNO Y, 1983, BIKEN J, V26, P161
   Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464
   Pan American Health O, 2016, GUID ZIK VIR DIS COM
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   PEPE MS, 2004, STAT EVALUATION MED
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325
   Rudolph T, 2007, EUR J NEUROL, V14, P603, DOI 10.1111/j.1468-1331.2007.01758.x
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   STEVENS JC, 1988, NEUROLOGY, V38, P134, DOI 10.1212/WNL.38.1.134
   Tolosa N, 2016, PROTOCOLO VIGILANCIA
   VESSEY MP, 1990, INT J EPIDEMIOL, V19, P655, DOI 10.1093/ije/19.3.655
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Vouga M, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30013-2
   WHO, 2006, WHO CHILD GROWTH STA
   Wiwanitkit V, 2016, ARQ NEURO-PSIQUIAT, V74, P692, DOI 10.1590/0004-282X20160089
   World Health Organization, 2016, SURV ZIK VIR INF MIC
   YANAGIHARA N, 1988, ANN OTO RHINOL LARYN, V97, P3
NR 70
TC 3
Z9 3
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 24
PY 2018
VL 18
AR 656
DI 10.1186/s12889-018-5566-7
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH4GV
UT WOS:000433362200004
PM 29793453
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tham, HW
   Balasubramaniam, V
   Ooi, MK
   Chew, MF
AF Tham, Hong-Wai
   Balasubramaniam, Vinod
   Ooi, Man K.
   Chew, Miaw-Fang
TI Viral Determinants and Vector Competence of Zika Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE Zika virus; arboviruses; mosquitoes; viral determinants; vector
   competence
ID JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; AEDES-AEGYPTI; RNA
   INTERFERENCE; CULEX-QUINQUEFASCIATUS; TRANSOVARIAL TRANSMISSION;
   VERTICAL TRANSMISSION; ANTIGEN DISTRIBUTION; TISSUE TROPISMS; INFECTION
AB Zika virus (ZIKV) has emerged as a new global health threat. Since its first discovery in Zika forest in Uganda, this virus has been isolated from several mosquito species, including Aedes aegypti and Aedes albopictus. The geographical distribution of these mosquito species across tropical and subtropical regions has led to several outbreaks, including the recent pandemic in Brazil, followed by the Pacific islands and other areas of North and South America. This has gained attention of the scientific community to elucidate the epidemiology and transmission of ZIKV. Despite its strong attention on clinical aspects for healthcare professionals, the relationships between ZIKV and its principal vectors, A. aegypti and A. albopictus, have not gained substantial interest in the scientific research community. As such, this review aims to summarize the current knowledge on ZIKV tropism and some important mechanisms which may be employed by the virus for effective strategies on viral survival in mosquitoes. In addition, this review identifies the areas of research that should be placed attention to, for which to be exploited for novel mosquito control strategies.
C1 [Tham, Hong-Wai] SEGi Univ, Fac Pharm, Biol Res Lab, Petaling Jaya, Malaysia.
   [Balasubramaniam, Vinod; Ooi, Man K.] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Subang Jaya, Malaysia.
   [Chew, Miaw-Fang] Sunway Univ, Sch Sci & Technol, Ctr Virus & Vaccine Res, Subang Jaya, Malaysia.
RP Tham, HW (corresponding author), SEGi Univ, Fac Pharm, Biol Res Lab, Petaling Jaya, Malaysia.
EM thamhongwai@outlook.my
RI RMT Balasubramaniam, Vinod/B-6957-2017
OI RMT Balasubramaniam, Vinod/0000-0001-9583-307X
FU Centre for Virus and Vaccine Research, School of Science and Technology,
   Sunway University; Virus-Host Interaction Research Group, Monash
   University Malaysia; Faculty of Pharmacy and Research and Innovation
   Management Center (RIMC), SEGi University
FX M-FC contributed to this review with the support of Centre for Virus and
   Vaccine Research, School of Science and Technology, Sunway University.
   MO and VB were supported by Virus-Host Interaction Research Group,
   Monash University Malaysia. H-WT was supported by the Faculty of
   Pharmacy and Research and Innovation Management Center (RIMC), SEGi
   University.
CR ADEKOLUJOHN EO, 1983, T ROY SOC TROP MED H, V77, P149, DOI 10.1016/0035-9203(83)90053-6
   Agudelo-Romero P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002397
   AITKEN THG, 1979, AM J TROP MED HYG, V28, P119, DOI 10.4269/ajtmh.1979.28.119
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Arjona A, 2011, CELL MICROBIOL, V13, P1648, DOI 10.1111/j.1462-5822.2011.01649.x
   Barber GN, 2001, CELL DEATH DIFFER, V8, P113, DOI 10.1038/sj.cdd.4400823
   Bartholomay LC, 2010, SCIENCE, V330, P88, DOI 10.1126/science.1193162
   Bouri N, 2012, PUBLIC HEALTH REP, V127, P259, DOI 10.1177/003335491212700305
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cime-Castillo J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/504187
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   DOI R, 1967, JPN J EXP MED, V37, P227
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Franz AWE, 2009, INSECT MOL BIOL, V18, P661, DOI 10.1111/j.1365-2583.2009.00908.x
   Franz Alexander W E, 2014, Curr Trop Med Rep, V1, P21
   Freire C. C. M., 2018, MEM I O CRUZ, V113, P1, DOI [10.1590/0074-027601, DOI 10.1590/0074-027601]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   Gonzalez-Escobar G, 2017, REV PANAM SALUD PUBL, V41
   GOULD DOUGLAS J., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P429, DOI 10.1016/0035-9203(62)90018-4
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Jia F, 2016, VIROLOGY, V490, P109, DOI 10.1016/j.virol.2016.01.001
   Kantor AM, 2017, INSECT MOL BIOL, V26, P113, DOI 10.1111/imb.12275
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LEAKE CJ, 1987, T ROY SOC TROP MED H, V81, P681, DOI 10.1016/0035-9203(87)90454-8
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Linthicum KJ, 1996, MED VET ENTOMOL, V10, P87, DOI 10.1111/j.1365-2915.1996.tb00086.x
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005511
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martins NE, 2014, P NATL ACAD SCI USA, V111, P5938, DOI 10.1073/pnas.1400378111
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McElroy KL, 2008, VECTOR-BORNE ZOONOT, V8, P675, DOI 10.1089/vbz.2007.0269
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mourya DT, 2000, INDIAN J MED RES, V111, P157
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Plauzolles A, 2015, INFECT DRUG RESIST, V8, P63, DOI 10.2147/IDR.S49891
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Qsim M, 2017, CRIT REV EUKAR GENE, V27, P331, DOI 10.1615/CritRevEukaryotGeneExpr.2017019937
   Robin Y., 1975, Bulletin Soc Path Exot, V68, P249
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Romoser WS, 2004, J MED ENTOMOL, V41, P467, DOI 10.1603/0022-2585-41.3.467
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   SALUZZO JF, 1982, B SOC PATHOL EXOT, V75, P262
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   SMITHBURN KC, 1954, AM J TROP MED HYG, V3, P9, DOI 10.4269/ajtmh.1954.3.9
   TAKAHASHI M, 1979, AM J TROP MED HYG, V28, P122, DOI 10.4269/ajtmh.1979.28.122
   Tappe D, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917.ES2014.19.4.20685, DOI 10.2807/1560-7917.ES2014.19.4.20685]
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Tham HW, 2015, J INFECT DEV COUNTR, V9, P1338, DOI 10.3855/jidc.6422
   Tham HW, 2014, VIRUSES-BASEL, V6, P5028, DOI 10.3390/v6125028
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tsai CW, 2008, APPL ENVIRON MICROB, V74, P3251, DOI 10.1128/AEM.02248-07
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Whitten MMA, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0042
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Yokoyama S, 2017, MOL BIOL EVOL, V34, P525, DOI 10.1093/molbev/msw270
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 142
TC 9
Z9 9
U1 1
U2 9
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 23
PY 2018
VL 9
AR 1040
DI 10.3389/fmicb.2018.01040
PG 11
WC Microbiology
SC Microbiology
GA GG6KS
UT WOS:000432805700001
PM 29875751
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU James, WHM
   Tejedor-Garavito, N
   Hanspal, SE
   Campbell-Sutton, A
   Hornby, GM
   Pezzulo, C
   Nilsen, K
   Sorichetta, A
   Ruktanonchai, CW
   Carioli, A
   Kerr, D
   Matthews, Z
   Tatem, AJ
AF James, W. H. M.
   Tejedor-Garavito, N.
   Hanspal, S. E.
   Campbell-Sutton, A.
   Hornby, G. M.
   Pezzulo, C.
   Nilsen, K.
   Sorichetta, A.
   Ruktanonchai, C. W.
   Carioli, A.
   Kerr, D.
   Matthews, Z.
   Tatem, A. J.
TI Data Descriptor: Gridded birth and pregnancy datasets for Africa, Latin
   America and the Caribbean
SO SCIENTIFIC DATA
LA English
DT Article; Data Paper
ID CHILD HEALTH; NEWBORN; TRENDS
AB Understanding the fine scale spatial distribution of births and pregnancies is crucial for informing planning decisions related to public health. This is especially important in lower income countries where infectious disease is a major concern for pregnant women and new-borns, as highlighted by the recent Zika virus epidemic. Despite this, the spatial detail of basic data on the numbers and distribution of births and pregnancies is often of a coarse resolution and difficult to obtain, with no co-ordination between countries and organisations to create one consistent set of subnational estimates. To begin to address this issue, under the framework of the WorldPop program, an open access archive of high resolution gridded birth and pregnancy distribution datasets for all African, Latin America and Caribbean countries has been created. Datasets were produced using the most recent and finest level census and official population estimate data available and are at a resolution of 30 arc seconds (approximately 1 km at the equator). All products are available through WorldPop.
C1 [James, W. H. M.; Tejedor-Garavito, N.; Hanspal, S. E.; Hornby, G. M.; Pezzulo, C.; Nilsen, K.; Sorichetta, A.; Ruktanonchai, C. W.; Carioli, A.; Kerr, D.; Tatem, A. J.] Univ Southampton, WorldPop Geog & Environm, Highfield Campus, Southampton SO17 1BJ, Hants, England.
   [Tejedor-Garavito, N.; Pezzulo, C.; Sorichetta, A.; Ruktanonchai, C. W.; Tatem, A. J.] Flowminder Fdn, Roslagsgatan 17, SE-11355 Stockholm, Sweden.
   [Tejedor-Garavito, N.; Campbell-Sutton, A.; Hornby, G. M.] Univ Southampton, GeoData, Highfield Campus, Southampton SO17 1BJ, Hants, England.
   [Matthews, Z.] Univ Southampton, Fac Social & Human Sci, Div Social Stat & Demog, Southampton SO17 1BJ, Hants, England.
   [Matthews, Z.] Univ Southampton, Fac Social & Human Sci, Ctr Global Hlth Populat Poverty & Policy, Southampton SO17 1BJ, Hants, England.
RP Tejedor-Garavito, N (corresponding author), Univ Southampton, WorldPop Geog & Environm, Highfield Campus, Southampton SO17 1BJ, Hants, England.; Tejedor-Garavito, N (corresponding author), Flowminder Fdn, Roslagsgatan 17, SE-11355 Stockholm, Sweden.; Tejedor-Garavito, N (corresponding author), Univ Southampton, GeoData, Highfield Campus, Southampton SO17 1BJ, Hants, England.
EM ntg@geodata.soton.ac.uk
RI ; Tejedor, Natalia/A-5601-2012
OI Hornby, Graeme/0000-0002-2833-8711; Sorichetta,
   Alessandro/0000-0002-3576-5826; James, William/0000-0002-3273-4688;
   Tejedor, Natalia/0000-0002-1140-6263
FU Wellcome TrustWellcome Trust [204613/Z/16/Z, 106866/Z/15/Z]; UK
   Department for International Development (DFID); National Institute of
   Allergy and Infectious Diseases at the National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI089674]; Bill & Melinda Gates
   FoundationGates Foundation [OPP1106427, OPP1134076, OPP1094793]; Clinton
   Health Access Initiative
FX This work was principally funded by the Wellcome Trust (grant number:
   204613/Z/16/Z) and UK Department for International Development (DFID).
   A.J.T was also supported by funding from the National Institute of
   Allergy and Infectious Diseases at the National Institutes of Health
   (U19AI089674), the Bill & Melinda Gates Foundation (OPP1106427,
   OPP1134076, OPP1094793), the Clinton Health Access Initiative, and the
   Wellcome Trust (106866/Z/15/Z).
CR [Anonymous], 2016, PROGR SUST DEV GOALS
   Armstrong CE, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3404-3
   Balk DL, 2006, ADV PARASIT, V62, P119, DOI 10.1016/S0065-308X(05)62004-0
   CBS-Statistics Netherlands, 2016, TRENDS CAR NETH 2016
   Central Bureau of Statistics-Aruba, 2016, AG SPEC FERT RAT 199
   Curacao Central Bureau of Statistics, 2013, STAT YB 2013
   Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221
   Department of Statistics of the Ministry of Finance of The Bahamas, 2013, VIT STAT REP 2013
   Direccion General de Estadistica Encuestas y Censos-Paraguay, 2016, AN 3 NAC VIV INSCR A
   Economics and Statistics Office Government of the Cayman Islands, 2015, POP VIT STAT
   Falkland Islands Government, 2014, STAT YB 2014
   Gobierno de Puerto Rico-Departamento de Salud, 2010, INF AN EST VIT
   Government of Jamaica, 2013, VIT STAT
   Graham Wendy, 2010, MATERNAL INFANT DEAT, P3
   Hijmans R, 2017, GLOBAL ADM AREAS
   ICF International, 1994, DEM HLTH SURV
   Institut National de la Statistique et des Etudes Economiques France, 2013, 50450 I NAT STAT E
   Instituto Brasileiro de Geografia e Estatistica, 2016, EST REG CIV TAB 2609
   Instituto Nacional de Estadistica y Censos-Costa Rica, 2011, NAC
   Instituto Nacional de Estadistica y Censos-Panama, 2012, EST VIT, VII
   Instituto Nacional de Estadistica y Geografia-Mexico, 2015, NAC REG
   Instituto Nacional de Estadistica-Uruguay, 2015, EST VIT
   Instituto Nacional de Estadistica-Venezuela, 2016, DEM EST VIT
   Instituto Nacional de Estadisticas e Informacion de Salud de Chile, 2013, EST NAT MORT CHIL 20
   Instituto Nacional de Estadisticas-Ecuador, 2012, EST NAC
   James W. H. M, 2017, FIGSHARE, DOI [10.6084/m9.figshare.5464147.v1(2017), DOI 10.6084/M9.FIGSHARE.5464147.V1]
   Lloyd CT, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.1
   Ministerio de Salud Republica Argentina, 2013, EST VIT 2012
   Pezzulo C, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.89
   Pullum T., 2017, 19 ICF INT
   Pullum T, 2012, COMMUNICATION
   Pullum T., 2014, 11 ICF INT
   Ruktanonchai CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164519
   Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003
   Schoumaker B, 2014, 12 ICF INT
   Sedgh G, 2014, STUD FAMILY PLANN, V45, P301, DOI 10.1111/j.1728-4465.2014.00393.x
   Statistical Office Central Planning Division, 2013, ST VINC GREAN POP VI
   Statistics Botswana, 2014, VIT STAT REP 2014
   Statistics Office Corporate Policy and Planning Unit (CPPU)-Saint Helena, 2013, STAT YB 2012 13
   Statistics South Africa, 2013, REC LIV BIRTHS
   Stevens F., 2015, SOURCE CODE WORLDPOP, DOI [10.6084/m9.figshare.1491490.v3(2015), DOI 10.6084/M9.FIGSHARE.1491490.V3]
   Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042
   Tatem AJ, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.4
   Tatem AJ, 2014, INT J HEALTH GEOGR, V13, DOI 10.1186/1476-072X-13-2
   The State of Eritrea National Statistics Office (NSO) Fafo Institute for Applied International Studies (AIS), 2013, ER POP HLTH SURV 201
   UNAIDS, 2010, GLOB REP UNAIDS REP
   United Nations, 2017, ESAPWP248 UN POP DIV
   United Nations, 2016, ARES701 UN
   United Nations, 2017, WORLD POP PROSP 2017
   United Nations, 2017, STAT WORLDS MIDW AN
   United Nations, 2008, WORLD FERT DAT 2008
   United Nations Children's Fund (UNICEF), 2011, MULT IND CLUST SURV
   van Rossum G, 1991, CWI Q, V4, P283
   Victora CG, 2017, LANCET GLOB HEALTH, V5, pE402, DOI [10.1016/s2214-109x(17)30077-3, 10.1016/S2214-109X(17)30077-3]
   Victora CG, 2003, LANCET, V362, P233, DOI 10.1016/S0140-6736(03)13917-7
   World Bank, 2014, WORLD DEV IND
   World Health Organisation, 2016, WHORHR1523
NR 57
TC 2
Z9 2
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2052-4463
J9 SCI DATA
JI Sci. Data
PD MAY 22
PY 2018
VL 5
AR 180090
DI 10.1038/sdata.2018.90
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GG4NU
UT WOS:000432674300001
PM 29786689
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Cui, LY
   Zou, P
   Meng, QS
   Lu, L
   Zhang, JY
AF Cui, Liyuan
   Zou, Peng
   Meng, Qingshuo
   Lu, Lu
   Zhang, Jiayi
TI Intra-amniotic Injection of Mouse Embryos
SO BIO-PROTOCOL
LA English
DT Article
DE Intra-amniotic; Embryos; Virus; Infection
AB Recent outbreaks of infectious neuro-developmental diseases such as congenital Zika syndrome - have led to a demand for prognosis data from animal models. We developed an intra-amniotic injection mice model that allows Zika virus (ZIKV) infected mice to grow to puberty. In this system, ZIKV is injected into the amniotic fluid of pregnant mice and infected embryos thereafter. ZIKV-infected mice show several symptoms of clinical 'congenital Zika syndrome', including decreased brain volume and mis-laminated retina. We also evaluated several behavioral functions of these ZIKV-infected mice, for example, after the mice reach puberty, they have visual and motor defects. This technique can be used to screen and evaluate drug candidates and may help evaluate the prognosis of infectious neuro-developmental diseases.
C1 [Lu, Lu; Zhang, Jiayi] Fudan Univ, State Key Lab Med Neurobiol, Inst Brain Sci,Minist Educ,Minist Hlth, Collaborat Innovat Ctr Brain Sci,Key Lab Med Mol, Shanghai, Peoples R China.
   Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
RP Lu, L; Zhang, JY (corresponding author), Fudan Univ, State Key Lab Med Neurobiol, Inst Brain Sci,Minist Educ,Minist Hlth, Collaborat Innovat Ctr Brain Sci,Key Lab Med Mol, Shanghai, Peoples R China.
EM lul@fudan.edu.cn; jiayizhang@fudan.edu.cn
RI Lu, Lu/K-7070-2014
OI Lu, Lu/0000-0002-2255-0391
FU NSF of ChinaNational Natural Science Foundation of China [31771195,
   81790640]; Young 1000 Plan; Ministry of Science and Technology of the
   People's Republic of ChinaMinistry of Science and Technology, China
   [2015AA020512, 2015AA020930, 2016YFC1202901]
FX The authors declare no competing interests. This protocol was adapted
   from Cui et al. (2017). J.Z. thanks the following funding agencies for
   supporting this work: the NSF of China (31771195, 81790640), the Young
   1000 Plan and Ministry of Science and Technology of the People's
   Republic of China (2015AA020512). L.L. thanks the following funding
   agencies for supporting this work: Ministry of Science and Technology of
   the People's Republic of China (2015AA020930 and 2016YFC1202901).
CR Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
NR 1
TC 0
Z9 0
U1 1
U2 1
PU BIO-PROTOCOL
PI SUNNYVALE
PA PO BOX 2073, SUNNYVALE, CA 94087 USA
EI 2331-8325
J9 BIO-PROTOCOL
JI Bio-protocol
PD MAY 20
PY 2018
VL 8
IS 10
AR e2854
DI 10.21769/BioProtoc.2854
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA HK4UZ
UT WOS:000457959900012
DA 2020-07-08
ER

PT J
AU Diez-Fernandez, A
   Martinez-de la Puente, J
   Ruiz, S
   Gutierrez-Lopez, R
   Soriguer, R
   Figuerola, J
AF Diez-Fernandez, Alazne
   Martinez-de la Puente, Josue
   Ruiz, Santiago
   Gutierrez-Lopez, Rafael
   Soriguer, Ramon
   Figuerola, Jordi
TI Aedes vittatus in Spain: current distribution, barcoding
   characterization and potential role as a vector of human diseases
SO PARASITES & VECTORS
LA English
DT Article
DE DNA barcoding; Aedes mosquitoes; Vector-borne diseases
ID MOSQUITOS DIPTERA-CULICIDAE; YELLOW-FEVER; HUMAN HEALTH; VIRUS;
   CHIKUNGUNYA; HIPPOBOSCIDAE; OUTBREAK; ECOLOGY; EUROPE; REGION
AB Background: Aedes vittatus is currently found in Africa, Asia and Europe, where it acts as a vector of pathogens causing animal and human diseases (e.g. chikungunya, Zika and dengue). Like other Aedes species, Ae. vittatus is able to breed in artificial containers. The ECDC has recently highlighted the need for molecular tools (i.e. barcoding characterization) that enable Aedes species to be identified in entomological surveys.
   Results: We sampled mosquito larvae and adults in southern Spain and used a molecular approach to amplify and sequence a fragment of the cytochrome c oxidase subunit 1 gene (barcoding region) of the mosquitoes. The blast comparison of the mosquito sequences isolated from Spain with those deposited in public databases provided a >= 99% similarity with sequences for two Aedes mosquitoes, Ae. vittatus and Ae. cogilli, while similarities with other Aedes species were <= 94%. Aedes cogilli is only present in India and there are no records of this species from Europe.
   Conclusions: Due to the low genetic differences between Ae. vittatus and Ae. cogilli, the barcoding region should not be used as the only method for identifying Ae. vittatus, especially in areas where both of these Aedes species are present. This type of analysis should thus be combined with morphological identification using available keys and/or the characterization of other molecular markers. In addition, further entomological surveys should be conducted in order to identify the fine-scale distribution of this mosquito species in Europe.
C1 [Diez-Fernandez, Alazne; Martinez-de la Puente, Josue; Gutierrez-Lopez, Rafael; Soriguer, Ramon; Figuerola, Jordi] CSIC, EBD, Calle Americo Vespucio 26, E-41092 Seville, Spain.
   [Martinez-de la Puente, Josue; Ruiz, Santiago; Soriguer, Ramon; Figuerola, Jordi] CIBERESP, Seville, Spain.
   [Ruiz, Santiago] Diputac Huelva, Serv Control Mosquitos, Huelva, Spain.
RP Diez-Fernandez, A (corresponding author), CSIC, EBD, Calle Americo Vespucio 26, E-41092 Seville, Spain.
EM adiezfer@ebd.csic.es
RI Diez-Fernandez, Alazne/AAB-6177-2020; Figuerola, Jordi/B-7917-2008; la
   Puente, Josue Martinez-de/E-8597-2011; Gutierrez-Lopez,
   Rafael/N-1348-2017; Diez-Fernandez, Alazne/AAI-7373-2020
OI Diez-Fernandez, Alazne/0000-0002-4165-6693; Figuerola,
   Jordi/0000-0002-4664-9011; la Puente, Josue
   Martinez-de/0000-0001-8055-4115; Gutierrez-Lopez,
   Rafael/0000-0003-0107-5357; 
FU Spanish Ministerio de Economia y Competitividad [CGL2015-65055-P];
   European Regional Development's funds (FEDER)European Union (EU);
   Severo-Ochoa grant [SVP-2014-068571]; FPI grant [BES-2013-065274];
   Leonardo Grant for Researchers and Cultural Creators, BBVA
   FoundationBBVA Foundation; CSIC Open Access Publication Support
   Initiative through its Unit of Information Resources for Research
   (URICI)
FX This study was funded by the CGL2015-65055-P project from the Spanish
   Ministerio de Economia y Competitividad and European Regional
   Development's funds (FEDER). ADF and RGL were supported by Severo-Ochoa
   grant (SVP-2014-068571) and a FPI grant (BES-2013-065274), respectively.
   JMP was partially supported by a 2017 Leonardo Grant for Researchers and
   Cultural Creators, BBVA Foundation. The Foundation accepts no
   responsibility for the opinions, statements and contents included in the
   project and/or the results thereof, which are entirely the
   responsibility of the authors. We acknowledge support of the publication
   fee by the CSIC Open Access Publication Support Initiative through its
   Unit of Information Resources for Research (URICI).
CR Ajamma Yvonne Ukamaka, 2016, F1000Res, V5, P1949
   Angel Bennet, 2008, Journal of Vector Borne Diseases, V45, P56
   Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097268
   Attoui H, 2007, J GEN VIROL, V88, P3078, DOI 10.1099/vir.0.83076-0
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Bernues-Baneres Alberto, 2013, Biodiversity Journal, V4, P335
   Bueno Mari Ruben, 2010, Dugesiana, V17, P143
   Bueno-Mari R., 2012, European Mosquito Bulletin, P91
   Cancrini G, 2007, J MED ENTOMOL, V44, P1064, DOI 10.1603/0022-2585(2007)44[1064:AAACPI]2.0.CO;2
   Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443
   Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo M, 2005, AM J TROP MED HYG, V73, P445, DOI 10.4269/ajtmh.2005.73.445
   ECDC, 2012, GUID SURV INV MOSQ E
   ECDC, 2014, GUID SURV NAT MOSQ E
   Fazakerley JK, 2002, J NEUROVIROL, V8, P66, DOI 10.1080/135502802901068000
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Godfray HCJ, 2002, NATURE, V417, P17, DOI 10.1038/417017a
   Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0
   Gutierrez-Lopez R, 2015, J VECTOR ECOL, V40, P11, DOI 10.1111/jvec.12127
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   HUANG Y-M, 1977, Contributions of the American Entomological Institute, V14, P1
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Ngoagouni C, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-175
   Ochieng C, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-140
   Odhiambo C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105446
   Ondrejicka DA, 2014, TRENDS PARASITOL, V30, P582, DOI 10.1016/j.pt.2014.09.003
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schaffner E., 2001, MOSQUITOES EUROPE ID
   Schaffner F, 2009, MED VET ENTOMOL, V23, P448, DOI 10.1111/j.1365-2915.2009.00825.x
   SERVICE M. W., 1965, BULL ENTOMOL RES, V55, P637, DOI 10.1017/S0007485300049749
   SERVICE MW, 1970, T ROY ENT SOC LONDON, V122, P101
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Vazeille M, 2008, ACTA TROP, V105, P200, DOI 10.1016/j.actatropica.2007.09.009
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wahid B, 2016, ASIAN PAC J TROP MED, V9, P723, DOI 10.1016/j.apjtm.2016.06.019
   Wang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047051
   Whiteman NK, 2006, J PARASITOL, V92, P1218, DOI 10.1645/GE-918R.1
   Wilson J. John, 2015, Academic Journal of Entomology, V8, P80
   Young KI, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2341-z
NR 45
TC 1
Z9 1
U1 2
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 18
PY 2018
VL 11
AR 297
DI 10.1186/s13071-018-2879-4
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GG4XR
UT WOS:000432700100001
PM 29773077
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martinot, AJ
   Abbink, P
   Afacan, O
   Prohl, AK
   Bronson, R
   Hecht, JL
   Borducchi, EN
   Larocca, RA
   Peterson, RL
   Rinaldi, W
   Ferguson, M
   Didier, PJ
   Weiss, D
   Lewis, MG
   De La Barrera, RA
   Yang, E
   Warfield, SK
   Barouch, DH
AF Martinot, Amanda J.
   Abbink, Peter
   Afacan, Onur
   Prohl, Anna K.
   Bronson, Roderick
   Hecht, Jonathan L.
   Borducchi, Erica N.
   Larocca, Rafael A.
   Peterson, Rebecca L.
   Rinaldi, William
   Ferguson, Melissa
   Didier, Peter J.
   Weiss, Deborah
   Lewis, Mark G.
   De La Barrera, Rafael A.
   Yang, Edward
   Warfield, Simon K.
   Barouch, Dan H.
TI Fetal Neuropathology in Zika Virus-Infected Pregnant Female Rhesus
   Monkeys
SO CELL
LA English
DT Article
ID BRAIN MRI; GANGLIONIC EMINENCE; BIRTH-DEFECTS; INFANTS; NEURONS;
   VACCINE; REPLICATION; PROTECTION; SPECTRUM; PRIMATE
AB The development of interventions to prevent congenital Zika syndrome (CZS) has been limited by the lack of an established nonhuman primate model. Here we show that infection of female rhesus monkeys early in pregnancy with Zika virus (ZIKV) recapitulates many features of CZS in humans. We infected 9 pregnant monkeys with ZIKV, 6 early in pregnancy (weeks 6-7 of gestation) and 3 later in pregnancy (weeks 12-14 of gestation), and compared findings with uninfected controls. 100% (6 of 6) of monkeys infected early in pregnancy exhibited prolonged maternal viremia and fetal neuropathology, including fetal loss, smaller brain size, and histopathologic brain lesions, including microcalcifications, hemorrhage, necrosis, vasculitis, gliosis, and apoptosis of neuroprogenitor cells. High-resolution MRI demonstrated concordant lesions indicative of deep gray matter injury. We also observed spinal, ocular, and neuromuscular pathology. Our data show that vascular compromise and neuroprogenitor cell dysfunction are hallmarks of CZS pathogenesis, suggesting novel strategies to prevent and to treat this disease.
C1 [Martinot, Amanda J.; Abbink, Peter; Borducchi, Erica N.; Larocca, Rafael A.; Peterson, Rebecca L.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.
   [Afacan, Onur; Prohl, Anna K.; Yang, Edward; Warfield, Simon K.] Harvard Med Sch, Boston Childrens Hosp, Dept Radiol, Computat Radiol Lab, Boston, MA 02115 USA.
   [Bronson, Roderick] Harvard Med Sch, Boston, MA 02115 USA.
   [Hecht, Jonathan L.] Beth Israel Deaconess Med Ctr, Div Anat Pathol, Boston, MA 02115 USA.
   [Rinaldi, William; Ferguson, Melissa] Alphagenesis, Yemassee, SC 29945 USA.
   [Didier, Peter J.] Tulane Univ, Tulane Natl Primate Res Ctr, Covington, LA 70433 USA.
   [Weiss, Deborah; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA.
   [De La Barrera, Rafael A.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA.
   [Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
RP Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.
EM dbarouch@bidmc.harvard.edu
RI Yang, Edward/Q-8175-2019; Barouch, Dan/Y-3918-2019
OI Warfield, Simon/0000-0002-7659-3880
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI096040, AI100663, AI124377]; Ragon
   Institute of MGH, MIT, and Harvard
FX We thank J. Estes, S. Westmoreland, M. Boyd, R. Nityanandam, N. Mercado,
   Z. Li, M. Kirilova, J. LeSuer, M. Kamath, S. Khatiwada, A. Agarwal, P.
   Gandhi, and A. Chandrashekar for generous advice, assistance, and
   reagents. We acknowledge support from the NIH (AI096040, AI100663,
   AI124377) and the Ragon Institute of MGH, MIT, and Harvard.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Del Bigio MR, 2011, BRAIN, V134, P1344, DOI 10.1093/brain/awr052
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Mejdoubi M, 2017, NEW ENGL J MED, V377, P1399, DOI 10.1056/NEJMc1612813
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sousa AQ, 2017, EMERG INFECT DIS, V23, P1164, DOI 10.3201/eid2307.162019
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ulfig N, 2002, ANAT RECORD, V267, P191, DOI 10.1002/ar.10104
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Zecevic N, 2001, J NEUROSCI, V21, P5607
NR 38
TC 41
Z9 42
U1 1
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 17
PY 2018
VL 173
IS 5
BP 1111
EP +
DI 10.1016/j.cell.2018.03.019
PG 22
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GG1UA
UT WOS:000432471700009
PM 29606355
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Vasquez, C
   Mauriello, PJ
   Beier, JC
AF Wilke, Andre B. B.
   Vasquez, Chalmers
   Mauriello, Paul J.
   Beier, John C.
TI Ornamental bromeliads of Miami-Dade County, Florida are important
   breeding sites for Aedes aegypti (Diptera: Culicidae)
SO PARASITES & VECTORS
LA English
DT Article
DE Vector ecology; Urbanization; Bromeliaceae; Zika virus
ID INTEGRATED VECTOR MANAGEMENT; ZIKA VIRUS; BIOTIC HOMOGENIZATION;
   INHABITING MOSQUITOS; YELLOW-FEVER; AMERICA; URBANIZATION; DENGUE;
   TRANSMISSION; ALBOPICTUS
AB Background: A major public health concern is the emergence and geographical spread of vector-borne diseases such as Zika and yellow fever. Ornamental bromeliads retaining water in their leaf axils represent potential breeding sites for mosquitoes. As the role of ornamental bromeliads in breeding Aedes aegypti in Miami-Dade County, Florida is unknown, we hypothesize that ornamental bromeliads are important breeding sites for Ae. aegypti. Our objective was to survey bromeliads in areas with high densities of adult Ae. aegypti, including those with 2016 local transmission of Zika virus.
   Methods: Ornamental bromeliads were surveyed for the presence of immature mosquitoes at 51 locations of Miami-Dade County, Florida. Bromeliads were sampled for the presence of immature stages of mosquitoes, their reservoirs were drained and screened for the presence of immature mosquitoes. Immature mosquitoes were stored in plastic containers and preserved in 70% ethanol until morphological identification. Biodiversity of species assemblages was assessed by Shannon's and Simpson's indices, and individual rarefaction curves and plots of cumulative abundance, Shannon's index and evenness profiles.
   Results: Ornamental bromeliads were present in all surveyed areas, yielding a total of 765 immature mosquitoes, comprising five taxonomic units: Ae. aegypti, Wyeomyia mitchellii, Wyeomyia vanduzeei, Culex quinquefasciatus and Culex biscaynensis. The biodiversity indices point to a low diversity scenario with a highly dominant species, Ae. aegypti.
   Discussion: Our findings suggest that ornamental bromeliads are contributing for the proliferation of Ae. aegypti in the County of Miami-Dade, which may indicate a shift in the paradigm of usage of bromeliads as breeding sites, highlighting that ornamental phytotelmata bromeliads are to be considered in future vector-control strategies to control Zika and other arboviruses.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Vasquez, Chalmers; Mauriello, Paul J.] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
   [Mauriello, Paul J.] Miami Dade Cty Dept Solid Waste Management, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU CDCCentre National de la Recherche Scientifique (CNRS)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA [1U01CK000510-01]
FX This research was supported by CDC (https://www.cdc.gov/) grant
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program. CDC had no role in the
   design of the study and collection, analysis, and interpretation of data
   and in writing the manuscript.
CR Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown SC, 2016, AM J PREV MED, V51, P78, DOI 10.1016/j.amepre.2016.02.008
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Chadee DD, 2016, ACTA TROP, V156, P137, DOI 10.1016/j.actatropica.2015.12.022
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Chitolina RF, 2016, ACTA TROP, V164, P290, DOI 10.1016/j.actatropica.2016.07.013
   Colwell RK, 2012, J PLANT ECOL, V5, P3, DOI 10.1093/jpe/rtr044
   Costa-da-Silva AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005630
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Darsie Jr RF, 2000, TECH B FLORIDA MOSQ, V1
   de Pina-Costa A, 2014, MEM I OSWALDO CRUZ, V109, P618, DOI 10.1590/0074-0276140228
   Etienne C, 2017, AM J TROP MED HYG, V97, P16, DOI 10.4269/ajtmh.17-0207
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002
   Frank J.H., 2009, Terrestrial Arthropod Reviews, V1, P125
   Guagliardo SA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003033
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lizzi KM, 2014, TRENDS PARASITOL, V30, P394, DOI 10.1016/j.pt.2014.06.001
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Marrelli MT, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-127
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   Mocellin MG, 2009, MEM I OSWALDO CRUZ, V104, P1171, DOI 10.1590/S0074-02762009000800015
   O'Meara GF, 2003, J VECTOR ECOL, V28, P37
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Ramasamy R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001369
   Ritchie SA, 1997, J AM MOSQUITO CONTR, V13, P201
   Santos CB, 2011, NEOTROP ENTOMOL, V40, P278, DOI 10.1590/S1519-566X2011000200019
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Talaga S, 2017, URBAN ECOSYST, V20, P1001, DOI 10.1007/s11252-017-0653-6
   WHO, 2013, OUTLOOKS PEST MANAG, V24, P142, DOI 10.1564/v24_jun_14
   WHO, 2004, GLOB STRAT FRAM INT, P10
   World Health Organization, 2016, ZIK STRAT RESP PLAN, P50
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 41
TC 10
Z9 10
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 17
PY 2018
VL 11
AR 283
DI 10.1186/s13071-018-2866-9
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GG4XJ
UT WOS:000432699300001
PM 29769105
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rabelo, K
   Souza, LJ
   Salomao, NG
   Oliveira, ERA
   Sentinelli, LD
   Lacerda, MS
   Saraquino, PB
   Rosman, FC
   Basilio-de-Oliveira, R
   Carvalho, JJ
   Paes, MV
AF Rabelo, Kissila
   Souza, Luiz J.
   Salomao, Natalia G.
   Oliveira, Edson R. A.
   Sentinelli, Lynna de Paula
   Lacerda, Marcelle S.
   Saraquino, Pedro B.
   Rosman, Fernando C.
   Basilio-de-Oliveira, Rodrigo
   Carvalho, Jorge J.
   Paes, Marciano, V
TI Placental Inflammation and Fetal Injury in a Rare Zika Case Associated
   With Guillain-Barre Syndrome and Abortion
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; immune response; Guillain-Barre syndrome; fetal infection;
   histopathology
ID IMMUNE-SYSTEM; VIRUS; INFECTION; GROWTH; PREGNANCY; PATHOLOGY; CELLS
AB Zika virus (ZIKV) is an emerging virus involved in recent outbreaks in Brazil. The association between the virus and Guillain-Barre syndrome (GBS) or congenital disorders has raised a worldwide concern. In this work, we investigated a rare Zika case, which was associated with GBS and spontaneous retained abortion. Using specific anti-ZIKV staining, the virus was identified in placenta (mainly in Hofbauer cells) and in several fetal tissues, such as brain, lungs, kidneys, skin and liver. Histological analyses of the placenta and fetal organs revealed different types of tissue abnormalities, which included inflammation, hemorrhage, edema and necrosis in placenta, as well as tissue disorganization in the fetus. Increased cellularity (Hofbauer cells and TCD8(+) lymphocytes), expression of local pro-inflammatory cytokines such as IFN-gamma and TNF-alpha, and other markers, such as RANTES/CCL5 and VEGFR2, supported placental inflammation and dysfunction. The commitment of the maternal-fetal link in association with fetal damage gave rise to a discussion regarding the influence of the maternal immunity toward the fetal development. Findings presented in this work may help understanding the ZIKV immunopathogenesis under the rare contexts of spontaneous abortions in association with GBS.
C1 [Rabelo, Kissila; Carvalho, Jorge J.] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, Rio De Janeiro, Brazil.
   [Souza, Luiz J.; Sentinelli, Lynna de Paula; Lacerda, Marcelle S.; Saraquino, Pedro B.] Fac Med Campos, Rio De Janeiro, Brazil.
   [Salomao, Natalia G.; Paes, Marciano, V] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
   [Oliveira, Edson R. A.] Univ Fed Rio de Janeiro, Lab Modelagem Mol, Inst Quim Organ, Rio De Janeiro, Brazil.
   [Rosman, Fernando C.] Hosp Municipal Jesus, Anat Patol, Rio De Janeiro, Brazil.
   [Basilio-de-Oliveira, Rodrigo] Univ Fed Estado Rio de Janeiro, Anat Patol, Rio De Janeiro, Brazil.
RP Paes, MV (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, Rio De Janeiro, Brazil.
EM marciano@ioc.fiocruz.br
OI Carvalho, Jorge/0000-0002-9426-6381; Rabelo,
   Kissila/0000-0001-7579-7788; Paes, Marciano/0000-0002-2266-2801;
   Oliveira, Edson RA/0000-0002-8606-7454
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/010.001.498/2016,
   E-26/202.003/2016, E-26/110.511/2014]
FX This work was supported by CNPq and FAPERJ (E-26/010.001.498/2016,
   E-26/202.003/2016 and E-26/110.511/2014). We also thank the working team
   from Platform of Confocal at the State University of Rio de Janeiro
   (UERJ) for the assistance with experiments.
CR Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Bayer A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.060
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x
   Chen JC, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-165
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kuivanen S, 2017, J GEN VIROL, V98, P1744, DOI 10.1099/jgv.0.000857
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   MEDAWAR PB, 1948, BRIT J EXP PATHOL, V29, P58
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mor G, 2016, AM J REPROD IMMUNOL, V75, P421, DOI 10.1111/aji.12505
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Ouyang Y, 2014, PLACENTA, V35, pS69, DOI 10.1016/j.placenta.2013.11.002
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rosenfeld AB, 2017, P NATL ACAD SCI USA, V114, P12273, DOI 10.1073/pnas.1714624114
   Schaub B, 2017, ULTRASOUND OBST GYN, V49, P658, DOI 10.1002/uog.17210
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tsatsaris V, 2003, J CLIN ENDOCR METAB, V88, P5555, DOI 10.1210/jc.2003-030528
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 44
TC 5
Z9 5
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 16
PY 2018
VL 9
AR 1018
DI 10.3389/fmicb.2018.01018
PG 10
WC Microbiology
SC Microbiology
GA GF9KM
UT WOS:000432295800001
PM 29867903
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Makiala-Mandanda, S
   Ahuka-Mundeke, S
   Abbate, JL
   Pukuta-Simbu, E
   Nsio-Mbeta, J
   Berthet, N
   Leroy, EM
   Becquart, P
   Muyembe-Tamfum, JJ
AF Makiala-Mandanda, Sheila
   Ahuka-Mundeke, Steve
   Abbate, Jessica L.
   Pukuta-Simbu, Elisabeth
   Nsio-Mbeta, Justus
   Berthet, Nicolas
   Leroy, Eric Maurice
   Becquart, Pierre
   Muyembe-Tamfum, Jean-Jacques
TI Identification of Dengue and Chikungunya Cases Among Suspected Cases of
   Yellow Fever in the Democratic Republic of the Congo
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE dengue; Chikungunya; yellow fever; DRC
ID CONCURRENT CHIKUNGUNYA; VIRUS; OUTBREAK; ARBOVIRUS; EPIDEMIC;
   QUANTIFICATION; INFECTIONS; PREVALENCE; TRAVELERS; ANGOLA
AB For more than 95% of acute febrile jaundice cases identified through surveillance for yellow fever, a reemerging arthropod-borne viral disease, no etiological exploration is ever done. The aim of this study was to test for other arthropod-borne viruses that can induce the same symptoms in patients enrolled in the yellow fever surveillance in the Democratic Republic of the Congo (DRC). Of 652 patients included in the surveillance of yellow fever in DRC from January 2003 to January 2012, 453 patients that tested negative for yellow fever virus (YFV) immunoglobulin M (IgM) antibodies were selected for the study. Real-time polymerase chain reaction was performed for the detection of dengue, West Nile, Chikungunya, O'nyong-nyong, Rift Valley fever, Zika, and YFV. The average age of patients was 22.1 years. We reported 16 cases (3.5%; confidence interval [CI]: 0.8-5.2) of dengue (serotypes 1 and 2) and 2 cases (0.4%; CI: 0.0-1.0) of Chikungunya. Three patients were co-infected with the two serotypes of dengue virus. Three cases of dengue were found in early July 2010 from the city of Titule (Oriental province) during a laboratory-confirmed outbreak of yellow fever, suggesting simultaneous circulation of dengue and yellow fever viruses. This study showed that dengue and Chikungunya viruses are potential causes of acute febrile jaundice in the DRC and highlights the need to consider dengue and Chikungunya diagnosis in the integrated disease surveillance and response program in the DRC. A prospective study is necessary to establish the epidemiology of these diseases.
C1 [Makiala-Mandanda, Sheila; Berthet, Nicolas; Leroy, Eric Maurice] CIRMF, Franceville, Gabon.
   [Makiala-Mandanda, Sheila; Ahuka-Mundeke, Steve; Muyembe-Tamfum, Jean-Jacques] CUK, Dept Microbiol, Kinshasa, DEM REP CONGO.
   [Ahuka-Mundeke, Steve; Pukuta-Simbu, Elisabeth; Muyembe-Tamfum, Jean-Jacques] INRB, Kinshasa, DEM REP CONGO.
   [Abbate, Jessica L.; Leroy, Eric Maurice; Becquart, Pierre] IRD, Montpellier, France.
   [Abbate, Jessica L.] UPMC, IRD, UMMISCO, UMR,UMI 209, Bondy, France.
   [Nsio-Mbeta, Justus] DLM, Kinshasa, DEM REP CONGO.
   [Berthet, Nicolas] CNRS, UMR3569, Paris, France.
   [Berthet, Nicolas] Inst Pasteur, Cellule Intervent Biol Urgence, Unite Environm & Risques Infect, Paris, France.
RP Makiala-Mandanda, S (corresponding author), CUK, Dept Microbiol, Kinshasa, DEM REP CONGO.
EM shemakiala@yahoo.fr
RI LEROY, Eric/I-4347-2016; Abbate, Jessica Lee/Q-5322-2019
OI LEROY, Eric/0000-0003-0022-0890; Abbate, Jessica Lee/0000-0003-2485-3334
FU Agence universitaire de la francophonie; Centre International de
   Recherches Medicales de Franceville (CIRMF) - Gabonese Government, Total
   Gabon; French Foreign Ministry; Institut National de Recherche
   Biomedicale (INRB) of Kinshasa, DRC; ANR JC "STORY''French National
   Research Agency (ANR)
FX We thank the Ministry of Public Health of the DRC, particularly the head
   of the Direction de lutte contre la maladie for allowing us to work on
   samples from the yellow fever surveillance program. We are also grateful
   to the medical staff who participated in the yellow fever surveillance
   program in the DRC, without whom we could not have obtained the samples
   included in this study. We also acknowledge the Agence universitaire de
   la francophonie for contributing funds to this project. This study was
   supported by the Centre International de Recherches Medicales de
   Franceville (CIRMF), which is funded by the Gabonese Government, Total
   Gabon and The French Foreign Ministry in collaboration with the the
   Institut National de Recherche Biomedicale (INRB) of Kinshasa, DRC.
   Postdoctoral support for J.L.A. was provided by ANR JC "STORY'' granted
   to Benjamin Roche.
CR Amarasinghe A, 2011, EMERG INFECT DIS, V17, P1349, DOI 10.3201/eid1708.101515
   Anand AC, 2015, J CLIN EXP HEPATOL, V5, pS116, DOI 10.1016/j.jceh.2014.05.007
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P181
   Baba M, 2013, J INFECT DEV COUNTR, V7, P51, DOI 10.3855/jidc.2411
   Bird BH, 2009, JAVMA-J AM VET MED A, V234, P883, DOI 10.2460/javma.234.7.883
   Caron M, 2012, CLIN INFECT DIS, V55, pE45, DOI 10.1093/cid/cis530
   Chen RB, 2011, VIRUSES-BASEL, V3, P1562, DOI 10.3390/v3091562
   Chong SE, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1666-y
   COURTOIS G., 1960, ANN SOC BEIGE MED TROP, V40, P29
   Dellagi K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004840
   Drosten C, 2002, J CLIN MICROBIOL, V40, P2323, DOI 10.1128/JCM.40.7.2323-2330.2002
   Farnon EC, 2010, AM J TROP MED HYG, V82, P1146, DOI 10.4269/ajtmh.2010.09-0105
   FILIPE AR, 1973, B WORLD HEALTH ORGAN, V49, P37
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Gould LH, 2008, T ROY SOC TROP MED H, V102, P1247, DOI 10.1016/j.trstmh.2008.04.014
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Jaenisch Thomas, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2010.140487
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Kasper MR, 2012, AM J TROP MED HYG, V86, P246, DOI 10.4269/ajtmh.2012.11-0409
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Makiala-Mandanda S, 2017, J CLIN MICROBIOL, V55, P1299, DOI 10.1128/JCM.01847-16
   Meltzer E, 2012, AM J TROP MED HYG, V86, P536, DOI 10.4269/ajtmh.2012.10-0670
   Ministry of Public Health, 2005, GUID PRIS CHARG EP Z
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moyen N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115938
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637
   Nkoghe D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001517
   Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885
   PANTHIER R., 1962, ANN SOC BEIGE MED TROP, V42, P65
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168
   Peyrefitte CN, 2007, EMERG INFECT DIS, V13, P768, DOI 10.3201/eid1305.061500
   Recker M, 2009, P ROY SOC B-BIOL SCI, V276, P2541, DOI 10.1098/rspb.2009.0331
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Samanta J, 2015, WORLD J CLIN CASES, V3, P125, DOI 10.12998/wjcc.v3.i2.125
   Singer M, 2017, GLOB PUBLIC HEALTH, V12, P1, DOI 10.1080/17441692.2016.1225112
   Syhavong B, 2010, T ROY SOC TROP MED H, V104, P475, DOI 10.1016/j.trstmh.2010.03.002
   Vainio J, 1998, WHOEPIGEN98, V1, P16
   WHO, 2013, YELL FEV DEM REP CON
   WHO, 2014, YELL FEV DEM REP CON
   WHO, 2016, CHIK KEN EM PREP RES
   WHO, 2010, YELL FEV DEM REP CON
   Woodall JP, 2016, INT J INFECT DIS, V48, P96, DOI 10.1016/j.ijid.2016.05.001
   WOODRUFF AW, 1978, BRIT MED J, V1, P956, DOI 10.1136/bmj.1.6118.956
NR 48
TC 6
Z9 6
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JUL
PY 2018
VL 18
IS 7
BP 364
EP 370
DI 10.1089/vbz.2017.2176
EA MAY 2018
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GL5CK
UT WOS:000432405500001
PM 29768102
DA 2020-07-08
ER

PT J
AU Philip, CM
AF Philip, C. M.
TI Zika: Florida's Experience Responding to an Emerging Public Health
   Threat
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Philip, C. M.] Florida Dept Hlth, Tallahassee, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2018
VL 110
IS 9
SI SI
MA L3
BP 712
EP 712
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GH6PF
UT WOS:000433565700003
DA 2020-07-08
ER

PT J
AU Rasmussen, SA
AF Rasmussen, S. A.
TI An Update on Zika Virus As a Cause of Birth Defects
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Rasmussen, S. A.] Ctr Dis Control & Prevent, Norcross, GA USA.
NR 0
TC 1
Z9 1
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2018
VL 110
IS 9
SI SI
MA S15
BP 722
EP 722
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GH6PF
UT WOS:000433565700018
DA 2020-07-08
ER

PT J
AU Baez-Santiago, MA
   Carr, C
   Ellington, S
   Jones, AM
   Fulton, A
   Reynolds, M
   Gilboa, SM
   Honein, MA
AF Baez-Santiago, M. A.
   Carr, C.
   Ellington, S.
   Jones, A. M.
   Fulton, A.
   Reynolds, M.
   Gilboa, S. M.
   Honein, M. A.
CA Uszpair Collaborators
TI Update from the United States Zika Pregnancy and Infant Registry
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Baez-Santiago, M. A.; Carr, C.; Ellington, S.; Jones, A. M.; Fulton, A.; Reynolds, M.; Gilboa, S. M.; Uszpair Collaborators] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Honein, M. A.] CDC, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2018
VL 110
IS 9
SI SI
MA W7
BP 748
EP 748
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GH6PF
UT WOS:000433565700067
DA 2020-07-08
ER

PT J
AU Ospina, ML
   Mercado, M
   Galang, RR
   Moore, CA
   Gonzalez, M
   Valencia, D
   Cuevas, L
   Pacheco, O
   Bermudez, A
   Dominguez, M
   Gilboa, SM
   Rozo, N
   Avila, G
   Honein, MA
   Prieto, F
AF Ospina, M. L.
   Mercado, M.
   Galang, R. R.
   Moore, C. A.
   Gonzalez, M.
   Valencia, D.
   Cuevas, L.
   Pacheco, O.
   Bermudez, A.
   Dominguez, M.
   Gilboa, S. M.
   Rozo, N.
   Avila, G.
   Honein, M. A.
   Prieto, F.
TI Surveillance of Microcephaly and Other Congenital Central Nervous System
   Malformations: The Colombian Experience during the 2015-2016 Zika Virus
   Epidemic
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Ospina, M. L.] Inst Nacl Salud, Direcc Gen, Bogota, Dc, Colombia.
   [Mercado, M.] Inst Nacl Salud, Direcc Invest Salud Publ, Bogota, Dc, Colombia.
   [Galang, R. R.; Moore, C. A.; Valencia, D.; Dominguez, M.; Gilboa, S. M.; Honein, M. A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Gonzalez, M.; Cuevas, L.; Pacheco, O.; Rozo, N.; Avila, G.; Prieto, F.] Inst Nacl Salud, Direcc Vigilancia & Anal Riesgo Salud Publ, Bogota, Dc, Colombia.
   [Bermudez, A.] Inst Nacl Salud, Direcc Redes Salud Publ, Bogota, Dc, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2018
VL 110
IS 9
SI SI
MA 26
BP 767
EP 767
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GH6PF
UT WOS:000433565700097
DA 2020-07-08
ER

PT J
AU Corchuelo, S
   Mercado, M
   Borbon, M
   Rico, A
   Parra, E
   Ospina, M
AF Corchuelo, S.
   Mercado, M.
   Borbon, M.
   Rico, A.
   Parra, E.
   Ospina, M.
TI Density of CD68+(Hofbauer) Cells in Zika Infected Placentas
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Corchuelo, S.; Borbon, M.] Gesath, Bogota, DC, Colombia.
   [Mercado, M.] Inst Nacl Salud, Direcc Invest Salud Publ, Bogota, DC, Colombia.
   [Rico, A.; Parra, E.] Inst Nacl Salud, Direcc Redes Salud Publ, Bogota, DC, Colombia.
   [Ospina, M.] Inst Nacl Salud, Direcc Gen, Bogota, DC, Colombia.
NR 0
TC 0
Z9 0
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2018
VL 110
IS 9
SI SI
MA P75
BP 806
EP 806
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GH6PF
UT WOS:000433565700171
DA 2020-07-08
ER

PT J
AU Sowunmi, S
   Eckert, V
   Griffin, A
AF Sowunmi, S.
   Eckert, V
   Griffin, A.
TI California: Pregnancy and Birth Outcomes of Registry-Enrolled
   Pregnancies Affected by Travel-Associated Zika Virus Infection
SO BIRTH DEFECTS RESEARCH
LA English
DT Meeting Abstract
C1 [Sowunmi, S.; Eckert, V; Griffin, A.] Calif Dept Publ Hlth, Calif Birth Defects Monitoring Program, Richmond, CA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY 15
PY 2018
VL 110
IS 9
SI SI
MA P74
BP 806
EP 806
PG 1
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA GH6PF
UT WOS:000433565700170
DA 2020-07-08
ER

PT J
AU Depoux, A
   Philibert, A
   Rabier, S
   Philippe, HJ
   Fontanet, A
   Flahault, A
AF Depoux, Anneliese
   Philibert, Aline
   Rabier, Serge
   Philippe, Henri-Jean
   Fontanet, Arnaud
   Flahault, Antoine
TI A multi-faceted pandemic: a review of the state of knowledge on the Zika
   virus
SO PUBLIC HEALTH REVIEWS
LA English
DT Review
DE ZIKV; Neurologic disorders; Vector control; Microcephaly; Aedes aegypti;
   MOOC; Health promotion; Health policies; Health management; WHO
ID CLIMATE-CHANGE; BIRTH-DEFECTS; EL-NINO; TRANSMISSION; EMERGENCY; STRAIN
AB While until recently the small and isolated Zika outbreaks in Eastern Asia and Pacific islands had been overlooked, the large-scale outbreak that started in Brazil in 2015 and the increase of microcephaly cases in the same place and time made media headlines. Considered as harmless until recently, Zika has given rise to an important global crisis that poses not only health challenges but also environmental, economical, social, and ethical challenges for states and people around the world. The main objective of this paper is to review the recent Zika outbreak by covering a broad range of disciplines and their interactions. This paper synthetises experts' interviews and reactions conducted during a Massive Open Online Course (MOOC) entitled "In the footsteps of Zika. approaching the unknown." It reviews knowledge and uncertainties around epidemiology, geographical dispersion of the virus and its vectors through globalization and climate change, and also its modes of transmission, diagnosis, symptoms, and treatment of the disease. The resulting societal and ethical issues in pregnancy and women of reproductive age were also addressed as well as the global outbreak alert and response network in international organizations and social media. This paper attempted to combine each piece of the jigsaw puzzle of the Zika phenomenon to complete the best realistic picture, while keeping in mind the balance between the interdisciplinary nature and international context of Zika and its unique characteristics.
C1 [Depoux, Anneliese; Philibert, Aline; Rabier, Serge; Flahault, Antoine] Univ Sorbonne Paris Cite, Ctr Virchow Villerme, Paris, France.
   [Depoux, Anneliese] Univ Paris Sorbonne, CELSA, GRIPIC, EA 1498, Paris, France.
   [Philibert, Aline] Univ Quebec, Interdisciplinary Res Ctr Well Being Hlth Soc & E, Montreal, PQ, Canada.
   [Philippe, Henri-Jean] Univ Paris 05, Fac Med, Paris, France.
   [Philippe, Henri-Jean] Hop Cochin, AP HP, HUPC, Serv Chirurg Gen Plast & Ambulatoire, Paris, France.
   [Fontanet, Arnaud] Conservatoire Natl Arts & Metiers, Unite PACRI, Paris, France.
   [Fontanet, Arnaud] Inst Pasteur, Emerging Dis Epidemiol Unit, Paris, France.
   [Flahault, Antoine] Univ Geneva, Inst Global Hlth, Fac Med, Geneva, Switzerland.
RP Depoux, A (corresponding author), Univ Sorbonne Paris Cite, Ctr Virchow Villerme, Paris, France.; Depoux, A (corresponding author), Univ Paris Sorbonne, CELSA, GRIPIC, EA 1498, Paris, France.
EM anneliese.depoux@uspc.fr
FU Centre Virchow-Villerme
FX Funded as part of Centre Virchow-Villerme.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   [Anonymous], ZIK VIR
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brinkmann A, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101743
   Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chitti Sai V., 2016, VirusDisease, V27, P211, DOI 10.1007/s13337-016-0317-9
   COHEN SA, 1994, FAM PLANN PERSPECT, V26, P272, DOI 10.2307/2135895
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Direction de la Sante Polynesie Francaise BdVs, B SURV SAN POL FRANC
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 10 05 2016 RRA ZIK V
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Flahault A, 2016, PUBLIC HEALTH REV, V37, DOI 10.1186/s40985-016-0035-2
   Health NC for E, CLIM HLTH PROGR
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kelly B, 2015, BMC PUBLIC HLTH, V15
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Liyanagunawardena TR, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3439
   Lustig Y, 2017, J CLIN MICROBIOL
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Manjarres-Suarez Alejandra, 2013, Rev. costarric. salud pública, V22, P68
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Mitchell C., 2016, ZIKA CUMULATIVE CASE
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Organization WH, 2016, ZIK STRAT RESP FRAM
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Paz-Bailey G, 2017, N ENGL J MED
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   WHO, WHO ZIK APP
   WHO, WHO ZIK VIR SIT REP
   WHO, MOSQ VECT CONTR EM R
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 52
TC 11
Z9 12
U1 0
U2 11
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2107-6952
J9 PUBLIC HEALTH REV
JI Public Health Rev.
PD MAY 15
PY 2018
VL 39
AR UNSP 10
DI 10.1186/s40985-018-0087-6
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH3OK
UT WOS:000433311800001
PM 29785319
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Alimonti, JB
   Ribecco-Lutkiewicz, M
   Sodja, C
   Jezierski, A
   Stanimirovic, DB
   Liu, Q
   Haqqani, AS
   Conlan, W
   Bani-Yaghoub, M
AF Alimonti, Judie B.
   Ribecco-Lutkiewicz, Maria
   Sodja, Caroline
   Jezierski, Anna
   Stanimirovic, Danica B.
   Liu, Qing
   Haqqani, Arsalan S.
   Conlan, Wayne
   Bani-Yaghoub, Mahmud
TI Zika virus crosses an in vitro human blood brain barrier model
SO FLUIDS AND BARRIERS OF THE CNS
LA English
DT Article
DE Zika virus; Brain endothelial cells; Blood-brain barrier model; iPSC;
   AXL; Neural progenitors
ID NEURAL PROGENITORS; CEREBRAL ORGANOIDS; ENDOTHELIAL-CELLS;
   MASS-SPECTROMETRY; INFECTION; AXL; ADULTS; VIVO
AB Zika virus (ZIKV) is a flavivirus that is highly neurotropic causing congenital abnormalities and neurological damage to the central nervous systems (CNS). In this study, we used a human induced pluripotent stem cell (iPSC)-derived blood brain barrier (BBB) model to demonstrate that ZIKV can infect brain endothelial cells (i-BECs) without compromising the BBB barrier integrity or permeability. Although no disruption to the BBB was observed post-infection, ZIKV particles were released on the abluminal side of the BBB model and infected underlying iPSC-derived neural progenitor cells (i-NPs). AXL, a putative ZIKV cellular entry receptor, was also highly expressed in ZIKV-susceptible i-BECand i-NPs. This iPSC-derived BBB model can help elucidate the mechanism by which ZIKV can infect BECs, cross the BBB and gain access to the CNS.
C1 [Alimonti, Judie B.; Haqqani, Arsalan S.; Conlan, Wayne] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, 100 Sussex Dr, Ottawa, ON, Canada.
   [Ribecco-Lutkiewicz, Maria; Sodja, Caroline; Jezierski, Anna; Stanimirovic, Danica B.; Liu, Qing; Bani-Yaghoub, Mahmud] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Bldg M54-1200,Montreal Rd, Ottawa, ON K1A 0R6, Canada.
RP Jezierski, A (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Bldg M54-1200,Montreal Rd, Ottawa, ON K1A 0R6, Canada.
EM anna.jezierski@nrc-cnrc.gc.ca
FU National Research Council of Canada
FX This study was funded by the National Research Council of Canada.
CR Ahrne E, 2013, PROTEOMICS, V13, P2567, DOI 10.1002/pmic.201300135
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Coisne C, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-7
   Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Doran KS, 2013, COLD SPRING HARB PER, P3
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Haqqani Arsalan S., 2008, V439, P241, DOI 10.1007/978-1-59745-188-8_17
   Haqqani AS, 2011, METHODS MOL BIOL, V686, P337, DOI 10.1007/978-1-60761-938-3_16
   Helms HC, 2016, J CEREBR BLOOD F MET, V36, P862, DOI 10.1177/0271678X16630991
   Jezierski A, 2010, STEM CELL REV REP, V6, P199, DOI 10.1007/s12015-010-9116-7
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kim BJ, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00398-17
   Kim K, 2016, TRENDS MICROBIOL, V24, P622, DOI 10.1016/j.tim.2016.06.002
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Lin MY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13980-2
   Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Muruganandam A, 1997, FASEB J, V11, P1187
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rendelman B., 2016, METHOD MOL BIOL, V1435, P61
   Ribecco-Lutkiewicz M, 2018, SCI REP
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Stanimirovic DB, 2015, EXPERT OPIN DRUG DIS, V10, P141, DOI 10.1517/17460441.2015.974545
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
NR 40
TC 16
Z9 16
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-8118
J9 FLUIDS BARRIERS CNS
JI Fluids Barriers CNS
PD MAY 15
PY 2018
VL 15
AR 15
DI 10.1186/s12987-018-0100-y
PG 9
WC Neurosciences
SC Neurosciences & Neurology
GA GH2SB
UT WOS:000433251000001
PM 29759080
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dhimal, M
   Dahal, S
   Dhimal, ML
   Mishra, SR
   Karki, KB
   Aryal, KK
   Haque, U
   Kabir, MI
   Guin, P
   Butt, AM
   Harapan, H
   Liu, QY
   Chu, C
   Montag, D
   Groneberg, DA
   Pandey, BD
   Kuch, U
   Muller, R
AF Dhimal, Meghnath
   Dahal, Sushma
   Dhimal, Mandira Lamichhane
   Mishra, Shiva Raj
   Karki, Khem B.
   Aryal, Krishna Kumar
   Haque, Ubydul
   Kabir, Md Iqbal
   Guin, Pradeep
   Butt, Azeem Mehmood
   Harapan, Harapan
   Liu, Qi-Yong
   Chu, Cordia
   Montag, Doreen
   Groneberg, David Alexander
   Pandey, Basu Dev
   Kuch, Ulrich
   Mueller, Ruth
TI Threats of Zika virus transmission for Asia and its Hindu-Kush Himalayan
   region
SO INFECTIOUS DISEASES OF POVERTY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; Dengue virus; Chikungunya virus; Hindu
   Kush Himalayas; Mountain; Poverty; Zika virus
ID CHIKUNGUNYA VIRUS; JAPANESE ENCEPHALITIS; AEDES-AEGYPTI; DENGUE VIRUS;
   INFECTION; EPIDEMIC; OUTBREAK; VECTORS; MALARIA; FEVER
AB Asia and its Hindu Kush Himalayan (HKH) region is particularly vulnerable to environmental change, especially climate and land use changes further influenced by rapid population growth, high level of poverty and unsustainable development. Asia has been a hotspot of dengue fever and chikungunya mainly due to its dense human population, unplanned urbanization and poverty. In an urban cycle, dengue virus (DENV) and chikungunya virus (CHIKV) are transmitted by Aedes aegypti and Ae. albopictus mosquitoes which are also competent vectors of Zika virus (ZIKV). Over the last decade, DENV and CHIKV transmissions by Ae. aegypti have extended to the Himalayan countries of Bhutan and Nepal and ZIKV could follow in the footsteps of these viruses in the HKH region. The already established distribution of human-biting Aedes mosquito vectors and a naive population with lack of immunity against ZIKV places the HKH region at a higher risk of ZIKV. Some of the countries in the HKH region have already reported ZIKV cases. We have documented an increasing threat of ZIKV in Asia and its HKH region because of the high abundance and wide distribution of human-biting mosquito vectors, climate change, poverty, report of indigenous cases in the region, increasing numbers of imported cases and a naive population with lack of immunity against ZIKV. An outbreak anywhere is potentially a threat everywhere. Therefore, in order to ensure international health security, all efforts to prevent, detect, and respond to ZIKV ought to be intensified now in Asia and its HKH region. To prepare for possible ZIKV outbreaks, Asia and the HKH region can also learn from the success stories and strategies adopted by other regions and countries in preventing ZIKV and associated complications. The future control strategies for DENV, CHIKV and ZIKV should be considered in tandem with the threat to human well-being that is posed by other emerging and re-emerging vector-borne and zoonotic diseases, and by the continuing urgent need to strengthen public primary healthcare systems in the region.
C1 [Dhimal, Meghnath; Dahal, Sushma; Karki, Khem B.; Aryal, Krishna Kumar] NHRC, Ramshah Path, Kathmandu, Nepal.
   [Dhimal, Meghnath; Dhimal, Mandira Lamichhane; Groneberg, David Alexander; Kuch, Ulrich; Mueller, Ruth] Goethe Univ, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.
   [Dhimal, Mandira Lamichhane] Goethe Univ, Fac Social Sci, Frankfurt, Germany.
   [Mishra, Shiva Raj] Univ Queensland, Brisbane, Qld, Australia.
   [Haque, Ubydul] Baldwin Wallace Univ, Dept Publ Hlth, Berea, OH USA.
   [Kabir, Md Iqbal] Natl Inst Prevent & Social Med, Dept Epidemiol, Minist Hlth & Family Welfare, Dhaka, Bangladesh.
   [Guin, Pradeep] Publ Hlth Fdn India, Gurgaon, Haryana, India.
   [Guin, Pradeep] Ctr Environm Hlth, Gurgaon, Haryana, India.
   [Butt, Azeem Mehmood] COMSATS Inst Informat Technol CIIT, Dept Biosci, Translat Genom Lab, Islamabad 45550, Pakistan.
   [Harapan, Harapan] Syiah Kuala Univ, Sch Med, Med Res Unit, Banda Aceh, Indonesia.
   [Liu, Qi-Yong] China CDC, WHO Collaborating Ctr Vector Surveillance & Manag, SKLID, CCID,ICDC, Beijing, Peoples R China.
   [Chu, Cordia] Griffith Univ, Ctr Environm & Populat Hlth, Nathan, Qld, Australia.
   [Montag, Doreen] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, Barts & London Sch Med, London, England.
   [Pandey, Basu Dev] Govt Nepal, Dept Hlth Serv, Minist Hlth, Kathmandu, Nepal.
RP Dhimal, M (corresponding author), NHRC, Ramshah Path, Kathmandu, Nepal.; Dhimal, M (corresponding author), Goethe Univ, Inst Occupat Med Social Med & Environm Med, Frankfurt, Germany.
EM meghdhimal@gmail.com
RI Harapan, Harapan/I-8741-2016; Butt, Azeem Mehmood/B-6249-2014; Muller,
   Ruth/D-2551-2009
OI Harapan, Harapan/0000-0001-7630-8413; Butt, Azeem
   Mehmood/0000-0001-5897-6848; Dhimal, Meghnath/0000-0001-7176-7821; Chu,
   Cordia/0000-0002-3683-5638; Muller, Ruth/0000-0003-3909-3876; Lamichhane
   Dhimal, Mandira/0000-0003-0258-5148
FU Federal Ministry of Education and Research of Germany (BMBF) under the
   project AECO as part of the National Research Network on Zoonotic
   Infectious Diseases of GermanyFederal Ministry of Education & Research
   (BMBF) [01Kl1717]
FX No specific funding was received for this research. However, the work of
   RM, UK and DAG was funded by the Federal Ministry of Education and
   Research of Germany (BMBF) under the project AECO (number 01Kl1717) as
   part of the National Research Network on Zoonotic Infectious Diseases of
   Germany.
CR Aditya G, 2009, INDIAN J MED RES, V129, P455
   [Anonymous], 2016, LANCET, V387, P96, DOI 10.1016/S0140-6736(16)00014-3
   [Anonymous], 2017, BDNEWS24
   [Anonymous], 2016, S CHINA MORNING POST
   Baylis M, 2016, T ROY SOC TROP MED H, V110, P209, DOI 10.1093/trstmh/trw012
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blagrove MSC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005604
   Butt AM, 2016, LANCET GLOB HEALTH, V4, pE913, DOI 10.1016/S2214-109X(16)30246-7
   CDC, 2016, ZIK TRAV INF
   Cetron M, 2016, MMWR-MORBID MORTAL W, V65, P267, DOI 10.15585/mmwr.mm6510e1
   Chen B, 2015, LANCET, V385, P1621, DOI 10.1016/S0140-6736(15)60793-0
   Dhimal M, 2015, J Nepal Health Res Counc, V13, P248
   Dhimal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129869
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dhimal M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0540-4
   Dhimal M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102028
   Dhimal M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003035
   Dhiman RC, 2011, CURR SCI INDIA, V101, P372
   Dorji T, 2009, EMERG INFECT DIS, V15, P1630, DOI 10.3201/eid1510.090123
   Doss CGP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0234-6
   Dyer O, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5577
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Gerlitz JY, 2017, CLIM DEV, V9, P124, DOI 10.1080/17565529.2016.1145099
   Gerlitz JY, 2012, CAN J DEV STUD, V33, P250, DOI 10.1080/02255189.2012.689613
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   International Centre for Integrated Mountain Development, 2017, HIND KUSH HIM REG
   IPCC, 2014, CLIM CHANG 2014 IMP
   Johnson M., 2016, COYOTE BIOSCIENCE PO
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Li YX, 2011, EMERG INFECT DIS, V17, P934, DOI 10.3201/eid1705.101417
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Malla S, 2008, EMERG INFECT DIS, V14, P1669, DOI 10.3201/eid1410.080432
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Ng LC, 2010, INFECT GENET EVOL, V10, P876, DOI 10.1016/j.meegid.2010.07.012
   Organization WH, 2017, EM PREP RESP ZIK VIR
   Pandey Basu D, 2013, Trop Med Health, V41, P103, DOI 10.2149/tmh.2012-17
   Pandey BD, 2015, AM J TROP MED HYG, V93, P697, DOI 10.4269/ajtmh.15-0092
   Peterson A Townsend, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a832cf06c4bf89fb2e15cb29d374f9de
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pun SB, 2014, J INFECT DEV COUNTR, V8, P790, DOI 10.3855/jidc.3701
   Rao M., 2017, DID ZIKA VIRUS GET I
   Rauf M, 2017, LANCET INFECT DIS, V17, P258, DOI 10.1016/S1473-3099(17)30074-9
   Reuters, 2016, REUTERS
   Rodriguez-Morales Alfonso J, 2017, Infez Med, V25, P241
   Rutvisuttinunt W, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0606-0
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741
   Singh SP, 2011, CLIMATE CHANGE HINDU
   Tabachnick WJ, 2016, INSECTS, V7, DOI 10.3390/insects7040050
   Tambo E, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0148-3
   Teng Y, 2017, J INFECTION, V74, P484, DOI 10.1016/j.jinf.2017.01.015
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wangchuk S, 2013, EMERG INFECT DIS, V19, P1681, DOI 10.3201/eid1910.130453
   Waters R., CUBA IS WAGING ORG I
   Watts AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178211
   WHO, 2017, DENG CONTR CHIK
   World Health Organization, 2016, ZIK OUTRB WHOS GLOB
   World Health Organization, 2017, ZIK VIR ZIKV CLASS T
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization (WHO), 2016, ZIK STRAT RESP PLAN
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 67
TC 4
Z9 4
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2095-5162
EI 2049-9957
J9 INFECT DIS POVERTY
JI Infect. Dis. Poverty
PD MAY 15
PY 2018
VL 7
AR 40
DI 10.1186/s40249-018-0426-3
PG 7
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GG4SB
UT WOS:000432685400001
PM 29759076
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mier-y-Teran-Romero, L
   Delorey, MJ
   Sejvar, JJ
   Johansson, MA
AF Mier-y-Teran-Romero, Luis
   Delorey, Mark J.
   Sejvar, James J.
   Johansson, Michael A.
TI Guillain-Barre syndrome risk among individuals infected with Zika virus:
   a multi-country assessment
SO BMC MEDICINE
LA English
DT Article
DE Guillain-Barre syndrome; Zika virus; neurological disorder; vector-borne
   diseases
ID PROGNOSIS
AB Background: Countries with ongoing outbreaks of Zika virus have observed a notable rise in reported cases of Guillain-Barre syndrome (GBS), with mounting evidence of a causal link between Zika virus infection and the neurological syndrome However, the risk of GBS following a Zika virus infection is not well characterized In this work, we used data from 11 locations with publicly available data to estimate the risk of GBS following an infection with Zika virus, as well as the location specific incidence of infection and the number of suspect GBS cases reported per infection.
   Methods: We built a mathematical inference framework utilizing data from 11 locations that had reported suspect Zika and GBS cases, two with completed outbreaks prior to 2015 (French Polynesia and Yap) and nine others in the Americas covering partial outbreaks and where transmission was ongoing as of early 2017.
   Results: We estimated that 2.0 (95% credible interval 0.5-4.5) reported GBS cases may occur per 10,000 Zika virus infections The frequency of reported suspect Zika cases varied substantially and was highly uncertain, with a mean of 0.11 (95% credible interval 0.01-0.24) suspect cases reported per infection.
   Conclusions: These estimates can help efforts to prepare for the GBS cases that may occur during Zika epidemics and highlight the need to better understand the relationship between infection and the reported incidence of clinical disease.
C1 [Mier-y-Teran-Romero, Luis; Johansson, Michael A.] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.
   [Delorey, Mark J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
   [Sejvar, James J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Div High Consequence Pathogens & Pathol, Ft Collins, CO USA.
   [Johansson, Michael A.] Harvard Univ, TH Chan Sch Publ Hlth, Cambridge, MA 02138 USA.
RP Mier-y-Teran-Romero, L (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.
EM lmier-y@jhsph.edu
OI Johansson, Michael/0000-0002-5090-7722
FU Models of Infectious Disease Agent Study program [1U54GM088558]
FX MAJ received partial support from the Models of Infectious Disease Agent
   Study program (Cooperative Agreement 1U54GM088558).
CR [Anonymous], 2016, B EPIDEMIOLOGICO SEM
   [Anonymous], 2017, INF SEM ENF ARB SEM
   [Anonymous], 2016, B EP SEM REP DOM SEM
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Brasil, 2010, CENS DEM
   BRISCOE DM, 1987, ARCH DIS CHILD, V62, P733, DOI 10.1136/adc.62.7.733
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   CDC, 2016, CDC CONCL ZIK CAUS M
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Krauer F, PLOS MED
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Mallet HP, 2015, POLYNESIE FRANCAISE
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   RANTALA H, 1991, ARCH DIS CHILD, V66, P706, DOI 10.1136/adc.66.6.706
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   United Nations, 2015, WORLD POP PROSP
   van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4
   World Health Organization, 2016, ZIK SIT REP
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 25
TC 14
Z9 14
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1741-7015
J9 BMC MED
JI BMC Med.
PD MAY 15
PY 2018
VL 16
AR 67
DI 10.1186/S12916-018-1052-4
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA GG0FI
UT WOS:000432353500001
PM 29759069
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bowman, NM
   Akialis, K
   Cave, G
   Barrera, R
   Apperson, CS
   Meshnick, SR
AF Bowman, Natalie M.
   Akialis, Kristin
   Cave, Grayson
   Barrera, Roberto
   Apperson, Charles S.
   Meshnick, Steven R.
TI Pyrethroid insecticides maintain repellent effect on knock-down
   resistant populations of Aedes aegypti mosquitoes
SO PLOS ONE
LA English
DT Article
ID RTS,S/AS01 MALARIA VACCINE; AEGYPTI DIPTERA-CULICIDAE; LONE STAR TICK;
   YELLOW-FEVER OUTBREAK; PERSONAL PROTECTION; PRESSURIZED SPRAYS;
   IXODES-RICINUS; BEHAVIORAL-RESPONSES; RESIDUAL ACTIVITY;
   CONTROLLED-TRIAL
AB Pyrethroid-treated clothing is commonly worn for protection against mosquitoes; pyrethroids are both insecticides and repellents. Pyrethroid resistance has become increasingly common in Aedes aegypti, the vector of dengue, Zika, and other arboviruses, but it is not clear whether resistance is associated with reductions in repellency. In order to determine whether long-lasting permethrin impregnated (LLPI) clothing is protective, we used Aedes aegypti from New Orleans, LA (pyrethroid-sensitive) and San Juan, PR (resistant) to measure both lethality and repellency. PCR and Sanger sequencing were used to confirm resistance status by detecting mutations in the kdr gene at positions 1016 and 1534. Arm-incage trials of 100 Aedes aegypti females from both populations were performed for 10 minutes to bare arm or an arm clothed in untreated military camouflage or military camouflage impregnated with deltamethrin, permethrin, or etofenprox. Trials were repeated 4-5 times on different days. Number of landings, number of blood meals, and immediate and 24-hour mortality were recorded. Mortality was extremely low in all trials. Compared to untreated cloth, mosquitoes demonstrated a trend towards a 2%-63% reduction in landings and a statistically significant 78-100% reduction in blood feeding on pyrethroid-treated cloth for most insecticides. Effects were observed in both pyrethroid-sensitive and pyrethroid-resistant mosquito populations. Our data show that kdr mutations are associated with pyrethroid resistance but are likely not the only contributors. Pyrethroids appear to maintain repellent effect against resistant mosquitoes. This finding suggests that even in places where pyrethroid resistance is widespread, permethrin still has a role for use as a repellent on clothing to protect against mosquito bites.
C1 [Bowman, Natalie M.] Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA.
   [Akialis, Kristin; Meshnick, Steven R.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA.
   [Cave, Grayson; Apperson, Charles S.] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC USA.
   [Barrera, Roberto] Ctr Dis Control & Prevent, San Juan, PR USA.
RP Bowman, NM (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27599 USA.
EM nbowman@med.unc.edu
OI Bowman, Natalie/0000-0003-4260-8009
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [K23 AI113197]
CR Achee NL, 2009, J AM MOSQUITO CONTR, V25, P156, DOI 10.2987/08-5831.1
   Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685
   Agnandji ST, 2011, NEW ENGL J MED, V365, P1863, DOI 10.1056/NEJMoa1102287
   Agossa FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145207
   Agramonte NM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005954
   [Anonymous], 2017, Wkly Epidemiol Rec, V92, P345
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P186
   Banks SD, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004109
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chattopadhyay P, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-284
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   EVANS SR, 1990, J MED ENTOMOL, V27, P829, DOI 10.1093/jmedent/27.5.829
   Faulde M, 2008, INT J MED MICROBIOL, V298, P321, DOI 10.1016/j.ijmm.2007.11.007
   Faulde M, 2006, INT J MED MICROBIOL, V296, P225, DOI 10.1016/j.ijmm.2006.01.008
   Faulde MK, 2006, MIL MED, V171, P472, DOI 10.7205/MILMED.171.6.472
   Faulde MK, 2003, J MED ENTOMOL, V40, P935, DOI 10.1603/0022-2585-40.6.935
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Jordan RA, 2012, J MED ENTOMOL, V49, P101, DOI 10.1603/ME10241
   Kittayapong P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005197
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   LANE RS, 1989, EXP APPL ACAROL, V6, P343, DOI 10.1007/BF01193304
   Lardeux F, 2008, T ROY SOC TROP MED H, V102, P485, DOI 10.1016/j.trstmh.2008.02.006
   Londono-Renteria B, 2015, AM J TROP MED HYG, V93, P869, DOI 10.4269/ajtmh.15-0130
   Manda H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002074
   Mharakurwa S, 2011, P NATL ACAD SCI USA, V108, P18796, DOI 10.1073/pnas.1116162108
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Miller NJ, 2011, J MED ENTOMOL, V48, P327, DOI 10.1603/ME10158
   Miot Helio Amante, 2008, Dermatol Online J, V14, P1
   Most B, 2017, PARASITOL RES, V116, P677, DOI 10.1007/s00436-016-5333-6
   MOUNT GA, 1983, J ECON ENTOMOL, V76, P529, DOI 10.1093/jee/76.3.529
   Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2
   Orsborne J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152805
   Otshudiema JO, 2017, MMWR-MORBID MORTAL W, V66, P335, DOI 10.15585/mmwr.mm6612a5
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Sathantriphop S, 2014, J MED ENTOMOL, V51, P1182, DOI 10.1603/ME13191
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   SCHRECK CE, 1982, J ECON ENTOMOL, V75, P1059, DOI 10.1093/jee/75.6.1059
   SCHRECK CE, 1982, J MED ENTOMOL, V19, P143, DOI 10.1093/jmedent/19.2.143
   SCHRECK CE, 1986, J MED ENTOMOL, V23, P396, DOI 10.1093/jmedent/23.4.396
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Stell FM, 2013, MED VET ENTOMOL, V27, P284, DOI 10.1111/j.1365-2915.2012.01048.x
   Thanispong K, 2009, J MED ENTOMOL, V46, P1407, DOI 10.1603/033.046.0622
   Tinto H, 2015, LANCET, V386, P31, DOI 10.1016/S0140-6736(15)60721-8
   Trexler JD, 2003, J MED ENTOMOL, V40, P841, DOI 10.1603/0022-2585-40.6.841
   Vaughn MF, 2014, AM J PREV MED, V46, P473, DOI 10.1016/j.amepre.2014.01.008
   Vaughn MF, 2011, VECTOR-BORNE ZOONOT, V11, P869, DOI 10.1089/vbz.2010.0158
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vos T, 2016, LANCET, V388, P1545, DOI 10.1016/S0140-6736(16)31678-6
   Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4
   Wallace JW, 2016, VECTOR-BORNE ZOONOT, V16, P302, DOI 10.1089/vbz.2015.1887
   WHO, 2006, PEST THEIR APPL CONT
   Witting-Bissinger BE, 2008, J MED ENTOMOL, V45, P891, DOI 10.1603/0022-2585(2008)45[891:NARBIA]2.0.CO;2
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
NR 61
TC 6
Z9 5
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 15
PY 2018
VL 13
IS 5
AR e0196410
DI 10.1371/journal.pone.0196410
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF7AA
UT WOS:000432118800010
PM 29763445
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Elizondo-Quiroga, D
   Medina-Sanchez, A
   Sanchez-Gonzalez, JM
   Eckert, KA
   Villalobos-Sanchez, E
   Navarro-Zuniga, AR
   Sanchez-Tejeda, G
   Correa-Morales, F
   Gonzalez-Acosta, C
   Arias, CF
   Lopez, S
   del Angel, RM
   Pando-Robles, V
   Elizondo-Quiroga, AE
AF Elizondo-Quiroga, Darwin
   Medina-Sanchez, Aaron
   Sanchez-Gonzalez, Jorge M.
   Allison Eckert, Kristen
   Villalobos-Sanchez, Erendira
   Rigoberto Navarro-Zuniga, Antonio
   Sanchez-Tejeda, Gustavo
   Correa-Morales, Fabian
   Gonzalez-Acosta, Cassandra
   Arias, Carlos F.
   Lopez, Susana
   Maria del Angel, Rosa
   Pando-Robles, Victoria
   Elizondo-Quiroga, Armando E.
TI Zika Virus in Salivary Glands of Five Different Species of Wild-Caught
   Mosquitoes from Mexico (vol 8, 809, 2018)
SO SCIENTIFIC REPORTS
LA English
DT Correction
C1 [Elizondo-Quiroga, Darwin; Villalobos-Sanchez, Erendira] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Unidad Biotecnol Med & Farmaceut, Guadalajara, Jalisco, Mexico.
   [Medina-Sanchez, Aaron; Sanchez-Gonzalez, Jorge M.; Rigoberto Navarro-Zuniga, Antonio; Elizondo-Quiroga, Armando E.] Secretaria Salud Jalisco, Guadalajara, Jalisco, Mexico.
   [Sanchez-Tejeda, Gustavo; Correa-Morales, Fabian; Gonzalez-Acosta, Cassandra] Secretaria Salud Mexico, Ctr Nacl Programas Prevent & Control Enfermedades, Direcc Programa Enfermedades Transmitidas Vector, Mexico City, DF, Mexico.
   [Arias, Carlos F.; Lopez, Susana] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca, Morelos, Mexico.
   [Maria del Angel, Rosa] Ctr Invest & Estudios Avanzados IPN, Dept Infectom & Patogenesis Mol, Mexico City, DF, Mexico.
   [Pando-Robles, Victoria] CISEI, Inst Nacl Salud Publ, Cuernavaca, Morelos, Mexico.
RP Elizondo-Quiroga, AE (corresponding author), Secretaria Salud Jalisco, Guadalajara, Jalisco, Mexico.
EM aelizondoq@gmail.com
OI Correa Morales, Fabian/0000-0002-6193-1242; Arias,
   Carlos/0000-0003-3130-4501; Elizondo, Darwin/0000-0002-7256-947X;
   PANDO-ROBLES, VICTORIA/0000-0002-9633-5627; Gonzalez Acosta,
   Cassandra/0000-0003-2682-908X
FU National Council for Science and Technology (CONACyT)-Mexico through the
   Mexican Network for Virology
FX This project was partially supported by the National Council for Science
   and Technology (CONACyT)-Mexico through the Mexican Network for
   Virology. We are indebted to Drs. Jose Narro Robles, Pablo Kuri Morales,
   Cuitlahuac Ruiz Matus, and Jesus Felipe Gonzalez Roldan from the
   Secretaria de Salud of Mexico for their help and support to carry out
   this work. We also thank the personnel of the Unidad de Investigacion
   Entomologica de Occidente for their assistance in the collection of
   mosquitoes and separation of species. We thank Rito Geronimo Aguirre
   Cortes, for the elaboration of the collection maps. We also would like
   to thank Brian Walsh from CIATEJ/Peace Corps for his valuable remarks in
   editing the English of the manuscript.
CR Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
NR 1
TC 26
Z9 26
U1 1
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 15
PY 2018
VL 8
AR 7887
DI 10.1038/s41598-018-25807-9
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GF6WX
UT WOS:000432110000006
PM 29339746
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saa, P
   Proctor, M
   Foster, G
   Krysztof, D
   Winton, C
   Linnen, JM
   Gao, K
   Brodsky, JP
   Limberger, RJ
   Dodd, RY
   Stramer, SL
AF Saa, Paula
   Proctor, Melanie
   Foster, Gregory
   Krysztof, David
   Winton, Colleen
   Linnen, Jeffrey M.
   Gao, Kui
   Brodsky, Jaye P.
   Limberger, Ronald J.
   Dodd, Roger Y.
   Stramer, Susan L.
TI Investigational Testing for Zika Virus among US Blood Donors
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID TRANSMISSION; INFECTION; STATES
AB BACKGROUND
   Because of the potential severe clinical consequences of Zika virus (ZIKV) infection, the large numbers of asymptomatic travelers returning from ZIKV-active areas, the detection of ZIKV nucleic acid in blood, and reports of transmission of ZIKV through transfusion, in 2016 the Food and Drug Administration released recommendations for individual-unit nucleic acid testing to minimize the risk of transmission of ZIKV through blood transfusions.
   METHODS
   The American Red Cross implemented investigational screening of donated blood for ZIKV RNA by means of transcription-mediated amplification (TMA). Confirmatory testing of reactive donations involved repeat TMA, TMA testing in exploratory mini-pools, real-time reverse-transcriptase polymerase chain reaction, IgM serologic testing, and red-cell TMA. Viral loads in plasma and red cells were estimated by means of end-point TMA. The costs of interdicting a donation that was confirmed to be positive were calculated for the 15-month period between June 2016 and September 2017.
   RESULTS
   Of the 4,325,889 donations that were screened, 393,713 (9%) were initially tested in 24,611 minipools, and no reactive donations were found. Of the 3,932,176 donations that were subsequently tested individually, 160 were initially reactive and 9 were confirmed positive (a 1:480,654 confirmed-positive rate overall; positive predictive value, 5.6%; specificity, 99.997%). Six (67%) of the confirmed-positive donations were reactive on repeat TMA, of which 4 were IgM-negative; of these 4, all 3 that could be tested were reactive on minipool TMA. Two confirmed-positive donors had infections that had been transmitted locally (in Florida), 6 had traveled to ZIKV-active areas, and 1 had received an experimental ZIKV vaccine. ZIKV RNA levels in red cells ranged from 40 to 800,000 copies per milliliter and were detected up to 154 days after donation, as compared with 80 days of detection in plasma at levels of 12 to 20,000 copies per milliliter. On the basis of industry-reported costs of testing and the yield of the tests in our study, the cost of identifying 8 mosquito-borne ZIKV infections through individual-unit nucleic acid testing was $5.3 million per ZIKV RNA-positive donation.
   CONCLUSIONS
   Screening of U.S. blood donations for ZIKV by individual-donation TMA was costly and had a low yield. Among the 9 confirmed ZIKV-positive donations, only 4 were IgM-negative; of these donations, all 3 that were tested were reactive on minipool TMA.
C1 [Saa, Paula; Proctor, Melanie; Foster, Gregory; Krysztof, David; Winton, Colleen; Dodd, Roger Y.; Stramer, Susan L.] Amer Red Cross, Sci Affairs, Gaithersburg, MD 20877 USA.
   [Linnen, Jeffrey M.; Gao, Kui] Grifols Diagnost Solut, San Diego, CA USA.
   [Brodsky, Jaye P.] Qual Analyt, Riverwoods, IL USA.
   [Limberger, Ronald J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
RP Stramer, SL (corresponding author), Amer Red Cross, 9315 Gaither Rd, Gaithersburg, MD 20877 USA.
EM susan.stramer@redcross.org
FU American Red Cross and Grifols Diagnostic Solutions
FX Supported by the American Red Cross and Grifols Diagnostic Solutions.
CR [Anonymous], 2017, ZIK MAC ELISA
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Food and Drug Administration, 2016, DON SCREEN REC RED R
   Food and Drug Administration, 2016, REV REC RED RISK ZIK
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gao K, 2017, 27 REG C ISBT COP JU
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Groves JA, 2017, TRANSFUSION, V57, P850, DOI 10.1111/trf.14018
   Klein HG, 2017, NEW ENGL J MED, V377, P1485, DOI 10.1056/NEJMsb1706496
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paz-Bailey G, 2017, NEW ENGL J MED, DOI [10.1056/NEJMoa1613108, DOI 10.1056/NEJM0A1613108]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
NR 40
TC 24
Z9 24
U1 0
U2 6
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 10
PY 2018
VL 378
IS 19
BP 1778
EP 1788
DI 10.1056/NEJMoa1714977
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA GF2MO
UT WOS:000431774400005
PM 29742375
DA 2020-07-08
ER

PT J
AU Bloch, EM
   Ness, PM
   Tobian, AAR
   Sugarman, J
AF Bloch, Evan M.
   Ness, Paul M.
   Tobian, Aaron A. R.
   Sugarman, Jeremy
TI Revisiting Blood Safety Practices Given Emerging Data about Zika Virus
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID UNITED-STATES; DECISION-MAKING; TRANSFUSION; RNA; INFECTION; DONATIONS;
   DONORS
C1 [Bloch, Evan M.; Ness, Paul M.; Tobian, Aaron A. R.; Sugarman, Jeremy] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.
   [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD USA.
RP Bloch, EM (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.
OI Sugarman, Jeremy/0000-0001-7022-8332
CR Alliance of Blood Operators, 2015, RISK BAS DEC MAK FRA
   [Anonymous], 2017, 2017 M MAT
   [Anonymous], 1998, WINGSPR C PREV PRINC
   [Anonymous], 2015, CUM ZIK VIR DISC CAS
   [Anonymous], 2017, ZIK VIR CLASS TABL
   [Anonymous], 2016, REDS 3 ZIK VIR RES
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bennett JL, 2011, TRANSFUS MED REV, V25, P267, DOI 10.1016/j.tmrv.2011.05.002
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   *COMM EUR COMM, 2000, COMM COMM PREC PRINC
   Custer B, 2009, TRANSFUS MED REV, V23, P1, DOI 10.1016/j.tmrv.2008.09.001
   Dodd RY, 2016, TRANSFUSION, V56, P2781, DOI 10.1111/trf.13759
   Ellingson KD, 2017, TRANSFUSION, V57, P1625, DOI 10.1111/trf.14164
   Food and Drug Administration (FDA), 2016, REC DON SCREEN DEF P
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Herriman R, 2015, OUTBREAK NEWS T 1218
   Herwaldt BL, 2011, ANN INTERN MED, V155, P509, DOI 10.7326/0003-4819-155-8-201110180-00362
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kramer K, 2017, VOX SANG, V112, P417, DOI 10.1111/vox.12525
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Kuklina EV, 2009, OBSTET GYNECOL, V113, P293, DOI 10.1097/AOG.0b013e3181954e5b
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pan American Health Organization, 2017, REG ZIK VIR EP UPD A
   Pate LL, 2017, TRANSFUSION, V57, p26A
   Paules CI, 2017, JAMA-J AM MED ASSOC, V317, P691, DOI 10.1001/jama.2016.21079
   Paz-Bailey G, 2017, N ENGL J MED
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Saa PP, 2017, TRANSFUSION, V57, p25A
   Sabino EC, 2016, J INFECT DIS, V213, P694, DOI 10.1093/infdis/jiv326
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
NR 36
TC 8
Z9 8
U1 0
U2 1
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 10
PY 2018
VL 378
IS 19
BP 1837
EP 1841
DI 10.1056/NEJMsb1704752
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA GF2MO
UT WOS:000431774400013
PM 29742377
DA 2020-07-08
ER

PT J
AU Gorman, MJ
   Caine, EA
   Zaitsev, K
   Begley, MC
   Weger-Lucarelli, J
   Uccellini, MB
   Tripathi, S
   Morrison, J
   Yount, BL
   Dinnon, KH
   Ruckert, C
   Young, MC
   Zhu, Z
   Robertson, SJ
   McNally, KL
   Ye, J
   Cao, B
   Mysorekar, IU
   Ebel, GD
   Baric, RS
   Best, SM
   Artyomov, MN
   Garcia-Sastre, A
   Diamond, MS
AF Gorman, Matthew J.
   Caine, Elizabeth A.
   Zaitsev, Konstantin
   Begley, Matthew C.
   Weger-Lucarelli, James
   Uccellini, Melissa B.
   Tripathi, Shashank
   Morrison, Juliet
   Yount, Boyd L.
   Dinnon, Kenneth H., III
   Ruckert, Claudia
   Young, Michael C.
   Zhu, Zhe
   Robertson, Shelly J.
   McNally, Kristin L.
   Ye, Jing
   Cao, Bin
   Mysorekar, Indira U.
   Ebel, Gregory D.
   Baric, Ralph S.
   Best, Sonja M.
   Artyomov, Maxim N.
   Garcia-Sastre, Adolfo
   Diamond, Michael S.
TI An Immunocompetent Mouse Model of Zika Virus Infection
SO CELL HOST & MICROBE
LA English
DT Article
ID NEURAL STEM-CELLS; GLIAL-CELLS; NS4B; HETEROGENEITY; PATHOGENESIS;
   REPLICATION; ANTIBODY; PROTEIN; BRAIN; LEADS
AB Progress toward understanding Zika virus (ZIKV) pathogenesis is hindered by lack of immunocompetent small animal models, in part because ZIKV fails to effectively antagonize Stat2-dependent interferon (IFN) responses in mice. To address this limitation, we first passaged an African ZIKV strain (ZIKV-Dak-41525) through Rag1(-/-) mice to obtain a mouse-adapted virus (ZIKV-Dak-MA) that was more virulent than ZIKV-Dak-41525 in mice treated with an anti-Ifnar1 antibody. A G18R substitution in NS4B was the genetic basis for the increased replication, and resulted in decreased IFN-beta production, diminished IFN-stimulated gene expression, and the greater brain infection observed with ZIKV-Dak-MA. To generate a fully immunocompetent mouse model of ZIKV infection, human STAT2 was introduced into the mouse Stat2 locus (hSTAT2 KI). Subcutaneous inoculation of pregnant hSTAT2 KI mice with ZIKV-Dak-MA resulted in spread to the placenta and fetal brain. An immunocompetent mouse model of ZIKV infection may prove valuable for evaluating countermeasures to limit disease.
C1 [Gorman, Matthew J.; Zaitsev, Konstantin; Mysorekar, Indira U.; Artyomov, Maxim N.; Diamond, Michael S.] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.
   [Caine, Elizabeth A.; Ye, Jing; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Cao, Bin; Mysorekar, Indira U.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Artyomov, Maxim N.; Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63130 USA.
   [Begley, Matthew C.; Yount, Boyd L.; Dinnon, Kenneth H., III; Baric, Ralph S.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC USA.
   [Begley, Matthew C.; Yount, Boyd L.; Dinnon, Kenneth H., III; Baric, Ralph S.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA.
   [Weger-Lucarelli, James; Ruckert, Claudia; Young, Michael C.; Ebel, Gregory D.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Uccellini, Melissa B.; Tripathi, Shashank; Morrison, Juliet; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Div Infect Dis, Dept Med, New York, NY 10029 USA.
   [Uccellini, Melissa B.; Tripathi, Shashank; Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA.
   [Zhu, Zhe] Univ Calif San Diego, Sch Med, Dept Med, Div Regenerat Med, La Jolla, CA 92093 USA.
   [Robertson, Shelly J.; McNally, Kristin L.; Best, Sonja M.] NIAID, Lab Virol, Rocky Mt Labs, NIH, Hamilton, MT USA.
   [Zaitsev, Konstantin] ITMO Univ, Comp Technol Dept, St Petersburg, Russia.
RP Diamond, MS (corresponding author), Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63130 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63130 USA.
EM diamond@wusm.wustl.edu
RI Diamond, Michael/AAH-1733-2019; Zhu, Zhe/H-6009-2019
OI Diamond, Michael/0000-0002-8791-3165; Zhu, Zhe/0000-0002-5385-948X;
   Morrison, Juliet/0000-0001-7387-6351; Begley,
   Matthew/0000-0003-4852-7656; Ruckert, Claudia/0000-0003-3732-6752;
   Weger-Lucarelli, James/0000-0002-9483-1694; Zaitsev,
   Konstantin/0000-0003-3749-0886
FU NCI Cancer CenterUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P30 CA91842]; ICTS/CTSA Grant [UL1 TR000448]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI073755, R01 AI104972, U19 AI083019, R01
   HD091218, U19 AI118610, R21 AI129486, R01 AI100625, R01 AI107810];
   Division of Intramural Research, National Institute of Allergy and
   Infectious Diseases, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID); Government of Russian
   Federation grant [074-U01]
FX We acknowledge the Genome Technology Access Center at Washington
   University for help with genomic analysis. The center is partially
   supported by NCI Cancer Center Support Grant P30 CA91842 and by
   ICTS/CTSA Grant UL1 TR000448. This work also was supported by grants
   from the NIH (R01 AI073755, R01 AI104972, and U19 AI083019 to M.S.D.;
   R01 HD091218 to I.U.M. and M.S.D.; U19 AI118610 and R21 AI129486 to
   A.G.-S; and R01 AI100625 and R01 AI107810 to R.S.B.) and by the Division
   of Intramural Research, National Institute of Allergy and Infectious
   Diseases, NIH. K.Z. was supported by Government of Russian Federation
   grant 074-U01.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Butler A, 2017, BIORXIV, V21, P627
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Daniels BP, 2017, J CLIN INVEST, V127, P843, DOI 10.1172/JCI88720
   Daniels BP, 2014, MBIO, V5, DOI 10.1128/mBio.01476-14
   Dulken BW, 2017, CELL REP, V18, P777, DOI 10.1016/j.celrep.2016.12.060
   Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Kowalczyk MS, 2015, GENOME RES, V25, P1860, DOI 10.1101/gr.192237.115
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Messer WB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001486
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Widman DG, 2017, MBIO, V8, DOI [10.1128/mBio.02014-16, 10.1128/mbio.02014-16]
   Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 54
TC 59
Z9 59
U1 3
U2 21
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 9
PY 2018
VL 23
IS 5
BP 672
EP +
DI 10.1016/j.chom.2018.04.003
PG 20
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GG1GW
UT WOS:000432436400014
PM 29746837
OA Green Published, Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Pettersson, JHO
   Bohlin, J
   Dupont-Rouzeyrol, M
   Brynildsrud, OB
   Alfsnes, K
   Cao-Lormeau, VM
   Gaunt, MW
   Falconar, AK
   De Lamballerie, X
   Eldholm, V
   Musso, D
   Gould, EA
AF Pettersson, John H-O
   Bohlin, Jon
   Dupont-Rouzeyrol, Myrielle
   Brynildsrud, Ola B.
   Alfsnes, Kristian
   Cao-Lormeau, Van-Mai
   Gaunt, Michael W.
   Falconar, Andrew K.
   De Lamballerie, Xavier
   Eldholm, Vegard
   Musso, Didier
   Gould, Ernest A.
TI Re-visiting the evolution, dispersal and epidemiology of Zika virus in
   Asia
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID INFECTION; EMERGENCE; PROSPECTS; OUTBREAK
AB Based on serological evidence and viral isolation, Zika virus (ZIKV) has circulated for many years relatively benignly in a sylvatic cycle in Africa and an urban cycle in South East Asia (SEA). With the recent availability of limited but novel Indian ZIKV sequences to add to the plethora of SEA sequences, we traced the phylogenetic history and spatio-temporal dispersal pattern of ZIKV in Asia prior to its explosive emergence in the Pacific region and the Americas. These analyses demonstrated that the introduction and dispersal of ZIKV on the Pacific islands were preceded by an extended period of relatively silent transmission in SEA, enabling the virus to expand geographically and evolve adaptively before its unanticipated introduction to immunologically naive populations on the Pacific islands and in the Americas. Our findings reveal new features of the evolution and dispersal of this intriguing virus and may benefit future disease control strategies.
C1 [Pettersson, John H-O; Bohlin, Jon; Brynildsrud, Ola B.; Alfsnes, Kristian; Eldholm, Vegard] Norwegian Inst Publ Hlth, Infect Dis Control & Environm Hlth, Oslo, Norway.
   [Pettersson, John H-O] Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.
   [Pettersson, John H-O] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.
   [Pettersson, John H-O] Natl Vet Inst, Dept Microbiol, Uppsala, Sweden.
   [Pettersson, John H-O] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol IMBIM, Uppsala, Sweden.
   [Dupont-Rouzeyrol, Myrielle] Inst Pasteur Nouvelle Caledonie, Unite Rech Expertise Dengue & Autres Arboviroses, Noumea, New Caledonia.
   [Cao-Lormeau, Van-Mai; Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Cao-Lormeau, Van-Mai; Musso, Didier] Aix Marseille Univ, IHU Mediterranee Infect, VITROME, IRD,AP HM,SSA, Marseille, France.
   [Gaunt, Michael W.] London Sch Hyg & Trop Med, London, England.
   [Falconar, Andrew K.] Univ Norte, Dept Med, Barranquilla, Colombia.
   [De Lamballerie, Xavier; Gould, Ernest A.] Aix Marseille Univ, UMR Unite Virus Emergents, IRD 190, IHU Mediterranee Infect,Inserm 1207, Marseille, France.
   [De Lamballerie, Xavier] Univ Mediterranee Infect, Inst Hosp, Publ Hosp Marseille, AP HM, Marseille, France.
RP Pettersson, JHO (corresponding author), Norwegian Inst Publ Hlth, Infect Dis Control & Environm Hlth, Oslo, Norway.; Pettersson, JHO (corresponding author), Univ Sydney, Charles Perkins Ctr, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia.; Pettersson, JHO (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.; Pettersson, JHO (corresponding author), Natl Vet Inst, Dept Microbiol, Uppsala, Sweden.; Pettersson, JHO (corresponding author), Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol IMBIM, Uppsala, Sweden.
EM John.Pettersson@gmail.com
RI Musso, Didier/P-7809-2016; Cao-Lormeau, Van-Mai/H-4879-2018; Musso,
   Didier/AAO-8178-2020; Eldholm, Vegard/I-4680-2019
OI Musso, Didier/0000-0002-9226-0971; Cao-Lormeau,
   Van-Mai/0000-0001-5606-7480; Musso, Didier/0000-0002-9226-0971; Eldholm,
   Vegard/0000-0001-6721-3375; Bohlin, Jon/0000-0002-0992-1311; Pettersson,
   John H.-O./0000-0001-6665-7492; Brynildsrud, Ola/0000-0001-7566-4133
FU ZIKAlliance project; ZikaPLAN project under European Union [734548,
   734584]; Swedish Research Council FORMASSwedish Research CouncilSwedish
   Research Council Formas [2015-710]
FX E.A.G., D.M., J.H.-O.P., M.D.-R., V.-M. C-L., V.E., and X.D.L. are
   members of the ZIKAlliance Programme of the European Union. M.W.G. and
   A.K.F. are members of the ZikaPLAN Programme of the European Union. This
   study was supported by the ZIKAlliance project and the ZikaPLAN project
   under European Union-Horizon 2020 programme (Grant Agreement Nos. 734548
   and 734584, respectively). J.H.-O.P. is supported by the Swedish
   Research Council FORMAS (Grant Agreement 2015-710).
CR Baele G, 2013, MOL BIOL EVOL, V30, P239, DOI 10.1093/molbev/mss243
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Vieira MACES, 2015, REV INST MED TROP SP, V57, P276, DOI 10.1590/S0036-46652015000300017
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Chu DT, 2017, EUR J CLIN MICROBIOL, V36, P2041, DOI 10.1007/s10096-017-3030-8
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Dupont-Rouzeyrol M, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.102
   Ellison DW, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00359-16
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fritz R, 2011, J VIROL, V85, P4377, DOI 10.1128/JVI.02458-10
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gould EA, 2003, ADV VIRUS RES, V59, P277, DOI 10.1016/S0065-3527(03)59008-X
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gu SH, 2017, VIRUS GENES, V53, P918, DOI 10.1007/s11262-017-1500-9
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   KARABATSOS N, 1978, AM J TROP MED HYG, V27, P372
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Livinso T., 2016, 17 FED STAT MICR
   Lorenz C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005959
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Maria AT, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.6.30131
   Miller MA, 2010, GAT COMP ENV WORKSH, P1, DOI [10.1109/GCE.2010.5676129, DOI 10.1109/GCE.2010.5676129]
   Musso D, 2017, LANCET INFECT DIS, V17, P255, DOI 10.1016/S1473-3099(17)30070-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   POND WILLIAM L., 1963, TRANS ROY SOC TROP MED AND HYG, V57, P364, DOI 10.1016/0035-9203(63)90100-7
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Sapkal GN, 2018, J INFECTION, V76, P314, DOI 10.1016/j.jinf.2017.09.020
   SMITH C E G, 1956, J Trop Med Hyg, V59, P243
   Smithburn K. C., 1950, J IMMUNOL, V1952, P223
   Smithburn K. C., 1950, J IMMUNOL BALTIM MD, V1954, P248
   SMITHBURN KC, 1954, AM J HYG, V59, P157, DOI 10.1093/oxfordjournals.aje.a119630
   Wang BH, 2018, J INFECTION, V76, P106, DOI 10.1016/j.jinf.2017.09.002
   Weaver SC, 2017, MBIO, V8, DOI 10.1128/mBio.02063-16
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002921
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   YOHAI VJ, 1987, ANN STAT, V15, P642, DOI 10.1214/aos/1176350366
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 60
TC 20
Z9 21
U1 1
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAY 9
PY 2018
VL 7
AR 79
DI 10.1038/s41426-018-0082-5
PG 8
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GG5RF
UT WOS:000432752700001
PM 29739925
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Strange, DP
   Zarandi, NP
   Trivedi, G
   Atala, A
   Bishop, CE
   Sadri-Ardekani, H
   Verma, S
AF Strange, Daniel P.
   Zarandi, Nima Pourhabibi
   Trivedi, Goral
   Atala, Anthony
   Bishop, Colin E.
   Sadri-Ardekani, Hooman
   Verma, Saguna
TI Human testicular organoid system as a novel tool to study Zika virus
   pathogenesis
SO EMERGING MICROBES & INFECTIONS
LA English
DT Letter
ID INFECTION; TESTES; SPERM
C1 [Strange, Daniel P.; Trivedi, Goral; Verma, Saguna] Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96813 USA.
   [Zarandi, Nima Pourhabibi; Atala, Anthony; Bishop, Colin E.; Sadri-Ardekani, Hooman] Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.
   [Atala, Anthony; Sadri-Ardekani, Hooman] Wake Forest Sch Med, Dept Urol, Winston Salem, NC 27101 USA.
RP Verma, S (corresponding author), Univ Hawaii Manoa, Dept Trop Med Med Microbiol & Pharmacol, John A Burns Sch Med, Honolulu, HI 96813 USA.; Sadri-Ardekani, H (corresponding author), Wake Forest Inst Regenerat Med, Winston Salem, NC 27101 USA.; Sadri-Ardekani, H (corresponding author), Wake Forest Sch Med, Dept Urol, Winston Salem, NC 27101 USA.
EM hsadri@wakehealth.edu; saguna@hawaii.edu
FU Centers of Biomedical Research Excellence, NIHUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Research Resources (NCRR) [P30GM114737]; Army, Navy,
   Air Force, and Health Affairs [W81XWH-13-2-0052]; NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [5U42RR006042];  [R21AI129465-01]
FX This work was supported by grants from R21AI129465-01 and Centers of
   Biomedical Research Excellence (P30GM114737), NIH. This work was also
   supported by the Army, Navy, Air Force, and Health Affairs to support
   the AFIRM II effort under Award number W81XWH-13-2-0052 and NIH grant
   5U42RR006042. We thank Dr. Vivek R. Nerurkar for providing ZIKV stock
   and critical feedback, and Dr. Steven Wong and his team for measuring
   testosterone at the Wake Forest Baptist Health diagnostic lab.
CR Alves-Lopes JP, 2017, BIOMATERIALS, V130, P76, DOI 10.1016/j.biomaterials.2017.03.025
   Baert Y, 2017, STEM CELL REP, V8, P30, DOI 10.1016/j.stemcr.2016.11.012
   Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790
   Dejucq N, 2001, MICROBIOL MOL BIOL R, V65, P208, DOI 10.1128/MMBR.65.2.208-231.2001
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pendergraft SS, 2017, BIOL REPROD, V96, P720, DOI 10.1095/biolreprod.116.143446
   Pettitt J, 2016, J INFECT DIS, V213, P1237, DOI 10.1093/infdis/jiv454
   Sato T, 2011, NATURE, V471, P504, DOI 10.1038/nature09850
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
NR 15
TC 15
Z9 15
U1 1
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD MAY 9
PY 2018
VL 7
AR 82
DI 10.1038/s41426-018-0080-7
PG 4
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GG5RF
UT WOS:000432752700004
PM 29739931
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tharakaraman, K
   Watanabe, S
   Chan, KR
   Huan, J
   Subramanian, V
   Chionh, YH
   Raguram, A
   Quinlan, D
   McBee, M
   Ong, EZ
   Gan, ES
   Tan, HC
   Tyagi, A
   Bhushan, S
   Lescar, J
   Vasudevan, SG
   Ooi, EE
   Sasisekharan, R
AF Tharakaraman, Kannan
   Watanabe, Satoru
   Chan, Kuan Rong
   Huan, Jia
   Subramanian, Vidya
   Chionh, Yok Hian
   Raguram, Aditya
   Quinlan, Devin
   McBee, Megan
   Ong, Eugenia Z.
   Gan, Esther S.
   Tan, Hwee Cheng
   Tyagi, Anu
   Bhushan, Shashi
   Lescar, Julien
   Vasudevan, Subhash G.
   Ooi, Eng Eong
   Sasisekharan, Ram
TI Rational Engineering and Characterization of an mAb that Neutralizes
   Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope
SO CELL HOST & MICROBE
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; STRUCTURAL BASIS; CRYO-EM;
   INFECTION; BRAZIL; TRANSMISSION; MICROSCOPY; SPECTRUM; DESIGN
AB Following the recent emergence of Zika virus (ZIKV), many murine and human neutralizing anti-ZIKV antibodies have been reported. Given the risk of virus escape mutants, engineering antibodies that target mutationally constrained epitopes with therapeutically relevant potencies can be valuable for combating future outbreaks. Here, we applied computational methods to engineer an antibody, ZAb_FLEP, that targets a highly networked and therefore mutationally constrained surface formed by the envelope protein dimer. ZAb_FLEP neutralized a breadth of ZIKV strains and protected mice in distinct in vivo models, including resolving vertical transmission and fetal mortality in infected pregnant mice. Serial passaging of ZIKV in the presence of ZAb_FLEP failed to generate viral escape mutants, suggesting that its epitope is indeed mutationally constrained. A single-particle cryo-EM reconstruction of the Fab-ZIKV complex validated the structural model and revealed insights into ZAb_FLEP's neutralization mechanism. ZAb_FLEP has potential as a therapeutic in future outbreaks.
C1 [Tharakaraman, Kannan; Subramanian, Vidya; Quinlan, Devin; Sasisekharan, Ram] MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Watanabe, Satoru; Chan, Kuan Rong; Ong, Eugenia Z.; Gan, Esther S.; Tan, Hwee Cheng; Vasudevan, Subhash G.; Ooi, Eng Eong] Duke NUS Grad Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.
   [Huan, Jia; Tyagi, Anu; Bhushan, Shashi; Lescar, Julien] Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Huan, Jia; Tyagi, Anu; Bhushan, Shashi; Lescar, Julien] Nanyang Technol Univ, 60 Nanyang Dr, Singapore 637551, Singapore.
   [Chionh, Yok Hian; McBee, Megan; Ooi, Eng Eong; Sasisekharan, Ram] Singapore MIT Alliance Res & Technol, Infectious Dis Interdisciplinary Res Grp, Singapore, Singapore.
   [Raguram, Aditya] Harvard Univ, Harvard Coll, Cambridge, MA 02138 USA.
RP Sasisekharan, R (corresponding author), MIT, Koch Inst Integrat Canc Res, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Ooi, EE (corresponding author), Duke NUS Grad Med Sch, Program Emerging Infect Dis, 8 Coll Rd, Singapore 169857, Singapore.; Ooi, EE; Sasisekharan, R (corresponding author), Singapore MIT Alliance Res & Technol, Infectious Dis Interdisciplinary Res Grp, Singapore, Singapore.
EM engeong.ooi@duke-nus.edu.sg; rams@mit.edu
RI amsalu, ribka/G-8780-2019
OI Ong, Eugenia/0000-0003-2187-7058; Gan, Esther/0000-0003-4992-424X;
   Raguram, Aditya/0000-0002-5749-7308; Bhushan,
   Shashi/0000-0002-8514-5959; Ooi, Eng Eong/0000-0002-0520-1544
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R01AI111395, 5R37 GM057073-21];
   National Research Foundation; NMRCNational Medical Research Council,
   Singapore [CBRG-0073-2014]
FX We thank Dr. Akshita Kumar for her help with sample preparation. We also
   thank Andrew Hatas, Dr. Rahul Raman, and Dr. V. Sasisekharan for
   technical support and helpful discussions in support of the manuscript.
   This work was funded in part by NIH Awards (1R01AI111395 and 5R37
   GM057073-21 to R.S.) and National Research Foundation-supported
   Interdisciplinary Research group in Infectious Diseases of SMART
   (Singapore MIT Alliance for Research and Technology). Support from NMRC
   grant CBRG-0073-2014 to J.L. is also acknowledged.
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Bell JM, 2016, METHODS, V100, P25, DOI 10.1016/j.ymeth.2016.02.018
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Chan KR, 2011, P NATL ACAD SCI USA, V108, P12479, DOI 10.1073/pnas.1106568108
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dudas G, 2017, NATURE, V544, P309, DOI 10.1038/nature22040
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HEINZ FX, 1994, ARCH VIROL, P339
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lai CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002451
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472
   Low JGH, 2006, ANN ACAD MED SINGAP, V35, P783
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rodriguez-Morales AJ, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0128-2
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tan JL, 2014, METHODS MOL BIOL, V1138, P41, DOI 10.1007/978-1-4939-0348-1_4
   ter Meulen J, 2011, INFECT DIS CLIN N AM, V25, P789, DOI 10.1016/j.idc.2011.07.006
   Tharakaraman K, 2013, P NATL ACAD SCI USA, V110, pE1555, DOI 10.1073/pnas.1303645110
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   Watterson D, 2016, SCI REP-UK, V6, DOI 10.1038/srep22791
   Ye XH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005454
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 40
TC 8
Z9 8
U1 1
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY 9
PY 2018
VL 23
IS 5
BP 618
EP +
DI 10.1016/j.chom.2018.04.004
PG 16
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GG1GW
UT WOS:000432436400008
PM 29746833
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU McGibbon, E
   Moy, M
   Vora, NM
   Dupuis, A
   Fine, A
   Kulas, K
   Limberger, R
   Liu, DK
   Rakeman, J
   St George, K
   Slavinski, S
AF McGibbon, Emily
   Moy, Morgan
   Vora, Neil M.
   Dupuis, Alan
   Fine, Annie
   Kulas, Karen
   Limberger, Ronald
   Liu, Dakai
   Rakeman, Jennifer
   St George, Kirsten
   Slavinski, Sally
CA New York City Zika Surveillance
TI Epidemiological Characteristics and Laboratory Findings of Zika Virus
   Cases in New York City, January 1, 2016-June 30, 2017
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Zika virus; surveillance; epidemiology; diagnosis
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; PROLONGED DETECTION; RNA;
   FLAVIVIRUSES; EXPOSURE; DISEASE; WOMEN
AB Background: An outbreak of Zika virus (ZIKV) began in May 2015 in Brazil and rapidly spread throughout the Americas; New York City (NYC) has a diverse population with similar to 1.8 million residents who were born in ZIKV-affected areas. Before July 24, 2017, the Centers for Disease Control and Prevention (CDC) ZIKV testing recommendations included nucleic acid amplification-based tests for serum and urine specimens collected <= 14 days of illness onset or last potential exposure, and ZIKV immunoglobulin M (IgM) assay when ZIKV RNA is not detected or for specimens collected within 2-12 weeks of illness onset or last potential exposure, followed by a plaque reduction neutralization test (PRNT). However, the New York public health laboratories and commercial laboratories tested specimens collected beyond these time frames.
   Methods: We analyzed 1080 noncongenital ZIKV cases in NYC residents who met the Council for State and Territorial Epidemiologist's ZIKV case definitions.
   Results: Among cases, 98% were travel associated, 1% were sexually transmitted, and 1% had unknown exposures; 412 (38%) cases were pregnant women. Of 672 patients with ZIKV RNA detected in serum or urine specimens, 48 (7%) tested positive >14 days after either symptom onset or last potential exposure date (range 15-99 days). Of 390 patients diagnosed based on serology alone (i.e., not tested or not detectable for ZIKV RNA), 60 (15%) had a positive ZIKV IgM and PRNT >12 weeks after symptom onset or last potential exposure date (range 85-273 days).
   Conclusion: Our findings correspond with CDC's updated guidance to test symptomatic pregnant women up to 12 weeks past onset of symptoms. ZIKV IgM antibody testing may also be warranted for pregnant women regardless of symptoms if their exposure occurred during their pregnancy or periconception period. Providers should understand the scope of diagnostic testing and its limitations to appropriately counsel patients, especially pregnant women.
C1 [McGibbon, Emily; Fine, Annie; Slavinski, Sally] New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, 42-09 28 St,WS 6-137,Box CN22A, Long Isl City, NY 11101 USA.
   [Moy, Morgan; Liu, Dakai; Rakeman, Jennifer] New York City Dept Hlth & Mental Hyg, Publ Hlth Lab, New York, NY USA.
   [Vora, Neil M.] New York City Dept Hlth & Mental Hyg, Long Isl City, NY USA.
   [Dupuis, Alan; Kulas, Karen; Limberger, Ronald; St George, Kirsten] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA.
RP McGibbon, E (corresponding author), New York City Dept Hlth & Mental Hyg, Bur Communicable Dis, 42-09 28 St,WS 6-137,Box CN22A, Long Isl City, NY 11101 USA.
EM elumeng@health.nyc.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Centers for Disease Control and Prevention, 2017, PROL IGM ANT RESP PE, V402
   Centers for Disease Control and Prevention, 2016, CAS COUNTS US
   Centers for Disease Control and Prevention. National Notifiable Disease Surveillance System, 2016, ZIK VIR DIS ZIK VIR
   Centers for Disease Control and Prevention Zika MAC ELISA instructions for use, 2017, ZIK MAC ELISA INSTR
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Jacobs-Wingo Jasmine, 2016, J Emerg Manag, V14, P391, DOI 10.5055/jem.2016.0303
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   New York City Department of Health, 2016, 2016 DOHMH HLTH AL 4
   New York State Department of Health and New York City Department of Health and Mental Hygiene, 2016, LAB REP COMM DIS
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pan American Health Organization, 2015, EP AL NEUR SYNDR CON
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P315, DOI 10.15585/mmwr.mm6512e2
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   U.S. Census Bureau, 2016, 2011 2015 AM COMM SU
   U.S. Food and Drug Administration, 2016, ZIK VIR EM US AUTH
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 33
TC 1
Z9 1
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JUL
PY 2018
VL 18
IS 7
BP 382
EP 389
DI 10.1089/vbz.2017.2223
EA MAY 2018
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GL5CK
UT WOS:000432044600001
PM 29742003
DA 2020-07-08
ER

PT J
AU Goz, E
   Tsalenchuck, Y
   Benaroya, RO
   Zafrir, Z
   Atar, S
   Altman, T
   Julander, J
   Tuller, T
AF Goz, Eli
   Tsalenchuck, Yael
   Benaroya, Rony Oren
   Zafrir, Zohar
   Atar, Shimshi
   Altman, Tahel
   Julander, Justin
   Tuller, Tamir
TI Generation and comparative genomics of synthetic dengue viruses
SO BMC BIOINFORMATICS
LA English
DT Article; Proceedings Paper
CT 15th Annual Research in Computational Molecular Biology (RECOMB)
   Comparative Genomics Satellite Workshop - Bioinformatics
CY OCT 04-06, 2017
CL Barcelona, SPAIN
DE Synthetic virology; RNA viruses; Viral evolution; Flavivirus; Viral
   comparative genomics; Silent and non-synonymous mutations
ID SYNONYMOUS CODON USAGE; RNA VIRUSES; ZIKA VIRUS; MUTATIONAL ROBUSTNESS;
   EVOLUTION; GENE; BIOTECHNOLOGY; BIAS; DNA; CONSTRUCTION
AB Background: Synthetic virology is an important multidisciplinary scientific field, with emerging applications in biotechnology and medicine, aiming at developing methods to generate and engineer synthetic viruses. In particular, many of the RNA viruses, including among others the Dengue and Zika, are widespread pathogens of significant importance to human health. The ability to design and synthesize such viruses may contribute to exploring novel approaches for developing vaccines and virus based therapies.
   Results: Here we develop a full multidisciplinary pipeline for generation and analysis of synthetic RNA viruses and specifically apply it to Dengue virus serotype 2 (DENV-2). The major steps of the pipeline include comparative genomics of endogenous and synthetic viral strains. Specifically, we show that although the synthetic DENV-2 viruses were found to have lower nucleotide variability, their phenotype, as reflected in the study of the AG129 mouse model morbidity, RNA levels, and neutralization antibodies, is similar or even more pathogenic in comparison to the wildtype master strain. Additionally, the highly variable positions, identified in the analyzed DENV-2 population, were found to overlap with less conserved homologous positions in Zika virus and other Dengue serotypes. These results may suggest that synthetic DENV-2 could enhance virulence if the correct sequence is selected.
   Conclusions: The approach reported in this study can be used to generate and analyze synthetic RNA viruses both on genotypic and on phenotypic level. It could be applied for understanding the functionality and the fitness effects of any set of mutations in viral RNA and for editing RNA viruses for various target applications.
C1 [Goz, Eli; Zafrir, Zohar; Atar, Shimshi; Tuller, Tamir] Tel Aviv Univ, Dept Biomed Engn, Tel Aviv, Israel.
   [Goz, Eli; Tsalenchuck, Yael; Benaroya, Rony Oren; Zafrir, Zohar; Altman, Tahel; Tuller, Tamir] SynVaccineLtd Ramat Hachayal, Tel Aviv, Israel.
   [Julander, Justin] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.
   [Tuller, Tamir] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.
RP Tuller, T (corresponding author), Tel Aviv Univ, Dept Biomed Engn, Tel Aviv, Israel.; Tuller, T (corresponding author), SynVaccineLtd Ramat Hachayal, Tel Aviv, Israel.; Tuller, T (corresponding author), Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel.
EM tamirtul@post.tau.ac.il
OI Tuller, Tamir/0000-0003-4194-7068
FU Edmond J. Safra Center for Bioinformatics at Tel-Aviv University;
   Minerva ARCHES award; TAU
FX E.G. is supported, in part, by a fellowship from the Edmond J. Safra
   Center for Bioinformatics at Tel-Aviv University. T.T. is partially
   supported by the Minerva ARCHES award. The publication cost of this
   paper was funded by TAU.
CR Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI 10.1093/nar/gkv1290
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Aragones L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000797
   Aubry F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138703
   Aubry F, 2014, J GEN VIROL, V95, P2462, DOI 10.1099/vir.0.068023-0
   Bull JJ, 2012, MOL BIOL EVOL, V29, P2997, DOI 10.1093/molbev/mss119
   Burns CC, 2006, J VIROL, V80, P3259, DOI 10.1128/JVI.80.7.3259-3272.2006
   Cheng XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074109
   Coleman JR, 2008, SCIENCE, V320, P1784, DOI 10.1126/science.1155761
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Santos JJD, 2013, MEM I OSWALDO CRUZ, V108, P983, DOI 10.1590/0074-0276130298
   Dana A, 2014, NUCLEIC ACIDS RES, V42, P9171, DOI 10.1093/nar/gku646
   Das S, 2006, VIRUS RES, V117, P227, DOI 10.1016/j.virusres.2005.10.007
   Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11
   Du RK, 2015, VIROL SIN, V30, P354, DOI 10.1007/s12250-015-3623-2
   EIGEN M, 1993, SCI AM, V269, P42, DOI 10.1038/scientificamerican0793-42
   Ekins Sean, 2016, F1000Res, V5, P275
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   GARRISON E, 2012, GENOMICS, V1207, P3907, DOI DOI 10.1101/1207.3907
   Goodfellow I, 2000, J VIROL, V74, P4590, DOI 10.1128/JVI.74.10.4590-4600.2000
   Goz E, 2017, DNA RES, V24, P333, DOI 10.1093/dnares/dsx005
   Goz E, 2016, J COMPUT BIOL, V23, P641, DOI 10.1089/cmb.2016.0052
   Goz E, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S10-S4
   Greenbaum BD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000079
   Gu WJ, 2004, VIRUS RES, V101, P155, DOI 10.1016/j.virusres.2004.01.006
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Jenkins GM, 2001, J MOL EVOL, V52, P383, DOI 10.1007/s002390010168
   Jia RY, 2009, VIRUS GENES, V38, P96, DOI 10.1007/s11262-008-0295-0
   KARLIN S, 1994, J VIROL, V68, P2889, DOI 10.1128/JVI.68.5.2889-2897.1994
   KARLIN S, 1995, TRENDS GENET, V11, P283
   Kaufman HL, 2015, NAT REV DRUG DISCOV, V14, P642, DOI 10.1038/nrd4663
   Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324
   Lauring AS, 2013, NAT REV MICROBIOL, V11, P327, DOI 10.1038/nrmicro3003
   Lauring AS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001005
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu YS, 2011, INFECT GENET EVOL, V11, P1168, DOI 10.1016/j.meegid.2011.02.018
   Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26
   Martrus G, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-78
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pu SY, 2011, J VIROL, V85, P2927, DOI 10.1128/JVI.01986-10
   Read Andrew F., 1994, Trends in Microbiology, V2, P73, DOI 10.1016/0966-842X(94)90537-1
   Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853
   Rima BK, 1997, J GEN VIROL, V78, P2859, DOI 10.1099/0022-1317-78-11-2859
   Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904
   Sainsbury F, 2010, ANNU REV PHYTOPATHOL, V48, P437, DOI 10.1146/annurev-phyto-073009-114242
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Siridechadilok B, 2013, J VIROL, V87, P12667, DOI 10.1128/JVI.02261-13
   Soto CM, 2010, CURR OPIN BIOTECH, V21, P426, DOI 10.1016/j.copbio.2010.07.004
   STEINHAUER DA, 1987, ANNU REV MICROBIOL, V41, P409, DOI 10.1146/annurev.mi.41.100187.002205
   Tao P, 2009, VIRUS GENES, V38, P104, DOI 10.1007/s11262-008-0296-z
   Tulloch F, 2014, ELIFE, V3, DOI 10.7554/eLife.04531
   WANG AHJ, 1984, CELL, V37, P321, DOI 10.1016/0092-8674(84)90328-3
   WRIGHT F, 1990, GENE, V87, P23, DOI 10.1016/0378-1119(90)90491-9
   Yakovchuk P, 2006, NUCLEIC ACIDS RES, V34, P564, DOI 10.1093/nar/gkj454
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhou JH, 2010, VET RES COMMUN, V34, P393, DOI 10.1007/s11259-010-9359-4
NR 59
TC 1
Z9 1
U1 2
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAY 8
PY 2018
VL 19
SU 6
AR 140
DI 10.1186/s12859-018-2132-3
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA GF9IQ
UT WOS:000432290100001
PM 29745863
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rees, EE
   Petukhova, T
   Mascarenhas, M
   Pelcat, Y
   Ogden, NH
AF Rees, Erin E.
   Petukhova, Tatiana
   Mascarenhas, Mariola
   Pelcat, Yann
   Ogden, Nicholas H.
TI Environmental and social determinants of population vulnerability to
   Zika virus emergence at the local scale
SO PARASITES & VECTORS
LA English
DT Article
DE Zika; Environmental determinants; Public health surveillance; Social
   bias; Risk analysis; Logistic regression model; Accelerated failure time
   survival model; Colombia
ID AEDES-AEGYPTI; SEXUAL TRANSMISSION; DENGUE; DIPTERA; CHIKUNGUNYA;
   ALBOPICTUS; CULICIDAE; INFECTION; COLOMBIA; CLIMATE
AB Background: Zika virus (ZIKV) spread rapidly in the Americas in 2015. Targeting effective public health interventions for inhabitants of, and travellers to and from, affected countries depends on understanding the risk of ZIKV emergence (and re-emergence) at the local scale. We explore the extent to which environmental, social and neighbourhood disease intensity variables influenced emergence dynamics. Our objective was to characterise population vulnerability given the potential for sustained autochthonous ZIKV transmission and the timing of emergence. Logistic regression models estimated the probability of reporting at least one case of ZIKV in a given municipality over the course of the study period as an indicator for sustained transmission; while accelerated failure time (AFT) survival models estimated the time to a first reported case of ZIKV in week t for a given municipality as an indicator for timing of emergence.
   Results: Sustained autochthonous ZIKV transmission was best described at the temporal scale of the study period (almost one year), such that high levels of study period precipitation and low mean study period temperature reduced the probability. Timing of ZIKV emergence was best described at the weekly scale for precipitation in that high precipitation in the current week delayed reporting. Both modelling approaches detected an effect of high poverty on reducing/slowing case detection, especially when inter-municipal road connectivity was low. We also found that proximity to municipalities reporting ZIKV had an effect to reduce timing of emergence when located, on average, less than 100 km away.
   Conclusions: The different modelling approaches help distinguish between large temporal scale factors driving vector habitat suitability and short temporal scale factors affecting the speed of spread. We find evidence for inter-municipal movements of infected people as a local-scale driver of spatial spread. The negative association with poverty suggests reduced case reporting in poorer areas. Overall, relatively simplistic models may be able to predict the vulnerability of populations to autochthonous ZIKV transmission at the local scale.
C1 [Rees, Erin E.; Pelcat, Yann; Ogden, Nicholas H.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, St Hyacinthe, PQ, Canada.
   [Petukhova, Tatiana; Mascarenhas, Mariola] Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, Guelph, ON, Canada.
RP Rees, EE (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Publ Hlth Risk Sci Div, St Hyacinthe, PQ, Canada.
EM erin.rees@canada.ca
FU Public Health Agency of Canada
FX This study was funded by the Public Health Agency of Canada. This
   article was reviewed and approved for submission by the funding source.
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Althouse BM, 2015, AM J TROP MED HYG, V92, P88, DOI 10.4269/ajtmh.13-0617
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Beck N, 1998, AM J POLIT SCI, V42, P1260, DOI 10.2307/2991857
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Bustamente Roldan J, 2011, QUALITY LIFE NATL SU
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Choi Y, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2923-2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Diaz BY, 2013, ISER WORKING PAPER S
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   Hotez PJ, 2014, PLOS NEGLECT TROP D, V8, P4
   HOTEZ PJ, 2011, PLOS NEGLECT TROP D, V5
   Koenraadt CJM, 2008, J MED ENTOMOL, V45, P28, DOI 10.1603/0022-2585(2008)45[28:FEOROC]2.0.CO;2
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lemeshow S., 2004, APPL LOGISTIC REGRES
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Musso D, 2017, LANCET INFECT DIS, V17, P782, DOI 10.1016/S1473-3099(17)30251-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nah K, 2016, PEERJ, V4, DOI 10.7717/peerj.1904
   Ogden NH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1977-z
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Pan American Health Organization, 2017, ZIK EP REP COL
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   PERERA N, 2016, ZIKA I NAC SALUD, P1
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Pontes RJS, 2000, AM J TROP MED HYG, V62, P378, DOI 10.4269/ajtmh.2000.62.378
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Shi WF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.68
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Suarez M. F., 1981, Biomedica, V1, P225
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Tri-council (Canadian Institutes of Health Research Natural. Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada), 2014, TRIC POL STAT ETH CO
   Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Wan Z, 2015, MOD11C2 MODIS TERRA, DOI [10.5067/MODIS/MOD11C2.006, DOI 10.5067/MODIS/MOD11C2.006.ACCESSED]
   Wijayanti SPM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004964
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 58
TC 4
Z9 4
U1 1
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 8
PY 2018
VL 11
AR 290
DI 10.1186/s13071-018-2867-8
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GF3EI
UT WOS:000431828000002
PM 29739467
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Paula, AR
   Silva, LEI
   Ribeiro, A
   Butt, TM
   Silva, CP
   Samuels, RI
AF Paula, Adriano R.
   Silva, Leila E., I
   Ribeiro, Anderson
   Butt, Tariq M.
   Silva, Carlos P.
   Samuels, Richard, I
TI Improving the delivery and efficiency of fungus-impregnated cloths for
   control of adult Aedes aegypti using a synthetic attractive lure
SO PARASITES & VECTORS
LA English
DT Article
DE Fungal virulence; Intra-domicile conditions; Attractive lure; Traps;
   Vector; Insect; Dengue; Zika
ID DENGUE VECTOR CONTROL; DIPTERA-CULICIDAE; METARHIZIUM-ANISOPLIAE;
   CULEX-QUINQUEFASCIATUS; TRAPS; COLLECTION; MALARIA; BRAZIL
AB Background: Entomopathogenic fungi are highly promising agents for controlling Aedes aegypti mosquitoes. Deploying fungus-impregnated black cloths in PET traps efficiently reduced Ae. aegypti female survival rates under intra-domicile conditions. With the aim of further increasing the effectiveness of the traps, the addition of attractive lures to fungus-impregnated traps was evaluated.
   Methods: Black cloths were suspended inside 2 l plastic bottles called "PET traps". These traps were placed in rooms simulating human residences. The first experiments evaluated the attraction of mosquitoes to PET traps with black cloths covered in adhesive film with and without synthetic lures (AtrAedes (TM)). Traps were left in the test rooms for either 24 or 48 h. The attractiveness of the lures over time was also evaluated. The efficiency of PET traps with fungus-impregnated black cloths associated with lures was compared to that of traps without lures.
   Results: The highest percentage of captured mosquitoes (31 and 66%) were observed in PET traps with black cloths covered in adhesive film + attractive lure maintained in test rooms for 24 h and 48 h, respectively. Black cloths covered in adhesive film captured 17 or 36% of the mosquitoes at 24 h and 48 h, respectively. The attractiveness of the lures fell gradually over time, capturing 37% after 5 days on the bench and 22% of the mosquitoes after 30 days exposure to ambient conditions. Associating attractive synthetic lures with black cloths impregnated with M. anisopliae placed in test rooms for 120 h reduced mean survival to 32%, whilst black cloths impregnated with M. anisopliae without lures resulted in a 48% survival rate. Using Beauveria bassiana in the traps resulted in a 52% reduction in mosquito survival, whilst combining Beauveria and AtrAedes resulted in a 36% survival rate. PET traps impregnated with fungus + AtrAedes resulted in similar reductions in survival when left in the rooms for 24, 48, 72 or 120 h.
   Conclusions: AtrAedes increased attractiveness of PET traps with black cloths under intra-domicile conditions and when associated with M. anisopliae or B. bassiana, significantly reduced Aedes survival. This strategy will reduce the number of PET traps necessary per household.
C1 [Paula, Adriano R.; Silva, Leila E., I; Ribeiro, Anderson; Samuels, Richard, I] Univ Estadual Norte Fluminense, Dept Entomol & Plant Pathol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
   [Butt, Tariq M.] Swansea Univ, Coll Sci, Dept Biosci, Singleton Pk, Swansea SA2 8PP, W Glam, Wales.
   [Silva, Carlos P.] Univ Fed Santa Catarina, Dept Bioquim, BR-88040900 Florianopolis, SC, Brazil.
RP Samuels, RI (corresponding author), Univ Estadual Norte Fluminense, Dept Entomol & Plant Pathol, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.
EM richardiansamuels@gmail.com
RI Samuels, Richard/I-2108-2019
OI Samuels, Richard/0000-0003-1814-2456; Silva, Carlos/0000-0001-5112-7050
FU FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.336/2016, E-26/203.006/2016];
   CNPqNational Council for Scientific and Technological Development (CNPq)
   [431766/2016-9]
FX The study was funded by FAPERJ (E-26/201.336/2016, E-26/203.006/2016)
   and CNPq 431766/2016-9.
CR de Paula AR, 2008, BIOCONTROL SCI TECHN, V18, P1017, DOI 10.1080/09583150802509199
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Eiras AE, 2014, J MED ENTOMOL, V51, P200, DOI 10.1603/ME13104
   Eiras AE, 2009, CAD SAUDE PUBLICA, V25, pS45, DOI 10.1590/S0102-311X2009001300005
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Farenhorst M, 2008, AM J TROP MED HYG, V78, P910, DOI 10.4269/ajtmh.2008.78.910
   GARCIAMUNGUIA AM, 2011, PARASITE VECTOR, V4
   George J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108894
   HECHT OTTO, 1963, ENTOMOL EXPTL ET APPL, V6, P63, DOI 10.1111/j.1570-7458.1963.tb00603.x
   Heringer L, 2016, J MED ENTOMOL, V53, P873, DOI 10.1093/jme/tjw051
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Irish SR, 2015, J AM MOSQUITO CONTR, V31, P107, DOI 10.2987/14-6420R.1
   Lwetoijera DW, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-18
   Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8
   Mnyone LL, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-87
   Paula AR, 2013, LETT APPL MICROBIOL, V57, P157, DOI 10.1111/lam.12090
   Paula AR, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-256
   Pereira CR, 2009, BIOCONTROL SCI TECHN, V19, P881, DOI 10.1080/09583150903147659
   Reyes-Villanueva F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-171
   Samuels Richard I., 2016, Open Access Insect Physiology, V6, P25
   Santos AH, 2009, BIOL CONTROL, V50, P37, DOI 10.1016/j.biocontrol.2009.01.018
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Silva LEI, 2018, J APPL ENTOMOL, V142, P59, DOI 10.1111/jen.12402
   Snetselaar J, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-200
   Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638
   Thornton JH, 2016, J VECTOR ECOL, V41, P265, DOI 10.1111/jvec.12221
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yakob Laith, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.45deb8e03a438c4d088afb4fafae8747
NR 28
TC 2
Z9 2
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 4
PY 2018
VL 11
AR 285
DI 10.1186/s13071-018-2871-z
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GF3EG
UT WOS:000431827800002
PM 29728121
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ebuenyi, ID
   Bhuyan, SS
   Bain, LE
AF Ebuenyi, Ikenna Desmond
   Bhuyan, Soumitra Sudip
   Bain, Luchuo Engelbert
TI Zika Virus infection and microcephaly: anxiety burden for women
SO PAN AFRICAN MEDICAL JOURNAL
LA English
DT Editorial Material
DE Zika virus; microcephaly; anxiety
AB The re-emergence of Zika virus in Brazil and other contiguous countries is a source of anxiety for pregnant women on account of its association with microcephaly. Adverse pregnancy outcome has huge mental health implications. It is essential for health providers to incorporate psychosocial care as part of pre and postnatal care for women in all countries affected by the Zika virus infection.
C1 [Ebuenyi, Ikenna Desmond; Bain, Luchuo Engelbert] Vrije Univ, Athena Inst, Fac Earth & Life Sci, Amsterdam, Netherlands.
   [Bhuyan, Soumitra Sudip] Univ Memphis, Div Hlth Syst Management & Policy, Memphis, TN 38152 USA.
RP Ebuenyi, ID (corresponding author), Vrije Univ, Athena Inst, Fac Earth & Life Sci, Amsterdam, Netherlands.
CR Al-Gailani S., 2016, RUBELLA ZIKA PREGNAN
   Awah Paschal Kum, 2015, Pan Afr Med J, V22 Suppl 1, P18, DOI 10.11694/pamj.supp.2015.22.1.6652
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burke RM, 2016, BRIT J GEN PRACT, V66, P122, DOI 10.3399/bjgp16X683917
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Oliveira SJGD, 2016, ARCH WOMEN MENT HLTH, V19, P1149, DOI 10.1007/s00737-016-0654-0
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Sappenfield E, 2013, INFECT DIS OBSTET GY, V2013
   Women Enabled International, 2016, TALK POINTS ZIK MICR
   World Health Organization, 2016, ZIK VIR SIT REP 2016
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
NR 12
TC 0
Z9 0
U1 2
U2 3
PU AFRICAN FIELD EPIDEMIOLOGY NETWORK-AFENET
PI KAMPALA
PA PO BOX 12874, KAMPALA, 00000, UGANDA
SN 1937-8688
J9 PAN AFR MED J
JI Pan Afr. Med. J.
PD MAY 3
PY 2018
VL 30
AR 2
DI 10.11604/pamj.2018.30.2.11794
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GH7MD
UT WOS:000433628100001
PM 30123405
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lalle, E
   Colavita, F
   Iannetta, M
   Tekle, SG
   Carletti, F
   Scorzolini, L
   Bordi, L
   Vincenti, D
   Castilletti, C
   Ippolito, G
   Capobianchi, MR
   Nicastri, E
AF Lalle, Eleonora
   Colavita, Francesca
   Iannetta, Marco
   Tekle, Saba Gebremeskel
   Carletti, Fabrizio
   Scorzolini, Laura
   Bordi, Licia
   Vincenti, Donatella
   Castilletti, Concetta
   Ippolito, Giuseppe
   Capobianchi, Maria Rosaria
   Nicastri, Emanuele
TI Prolonged detection of dengue virus RNA in the semen of a man returning
   from Thailand to Italy, January 2018
SO EUROSURVEILLANCE
LA English
DT Article
ID ZIKA VIRUS; SEXUAL TRANSMISSION; URINE
AB This study reports the presence of dengue virus RNA in longitudinally collected semen samples of a previously healthy Caucasian man, returning to Italy from Thailand with primary dengue fever, up to 37 days post-symptom onset, when viraemia and viruria were undetectable. This finding, coupled with the evidence of dengue virus negative-strand RNA, an indirect marker of ongoing viral replication, in the cellular fraction of semen, indicates a need to further investigate possible sexual transmission.
C1 [Lalle, Eleonora; Colavita, Francesca; Iannetta, Marco; Tekle, Saba Gebremeskel; Carletti, Fabrizio; Scorzolini, Laura; Bordi, Licia; Vincenti, Donatella; Castilletti, Concetta; Ippolito, Giuseppe; Capobianchi, Maria Rosaria; Nicastri, Emanuele] IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
RP Castilletti, C (corresponding author), IRCCS, Natl Inst Infect Dis Lazzaro Spallanzani, Rome, Italy.
EM concetta.castilletti@inmi.it
RI Castilletti, Concetta/B-6545-2016; Castilletti, Concetta/AAA-8408-2019;
   nicastri, emanuele/K-7780-2016; Iannetta, Marco/M-4619-2019; Iannetta,
   Marco/B-5596-2017; Colavita, Francesca/I-8848-2018
OI Castilletti, Concetta/0000-0001-9819-236X; Castilletti,
   Concetta/0000-0001-9819-236X; nicastri, emanuele/0000-0002-5606-8712;
   Iannetta, Marco/0000-0002-6938-8627; Iannetta,
   Marco/0000-0002-6938-8627; Colavita, Francesca/0000-0003-0640-8667;
   gebremeskel tekle, saba/0000-0001-5332-3055; lalle,
   eleonora/0000-0002-7063-9905; Ippolito, Giuseppe/0000-0002-1076-2979;
   PERNO, CARLO FEDERICO/0000-0002-0825-5388
FU Italian Ministry of HealthMinistry of Health, Italy [RF-2016-02364155,
   GR-2016-02362110]; European Union's Horizon research and innovation
   programme [653316]
FX This work was supported by grants of Italian Ministry of Health, for
   "Ricerca Corrente" and "Ricerca Finalizzata" (RF-2016-02364155 and
   GR-2016-02362110), and received funding from the European Union's
   Horizon 2020 research and innovation programme under grant agreement No
   653316 (EVAg).
CR Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Biava M, 2018, NEW MICROBIOL, V41, P30
   Biava M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006065
   Chen Lin H, 2016, Trop Dis Travel Med Vaccines, V2, P15, DOI 10.1186/s40794-016-0032-y
   Chye JK, 1997, CLIN INFECT DIS, V25, P1374, DOI 10.1086/516126
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   European Centre for Disease Prevention and Control (ECDC), SURV ATL INF DIS
   Iannetta M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.34.30600
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
NR 14
TC 10
Z9 10
U1 0
U2 1
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAY 3
PY 2018
VL 23
IS 18
BP 7
EP 9
AR 18-00197
DI 10.2807/1560-7917.ES.2018.23.18.18-00197
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA GE7JU
UT WOS:000431410200002
PM 29741153
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barros, JBD
   da Silva, PAN
   Koga, RDR
   Gonzalez-Dias, P
   Carmo, JR
   Nagib, PRA
   Coelho, V
   Nakaya, HI
   Fonseca, SG
   Pfrimer, IAH
AF de Sousa Barros, Jessica Barletto
   Neves da Silva, Paulo Alex
   Rocha Koga, Rosemary de Carvalho
   Gonzalez-Dias, Patricia
   Carmo Filho, Jose Rodrigues
   Alo Nagib, Patricia Resende
   Coelho, Veronica
   Nakaya, Helder I.
   Fonseca, Simone Goncalves
   Hoffmann Pfrimer, Irmtraut Araci
TI Acute Zika Virus Infection in an Endemic Area Shows Modest
   Proinflammatory Systemic Immunoactivation and Cytokine-Symptom
   Associations
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE acute Zika virus infection; cytokines; chemokines; symptoms; immune
   response; low viremia; immunoactivation
ID SERUM-LEVELS; MIGRAINE; CELLS; CCL3/MIP-1-ALPHA; PATHOGENESIS;
   MONOCYTES; DISEASE; TARGET
AB An early immune response to Zika virus (ZIKV) infection may determine its clinical manifestation and outcome, including neurological effects. However, low-grade and transient viremia limits the prompt diagnosis of acute ZIKV infection. We have investigated the plasma cytokine, chemokine, and growth factor profiles of 36 individuals from an endemic area displaying different symptoms such as exanthema, headache, myalgia, arthralgia, fever, hyperemia, swelling, itching, and nausea during early-phase infection. These profiles were then associated with symptoms, revealing important aspects of the immunopathophysiology of ZIKV infection. The levels of some cytokines/chemokines were significantly higher in acute ZIKV-infected individuals compared to healthy donors, including interferon (IFN) gamma-induced protein 10 (IP-10), regulated on activation, normal T cell expressed and secreted (RANTES), IFN-gamma interleukin (IL)-9, IL-7, IL-5, and IL-1ra, including some with predominantly immunoregulatory activity. Of note, we found that higher levels of IP-10 and IL-5 in ZIKV-infected individuals were strongly associated with exanthema and headache, respectively. Also, higher levels of IL-1ra were associated with subjects with arthralgia, whereas those with fever showed lower levels of granulocytecolony stimulating factor (G-CSF). No correlation was observed between the number of symptoms and ZIKV viral load. Interestingly, only IP-10 showed significantly decreased levels in the recovery phase. In conclusion, our results indicate that acute ZIKV infection in a larger cohort resident to an endemic area displays a modest systemic immune activation profile, involving both proinflammatory and immunoregulatory cytokines and chemokines that could participate of virus control. In addition, we showed that differential cytokine/chemokine levels are related to specific clinical symptoms, suggesting their participation in underlying mechanisms.
C1 [de Sousa Barros, Jessica Barletto; Rocha Koga, Rosemary de Carvalho; Carmo Filho, Jose Rodrigues; Hoffmann Pfrimer, Irmtraut Araci] Pontifical Catholic Univ Goias, Sch Med Pharmaceut & Biomed Sci, Dept Master Environm Sci & Hlth, Goiania, Go, Brazil.
   [Neves da Silva, Paulo Alex; Alo Nagib, Patricia Resende; Fonseca, Simone Goncalves] Univ Fed Goias, Dept Microbiol Immunol Parasitol & Pathol, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.
   [Gonzalez-Dias, Patricia; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, Sao Paulo, Brazil.
   [Coelho, Veronica] Univ Sao Paulo, Sch Med, Immunol Lab, Heart Inst InCor, Sao Paulo, Brazil.
   [Coelho, Veronica; Fonseca, Simone Goncalves] INCT, Iii, Natl Inst Sci & Technol, Sao Paulo, Brazil.
RP Pfrimer, IAH (corresponding author), Pontifical Catholic Univ Goias, Sch Med Pharmaceut & Biomed Sci, Dept Master Environm Sci & Hlth, Goiania, Go, Brazil.; Fonseca, SG (corresponding author), Univ Fed Goias, Dept Microbiol Immunol Parasitol & Pathol, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Pathophysiol & Toxicol, Sao Paulo, Brazil.; Fonseca, SG (corresponding author), INCT, Iii, Natl Inst Sci & Technol, Sao Paulo, Brazil.
EM hnakaya@usp.br; fonseca.simone@gmail.com; araci@pfrimer.com.br
RI Nakaya, Helder/A-1397-2010; FONSECA, SIMONE GONCALVES/U-9278-2019;
   Nakaya, Helder/AAF-1738-2020
OI Nakaya, Helder/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108;
   Gonzalez-Dias, Patricia/0000-0002-6434-3841; Coelho,
   Veronica/0000-0002-0989-2581
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq); Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/08216-2]
FX This work was funded by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES) fellowship (to JB), and research fellowships from
   the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (to VC
   and HN). The research leading to these results received funding from the
   Sao Paulo Research Foundation (FAPESP) under grant agreement no.
   2013/08216-2 (Center for Research in Inflammatory Diseases-CRID) (to
   HN).
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Bockowski L, 2010, PHARMACOL REP, V62, P287
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   BRASIL - Secretaria de Vigilancia em Saude Ministerio da Saude (SVS-MS, 2018, B EPIDEMIOLOGICO, V49, P5
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cassatella MA, 1997, EUR J IMMUNOL, V27, P111, DOI 10.1002/eji.1830270117
   Chalan P, 2016, SCI REP-UK, V6, DOI 10.1038/srep26021
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cutolo M, 2004, Reumatismo, V56, P41
   Dayer JM, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00293
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Domingues RB, 2016, ARQ NEURO-PSIQUIAT, V74, P626, DOI 10.1590/0004-282X20160096
   Duarte H, 2015, NEUROL SCI, V36, P203, DOI 10.1007/s10072-014-1931-1
   Fallahi P, 2016, CLIN TER, V167, pE186, DOI 10.7417/CT.2016.1966
   Fernandez TD, 2009, CURR OPIN INFECT DIS, V22, P272, DOI 10.1097/QCO.0b013e3283298e62
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Genin P, 2000, REV IMMUNOGENET, V2, P3
   Glass William G, 2003, Curr Opin Allergy Clin Immunol, V3, P467, DOI 10.1097/00130832-200312000-00008
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Konno S, 2002, AM J RESP CELL MOL, V26, P594, DOI 10.1165/ajrcmb.26.5.4438
   Koraka P, 2003, J MED VIROL, V70, P91, DOI 10.1002/jmv.10358
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Laing Emma, 2010, BMC Res Notes, V3, P221, DOI 10.1186/1756-0500-3-221
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liu MX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014706
   Maciel IJ, 2008, REV PATOLOGIA TROPIC, V37, P2, DOI [10.5216/rpt.v37i2.4998, DOI 10.5216/RPT.V37I2.4998]
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Munno I, 1998, HEADACHE, V38, P465, DOI 10.1046/j.1526-4610.1998.3806465.x
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pinto VL, 2015, ACTA MEDICA PORT, V28, P760, DOI 10.20344/amp.6929
   Restrepo BN, 2008, AM J TROP MED HYG, V79, P673, DOI 10.4269/ajtmh.2008.79.673
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Vazquez S, 2005, J CLIN VIROL, V33, P132, DOI 10.1016/j.jcv.2004.10.013
   Vazquez S, 2014, J MED VIROL, V86, P1576, DOI 10.1002/jmv.23833
   Wang F, 2016, ASIAN PAC J ALLERGY, V34, P236, DOI 10.12932/AP0679
   Zhu X, 2012, CURR ONCOL, V19, pE239, DOI 10.3747/co.19.948
NR 49
TC 7
Z9 7
U1 0
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD MAY 3
PY 2018
VL 9
AR 821
DI 10.3389/fimmu.2018.00821
PG 11
WC Immunology
SC Immunology
GA GE6JS
UT WOS:000431333200001
PM 29774022
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carabali, M
   Austin, N
   King, NB
   Kaufman, JS
AF Carabali, Mabel
   Austin, Nichole
   King, Nicholas B.
   Kaufman, Jay S.
TI The Zika epidemic and abortion in Latin America: a scoping review
SO GLOBAL HEALTH RESEARCH AND POLICY
LA English
DT Review
DE Zika; Congenital Zika syndrome; Latin America; Abortion; Public health
   practice; Maternal and child health
AB Background Latin America presently has the world's highest burden of Zika virus, but there are unexplained differences in national rates of congenital malformations collectively referred to as Congenital Zika Syndrome (CZS) in the region. While Zika virulence and case detection likely contribute to these differences, policy-related factors, including access to abortion, may play important roles. Our goal was to assess perspectives on, and access to, abortion in Latin America in the context of the Zika epidemic. Methods We conducted a scoping review of peer-reviewed and gray literature published between January 2015 and December 2016, written in English, Spanish, Portuguese, or French. We searched PubMed, Scielo, and Google Scholar for literature on Zika and/or CZS and abortion, and used automated and manual review methods to synthesize the existing information. Results 36 publications met our inclusion criteria, the majority of which were qualitative. Publications were generally in favor of increased access to safe abortion as a policy-level response for mitigating the impact of CZS, but issues with implementation were cited as the main challenge. Aside from the reform of abortion regulation in Colombia, we did not find evidence that the Zika epidemic had triggered shifts in abortion policy in other countries. Conclusion Abortion policy in the region remained largely unchanged following the Zika epidemic. Further empirical research on abortion access and differential rates of CZS across Latin American countries is required.
C1 [Carabali, Mabel; Austin, Nichole; King, Nicholas B.; Kaufman, Jay S.] McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West,Purvis Hall Room 17A, Montreal, PQ H3A 1A2, Canada.
   [King, Nicholas B.] McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada.
RP Carabali, M (corresponding author), McGill Univ, Fac Med, Dept Epidemiol Biostat & Occupat Hlth, 1020 Pine Ave West,Purvis Hall Room 17A, Montreal, PQ H3A 1A2, Canada.
EM mabel.carabali@mail.mcgill.ca
OI Kaufman, Jay/0000-0003-1606-401X; Carabali, Mabel/0000-0002-9171-0483
FU Department of Medicine at McGill University; Fonds de Recherche du
   Quebec -Sante (FRQS)
FX Mabel Carabali holds a Richard H. Tomlinson doctoral fellowship from the
   Department of Medicine at McGill University. Nichole Austin holds a
   doctoral award from the Fonds de Recherche du Quebec -Sante (FRQS).
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Anderson C. Fernandez, 2016, NACLA REPORT AM, V48, P15
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   [Anonymous], 2016, GUID ZIK VIR DIS COM
   [Anonymous], 2016, ZIK SUSP CONF CAS RE
   Arksey H, 2005, INT J SOC RES METHOD, V8, P19, DOI DOI 10.1080/1364557032000119616
   Ballantyne A, 2009, AM J BIOETHICS, V9, P48, DOI 10.1080/15265160902984996
   Becker R, 2016, NAT MED, V22, P225, DOI 10.1038/nm0316-225
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Brown C, 2016, CAN MED ASSOC J, V188, pE34, DOI 10.1503/cmaj.109-5212
   Buchbinder M, 2016, HASTINGS CENT REP, V46, P22, DOI 10.1002/hast.545
   Burke A, 2016, SEMIN REPROD MED, V34, P305, DOI 10.1055/s-0036-1592068
   Butler Declan, 2016, Nature, V531, P153, DOI 10.1038/nature.2016.19502
   Carless W., 2016, PART SERIES BODY POL
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Chowell G, 2016, PLOS CURRENTS OUTBRE, V8, P1
   de Camargo TMCR, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00071516
   COLLUCCI C, 2016, BMJ CLIN RES ED, V354, DOI DOI 10.1136/BMJ.I4657
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darney BG, 2017, OBSTET GYNECOL, V129, P638, DOI [10.1097/AOG.0000000000001914, 10.1097/aog.0000000000001914]
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Davis K, 2009, INT J NURS STUD, V46, P1386, DOI 10.1016/j.ijnurstu.2009.02.010
   de Carvalho BR, 2016, J BRAS REPROD ASSIST, V20, P159, DOI 10.5935/1518-0557.20160034
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Erdman JN, 2013, INT J GYNECOL OBSTET, V120, P200, DOI 10.1016/j.ijgo.2012.10.009
   Erdman JN, 2012, INT J GYNECOL OBSTET, V118, P83, DOI 10.1016/j.ijgo.2012.04.002
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faundes A, 2007, REPROD HEALTH MATTER, V15, P130, DOI 10.1016/S0968-8080(07)29300-0
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Galli B, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00031116
   Garsd J., 2016, ZIKA VIRUS ISNT 1 DI
   Gawron LM, 2017, CONTRACEPTION, V95, P175, DOI 10.1016/j.contraception.2016.08.020
   Goldthwaite LM, 2016, CURR OPIN OBSTET GYN, V28, P499, DOI 10.1097/GCO.0000000000000323
   Gostin LO, 2016, LANCET INFECT DIS, V16, P1099, DOI 10.1016/S1473-3099(16)30332-2
   Guttmacher Institute, 2016, GOOD REPR HLTH POL S, V2017
   Harris LH, 2016, AM J BIOETHICS, V16, P1, DOI 10.1080/15265161.2016.1177367
   Hodge JG, 2016, DISASTER MED PUBLIC, V10, P713, DOI 10.1017/dmp.2016.34
   Brosco JH, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2095
   Howard AR, 2016, COMMONWEAL, V143, P12
   Joerg D, 2016, COUNTERING ZIKA GLOB
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Levac D, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-69
   Machado-Alba JE, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30429-9
   MAYOR S, 2016, BMJ CLIN RES ED, V353, DOI DOI 10.1136/BMJ.I3492
   McNeil Jr Donald G., 2016, NY TIMES
   Miller M, 2016, WASHINGTON POST
   Miller M., 2016, HUMANIST, V76, P9
   MINSALUD C, 2016, LINEAMIENTOS PROVISI
   Morgan LM, 2012, ANTHROPOL MED, V19, P241, DOI 10.1080/13648470.2012.675046
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Nolan R, 2016, NEW YORK HARPERS MAG
   O'Brien J, 2016, CONSCIENCE, V37, P60
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Perry C Nicolás, 2017, Rev. chil. obstet. ginecol., V82, P89
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pew Research Center, REL PUBL LIF, P2014
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pluye P, 2010, COLLABORATIVE DEV MI
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Prada E, 2013, INT PERSPECT SEX R H, V39, P114, DOI 10.1363/3911413
   Reefhuis J, 2016, EMERG INFECT DIS, V22, P828, DOI 10.3201/eid2205.160290
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Bueno MAS, 2016, EINSTEIN-SAO PAULO, V14, pXIII, DOI 10.1590/S1679-45082016ED3725
   Sedacca N, 2016, ABORTIONE LATIN AM I, P36
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Stern AM, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00081516
   Swanson KW, 2015, J LAW MED ETHICS, V43, P312, DOI 10.1111/jlme.12247
   Tavares MP, 2016, CONTRACEPTION, V94, P109, DOI 10.1016/j.contraception.2016.04.006
   Ventura M, 2016, DIREITO PRAX, V7, P622, DOI 10.12957/dep.2016.25168
   Villa R, 2016, CLIN TER, V167, P7, DOI 10.7417/CT.2016.1907
   Vlassoff M, 2009, INT PERSPECT SEX R H, V35, P114, DOI [10.1363/3511409, 10.1363/ipsrh.35.114.09]
   WHO/UNICEF JMP, 2016, INDEX TB GUID GUID M, P11
   Young-Lee P, 2016, GUARDIAN, P15
   Young-Lee P., 2016, GUARDIAN
NR 87
TC 3
Z9 3
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2397-0642
J9 GLOB HEALTH RES POL
JI Glob. Health Res. Policy
PD MAY 3
PY 2018
VL 3
IS 1
AR UNSP 15
DI 10.1186/s41256-018-0069-8
PG 9
GA VJ0RM
UT WOS:000526810300001
PM 29750204
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pereira, TN
   Rocha, MN
   Sucupira, PHF
   Carvalho, FD
   Moreira, LA
AF Pereira, Thiago Nunes
   Rocha, Marcele Neves
   Ferreira Sucupira, Pedro Henrique
   Carvalho, Fabiano Duarte
   Moreira, Luciano Andrade
TI Wolbachia significantly impacts the vector competence of Aedes aegypti
   for Mayaro virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN-DISEASE AGENT; BLOCKS DENGUE; INFECTION; STRAIN; BRAZIL;
   TRANSMISSION; FEVER; BLOOD
AB Wolbachia, an intracellular endosymbiont present in up to 70% of all insect species, has been suggested as a sustainable strategy for the control of arboviruses such as Dengue, Zika and Chikungunya. As Mayaro virus outbreaks have also been reported in Latin American countries, the objective of this study was to evaluate the vector competence of Brazilian field-collected Ae. aegypti and the impact of Wolbachia (wMel strain) upon this virus. Our in vitro studies with Aag2 cells showed that Mayaro virus can rapidly multiply, whereas in wMel-infected Aag2 cells, viral growth was significantly impaired. In addition, C6/36 cells seem to have alterations when infected by Mayaro virus. In vivo experiments showed that field-collected Ae. aegypti mosquitoes are highly permissive to Mayaro virus infection, and high viral prevalence was observed in the saliva. On the other hand, Wolbachia-harboring mosquitoes showed significantly impaired capability to transmit Mayaro virus. Our results suggest that the use of Wolbachia-harboring mosquitoes may represent an effective mechanism for the reduction of Mayaro virus transmission throughout Latin America.
C1 [Pereira, Thiago Nunes; Rocha, Marcele Neves; Ferreira Sucupira, Pedro Henrique; Carvalho, Fabiano Duarte; Moreira, Luciano Andrade] Fiocruz MS, Endossimbiontes & Interacao Patogeno Vetor, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
RP Moreira, LA (corresponding author), Fiocruz MS, Endossimbiontes & Interacao Patogeno Vetor, Ctr Pesquisas Rene Rachou, BR-30190002 Belo Horizonte, MG, Brazil.
EM luciano@minas.fiocruz.br
OI Sucupira, Pedro/0000-0002-1997-1590; Moreira,
   Luciano/0000-0002-9240-3506; Rocha, Marcele/0000-0001-7130-6961
FU FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); CNPqNational
   Council for Scientific and Technological Development (CNPq); CAPESCAPES;
   Brazilian Ministry of Health; Bill and Melinda Gates FoundationGates
   Foundation
FX We wish to thank Prof. Scott L. O'Neill for the donation of the original
   wMel infected mosquito line and Dra. Ana Maria Bispo de Filippis for
   donating the MAYV strain. We also acknowledge Dr. Heverton Leandro
   Carneiro Dutra, Simone Brutman Elias Mansur for technical assistance and
   Dr. Eric Pearce Caragata for reviewing the manuscript. We are in debt to
   Dr. Marco Antonio Silva Campos and Dr. Alexandre de Magalhaes Vieira
   Machado and your team, who provided viral culture infrastructure in the
   laboratory of Imunologia de Doencas Virais (IRR - FIOCRUZ). We are
   grateful to all members of the Mosquitos Vetores Group (MV - IRR/FIOCRUZ
   and the team of Eliminar a Dengue: Desafio Brasil, particularly the
   Entomology team for providing field mosquito eggs. This work was
   supported by FAPEMIG, CNPq (LAM), CAPES (TNP and PHFS), the Brazilian
   Ministry of Health and a grant to Monash University from the Bill and
   Melinda Gates Foundation.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, P1
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Calisher C H, 1974, Bull Pan Am Health Organ, V8, P243
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   CAUSEY OR, 1957, AM J TROP MED HYG, V6, P1017, DOI 10.4269/ajtmh.1957.6.1017
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   CLEMENTS AN, 1963, PHYSL MOSQUITOES
   Figueiredo Regina Maria Pinto De, 2004, Rev. Soc. Bras. Med. Trop., V37, P476, DOI 10.1590/S0037-86822004000600009
   DULBECCO R, 1953, COLD SPRING HARB SYM, V18, P273, DOI 10.1101/SQB.1953.018.01.039
   Figueiredo L T, 1990, Rev Soc Bras Med Trop, V23, P13, DOI 10.1590/S0037-86821990000100003
   Forshey B. M., 2010, PLOS NEGLECT TROP D, V4, P2000
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Mourao MPG, 2012, VECTOR-BORNE ZOONOT, V12, P42, DOI 10.1089/vbz.2011.0669
   Halsey ES, 2013, EMERG INFECT DIS, V19, P1839, DOI 10.3201/eid1911.130777
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   KARBAAT J, 1964, TROP GEOGR MED, V16, P370
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Long KC, 2011, AM J TROP MED HYG, V85, P750, DOI 10.4269/ajtmh.2011.11-0359
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Munoz M, 2012, BIOMEDICA, V32, P286, DOI 10.1590/S0120-41572012000300017
   PINHEIRO FP, 1981, AM J TROP MED HYG, V30, P674, DOI 10.4269/ajtmh.1981.30.674
   Richards SL, 2007, VIRUS RES, V129, P224, DOI 10.1016/j.virusres.2007.06.019
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Silva-Nunes Mônica da, 2006, Cad. Saúde Pública, V22, P1325, DOI 10.1590/S0102-311X2006000600021
   Staples E. J., 2014, NEW ENGL J MED, V371, P885
   Tavares-Neto José, 2004, Rev. Soc. Bras. Med. Trop., V37, P1, DOI 10.1590/S0037-86822004000100001
   Tchankouo-Nguetcheu S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013149
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Ye Y. H., 2015, PLOS NEGLECT TROP D, V6
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Zuchi N, 2014, MEM I OSWALDO CRUZ, V109, P820, DOI 10.1590/0074-0276140108
NR 44
TC 7
Z9 7
U1 1
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 2
PY 2018
VL 8
AR 6889
DI 10.1038/s41598-018-25236-8
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE4QZ
UT WOS:000431203100018
PM 29720714
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Qiu, TY
   Yang, YY
   Qiu, JX
   Huang, Y
   Xu, TL
   Xiao, H
   Wu, DF
   Zhang, QC
   Zhou, C
   Zhang, XY
   Tang, KL
   Xu, JQ
   Cao, ZW
AF Qiu, Tianyi
   Yang, Yiyan
   Qiu, Jingxuan
   Huang, Yang
   Xu, Tianlei
   Xiao, Han
   Wu, Dingfeng
   Zhang, Qingchen
   Zhou, Chen
   Zhang, Xiaoyan
   Tang, Kailin
   Xu, Jianqing
   Cao, Zhiwei
TI CE-BLAST makes it possible to compute antigenic similarity for newly
   emerging pathogens
SO NATURE COMMUNICATIONS
LA English
DT Article
ID INFLUENZA-VIRUS; STRUCTURAL BASIS; ZIKA VIRUS; PROTEIN; NEUTRALIZATION;
   ANTIBODIES; HEMAGGLUTININ; DETERMINANTS; SPECIFICITY; RECOGNITION
AB Major challenges in vaccine development include rapidly selecting or designing immunogens for raising cross-protective immunity against different intra-or inter-subtypic pathogens, especially for the newly emerging varieties. Here we propose a computational method, Conformational Epitope (CE)-BLAST, for calculating the antigenic similarity among different pathogens with stable and high performance, which is independent of the prior binding-assay information, unlike the currently available models that heavily rely on the historical experimental data. Tool validation incorporates influenza-related experimental data sufficient for stability and reliability determination. Application to dengue-related data demonstrates high harmonization between the computed clusters and the experimental serological data, undetectable by classical grouping. CE-BLAST identifies the potential cross-reactive epitope between the recent zika pathogen and the dengue virus, precisely corroborated by experimental data. The high performance of the pathogens without the experimental binding data suggests the potential utility of CE-BLAST to rapidly design cross-protective vaccines or promptly determine the efficacy of the currently marketed vaccine against emerging pathogens, which are the critical factors for containing emerging disease outbreaks.
C1 [Qiu, Tianyi; Yang, Yiyan; Qiu, Jingxuan; Xu, Tianlei; Wu, Dingfeng; Zhang, Qingchen; Zhou, Chen; Tang, Kailin; Cao, Zhiwei] Tongji Univ, Shanghai Peoples Hosp 10, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.
   [Qiu, Tianyi; Huang, Yang; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Sch, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
   [Qiu, Tianyi; Huang, Yang; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Med Sch, Inst Biomed Sci, Shanghai 200032, Peoples R China.
   [Xu, Tianlei] Emory Univ, Dept Math & Computat Sci, Atlanta, GA 30322 USA.
   [Xiao, Han] Univ Helsinki, Dept Comp Sci, FI-00014 Helsinki, Finland.
RP Cao, ZW (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Sch Life Sci & Technol, Shanghai 200092, Peoples R China.; Xu, JQ (corresponding author), Fudan Univ, Shanghai Med Sch, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.; Xu, JQ (corresponding author), Fudan Univ, Shanghai Med Sch, Inst Biomed Sci, Shanghai 200032, Peoples R China.
EM xujianqing@shphc.org.cn; zwcao@tongji.edu.cn
OI Xu, Tianlei/0000-0001-9382-6917
FU Ministry of Science and Technology ChinaMinistry of Science and
   Technology, China [2010CB833601]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31171272]; National
   Postdoctoral Program for Innovative Talents [BX201600033]; China
   Postdoctoral Science FoundationChina Postdoctoral Science Foundation
   [2017M611451]
FX This work was supported in part by grants from Ministry of Science and
   Technology China (2010CB833601), the National Natural Science Foundation
   of China (31171272), the National Postdoctoral Program for Innovative
   Talents (BX201600033) and the China Postdoctoral Science Foundation
   Funded Project (2017M611451). Also, we appreciated that Prof. Yuzong
   Chen and Xian Zeng, from National University of Singapore, helped us to
   build the mirror server of CE-BLAST in NUS.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   Bock ME, 2007, J COMPUT BIOL, V14, P285, DOI 10.1089/cmb.2006.0145
   Bronstein AM, 2006, P NATL ACAD SCI USA, V103, P1168, DOI 10.1073/pnas.0508601103
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Du XJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1710
   GOLDSBY RA, 2003, J IMMUNOLOGY
   HUBBARD SJ, 1992, FARADAY DISCUSS, V93, P13, DOI 10.1039/fd9929300013
   Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150
   Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017
   Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998
   Krammer F., 2015, NAT REV DRUG DISCOV, V14, P294
   Lees WD, 2010, BIOINFORMATICS, V26, P1403, DOI 10.1093/bioinformatics/btq160
   Liao YC, 2009, NUCLEIC ACIDS RES, V37, pW643, DOI 10.1093/nar/gkp321
   Lo Conte L, 1999, J MOL BIOL, V285, P2177
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qiu JX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31156
   Reeve R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001027
   Roitt IM, 1996, IMMUNOLOGY
   Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628
   Shulman-Peleg A, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-43
   Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tharakaraman K, 2013, CELL, V153, P1475, DOI 10.1016/j.cell.2013.05.035
   Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Yang JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106660
   Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
NR 30
TC 5
Z9 5
U1 2
U2 16
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 2
PY 2018
VL 9
AR 1772
DI 10.1038/s41467-018-04171-2
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE4SG
UT WOS:000431206400013
PM 29720583
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Morris, G
   Barichello, T
   Stubbs, B
   Kohler, CA
   Carvalho, AF
   Maes, M
AF Morris, Gerwyn
   Barichello, Tatiana
   Stubbs, Brendon
   Kohler, Cristiano A.
   Carvalho, Andre F.
   Maes, Michael
TI Zika Virus as an Emerging Neuropathogen: Mechanisms of Neurovirulence
   and Neuro-Immune Interactions
SO MOLECULAR NEUROBIOLOGY
LA English
DT Review
DE Zika virus; Neurodevelopment; Microcephaly; Guillain-Barre syndrome;
   Perinatal infection; Neurology; Psychiatry; Autoimmunity; Cytokines
ID GUILLAIN-BARRE-SYNDROME; WEST-NILE-VIRUS; UNFOLDED PROTEIN RESPONSE;
   TOLL-LIKE RECEPTORS; ANTIBODY-DEPENDENT ENHANCEMENT; I INTERFERON
   RESPONSES; REGULATORY T-CELLS; DENGUE VIRUS; MULTIPLE-SCLEROSIS; NS1
   PROTEIN
AB Zika virus (ZIKV) is an emerging arbovirus of the genus Flaviviridae, which causes a febrile illness and has spread from across the Pacific to the Americas in a short timeframe. Convincing evidence has implicated the ZIKV to incident cases of neonatal microcephaly and a set of neurodevelopmental abnormalities referred to as the congenital Zika virus syndrome. In addition, emerging data points to an association with the ZIKV and the development of the so-called Guillain-Barre syndrome, an acute autoimmune polyneuropathy. Accumulating knowledge suggests that neurovirulent strains of the ZIKV have evolved from less pathogenic lineages of the virus. Nevertheless, mechanisms of neurovirulence and host-pathogen neuro-immune interactions remain incompletely elucidated. This review provides a critical discussion of genetic and structural alterations in the ZIKV which could have contributed to the emergence of neurovirulent strains. In addition, a mechanistic framework of neuro-immune mechanisms related to the emergence of neuropathology after ZIKV infection is discussed. Recent advances in knowledge point to avenues for the development of a putative vaccine as well as novel therapeutic strategies. Nevertheless, there are unique unmet challenges that need to be addressed in this regard. Finally, a research agenda is proposed.
C1 [Morris, Gerwyn] Tir Na Nog, Bryn Rd Seaside 87, Llanelli SA15 2LW, Wales.
   [Barichello, Tatiana] Univ Southern Santa Catarina UNESC, Lab Expt Microbiol, Grad Program Hlth Sci, Hlth Sci Unit, Criciuma, SC, Brazil.
   [Barichello, Tatiana] Univ Texas Hlth Sci Ctr Houston UTHlth, McGovern Med Sch, Dept Psychiat & Behav Sci, Translat Psychiat Program, Houston, TX USA.
   [Barichello, Tatiana] Univ Texas Grad Sch Biomed Sci Houston, Neurosci Grad Program, Houston, TX USA.
   [Stubbs, Brendon] South London & Maudsley NHS Fdn Trust, Physiotherapy Dept, Denmark Hill, London SE5 8AZ, England.
   [Stubbs, Brendon] Kings Coll London, Inst Psychiat Psychol & Neurosci, Hlth Serv & Populat Res Dept, De Crespigny Pk, London SE5 8AF, England.
   [Stubbs, Brendon] Anglia Ruskin Univ, Fac Hlth Social Care & Educ, Bishop Hall Lane, Chelmsford CM1 1SQ, Essex, England.
   [Kohler, Cristiano A.; Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Kohler, Cristiano A.; Carvalho, Andre F.] Univ Fed Ceara, Fac Med, Translat Psychiat Res Grp, Fortaleza, Ceara, Brazil.
   [Maes, Michael] Deakin Univ, Barwon Hlth, Sch Med, IMPACT Strateg Res Ctr, POB 291, Geelong, Vic 3220, Australia.
   [Maes, Michael] Univ Estadual Londrina, Hlth Sci Postgrad Program, Hlth Sci Ctr, Londrina, Parana, Brazil.
   [Maes, Michael] Chulalongkorn Univ, Dept Psychiat, Fac Med, Bangkok, Thailand.
   [Maes, Michael] Revitalis, Waalre, Netherlands.
   [Maes, Michael] Med Univ Plovdiv, Dept Psychiat, Plovdiv, Bulgaria.
RP Maes, M (corresponding author), Deakin Univ, Barwon Hlth, Sch Med, IMPACT Strateg Res Ctr, POB 291, Geelong, Vic 3220, Australia.; Maes, M (corresponding author), Univ Estadual Londrina, Hlth Sci Postgrad Program, Hlth Sci Ctr, Londrina, Parana, Brazil.; Maes, M (corresponding author), Chulalongkorn Univ, Dept Psychiat, Fac Med, Bangkok, Thailand.; Maes, M (corresponding author), Revitalis, Waalre, Netherlands.; Maes, M (corresponding author), Med Univ Plovdiv, Dept Psychiat, Plovdiv, Bulgaria.
EM dr.michaelmaes@hotmail.com
RI Maes, Michael/B-8546-2011; Stubbs, Brendon/X-1904-2018; Barichello,
   Tatiana/E-2725-2013
OI Maes, Michael/0000-0002-2012-871X; Stubbs, Brendon/0000-0001-7387-3791;
   Barichello, Tatiana/0000-0001-7776-8454
FU Department of HealthDiabetes UK [ICA-CL-2017-03-001]
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Acosta EG, 2016, EXPERT REV VACCINES, V15, P467, DOI 10.1586/14760584.2016.1121814
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Alen MMF, 2012, ANTIVIR RES, V96, P280, DOI 10.1016/j.antiviral.2012.10.007
   Alimov A, 2013, METAB BRAIN DIS, V28, P667, DOI 10.1007/s11011-013-9430-2
   Amin H, 1997, ACTA PAEDIATR, V86, P306, DOI 10.1111/j.1651-2227.1997.tb08895.x
   Amorim JH, 2012, VACCINE, V30, P837, DOI 10.1016/j.vaccine.2011.12.034
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ang CW, 2004, TRENDS IMMUNOL, V25, P61, DOI 10.1016/j.it.2003.12.004
   Ang CW, 1999, NEUROLOGY, V53, P2122, DOI 10.1212/WNL.53.9.2122
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Asnis DS, 2000, CLIN INFECT DIS, V30, P413, DOI 10.1086/313737
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Babaloo Z, 2015, IMMUNOL LETT, V164, P76, DOI 10.1016/j.imlet.2015.01.001
   Babcock AA, 2006, J NEUROSCI, V26, P12826, DOI 10.1523/JNEUROSCI.4937-05.2006
   Barak B, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00272
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Bavia L, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0541-3
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Bornsen L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118830
   Boersma MCH, 2011, J NEUROSCI, V31, P5414, DOI 10.1523/JNEUROSCI.2456-10.2011
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Borrell V, 2014, NEUROSCI RES, V86, P14, DOI 10.1016/j.neures.2014.04.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Bueter W, 2009, PEDIATR RES, V66, P487, DOI 10.1203/PDR.0b013e3181baa083
   Butt AM, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.106
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campanati L, 2016, BIORXIV, DOI [10.1101/046599, DOI 10.1101/046599]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Caporale CM, 2006, J NEUROIMMUNOL, V177, P112, DOI 10.1016/j.jneuroim.2006.05.018
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen MY, 2009, EUR J IMMUNOL, V39, P2525, DOI 10.1002/eji.200838879
   Cheng HJ, 2015, AM J TROP MED HYG, V92, P989, DOI 10.4269/ajtmh.14-0162
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Chuang YC, 2016, J IMMUNOL, V196, P1218, DOI 10.4049/jimmunol.1500057
   Chuang YC, 2013, THROMB HAEMOSTASIS, V110, P358, DOI 10.1160/TH13-02-0149
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343
   Corona-Rivera JR, 2001, EUR J PEDIATR, V160, P664, DOI 10.1007/s004310100813
   Costa F, 2016, ANN INTERN MED, V164, P689, DOI 10.7326/M16-0332
   Courcet JB, 2012, J MED GENET, V49, P731, DOI 10.1136/jmedgenet-2012-101251
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dalakas MC, 2015, BBA-MOL BASIS DIS, V1852, P658, DOI 10.1016/j.bbadis.2014.06.013
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Giglio L, 2015, ACTA NEUROL SCAND, V131, P336, DOI 10.1111/ane.12364
   De Miranda J, 2010, MBIO, V1, DOI 10.1128/mBio.00176-10
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dourado ME, 2012, ACTA NEUROL SCAND, V125, P47, DOI 10.1111/j.1600-0404.2011.01503.x
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durelli L, 2009, ANN NEUROL, V65, P499, DOI 10.1002/ana.21652
   Ebrahimi-Fakhari D, 2016, BRAIN, V139, P317, DOI 10.1093/brain/awv371
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069
   Falivelli G, 2012, HUM MOL GENET, V21, P4761, DOI 10.1093/hmg/dds320
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fekih-Mrissa N, 2014, CLIN NEUROL NEUROSUR, V121, P19, DOI 10.1016/j.clineuro.2014.03.014
   Feng X, 2016, NEUROLOGY, V86
   Feng X, 2012, ARCH NEUROL-CHICAGO, V69, P1303, DOI 10.1001/archneurol.2012.465
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Fisher D, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0737-9
   Flingai S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12616
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Foley JF, 2007, SCI SIGNAL, V2007, ptw113, DOI [10.1126/stke.3802007tw113, DOI 10.1126/STKE.3802007TW113]
   Forrest CM, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-22
   Frank CL, 2010, J BIOL CHEM, V285, P33324, DOI 10.1074/jbc.M110.140699
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Fribley A, 2009, METHODS MOL BIOL, V559, P191, DOI 10.1007/978-1-60327-017-5_14
   Gabis L, 1997, J PERINAT MED, V25, P213
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Godin JD, 2016, TRENDS NEUROSCI, V39, P394, DOI 10.1016/j.tins.2016.04.002
   Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06
   Golan D, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-60
   Gonzalez-Quevedo A, 2009, NEUROL INDIA, V57, P288, DOI 10.4103/0028-3886.53282
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Greco Marilena, 2016, J Clin Med Res, V8, P196, DOI 10.14740/jocmr2413w
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halliday M, 2015, NEUROPATH APPL NEURO, V41, P414, DOI 10.1111/nan.12211
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamzaoui A, 2014, IMMUNOBIOLOGY, V219, P873, DOI 10.1016/j.imbio.2014.07.009
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hershey T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040604
   Ho HH, 2006, J BIOL CHEM, V281, P14111, DOI 10.1074/jbc.M511797200
   Houliston RS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181750
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Ishikawa T, 2011, VACCINE, V29, P7444, DOI 10.1016/j.vaccine.2011.07.058
   Islam Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043976
   Jiao H, 2012, MOL BIOL REP, V39, P1537, DOI 10.1007/s11033-011-0892-1
   Jin PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131374
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kahoud RJ, 2014, DEV DYNAM, V243, P440, DOI 10.1002/dvdy.24090
   Kalinke U, 2012, IMMUNOL CELL BIOL, V90, P505, DOI 10.1038/icb.2012.8
   Kaul D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037767
   Kawada K, 2014, J NEUROSCI RES, V92, P1122, DOI 10.1002/jnr.23389
   Kivity S, 2014, J AUTOIMMUN, V51, P17, DOI 10.1016/j.jaut.2014.02.008
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Klinman D M, 2000, Dev Biol (Basel), V104, P45
   Kochakarn T, 2016, ASIAN PAC J TROP MED, V9, P1026, DOI 10.1016/j.apjtm.2016.10.002
   Kolter Thomas, 2012, ISRN Biochem, V2012, P506160, DOI 10.5402/2012/506160
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Kusunoki S, 1999, MUSCLE NERVE, V22, P1071, DOI 10.1002/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Monique L, 2006, J MOL NEUROSCI, V29, P185, DOI 10.1385/JMN/29:03:185
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Lai CJ, 2007, J VIROL, V81, P12766, DOI 10.1128/JVI.01420-07
   Lakatosova S, 2012, INT J BIOCHEM CELL B, V44, P1501, DOI 10.1016/j.biocel.2012.06.002
   Lambert SR, 2007, BRIT J OPHTHALMOL, V91, P1418, DOI 10.1136/bjo.2007.117960
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lange CM, 2014, J IMMUNOL, V192, P6037, DOI 10.4049/jimmunol.1302296
   Lanteri MC, 2009, J CLIN INVEST, V119, P3266, DOI 10.1172/JCI39387
   Lathia JD, 2008, J NEUROSCI, V28, P13978, DOI 10.1523/JNEUROSCI.2140-08.2008
   Lauren M., 2016, BIORXIV, DOI [10.1101/050112, DOI 10.1101/050112]
   Lazarus C, 2016, LANCET, V388, P9, DOI 10.1016/S0140-6736(16)30509-8
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002
   Leis AA, 2014, MUSCLE NERVE, V49, P26, DOI 10.1002/mus.23869
   Leroy Jules G, 2005, Adv Pediatr, V52, P261, DOI 10.1016/j.yapd.2005.04.003
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Liang SL, 2012, IMMUNOPHARM IMMUNOT, V34, P1039, DOI 10.3109/08923973.2012.697469
   Lin AE, 2007, CURR OPIN IMMUNOL, V19, P665, DOI 10.1016/j.coi.2007.10.002
   Lin CF, 2002, J IMMUNOL, V169, P657, DOI 10.4049/jimmunol.169.2.657
   Lin YS, 2011, EXP BIOL MED, V236, P515, DOI 10.1258/ebm.2011.010339
   Lin YL, 1998, J VIROL, V72, P191, DOI 10.1128/JVI.72.1.191-200.1998
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma YH, 2006, J CELL BIOL, V175, P209, DOI 10.1083/jcb.200606016
   Macedo DS, 2012, BRAZ J MED BIOL RES, V45, P179, DOI 10.1590/S0100-879X2012007500031
   MACFARLANE DW, 1975, PEDIATRICS, V55, P797
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Magira EE, 2003, J IMMUNOL, V170, P3074, DOI 10.4049/jimmunol.170.6.3074
   Maringer K, 2014, CYTOKINE GROWTH F R, V25, P669, DOI 10.1016/j.cytogfr.2014.08.004
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   Martinez C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065818
   Martinez S, 2013, FRONT NEUROANAT, V7, DOI 10.3389/fnana.2013.00018
   May M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161355
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mimura N, 2008, MOL CELL BIOL, V28, P293, DOI 10.1128/MCB.00473-07
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mithal Ambrish, 2014, Indian J Endocrinol Metab, V18, P593, DOI 10.4103/2230-8210.139204
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Monos DS, 1997, J INFECT DIS, V176, pS180, DOI 10.1086/513786
   MOORE CA, 1990, J PEDIATR-US, V116, P383, DOI 10.1016/S0022-3476(05)82825-2
   Moratorio G, 2013, INFECT GENET EVOL, V14, P396, DOI 10.1016/j.meegid.2013.01.001
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Muller M, 2012, MULT SCLER J, V18, P236, DOI 10.1177/1352458511416837
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Nachamkin I, 2007, NEUROLOGY, V69, P1665, DOI 10.1212/01.wnl.0000265396.87983.bd
   Nurieva RI, 2010, IMMUNITY, V32, P670, DOI 10.1016/j.immuni.2010.05.002
   Nyati KK, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/758639
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E, 2014, EUROSURVEILLANCE, V19, P4
   Ogen-Shtern N, 2016, BRAIN RES, V1648, P658, DOI 10.1016/j.brainres.2016.03.044
   Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005
   Okun E, 2010, P NATL ACAD SCI USA, V107, P15625, DOI 10.1073/pnas.1005807107
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Park Soochul, 2013, Exp Neurobiol, V22, P143, DOI 10.5607/en.2013.22.3.143
   Parlato S, 2010, BLOOD, V115, P1554, DOI 10.1182/blood-2009-07-234468
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Reder AT, 2014, J INTERF CYTOK RES, V34, P589, DOI 10.1089/jir.2013.0158
   Reihani H, FRONT IMMUNOL, DOI [10.3389/conf.fimmu.2013.02.00597, DOI 10.3389/CONF.FIMMU.2013.02.00597]
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rolfe AJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0110-x
   Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629
   Romero RS, 2015, J NEUROL NEUROSUR PS, V86, P587, DOI 10.1136/jnnp-2014-308113
   Rostami A, 2013, J NEUROL SCI, V333, P76, DOI 10.1016/j.jns.2013.03.002
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sang DQ, 2012, J NEUROIMMUNOL, V246, P65, DOI 10.1016/j.jneuroim.2012.03.006
   Sasaki T, 2013, ANTIVIR RES, V98, P423, DOI 10.1016/j.antiviral.2013.03.018
   Scheper W, 2015, ACTA NEUROPATHOL, V130, P315, DOI 10.1007/s00401-015-1462-8
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shackelton LA, 2006, J MOL EVOL, V62, P551, DOI 10.1007/s00239-005-0221-1
   Shah SZA, 2015, J MOL NEUROSCI, V57, P529, DOI 10.1007/s12031-015-0633-3
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614
   Sinha S, 2010, ACTA NEUROL SCAND, V122, P21, DOI 10.1111/j.1600-0404.2009.01229.x
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Skull SA, 1997, MED J AUSTRALIA, V166, P412, DOI 10.5694/j.1326-5377.1997.tb123191.x
   Sotirchos ES, 2016, NEUROLOGY, V86, P382, DOI 10.1212/WNL.0000000000002316
   Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tam CC, 2006, J INFECT DIS, V194, P95, DOI 10.1086/504294
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang SC, 2007, P NATL ACAD SCI USA, V104, P13798, DOI 10.1073/pnas.0702553104
   Tang X, 2015, MOL CELL BIOCHEM, V407, P197, DOI 10.1007/s11010-015-2469-0
   Tao YZ, 2014, J IMMUNOL, V192, P5610, DOI 10.4049/jimmunol.1302580
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tillu H, 2016, EUR J CLIN MICROBIOL, V35, P453, DOI 10.1007/s10096-015-2561-0
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   van der Pol WL, 2000, NEUROLOGY, V54, P1661, DOI 10.1212/WNL.54.8.1661
   van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328
   Vannucci RC, 2012, EARLY HUM DEV, V88, P135, DOI 10.1016/j.earlhumdev.2011.07.012
   Ventura CV, 2016, OSLI RETINA, V47, P952, DOI 10.3928/23258160-20161004-09
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wakerley BR, 2013, EXPERT REV CLIN IMMU, V9, P627, DOI 10.1586/1744666X.2013.811119
   Waschbisch A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115488
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Wei X, 2015, ELIFE, V4, DOI 10.7554/eLife.06963
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Wu LY, 2012, J NEUROIMMUNOL, V243, P18, DOI 10.1016/j.jneuroim.2011.12.003
   Wu XJ, 2016, EXPERT OPIN THER TAR, V20, P209, DOI 10.1517/14728222.2016.1086751
   Yaddanapudi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026766
   Yamaguchi KD, 2008, J NEUROIMMUNOL, V195, P116, DOI 10.1016/j.jneuroim.2007.12.007
   Yu Z, 2017, J CEREBR BLOOD F MET, V37, P1069, DOI 10.1177/0271678X16650218
   Yuki N, 1997, J INFECT DIS, V176, pS150, DOI 10.1086/513800
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005
   Zhang X, 2011, J IMMUNOL, V187, P3431, DOI 10.4049/jimmunol.1100580
   Zhang X, 2010, CLIN NEUROL NEUROSUR, V112, P641, DOI 10.1016/j.clineuro.2010.04.020
   Zhang X, 2009, J IMMUNOL, V182, P3928, DOI 10.4049/jimmunol.0802226
   Zhang YJ, 2012, IEEE INFOCOM SER, P10, DOI 10.1109/INFCOM.2012.6195468
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zipfel PF, 1999, MOL IMMUNOL, V36, P241, DOI 10.1016/S0161-5890(99)00038-3
NR 287
TC 9
Z9 10
U1 0
U2 2
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0893-7648
EI 1559-1182
J9 MOL NEUROBIOL
JI Mol. Neurobiol.
PD MAY
PY 2018
VL 55
IS 5
BP 4160
EP 4184
DI 10.1007/s12035-017-0635-y
PG 25
WC Neurosciences
SC Neurosciences & Neurology
GA GB7EY
UT WOS:000429238900044
PM 28601976
DA 2020-07-08
ER

PT J
AU Demina, AV
   Edri, A
   Fridman, L
   Rouvinski, A
   Lobel, L
   Hertz, T
AF Demina, Anna Vladimirovna
   Edri, Avishay
   Fridman, Lilach
   Rouvinski, Alex
   Lobel, Leslie
   Hertz, Tomer
TI TBE vaccine and post TBE disease Abs drive antibody dependent
   enhancement of Zika infection
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Demina, Anna Vladimirovna; Edri, Avishay; Fridman, Lilach; Lobel, Leslie; Hertz, Tomer] Ben Gurion Univ Negev, Dept Microbiol Immunol & Genet, Beer Sheva, Israel.
   [Demina, Anna Vladimirovna; Hertz, Tomer] Natl Ctr Biotechnol Negev, IL-84105 Beer Sheva, Israel.
   [Demina, Anna Vladimirovna] State Res Ctr Virol & Biotechnol Vector Koltsovo, Koltsov 630559, Novosibirsk Reg, Russia.
   [Rouvinski, Alex] Hebrew Univ Jerusalem, Hadassah Med Sch, Kuvin Ctr Study Infect & Trop Dis, Inst Med Res Israel Canada,Dept Microbiol & Mol G, Jerusalem, Israel.
   [Hertz, Tomer] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA.
RI Hertz, Tomer/S-5744-2016
OI Hertz, Tomer/0000-0002-0561-1578
NR 0
TC 0
Z9 0
U1 0
U2 2
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 182.9
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977703309
DA 2020-07-08
ER

PT J
AU Grifoni, A
   Pham, J
   Peters, B
   De-Oliveira-Pinto, ML
   de Silva, A
   Durbin, A
   Diehl, SA
   Harris, E
   Crowe, J
   Busch, M
   Vivanco-Cid, H
   Graham, BS
   Turtle, L
   Kallas, E
   Watkins, D
   Weiskopf, D
   Sette, A
AF Grifoni, Alba
   Pham, John
   Peters, Bjorn
   de-Oliveira-Pinto, Maria Luzia
   de Silva, Aravinda
   Durbin, Anna
   Diehl, Sean A.
   Harris, Eva
   Crowe, James
   Busch, Micheal
   Vivanco-Cid, Hector
   Graham, Barney S.
   Turtle, Lance
   Kallas, Esper
   Watkins, David
   Weiskopf, Daniela
   Sette, Alessandro
TI ZIKV-specific CD8 T cell immunity in humans is affected by DENV
   pre-exposure
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Grifoni, Alba; Pham, John; Peters, Bjorn; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Allergy & Immunol, La Jolla, CA USA.
   [de-Oliveira-Pinto, Maria Luzia] Oswaldo Cruz Fndn FIOCRUZ, Rio De Janeiro, Brazil.
   [de Silva, Aravinda] Univ N Carolina, Chapel Hill, NC 27515 USA.
   [Durbin, Anna] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Diehl, Sean A.] Univ Vermont, Burlington, VT 05405 USA.
   [Harris, Eva] Univ Calif Berkeley, Berkeley, CA 94720 USA.
   [Crowe, James] Vanderbilt Univ, Med Ctr, Nashville, TN USA.
   [Busch, Micheal] Blood Syst Res Inst, San Francisco, CA USA.
   [Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Med Biol, Mexico City, DF, Mexico.
   [Graham, Barney S.] NIAID, NIH, North Bethesda, MD USA.
   [Turtle, Lance] Univ Liverpool, Liverpool, Merseyside, England.
   [Kallas, Esper] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil.
   [Watkins, David] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
RI Graham, Barney S./AAC-5898-2019; Crowe, James E./B-5549-2009; Diehl,
   Sean/AAE-2779-2020
OI Graham, Barney S./0000-0001-8112-0853; Crowe, James
   E./0000-0002-0049-1079; Diehl, Sean/0000-0001-9700-235X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 61.8
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977704180
DA 2020-07-08
ER

PT J
AU Kumar, A
   Singh, PK
   Giri, S
AF Kumar, Ashok
   Singh, Pawan Kumar
   Giri, Shailendra
TI AMP-activated kinase (AMPK) promotes innate immunity and antiviral
   defense against Zika virus induced ocular infection
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Kumar, Ashok; Singh, Pawan Kumar] Wayne State Univ, Sch Med, Detroit, MI 48202 USA.
   [Giri, Shailendra] Henry Ford Hlth Syst, Detroit, MI USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977700260
DA 2020-07-08
ER

PT J
AU Luo, HL
   Winkelmann, E
   Fernandez-Salas, I
   Li, L
   Mayer, SV
   Daniz-Lozano, R
   Sanchez-Casas, RM
   Vasilakis, N
   Tesh, R
   Barrett, AD
   Weaver, SC
   Wang, T
AF Luo, Huanle
   Winkelmann, Evandro
   Fernandez-Salas, Ildefonso
   Li, Li
   Mayer, Sandra V.
   Daniz-Lozano, Rogelio
   Ma Sanchez-Casas, Rosa
   Vasilakis, Nikos
   Tesh, Robert
   Barrett, Alan D.
   Weaver, Scott C.
   Wang, Tian
TI Zika, dengue and yellow fever viruses induce differential anti-viral
   immune responses in human monocytic and first trimester trophoblast
   cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Luo, Huanle; Winkelmann, Evandro; Li, Li; Mayer, Sandra V.; Vasilakis, Nikos; Tesh, Robert; Barrett, Alan D.; Weaver, Scott C.; Wang, Tian] Univ Texas Med Br, Galveston, TX USA.
   [Fernandez-Salas, Ildefonso; Daniz-Lozano, Rogelio] Inst Nacl Salud Publ, Ctr Reg Salud Publ, Mexico City, DF, Mexico.
   [Ma Sanchez-Casas, Rosa] Univ Autonoma Nuevo Leon, FMVZ CIDICS, Monterrey Nl Mexico, Mexico.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 168.7
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977702343
DA 2020-07-08
ER

PT J
AU Strbo, N
   Romero, L
   Fisher, E
   Garcia, D
AF Strbo, Natasa
   Romero, Laura
   Fisher, Eva
   Garcia, Denisse
TI Induction of Zika specific CD8 T cell responses in the placenta after
   heat shock protein gp96-Ig vaccination
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Strbo, Natasa; Romero, Laura; Fisher, Eva; Garcia, Denisse] Univ Miami, Miller Sch Med, Coral Gables, FL 33124 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 180.19
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977703265
DA 2020-07-08
ER

PT J
AU Venkateswaran, N
   Sarwar, J
   Parameswaran, N
   Krishnan, KVV
   Nelson, WM
AF Venkateswaran, Neeraja
   Sarwar, Jawad
   Parameswaran, Nishanth
   Krishnan, Krish V. V.
   Nelson, William M.
TI Validation of a fluorescent microsphere multiplex serology assay for
   differential diagnosis of exposure to Zika virus and other closely
   related arboviruses
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Venkateswaran, Neeraja; Nelson, William M.] Tetracore Inc, Rockville, MD USA.
   [Sarwar, Jawad; Parameswaran, Nishanth] Omni Array Biotechnol LLC, Rockville, MD USA.
   [Krishnan, Krish V. V.] Calif State Univ Fresno, Fresno, CA 93740 USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 126.25
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977702168
DA 2020-07-08
ER

PT J
AU Yu, L
   Gao, XJ
   Wen, YF
   Wang, J
   Hong, WX
   Li, CL
   Zhao, LZ
   Yin, CB
   Jin, X
   Zhang, FC
AF Yu, Lei
   Gao, Xiujie
   Wen, Yingfen
   Wang, Jian
   Hong, Wenxin
   Li, Chunlin
   Zhao, Lingzhai
   Yin, Chibiao
   Jin, Xia
   Zhang, Fuchun
TI Delayed and highly specific antibody response to nonstructural protein 1
   (NS1) revealed during natural ZIKV infection by NS1-based capture ELISA
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Yu, Lei; Gao, Xiujie; Wen, Yingfen; Wang, Jian; Hong, Wenxin; Li, Chunlin; Zhao, Lingzhai; Yin, Chibiao; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Guangdong, Peoples R China.
   [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Viral Dis & Vaccine Translat Res Unit, Beijing, Peoples R China.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 182.30
PG 3
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977703327
DA 2020-07-08
ER

PT J
AU Zhao, HY
   Crowe, JE
   Diamond, MS
   Fremont, DH
AF Zhao, Haiyan
   Crowe, James E., Jr.
   Diamond, Michael S.
   Fremont, Daved H.
TI Mechanisms of Zika virus antibody neutralization
SO JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Association-of-Immunologists (AAI)
CY MAY 04-08, 2018
CL Austin, TX
SP Amer Assoc Immunologists
C1 [Zhao, Haiyan; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, St Louis, MO USA.
   [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Nashville, TN USA.
RI Diamond, Michael/AAH-1733-2019; Crowe, James E./B-5549-2009
OI Diamond, Michael/0000-0002-8791-3165; Crowe, James
   E./0000-0002-0049-1079
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAY 1
PY 2018
VL 200
IS 1
SU S
MA 182.7
PG 2
WC Immunology
SC Immunology
GA HN1WM
UT WOS:000459977703308
DA 2020-07-08
ER

PT J
AU Rodo, C
   Suy, A
   Sulleiro, E
   Soriano-Arandes, A
   Anton, A
   Garcia-Ruiz, I
   Arevalo, S
   Vazquez, E
   Vazquez, A
   de Ory, F
   Sanchez-Seco, MP
   Rodrigo, C
   Pumarola, T
   Carreras, E
AF Rodo, C.
   Suy, A.
   Sulleiro, E.
   Soriano-Arandes, A.
   Anton, A.
   Garcia-Ruiz, I
   Arevalo, S.
   Vazquez, E.
   Vazquez, A.
   de Ory, F.
   Sanchez-Seco, M. P.
   Rodrigo, C.
   Pumarola, T.
   Carreras, E.
TI In utero negativization of Zika virus in a foetus with serious central
   nervous system abnormalities
SO CLINICAL MICROBIOLOGY AND INFECTION
LA English
DT Article
DE Amniotic fluid; Brain diseases; Congenital; Foetus; Prenatal diagnosis;
   Zika virus
ID PREGNANCY
AB We describe a case of a pregnant woman with Zika virus (ZIKV) infection and a foetus with severe brain malformations. ZIKV tested positive in amniotic fluid at 19 weeks but was negative at delivery. The newborn did not meet the case definition of congenital ZIKV syndrome because neither ZIKV RNA nor IgM antibodies were detected; however, prenatal brain lesions were confirmed after birth (Graphical Abstract). (C) 2017 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
C1 [Rodo, C.; Suy, A.; Sulleiro, E.; Soriano-Arandes, A.; Anton, A.; Garcia-Ruiz, I; Arevalo, S.; Vazquez, E.; Rodrigo, C.; Pumarola, T.; Carreras, E.] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Barcelona, Spain.
   [Vazquez, A.; de Ory, F.; Sanchez-Seco, M. P.] Inst Salud Carlos III, Natl Ctr Microbiol, Madrid, Spain.
   [Vazquez, A.; de Ory, F.; Sanchez-Seco, M. P.] CIBERESP, Madrid, Spain.
RP Rodo, C (corresponding author), Hosp Univ Vall dHebron, Dept Obstet, Maternal Foetal Med Unit, Ps Vall dHebron 119-129, Barcelona 08035, Spain.
EM crodo@vhebron.net
RI Vazquez, Ana/H-4911-2013; Pumarola, Tomas/AAB-5532-2019; Rodrigo,
   Carlos/F-7602-2017; RODO, CARLOTA/K-9179-2017; Soriano-Arandes,
   Antoni/G-6851-2013; Anton, Andres/B-3308-2011; Arandes, Antonio
   Soriano/Q-3348-2016
OI Vazquez, Ana/0000-0002-9872-3316; Pumarola, Tomas/0000-0002-5171-7461;
   Rodrigo, Carlos/0000-0003-1140-2585; RODO, CARLOTA/0000-0001-8801-5677;
   Anton, Andres/0000-0002-1476-0815; Arandes, Antonio
   Soriano/0000-0001-9613-7228; SANCHEZ-SECO, MARIA
   PAZ/0000-0001-9033-7704; Suy Franch, Anna/0000-0003-2987-6105; Arevalo
   Martinez, Silvia/0000-0001-8169-1322; Sulleiro,
   Elena/0000-0002-9783-6060
CR Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Bocanegra C, 2016, CLIN MICROBIOL INFEC, V22, P648, DOI 10.1016/j.cmi.2016.03.025
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
NR 5
TC 5
Z9 5
U1 0
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1198-743X
EI 1469-0691
J9 CLIN MICROBIOL INFEC
JI Clin. Microbiol. Infect.
PD MAY
PY 2018
VL 24
IS 5
AR 549.e1
DI 10.1016/j.cmi.2017.09.022
PG 3
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA GD6YV
UT WOS:000430656300021
PM 29030170
OA Bronze
DA 2020-07-08
ER

PT J
AU Gonce, A
   Martinez, MJ
   Marban-Castro, E
   Saco, A
   Soler, A
   Alvarez-Mora, MI
   Peiro, A
   Gonzalo, V
   Hale, G
   Bhatnagar, J
   Lopez, M
   Zaki, S
   Ordi, J
   Bardaji, A
AF Gonce, Anna
   Martinez, Miguel J.
   Marban-Castro, Elena
   Saco, Adela
   Soler, Anna
   Isabel Alvarez-Mora, Maria
   Peiro, Aida
   Gonzalo, Veronica
   Hale, Gillian
   Bhatnagar, Julu
   Lopez, Marta
   Zaki, Sherif
   Ordi, Jaume
   Bardaji, Azucena
TI Spontaneous Abortion Associated with Zika Virus Infection and Persistent
   Viremia
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID MISCARRIAGE; BRAIN
AB We report a case of spontaneous abortion associated with Zika virus infection in a pregnant woman who traveled from Spain to the Dominican Republic and developed a rash. Maternal Zika viremia persisted at least 31 days after onset of symptoms and 21 days after uterine evacuation.
C1 [Gonce, Anna; Lopez, Marta] BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Barcelona, Spain.
   [Martinez, Miguel J.; Marban-Castro, Elena; Ordi, Jaume; Bardaji, Azucena] Univ Barcelona, Hosp Clin, ISGlobal, Rossello 132,5-1, E-08036 Barcelona, Spain.
   [Martinez, Miguel J.; Saco, Adela; Peiro, Aida; Gonzalo, Veronica; Ordi, Jaume] Hosp Clin Barcelona, Barcelona, Spain.
   [Soler, Anna; Isabel Alvarez-Mora, Maria] Hosp Clin Barcelona, IDIBAPS, Barcelona, Spain.
   [Soler, Anna; Isabel Alvarez-Mora, Maria] CIBERER, Barcelona, Spain.
   [Hale, Gillian; Bhatnagar, Julu; Zaki, Sherif] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Bardaji, A (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Rossello 132,5-1, E-08036 Barcelona, Spain.
EM azucena.bardaji@isglobal.org
RI Saco, Adela/AAC-7262-2020; Bardaji, Azucena/AAE-9145-2019; Ordi,
   Jaume/X-4524-2018; Alonso, Azucena Bardaji/V-5978-2018
OI Saco, Adela/0000-0001-9935-9045; Bardaji, Azucena/0000-0002-5135-0540;
   Ordi, Jaume/0000-0002-4820-7954; Alonso, Azucena
   Bardaji/0000-0002-5135-0540; Martinez, Miguel
   Julian/0000-0002-0682-1075; Marban-Castro, Elena/0000-0002-9715-0595;
   Peiro Mestres, Aida/0000-0001-5484-7758
FU ISCIII-AES-Proyectos de Investigacion en Salud, Government of Spain
   [PI16/0123]
FX This work was funded by grant no. PI16/0123. ISCIII-AES-Proyectos de
   Investigacion en Salud, 2016, Government of Spain.
CR Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Schaub B, 2016, EUR J OBSTET GYN R B, V207, P240, DOI 10.1016/j.ejogrb.2016.10.041
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
NR 5
TC 11
Z9 11
U1 0
U2 5
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2018
VL 24
IS 5
BP 933
EP 935
DI 10.3201/eid2405.171479
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GD2TP
UT WOS:000430355500025
PM 29664372
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Benelli, G
AF Benelli, Giovanni
TI Mode of action of nanoparticles against insects
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Review
DE Acetylcholinesterase; Acute toxicity; Alumina nanoparticles; Aquatic
   toxicology; CYP450 isoenzymes; Dengue; Insecticide; Integrated vector
   management; Invertebrate toxicology; Lyme disease; Malaria; Mechanism of
   action; Mites; Mosquito control; Mosquito vectors; Polystyrene
   nanoparticles; Silica nanoparticles; Silver nanoparticles; Ticks;
   Titania nanoparticles; Trypsin inhibitor; Zinc oxide nanoparticles; Zika
   virus
ID SYNTHESIZED SILVER NANOPARTICLES; VECTOR AEDES-AEGYPTI; RHIPICEPHALUS
   BOOPHILUS MICROPLUS; GOLD-NANOPARTICLES; MOSQUITO VECTORS; ZIKA VIRUS;
   CHIRONOMUS-RIPARIUS; DROSOPHILA-MELANOGASTER; CULEX-QUINQUEFASCIATUS;
   PREDATION EFFICIENCY
AB The employment of nanoparticles obtained through various synthesis routes as novel pesticides recently attracted high research attention. An impressive number of studies have been conducted to test their toxic potential against a wide number of arthropod pests and vectors, with major emphasis on mosquitoes and ticks. However, precise information on the mechanisms of action of nanoparticles against insects and mites are limited, with the noteworthy exception of silica, alumina, silver, and graphene oxide nanoparticles on insects, while no information is available for mites. Here, I summarize current knowledge about the mechanisms of action of nanoparticles against insects. Both silver and graphene oxide nanoparticles have a significant impact on insect antioxidant and detoxifying enzymes, leading to oxidative stress and cell death. Ag nanoparticles also reduced acetylcholinesterase activity, while polystyrene nanoparticles inhibited CYP450 isoenzymes. Au nanoparticles can act as trypsin inhibitors and disrupt development and reproduction. Metal nanoparticles can bind to S and P in proteins and nucleic acids, respectively, leading to a decrease in membrane permeability, therefore to organelle and enzyme denaturation, followed by cell death. Besides, Ag nanoparticles up- and downregulate key insect genes, reducing protein synthesis and gonadotrophin release, leading to developmental damages and reproductive failure. The toxicity of SiO2 and Al2O3 nanoparticles is due to their binding to the insect cuticle, followed by physico-sorption of waxes and lipids, leading to insect dehydration. In the final section, insect nanotoxicology research trends are critically discussed, outlining major challenges to predict the ecotoxicological consequences arising from the real-world use of nanoparticles as pesticides.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Benelli, Giovanni] St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Benelli, G (corresponding author), St Anna Sch Adv Studies, BioRobot Inst, Viale Rinaldo Piaggio 34, I-56025 Pisa, Italy.
EM benelli.giovanni@gmail.com
CR Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Afrasiabi Z, 2016, ARCH INSECT BIOCHEM, V93, P190, DOI 10.1002/arch.21351
   Alyahya SA, 2018, J PHOTOCH PHOTOBIO B, V181, P70, DOI 10.1016/j.jphotobiol.2018.02.019
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186
   Arumugam G, 2016, APPL NANOSCI, V6, P445, DOI 10.1007/s13204-015-0446-2
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Athanassiou CG, 2018, J PEST SCI, V91, P1, DOI 10.1007/s10340-017-0898-0
   Avalos A, 2015, FOOD CHEM TOXICOL, V85, P114, DOI 10.1016/j.fct.2015.06.024
   Ayano H, 2014, J BIOSCI BIOENG, V117, P576, DOI 10.1016/j.jbiosc.2013.10.010
   Azarudeen RMST, 2017, J CLUST SCI, V28, P179, DOI 10.1007/s10876-016-1067-y
   Azarudeen RMST, 2016, RSC ADV, V6, P96573, DOI 10.1039/c6ra23208f
   Aziz A, 2018, J PHOTOCH PHOTOBIO B, V180, P225, DOI 10.1016/j.jphotobiol.2018.02.012
   Balalakshmi C, 2017, J PHOTOCH PHOTOBIO B, V173, P598, DOI 10.1016/j.jphotobiol.2017.06.040
   Banumathi B, 2017, VET PARASITOL, V244, P102, DOI 10.1016/j.vetpar.2017.07.021
   Banumathi B, 2017, J CLUST SCI, V28, P2027, DOI 10.1007/s10876-017-1201-5
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Barik TK, 2008, PARASITOL RES, V103, P253, DOI 10.1007/s00436-008-0975-7
   Barik TK, 2012, PARASITOL RES, V111, P1075, DOI 10.1007/s00436-012-2934-6
   Benelli G, 2018, ACTA TROP, V182, P80, DOI 10.1016/j.actatropica.2018.02.015
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10184, DOI 10.1007/s11356-017-9752-4
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bharani SA, 2017, J ENVIRON CHEM ENG, V5, P453, DOI 10.1016/j.jece.2016.12.023
   Bianchini A, 2003, ENVIRON TOXICOL CHEM, V22, P1361, DOI [10.1002/etc.5620220624, 10.1897/1551-5028(2003)022&lt;1361:MOASTI&gt;2.0.CO;2]
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chifiriuc MC, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020036
   Debnath N, 2011, J PEST SCI, V84, P99, DOI 10.1007/s10340-010-0332-3
   Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440
   Duran N, 2017, J BRAZIL CHEM SOC, V28, P927, DOI 10.21577/0103-5053.20170045
   Dziewiecka M, 2016, J HAZARD MATER, V305, P30, DOI 10.1016/j.jhazmat.2015.11.021
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   Fouad H, 2018, ARTIF CELL NANOMED B, V46, P558, DOI 10.1080/21691401.2017.1329739
   Frohlich E, 2010, TOXICOL APPL PHARM, V242, P326, DOI 10.1016/j.taap.2009.11.002
   Fruijtier-Polloth C, 2012, TOXICOLOGY, V294, P61, DOI 10.1016/j.tox.2012.02.001
   Ga'al H, 2018, PESTIC BIOCHEM PHYS, V144, P49, DOI 10.1016/j.pestbp.2017.11.004
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Heng MY, 2013, TRAC-TREND ANAL CHEM, V50, P1, DOI 10.1016/j.trac.2013.03.012
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Jayaseelan C, 2018, ENVIRON SCI POLLUT R, V25, P324, DOI 10.1007/s11356-017-0428-x
   Jha A. K., 2012, Journal of Bionanoscience, V6, P99, DOI 10.1166/jbns.2012.1076
   Jiang XM, 2015, NANOTOXICOLOGY, V9, P181, DOI 10.3109/17435390.2014.907457
   Jinu U., 2018, J PHOTOCH PHOTOBIO B, V178, P496
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kamaraj C, 2017, J CLUST SCI, V28, P1667, DOI 10.1007/s10876-017-1180-6
   Kavallieratos NG, 2018, ENVIRON SCI POLLUT R, V25, P10407, DOI 10.1007/s11356-017-9565-5
   Khater H, 2016, PARASITOL RES, V115, P3747, DOI 10.1007/s00436-016-5136-9
   Kirthi AV, 2011, PARASITOL RES, V109, P461, DOI 10.1007/s00436-011-2277-8
   Lee SW, 2009, ENVIRON TOXICOL PHAR, V28, P86, DOI 10.1016/j.etap.2009.03.001
   Li FC, 2014, J CHEM ECOL, V40, P913, DOI 10.1007/s10886-014-0487-0
   Liu XY, 2009, ENVIRON SCI TECHNOL, V43, P6357, DOI 10.1021/es901079z
   Mao BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20728-z
   Maurer-Jones MA, 2013, ANAL CHEM, V85, P3036, DOI 10.1021/ac303636s
   Mommaerts V, 2012, NANOTOXICOLOGY, V6, P554, DOI 10.3109/17435390.2011.590905
   Murugan K, 2018, ENVIRON SCI POLLUT R, V25, P10504, DOI 10.1007/s11356-017-0313-7
   Murugan K, 2016, ENVIRON SCI POLLUT R, V23, P16671, DOI 10.1007/s11356-016-6832-9
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P318, DOI 10.1016/j.ecoenv.2016.06.021
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Nair PMG, 2013, CHEMOSPHERE, V92, P592, DOI 10.1016/j.chemosphere.2013.03.060
   Nair PMG, 2012, ENVIRON TOXICOL PHAR, V33, P98, DOI 10.1016/j.etap.2011.09.006
   Nair PMG, 2011, AQUAT TOXICOL, V101, P550, DOI 10.1016/j.aquatox.2010.12.006
   Nair PMG, 2011, AQUAT TOXICOL, V101, P31, DOI 10.1016/j.aquatox.2010.08.013
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001
   Narkhede CP, 2016, BIOCATAL AGRIC BIOTE, V8, P8, DOI 10.1016/j.bcab.2016.07.004
   Ong C, 2015, NANOTOXICOLOGY, V9, P396, DOI 10.3109/17435390.2014.940405
   Panacek A, 2011, ENVIRON SCI TECHNOL, V45, P4974, DOI 10.1021/es104216b
   Patil CD, 2016, ENZYME MICROB TECH, V92, P18, DOI 10.1016/j.enzmictec.2016.06.005
   Pavela R, 2017, IND CROP PROD, V97, P338, DOI 10.1016/j.indcrop.2016.12.046
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, PLANT PROTECT SCI, V52, P229, DOI 10.17221/31/2016-PPS
   Pavunraj M, 2017, J CLUST SCI, V28, P2477, DOI 10.1007/s10876-017-1235-8
   Philbrook NA, 2011, TOXICOL APPL PHARM, V257, P429, DOI 10.1016/j.taap.2011.09.027
   Rai M, 2014, APPL MICROBIOL BIOT, V98, P1951, DOI 10.1007/s00253-013-5473-x
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Rajakumar G, 2012, RES VET SCI, V93, P303, DOI 10.1016/j.rvsc.2011.08.001
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rani PU, 2014, J PEST SCI, V87, P191, DOI 10.1007/s10340-013-0538-2
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Salunkhe RB, 2011, PARASITOL RES, V109, P823, DOI 10.1007/s00436-011-2328-1
   Santo-Orihuela PL, 2016, CURR PHARM BIOTECHNO, V17, P465, DOI 10.2174/138920101705160303165604
   Sharon M., 2010, J PHYTOL, V2, P83
   Shoaib A, 2018, TOXICOL ENVIRON CHEM, V100, P80, DOI 10.1080/02772248.2017.1387786
   Small T, 2016, SCI TOTAL ENVIRON, V565, P882, DOI 10.1016/j.scitotenv.2016.02.032
   Sooresh A, 2011, ACS APPL MATER INTER, V3, P3779, DOI 10.1021/am201167v
   Stadler T, 2017, B INSECTOL, V70, P17
   Stevenson PC, 2017, IND CROP PROD, V110, P2, DOI 10.1016/j.indcrop.2017.08.034
   Subramaniam J, 2017, J CLUST SCI, V28, P413, DOI 10.1007/s10876-016-1113-9
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Sujitha V, 2017, AQUAT TOXICOL, V188, P100, DOI 10.1016/j.aquatox.2017.04.015
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Sultana N, 2018, ENVIRON CHEM LETT, V16, P1017, DOI 10.1007/s10311-018-0712-0
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Teimouri M, 2018, J CLEAN PROD, V184, P740, DOI 10.1016/j.jclepro.2018.02.268
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Xie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101062
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yasur J, 2015, CHEMOSPHERE, V124, P92, DOI 10.1016/j.chemosphere.2014.11.029
NR 114
TC 81
Z9 82
U1 22
U2 166
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD MAY
PY 2018
VL 25
IS 13
SI SI
BP 12329
EP 12341
DI 10.1007/s11356-018-1850-4
PG 13
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GF3UZ
UT WOS:000431883500013
PM 29611126
DA 2020-07-08
ER

PT J
AU Jamrozik, E
   Selgelid, MJ
AF Jamrozik, Euzebiusz
   Selgelid, Michael J.
TI Ethics, health policy, and Zika: From emergency to global epidemic?
SO JOURNAL OF MEDICAL ETHICS
LA English
DT Article
DE public health ethics; abortion; epidemiology; interests of woman; fetus;
   father
ID VIRUS-INFECTION; BIRTH-DEFECTS; PREGNANCY; BRAZIL; MOSQUITOS;
   TRANSMISSION; OUTBREAK; INFANTS; VACCINE; UPDATE
AB Zika virus was recognised in 2016 as an important vector-borne cause of congenital malformations and Guillain-Barre syndrome, during a major epidemic in Latin America, centred in Northeastern Brazil. The WHO and Pan American Health Organisation (PAHO), with partner agencies, initiated a coordinated global response including public health intervention and urgent scientific research, as well as ethical analysis as a vital element of policy design. In this paper, we summarise the major ethical issues raised during the Zika epidemic, highlighting the PAHO ethics guidance and the role of ethics in emergency responses, before turning to ethical issues that are yet to be resolved. Zika raises traditional bioethical issues related to reproduction, prenatal diagnosis of serious malformations and unjust disparities in health outcomes. But the epidemic has also highlighted important issues of growing interest in public health ethics, such as the international spread of infectious disease; the central importance of reproductive healthcare in preventing maternal and neonatal morbidity and mortality; diagnostic and reporting biases; vector control and the links between vectors, climate change, and disparities in the global burden of disease. Finally, there are controversies regarding Zika vaccine research and eventual deployment. Zika virus was a neglected disease for over 50 years before the outbreak in Brazil. As it continues to spread, public health agencies should promote gender equity and disease control efforts in Latin America, while preparing for the possibility of a global epidemic.
C1 [Jamrozik, Euzebiusz; Selgelid, Michael J.] Monash Univ, Monash Bioeth Ctr, Clayton, Vic 3800, Australia.
   [Jamrozik, Euzebiusz] Royal Melbourne Hosp, Dept Gen Med, Melbourne, Vic, Australia.
RP Jamrozik, E (corresponding author), Monash Univ, Monash Bioeth Ctr, Clayton, Vic 3800, Australia.
EM zeb.jamrozik@monash.edu
RI Jamrozik, Euzebiusz/AAF-4512-2020
OI Jamrozik, Euzebiusz/0000-0001-5940-602X
FU Australian Government Research Training Program ScholarshipAustralian
   GovernmentDepartment of Industry, Innovation and Science
FX This research is supported by an Australian Government Research Training
   Program Scholarship.
CR Agrawal S, 2007, ARCH DIS CHILDHOOD-E, V92, P161, DOI 10.1136/adc.2004.065706
   Ahman E, 2011, UNSAFE ABORTION GLOB
   [Anonymous], 2016, LANCET GLOB HEALTH, V4, pE427, DOI 10.1016/S2214-109X(16)30109-7
   [Anonymous], 2016, ZIK ETH CONS ETH GUI
   Bambery B, 2016, PUBLIC HEALTH ETH-UK, V9, P92, DOI 10.1093/phe/phv026
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   Byron K, 2017, J MED ETHICS, V43, P334, DOI 10.1136/medethics-2016-103862
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chastel C, 2011, Bull Soc Pathol Exot, V104, P213, DOI 10.1007/s13149-011-0165-1
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gillott J, 2001, J MED ETHICS, V27, P21
   Guttmacher Institute, 2017, FACT SHEET AB LAT AM
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Human Rights Watch, 2017, NEGL UNPR IMP ZIK OU
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Jaenisch T, 2015, ESTIMATING RISK MICR
   Jamrozik E, 2016, ETHICS CLIMATE CHANG, P59
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Killian C, 2017, CONTEXTS, V16, P36, DOI [10. 1177/1536504217696062, DOI 10.1177/1536504217696062]
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lavery JV, 2008, AM J TROP MED HYG, V79, P312, DOI 10.4269/ajtmh.2008.79.312
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Leviton A, 2002, EARLY HUM DEV, V69, P91, DOI 10.1016/S0378-3782(02)00065-8
   Lipsitch M, 2016, SCIENCE, V353, P1094, DOI 10.1126/science.aai8126
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Natale V, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003735
   Owens S, 2016, NEUROLOGY NOW
   PAHO Pan American Health Organization (PAHO), 2017, ZIK CUM CAS
   PAHO & WHO, 2015, EP AL NEUR SYNDR CON
   Resnik DB, 2014, DEV WORLD BIOETH, V14, P37, DOI 10.1111/dewb.12011
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rick AM, 2017, LANCET GLOB HEALTH, V5, P16
   Selgelid MJ, 2008, DEV WORLD BIOETH, V8, P115, DOI 10.1111/j.1471-8847.2007.00185.x
   Selgelid MJ, 2016, WHAT ARE REAL RISKS
   Shah SK, 2017, ETHICAL CONSIDERATIO
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Simmins CH, 2016, B WORLD HEALTH ORGAN, DOI [10.2471/BLT.16.171223, DOI 10.2471/BLT.16.171223]
   de Araujo JSS, 2016, B WORLD HEALTH ORGAN, V94, P835, DOI 10.2471/BLT.16.170639
   The Ethics Working Group on ZIKV Research & Pregnancy, 2017, PREGN WOM ZIK VIR VA
   The International Sub Committee of British Council of Disabled People, 1999, NEW GEN DIS PEOPL DI
   UNDP/IFRC, 2017, SOC IMP ASS ZIK VIR
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Vouga M, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30013-2
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   World Health Organization, 2014, GUID FRAM TEST GEN M
NR 58
TC 1
Z9 1
U1 2
U2 16
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-6800
EI 1473-4257
J9 J MED ETHICS
JI J. Med. Ethics
PD MAY
PY 2018
VL 44
IS 5
BP 343
EP 348
DI 10.1136/medethics-2017-104389
PG 6
WC Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical
SC Social Sciences - Other Topics; Medical Ethics; Social Issues;
   Biomedical Social Sciences
GA GE7GF
UT WOS:000431400600014
PM 29146711
DA 2020-07-08
ER

PT J
AU Ribeiro, GS
   Kikuti, M
   Tauro, LB
   Cardoso, CW
   Paploski, IAD
   Ko, AI
   Weaver, SC
   Reis, MG
   Kitron, U
AF Ribeiro, Guilherme S.
   Kikuti, Mariana
   Tauro, Laura B.
   Cardoso, Cristiane W.
   Paploski, Igor A. D.
   Ko, Albert I.
   Weaver, Scott C.
   Reis, Mitermayer G.
   Kitron, Uriel
TI Can Zika virus antibodies cross-protect against dengue virus?
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID INFECTION
C1 [Ribeiro, Guilherme S.; Kikuti, Mariana; Tauro, Laura B.; Paploski, Igor A. D.; Ko, Albert I.; Reis, Mitermayer G.; Kitron, Uriel] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Ribeiro, Guilherme S.; Kikuti, Mariana; Paploski, Igor A. D.; Reis, Mitermayer G.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Cardoso, Cristiane W.] Secretaria Municipal Saude Salvador, Salvador, BA, Brazil.
   [Ko, Albert I.] Yale Univ, New Haven, CT USA.
   [Weaver, Scott C.] Univ Texas Med Branch, Galveston, TX 77555 USA.
   [Kitron, Uriel] Emory Univ, Atlanta, GA 30322 USA.
RP Ribeiro, GS (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.; Ribeiro, GS (corresponding author), Univ Fed Bahia, Salvador, BA, Brazil.
EM guilherme.ribeiro@bahia.fiocruz.br
RI Ribeiro, Guilherme/B-6624-2008; Paploski, Igor AD/D-7015-2014; Ko,
   Albert Icksang/P-2343-2015; Kikuti, Mariana/G-2313-2017; Reis,
   Mitermayer/AAO-9742-2020
OI Ribeiro, Guilherme/0000-0002-6798-2059; Paploski, Igor
   AD/0000-0002-3689-2042; Ko, Albert Icksang/0000-0001-9023-2339; Kikuti,
   Mariana/0000-0001-8119-7236; Reis, Mitermayer/0000-0002-3051-9060;
   Cardoso, Cristiane/0000-0001-5432-1174
CR BRASIL, 2018, B EPIDEMIOLOGICO, V49, P1, DOI DOI 10.1111/are.13485
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
NR 4
TC 4
Z9 4
U1 0
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD MAY
PY 2018
VL 6
IS 5
BP E495
EP E495
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC5ZU
UT WOS:000429870700014
PM 29653620
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Musso, D
   Bossin, H
   Mallet, HP
   Besnard, M
   Broult, J
   Baudouin, L
   Levi, JE
   Sabino, EC
   Ghawche, F
   Lanteri, MC
   Baud, D
AF Musso, Didier
   Bossin, Herve
   Mallet, Henri Pierre
   Besnard, Marianne
   Broult, Julien
   Baudouin, Laure
   Levi, Jose Eduardo
   Sabino, Ester C.
   Ghawche, Frederic
   Lanteri, Marion C.
   Baud, David
TI Zika virus in French Polynesia 2013-14: anatomy of a completed outbreak
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID GUILLAIN-BARRE-SYNDROME; MALE SEXUAL TRANSMISSION; ROSS RIVER VIRUS;
   CHIKUNGUNYA VIRUS; MOSQUITO-BORNE; DIPTERA-CULICIDAE; DENGUE VIRUSES;
   PREGNANT-WOMEN; AEDES-AEGYPTI; NEW-CALEDONIA
AB The Zika virus crisis exemplified the risk associated with emerging pathogens and was a reminder that preparedness for the worst-case scenario, although challenging, is needed. Herein, we review all data reported during the unexpected emergence of Zika virus in French Polynesia in late 2013. We focus on the new findings reported during this outbreak, especially the first description of severe neurological complications in adults and the retrospective description of CNS malformations in neonates, the isolation of Zika virus in semen, the potential for blood-transfusion transmission, mother-to-child transmission, and the development of new diagnostic assays. We describe the effect of this outbreak on health systems, the implementation of vector-borne control strategies, and the line of communication used to alert the international community of the new risk associated with Zika virus. This outbreak highlighted the need for careful monitoring of all unexpected events that occur during an emergence, to implement surveillance and research programmes in parallel to management of cases, and to be prepared to the worst-case scenario.
C1 [Musso, Didier] Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, F-98713 Tahiti, French Polynesi, France.
   [Bossin, Herve] Inst Louis Malarde, Unite Entomol Med, Tahiti, French Polynesi, France.
   [Mallet, Henri Pierre] Direct Sante Papeete, Bur Veille Sanit, Tahiti, French Polynesi, France.
   [Besnard, Marianne] Ctr Hosp Taaone, Serv Reanimat Neonatale, Tahiti, French Polynesi, France.
   [Broult, Julien] Ctr Hosp Taaone, Ctr Transfus Sanguine, Tahiti, French Polynesi, France.
   [Ghawche, Frederic] Ctr Hosp Taaone, Serv Neurol, Tahiti, French Polynesi, France.
   [Levi, Jose Eduardo; Sabino, Ester C.] Univ Sao Paulo, Trop Med Inst, Sao Paulo, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Dept Infect Dis, Med Sch, Sao Paulo, Brazil.
   [Levi, Jose Eduardo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Lanteri, Marion C.] Blood Syst Res Inst, San Francisco, CA USA.
   [Lanteri, Marion C.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Lanteri, Marion C.] Cerus Corp, Concord, CA USA.
   [Baud, David] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
RP Musso, D (corresponding author), Inst Louis Malarde, Pole Rech & Veille Malad Infect Emergentes, F-98713 Tahiti, French Polynesi, France.
EM dmusso@ilm.pf
RI Sabino, Ester Cerdeira/F-7750-2010; Musso, Didier/P-7809-2016; amsalu,
   ribka/G-8780-2019; Musso, Didier/AAO-8178-2020
OI Sabino, Ester Cerdeira/0000-0003-2623-5126; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Baud,
   David/0000-0001-9914-6496
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
   Abraham Alon, 2011, J Clin Neuromuscul Dis, V12, P113, DOI 10.1097/CND.0b013e318209ef9a
   American Association of Blood Banks, 2016, AM ASS BLOOD BANKS A
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Aubry M, 2015, INT J INFECT DIS, V37, P19, DOI 10.1016/j.ijid.2015.06.005
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Barber B, 2009, AUST FAM PHYSICIAN, V38, P586
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Baud D, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5319
   Baud D, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30008-1
   Bel M., 2007, ZIKA VIRUS PRELIMINA
   Belkin J.N., 1962, MOSQUITOES S PACIFIC, VI
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bourtzis K, 2014, ACTA TROP
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chraibi S, 2016, J CLIN VIROL, V83, P61, DOI 10.1016/j.jcv.2016.08.299
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Cressey D, 2015, NATURE, V517, P255, DOI 10.1038/517255a
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dickens BL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw103
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   ECDC, 2016, ZIK VIR SAF SUBST HU
   Esack A, 1999, W INDIAN MED J, V48, P36
   European Centre for Disease Prevention and Control, 2014, MON CURR THREATS ECD
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS MICR BR
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FDA, 2016, REV REC RED RISK ZIK
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2007, FIELDS VIROLOGY, P1155
   Guillaumot Laurent, 2005, Pac Health Dialog, V12, P45
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hamer DH, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0571-z
   Hapairai LK, 2013, J MED ENTOMOL, V50, P965, DOI 10.1603/ME12246
   Hapairai LK, 2013, J MED ENTOMOL, V50, P731, DOI 10.1603/ME12270
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Jimenez A, 2017, TRANSFUS MED REV, V31, P1, DOI 10.1016/j.tmrv.2016.08.001
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kessler CM, 2016, CLIN ADV HEMATOL ONC, V14, P677
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kutsuna S, 2017, J INFECT CHEMOTHER, V23, P114, DOI 10.1016/j.jiac.2016.08.003
   Laigret J, 1967, Bull Soc Pathol Exot Filiales, V60, P339
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mallet H-P, 2016, B EPIDEMIOLOGIQUE HE, V2016, P20
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mercer DR, 2012, J MED ENTOMOL, V49, P51, DOI 10.1603/ME11087
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, ISBT SCI SERIES, V12, P254
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0551-8
   Musso D, 2017, BLOOD TRANSFUS-ITALY, V15, P272, DOI 10.2450/2016.0003-16
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, LANCET, V387, P1812, DOI 10.1016/S0140-6736(16)30317-8
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nhan TX, 2015, CLIN MICROBIOL INFEC, V21, pE47, DOI 10.1016/j.cmi.2015.02.018
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roth Adam, 2014, Emerg Infect Dis, V20, DOI 10.3201/eid2008.130696
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Santa Maria F, 2016, TRANSFUSION, V56, P33
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Singh Narendra, 2005, Pac Health Dialog, V12, P111
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Trosemeier J-H, 2016, GENOME ANNOUNC, V4
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Waehre T, 2014, EMERG INFECT DIS, V20, P1412, DOI 10.3201/eid2008.140302
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2016, MAINT SAF AD BLOOD S
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 136
TC 31
Z9 32
U1 4
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2018
VL 18
IS 5
BP E172
EP E182
DI 10.1016/S1473-3099(17)30446-2
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA GD5TN
UT WOS:000430569700003
PM 29150310
DA 2020-07-08
ER

PT J
AU Schultz, MJ
   Tan, AL
   Gray, CN
   Isern, S
   Michael, SF
   Frydman, HM
   Connor, JH
AF Schultz, M. J.
   Tan, A. L.
   Gray, C. N.
   Isern, S.
   Michael, S. F.
   Frydman, H. M.
   Connor, J. H.
TI Wolbachia wStri Blocks Zika Virus Growth at Two Independent Stages of
   Viral Replication
SO MBIO
LA English
DT Article
DE Wolbachia; arbovirus; arthropod vectors; biocontrol; mechanisms of
   action
ID YELLOW-FEVER OUTBREAK; DENGUE VIRUS; MEDIATED BLOCKING;
   AEDES-ALBOPICTUS; MOSQUITO HOST; TRANSMISSION; CHIKUNGUNYA; INFECTION;
   METHYLTRANSFERASE; METHYLATION
AB Mosquito-transmitted viruses are spread globally and present a great risk to human health. Among the many approaches investigated to limit the diseases caused by these viruses are attempts to make mosquitos resistant to virus infection. Coinfection of mosquitos with the bacterium Wolbachia pipientis from super-group A is a recent strategy employed to reduce the capacity for major vectors in the Aedes mosquito genus to transmit viruses, including dengue virus (DENV), Chikungunya virus (CHIKV), and Zika virus (ZIKV). Recently, a supergroup B Wolbachia wStri, isolated from Laodelphax striatellus, was shown to inhibit multiple lineages of ZIKV in Aedes albopictus cells. Here, we show that wStri blocks the growth of positive-sense RNA viruses DENV, CHIKV, ZIKV, and yellow fever virus by greater than 99.9%. wStri presence did not affect the growth of the negative-sense RNA viruses LaCrosse virus or vesicular stomatitis virus. Investigation of the stages of the ZIKV life cycle inhibited by wStri identified two distinct blocks in viral replication. We found a reduction of ZIKV entry into wStri-infected cells. This was partially rescued by the addition of a cholesterol-lipid supplement. Independent of entry, transfected viral genome was unable to replicate in Wolbachia-infected cells. RNA transfection and metabolic labeling studies suggested that this replication defect is at the level of RNA translation, where we saw a 66% reduction in mosquito protein synthesis in wStri-infected cells. This study's findings increase the potential for application of wStri to block additional arboviruses and also identify specific blocks in viral infection caused by Wolbachia coinfection.
   IMPORTANCE Dengue, Zika, and yellow fever viruses are mosquito-transmitted diseases that have spread throughout the world, causing millions of infections and thousands of deaths each year. Existing programs that seek to contain these diseases through elimination of the mosquito population have so far failed, making it crucial to explore new ways of limiting the spread of these viruses. Here, we show that introduction of an insect symbiont Wolbachia wStri, into mosquito cells is highly effective at reducing yellow fever virus, dengue virus, Zika virus, and Chikungunya virus production. Reduction of virus replication was attributable to decreases in entry and a strong block of virus gene expression at the translational level. These findings expand the potential use of Wolbachia wStri to block viruses and identify two separate steps for limiting virus replication in mosquitos that could be targeted via microbes or other means as an antiviral strategy.
C1 [Schultz, M. J.; Frydman, H. M.] Boston Univ, Dept Biol, 5 Cummington St, Boston, MA 02215 USA.
   [Schultz, M. J.] Boston Univ, Mol Biol Cell Biol & Biochem Grad Program, Boston, MA 02215 USA.
   [Schultz, M. J.; Frydman, H. M.; Connor, J. H.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.
   [Tan, A. L.; Gray, C. N.; Isern, S.; Michael, S. F.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL USA.
   [Connor, J. H.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
RP Connor, JH (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.; Connor, JH (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
EM jhconnor@bu.edu
RI Schultz, Michaela/AAP-1140-2020
OI Frydman, Horacio/0000-0003-0191-7948; Connor, John/0000-0002-8867-7256
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI099210]
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Amuzu HE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005145
   Baldridge G, 2017, RES MICROBIOL, V168, P609, DOI 10.1016/j.resmic.2017.04.005
   Barrett ADT, 2017, VACCINE, V35, P5951, DOI 10.1016/j.vaccine.2017.03.032
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Chen RB, 2016, J VIROL, V90, P10600, DOI 10.1128/JVI.01166-16
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Dodson BL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006050
   Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3
   Falckenhayn C, 2016, SCI REP-UK, V6, DOI 10.1038/srep36444
   Fallon AM, 2013, IN VITRO CELL DEV-AN, V49, P66, DOI 10.1007/s11626-012-9571-3
   Fields B.N., 2013, FIELDS VIROLOGY
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gerth M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6117
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Goldani LZ, 2017, BRAZ J INFECT DIS, V21, P123, DOI 10.1016/j.bjid.2017.02.004
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Nisalak A, 2016, AM J TROP MED HYG, V94, P1342, DOI 10.4269/ajtmh.15-0337
   Otshudiema JO, 2017, MMWR-MORBID MORTAL W, V66, P335, DOI 10.15585/mmwr.mm6612a5
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   PATTON JT, 1984, J VIROL, V49, P303, DOI 10.1128/JVI.49.2.303-309.1984
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Raquin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125066
   Rice DW, 2017, GENOME BIOL EVOL, V9, P1925, DOI 10.1093/gbe/evx139
   Saucereau Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3985-y
   Schoenberg DR, 2012, NAT REV GENET, V13, P246, DOI 10.1038/nrg3160
   Schultz MJ, 2018, DNA CELL BIOL, V37, P2, DOI 10.1089/dna.2017.4025
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Shanmugam R, 2015, CELL DISCOV, V1, DOI 10.1038/celldisc.2015.10
   Sheehan KB, 2016, MBIO, V7, DOI 10.1128/mBio.00622-16
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   Suh E, 2017, ACTA TROP, V172, P232, DOI 10.1016/j.actatropica.2017.05.015
   Taber ED, 2017, J VECTOR ECOL, V42, P3, DOI 10.1111/jvec.12234
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Toomey ME, 2013, P NATL ACAD SCI USA, V110, P10788, DOI 10.1073/pnas.1301524110
   Tuorto F, 2015, EMBO J, V34, P2350, DOI 10.15252/embj.201591382
   Tuorto F, 2012, NAT STRUCT MOL BIOL, V19, P900, DOI 10.1038/nsmb.2357
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   van Meer MMM, 1999, INSECT MOL BIOL, V8, P399, DOI 10.1046/j.1365-2583.1999.83129.x
   Voronin D, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0462-1
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yamada H, 2014, J MED ENTOMOL, V51, P811, DOI 10.1603/ME13223
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 71
TC 12
Z9 12
U1 1
U2 17
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2150-7511
J9 MBIO
JI mBio
PD MAY-JUN
PY 2018
VL 9
IS 3
AR e00738-18
DI 10.1128/mBio.00738-18
PG 15
WC Microbiology
SC Microbiology
GA GG9WG
UT WOS:000433051200018
PM 29789369
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Walker, LM
   Burton, DR
AF Walker, Laura M.
   Burton, Dennis R.
TI Passive immunotherapy of viral infections: 'super-antibodies' enter the
   fray
SO NATURE REVIEWS IMMUNOLOGY
LA English
DT Review
ID BROADLY NEUTRALIZING ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES;
   RESPIRATORY SYNCYTIAL VIRUS; SIMIAN/HUMAN IMMUNODEFICIENCY VIRUS; DENGUE
   VIRUS; ZIKA VIRUS; NONHUMAN-PRIMATES; HIV-ANTIBODIES; B-CELLS;
   POSTEXPOSURE EFFICACY
AB Antibodies have been used for more than 100 years in the therapy of infectious diseases, but a new generation of highly potent and/or broadly cross-reactive human monoclonal antibodies (sometimes referred to as 'super-antibodies') offers new opportunities for intervention. The isolation of these antibodies, most of which are rarely induced in human infections, has primarily been achieved by large-scale screening for suitable donors and new single B cell approaches to human monoclonal antibody generation. Engineering the antibodies to improve half-life and effector functions has further augmented their in vivo activity in some cases. Super-antibodies offer promise for the prophylaxis and therapy of infections with a range of viruses, including those that are highly antigenically variable and those that are newly emerging or that have pandemic potential. The next few years will be decisive in the realization of the promise of super-antibodies.
C1 [Walker, Laura M.] Adimab LLC, Lebanon, NH 03766 USA.
   [Burton, Dennis R.] Scripps Res Inst, Ctr HIV AIDS Vaccine Immunol & Immunogen Discover, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.
   [Burton, Dennis R.] Scripps Res Inst, Int AIDS Vaccine Initiat Neutralizing Antibody Ct, La Jolla, CA 92037 USA.
   [Burton, Dennis R.] Massachusetts Gen Hosp, MIT, Ragon Inst, Cambridge, MA 02139 USA.
   [Burton, Dennis R.] Harvard Univ, Cambridge, MA 02139 USA.
RP Walker, LM (corresponding author), Adimab LLC, Lebanon, NH 03766 USA.
EM laura.walker@adimab.com; burton@scripps.edu
FU US National Institute of Allergy and Infectious DiseaseUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   International AIDS Vaccine Initiative; Bill and Melinda Gates
   FoundationGates Foundation; Ragon Institute
FX The authors thank J. Mascola, D. Sok and M. Vasquez for comments on the
   manuscript. The authors also thank L. Hangartner and C. Corbaci for
   assistance with figure preparation. D. R. B. acknowledges the financial
   support from the US National Institute of Allergy and Infectious
   Disease, the International AIDS Vaccine Initiative, the Bill and Melinda
   Gates Foundation and the Ragon Institute.
CR Andrews SF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2676
   Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522
   Babcook JS, 1996, P NATL ACAD SCI USA, V93, P7843, DOI 10.1073/pnas.93.15.7843
   Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660
   Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Berry JD, 2011, NEW BIOTECHNOL, V28, P489, DOI 10.1016/j.nbt.2011.03.018
   Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553
   Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11
   Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788
   Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108
   Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262
   Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158
   Burton DR, 2012, SCIENCE, V337, P183, DOI 10.1126/science.1225416
   Burton DR, 1997, P NATL ACAD SCI USA, V94, P10018, DOI 10.1073/pnas.94.19.10018
   Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268
   Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411
   Chen ZC, 2013, P NATL ACAD SCI USA, V110, P20242, DOI 10.1073/pnas.1320041110
   Corti D, 2017, CURR OPIN VIROL, V24, P60, DOI 10.1016/j.coviro.2017.03.002
   Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224
   Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112
   Corti D, 2013, NATURE, V501, P439, DOI 10.1038/nature12442
   Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916
   Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669
   Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200
   De Benedictis P, 2016, EMBO MOL MED, V8, P407, DOI 10.15252/emmm.201505986
   Deal CE, 2015, CURR OPIN HIV AIDS, V10, P190, DOI 10.1097/COH.0000000000000145
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Detalle L, 2016, ANTIMICROB AGENTS CH, V60, P6, DOI 10.1128/AAC.01802-15
   Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036
   Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09
   Dreyfus C, 2012, SCIENCE, V337, P1343, DOI 10.1126/science.1222908
   Dye JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24897
   Falkowska E, 2014, IMMUNITY, V40, P657, DOI 10.1016/j.immuni.2014.04.009
   Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11
   Flingai S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12616
   Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022
   Gao GP, 2004, BLOOD, V103, P3300, DOI 10.1182/blood-2003-11-3852
   Gardner CL, 2017, J VIROL, V91, DOI 10.1128/JVI.00226-17
   Gardner MR, 2015, NATURE, V519, P87, DOI 10.1038/nature14264
   Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677
   Gilchuk I, 2016, CELL, V167, P684, DOI 10.1016/j.cell.2016.09.049
   Gilman MSA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaj1879
   Graham BS, 2015, CURR OPIN HIV AIDS, V10, P129, DOI 10.1097/COH.0000000000000154
   Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11
   Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974
   Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433
   Hey A, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.AID-0026-2014
   Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200
   Hooper JW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010082
   Horwitz JA, 2013, P NATL ACAD SCI USA, V110, P16538, DOI 10.1073/pnas.1315295110
   Hu J, 2010, WORLD J PEDIATR, V6, P296, DOI 10.1007/s12519-010-0230-z
   Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027
   Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117
   HUSE WD, 1989, SCIENCE, V246, P1275, DOI 10.1126/science.2531466
   JAHRLING PB, 1985, T ROY SOC TROP MED H, V79, P380, DOI 10.1016/0035-9203(85)90388-8
   Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967
   Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043
   Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4235
   Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1321
   Ko SY, 2014, NATURE, V514, P642, DOI 10.1038/nature13612
   Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071
   Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516
   Kwong PD, 2012, IMMUNITY, V37, P412, DOI 10.1016/j.immuni.2012.08.012
   Lanzavecchia A, 2007, CURR OPIN BIOTECH, V18, P523, DOI 10.1016/j.copbio.2007.10.011
   Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103
   Lee EC, 2014, NAT BIOTECHNOL, V32, P356, DOI 10.1038/nbt.2825
   Lee JE, 2008, NATURE, V454, P177, DOI 10.1038/nature07082
   Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017
   Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109
   Li Y, 2013, J EXP MED, V210, P1493, DOI 10.1084/jem.20130212
   Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624
   Luke T, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1061
   Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752
   Macagno A, 2010, J VIROL, V84, P1005, DOI 10.1128/JVI.01809-09
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999
   Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318
   MCCAFFERTY J, 1990, NATURE, V348, P552, DOI 10.1038/348552a0
   McCoy LE, 2017, IMMUNOL REV, V275, P11, DOI 10.1111/imr.12484
   McLellan JS, 2013, SCIENCE, V340, P1113, DOI 10.1126/science.1234914
   Medina-Ramirez M, 2011, J VIROL, V85, P5804, DOI 10.1128/JVI.02482-10
   Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731
   Mire CE, 2017, NAT MED, V23, P1146, DOI 10.1038/nm.4396
   Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117
   Murphy AJ, 2014, P NATL ACAD SCI USA, V111, P5153, DOI 10.1073/pnas.1324022111
   Muthumani K, 2013, HUM VACC IMMUNOTHER, V9, P2253, DOI 10.4161/hv.26498
   Nair N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam5434
   Nault JC, 2015, NAT GENET, V47, P1187, DOI 10.1038/ng.3389
   Null D, 1998, PEDIATRICS, V102, P531, DOI 10.1542/peds.102.3.531
   Pardi N, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14630
   Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001
   Pascal KE, 2015, P NATL ACAD SCI USA, V112, P8738, DOI 10.1073/pnas.1510830112
   Paules CI, 2017, J INFECT DIS, V216, P356, DOI 10.1093/infdis/jix292
   Poignard P, 1999, IMMUNITY, V10, P431, DOI 10.1016/S1074-7613(00)80043-6
   Prabakaran M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005672
   Presta LG, 2008, CURR OPIN IMMUNOL, V20, P460, DOI 10.1016/j.coi.2008.06.012
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Qian HW, 2017, CELL, V169, P1228, DOI 10.1016/j.cell.2017.05.020
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Qiu XG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001575
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson JE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11544
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Rossey I, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14158
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08
   Saunders KO, 2015, J VIROL, V89, P5895, DOI 10.1128/JVI.00210-15
   Saylor C, 2009, VACCINE, V27, pG38, DOI 10.1016/j.vaccine.2009.09.105
   Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Schepens B, 2011, J INFECT DIS, V204, P1692, DOI 10.1093/infdis/jir622
   Scherer EM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004461
   Schoofs T, 2016, SCIENCE, V352, P997, DOI 10.1126/science.aaf0972
   Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494
   Shingai M, 2013, NATURE, V503, P277, DOI 10.1038/nature12746
   Silveira ELV, 2015, J IMMUNOL METHODS, V416, P69, DOI 10.1016/j.jim.2014.11.003
   Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09
   Smith SA, 2015, CELL HOST MICROBE, V18, P86, DOI 10.1016/j.chom.2015.06.009
   Sok D, 2017, NATURE, V548, P108, DOI 10.1038/nature23301
   Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111
   Sommerstein R, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005276
   Sparrow E, 2017, B WORLD HEALTH ORGAN, V95, P235, DOI [10.2471/BLT.16.178061, 10.2471/blt.16.178061]
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   STEVENS RH, 1979, J IMMUNOL, V122, P2498
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   Tahara M, 2013, J VIROL, V87, P666, DOI 10.1128/JVI.02033-12
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Tjelle TE, 2004, MOL THER, V9, P328, DOI 10.1016/j.ymthe.2003.12.007
   Van Heeke G, 2017, PHARMACOL THERAPEUT, V169, P47, DOI 10.1016/j.pharmthera.2016.06.012
   Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373
   Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
   Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037
   Wen XW, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.272
   West AP, 2014, CELL, V156, P633, DOI 10.1016/j.cell.2014.01.052
   Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664
   Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352
   Wu NC, 2017, J MOL BIOL, V429, P2694, DOI 10.1016/j.jmb.2017.06.015
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630
   Yu XQ, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01020-16, 10.1128/aac.01020-16]
   Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601
   Zeitlin L, 2016, P NATL ACAD SCI USA, V113, P4458, DOI 10.1073/pnas.1600996113
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
   Zhu Q, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj1928
NR 156
TC 54
Z9 54
U1 5
U2 30
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-1733
EI 1474-1741
J9 NAT REV IMMUNOL
JI Nat. Rev. Immunol.
PD MAY
PY 2018
VL 18
IS 5
BP 297
EP 308
DI 10.1038/nri.2017.148
PG 12
WC Immunology
SC Immunology
GA GE1DD
UT WOS:000430956100010
PM 29379211
OA Green Published
DA 2020-07-08
ER

PT J
AU Seferovic, M
   Sanchez-San Martin, C
   Tardif, SD
   Rutherford, J
   Castro, ECC
   Li, T
   Hodara, VL
   Parodi, LM
   Giavedoni, L
   Layne-Colon, D
   Tamhankar, M
   Yagi, S
   Martyn, C
   Reyes, K
   Suter, MA
   Aagaard, KM
   Chiu, CY
   Patterson, JL
AF Seferovic, Maxim
   Sanchez-San Martin, Claudia
   Tardif, Suzette D.
   Rutherford, Julienne
   Castro, Eumenia C. C.
   Li, Tony
   Hodara, Vida L.
   Parodi, Laura M.
   Giavedoni, Luis
   Layne-Colon, Donna
   Tamhankar, Manasi
   Yagi, Shigeo
   Martyn, Calla
   Reyes, Kevin
   Suter, Melissa A.
   Aagaard, Kjersti M.
   Chiu, Charles Y.
   Patterson, Jean L.
TI Experimental Zika Virus Infection in the Pregnant Common Marmoset
   Induces Spontaneous Fetal Loss and Neurodevelopmental Abnormalities
SO SCIENTIFIC REPORTS
LA English
DT Article
ID HUMAN PLACENTAL TROPHOBLASTS; NONHUMAN PRIMATE MODEL;
   CALLITHRIX-JACCHUS; CASE SERIES; PATHOLOGY; VIREMIA; BRAIN; REPLICATION;
   PERSISTENCE; EXPRESSION
AB During its most recent outbreak across the Americas, Zika virus (ZIKV) was surprisingly shown to cause fetal loss and congenital malformations in acutely and chronically infected pregnant women. However, understanding the underlying pathogenesis of ZIKV congenital disease has been hampered by a lack of relevant in vivo experimental models. Here we present a candidate New World monkey model of ZIKV infection in pregnant marmosets that faithfully recapitulates human disease. ZIKV inoculation at the human-equivalent of early gestation caused an asymptomatic seroconversion, induction of type I/II interferon-associated genes and proinflammatory cytokines, and persistent viremia and viruria. Spontaneous pregnancy loss was observed 16-18 days post-infection, with extensive active placental viral replication and fetal neurocellular disorganization similar to that seen in humans. These findings underscore the key role of the placenta as a conduit for fetal infection, and demonstrate the utility of marmosets as a highly relevant model for studying congenital ZIKV disease and pregnancy loss.
C1 [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.
   [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Baylor Coll Med, Dept Pathol & Lab Med, Houston, TX 77030 USA.
   [Seferovic, Maxim; Castro, Eumenia C. C.; Suter, Melissa A.; Aagaard, Kjersti M.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Sanchez-San Martin, Claudia; Li, Tony; Martyn, Calla; Reyes, Kevin; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
   [Tardif, Suzette D.; Hodara, Vida L.; Parodi, Laura M.; Giavedoni, Luis; Layne-Colon, Donna] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA.
   [Rutherford, Julienne] Univ Illinois, Dept Women Children & Family Hlth Sci, Chicago, IL 60612 USA.
   [Hodara, Vida L.; Parodi, Laura M.; Giavedoni, Luis; Tamhankar, Manasi; Patterson, Jean L.] Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78245 USA.
   [Yagi, Shigeo] Calif Dept Publ Hlth, Richmond, CA 94804 USA.
   [Chiu, Charles Y.] Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA.
RP Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.; Patterson, JL (corresponding author), Texas Biomed Res Inst, Dept Virol & Immunol, San Antonio, TX 78245 USA.; Chiu, CY (corresponding author), Univ Calif San Francisco, Dept Med Infect Dis, San Francisco, CA 94143 USA.
EM charles.chiu@ucsf.edu; jpatters@txbiomed.org
OI Rutherford, Julienne/0000-0001-6536-6888
FU Southwest National Primate Research Center [P51-OD11133]; Texas
   Biomedical Research Institute; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01-HL105704,
   R21-AI129455, R24-DK090964, R01-HD091731, R01 DK089201]
FX We would like to acknowledge Lark Coffey from UC Davis and Marion
   Lanteri from Blood Systems Research Institute for kindly sharing their
   P3 stock of ZIKV Brazil strain SPH2015. We also thank Julien Theze at
   Oxford University for assistance in reviewing available ZIKV reference
   genomes in GenBank. We thank Anthony Chiu for line art drawing of the
   embryo images shown in Fig. 8. The animal work in this study was
   supported by the Southwest National Primate Research Center
   (P51-OD11133) and Texas Biomedical Research Institute. This study was
   supported in part by NIH grants R01-HL105704 and R21-AI129455 to CYC and
   R24-DK090964, R01-HD091731, and R01 DK089201 to KMA. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638
   Arredondo F, 2006, SEMIN REPROD MED, V24, P33, DOI 10.1055/s-2006-931799
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Burton GJ, 2010, PLACENTA, V31, pA17
   Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06
   Carrion R, 2012, CURR OPIN VIROL, V2, P357, DOI 10.1016/j.coviro.2012.02.007
   Carrion R, 2011, VIROLOGY, V420, P117, DOI 10.1016/j.virol.2011.08.022
   Chen JG, 2017, CHINA PERSPECTIVE, P21
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cunha MS, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00032-16
   DICK GWA, 1953, T ROY SOC TROP MED H, V47, P13, DOI 10.1016/0035-9203(53)90021-2
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Focosi D, 2016, CLIN INFECT DIS, V63, P227, DOI 10.1093/cid/ciw210
   Fox E. J., 2014, NEXT GENER SEQ APPL, V1
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jaquish CE, 1996, J MED PRIMATOL, V25, P57, DOI 10.1111/j.1600-0684.1996.tb00194.x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Leyser M, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0048
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   LUNN SF, 1983, FOLIA PRIMATOL, V41, P204, DOI 10.1159/000156132
   Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Moi ML, 2014, J GEN VIROL, V95, P591, DOI 10.1099/vir.0.060384-0
   Naccache SN, 2014, GENOME RES, V24, P1180, DOI 10.1101/gr.171934.113
   Neubert D., 1988, NONHUMAN PRIMATES DE, P129
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Ozhan G, 2013, DEV CELL, V26, P331, DOI 10.1016/j.devcel.2013.07.020
   Oz OK, 2007, J BONE MINER RES, V22, P1893, DOI 10.1359/JBMR.070808
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Rutherford JN, 2009, PLACENTA, V30, P105, DOI 10.1016/j.placenta.2008.10.010
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Suzuki Y, 2008, J BONE MINER RES, V23, P1249, DOI 10.1359/JBMR.080314
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tardif SD, 1998, J MED PRIMATOL, V27, P28, DOI 10.1111/j.1600-0684.1998.tb00065.x
   Tardif SD, 2003, COMPARATIVE MED, V53, P364
   Uuskula L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049248
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Vanchiere J., 2016, OPEN FORUM INFECT S1, V3, DOI [10.1093/ofid/ofw172.468, DOI 10.1093/OFID/OFW172.468]
   Verstrepen BE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002797
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 61
TC 23
Z9 23
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 1
PY 2018
VL 8
AR 6851
DI 10.1038/s41598-018-25205-1
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE3LG
UT WOS:000431114200030
PM 29717225
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Samuel, GH
   Adelman, ZN
   Myles, KM
AF Samuel, Glady Hazitha
   Adelman, Zach N.
   Myles, Kevin M.
TI Antiviral Immunity and Virus-Mediated Antagonism in Disease Vector
   Mosquitoes
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID NONSTRUCTURAL PROTEIN NSS; RNA-SILENCING SUPPRESSION; STAT SIGNALING
   PATHWAY; DOUBLE-STRANDED-RNA; DENGUE VIRUS; AEDES-AEGYPTI;
   DROSOPHILA-MELANOGASTER; ANOPHELES-GAMBIAE; ALPHA-INTERFERON; INITIATION
   STEP
AB More than 100 pathogens, spanning multiple virus families, broadly termed 'arthropod-borne viruses (arboviruses)' have been associated with human and/or animal diseases. These viruses persist in nature through transmission cycles that involve alternating replication in susceptible vertebrate and invertebrate hosts. Collectively, these viruses are among the greatest burdens to global health, due to their widespread prevalence, and the severe morbidity and mortality they cause in human and animal hosts. Specific examples of mosquito-borne pathogens include Zika virus (ZIKV), West Nile virus (WNV), dengue virus serotypes 1-4 (DENV 1-4), Japanese encephalitis virus (JEV), yellow fever virus (YFV), chikungunya virus (CHIKV), and Rift Valley fever virus (RVFV). Interactions between arboviruses and the immune pathways of vertebrate hosts have been extensively reviewed. In this review we focus on the antiviral immune pathways present in mosquitoes. We also discuss mechanisms by which mosquito-borne viruses may antagonize antiviral pathways in disease vectors. Finally, we elaborate on the possibility that mosquito-borne viruses may be engaged in an evolutionary arms race with their invertebrate vector hosts, and the possible implications of this for understanding the transmission of mosquito-borne viruses.
C1 [Samuel, Glady Hazitha; Adelman, Zach N.; Myles, Kevin M.] Texas A&M Univ, Minnie Belle Heep Ctr, Dept Entomol, College Stn, TX 77843 USA.
RP Myles, KM (corresponding author), Texas A&M Univ, Minnie Belle Heep Ctr, Dept Entomol, College Stn, TX 77843 USA.
EM mylesk@tamu.edu
OI Adelman, Zach/0000-0001-5901-7171
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI119081, R01 AI077726]
CR Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8
   Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Ayllon J, 2015, CURR TOP MICROBIOL, V386, P73, DOI 10.1007/82_2014_400
   Azevedo J, 2010, GENE DEV, V24, P904, DOI 10.1101/gad.1908710
   Basu S, 2015, P NATL ACAD SCI USA, V112, P4038, DOI 10.1073/pnas.1502370112
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664
   Campbell CL, 2014, INSECT MOL BIOL, V23, P132, DOI 10.1111/imb.12070
   Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47
   Campbell CL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-425
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   CHAMBERLAIN R, 1961, ANNU REV ENTOMOL, V6, P371, DOI 10.1146/annurev.en.06.010161.002103
   Chao JA, 2005, NAT STRUCT MOL BIOL, V12, P952, DOI 10.1038/nsmb1005
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Cirimotich CM, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-49
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214
   Diaz-Pendon JA, 2007, PLANT CELL, V19, P2053, DOI 10.1105/tpc.106.047449
   Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335
   Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Gunawardane LS, 2007, SCIENCE, V315, P1587, DOI 10.1126/science.1140494
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Han BW, 2015, SCIENCE, V348, P817, DOI 10.1126/science.aaa1264
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hayashi R, 2016, NATURE, V539, P588, DOI 10.1038/nature20162
   Hess AM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-45
   Ho LJ, 2005, J IMMUNOL, V174, P8163, DOI 10.4049/jimmunol.174.12.8163
   Hussain M, 2014, P NATL ACAD SCI USA, V111, P2746, DOI 10.1073/pnas.1320123111
   Hussain M, 2012, NUCLEIC ACIDS RES, V40, P2210, DOI 10.1093/nar/gkr848
   Iki T, 2017, RNA, V23, P639, DOI 10.1261/rna.060434.116
   Kakumani PK, 2013, J VIROL, V87, P8870, DOI 10.1128/JVI.02774-12
   Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8
   Lakatos L, 2004, EMBO J, V23, P876, DOI 10.1038/sj.emboj.7600096
   Lau NC, 2009, GENOME RES, V19, P1776, DOI 10.1101/gr.094896.109
   Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2
   Leger P, 2013, J VIROL, V87, P1631, DOI 10.1128/JVI.02795-12
   Lewis SH, 2016, GENOME BIOL EVOL, V8, P507, DOI 10.1093/gbe/evw018
   Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027
   Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948
   Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Lin RJ, 2004, J VIROL, V78, P9285, DOI 10.1128/JVI.78.17.9285-9294.2004
   Lingel A, 2005, EMBO REP, V6, P1149, DOI 10.1038/sj.embor.7400583
   Lu R, 2005, NATURE, V436, P1040, DOI 10.1038/nature03870
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040
   Marques JT, 2016, CURR OPIN MICROBIOL, V32, P71, DOI 10.1016/j.mib.2016.05.002
   Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044
   McFarlane M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002994
   Merai Z., 2006, VIROLOGY, V80, P5747
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605
   Mohn F, 2015, SCIENCE, V348, P812, DOI 10.1126/science.aaa1039
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   MURPHY FA, 1975, ANN NY ACAD SCI, V266, P197, DOI 10.1111/j.1749-6632.1975.tb35101.x
   Murray GGR, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0965
   Myles KM, 2009, RNA BIOL, V6, P387, DOI 10.4161/rna.6.4.8946
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Nayak A, 2010, NAT STRUCT MOL BIOL, V17, P547, DOI 10.1038/nsmb.1810
   Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307
   O'Neal ST, 2014, VIRUSES-BASEL, V6, P4314, DOI 10.3390/v6114314
   Obbard DJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000698
   Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041
   Qu F, 2003, J VIROL, V77, P511, DOI 10.1128/JVI.77.1.511-522.2003
   Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020
   Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501
   Saldana MA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005760
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2013, J GEN VIROL, V94, P1680, DOI 10.1099/vir.0.053850-0
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1
   Scott JC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000848
   Shrinet J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002616
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Skalsky RL, 2014, P NATL ACAD SCI USA, V111, pE2359, DOI 10.1073/pnas.1406854111
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Szemiel AM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001823
   Tassetto M, 2017, CELL, V169, P314, DOI 10.1016/j.cell.2017.03.033
   Tomari Y, 2007, CELL, V130, P299, DOI 10.1016/j.cell.2007.05.057
   Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   Valli A, 2007, J GEN VIROL, V88, P1016, DOI 10.1099/vir.0.82402-0
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   van Mierlo JT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002872
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Varjak M, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00144-17, 10.1128/msphere.00144-17]
   Vodovar N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030861
   Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694
   Waterhouse RM, 2007, SCIENCE, V316, P1738, DOI 10.1126/science.1139862
   Weaver SC, 1999, J VIROL, V73, P4316, DOI 10.1128/JVI.73.5.4316-4326.1999
   WEAVER SC, 1994, J VIROL, V68, P158, DOI 10.1128/JVI.68.1.158-169.1994
   Weber F, 2001, VIROLOGY, V281, P67, DOI 10.1006/viro.2000.0774
   WEI N, 1992, VIROLOGY, V190, P346, DOI 10.1016/0042-6822(92)91221-F
   Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Yan H, 2014, J MED VIROL, V86, P1428, DOI 10.1002/jmv.23815
   Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102
NR 128
TC 16
Z9 16
U1 2
U2 25
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD MAY
PY 2018
VL 26
IS 5
BP 447
EP 461
DI 10.1016/j.tim.2017.12.005
PG 15
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA GD2KB
UT WOS:000430327400008
PM 29395729
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Subudhi, BB
   Chattopadhyay, S
   Mishra, P
   Kumar, A
AF Subudhi, Bharat Bhusan
   Chattopadhyay, Soma
   Mishra, Priyadarsee
   Kumar, Abhishek
TI Current Strategies for Inhibition of Chikungunya Infection
SO VIRUSES-BASEL
LA English
DT Review
DE alphavirus; antiviral; chikungunya; drug likeness; drug targets;
   pre-clinical validation
ID HEPATITIS-C VIRUS; INDUCED CELL-DEATH; SPECTRUM ANTIVIRAL ACTIVITY; NSP2
   PROTEASE INHIBITORS; SEMLIKI-FOREST-VIRUS; IN-VITRO; MYCOPHENOLIC-ACID;
   GREEN TEA; FAVIPIRAVIR T-705; AEDES-ALBOPICTUS
AB Increasing incidences of Chikungunya virus (CHIKV) infection and co-infections with Dengue/Zika virus have highlighted the urgency for CHIKV management. Failure in developing effective vaccines or specific antivirals has fuelled further research. This review discusses updated strategies of CHIKV inhibition and provides possible future directions. In addition, it analyzes advances in CHIKV lifecycle, drug-target development, and potential hits obtained by in silico and experimental methods. Molecules identified with anti-CHIKV properties using traditional/rational drug design and their potential to succeed in subsequent stages of drug development have also been discussed. Possibilities of repurposing existing drugs based on their in vitro findings have also been elucidated. Probable modes of interference of these compounds at various stages of infection, including entry and replication, have been highlighted. The use of host factors as targets to identify antivirals against CHIKV has been addressed. While most of the earlier antivirals were effective in the early phases of the CHIKV life cycle, this review is also focused on drug candidates that are effective at multiple stages of its life cycle. Since most of these antivirals require validation in preclinical and clinical models, the challenges regarding this have been discussed and will provide critical information for further research.
C1 [Subudhi, Bharat Bhusan; Mishra, Priyadarsee] Siksha O Anusandhan Deemed Be Univ, Sch Pharmaceut Sci, Bhubaneswar 751029, Odisha, India.
   [Chattopadhyay, Soma; Kumar, Abhishek] Inst Life Sci, Bhubaneswar 751023, Odisha, India.
RP Subudhi, BB (corresponding author), Siksha O Anusandhan Deemed Be Univ, Sch Pharmaceut Sci, Bhubaneswar 751029, Odisha, India.; Chattopadhyay, S (corresponding author), Inst Life Sci, Bhubaneswar 751023, Odisha, India.
EM bharatbhusans@gmail.com; sochat.ils@gmail.com;
   priyadarsee_pharma@yahoo.co.in; abhishekbt13@gmail.com
RI Kumar, Abhishek/AAO-1910-2020
OI Kumar, Abhishek/0000-0001-5880-8123
FU SERB, Department of Science and technology, Government of India
   [EMR/2015/002433]
FX This work was partly funded by SERB (Research Grant No.
   EMR/2015/002433), Department of Science and technology, Government of
   India.
CR Abdel-Aal MT, 2010, ARCH PHARM RES, V33, P797, DOI 10.1007/s12272-010-0601-y
   Agarwal T, 2015, INDIAN J PHARM SCI, V77, P453
   Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007
   Albulescu IC, 2015, ANTIVIR RES, V121, P39, DOI 10.1016/j.antiviral.2015.06.013
   Allard PM, 2012, PHYTOCHEMISTRY, V84, P160, DOI 10.1016/j.phytochem.2012.07.023
   Ashbrook AW, 2014, J VIROL, V88, P12180, DOI 10.1128/JVI.01672-14
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Bassetto M, 2013, ANTIVIR RES, V98, P12, DOI 10.1016/j.antiviral.2013.01.002
   BELARDELLI F, 1995, APMIS, V103, P161, DOI 10.1111/j.1699-0463.1995.tb01092.x
   Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479
   Bernard Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025302
   Bhat AS, 2007, TOXICOL MECH METHOD, V17, P441, DOI 10.1080/15376510601177654
   Bhattacharya S, 2009, J INFECTION, V59, P377, DOI 10.1016/j.jinf.2009.09.014
   Bhooshan S, 2015, INT J HEALTHCARE BIO, V03, P117
   Blaising J, 2014, ANTIVIR RES, V107, P84, DOI 10.1016/j.antiviral.2014.04.006
   Borah A, 2013, CNS NEUROSCI THER, V19, P847, DOI 10.1111/cns.12175
   Bourai M, 2012, J VIROL, V86, P3121, DOI 10.1128/JVI.06390-11
   Bourjot M, 2012, FITOTERAPIA, V83, P1076, DOI 10.1016/j.fitote.2012.05.004
   Brehin AC, 2009, VIROLOGY, V384, P216, DOI 10.1016/j.virol.2008.10.021
   Briolant S, 2004, ANTIVIR RES, V61, P111, DOI 10.1016/j.antiviral.2003.09.005
   Calabrese C, 2000, PHYTOTHER RES, V14, P333, DOI 10.1002/1099-1573(200008)14:5&lt;333::AID-PTR584&gt;3.0.CO;2-D
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Caroline AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002790
   Chan Yi-Hao, 2015, Med Sci (Basel), V3, P64, DOI 10.3390/medsci3030064
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chatterjee S N, 1965, J Indian Med Assoc, V45, P314
   Chen JX, 2009, BIOL PHARM BULL, V32, P1385, DOI 10.1248/bpb.32.1385
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   CLINE JC, 1969, APPL MICROBIOL, V18, P14, DOI 10.1128/AEM.18.1.14-20.1969
   Colpitts CC, 2014, J VIROL, V88, P7806, DOI 10.1128/JVI.00896-14
   Corlay N, 2014, FITOTERAPIA, V97, P87, DOI 10.1016/j.fitote.2014.05.015
   Craig J., 2010, PROGR MOL BIOL TRANS, V95
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   CRUTCHER WA, 1975, BRIT J DERMATOL, V92, P199, DOI 10.1111/j.1365-2133.1975.tb03059.x
   Cruz DJM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002471
   Das I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100531
   Dash PK, 2008, BIOCHEM BIOPH RES CO, V376, P718, DOI 10.1016/j.bbrc.2008.09.040
   De I, 2003, J VIROL, V77, P13106, DOI 10.1128/JVI.77.24.13106-13116.2003
   De Lamballerie X, 2008, VECTOR-BORNE ZOONOT, V8, P837, DOI 10.1089/vbz.2008.0049
   Delang L, 2014, J ANTIMICROB CHEMOTH, V69, P2770, DOI 10.1093/jac/dku209
   Delogu I, 2011, ANTIVIR RES, V90, P99, DOI 10.1016/j.antiviral.2011.03.182
   DENEAU DG, 1975, DERMATOLOGICA, V151, P158, DOI 10.1159/000251329
   Devappa RK, 2011, J AM OIL CHEM SOC, V88, P301, DOI 10.1007/s11746-010-1720-9
   Di Mola A, 2014, BIOORGAN MED CHEM, V22, P6014, DOI 10.1016/j.bmc.2014.09.013
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Efferth T, 2003, N-S ARCH PHARMACOL, V367, P56, DOI 10.1007/s00210-002-0632-0
   Ekins S, 2007, BRIT J PHARMACOL, V152, P9, DOI 10.1038/sj.bjp.0707305
   Fong RH, 2014, J VIROL, V88, P14364, DOI 10.1128/JVI.01943-14
   Fraisier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091397
   FREEDMAN A, 1960, ANN RHEUM DIS, V19, P243, DOI 10.1136/ard.19.3.243
   Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x
   Fros JJ, 2012, J VIROL, V86, P10873, DOI 10.1128/JVI.01506-12
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   GAGARINOVA VM, 1993, ZH MIKROB EPID IMMUN, P40
   Gallegos KM, 2016, J INFECT DIS, V214, P1192, DOI 10.1093/infdis/jiw358
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Gastaminza P, 2010, P NATL ACAD SCI USA, V107, P291, DOI 10.1073/pnas.0912966107
   Geller R, 2007, GENE DEV, V21, P195, DOI 10.1101/gad.1505307
   Geller R, 2012, BBA-MOL CELL RES, V1823, P698, DOI 10.1016/j.bbamcr.2011.11.007
   Gigante A, 2017, ANTIVIR RES, V144, P216, DOI 10.1016/j.antiviral.2017.06.003
   Gigante A, 2014, J MED CHEM, V57, P4000, DOI 10.1021/jm401844c
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x
   Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791
   Grudkowska M, 2004, ACTA BIOCHIM POL, V51, P609
   Gupta DK, 2014, MAR DRUGS, V12, P115, DOI 10.3390/md12010115
   HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599
   Ho YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133511
   Hong EM, 2006, J VIROL, V80, P8848, DOI 10.1128/JVI.00619-06
   Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x
   Hwu JR, 2017, ANTIVIR RES, V146, P96, DOI 10.1016/j.antiviral.2017.08.008
   Hwu JR, 2015, ANTIVIR RES, V118, P103, DOI 10.1016/j.antiviral.2015.03.013
   Jadav SS, 2012, INT SCHOLARLY SCI RE, V6, P718
   Jadav SS, 2015, LETT DRUG DES DISCOV, V12, P292
   Jadav SS, 2015, EUR J MED CHEM, V89, P172, DOI 10.1016/j.ejmech.2014.10.042
   Jain PK, 2013, J LIPOSOME RES, V23, P110, DOI 10.3109/08982104.2012.753456
   Jhaveri K, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S65804
   Jones PH, 2013, VIROLOGY, V438, P37, DOI 10.1016/j.virol.2013.01.010
   Jose J, 2012, J VIROL, V86, P2585, DOI 10.1128/JVI.05860-11
   Joycharat N, 2008, PHYTOCHEMISTRY, V69, P206, DOI 10.1016/j.phytochem.2007.06.016
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Karpe YA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022336
   Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12
   Khan M, 2011, ANTIVIR RES, V89, P1, DOI 10.1016/j.antiviral.2010.10.009
   Khan M, 2010, J MED VIROL, V82, P817, DOI 10.1002/jmv.21663
   Kohli N, 2014, MOL THER, V22, P535, DOI 10.1038/mt.2013.273
   Kostova I, 2006, BIOINORG CHEM APPL, V2006, DOI [10.1155/BCA/2006/68274, 10.1155/BCA/2006/25651]
   Kumar S, 2015, ARCH VIROL, V160, P2749, DOI 10.1007/s00705-015-2564-2
   Kumar SP, 2012, INT J PHARM LIFE SC, V3, P1752
   Kuo SC, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-44
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Lam S K, 2001, Southeast Asian J Trop Med Public Health, V32, P447
   Lam S, 2015, SCI REP-UK, V5, DOI 10.1038/srep12727
   Lam S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046396
   Langridge W, 2010, CURR OPIN INVEST DR, V11, P919
   Langsjoen RM, 2017, ANTIVIR RES, V143, P246, DOI 10.1016/j.antiviral.2017.04.014
   Lani R, 2015, SCI REP-UK, V5, DOI 10.1038/srep11421
   Le Coupanec A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081708
   Lee JC, 2014, BRIT J PHARMACOL, V171, P237, DOI 10.1111/bph.12440
   Lee MJ, 2002, CANCER EPIDEM BIOMAR, V11, P1025
   Li L, 2010, NATURE, V468, P705, DOI 10.1038/nature09546
   Li YG, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-114
   Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007
   Liu WD, 2016, J DRUG TARGET, V24, P694, DOI 10.3109/1061186X.2016.1157883
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Lu King M., 1982, J CHEM SOC CHEM COMM, P1150, DOI DOI 10.1039/C39820001150
   Lucas-Hourani M, 2013, J BIOMOL SCREEN, V18, P172, DOI 10.1177/1087057112460091
   Madureira AM, 2003, NAT PROD RES, V17, P375, DOI 10.1080/14786410310001605841
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   MATHEW D, 2018, SCI DIRECT, V40, P692, DOI DOI 10.1016/J.JFF.2017.12.017
   Matsumiya T, 2010, CRIT REV IMMUNOL, V30, P489, DOI 10.1615/CritRevImmunol.v30.i6.10
   Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160
   Mishra P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20122
   Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Murali KS, 2015, ASIAN PAC J TROP MED, V8, P352, DOI 10.1016/S1995-7645(14)60343-6
   Nguyen PTV, 2015, J MOL GRAPH MODEL, V57, P1, DOI 10.1016/j.jmgm.2015.01.001
   Nguyen PTV, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2216-6
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P1277, DOI 10.1021/acs.jnatprod.5b00073
   Nothias-Scaglia LF, 2014, J NAT PROD, V77, P1505, DOI 10.1021/np500271u
   OBROSOVASEROVA NP, 1991, VOP VIRUSOL+, V36, P380
   Oestereich L, 2016, J INFECT DIS, V213, P934, DOI 10.1093/infdis/jiv522
   Olagnier D, 2014, J VIROL, V88, P4180, DOI 10.1128/JVI.03114-13
   Ordonez P, 2012, ANTIMICROB AGENTS CH, V56, P2581, DOI 10.1128/AAC.06307-11
   Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200
   Paeshuyse J, 2011, CURR OPIN VIROL, V1, P590, DOI 10.1016/j.coviro.2011.10.030
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Parashar D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002405
   Patil D, 2013, INDIAN J VIROL, V24, P220, DOI 10.1007/s13337-013-0154-z
   Pecheur EI, 2016, J VIROL, V90, P3086, DOI 10.1128/JVI.02077-15
   Perera R, 2001, J VIROL, V75, P1, DOI 10.1128/JVI.75.1.1-10.2001
   PHALEN T, 1991, J CELL BIOL, V112, P615, DOI 10.1083/jcb.112.4.615
   PHILLIPS BM, 1971, TOXICOL APPL PHARM, V18, P220, DOI 10.1016/0041-008X(71)90330-9
   PLEVOVA J, 1970, TOXICOL APPL PHARM, V17, P511, DOI 10.1016/0041-008X(70)90208-5
   Pohjala L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028923
   Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012
   Priya R, 2014, VIRUS RES, V189, P194, DOI 10.1016/j.virusres.2014.05.010
   RADA B, 1977, ANN NY ACAD SCI, V284, P410, DOI 10.1111/j.1749-6632.1977.tb21977.x
   Rashad AA, 2018, TETRAHEDRON, V74, P1294, DOI 10.1016/j.tet.2017.12.053
   Rashad AA, 2014, J MED CHEM, V57, P1147, DOI 10.1021/jm400460d
   Rathore APS, 2014, ANTIVIR RES, V103, P7, DOI 10.1016/j.antiviral.2013.12.010
   Rathore APS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-36
   Reid S, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.61
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rothan HA, 2016, ANTIVIR RES, V127, P50, DOI 10.1016/j.antiviral.2016.01.006
   Rothan HA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126360
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Rungrotmongkol T, 2010, J MOL GRAPH MODEL, V29, P347, DOI 10.1016/j.jmgm.2010.09.010
   Rybicki EP, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0205-0
   Saisawang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17125
   Sangeetha Kothandan, 2014, Asian Pacific Journal of Tropical Disease, V4, pS111
   Saswat T, 2015, INFECT GENET EVOL, V35, P134, DOI 10.1016/j.meegid.2015.08.006
   Savarino A, 2003, LANCET INFECT DIS, V3, P722, DOI 10.1016/S1473-3099(03)00806-5
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Schito ML, 2003, AIDS RES HUM RETROV, V19, P91, DOI 10.1089/088922203762688595
   Scholte FEM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071047
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Schwartz O, 2010, NAT REV MICROBIOL, V8, P491, DOI 10.1038/nrmicro2368
   Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004
   Seyedi SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24027
   Sharma R, 2016, VIROLOGY, V498, P265, DOI 10.1016/j.virol.2016.08.029
   Shi ZQ, 2014, J CHROMATOGR A, V1345, P78, DOI 10.1016/j.chroma.2014.04.015
   Shin G, 2012, P NATL ACAD SCI USA, V109, P16534, DOI 10.1073/pnas.1210418109
   Farias KJS, 2015, VIRAL IMMUNOL, V28, P161, DOI 10.1089/vim.2014.0090
   Silva LA, 2014, J VIROL, V88, P2385, DOI 10.1128/JVI.03116-13
   Singh KD, 2012, J MOL MODEL, V18, P39, DOI 10.1007/s00894-011-1018-3
   Smee DF, 2001, ANTIVIR CHEM CHEMOTH, V12, P327, DOI 10.1177/095632020101200602
   SMITH TJ, 1995, P NATL ACAD SCI USA, V92, P10648, DOI 10.1073/pnas.92.23.10648
   Smither SJ, 2014, ANTIVIR RES, V104, P153, DOI 10.1016/j.antiviral.2014.01.012
   Snyder JE, 2013, J VIROL, V87, P8511, DOI 10.1128/JVI.00449-13
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   Stahura FL, 2004, COMB CHEM HIGH T SCR, V7, P259
   Staveness D, 2016, J NAT PROD, V79, P675, DOI 10.1021/acs.jnatprod.5b01016
   Staveness D, 2016, J NAT PROD, V79, P680, DOI 10.1021/acs.jnatprod.5b01017
   Steinmann J, 2013, BRIT J PHARMACOL, V168, P1059, DOI 10.1111/bph.12009
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004
   Teng TS, 2012, J CLIN INVEST, V122, P4447, DOI 10.1172/JCI63120
   Termsarasab P, 2012, J NEUROIMMUNOL, V249, P83, DOI 10.1016/j.jneuroim.2012.04.016
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tillhon M, 2012, BIOCHEM PHARMACOL, V84, P1260, DOI 10.1016/j.bcp.2012.07.018
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006835
   Turner TL, 2014, CLINICOECONOMIC OUTC, V6, P217, DOI 10.2147/CEOR.S60710
   van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   von Rhein C, 2016, ANTIVIR RES, V125, P51, DOI 10.1016/j.antiviral.2015.11.007
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wada Y, 2017, VIROLOGY, V505, P102, DOI 10.1016/j.virol.2017.02.014
   Waggoner JJ, 2015, EXPERT REV ANTI-INFE, V13, P291, DOI 10.1586/14787210.2015.995634
   Wagoner J, 2010, HEPATOLOGY, V51, P1912, DOI 10.1002/hep.23587
   Wang JG, 2014, MOL CELL PROTEOMICS, V13, P876, DOI 10.1074/mcp.M113.029793
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Wintachai P, 2015, SCI REP-UK, V5, DOI 10.1038/srep14179
   Wintachai P, 2015, MICROBIOL IMMUNOL, V59, P129, DOI 10.1111/1348-0421.12230
   Wintachai P, 2012, J MED VIROL, V84, P1757, DOI 10.1002/jmv.23403
   Ye F, 2013, BIOCHEM J, V455, P1, DOI 10.1042/BJ20130783
   Zandi K, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-560
   Zhang L, 2010, PHYTOCHEMISTRY, V71, P1879, DOI 10.1016/j.phytochem.2010.08.008
   Zhang XY, 2003, J VIROL, V77, P2981, DOI 10.1128/JVI.77.5.2981-2989.2003
NR 210
TC 16
Z9 16
U1 0
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2018
VL 10
IS 5
AR 235
DI 10.3390/v10050235
PG 40
WC Virology
SC Virology
GA GJ3LX
UT WOS:000435198000020
PM 29751486
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fernandes, JN
   dos Santos, LMB
   Chouin-Carneiro, T
   Pavan, MG
   Garcia, GA
   David, MR
   Beier, JC
   Dowell, FE
   Maciel-de-Freitas, R
   Sikulu-Lord, MT
AF Fernandes, Jill N.
   dos Santos, Lilha M. B.
   Chouin-Carneiro, Thais
   Pavan, Marcio G.
   Garcia, Gabriela A.
   David, Mariana R.
   Beier, John C.
   Dowell, Floyd E.
   Maciel-de-Freitas, Rafael
   Sikulu-Lord, Maggy T.
TI Rapid, noninvasive detection of Zika virus in Aedes aegypti mosquitoes
   by near-infrared spectroscopy
SO SCIENCE ADVANCES
LA English
DT Article
ID ZIKA VIRUS; AEGYPTI MOSQUITOS; VECTOR CONTROL; BRAZIL; AGE;
   SURVEILLANCE; INFECTION; AMERICA; TOOL
AB The accelerating global spread of arboviruses, such as Zika virus (ZIKV), highlights the need for more proactive mosquito surveillance. However, a major challenge during arbovirus outbreaks has been the lack of rapid and affordable tests for pathogen detection in mosquitoes. We show for the first time that near-infrared spectroscopy (NIRS) is a rapid, reagent-free, and cost-effective tool that can be used to noninvasively detect ZIKV in heads and thoraces of intact Aedes aegypti mosquitoes with prediction accuracies of 94.2 to 99.3% relative to quantitative reverse transcription polymerase chain reaction (RT-qPCR). NIRS involves simply shining a beam of light on a mosquito to collect a diagnostic spectrum. We estimated in this study that NIRS is 18 times faster and 110 times cheaper than RT-qPCR. We anticipate that NIRS will be expanded upon for identifying potential arbovirus hotspots to guide the spatial prioritization of vector control.
C1 [Fernandes, Jill N.; Sikulu-Lord, Maggy T.] Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia.
   [dos Santos, Lilha M. B.; Chouin-Carneiro, Thais; Pavan, Marcio G.; Garcia, Gabriela A.; David, Mariana R.; Maciel-de-Freitas, Rafael] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Beier, John C.; Dowell, Floyd E.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Dowell, Floyd E.] USDA ARS, Ctr Grain & Anim Hlth Res, 1515 Coll Ave, Manhattan, KS 66502 USA.
   [Maciel-de-Freitas, Rafael] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, BR-21941901 Rio De Janeiro, Brazil.
RP Sikulu-Lord, MT (corresponding author), Univ Queensland, Queensland Alliance Agr & Food Innovat, St Lucia, Qld 4072, Australia.
EM maggy.lord@uq.edu.au
RI Fernandes, Jill/J-3068-2017; Sikulu, Maggy/L-8158-2017
OI Fernandes, Jill/0000-0001-7704-072X; Sikulu, Maggy/0000-0002-9346-2970;
   Garcia, Gabriela/0000-0002-7400-0367; Maciel-de-Freitas,
   Rafael/0000-0002-2198-6492; Rocha David, Mariana/0000-0003-1241-3585
FU United States Agency for International Development Combating Zika and
   Future ThreatsUnited States Agency for International Development (USAID)
   [AID-OAA-F-16-00100]; Brazilian Research Councils
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-DecitE14/2016 [440929/2016-4]; Fundacao de
   Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E18/2015]; Government of Canada [0781-06]
FX This work was supported by the United States Agency for International
   Development Combating Zika and Future Threats (award no.
   AID-OAA-F-16-00100), the Brazilian Research Councils
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-DecitE14/2016 (award no. 440929/2016-4),
   and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro E18/2015.
   Grand Challenges Canada Stars for Global Health funded by the Government
   of Canada provided funding for pilot data collection (award no.
   0781-06). The funders had no role in the study design, data collection,
   analysis, decision to publish, or preparation of the manuscript. The
   corresponding author had full access to all the data in the study and
   had the final responsibility for the decision to submit for publication.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Bale G, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.091307
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Burns D. A., 2008, HDB NEAR INFRARED AN
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diallo M, 2016, J INFECT DIS, V214, pS459, DOI 10.1093/infdis/jiw397
   Dowell FE, 2005, B ENTOMOL RES, V95, P249, DOI 10.1079/BER2004357
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gu WD, 2004, AM J TROP MED HYG, V71, P636, DOI 10.4269/ajtmh.2004.71.636
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Johnson BJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1114-9
   Liebman K, 2015, AM J TROP MED HYG, V92, P1070, DOI 10.4269/ajtmh.14-0790
   Mayagaya VS, 2009, AM J TROP MED HYG, V81, P622, DOI 10.4269/ajtmh.2009.09-0192
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pepin KM, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0659-y
   Perez-Mendoza J, 2002, J MED ENTOMOL, V39, P499, DOI 10.1603/0022-2585-39.3.499
   Phelps C, 2017, VACCINE, V35, pA46, DOI 10.1016/j.vaccine.2016.08.090
   Reeves WK, 2010, MED VET ENTOMOL, V24, P32, DOI 10.1111/j.1365-2915.2009.00843.x
   Roggo Y, 2007, J PHARMACEUT BIOMED, V44, P683, DOI 10.1016/j.jpba.2007.03.023
   Saade J, 2008, SPECTROSC-INT J, V22, P387, DOI 10.1155/2008/419783
   Sakudo A, 2006, BIOCHEM BIOPH RES CO, V341, P279, DOI 10.1016/j.bbrc.2005.12.153
   Sakudo A, 2005, MICROBIOL IMMUNOL, V49, P695, DOI 10.1111/j.1348-0421.2005.tb03648.x
   Sakudo A, 2012, CLIN CHIM ACTA, V414, P130, DOI 10.1016/j.cca.2012.08.022
   Sikulu M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-49
   Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005040
   Sikulu-Lord MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004759
   Sylvestre G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-155
   Wasik D, 2018, ANAL CHEM, V90, P679, DOI 10.1021/acs.analchem.7b03407
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   WHO [World Health Organization], 2016, MOSQ VECT CONTR EM R
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
NR 39
TC 11
Z9 11
U1 6
U2 11
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD MAY
PY 2018
VL 4
IS 5
AR eaat0496
DI 10.1126/sciadv.aat0496
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS0IF
UT WOS:000443174800024
PM 29806030
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Watkins, AM
   Geniesse, C
   Kladwang, W
   Zakrevsky, P
   Jaeger, L
   Das, R
AF Watkins, Andrew M.
   Geniesse, Caleb
   Kladwang, Wipapat
   Zakrevsky, Paul
   Jaeger, Luc
   Das, Rhiju
TI Blind prediction of noncanonical RNA structure at atomic accuracy
SO SCIENCE ADVANCES
LA English
DT Article
ID GROUP-I INTRON; CRYSTAL-STRUCTURE; ANGSTROM RESOLUTION; INTERNAL LOOP;
   NMR STRUCTURE; BINDING-SITE; BULGE LOOPS; RECOGNITION; TETRALOOP; DOMAIN
AB Prediction of RNA structure from nucleotide sequence remains an unsolved grand challenge of biochemistry and requires distinct concepts from protein structure prediction. Despite extensive algorithmic development in recent years, modeling of noncanonical base pairs of new RNA structural motifs has not been achieved in blind challenges. We report a stepwise Monte Carlo (SWM) method with a unique add-and-delete move set that enables predictions of noncanonical base pairs of complex RNA structures. A benchmark of 82 diverse motifs establishes the method's general ability to recover noncanonical pairs ab initio, including multistrand motifs that have been refractory to prior approaches. In a blind challenge, SWM models predicted nucleotide-resolution chemical mapping and compensatory mutagenesis experiments for three in vitro selected tetraloop/receptors with previously unsolved structures (C7.2, C7.10, and R1). As a final test, SWM blindly and correctly predicted all noncanonical pairs of a Zika virus double pseudoknot during a recent community-wide RNA-Puzzle. Stepwise structure formation, as encoded in the SWM method, enables modeling of noncanonical RNA structure in a variety of previously intractable problems.
C1 [Watkins, Andrew M.; Geniesse, Caleb; Kladwang, Wipapat; Das, Rhiju] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.
   [Geniesse, Caleb; Das, Rhiju] Stanford Univ, Biophys Program, Stanford, CA 94305 USA.
   [Zakrevsky, Paul; Jaeger, Luc] Univ Calif Santa Barbara, Dept Chem & Biochem, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.
   [Das, Rhiju] Stanford Univ, Dept Phys, Stanford, CA 94305 USA.
   [Zakrevsky, Paul] NCI, RNA Biol Lab, Ctr Canc Res, Frederick, MD 21702 USA.
RP Das, R (corresponding author), Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA.; Das, R (corresponding author), Stanford Univ, Biophys Program, Stanford, CA 94305 USA.; Das, R (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.
EM rhiju@stanford.edu
OI Watkins, Andrew/0000-0003-1617-1720; Geniesse,
   Caleb/0000-0002-7897-8338; Das, Rhiju/0000-0001-7497-0972
FU Burroughs Wellcome Fund [CASI (Career Awards at the Scientific
   Interface)]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21 CA219847, R35
   GM122579, R21 GM102716]; University of California, Santa Barbara
   Academic SenateUniversity of California System; RosettaCommons grant
FX We acknowledge financial support from the Burroughs Wellcome Fund [CASI
   (Career Awards at the Scientific Interface) to R.D.], NIH grants R21
   CA219847, R35 GM122579, and R21 GM102716 (to R.D.), intramural research
   grants from the University of California, Santa Barbara Academic Senate
   (to L.J.), and a RosettaCommons grant.
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125
   Blose JM, 2007, BIOCHEMISTRY-US, V46, P15123, DOI 10.1021/bi700736f
   Boniecki MJ, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1479
   Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801
   Burkard ME, 2000, BIOCHEMISTRY-US, V39, P11748, DOI 10.1021/bi000720i
   Byrne RT, 2010, NUCLEIC ACIDS RES, V38, P4154, DOI 10.1093/nar/gkq133
   Cate JH, 1996, SCIENCE, V273, P1678, DOI 10.1126/science.273.5282.1678
   Cheng CY, 2015, METHOD ENZYMOL, V553, P35, DOI 10.1016/bs.mie.2014.10.051
   Chou FC, 2016, P NATL ACAD SCI USA, V113, P8430, DOI 10.1073/pnas.1523335113
   Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]
   Correll CC, 2003, NUCLEIC ACIDS RES, V31, P6806, DOI 10.1093/nar/gkg908
   Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2
   Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289
   Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   Das R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074830
   Das R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020044
   Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/NMETH.1433, 10.1038/nmeth.1433]
   Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398
   Deng JP, 2003, ACTA CRYSTALLOGR D, V59, P1004, DOI 10.1107/S0907444903006747
   Dibrov S, 2011, ACTA CRYSTALLOGR D, V67, P97, DOI 10.1107/S0907444910050900
   Eddy SR, 2004, NAT BIOTECHNOL, V22, P1457, DOI 10.1038/nbt1104-1457
   Egli M, 2002, P NATL ACAD SCI USA, V99, P4302, DOI 10.1073/pnas.062055599
   Feig AL, 1998, SCIENCE, V279, P81, DOI 10.1126/science.279.5347.81
   Ferkingho ff-Borg J., 2012, BAYESIAN METHODS STR, P49
   Geary C, 2008, NUCLEIC ACIDS RES, V36, P1138, DOI 10.1093/nar/gkm1048
   Geary C, 2017, NANO LETT, V17, P7095, DOI 10.1021/acs.nanolett.7b03842
   Gilbert SD, 2008, NAT STRUCT MOL BIOL, V15, P177, DOI 10.1038/nsmb.1371
   Ha SC, 2005, NATURE, V437, P1183, DOI 10.1038/nature04088
   Heo L, 2018, PROTEINS, V86, P177, DOI 10.1002/prot.25393
   Huang LL, 2010, MOL CELL, V40, P774, DOI 10.1016/j.molcel.2010.11.026
   Huang PS, 2016, NAT CHEM BIOL, V12, P29, DOI [10.1038/nchembio.1966, 10.1038/NCHEMBIO.1966]
   Ippolito JA, 2000, J MOL BIOL, V295, P711, DOI 10.1006/jmbi.1999.3405
   Jaeger L, 2009, NUCLEIC ACIDS RES, V37, P215, DOI 10.1093/nar/gkn911
   Jucker FM, 1996, J MOL BIOL, V264, P968, DOI 10.1006/jmbi.1996.0690
   Kennedy SD, 2012, BIOCHEMISTRY-US, V51, P9257, DOI 10.1021/bi301372t
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kinch L, 2011, PROTEINS, V79, P59, DOI 10.1002/prot.23181
   Kladwang W, 2014, BIOCHEMISTRY-US, V53, P3063, DOI 10.1021/bi5003426
   Klein DJ, 2004, J MOL BIOL, V340, P141, DOI 10.1016/j.jmb.2004.03.076
   Kleinert H., 2009, PATH INTEGRALS QUANT, P1015
   Krokhotin A, 2015, BIOINFORMATICS, V31, P2891, DOI 10.1093/bioinformatics/btv221
   Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427
   Lerman YV, 2011, RNA, V17, P1664, DOI 10.1261/rna.2641911
   LONGFELLOW CE, 1990, BIOCHEMISTRY-US, V29, P278, DOI 10.1021/bi00453a038
   Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551
   Martick M, 2008, CHEM BIOL, V15, P332, DOI 10.1016/j.chembiol.2008.03.010
   Meyer M, 2014, P NATL ACAD SCI USA, V111, P7659, DOI 10.1073/pnas.1322248111
   Miao Z, 2017, RNA, V23, P655, DOI 10.1261/rna.060368.116
   Montange RK, 2006, NATURE, V441, P1172, DOI 10.1038/nature04819
   Moretti R, 2018, PROTEIN SCI, V27, P259, DOI 10.1002/pro.3313
   MURPHY FL, 1994, J MOL BIOL, V236, P49, DOI 10.1006/jmbi.1994.1117
   Nozinovic S, 2010, NUCLEIC ACIDS RES, V38, P683, DOI 10.1093/nar/gkp956
   Ovchinnikov S, 2018, PROTEINS, V86, P113, DOI 10.1002/prot.25390
   Ovchinnikov S, 2016, PROTEINS, V84, P67, DOI 10.1002/prot.24974
   Pan BC, 2006, J MOL BIOL, V363, P451, DOI 10.1016/j.jmb.2006.08.022
   Pan BC, 2003, STRUCTURE, V11, P1423, DOI 10.1016/j.str.2003.09.017
   Pan BC, 2003, STRUCTURE, V11, P815, DOI 10.1016/S0969-2126(03)00107-2
   Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684
   Renfrew PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032637
   Robertson MP, 2007, SCIENCE, V315, P1549, DOI 10.1126/science.1136231
   Robertson MP, 2005, PLOS BIOL, V3, P86, DOI 10.1371/journal.pbio.0030005
   Rose PW, 2017, NUCLEIC ACIDS RES, V45, pD271, DOI 10.1093/nar/gkw1000
   Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y
   Safaee N, 2013, ANGEW CHEM INT EDIT, V52, P10370, DOI 10.1002/anie.201303461
   SANTALUCIA J, 1993, BIOCHEMISTRY-US, V32, P12612, DOI 10.1021/bi00210a009
   Serganov A, 2004, CHEM BIOL, V11, P1729, DOI 10.1016/j.chembiol.2004.11.018
   Shi HJ, 2000, RNA, V6, P1091, DOI 10.1017/S1355838200000364
   Sripakdeevong P, 2014, NAT METHODS, V11, P413, DOI [10.1038/NMETH.2876, 10.1038/nmeth.2876]
   Sripakdeevong P, 2011, P NATL ACAD SCI USA, V108, P20573, DOI 10.1073/pnas.1106516108
   Suslov NB, 2015, NAT CHEM BIOL, V11, P840, DOI 10.1038/nchembio.1929
   Szewczak AA, 1997, RNA, V3, P838
   Tan D, 2018, P NATL ACAD SCI USA, V115, pE1346, DOI 10.1073/pnas.1713027115
   Tarjan R., 1972, SIAM Journal on Computing, V1, P146, DOI 10.1137/0201010
   Thore S, 2008, J AM CHEM SOC, V130, P8116, DOI 10.1021/ja801708e
   Thulasi P, 2010, BIOCHEMISTRY-US, V49, P9058, DOI 10.1021/bi101164s
   Wang JM, 2010, ACTA CRYSTALLOGR D, V66, P988, DOI 10.1107/S0907444910029938
   Wedekind JE, 2003, BIOCHEMISTRY-US, V42, P9554, DOI 10.1021/bi0300783
   Wu M, 1996, BIOCHEMISTRY-US, V35, P9677, DOI 10.1021/bi960133q
   Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425
   Ye JD, 2008, P NATL ACAD SCI USA, V105, P82, DOI 10.1073/pnas.0709082105
   Yesselman J. D., 2017, BIORXIV, V2017
   Yesselman JD, 2018, NUCLEIC ACIDS RES, V46, pD375, DOI 10.1093/nar/gkx873
   Yoon S, 2011, BIOINFORMATICS, V27, P1798, DOI 10.1093/bioinformatics/btr277
   Zhao CH, 2017, METHODS MOL BIOL, V1654, P3, DOI 10.1007/978-1-4939-7231-9_1
   Zhao Q, 2008, ACTA CRYSTALLOGR D, V64, P436, DOI 10.1107/S0907444908002011
NR 87
TC 9
Z9 9
U1 0
U2 5
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD MAY
PY 2018
VL 4
IS 5
AR eaar5316
DI 10.1126/sciadv.aar5316
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS0IF
UT WOS:000443174800018
PM 29806027
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Adamian, S
   Bachelor, B
   Mittra, T
   Andres, S
   Hodges, F
   Shaw, R
AF Adamian, Shant
   Bachelor, Brooke
   Mittra, Trivia
   Andres, Sarah
   Hodges, Fiona
   Shaw, Rebecca
TI Zika Virus Knowledge, Health Education, and Contraceptive Use Among
   Rural Dominican Republic Communities
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 27-30, 2018
CL Austin, TX
SP Amer Coll Obstetricians & Gynecologists
C1 [Adamian, Shant] Des Moines Univ, Des Moines, IA USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2018
VL 131
SU 1
MA 12I
BP 101S
EP 102S
DI 10.1097/01.AOG.0000533440.80848.1f
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3IJ
UT WOS:000442482900347
DA 2020-07-08
ER

PT J
AU Alholm, Z
   Zwick, R
   Ault, K
   Fitzgeralck, S
   Satterwhite, C
AF Alholm, Zachary
   Zwick, Ryan
   Ault, Kevin
   Fitzgeralck, Sharon
   Satterwhite, Catherine
TI Pregnant Women's History of Vaccination and Acceptance of Hypothetical
   Zika Vaccine
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 27-30, 2018
CL Austin, TX
SP Amer Coll Obstetricians & Gynecologists
C1 [Alholm, Zachary] Univ Kansas, Sch Med, Kansas City, KS USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2018
VL 131
SU 1
MA 15I
BP 102S
EP 102S
DI 10.1097/01.AOG.0000533443.65601.ee
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3IJ
UT WOS:000442482900350
DA 2020-07-08
ER

PT J
AU Chandrasekaran, N
   Marotta, M
   Taldone, S
   Singh, V
   Koru-Sengul, T
   Curry, C
AF Chandrasekaran, Neeraja
   Marotta, Mabel
   Taldone, Sabrina
   Singh, Vivek
   Koru-Sengul, Tulay
   Curry, Christine
TI Individual Knowledge, Attitudes, and Practices Regarding Zika Virus
   During Pregnancy in Miami
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 27-30, 2018
CL Austin, TX
SP Amer Coll Obstetricians & Gynecologists
C1 [Chandrasekaran, Neeraja] Univ Miami, Morehouse Sch Med, Miami, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2018
VL 131
SU 1
MA 19I
BP 103S
EP 103S
DI 10.1097/01.AOG.0000533446.69653.25
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3IJ
UT WOS:000442482900354
DA 2020-07-08
ER

PT J
AU Chandrasekaran, N
   Marotta, M
   Taldone, S
   Singh, V
   Koru-Sengul, T
   Curry, C
AF Chandrasekaran, Neeraja
   Marotta, Mabel
   Taldone, Sabrina
   Singh, Vivek
   Koru-Sengul, Tulay
   Curry, Christine
TI Socioeconomic Disparities in Knowledge and Behaviors of Zika virus in
   Pregnant Women
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 27-30, 2018
CL Austin, TX
SP Amer Coll Obstetricians & Gynecologists
C1 [Chandrasekaran, Neeraja] Univ Miami, Morehouse Sch Med, Miami, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2018
VL 131
SU 1
MA 6J
BP 110S
EP 111S
DI 10.1097/01.AOG.0000533471.93417.4f
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3IJ
UT WOS:000442482900380
DA 2020-07-08
ER

PT J
AU Goldfarb, I
   Jaffe, E
   Lyerly, A
AF Goldfarb, Ilona
   Jaffe, Elana
   Lyerly, Anne
TI Pregnant Women's Attitudes Toward Zika Virus Vaccine Study Participation
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists (ACOG)
CY APR 27-30, 2018
CL Austin, TX
SP Amer Coll Obstetricians & Gynecologists
C1 [Goldfarb, Ilona] Massachusetts Gen Hosp, Boston, MA 02114 USA.
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2018
VL 131
SU 1
MA 8J
BP 111S
EP 111S
DI 10.1097/01.AOG.0000533473.70546.80
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3IJ
UT WOS:000442482900382
DA 2020-07-08
ER

PT J
AU Oduyebo, T
   Viens, L
   Rechtman, L
   Ritsick, M
   Hillard, C
   Meaney-Delman, D
AF Oduyebo, Titilope
   Viens, Laura
   Rechtman, Lindsay
   Ritsick, Maggie
   Hillard, Christina
   Meaney-Delman, Dana
TI Zika Care Connect: Establishing a Provider Network for the Management of
   Zika Virus
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 27-30, 2018
CL Austin, TX
SP Amer Coll Obstetricians & Gynecologists
C1 [Oduyebo, Titilope] Ctr Dis Control & Prevent, Atlanta, GA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2018
VL 131
SU 1
MA 5K
BP 121S
EP 121S
DI 10.1097/01.AOG.0000533508.09489.63
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GR3IJ
UT WOS:000442482900416
DA 2020-07-08
ER

PT J
AU Lubin, JA
   Zhang, RR
   Kuo, JS
AF Lubin, Jonathan A.
   Zhang, Ray R.
   Kuo, John S.
TI Zika Virus has Oncolytic Activity Against Glioblastoma Stem Cells
SO NEUROSURGERY
LA English
DT Editorial Material
ID GLIOMA
C1 [Lubin, Jonathan A.; Zhang, Ray R.; Kuo, John S.] Univ Wisconsin, Dept Neurosurg, Madison, WI 53706 USA.
RP Lubin, JA (corresponding author), Univ Wisconsin, Dept Neurosurg, Madison, WI 53706 USA.
RI Kuo, John/D-3561-2013
OI Kuo, John/0000-0001-6809-4806
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [T32 GM008692]
CR Cloughesy TF, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9784
   Lowenstein PR, 2018, CLIN IMMUNOL, V189, P43, DOI 10.1016/j.clim.2017.07.006
   MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 4
TC 7
Z9 7
U1 2
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0148-396X
EI 1524-4040
J9 NEUROSURGERY
JI Neurosurgery
PD MAY
PY 2018
VL 82
IS 5
BP E113
EP E114
DI 10.1093/neuros/nyy047
PG 2
WC Clinical Neurology; Surgery
SC Neurosciences & Neurology; Surgery
GA GO1FE
UT WOS:000439693800009
PM 29669124
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Nasir, S
   Ahmed, J
AF Nasir, Saima
   Ahmed, Jamila
TI A Bibliometric Analysis of Research on Zika Virus Indexed in Web of
   Science
SO ADVANCEMENTS IN LIFE SCIENCES
LA English
DT Article
DE Pakistan; Zika; virus; research productivity; bibliometric
ID TROPICAL-MEDICINE; LEISHMANIASIS; TRANSMISSION; INFECTION; OUTBREAK;
   TRENDS; STATES
AB Background: The spread of Zika virus is of great concern as it is recently becoming the third global infectious disease outburst after H1N1 flu and the Ebola virus infections. Centre for Disease Control (CDC) categorized Pakistan, India, and Bangladesh as countries vulnerable to Zika Risk. Realizing health implications of this emerging epidemic, it is a dire need to build an all-inclusive view of the status of research on Zika virus disease, and a lucid picture of the research output and scientific collaborations in the field.
   Methods: All the articles published globally on Zika virus during 2008-2017 and documented in Web of Science were analyzed using Microsoft Excel and Word Cloud tool. The data were extracted from all databases of the Web of Science, obtaining a total of 3384 articles for analysis.
   Results: 3384 records on Zika virus research were indexed in the Web of Science database during 2008-2017. The retrieved data indicate that over the past ten years, not much research has been done on this virus and the focus shifted to research on Zika in the last three years only and the number of researches increased from just 38 in 2015 to 1962 in 2017. Pakistan has a low share in global publications on Zika with a total number of 24 publications. "Honein Margaret" is considered the most active researcher in the field, by contributing to 80 articles. Most of the published research on Zika virus is from US (47.07%).
   Conclusion: When compared with other countries, the contribution of Pakistan is negligible with a global share of 0.71% on Zika virus. Serious focus on research is needed in this field realizing the severe medical, ethical, and economic implications of this emerging epidemic in Pakistan.
C1 [Nasir, Saima] Pakistan Council Sci & Technol, Islamabad, Pakistan.
   [Ahmed, Jamila] Allama Iqbal Open Univ, Islamabad, Pakistan.
RP Nasir, S (corresponding author), Pakistan Council Sci & Technol, Islamabad, Pakistan.
EM saimanasir2007@hotmail.com
CR Afzal MF, 2015, MERIT RES J MED MED, V3, P69
   Ai JW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.42
   Baba SS, 1999, COMP IMMUNOL MICROB, V22, P71, DOI 10.1016/S0147-9571(98)00003-4
   Bornmann L, 2009, EMBO REP, V10, P2, DOI 10.1038/embor.2008.233
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Costa Lima J A, 1985, Educ Med Salud, V19, P209
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Drubin DG, 2012, MOL BIOL CELL, V23, P1399, DOI 10.1091/mbc.E12-02-0108
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Dyer O, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2167
   Falagas ME, 2006, ACTA TROP, V99, P155, DOI 10.1016/j.actatropica.2006.07.011
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Galan-Huerta K, 2016, MED U, V18, P115, DOI DOI 10.1016/J.RMU.2016.05.003
   Glover SW, 2004, TROP MED INT HEALTH, V9, P1327, DOI 10.1111/j.1365-3156.2004.01331.x
   Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Huamani C, 2014, REV INST MED TROP SP, V56, P381, DOI 10.1590/S0036-46652014000500003
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Keiser J, 2005, SCIENTOMETRICS, V62, P351, DOI 10.1007/s11192-005-0027-3
   Keiser J, 2004, BRIT MED J, V328, P1229, DOI 10.1136/bmj.38069.518137.F6
   Khasseh A. A., 2016, J MED MICROBIOL, V10, P63
   Khasseh A. A., 2011, J MED MICROBIOL, V5, P53
   Korhonen EM, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.2.30107
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Morel CM, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000501
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Picone O, 2016, REV SAGE FEMME, V15, P183
   Ramos JM, 2008, INT J TUBERC LUNG D, V12, P1461
   Soosaraei M, 2018, ANN MED SUR IN PRESS, P2630
   Uzun A, 1998, INT INF LIBR REV, V30, P169, DOI 10.1006/iilr.1998.0093
   Vioque J, 2010, OBES REV, V11, P603, DOI 10.1111/j.1467-789X.2009.00647.x
   Xiang B, 2017, J INFECTION, V74, P328, DOI 10.1016/j.jinf.2017.01.004
   Zheng HC, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-28
   Zhong YB, 2016, CHINESE MED J-PEKING, V129, P2013, DOI 10.4103/0366-6999.187864
NR 38
TC 2
Z9 2
U1 2
U2 5
PU CENTRE EXCELLENCE MOLECULAR BIOLOGY-CEMB
PI LAHORE
PA 87-WEST BANK, CANAL RD, LAHORE, 00000, PAKISTAN
SN 2310-5380
J9 ADVAN LIFE SCI
JI Advan. Life Sci.
PD MAY
PY 2018
VL 5
IS 3
BP 88
EP 95
PG 8
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA GN8TY
UT WOS:000439447900002
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mutebi, JP
   Crabtree, MB
   Kading, RC
   Powers, AM
   Ledermann, JP
   Mossel, EC
   Zeidner, N
   Lutwama, JJ
   Miller, BR
AF Mutebi, J. -P.
   Crabtree, M. B.
   Kading, R. C.
   Powers, A. M.
   Ledermann, J. P.
   Mossel, E. C.
   Zeidner, N.
   Lutwama, J. J.
   Miller, B. R.
TI Mosquitoes of Northwestern Uganda
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Mosquito; species composition; Uganda; Paraa; Chobe
ID RIFT-VALLEY-FEVER; ONYONG-NYONG FEVER; YELLOW-FEVER; WEST-NILE; SPECIES
   COMPOSITION; RELATIVE ABUNDANCE; ZIKA VIRUS; AFRICA; VECTORS;
   ARBOVIRUSES
AB Despite evidence of arbovirus activity in northwestern Uganda (West Nile Sub-region), there is very limited information on the mosquito fauna of this region. The only published study reported 52 mosquito species in northwestern Uganda but this study took place in 1950 and the information has not been updated for more than 60 yr. In January and June 2011, CO2 baited-light traps were used to collect 49,231 mosquitoes from four different locations, Paraa (9,487), Chobe (20,025), Sunguru (759), and Rhino Camp (18,960). Overall, 72 mosquito species representing 11 genera were collected. The largest number of distinct species was collected at Chobe (43 species), followed by Paraa (40), Sunguru (34), and Rhino Camp (25). Only eight of the 72 species (11.1%) were collected from all four sites: Aedes (Stegomyia) aegypti formosus (Walker), Anopheles (Cellia) funestus group, Culex (Culex) decens group, Cx. (Culex) neavei Theobald, Cx. (Culex) univittatus Theobald, Cx. (Culiciomyia) cinereus Theobald, Cx. (Oculeomyia) poicilipes (Theobald), and Mansonia (Mansonoides) uniformis (Theobald). Fifty-four species were detected in northwestern Uganda for the first time; however, these species have been detected elsewhere in Uganda and do not represent new introductions to the country. Thirty-three species collected during this study have previously been implicated in the transmission of arboviruses of public health importance.
C1 [Mutebi, J. -P.; Crabtree, M. B.; Powers, A. M.; Ledermann, J. P.; Mossel, E. C.; Zeidner, N.; Miller, B. R.] Ctr Dis Control & Prevent CDC, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Kading, R. C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Lutwama, J. J.] UVRI, Dept Arbovirol, POB 49, Entebbe, Uganda.
RP Mutebi, JP (corresponding author), Ctr Dis Control & Prevent CDC, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM JMutebi@cdc.gov
FU USAID Emerging Pandemic Threat ProgramUnited States Agency for
   International Development (USAID)
FX We thank F. Ssenfunka, J.-B. Lwanga, S. Wakaalo, J. Mugga, G. Kyazze,
   and D. Ssemwogerere of UVRI, J. M. Tendo of the Uganda Plague
   Laboratory, Arua, V. Andama of Vurra Sub county Local Government, Arua,
   K. SaxtonShaw and E. Borland of CDC Ft. Collins for field assistance
   during this project. We thank J. Pecor and Y.-M. Huang of the
   Smithsonian Institute for their assistance in verifying mosquito
   identifications. Lastly, we thank Dr. R. Rosenberg for his assistance
   and support during this project. This study was supported in part by
   funds from USAID Emerging Pandemic Threat Program.
CR (CDC) Centers for Diseases Control and Prevention, 2012, ARBV CAT ARBOCAT
   Choi KS, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-173
   Choi KS, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-283
   Cohuet A, 2003, AM J TROP MED HYG, V69, P200, DOI 10.4269/ajtmh.2003.69.200
   Corbet P. S., 1958, Proceedings of the Royal Entomological Society of London (B), V27, P127
   CORBET P. S., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P463, DOI 10.1016/0035-9203(61)90095-5
   Diallo M, 2005, MED VET ENTOMOL, V19, P119, DOI 10.1111/j.0269-283X.2005.00564.x
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P600, DOI 10.1016/0035-9203(52)90021-7
   Edwards F.W., 1941, MOSQUITOES ETHIOPIAN
   Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218
   GERMAIN M, 1980, AM J TROP MED HYG, V29, P929, DOI 10.4269/ajtmh.1980.29.929
   Gillett J. D., 1972, COMMON AFRICAN MOSQU
   GILLETT JD, 1946, B ENTOMOL RES, V36, P425, DOI 10.1017/S0007485300024081
   Gillies MT, 1987, ANOPHELINAE AFRICA S
   GILLIES MT, 1968, ANOPHELINAE AFRICA S
   HADDOW AJ, 1951, B ENTOMOL RES, V42, P207, DOI 10.1017/S0007485300025311
   HADDOW AJ, 1946, B ENTOMOL RES, V37, P57, DOI 10.1017/S0007485300021994
   HADDOW AJ, 1949, B ENTOMOL RES, V40, P169, DOI 10.1017/S0007485300024482
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218, DOI 10.1080/00034983.1948.11685365
   HADDOW AJ, 1950, ANN TROP MED PARASIT, V44, P281, DOI 10.1080/00034983.1950.11685450
   HENDERSON BE, 1970, B WORLD HEALTH ORGAN, V42, P797
   HOPKINS GHE, 1952, MOSQUITOES ETHIOPIAN
   Huang YM, 2004, ZOOTAXA, P1
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Institut Pastuer de Dakar, 2000, RAPP ANN
   Jupp P.G., 1996, MOSQUITOES SO AFRICA
   JUPP PG, 1986, S AFR MED J, V70, P218
   Kaddumukasa MA, 2014, J MED ENTOMOL, V51, P104, DOI 10.1603/ME12269
   Koekemoer LL, 2002, AM J TROP MED HYG, V66, P804, DOI 10.4269/ajtmh.2002.66.804
   LEE VH, 1972, B WORLD HEALTH ORGAN, V46, P669
   LUMSDEN WHR, 1951, T ROY SOC TROP MED H, V45, P53, DOI 10.1016/S0035-9203(51)90544-5
   Lutwama JJ, 1999, AM J TROP MED HYG, V61, P158, DOI 10.4269/ajtmh.1999.61.158
   MAHAFFY A. F., 1942, TRANS ROY SOC TROP MED AND HYG, V36, P9, DOI 10.1016/S0035-9203(42)90051-8
   MAHAFFY AF, 1946, T ROY SOC TROP MED H, V40, P57, DOI 10.1016/0035-9203(46)90062-4
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mayanja Martin, 2014, Journal of Entomology and Zoology Studies, V2, P317
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McINTOSH B. M., 1961, TRANS ROY SOC TROP MED AND HYG, V55, P192, DOI 10.1016/0035-9203(61)90025-6
   MCINTOSH BM, 1986, S AFR MED J, P69
   MCINTOSH BM, 1972, J MED ENTOMOL, V9, P155
   Meegan J, 1988, ARBOVIRUSES EPIDEMIO
   Monaghan A. J., 2012, J APPL METEOROL, DOI [101175/Climat.JAMC-D-11-0195, DOI 10.1175/CLIMAT.JAMC-D-11-0195]
   MONATH TP, 1988, ARBOVIRUSES EPIDEMIO
   Mutebi JP, 2012, J MED ENTOMOL, V49, P1289, DOI 10.1603/ME12111
   SAWYER W. A., 1936, Transactions of the Royal Society of Tropical Medicine and Hygiene, V29, P397, DOI 10.1016/S0035-9203(36)90055-X
   SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   SMITHBURN KC, 1948, BRIT J EXP PATHOL, V29, P107
   SMITHBURN KC, 1946, AM J TROP MED, V26, P261
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   SMITHBURN KC, 1951, P SOC EXP BIOL MED, V77, P130, DOI 10.3181/00379727-77-18700
   Smithburn KC, 1944, J IMMUNOL, V49, P141
   Smithburn KC, 1941, AM J TROP MED HYG, V21, P75
   Spillings BL, 2009, AM J TROP MED HYG, V81, P510, DOI 10.4269/ajtmh.2009.81.510
   Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480
   Vinogradova E B, 2003, Dokl Biol Sci, V389, P172, DOI 10.1023/A:1023447615060
   WILLIAMS MC, 1965, T ROY SOC TROP MED H, V59, P300, DOI 10.1016/0035-9203(65)90012-X
   Woodhall J. P., 1964, P E AFRIC ACAD, V2, P141
NR 60
TC 3
Z9 3
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2018
VL 55
IS 3
BP 587
EP 599
DI 10.1093/jme/tjx220
PG 13
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GM5ZI
UT WOS:000438231600012
PM 29444287
OA Bronze
DA 2020-07-08
ER

PT J
AU Burkhalter, KL
   Wiggins, K
   Burkett-Cadena, N
   Alto, BW
AF Burkhalter, Kristen L.
   Wiggins, Keenan
   Burkett-Cadena, Nathan
   Alto, Barry W.
TI Laboratory Evaluation of Commercially Available Platforms to Detect West
   Nile and Zika Viruses From Honey Cards
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE RAMP test; West Nile virus; Zika virus; ProAmpRT LAMP assay; honey cards
ID ARBOVIRUS SURVEILLANCE; INFECTION; TRANSMISSION; MOSQUITOS; FLORIDA;
   SYSTEM; BIRDS; ASSAY
AB Commercially available assays utilizing antigen or nucleic acid detection chemistries provide options for mosquito control districts to screen their mosquito populations for arboviruses and make timely operational decisions regarding vector control. These assays may be utilized even more advantageously when combined with honey-soaked nucleic acid preservation substrate ('honey card') testing by reducing or replacing the time-and labor-intensive efforts of identifying and processing mosquito pools. We tested artificially inoculated honey cards and cards fed upon individually by West Nile virus (WNV) and Zika virus (ZIKV)-infected mosquitoes with three assays to compare detection rates and the limit of detection for each platform with respect to virus detection of a single infected mosquito and quantify the time interval of virus preservation on the cards. Assays evaluated included CDC protocols for real-time reverse transcriptase polymerase chain reaction (RT-PCR) for WNV and ZIKV, Pro-Lab Diagnostics ProAmpRT WNV loop-mediated amplification (LAMP) and ZIKV LAMP assays, and the Rapid Analyte Measurement Platform (RAMP) WNV assay. Real-time RT-PCR was the most sensitive assay and the most robust to viral RNA degradation over time. To maximize the detection of virus, honey cards should be left in the traps <= 1 d if using LAMP assays and <= 3 d if using real-time RT-PCR to detect viruses from field samples. The WNV RAMP assay, although effective for pool screening, lacks sensitivity required for honey card surveillance. Future studies may determine the minimum number of infectious mosquitoes required to feed on a honey card that would be reliably detected by the LAMP or RAMP assays.
C1 [Burkhalter, Kristen L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
   [Wiggins, Keenan; Burkett-Cadena, Nathan; Alto, Barry W.] Univ Florida IFAS, Florida Med Entomol Lab, 200 9th St SE, Vero Beach, FL 32962 USA.
RP Burkhalter, KL (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM ktb3@cdc.gov
OI Burkett-Cadena, Nathan/0000-0001-6168-1637
FU Florida Department of Agriculture and Consumer Services [023592]
FX We wish to express our gratitude to James Newman at the University of
   Florida for his assistance in preparing Fig. 1. We thank Brandy Russell
   at the Centers for Disease Control and Prevention for the production of
   Zika virus and Alberto van Olphen for providing the USTOP cards used in
   this study. This work was supported by the Florida Department of
   Agriculture and Consumer Services contract number 023592.
CR Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Alto BW, 2014, VECTOR-BORNE ZOONOT, V14, P606, DOI 10.1089/vbz.2013.1501
   Burkett-Cadena ND, 2016, J MED ENTOMOL, V53, P1449, DOI 10.1093/jme/tjw106
   Burkhalter KL, 2014, J AM MOSQUITO CONTR, V30, P21, DOI 10.2987/13-6386.1
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759
   Fortuna C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1067-z
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guerrero-Sanchez S, 2011, EMERG INFECT DIS, V17, P2245, DOI 10.3201/eid1712.110294
   Hall-Mendelin S, 2010, P NATL ACAD SCI USA, V107, P11255, DOI 10.1073/pnas.1002040107
   Johnson BJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1114-9
   Kaur P., 2016, INFECT VIRAL QUANTIF, P93
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000
   Lothrop HD, 2012, J MED ENTOMOL, V49, P1466, DOI 10.1603/ME12117
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Richards SL, 2012, J MED ENTOMOL, V49, P132, DOI 10.1603/ME10280
   Ritchie SA, 2013, J MED ENTOMOL, V50, P185, DOI 10.1603/ME12112
   van den Hurk AF, 2014, VECTOR-BORNE ZOONOT, V14, P66, DOI 10.1089/vbz.2013.1373
NR 22
TC 2
Z9 2
U1 1
U2 6
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAY
PY 2018
VL 55
IS 3
BP 717
EP 722
DI 10.1093/jme/tjy005
PG 6
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA GM5ZI
UT WOS:000438231600027
PM 29462341
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Philip, C
   Wells, KT
   Eggert, R
   Elmore, J
   Jean, R
   Johnson, J
   Lane, J
   Lopez, X
   Rivera, L
   Samir, E
   Strokin, N
   Villalta, Y
   Ynestroza, R
AF Philip, Celeste
   Wells, Kelli T.
   Eggert, Russell
   Elmore, Jennifer
   Jean, Reynald
   Johnson, Jennifer
   Lane, Jeanne
   Lopez, Ximena
   Rivera, Lillian
   Samir, Elmir
   Strokin, Natasha
   Villalta, Yesenia
   Ynestroza, Rene
TI Accreditation's Role in Bolstering Resilience in the Face of the Zika
   Virus Outbreak
SO JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE
LA English
DT Article
DE Florida Department of Health; Miami-Dade; PHAB accreditation; PHAB
   Domain 2; Zika
ID BIRTH-DEFECTS; PREGNANCY; INFANTS; STATES; WOMEN
AB The Florida Department of Health (Department) received accreditation status as an integrated public health system from the Public Health Accreditation Board (PHAB) in 2 phases: the State Health Office received accreditation in June 2014 and the 67 county health departments received accreditation in March 2016. Six weeks after PHAB awarded accreditation to the Department as an integrated public health system in March 2016, the World Health Organization declared the Zika outbreak in the Americas a Public Health Emergency of International Concern. Even in that short time, integrated public health accreditation, along with the other components of the Department's performance management system, allowed the Department to address this public health emergency, especially in Miami-Dade County, where the impact of Zika was significant. This case report describes the local response in Miami-Dade County and supporting statewide efforts. Public health departments should consider how public health accreditation could strengthen their ability to fulfill their public health mission. This article provides rationale for state and local health departments to seek accreditation.
C1 [Eggert, Russell] Florida Dept Hlth, Div Dis Control & Hlth Protect, Bur Epidemiol, Tallahassee, FL USA.
   [Johnson, Jennifer; Lane, Jeanne] Florida Dept Hlth, Div Publ Hlth Stat & Performance Management, 2585 Merchants Row Blvd, Tallahassee, FL 32399 USA.
   [Philip, Celeste; Wells, Kelli T.; Elmore, Jennifer] Florida Dept Hlth, Tallahassee, FL USA.
   [Jean, Reynald] TB & Epidemiol Dis Control Immunizat Serv, Miami, FL USA.
   [Samir, Elmir] Environm Hlth & Engn Serv, Miami, FL USA.
   [Lopez, Ximena; Rivera, Lillian; Strokin, Natasha; Ynestroza, Rene] Florida Dept Hlth Miami Dade Cty, Miami, FL USA.
   [Villalta, Yesenia] Florida Dept Hlth Miami Dade Cty, Perrine, FL USA.
RP Lane, J (corresponding author), Florida Dept Hlth, Div Publ Hlth Stat & Performance Management, 2585 Merchants Row Blvd, Tallahassee, FL 32399 USA.
EM Jeanne.Lane@flhealth.gov
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
NR 7
TC 1
Z9 1
U1 1
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1078-4659
EI 1550-5022
J9 J PUBLIC HEALTH MAN
JI J. Public Health Manag. Pract.
PD MAY-JUN
PY 2018
VL 24
SU 3
BP S92
EP S94
DI 10.1097/PHH.0000000000000721
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL9MU
UT WOS:000437659600021
PM 29595610
DA 2020-07-08
ER

PT J
AU Burger-Calderon, R
   Gonzalez, K
   Ojeda, S
   Zambrana, JV
   Sanchez, N
   Cruz, CC
   Laguna, HS
   Bustos, F
   Plazaola, M
   Mercado, BL
   Elizondo, D
   Arguello, S
   Monterrey, JC
   Nunez, A
   Coloma, J
   Waggoner, JJ
   Gordon, A
   Kuan, G
   Balmaseda, A
   Harris, E
AF Burger-Calderon, Raquel
   Gonzalez, Karla
   Ojeda, Sergio
   Zambrana, Jose Victor
   Sanchez, Nery
   Cruz, Cristhiam Cerpas
   Laguna, Harold Suazo
   Bustos, Fausto
   Plazaola, Miguel
   Mercado, Brenda Lopez
   Elizondo, Douglas
   Arguello, Sonia
   Monterrey, Jairo Carey
   Nunez, Andrea
   Coloma, Josefina
   Waggoner, Jesse J.
   Gordon, Aubree
   Kuan, Guillermina
   Balmaseda, Angel
   Harris, Eva
TI Zika virus infection in Nicaraguan households
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SEXUAL TRANSMISSION; DENGUE; DISEASE; COHORT; CHIKUNGUNYA; ANTIBODIES;
   DIAGNOSIS; CLUSTER; STATES; BRAZIL
AB Zika virus (ZIKV) infection recently caused major epidemics in the Americas and is linked to congenital birth defects and Guillain-Barre Syndrome. A pilot study of ZIKV infection in Nicaraguan households was conducted from August 31 to October 21, 2016, in Managua, Nicaragua. We enrolled 33 laboratory-confirmed Zika index cases and their household members (109 contacts) and followed them on days 3-4, 6-7, 9-10, and 21, collecting serum/plasma, urine, and saliva specimens along with clinical, demographic, and socio-economic status information. Collected samples were processed by rRT-PCR to determine viral load (VL) and duration of detectable ZIKV RNA in human bodily fluids. At enrollment, 11 (10%) contacts were ZIKV rRT-PCR-positive and 23 (21%) were positive by IgM antibodies; 3 incident cases were detected during the study period. Twenty of 33 (61%) index households had contacts with ZIKV infection, with an average of 1.9 (range 1-6) positive contacts per household, and in 60% of these households, >= 50% of the members were positive for ZIKV infection. Analysis of clinical information allowed us to estimate the symptomatic to asymptomatic (S:A) ratio of 14:23 (1:1.6) among the contacts, finding 62% of the infections to be asymptomatic. The maximum number of days during which ZIKV RNA was detected was 7 days post-symptom onset in saliva and serum/plasma and 22 days in urine. Overall, VL levels in serum/plasma, saliva, and urine specimens were comparable, with means of 5.6, 5.3 and 4.5 log(10) copies/ml respectively, with serum attaining the highest VL peak at 8.1 log(10) copies/ml. Detecting ZIKV RNA in saliva over a similar time-period and level as in serum/plasma indicates that saliva could potentially serve as a more accessible diagnostic sample. Finding the majority of infections to be asymptomatic emphasizes the importance of silent ZIKV transmission and helps inform public health interventions in the region and globally.
C1 [Burger-Calderon, Raquel; Bustos, Fausto; Coloma, Josefina; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Burger-Calderon, Raquel; Gonzalez, Karla; Ojeda, Sergio; Zambrana, Jose Victor; Sanchez, Nery; Cruz, Cristhiam Cerpas; Laguna, Harold Suazo; Plazaola, Miguel; Mercado, Brenda Lopez; Elizondo, Douglas; Arguello, Sonia; Monterrey, Jairo Carey; Nunez, Andrea; Coloma, Josefina; Balmaseda, Angel] Sustainable Sci Inst, Managua, Nicaragua.
   [Gonzalez, Karla; Cruz, Cristhiam Cerpas; Nunez, Andrea; Balmaseda, Angel] Minist Hlth, Ctr Nacl Diagnost & Referencia, Lab Nacl Virol, Managua, Nicaragua.
   [Waggoner, Jesse J.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA USA.
   [Gordon, Aubree] Univ Michigan, Dept Epidemiol, Sch Publ Hlth, Ann Arbor, MI 48109 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
RI Gordon, Aubree/X-1113-2019; Zambrana, Jose Victor/Q-3214-2019
OI Gordon, Aubree/0000-0002-9352-7877; Zambrana, Jose
   Victor/0000-0003-0107-6173; Bustos Carrillo, Fausto/0000-0002-7263-5625
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01AI106695, R01AI099631]
FX This research was funded by grants P01AI106695 (EH) and R01AI099631 (AB)
   from the National Institute of Allergy and Infectious Diseases of the
   National Institutes of Health. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2016, AM J TROP MED HYG, V94, P397, DOI 10.4269/ajtmh.15-0413
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beckett CG, 2005, AM J TROP MED HYG, V72, P777, DOI 10.4269/ajtmh.2005.72.777
   Bhadelia Nahid, 2016, Evid Based Med, V21, P193, DOI 10.1136/ebmed-2016-110476
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gonzalez K, 2017, PAN AM J PUBLIC HLTH, V41
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gupta P, 1997, J VIROL, V71, P6271, DOI 10.1128/JVI.71.8.6271-6275.1997
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hurtado-Villa P, 2017, PEDIATR INFECT DIS J, V36, P1017, DOI [10.1097/INF.0000000000001670, 10.1097/inf.0000000000001670]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P1260, DOI 10.3201/eid2308.170479
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   McCloskey B, 2017, PUBLIC HEALTH, V150, P87, DOI 10.1016/j.puhe.2017.05.008
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Newman CM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00246-8
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   (PAHO) PAHO, 2017, CUM ZIK REP
   PAHO/ WHO, 2017, REG ZIK EP UPD AM AU
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Reyes M, 2010, AM J TROP MED HYG, V83, P683, DOI 10.4269/ajtmh.2010.10-0023
   Reynolds M. R., 2016, MMWR-MORBID MORTAL W, V66, P366, DOI DOI 10.15585/MMWR.MM6613E1
   Riley S, 2008, PLOS MED, V5, P1540, DOI 10.1371/journal.pmed.0050220
   Roze B, 2017, CLIN INFECT DIS, V65, P1462, DOI 10.1093/cid/cix588
   Galo SS, 2017, REV PANAM SALUD PUBL, V41
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Team RC, 2017, R LANG ENV STAT COMP
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759
NR 62
TC 5
Z9 5
U1 1
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006518
DI 10.1371/journal.pntd.0006518
PG 19
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900057
PM 29851968
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Huber, JH
   Childs, ML
   Caldwell, JM
   Mordecai, EA
AF Huber, John H.
   Childs, Marissa L.
   Caldwell, Jamie M.
   Mordecai, Erin A.
TI Seasonal temperature variation influences climate suitability for
   dengue, chikungunya, and Zika transmission
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AEDES-AEGYPTI DIPTERA; VIRUS; RATES; PROSPECTS; EPIDEMICS; SURVIVAL;
   DYNAMICS; AMERICA; IMPACT; FEVER
AB Dengue, chikungunya, and Zika virus epidemics transmitted by Aedes aegypti mosquitoes have recently (re)emerged and spread throughout the Americas, Southeast Asia, the Pacific Islands, and elsewhere. Understanding how environmental conditions affect epidemic dynamics is critical for predicting and responding to the geographic and seasonal spread of disease. Specifically, we lack a mechanistic understanding of how seasonal variation in temperature affects epidemic magnitude and duration. Here, we develop a dynamic disease transmission model for dengue virus and Aedes aegypti mosquitoes that integrates mechanistic, empirically parameterized, and independently validated mosquito and virus trait thermal responses under seasonally varying temperatures. We examine the influence of seasonal temperature mean, variation, and temperature at the start of the epidemic on disease dynamics. We find that at both constant and seasonally varying temperatures, warmer temperatures at the start of epidemics promote more rapid epidemics due to faster burnout of the susceptible population. By contrast, intermediate temperatures (24-25 degrees C) at epidemic onset produced the largest epidemics in both constant and seasonally varying temperature regimes. When seasonal temperature variation was low, 25-35 degrees C annual average temperatures produced the largest epidemics, but this range shifted to cooler temperatures as seasonal temperature variation increased (analogous to previous results for diurnal temperature variation). Tropical and sub-tropical cities such as Rio de Janeiro, Fortaleza, and Salvador, Brazil; Cali, Cartagena, and Barranquilla, Colombia; Delhi, India; Guangzhou, China; and Manila, Philippines have mean annual temperatures and seasonal temperature ranges that produced the largest epidemics. However, more temperate cities like Shanghai, China had high epidemic suitability because large seasonal variation offset moderate annual average temperatures. By accounting for seasonal variation in temperature, the model provides a baseline for mechanistically understanding environmental suitability for virus transmission by Aedes aegypti. Overlaying the impact of human activities and socioeconomic factors onto this mechanistic temperature-dependent framework is critical for understanding likelihood and magnitude of outbreaks.
C1 [Huber, John H.] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA.
   [Huber, John H.; Caldwell, Jamie M.; Mordecai, Erin A.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
   [Childs, Marissa L.] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA.
RP Mordecai, EA (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.
EM emordeca@stanford.edu
OI Sziklay, Jamie/0000-0002-6220-918X; Mordecai, Erin/0000-0002-4402-5547
FU National Science FoundationNational Science Foundation (NSF)
   [DEB-1518681]; NSFNational Science Foundation (NSF) [DEB-1640780];
   Stanford University Center for Innovation in Global Health; Stanford
   University Woods Institute for the Environment, Environmental Ventures
   Program; Lindsay Family EIPER Fellowship
FX JHH and EAM were funded by the National Science Foundation (DEB-1518681;
   www.nsf.gov). EAM was also funded by NSF (DEB-1640780; www.nsf.gov) and
   the Stanford University Center for Innovation in Global Health
   (https://globalhealth.stanford.edu/). EAM and JMC were funded by the
   Stanford University Woods Institute for the Environment, Environmental
   Ventures Program
   (https://woods.stanford.edu/research/environmental-venture-projects).
   MLC acknowledges funding from the Lindsay Family EIPER Fellowship
   (https://pangea.stanford.edu/eiper). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Beserra EB, 2009, IHERINGIA SER ZOOL, V99, P142, DOI 10.1590/S0073-47212009000200004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Coburn BJ, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-30
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Kamimura Kiyoshi, 2002, Medical Entomology and Zoology, V53, P53
   Khan Kamran, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.2134a0a7bf37fd8d388181539fea2da5
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lourenco J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003083
   MCLEAN DM, 1974, CAN J MICROBIOL, V20, P255, DOI 10.1139/m74-040
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morin CW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004002
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nsoesie EO, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.20.30234
   PAHO, 2017, REG ZIK EP UPD
   Palamara GM, 2014, ECOL EVOL, V4, P4736, DOI 10.1002/ece3.1309
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins T Alex, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1179, DOI 10.1017/S0950268809002052
   Yang HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152186
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 43
TC 11
Z9 11
U1 4
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006451
DI 10.1371/journal.pntd.0006451
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900021
PM 29746468
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schirmer, PL
   Wendelboe, A
   Lucero-Obusan, CA
   Ryono, RA
   Winters, MA
   Oda, G
   Martinez, M
   Saavedra, S
   Holodniy, M
AF Schirmer, Patricia L.
   Wendelboe, Aaron
   Lucero-Obusan, Cynthia A.
   Ryono, Russell A.
   Winters, Mark A.
   Oda, Gina
   Martinez, Mirsonia
   Saavedra, Sonia
   Holodniy, Mark
TI Zika virus infection in the Veterans Health Administration (VHA),
   2015-2016
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; PUERTO-RICO; BIRTH-DEFECTS; TRANSMISSION;
   OUTBREAK; BAHIA
AB Background
   Zika virus (ZIKV) is an important flavivirus infection. Although ZIKV infection is rarely fatal, risk for severe disease in adults is not well described. Our objective was to describe the spectrum of illness in U.S. Veterans with ZIKV infection.
   Methodology
   Case series study including patients with laboratory-confirmed or presumed positive ZIKV infection in all Veterans Health Administration (VHA) medical centers. Adjusted odds ratios of clinical variables associated with hospitalization and neurologic complications was performed.
   Principal findings
   Of 1,538 patients tested between 12/2015-10/2016 and observed through 3/2017, 736 (48%) were RT-PCR or confirmed IgM positive; 655 (89%) were male, and 683 (93%) from VA Caribbean Healthcare System (VACHCS). Ninety-four (13%) were hospitalized, 91 (12%) in the VACHCS. Nineteen (3%) died after ZIKV infection. Hospitalization was associated with increased Charlson co-morbidity index (adjusted odds ratio [OR] 1.2; 95% confidence interval [CI], 1.1-1.3), underlying connective tissue disease (OR, 29.5; CI, 3.6244.7), congestive heart failure (OR, 6; CI, 2-18.5), dementia (OR, 3.6; CI, 1.1-11.2), neurologic symptom presentation (OR, 3.9; CI, 1.7-9.2), leukocytosis (OR, 11.8; CI, 4.5-31), thrombocytopenia (OR, 7.8; CI, 3.3-18.6), acute kidney injury (OR, 28.9; CI, 5.8-145.1), or using glucocorticoids within 30 days of testing (OR, 13.3; CI 1.3-133). Patients presenting with rash were less likely to be hospitalized (OR, 0.29; CI, 0.13-0.66). Risk for neurologic complications increased with hospitalization (OR, 5.9; CI 2.9-12.2), cerebrovascular disease (OR 4.9; CI 1.7-14.4), and dementia (OR 2.8; CI 1.2-6.6).
   Conclusion
   Older Veterans with multiple comorbidities or presenting with neurologic symptoms were at increased risk for hospitalization and neurological complications after ZIKV infection.
C1 [Schirmer, Patricia L.; Lucero-Obusan, Cynthia A.; Ryono, Russell A.; Oda, Gina; Holodniy, Mark] US Dept Vet Affairs, Publ Hlth Surveillance & Res, Washington, DC 20420 USA.
   [Wendelboe, Aaron] Univ Oklahoma, Hlth Sci Ctr, Oklahoma City, OK USA.
   [Winters, Mark A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA.
   [Winters, Mark A.; Holodniy, Mark] Stanford Univ, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
   [Martinez, Mirsonia; Saavedra, Sonia] VA Caribbean Hlth Care Syst, San Juan, PR USA.
RP Schirmer, PL (corresponding author), US Dept Vet Affairs, Publ Hlth Surveillance & Res, Washington, DC 20420 USA.
EM patricia.schirmer@va.gov
FU Department of Veterans AffairsUS Department of Veterans Affairs; VHA
FX This study was funded by intramural funds in the Department of Veterans
   Affairs and VHA had no role in the collection, analysis, or
   interpretation of the data. The author(s) received no specific funding
   for this work.
CR Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1
   [Anonymous], 2016, MMWR-MORBID MORTAL W, V65, P474, DOI 10.15585/mmwr.mm6518e1
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Blazquez Ana-Belen, 2016, World J Virol, V5, P135
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Centers for Disease Control and Prevention, 2017, TRIOPLEX REAL TIME R
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, 2017, ZIK VIR CAS COUNTS U
   Centers for Disease Control and Prevention, 2017, TYP ZIK VIR TESTS
   Centers for Disease Control and Prevention, 2016, ZIK MAC ELISA
   CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Departamento de Salud de Puerto Rico, 2017, INF SEM ENF ARB ARBO
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   International Society of Nephrology, 2012, KIDNEY INT S
   Jimenez Corona ME, 2016, PLOS CURR, V8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   National Institute of Allergy and Infectious Diseases D National Institutes of Health, 2007, DIV MICR INF DIS DMI
   Pacheco O, 2016, N ENGL J MED
   Pan American Health Organization WHO Regional Office for the Americas, 2016, ZIK CAS CONG SYNDR A
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rogers William H, 2004, J Ambul Care Manage, V27, P249
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Savino W, 2017, GERONTOLOGY, V63, P210, DOI 10.1159/000453579
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   U. S Department of Veterans Affairs, 2011, 2011 VA HDB, V2017
   U. S. Department of Veterans Affairs, 2015, VET POP PROJ MOD 201
   U. S. Department of Veterans Affairs, 2017, VA BEN HLTH CAR UT
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 47
TC 3
Z9 3
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006416
DI 10.1371/journal.pntd.0006416
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900015
PM 29795560
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Taracena, ML
   Bottino-Rojas, V
   Talyuli, OAC
   Walter-Nuno, AB
   Oliveira, JAHM
   Anglero-Rodriguez, YI
   Wells, MB
   Dimopoulos, G
   Oliveira, PL
   Paiva-Silva, GO
AF Taracena, Mabel L.
   Bottino-Rojas, Vanessa
   Talyuli, Octavio A. C.
   Walter-Nuno, Ana Beatriz
   Oliveira, Jose A. Henrique M.
   Anglero-Rodriguez, Yesseinia I.
   Wells, Michael B.
   Dimopoulos, George
   Oliveira, Pedro L.
   Paiva-Silva, Gabriela O.
TI Regulation of midgut cell proliferation impacts Aedes aegypti
   susceptibility to dengue virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BLOOD-FEEDING ARTHROPODS; STEM-CELLS; PERITROPHIC MATRIX; REACTIVE
   OXYGEN; ANOPHELES-GAMBIAE; DROSOPHILA GUT; DUAL OXIDASE; INFECTION;
   MOSQUITO; CULICIDAE
AB Aedes aegypti is the vector of some of the most important vector-borne diseases like dengue, chikungunya, zika and yellow fever, affecting millions of people worldwide. The cellular processes that follow a blood meal in the mosquito midgut are directly associated with pathogen transmission. We studied the homeostatic response of the midgut against oxidative stress, as well as bacterial and dengue virus (DENV) infections, focusing on the proliferative ability of the intestinal stem cells (ISC). Inhibition of the peritrophic matrix (PM) formation led to an increase in reactive oxygen species (ROS) production by the epithelial cells in response to contact with the resident microbiota, suggesting that maintenance of low levels of ROS in the intestinal lumen is key to keep ISCs division in balance. We show that dengue virus infection induces midgut cell division in both DENV susceptible (Rockefeller) and refractory (Orlando) mosquito strains. However, the susceptible strain delays the activation of the regeneration process compared with the refractory strain. Impairment of the Delta/Notch signaling, by silencing the Notch ligand Delta using RNAi, significantly increased the susceptibility of the refractory strains to DENV infection of the midgut. We propose that this cell replenishment is essential to control viral infection in the mosquito. Our study demonstrates that the intestinal epithelium of the blood fed mosquito is able to respond and defend against different challenges, including virus infection. In addition, we provide unprecedented evidence that the activation of a cellular regenerative program in the midgut is important for the determination of the mosquito vectorial competence.
C1 [Taracena, Mabel L.; Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Walter-Nuno, Ana Beatriz; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] Univ Fed Rio de Janeiro, Inst Bioqum Med Leopoldo de Meis, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.
   [Taracena, Mabel L.; Bottino-Rojas, Vanessa; Talyuli, Octavio A. C.; Walter-Nuno, Ana Beatriz; Oliveira, Jose A. Henrique M.; Oliveira, Pedro L.; Paiva-Silva, Gabriela O.] INCT EM, Rio De Janeiro, Brazil.
   [Oliveira, Jose A. Henrique M.] Univ Fed Santa Catarina, Dept Microbiol Imunol & Parasitol, Florianopolis, SC, Brazil.
   [Anglero-Rodriguez, Yesseinia I.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Wells, Michael B.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA.
   [Wells, Michael B.] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Malaria Res Inst, Baltimore, MD USA.
RP Paiva-Silva, GO (corresponding author), Univ Fed Rio de Janeiro, Inst Bioqum Med Leopoldo de Meis, Programa Biol Mol & Biotecnol, Rio De Janeiro, Brazil.; Paiva-Silva, GO (corresponding author), INCT EM, Rio De Janeiro, Brazil.
EM gosilva@bioqmed.ufrj.br
RI Taracena, Mabel/G-4535-2017
OI Taracena, Mabel/0000-0002-5918-7776; /0000-0003-3814-5312;
   Bottino-Rojas, Vanessa/0000-0001-8019-9942
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [16/2014]; Fundagao Carlos Chagas Filho de Amparo a Pesquisa de
   Estado do Rio de Janeiro (FAPERJ) [26/010.001545/2014]; National
   Institutes of Health, National Institute for Allergy and Infectious
   DiseaseUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01A1101431]
FX This work was supported by grants from the Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq) (INCT_EM, 16/2014) to
   GOPS and PLO, Fundagao Carlos Chagas Filho de Amparo a Pesquisa de
   Estado do Rio de Janeiro (FAPERJ)(26/010.001545/2014) and by National
   Institutes of Health, National Institute for Allergy and Infectious
   Disease, R01A1101431 to GD. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016
   Ayyaz A, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00098
   Bae YS, 2010, TRENDS IMMUNOL, V31, P278, DOI 10.1016/j.it.2010.05.003
   Behura SK, 2014, FUNCT INTEGR GENOMIC, V14, P581, DOI 10.1007/s10142-014-0376-1
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Behura SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021504
   Billingsley P. F., 1996, P3
   Broderick NA, 2014, MBIO, V5, DOI 10.1128/mBio.01117-14
   BROWN MR, 1985, TISSUE CELL, V17, P709, DOI 10.1016/0040-8166(85)90006-0
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Chauhan C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047350
   Cheng G, 2016, TRENDS PARASITOL, V32, P177, DOI 10.1016/j.pt.2015.09.009
   Clem RJ, 2016, J GEN VIROL, V97, P1033, DOI 10.1099/jgv.0.000429
   Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Fernandes KM, 2014, PARASITOL INT, V63, P506, DOI 10.1016/j.parint.2014.01.004
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Guo Z, 2015, SCIENCE, V350, DOI 10.1126/science.aab0988
   Gusmao DS, 2010, ACTA TROP, V115, P275, DOI 10.1016/j.actatropica.2010.04.011
   Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311
   Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007
   Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765
   Janeh M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44594
   Jiang HQ, 2012, CURR OPIN GENET DEV, V22, P354, DOI 10.1016/j.gde.2012.04.002
   Jin YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005634
   Kalyanaraman B, 2012, FREE RADICAL BIO MED, V52, P1, DOI 10.1016/j.freeradbiomed.2011.09.030
   Kelkenberg M, 2015, INSECT BIOCHEM MOLEC, V56, P21, DOI 10.1016/j.ibmb.2014.11.005
   Kim SH, 2014, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00116
   KLOWDEN MJ, 1994, J MED ENTOMOL, V31, P618, DOI 10.1093/jmedent/31.4.618
   Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371
   Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200
   O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112
   Ocampo CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061187
   Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333
   Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606
   Oliveira JHM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005525
   Oliveira JHM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001320
   Opota O, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002259
   Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Romoser WS, 2004, J MED ENTOMOL, V41, P467, DOI 10.1603/0022-2585-41.3.467
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73
   Serrato-Salas J, 2018, DEV COMP IMMUNOL, V84, P28, DOI 10.1016/j.dci.2018.01.022
   Severson DW, 2016, INSECTS, V7, DOI 10.3390/insects7040058
   Shao L, 2001, ARCH INSECT BIOCHEM, V47, P119, DOI 10.1002/arch.1042.abs
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Sterkel M, 2017, TRENDS PARASITOL, V33, P633, DOI 10.1016/j.pt.2017.04.008
   Valzania L, 2018, P NATL ACAD SCI USA, V115, P457, DOI 10.1073/pnas.1719063115
   VanDussen KL, 2012, DEVELOPMENT, V139, P488, DOI 10.1242/dev.070763
   Wang H, 2012, J VIROL, V86, P6546, DOI 10.1128/JVI.00125-12
NR 61
TC 10
Z9 11
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006498
DI 10.1371/journal.pntd.0006498
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900046
PM 29782512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU White, SK
   Mavian, C
   Elbadry, MA
   De Rochars, VMB
   Paisie, T
   Telisma, T
   Salemi, M
   Lednicky, JA
   Morris, JG
AF White, Sarah K.
   Mavian, Carla
   Elbadry, Maha A.
   De Rochars, Valery Madsen Beau
   Paisie, Taylor
   Telisma, Taina
   Salemi, Marco
   Lednicky, John A.
   Morris, J. Glenn, Jr.
TI Detection and phylogenetic characterization of arbovirus dual-infections
   among persons during a chikungunya fever outbreak, Haiti 2014
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MAYARO VIRUS; IQ-TREE; DENGUE; ZIKA; COINFECTION; EVOLUTIONARY;
   ACCURACY; ILLNESS; CHILD; DNA
AB In the context of recent arbovirus epidemics, questions about the frequency of simultaneous infection of patients with different arbovirus pecies have been raised. In 2014, a major Chikungunya virus (CHIKV) epidemic impacted the Caribbean and South America. As part of ongoing screening of schoolchildren presenting with acute undifferentiated febrile illness in rural Haiti, we used RT-PCR to identify CHIKV infections in 82 of 100 children with this diagnosis during May August 2014. Among these, eight were infected with a second arbovirus: sixwith Zika virus (ZIKV), one with Dengue virus serotype 2, and one with Mayaro virus (MAYV). These dual infections were only detected following culture of the specimen, suggesting low viral loads of the co-infecting species. Phylogenetic analyses indicated that the ZIKV and MAYV strains differ from those detected later in 2014 and 2015, respectively. oreover, CHIKV and ZIKV strains from co-infected patients clustered monophyletically in their respective phylogeny, and clock calibration traced back the common ancestor of each Glade to an overlapping timeframe of introduction of these arboviruses onto the island.
C1 [White, Sarah K.; Mavian, Carla; Elbadry, Maha A.; De Rochars, Valery Madsen Beau; Paisie, Taylor; Salemi, Marco; Lednicky, John A.; Morris, J. Glenn, Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32608 USA.
   [White, Sarah K.; Elbadry, Maha A.; Lednicky, John A.] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Environm & Global Hlth, Gainesville, FL USA.
   [Mavian, Carla; Paisie, Taylor; Salemi, Marco] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA.
   [De Rochars, Valery Madsen Beau] Univ Florida, Dept Hlth Serv Res, Coll Publ Hlth & Hlth Profess, Gainesville, FL USA.
   [Telisma, Taina] Christianville Fdn Sch Clin, Gressier, Haiti.
   [Morris, J. Glenn, Jr.] Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA.
RP Morris, JG (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32608 USA.; Morris, JG (corresponding author), Univ Florida, Coll Med, Dept Med, Gainesville, FL 32610 USA.
EM jgmorris@epi.ufl.edu
RI Elbadry, Maha Adel/AAH-4444-2020; Lednicky, John A/C-5678-2012; mavian,
   carla/H-3410-2019
OI Elbadry, Maha Adel/0000-0002-6089-4523; mavian,
   carla/0000-0003-3819-5520; Paisie, Taylor/0000-0002-6024-2744
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01 A126357-01S1]; University of Florida Emerging Pathogens Institute
FX This work was funded in part by grant R01 A126357-01S1 from the National
   Institute of Allergy and Infectious Diseases
   (https://www.niaid.nih.govi) awarded to JGM and pilot grant funding from
   the University of Florida Emerging Pathogens Institute
   (www.epi.ufl.edu). The funders had no ole in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Auguste AJ, 2015, EMERG INFECT DIS, V21, P1742, DOI 10.3201/eid2110.141660
   Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084
   Ball JD, 2018, CLIN EPIDEMIOLOGIC P
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Christenbury JG, 2010, J VIROL METHODS, V169, P202, DOI 10.1016/j.jviromet.2010.06.013
   De Rochars VEMB, 2015, AM J TROP MED HYG, V92, P752, DOI 10.4269/ajtmh.14-0059
   De Rochars VMB, 2017, AM J TROP MED HYG, V96, P144, DOI [10.4269/ajtmh.16-0685, 10.4269/ajtmh.16-0585]
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075
   Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017
   Elbadry M, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00331-17, 10.1128/genomea.00331-17]
   ElBadry M, 2016, PEDIATR INFECT DIS J, V35, P1048, DOI 10.1097/INF.0000000000001283
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Iovine NM, 2017, CLIN INFECT DIS, V64, P72, DOI 10.1093/cid/ciw667
   KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Lednicky J, 2016, EMERG INFECT DIS, V22, P2000, DOI 10.3201/eid2211.161015
   Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Nasci RS, 2014, EMERG INFECT DIS, V20, P1394, DOI 10.3201/eid2008.140333
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sardi SI, 2016, J CLIN MICROBIOL, V54, P2348, DOI 10.1128/JCM.00877-16
   Schilling S, 2009, J CLIN VIROL, V45, P163, DOI 10.1016/j.jcv.2009.04.001
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   Stapleford KA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004402
   Strimmer K, 2001, MOL BIOL EVOL, V18, P2298, DOI 10.1093/oxfordjournals.molbev.a003776
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256
   Vasconcelos PF, 2000, VECTOR BORNE ZOONOTI
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Weaver SC, 2016, ANTIVIRAL RES
   White SK, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00148-17, 10.1128/genomea.00148-17]
   White SK, 2017, MICROBIOL RESOUR ANN, V5, DOI [10.1128/genomeA.00782-17, 10.1128/genomea.00782-17]
   Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371
   Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 48
TC 9
Z9 9
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAY
PY 2018
VL 12
IS 5
AR e0006505
DI 10.1371/journal.pntd.0006505
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH9WW
UT WOS:000434021900050
PM 29851952
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Matsuno, K
   Kajihara, M
   Nakao, R
   Nao, N
   Mori-Kajihara, A
   Muramatsu, M
   Qiu, YJ
   Torii, S
   Igarashi, M
   Kasajima, N
   Mizuma, K
   Yoshii, K
   Sawa, H
   Sugimoto, C
   Takada, A
   Ebihara, H
AF Matsuno, Keita
   Kajihara, Masahiro
   Nakao, Ryo
   Nao, Naganori
   Mori-Kajihara, Akina
   Muramatsu, Mieko
   Qiu, Yongjin
   Torii, Shiho
   Igarashi, Manabu
   Kasajima, Nodoka
   Mizuma, Keita
   Yoshii, Kentaro
   Sawa, Hirofumi
   Sugimoto, Chihiro
   Takada, Ayato
   Ebihara, Hideki
TI The Unique Phylogenetic Position of a Novel Tick-Borne Phlebovirus
   Ensures an Ixodid Origin of the Genus Phlebovirus
SO MSPHERE
LA English
DT Article
DE ancestral state; evolution; phylogenetic analysis; tick-borne
   phlebovirus
ID VALLEY FEVER VIRUS; THROMBOCYTOPENIA SYNDROME; ZIKA VIRUS; EVOLUTIONARY;
   IDENTIFICATION; BUNYAVIRIDAE; SEQUENCES; MOSQUITOS; CHINA; ANTIBODIES
AB The recent emergence of novel tick-borne RNA viruses has complicated the epidemiological landscape of tick-borne infectious diseases, posing a significant challenge to public health systems that seek to counteract tick-borne diseases. The identification of two novel tick-borne phleboviruses (TBPVs), severe fever with thrombocytopenia syndrome virus (SFTSV) and Heartland virus (HRTV), as causative agents of severe illness in humans has accelerated the investigation and discoveries of novel TBPVs. In the present study, we isolated a novel TBPV designated Mukawa virus (MKWV) from host-questing lxodes persulcatus females captured in Japan. Genetic characterization revealed that MKWV is a member of the genus Phlebovirus in the family Phenuiviridae. Interestingly, MKWV is genetically distinct from other known TBPVs and shares a most recent common ancestor with mosquito/sandflyborne (insect-borne) phleboviruses. Despite its genetic similarity to insect-borne phleboviruses, the molecular footprints of its viral proteins and its biological characteristics define MKWV as a tick-borne virus that can be transmitted to mammals. A phylogenetic ancestral-state reconstruction for arthropod vectors of phleboviruses including MKWV based on viral L segment sequences indicated that ticks likely harbored ancestral phleboviruses that evolved into both the tick-borne and MKWV/insect-borne phlebovirus lineages. Overall, our findings suggest that most of the phlebovirus evolution has occurred in hard ticks to generate divergent viruses, which may provide a seminal foundation for understanding the mechanisms underlying the evolution and emergence of pathogenic phleboviruses, such as Rift Valley fever virus and SFTSV/HRTV.
   IMPORTANCE The emergence of novel tick-borne RNA viruses causing severe illness in humans has complicated the epidemiological landscape of tick-borne diseases, requiring further investigation to safeguard public health. In the present study, we discovered a novel tick-borne phlebovirus from lxodes persulcatus ticks in Japan. While its viral RNA genome sequences were similar to those of mosquito/sandfly-borne viruses, molecular and biological footprints confirmed that this is a tick-borne virus. The unique evolutionary position of the virus allowed us to estimate the ancestral phlebovirus vector, which was likely a hard tick. Our findings may provide a better understanding of the evolution and emergence of phleboviruses associated with emerging infectious diseases, such as severe fever with thrombocytopenia syndrome (SFTS) and Heartland virus disease.
C1 [Matsuno, Keita; Mizuma, Keita] Hokkaido Univ, Fac Vet Med, Lab Microbiol, Sapporo, Hokkaido, Japan.
   [Matsuno, Keita; Igarashi, Manabu; Sawa, Hirofumi; Sugimoto, Chihiro; Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Div Int Serv, Sapporo, Hokkaido, Japan.
   [Kajihara, Masahiro; Mori-Kajihara, Akina; Muramatsu, Mieko; Igarashi, Manabu; Kasajima, Nodoka; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan.
   [Nakao, Ryo] Hokkaido Univ, Fac Vet Med, Lab Parasitol, Sapporo, Hokkaido, Japan.
   [Nao, Naganori] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan.
   [Qiu, Yongjin] Univ Zambia, Hokkaido Univ, Res Ctr Zoonosis Control, Hokudai Ctr Zoonosis Control Zambia, Lusaka, Zambia.
   [Torii, Shiho; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido, Japan.
   [Yoshii, Kentaro] Hokkaido Univ, Fac Vet Med, Lab Publ Hlth, Sapporo, Hokkaido, Japan.
   [Sugimoto, Chihiro] Hokkaido Univ, Res Ctr Zoonosis Control, Div Collaborat & Educ, Sapporo, Hokkaido, Japan.
   [Ebihara, Hideki] Mayo Clin, Dept Mol Med, Rochester, MN USA.
RP Ebihara, H (corresponding author), Mayo Clin, Dept Mol Med, Rochester, MN USA.
EM Ebihara.Hideki@mayo.edu
RI Igarashi, Manabu/F-6871-2012; Kajihara, Masahiro/AAF-5724-2020; Sawa,
   Hirofumi/F-6954-2012
FU Akiyama Life Science Foundation; MEXT/JSPS KAKENHIMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [JP17KT0045, JP16K18791, JP16H06431, JP16H06429, JP16K21723, JP16H05805,
   JP15K18778]; Japan Initiative for Global Research Network on Infectious
   Diseases (J-GRID)Ministry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT); Japan Initiative for Progress of Research on
   Infectious Disease for Global Epidemic (J-PRIDE) (AMED grant)
   [JP18fm0108008, JP17fm0208001]; AMED/Japan International Cooperation
   Agency (JICA) of the Science and Technology Research Partnership for
   Sustainable Development (SATREPS)Japan Agency for Medical Research and
   Development (AMED); Fusion-H program from Hokkaido University
FX This study was partly supported by the Akiyama Life Science Foundation,
   MEXT/JSPS KAKENHI (grant numbers JP17KT0045, JP16K18791, JP16H06431,
   JP16H06429, JP16K21723, JP16H05805, and JP15K18778), the Japan
   Initiative for Global Research Network on Infectious Diseases (J-GRID)
   and the Japan Initiative for Progress of Research on Infectious Disease
   for Global Epidemic (J-PRIDE) (AMED grant no. JP18fm0108008 and
   JP17fm0208001, respectively), AMED/Japan International Cooperation
   Agency (JICA) within the framework of the Science and Technology
   Research Partnership for Sustainable Development (SATREPS), and the
   Fusion-H program from Hokkaido University. The funders had no role in
   study design, data collection and interpretation, or the decision to
   submit the work for publication.
CR Adams MJ, 2017, ARCH VIROL, V162, P1441, DOI 10.1007/s00705-016-3215-y
   Alberdi MP, 2012, TICKS TICK-BORNE DIS, V3, P137, DOI 10.1016/j.ttbdis.2012.05.002
   Auguste AJ, 2014, J GEN VIROL, V95, P481, DOI 10.1099/vir.0.058412-0
   Bird BH, 2011, J VIROL, V85, P12901, DOI 10.1128/JVI.06046-11
   Brault AC, 2009, VET RES, V40, DOI 10.1051/vetres/2009026
   Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Isogai E, 1996, MICROBIOL IMMUNOL, V40, P13, DOI 10.1111/j.1348-0421.1996.tb03311.x
   Kainulainen M, 2016, J VIROL, V90, P6140, DOI 10.1128/JVI.00016-16
   Kim KH, 2013, EMERG INFECT DIS, V19, P1892, DOI 10.3201/eid1911.130792
   Li CX, 2015, ELIFE, V4, DOI 10.7554/eLife.05378
   Li Z, 2005, J VIROL METHODS, V130, P154, DOI 10.1016/j.jviromet.2005.06.022
   Li ZF, 2014, J CLIN VIROL, V60, P185, DOI 10.1016/j.jcv.2014.03.020
   Liu JW, 2014, EMERG INFECT DIS, V20, P2126, DOI 10.3201/eid2012.141013
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Maddison WP, 2016, MESQUITE MODULAR SYS, V3
   Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11
   Marklewitz M, 2015, P NATL ACAD SCI USA, V112, P7536, DOI 10.1073/pnas.1502036112
   Matsuno K, 2015, J VIROL, V89, P594, DOI 10.1128/JVI.02704-14
   Matsuno K, 2013, J VIROL, V87, P3719, DOI 10.1128/JVI.02845-12
   McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378
   Miyamoto K, 1998, Kansenshogaku Zasshi, V72, P512
   Morrison TE, 2014, J VIROL, V88, P11644, DOI 10.1128/JVI.01432-14
   MUNDERLOH UG, 1989, EXP APPL ACAROL, V7, P219, DOI 10.1007/BF01194061
   Murase Y, 2011, VET MICROBIOL, V149, P504, DOI 10.1016/j.vetmic.2010.11.025
   Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039
   Nakao R, 2017, TICKS TICK-BORNE DIS, V8, P103, DOI 10.1016/j.ttbdis.2016.10.005
   Nakao R, 2013, ISME J, V7, P1003, DOI 10.1038/ismej.2012.171
   National Institute of Infectious Diseases, 2016, INFECT AGENTS SURVEI
   Palacios G, 2013, J VIROL, V87, P3187, DOI 10.1128/JVI.02719-12
   Plyusnin A, 2011, VIRUS TAXONOMY, P725
   Raikova A P, 1971, Vopr Virusol, V16, P731
   Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6
   Takahashi T, 2014, J INFECT DIS, V209, P816, DOI 10.1093/infdis/jit603
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07
   Wuerth JD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060174
   Xing Z, 2013, EMERG INFECT DIS, V19, P1487, DOI [10.3201/eid1908.130165, 10.3201/eid1909.130165]
   Yadav S, 2016, J CLIN DIAGN RES, V10, pDM1, DOI 10.7860/JCDR/2016/19170.8133
   Yu XJ, 2011, NEW ENGL J MED, V364, P1523, DOI 10.1056/NEJMoa1010095
NR 43
TC 9
Z9 10
U1 2
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 2379-5042
J9 MSPHERE
JI mSphere
PD MAY-JUN
PY 2018
VL 3
IS 3
AR e00239-18
DI 10.1128/mSphere.00239-18
PG 14
WC Microbiology
SC Microbiology
GA GL5TU
UT WOS:000437234900035
PM 29898985
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cassuto, NG
   Marras, G
   Jacomo, V
   Bouret, D
AF Cassuto, N. G.
   Marras, G.
   Jacomo, V.
   Bouret, D.
TI Persistence of Zika virus in gradient sperm preparation
SO JOURNAL OF GYNECOLOGY OBSTETRICS AND HUMAN REPRODUCTION
LA English
DT Letter
ID SEMEN
C1 [Cassuto, N. G.; Marras, G.; Bouret, D.] Drouot Lab, ART Unit, 21 Rue Drouot, F-75009 Paris, Ile De France, France.
   [Jacomo, V.] Biomnis Lab, 17-19 Ave Tony Garnier,BP 7322, F-69357 Lyon 07, France.
RP Cassuto, NG (corresponding author), Drouot Lab, ART Unit, 21 Rue Drouot, F-75009 Paris, Ile De France, France.
EM guycassuto@labodrouot.com; giulia.marras1@gmail.coth;
   veronique.jacomo@biomnis.com; dominiquebouret@labodrouot.com
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cassuto NG, 2002, HUM REPROD, V17, P3153, DOI 10.1093/humrep/17.12.3153
   Gornet ME, 2016, SEMIN REPROD MED, V34, P285, DOI 10.1055/s-0036-1592312
   Jindal SK, 2016, REPROD BIOMED ONLINE, V33, P121, DOI 10.1016/j.rbmo.2016.04.015
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
NR 6
TC 3
Z9 3
U1 0
U2 2
PU ELSEVIER MASSON, CORPORATION OFFICE
PI PARIS
PA 65 CAMILLE DESMOULINS CS50083 ISSY-LES-MOULINEAUX, 92442 PARIS, FRANCE
SN 2468-7847
EI 1773-0430
J9 J GYNECOL OBSTET HUM
JI J. Gynecol. Obstet. Hum. Reprod.
PD MAY
PY 2018
VL 47
IS 5
BP 211
EP 212
DI 10.1016/j.jogoh.2018.02.004
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GK8YS
UT WOS:000436521300008
PM 29510270
DA 2020-07-08
ER

PT J
AU Philips, C
AF Philips, Celeste
TI Zika: Florida's experience responding to an emerging public health
   threat
SO NEUROTOXICOLOGY AND TERATOLOGY
LA English
DT Meeting Abstract
CT 42nd Annual Meeting of the Developmental-Neurotoxicology-Society Held in
   conjunction with the 58th Annual Meeting of the Teratology-Society
CY JUN 23-27, 2018
CL Clearwater Beach, FL
SP Dev Neurotoxicol Soc, Teratol Soc
C1 [Philips, Celeste] Florida Dept Hlth, Tallahassee, FL USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0892-0362
EI 1872-9738
J9 NEUROTOXICOL TERATOL
JI Neurotoxicol. Teratol.
PD MAY-JUN
PY 2018
VL 67
MA DNTS 18
BP 80
EP 80
PG 1
WC Neurosciences; Toxicology
SC Neurosciences & Neurology; Toxicology
GA GL0HV
UT WOS:000436651500027
DA 2020-07-08
ER

PT J
AU Alvarado-Socarras, JL
   Idrovo, AJ
   Contreras-Garcia, GA
   Rodriguez-Morales, AJ
   Audcent, TA
   Mogollon-Mendoza, AC
   Paniz-Mondolfi, A
AF Alvarado-Socarras, Jorge L.
   Idrovo, Alvaro J.
   Contreras-Garcia, Gustavo A.
   Rodriguez-Morales, Alfonso J.
   Audcent, Tobey A.
   Mogollon-Mendoza, Adriana C.
   Paniz-Mondolfi, Alberto
TI Congenital microcephaly: A diagnostic challenge during Zika epidemics
SO TRAVEL MEDICINE AND INFECTIOUS DISEASE
LA English
DT Review
DE Microcephaly; Zika; TORCH; Pregnancy infections; Latin America
ID VIRUS-INFECTION; MALFORMATION; AMERICA; BRAZIL
AB The multiple, wide and diverse etiologies of congenital microcephaly are complex and multifactorial. Recent advances in genetic testing have improved understanding of novel genetic causes of congenital microcephaly. The recent Zika virus (ZIKV) epidemic in Latin America has highlighted the need for a better understanding of the underlying pathological mechanisms of microcephaly including both infectious and non-infectious causes. The diagnostic approach to microcephaly needs to include potential infectious and genetic etiologies, as well as environmental in-utero exposures such as alcohol, toxins, and medications. Emerging genetic alterations linked to microcephaly include abnormal mitotic microtubule spindle structure and abnormal function of centrosomes. We discuss the diagnostic challenge of congenital microcephaly in the context of understanding the links with ZIKV emergence as a new etiological factor involved in this birth defect.
C1 [Alvarado-Socarras, Jorge L.] Fdn Cardiovasc Colombia, Dept Pediat, Neonatal Unit, Floridablanca, Santander, Colombia.
   [Alvarado-Socarras, Jorge L.; Rodriguez-Morales, Alfonso J.] OLFIS, Bucaramanga, Santander, Colombia.
   [Alvarado-Socarras, Jorge L.; Rodriguez-Morales, Alfonso J.] Colombian Collaborat Network Zika RECOLZIKA, Pereira, Risaralda, Colombia.
   [Idrovo, Alvaro J.] Univ Ind Santander, Sch Med, Publ Hlth Dept, Bucaramanga, Colombia.
   [Contreras-Garcia, Gustavo A.] Univ Ind Santander, Res Grp Human Genet, Bucaramanga, Colombia.
   [Rodriguez-Morales, Alfonso J.] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Audcent, Tobey A.] Childrens Hosp Eastern Ontario, 401 Smyth Rd, Ottawa, ON K1H 8L1, Canada.
   [Mogollon-Mendoza, Adriana C.] Infect Dis Res Incubator, Caracas, Venezuela.
   [Mogollon-Mendoza, Adriana C.] Zoonosis & Emerging Pathogens Reg Collaborat Netw, Caracas, Venezuela.
   [Mogollon-Mendoza, Adriana C.] Univ Centroccidental Lisandro Alvarado, Coll Med, Hlth Sci Dept, Barquisimeto, Lara, Venezuela.
   [Paniz-Mondolfi, Alberto] IDB Biomed Res Ctr, Dept Infect Dis & Trop Med, Infect Dis Pathol Lab IDB, Barquisimeto, Venezuela.
   [Paniz-Mondolfi, Alberto] Inst Venezolano Los Seguros Sociales IVSS, Directorate Hlth, Caracas, Dtto Capital, Venezuela.
RP Rodriguez-Morales, AJ (corresponding author), Univ Tecnol Pereira, Fac Hlth Sci, Publ Hlth & Infect Res Grp, Pereira, Risaralda, Colombia.
EM arodriguezm@utp.edu.co
RI AJ, Rodriguez-Morales/R-9765-2016
OI AJ, Rodriguez-Morales/0000-0001-9773-2192; Idrovo, Alvaro
   J/0000-0001-9579-1463
CR Abdel-Salam GMH, 2008, AM J MED GENET A, V146A, P2929, DOI 10.1002/ajmg.a.32549
   Abdel-SalamMicrocephaly Ghada MH, 2008, AM J MED GENET A, V146A, P2929
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Socarras JLA, 2016, ARCH ARGENT PEDIATR, V114, pE396
   Alvarado-Socarras JL, 2016, ULTRASOUND OBST GYN, V47, P525, DOI 10.1002/uog.15885
   [Anonymous], 2016, INTERIM GUIDELINES E
   [Anonymous], 2016, WHOZIKVMOC163
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Auger N, 2017, ARCH DIS CHILD-FETAL, P1
   Baquero Artigao, 2013, AN PEDIAT, V79
   Baquero-Artigao F, 2009, AN PEDIATR, V71, P535, DOI 10.1016/j.anpedi.2009.07.029
   Barkovich AJ, 1998, NEUROPEDIATRICS, V29, P113, DOI 10.1055/s-2007-973545
   BenItez LS, 2009, ARCH PEDIATR URUG, V80, P237
   Book JA, 1953, AM J MENT DEF, V57, P637
   Boom JA., MICROCEPHALY INFANT
   Boom JA, MICROCEPHALY INFANTS
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   Dolk H, 2003, BRIT MED BULL, V68, P25, DOI 10.1093/bmb/ldg024
   DOLK H, 1991, DEV MED CHILD NEUROL, V33, P974
   Douglas L, 2001, FETAL DIAGN THER, V16, P323, DOI 10.1159/000053935
   Dzieciolowska S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40067
   Enrique Valdes R, 2008, REV CHIL OBSTET GINC, V73, P205
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Hughes Brenna L., CYNTHIA GYAMFI BANNE
   Kaneko M, 2013, J PERINATOL, V33, P831, DOI 10.1038/jp.2013.87
   Kleber de Oliveira W, 2015, MMWR
   KOMAI T, 1955, AM J HUM GENET, V7, P51
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   Marrs C, 2016, AM J PERINAT, V33, P625, DOI 10.1055/s-0036-1580089
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nard JA., 1997, COMMON CHRONIC SYMPT
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Piro E, 2013, ACTA MEDICA MEDITERR, V29, P327
   Purugganan OH, 2006, PEDIAT REV, V27
   Quinto L, 2017, J TROP PEDIATRICS, P01
   Rajab A, 2007, AM J MED GENET A, V143A, P2761, DOI 10.1002/ajmg.a.31955
   ROCHE AF, 1987, PEDIATRICS, V79, P706
   Rodriguez Morales AJ, 2015, ARCH MED, V11, pe3
   Rodriguez-Morales AJ, 2017, JPN J RADIOL, V35, P86, DOI 10.1007/s11604-016-0603-x
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P5, DOI 10.1016/j.tmaid.2016.01.011
   ROUTH D K, 1979, Journal of Pediatric Psychology, V4, P67, DOI 10.1093/jpepsy/4.1.67
   Royal College of Obstetricians & Gynaecologists, INT RCOG RCM PHE HPS
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seltzer LE, 2014, AM J MED GENET C, V166, P140, DOI 10.1002/ajmg.c.31400
   Tijana Stajner, 2016, PRENATAL EARLY POSTN
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Villamil-Gomez WE, 2016, TRAVEL MED INFECT DI, V14, P155, DOI 10.1016/j.tmaid.2016.02.004
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
NR 62
TC 8
Z9 9
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1477-8939
EI 1873-0442
J9 TRAVEL MED INFECT DI
JI Travel Med. Infect. Dis.
PD MAY-JUN
PY 2018
VL 23
BP 14
EP 20
DI 10.1016/j.tmaid.2018.02.002
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GK9MG
UT WOS:000436573700004
PM 29471046
DA 2020-07-08
ER

PT J
AU Esquivel, R
   Patel, A
   Kudchodkar, S
   Park, D
   Stettler, K
   Choi, H
   Borole, P
   Asija, K
   Ramos, S
   Smith, T
   Yan, J
   Guibinga, G
   Broderick, K
   Muthumani, K
   Corti, D
   Humeau, L
   Weiner, D
AF Esquivel, Rianne
   Patel, Ami
   Kudchodkar, Sagar
   Park, Daniel
   Stettler, Karin
   Choi, Hyeree
   Borole, Piyush
   Asija, Kanika
   Ramos, Stephanie
   Smith, Trevor
   Yan, Jian
   Guibinga, Ghiabe
   Broderick, Kate
   Muthumani, Kar
   Corti, Davide
   Humeau, Laurent
   Weiner, David
TI An Optimized DNA Encoded Monoclonal Antibody (DMAb) Prevents Zika Virus
   Infection and Severe Testicular Atrophy in Mice
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 16-19, 2018
CL Chicago, IL
SP Amer Soc Gene & Cell Therapy
C1 [Esquivel, Rianne; Patel, Ami; Kudchodkar, Sagar; Park, Daniel; Choi, Hyeree; Borole, Piyush; Asija, Kanika; Muthumani, Kar; Weiner, David] Wistar Inst Anat & Biol, Vaccine & Immunotherapy Ctr, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Stettler, Karin; Corti, Davide] Humabs Biomed SA, Bellinzona, Switzerland.
   [Ramos, Stephanie; Smith, Trevor; Yan, Jian; Guibinga, Ghiabe; Broderick, Kate; Humeau, Laurent] Inovio Pharmaceut, Plymouth Meeting, PA USA.
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065
NR 0
TC 0
Z9 0
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2018
VL 26
IS 5
SU 1
MA 522
BP 244
EP 244
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA GJ4HT
UT WOS:000435342203082
DA 2020-07-08
ER

PT J
AU Guibinga, GH
   Ramos, S
   Liu, XG
   Chen, J
   Reed, C
   Cooch, N
   Lyubinetsky, S
   Smith, T
   Yan, J
   Kudchodkar, S
   Esquivel, R
   Patel, A
   Muthumani, K
   Weiner, D
   Broderick, K
   Humeau, L
AF Guibinga, Ghiabe H.
   Ramos, Stephanie
   Liu, Xinggang
   Chen, Jing
   Reed, Charles
   Cooch, Neil
   Lyubinetsky, Sergey
   Smith, Trevor
   Yan, Jian
   Kudchodkar, Sagar
   Esquivel, Rianne
   Patel, Ami
   Muthumani, Kar
   Weiner, David
   Broderick, Kate
   Humeau, Laurent
TI Evaluation of a Multivalent scFv-Fc DNA-Encoded Monoclonal Antibodies
   (dMAbTM) Platform against Zika Virus (ZIKV) and Dengue Virus (DENV)
   Infections
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 16-19, 2018
CL Chicago, IL
SP Amer Soc Gene & Cell Therapy
C1 [Guibinga, Ghiabe H.; Ramos, Stephanie; Liu, Xinggang; Chen, Jing; Reed, Charles; Cooch, Neil; Lyubinetsky, Sergey; Smith, Trevor; Yan, Jian; Broderick, Kate; Humeau, Laurent] Inovio Pharmaceut, San Diego, CA USA.
   [Kudchodkar, Sagar; Esquivel, Rianne; Patel, Ami; Muthumani, Kar; Weiner, David] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2018
VL 26
IS 5
SU 1
MA 529
BP 247
EP 247
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA GJ4HT
UT WOS:000435342203089
DA 2020-07-08
ER

PT J
AU Cooch, N
   Guibinga, G
   Chen, J
   Reed, C
   Esquivel, R
   Patel, A
   Ramos, S
   Yan, J
   Broderick, K
   Weiner, D
   Humeau, L
AF Cooch, Neil
   Guibinga, Ghiabe
   Chen, Jing
   Reed, Charles
   Esquivel, Rianne
   Patel, Ami
   Ramos, Stephanie
   Yan, Jian
   Broderick, Kate
   Weiner, David
   Humeau, Laurent
TI Exploration of Gene Optimization and scFv-Fc Reformatting as Strategies
   to Increase In Vivo Expression Levels of DNA-Encoded Monoclonal
   Antibodies (DMAbs) against Zika Virus
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 16-19, 2018
CL Chicago, IL
SP Amer Soc Gene & Cell Therapy
C1 [Cooch, Neil; Guibinga, Ghiabe; Chen, Jing; Reed, Charles; Ramos, Stephanie; Yan, Jian; Broderick, Kate; Humeau, Laurent] Inovio Pharmaceut, Plymouth Meeting, PA USA.
   [Esquivel, Rianne; Patel, Ami; Weiner, David] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2018
VL 26
IS 5
SU 1
MA 583
BP 270
EP 271
PG 2
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA GJ4HT
UT WOS:000435342204014
DA 2020-07-08
ER

PT J
AU Reuschel, EL
   Zaidi, FI
   Kudchodkar, SB
   Choi, H
   Boyer, JD
   Roberts, CC
   Remigio, C
   Park, YK
   Jeong, M
   Racine, T
   Trottier, S
   Krieger, D
   Muthumani, K
   Kobinger, GP
   White, S
   Weiner, DB
   Tebas, P
   Maslow, JN
AF Reuschel, Emma L.
   Zaidi, Faraz I.
   Kudchodkar, Sagar B.
   Choi, Hyeree
   Boyer, Jean D.
   Roberts, Christine C.
   Remigio, Celine
   Park, Young K.
   Jeong, Moonsup
   Racine, Trina
   Trottier, Sylvie
   Krieger, Diane
   Muthumani, Kar
   Kobinger, Gary P.
   White, Scott
   Weiner, David B.
   Tebas, Pablo
   Maslow, Joel N.
TI Intradermal Delivery of a Synthetic, Consensus DNA Vaccine against Zika
   Virus, Gls-5700, is Highly Immunogenic in Humans Inducing Humoral and
   Cellular Immunity That is Maintained for over One Year
SO MOLECULAR THERAPY
LA English
DT Meeting Abstract
CT 21st Annual Meeting of the American-Society-of-Gene-and-Cell-Therapy
   (ASGCT)
CY MAY 16-19, 2018
CL Chicago, IL
SP Amer Soc Gene & Cell Therapy
C1 [Reuschel, Emma L.; Zaidi, Faraz I.; Kudchodkar, Sagar B.; Choi, Hyeree; Muthumani, Kar; Weiner, David B.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.
   [Boyer, Jean D.; White, Scott] Inovio Pharmaceut, Plymouth Meeting, PA USA.
   [Roberts, Christine C.; Remigio, Celine; Park, Young K.; Jeong, Moonsup; Maslow, Joel N.] GeneOne Life Sci Inc, Seoul, South Korea.
   [Racine, Trina; Kobinger, Gary P.] Univ Laval, Quebec City, PQ, Canada.
   [Trottier, Sylvie] Ctr Hosp Univ Quebec, Quebec City, PQ, Canada.
   [Krieger, Diane] 6QPS Miami Res Associates, Miami, FL USA.
   [Tebas, Pablo] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
RI Muthumani, Kar/AAQ-4939-2020
OI Muthumani, Kar/0000-0002-6807-2065
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY
PY 2018
VL 26
IS 5
SU 1
MA 1003
BP 459
EP 459
PG 1
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA GJ4HT
UT WOS:000435342205214
DA 2020-07-08
ER

PT J
AU Leier, HC
   Messer, WB
   Tafesse, FG
AF Leier, Hans C.
   Messer, William B.
   Tafesse, Fikadu G.
TI Lipids and pathogenic flaviviruses: An intimate union
SO PLOS PATHOGENS
LA English
DT Article
ID DENGUE VIRUS-INFECTION; FATTY-ACID SYNTHASE; MEMBRANE CURVATURE; ZIKA
   VIRUS; VIRAL REPLICATION; CHOLESTEROL; PROTEINS; ENVELOPE; SITES;
   PERSPECTIVE
C1 [Leier, Hans C.; Messer, William B.; Tafesse, Fikadu G.] OHSU, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA.
   [Messer, William B.] OHSU, Div Infect Dis, Dept Med, Portland, OR USA.
RP Tafesse, FG (corresponding author), OHSU, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA.
EM tafesse@ohsu.edu
OI Tafesse, Fikadu/0000-0002-8575-4164
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI133631]; Collins
   Medical Trust [GMMBI0265A]
FX This work was funded by the National Institute of Health grant
   R21AI133631 and the Collins Medical Trust (GMMBI0265A). The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Baumgart T, 2011, ANNU REV PHYS CHEM, V62, P483, DOI 10.1146/annurev.physchem.012809.103450
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Cloetta D, 2013, J NEUROSCI, V33, P7799, DOI 10.1523/JNEUROSCI.3294-12.2013
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719
   Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Haberkant P, 2016, ACS CHEM BIOL, V11, P222, DOI 10.1021/acschembio.5b00810
   Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   King NJC, 2007, IMMUNOL CELL BIOL, V85, P33, DOI 10.1038/sj.icb.7100012
   Li C, 2016, J NANOMATER, V2016, P10, DOI DOI 10.3389/FPLS.2016.01356
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Martin-Acebes MA, 2014, J VIROL, V88, P12041, DOI 10.1128/JVI.02061-14
   Martin-Acebes MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024970
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Melo CFOR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164377
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Soto-Acosta R, 2013, VIROLOGY, V442, P132, DOI 10.1016/j.virol.2013.04.003
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Thaa B, 2010, BBA-MOL CELL RES, V1803, P507, DOI 10.1016/j.bbamcr.2010.01.011
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Wang PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008325
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhang W, 2013, J STRUCT BIOL, V183, P86, DOI 10.1016/j.jsb.2013.04.005
NR 41
TC 12
Z9 12
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2018
VL 14
IS 5
AR e1006952
DI 10.1371/journal.ppat.1006952
PG 7
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GH9YP
UT WOS:000434026400003
PM 29746606
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Voigt, V
   Andoniou, CE
   Schuster, IS
   Oszmiana, A
   Ong, ML
   Fleming, P
   Forrester, JV
   Degli-Esposti, MA
AF Voigt, Valentina
   Andoniou, Christopher E.
   Schuster, Iona S.
   Oszmiana, Anna
   Ong, Monique L.
   Fleming, Peter
   Forrester, John V.
   Degli-Esposti, Mariapia A.
TI Cytomegalovirus establishes a latent reservoir and triggers long-lasting
   inflammation in the eye
SO PLOS PATHOGENS
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; MEMORY T-CELLS; MURINE CYTOMEGALOVIRUS;
   IMMUNOCOMPETENT PATIENTS; CMV INFECTION; EBOLA-VIRUS; CORNEAL
   ENDOTHELIITIS; OCULAR INFECTION; ANTERIOR UVEITIS; INTERFERON-GAMMA
AB Recent outbreaks of Ebola and Zika have highlighted the possibility that viruses may cause enduring infections in tissues like the eye, including the neural retina, which have been considered immune privileged. Whether this is a peculiarity of exotic viruses remains unclear, since the impact of more common viral infections on neural compartments has not been examined, especially in immunocompetent hosts. Cytomegalovirus is a common, universally distributed pathogen, generally innocuous in healthy individuals. Whether in immunocompetent hosts cytomegalovirus can access the eye, and reside there indefinitely, was unknown. Using the well-established murine cytomegalovirus infection model, we show that systemic infection of immunocompetent hosts results in broad ocular infection, chronic inflammation and establishment of a latent viral pool in the eye. Infection leads to infiltration and accumulation of anti-viral CD8(+) T cells in the eye, and to the development of tissue resident memory T cells that localize to the eye, including the retina. These findings identify the eye as an unexpected reservoir for cytomegalovirus, and suggest that common viruses may target this organ more frequently than appreciated. Notably, they also highlight that infection triggers sustained inflammatory responses in the eye, including the neural retina.
C1 [Voigt, Valentina; Andoniou, Christopher E.; Schuster, Iona S.; Oszmiana, Anna; Ong, Monique L.; Fleming, Peter; Forrester, John V.; Degli-Esposti, Mariapia A.] Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Crawley, WA, Australia.
   [Voigt, Valentina; Andoniou, Christopher E.; Schuster, Iona S.; Oszmiana, Anna; Ong, Monique L.; Fleming, Peter; Forrester, John V.; Degli-Esposti, Mariapia A.] Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia.
   [Forrester, John V.] Univ Aberdeen, Div Appl Med, Sect Immunol & Infect, Inst Med Sci, Aberdeen, Scotland.
RP Degli-Esposti, MA (corresponding author), Univ Western Australia, Ctr Ophthalmol & Visual Sci, Immunol & Virol Program, Crawley, WA, Australia.; Degli-Esposti, MA (corresponding author), Lions Eye Inst, Ctr Expt Immunol, Nedlands, WA, Australia.
EM mariapia@lei.org.au
RI ; Oszmiana, Anna/F-6915-2015
OI Andoniou, Christopher/0000-0003-0566-3180; Oszmiana,
   Anna/0000-0003-1501-4184
FU National Health and Medical Research Council of AustraliaNational Health
   and Medical Research Council of Australia [1071822, 1003683]; Stan
   Perron Charitable Trust [01]; Hardie Foundation [01]; John Forrester
   Senior Research Fellowship
FX Funding for this study was provided by: National Health and Medical
   Research Council of Australia: Program Grant #1071822; Principle
   Research Fellowship to MD-E #1003683; https://www.nhmrc.gov.au/ Stan
   Perron Charitable Trust Grant #01 Hardie Foundation Grant #01 CEA holds
   the John Forrester Senior Research Fellowship The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ambati J, 2013, NAT REV IMMUNOL, V13, P438, DOI 10.1038/nri3459
   Andrews DM, 2010, J EXP MED, V207, P1333, DOI 10.1084/jem.20091193
   BALE JF, 1991, INVEST OPHTH VIS SCI, V32, P1749
   BALE JF, 1990, INVEST OPHTH VIS SCI, V31, P1575
   Boppana SB, 2013, CYTOMEGALOVIRUSES: FROM MOLECULAR PATHOGENESIS TO INTERVENTION, VOL II, P1
   Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655
   Carmichael A, 2012, EYE, V26, P237, DOI 10.1038/eye.2011.327
   Chee SP, 2008, AM J OPHTHALMOL, V145, P834, DOI 10.1016/j.ajo.2007.12.015
   Chee SP, 2007, OPHTHALMOLOGY, V114, P798, DOI 10.1016/j.ophtha.2006.07.057
   Cheeran MCJ, 2009, CLIN MICROBIOL REV, V22, P99, DOI 10.1128/CMR.00023-08
   Crough T, 2009, CLIN MICROBIOL REV, V22, P76, DOI 10.1128/CMR.00034-08
   Duan YP, 1996, INVEST OPHTH VIS SCI, V37, P935
   Forrester JV, 2010, IMMUNOL REV, V234, P282, DOI 10.1111/j.0105-2896.2009.00873.x
   Fuji S, 2017, CURR OPIN INFECT DIS, V30, P372, DOI 10.1097/QCO.0000000000000375
   Gabrielli L, 2012, CLIN MICROBIOL INFEC, V18, pE419, DOI 10.1111/j.1469-0691.2012.03983.x
   GAO EK, 1995, INVEST OPHTH VIS SCI, V36, P2322
   GOLDEN MP, 1994, MEDICINE, V73, P246, DOI 10.1097/00005792-199409000-00003
   Griffiths P, 2015, J PATHOL, V235, P288, DOI 10.1002/path.4437
   Gupta A, 2009, EYE, V23, P873, DOI 10.1038/eye.2008.124
   Jacobson MA, 2000, CLIN INFECT DIS, V30, P231, DOI 10.1086/313612
   Kawasaki H, 2017, PATHOL INT, V67, P72, DOI 10.1111/pin.12502
   KEIL GM, 1985, J VIROL, V54, P422, DOI 10.1128/JVI.54.2.422-428.1985
   Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38
   Koizumi N, 2006, AM J OPHTHALMOL, V141, P564, DOI 10.1016/j.ajo.2005.09.021
   Koizumi N, 2008, OPHTHALMOLOGY, V115, P292, DOI 10.1016/j.ophtha.2007.04.053
   Koontz T, 2008, J EXP MED, V205, P423, DOI 10.1084/jem.20071489
   Lazzarotto T, 2014, SCAND J CLIN LAB INV, V74, P34, DOI 10.3109/00365513.2014.936679
   Lee KG, 2016, CLIN NEPHROL, V86, P154, DOI 10.5414/CN108811
   Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413
   Magro C, 2005, APPL IMMUNOHISTO M M, V13, P268, DOI 10.1097/01.pai.0000137911.39736.95
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   MOCARSKI ES, 2007, FIELDS VIROLOGY, P2702
   Mutnal MB, 2011, J NEUROVIROL, V17, P424, DOI 10.1007/s13365-011-0042-5
   Ong ML, 2013, BLOOD, V122, P55, DOI 10.1182/blood-2012-12-471227
   Port AD, 2017, J OCUL PHARMACOL TH, V33, P224, DOI 10.1089/jop.2016.0140
   Rafailidis PI, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-47
   Reddehase MJ, 2002, J CLIN VIROL, V25, pS23
   Reddy SM, 2010, BONE MARROW TRANSPL, V45, P979, DOI 10.1038/bmt.2010.35
   Reuter JD, 2004, J VIROL, V78, P1473, DOI 10.1128/JVI.78.3.1473-1487.2004
   Rosato PC, 2017, CURR OPIN VIROL, V22, P44, DOI 10.1016/j.coviro.2016.11.011
   Schmidt-Hieber M, 2016, ANN ONCOL, V27, P1207, DOI 10.1093/annonc/mdw155
   Seckert CK, 2009, J VIROL, V83, P8869, DOI 10.1128/JVI.00870-09
   Sissons JGP, 2015, MED MICROBIOL IMMUN, V204, P307, DOI 10.1007/s00430-015-0415-0
   Slavuljica I, 2015, CELL MOL IMMUNOL, V12, P180, DOI 10.1038/cmi.2014.51
   Smith CJ, 2015, CELL REP, V13, P1137, DOI 10.1016/j.celrep.2015.09.076
   Stahl FR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003828
   Tiffany A, 2016, CLIN INFECT DIS, V62, P1360, DOI 10.1093/cid/ciw158
   van Boxtel LAA, 2007, OPHTHALMOLOGY, V114, P1358, DOI 10.1016/j.ophtha.2006.09.035
   Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306
   Xhaard A, 2007, TRANSPLANTATION, V83, P80, DOI 10.1097/01.tp.0000239512.94181.e9
   Yeh S, 2015, NEW ENGL J MED, V373, P1982, DOI 10.1056/NEJMc1510459
   Zhang M, 2008, INVEST OPHTH VIS SCI, V49, P295, DOI 10.1167/iovs.07-0612
   Zinkernagel MS, 2013, AM J PATHOL, V182, P875, DOI 10.1016/j.ajpath.2012.11.031
NR 53
TC 8
Z9 8
U1 1
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2018
VL 14
IS 5
AR e1007040
DI 10.1371/journal.ppat.1007040
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA GH9YP
UT WOS:000434026400028
PM 29852019
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU da Silva, S
   Martins, DOS
   Jardim, ACG
AF da Silva, Suely
   Silva Martins, Daniel Oliveira
   Gomes Jardim, Ana Carolina
TI A Review of the Ongoing Research on Zika Virus Treatment
SO VIRUSES-BASEL
LA English
DT Review
DE Zika fever; ZIKV; treatment; antiviral; screen of drugs
ID HEPATITIS-C VIRUS; NS2B-NS3 PROTEASE; RHESUS-MONKEYS; INHIBITS ZIKA;
   GREEN TEA; EPIGALLOCATECHIN GALLATE; ANTIVIRAL ACTIVITY; APPROVED DRUGS;
   INFECTION; REPLICATION
AB The Zika fever is an arboviral disease resulting from the infection with Zika virus (ZIKV). The virus is transmitted to humans by the bite of Aedes mosquitos, mainly Aedes aegypti and Aedes albopictus. ZIKV has been detected for decades in African and Asian regions and, since 2007, has spread to other continents; among them, infections are most reported in the Americas. This can be explained by the presence of vectors in highly populated and tropical regions where people are susceptible to contamination. ZIKV has been considered by the World Health Organization a serious public health problem because of the increasing number of cases of congenital malformation and neurological disorders related to its infection, such as microcephaly, Guillain-Barre syndrome, meningoencephalitis, and myelitis. There is no vaccine or specific antiviral against ZIKV. The infection is best prevented by avoiding mosquito bite, and the treatment of infected patients is palliative. In this context, the search for efficient antivirals is necessary but remains challenging. Here, we aim to review the molecules that have been described to interfere with ZIKV life cycle and discuss their potential use in ZIKV therapy.
C1 [da Silva, Suely; Silva Martins, Daniel Oliveira; Gomes Jardim, Ana Carolina] Univ Fed Uberlandia, Inst Biomed Sci, Virol Lab, ICBIM, BR-38405302 Uberlandia, MG, Brazil.
   [da Silva, Suely; Silva Martins, Daniel Oliveira; Gomes Jardim, Ana Carolina] Sao Paulo State Univ, IBILCE, Genom Study Lab, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
RP Jardim, ACG (corresponding author), Univ Fed Uberlandia, Inst Biomed Sci, Virol Lab, ICBIM, BR-38405302 Uberlandia, MG, Brazil.; Jardim, ACG (corresponding author), Sao Paulo State Univ, IBILCE, Genom Study Lab, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil.
EM suelysilva0712@hotmail.com; danielosmartins@gmail.com; jardim@ufu.br
RI Jardim, Ana Carolina Gomes/H-3615-2012
OI Jardim, Ana Carolina Gomes/0000-0002-6348-7923; Martins, Daniel Oliveira
   Silva/0000-0002-8722-2663
FU CNPQ (National Counsel of Technological and Scientific
   Development)National Council for Scientific and Technological
   Development (CNPq) [445021/2014-4, 2017BIO026]; FAPEMIG (Minas Gerais
   Research Foundation)Minas Gerais State Research Foundation (FAPEMIG)
   [APQ-00587-14, SICONV 793988/2013]; Royal Society-Newton Advanced
   Fellowship [NA 150195]; CAPES (Coordination for the Improvement of
   Higher Education Personnel)CAPES
FX We would like to thank CNPQ (National Counsel of Technological and
   Scientific Development-grant 445021/2014-4; 2017BIO026), FAPEMIG (Minas
   Gerais Research Foundation-APQ-00587-14, SICONV 793988/2013), Royal
   Society-Newton Advanced Fellowship (grant reference NA 150195) and CAPES
   (Coordination for the Improvement of Higher Education Personnel) for
   financial support).
CR Adiga R, 2016, J MED VIROL, V88, P1821, DOI 10.1002/jmv.24615
   Arbuckle JH, 2017, MBIO, V8, DOI [10.1128/mBio.01141-17, 10.1128/mbio.01141-17]
   Asif G, 2007, ANTIMICROB AGENTS CH, V51, P2424, DOI 10.1128/AAC.01498-06
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barbosa-Limaa G, 2017, EUR J MED CHEM, V127, P334, DOI 10.1016/j.ejmech.2016.12.058
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Beadle JR, 2006, J MED CHEM, V49, P2010, DOI 10.1021/jm050473m
   Behrendt P, 2017, ANTIVIR RES, V147, P19, DOI 10.1016/j.antiviral.2017.09.006
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Calland N, 2012, VIRUSES-BASEL, V4, P2197, DOI 10.3390/v4102197
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1960, DOI 10.3201/eid2011.141380
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200
   Centers for Disease Control, 2016, ZIK BAS VIR PROT IT
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen HC, 1996, ANTIMICROB AGENTS CH, V40, P2332, DOI 10.1128/AAC.40.10.2332
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Carvalho OV, 2017, INT J ANTIMICROB AG, V50, P718, DOI 10.1016/j.ijantimicag.2017.08.016
   De Clercq E, 2000, NUCLEOS NUCLEOT NUCL, V19, P1531, DOI 10.1080/15257770008045444
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Gao M, 2010, NATURE, V465, P96, DOI 10.1038/nature08960
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   Gentile I, 2015, EXPERT OPIN DRUG DIS, V10, P1363, DOI 10.1517/17460441.2015.1094051
   Ghezzi S, 2017, ANTIVIR RES, V140, P13, DOI 10.1016/j.antiviral.2016.12.023
   Ginther OJ, 2012, THERIOGENOLOGY, V78, P1969, DOI 10.1016/j.theriogenology.2012.08.003
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hernandez-Santiago BI, 2005, ANTIMICROB AGENTS CH, V49, P2589, DOI 10.1128/AAC.49.7.2589-2597.2005
   Isaacs CE, 2008, ANTIMICROB AGENTS CH, V52, P962, DOI 10.1128/AAC.00825-07
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kato F, 2016, ANTIVIR RES, V131, P141, DOI 10.1016/j.antiviral.2016.04.014
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1
   Mao SL, 2004, BIOORG MED CHEM LETT, V14, P4991, DOI 10.1016/j.bmcl.2004.07.016
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Murata K, 2018, GUT, V67, P362, DOI 10.1136/gutjnl-2016-312653
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perachon S, 1999, EUR J PHARMACOL, V366, P293, DOI 10.1016/S0014-2999(98)00896-6
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Raekiansyah M, 2018, ARCH VIROL, V163, P1649, DOI 10.1007/s00705-018-3769-y
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Samarasekera U, 2016, LANCET, V387, P521, DOI 10.1016/S0140-6736(16)00257-9
   Shapshak P., 2015, ZIKA VIRUS GLOBAL VI, P477
   Shome S, 2016, J PHARM PHARMACOL, V68, P1481, DOI 10.1111/jphp.12611
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soderholm S, 2016, ANTIVIR RES, V126, P69, DOI 10.1016/j.antiviral.2015.12.011
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Vinet L, 2011, J PHYS A-MATH THEOR, V44, DOI 10.1088/1751-8113/44/8/085201
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   WHO, 2016, CURR ZIK PROD PIP, P1
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, 2017, SAF MAN DRINK WAT TH, P1
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
NR 92
TC 11
Z9 11
U1 0
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2018
VL 10
IS 5
AR 255
DI 10.3390/v10050255
PG 18
WC Virology
SC Virology
GA GJ3LX
UT WOS:000435198000040
PM 29758005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lee, I
   Bos, S
   Li, G
   Wang, SS
   Gadea, G
   Despres, P
   Zhao, RY
AF Lee, Ina
   Bos, Sandra
   Li, Ge
   Wang, Shusheng
   Gadea, Gilles
   Despres, Philippe
   Zhao, Richard Y.
TI Probing Molecular Insights into Zika Virus-Host Interactions
SO VIRUSES-BASEL
LA English
DT Review
DE zika virus; ZIKV-host interactions; viral pathogenesis; cell surface
   receptors; antiviral responses; viral counteraction; cytopathic effects;
   microcephaly; ZIKV-associated neurologic disorders
ID HUMAN-ANTIBODY RESPONSES; NEURAL STEM-CELLS; DENGUE VIRUS; NS2B-NS3
   PROTEASE; PHOSPHATIDYLSERINE RECEPTORS; CEREBRAL ORGANOIDS; CYTOPATHIC
   FACTORS; CAPSID PROTEIN; IN-VITRO; INFECTION
AB The recent Zika virus (ZIKV) outbreak in the Americas surprised all of us because of its rapid spread and association with neurologic disorders including fetal microcephaly, brain and ocular anomalies, and Guillain-Barre syndrome. In response to this global health crisis, unprecedented and world-wide efforts are taking place to study the ZIKV-related human diseases. Much has been learned about this virus in the areas of epidemiology, genetic diversity, protein structures, and clinical manifestations, such as consequences of ZIKV infection on fetal brain development. However, progress on understanding the molecular mechanism underlying ZIKV-associated neurologic disorders remains elusive. To date, we still lack a good understanding of; (1) what virologic factors are involved in the ZIKV-associated human diseases; (2) which ZIKV protein(s) contributes to the enhanced viral pathogenicity; and (3) how do the newly adapted and pandemic ZIKV strains alter their interactions with the host cells leading to neurologic defects? The goal of this review is to explore the molecular insights into the ZIKV-host interactions with an emphasis on host cell receptor usage for viral entry, cell innate immunity to ZIKV, and the ability of ZIKV to subvert antiviral responses and to cause cytopathic effects. We hope this literature review will inspire additional molecular studies focusing on ZIKV-host Interactions.
C1 [Lee, Ina; Li, Ge; Wang, Shusheng; Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.
   [Bos, Sandra; Gadea, Gilles; Despres, Philippe] Univ la Reunion, CNRS UMR 9192, INSERM U1187,Plateforme Technolog CYROI, IRD UMR 249,Unite Mixte Proc Infectieux Milieu In, F-94791 St Clotilde, La Reunion, France.
   [Zhao, Richard Y.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA.
   [Zhao, Richard Y.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
RP Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Global Hlth, Baltimore, MD 21201 USA.; Zhao, RY (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.
EM ilee1@umm.edu; sandrabos.lab@gmail.com; GLi@som.umaryland.edu;
   shushengwang018@gmail.com; gilles.gadea@inserm.fr;
   philippe.despres@univ-reunion.fr; rzhao@som.umaryland.edu
OI BOS, Sandra/0000-0001-5036-0336; Zhao, Richard Y./0000-0003-3424-2852;
   Gilles, Gadea/0000-0001-6325-4866
FU National Institute of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [NIH R21 AI129369];
   University of Maryland Medical Center; ZIKAlert project (European
   Union-Region Reunion programme) [SYNERGY: RE0001902]; La Reunion Island
   University (Ecole Doctorale STS); French ministry MEESR
FX We want to thank all of those who have contributed our understanding of
   the emerging Zika virus especially those studies molecular mechanism
   underlying Zika virus host interactions. We also want to apologize in
   advance if we have missed any important references that we should have
   included in this review. This work was supported in part by funding from
   the National Institute of Health (NIH R21 AI129369) and University of
   Maryland Medical Center (to R.Y.Z). This work was also supported by the
   ZIKAlert project (European Union-Region Reunion programme under grant
   agreement no SYNERGY: RE0001902). S.B. has PhD degree scholarship from
   La Reunion Island University (Ecole Doctorale STS), funded by the French
   ministry MEESR.
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Bukrinsky M, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0139-5
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chiramel AI, 2018, VIRUS RES, V254, P34, DOI 10.1016/j.virusres.2017.09.006
   Cohen J, 2017, SCIENCE, V355, P1362, DOI 10.1126/science.355.6332.1362
   Colavita F, 2018, J RHEUMATOL, V45, P443, DOI 10.3899/jrheum.170835
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Delatorre E, 2017, MEM I OSWALDO CRUZ, V112, P793, DOI 10.1590/0074-02760170299
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fenyvuesvolgyi C, 2005, BBA-MOL CELL RES, V1746, P155, DOI 10.1016/j.bbamcr.2005.09.006
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gallichotte EN, 2017, J INFECT DIS, V216, P1196, DOI 10.1093/infdis/jix473
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Vallejo JJ, 2013, MOL IMMUNOL, V53, P387, DOI 10.1016/j.molimm.2012.09.012
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Nguyen HN, 2016, CELL RES, V26, P753, DOI 10.1038/cr.2016.68
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2017, INFECT GENET EVOL, V49, P134, DOI 10.1016/j.meegid.2017.01.015
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris E, 2006, NOVART FDN SYMP, V277, P251
   Harris E, 2006, NOVART FDN SYMP, V277, P40
   Harris Eva, 2006, Novartis Found Symp, V277, P23, DOI 10.1002/0470058005.ch3
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li G, 2018, METHODS MOL BIOL, V1721, P47, DOI 10.1007/978-1-4939-7546-4_5
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li L, 2005, CELL RES, V15, P923, DOI 10.1038/sj.cr.7290370
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin JC, 2014, J IMMUNOL, V193, P1258, DOI 10.4049/jimmunol.1302675
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Melino S, 2006, FEBS J, V273, P3650, DOI 10.1111/j.1742-4658.2006.05369.x
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moran M, 2014, BBA-MOL BASIS DIS, V1842, P1059, DOI 10.1016/j.bbadis.2014.03.013
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nasmyth K, 2001, CELL, V107, P689, DOI 10.1016/S0092-8674(01)00604-3
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nurse P, 2002, CHEMBIOCHEM, V3, P596, DOI 10.1002/1439-7633(20020703)3:7<596::AID-CBIC596>3.0.CO;2-U
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Romero-Brey I, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060160
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sahiner F, 2017, PEDIATR INFECT DIS J, V36, pE341, DOI 10.1097/INF.0000000000001689
   Salam AP, 2018, LANCET INFECT DIS, V18, P144, DOI 10.1016/S1473-3099(18)30020-3
   Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Shimojima M, 2012, J VIROL, V86, P2067, DOI 10.1128/JVI.06451-11
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Stefanik M, 2018, BMC NEUROSCI, V19, DOI 10.1186/s12868-018-0407-2
   Stock NK, 2015, J VIROL METHODS, V222, P110, DOI 10.1016/j.jviromet.2015.06.006
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Thepparit C, 2004, J VIROL, V78, P12647, DOI 10.1128/JVI.78.22.12647-12656.2004
   Tooze SA, 2016, CELL, V167, P1433, DOI 10.1016/j.cell.2016.11.023
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Viranaicken W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010038
   Wang DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42580
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie DY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0006-9
   Yang TC, 2009, VIRUS RES, V143, P77, DOI 10.1016/j.virusres.2009.03.007
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zhao RY, 2017, MICROB CELL, V4, P311, DOI 10.15698/mic2017.10.592
   Zhao YQ, 1998, BIOTECHNIQUES, V25, P438, DOI 10.2144/98253st06
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 164
TC 22
Z9 22
U1 1
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2018
VL 10
IS 5
AR 233
DI 10.3390/v10050233
PG 26
WC Virology
SC Virology
GA GJ3LX
UT WOS:000435198000018
PM 29724036
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Peng, HP
   Liu, B
   Yves, TD
   He, YH
   Wang, SJ
   Tang, HL
   Ren, H
   Zhao, P
   Qi, ZT
   Qin, ZL
AF Peng, Haoran
   Liu, Bin
   Yves, Toure Doueu
   He, Yanhua
   Wang, Shijie
   Tang, Hailin
   Ren, Hao
   Zhao, Ping
   Qi, Zhongtian
   Qin, Zhaoling
TI Zika Virus Induces Autophagy in Human Umbilical Vein Endothelial Cells
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; autophagy; LC3; Beclin-1; viral replication; virus
   production
ID INSULIN-RESISTANCE; SIGNALING PATHWAY; STRESS-RESPONSE; INFECTION;
   DEATH; REPLICATION; DEGRADATION; HOST; RNA; PHOSPHATIDYLINOSITOL
AB Autophagy is a common strategy for cell protection; however, some viruses can in turn adopt cellular autophagy to promote viral replication. Zika virus (ZIKV) is the pathogen that causes Zika viral disease, and it is a mosquito-borne virus. However, its pathogenesis, especially the interaction between ZIKV and target cells during the early stages of infection, is still unclear. In this study, we demonstrate that infecting human umbilical vein endothelial cells (HUVEC) with ZIKV triggers cellular autophagy. We observed both an increase in the conversion of LC3-I to LC3-II and increased accumulation of fluorescent cells with LC3 dots, which are considered to be the two key indicators of autophagy. The ratio of LC3-II/GAPDH in each group was significantly increased at different times after ZIKV infection at different MOIs, indicating that the production of lipidated LC3-II increased. Moreover, both the ratio of LC3-II/GAPDH and the expression of viral NS3 protein increased with increasing time of viral infection. The expression level of p62 decreased gradually from 12 h post-infection. Expression profile of double fluorescent protein labelling LC3 indicated that the autophagy induced by ZIKV infection was a complete process. We further investigated the role of autophagy in ZIKV replication. We demonstrated that either the treatment with inhibitors of autophagosomes formation or short hairpin RNA targeting the Beclin-1 gene, which is critical for the formation of autophagosomes, significantly reduced viral production. Taken together, our results indicate that ZIKV infection induces autophagy of HUVEC, and inhibition of ZIKV-induced autophagy restrains viral replication.
C1 [Peng, Haoran; Liu, Bin; Yves, Toure Doueu; He, Yanhua; Wang, Shijie; Tang, Hailin; Ren, Hao; Zhao, Ping; Qi, Zhongtian; Qin, Zhaoling] Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai 200433, Peoples R China.
RP Qi, ZT; Qin, ZL (corresponding author), Second Mil Med Univ, Shanghai Key Lab Med Biodef, Dept Microbiol, Shanghai 200433, Peoples R China.
EM phran@126.com; smmuliubin@163.com; chabaiichabaii@gmail.com;
   hyh0556@163.com; 15026921726@163.com; hailint@163.com; hren2013@139.com;
   pnzhao@163.com; qizt@smmu.edu.cn; zhlingqin@hotmail.com
OI Liu, Bin/0000-0002-4331-7943
FU national key research and development program of China [2016YFC1202903];
   key discipline project of Shanghai public health 3-year action plan
   [15GWZK0103]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81171564, 81521091]
FX This work was supported by national key research and development program
   of China (2016YFC1202903), the key discipline project of Shanghai public
   health 3-year action plan (15GWZK0103), and the National Natural Science
   Foundation of China (No. 81171564, 81521091).
CR Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002
   Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Clippinger AJ, 2011, J VIROL, V85, P9369, DOI 10.1128/JVI.05102-11
   Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751
   Dash S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050150
   Delbruck M, 1940, J GEN PHYSIOL, V23, P643, DOI 10.1085/jgp.23.5.643
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Gao TT, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0241-4
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Joubert PE, 2012, J EXP MED, V209, P1029, DOI 10.1084/jem.20110996
   Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017
   Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720
   Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338
   Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717
   Kong D, 2008, CANCER SCI, V99, P1734, DOI 10.1111/j.1349-7006.2008.00891.x
   Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   McNulty S, 2013, J VIROL, V87, P912, DOI 10.1128/JVI.02415-12
   Meng CC, 2012, ARCH VIROL, V157, P1011, DOI 10.1007/s00705-012-1270-6
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   POWIS G, 1994, CANCER RES, V54, P2419
   Qin ZL, 2007, J VIROL METHODS, V145, P146, DOI 10.1016/j.jviromet.2007.05.017
   Qin ZL, 2004, BIOCHEM BIOPH RES CO, V324, P1186, DOI 10.1016/j.bbrc.2004.09.180
   Schlegel A, 1996, J VIROL, V70, P6576, DOI 10.1128/JVI.70.10.6576-6588.1996
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Stohr S, 2016, GUT, V65, P2017, DOI 10.1136/gutjnl-2014-308971
   Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176
   Yu XL, 2015, AUTOPHAGY, V11, P1711, DOI 10.1080/15548627.2015.1043076
   Zhai X, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1001, DOI 10.1134/S0006297915080052
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zhou CH, 2012, AUTOPHAGY, V8, P1215, DOI 10.4161/auto.20284
NR 46
TC 16
Z9 16
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2018
VL 10
IS 5
AR 259
DI 10.3390/v10050259
PG 12
WC Virology
SC Virology
GA GJ3LX
UT WOS:000435198000044
PM 29762492
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rayner, JO
   Kalkeri, R
   Goebel, S
   Cai, ZH
   Green, B
   Lin, SL
   Snyder, B
   Hagelin, K
   Walters, KB
   Koide, F
AF Rayner, Jonathan O.
   Kalkeri, Raj
   Goebel, Scott
   Cai, Zhaohui
   Green, Brian
   Lin, Shuling
   Snyder, Beth
   Hagelin, Kimberly
   Walters, Kevin B.
   Koide, Fusataka
TI Comparative Pathogenesis of Asian and African-Lineage Zika Virus in
   Indian Rhesus Macaque's and Development of a Non-Human Primate Model
   Suitable for the Evaluation of New Drugs and Vaccines
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; ZIKV; rhesus macaques; Non-human primates; NHP; infection;
   natural history; Asian-lineage; African-lineage
ID INFECTION; INOCULATION; OUTBREAK; BRAZIL
AB The establishment of a well characterized non-human primate model of Zika virus (ZIKV) infection is critical for the development of medical interventions. In this study, challenging Indian rhesus macaques (IRMs) with ZIKV strains of the Asian lineage resulted in dose-dependent peak viral loads between days 2 and 5 post infection and a robust immune response which protected the animals from homologous and heterologous re-challenge. In contrast, viremia in IRMs challenged with an African lineage strain was below the assay's lower limit of quantitation, and the immune response was insufficient to protect from re-challenge. These results corroborate previous observations but are contrary to reports using other African strains, obviating the need for additional studies to elucidate the variables contributing to the disparities. Nonetheless, the utility of an Asian lineage ZIKV IRM model for countermeasure development was verified by vaccinating animals with a formalin inactivated reference vaccine and demonstrating sterilizing immunity against a subsequent subcutaneous challenge.
C1 [Rayner, Jonathan O.] Southern Res Inst, Dept Infect Dis Res, Birmingham, AL 35205 USA.
   [Rayner, Jonathan O.] Univ S Alabama, Dept Microbiol & Immunol, Mobile, AL 36688 USA.
   [Kalkeri, Raj; Goebel, Scott; Cai, Zhaohui; Green, Brian; Lin, Shuling; Snyder, Beth; Hagelin, Kimberly; Walters, Kevin B.; Koide, Fusataka] Southern Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA.
RP Koide, F (corresponding author), Southern Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA.
EM jrayner@southalabama.edu; rkalkeri@southernresearch.org;
   sgoebel@southernresearch.org; zcai@southernresearch.org;
   bgreen@southernresearch.org; slin@southernresearch.org;
   bsnyder@southernresearch.org; khagelin@southernresearch.org;
   kwalters@southernresearch.org; fkoide@southernresearch.org
OI Rayner, Jonathan/0000-0002-2091-7604
FU National Institutes of Health (NIH)/National Institute of Allergy and
   Infectious Diseases (NIAID)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272201000022I,
   HHSN2720006]
FX The research reported in this publication was supported by the National
   Institutes of Health (NIH)/National Institute of Allergy and Infectious
   Diseases (NIAID) contract HHSN272201000022I; C33 Task Order No.
   HHSN2720006 (Development of a Non-Human Primate Model of Zika Virus
   Infection for Product Evaluation).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gong Z, 2017, GENOME BIOL EVOL, V9, P2940, DOI 10.1093/gbe/evx223
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Rayner J.O., 2016, VIRAL RNA WAS ONLY D
   Report S, 2017, ZIK VIR MICR GUILL B
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 45
TC 8
Z9 8
U1 0
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2018
VL 10
IS 5
AR 229
DI 10.3390/v10050229
PG 16
WC Virology
SC Virology
GA GJ3LX
UT WOS:000435198000014
PM 29723973
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Taylor, CT
   Mackay, IM
   McMahon, JL
   Wheatley, SL
   Moore, PR
   Finger, MJ
   Hewitson, GR
   Moore, FA
AF Taylor, Carmel T.
   Mackay, Ian M.
   McMahon, Jamie L.
   Wheatley, Sarah L.
   Moore, Peter R.
   Finger, Mitchell J.
   Hewitson, Glen R.
   Moore, Frederick A.
TI Detection of Specific ZIKV IgM in Travelers Using a Multiplexed
   Flavivirus Microsphere Immunoassay
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; serology; flavivirus; microsphere immunoassay; validated;
   optimised; dengue virus
ID VIRUS-INFECTION; DENGUE; CHIKUNGUNYA; COINFECTION; DIAGNOSIS; VIREMIA;
   STATES; ASSAY
AB Zika virus (ZIKV) has spread widely in the Pacific and recently throughout the Americas. Unless detected by RT-PCR, confirming an acute ZIKV infection can be challenging. We developed and validated a multiplexed flavivirus immunoglobulin M (IgM) microsphere immunoassay (flaviMIA) which can differentiate ZIKV-specific IgM from that due to other flavivirus infections in humans. The flaviMIA bound 12 inactivated flavivirus antigens, including those from ZIKV and yellow fever virus (YFV), to distinct anti-flavivirus antibody coupled beads. These beads were used to interrogate sera from patients with suspected ZIKV infection following travel to relevant countries. FlaviMIA results were validated by comparison to the ZIKV plaque reduction neutralization test (PRNT). The results highlight the complexity of serological ZIKV diagnosis, particularly in patients previously exposed to, or vaccinated against, other flaviviruses. We confirmed 99 patients with ZIKV infection by a combination of RT-PCR and serology. Importantly, ZIKV antibodies could be discriminated from those ascribed to other flavivirus infections. Serological results were sometimes confounded by the presence of pre-existing antibodies attributed to previous flavivirus infection or vaccination. Where RT-PCR results were negative, testing of appropriately timed paired sera was necessary to demonstrate seroconversion or differentiation of recent from past infection with or exposure to ZIKV.
C1 [Taylor, Carmel T.; Mackay, Ian M.; McMahon, Jamie L.; Wheatley, Sarah L.; Moore, Peter R.; Finger, Mitchell J.; Hewitson, Glen R.; Moore, Frederick A.] Queensland Hlth, Publ Hlth Virol Forens & Sci Serv, Coopers Plains, Qld 4108, Australia.
RP Taylor, CT (corresponding author), Queensland Hlth, Publ Hlth Virol Forens & Sci Serv, Coopers Plains, Qld 4108, Australia.
EM carmel.taylor@health.qld.gov.au; ian.mackay@health.qld.gov.au;
   Jamie.McMahon@health.qld.gov.au; Sarah.Wheatley@health.qld.gov.au;
   Peter.Moore2@health.qld.gov.au; Mitchell.Finger@health.qld.gov.au;
   Glen.Hewitson@health.qld.gov.au; Frederick.Moore@health.qld.gov.au
RI ; Mackay, Ian M./B-2537-2010
OI Taylor, Carmel/0000-0001-6283-2695; Mackay, Ian M./0000-0003-3598-2350;
   McMahon, Jamie/0000-0002-9304-1500
CR Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Basile AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075670
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faccini-Martinez AA, 2016, J INFECT PUBLIC HEAL, V9, P687, DOI 10.1016/j.jiph.2016.01.001
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Hennessey MJ, 2016, AM J TROP MED HYG, V95, P212, DOI 10.4269/ajtmh.16-0049
   Hubner R., ZIKA VIRUS BRAZIL 16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pan American Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pyke Alyssa T, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.849adc0ad16beec4536695281707f785
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Pyke AT, 2004, BMC MICROBIOL, V4, DOI 10.1186/1471-2180-4-3
   ROEHRIG JT, 1983, VIROLOGY, V128, P118, DOI 10.1016/0042-6822(83)90323-9
   Ronnberg B, 2017, MED MICROBIOL IMMUN, V206, P383, DOI 10.1007/s00430-017-0517-y
   Schilling S, 2004, J CLIN VIROL, V31, P179, DOI 10.1016/j.jcv.2004.03.020
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Taylor C, 2005, CLIN DIAGN LAB IMMUN, V12, P371, DOI 10.1128/CDLI.12.3.371-374.2005
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 32
TC 5
Z9 5
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAY
PY 2018
VL 10
IS 5
AR 253
DI 10.3390/v10050253
PG 15
WC Virology
SC Virology
GA GJ3LX
UT WOS:000435198000038
PM 29757218
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sarukhanyan, E
   Shityakov, S
   Dandekar, T
AF Sarukhanyan, Edita
   Shityakov, Sergey
   Dandekar, Thomas
TI In Silico Designed Axl Receptor Blocking Drug Candidates Against Zika
   Virus Infection
SO ACS OMEGA
LA English
DT Article
ID SMALL-MOLECULE INHIBITORS; COMPUTATIONAL APPROACH; SEXUAL TRANSMISSION;
   PROTEIN; CELLS; DISCOVERY; IDENTIFICATION; KINASE; VISUALIZATION;
   ACTIVATION
AB After a large outbreak in Brazil, novel drugs against Zika virus became extremely necessary. Evaluation of virus-based pharmacological strategies concerning essential host factors brought us to the idea that targeting the Axl receptor by blocking its dimerization function could be critical for virus entry. Starting from experimentally validated compounds, such as RU-301, RU-302, warfarin, and R428, we identified a novel compound 2' (R428 derivative) to be the most potent for this task amongst a number of alternative compounds and leads. The improved affinity of compound 2' was confirmed by molecular docking as well as molecular dynamics simulation techniques using implicit solvation models. The current study summarizes a new possibility for inhibition of the Axl function as a potential target for future antiviral therapies.
C1 [Sarukhanyan, Edita; Dandekar, Thomas] Univ Wurzburg, Bioctr, Dept Bioinformat, Hubland, D-97074 Wurzburg, Germany.
   [Shityakov, Sergey] Univ Hosp Wurzburg, Dept Anesthesia & Crit Care, Oberdurrbacher Str 6, D-97080 Wurzburg, Germany.
RP Dandekar, T (corresponding author), Univ Wurzburg, Bioctr, Dept Bioinformat, Hubland, D-97074 Wurzburg, Germany.
EM dandekar@biozentrum.uni-wuerzburg.de
RI Dandekar, Thomas/A-4431-2017
OI Dandekar, Thomas/0000-0003-1886-7625
FU BMBFFederal Ministry of Education & Research (BMBF) [FKZ 031L0129B]
FX Funding by BMBF (FKZ 031L0129B), calculation time at Rechenzentrum of
   the University of Wurzburg and stylistic corrections by the native
   speaker, Jennifer Heilig, are gratefully acknowledged.
CR Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Budryn G, 2015, FOOD CHEM, V168, P276, DOI 10.1016/j.foodchem.2014.07.056
   Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290
   Ceron-Carrasco JP, 2016, COMPUT THEOR CHEM, V1077, P65, DOI 10.1016/j.comptc.2015.10.028
   Ceron-Carrasco JP, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2401-7
   Chen YC, 2015, TRENDS PHARMACOL SCI, V36, P78, DOI 10.1016/j.tips.2014.12.001
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Wispelaere M, 2017, ANTIVIR RES, V139, P171, DOI 10.1016/j.antiviral.2016.12.017
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Ekins S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-13
   ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gammon DB, 2008, J VIROL, V82, P12520, DOI 10.1128/JVI.01528-08
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gay CM, 2017, BRIT J CANCER, V116, P415, DOI 10.1038/bjc.2016.428
   Gesteira TF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070880
   Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7
   Gupta SK, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1748-1
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Imbernon B., 2017, INT J HIGH PERFORM C
   Khan MA, 2015, SCAND J IMMUNOL, V82, P25, DOI 10.1111/sji.12302
   Kim SY, 2017, BIOCHEMISTRY-US, V56, P1151, DOI 10.1021/acs.biochem.6b01056
   Kimani SG, 2017, SCI REP-UK, V7, DOI 10.1038/srep43908
   Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Liang C, 2016, PROTEOMES, V4, DOI 10.3390/proteomes4010008
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Mollard A, 2011, ACS MED CHEM LETT, V2, P907, DOI 10.1021/ml200198x
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Myers SH, 2016, J MED CHEM, V59, P3593, DOI 10.1021/acs.jmedchem.5b01273
   Navarro-Fernandez J, 2012, J MED CHEM, V55, P6403, DOI 10.1021/jm300621j
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Oscherwitz J, 2009, INFECT IMMUN, V77, P3380, DOI 10.1128/IAI.00358-09
   Peng C, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002082
   Perez-Sanchez H, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2914-x
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sanchez-Linares I, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S14-S13
   Sasaki T, 2006, EMBO J, V25, P80, DOI 10.1038/sj.emboj.7600912
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Shityakov S, 2017, COMPUT BIOL CHEM, V70, P191, DOI 10.1016/j.compbiolchem.2017.06.004
   Shityakov S, 2012, INT J NANOMED, V7, P3211, DOI 10.2147/IJN.S31373
   Smith JL, 2017, J VIROL, V91, DOI 10.1128/JVI.02388-16
   Son MY, 2014, HUM MOL GENET, V23, P1802, DOI 10.1093/hmg/ddt571
   Sousa SF, 2006, PROTEINS, V65, P15, DOI 10.1002/prot.21082
   Strasfeld L, 2010, INFECT DIS CLIN N AM, V24, P413, DOI 10.1016/j.idc.2010.01.001
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Wang ZY, 2017, J GEN VIROL, V98, P2061, DOI 10.1099/jgv.0.000886
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
NR 72
TC 3
Z9 3
U1 1
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD MAY
PY 2018
VL 3
IS 5
BP 5281
EP 5290
DI 10.1021/acsomega.8b00223
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA GI4QC
UT WOS:000434355300064
PM 30023915
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Durham, DP
   Fitzpatrick, MC
   Ndeffo-Mbah, ML
   Parpia, AS
   Michael, NL
   Galvani, AP
AF Durham, David P.
   Fitzpatrick, Meagan C.
   Ndeffo-Mbah, Martial L.
   Parpia, Alyssa S.
   Michael, Nelson L.
   Galvani, Alison P.
TI Evaluating Vaccination Strategies for Zika Virus in the Americas
SO ANNALS OF INTERNAL MEDICINE
LA English
DT Article
ID CHIKUNGUNYA VIRUS; DENGUE VIRUS; PUERTO-RICO; INFECTION; TRANSMISSION;
   EPIDEMIC; OUTBREAK; BRAZIL; WOMEN; MODEL
AB Background: Mosquito-borne and sexually transmitted Zika virus has become widespread across Central and South America and the Caribbean. Many Zika vaccine candidates are under active development.
   Objective: To quantify the effect of Zika vaccine prioritization of females aged 9 to 49 years, followed by males aged 9 to 49 years, on incidence of prenatal Zika infections.
   Design: A compartmental model of Zika transmission between mosquitoes and humans was developed and calibrated to empirical estimates of country-specific mosquito density. Mosquitoes were stratified into susceptible, exposed, and infected groups; humans were stratified into susceptible, exposed, infected, recovered, and vaccinated groups. Age-specific fertility rates, Zika sexual transmission, and country-specific demographics were incorporated.
   Setting: 34 countries and territories in the Americas with documented Zika outbreaks.
   Target Population: Males and females aged 9 to 49 years.
   Intervention: Age-and sex-targeted immunization using a Zika vaccine with 75% efficacy.
   Measurements: Annual prenatal Zika infections.
   Results: For a base-case vaccine efficacy of 75% and vaccination coverage of 90%, immunizing females aged 9 to 49 years (the World Health Organization target population) would reduce the incidence of prenatal infections by at least 94%, depending on the country-specific Zika attack rate. In regions where an outbreak is not expected for at least 10 years, vaccination of women aged 15 to 29 years is more efficient than that of women aged 30 years or older.
   Limitation: Population-level modeling may not capture all local and neighborhood-level heterogeneity in mosquito abundance or Zika incidence.
   Conclusion: A Zika vaccine of moderate to high efficacy may virtually eliminate prenatal infections through a combination of direct protection and transmission reduction. Efficiency of age-specific targeting of Zika vaccination depends on the timing of future outbreaks.
C1 [Durham, David P.; Fitzpatrick, Meagan C.; Ndeffo-Mbah, Martial L.; Parpia, Alyssa S.; Galvani, Alison P.] Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, 135 Coll St, New Haven, CT 06510 USA.
   [Fitzpatrick, Meagan C.] Univ Maryland, Sch Med, Ctr Vaccine Dev, Baltimore, MD 21201 USA.
   [Michael, Nelson L.] Walter Reed Army Inst Res, US Mil HIV Res Program, 6720A Rockledge Dr, Bethesda, MD 20817 USA.
RP Galvani, AP (corresponding author), Yale Sch Publ Hlth, Ctr Infect Dis Modeling & Anal, 135 Coll St, New Haven, CT 06510 USA.
EM alison.galvani@yale.edu
OI Fitzpatrick, Meagan/0000-0002-5248-2668
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; National Institutes
   of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U01 GM087719, U01
   GM105627]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 AI007524,
   RR19895, RR029676-01]
FX National Institutes of Health.; By grants U01 GM087719 and U01 GM105627
   from the National Institutes of Health (NIH). Dr. Fitzpatrick was also
   supported by grant T32 AI007524 from the NIH. Simulations were run on
   the Yale University Biomedical High Performance Computing Center, which
   is supported by NIH grants RR19895 and RR029676-01.
CR Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Durham DP, 2016, P NATL ACAD SCI USA, V113, P5107, DOI 10.1073/pnas.1515528113
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Gagnon AS, 2002, INT J BIOMETEOROL, V46, P81, DOI 10.1007/s00484-001-0119-6
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Ikejezie J, 2017, MMWR-MORBID MORTAL W, V66, P329, DOI 10.15585/mmwr.mm6612a4
   Juarez F, 2006, INT FAM PLAN PERSPEC, V32, P62, DOI 10.1363/3206206
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   LYON J, 2017, JAMA-J AM MED ASSOC, V318, P689, DOI DOI 10.1001/JAMA.2017.11200
   Pan American Health Organization, ZIK SUSP CONF CAS RE
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Rodriguez DM, DATA REPOSITORY PUBL
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   SAWYER W. A., 1931, JOUR PREV MED, V5, P413
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Vannice KS, 2016, VACCINE, V34, P2934, DOI 10.1016/j.vaccine.2015.12.073
   Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8
   World Health Organization (WHO), WHO UNICEF ZIK VIR Z
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zucker J, 2017, EMERG INFECT DIS, V23, P1047, DOI 10.3201/eid2306.162029
   Zwizwai R, 2016, LANCET INFECT DIS, V16, P157, DOI 10.1016/S1473-3099(16)00023-2
NR 45
TC 6
Z9 6
U1 0
U2 9
PU AMER COLL PHYSICIANS
PI PHILADELPHIA
PA INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN 0003-4819
EI 1539-3704
J9 ANN INTERN MED
JI Ann. Intern. Med.
PD MAY 1
PY 2018
VL 168
IS 9
BP 621
EP +
DI 10.7326/M17-0641
PG 11
WC Medicine, General & Internal
SC General & Internal Medicine
GA GI3BZ
UT WOS:000434247300004
PM 29610863
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Eder, J
   Geijtenbeek, TBH
AF Eder, J.
   Geijtenbeek, T. B. H.
TI Human vaginal and skin dendritic cell subsets control ZIKA virus
   infection
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Meeting Abstract
CT 15th International Symposium on Dendritic Cells (DC)
CY JUN 10-14, 2018
CL Aachen, GERMANY
C1 [Eder, J.; Geijtenbeek, T. B. H.] Acad Med Ctr, Expt Immunol, Amsterdam, Netherlands.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0014-2980
EI 1521-4141
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD MAY
PY 2018
VL 48
SU 1
MA P-230
BP 152
EP 152
PG 1
WC Immunology
SC Immunology
GA GI1CF
UT WOS:000434106700228
DA 2020-07-08
ER

PT J
AU Ming, GL
AF Ming, Guo-li
TI Modeling Human Brain Development and Developmental Diseases Using HiPSCs
SO BIOLOGICAL PSYCHIATRY
LA English
DT Meeting Abstract
CT 73rd Annual Scientific Convention and Meeting of the
   Society-of-Biological-Psychiatry (SOBP)
CY MAY 10-12, 2018
CL New York, NY
SP Soc Biol Psychiat
DE Brain Organoids; Zika Virus; Human Brain Development
C1 [Ming, Guo-li] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD MAY 1
PY 2018
VL 83
IS 9
SU S
MA 93
BP S39
EP S39
DI 10.1016/j.biopsych.2018.02.111
PG 1
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA GG1SD
UT WOS:000432466300094
DA 2020-07-08
ER

PT J
AU Brewster, CD
   Chotiwan, N
   Perera, R
   Quackenbush, SL
   Rovnak, J
AF Brewster, Connie D.
   Chotiwan, Nunya
   Perera, Rushika
   Quackenbush, Sandra L.
   Rovnak, Joel
TI LAMP assays of Zika virus and other infectious agents will inevitably
   see expanded use due to their simplicity, sensitivity, specificity, and
   economy
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Letter
C1 [Brewster, Connie D.; Chotiwan, Nunya; Perera, Rushika; Quackenbush, Sandra L.; Rovnak, Joel] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Chotiwan, Nunya; Perera, Rushika] Colorado State Univ, Coll Vet Med & Biomed Sci, Arthropod Borne Infect Dis Labs, Ft Collins, CO 80523 USA.
RP Rovnak, J (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
EM joel.rovnak@colostate.edu
OI Chotiwan, Nunya/0000-0003-3214-6605
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R21 AI129488]
CR Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 3
TC 1
Z9 1
U1 0
U2 0
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD MAY
PY 2018
VL 6
IS 10
AR 196
DI 10.21037/atm.2018.03.01
PG 2
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA GH3SK
UT WOS:000433322300028
PM 29951518
OA Green Published
DA 2020-07-08
ER

PT J
AU Aguiar, BS
   Lorenz, C
   Virginio, F
   Suesdek, L
   Chiaravalloti-Neto, F
AF Aguiar, Breno S.
   Lorenz, Camila
   Virginio, Flavia
   Suesdek, Lincoln
   Chiaravalloti-Neto, Francisco
TI Potential risks of Zika and chikungunya outbreaks in Brazil: A modeling
   study
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Epidemic; Microcephaly; Maxent; Socio-environmental conditions
ID AEDES-AEGYPTI; VECTOR-BORNE; VIRUS; TRANSMISSION; TEMPERATURE; DENGUE;
   POPULATIONS; INFECTION; PATTERNS; AMERICA
AB Objectives: While Brazil has witnessed an unprecedented Zika (ZIK) epidemic, chikungunya (CHIK) has also recently come into prominence as a threat in the Americas. The aim of this study was to identify the regions with increased probabilities of ZIK and CHIK occurrence, based on environmental and social conditions.
   Methods: A statistical Maxent model was used to assess the potential spatial risk of ZIK and CHIK dissemination; this considered the number of probable autochthonous ZIK and CHIK cases in 2015 and 2016, along with environmental variables and social indicators.
   Results: Land use was the most significant variable that best defined the distribution of ZIK and CHIK. Of the social variables, garbage destination, type of sanitary installation, and pipe-borne water were the most significant. An estimated 65 million people in Brazil live in areas at high risk of ZIK and 75 million people in areas at high risk of CHIK. The southeast and northeast regions of Brazil presented the largest areas of high risk for both ZIK and CHIK.
   Conclusions: Many areas across the Brazilian territory are exposed to ZIK or CHIK infection risks, which are related mainly to land use. The study findings offer valuable information to support time-sensitive public health decision-making at the local and national levels. (C) 2018 Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Aguiar, Breno S.; Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Sao Paulo, Brazil.
   [Lorenz, Camila; Virginio, Flavia; Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, Brazil.
   [Lorenz, Camila; Virginio, Flavia; Suesdek, Lincoln] Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Biol Relacao Patogenohospedeiro, Dept Parasitol, Edificio 2,Av Prof Lineu Prestes 2415, BR-05508900 Sao Paulo, Brazil.
   [Suesdek, Lincoln] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
RP Virginio, F (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Programa Posgrad Biol Relacao Patogenohospedeiro, Dept Parasitol, Edificio 2,Av Prof Lineu Prestes 2415, BR-05508900 Sao Paulo, Brazil.
EM flavia.virginio@butantan.gov.br
RI Neto, Francisco Chiaravalloti/F-8006-2012; Aguiar, Breno/E-8252-2019;
   Suesdek, Lincoln/C-7943-2013; Virginio, Flavia/H-8281-2014; Virginio,
   Flavia/AAN-4999-2020; Lorenz, Camila/C-3635-2019
OI Neto, Francisco Chiaravalloti/0000-0003-2686-8740; Aguiar,
   Breno/0000-0002-6621-228X; Suesdek, Lincoln/0000-0001-6829-738X;
   Virginio, Flavia/0000-0003-1803-114X; Virginio,
   Flavia/0000-0003-1803-114X; Lorenz, Camila/0000-0003-2121-9063
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [23038.005.274/2011-24, 1275/2011]; Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) [2014/27172-9, 2013/05521-9]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq) [311805/2014-0]
FX This work was supported by the Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES) (grant numbers 23038.005.274/2011-24 and
   1275/2011 for FV), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) (grant number 2014/27172-9 for LS and 2013/05521-9 for CL), and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)
   (grant number 311805/2014-0 for LS).
CR Anyamba A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001465
   Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Centers for Disease Control and Prevention (CDC), 2016, CHIK VIR SYMPT DIAGN
   Coelho GE, 2012, REV INST MED TROP SP, V54, pS13, DOI 10.1590/S0036-46652012000700006
   Coffey LL, 2016, VIRUSES, V6, P4628
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Garin AB, 2000, INT J BIOMETEOROL, V44, P148, DOI 10.1007/s004840000051
   Diallo M, 1999, AM J TROP MED HYG, V60, P281, DOI 10.4269/ajtmh.1999.60.281
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gubler DJ, 2001, ENVIRON HEALTH PERSP, V109, P223, DOI 10.2307/3435012
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guzzetta G, 2016, EURO SURVEILL, V21
   Health Surveillance Department of the Ministry of Health (SVS/ MS), 2017, EP B DENG ZIK CHIK
   Higgs S, 2015, VECTOR-BORNE ZOONOT, V15, P231, DOI 10.1089/vbz.2014.1745
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2012, RES GER UN CENS DEM
   IPCC, 2014, CLIMATE CHANGE 2014
   LaBeaud AD, 2017, ZIKA VIRUS INFECT OV
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   MARSHALL RJ, 1991, J ROY STAT SOC A STA, V154, P421, DOI 10.2307/2983152
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Nakhapakorn Kanchana, 2005, Int J Health Geogr, V4, P13
   National Council of Health Municipal Departments (CONASEMS), 2014, LIRAA DAT COLL
   Nsoesie EO, 2016, EUROPEAN COMMUNICABL, V21, P1, DOI DOI 10.2807/1560-7917.ES.2016.21.20.30234
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Phillips SJ, 2004, MAXENT SOFTWARE MODE
   QGIS Development Team, 2016, QGIS GEOGR INF SYST
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rochlin I, 2013, BIOL INVASIONS, V15, P991, DOI 10.1007/s10530-012-0345-3
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Tsuzuki A, 2009, ACTA TROP, V111, P325, DOI 10.1016/j.actatropica.2009.05.010
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
   World Health Organization (WHO), 2017, MED CTR CHIK
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 43
TC 11
Z9 11
U1 0
U2 8
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAY
PY 2018
VL 70
BP 20
EP 29
DI 10.1016/j.ijid.2018.02.007
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA GG4HU
UT WOS:000432658100004
PM 29454041
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Li, C
   Gao, F
   Yu, L
   Wang, RK
   Jiang, YS
   Shi, XL
   Yin, CB
   Tang, XP
   Zhang, FC
   Xu, ZH
   Zhang, LQ
AF Li, Cui
   Gao, Fei
   Yu, Lei
   Wang, Ruoke
   Jiang, Yisheng
   Shi, Xuanling
   Yin, Chibiao
   Tang, Xiaoping
   Zhang, Fuchun
   Xu, Zhiheng
   Zhang, Linqi
TI A Single Injection of Human Neutralizing Antibody Protects against Zika
   Virus Infection and Microcephaly in Developing Mouse Embryos
SO CELL REPORTS
LA English
DT Article
ID DENGUE VIRUS; NEURAL PROGENITORS; CROSS-REACTIVITY; BRAIN ORGANOIDS;
   HIGHLY POTENT; VACCINE; SPECIFICITY
AB Zika virus (ZIKV) is a mosquito-transmitted flavivirus that is generally benign in humans. However, an emergent strain of ZIKV has become widespread, causing severe pre-and post-natal neurological defects. There is now an urgent need for prophylactic and therapeutic agents. To address this, we investigated six human monoclonal antibodies with ZIKV epitope specificity and neutralizing activity in mouse models of ZIKV infection and microcephaly. A single intraperitoneal injection of these antibodies conveyed distinct levels of adult and in utero protection from ZIKV infection, which closely mirrored their respective in vitro neutralizing activities. One antibody, ZK2B10, showed the most potent neutralization activity, completely protected uninfected mice, and markedly reduced tissue pathology in infected mice. Thus, ZK2B10 is a promising candidate for the development of antibody-based interventions and informs the rational design of ZIKV vaccine.
C1 [Li, Cui; Jiang, Yisheng; Xu, Zhiheng] Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.
   [Gao, Fei; Wang, Ruoke; Shi, Xuanling; Zhang, Linqi] Tsinghua Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Comprehens AIDS Res Ctr,Dept Basic Med Sci, Beijing 100084, Peoples R China.
   [Li, Cui; Jiang, Yisheng; Xu, Zhiheng] Univ Chinese Acad Sci, Beijing 100101, Peoples R China.
   [Yu, Lei; Yin, Chibiao; Tang, Xiaoping; Zhang, Fuchun] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Guangdong, Peoples R China.
   [Xu, Zhiheng] Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
RP Xu, ZH (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, CAS Ctr Excellence Brain Sci & Intelligence Techn, State Key Lab Mol Dev Biol, Beijing 100101, Peoples R China.; Zhang, LQ (corresponding author), Tsinghua Univ, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Comprehens AIDS Res Ctr,Dept Basic Med Sci, Beijing 100084, Peoples R China.; Xu, ZH (corresponding author), Univ Chinese Acad Sci, Beijing 100101, Peoples R China.; Xu, ZH (corresponding author), Beijing Inst Brain Disorders, Parkinsons Dis Ctr, Beijing 100101, Peoples R China.
EM zhxu@genetics.ac.cn; zhanglinqi@tsinghua.edu.cn
OI Li, Cui/0000-0001-9777-9628; Xu, Zhiheng/0000-0002-4809-2851
FU National Natural Science FoundationNational Natural Science Foundation
   of China [81530065, 31430037, 81590762]; Grand Challenge China
   [81661128042]; Innovation Program of the Chinese Academy of
   SciencesKnowledge Innovation Program of the Chinese Academy of Sciences
   [QYZDJ-SSWSMC007]; National Science and Technology Major Projects
   [2012ZX10001-006, 2012ZX10001-004, 2012ZX10001-009, 2017ZX10305501-003];
   Beijing Brain Project [Z161100002616004]; Ministry of Science and
   Technology of ChinaMinistry of Science and Technology, China
   [2014CB542500-03]; Special Program of Guangdong Provincial Department of
   Science and Technology [2016A020248001]; Guangzhou Health Care and
   Cooperation Innovation Major grant [20174020229]
FX We are grateful to the ZIKV convalescent patient for donating his blood
   samples and Drs. Jiang Wang, Wenxin Hong, and Lingzhai Zhao for
   providing the patient with treatment and care. We thank Drs. Cheng-Feng
   Qin and Gong Cheng for providing the Zika virus isolate GZ01 and for
   assisting with evaluations of antibody protective activity in AG6 mice.
   Wealso thank Ms. Angela Fan for editing the manuscript. This work was
   supported by National Natural Science Foundation awards 81530065,
   31430037, and 81590762 and partially by Grand Challenge China
   81661128042, the Innovation Program of the Chinese Academy of Sciences
   (QYZDJ-SSWSMC007), the National Science and Technology Major Projects
   (2012ZX10001-006, 2012ZX10001-004, and 2012ZX10001-009), the Beijing
   Brain Project (Z161100002616004), and the Ministry of Science and
   Technology of China (2014CB542500-03). The project was also supported by
   the National Science and Technology Major Projects (2017ZX10305501-003),
   the Special Program of Guangdong Provincial Department of Science and
   Technology (#2016A020248001), and the Guangzhou Health Care and
   Cooperation Innovation Major grant (20174020229).
CR Burton DR, 2016, ANNU REV IMMUNOL, V34, P635, DOI 10.1146/annurev-immunol-041015-055515
   Corti D, 2013, ANNU REV IMMUNOL, V31, P705, DOI 10.1146/annurev-immunol-032712-095916
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Marston HD, 2016, NEW ENGL J MED, V375, P1209, DOI 10.1056/NEJMp1607762
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang FC, 2016, LANCET INFECT DIS, V16, P641, DOI 10.1016/S1473-3099(16)30070-6
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 41
TC 11
Z9 14
U1 1
U2 5
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD MAY 1
PY 2018
VL 23
IS 5
BP 1424
EP 1434
DI 10.1016/j.celrep.2018.04.005
PG 11
WC Cell Biology
SC Cell Biology
GA GG1NT
UT WOS:000432454500015
PM 29719255
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Xia, HJ
   Xie, XP
   Shan, C
   Shi, PY
AF Xia, Hongjie
   Xie, Xuping
   Shan, Chao
   Shi, Pei-Yong
TI Potential Mechanisms for Enhanced Zika Epidemic and Disease
SO ACS INFECTIOUS DISEASES
LA English
DT Editorial Material
ID DENGUE VIRUS; PATHOGENESIS; AMERICA; COMPETENCE; FLAVIVIRUS; INFECTION;
   MOSQUITOS; IMMUNITY; PROTEIN
AB A number of mechanisms have driven the explosive epidemics and severe diseases of Zika virus since 2007. Here, we comment on how herd immunity, heterologous flavivirus preimmunity, and viral mutations could enhance the epidemic potential and disease severity of Zika virus in humans.
C1 [Xia, Hongjie; Xie, Xuping; Shan, Chao; Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Inst Translat Sci, 301 Univ Blvd, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Sealy Ctr Vaccine Dev, 301 Univ Blvd, Galveston, TX 77555 USA.
RP Shan, C; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, 301 Univ Blvd, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, 301 Univ Blvd, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, 301 Univ Blvd, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, 301 Univ Blvd, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Inst Translat Sci, 301 Univ Blvd, Galveston, TX 77555 USA.; Shi, PY (corresponding author), Univ Texas Med Branch, Sealy Ctr Vaccine Dev, 301 Univ Blvd, Galveston, TX 77555 USA.
EM chshan@utmb.edu; peshi@utmb.edu
RI Xie, Xuping/AAD-7406-2019; Xia, Hongjie/M-9241-2019
OI Xia, Hongjie/0000-0002-2520-7038
FU University of Texas STARS Award; CDC grant for the Western Gulf Center
   of Excellence for Vector-Borne Diseases; Pan American Health
   Organization [SCON2016-01353]; Kleberg Foundation Award; UTMB CTSAUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Advancing Translational
   Sciences (NCATS) [UL1TR-001439]; NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [AI127744]
FX P.-Y.S. was supported by University of Texas STARS Award, CDC grant for
   the Western Gulf Center of Excellence for Vector-Borne Diseases, Pan
   American Health Organization grant SCON2016-01353, the Kleberg
   Foundation Award, UTMB CTSA UL1TR-001439, and NIH grant AI127744.
CR Alkan C, 2015, J VIROL, V89, P11773, DOI 10.1128/JVI.01543-15
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FitzSimmons J, 2016, NEW ENGL J MED, V375, P293, DOI 10.1056/NEJMc1606769
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 27
TC 4
Z9 4
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAY
PY 2018
VL 4
IS 5
BP 656
EP 659
DI 10.1021/acsinfecdis.8b00004
PG 7
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA GG1WL
UT WOS:000432478400002
PM 29355007
DA 2020-07-08
ER

PT J
AU Fernandes, JN
   Moise, IK
   Maranto, GL
   Beier, JC
AF Fernandes, Jill N.
   Moise, Imelda K.
   Maranto, Gina L.
   Beier, John C.
TI Revamping Mosquito-borne Disease Control to Tackle Future Threats
SO TRENDS IN PARASITOLOGY
LA English
DT Review
ID AEDES-AEGYPTI; YELLOW-FEVER; ZIKA VIRUS; MALARIA CONTROL; DENGUE;
   MANAGEMENT; CRISPR-CAS9; CHIKUNGUNYA; POPULATION; CHALLENGES
AB The global approach to mosquito-borne diseases (MBDs) is in need of critical re-evaluation. Although there have been dramatic reductions in malaria incidence since 2000, malaria elimination from high-transmission settings remains problematic. At the same time, arbovirus outbreaks have increased in their frequency and impact. The 2015-2016 Zika virus epidemic exposed the dire state of MBD control in many countries, calling for united global action. Despite international resolve to prevent future epidemics, current practices in MBD control are mostly reactive and of limited efficacy. In this Opinion article, we summarize the views of 25 international mosquito experts about the current state of MBD control and highlight the issues that must be addressed in order to tackle emerging threats on the horizon.
C1 [Fernandes, Jill N.] Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, Global Integrated Dis Surveillance Grp, St Lucia, Qld 4072, Australia.
   [Fernandes, Jill N.; Maranto, Gina L.] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33146 USA.
   [Moise, Imelda K.] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33146 USA.
   [Moise, Imelda K.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
RP Fernandes, JN (corresponding author), Univ Queensland, Ctr Anim Sci, Queensland Alliance Agr & Food Innovat, Global Integrated Dis Surveillance Grp, St Lucia, Qld 4072, Australia.; Fernandes, JN (corresponding author), Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33146 USA.
EM j.ulrich@uq.edu.au
RI Moise, Imelda K/AAL-7226-2020; Fernandes, Jill/J-3068-2017
OI Moise, Imelda K/0000-0003-0222-780X; Fernandes, Jill/0000-0001-7704-072X
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI100968]; Centers for
   Disease Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [1U01CK000510-01]
FX We would like to thank the 25 international mosquito-borne disease
   control experts for their contributions of invaluable insights. In
   addition, we thank the Ecological Society of America for hosting our
   expert panel at the International of Congress of Entomology XXV. This
   study was supported by the National Institute of Allergy and Infectious
   Diseases of the National Institutes of Health under Award Number
   R01AI100968. The content is solely the responsibility of the authors,
   and does not necessarily represent the official views of the National
   Institutes of Health. This research was also supported by Centers for
   Disease Control and Prevention (https://www.cdc.gov/) grant
   1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program.
CR Adouchief S, 2016, REV MED VIROL, V26, P221, DOI 10.1002/rmv.1876
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Baird JK, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4454-x
   Becker N, 1997, PARASITOL TODAY, V13, P485, DOI 10.1016/S0169-4758(97)01154-X
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Biswas AK, 2013, IEEE SENS J, V13, P4423, DOI 10.1109/JSEN.2013.2274271
   Bloom BR, 2011, NATURE, V473, P143, DOI 10.1038/473143a
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carvalho DO, 2014, JOVE-J VIS EXP, DOI 10.3791/3579
   Cauchemez S, 2014, EUROSURVEILLANCE, V19, P15, DOI 10.2807/1560-7917.ES2014.19.28.20854
   Dong SZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122353
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flies EJ, 2015, VECTOR-BORNE ZOONOT, V15, P397, DOI 10.1089/vbz.2014.1759
   Frenk J, 2016, AM J PUBLIC HEALTH, V106, P1906, DOI 10.2105/AJPH.2016.303399
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2012, NAT BIOTECHNOL, V30, P828, DOI 10.1038/nbt.2350
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   Hayden MH, 2015, AM J TROP MED HYG, V93, P397, DOI 10.4269/ajtmh.15-0128
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1
   Kiefer S, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0245-5
   Killeen GF, 2002, LANCET INFECT DIS, V2, P618, DOI 10.1016/S1473-3099(02)00397-3
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   Lacroix R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042771
   Monath TP, 2016, LANCET, V387, P1599, DOI 10.1016/S0140-6736(16)30195-7
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Okia M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1269-7
   Pang TK, 2012, NAT MED, V18, P646, DOI 10.1038/nm0512-646
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pombi M., 2015, MALARIA J, V14, P1
   Potamitis I, 2016, APPL ACOUST, V109, P54, DOI 10.1016/j.apacoust.2016.03.005
   Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004
   Ritchie S. A., 2002, Dengue Bulletin, V26, P7
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Slutsker L., 2013, MALARIA J, V12, P1
   SOPER FL, 1967, B WORLD HEALTH ORGAN, V36, P521
   Sylvestre G, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-155
   The malERA Consultative Group on Integration Strategies, 2011, PLOS MED, V8
   Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Wasik D, 2018, ANAL CHEM, V90, P679, DOI 10.1021/acs.analchem.7b03407
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2016, WORLD MAL REP 2016
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Wilson ME, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-014-0457-2
   World Health Organization, 2015, GLOB TECHN STRAT MAL
   World Health Organization, 2011, SPEC PROGR RES TRAIN
   World Health Organization, 2015, WORLD MAL REP 2015
   World Health Organization, 2012, HDB INT VECT MAN
   World Health Organization (WHO), 2008, GLOB MAL CONTR EL RE
   Zaim M, 2000, MED VET ENTOMOL, V14, P1, DOI 10.1046/j.1365-2915.2000.00211.x
NR 55
TC 24
Z9 24
U1 0
U2 22
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1471-4922
EI 1471-5007
J9 TRENDS PARASITOL
JI Trends Parasitol.
PD MAY
PY 2018
VL 34
IS 5
BP 359
EP 368
DI 10.1016/j.pt.2018.01.005
PG 10
WC Parasitology
SC Parasitology
GA GG1NI
UT WOS:000432453300004
PM 29500034
DA 2020-07-08
ER

PT J
AU McFee, RB
   Bush, LM
   Vazquez-Pertejo, MT
AF McFee, Robin B.
   Bush, Larry M.
   Vazquez-Pertejo, Maria T.
TI Selected Epidemics and Emerging Pathogens - Vector Borne Illnesses
SO DM DISEASE-A-MONTH
LA English
DT Article
ID MOUNTAIN-SPOTTED-FEVER; DENGUE VIRUS-INFECTION; HUMAN GRANULOCYTIC
   ANAPLASMOSIS; ENZOOTIC TRANSMISSION CYCLE; POLYMERASE-CHAIN-REACTION;
   ZIKA VIRUS; LYME-DISEASE; UNITED-STATES; BORRELIA-BURGDORFERI; ERYTHEMA
   MIGRANS
C1 [McFee, Robin B.] Lincoln Mem Univ, Debusk Coll Osteopath Med, Harrogate, TN USA.
   [McFee, Robin B.] Lincoln Mem Univ, Debusk Coll Osteopath Med, Dept Emergency Family Med, Harrogate, TN 37752 USA.
   [Bush, Larry M.] Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL 33431 USA.
   [Bush, Larry M.] Univ Miami, Miller Sch Med, Palm Beach Cty, FL USA.
   [Vazquez-Pertejo, Maria T.] BlueHlth LLC, Wellington Reg Med Ctr, Dept Pathol & Lab Med, Palm Beach Cty, FL USA.
RP McFee, RB (corresponding author), Lincoln Mem Univ, Debusk Coll Osteopath Med, Dept Emergency Family Med, Harrogate, TN 37752 USA.; Bush, LM (corresponding author), Comprehens Infect Dis, 10115 Forest Hill,Blvd,Suite 102, Wellington, FL 33414 USA.
EM drrbmcfee@gmail.com; drlarry561@aol.com
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Acharya P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00889
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aguero-Rosenfeld ME, 2008, INFECT DIS CLIN N AM, V22, P301, DOI 10.1016/j.idc.2007.12.005
   Al-Bari MAA, 2017, PHARMACOL RES PERSPE, V5, DOI 10.1002/prp2.293
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Aleanizy FS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2137-3
   Amdekar S, 2017, VIRAL IMMUNOL
   [Anonymous], VIR HEM FEV FACT SHE
   [Anonymous], ROCK MOUNT WOOD TICK
   [Anonymous], TICK BORN ILLN
   [Anonymous], DENG VIR
   [Anonymous], DENG VACC RES
   [Anonymous], INF DIS POT RISK TRA
   [Anonymous], D VAR TICK IM
   [Anonymous], 2001, AGING TRENDS, V1
   [Anonymous], ROCK MOUNT SPOTT FEV
   [Anonymous], 2013, DEV CAND DENG VACC S
   [Anonymous], G BARR SYNDR GBS
   [Anonymous], MOSQ BORN OTH INS BO
   [Anonymous], DENG SERV DENG FACT
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P668, DOI 10.1590/0037-8682-0279-2016
   ARCHIBALD LK, 1995, CLIN INFECT DIS, V20, P1122, DOI 10.1093/clinids/20.5.1122
   Avery RA, 2005, PEDIATR INFECT DIS J, V24, P705, DOI 10.1097/01.inf.0000172903.14077.4c
   Bacon Rendi Murphree, 2008, Morbidity and Mortality Weekly Report, V57, P1
   Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Bakken JS, 2000, CLIN INFECT DIS, V31, P554, DOI 10.1086/313948
   Bakken JS, 2004, INFECT MED, V21, P433
   Bakken JS, 2001, CLIN INFECT DIS, V32, P862, DOI 10.1086/319350
   Bakken JS, 1996, JAMA-J AM MED ASSOC, V275, P199, DOI 10.1001/jama.275.3.199
   Bankoff J, 2007, TOXICO TERRORISM, P383
   BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986
   Barnett ED, 2008, MED CLIN N AM, V92, P1447, DOI 10.1016/j.mcna.2008.07.001
   BEATTY ME, 2009, AM J TROP MED HYG S, V81, P231
   Berende A, 2016, NEW ENGL J MED, V374, P1209, DOI 10.1056/NEJMoa1505425
   Bettadapura J, 2013, INDIAN J MED RES, V138, P762
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biggs HM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6502a1
   Blacksell SD, 2007, CLIN VACCINE IMMUNOL, V14, P1458, DOI 10.1128/CVI.00482-06
   Borg R, 2005, SCAND J INFECT DIS, V37, P449, DOI 10.1080/00365540510027228
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brantley RK, 2001, PEDIATR INFECT DIS J, V20, P231, DOI 10.1097/00006454-200102000-00028
   BROUQUI P, 1992, ANTIMICROB AGENTS CH, V36, P2799, DOI 10.1128/AAC.36.12.2799
   BROWN RN, 1992, SCIENCE, V256, P1439, DOI 10.1126/science.1604318
   BRUYN GAW, 1994, BRIT J RHEUMATOL, V33, P862
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Bullard-Feibelman KM, ANTIVIRAL RES, V137, P134
   BURGDORFER W, 1993, CLIN DERMATOL, V11, P335, DOI 10.1016/0738-081X(93)90087-S
   BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737
   Bustamante ME, 1943, REV I SALUBRIDAD ENF, P189
   California Health Alert Network, VECT BORN ILLN PUBL
   Campagna Delmina de S., 2006, J. Pediatr. (Rio J.), V82, P354, DOI [10.2223/JPED.1522, 10.1590/S0021-75572006000600008]
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canver CC, 2000, ANN THORAC SURG, V70, P283, DOI 10.1016/S0003-4975(00)01452-1
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   Carlos CC, 2005, AM J TROP MED HYG, V73, P435, DOI 10.4269/ajtmh.2005.73.435
   Castelli F, 2017, CLIN MICROBIOL INFEC, V23, P283, DOI 10.1016/j.cmi.2017.03.012
   CDC, 2005, MMWR, V52
   CDC, MICR
   CDC, ROCK MOUNT SPOTT FEV
   CDC, LYM DIS
   CDC, DENG CLIN DIAGN
   CDC, TICKS
   CDC, FACT SHEET VIR HEM F
   CDC Dengue, TOURN TEST
   Centers for Disease Control and Prevenetion (CDC), ZIK MOSQ VECT
   Centers for Disease Control and Prevention, AN
   Centers for Disease Control and Prevention, MOSQ AV
   Centers for Disease Control and Prevention (CDC), 2000, MMWR Morb Mortal Wkly Rep, V49, P885
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P407
   Centers for Disease Control and Prevention (CDC), TICK REM
   Centers for Disease Control and Prevention (CDC), IM LIB TEM ZIK VIR
   Centers for Disease Control and Prevention (CDC), CHIK VIR
   Centers for Disease Control and Prevention (CDC), DOX RICK INF
   Centers for Disease Control and Prevention (CDC), MOSQ CONTR
   Centers for Disease Control and Prevention (CDC), ZIK
   Centers for Disease Control and Protection, 2016, EST RANG AED AEG AED
   Cerar D, 2010, AM J MED, V123, P79, DOI 10.1016/j.amjmed.2009.05.011
   Chaaithanya IK, 2014, INDIAN J MED RES, V140, P142
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan ESL, 2002, ARTHRITIS RES, V4, P266, DOI 10.1186/ar419
   Chaves NJ, 2017, MED J AUSTRALIA, V206, P310, DOI 10.5694/mja16.00826
   Chen LH, 2008, MED CLIN N AM, V92, P1409, DOI 10.1016/j.mcna.2008.07.005
   Cherry CC, 2016, TRAVEL MED INFECT DI, V14, P475, DOI 10.1016/j.tmaid.2016.08.011
   Chow A, 2011, J INFECT DIS, V203, P149, DOI 10.1093/infdis/jiq042
   CIESIELSKI CA, 1989, REV INFECT DIS, V11, pS1435
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   CLARK G, CDC TRAVELERS INFORM
   Clark G, CDC TRAV INF DENG FE
   Cobelens FGJ, 2002, TROP MED INT HEALTH, V7, P331, DOI 10.1046/j.1365-3156.2002.00864.x
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Connally NP, 2009, AM J PREV MED, V37, P201, DOI 10.1016/j.amepre.2009.04.026
   Dalrymple NA, 2012, ADV VIROL, V2012, DOI 10.1155/2012/840654
   DALTON MJ, 1995, AM J TROP MED HYG, V52, P405, DOI 10.4269/ajtmh.1995.52.405
   Dattwyler RJ, 1997, NEW ENGL J MED, V337, P289, DOI 10.1056/NEJM199707313370501
   DAVIS AE, 1982, JAMA-J AM MED ASSOC, V247, P2811, DOI 10.1001/jama.247.20.2811
   de Sousa Adriano Miranda, 2006, Journal of Infection and Chemotherapy, V12, P396, DOI 10.1007/s10156-006-0475-6
   DeBiasi RL, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0450-9
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DEKONING J, 1989, J INFECT DIS, V160, P150, DOI 10.1093/infdis/160.1.150
   Demma LJ, 2005, AM J TROP MED HYG, V73, P400, DOI 10.4269/ajtmh.2005.73.400
   Demma LJ, 2005, NEW ENGL J MED, V353, P587, DOI 10.1056/NEJMoa050043
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diouf K, 2017, OBSTET GYNECOL SURV, V72, P309, DOI 10.1097/OGX.0000000000000433
   Donahue KE, 2012, DRUG THERAPY RHEUMAT, P55
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Drouin EE, 2013, ARTHRITIS RHEUM-US, V65, P186, DOI 10.1002/art.37732
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dumler JS, 2001, INT J SYST EVOL MICR, V51, P2145, DOI 10.1099/00207713-51-6-2145
   Dupont-Rouzeyrol M, 2012, VECTOR-BORNE ZOONOT, V12, P1036, DOI 10.1089/vbz.2011.0937
   Dupuis AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-185
   Durbin AP, 2010, CURR TOP MICROBIOL, V338, P129, DOI 10.1007/978-3-642-02215-9_10
   Eisen L, 2013, J MED ENTOMOL, V50, P467, DOI 10.1603/ME12245
   El Khoury MY, 2013, EMERG INFECT DIS, V19, P1926, DOI 10.3201/eid1912.130903
   Elchos BN, 2003, J AM VET MED ASSOC, V223, P1450, DOI 10.2460/javma.2003.223.1450
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741
   Estrada-Pena A, 1999, EXP APPL ACAROL, V23, P685, DOI 10.1023/A:1006241108739
   Ewald PW, 1996, EMERG INFECT DIS, V2, P245, DOI 10.3201/eid0204.960401
   Fallon BA, 2014, CLIN INFECT DIS, V59, P1705, DOI 10.1093/cid/ciu703
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fauci AS, 2001, CLIN INFECT DIS, V32, P675, DOI 10.1086/319235
   Feder HM, 2007, NEW ENGL J MED, V357, P1422, DOI 10.1056/NEJMra072023
   FEDER HM, 1995, AM J MED, V99, P412, DOI 10.1016/S0002-9343(99)80190-9
   Ferreira-Sarmiento Susana, 2015, Salud, Barranquilla, V31, P631, DOI 10.14482/sun.31.3.7352
   FICHTENBAUM CJ, 1993, AM J MED, V95, P351, DOI 10.1016/0002-9343(93)90302-6
   Fink J, 2006, REV MED VIROL, V16, P263, DOI 10.1002/rmv.507
   FISHBEIN DB, 1994, ANN INTERN MED, V120, P736, DOI 10.7326/0003-4819-120-9-199405010-00003
   FISHBEIN DB, 1995, NEW ENGL J MED, V333, P452, DOI 10.1056/NEJM199508173330711
   Forrester JD, 2014, CLIN INFECT DIS, V59, P996, DOI 10.1093/cid/ciu411
   Freedman DO, 2016, NEW ENGL J MED, V375, P247, DOI 10.1056/NEJMra1508815
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Ganu Mohini A, 2011, J Assoc Physicians India, V59, P83
   Garcia-Rejon JE, 2011, AM J TROP MED HYG, V84, P489, DOI 10.4269/ajtmh.2011.10-0654
   Garcia-Rivera EJ, 2009, P R HEALTH SCI J, V28, P114
   Gardner SL, 2003, ANN NY ACAD SCI, V990, P80, DOI 10.1111/j.1749-6632.2003.tb07341.x
   Gera C, 2010, NEUROL INDIA, V58, P595, DOI 10.4103/0028-3886.68661
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Goddard Jerome, 2002, J Agromedicine, V8, P25, DOI 10.1300/J096v08n02_06
   GOLDBERG NS, 1992, ARCH DERMATOL, V128, P1495, DOI 10.1001/archderm.128.11.1495
   Griffin LA, 2016, MMWR-MORBID MORTAL W, V65, P1032
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gugliotta JL, 2013, NEW ENGL J MED, V368, P240, DOI 10.1056/NEJMoa1209039
   Guha-Sapir D, 2005, EMERG THEMES EPIDEMI, V2, DOI 10.1186/1742-7622-2-1
   Guilarde AO, 2008, J INFECT DIS, V197, P817, DOI 10.1086/528805
   Guzman MG, 2011, DRUG FUTURE, V36, P45, DOI 10.1358/dof.2011.036.01.1583182
   Guzman Maria, 2004, Expert Rev Vaccines, V3, P511, DOI 10.1586/14760584.3.5.511
   Guzman Maria G., 2002, International Journal of Infectious Diseases, V6, P118, DOI 10.1016/S1201-9712(02)90072-X
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Gyawali N, 2016, J VECTOR DIS, V53, P293
   Halperin JJ, 2008, NEUROLOGY, V70, P986, DOI 10.1212/01.WNL.0000291407.40667.69
   Halperin JJ, 2015, INFECT DIS CLIN N AM, V29, P241, DOI 10.1016/j.idc.2015.02.002
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2006, REV PANAM SALUD PUBL, V20, P407, DOI 10.1590/S1020-49892006001100007
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Harkess J R, 1991, Infect Dis Clin North Am, V5, P37
   HATTWICK MAW, 1978, JAMA-J AM MED ASSOC, V240, P1499
   Hayes EB, 2003, NEW ENGL J MED, V348, P2424, DOI 10.1056/NEJMra021397
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   HELMICK CG, 1984, J INFECT DIS, V150, P480, DOI 10.1093/infdis/150.4.480
   Herman-Giddens ME, 2012, CLIN INFECT DIS, V54, P887, DOI 10.1093/cid/cir1009
   Higa Yukiko, 2011, Tropical Medicine and Health, V39, P17, DOI 10.2149/tmh.2011-S04
   HIGASHI N, 1968, Journal of Electron Microscopy, V17, P178
   Hirschler B., 2013, REUTERS
   Ho LJ, 2001, J IMMUNOL, V166, P1499, DOI 10.4049/jimmunol.166.3.1499
   Hoen AG, 2009, P NATL ACAD SCI USA, V106, P15013, DOI 10.1073/pnas.0903810106
   Holman RC, 2001, J INFECT DIS, V184, P1437, DOI 10.1086/324372
   Hon KL, 2013, TRAVEL MED INFECT DI
   Hua C, 2017, CURR RHEUMATOL REP, V19, DOI 10.1007/s11926-017-0694-0
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Huntington MK, 2016, AM FAM PHYSICIAN, V94, P551
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Isada CM, 2003, DENGUE INFECT DIS HD, P109
   Isada CM, 2003, MEASLES INFECT DIS H, P205
   Ismail N, 2017, CLIN LAB MED, V37, P317, DOI 10.1016/j.cll.2017.01.006
   Jackson ST, 2008, W INDIAN MED J, V57, P373
   Jacobs RF, 1997, J PEDIATR-US, V131, P184, DOI 10.1016/S0022-3476(97)70152-5
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Jelinek T, 1997, ARCH INTERN MED, V157, P2367, DOI 10.1001/archinte.157.20.2367
   Jlostad U, 2008, LANCET NEUROL, V7, P690
   John DV, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0191-6
   Jones KL, 2009, ARTHRITIS RHEUM-US, V60, P2174, DOI 10.1002/art.24812
   Kalina P, 2005, NEURORADIOLOGY, V47, P903, DOI 10.1007/s00234-005-1440-2
   Kalish RA, 2001, CLIN INFECT DIS, V33, P780, DOI 10.1086/322669
   Kamel MG, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005715
   Kan L, 1998, PEDIATR NEUROL, V18, P439, DOI 10.1016/S0887-8994(97)00215-4
   KARMA A, 1995, AM J OPHTHALMOL, V119, P127, DOI 10.1016/S0002-9394(14)73864-4
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   KIRKLAND KB, 1995, CLIN INFECT DIS, V20, P1118, DOI 10.1093/clinids/20.5.1118
   Kittigul L, 2007, J CLIN VIROL, V39, P76, DOI 10.1016/j.jcv.2007.04.006
   Klein MB, 1997, ANTIMICROB AGENTS CH, V41, P76, DOI 10.1128/AAC.41.1.76
   Klempner MS, 2001, NEW ENGL J MED, V345, P85, DOI 10.1056/NEJM200107123450202
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Krause PJ, 2008, CLIN INFECT DIS, V46, P370, DOI 10.1086/525852
   Krupp LB, 2003, NEUROLOGY, V60, P1923, DOI 10.1212/01.WNL.0000071227.23769.9E
   Kumar Sudhir, 2005, Neurol India, V53, P250
   Kurosu T, 2007, BIOCHEM BIOPH RES CO, V362, P1051, DOI 10.1016/j.bbrc.2007.08.137
   Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017
   Lagrange C, REUTERS SANOFI START
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lantos PM, 2015, CLIN INFECT DIS, V61, P1374, DOI 10.1093/cid/civ584
   Lantos PM, 2010, CLIN INFECT DIS, V51, P1, DOI 10.1086/654809
   LaRocque RC, 2010, J TRAVEL MED, V17, P387, DOI 10.1111/j.1708-8305.2010.00457.x
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Lederberg J, 1992, EMERGING INFECT MICR
   Li X, 2011, ARTHRITIS RHEUM-US, V63, P2238, DOI 10.1002/art.30384
   Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870
   Lindsey NP, 2015, MMWR-MORBID MORTAL W, V64, P929, DOI 10.15585/mmwr.mm6434a1
   Logar M, 2004, INFECTION, V32, P15, DOI 10.1007/s15010-004-3042-z
   LOGIGIAN EL, 1990, NEW ENGL J MED, V323, P1438, DOI 10.1056/NEJM199011223232102
   Horcada ML, 2015, REUMATOL CLIN, V11, P161, DOI 10.1016/j.reuma.2014.07.005
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Luft BJ, 1996, ANN INTERN MED, V124, P785, DOI 10.7326/0003-4819-124-9-199605010-00002
   Mace KE, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6612a1
   MALANE MS, 1991, ANN INTERN MED, V114, P490, DOI 10.7326/0003-4819-114-6-490
   Malvy D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-200
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Martini G A, 1968, Ger Med Mon, V13, P457
   Masters E, 1998, ARCH DERMATOL, V134, P955, DOI 10.1001/archderm.134.8.955
   Mathew AJ, 2011, INT J CLIN PRACT, V65, P1306, DOI 10.1111/j.1742-1241.2011.02792.x
   MATUSCHKA FR, 1995, LANCET, V346, P1367, DOI 10.1016/S0140-6736(95)92382-9
   Mayxay M, 2011, TROP MED INT HEALTH, V16, P127, DOI 10.1111/j.1365-3156.2010.02641.x
   McBride WJH, 2007, EMERG INFECT DIS, V13, P1742, DOI 10.3201/eid1311.070099
   McFee RB, 2008, DIS MON, V54, P33
   McFee RB, 2017, DIS MONTH, V63, P235
   MCFEE RB, 2006, J HOPKINS ADV STUD M, V6, P431
   McFee RB, 2007, TOXICO TERRORISM
   McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965
   Mead P, 2011, EMERG INFECT DIS, V17, P1710, DOI 10.3201/eid1709.110210
   Mejia CR, 2018, REUMATOL CLIN, V14, P97, DOI 10.1016/j.reuma.2017.01.006
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   Molloy PJ, 2015, ANN INTERN MED, V163, P91, DOI 10.7326/M15-0333
   Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a
   Mullegger RR, 2004, EUR J DERMATOL, V14, P296
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nadelman RB, 1996, AM J MED, V100, P502, DOI 10.1016/S0002-9343(95)99915-9
   NADELMAN RB, 1995, AM J MED, V98, pS15, DOI 10.1016/S0002-9343(99)80040-0
   Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256
   National Institutes of Occupational and Safety Health Institutes, MOSQ VECT
   NCHS-FASTATS, LEAD CAUS DEATH DAT
   Nesenius M, 2013, AM J TROP MED HYG, V88, P397
   Ng LFP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004261
   NOCTON JJ, 1994, NEW ENGL J MED, V330, P229, DOI 10.1056/NEJM199401273300401
   Noisakran S, 2010, ADV VIROL, V2010, DOI 10.1155/2010/164878
   Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5
   O'Reilly M, 2003, ANN NY ACAD SCI, V990, P295, DOI 10.1111/j.1749-6632.2003.tb07379.x
   Obenauer JF, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0078-1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Okeoma CM., 2016, CHIKUNGUNYA VIRUS AD
   Olano JR, 2003, EMERG INFECT DIS, V9, P1579, DOI 10.3201/eid0912.020733
   Oliver JH, 2003, P NATL ACAD SCI USA, V100, P11642, DOI 10.1073/pnas.1434553100
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   PACHNER AR, 1985, NEUROLOGY, V35, P47, DOI 10.1212/WNL.35.1.47
   Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003
   Paddock CD, 2002, AM J TROP MED HYG, V66, P197, DOI 10.4269/ajtmh.2002.66.197
   Padilla C, 2016, J CLIN ANESTH, V35, P136, DOI 10.1016/j.jclinane.2016.07.034
   Padmakumar B, 2009, INDIAN J RHEUMATOL, V4, P94, DOI DOI 10.1016/S0973-3698(10)60189-6
   Pan American Health Organization, CHIK
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Pereira KA, 2017, CLIN RHEUMATOL, DOI [10.1007/s10067-017-3766, DOI 10.1007/S10067-017-3766]
   Perez-Perez J, 2017, BIOMEDICA, V37, DOI [10.7705/biomedica.v37i0.3467, 10.7705/biomedica.v34i2.3467]
   Perlman S, 2013, MBIO, V4, DOI 10.1128/mBio.00002-13
   Peters CJ, 2005, MANDELL DOUGLAS BENN, V2, P3626
   Peters CJ, 1997, ATLAS INFECT DIS, VVIII, DOI DOI 10.1-10.26
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pickering L, 2003, 2003 RED BOOK REPORT, P532
   PICKERING LK, 2003, 2003 RED BOOK REPORT, P266
   Pineda C, 2016, CLIN RHEUMATOL, V35, P2381, DOI 10.1007/s10067-016-3390-y
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Plotkin SA, 2011, CLIN INFECT DIS S3, P5271
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pongsumpun P., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P255
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Pritt BS, 2016, LANCET INFECT DIS, V16, P556, DOI 10.1016/S1473-3099(15)00464-8
   Pritt BS, 2011, NEW ENGL J MED, V365, P422, DOI 10.1056/NEJMoa1010493
   Puccioni-Sohler M, 2006, J INFECT CHEMOTHER
   Puccioni-Sohler M, 2012, NEUROL INT, V4, P65, DOI 10.4081/ni.2012.e15
   Ranjit S, 2011, PEDIATR CRIT CARE ME, V12, P90, DOI 10.1097/PCC.0b013e3181e911a7
   Rauter C, 2005, APPL ENVIRON MICROB, V71, P7203, DOI 10.1128/AEM.71.11.7203-7216.2005
   Ray G, 2013, MMWR-MORBID MORTAL W, V62, P993
   REZNICK JW, 1986, AM J MED, V81, P923, DOI 10.1016/0002-9343(86)90370-0
   Richards SL, 2010, J VECTOR ECOL, V35, P439, DOI 10.1111/j.1948-7134.2010.00105.x
   Rico-Hesse R, 2007, CLIN INFECT DIS, V44, P1462, DOI 10.1086/517587
   Ripoll CM, 1999, AM J TROP MED HYG, V61, P350, DOI 10.4269/ajtmh.1999.61.350
   Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P360, DOI 10.12688/f1000research.8235.1
   Rosa Chamith Thushanga, 2017, BMC Res Notes, V10, P26, DOI 10.1186/s13104-016-2330-x
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rudenko N, 2008, J CLIN MICROBIOL, V46, P3540, DOI 10.1128/JCM.01032-08
   RUDERMAN EM, 1995, J INFECT DIS, V171, P362, DOI 10.1093/infdis/171.2.362
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Samra JA, 2017, J CHILD NEUROL, V32, P712, DOI 10.1177/0883073817701879
   Sanchez E, 2016, JAMA-J AM MED ASSOC, V315, P1767, DOI 10.1001/jama.2016.2884
   Sanders John W, 2017, Trop Dis Travel Med Vaccines, V3, P3, DOI 10.1186/s40794-017-0046-0
   Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017
   SCHOEN RT, 1991, ARTHRITIS RHEUM, V34, P1056, DOI 10.1002/art.1780340817
   Schriefer ME, 2015, CLIN LAB MED, V35, P797, DOI 10.1016/j.cll.2015.08.001
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Seriburi V, 2012, CLIN MICROBIOL INFEC, V18, P1236, DOI 10.1111/j.1469-0691.2011.03749.x
   SEXTON DJ, 1992, CLIN INFECT DIS, V15, P439, DOI 10.1093/clind/15.3.439
   SEXTON DJ, 2006, TROPICAL INFECT DIS, P539
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sharma SK, 2006, CHEST, V130, P261, DOI 10.1016/S0012-3692(15)50981-1
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Simon F, 2015, MED MALADIES INFECT, V45, P243, DOI 10.1016/j.medmal.2015.05.007
   Sirikutt Pugpen, 2014, Journal of the Medical Association of Thailand, V97, pS220
   Sissoko D, 2009, NEGL TROP DIS, V3, pe389, DOI [10.1371/journal.pntd.0000389, DOI 10.1371/JOURNAL.PNTD.0000389]
   Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005
   Smith S., MEASLES OUTBREAK SHO
   Soares CN, 2006, J NEUROL SCI, V249, P19, DOI 10.1016/j.jns.2006.05.068
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Solignat M, 2009, VIROLOGY, V393, P183, DOI 10.1016/j.virol.2009.07.024
   SONNESYN SW, 1995, AM J CARDIOL, V76, P97, DOI 10.1016/S0002-9149(99)80814-5
   Stanaway J.D., 2016, LANCET INFECT DIS
   Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   STEERE AC, 1983, ANN INTERN MED, V99, P76, DOI 10.7326/0003-4819-99-1-76
   Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI 10.1172/JCI21681
   STEERE AC, 1990, J INFECT DIS, V161, P1203, DOI 10.1093/infdis/161.6.1203
   STEERE AC, 1980, ANN INTERN MED, V93, P8, DOI 10.7326/0003-4819-93-1-8
   STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906
   STEERE AC, 1977, ARTHRITIS RHEUM, V20, P7, DOI 10.1002/art.1780200102
   Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207
   STEERE AC, 1994, ARTHRITIS RHEUM-US, V37, P878, DOI 10.1002/art.1780370616
   STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725
   Steere AC, 2001, CLIN INFECT DIS S3, V52, pS259
   Steere AC, 2008, CLIN INFECT DIS, V47, P188, DOI 10.1086/589242
   Steere AC, 2006, ARTHRITIS RHEUM-US, V54, P3079, DOI 10.1002/art.22131
   STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84
   Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06
   Stienlauf S, 2005, J TRAVEL MED, V12, P136, DOI 10.2310/7060.2005.12308
   Strle F, 1996, INFECTION, V24, P64, DOI 10.1007/BF01780661
   Stupica D, 2012, CLIN INFECT DIS, V55, P343, DOI 10.1093/cid/cis402
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Swaminathan S, 2010, EXPERT OPIN THER PAT, V20, P819, DOI 10.1517/13543771003767476
   Swierkot J, 2006, PHARMACOL REP, V58, P473
   Tambyah PA, 2008, NEW ENGL J MED, V359, P1526, DOI 10.1056/NEJMc0708673
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Telford SR, 1997, EMERG INFECT DIS, V3, P165, DOI 10.3201/eid0302.970209
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Thisyakorn Usa, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P504
   Thompson H, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0594-5
   Thorner AR, 1998, CLIN INFECT DIS, V27, P1353, DOI 10.1086/515037
   Thwaites GE, 2017, NEW ENGL J MED, V376, P548, DOI 10.1056/NEJMra1508435
   Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05
   Todd SR, 2015, J PEDIATR-US, V166, P1246, DOI 10.1016/j.jpeds.2015.02.015
   Tomashek KM, 2012, DENGUE FEVER DENGUE
   Treadwell TA, 2000, AM J TROP MED HYG, V63, P21, DOI 10.4269/ajtmh.2000.63.21
   Van Herck K, 2004, J TRAVEL MED, V11, P3, DOI 10.2310/7060.2004.13609
   Van Kleef E., GEOGRAPHIC DISTRIBUT
   VANDERLINDE MR, 1991, SCAND J INFECT DIS, P81
   Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018
   Vazquez-Prokopec G, 2013, TRACKING SPREAD DENG
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818
   Volovitz B, 2007, CLIN PEDIATR, V46, P121, DOI 10.1177/0009922806290026
   Vora Neil, 2008, Medscape J Med, V10, P238
   WALKER DH, 1995, CLIN INFECT DIS, V20, P1111, DOI 10.1093/clinids/20.5.1111
   WALKER DH, 1983, ARCH PATHOL LAB MED, V107, P121
   Walker DH, 1999, ANTIMICROBIAL, P562
   WALKER DH, 2005, MANDELL DOUGLAS BENN, P2287
   Wearing HJ, 2006, P NATL ACAD SCI USA, V103, P11802, DOI 10.1073/pnas.0602960103
   Wharton M, 1990, MMWR Recomm Rep, V39, P1
   WHO, 2009, WHO TECH REP SER, V958, P1
   Wilder-Smith A, 2005, NEW ENGL J MED, V353, P924, DOI 10.1056/NEJMra041927
   Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173
   World Health Organization, GUID CLIN MAN CHIK F
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   World Health Organization, 2016, VECT BORN DIS
   World Health Organization, 2008, GUD CLIN MAN CHIK FE
   World Health Organization (WHO), 2016, ADV GROUP EXP DENG V
   World Health Organization (WHO), VECT BORN DIS
   World Health Organization (WHO), DENG PREV CONTR STRA
   World Health Organization (WHO), DENG VACC POS PAP 20
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
   World Tourism Organization, 2011, UNWTO TOUR HIGHL 201
   Wormser GP, 2008, J INFECT DIS, V198, P1358, DOI 10.1086/592279
   Wormser GP, 2006, CLIN INFECT DIS, V43, P1089, DOI 10.1086/508667
   Wormser GP, 2014, MED MICROBIOL IMMUN, V203, P65, DOI 10.1007/s00430-013-0315-0
   Wormser GP, 2013, J CLIN MICROBIOL, V51, P954, DOI 10.1128/JCM.02929-12
   Wormser GP, 2013, DIAGN MICR INFEC DIS, V75, P9, DOI 10.1016/j.diagmicrobio.2012.09.003
   Wormser GP, 2005, ANN INTERN MED, V142, P751, DOI 10.7326/0003-4819-142-9-200505030-00011
   Wormser GP, 2005, CLIN INFECT DIS, V41, P958, DOI 10.1086/432935
   Wormser GP, 2001, NEW ENGL J MED, V345, P79
   Yacoub S, 2015, LANCET, V385, P102, DOI 10.1016/S0140-6736(15)60417-2
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yamamoto Yuuji, 2002, Journal of Infection and Chemotherapy, V8, P175, DOI 10.1007/s101560200030
   Yu XF, 2014, J VIROL, V88, P3423, DOI 10.1128/JVI.02059-13
NR 404
TC 9
Z9 10
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0011-5029
EI 1557-8194
J9 DM-DIS MON
JI DM-Dis.-a-Mon.
PD MAY
PY 2018
VL 64
IS 5
BP 163
EP 275
PG 113
WC Medicine, General & Internal
SC General & Internal Medicine
GA GF4KP
UT WOS:000431932000002
PM 29525372
OA Green Published
DA 2020-07-08
ER

PT J
AU Hageman, JR
AF Hageman, Joseph R.
TI Is It Okay to Travel?
SO PEDIATRIC ANNALS
LA English
DT Editorial Material
ID ZIKA VIRUS
C1 [Hageman, Joseph R.] Comer Childrens Hosp, Sect Neonatol, Qual Improvement, Chicago, IL 60637 USA.
   [Hageman, Joseph R.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA.
   [Hageman, Joseph R.] NorthShore Univ HealthSyst, Evanston, IL 60201 USA.
RP Hageman, JR (corresponding author), Comer Childrens Hosp, Sect Neonatol, Qual Improvement, Chicago, IL 60637 USA.; Hageman, JR (corresponding author), Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA.; Hageman, JR (corresponding author), NorthShore Univ HealthSyst, Evanston, IL 60201 USA.
EM pedann@Healio.com
RI Hageman, Joseph R/O-4324-2019
OI Hageman, Joseph R/0000-0002-3181-8046
CR Heald-Sargent T, 2017, PEDIATR ANN, V46, pE428, DOI 10.3928/19382359-20171025-01
   MacDonald PDM, 2018, PEDIATRICS, V141, pS137, DOI 10.1542/peds.2017-2038B
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
NR 3
TC 0
Z9 0
U1 0
U2 1
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0090-4481
EI 1938-2359
J9 PEDIATR ANN
JI Pediatr. Ann.
PD MAY
PY 2018
VL 47
IS 5
BP E179
EP E179
DI 10.3928/19382359-20180425-01
PG 1
WC Pediatrics
SC Pediatrics
GA GF8HM
UT WOS:000432210600001
PM 29750282
DA 2020-07-08
ER

PT J
AU Hall, RA
   Hobson-Peters, J
AF Hall, Roy A.
   Hobson-Peters, Jody
TI Newly discovered mosquito viruses help control vector-borne viral
   diseases
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID WEST NILE VIRUS; INSECT-SPECIFIC FLAVIVIRUS; TRANSMISSION; AUSTRALIA;
   COINFECTION
AB Many well-known mosquito-borne viruses such as dengue, Zika, West Nile, chikungunya and Ross River viruses can be transmitted to vertebratesandare associated withdisease in man or animals. However, the use of deep sequencing and other open-minded approaches to detect viruses in mosquitoes have uncovered many new RNA viruses, most of which do not infect vertebrates. The discovery of these 'insect-specific' viruses (ISVs) has redefined the mosquito virome and prompted the lines of viral taxonomic classification to be redrawn(1,2). Despite their benign phenotype, ISVs have become a hot topic of research, with recent studies indicating they have significant application for biotechnology.
C1 [Hall, Roy A.; Hobson-Peters, Jody] Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
RP Hall, RA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Australian Infect Dis Res Ctr, St Lucia, Qld 4072, Australia.
EM roy.hall@uq.edu.au; j.peters2@uq.edu.au
CR Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Colmant AMG, 2017, ARCH VIROL, V162, P3529, DOI 10.1007/s00705-017-3515-x
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Colmant AMG, 2016, J GEN VIROL, V97, P1087, DOI 10.1099/jgv.0.000430
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Harrison JJ, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050141
   Hobson-Peters J, 2016, VIROLOGY, V489, P269, DOI 10.1016/j.virol.2015.11.003
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   McLean BJ, 2015, VIROLOGY, V486, P272, DOI 10.1016/j.virol.2015.07.021
   O'Brien CA, 2017, EVOL BIOINFORM, V13, DOI 10.1177/1176934317691269
   O'Brien CA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003629
   Piyasena TBH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03120-1
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Warrilow D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091103
NR 18
TC 1
Z9 1
U1 0
U2 2
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2018
VL 39
IS 2
BP 72
EP 75
DI 10.1071/MA18020
PG 4
WC Microbiology
SC Microbiology
GA GF7XJ
UT WOS:000432181400004
DA 2020-07-08
ER

PT J
AU Mackenzie, JS
   van den Hurk, AF
AF Mackenzie, John S.
   van den Hurk, Andrew F.
TI The risks to Australia from emerging and exotic arboviruses
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID WEST-NILE VIRUS; JAPANESE ENCEPHALITIS-VIRUS; YELLOW-FEVER VIRUS; VECTOR
   COMPETENCE; ZIKA VIRUS; CHIKUNGUNYA VIRUS; SPREAD; MOSQUITOS; DENGUE;
   FLAVIVIRUSES
AB The recent pandemic spread of mosquito-borne arboviruses across multiple continents, as exemplified by West Nile (WNV)(1), chikungunya (CHIKV)(2), and Zika (ZIKV)(3) viruses, together with the continuing disease burden of epidemic dengue viruses (DENVs)(1), multiple importations of yellow fever virus (YFV) into populous areas of Asia(4), and the potential threat of some other, possibly unknown, emerging arboviral threat, constitute a wake-up call for governments to strengthen surveillance programmes and enhance research into mosquito-transmitted diseases(5-7). Rift Valley fever(8) (RVFV) and Japanese encephalitis(1,9) (JEV) viruses are also important examples of threats to human and/or livestock health. Australia is vulnerable to these arboviral diseases, with risk of importation and outbreak potential varying between viruses(10). The risk of exotic arboviral diseases establishing transmission cycles in Australia is dependent on the availability of competent vectors and suitable vertebrate hosts. Therefore, knowledge of the vector competence of Australian mosquito species for exotic arboviruses, potential for the introduction and establishment of exotic vector species, and suitability of vertebrate hosts, are essential components of understanding and mitigating these arboviral threats.
C1 [Mackenzie, John S.] Curtin Univ, Fac Med Sci, Perth, WA, Australia.
   [Mackenzie, John S.] PathWest, Perth, WA, Australia.
   [Mackenzie, John S.] 5E,16 Kings Pk Ave, Crawley, WA 6009, Australia.
   [van den Hurk, Andrew F.] Queensland Govt, Dept Hlth, Forens & Sci Serv, Publ Hlth Virol, 39 Kessels Rd, Coopers Plains, Qld 4108, Australia.
RP Mackenzie, JS (corresponding author), Curtin Univ, Fac Med Sci, Perth, WA, Australia.; Mackenzie, JS (corresponding author), PathWest, Perth, WA, Australia.; Mackenzie, JS (corresponding author), 5E,16 Kings Pk Ave, Crawley, WA 6009, Australia.
EM J.Mackenzie@curtin.edu.au; andrew.vandenhurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019; /S-4986-2019
OI van den Hurk, Andrew/0000-0001-6262-831X; /0000-0002-5918-2190
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Chen ZH, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.89
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Hall RA, 2002, CURR TOP MICROBIOL, V267, P253
   Hall RA, 2016, ARBOVIRUSES: MOLECULAR BIOLOGY, EVOLUTION AND CONTROL, P135
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hernandez-Jover M, 2013, PREV VET MED, V109, P186, DOI 10.1016/j.prevetmed.2012.09.018
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Jansen CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134975
   Jansen CC, 2008, VECTOR-BORNE ZOONOT, V8, P805, DOI 10.1089/vbz.2008.0037
   Kiely P, 2017, MED J AUSTRALIA, V206, P455, DOI 10.5694/mja16.00833
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Mackenzie JS, 2003, MED J AUSTRALIA, V178, P5, DOI 10.5694/j.1326-5377.2003.tb05029.x
   Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P49
   Mackenzie JS, 1994, RECENT ADV MICROBIOL, V2, P1
   Muzari MO, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005286
   Nicholson J, 2014, J MED ENTOMOL, V51, P661, DOI 10.1603/ME13204
   Pepin M, 2010, VET RES, V41, DOI 10.1051/vetres/2010033
   Russell RC, 2009, MED J AUSTRALIA, V190, P265, DOI 10.5694/j.1326-5377.2009.tb02393.x
   Turell MJ, 1998, J MED ENTOMOL, V35, P132, DOI 10.1093/jmedent/35.2.132
   Van Den Hurk AF, 2010, ANN TROP MED PARASIT, V104, P623, DOI 10.1179/136485910X12851868779984
   van den Hurk AF, 2016, NEGLECT TROP DIS, P193, DOI 10.1007/978-3-319-43148-2_8
   van den Hurk AF, 2011, AM J TROP MED HYG, V85, P446, DOI 10.4269/ajtmh.2011.11-0061
   van den Hurk AF, 2010, VECTOR-BORNE ZOONOT, V10, P489, DOI 10.1089/vbz.2009.0106
   van den Hurk AF, 2009, ANNU REV ENTOMOL, V54, P17, DOI 10.1146/annurev.ento.54.110807.090510
   Viennet E, 2013, COMMUN DIS INTELL, V37, pE136
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Zhang W, 2017, J GEN VIROL, V98, P2413, DOI 10.1099/jgv.0.000908
NR 34
TC 0
Z9 0
U1 0
U2 8
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2018
VL 39
IS 2
BP 84
EP 87
DI 10.1071/MA18023
PG 4
WC Microbiology
SC Microbiology
GA GF7XJ
UT WOS:000432181400007
DA 2020-07-08
ER

PT J
AU Sam, JIC
AF Sam, Jamal I-Ching
TI The Asia-Pacific origins of the current outbreaks of Zika virus
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID TRANSMISSION; CHIKUNGUNYA; COMPETENCE; DENGUE
AB Zika virus (ZIKV) is a mosquito- borne arbovirus from the Flaviviridae family, first isolated in 1947 from a monkey in Uganda. In the ensuing decades up to the 2000s, there have been sporadic reports of infections and seropositivity in humans in Africa and Asia(1,2). The first isolation of ZIKV outside Africa was from Aedes aegypti mosquitoes in Malaysia in 1966(3). Seropositivity has also been reported in wild monkeys in Malaysia(3), although the relevance of this in sylvatic transmission of ZIKV is unknown. These studies suggest that there was endemic and mostly undetected transmission in Asia during this period. Re-emergence from Asia has now brought this relatively neglected virus into the focus of global attention.
C1 [Sam, Jamal I-Ching] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.
RP Sam, JIC (corresponding author), Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur 50603, Malaysia.
EM jicsam@ummc.edu.my
RI Sam, Jamal I-Ching/B-8688-2010
OI Sam, Jamal I-Ching/0000-0002-1296-7898
FU Malaysia One Health University Network; Ministry of Education
   [FP016-2017A]
FX The author has received funding for ZIKV research from the Malaysia One
   Health University Network and the Ministry of Education (Fundamental
   Research Grant no. FP016-2017A).
CR Australian Government Department of Health, 2018, SUMM INF OV ACQ VECT
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ledermann JP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003188
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Viennet Elvina, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.73d82b08998c6d729c41ef6cdcc80176
   Wang BH, 2018, J INFECTION, V76, P106, DOI 10.1016/j.jinf.2017.09.002
NR 20
TC 0
Z9 0
U1 1
U2 7
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2018
VL 39
IS 2
BP 91
EP 92
DI 10.1071/MA18026
PG 2
WC Microbiology
SC Microbiology
GA GF7XJ
UT WOS:000432181400009
DA 2020-07-08
ER

PT J
AU Rawlinson, W
AF Rawlinson, William
TI Arboviruses in pregnancy: consequences of maternal and fetal infection
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID ROSS RIVER VIRUS; ZIKA VIRUS; INFANTS; TRANSMISSION; DISEASE; FEVER
AB Epidemics and localised outbreaks of infections due to arthropod borne (arbo) viruses, have been described for hundreds of years. Few viruses to date are known to transmit from mother to fetus, causing either teratogenic effects or fetal demise (see recent reviews Charlier et al.(1) and Marinho et al.(2)). Many arboviruses are zoonotic but there appear to be few parallels between the effect of these viruses following human or animal infection during pregnancy. Higher rates of MTCT (mother to child transmission) may be seen (1) where herd immunity is reduced, either because virus is newly introduced into a population (as occurred in Brazil with ZIKV), or where the virus has only recently become endemic (as occurred with West Nile virus (WNV) in the USA in the 1990s), (2) where the arthropod vector is present, (3) where the vector transmits virus efficiently, and (4) in groups of pregnant women exposed, allowing transmission(3).
C1 [Rawlinson, William] Prince Wales Hosp, Dept Microbiol NSW Hlth Pathol, Serol & Virol Div, Sydney, NSW, Australia.
   [Rawlinson, William] Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.
   [Rawlinson, William] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia.
   [Rawlinson, William] Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
RP Rawlinson, W (corresponding author), Prince Wales Hosp, Dept Microbiol NSW Hlth Pathol, Serol & Virol Div, Sydney, NSW, Australia.; Rawlinson, W (corresponding author), Univ New South Wales, Sch Womens & Childrens Hlth, Sydney, NSW, Australia.; Rawlinson, W (corresponding author), Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia.; Rawlinson, W (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.
EM w.rawlinson@unsw.edu.au
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P198, DOI 10.4269/ajtmh.1981.30.198
   AASKOV JG, 1981, MED J AUSTRALIA, V2, P20, DOI 10.5694/j.1326-5377.1981.tb132048.x
   ALECK KA, 1983, AM J TROP MED HYG, V32, P618, DOI 10.4269/ajtmh.1983.32.618
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Maidji E, 2010, AM J PATHOL, V177, P1298, DOI 10.2353/ajpath.2010.091210
   Marinho Penelope Saldanha, 2017, Matern Health Neonatol Perinatol, V3, P17, DOI 10.1186/s40748-017-0054-0
   McGready R, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000888
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Rawlinson W, 2016, MICROBIOL AUST, V37, P170, DOI 10.1071/MA16057
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Scott GM, 2012, J INFECT DIS, V205, P1305, DOI 10.1093/infdis/jis186
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Tsai TF, 2006, PEDIATRICS, V117, P936, DOI 10.1542/peds.2005-2729
   Van Zuylen WJ, 2016, J VIROL, V90, P1108, DOI 10.1128/JVI.02588-15
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WENGER F, 1977, TERATOLOGY, V16, P359, DOI 10.1002/tera.1420160317
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 28
TC 0
Z9 0
U1 1
U2 2
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2018
VL 39
IS 2
BP 96
EP 98
DI 10.1071/MA18028
PG 3
WC Microbiology
SC Microbiology
GA GF7XJ
UT WOS:000432181400011
DA 2020-07-08
ER

PT J
AU Gibbs, T
   Speers, DJ
AF Gibbs, Tristan
   Speers, David J.
TI Neurological disease caused by flavivirus infections
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
ID MURRAY VALLEY ENCEPHALITIS; WEST-NILE-VIRUS; ZIKA VIRUS; AUSTRALIA;
   COMPLICATIONS
AB The Flavivirus genus contains dozens of species with varying geographical distributions. Most flavivirus infections in humans are asymptomatic or manifest as a non-specific febrile illness, sometimes accompanied by rash or arthralgia. Certain species are more commonly associated with neurological disease and may be termed neurotropic flaviviruses. Several flaviviruses endemic to Australia and our near northern neighbours are neurotropic, such as Murray Valley encephalitis virus, West Nile (Kunjin) virus and Japanese encephalitis virus. Flavivirus neurological disease ranges from self-limiting meningitis to fulminant encephalitis causing permanent debilitating neurological sequelae or death. The recent Zika virus outbreak in South America has highlighted the dramatic effects of flavivirus neurotropism on the developing brain. This article focuses on the neurotropic flaviviruses endemic to Australia and those of international significance.
C1 [Gibbs, Tristan; Speers, David J.] Queen Elizabeth II QEII Med Ctr, Dept Microbiol, PathWest Lab Med WA LMWA, Hosp Ave, Nedlands, WA 6009, Australia.
   [Gibbs, Tristan; Speers, David J.] Univ Western Australia, Fac Hlth & Med Sci, Sch Med, 35 Stirling Highway, Crawley, WA 6009, Australia.
RP Gibbs, T (corresponding author), Queen Elizabeth II QEII Med Ctr, Dept Microbiol, PathWest Lab Med WA LMWA, Hosp Ave, Nedlands, WA 6009, Australia.; Gibbs, T (corresponding author), Univ Western Australia, Fac Hlth & Med Sci, Sch Med, 35 Stirling Highway, Crawley, WA 6009, Australia.
EM tristan.gibbs@health.wa.gov.au
CR Australian Government Department of Health, 2018, AUSTR NAT NOT DIS CA
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Centers for Disease Control and Prevention, 2018, W NIL VIR STAT
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hills S. L., 2015, CONTROL COMMUNICABLE, P36
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Knox J, 2012, MED J AUSTRALIA, V196, P322, DOI 10.5694/mja11.11026
   Krow-Lucal E, 2017, MMWR-MORBID MORTAL W, V66, P51, DOI 10.15585/mmwr.mm6602a3
   Mackenzie J., 2008, CONTROL COMMUNICABLE, P42
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2003, JAMA-J AM MED ASSOC, V290, P524, DOI 10.1001/jama.290.4.524
   Prow NA, 2013, INT J ENV RES PUB HE, V10, P6255, DOI 10.3390/ijerph10126255
   Selvey LA, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0672-3
   Selvey LA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002656
   Smith DW, 2011, TRAVEL MED INFECT DI, V9, P113, DOI 10.1016/j.tmaid.2010.05.005
   Speers DJ, 2013, AM J TROP MED HYG, V88, P481, DOI 10.4269/ajtmh.12-0379
   Williamson PC, 2017, EPIDEMIOL INFECT, V145, P2536, DOI 10.1017/S0950268816000042
NR 22
TC 0
Z9 0
U1 1
U2 2
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2018
VL 39
IS 2
BP 99
EP 102
DI 10.1071/MA18029
PG 4
WC Microbiology
SC Microbiology
GA GF7XJ
UT WOS:000432181400012
DA 2020-07-08
ER

PT J
AU Sly, A
   Mack, C
AF Sly, Angus
   Mack, Callum
TI Protecting Australia from disease vectors: exotic mosquito management at
   the border
SO MICROBIOLOGY AUSTRALIA
LA English
DT Article
AB Mosquitoes, through the diseases they transmit, are considered the deadliest animals in the world(1). While Australia is relatively free of many of the mosquito species capable of transmitting diseases such as dengue, yellow fever, chikungunya, and Zika virus, Australia is not immune to the risk of these arboviruses becoming endemic through the introduction of exotic mosquito vectors. In 150 separate instances there were 525 individual exotic mosquitoes detected at the Australian border between 2014 and 2017 (Department of Agriculture and Water Resources, unpublished data). Accordingly, there is a strong focus on surveillance and control activities to prevent exotic mosquito incursions and possible local establishment.
C1 [Sly, Angus] Dept Agr & Water Resources, Pathway Surveillance & Operat Sci Compliance Div, GPO Box 858, Canberra, ACT 2601, Australia.
   [Mack, Callum] Australian Govt Dept Hlth, Off Hlth Protect, GPO Box 9848, Canberra, ACT 2601, Australia.
RP Sly, A (corresponding author), Dept Agr & Water Resources, Pathway Surveillance & Operat Sci Compliance Div, GPO Box 858, Canberra, ACT 2601, Australia.
EM Angus.Sly@agriculture.gov.au; Callum.Mack@health.gov.au
CR [Anonymous], 2016, INT HLTH REG
   Australian Government Department of Health, 2017, RESP GUID EX MOSQ DE
   Australian Government Department of Health, 2018, NAT NOT DIS SURV SYS
   Queensland Health, 2015, QUEENSL DENG MAN PLA
   Rasic G, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-275
   World Health Organization (WHO), 2018, MOSQ BORN DIS
NR 6
TC 0
Z9 0
U1 0
U2 12
PU CSIRO PUBLISHING
PI CLAYTON
PA UNIPARK, BLDG 1, LEVEL 1, 195 WELLINGTON RD, LOCKED BAG 10, CLAYTON, VIC
   3168, AUSTRALIA
SN 1324-4272
EI 2201-9189
J9 MICROBIOL AUST
JI Microbiol. Aust.
PD MAY
PY 2018
VL 39
IS 2
BP 108
EP 110
DI 10.1071/MA18032
PG 3
WC Microbiology
SC Microbiology
GA GF7XJ
UT WOS:000432181400015
DA 2020-07-08
ER

PT J
AU Vijaykumar, S
   Nowak, G
   Himelboim, I
   Jin, Y
AF Vijaykumar, Santosh
   Nowak, Glen
   Himelboim, Itai
   Jin, Yan
TI Virtual Zika transmission after the first US case: who said what and how
   it spread on Twitter
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE Zika; Twitter; risk communication; social media; influence
ID SOCIAL MEDIA; EBOLA; NEWS; MISINFORMATION; CONSEQUENCES; SURVEILLANCE;
   BEHAVIOR; VOTERS; TWEETS
AB Background: This paper goes beyond detecting specific themes within Zika-related chatter on Twitter, to identify the key actors who influence the diffusive process through which some themes become more amplified than others.
   Methods: We collected all Zika-related tweets during the 3 months immediately after the first U.S. case of Zika. After the tweets were categorized into 12 themes, a cross-section were grouped into weekly datasets. to capture 12 amplifier/user groups, and analyzed by 4 amplification modes: mentions, retweets, talkers. and Twitter-wide amplifiers.
   Results: We analyzed 3.057,130 tweets in the United States and categorized 4997 users. The most talked about theme was Zika transmission (similar to 58%). News media, public health institutions, and grassroots users were the most visible and frequent sources and disseminators of Zika-related Twitter content. Grassroots users were the primary sources and disseminators of conspiracy theories.
   Conclusions: Social media analytics enable public health institutions to quickly learn what information is being disseminated, and by whom, regarding infectious diseases. Such information can help public health institutions identify and engage with news media and other active information providers. It also provides insights into media and public concerns, accuracy of information on Twitter, and information gaps. The study identifies implications for pandemic preparedness and response in the digital era and presents the agenda for future research and practice. (C) 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Vijaykumar, Santosh] Northumbria Univ, Dept Psychol, Room 142,Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
   [Nowak, Glen; Himelboim, Itai; Jin, Yan] Univ Georgia, Grady Coll Journalism & Mass Commun, Athens, GA 30602 USA.
RP Vijaykumar, S (corresponding author), Northumbria Univ, Dept Psychol, Room 142,Northumberland Bldg, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England.
EM santosh.vijaykumar@northumbria.ac.uk
OI , Itai/0000-0001-7981-5613; Nowak, Glen/0000-0002-9153-2189
CR ALLCOTT H, 2017, J ECON PERSPECT, V31, P211, DOI [DOI 10.1257/jep.31.2.211, DOI 10.1257/JEP.31.2.211]
   [Anonymous], NUMB MONTHL ACT TWIT
   Aramaki E., 2011, P C EMP METH NAT LAN
   Bakshy E., 2011, P 4 ACM INT C WEB SE
   Bernardo TM, 2013, J MED INTERNET RES, V15, P239, DOI 10.2196/jmir.2740
   Bode L, 2015, J COMMUN, V65, P619, DOI 10.1111/jcom.12166
   Borge-Holthoefer J, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026116
   Brownstein JS, 2009, NEW ENGL J MED, V360, P2153, DOI 10.1056/NEJMp0904012
   Cha M., 2010, ICWSM, V10, P30, DOI DOI 10.1016/J.IPM.2016.04.003
   Chew C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014118
   Chou WYS, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1249
   Chung JE, 2016, J HEALTH COMMUN, V21, P517, DOI 10.1080/10810730.2015.1103332
   Fowler A, 2014, ELECT STUD, V34, P100, DOI 10.1016/j.electstud.2013.09.009
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Guidry JPD, 2017, PUBLIC RELAT REV, V43, P477, DOI 10.1016/j.pubrev.2017.04.009
   Househ M, 2016, HEALTH INFORM J, V22, P470, DOI 10.1177/1460458214568037
   KEIM ME, 2010, AM J DISASTER MED, V6, P47, DOI DOI 10.5055/AJDM.2010.0000
   Khatua A, 2016, P IEEE 18 INT C E HL
   Korda H, 2013, HEALTH PROMOT PRACT, V14, P15, DOI 10.1177/1524839911405850
   Kwak H., 2010, P 19 INT C WORLD WID
   McAllister-Spooner SM, 2009, PUBLIC RELAT REV, V35, P320, DOI 10.1016/j.pubrev.2009.03.008
   Merchant RM, 2011, NEW ENGL J MED, V365, P289, DOI 10.1056/NEJMp1103591
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Oyeyemi SO, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6178
   Paul M.J., 2011, ICWSM, V2011, P265
   Petrovic S., 2011, P 5 INT AAAI C WEBL
   Pidgeon N., 2003, SOCIAL AMPLIFICATION
   Reedy J, 2014, SOC SCI QUART, V95, P1399, DOI 10.1111/ssqu.12102
   Rosado L., FACEBOOK CONTINUES D
   Signorini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019467
   Sommerfeldt EJ, 2012, PUBLIC RELAT REV, V38, P303, DOI 10.1016/j.pubrev.2012.01.001
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Tafuri S, 2014, VACCINE, V32, P4860, DOI 10.1016/j.vaccine.2013.11.006
   Thackeray R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-242
   van Lent LGG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7219
   Vijaykumar S, 2017, J AM MED INFORM ASSN, V24, P1155, DOI 10.1093/jamia/ocx028
   Vijaykumar S, 2015, J HOMEL SECUR EMERG, V12, P653, DOI 10.1515/jhsem-2014-0072
   Wagner L., ZIKA PROOF HOPE SOLO
   Weeks BE, 2015, J COMMUN, V65, P699, DOI 10.1111/jcom.12164
   Wong R, 2017, J PUBLIC HEALTH MAN, V23, pE16, DOI 10.1097/PHH.0000000000000342
   World Health Organization, 2016, ZIK STRAT RESP FRAM
   Yoon S, 2012, NI 2012
   Yoon S, 2013, AM J PREV MED, V45, P122, DOI 10.1016/j.amepre.2013.02.025
NR 46
TC 9
Z9 9
U1 20
U2 32
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD MAY
PY 2018
VL 46
IS 5
BP 549
EP 557
DI 10.1016/j.ajic.2017.10.015
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GF7MM
UT WOS:000432152300015
PM 29306490
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Pohl, L
   Raulin, C
   Raulin, S
AF Pohl, Laura
   Raulin, Christian
   Raulin, Sabine
TI Zika virus in Germany: case report and possible routes of transmission
SO JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
LA English
DT Letter
C1 [Pohl, Laura; Raulin, Christian; Raulin, Sabine] Drs Raulin & Colleagues, Med Clin, Karlsruhe, Germany.
RP Raulin, C (corresponding author), MVZ Dres Raulin & Kollegen, Kaiserstr 104, D-76133 Karlsruhe, Germany.
EM info@raulin.de
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2017, BADISCHE NEUESTE NAC
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kuna A, 2016, INT MARIT HEALTH, V67, P179, DOI 10.5603/IMH.2016.0033
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tappe D, 2014, EUROSURVEILLANCE, V19, DOI [10.2807/1560-7917.ES2014.19.4.20685, DOI 10.2807/1560-7917.ES2014.19.4.20685]
   Tjandra ET, 2017, J DTSCH DERMATOL GES, V15, P82, DOI 10.1111/ddg.12941
NR 13
TC 3
Z9 3
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1610-0379
EI 1610-0387
J9 J DTSCH DERMATOL GES
JI J. Dtsch. Dermatol. Ges.
PD MAY
PY 2018
VL 16
IS 5
BP 599
EP 602
DI 10.1111/ddg.13503
PG 4
WC Dermatology
SC Dermatology
GA GF5KH
UT WOS:000432005400009
PM 29603598
DA 2020-07-08
ER

PT J
AU Mendoza-Gallegos, RA
   Rios, A
   Garcia-Cordero, JL
AF Mendoza-Gallegos, Roberto A.
   Rios, Amelia
   Garcia-Cordero, Jose L.
TI An Affordable and Portable Thermocycler for Real-Time PCR Made of
   3D-Printed Parts and Off-the-Shelf Electronics
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID CAPILLARY-ELECTROPHORESIS; RAPID DETECTION; INSTRUMENT-FREE; ZIKA VIRUS;
   SAMPLE; CARE; DEVICE; PLATFORM; AMPLIFICATION; DIAGNOSTICS
AB The polymerase chain reaction (PCR) is a sought-after nucleic acid amplification technique used in the detection of several diseases. However, one of the main limitations of this and other nucleic acid amplification assays is the complexity, size, maintenance, and cost of their operational instrumentation. This limits the use of PCR applications in settings that cannot afford the instruments but that may have access to basic electrical, electronic, and optical components and the expertise to build them. To provide a more accessible platform, we developed a low-cost, palm-size, and portable instrument to perform real-time PCR (qPCR). The thermocycler leverages a copper-sheathed power resistor and a computer fan, in tandem with basic electronic components controlled from a single-board computer. The instrument incorporates a 3D-printed chassis and a custom-made fluorescence optical setup based on a CMOS camera and a blue LED. Results are displayed in real-time on a tablet. We also fabricated simple acrylic microdevices consisting of four wells (2 mu L in volume each) where PCR reactions take place. To test our instrument, we performed qPCR on a series of cDNA dilutions spanning 4 orders of magnitude, achieving similar limits of detection as those achieved by a benchtop thermocycler. We envision our instrument being utilized to enable routine monitoring and diagnosis of certain diseases in low-resource areas.
C1 [Mendoza-Gallegos, Roberto A.; Rios, Amelia; Garcia-Cordero, Jose L.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Monterrey, Parque PIIT, Apodaca 66628, Nuevo Leon, Mexico.
RP Garcia-Cordero, JL (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Unidad Monterrey, Parque PIIT, Apodaca 66628, Nuevo Leon, Mexico.
EM jlgarciac@cinvestav.mx
RI Garcia-Cordero, Jose L/D-1591-2009; Garcia-Cordero, Jose/AAE-7866-2020
OI Garcia-Cordero, Jose L/0000-0002-3868-7405; Garcia-Cordero,
   Jose/0000-0002-3868-7405
FU Mexico's CONACyTConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [256097, 262771, FC-1132]
FX This work was funded by Mexico's CONACyT under grants No. 256097,
   262771, and FC-1132. We would like to thank Prof. Chris Backhouse &
   Samuel Tristan for helpful discussions.
CR Agrawal N, 2007, ANGEW CHEM INT EDIT, V46, P4316, DOI 10.1002/anie.200700306
   Ahrberg CD, 2016, ANAL CHEM, V88, P4803, DOI 10.1021/acs.analchem.6b00278
   Ahrberg CD, 2016, LAB CHIP, V16, P586, DOI 10.1039/c5lc01415h
   Angione SL, 2012, ANAL CHEM, V84, P2654, DOI 10.1021/ac202532a
   Bennett DE, 2008, ANTIVIR THER, V13, P1
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chan K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158502
   Chung KH, 2010, LAB CHIP, V10, P202, DOI 10.1039/b915022f
   Hsieh YF, 2013, SENSOR ACTUAT B-CHEM, V183, P434, DOI 10.1016/j.snb.2013.04.003
   Jiang L, 2014, SCI REP-UK, V4, DOI 10.1038/srep04137
   Kaigala GV, 2008, ANALYST, V133, P331, DOI 10.1039/b714308g
   Lafleur LK, 2016, LAB CHIP, V16, P3777, DOI 10.1039/c6lc00677a
   Lagally ET, 2004, ANAL CHEM, V76, P3162, DOI 10.1021/ac035310p
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Lim S, 2014, J CHROMATOGR B, V963, P134, DOI 10.1016/j.jchromb.2014.06.004
   Liu P, 2007, ANAL CHEM, V79, P1881, DOI 10.1021/ac061961k
   Lounsbury JA, 2013, LAB CHIP, V13, P1384, DOI 10.1039/c3lc41326h
   Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050
   Neuzil P, 2010, LAB CHIP, V10, P2632, DOI 10.1039/c004921b
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Pak N, 2012, BIOMED MICRODEVICES, V14, P427, DOI 10.1007/s10544-011-9619-2
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Priye A, 2016, ANAL CHEM, V88, P4651, DOI 10.1021/acs.analchem.5b04153
   Qiu XB, 2010, LAB CHIP, V10, P3170, DOI [10.1039/c0lc00038h, 10.1039/c01c00038h]
   Shu BW, 2017, BIOSENS BIOELECTRON, V97, P360, DOI 10.1016/j.bios.2017.06.014
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tanriverdi S, 2010, J INFECT DIS, V201, pS52, DOI 10.1086/650387
   Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278
   Walker FM, 2014, ANAL CHEM, V86, P9236, DOI 10.1021/ac5022419
   Wheeler EK, 2004, ANAL CHEM, V76, P4011, DOI 10.1021/ac034941g
   Wong G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131701
   Xiang Q, 2007, BIOMED MICRODEVICES, V9, P443, DOI 10.1007/s10544-007-9048-4
   Xu GL, 2010, LAB CHIP, V10, P3103, DOI 10.1039/c005265e
NR 33
TC 14
Z9 14
U1 6
U2 40
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD MAY 1
PY 2018
VL 90
IS 9
BP 5563
EP 5568
DI 10.1021/acs.analchem.7b04843
PG 6
WC Chemistry, Analytical
SC Chemistry
GA GE8EI
UT WOS:000431464400010
PM 29624373
DA 2020-07-08
ER

PT J
AU GeurtsvanKessel, CH
   Islam, Z
   Islam, MB
   Kamga, S
   Papri, N
   van de Vijver, DAMC
   Reusken, C
   Mogling, R
   Heikema, AP
   Jahan, I
   Pradel, FK
   Pavlicek, RL
   Mohammad, QD
   Koopmans, MPG
   Jacobs, BC
   Endtz, HP
AF GeurtsvanKessel, Corine H.
   Islam, Zhahirul
   Islam, Md. Badrul
   Kamga, Sandra
   Papri, Nowshin
   van de Vijver, David A. M. C.
   Reusken, Chantal
   Mogling, Ramona
   Heikema, Astrid P.
   Jahan, Israt
   Pradel, Florence K.
   Pavlicek, Rebecca L.
   Mohammad, Quazi D.
   Koopmans, Marion P. G.
   Jacobs, Bart C.
   Endtz, Hubert P.
TI Zika virus and Guillain-Barre syndrome in Bangladesh
SO ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY
LA English
DT Article
ID LINKED IMMUNOSORBENT ASSAYS; DECEMBER 2015; CASE SERIES; INFECTION;
   MICRONESIA; VALIDATION; DIAGNOSIS; COLOMBIA; CRITERIA; COHORT
AB Objective: Previous studies have associated Guillain-Barre syndrome (GBS) with Zika virus (ZIKV) outbreaks in South America and Oceania. In Asia, ZIKV is known to circulate widely, but the association with Guillain-Barre syndrome is unclear. We investigated whether endemic ZIKV infection is associated with the development of GBS. Methods: A prospective study was conducted from 2011 to 2015 in Bangladesh. A total of 418 patients and 418 healthy family controls were included in the study. Patients were diagnosed with GBS prior to inclusion according to established criteria. Detailed information on the epidemiology, clinical presentation, electrophysiology, diagnosis, disease severity, and clinical course were obtained during a follow-up of 1 year using a predefined protocol. Results: ZIKV-neutralizing antibodies were detected in our study from 2013 onwards. The prevalence of ZIKV-neutralizing antibodies was not significantly higher in patients with GBS compared to healthy controls (OR 2.23, P = 0.14, 95% CI 0.77-6.53). Serological evidence for prior ZIKV infection in patients with GBS was associated with more frequent cranial, sensory, and autonomic nerve involvement compared to GBS patients with Campylobacter jejuni, the predominant preceding infection in GBS worldwide. Nerve-conduction studies revealed that ZIKV antibodies were associated with a demyelinating subtype of GBS, while C. jejuni infections were related to an axonal subtype. Interpretation: No significant association was found between ZIKV infection and GBS in Bangladesh, but GBS following ZIKV infection was characterized by a distinct clinical and electrophysiological subtype compared to C. jejuni infection. These findings indicate that ZIKV may precede a specific GBS subtype but the risk is low.
C1 [GeurtsvanKessel, Corine H.; Kamga, Sandra; van de Vijver, David A. M. C.; Reusken, Chantal; Mogling, Ramona; Koopmans, Marion P. G.] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Islam, Zhahirul; Islam, Md. Badrul; Papri, Nowshin; Jahan, Israt; Endtz, Hubert P.] Icddr B, Lab Sci & Serv Div, Dhaka, Bangladesh.
   [Islam, Md. Badrul; Heikema, Astrid P.; Endtz, Hubert P.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
   [Pradel, Florence K.; Endtz, Hubert P.] Fdn Merieux, Lyon, France.
   [Pavlicek, Rebecca L.] Naval Med Res Ctr Asia, Singapore, Singapore.
   [Mohammad, Quazi D.] Natl Inst Neurosci & Hosp, Dhaka, Bangladesh.
   [Jacobs, Bart C.] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart C.] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
RP GeurtsvanKessel, CH (corresponding author), Erasmus MC, Off Na 1018,Wytemaweg 80, NL-3015 CN Rotterdam, Netherlands.
EM c.geurtsvankessel@erasmusmc.nl
RI Koopmans, Marion/Y-9170-2019
OI Koopmans, Marion/0000-0002-5204-2312; Pradel,
   Florence/0000-0002-1023-0796
FU GBS-CIDP Foundation International; U.S. Department of Defense Global
   Emerging Infections Surveillance and Response Program (GEIS); European
   Union's Horizon research and innovation program (ZikALLIANCE) [734548];
   European Union's Horizon research and innovation program (ZikaPLAN)
   [734584]
FX This project received funding from the GBS-CIDP Foundation
   International, U.S. Department of Defense Global Emerging Infections
   Surveillance and Response Program (GEIS), and the European Union's
   Horizon 2020 research and innovation program (ZikALLIANCE grant
   agreement No. 734548, ZikaPLAN grant agreement No. 734584).
CR Ang CW, 2007, CLIN MICROBIOL INFEC, V13, P915, DOI 10.1111/j.1469-0691.2007.01765.x
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Fokke C, 2014, BRAIN, V137, P33, DOI 10.1093/brain/awt285
   Frontera JA, 2016, NEW ENGL J MED, V375, P1581, DOI 10.1056/NEJMe1611840
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2
   Islam Z, 2010, NEUROLOGY, V74, P581, DOI 10.1212/WNL.0b013e3181cff735
   Jacobs BC, 2017, J PERIPHER NERV SYST, V22, P68, DOI 10.1111/jns.12209
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Muraduzzaman AKM, 2017, ASIAN PAC J TROP MED, V10, P925, DOI 10.1016/j.apjtm.2017.08.015
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Orlikowski D, 2011, CLIN INFECT DIS, V52, P837, DOI 10.1093/cid/cir074
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Roze B, 2016, EUROSURVEILLANCE, P21, DOI DOI 10.28707/1560-7917.ES.2016.21.9.30154
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 36
TC 9
Z9 10
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2328-9503
J9 ANN CLIN TRANSL NEUR
JI Ann. Clin. Transl. Neurol.
PD MAY
PY 2018
VL 5
IS 5
BP 606
EP 615
DI 10.1002/acn3.556
PG 10
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GF4XV
UT WOS:000431968300009
PM 29761123
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mehta, R
   Gerardin, P
   de Brito, CAA
   Soares, CN
   Ferreira, MLB
   Solomon, T
AF Mehta, Ravi
   Gerardin, Patrick
   Antunes de Brito, Carlos Alexandre
   Soares, Cristiane Nascimento
   Brito Ferreira, Maria Lucia
   Solomon, Tom
TI The neurological complications of chikungunya virus: A systematic review
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE acute disseminated encephalomyelitis; chikungunya; complications;
   congenital infections; encephalitis; Guillain-Barre syndrome; myelitis;
   neonatal infection; neurological; optic neuritis; retinitis; uveitis
ID GUILLAIN-BARRE-SYNDROME; ZIKA VIRUS; NEONATAL CHIKUNGUNYA;
   HEMORRHAGIC-FEVER; CASE DEFINITIONS; REUNION ISLAND; SINGLE-CENTER;
   INFECTION; MANIFESTATIONS; DENGUE
AB We performed a systematic review on the neurological complications of chikungunya virus. Such complications are being reported increasingly, owing primarily to the scale of recent epidemics but also to a growing understanding of the virus' neurovirulence. We performed a thorough literature search using PubMed and Scopus databases, summating the data on all published reports of neurological disease associated with chikungunya virus. We appraised the data for each major condition in adults, children, and neonates, as well as evaluating the latest evidence on disease pathogenesis and management strategies. The review provides a comprehensive summary for clinicians, public health officials, and researchers tackling the challenges associated with this important emerging pathogen.
C1 [Mehta, Ravi; Solomon, Tom] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England.
   [Gerardin, Patrick] CHU Reunion, INSERM, CIC1410, St Pierre, Reunion, France.
   [Gerardin, Patrick] Univ Reunion, CHU, CYROI, UM PIMIT CNRS 9192 134,INSERM,U1187,IRD 249, St Pierre, Reunion, France.
   [Antunes de Brito, Carlos Alexandre] Univ Fed Pernambuco, Dept Infect Dis, Recife, PE, Brazil.
   [Soares, Cristiane Nascimento] Hosp Fed Servidores Estado, Dept Neurol, Rio De Janeiro, Brazil.
   [Brito Ferreira, Maria Lucia] Hosp Restauracao, Dept Neurol, Ave Agamenon Magalhaes, Recife, PE, Brazil.
   [Solomon, Tom] Walton Ctr NHS Fdn Trust, Dept Neurol, Liverpool, Merseyside, England.
   [Mehta, Ravi; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
RP Mehta, R; Solomon, T (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 7BE, Merseyside, England.
EM ravi.mehta@liverpool.ac.uk; tsolomon@liv.ac.uk
OI Solomon, Tom/0000-0001-7266-6547
FU European Union's Horizon research and innovation programme [734584];
   National Institute for Health Research Health Protection Research Unit
   (NIHR HPRU); Medical Research CouncilMedical Research Council UK (MRC)
   [MC_PC_15096]
FX European Union's Horizon 2020 research and innovation programme,
   Grant/Award Number: 734584; National Institute for Health Research
   Health Protection Research Unit (NIHR HPRU); Medical Research Council,
   Grant/Award Number: MC_PC_15096
CR Abdelnabi R, 2016, METHODS MOL BIOL, V1426, P243, DOI 10.1007/978-1-4939-3618-2_22
   Abraham R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075854
   Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Agarwal A, 2017, J NEUROVIROL
   Akileswaran C, 2016, NEW ENGL J MED, V375, P1906, DOI 10.1056/NEJMc1611877
   Alvarado-Socarras JL, 2016, J PEDIAT INF DIS SOC, V5, pE17, DOI 10.1093/jpids/piw021
   Arragain L, 2017, J PEDIAT INF DIS SOC, V6, P324, DOI 10.1093/jpids/piw058
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Bandeira AC, 2016, IDCases, V6, P100, DOI 10.1016/j.idcr.2016.10.007
   Bandeira AC, 2016, IDCases, V5, P57, DOI 10.1016/j.idcr.2016.07.008
   Bank AM, 2016, J NEUROVIROL, V22, P125, DOI 10.1007/s13365-015-0372-9
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Benzekri R, 2016, AM J TROP MED HYG, V95, P180, DOI 10.4269/ajtmh.15-0547
   Bhavana K, 2008, INT J PEDIATR OTORHI, V72, P257, DOI 10.1016/j.ijporl.2007.09.022
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Campos GS, 2017, PEDIAT INFECT DIS J
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   CAREY DE, 1969, T ROY SOC TROP MED H, V63, P434, DOI 10.1016/0035-9203(69)90030-3
   Casolari S, 2008, SCAND J INFECT DIS, V40, P995, DOI 10.1080/00365540802419055
   Centers for Disease Control and Prevention, 2016, COUNTRIES AND TERRIT
   Cerny T, 2017, NEUROCRIT CARE
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Chatterjee S N, 1965, J Indian Med Assoc, V45, P314
   Chiam CW, 2015, J GEN VIROL, V96, P3243, DOI 10.1099/jgv.0.000263
   Chopra A, 2014, ARTHRITIS RHEUMATOL, V66, P319, DOI 10.1002/art.38221
   Choudhary N, 2016, J CLIN DIAGN RES, V10, pOD19, DOI 10.7860/JCDR/2016/13095.7777
   Chung SJ, 2013, J CLIN VIROL, V57, P187, DOI 10.1016/j.jcv.2013.01.004
   Chusri S, 2011, AM J TROP MED HYG, V85, P386, DOI 10.4269/ajtmh.2011.10-0725
   Crosby L, 2016, INT J INFECT DIS, V48, P78, DOI 10.1016/j.ijid.2016.05.010
   Das S, 2014, J PEDIAT INF DIS-GER, V9, P37, DOI 10.3233/JPI-140414
   Das T, 2015, J GEN VIROL, V96, P294, DOI 10.1099/vir.0.071175-0
   Sa PKD, 2017, REV SOC BRAS MED TRO, V50, P265, DOI 10.1590/0037-8682-0375-2016
   Dutta P, 2017, INT OPHTHALMOL
   Economopoulou A, 2009, EPIDEMIOL INFECT, V137, P534, DOI 10.1017/S0950268808001167
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Ernould S, 2008, ARCH PEDIATRIE, V15, P253, DOI 10.1016/j.arcped.2007.10.019
   Fritel X, 2010, EMERG INFECT DIS, V16, P418, DOI 10.3201/eid1603.091403
   Frohman EM, 2010, NEW ENGL J MED, V363, P564, DOI 10.1056/NEJMcp1001112
   Galatas B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004281
   Ganesan K, 2008, AM J NEURORADIOL, V29, P1636, DOI 10.3174/ajnr.A1133
   Gauri L A, 2012, J Assoc Physicians India, V60, P68
   Gay N, 2016, AM J TROP MED HYG, V94, P393, DOI 10.4269/ajtmh.15-0308
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Gopakumar H, 2012, J CLIN NEONATOL, V1, P155, DOI 10.4103/2249-4847.101704
   Gupta D, 2015, INDIAN J PEDIATR, V82, P1065, DOI 10.1007/s12098-015-1751-1
   Her ZS, 2015, EMBO MOL MED, V7, P24, DOI 10.15252/emmm.201404459
   Horwood PF, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.15
   Inglis FM, 2016, J NEUROVIROL, V22, P140, DOI 10.1007/s13365-015-0378-3
   Jacobs BC, 1996, ANN NEUROL, V40, P181, DOI 10.1002/ana.410400209
   JADHAV M, 1965, INDIAN J MED RES, V53, P764
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Kalita J, 2013, INFECTION, V41, P727, DOI 10.1007/s15010-013-0406-2
   Karthiga V, 2016, J PEDIATR NEUROSCI, V11, P223, DOI 10.4103/1817-1745.193369
   Kashyap RS, 2014, NEUROIMMUNOMODULAT, V21, P338, DOI 10.1159/000358240
   Kee ACL, 2010, EMERG INFECT DIS, V16, P1038, DOI 10.3201/eid1606.091115
   Krishnan M, 2012, J GLOB INFECT DIS, V4, P207, DOI 10.4103/0974-777X.103898
   Krupp LB, 2013, MULT SCLER J, V19, P1261, DOI 10.1177/1352458513484547
   Lalitha P, 2007, AM J OPHTHALMOL, V144, P552, DOI 10.1016/j.ajo.2007.06.002
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lemant J, 2008, CRIT CARE MED, V36, P2536, DOI 10.1097/CCM.0b013e318183f2d2
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lewthwaite P, 2009, EMERG INFECT DIS, V15, P329, DOI 10.3201/eid1502.080902
   Lin J, 2016, OCUL IMMUNOL INFLAMM, P1
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   Mahendradas P, 2008, OPHTHALMOLOGY, V115, P287, DOI 10.1016/j.ophtha.2007.03.085
   Mahendradas P, 2013, J OPHTHALMIC INFLAMM, V3, DOI 10.1186/1869-5760-3-19
   Mahendradas P, 2010, INDIAN J OPHTHALMOL, V58, P545, DOI 10.4103/0301-4738.71707
   Mahesh G, 2009, INDIAN J OPHTHALMOL, V57, P148, DOI 10.4103/0301-4738.45508
   Maity Pranab, 2014, J Assoc Physicians India, V62, P441
   Martins HAL, 2016, J NEUROINFECT DIS, V7
   Mittal A, 2007, ARCH OPHTHALMOL-CHIC, V125, P1381, DOI 10.1001/archopht.125.10.1381
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musthafa A K Mohamed, 2008, J Assoc Physicians India, V56, P473
   Nagpal K, 2017, J NEUROVIROL
   Nair AG, 2012, J OPHTHALMIC INFLAMM, V2, P39, DOI 10.1007/s12348-011-0038-6
   Nascimento LB, 2017, LANCET INFECT DIS
   Nelson J, 2014, J CLIN MICROBIOL, V52, P3459, DOI 10.1128/JCM.01288-14
   NIMMANNITYA S, 1969, AM J TROP MED HYG, V18, P954, DOI 10.4269/ajtmh.1969.18.954
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Pan American Health Organisation, 2017, NEW CASES OF CHIKUNG
   Powers AM, 2000, J GEN VIROL, V81, P471, DOI 10.1099/0022-1317-81-2-471
   Priya R, 2014, VIRUS RES, V189, P194, DOI 10.1016/j.virusres.2014.05.010
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Ramos R, 2017, PEDIAT INFECT DIS J
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Ribeiro CF, 2013, J PEDIATR-US, V163, P1514, DOI 10.1016/j.jpeds.2013.06.040
   Lyra PPR, 2016, AJP REP, V6, pE299, DOI 10.1055/s-0036-1587323
   Robillard PY, 2006, PRESSE MED, V35, P785, DOI 10.1016/S0755-4982(06)74690-5
   Robin S, 2008, J CHILD NEUROL, V23, P1028, DOI 10.1177/0883073808314151
   ROBINSON M C, 1955, Trans R Soc Trop Med Hyg, V49, P28, DOI [10.1016/0035-9203(55)90080-8, 10.1016/0035-9203(57)90022-6]
   Rocha VFD, 2017, OCUL IMMUNOL INFLAMM, P1
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rolle A, 2016, EMERG INFECT DIS, V22, P891, DOI 10.3201/eid2205.151449
   Rose N, 2011, INT J INFECT DIS, V15, pE147, DOI 10.1016/j.ijid.2010.10.004
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Samra JA, 2017, J CHILD NEUROL, V32, P712, DOI 10.1177/0883073817701879
   Scott SSO, 2017, J NEUROVIROL
   Scripsema Nicole K, 2015, Retin Cases Brief Rep, V9, P352, DOI 10.1097/ICB.0000000000000232
   Sejvar JJ, 2007, VACCINE, V25, P5771, DOI 10.1016/j.vaccine.2007.04.060
   SHAH KV, 1964, INDIAN J MED RES, V52, P676
   Shaikh NJ, 2015, INDIAN J MED MICROBI, V33, P454, DOI 10.4103/0255-0857.158600
   Sharma Swati, 2016, Infect Dis Obstet Gynecol, V2016, P5046091, DOI 10.1155/2016/5046091
   Shenoy S, 2012, INDIAN PEDIATR, V49, P238
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   Singh A, 2017, INDIAN PEDIATR, V54, P249, DOI 10.1007/s13312-017-1040-3
   Singh SS, 2008, EPIDEMIOL INFECT, V136, P1277, DOI 10.1017/S0950268807009739
   Sissoko D, 2008, T ROY SOC TROP MED H, V102, P780, DOI 10.1016/j.trstmh.2008.02.018
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014
   Solomon T, 2000, LANCET, V355, P1053, DOI 10.1016/S0140-6736(00)02036-5
   Solomon T, 2004, INFECT CENTRAL NERVO
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Suryawanshi SD, 2009, INDIAN J MED RES, V129, P438
   Tandale BV, 2009, J CLIN VIROL, V46, P145, DOI 10.1016/j.jcv.2009.06.027
   Taraphdar D, 2015, INDIAN J MED MICROBI, V33, pS153, DOI 10.4103/0255-0857.150946
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   THIRUVENGADAM KV, 1965, INDIAN J MED RES, V53, P729
   Torres JR, 2016, INT J INFECT DIS, V51, P85, DOI 10.1016/j.ijid.2016.09.009
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vazeille M, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000706
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HLTH
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Villamil-Gomez W, 2015, J TROP PEDIATRICS, V61, P386, DOI 10.1093/tropej/fmv051
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   Vishwanath S, 2014, INT OPHTHALMOL, V34, P851, DOI 10.1007/s10792-013-9891-7
   Wadia R. S., 2007, Annals of the Indian Academy of Neurology, V10, P198
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Witayathawornwong P, 2012, SE ASIAN J TROP MED, V43, P62
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 143
TC 25
Z9 25
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD MAY
PY 2018
VL 28
IS 3
AR e1978
DI 10.1002/rmv.1978
PG 24
WC Virology
SC Virology
GA GF5TT
UT WOS:000432031400005
PM 29671914
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Huang, M
   ElTayeby, O
   Zolnoori, M
   Yao, LX
AF Huang, Ming
   ElTayeby, Omar
   Zolnoori, Maryam
   Yao, Lixia
TI Public Opinions Toward Diseases: Infodemiological Study on News Media
   Data
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE news; Reuters; public policy; text mining; sentiment analysis; topic
   modeling; unmet medical need; research priority
ID H5N1; LIMITATIONS; HEALTH; NEEDS; UMLS
AB Background: Society always has limited resources to expend on health care, or anything else. What are the unmet medical needs? How do we allocate limited resources to maximize the health and welfare of the people? These challenging questions might be re-examined systematically within an infodemiological frame on a much larger scale, leveraging the latest advancement in information technology and data science.
   Objective: We expanded our previous work by investigating news media data to reveal the coverage of different diseases and medical conditions, together with their sentiments and topics in news articles over three decades. We were motivated to do so since news media plays a significant role in politics and affects the public policy making.
   Methods: We analyzed over 3.5 million archive news articles from Reuters media during the periods of 1996/1997, 2008 and 2016, using summary statistics, sentiment analysis, and topic modeling. Summary statistics illustrated the coverage of various diseases and medical conditions during the last 3 decades. Sentiment analysis and topic modeling helped us automatically detect the sentiments of news articles (ie, positive versus negative) and topics (ie, a series of keywords) associated with each disease over time.
   Results: The percentages of news articles mentioning diseases and medical conditions were 0.44%, 0.57% and 0.81% in the three time periods, suggesting that news media or the public has gradually increased its interests in medicine since 1996. Certain diseases such as other malignant neoplasm (34%), other infectious diseases (20%), and influenza (11%) represented the most covered diseases. Two hundred and twenty-six diseases and medical conditions (97.8%) were found to have neutral or negative sentiments in the news articles. Using topic modeling, we identified meaningful topics on these diseases and medical conditions. For instance, the smoking theme appeared in the news articles on other malignant neoplasm only during 1996/1997. The topic phrases HIV and Zika virus were linked to other infectious diseases during 1996/1997 and 2016, respectively.
   Conclusions: The multi-dimensional analysis of news media data allows the discovery of focus, sentiments and topics of news media in terms of diseases and medical conditions. These infodemiological discoveries could shed light on unmet medical needs and research priorities for future and provide guidance for the decision making in public policy.
C1 [Huang, Ming; Zolnoori, Maryam; Yao, Lixia] Mayo Clin, Dept Hlth Sci Res, 200 First St SW, Rochester, MN 55905 USA.
   [ElTayeby, Omar] Univ N Carolina, Dept Comp Sci, Charlotte, NC 28223 USA.
RP Yao, LX (corresponding author), Mayo Clin, Dept Hlth Sci Res, 200 First St SW, Rochester, MN 55905 USA.
EM Yao.Lixia@mayo.edu
RI Huang, Ming/C-9557-2014
OI Huang, Ming/0000-0001-7367-3626
FU Mayo Clinic Center for Clinical and Translational Science from the
   National Institutes of Health/National Center for Advancing
   Translational Sciences [UL1TR002377]; National Library of MedicineUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Library of Medicine (NLM) [5K01LM012102]
FX Funding for this study was provided by the Mayo Clinic Center for
   Clinical and Translational Science (UL1TR002377) from the National
   Institutes of Health/National Center for Advancing Translational
   Sciences and the National Library of Medicine (5K01LM012102).
CR [Anonymous], 2009, UMLS REF MAN
   [Anonymous], 2018, REUT CORP RCV1 RCV2
   Arceneaux K, 2016, AM J POLIT SCI, V60, P5, DOI 10.1111/ajps.12171
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cardoso F, 2017, ANN ONCOL, V28, P208, DOI 10.1093/annonc/mdw571
   Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798
   Duru G, 2002, PHARMACOECONOMICS, V20, P463, DOI 10.2165/00019053-200220070-00004
   Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157
   Ferlay J, 2013, GLOBOCAN 2012 ESTIMA
   Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2
   Gillum LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016837
   Greaves F, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2721
   Griffon N, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-12
   Gross CP, 1999, NEW ENGL J MED, V340, P1881, DOI 10.1056/NEJM199906173402406
   Hansen V, 2016, JAMA-J AM MED ASSOC, V316, P2149, DOI 10.1001/jama.2016.12423
   Hebbring SJ, 2014, IMMUNOLOGY, V141, P157, DOI 10.1111/imm.12195
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hutto CJ, 2014, 2014 8 INT AAAI C WE
   Kagashe I, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7393
   Kaur H., 2017, RES REV J COMP BIOL, V6, P26
   King G, 2017, SCIENCE, V358, P776, DOI 10.1126/science.aao1100
   Lai SJ, 2016, LANCET INFECT DIS, V16, pE108, DOI 10.1016/S1473-3099(16)00153-5
   Lee DH, 2017, J VET SCI, V18, P269, DOI [10.4142/jvs.2017.18.S1.269, 10.4142/jvs.2017.18.s1.269]
   Lewis DD, 2004, J MACH LEARN RES, V5, P361
   Li XL, 2015, INT J ENV RES PUB HE, V12, P5026, DOI 10.3390/ijerph120505026
   Metwally O, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7485
   Mojtabai R, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1878
   Nagarajan S, 2009, VET REC, V164, P128, DOI 10.1136/vr.164.4.128
   Normand C, 2009, J PAIN SYMPTOM MANAG, V38, P27, DOI 10.1016/j.jpainsymman.2009.04.005
   Pratt Laura A, 2017, NCHS Data Brief, P1
   Qiu RY, 2017, LECT NOTES ARTIF INT, V10351, P374, DOI 10.1007/978-3-319-60045-1_39
   Rehurek Radim, 2010, P LREC 2010 WORKSH N, P46, DOI [10.13140/2.1.2393.1847, DOI 10.13140/2.1.2393.1847]
   Reuters, 2018, REUTERS
   Rose T, 2002, 2002 MAY P 3 INT C L
   Sampat BN, 2013, MILBANK Q, V91, P163, DOI 10.1111/milq.12005
   SCHUYLER PL, 1993, B MED LIBR ASSOC, V81, P217
   Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387
   Sun XL, 2013, J AM SOC INF SCI TEC, V64, P321, DOI 10.1002/asi.22740
   Surian D, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6045
   Tapi Nzali Mike Donald, 2017, JMIR Med Inform, V5, pe23, DOI 10.2196/medinform.7779
   World Health Organization, 2004, GLOB BURD DIS UPD TA
   Yao LX, 2015, NAT BIOTECHNOL, V33, P807, DOI 10.1038/nbt.3276
NR 45
TC 3
Z9 3
U1 1
U2 14
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAY
PY 2018
VL 20
IS 5
AR e10047
DI 10.2196/10047
PG 12
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA GF1UD
UT WOS:000431720200001
PM 29739741
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gopinath, S
   Kim, MV
   Rakib, T
   Wong, PW
   van Zandt, M
   Barry, NA
   Kaisho, T
   Goodman, AL
   Iwasaki, A
AF Gopinath, Smita
   Kim, Myoungjoo V.
   Rakib, Tasfia
   Wong, Patrick W.
   van Zandt, Michael
   Barry, Natasha A.
   Kaisho, Tsuneyasu
   Goodman, Andrew L.
   Iwasaki, Akiko
TI Topical application of aminoglycoside antibiotics enhances host
   resistance to viral infections in a microbiota-independent manner
SO NATURE MICROBIOLOGY
LA English
DT Article
ID SENSORY HAIR-CELLS; INFLUENZA-A VIRUS; DENDRITIC CELLS; RIBOSOMAL-RNA;
   ZIKA VIRUS; IMMUNE-RESPONSES; GENE-EXPRESSION; TISSUE-RESIDENT; GENITAL
   HERPES; T-CELLS
AB Antibiotics are widely used to treat infections in humans. However, the impact of antibiotic use on host cells is understudied. Here we identify an antiviral effect of commonly used aminoglycoside antibiotics. We show that topical mucosal application of aminoglycosides prophylactically increased host resistance to a broad range of viral infections including herpes simplex viruses, influenza A virus and Zika virus. Aminoglycoside treatment also reduced viral replication in primary human cells. This antiviral activity was independent of the microbiota, because aminoglycoside treatment protected germ-free mice. Microarray analysis uncovered a marked upregulation of transcripts for interferon-stimulated genes (ISGs) following aminoglycoside application. ISG induction was mediated by Toll-like receptor 3, and required Toll/interleukin-1-receptor-domain-containing adapter-inducing interferon-beta signalling adaptor, and Interferon regulatory factors 3 and 7, transcription factors that promote ISG expression. XCR1(+) dendritic cells, which uniquely express Toll-like receptor 3, were recruited to the vaginal mucosa upon aminoglycoside treatment and were required for ISG induction. These results highlight an unexpected ability of aminoglycoside antibiotics to confer broad antiviral resistance in vivo.
C1 [Gopinath, Smita; Goodman, Andrew L.; Iwasaki, Akiko] Howard Hughes Med Inst, New Haven, CT 06510 USA.
   [Gopinath, Smita; Kim, Myoungjoo V.; Rakib, Tasfia; Wong, Patrick W.; Iwasaki, Akiko] Yale Univ, Dept Immunol, New Haven, CT 06520 USA.
   [van Zandt, Michael] New England Discovery Partners, Branford, CT USA.
   [Barry, Natasha A.; Goodman, Andrew L.] Yale Univ, Dept Microbial Pathogenesis, New Haven, CT USA.
   [Barry, Natasha A.; Goodman, Andrew L.] Yale Univ, Microbial Sci Inst, New Haven, CT USA.
   [Kaisho, Tsuneyasu] Wakayama Med Univ, Inst Adv Med, Dept Immunol, Wakayama, Japan.
RP Iwasaki, A (corresponding author), Howard Hughes Med Inst, New Haven, CT 06510 USA.; Iwasaki, A (corresponding author), Yale Univ, Dept Immunol, New Haven, CT 06520 USA.
EM akiko.iwasaki@yale.edu
RI Iwasaki, Akiko/Z-1591-2019
OI Iwasaki, Akiko/0000-0002-7824-9856
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI054359,
   R56AI125504, R01EB000487, 1R21AI131284]; James Hudson Brown-Alexander
   Brown Coxe Postdoctoral Fellowships at Yale University
FX The authors thank Y. Kong for his help with analysing the microarray
   data, and H. Dong for animal support. The authors also thank P. Biswal
   for help with visualizing the microarray data. This study was supported
   by funding from the National Institutes of Health (AI054359,
   R56AI125504, R01EB000487 and 1R21AI131284 to A.I.). A. I. and A.L.G. are
   Investigator and Faculty Scholar of Howard Hughes Medical Institute.
   S.G. and M.V.K. are recipients of the James Hudson Brown-Alexander Brown
   Coxe Postdoctoral Fellowships at Yale University.
CR Assas BM, 2016, IMMUNOLOGY, V147, P292, DOI 10.1111/imm.12562
   Badal S, 2015, J BIOL CHEM, V290, P22287, DOI 10.1074/jbc.M115.671222
   Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724
   BEGG EJ, 1995, BRIT J CLIN PHARMACO, V39, P597
   Busscher GF, 2005, CHEM REV, V105, P775, DOI 10.1021/cr0404085
   Cheng Alan G, 2005, Curr Opin Otolaryngol Head Neck Surg, V13, P343, DOI 10.1097/01.moo.0000186799.45377.63
   Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778
   Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717
   Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207
   Grimm D, 2007, P NATL ACAD SCI USA, V104, P6806, DOI 10.1073/pnas.0701849104
   Haller O, 2015, TRENDS MICROBIOL, V23, P154, DOI 10.1016/j.tim.2014.12.003
   Hashino E, 1995, BRAIN RES, V704, P135, DOI 10.1016/0006-8993(95)01198-6
   Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091
   Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464
   Hong S, 2015, J BIOL CHEM, V290, P19273, DOI 10.1074/jbc.M115.655092
   HORISBERGER MA, 1983, P NATL ACAD SCI-BIOL, V80, P1910, DOI 10.1073/pnas.80.7.1910
   Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108
   Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530
   Iyoda T, 2002, J EXP MED, V195, P1289, DOI 10.1084/jem.20020161
   Kalghatgi S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006055
   Khoury-Hanold W, 2016, CELL HOST MICROBE, V19, P788, DOI 10.1016/j.chom.2016.05.008
   LAURENT G, 1990, BIOCHEM PHARMACOL, V40, P2383, DOI 10.1016/0006-2952(90)90078-Y
   Linehan MM, 2004, J VIROL, V78, P2530, DOI 10.1128/JVI.78.5.2530-2536.2004
   Matsui JI, 2004, J NEUROBIOL, V61, P250, DOI 10.1002/neu.20054
   MCDERMOTT MR, 1984, J VIROL, V51, P747, DOI 10.1128/JVI.51.3.747-753.1984
   MEIER E, 1988, J VIROL, V62, P2386, DOI 10.1128/JVI.62.7.2386-2393.1988
   Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370
   MOESTRUP SK, 1995, J CLIN INVEST, V96, P1404, DOI 10.1172/JCI118176
   Morgun A, 2015, GUT, V64, P1732, DOI 10.1136/gutjnl-2014-308820
   Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034
   Myrdal SE, 2005, HEARING RES, V204, P170, DOI 10.1016/j.heares.2005.02.005
   Porter JD, 2016, J ANTIMICROB CHEMOTH, V71, P2767, DOI 10.1093/jac/dkw222
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Recht MI, 1996, J MOL BIOL, V262, P421, DOI 10.1006/jmbi.1996.0526
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rizzi Mark Douglas, 2007, Curr Opin Otolaryngol Head Neck Surg, V15, P352, DOI 10.1097/MOO.0b013e3282ef772d
   Ryu DH, 2001, BIOORGAN MED CHEM, V9, P2601
   Schiffer JT, 2013, NAT MED, V19, P280, DOI 10.1038/nm.3103
   Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326
   Shin HN, 2013, TRENDS IMMUNOL, V34, P487, DOI 10.1016/j.it.2013.08.001
   Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522
   Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x
   Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708
   STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518
   Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004
   Walter F, 1999, CURR OPIN CHEM BIOL, V3, P694, DOI 10.1016/S1367-5931(99)00028-9
   Wargo Kurt A, 2014, J Pharm Pract, V27, P573, DOI 10.1177/0897190014546836
   Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155
   Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262
   Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798
   Yang JH, 2017, CELL HOST MICROBE, V22, P757, DOI 10.1016/j.chom.2017.10.020
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 54
TC 16
Z9 17
U1 2
U2 17
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
PD MAY
PY 2018
VL 3
IS 5
BP 611
EP 621
DI 10.1038/s41564-018-0138-2
PG 11
WC Microbiology
SC Microbiology
GA GE4GB
UT WOS:000431172300015
PM 29632368
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Persaud, M
   Martinez-Lopez, A
   Buffone, C
   Porcelli, SA
   Diaz-Griffero, F
AF Persaud, Mirjana
   Martinez-Lopez, Alicia
   Buffone, Cindy
   Porcelli, Steven A.
   Diaz-Griffero, Felipe
TI Infection by Zika viruses requires the transmembrane protein AXL,
   endocytosis and low pH
SO VIROLOGY
LA English
DT Article
DE ZIKA; Entry; Low-pH; Endocytosis; Clathrin
ID HUMAN GLIAL-CELLS; PHOSPHATIDYLSERINE RECEPTORS; SEXUAL TRANSMISSION;
   MEMBRANE-FUSION; ENTRY; MICE; FLAVIVIRUSES; REPLICATION; PROPAGATION;
   REVEALS
AB The recent Zika virus (ZIKV) outbreak in Brazil has suggested associations of this virus infection with neurological disorders, including microcephaly in newborn infants and Guillian-Barre syndrome in adults. Previous reports have shown that AXL, a transmembrane receptor tyrosine kinase protein, is essential for ZIKV infection of mammalian cells, but this remains controversial. Here, we have assessed the involvement of AXL in the ability of ZIKV to infect mammalian cells, and also the requirement for endocytosis and acidic pH. We demonstrated that AXL is essential for ZIKV infection of human fibroblast cell line HT1080 as the targeted deletion of the gene for AXL in HT1080 cells made them no longer susceptible to ZIKV infection. Our results also showed that infection was prevented by lysosomotropic agents such as ammonium chloride, chloroquine and bafilomycin A1, which neutralize the normally acidic pH of endosomal compartments. Infection by ZIKV was also blocked by chlorpromazine, indicating a requirement for clathrin-mediated endocytosis. Taken together, our findings suggest that AXL most likely serves as an attachment factor for ZIKV on the cell surface, and that productive infection requires endocytosis and delivery of the virus to acidified intracellular compartments.
C1 [Persaud, Mirjana; Martinez-Lopez, Alicia; Buffone, Cindy; Porcelli, Steven A.; Diaz-Griffero, Felipe] Albert Einstein Coll Med, Dept Microbiol & Immunol, 1301 Morris Pk Price Ctr 501, Bronx, NY 10461 USA.
   [Porcelli, Steven A.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.
RP Diaz-Griffero, F (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, 1301 Morris Pk Price Ctr 501, Bronx, NY 10461 USA.
EM Felipe.Diaz-Griffero@einstein.yu.edu
OI buffone, cindy/0000-0003-1286-7245
FU NIAID NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [T32 AI007501]
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   da Fonseca NJ, 2017, BIOCHEM BIOPH RES CO, V492, P565, DOI 10.1016/j.bbrc.2017.01.041
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Diaz-Griffero F, 2002, J VIROL, V76, P12866, DOI 10.1128/JVI.76.24.12866-12876.2002
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Lienlaf M, 2011, J VIROL, V85, P8725, DOI 10.1128/JVI.00497-11
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Mukherjee S, 2014, METHODS MOL BIOL, V1138, P75, DOI 10.1007/978-1-4939-0348-1_6
   Pho MT, 2000, J VIROL, V74, P2288, DOI 10.1128/JVI.74.5.2288-2292.2000
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   RANDOLPH VB, 1990, J GEN VIROL, V71, P1845, DOI 10.1099/0022-1317-71-8-1845
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Stiasny K, 2006, J GEN VIROL, V87, P2755, DOI 10.1099/vir.0.82210-0
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   VOROVITCH MF, 1991, ARCH VIROL, V118, P133, DOI 10.1007/BF01311309
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 39
TC 20
Z9 20
U1 0
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAY
PY 2018
VL 518
BP 301
EP 312
DI 10.1016/j.virol.2018.03.009
PG 12
WC Virology
SC Virology
GA GE7CQ
UT WOS:000431388000032
PM 29574335
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Schultz, MJ
   Frydman, HM
   Connor, JH
AF Schultz, Michaela J.
   Frydman, Horacio M.
   Connor, John H.
TI Dual Insect specific virus infection limits Arbovirus replication in
   Aedes mosquito cells
SO VIROLOGY
LA English
DT Article
DE Arbovirus; Aedes; Coinfection; Superinfection; Mosquito cell lines; Zika
   virus; Phasi Charoen like virus; Cell fusing agent virus; Insect
   specific virus
ID FUSING AGENT VIRUS; ZIKA VIRUS; VECTOR COMPETENCE; ALBOPICTUS; AEGYPTI;
   FLAVIVIRUS; TRANSMISSION; SUSCEPTIBILITY; EVOLUTIONARY; TRISERIATUS
AB Aedes mosquitoes are vectors for many pathogenic viruses. Cell culture systems facilitate the investigation of virus growth in the mosquito vector. We found Zika virus (ZIKV) growth to be consistent in A. albopictus cells but hypervariable in A. aegypti cell lines. As a potential explanation of this variability, we tested the hypothesis that our cells harbored opportunistic viruses. We screened Aedes cell lines for the presence of insect specific viruses (ISVs), Cell-fusing agent virus (CFAV) and Phasi charoen-like virus (PCLV). PCLV was present in the ZIKV-growth-variable A. aegypti cell lines but absent in A. albopictus lines, suggesting that these ISVs may interfere with ZIKV growth. In support of this hypothesis, PCLV infection of CFAV-positive A. albopictus cells inhibited the growth of ZIKV, dengue virus and La Crosse virus. These data suggest ISV infection of cell lines can impact arbovirus growth leading to significant changes in cell permissivity to arbovirus infection.
C1 [Schultz, Michaela J.; Frydman, Horacio M.] Boston Univ, Dept Biol, 5 Cummington Mall, Boston, MA 02215 USA.
   [Schultz, Michaela J.; Frydman, Horacio M.; Connor, John H.] Boston Univ, Natl Emerging Infect Dis Labs, 620 Albany St, Boston, MA 02118 USA.
   [Connor, John H.] Boston Univ, Dept Microbiol, Sch Med, 72 East Concord St, Boston, MA 02118 USA.
RP Connor, JH (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, 620 Albany St, Boston, MA 02118 USA.
EM jhconnor@bu.edu
RI Schultz, Michaela/AAP-1140-2020
OI Schultz, Michaela/0000-0002-5054-8029
FU BU NEIDL; National Institute of Allergy and Infectious DiseasesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R21 NS101151, R56AI1097489, 1R56AI097589-01A1]
FX The Directors Fund, BU NEIDL; R21 NS101151 and R56AI1097489, National
   Institute of Allergy and Infectious Diseases; 1R56AI097589-01A1 National
   Institute of Allergy and Infectious Diseases. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Bara JJ, 2016, J MED ENTOMOL, V53, P1415, DOI 10.1093/jme/tjw097
   Bewick S, 2016, EMERG INFECT DIS, V22, P1921, DOI 10.3201/eid2211.160308
   Blitvich B. J., 2015, VIRUSES, V7
   Bolling B., 2015, VIRUSES, V7
   Bolling B. G., 2011, AM J TROP MED, V85
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Cafferata Maria Luisa, 2013, Value Health Reg Issues, V2, P347, DOI 10.1016/j.vhri.2013.10.002
   Chandler JA, 2014, VIROLOGY, V464, P312, DOI 10.1016/j.virol.2014.06.036
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0
   Coutinho-Abreu IV, 2010, PARASITOL INT, V59, P1, DOI 10.1016/j.parint.2009.10.002
   Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hall RA, 2016, EVOL BIOINFORM, V12, P35, DOI 10.4137/EBO.S40740
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Karpf AR, 1997, J VIROL, V71, P7119, DOI 10.1128/JVI.71.9.7119-7123.1997
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Lee SF, 2012, APPL ENVIRON MICROB, V78, P4740, DOI 10.1128/AEM.00069-12
   Maringer K, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3432-5
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Nicholson CO, 2011, ANTIVIR RES, V89, P71, DOI 10.1016/j.antiviral.2010.11.008
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135
   Sang R. C., 2003, ARCH VIROL, V148
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schultz MJ, 2018, DNA CELL BIOL, V37, P2, DOI 10.1089/dna.2017.4025
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Singh K R, 1971, Curr Top Microbiol Immunol, V55, P127
   Singh K. R., 1967, CURR SCI, V36
   SINGH KRP, 1968, CURR SCI INDIA, V37, P65
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Taber ED, 2017, J VECTOR ECOL, V42, P3, DOI 10.1111/jvec.12234
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Vasilakis N, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-97
   Vasilakis N, 2013, J VIROL, V87, P2475, DOI 10.1128/JVI.00776-12
   Walker T, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-382
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Westby KM, 2015, J AM MOSQUITO CONTR, V31, P233, DOI 10.2987/moco-31-03-233-241.1
   WHITE LA, 1987, J CLIN MICROBIOL, V25, P1221, DOI 10.1128/JCM.25.7.1221-1224.1987
   Wikan N, 2009, J VIROL METHODS, V157, P227, DOI 10.1016/j.jviromet.2008.12.019
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Zhang GM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07279-5
NR 57
TC 20
Z9 20
U1 0
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD MAY
PY 2018
VL 518
BP 406
EP 413
DI 10.1016/j.virol.2018.03.022
PG 8
WC Virology
SC Virology
GA GE7CQ
UT WOS:000431388000043
PM 29625404
OA Bronze
DA 2020-07-08
ER

PT J
AU Rothan, HA
   Bidokhti, MRM
   Byrareddy, SN
AF Rothan, Hussin A.
   Bidokhti, Mehdi R. M.
   Byrareddy, Siddappa N.
TI Current concerns and perspectives on Zika virus co-infection with
   arboviruses and HIV
SO JOURNAL OF AUTOIMMUNITY
LA English
DT Article
DE Zika virus; HIV; Flavivirus; Dengue; Chikungunya; Co-circulation;
   Vaccination; Co-infection
ID GUILLAIN-BARRE-SYNDROME; TROPICAL INFECTIOUS-DISEASES; DENGUE VIRUS;
   CYTOPLASMIC INCOMPATIBILITY; PLACENTAL PATHOLOGY; CROSS-REACTIVITY;
   ENVELOPE PROTEIN; VIRAL-INFECTION; CO-CIRCULATION; BLOCKS DENGUE
AB Dissemination of vector-borne viruses, such as Zika virus (ZIKV), in tropical and sub-tropical regions has a complicated impact on the immunopathogenesis of other endemic viruses such as dengue virus (DENV), chikungunya virus (CHIKV) and human immunodeficiency virus (HIV). The consequences of the possible co-infections with these viruses have specifically shown significant impact on the treatment and vaccination strategies. ZIKV is a mosquito-borne flavivirus from African and Asian lineages that causes neurological complications in infected humans. Many of DENV and CHIKV endemic regions have been experiencing outbreaks of ZIKV infection. Intriguingly, the mosquitoes, Aedes Aegypti and Aedes Albo-pictus, can simultaneously transmit all the combinations of ZIKV, DENV, and CHIKV to the humans. The co-circulation of these viruses leads to a complicated immune response due to the pre-existence or coexistence of ZIKV infection with DENY and CHIKV infections. The non-vector transmission of ZIKV, especially, via sexual intercourse and placenta represents an additional burden that may hander the treatment strategies of other sexually transmitted diseases such as HIV. Collectively, ZIKV co-circulation and co-infection with other viruses have inevitable impact on the host immune response, diagnosis techniques, and vaccine development strategies for the control of these co-infections. (C) 2018 Elsevier Ltd. All rights reserved.
C1 [Rothan, Hussin A.] Int Med Univ, Dept Human Biol, Kuala Lumpur 57000, Malaysia.
   [Bidokhti, Mehdi R. M.; Byrareddy, Siddappa N.] UNMC, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
RP Byrareddy, SN (corresponding author), UNMC, Coll Med, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
EM hussinrothan@imu.edu.my; mehdi.bidokhti@unmc.edu; sid.byrareddy@unmc.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI113883,
   R21AI114415, R21MH113455]; Nebraska Neuroscience Alliance Endowed Fund
   Award
FX This work is supported in part by the National Institutes of Health
   [R01AI113883; R21AI114415; and R21MH113455] and Nebraska Neuroscience
   Alliance Endowed Fund Award to SNB.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Agarwal A, 2017, J NEUROVIROL, V23, P504, DOI 10.1007/s13365-017-0516-1
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Andrade D. V., 2017, VIRUS RES, V17
   [Anonymous], 2017, EPIDEMIC EMERGING DI
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brelsfoard CL, 2011, J MED ENTOMOL, V48, P1008, DOI 10.1603/ME10202
   Brito CAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005583
   Cabral-Castro MJ, 2016, J CLIN VIROL, V82, P108, DOI 10.1016/j.jcv.2016.07.017
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caragata EP, 2016, FUTURE MICROBIOL, V11, P1499, DOI 10.2217/fmb-2016-0177
   Caragata EP, 2016, MICROB CELL, V3, P293, DOI 10.15698/mic2016.07.513
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chahal JS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00193-w
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   Cherabuddi Kartikeya, 2016, JMM Case Rep, V3, pe005072, DOI 10.1099/jmmcr.0.005072
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Christie CDC, 2016, W INDIAN MED J, V65, P239, DOI 10.7727/wimj.2016.454
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Colombo TE, 2017, J CLIN VIROL, V96, P20, DOI 10.1016/j.jcv.2017.09.002
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005947
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P785, DOI 10.1038/ni0715-785a
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Dickens BL, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw103
   Doughty CT, 2017, CURR NEUROL NEUROSCI, V17, DOI 10.1007/s11910-017-0724-3
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Goodwin CM, 2015, TRENDS MICROBIOL, V23, P789, DOI 10.1016/j.tim.2015.08.007
   Gotuzzo E, 2013, AM J TROP MED HYG, V89, P434, DOI 10.4269/ajtmh.13-0264
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gregianini TS, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1943
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Haslwanter D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006643
   Henein S, 2017, J INFECT DIS, V215, P351, DOI 10.1093/infdis/jiw576
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Hueston L, 2017, J INFECT DIS, V216, P612, DOI 10.1093/infdis/jix344
   Joao Esau Custodio, 2017, Pediatr Infect Dis J, V36, P500, DOI 10.1097/INF.0000000000001482
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Karp CL, 2007, CLIN INFECT DIS, V45, P1214, DOI 10.1086/522180
   Karp CL, 1999, CLIN INFECT DIS, V28, P947, DOI 10.1086/514745
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Lagunas-Rangel FA, 2017, J VIRUS ERAD, V3, P124
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu SQ, 2018, J MED VIROL, V90, P389, DOI 10.1002/jmv.24970
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Metz SW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04767-6
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   MONLUN E, 1993, B SOC PATHOL EXOT, V86, P21
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oom AL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05980-z
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pang JX, 2015, AM J TROP MED HYG, V92, P1156, DOI 10.4269/ajtmh.15-0031
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Puccioni-Sohler M, 2017, ARQ NEURO-PSIQUIAT, V75, P123, DOI [10.1590/0004-282X20160189, 10.1590/0004-282x20160189]
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Ritchie SA, 2017, J INFECT DIS, V215, pS103, DOI 10.1093/infdis/jiw575
   Ritter JM, 2017, ARCH PATHOL LAB MED, V141, P49, DOI 10.5858/arpa.2016-0397-SA
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Ross PA, 2017, JOVE-J VIS EXP, DOI 10.3791/56124
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Saucereau Y, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3985-y
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Selin LK, 1998, J EXP MED, V188, P1705, DOI 10.1084/jem.188.9.1705
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Simmons CP, 2015, NEW ENGL J MED, V373, P1263, DOI 10.1056/NEJMe1509442
   Solomon T, 2001, J INFECTION, V42, P104, DOI 10.1053/jinf.2001.0802
   Souares Y, 2000, Pac Health Dialog, V7, P11
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tan CH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005496
   Tappe D, 2013, EURO SURVEILL, V19
   Thomas SJ, 2016, NEW ENGL J MED, V375, P1212, DOI 10.1056/NEJMp1609300
   Torrentes-Carvalho A, 2016, CLIN IMMUNOL, V164, P95, DOI 10.1016/j.clim.2016.01.005
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Urbani S, 2005, J EXP MED, V201, P675, DOI 10.1084/jem.20041058
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Villamil-Gomez W, 2016, ENFERM INFEC MICR CL, V34, P140, DOI 10.1016/j.eimc.2015.05.012
   Villamil-Gomez WE, 2016, J INFECT PUBLIC HEAL, V9, P684, DOI 10.1016/j.jiph.2015.12.002
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Welsh RM, 2010, IMMUNOL REV, V235, P244, DOI 10.1111/j.0105-2896.2010.00897.x
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wiwanitkit V, 2016, AUTOIMMUN REV, V15, P855, DOI 10.1016/j.autrev.2016.04.002
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Xie X., 2017, MBIO, P8
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yuan S, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00062
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
   Zhang GM, 2016, J GEN VIROL, V97, P3427, DOI 10.1099/jgv.0.000653
NR 134
TC 22
Z9 22
U1 2
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0896-8411
EI 1095-9157
J9 J AUTOIMMUN
JI J. Autoimmun.
PD MAY
PY 2018
VL 89
BP 11
EP 20
DI 10.1016/j.jaut.2018.01.002
PG 10
WC Immunology
SC Immunology
GA GE4BA
UT WOS:000431158100002
PM 29352633
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hernandez-Avila, JE
   Palacio-Mejia, LS
   Lopez-Gatell, H
   Alpuche-Aranda, CM
   Molina-Velez, D
   Gonzalez-Gonzalez, L
   Hernandez-Avila, M
AF Eugenio Hernandez-Avila, Juan
   Sofia Palacio-Mejia, Lina
   Lopez-Gatell, Hugo
   Alpuche-Aranda, Celia M.
   Molina-Velez, Diana
   Gonzalez-Gonzalez, Leonel
   Hernandez-Avila, Mauricio
TI Zika virus infection estimates, Mexico
SO BULLETIN OF THE WORLD HEALTH ORGANIZATION
LA English
DT Article
ID BIRTH-DEFECTS; PREGNANCY; CERTIFICATE; SENSITIVITY; DENGUE; STATES
AB Objective To assess the magnitude of the Mexican epidemic of Zika virus infection and the associated risk of microcephaly.
   Methods From the reported number of laboratory-confirmed symptomatic infections among pregnant women and the relevant birth rate, we estimated the number of symptomatic cases of infection that occurred in Mexico between 25 November 2015, when the first confirmed Mexican case was reported, and 20 August 2016. We used data from the birth certificates to compare mean monthly incidences of congenital microcephaly before (1 January 2010-30 November 2015) and after (1 December 2015-30 September 2017) the introduction of Zika virus, stratifying the data according to whether the mother's place of residence was at an altitude of at least 2200 m above sea level. We used Poisson interrupted time series, statistical modelling and graphical analyses.
   Findings Our estimated number of symptomatic cases of infection that may have occurred in the general population of Mexico between 25 November 2015 and 20 August 2016, 60 172, was 7.3-fold higher than the corresponding number of reported cases. The monthly numbers of microcephaly cases per 100 000 live births were significantly higher after the introduction of the virus than before (incidence rate ratio, IRR: 2.9; 95% confidence interval, CI: 2.3 to 3.6), especially among the babies of women living at altitudes below 2200 m (IRR: 3.4; 95% CI: 2.9 to 3.9).
   Conclusion The Mexican epidemic appears to be much larger than indicated by estimates based solely on counts of laboratory-confirmed cases, and to be associated with significantly increased risk of microcephaly.
C1 [Eugenio Hernandez-Avila, Juan; Lopez-Gatell, Hugo; Alpuche-Aranda, Celia M.; Molina-Velez, Diana; Gonzalez-Gonzalez, Leonel] Natl Inst Publ Hlth, Cuernavaca, Morelos, Mexico.
   [Sofia Palacio-Mejia, Lina] Natl Council Sci & Technol, Mexico City, DF, Mexico.
   [Hernandez-Avila, Mauricio] Univ Guadalajara, Ctr Univ los Altos, Carretera Yahualica,Km 7-5, Tepatitlan De Morelos 47600, Jalisco, Mexico.
RP Hernandez-Avila, M (corresponding author), Univ Guadalajara, Ctr Univ los Altos, Carretera Yahualica,Km 7-5, Tepatitlan De Morelos 47600, Jalisco, Mexico.
EM mhenran.salud@gmail.com
RI amsalu, ribka/G-8780-2019; Molina-Velez, Diana/C-7308-2016; Palacio
   Mejia, Lina Sofia/C-8725-2014
OI Molina-Velez, Diana/0000-0003-1477-7884; Hernandez-Avila, Juan
   Eugenio/0000-0001-9638-6718; Palacio Mejia, Lina
   Sofia/0000-0003-3203-9420
CR Aghaeepour N, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan2946
   [Anonymous], 2016, ZIK VIR INF
   [Anonymous], 2016, CUB DIN INF SAL NAC
   [Anonymous], 2016, SERV INF OLAP EGR HO
   [Anonymous], 2017, ZIK EP REP
   [Anonymous], 2016, SERV INF OLAP DEF
   [Anonymous], 2015, MAN PROC EST VIG EP
   [Anonymous], 2013, MAJ BIRTH DEF DAT PE
   [Anonymous], 2016, B ENF IMSS
   [Anonymous], 2011, CENS POBL VIV 2010
   [Anonymous], 2016, LIN EST VIG EP DIAGN
   Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098
   Boulet SL, 2011, PUBLIC HEALTH REP, V126, P186, DOI 10.1177/003335491112600209
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cleveland RC, 1990, J OFF STAT, V6, P3, DOI DOI 10.1016/J.SOILBIO.2009.09.001
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Datos abiertos, 2012, DAT AB IND DEM 1990
   Datos abiertos, 2012, DAT AB ENT FED 2010
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fourth meeting of the Emergency Committee under the International Health Regulations, 2005, 4 M EM COMM INT HLTH
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gould WW, 1993, STATA TECHNICAL B, V3
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Henshaw SK, 1998, FAM PLANN PERSPECT, V30, P24, DOI 10.2307/2991522
   Heredia-Pi I, 2013, SALUD PUBLICA MEXICO, V55, pS249
   HOLTZMAN NA, 1986, ANNU REV PUBL HEALTH, V7, P237, DOI 10.1146/annurev.pu.07.050186.001321
   Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152
   Jimenez Corona Maria Eugenia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Mai CT, 2013, BIRTH DEFECTS RES A, V97, P709, DOI 10.1002/bdra.23198
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Ospina Martinez ML, 2017, ZIKA EN COLOMBIA
   Pacheco O, 2016, NEW ENGL J MED, DOI [10.1056/NEJMoa1604037, DOI 10.1056/NEJM0A1604037]
   Pan American Health Organization, 2015, ZIK CAS CONG SYNDR A
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Salemi JL, 2017, PAEDIATR PERINAT EP, V31, P67, DOI 10.1111/ppe.12326
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Torres-Galicia I, 2014, GAC MED MEX, V150, P122
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   World Health Organization, 2016, SURV ZIK VIR INF MIC
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 47
TC 5
Z9 5
U1 1
U2 5
PU WORLD HEALTH ORGANIZATION
PI GENEVA 27
PA MARKETING AND DISSEMINATION, CH-1211 GENEVA 27, SWITZERLAND
SN 0042-9686
EI 1564-0604
J9 B WORLD HEALTH ORGAN
JI Bull. World Health Organ.
PD MAY
PY 2018
VL 96
IS 5
BP 306
EP 313
DI 10.2471/BLT.17.201004
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GE4WC
UT WOS:000431217400006
PM 29875515
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU dos Reis, CA
   Florentino, HD
   Colon, D
   Rosa, SRF
   Cantane, DR
AF dos Reis, Celia A.
   Florentino, Helenice de O.
   Colon, Diego
   Fleury Rosa, Suelia R.
   Cantane, Daniela R.
TI An approach of the exact linearization techniques to analysis of
   population dynamics of the mosquito Aedes aegypti
SO MATHEMATICAL BIOSCIENCES
LA English
DT Article
DE Aedes aegypti; Dynamic model; Exact linearization techniques; Dengue;
   Chikungunya; Zika
ID DENGUE; FEVER
AB Dengue fever, chikungunya and zika are caused by different viruses and mainly transmitted by Aedes aegypti mosquitoes. These diseases have received special attention of public health officials due to the large number of infected people in tropical and subtropical countries and the possible sequels that those diseases can cause. In severe cases, the infection can have devastating effects, affecting the central nervous system, muscles, brain and respiratory system, often resulting in death. Vaccines against these diseases are still under development and, therefore, current studies are focused on the treatment of diseases and vector (mosquito) control. This work focuses on this last topic, and presents the analysis of a mathematical model describing the population dynamics of Aedes aegypti, as well as present the design of a control law for the mosquito population (vector control) via exact linearization techniques and optimal control. This control strategy optimizes the use of resources for vector control, and focuses on the aquatic stage of the mosquito life. Theoretical and computational results are also presented.
C1 [dos Reis, Celia A.] UNESP, FC, Dept Matemat, BR-17033360 Bauru, SP, Brazil.
   [Florentino, Helenice de O.; Cantane, Daniela R.] UNESP, IB, Dept Bioestat, BR-18618670 Botucatu, SP, Brazil.
   [Colon, Diego] Univ Sao Paulo, POLI, LAC PTC, BR-05508900 Sao Paulo, SP, Brazil.
   [Fleury Rosa, Suelia R.] Univ Brasilia, UnB, Brasilia, DF, Brazil.
RP Florentino, HD (corresponding author), UNESP, IB, Dept Bioestat, BR-18618670 Botucatu, SP, Brazil.
EM celia@fc.unesp.br; helenice@ibb.unesp.br; diego@lac.usp.br;
   suelia@unb.br
RI Colon, Diego/AAG-4290-2019; Colon, Diego/M-1584-2017; de Siqueira
   Rodrigues Fleury Rosa, Suelia/U-5343-2019; Florentino, Helenice de
   Oliveira/C-4308-2012
OI Colon, Diego/0000-0003-3709-6790; Colon, Diego/0000-0003-3709-6790; de
   Siqueira Rodrigues Fleury Rosa, Suelia/0000-0002-1247-9050; Florentino,
   Helenice de Oliveira/0000-0003-2740-8826; Cantane,
   Daniela/0000-0001-5561-3929
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2009/15098-0, 2014/01604-0]; FUNDUNESP/PROPE/UNESP; CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [302454/2016-0]; CAPESCAPES; PROPG UNESP
FX We wish to thank FAPESP (Grant No. 2009/15098-0 and 2014/01604-0),
   FUNDUNESP/PROPE/UNESP, CNPq (302454/2016-0), CAPES and PROPG UNESP for
   their financial support.
CR Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chen LQ, 1999, NONLINEAR DYNAM, V20, P309, DOI 10.1023/A:1008312908664
   Deb K., 2001, MULTIOBJECTIVE OPTIM
   Esteva L, 2005, MATH BIOSCI, V198, P132, DOI 10.1016/j.mbs.2005.06.004
   Fiorentino HO, 2014, MATH BIOSCI, V258, P77, DOI 10.1016/j.mbs.2014.08.013
   Hansen P, 2008, 4OR-Q J OPER RES, V6, P319, DOI 10.1007/s10288-008-0089-1
   Isidori A., 1995, NONLINEAR CONTROL SY
   Khalil H. K., 2002, NONLINEAR SYSTEMS
   Koiller M. A. S., 2014, RR8462 INRIA
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Slotine J.J.E., 1991, APPL NONLINEAR CONTR
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   WHO-World Health Organization, 2017, DAWNS SEV DENG
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
NR 15
TC 0
Z9 0
U1 0
U2 6
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0025-5564
EI 1879-3134
J9 MATH BIOSCI
JI Math. Biosci.
PD MAY
PY 2018
VL 299
BP 51
EP 57
DI 10.1016/j.mbs.2017.12.001
PG 7
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA GE4AK
UT WOS:000431156500004
PM 29253493
OA Green Published
DA 2020-07-08
ER

PT J
AU Catton, M
   Gray, G
   Griffin, D
   Hasegawa, H
   Kent, SJ
   Mackenzie, J
   McSweegan, E
   Mercer, N
   Wang, LF
AF Catton, Mike
   Gray, Glenda
   Griffin, Diane
   Hasegawa, Hideki
   Kent, Stephen J.
   Mackenzie, Jason
   McSweegan, Edward
   Mercer, Natalia
   Wang, Linfa
TI 2017 international meeting of the Global Virus Network
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Global virus network; Emerging viruses; International collaborations;
   Medical virology
ID HEPATITIS-C; T-CELLS; INFECTION; HIV; ZIKA; EVOLUTION; EFFICACY; STRESS
AB The Global Virus Network (GVN) was established in 2011 to strengthen research and responses to emerging viral causes of human disease and to prepare against new viral pandemics. There are now 40 GVN Centers of Excellence and 6 Affiliate laboratories in 24 countries. The 2017 meeting was held from September 25-27 in Melbourne, Australia, and was hosted by the Peter Doherty Institute for Infection and Immunity and the Institut Pasteur. This report highlights the recent accomplishments of GVN researchers in several important areas of medical virology, including the recent Zika epidemic, infections by human papillomavirus, influenza, HIV, hepatitis C, HTLV-1, and chikungunya viruses, and new and emerging viruses in the Australasia region. Plans for the 2018 meeting also are noted.
C1 [Catton, Mike] Peter Doherty Inst Infect & Immun, Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia.
   [Gray, Glenda] South African Med Res Council, Cape Town, South Africa.
   [Griffin, Diane] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Hasegawa, Hideki] Natl Inst Infect Dis, Tokyo, Japan.
   [Kent, Stephen J.; Mackenzie, Jason] Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.
   [McSweegan, Edward; Mercer, Natalia] Global Virus Network, 725 W Lombard St,Rm S-420, Baltimore, MD 21201 USA.
   [Wang, Linfa] Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore, Singapore.
RP McSweegan, E (corresponding author), Global Virus Network, 725 W Lombard St,Rm S-420, Baltimore, MD 21201 USA.
EM emcsweegan@gvn.org
RI Kent, Stephen/AAL-5101-2020
OI Kent, Stephen/0000-0002-8539-4891; Mackenzie, Jason/0000-0001-6613-8350
FU AbbvieAbbott Laboratories; Australian Centre for HIV and Hepatitis
   Virology Research (ACH2); Australian Centre for Hepatitis Virology;
   Bioniz; Club Melbourne; CSL Limited; FORT National Biopharmaceutical
   Company; GileadGilead Sciences; Institute of Human Virology/Nigeria;
   Melbourne Convention Exhibition Centre; ViiV Healthcare
FX We thank the participants who presented their data at the 2017
   International GVN Meeting. We thank The Peter Doherty Institute for
   Infection and Immunity, and the Australasian Society for HIV, Viral
   Hepatitis and Sexual Health Medicine (ASHM) for their outstanding
   management of the meeting and related events. Support also was provided
   by numerous sponsors, including, Abbvie, the Australian Centre for HIV
   and Hepatitis Virology Research (ACH<SUP>2</SUP>), the Australian Centre
   for Hepatitis Virology, Bioniz, Club Melbourne, CSL Limited, FORT
   National Biopharmaceutical Company, Gilead, The Institute of Human
   Virology/Nigeria, the Melbourne Convention Exhibition Centre, and ViiV
   Healthcare.
CR Akkina R, 2017, ANTIVIR RES, V142, P21, DOI 10.1016/j.antiviral.2017.03.005
   Alfano N, 2016, J VIROL, V90, P8169, DOI 10.1128/JVI.00723-16
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886
   Botting RA, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1923
   Brown A, 2016, SOC PSYCH PSYCH EPID, V51, P211, DOI 10.1007/s00127-015-1100-8
   Check Hayden E., 2013, NAT NEWS, DOI [10.1038/nature.2013.14324, DOI 10.1038/NATURE.2013.14324]
   Cheung AKL, 2017, NAT MICROBIOL, V2, P1389, DOI 10.1038/s41564-017-0006-5
   Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a
   ECDC, 2015, GEOGR DISTR AR HIGH
   Einsiedel L, 2018, J VIRUS ERAD, V4, P48
   Einsiedel L, 2016, J CLIN VIROL, V78, P93, DOI 10.1016/j.jcv.2016.03.006
   Einsiedel L, 2012, CLIN INFECT DIS, V54, P43, DOI 10.1093/cid/cir766
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Gallo RC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01800
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gray GE, 2016, CURR OPIN VIROL, V17, P104, DOI 10.1016/j.coviro.2016.02.010
   Hayward JA, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-35
   Hiener B, 2017, CELL REP, V21, P813, DOI 10.1016/j.celrep.2017.09.081
   Hobbs M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16171-1
   Hu S, 2017, VIROLOGY, V501, P115, DOI 10.1016/j.virol.2016.11.013
   Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752
   Mann A, 2011, NAT MED, V17, P394, DOI 10.1038/nm0411-394a
   Mathur P, 2017, ANTIVIR RES, V146, P184, DOI 10.1016/j.antiviral.2017.09.007
   Mire CE, 2017, NAT MED, V23, P1146, DOI 10.1038/nm.4396
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nelson TM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44423
   Nix WA, 2013, J GEN VIROL, V94, P2017, DOI 10.1099/vir.0.053827-0
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Pedrana AE, 2017, EXPERT REV CLIN PHAR, V10, P1023, DOI 10.1080/17512433.2017.1383894
   Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492
   Revill P, 2016, NAT REV GASTRO HEPAT, V13, P239, DOI 10.1038/nrgastro.2016.7
   Roche B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05957-y
   Satou Y, 2016, P NATL ACAD SCI USA, V113, P3054, DOI 10.1073/pnas.1423199113
   Schmitt K, 2018, VIROLOGY, V515, P235, DOI 10.1016/j.virol.2017.12.026
   Schmitt K, 2017, VIROLOGY, V510, P175, DOI 10.1016/j.virol.2017.07.005
   Sogaard OS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005142
   Sutton T. C., 2017, J VIROL, DOI [10.1128/JVI.00895-17.JVI.00895-17, DOI 10.1128/JVI.00895-17.JVI.00895-17]
   Tagaya Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01425
   Tarlinton RE, 2006, NATURE, V442, P79, DOI 10.1038/nature04841
   Watashi K, 2014, INT J MOL SCI, V15, P2892, DOI 10.3390/ijms15022892
   Wu GX, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92901
   Yozwiak NL, 2016, CELL, V166, P5, DOI 10.1016/j.cell.2016.06.029
   Zhang GJ, 2013, SCIENCE, V339, P456, DOI 10.1126/science.1230835
NR 47
TC 1
Z9 1
U1 1
U2 8
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2018
VL 153
BP 60
EP 69
DI 10.1016/j.antiviral.2018.02.001
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GE0GW
UT WOS:000430893100007
PM 29421321
OA Green Published
DA 2020-07-08
ER

PT J
AU Ono, SK
   Bassit, L
   Van Vaisberg, V
   Alves, VAF
   Caldini, EG
   Herman, BD
   Shabman, R
   Fedorova, NB
   Paranagua-Vezozzo, D
   Sampaio, CT
   Lages, RB
   Terrabuio, D
   Andraus, W
   Schinazi, RF
   Carrilho, FJ
AF Ono, Suzane Kioko
   Bassit, Leda
   Van Vaisberg, Victor
   Ferreira Alves, Venancio Avancini
   Caldini, Elia G.
   Herman, Brian D.
   Shabman, Reed
   Fedorova, Nadia B.
   Paranagua-Vezozzo, Denise
   Sampaio, Caroline Torres
   Lages, Rafael Bandeira
   Terrabuio, Debora
   Andraus, Wellington
   Schinazi, Raymond F.
   Carrilho, Flair Jose
TI Acute acalculous cholecystitis during zika virus infection in an
   immunocompromised patient
SO HEPATOLOGY
LA English
DT Editorial Material
C1 [Ono, Suzane Kioko; Van Vaisberg, Victor; Paranagua-Vezozzo, Denise; Sampaio, Caroline Torres; Lages, Rafael Bandeira; Terrabuio, Debora; Andraus, Wellington; Carrilho, Flair Jose] Univ Sao Paulo, Sch Med, Div Clin Gastroenterol & Hepatol, Dept Gastroenterol,Hosp Clin, Sao Paulo, Brazil.
   [Bassit, Leda; Herman, Brian D.; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, Atlanta, GA USA.
   [Ferreira Alves, Venancio Avancini; Caldini, Elia G.] Univ Sao Paulo, Dept Pathol, Sch Med, Sao Paulo, Brazil.
   [Shabman, Reed; Fedorova, Nadia B.] J Craig Venter Inst, Rockville, MD USA.
RP Ono, SK (corresponding author), Univ Sao Paulo, Sch Med, Dept Gastroenterol, Ave Dr Eneas Carvalho de Aguiar,255 ICHC, BR-05403000 Sao Paulo, Brazil.
EM suzane.ono@fm.usp.br
RI Caldini, Elia G/F-1105-2011; Paranagua-Vezozzo, Denise
   Cerqueira/N-7270-2014; Andraus, Wellington/G-1860-2012
OI Paranagua-Vezozzo, Denise Cerqueira/0000-0002-9606-4935; Andraus,
   Wellington/0000-0002-5162-138X; Vaisberg, Victor/0000-0002-2454-6273;
   caldini, elia/0000-0001-5322-3812
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [P30 AI050409, R21 AI129607]; Alves de
   Queiroz Family Fund for Research
FX Supported by NIH sponsored Center for AIDS Research grant P30 AI050409
   (to R.F.S.) and R21 AI129607 (to R.F.S.); Alves de Queiroz Family Fund
   for Research sponsored the Department of Gastroenterology. R.F.S. and
   N.F. report grants from the National Institute of Allergy and Infectious
   Diseases for Zika virus research, outside the submitted work.
CR dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Hakala T, 1997, BRIT J SURG, V84, P1249
   Nimmagadda SS, 2014, J CLIN DIAGN RES, V8, P71, DOI 10.7860/JCDR/2014/6885.3960
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Poddighe D, 2015, INT J HEPATOL, DOI 10.1155/2015/459608
   Sarmiento-Ospina A, 2016, LANCET INFECT DIS, V16, P523, DOI 10.1016/S1473-3099(16)30006-8
NR 6
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD MAY
PY 2018
VL 67
IS 5
BP 2051
EP 2054
DI 10.1002/hep.29682
PG 4
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA GD3FF
UT WOS:000430388500038
PM 29171859
OA Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Wang, WK
   Gubler, DJ
AF Wang, Wei-Kung
   Gubler, Duane J.
TI Potential Point-of-Care Testing for Dengue Virus in the Field
SO JOURNAL OF CLINICAL MICROBIOLOGY
LA English
DT Editorial Material
ID INSULATED ISOTHERMAL PCR; RAPID DETECTION; CHIKUNGUNYA; MULTIPLEX;
   ASSAY; MALARIA; DIFFERENTIATION; VALIDATION; SEROTYPES; ZIKA
AB The four serotypes of dengue virus (DENV) cause one of the most important and rapidly emerging mosquito-borne viral diseases in humans. Of the currently available diagnostic tests for dengue, the reverse transcription-PCR (RT-PCR) assay is the most sensitive and specific, and so it is commonly used as the gold standard. However, the requirement of a sophisticated and expensive thermal cycler makes it very difficult to use as a point-of-care diagnostic test in resource-limited regions where dengue is endemic. Tsai et al. (J Clin Microbiol 56:e01865-17, 2018, https://doi.org/10.1128/JCM.01865-17) report the analytical and clinical performances of a reverse transcription-insulated isothermal PCR (RT-iiPCR) assay with a portable nucleic acid analyzer for rapid detection of the four DENV serotypes; its reproducibility and complete agreement on clinical samples with the multiplex RT-PCR assay developed by the Centers for Disease Control and Prevention suggest that the dengue RT-iiPCR is a potential point-of-care test. Compared with other DENV RNA detection methods, the unique isothermal PCR design of RT-iiPCR, together with further improvements, would represent a promising new type of field-deployable diagnostic test for dengue.
C1 [Wang, Wei-Kung] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
   [Gubler, Duane J.] Duke NUS Grad Med Sch, Program Emerging Infect Dis, Singapore, Singapore.
RP Wang, WK (corresponding author), Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
EM wangwk@hawaii.edu
FU National Institute of Allergy and Infectious Diseases, NIHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI110769-01]; Duke-NUS Medical School (Singapore)
FX This work was supported by grant R01AI110769-01 (to W.-K.W.) from the
   National Institute of Allergy and Infectious Diseases, NIH, and Duke-NUS
   Medical School (Singapore). The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Ambagala A, 2017, TRANSBOUND EMERG DIS, V64, P476, DOI 10.1111/tbed.12388
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Britton S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1158-0
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chang HFG, 2012, BIOTECHNOL J, V7, P662, DOI 10.1002/biot.201100453
   Chua KH, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1183-z
   Go YY, 2017, J MOL DIAGN, V19, P817, DOI 10.1016/j.jmoldx.2017.06.007
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Lau YL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138694
   Li SH, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-360
   Lu X, 2012, AM J TROP MED HYG, V87, P947, DOI 10.4269/ajtmh.2012.11-0721
   Neeraja M, 2015, J VIROL METHODS, V211, P22, DOI 10.1016/j.jviromet.2014.10.005
   Oriero EC, 2015, J ANTIMICROB CHEMOTH, V70, P2, DOI 10.1093/jac/dku343
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pang JX, 2017, J CLIN MICROBIOL, V55, P3339, DOI 10.1128/JCM.00707-17
   Parida M, 2005, J CLIN MICROBIOL, V43, P2895, DOI 10.1128/JCM.43.6.2895-2903.2005
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Simmons M, 2016, J CLIN MICROBIOL, V54, P1766, DOI 10.1128/JCM.00299-16
   Tsai JJ, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01865-17, 10.1128/JCM.01865-17]
   Tsai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045278
   Tsen HY, 2013, J FOOD PROTECT, V76, P1322, DOI 10.4315/0362-028X.JFP-12-553
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341
   World Health Organization, 2009, DENG HEM FEV DIAGN T
NR 25
TC 7
Z9 7
U1 2
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0095-1137
EI 1098-660X
J9 J CLIN MICROBIOL
JI J. Clin. Microbiol.
PD MAY
PY 2018
VL 56
IS 5
AR UNSP e00203-18
DI 10.1128/JCM.00203-18
PG 4
WC Microbiology
SC Microbiology
GA GD9TV
UT WOS:000430856400009
PM 29514934
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Horstick, O
   Runge-Ranzinger, S
AF Horstick, Olaf
   Runge-Ranzinger, Silvia
TI Protection of the house against Chagas disease, dengue, leishmaniasis,
   and lymphatic filariasis: a systematic review
SO LANCET INFECTIOUS DISEASES
LA English
DT Review
ID INSECTICIDE-TREATED CURTAINS; RANDOMIZED CONTROLLED-TRIAL; WATER
   CONTAINER COVERS; VECTOR CONTROL; CUTANEOUS LEISHMANIASIS;
   AEDES-AEGYPTI; VISCERAL LEISHMANIASIS; IMPREGNATED CURTAINS;
   TRANSMISSION; DISTRICT
AB In light of the recent Zika virus outbreak, vector control has received renewed interest. However, which interventions are efficacious and community effective and how to best deliver them remains unclear. Following PRISMA guidelines, we did a systematic review to assess evidence for applied vector control interventions providing protection against Chagas disease, dengue, leishmaniasis, and lymphatic filariasis at the household level. We searched for published literature and grey literature between Jan 1, 1980, and Nov 30, 2015, and updated our search on April 2, 2017, using databases including the Cochrane, Embase, LILACS, PubMed, Web of Science, and WHOLIS. The Cochrane Collaboration's tool for assessing risk of bias was used. Inclusion criteria included studies reporting vector control interventions in and around a house or dwelling; and use of insecticides as sprays on netting or screens, and any method to control larval breeding in water containers in and around the home. 1416 articles were assessed and 32 articles included. The most effective interventions affecting vector indices for multiple diseases were found to be intradomiciliary residual spraying, insecticide-treated materials (especially insecticide-treated nets or curtains), and treatment of larval habitats with biological and chemical methods. Waste management and clean- up campaigns reduce vector populations, although to a lesser extent than other interventions and not consistently. Modifications to the structure of homes (eg, wall plastering) had no impact on the control of vectors. Protection of the house and its surroundings might affect the transmission of several diseases. The most effective interventions should be prioritised when vector control programmes are designed; however, the quality of delivery (ie, coverage and reapplication) of interventions is a crucial factor to ensure their effectiveness. Additional randomised trials that assess the measures of human disease and eventually target several diseases with a combination of interventions that protect the household and its inhabitants against multiple vectors, are needed to inform global policy in this area.
C1 [Horstick, Olaf; Runge-Ranzinger, Silvia] Heidelberg Univ, Inst Publ Hlth, D-69120 Heidelberg, Germany.
   [Runge-Ranzinger, Silvia] WHO, Special Programme Res & Training Trop Dis, Geneva, Switzerland.
RP Runge-Ranzinger, S (corresponding author), Heidelberg Univ, Inst Publ Hlth, D-69120 Heidelberg, Germany.
EM s.runge-ranzinger@t-online.de
FU World Health Organization's Special Program for Research and Training in
   Tropical Diseases (WHO/TDR Project) [B40295]
FX This systematic review was funded by the World Health Organization's
   Special Program for Research and Training in Tropical Diseases (WHO/TDR
   Project ID B40295).
CR Abeyewickreme W, 2012, PATHOG GLOB HEALTH, V106, P479, DOI 10.1179/2047773212Y.0000000060
   Andersson N, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h3267
   Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056
   Bogh C, 1998, MED VET ENTOMOL, V12, P52, DOI 10.1046/j.1365-2915.1998.00091.x
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Caprara A, 2015, T ROY SOC TROP MED H, V109, P99, DOI 10.1093/trstmh/tru187
   Cecere MC, 2013, J MED ENTOMOL, V50, P394, DOI 10.1603/ME12109
   Che-Mendoza A, 2015, T ROY SOC TROP MED H, V109, P106, DOI 10.1093/trstmh/tru189
   Chowdhury R, 2011, AM J TROP MED HYG, V84, P662, DOI 10.4269/ajtmh.2011.10-0682
   De Urioste-Stone SM, 2015, T ROY SOC TROP MED H, V109, P159, DOI 10.1093/trstmh/tru202
   Degener CM, 2014, J MED ENTOMOL, V51, P408, DOI 10.1603/ME13107
   Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002
   Dinesh DS, 2008, TROP MED INT HEALTH, V13, P953, DOI 10.1111/j.1365-3156.2008.02096.x
   Emami M. M., 2009, Eastern Mediterranean Health Journal, V15, P1075
   Erlanger TE, 2008, MED VET ENTOMOL, V22, P203, DOI 10.1111/j.1365-2915.2008.00740.x
   Espinoza-Gomez F, 2002, J EPIDEMIOL COMMUN H, V56, P148, DOI 10.1136/jech.56.2.148
   Feliciangeli MD, 2003, T ROY SOC TROP MED H, V97, P641
   Focks DA, 2000, AM J TROP MED HYG, V62, P11, DOI 10.4269/ajtmh.2000.62.11
   Gidwani K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001296
   Golding N, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0491-4
   Gonzalez U, 2015, COCHRANE DB SYST REV, V5
   Gurtler RE, 2004, B WORLD HEALTH ORGAN, V82, P196
   Herber O, 2003, ACTA TROP, V88, P33, DOI 10.1016/S0001-706X(03)00193-1
   Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928
   Horstick Olaf, 2015, Southeast Asian J Trop Med Public Health, V46 Suppl 1, P131
   Horstick O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003632
   Huda MM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1881-8
   Jalouk L, 2007, T ROY SOC TROP MED H, V101, P360, DOI 10.1016/j.trstmh.2006.07.011
   Joshi AB, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-54
   Kittayapong P, 2012, PATHOG GLOB HEALTH, V106, P446, DOI 10.1179/2047773212Y.0000000059
   Kroeger A, 2003, AM J TROP MED HYG, V68, P307, DOI 10.4269/ajtmh.2003.68.307
   Kroeger A, 2002, BMJ-BRIT MED J, V325, P810, DOI 10.1136/bmj.325.7368.810
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Lenhart A, 2013, AM J TROP MED HYG, V88, P254, DOI 10.4269/ajtmh.2012.12-0423
   Manrique-Saide P, 2015, EMERG INFECT DIS, V21, P308, DOI 10.3201/eid2102.140533
   Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097
   Mondal D, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004932
   Nadim A, 2009, EVALUATION PYRETHROI
   Nagpal S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002238
   Nathan MB, 2006, ANN TROP MED PARASIT, V100, pS1, DOI 10.1179/136485906X105462
   Oliveira Filho AM, 2000, CAD SAUDE PUBLICA, V16, pS105
   Picado A, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6760
   Picado A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000587
   Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Reyburn H, 2000, T ROY SOC TROP MED H, V94, P361, DOI 10.1016/S0035-9203(00)90104-4
   Saadatian-Elahi M, 2016, VACCINE, V34, P1139, DOI 10.1016/j.vaccine.2016.01.021
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Stockdale L, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002278
   Werneck GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003172
   WHO, 2009, INT VECT MAN WORK GR
   WHO, 2009, DENG GUID DIAGN PREV
   Wilson AL, 2015, TRENDS PARASITOL, V31, P380, DOI 10.1016/j.pt.2015.04.015
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   World Health Organization, 2014, GLOB BRIEF VECT BORN
NR 55
TC 6
Z9 6
U1 2
U2 16
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2018
VL 18
IS 5
BP E147
EP E158
DI 10.1016/S1473-3099(17)30422-X
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA GD5TN
UT WOS:000430569700001
PM 29074038
DA 2020-07-08
ER

PT J
AU Kaye, D
AF Kaye, Donald
TI Takeda Initiates Phase 1 Clinical Trial of Zika Vaccine Candidate
SO CLINICAL INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD MAY 1
PY 2018
VL 66
IS 9
BP II
EP II
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GD7IF
UT WOS:000430684600004
DA 2020-07-08
ER

PT J
AU Wang, BX
   Thurmond, S
   Hai, R
   Song, JK
AF Wang, Boxiao
   Thurmond, Stephanie
   Hai, Rong
   Song, Jikui
TI Structure and function of Zika virus NS5 protein: perspectives for drug
   design
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Review
DE Viral replication; Flavivirus; Non-structural protein 5; RNA capping;
   Pathogen-host interaction; Drug discovery; Antiviral inhibitors
ID HEPATITIS-C VIRUS; DEPENDENT RNA-POLYMERASE; DE-NOVO INITIATION;
   ENCEPHALITIS-VIRUS; JAPANESE-ENCEPHALITIS; CRYSTAL-STRUCTURE; NUCLEOSIDE
   INHIBITORS; ANTIVIRAL ACTIVITY; VIRAL REPLICATION; IN-VITRO
AB Zika virus (ZIKV) belongs to the positive-sense single-stranded RNA-containing Flaviviridae family. Its recent outbreak and association with human diseases (e.g. neurological disorders) have raised global health concerns, and an urgency to develop a therapeutic strategy against ZIKV infection. However, there is no currently approved antiviral against ZIKV. Here we present a comprehensive overview on recent progress in structure-function investigation of ZIKV NS5 protein, the largest non-structural protein of ZIKV, which is responsible for replication of the viral genome, RNA capping and suppression of host interferon responses. Structural comparison of the N-terminal methyltransferase domain and C-terminal RNA-dependent RNA polymerase domain of ZIKV NS5 with their counterparts from related viruses provides mechanistic insights into ZIKV NS5-mediated RNA replication, and identifies residues critical for its enzymatic activities. Finally, a collection of recently identified small molecule inhibitors against ZIKV NS5 or its closely related flavivirus homologues are also discussed.
C1 [Wang, Boxiao; Song, Jikui] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.
   [Thurmond, Stephanie; Hai, Rong] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
RP Song, JK (corresponding author), Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA.; Hai, R (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.
EM ronghai@ucr.edu; jikui.song@ucr.edu
FU March of Dimes FoundationMarch of Dimes [1-FY15-345]; Kimmel Scholar
   Award from Sidney Kimmel Foundation for Cancer Research; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [1R35GM119721]; Trans fund of state of California
   [AB2664]
FX This work was supported by March of Dimes Foundation (1-FY15-345),
   Kimmel Scholar Award from Sidney Kimmel Foundation for Cancer Research
   and NIH (1R35GM119721) to J.S. This work is also partly funded by Trans
   fund of state of California (AB2664) to J.S. and R.H.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Benarroch D, 2004, VIROLOGY, V328, P208, DOI 10.1016/j.virol.2004.07.004
   Best SM, 2005, J VIROL, V79, P12828, DOI 10.1128/JVI.79.20.12828-12839.2005
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Bressanelli S, 2002, J VIROL, V76, P3482, DOI 10.1128/JVI.76.7.3482-3492.2002
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   Butcher SJ, 2001, NATURE, V410, P235, DOI 10.1038/35065653
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castro C, 2009, NAT STRUCT MOL BIOL, V16, P212, DOI 10.1038/nsmb.1540
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chatelain G, 2013, EUR J MED CHEM, V65, P249, DOI 10.1016/j.ejmech.2013.04.034
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Choi KH, 2009, CURR OPIN STRUC BIOL, V19, P746, DOI 10.1016/j.sbi.2009.10.015
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Eltahla AA, 2015, VIRUSES-BASEL, V7, P5206, DOI 10.3390/v7102868
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Ferrer-Orta C, 2006, CURR OPIN STRUC BIOL, V16, P27, DOI 10.1016/j.sbi.2005.12.002
   Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GUIRAKHOO F, 1991, J GEN VIROL, V72, P1323, DOI 10.1099/0022-1317-72-6-1323
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Iglesias NG, 2011, J VIROL, V85, P5745, DOI 10.1128/JVI.02343-10
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jain R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01756-7
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Keating GM, 2014, DRUGS, V74, P273, DOI 10.1007/s40265-014-0179-7
   Kohler JJ, 2007, ENVIRON MOL MUTAGEN, V48, P166, DOI 10.1002/em.20223
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lam AM, 2014, ANTIMICROB AGENTS CH, V58, P6861, DOI 10.1128/AAC.03847-14
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Li F, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.10
   Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Liu Lihui, 2010, Front Biol (Beijing), V5, P286
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Migliaccio G, 2003, J BIOL CHEM, V278, P49164, DOI 10.1074/jbc.M305041200
   Morozova O V, 1991, Biomed Sci, V2, P183
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Qing J, 2016, ANTIVIR RES, V126, P43, DOI 10.1016/j.antiviral.2015.12.010
   Ranjith-Kumar CT, 2002, J VIROL, V76, P12526, DOI 10.1128/JVI.76.24.12526-12536.2002
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Salgado PS, 2004, STRUCTURE, V12, P307, DOI 10.1016/j.str.2004.01.012
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schul W, 2007, J INFECT DIS, V195, P665, DOI 10.1086/511310
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Selisko B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002912
   Selisko B, 2010, J GEN VIROL, V91, P112, DOI 10.1099/vir.0.015511-0
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shu B, 2017, RNA BIOL, V14, P1314, DOI 10.1080/15476286.2017.1300221
   Sofia MJ, 2010, J MED CHEM, V53, P7202, DOI 10.1021/jm100863x
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   Tsai CH, 2006, CURR PHARM DESIGN, V12, P1339, DOI 10.2174/138161206776361156
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou AM, 1999, VIROLOGY, V258, P435, DOI 10.1006/viro.1999.9738
   Zhou H, 2017, ONCOTARGET, V8, P14830, DOI 10.18632/oncotarget.14780
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 124
TC 16
Z9 16
U1 2
U2 20
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
EI 1420-9071
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD MAY
PY 2018
VL 75
IS 10
BP 1723
EP 1736
DI 10.1007/s00018-018-2751-x
PG 14
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA GD5HS
UT WOS:000430538600002
PM 29423529
OA Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Rojas-Pinzon, PA
   Silva-Fernandez, JJ
   Dussan, J
AF Rojas-Pinzon, Paula A.
   Silva-Fernandez, Juan J.
   Dussan, Jenny
TI Laboratory and simulated-field bioassays for assessing mixed cultures of
   Lysinibacillus sphaericus against Aedes aegypti (Diptera: Culicidae)
   larvae resistant to temephos
SO APPLIED ENTOMOLOGY AND ZOOLOGY
LA English
DT Article
DE Aedes aegypti; Temephos-resistant; Lysinibacillus sphaericus; Vegetative
   cells; Simulated field
ID LARVICIDAL ACTIVITY; CANNIBALISM; ISRAELENSIS
AB Aedes aegypti (L.) is the main vector of tropical diseases such as dengue, chikungunya and Zika. Due to the overuse of insecticides, Ae. aegypti resistant populations have increased. Biological control with Lysinibacillus sphaericus (Ahmed) has been used against Culex sp. and Anopheles sp. Although Ae. aegypti is refractory to the binary toxin of L. sphaericus spores, vegetative cells have been shown to be effective against Ae. aegypti larvae. In this work, the effect of L. sphaericus vegetative cells on Ae. aegypti temephos-resistant larvae was assessed under lab and simulated field conditions. L. sphaericus caused about 90% mortality of insecticide-resistant Ae. aegypti larvae under simulated field conditions. Likewise, Ae. aegypti larvae were more sensitive to mixed cultures of L. sphaericus than to individual strains; then, the most effective mixed culture exhibited an LC50 of 1.21 x 10(5) CFU/mL with Rockefeller larvae and 8.04 x 10(4) CFU/mL with field-collected larvae. Additionally, we found that mixed cultures composed of two L. sphaericus strains were more effective than a culture formed by the three strains. Our results suggest that mixed cultures comprising L. sphaericus vegetative cells could be useful for controlling temephos-resistant populations of Ae. aegypti, as evidenced by the effectiveness demonstrated under laboratory and simulated field conditions.
C1 [Rojas-Pinzon, Paula A.; Silva-Fernandez, Juan J.; Dussan, Jenny] Univ Andes, Dept Biol Sci, Microbiol Res Ctr CIMIC, Carrera 1 18 A-10,J-206, Bogota, Colombia.
   [Silva-Fernandez, Juan J.] Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.
RP Dussan, J (corresponding author), Univ Andes, Dept Biol Sci, Microbiol Res Ctr CIMIC, Carrera 1 18 A-10,J-206, Bogota, Colombia.
EM pa.rojas2807@uniandes.edu.co; js3274@cornell.edu;
   jdussan@uniandes.edu.co
OI Dussan G., Jenny/0000-0002-9901-1214
FU School of Science at Universidad de los Andes and the Microbiological
   Research Center (CIMIC)
FX We are grateful to the National Institute of Health (INS) in Bogota,
   Colombia, for the donated individuals, and to Marlon Salgado and Nestor
   Pintor for the field-strain collection. We want to thank Nicole Adriana
   Bruskewitz and Douglas Waters for the language assistance. We also want
   to thank Camilo Andres Gomez-Garzon for critical review of the
   manuscript. This study was funded by the Research Fund at the School of
   Science at Universidad de los Andes and the Microbiological Research
   Center (CIMIC).
CR Llinas GA, 2010, MEM I OSWALDO CRUZ, V105, P113, DOI 10.1590/S0074-02762010000100019
   Rojas-Pinzon PA, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2348-9
   Rojas-Pinzon PA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2171-z
   Arshad S, 2015, J PAK MED ASSOC, V65, P3
   Bauer L.S., 2008, NEWSL MICH ENTOMOL S, V53, P38
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008
   Allievi MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111114
   Macoris MDD, 2014, REV SOC BRAS MED TRO, V47, P573, DOI 10.1590/0037-8682-0141-2014
   de Araujo AP, 2007, BIOL CONTROL, V41, P339, DOI 10.1016/j.biocontrol.2007.03.002
   de Melo-Santos MAV, 2001, MEM I OSWALDO CRUZ, V96, P859, DOI 10.1590/S0074-02762001000600020
   De Souza ML, 1998, APPL ENVIRON MICROB, V64, P178
   Dong YH, 2005, J MICROBIOL, V43, P101
   Dong YH, 2004, APPL ENVIRON MICROB, V70, P954, DOI 10.1128/AEM.70.2.954-960.2004
   Dussan J., 2002, REV COLOMB BIOTECNOL, V4, P89
   Gonzalez-Pastor JE, 2011, FEMS MICROBIOL REV, V35, P415, DOI 10.1111/j.1574-6976.2010.00253.x
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Gomez-Garzon C, 2017, CAN J MICROBIOL, V63, P74, DOI 10.1139/cjm-2016-0323
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Hafeez F, 2011, PARASITOL RES, V109, P221, DOI 10.1007/s00436-010-2228-9
   Hernandez-Santana A, 2016, COMPLETE GENOME SEQU, DOI [10.1128/genomeA.00545-16, DOI 10.1128/GENOMEA.00545-16]
   Jain A, 2015, J PLANT PHYSIOL, V182, P79, DOI 10.1016/j.jplph.2015.05.004
   Jakka SRK, 2016, SCI REP-UK, V6, DOI 10.1038/srep27860
   Jurat-Fuentes JL, 2012, INSECT PATHOLOGY, 2ND EDITION, P265, DOI 10.1016/B978-0-12-384984-7.00008-7
   Kamareddine L, 2012, TOXINS, V4, P748, DOI 10.3390/toxins4090748
   Lee Dong Chan, 2013, Insects, V4, P217, DOI 10.3390/insects4020217
   Lopes J, 2010, BRAZ J BIOL, V70, P1109, DOI 10.1590/S1519-69842010000500029
   Lozano LC, 2013, WORLD J MICROB BIOT, V29, P1383, DOI 10.1007/s11274-013-1301-9
   Lozano LC, 2011, BIOTECHNOL LETT, V33, P2037, DOI 10.1007/s10529-011-0666-9
   Marchese S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045767
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Martinuz A, 2012, PHYTOPATHOLOGY, V102, P260, DOI 10.1094/PHYTO-04-11-0120
   Monnerat R., 2012, BIOASSAY, V7, P1, DOI DOI 10.14295/BA.V7.0.73
   Nandy SK, 2007, FEBS LETT, V581, P151, DOI 10.1016/j.febslet.2006.12.011
   Lemes ARN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107196
   Osborn FR, 2007, MEM I OSWALDO CRUZ, V102, P69, DOI 10.1590/S0074-02762007000100011
   Patowary K, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01092
   R Core Team, 2015, R LANG ENV STAT COMP
   Reiter P, 2001, GUIDELINES ASSESSING
   Rey A, 2016, COMPLETE GENOME SEQU, DOI [10.1128/genomeA.00257-16, DOI 10.1128/GENOMEA.00257-16]
   Rey A, 2016, GENOM DATA, V9, P78, DOI 10.1016/j.gdata.2016.06.002
   Roderick GK, 2003, NAT REV GENET, V4, P889, DOI 10.1038/nrg1201
   ROSENHEIM JA, 1989, J ECON ENTOMOL, V82, P331, DOI 10.1093/jee/82.2.331
   Rungrod A, 2009, BIOTECHNOL LETT, V31, P551, DOI 10.1007/s10529-008-9896-x
   Salazar FV, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-145
   Santacoloma L, 2012, BIOMEDICA, V32, P333, DOI [10.7705/biomedica.v32i3.680, 10.1590/S0120-41572012000300004]
   Tabashnik BE, 2012, J ECON ENTOMOL, V105, P767, DOI 10.1603/EC12080
   Tangsongcharoen C, 2015, J INVERTEBR PATHOL, V128, P57, DOI 10.1016/j.jip.2015.04.008
   Vega-Cabrera A, 2014, TOXINS, V6, P464, DOI 10.3390/toxins6020464
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
NR 50
TC 3
Z9 3
U1 3
U2 6
PU SPRINGER JAPAN KK
PI TOKYO
PA CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065,
   JAPAN
SN 0003-6862
EI 1347-605X
J9 APPL ENTOMOL ZOOL
JI Appl. Entomol. Zoolog.
PD MAY
PY 2018
VL 53
IS 2
BP 183
EP 191
DI 10.1007/s13355-017-0534-8
PG 9
WC Entomology
SC Entomology
GA GD5GW
UT WOS:000430536400002
DA 2020-07-08
ER

PT J
AU Victorio, CB
   Tham, JY
   Watanabe, S
   Sekula, A
   Ong, J
   Reolo, MJ
   Low, J
   Vasudevan, S
   Chacko, AM
AF Victorio, Carla Bianca
   Tham, Jing Yang
   Watanabe, Satoru
   Sekula, Agnieszka
   Ong, Joanne
   Reolo, Marie Jennifer
   Low, Jenny
   Vasudevan, Subhash
   Chacko, Ann-Marie
TI FDG-PET/CT imaging of Zika virus infection in a murine model
SO JOURNAL OF NUCLEAR MEDICINE
LA English
DT Meeting Abstract
CT Annual Meeting of the Society-of-Nuclear-Medicine-and-Molecular-Imaging
   (SNMMI)
CY JUN 23-26, 2018
CL Philadelphia, PA
SP Soc Nucl Med & Mol Imaging
C1 [Watanabe, Satoru; Low, Jenny; Vasudevan, Subhash] Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore, Singapore.
   [Victorio, Carla Bianca; Tham, Jing Yang; Sekula, Agnieszka; Ong, Joanne; Reolo, Marie Jennifer; Chacko, Ann-Marie] Duke NUS Med Sch, Canc & Stem Cell Biol Programme, Lab Translat & Mol Imaging, Singapore, Singapore.
   [Low, Jenny] Singapore Gen Hosp, Dept Infect Dis, Singapore, Singapore.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SOC NUCLEAR MEDICINE INC
PI RESTON
PA 1850 SAMUEL MORSE DR, RESTON, VA 20190-5316 USA
SN 0161-5505
EI 1535-5667
J9 J NUCL MED
JI J. Nucl. Med.
PD MAY 1
PY 2018
VL 59
SU 1
MA 448
PG 2
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA HX6BV
UT WOS:000467489900448
DA 2020-07-08
ER

PT J
AU Yang, LP
   Wang, R
   Yang, SX
   Ma, ZX
   Lin, SL
   Nan, YC
   Li, QS
   Tang, QY
   Zhang, YJ
AF Yang, Liping
   Wang, Rong
   Yang, Shixing
   Ma, Zexu
   Lin, Shaoli
   Nan, Yuchen
   Li, Qisheng
   Tang, Qiyi
   Zhang, Yan-Jin
TI Karyopherin Alpha 6 Is Required for Replication of Porcine Reproductive
   and Respiratory Syndrome Virus and Zika Virus
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE PRRSV; ZIKV; virus replication; nucleocytoplasmic trafficking system;
   karyopherin alpha 6; KPNA6; KPNA6 turnover; porcine reproductive and
   respiratory syndrome virus
ID NUCLEAR IMPORT; MONOCLONAL-ANTIBODIES; PROTEIN; TRANSPORT; INHIBIT;
   IMPORTIN-ALPHA-7; PATHOGENESIS; TRAFFICKING; INFECTION; SEQUENCE
AB Movement of macromolecules between the cytoplasm and the nucleus occurs through the nuclear pore complex (NPC). Karyopherins comprise a family of soluble transport factors facilitating the nucleocytoplasmic translocation of proteins through the NPC. In this study, we found that karyopherin alpha 6 (KPNA6; also known as importin alpha 7) was required for the optimal replication of porcine reproductive and respiratory syndrome virus (PRRSV) and Zika virus (ZIKV), which are positive-sense, single-stranded RNA viruses replicating in the cytoplasm. The KPNA6 protein level in virus-infected cells was much higher than that in mock-infected controls, whereas the KPNA6 transcript remains stable. Viral infection blocked the ubiquitin-proteasomal degradation of KPNA6, which led to an extension of the KPNA6 half-life and the elevation of the KPNA6 level in comparison to mock-infected cells. PRRSV nsp12 protein induced KPNA6 stabilization. KPNA6 silencing was detrimental to the replication of PRRSV, and KPNA6 knockout impaired ZIKV replication. Moreover, KPNA6 knockout blocked the nuclear translocation of PRRSV nsp1 beta but had a minimal effect on two other PRRSV proteins with nuclear localization. Exogenous restitution of KPNA6 expression in the KPNA6-knockout cells results in restoration of the nuclear translocation of PRRSV nsp1 beta and the replication of ZIKV. These results indicate that KPNA6 is an important cellular factor for the replication of PRRSV and ZIKV.
   IMPORTANCE Positive-sense, single-stranded RNA (+ssRNA) viruses replicate in the cytoplasm of infected cells. The roles of transport factors in the nucleocytoplasmic trafficking system for the replication of +ssRNA viruses are not known. In this study, we discovered that PRRSV and ZIKV viruses needed karyopherin alpha 6 (KPNA6), one of the transport factors, to enhance the virus replication. Our data showed that viral infection induced an elevation of the KPNA6 protein level due to an extension of the KPNA6 half-life via viral interference of the ubiquitin-proteasomal degradation of KPNA6. Notably, KPNA6 silencing or knockout dramatically reduced the replication of PRRSV and ZIKV. PRRSV nsp1 beta depended on KPNA6 to translocate into the nucleus. In addition, exogenous restitution of KPNA6 expression in KPNA6-knockout cells led to the restoration of nsp1 beta nuclear translocation and ZIKV replication. These results reveal a new aspect in the virus-cell interaction and may facilitate the development of novel antiviral therapeutics.
C1 [Yang, Liping; Wang, Rong; Yang, Shixing; Ma, Zexu; Lin, Shaoli; Nan, Yuchen; Zhang, Yan-Jin] Univ Maryland, Mol Virol Lab, VA MD Coll Vet Med, College Pk, MD 20742 USA.
   [Yang, Liping; Wang, Rong; Yang, Shixing; Ma, Zexu; Lin, Shaoli; Nan, Yuchen; Zhang, Yan-Jin] Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA.
   [Li, Qisheng] NIDDK, Liver Dis Branch, NIH, Bethesda, MD USA.
   [Tang, Qiyi] Howard Univ, Coll Med, Dept Microbiol, Washington, DC USA.
   [Wang, Rong] Xi An Jiao Tong Univ, Coll Med, Xian, Shaanxi, Peoples R China.
   [Yang, Shixing] Jiangsu Univ, Sch Med, Zhenjiang, Jiangsu, Peoples R China.
   [Nan, Yuchen] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China.
RP Zhang, YJ (corresponding author), Univ Maryland, Mol Virol Lab, VA MD Coll Vet Med, College Pk, MD 20742 USA.; Zhang, YJ (corresponding author), Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA.
EM zhangyj@umd.edu
RI Yang, Liping/AAA-9183-2019; ma, zexu/AAG-1431-2019; Zhang,
   Yanjin/H-5035-2019; Nan, Yuchen/F-9917-2014
OI Yang, Liping/0000-0001-9527-6015; Nan, Yuchen/0000-0002-4442-8004
FU Chinese Scholarship CouncilChina Scholarship Council; University of
   Maryland, College Park, MD
FX Z.M., R.W., and S.L. were partially sponsored by the Chinese Scholarship
   Council. This study was partially funded by a seed grant from the
   University of Maryland, College Park, MD.
CR BENFIELD DA, 1992, J VET DIAGN INVEST, V4, P127, DOI 10.1177/104063879200400202
   Bertram S, 2017, AM J PATHOL, V187, P831, DOI 10.1016/j.ajpath.2016.12.017
   Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064
   Chen J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01748
   Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0
   Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143
   Dong S, 2016, J PROTEOMICS, V146, P58, DOI 10.1016/j.jprot.2016.06.019
   DUARTE M, 1993, ADV EXP MED BIOL, V342, P55
   Faaberg K. S., 2012, VIRUS TAXONOMY, P796
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandez-Garcia MD, 2011, J VIROL, V85, P2980, DOI 10.1128/JVI.02483-10
   Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3
   Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011
   Gagne B, 2017, TRAFFIC, V18, P362, DOI 10.1111/tra.12480
   Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016
   Greber UF, 2005, CURR TOP MICROBIOL, V285, P109
   Guo R, 2016, J VIROL, V90, P5163, DOI 10.1128/JVI.00036-16
   Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240
   Han MY, 2017, VIROLOGY, V505, P42, DOI 10.1016/j.virol.2017.02.004
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Jung K, 2015, VET J, V204, P134, DOI 10.1016/j.tvjl.2015.02.017
   Kannan H, 2009, J VIROL, V83, P6375, DOI 10.1128/JVI.02571-08
   Kelley JB, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-63
   KIM HS, 1993, ARCH VIROL, V133, P477, DOI 10.1007/BF01313785
   Kuhn JH, 2016, ARCH VIROL, V161, P755, DOI 10.1007/s00705-015-2672-z
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li YH, 2014, P NATL ACAD SCI USA, V111, pE2172, DOI 10.1073/pnas.1321930111
   Lunney JK, 2016, ANNU REV ANIM BIOSCI, V4, P129, DOI 10.1146/annurev-animal-022114-111025
   Ma J, 2006, CELL SIGNAL, V18, P1117, DOI 10.1016/j.cellsig.2005.06.016
   Manns MP, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.6
   Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100
   McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754
   Meng XJ, 1996, J VET DIAGN INVEST, V8, P374, DOI 10.1177/104063879600800317
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004
   Nan YC, 2012, VIROLOGY, V432, P261, DOI 10.1016/j.virol.2012.05.015
   Nelson LM, 2000, J CELL BIOCHEM, V79, P225, DOI 10.1002/1097-4644(20001101)79:2<225::AID-JCB60>3.0.CO;2-A
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Patel D, 2008, ANTIVIR RES, V77, P95, DOI 10.1016/j.antiviral.2007.09.002
   Patel D, 2010, J VIROL, V84, P11045, DOI 10.1128/JVI.00655-10
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186
   Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143
   Reich NC, 2006, NAT REV IMMUNOL, V6, P602, DOI 10.1038/nri1885
   Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07
   Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05
   Resa-Infante P, 2015, J VIROL, V89, P9010, DOI 10.1128/JVI.00583-15
   Resa-Infante P, 2014, J VIROL, V88, P8166, DOI 10.1128/JVI.00270-14
   Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8
   Shi XB, 2013, J INTERF CYTOK RES, V33, P328, DOI 10.1089/jir.2012.0100
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Vasu SK, 2001, CURR OPIN CELL BIOL, V13, P363, DOI 10.1016/S0955-0674(00)00221-0
   Vihinen-Ranta M, 2002, J VIROL, V76, P1884, DOI 10.1128/JVI.76.4.1884-1891.2002
   Wang R, 2013, VACCINE, V31, P5537, DOI 10.1016/j.vaccine.2013.09.023
   Wang R, 2013, J VIROL, V87, P5219, DOI 10.1128/JVI.02643-12
   Yang LP, 2017, VET MICROBIOL, V209, P57, DOI 10.1016/j.vetmic.2016.12.036
   Yang LP, 2017, J VIROL, V91, DOI [10.1128/JVI.02087-16, 10.1128/jvi.02087-16]
   Yu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061967
   Zaitseva L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-11
   Zhang YJ, 2007, ANTIVIR RES, V73, P12, DOI 10.1016/j.antiviral.2006.05.017
   Zhang YJ, 2006, VET MICROBIOL, V117, P117, DOI 10.1016/j.vetmic.2006.06.006
   Zhang YJ, 1998, VET MICROBIOL, V63, P125, DOI 10.1016/S0378-1135(98)00231-4
NR 63
TC 6
Z9 6
U1 1
U2 12
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2018
VL 92
IS 9
AR e00072-18
DI 10.1128/JVI.00072-18
PG 14
WC Virology
SC Virology
GA GD1SI
UT WOS:000430281200006
PM 29444946
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Moreno-Madrinan, MJ
   Turell, M
AF Moreno-Madrinan, Max J.
   Turell, Michael
TI History of Mosquitoborne Diseases in the United States and Implications
   for New Pathogens
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; ZIKA VIRUS; BORNE TRANSMISSION; DENGUE OUTBREAKS;
   AEDES-ALBOPICTUS; AMERICA; VECTOR; INTRODUCTIONS; EPIDEMIOLOGY;
   CHIKUNGUNYA
AB The introduction and spread of West Nile virus and the recent introduction of chikungunya and Zika viruses into the Americas have raised concern about the potential for various tropical pathogens to become established in North America. A historical analysis of yellow fever and malaria incidences in the United States suggests that it is not merely a temperate climate that keeps these pathogens from becoming established. Instead, socioeconomic changes are the most likely explanation for why these pathogens essentially disappeared from the United States yet remain a problem in tropical areas. In contrast to these anthroponotic pathogens that require humans in their transmission cycle, zoonotic pathogens are only slightly affected by socioeconomic factors, which is why West Nile virus became established in North America. In light of increasing globalization, we need to be concerned about the introduction of pathogens such as Rift Valley fever, Japanese encephalitis, and Venezuelan equine encephalitis viruses.
C1 [Moreno-Madrinan, Max J.] Indiana Univ Purdue Univ, Fairbanks Sch Publ Hlth, Indianapolis, IN 46202 USA.
   [Turell, Michael] VectorID LLC, Frederick, MD USA.
RP Moreno-Madrinan, MJ (corresponding author), Indiana Univ Purdue Univ, Environm Hlth Sci, 1050 Wishard Blvd,Ste 6092, Indianapolis, IN 46202 USA.
EM mmorenom@iu.edu
CR Adalja AA, 2012, EMERG INFECT DIS, V18, P608, DOI 10.3201/eid1804.110968
   Arnebeck B., SHORT HIST YELLOW FE
   Arnold JN, 1884, NARRAGANSETT HIST RE, P136
   Capanna E, 2006, INT MICROBIOL, V9, P69
   CDC (Centers for Disease Control and Prevention), EL MAL US 1947 1951
   *CDCP, MAL FACTS
   Centers for Disease Control and Prevention, TRANSM RISKS
   Centers for Disease Control and Prevention, CROSS ENC
   Centers for Disease Control and Prevention, ZIK CAS US CUM ZIK V
   Centers for Disease Control and Prevention, E EQ ENC
   Centers for Disease Control and Prevention, FIN CUM MAPS DAT 199
   Centers for Disease Control and Prevention, ADV PEOPL LIV TRAV B
   Centers for Disease Control and Prevention National Center for Emerging and Zoonotic Infectious Diseases Division of Vec- tor-Borne Diseases, CHIK VIR US
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Crosby Molly Caldwe, 2007, AM PLAGUE UNTOLD STO
   Curtis RB, HIST MOSQUITOES MASS
   Delatte H, 2008, PARASITE, V15, P3, DOI 10.1051/parasite/2008151003
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Filler Scott J., 2006, Morbidity and Mortality Weekly Report, V55, P1
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   HARDEN FREDERICK W., 1967, MOSQUITO NEWS, V27, P60
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Humphreys M., 1998, Parassitologia (Rome), V40, P183
   Jobin W., DID US GET RID MALAR
   Kakkilaya BS, MALARIA WARS VICTIMS
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lindsey NP, 2014, MMWR-MORBID MORTAL W, V63, P521
   McCullough David, 1977, PATH SEAS CREATION P
   Moreno-Madrinan MJ, 2017, J MED ENTOMOL, V54, P251, DOI 10.1093/jme/tjw212
   Nelson B, 2016, PLOS CURR, V8
   Pan American Health Organization, ZIK CUM CAS
   Pan American Health Organization, GEOGR SPREAD CHIK AM
   PATTERSON KD, 1992, SOC SCI MED, V34, P855, DOI 10.1016/0277-9536(92)90255-O
   Pinheiro Fransisco P., 1997, World Health Statistics Quarterly, V50, P161
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reisen WK, 2013, VIRUSES-BASEL, V5, P2079, DOI 10.3390/v5092079
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Takken W, 2007, ECOL CONT VECTOR-BOR, V1, P1
   TURELL MJ, 1992, J MED ENTOMOL, V29, P49, DOI 10.1093/jmedent/29.1.49
   Yalcindag E, 2012, P NATL ACAD SCI USA, V109, P511, DOI 10.1073/pnas.1119058109
NR 47
TC 13
Z9 13
U1 2
U2 11
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2018
VL 24
IS 5
BP 821
EP 826
DI 10.3201/eid2405.171609
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GD2TP
UT WOS:000430355500001
PM 29664379
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wahnich, A
   Clark, S
   Bloch, D
   Kubinson, H
   Hrusa, G
   Liu, DK
   Rakeman, JL
   Deocharan, B
   Jones, L
   Slavinski, S
   Stoute, A
   Mathes, R
   Weiss, D
   Conners, EE
AF Wahnich, Amanda
   Clark, Sandhya
   Bloch, Danielle
   Kubinson, Hannah
   Hrusa, Gili
   Liu, Dakai
   Rakeman, Jennifer L.
   Deocharan, Bisram
   Jones, Lucretia
   Slavinski, Sally
   Stoute, Alaina
   Mathes, Robert
   Weiss, Don
   Conners, Erin E.
CA Sentinel Surveillance Working Grp
TI Surveillance for Mosquitoborne Transmission of Zika Virus, New York
   City, NY, USA, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID UNITED-STATES; MICRONESIA; OUTBREAK; AREAS
AB A large number of imported cases of Zika virus infection and the potential for transmission by Aedes albopictus mosquitoes prompted the New York City Department of Health and Mental Hygiene to conduct sentinel, enhanced passive, and syndromic surveillance for locally acquired mosquitoborne Zika virus infections in New York City, NY, USA, during June-October 2016. Suspected case=patients were those >5 years of age without a travel history or sexual exposure who had >= 3 compatible signs/symptoms (arthralgia, fever, conjunctivitis, or rash). We identified 15 suspected cases and tested urine samples for Zika virus by using real-time reverse transcription PCR; all results were negative. We identified 308 emergency department visits for Zika-like illness, 40,073 visits for fever, and 17 unique spatiotemporal clusters of visits for fever. We identified no evidence of local transmission. Our experience offers possible surveillance tools for jurisdictions concerned about local mosquitoborne Zika virus or other arboviral transmission.
C1 [Wahnich, Amanda; Clark, Sandhya; Bloch, Danielle; Kubinson, Hannah; Hrusa, Gili; Liu, Dakai; Rakeman, Jennifer L.; Deocharan, Bisram; Jones, Lucretia; Slavinski, Sally; Stoute, Alaina; Mathes, Robert; Weiss, Don; Conners, Erin E.] New York City Dept Hlth & Mental Hyg, Div Dis Control, Queens, NY USA.
RP Conners, EE (corresponding author), New York City Dept Hlth & Mental Hyg, 42-09 28th St,Work Stn 6-136, Queens, NY 11101 USA.
EM econners@health.nyc.gov
OI Szymczak, Wendy/0000-0002-0747-1169
FU Public Health Emergency Preparedness (PHEP) [NU90TP921856]; Epidemiology
   and Laboratory Capacity (ELC) for Infectious Diseases Cooperative
   Agreement from CDC [NU50CK000407-03]
FX This publication was supported by the Public Health Emergency
   Preparedness (PHEP) Cooperative Agreement (grant no. NU90TP921856) and
   by the Epidemiology and Laboratory Capacity (ELC) for Infectious
   Diseases Cooperative Agreement (grant no. NU50CK000407-03) from CDC.
CR [Anonymous], 2013, NEW NEW YORK CHAR CI
   Centers for Disease Control and Prevention, INT CDC ZIK IN PRESS
   Centers for Disease Control and Prevention, 2012, DENG AED ALB MOSQ
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Dasgupta S, 2016, MMWR-MORBID MORTAL W, V65, P395, DOI 10.15585/mmwr.mm6515e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gardner L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005487
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Heffernan R, 2004, EMERG INFECT DIS, V10, P858, DOI 10.3201/eid1005.030646
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Kleinman K, 2004, AM J EPIDEMIOL, V159, P217, DOI 10.1093/aje/kwh029
   Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee CT, 2016, MMWR-MORBID MORTAL W, V65, P629, DOI 10.15585/mmwr.mm6524e3
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lynfield R, 2010, PRINCIPLES PRACTICE, P236
   MacDonald PDM, 2012, METHODS FIELD EPIDEM
   Morse SS, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.OH-0002-2012
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Nelson B, 2016, PLOS CURR, V8
   New York City Department of Health and Mental Hygiene, 2017, ART 11 REP DIS COND
   New York City Department of Health and Mental Hygiene, PROT NYC MOSQ TRAPP
   New York State Department of Health, NYSDOH STAT MOSQ BOR
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   U. S. Census Bureau, 2016, AM COMM SURV 2010 20
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 32
TC 5
Z9 5
U1 0
U2 1
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2018
VL 24
IS 5
BP 827
EP 834
DI 10.3201/eid2405.170764
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GD2TP
UT WOS:000430355500002
PM 29664375
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fischer, C
   Pedroso, C
   Mendrone, A
   de Filippis, AMB
   Vallinoto, ACR
   Ribeiro, BM
   Durigon, EL
   Marques, ETA
   Campos, GS
   Viana, IFT
   Levi, JE
   Scarpelli, LC
   Nogueira, ML
   Bastos, MD
   Souza, NCS
   Khouri, R
   Lira, SMC
   Komninakis, SV
   Baronti, C
   Charrel, RN
   Kummerer, BM
   Drosten, C
   Brites, C
   de Lamballerie, X
   Niedrig, M
   Netto, EM
   Drexler, JF
AF Fischer, Carlo
   Pedroso, Celia
   Mendrone, Alfredo, Jr.
   Bispo de Filippis, Ana Maria
   Rosario Vallinoto, Antonio Carlos
   Ribeiro, Bergmann Morais
   Durigon, Edison Luiz
   Marques, Ernesto T. A., Jr.
   Campos, Gubio S.
   Viana, Isabelle F. T.
   Levi, Jose Eduardo
   Scarpelli, Luciano Cesar
   Nogueira, Mauricio Lacerda
   Bastos, Michele de Souza
   Santiago Souza, Nathalia C.
   Khouri, Ricardo
   Costa Lira, Sanny M.
   Komninakis, Shirley Vasconcelos
   Baronti, Cecile
   Charrel, Remi N.
   Kuemmerer, Beate M.
   Drosten, Christian
   Brites, Carlos
   de lamballerie, Xavier
   Niedrig, Matthias
   Netto, Eduardo Martins
   Drexler, Jan Felix
TI External Quality Assessment for Zika Virus Molecular Diagnostic Testing,
   Brazil
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INFECTION; LOAD
AB We conducted an external quality assessment of Zika virus molecular diagnostic tests in Brazil using a new Zika virus standard. Of 15 laboratories, 73% showed limited sensitivity and specificity. Viral load estimates varied significantly. Continuous quality assurance is required for adequate estimates of Zika virus-associated disease and determination of patient care.
C1 [Fischer, Carlo; Drosten, Christian; Drexler, Jan Felix] Charite, German Ctr Infect Res, Berlin, Germany.
   [Pedroso, Celia; Brites, Carlos; Netto, Eduardo Martins] Hosp Univ Prof Edgard Santos, LAPI, Salvador, BA, Brazil.
   [Mendrone, Alfredo, Jr.; Levi, Jose Eduardo] Fdn Prosangue Hemoctr Sao Paulo, Sao Paulo, Brazil.
   [Bispo de Filippis, Ana Maria] Inst Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Rosario Vallinoto, Antonio Carlos] Fed Univ Para, Belem, Para, Brazil.
   [Ribeiro, Bergmann Morais] Univ Brasilia, Brasilia, DF, Brazil.
   [Durigon, Edison Luiz; Levi, Jose Eduardo; Santiago Souza, Nathalia C.] Univ Sao Paulo, Sao Paulo, Brazil.
   [Marques, Ernesto T. A., Jr.; Viana, Isabelle F. T.] Fundacao Oswaldo Cruz, Pernambuco, Brazil.
   [Campos, Gubio S.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Levi, Jose Eduardo; Scarpelli, Luciano Cesar] Diagnost Amer DASA, Sao Paulo, Brazil.
   [Levi, Jose Eduardo; Costa Lira, Sanny M.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Sao Jose De Rio Preto, Brazil.
   [Bastos, Michele de Souza] Fdn Med Trop Dr Heitor Vieira Dourado, Manaus, Amazonas, Brazil.
   [Khouri, Ricardo] Fundacao Oswaldo Cruz, Salvador, BA, Brazil.
   [Komninakis, Shirley Vasconcelos] Univ Fed Sao Paulo, Sao Paulo, Brazil.
   [Baronti, Cecile; Charrel, Remi N.; de lamballerie, Xavier] Aix Marseille Univ, Marseille, France.
   [Baronti, Cecile; Charrel, Remi N.; de lamballerie, Xavier] Assistance Publ Hop Marseille, Marseille, France.
   [Kuemmerer, Beate M.] Univ Bonn, Med Ctr, Bonn, Germany.
   [Niedrig, Matthias] Robert Koch Inst, Berlin, Germany.
RP Drexler, JF (corresponding author), Inst Virol, Helmut Ruska Haus, Campus Charite Mitte,Charitepl 1, D-10098 Berlin, Germany.
EM felix.drexler@charite.de
RI Marques, Ernesto T. A/L-4967-2013; Komninakis, Shirley V/B-2915-2010;
   Khouri, Ricardo/M-3184-2018; Vallinoto, Antonio Carlos/AAL-9501-2020;
   Netto, Eduardo/D-1432-2013; Ribeiro, Bergmann Morais/C-7114-2015;
   Nogueira, Mauricio L/B-7599-2012; Viana, Isabelle/M-4435-2017
OI Marques, Ernesto T. A/0000-0003-3826-9358; Komninakis, Shirley
   V/0000-0001-7784-3418; Khouri, Ricardo/0000-0001-5664-4436; Vallinoto,
   Antonio Carlos/0000-0003-1135-6507; Netto, Eduardo/0000-0003-1691-6761;
   Ribeiro, Bergmann Morais/0000-0002-1061-196X; Nogueira, Mauricio
   L/0000-0003-1102-2419; Viana, Isabelle/0000-0003-4648-6635; Fischer,
   Carlo/0000-0001-9163-2406; Drexler, Jan Felix/0000-0002-3509-0232
FU German Centre for Infection Research; European Union's Horizon research
   and innovation program (ZIKAlliance) [734548]; EVAg [653316]
FX This work was supported by the German Centre for Infection Research
   through a fast-track program for Zika virus outbreak response to J.F.D.
   and is partially supported by the European Union's Horizon 2020 research
   and innovation program (ZIKAlliance, grant agreement no. 734548 to
   X.d.L. and EVAg, grant agreement no. 653316 to C.D.).
CR Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Domingo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036291
   Domingo C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000833
   Drexler JF, 2009, PLOS MED, V6, P210, DOI 10.1371/journal.pmed.1000031
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Niedrig M, 2006, CLIN CHEM, V52, P1851, DOI 10.1373/clinchem.2005.064451
NR 15
TC 10
Z9 10
U1 0
U2 8
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2018
VL 24
IS 5
BP 888
EP 892
DI 10.3201/eid2405.171747
PG 5
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GD2TP
UT WOS:000430355500012
PM 29470164
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Southwell, BG
   Ray, SE
   Vazquez, NN
   Ligorria, T
   Kelly, BJ
AF Southwell, Brian G.
   Ray, Sarah E.
   Vazquez, Natasha N.
   Ligorria, Tere
   Kelly, Bridget J.
TI A Mental Models Approach to Assessing Public Understanding of Zika
   Virus, Guatemala
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB Mental models are cognitive representations of phenomena that can constrain efforts to reduce infectious disease. In a study of Zika virus awareness in Guatemala, many participants referred to experiences with other mosquitoborne diseases during discussions of Zika virus. These results highlight the importance of past experiences for Zika virus understanding.
C1 [Southwell, Brian G.; Vazquez, Natasha N.] RTI Int, Res Triangle Pk, NC USA.
   [Ray, Sarah E.] RTI Int, Atlanta, GA USA.
   [Ligorria, Tere] RTI Int, Guatemala City, Guatemala.
   [Kelly, Bridget J.] RTI Int, Washington, DC USA.
RP Southwell, BG (corresponding author), RTI Int, Sci Publ Sphere Program, 3040 E Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
EM bsouthwell@rti.org
FU RTI International
FX RTI International sponsored the study that produced the information
   reported here as part of an in-kind donation to the Guatemala Ministry
   of Public Health and Social Assistance.
CR Center for Disease Control and Prevention, 2014, CRISIS EMERGENCY RIS
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Jhang JH, 2012, J MARKETING RES, V49, P247, DOI 10.1509/jmr.10.0428
   Johnson-Laird P. N., 1983, MENTAL MODELS
   Jones NA, 2011, ECOL SOC, V16
   Moreau CP, 2001, J MARKETING RES, V38, P14, DOI 10.1509/jmkr.38.1.14.18836
   Ray SE, 2016, INSIGHTS REGARDING Z
   SANDMAN P, CRISIS COMMUNICATION
   Southwell BG, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P607
   TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124
NR 10
TC 2
Z9 2
U1 0
U2 0
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2018
VL 24
IS 5
BP 938
EP 939
DI 10.3201/eid2405.171570
PG 2
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GD2TP
UT WOS:000430355500027
PM 29664390
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rosenstierne, MW
   Schaltz-Buchholzer, F
   Bruzadelli, F
   Co, A
   Cardoso, P
   Jorgensen, CS
   Michiels, J
   Heyndrickx, L
   Arien, KK
   Fischer, TK
   Fomsgaard, A
AF Rosenstierne, Maiken Worsoe
   Schaltz-Buchholzer, Frederik
   Bruzadelli, Fernanda
   Co, Asson
   Cardoso, Placido
   Jorgensen, Charlotte Svaerke
   Michiels, Johan
   Heyndrickx, Leo
   Arien, Kevin K.
   Fischer, Thea Kolsen
   Fomsgaard, Anders
TI Zika Virus IgG in Infants with Microcephaly, Guinea-Bissau, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB We analyzed blood samples from infants born with microcephaly and their mothers in Guinea-Bissau in 2016 for pathogens associated with birth defects. No Zika virus RNA was detected, but Zika virus IgG was highly prevalent. We recommend implementing pathogen screening of infants with congenital defects in Guinea-Bissau.
C1 [Rosenstierne, Maiken Worsoe; Schaltz-Buchholzer, Frederik; Jorgensen, Charlotte Svaerke; Fischer, Thea Kolsen; Fomsgaard, Anders] Statens Serum Inst, Copenhagen, Denmark.
   [Schaltz-Buchholzer, Frederik] Bandim Hlth Project, Bissau, Guinea Bissau.
   [Bruzadelli, Fernanda; Co, Asson] Field Epidemiol Training Program, Bissau, Guinea Bissau.
   [Cardoso, Placido] Inst Nacl Saude Publ, Bissau, Guinea Bissau.
   [Michiels, Johan; Heyndrickx, Leo; Arien, Kevin K.] Inst Trop Med Antwerp, Antwerp, Belgium.
   [Arien, Kevin K.] Univ Antwerp, Antwerp, Belgium.
   [Fomsgaard, Anders] Univ Southern Denmark, Odense, Denmark.
RP Rosenstierne, MW (corresponding author), Statens Serum Inst, Dept Microbiol Diagnost & Virol, Artillerivej 5, DK-2300 Copenhagen S, Denmark.
EM mwr@ssi.dk
RI Fischer, Thea K/AAH-9892-2019
OI Fischer, Thea K/0000-0003-4812-980X; Costa,
   Fernanda/0000-0001-5310-5592; Schaltz-Buchholzer,
   Frederik/0000-0001-7643-8322; Fomsgaard, Anders/0000-0003-4304-0603
FU ZikaPLAN through the European Union's Horizon Research and Innovation
   Programme [734584]
FX K.K.A. is supported by ZikaPLAN through the European Union's Horizon
   2020 Research and Innovation Programme (grant no. 734584).
CR Betunde AG, 2016, CASOS MICROCEFALIA G
   Centers for Disease Control and Prevention, ID CONG CYT CMV EARL
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4812
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Van Esbroeck M, 2016, EUROSURVEILLANCE, V21, P32, DOI 10.2807/1560-7917.ES.2016.21.21.30237
   WHO, 2016, SCREEN ASS MAN NEON
NR 10
TC 6
Z9 6
U1 0
U2 2
PU CENTERS  DISEASE CONTROL
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2018
VL 24
IS 5
BP 948
EP 950
DI 10.3201/eid2405.180153
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA GD2TP
UT WOS:000430355500032
PM 29664391
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pires, P
   Jungmann, P
   Galvao, JM
   Hazin, A
   Menezes, L
   Ximenes, R
   Tonni, G
   Araujo, E
AF Pires, Pedro
   Jungmann, Patricia
   Galvao, Jully Moura
   Hazin, Adriano
   Menezes, Luiza
   Ximenes, Ricardo
   Tonni, Gabriele
   Araujo Junior, Edward
TI Neuroimaging findings associated with congenital Zika virus syndrome:
   case series at the time of first epidemic outbreak in Pernambuco State,
   Brazil
SO CHILDS NERVOUS SYSTEM
LA English
DT Article
DE Congenital Zika virus syndrome; Microcephaly; Brain abnormalities;
   Ultrasound; Computed tomography; Magnetic resonance imaging
ID PRACTICE GUIDELINES; INFECTION; BRAIN
AB This study aimed to describe the prenatal and postnatal neuroimaging and clinical findings in a clinical series following congenital Zika virus syndrome during the first epidemic Zika virus (ZIKV) outbreak in the State of Pernambuco, Brazil.
   We (the authors) conducted a retrospective study of a prospectively collected case series of fetuses and neonates with microcephaly born to mothers with presumed/confirmed congenital ZIKV syndrome. Prenatal ultrasound findings were reviewed to identify potential central nervous system (CNS) abnormalities. Neonates underwent postnatal neuroimaging follow up by computed tomography (CT)-scan or magnetic resonance (MR) imaging.
   The prenatal and postnatal outcomes of eight fetuses/neonates born to mothers with presumed/confirmed congenital ZIKV syndrome were examined. The mean gestational age at ultrasound was 31.3 weeks. Severe microcephaly was identified in seven fetuses (87.5%), while ventriculomegaly and brain calcifications were detected in all fetuses. The mean gestational age at delivery and head circumference were 38 weeks and 30.2 cm, respectively. All cases of microcephaly but one was confirmed postnatally. Brain CT scans or MRIs were performed in seven newborns, and all had periventricular and/or parenchymal calcifications, symmetrical or asymmetrical ventriculomegaly, pachygyria, and reduced sulcation and gyration. MR imaging aided the detection of one undetected case of corpus callosum dysgenesis and was essential in documenting reduced mantel of the cerebral cortex and reduced gyration and sulcation, especially involving the parietal lobe. In addition, MR imaging was also able to display irregular interfaces with the subcortical white matter, a finding consistent with polymicrogyria, more frequently seen at the level of the frontal lobe and atrophic and thinned pons.
   Severe microcephaly and CNS abnormalities may be associated with congenital ZIKV syndrome.
C1 [Pires, Pedro; Galvao, Jully Moura; Menezes, Luiza] Pernambuco Univ UPE, Dept Maternal & Child, Recife, PE, Brazil.
   [Jungmann, Patricia] Pernambuco Univ UPE, Dept Pathol, Recife, PE, Brazil.
   [Hazin, Adriano] Inst Med Integral Prof Fernandes Figueira IMIP, Dept Radiol, Recife, PE, Brazil.
   [Ximenes, Ricardo] Fed Univ Pernambuco UFPE, Dept Trop Med, Recife, PE, Brazil.
   [Tonni, Gabriele] Guastalla Civil Hosp, AUSL Reggio Emilia, Dept Obstet & Gynecol, Reggio Emilia, Italy.
   [Araujo Junior, Edward] Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, SP, Brazil.
RP Araujo, E (corresponding author), Fed Univ Sao Paulo EPM UNIFESP, Dept Obstet, Paulista Sch Med, Rua Belchior Azevedo,156 Apto 111 Torre Vitoria, BR-05089030 Sao Paulo, SP, Brazil.
EM araujojred@terra.com.br
RI Junior, Edward Araujo/E-1228-2012; Tonni, Gabriele/AAM-9842-2020
OI Junior, Edward Araujo/0000-0002-6145-2532; 
CR ALAGAPPAN R, 1994, RADIOLOGY, V193, P405, DOI 10.1148/radiology.193.2.7972753
   Araujo E, 2017, CURR OPIN OBSTET GYN, V29, P95, DOI 10.1097/GCO.0000000000000345
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ribeiro Bruno Niemeyer de Freitas, 2017, Radiol Bras, V50, P314, DOI 10.1590/0100-3984.2017.0098
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
NR 20
TC 3
Z9 3
U1 0
U2 4
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0256-7040
EI 1433-0350
J9 CHILD NERV SYST
JI Childs Nerv. Syst.
PD MAY
PY 2018
VL 34
IS 5
BP 957
EP 963
DI 10.1007/s00381-017-3682-9
PG 7
WC Clinical Neurology; Pediatrics; Surgery
SC Neurosciences & Neurology; Pediatrics; Surgery
GA GC4YU
UT WOS:000429793400022
PM 29209885
OA Bronze
DA 2020-07-08
ER

PT J
AU Richard, V
   Aubry, M
AF Richard, Vaea
   Aubry, Maite
TI Method for simple and rapid concentration of Zika virus particles from
   infected cell-culture supernatants
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE Zika; Viral stock; Ultrafiltration; Concentration; Centrifugal filter
   device
ID GENE-TRANSFER; RETROVIRAL VECTORS; HIGH-TITER
AB Experimental studies on Zika virus (ZIKV) may require improvement of infectious titers in viral stocks obtained by cell culture amplification. The use of centrifugal filter devices to increase infectious titers of ZIKV from cell culture supernatants is highlighted here. A mean gain of 2.33 +/- 0.12 log(10) DICT50/mL was easily and rapidly obtained with this process. This efficient method of ultrafiltration may be applied to other viruses and be useful in various experimental studies requiring high viral titers.
C1 [Richard, Vaea; Aubry, Maite] Inst Louis Malarde, POB 30, F-98713 Papeete, French Polynesi, France.
   [Richard, Vaea; Aubry, Maite] Aix Marseille Univ, IRD, IHU Mediterranee Infect, AP HM,SSA,VITROME, Marseille, France.
RP Richard, V (corresponding author), Inst Louis Malarde, POB 30, F-98713 Papeete, French Polynesi, France.
EM vrichard@ilm.pf
OI Aubry, Maite/0000-0002-9913-5794; Richard, Vaea/0000-0001-8132-0740
CR Coelho SVA, 2017, J VIROL METHODS, V246, P65, DOI 10.1016/j.jviromet.2017.04.011
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   BURNS JC, 1993, P NATL ACAD SCI USA, V90, P8033, DOI 10.1073/pnas.90.17.8033
   Chu THT, 1997, J VIROL, V71, P720, DOI 10.1128/JVI.71.1.720-725.1997
   Huang KJ, 2008, AM J INFECT DIS, V4, P50, DOI 10.3844/ajidsp.2008.50.59
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266
   Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188
   Richard V, 2017, ACTA TROP, V173, P200, DOI 10.1016/j.actatropica.2017.04.036
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Richard V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138161
   Russell BJ, 2007, J VIROL METHODS, V145, P62, DOI 10.1016/j.jviromet.2007.05.008
   SAHA K, 1994, J VIROL METHODS, V46, P349, DOI 10.1016/0166-0934(94)90005-1
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   WUNNER WH, 1976, VIROLOGY, V73, P228, DOI 10.1016/0042-6822(76)90077-5
NR 16
TC 0
Z9 0
U1 0
U2 8
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD MAY
PY 2018
VL 255
BP 82
EP 83
DI 10.1016/j.jviromet.2018.02.014
PG 2
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA GC8FK
UT WOS:000430028300013
PM 29474814
OA Green Published
DA 2020-07-08
ER

PT J
AU Arien, KK
   Michiels, J
   Foque, N
   Heyndrickx, L
   Van Esbroeck, M
AF Arien, Kevin K.
   Michiels, Johan
   Foque, Nikki
   Heyndrickx, Leo
   Van Esbroeck, Marjan
TI Can Zika virus antibodies cross-protect against dengue virus?
SO LANCET GLOBAL HEALTH
LA English
DT Letter
ID INFECTION
C1 [Arien, Kevin K.; Michiels, Johan; Heyndrickx, Leo] Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.
   [Arien, Kevin K.; Michiels, Johan; Foque, Nikki; Heyndrickx, Leo; Van Esbroeck, Marjan] Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, B-2000 Antwerp, Belgium.
   [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
RP Arien, KK (corresponding author), Inst Trop Med, Dept Biomed Sci, Virol Unit, B-2000 Antwerp, Belgium.; Arien, KK (corresponding author), Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, B-2000 Antwerp, Belgium.; Arien, KK (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
EM karien@itg.be
OI Van Esbroeck, Marjan/0000-0002-7294-6319
CR Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   De Smet B, 2016, J CLIN VIROL, V80, P8, DOI 10.1016/j.jcv.2016.04.009
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
NR 4
TC 2
Z9 2
U1 0
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2214-109X
J9 LANCET GLOB HEALTH
JI Lancet Glob. Health
PD MAY
PY 2018
VL 6
IS 5
BP E494
EP E494
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GC5ZU
UT WOS:000429870700013
PM 29653619
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Han, YS
   Mesplede, T
   Xu, HT
   Quan, YD
   Wainberg, MA
AF Han, Yingshan
   Mesplede, Thibault
   Xu, Hongtao
   Quan, Yudong
   Wainberg, Mark A.
TI The antimalarial drug amodiaquine possesses anti-ZIKA virus activities
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article
DE amodiaquine; antiviral drug; repurposing; Zika
ID ANTIVIRAL DRUG; INFECTION; IDENTIFICATION; ASSAY; INHIBITORS; ANALOGS;
   CHLOROQUINE; SOFOSBUVIR; SCREEN; AGENTS
AB Zika virus (ZIKV) outbreak has emerged as a global health threat, particularly in tropical areas, over the past few years. No antiviral therapy or vaccine is available at present. For these reasons, repurposing clinically approved drugs against ZIKV infection may provide rapid and cost-effective global health benefits. Here, we explored this strategy and screened eight FDA-approved drugs for antiviral activity against ZIKV using a cell-based assay. Our results show that the antimalarial drug amodiaquine has anti-ZIKV activity with EC50 at low micromolar concentrations in cell culture. We further characterized amodiaquine antiviral activity against ZIKV and found that it targets early events of the viral replication cycle. Altogether, our results suggest that amodiaquine may be efficacious for the treatment of ZIKV infection.
C1 [Han, Yingshan; Mesplede, Thibault; Xu, Hongtao; Quan, Yudong; Wainberg, Mark A.] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, AIDS Ctr, Montreal, PQ, Canada.
   [Mesplede, Thibault; Wainberg, Mark A.] McGill Univ, Dept Microbiol & Immunol, Fac Med, Montreal, PQ, Canada.
RP Han, YS (corresponding author), McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, AIDS Ctr, Montreal, PQ, Canada.
EM yingshan.han@yahoo.com
FU Canadian Institutes of Health ResearchCanadian Institutes of Health
   Research (CIHR)
FX Canadian Institutes of Health Research
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Al-Bari MAA, 2015, J ANTIMICROB CHEMOTH, V70, P1608, DOI 10.1093/jac/dkv018
   Andjelic CD, 2008, MAR DRUGS, V6, P528, DOI 10.3390/md20080027
   Baer A, J VISUAL EXP JOVE, V2014
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Elfiky AA, 2016, J MED VIROL, V88, P2044, DOI 10.1002/jmv.24678
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Feoktistova M, 2016, COLD SPRING HARBOR P, V2016
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Han YS, 2017, J MED VIROL, V89, P397, DOI 10.1002/jmv.24660
   Han YS, 2015, J MED VIROL, V87, P2054, DOI 10.1002/jmv.24271
   Han Ying-Shan, 2015, Antiviral Chemistry & Chemotherapy, V24, P28, DOI 10.1177/2040206614566580
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Makhluf H, 2016, EXPERT OPIN DRUG DIS, V11, P921, DOI 10.1080/17460441.2016.1212013
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63
   McNeil CJ, 2017, J TROP PEDIATRICS, V63, P242, DOI 10.1093/tropej/fmw080
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Mushtaque M, 2015, EUR J MED CHEM, V90, P280, DOI 10.1016/j.ejmech.2014.11.022
   Naeem A, 2016, MOLECULES, V21, DOI 10.3390/molecules21040268
   Pai MY, 2015, METHODS MOL BIOL, V1263, P287, DOI 10.1007/978-1-4939-2269-7_22
   Parhizgar AR, 2017, IRAN J MED SCI, V42, P115
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Ronchetti R, 2016, EPIDEMIOL PREV, V40, P466, DOI 10.19191/EP16.6.P466.128
   Rothan HA, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-140
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Shirley DAT, 2017, PEDIATR CLIN N AM, V64, P937, DOI 10.1016/j.pcl.2017.03.012
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   YEH TJ, 1982, J CLIN MICROBIOL, V16, P413, DOI 10.1128/JCM.16.2.413-415.1982
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zilbermintz L, 2015, SCI REP-UK, V5, DOI 10.1038/srep13476
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 43
TC 16
Z9 16
U1 1
U2 32
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
PD MAY
PY 2018
VL 90
IS 5
BP 796
EP 802
DI 10.1002/jmv.25031
PG 7
WC Virology
SC Virology
GA FZ0JJ
UT WOS:000427254600003
PM 29315671
OA Bronze
DA 2020-07-08
ER

PT J
AU Saavedra-Rodriguez, K
   Maloof, FV
   Campbell, CL
   Garcia-Rejon, J
   Lenhart, A
   Penilla, P
   Rodriguez, A
   Sandoval, AA
   Flores, AE
   Ponce, G
   Lozano, S
   Black, WC
AF Saavedra-Rodriguez, Karla
   Maloof, Farah Vera
   Campbell, Corey L.
   Garcia-Rejon, Julian
   Lenhart, Audrey
   Penilla, Patricia
   Rodriguez, Americo
   Acero Sandoval, Arturo
   Flores, Adriana E.
   Ponce, Gustavo
   Lozano, Saul
   Black, William C.
TI Parallel evolution of vgsc mutations at domains IS6, IIS6 and IIIS6 in
   pyrethroid resistant Aedes aegypti from Mexico
SO SCIENTIFIC REPORTS
LA English
DT Article
ID GATED SODIUM-CHANNEL; DIPTERA-CULICIDAE; CROSS-RESISTANCE;
   RECEPTOR-SITES; GENE; DDT; INSECTICIDES; ALBOPICTUS; MECHANISMS; STATE
AB Aedes aegypti is the primary urban mosquito vector of viruses causing dengue, Zika and chikungunya fevers-for which vaccines and effective pharmaceuticals are still lacking. Current strategies to suppress arbovirus outbreaks include removal of larval-breeding sites and insecticide treatment of larval and adult populations. Insecticidal control of Ae. aegypti is challenging, due to a recent rapid global increase in knockdown-resistance (kdr) to pyrethroid insecticides. Widespread, heavy use of pyrethroid space-sprays has created an immense selection pressure for kdr, which is primarily under the control of the voltage-gated sodium channel gene (vgsc). To date, eleven replacements in vgsc have been discovered, published and shown to be associated with pyrethroid resistance to varying degrees. In Mexico, F1,534C and V1,016I have co-evolved in the last 16 years across Ae. aegypti populations. Recently, a novel replacement V410L was identified in Brazil and its effect on vgsc was confirmed by electrophysiology. Herein, we screened V410L in 25 Ae. aegypti historical collections from Mexico, the first heterozygote appeared in 2002 and frequencies have increased in the last 16 years alongside V1,016I and F1,534C. Knowledge of the specific vgsc replacements and their interaction to confer resistance is essential to predict and to develop strategies for resistance management.
C1 [Saavedra-Rodriguez, Karla; Maloof, Farah Vera; Campbell, Corey L.; Lozano, Saul; Black, William C.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
   [Garcia-Rejon, Julian] Univ Autonoma Yucatan, Ctr Invest Reg Dr Hideyo Noguchi, Lab Arbovirol, Merida, Mexico.
   [Lenhart, Audrey] Ctr Dis Control & Prevent, Div Parasit Dis & Malaria, Atlanta, GA USA.
   [Penilla, Patricia; Rodriguez, Americo; Acero Sandoval, Arturo] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.
   [Flores, Adriana E.; Ponce, Gustavo] Univ Autonoma Nuevo Leon, Fac Ciencias Biol, Lab Entomol Med, Monterrey, Mexico.
RP Black, WC (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Ft Collins, CO 80523 USA.
EM William.Black@colostate.edu
RI Vera, Farah/AAG-6007-2020; Flores, Adriana/J-1820-2012; Flores, Adriana
   E./AAM-4478-2020; Garcia-Rejon, Julian Everardo/E-4285-2017
OI Flores, Adriana/0000-0001-8554-8865; Flores, Adriana
   E./0000-0001-8554-8865; Acero-Sandoval, M. Arturo/0000-0003-0924-9243;
   Garcia-Rejon, Julian Everardo/0000-0002-6681-1581; Campbell, Corey
   L./0000-0002-6384-1259; Penilla, R. Patricia/0000-0002-0780-1527;
   Ponce-Garcia, Gustavo/0000-0003-0654-006X
FU National Institutes of Health/National Institute of Allergy and
   Infectious Diseases International Collaborations in Infectious Disease
   Research Program [U01-AI-088647]; Insecticide Resistance Management to
   Preserve Pyrethroid Resistance in Aedes aegypti [1R01AI121211-01A1];
   Fogarty Training Grant "Training in Dengue Prevention and Control"
   [2D43TW001130-08]
FX This study was funded by the National Institutes of Health/National
   Institute of Allergy and Infectious Diseases International
   Collaborations in Infectious Disease Research Program (U01-AI-088647)
   and "Insecticide Resistance Management to Preserve Pyrethroid Resistance
   in Aedes aegypti" (1R01AI121211-01A1). Farah Vera-Maloof, Arturo
   Acero-Sandoval and Patricia Penilla were supported by the Fogarty
   Training Grant "Training in Dengue Prevention and Control"
   (2D43TW001130-08).
CR Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Bariami V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001692
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   BLACK WC, 1997, MOL BIOL INSECT DIS, P361
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du Y.Z, 2014, ABSTR PAP AM CHEM S, V248
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Flores AE, 2013, J ECON ENTOMOL, V106, P959, DOI 10.1603/EC12284
   Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hopkins BW, 2010, INSECT BIOCHEM MOLEC, V40, P385, DOI 10.1016/j.ibmb.2010.03.004
   Kushwah RBS, 2015, J VECTOR DIS, V52, P95
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Maestre-Serrano R, 2014, PESTIC BIOCHEM PHYS, V116, P63, DOI 10.1016/j.pestbp.2014.09.014
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Marcombe S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-494
   McAllister JC, 2012, J VECTOR ECOL, V37, P325, DOI 10.1111/j.1948-7134.2012.00234.x
   Park Y, 1997, BIOCHEM BIOPH RES CO, V239, P688, DOI 10.1006/bbrc.1997.7511
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   SODERLUND DM, 1989, ANNU REV ENTOMOL, V34, P77, DOI 10.1146/annurev.en.34.010189.000453
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2
   Zhorov BS, 2017, NEUROTOXICOLOGY, V60, P171, DOI 10.1016/j.neuro.2016.08.013
NR 33
TC 14
Z9 14
U1 1
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 30
PY 2018
VL 8
AR 6747
DI 10.1038/s41598-018-25222-0
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE3IN
UT WOS:000431107100006
PM 29712956
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Vilar, WTS
   Sousa, ES
   Pinto, L
   de Araujo, MCU
   Pontes, MJC
AF Vilar, Welma T. S.
   Sousa, Emanuella S.
   Pinto, Licarion
   Ugulino de Araujo, Mario Cesar
   Coelho Pontes, Marcio Jose
TI Development and validation of a HPLC method to quantify DEET and IR3535
   in insect repellents
SO ANALYTICAL METHODS
LA English
DT Article
ID TANDEM MASS-SPECTROMETRY; SUNSCREEN OXYBENZONE; N,N-DIETHYL-M-TOLUAMIDE;
   DEGRADATION; PERMEATION; MECHANISM; LETHAL
AB The increasing number of cases of dengue, chikungunya, yellow fever and Zika virus has caused many people to use repellents to try to protect themselves from the Aedes aegypti mosquito that transmits these diseases. There are a variety of products that have different ingredients, concentrations, durations of action and prices. However, not all repellants can be used by children and pregnant women and in some cases, medical guidance is required. Repellents are classified as cosmetics and the two most commonly used active ingredients are N,N-diethyl-3-methylbenzamide (DEET) and ethyl-3-(N-n-butyl-N-acetyl) aminopropionate (IR3535). This is a report on the development of a rapid and reliable HPLC-DAD method, validated for the quantification of DEET and IR3535 in insect repellents. The following chromatographic parameters were used: a mobile phase of water/acetonitrile at an 80 : 20 (v/v) ratio, a flow rate of 0.3 mL min(-1) , and a detection wavelength of 210 nm. Before analysis, samples were diluted 20 000 and 10 000 times in water/acetonitrile (90 : 10, v/v) for DEET and IR3535, respectively. The method was validated and presented satisfactory linearity (0.25-22 mg L-1, r(2) = 0.9986 and 0.5-40 mg L-1, r(2) = 0.9976), limit of quantification (LOQ) (0.09 and 0.06 mg L-1 ), with the intra- and inter-day precision calculated using a Horwitz ratio of less than 2, and recoveries (89.2-111.6% and 94.7-109.2%) for DEET and IR3535, respectively. It is important to highlight that there is no reference method that allows the quantification of both active ingredients, simultaneously, in the analyzed samples, which is proposed in this work.
C1 [Vilar, Welma T. S.; Sousa, Emanuella S.; Pinto, Licarion; Ugulino de Araujo, Mario Cesar; Coelho Pontes, Marcio Jose] Univ Fed Paraiba, Dept Quim, Lab Automacao & Instrumentacao Quim Analit Quimio, BR-58005197 Joao Pessoa, Paraiba, Brazil.
RP Pontes, MJC (corresponding author), Univ Fed Paraiba, Dept Quim, Lab Automacao & Instrumentacao Quim Analit Quimio, BR-58005197 Joao Pessoa, Paraiba, Brazil.
EM marciocoelho@quimica.ufpb.br
RI Pinto, Licarion/N-8953-2013; Araujo, Mario C.U./H-6553-2013; amsalu,
   ribka/G-8780-2019; Sousa, Emanuella/F-7221-2019
OI Pinto, Licarion/0000-0002-8682-6174; Araujo, Mario
   C.U./0000-0002-7976-3494; 
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [420400/2016-8, 303649/2015-1, 423601/2016-4, 302349/2016-2]; CAPESCAPES
FX The authors acknowledge CNPq (420400/2016-8, 303649/2015-1,
   423601/2016-4, and 302349/2016-2) and CAPES for financial support, and
   research and scholar fellowships. They also thank sincerely the Merck
   (R) Company that kindly donated the standard of insect repellent IR3535.
   The English text of this paper has been revised by Sidney Pratt,
   Canadian, MAT (The Johns Hopkins University), RSAdip - TESL (Cambridge
   University).
CR Angelo T, 2016, J CHROMATOGR B, V1022, P81, DOI 10.1016/j.jchromb.2016.04.011
   Azilawati M. I., 2016, J CHROMATOGR A, V1353, P49
   Behniwal PK, 2017, INT J ENVIRON AN CH, V97, P548, DOI 10.1080/03067319.2017.1325881
   Broschard TH, 2013, TOXICOL LETT, V218, P246, DOI 10.1016/j.toxlet.2013.02.002
   Collins C. H., 2006, FUNDAMENTOS CROMATOG
   Costanzo SD, 2007, SCI TOTAL ENVIRON, V384, P214, DOI 10.1016/j.scitotenv.2007.05.036
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   Fink P, 2017, WATER RES, V108, P32, DOI 10.1016/j.watres.2016.10.083
   Islam J, 2017, ACTA TROP, V167, P216, DOI 10.1016/j.actatropica.2016.12.031
   Kasichayanula S, 2007, TOXICOL APPL PHARM, V223, P187, DOI 10.1016/j.taap.2007.05.016
   Kruve A, 2008, J CHROMATOGR A, V1187, P58, DOI 10.1016/j.chroma.2008.01.077
   Kruve A, 2015, ANAL CHIM ACTA, V870, P29, DOI 10.1016/j.aca.2015.02.017
   Kruve A, 2015, ANAL CHIM ACTA, V870, P8, DOI 10.1016/j.aca.2015.02.016
   Kuklenyik P, 2013, ANAL CHIM ACTA, V787, P267, DOI 10.1016/j.aca.2013.05.055
   Leal WS, 2014, CURR OPIN INSECT SCI, V6, P93, DOI 10.1016/j.cois.2014.10.007
   Licciardi S, 2006, MED VET ENTOMOL, V20, P288, DOI 10.1111/j.1365-2915.2006.00630.x
   Magnusson B., 2014, EURACHEM GUIDE FITNE
   Marselos SC, 2002, J CHROMATOGR A, V946, P295, DOI 10.1016/S0021-9673(01)01525-4
   McEachran AD, 2018, ENVIRON SCI POLLUT R, V25, P12451, DOI 10.1007/s11356-018-1505-5
   Merel S., 2016, ENVIRON INT, V96, P96
   Moreno-Gonzalez D, 2017, FOOD CHEM, V221, P1763, DOI 10.1016/j.foodchem.2016.10.107
   Ortiz MC, 2010, ANAL CHIM ACTA, V674, P123, DOI 10.1016/j.aca.2010.06.026
   Snyder LR, 2010, INTRO MODERN LIQUID
   Sreeneeranj K., 2005, J CHROMATOGR B, V822, P271
   Swale DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103713
   Tay KS, 2013, INT J ENVIRON SCI TE, V10, P103, DOI 10.1007/s13762-012-0081-3
   TECHNICAL DEET, 1999, WHOSRPT1R21999
   Wang T, 2006, INT J PHARMACEUT, V310, P110, DOI 10.1016/j.ijpharm.2005.11.039
   Wiles D, 2014, J ANAL TOXICOL, V38, P696, DOI 10.1093/jat/bku082
   Yu ZQ, 2017, CHEM ENG J, V317, P90, DOI 10.1016/j.cej.2017.02.068
NR 30
TC 1
Z9 1
U1 1
U2 10
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1759-9660
EI 1759-9679
J9 ANAL METHODS-UK
JI Anal. Methods
PD APR 28
PY 2018
VL 10
IS 16
BP 1911
EP 1917
DI 10.1039/c8ay00486b
PG 7
WC Chemistry, Analytical; Food Science & Technology; Spectroscopy
SC Chemistry; Food Science & Technology; Spectroscopy
GA GK0PH
UT WOS:000435813100013
DA 2020-07-08
ER

PT J
AU Wang, G
   Zheng, W
   Zhu, S
   Wu, ZH
   Lam, TTY
   Tong, YH
   Qi, RZ
AF Wang, Gang
   Zheng, Wei
   Zhu, Sheng
   Wu, Zhonghua
   Lam, Tommy Tsan-Yuk
   Tong, Yuanhua
   Qi, Runzi
TI A cluster of Zika virus infection among travellers returning to China
   from Samoa: a case tracing study
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Zika virus; imported case; case cluster; travellers; China
ID OUTBREAK; STATES
AB Background: A febrile man, who returned to China after a 9-day travel in Fiji and Samoa, was detected to be infected with Zika virus (ZIKV) at the port by Shenzhen Entry-Exit Inspection and Quarantine Bureau on 14 February 2016.
   Methods: The patient and his 32 travelling companions were traced for ZIKV infection. A standardised questionnaire was used to obtain the information on demographics, clinical manifestations and exposure history. Their samples were tested for ZIKV by quantitative reverse transcriptase polymerase chain reaction (qRT-PCR). The positive samples were subjected to viral culture and genome sequencing.
   Findings: Four of the 33 travellers were confirmed to be infected by ZIKV through qRT-PCR and viral culture, with an overall infection rate of 12%. Interestingly, one case (Patient 3) where high viremia levels were tested 4 days prior to symptoms. In addition, a 7-year-old girl was identified to have ZIKV infection on 17 February, but never had any manifestation. ZIKV was isolated from the four imported cases. Phylogenetic analysis based on whole genome sequences revealed that these isolates were similar to each other and close to the strain causing the French Polynesia outbreak in 2013.
   Interpretation: The travellers should be informed of the high risk for ZIKV infection during their stay in areas with active transmission and measures to prevent mosquito bites.
C1 [Wang, Gang; Zheng, Wei; Wu, Zhonghua; Qi, Runzi] Zhejiang Entry Exit Inspect & Quarantine Bur, Hangzhou, Zhejiang, Peoples R China.
   [Zhu, Sheng; Tong, Yuanhua] Yiwu Entry Exit Inspect & Quarantine Bur, Yiwu, Peoples R China.
   [Lam, Tommy Tsan-Yuk] Univ Hong Kong, Sch Publ Hlth, Influenza Res Ctr, State Key Lab Emerging Infect Dis, Hong Kong, Hong Kong, Peoples R China.
RP Qi, RZ (corresponding author), Zhejiang Entry Exit Inspect & Quarantine Bur, Hangzhou, Zhejiang, Peoples R China.
EM qrz@ziq.gov.cn
RI Lam, Tsan Yuk/D-4837-2012
OI Lam, Tsan Yuk/0000-0002-9769-1527
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, LANCET, V384, P1571, DOI 10.1016/S0140-6736(14)61977-2
   Chen LH, 2016, ANN INTERN MED, V164, P574, DOI 10.7326/L16-0075
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Gurukumar KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-10
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Kutsuna S, 2014, EUROSURVEILLANCE, V19, P8, DOI 10.2807/1560-7917.ES2014.19.4.20683
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Quam MB, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw059
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Summers DJ, 2015, J TRAVEL MED, V22, P338, DOI 10.1111/jtm.12208
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Weissenbock H, 2010, VET MICROBIOL, V140, P271, DOI 10.1016/j.vetmic.2009.08.025
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Wu F, 2011, VECTOR-BORNE ZOONOT, V11, P1181, DOI 10.1089/vbz.2010.0032
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhang JW, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw047
NR 33
TC 5
Z9 5
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD APR 28
PY 2018
VL 25
AR tay022
DI 10.1093/jtm/tay022
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0TV
UT WOS:000451513100001
PM 29718403
OA Bronze
DA 2020-07-08
ER

PT J
AU Gootenberg, JS
   Abudayyeh, OO
   Kellner, MJ
   Joung, J
   Collins, JJ
   Zhang, F
AF Gootenberg, Jonathan S.
   Abudayyeh, Omar O.
   Kellner, Max J.
   Joung, Julia
   Collins, James J.
   Zhang, Feng
TI Multiplexed and portable nucleic acid detection platform with Cas13,
   Cas12a, and Csm6
SO SCIENCE
LA English
DT Article
ID THERMOPHILUS; CRISPR-CAS13; CLEAVAGE; IMMUNITY; SYSTEMS
AB Rapid detection of nucleic acids is integral for clinical diagnostics and biotechnological applications. We recently developed a platform termed SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) that combines isothermal preamplification with Cas13 to detect single molecules of RNA or DNA. Through characterization of CRISPR enzymology and application development, we report here four advances integrated into SHERLOCK version 2 (SHERLOCKv2) (i) four-channel single-reaction multiplexing with orthogonal CRISPR enzymes; (ii) quantitative measurement of input as low as 2 attomolar; (iii) 3.5-fold increase in signal sensitivity by combining Cas13 with Csm6, an auxiliary CRISPR-associated enzyme; and (iv) lateral-flow readout. SHERLOCKv2 can detect Dengue or Zika virus single-stranded RNA as well as mutations in patient liquid biopsy samples via lateral flow, highlighting its potential as a multiplexable, portable, rapid, and quantitative detection platform of nucleic acids.
C1 [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Kellner, Max J.; Joung, Julia; Collins, James J.; Zhang, Feng] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Joung, Julia; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Joung, Julia; Zhang, Feng] MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Joung, Julia; Collins, James J.; Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.] Harvard Univ, Dept Syst Biol, Boston, MA 02115 USA.
   [Abudayyeh, Omar O.; Collins, James J.] MIT, Dept Hlth Sci & Technol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Collins, James J.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
   [Collins, James J.] Harvard Univ, Wyss Inst Biol Inspired Engn, Boston, MA 02115 USA.
RP Zhang, F (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.
EM zhang@broadinstitute.org
OI Abudayyeh, Omar/0000-0002-7979-3220
FU Paul and Daisy Soros Fellowship; NIH F30 National Research Service Award
   [1F30-CA210382]; Defense Threat Reduction AgencyUnited States Department
   of DefenseDefense Threat Reduction Agency [HDTRA1-14-1-0006]; Paul G.
   Allen Frontiers Group; Wyss Institute; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [1R01-HG009761, 1R01-MH110049, 1DP1-HL141201]; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute; New York Stem Cell Foundation;
   Simons Foundation; Paul G. Allen Family Foundation; Vallee Foundation;
   Poitras Center for Affective Disorders Research at MIT; Hock E. Tan and
   K. Lisa Yang Center for Autism Research at MIT; Skolkovo Institute of
   Science and Technology
FX O.O.A. is supported by a Paul and Daisy Soros Fellowship and a NIH F30
   National Research Service Award 1F30-CA210382. J.J.C. is supported by
   the Defense Threat Reduction Agency grant HDTRA1-14-1-0006, the Paul G.
   Allen Frontiers Group, and the Wyss Institute. F.Z. is a New York Stem
   Cell Foundation-Robertson Investigator. F.Z. is supported by NIH grants
   (1R01-HG009761, 1R01-MH110049, and 1DP1-HL141201); the Howard Hughes
   Medical Institute; the New York Stem Cell, Simons, Paul G. Allen Family,
   and Vallee Foundations; the Poitras Center for Affective Disorders
   Research at MIT; the Hock E. Tan and K. Lisa Yang Center for Autism
   Research at MIT; the Skolkovo Institute of Science and Technology; and
   J. and P. Poitras, R. Metcalfe, and D. Cheng.
CR Abudayyeh OO, 2017, NATURE, V550, P280, DOI 10.1038/nature24049
   Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Barletta JM, 2004, AM J CLIN PATHOL, V122, P20, DOI 10.1309/529T2WDNEB6X8VUN
   Chen J. S., 2017, BIORXIV PREPRINT
   COTTRELL S, 1992, LANCET, V340, P626, DOI 10.1016/0140-6736(92)92169-G
   Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180
   Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152
   East-Seletsky A, 2017, MOL CELL, V66, P373, DOI 10.1016/j.molcel.2017.04.008
   East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802
   Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053
   Kazlauskiene M, 2017, SCIENCE, V357, P605, DOI 10.1126/science.aao0100
   Niewoehner O, 2017, NATURE, V548, P543, DOI 10.1038/nature23467
   Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115
   Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027
   Shmakov S, 2017, NAT REV MICROBIOL, V15, P169, DOI 10.1038/nrmicro.2016.184
   Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008
   Smargon AA, 2017, MOL CELL, V65, P618, DOI 10.1016/j.molcel.2016.12.023
   Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005
   Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027
   World Health Organization, 2009, GUID US HIV TEST TEC
   Zhao WA, 2008, ANAL CHEM, V80, P8431, DOI 10.1021/ac801008q
   Zhao WA, 2008, SMALL, V4, P810, DOI 10.1002/smll.200700757
NR 24
TC 241
Z9 253
U1 84
U2 356
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 27
PY 2018
VL 360
IS 6387
BP 439
EP +
DI 10.1126/science.aaq0179
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE1AR
UT WOS:000430949600043
PM 29449508
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Myhrvold, C
   Freije, CA
   Gootenberg, JS
   Abudayyeh, OO
   Metsky, HC
   Durbin, AF
   Kellner, MJ
   Tan, AL
   Paul, LM
   Parham, LA
   Garcia, KF
   Barnes, KG
   Chak, B
   Mondini, A
   Nogueira, ML
   Isern, S
   Michael, SF
   Lorenzana, I
   Yozwiak, NL
   MacInnis, BL
   Bosch, I
   Gehrke, L
   Zhang, F
   Sabeti, PC
AF Myhrvold, Cameron
   Freije, Catherine A.
   Gootenberg, Jonathan S.
   Abudayyeh, Omar O.
   Metsky, Hayden C.
   Durbin, Ann F.
   Kellner, Max J.
   Tan, Amanda L.
   Paul, Lauren M.
   Parham, Leda A.
   Garcia, Kimberly F.
   Barnes, Kayla G.
   Chak, Bridget
   Mondini, Adriano
   Nogueira, Mauricio L.
   Isern, Sharon
   Michael, Scott F.
   Lorenzana, Ivette
   Yozwiak, Nathan L.
   MacInnis, Bronwyn L.
   Bosch, Irene
   Gehrke, Lee
   Zhang, Feng
   Sabeti, Pardis C.
TI Field-deployable viral diagnostics using CRISPR-Cas13
SO SCIENCE
LA English
DT Article
ID ZIKA-VIRUS; PCR; AMPLIFICATION; INFECTION; AMERICA; ASSAY
AB Mitigating global infectious disease requires diagnostic tools that are sensitive, specific, and rapidly field deployable. In this study, we demonstrate that the Cas13-based SHERLOCK (specific high-sensitivity enzymatic reporter unlocking) platform can detect Zika virus (ZIKV) and dengue virus (DENV) in patient samples at concentrations as low as 1 copy per microliter. We developed HUDSON (heating unextracted diagnostic samples to obliterate nucleases), a protocol that pairs with SHERLOCK for viral detection directly from bodily fluids, enabling instrument-free DENVdetection directly from patient samples in <2 hours. We further demonstrate that SHERLOCK can distinguish the four DENV serotypes, as well as region-specific strains of ZIKV from the 2015-2016 pandemic. Finally, we report the rapid (<1 week) design and testing of instrument-free assays to detect clinically relevant viral single-nucleotide polymorphisms.
C1 [Myhrvold, Cameron; Freije, Catherine A.; Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Metsky, Hayden C.; Kellner, Max J.; Barnes, Kayla G.; Chak, Bridget; Yozwiak, Nathan L.; MacInnis, Bronwyn L.; Zhang, Feng; Sabeti, Pardis C.] Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.
   [Myhrvold, Cameron; Freije, Catherine A.; Barnes, Kayla G.; Chak, Bridget; Yozwiak, Nathan L.; Zhang, Feng; Sabeti, Pardis C.] Harvard Univ, Dept Organismal & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.
   [Freije, Catherine A.; Durbin, Ann F.; Gehrke, Lee; Sabeti, Pardis C.] Harvard Med Sch, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA.
   [Gootenberg, Jonathan S.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA.
   [Gootenberg, Jonathan S.; Abudayyeh, Omar O.; Zhang, Feng] MIT, Dept Biol Engn, Cambridge, MA 02139 USA.
   [Abudayyeh, Omar O.] MIT, Dept Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Metsky, Hayden C.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.
   [Durbin, Ann F.; Bosch, Irene; Gehrke, Lee] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA.
   [Tan, Amanda L.; Paul, Lauren M.; Isern, Sharon; Michael, Scott F.] Florida Gulf Coast Univ, Dept Biol Sci, Ft Myers, FL 33965 USA.
   [Parham, Leda A.; Garcia, Kimberly F.; Lorenzana, Ivette] Univ Nacl Autonoma Honduras, Inst Invest Microbiol, Ctr Invest Genet, Tegucigalpa, Honduras.
   [Barnes, Kayla G.; MacInnis, Bronwyn L.; Sabeti, Pardis C.] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.
   [Mondini, Adriano] Sao Paulo State Univ, Sch Pharmaceut Sci, Araraquara Lab Publ Hlth, Sao Paulo, Brazil.
   [Nogueira, Mauricio L.] Fac Med Sao Jose do Rio Preto, Lab Pesquisas Virol, Sao Paulo, Brazil.
   [Bosch, Irene] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.
   [Gehrke, Lee] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.
   [Sabeti, Pardis C.] HHMI, Chevy Chase, MD 20815 USA.
RP Myhrvold, C; Freije, CA; Sabeti, PC (corresponding author), Broad Inst Massachusetts Inst Technol MIT & Harva, Cambridge, MA 02142 USA.; Myhrvold, C; Freije, CA; Sabeti, PC (corresponding author), Harvard Univ, Dept Organismal & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.; Freije, CA; Sabeti, PC (corresponding author), Harvard Med Sch, Div Med Sci, PhD Program Virol, Boston, MA 02115 USA.; Sabeti, PC (corresponding author), Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA.; Sabeti, PC (corresponding author), HHMI, Chevy Chase, MD 20815 USA.
EM cmyhrvol@broadinstitute.org; cfreije@broadinstitute.org;
   pardis@broadinstitute.org
RI Nogueira, Mauricio L/B-7599-2012; Mondini, Adriano/F-7446-2012; Mondini,
   Adriano/AAB-4358-2020
OI Nogueira, Mauricio L/0000-0003-1102-2419; Mondini,
   Adriano/0000-0002-5557-9721; Mondini, Adriano/0000-0002-5557-9721;
   Bosch, Irene/0000-0003-1352-5888; Paul, Lauren/0000-0001-5503-7570;
   Abudayyeh, Omar/0000-0002-7979-3220; Metsky, Hayden/0000-0002-8871-2349
FU HHMIHoward Hughes Medical Institute; Broad Institute Chemical Biology
   and Therapeutics Science Shark Tank; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [U19AI110818, F30 NRSA 1F30-CA210382, AI 100190, 1R01-HG009761,
   1R01-MH110049, 1DP1-HL141201]; Defense Advanced Research Projects
   AgencyUnited States Department of DefenseDefense Advanced Research
   Projects Agency (DARPA) [D18AC00006]; Paul and Daisy Soros fellowship;
   NIH National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI099210]; New York Stem Cell foundation; Allen foundation; Vallee
   foundation; Tan-Yang Center at MIT; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [13/21719-3]
FX We acknowledge funding from HHMI, the Broad Institute Chemical Biology
   and Therapeutics Science Shark Tank, NIH grant U19AI110818, and Defense
   Advanced Research Projects Agency grant D18AC00006. The views, opinions,
   and/or findings expressed should not be interpreted as representing the
   official views or policies of the Department of Defense or the U.S.
   government. This study has been approved for public release;
   distribution is unlimited. C.M. is supported by HHMI. O.O.A. is
   supported by a Paul and Daisy Soros fellowship and NIH grant F30 NRSA
   1F30-CA210382. S.I. and S.F.M. are supported by NIH National Institute
   of Allergy and Infectious Diseases grant R01AI099210. I.B. and L.G. are
   supported by NIH grant AI 100190. F.Z. is supported by NIH grants
   1R01-HG009761, 1R01-MH110049, and 1DP1-HL141201; HHMI; the New York Stem
   Cell, Allen, and Vallee foundations; the Tan-Yang Center at MIT; and J.
   and P. Poitras and R. Metcalfe. F.Z. is a New York Stem Cell
   Foundation-Robertson Investigator. M.L.N. is supported by the Sao Paulo
   Research Foundation (FAPESP; grant 13/21719-3) and is a Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Research
   Fellow.
CR Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Du Y, 2017, ANGEW CHEM INT EDIT, V56, P992, DOI 10.1002/anie.201609108
   East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Requena-Castro R, 2017, MEM I OSWALDO CRUZ, V112, P520, DOI 10.1590/0074-02760160468
   Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100
   Van Ness J, 2003, P NATL ACAD SCI USA, V100, P4504, DOI 10.1073/pnas.0730811100
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   WEICKMANN JL, 1982, J BIOL CHEM, V257, P8705
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 26
TC 131
Z9 133
U1 39
U2 168
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 27
PY 2018
VL 360
IS 6387
BP 444
EP 448
DI 10.1126/science.aas8836
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GE1AR
UT WOS:000430949600044
PM 29700266
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Gaburro, J
   Bhatti, A
   Sundaramoorthy, V
   Dearnley, M
   Green, D
   Nahavandi, S
   Paradkar, PN
   Duchemin, JB
AF Gaburro, Julie
   Bhatti, Asim
   Sundaramoorthy, Vinod
   Dearnley, Megan
   Green, Diane
   Nahavandi, Saeid
   Paradkar, Prasad N.
   Duchemin, Jean-Bernard
TI Zika virus-induced hyper excitation precedes death of mouse primary
   neuron
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika; Primary neuron; Microelectrode array; Excitotoxicity; Hyper
   excitation; Spike; Glutamate
ID GUILLAIN-BARRE-SYNDROME; GLUTAMATE NEUROTOXICITY; CORTICAL NETWORKS;
   CELL-CULTURE; INFECTION; BRAIN; GABA; PHARMACOLOGY; PROGENITORS;
   RECEPTORS
AB Background: Zika virus infection in new born is linked to congenital syndromes, especially microcephaly. Studies have shown that these neuropathies are the result of significant death of neuronal progenitor cells in the central nervous system of the embryo, targeted by the virus. Although cell death via apoptosis is well acknowledged, little is known about possible pathogenic cellular mechanisms triggering cell death in neurons.
   Methods: We used in vitro embryonic mouse primary neuron cultures to study possible upstream cellular mechanisms of cell death. Neuronal networks were grown on microelectrode array and electrical activity was recorded at different times post Zika virus infection. In addition to this method, we used confocal microscopy and Q-PCR techniques to observe morphological and molecular changes after infection.
   Results: Zika virus infection of mouse primary neurons triggers an early spiking excitation of neuron cultures, followed by dramatic loss of this activity. Using NMDA receptor antagonist, we show that this excitotoxicity mechanism, likely via glutamate, could also contribute to the observed nervous system defects in human embryos and could open new perspective regarding the causes of adult neuropathies.
   Conclusions: This model of excitotoxicity, in the context of neurotropic virus infection, highlights the significance of neuronal activity recording with microelectrode array and possibility of more than one lethal mechanism after Zika virus infection in the nervous system.
C1 [Gaburro, Julie; Sundaramoorthy, Vinod; Dearnley, Megan; Green, Diane; Paradkar, Prasad N.; Duchemin, Jean-Bernard] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.
   [Gaburro, Julie; Bhatti, Asim; Nahavandi, Saeid] Deakin Univ, IISRI, Geelong, Vic, Australia.
RP Duchemin, JB (corresponding author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.
EM Jean-Bernard.Duchemin@csiro.au
RI Duchemin, Jean-Bernard/AAE-8077-2020; Sundaramoorthy,
   Vinod/AAE-4302-2020; Sundaramoorthy, Vinod/M-6133-2018; Bhatti,
   Asim/G-2082-2010
OI Duchemin, Jean-Bernard/0000-0001-5044-4855; Sundaramoorthy,
   Vinod/0000-0001-6309-8031; Bhatti, Asim/0000-0001-6876-1437
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Blakely PK, 2009, J NEUROPATH EXP NEUR, V68, P1061, DOI 10.1097/NEN.0b013e3181b8ba14
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3
   Chiappalone M, 2005, NEUROCOMPUTING, V65, P653, DOI 10.1016/j.neucom.2004.10.094
   Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049
   CHOI DW, 1988, J NEUROSCI, V8, P185
   CHOI DW, 1990, ANNU REV NEUROSCI, V13, P171, DOI 10.1146/annurev.ne.13.030190.001131
   CHOI DW, 1987, J NEUROSCI, V7, P357
   CHOI DW, 1992, J NEUROBIOL, V23, P1261, DOI 10.1002/neu.480230915
   Cooper AJL, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020016
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola F. R., 2016, NATURE
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8
   Dang J., 2016, CELL STEM CELL
   Fernandez V, 2016, EMBO J, V35, P1021, DOI 10.15252/embj.201593701
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hales Chadwick M, 2010, J Vis Exp, DOI 10.3791/2056
   Haydon PG, 2001, NAT REV NEUROSCI, V2, P185, DOI 10.1038/35058528
   Hosie AM, 1996, BRIT J PHARMACOL, V119, P1577, DOI 10.1111/j.1476-5381.1996.tb16075.x
   Huang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep34793
   JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Li C, 2016, CELL STEM CELL
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   LUMMIS SCR, 1990, COMP BIOCHEM PHYS C, V95, P1, DOI 10.1016/0742-8413(90)90073-I
   McKenna MC, 2016, J NEUROSCI RES, V94, P1561, DOI 10.1002/jnr.23908
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ming GL, 2016, CELL STEM CELL, V19, P690, DOI 10.1016/j.stem.2016.11.014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nargi-Aizenman JL, 2001, J VIROL, V75, P7114, DOI 10.1128/JVI.75.15.7114-7121.2001
   NISTRI A, 1979, PROG NEUROBIOL, V13, P117, DOI 10.1016/0301-0082(79)90016-9
   Novellino A, 2011, FRONT NEUROENG, V4, P1
   Oh Y., 2017, NAT NEUROSCI
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pegoraro S, 2010, J CELL PHYSIOL, V222, P713, DOI 10.1002/jcp.21998
   ROSAHL TW, 1995, NATURE, V375, P488, DOI 10.1038/375488a0
   Satoh H, 2005, NEUROSCI LETT, V381, P125, DOI 10.1016/j.neulet.2005.02.007
   Schneider DS, 2008, NAT REV IMMUNOL, V8, P889, DOI 10.1038/nri2432
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Veerabhadrappa R, 2017, NEUROCOMPUTING, V249, P299, DOI 10.1016/j.neucom.2016.09.135
   Veerabhadrappa R, 2016, SCI REP-UK, V6, DOI 10.1038/srep28533
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 54
TC 7
Z9 7
U1 1
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1743-422X
J9 VIROL J
JI Virol. J.
PD APR 27
PY 2018
VL 15
AR 79
DI 10.1186/s12985-018-0989-4
PG 13
WC Virology
SC Virology
GA GE9AO
UT WOS:000431522500003
PM 29703263
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Smartt, CT
   Shin, D
   Kang, S
   Tabachnick, WJ
AF Smartt, Chelsea T.
   Shin, Dongyoung
   Kang, Seokyoung
   Tabachnick, Walter J.
TI Culex quinquefasciatus (Diptera: Culicidae) From Florida Transmitted
   Zika Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; mosquito; Culex quinquefasciatus; transmission; saliva
ID MOSQUITOS; AMERICA; BRAZIL
AB We report a laboratory colony of Culex quinquefasciatus mosquitoes were experimentally able to salivate Zika virus (ZIKV, Flaviviridae; Flavivirus) at 16 days post infection (dpi). ZIKV RNA was detected in bodies and in saliva deposited on filter paper cards with subsequent studies demonstrating the presence of live ZIKV in saliva.
C1 [Smartt, Chelsea T.; Shin, Dongyoung; Tabachnick, Walter J.] Univ Florida, Dept Entomol & Nematol, Florida Med Entomol Lab, IFAS, Gainesville, FL 32611 USA.
   [Kang, Seokyoung] Univ Florida, Coll Vet Med, Infect Dis & Immunol, Gainesville, FL USA.
RP Smartt, CT (corresponding author), Univ Florida, Dept Entomol & Nematol, Florida Med Entomol Lab, IFAS, Gainesville, FL 32611 USA.
EM ctsmart@ufl.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [5-U54-AI-057157-09/UNC SERCEB];
   Florida Department of Agriculture and Consumer Services grant
   [00119227]; Applied Mosquito Research fund [P0014951]; CDC grant:
   Southeastern Regional Center of Excellence in Vector-Borne Diseases: the
   Gateway Program [1U01CK000510-01]; University of Florida Open Access
   Publishing Fund
FX This research was supported in part by NIH (5-U54-AI-057157-09/UNC
   SERCEB) subcontract and the Florida Department of Agriculture and
   Consumer Services grant 00119227 to CS. This study was also supported in
   part by the Applied Mosquito Research fund for DS (Contract number
   P0014951) and the CDC grant 1U01CK000510-01: Southeastern Regional
   Center of Excellence in Vector-Borne Diseases: the Gateway Program for
   SK. Publication of this article was funded in part by the University of
   Florida Open Access Publishing Fund.
CR Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Shin D, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-513
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Tabachnick WJ, 2013, INT J ENV RES PUB HE, V10, P249, DOI 10.3390/ijerph10010249
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
NR 20
TC 12
Z9 13
U1 1
U2 4
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 26
PY 2018
VL 9
AR 768
DI 10.3389/fmicb.2018.00768
PG 4
WC Microbiology
SC Microbiology
GA GE0YJ
UT WOS:000430942900001
PM 29755428
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gaburro, J
   Bhatti, A
   Harper, J
   Jeanne, I
   Dearnley, M
   Green, D
   Nahavandi, S
   Paradkar, PN
   Duchemin, JB
AF Gaburro, Julie
   Bhatti, Asim
   Harper, Jenni
   Jeanne, Isabelle
   Dearnley, Megan
   Green, Diane
   Nahavandi, Saeid
   Paradkar, Prasad N.
   Duchemin, Jean-Bernard
TI Neurotropism and behavioral changes associated with Zika infection in
   the vector Aedes aegypti
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID GUILLAIN-BARRE-SYNDROME; CASE SERIES; VIRUS; DROSOPHILA; GABA;
   TRANSMISSION; MANIFESTATIONS; RECEPTORS
AB Understanding Zika virus infection dynamics is essential, as its recent emergence revealed possible devastating neuropathologies in humans, thus causing a major threat to public health worldwide. Recent research allowed breakthrough in our understanding of the virus and host pathogenesis; however, little is known on its impact on its main vector, Aedes aegypti. Here we show how Zika virus targets Aedes aegypti's neurons and induces changes in its behavior. Results are compared to dengue virus, another flavivirus, which triggers a different pattern of behavioral changes. We used microelectrode array technology to record electrical spiking activity of mosquito primary neurons post infections and discovered that only Zika virus causes an increase in spiking activity of the neuronal network. Confocal microscopy also revealed an increase in synapse connections for Zika virus-infected neuronal networks. Interestingly, the results also showed that mosquito responds to infection by overexpressing glutamate regulatory genes while maintaining virus levels. This neuro-excitation, possibly via glutamate, could contribute to the observed behavioral changes in Zika virus-infected Aedes aegypti females. This study reveals the importance of virus-vector interaction in arbovirus neurotropism, in humans and vector. However, it appears that the consequences differ in the two hosts, with neuropathology in human host, while behavioral changes in the mosquito vector that may be advantageous to the virus.
C1 [Gaburro, Julie; Harper, Jenni; Dearnley, Megan; Green, Diane; Paradkar, Prasad N.; Duchemin, Jean-Bernard] CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.
   [Gaburro, Julie; Bhatti, Asim; Nahavandi, Saeid] Deakin Univ, IISRI, Geelong, Vic, Australia.
   [Jeanne, Isabelle] Deakin Univ, Sch Med, Geelong, Vic, Australia.
RP Duchemin, JB (corresponding author), CSIRO Hlth & Biosecur, Australian Anim Hlth Lab, Geelong, Vic, Australia.
EM Jean-Bernard.Duchemin@csiro.au
RI Duchemin, Jean-Bernard/AAE-8077-2020; Paradkar, Prasad/D-4189-2011;
   Bhatti, Asim/G-2082-2010
OI Duchemin, Jean-Bernard/0000-0001-5044-4855; Paradkar,
   Prasad/0000-0002-6553-2214; Jeanne, Isabelle/0000-0002-5065-9685;
   Bhatti, Asim/0000-0001-6876-1437
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804
   Blakely PK, 2009, J NEUROPATH EXP NEUR, V68, P1061, DOI 10.1097/NEN.0b013e3181b8ba14
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Chao XD, 2010, NEUROCHEM RES, V35, P1224, DOI 10.1007/s11064-010-0178-3
   Chiappalone M, 2006, BRAIN RES, V1093, P41, DOI 10.1016/j.brainres.2006.03.049
   Clements A.N, 1999, BIOL MOSQUITOES SENS, V2
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dessau Ram Benny, 2008, Ugeskr Laeger, V170, P328
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Eigenbrode SD, 2018, ANNU REV ENTOMOL, V63, P169, DOI 10.1146/annurev-ento-020117-043119
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   FUJITA SC, 1982, P NATL ACAD SCI-BIOL, V79, P7929, DOI 10.1073/pnas.79.24.7929
   Gaburro J., 2017, VIROLOGY
   Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Girard YA, 2004, VECTOR-BORNE ZOONOT, V4, P109, DOI 10.1089/1530366041210729
   Griffin DE, 2005, CURR TOP MICROBIOL, V289, P57
   GRIMSTAD PR, 1980, J MED ENTOMOL, V17, P1, DOI 10.1093/jmedent/17.1.1
   Hales Chadwick M, 2010, J Vis Exp, DOI 10.3791/2056
   Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378
   Hosie AM, 1996, BRIT J PHARMACOL, V119, P1577, DOI 10.1111/j.1476-5381.1996.tb16075.x
   Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931
   JAPOUR AJ, 1993, ANTIMICROB AGENTS CH, V37, P1095, DOI 10.1128/AAC.37.5.1095
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Lima-Camara TN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017690
   Lima-Camara TN, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-304
   LUMMIS SCR, 1990, COMP BIOCHEM PHYS C, V95, P1, DOI 10.1016/0742-8413(90)90073-I
   Massobrio P, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-22
   McKenna MC, 2011, NEUROCHEM INT, V59, P525, DOI 10.1016/j.neuint.2011.07.003
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   NISTRI A, 1979, PROG NEUROBIOL, V13, P117, DOI 10.1016/0301-0082(79)90016-9
   Novellino A, 2011, FRONT NEUROENG, V4, P1
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pegoraro S, 2010, J CELL PHYSIOL, V222, P713, DOI 10.1002/jcp.21998
   Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Satoh H, 2005, NEUROSCI LETT, V381, P125, DOI 10.1016/j.neulet.2005.02.007
   Schuler-Faccini L., 2017, MOL NEUROBIOL, V55, P1
   Sejvar JJ, 2003, JAMA-J AM MED ASSOC, V290, P511, DOI 10.1001/jama.290.4.511
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Veerabhadrappa R, 2017, NEUROCOMPUTING, V249, P299, DOI 10.1016/j.neucom.2016.09.135
   Vogels CBF, 2017, J EXP BIOL, V220, P3598, DOI 10.1242/jeb.164186
   Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033
   Wickham H., 2015, GGPLOT2 IMPLEMENTATI
   Wood S. N., 2001, R NEWS, V1, P20, DOI DOI 10.1159/000323281
NR 61
TC 7
Z9 7
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 25
PY 2018
VL 7
AR 68
DI 10.1038/s41426-018-0069-2
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GF1UM
UT WOS:000431721100001
PM 29691362
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, J
   Kline, BA
   Kenny, TA
   Smith, DR
   Soloveva, V
   Beitzel, B
   Pang, S
   Lockett, S
   Hess, HF
   Palacios, G
   Kuhn, JH
   Sun, MG
   Zeng, XK
AF Liu, Jun
   Kline, Brandon A.
   Kenny, Tara A.
   Smith, Darci R.
   Soloveva, Veronica
   Beitzel, Brett
   Pang, Song
   Lockett, Stephen
   Hess, Harald F.
   Palacios, Gustavo
   Kuhn, Jens H.
   Sun, Mei G.
   Zeng, Xiankun
TI A novel sheet-like virus particle array is a hallmark of Zika virus
   infection
SO EMERGING MICROBES & INFECTIONS
LA English
DT Article
ID ULTRASTRUCTURAL CHARACTERIZATION; 3-DIMENSIONAL ARCHITECTURE;
   REPLICATION ORGANELLES; MEMBRANE STRUCTURES; ENCEPHALITIS-VIRUS; CELLS;
   FLAVIVIRIDAE; COMPARTMENTS; SITES; WEB
AB Zika virus (ZIKV) is an emerging flavivirus that caused thousands of human infections in recent years. Compared to other human flaviviruses, ZIKV replication is not well understood. Using fluorescent, transmission electron, and focused ion beam-scanning electron microscopy, we examined ZIKV replication dynamics in Vero 76 cells and in the brains of infected laboratory mice. We observed the progressive development of a perinuclear flaviviral replication factory both in vitro and in vivo. In vitro, we illustrated the ZIKV lifecycle from particle cell entry to egress. ZIKV particles assembled and aggregated in an induced convoluted membrane structure and ZIKV strain-specific membranous vesicles. While most mature virus particles egressed via membrane budding, some particles also likely trafficked through late endosomes and egressed through membrane abscission. Interestingly, we consistently observed a novel sheet-like virus particle array consisting of a single layer of ZIKV particles. Our study further defines ZIKV replication and identifies a novel hallmark of ZIKV infection.
C1 [Liu, Jun; Kline, Brandon A.; Kenny, Tara A.; Smith, Darci R.; Soloveva, Veronica; Beitzel, Brett; Palacios, Gustavo; Sun, Mei G.; Zeng, Xiankun] US Army Med Res Inst Infect Dis, Frederick, MD 21702 USA.
   [Pang, Song; Hess, Harald F.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.
   [Lockett, Stephen] Leidos Biomed Res Inc, Opt Microscopy & Anal Lab, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA.
   [Kuhn, Jens H.] NIAID, Integrated Res Facil Ft Detrick, NIH, Frederick, MD 21702 USA.
RP Sun, MG; Zeng, XK (corresponding author), US Army Med Res Inst Infect Dis, Frederick, MD 21702 USA.
EM mei.g.sun.civ@mail.mil; xiankun.zeng.fn@mail.mil
RI Palacios, Gustavo/I-7773-2015; Kuhn, Jens H./B-7615-2011
OI Palacios, Gustavo/0000-0001-5062-1938; Kuhn, Jens
   H./0000-0002-7800-6045; Zeng, Xiankun (Kevin)/0000-0003-3526-8755;
   Beitzel, Brett/0000-0002-3798-6411
FU U.S. Department of Defense Chemical Biological Defense Program through
   the Defense Advanced Research Projects Agency (DARPA) under U.S. Army
   Medical Research Institute of Infectious Diseases (USAMRIID) [15094637];
   U.S. National Cancer Institute, National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Cancer Institute (NCI)
   [HHSN261200800001E]; Battelle Memorial Institute; US National Institute
   of Allergy and Infectious Diseases (NIAID)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272200700016I]
FX At USAMRIID, we would like to thank Kathleen Kuehl and Kayla Coffin for
   electron microscope support, Julie Tran and Dr. Rajini Mudhasani for
   providing the DENV-2 virus preparation, MAJ Carl Soffler for
   facilitating the College Qualified Leaders (CQL) Internship Program, and
   Dr. Christopher D. Kane and LTC Robert Lowen for programmatic support.
   At IRF-Frederick, we would like to thank Laura Bollinger for critically
   editing the manuscript. We also would like to thank Dr. Steven Hou and
   Dr. Robert Pope for insightful discussions. Opinions, interpretations,
   conclusions, and recommendations are those of the authors and are not
   necessarily endorsed by the U.S. Army, the U.S. Department of Defense,
   or the U.S. Department of Health and Human Services, nor does mention of
   trade names, commercial products, or organizations imply endorsement by
   the U.S. Government. Funding for the performance of this project was
   provided in part by U.S. Department of Defense Chemical Biological
   Defense Program through the Defense Advanced Research Projects Agency
   (DARPA) under U.S. Army Medical Research Institute of Infectious
   Diseases (USAMRIID) project number 15094637. This project was also
   funded in part with federal funds from the U.S. National Cancer
   Institute, National Institutes of Health, under Contract No.
   HHSN261200800001E. This work was also supported in part through Battelle
   Memorial Institute's prime contract with the US National Institute of
   Allergy and Infectious Diseases (NIAID) under Contract No.
   HHSN272200700016I. J.H.K. performed this work as an employee of Battelle
   Memorial Institute.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Belov GA, 2012, CURR OPIN VIROL, V2, P740, DOI 10.1016/j.coviro.2012.09.006
   Brand C, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1437
   Chatel-Chaix L, 2014, J VIROL, V88, P5907, DOI 10.1128/JVI.03404-13
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Narayan K, 2015, NAT METHODS, V12, P1021, DOI [10.1038/NMETH.3623, 10.1038/nmeth.3623]
   Offerdahl DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047912
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Romero-Brey I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003056
   Shulla A, 2016, CURR OPIN MICROBIOL, V32, P82, DOI 10.1016/j.mib.2016.05.003
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   TAKAHASHI M, 1979, AM J TROP MED HYG, V28, P122, DOI 10.4269/ajtmh.1979.28.122
   Titze B, 2016, BIOL CELL, V108, P307, DOI 10.1111/boc.201600024
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   WHITFIELD SG, 1973, VIROLOGY, V56, P70, DOI 10.1016/0042-6822(73)90288-2
   Xu CS, 2017, ELIFE, V6, DOI 10.7554/eLife.25916
NR 29
TC 3
Z9 3
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2222-1751
J9 EMERG MICROBES INFEC
JI Emerg. Microbes Infect.
PD APR 25
PY 2018
VL 7
AR 69
DI 10.1038/s41426-018-0071-8
PG 11
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GF1UM
UT WOS:000431721100002
PM 29691373
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Barrows, NJ
   Campos, RK
   Liao, KC
   Prasanth, KR
   Soto-Acosta, R
   Yeh, SC
   Schott-Lerner, G
   Pompon, J
   Sessions, OM
   Bradrick, SS
   Garcia-Blanco, MA
AF Barrows, Nicholas J.
   Campos, Rafael K.
   Liao, Kuo-Chieh
   Prasanth, K. Reddisiva
   Soto-Acosta, Ruben
   Yeh, Shih-Chia
   Schott-Lerner, Geraldine
   Pompon, Julien
   Sessions, October M.
   Bradrick, Shelton S.
   Garcia-Blanco, Mariano A.
TI Biochemistry and Molecular Biology of Flaviviruses
SO CHEMICAL REVIEWS
LA English
DT Review
ID WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; JAPANESE ENCEPHALITIS-VIRUS;
   ANTIBODY-DEPENDENT ENHANCEMENT; MINUS-STRAND RNA; LA PROTEIN BINDS;
   INNATE ANTIVIRAL IMMUNITY; 3' UNTRANSLATED REGION; DENGUE-VIRUS; ZIKA
   VIRUS
AB Flaviviruses, such as dengue, Japanese encephalitis, tick-borne encephalitis, West Nile, yellow fever, and Zika viruses, are critically important human pathogens that sicken a staggeringly high number of humans every year. Most of these pathogens are transmitted by mosquitos, and not surprisingly, as the earth warms and human populations grow and move, their geographic reach is increasing. Flaviviruses are simple RNA-protein machines that carry out protein synthesis, genome replication, and virion packaging in close association with cellular lipid membranes. In this review, we examine the molecular biology of flaviviruses touching on the structure and function of viral components and how these interact with host factors. The latter are functionally divided into pro-viral and antiviral factors, both of which, not surprisingly, include many RNA binding proteins. In the interface between the virus and the hosts we highlight the role of a noncoding RNA produced by flaviviruses to impair antiviral host immune responses. Throughout the review, we highlight areas of intense investigation, or a need for it, and potential targets and tools to consider in the important battle against pathogenic flaviviruses.
C1 [Barrows, Nicholas J.; Campos, Rafael K.; Prasanth, K. Reddisiva; Soto-Acosta, Ruben; Schott-Lerner, Geraldine; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Barrows, Nicholas J.; Campos, Rafael K.] Duke Univ, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.
   [Liao, Kuo-Chieh; Yeh, Shih-Chia; Pompon, Julien; Sessions, October M.; Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
   [Pompon, Julien] Univ Montpellier, CNRS, IRD, MIVEGEC, F-34090 Montpellier, France.
   [Barrows, Nicholas J.] St Jude Childrens Res Hosp, Dept Chem Biol & Therapeut, 262 Danny Thomas Pl, Memphis, TN 38105 USA.
RP Bradrick, SS; Garcia-Blanco, MA (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Garcia-Blanco, MA (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
EM ssbradri@utmb.edu; maragarc@utmb.edu
RI Campos, Rafael Kroon/AAB-5135-2020
OI Campos, Rafael Kroon/0000-0002-4852-0449
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R01AI101431, 1R01CA204806];
   University of Texas System STARS Award; UTMB startup funds; NIG
   [NMRC/BNIG/2032/2015]; CBRG [NMRC/CBRG/0074/2014]; Duke-NUS Signature
   Research Programme - Agency for Science, Technology and Research
   (A*STAR), Singapore; Ministry of Health, SingaporeMinistry of
   Health-Singapore
FX The authors acknowledge financial support during the time this review
   was written. At UTMB we acknowledge funding from NIH 1R01AI101431, NIH
   1R01CA204806, the University of Texas System STARS Award, and UTMB
   startup funds to M.A.G.-B., and at Duke-NUS we acknowledge funding from
   and NIG (NMRC/BNIG/2032/2015) and CBRG (NMRC/CBRG/0074/2014) to J.P. and
   from the Duke-NUS Signature Research Programme funded by the Agency for
   Science, Technology and Research (A*STAR), Singapore, and the Ministry
   of Health, Singapore to M.A.G.-B.
CR Abbas YM, 2017, P NATL ACAD SCI USA, V114, pE2106, DOI 10.1073/pnas.1612444114
   Acharya D, 2016, METHODS MOL BIOL, V1435, P249, DOI 10.1007/978-1-4939-3670-0_19
   Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0
   Aguirre S, 2017, J VIROL, V91, DOI 10.1128/JVI.01081-16
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Allers K, 2015, CURR OPIN VIROL, V14, P24, DOI 10.1016/j.coviro.2015.06.007
   ALLISON SL, 1995, J VIROL, V69, P5816, DOI 10.1128/JVI.69.9.5816-5820.1995
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Angenvoort J, 2013, VET MICROBIOL, V167, P168, DOI 10.1016/j.vetmic.2013.08.013
   Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   [Anonymous], 2018, LANCET INFECT DIS, V18, P123, DOI DOI 10.1016/S1473-3099(18)30023-9
   [Anonymous], 2015, RISK ASSESSMENT MICR
   Anwar A, 2009, J BIOL CHEM, V284, P17021, DOI 10.1074/jbc.M109.006239
   Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007
   BALTIMORE D, 1971, BACTERIOL REV, V35, P235, DOI 10.1128/MMBR.35.3.235-241.1971
   Barba-Spaeth G, 2005, J EXP MED, V202, P1179, DOI 10.1084/jem.20051352
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrows N., 2014, DENGUE DENGUE HEMORR
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Barrows NJ, 2014, METHODS MOL BIOL, V1138, P285, DOI 10.1007/978-1-4939-0348-1_18
   Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Behura SK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001385
   Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055
   Bennett SN, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P322, DOI 10.1079/9781845939649.0322
   Berget S M, 1977, Brookhaven Symp Biol, P332
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhullar D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114931
   Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Blackwell JL, 1997, J VIROL, V71, P6433, DOI 10.1128/JVI.71.9.6433-6444.1997
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Blanco-Melo D, 2012, IMMUNITY, V37, P399, DOI 10.1016/j.immuni.2012.08.013
   Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14
   BOULTON RW, 1976, VIROLOGY, V69, P416, DOI 10.1016/0042-6822(76)90473-6
   Bozzacco L, 2016, J VIROL, V90, P3212, DOI 10.1128/JVI.03077-15
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Bradrick SS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02374
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   Brinton MA, 2001, ANN NY ACAD SCI, V951, P207
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Bujalowski PJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00047-17
   BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   CAHOUR A, 1992, J VIROL, V66, P1535, DOI 10.1128/JVI.66.3.1535-1542.1992
   Campos R. K, 2017, CURRENT TOPICS MICRO
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Caplen NJ, 2001, P NATL ACAD SCI USA, V98, P9742, DOI 10.1073/pnas.171251798
   Carlin AF, 2017, CELL REP, V21, P1600, DOI 10.1016/j.celrep.2017.10.054
   Carocci M, 2016, ANTIVIR RES, V128, P57, DOI 10.1016/j.antiviral.2016.02.005
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   CHAMBERS TJ, 1990, P NATL ACAD SCI USA, V87, P8898, DOI 10.1073/pnas.87.22.8898
   CHAMBERS TJ, 1990, VIROLOGY, V177, P159, DOI 10.1016/0042-6822(90)90470-C
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Chang DC, 2016, VIROLOGY, V499, P259, DOI 10.1016/j.virol.2016.09.022
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Charles A. S., 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.4ab8bc87c945eb41c-d8a49e127082620, DOI 10.1371/CURRENTS.OUTBREAKS.4AB8BC87C945EB41C-D8A49E127082620]
   Chatel-Chaix L, 2015, J VIROL, V89, P7170, DOI 10.1128/JVI.00867-15
   CHATURVEDI UC, 1980, J INFECT DIS, V141, P712, DOI 10.1093/infdis/141.6.712
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen CJ, 1997, J VIROL, V71, P3466, DOI 10.1128/JVI.71.5.3466-3473.1997
   Chen HW, 2013, J IMMUNOL, V191, P4194, DOI 10.4049/jimmunol.1300799
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cheng G, 2010, CELL, V142, P714, DOI 10.1016/j.cell.2010.07.038
   Chien HL, 2011, J VIROL, V85, P4698, DOI 10.1128/JVI.01950-10
   Chin JFL, 2007, MICROBES INFECT, V9, P1, DOI 10.1016/j.micinf.2006.09.009
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   CHOW LT, 1977, CELL, V12, P1, DOI 10.1016/0092-8674(77)90180-5
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004227
   Choy MM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004058
   Chu JJH, 2005, VIROLOGY, V339, P249, DOI 10.1016/j.virol.2005.05.026
   Chu JJH, 2005, J GEN VIROL, V86, P405, DOI 10.1099/vir.0.80411-0
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Chu JJH, 2003, VIROLOGY, V312, P458, DOI 10.1016/S0042-6822(03)00261-7
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cowling VH, 2010, BIOCHEM J, V425, P295, DOI 10.1042/BJ20091352
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   DALGARNO L, 1986, J MOL BIOL, V187, P309, DOI 10.1016/0022-2836(86)90435-3
   Dans AL, 2018, J CLIN EPIDEMIOL, V95, P137, DOI 10.1016/j.jclinepi.2017.11.019
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   Davis ME, 2015, VIROLOGY, V479, P52, DOI 10.1016/j.virol.2015.02.033
   Davis WG, 2007, J VIROL, V81, P10172, DOI 10.1128/JVI.00531-07
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012
   DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971
   Dever TE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013706
   Paploski IAD, 2018, ANN INTERN MED, V168, P301, DOI 10.7326/M17-1949
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dobler G, 2010, VET MICROBIOL, V140, P221, DOI 10.1016/j.vetmic.2009.08.024
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Dong HP, 2008, VIROLOGY, V377, P1, DOI 10.1016/j.virol.2008.04.026
   Dong HP, 2007, J VIROL, V81, P4412, DOI 10.1128/JVI.02455-06
   Dong HP, 2014, J GEN VIROL, V95, P763, DOI 10.1099/vir.0.062208-0
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Emara MM, 2008, J VIROL, V82, P10657, DOI 10.1128/JVI.00991-08
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Ertel KJ, 2017, ELIFE, V6, DOI 10.7554/eLife.25940
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Faggioni G, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-283
   Faggioni G, 2009, INT J MOL MED, V23, P509, DOI 10.3892/ijmm_00000158
   FALGOUT B, 1989, J VIROL, V63, P1852, DOI 10.1128/JVI.63.5.1852-1860.1989
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033
   Fischl W, 2011, CURR OPIN MICROBIOL, V14, P470, DOI 10.1016/j.mib.2011.07.012
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Friebe P, 2012, VIROLOGY, V422, P346, DOI 10.1016/j.virol.2011.10.025
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Garcia-Blanco MA, 2015, RNA, V21, P525, DOI 10.1261/rna.050138.115
   Garcia-Montalvo BM, 2004, VIRUS RES, V102, P141, DOI 10.1016/j.virusres.2004.01.024
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gomila RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016687
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Gottwein E, 2013, CURR TOP MICROBIOL, V371, P201, DOI 10.1007/978-3-642-37765-5_8
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Green AM, 2014, J MOL BIOL, V426, P1148, DOI 10.1016/j.jmb.2013.11.023
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler D. J., 2014, DENGUE DENGUE HEMMOR
   GUIRAKHOO F, 1992, VIROLOGY, V191, P921, DOI 10.1016/0042-6822(92)90267-S
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hazra B, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aaf5185
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Heaton NS, 2016, IMMUNITY, V44, P46, DOI 10.1016/j.immuni.2015.12.017
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2
   Hermance ME, 2017, VECTOR-BORNE ZOONOT, V17, P453, DOI 10.1089/vbz.2017.2110
   Hershey JWB, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011528
   Hirano M, 2017, P NATL ACAD SCI USA, V114, P9960, DOI 10.1073/pnas.1704454114
   Hirano M, 2014, J GEN VIROL, V95, P849, DOI 10.1099/vir.0.061432-0
   Hodge K, 2016, J BIOL CHEM, V291, P17437, DOI 10.1074/jbc.M116.724013
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   HSU CL, 1993, MOL CELL BIOL, V13, P4826, DOI 10.1128/MCB.13.8.4826
   Iglesias NG, 2015, TRAFFIC, V16, P962, DOI 10.1111/tra.12305
   Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978
   Issur M, 2009, RNA, V15, P2340, DOI 10.1261/rna.1609709
   Jan CH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8299
   Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521
   Jentes ES, 2011, LANCET INFECT DIS, V11, P622, DOI 10.1016/S1473-3099(11)70147-5
   Jomaa A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15470
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kanlaya R, 2010, J PROTEOME RES, V9, P4960, DOI 10.1021/pr100219y
   Katoh H, 2011, J VIROL, V85, P10976, DOI 10.1128/JVI.00846-11
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Keenan RJ, 2001, ANNU REV BIOCHEM, V70, P755, DOI 10.1146/annurev.biochem.70.1.755
   Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997
   Khromykh AA, 1999, J VIROL, V73, P9247, DOI 10.1128/JVI.73.11.9247-9255.1999
   Khromykh AA, 2000, J VIROL, V74, P3253, DOI 10.1128/JVI.74.7.3253-3263.2000
   Khromykh AA, 1998, J VIROL, V72, P7270, DOI 10.1128/JVI.72.9.7270-7279.1998
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kimura T, 2013, J VIROL, V87, P9997, DOI 10.1128/JVI.00883-13
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar P, 2014, NUCLEIC ACIDS RES, V42, P3228, DOI 10.1093/nar/gkt1321
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lazear HM, 2015, CURR OPIN VIROL, V11, P1, DOI 10.1016/j.coviro.2014.12.001
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lee ASY, 2016, NATURE, V536, P96, DOI 10.1038/nature18954
   Lee B, 2017, RNA, V23, P169, DOI 10.1261/rna.058784.116
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Lee E, 2000, J VIROL, V74, P24, DOI 10.1128/JVI.74.1.24-32.2000
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lei YF, 2011, J GEN VIROL, V92, P796, DOI 10.1099/vir.0.028597-0
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Lewis JK, 1998, P NATL ACAD SCI USA, V95, P6774, DOI 10.1073/pnas.95.12.6774
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002
   Li W, 2001, VIROLOGY, V287, P49, DOI 10.1006/viro.2001.1015
   Li X, 2014, HUM VACC IMMUNOTHER, V10, P3579, DOI 10.4161/21645515.2014.980197
   Li Y, 2013, SCIENCE, V342, P231, DOI 10.1126/science.1241911
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lim XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14339
   LIN C, 1993, J VIROL, V67, P2327, DOI 10.1128/JVI.67.4.2327-2335.1993
   Lin CC, 2004, J BIOL CHEM, V279, P3308, DOI 10.1074/jbc.M309749200
   Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Lindenbach M., 2013, FIELDS VIROLOGY
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Liu H, 2017, J VIROL, V91, DOI [10.1128/JVI.02234-16, 10.1128/jvi.02234-16]
   Liu K, 2017, J VIROL, V91, DOI [10.1128/jvi.01348-16, 10.1128/JVI.01348-16]
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lobigs M, 2004, J VIROL, V78, P178, DOI 10.1128/JVI.78.1.178-186.2004
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Lobigs M, 2010, VIROLOGY, V401, P80, DOI 10.1016/j.virol.2010.02.008
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Lumb JH, 2017, CELL REP, V20, P819, DOI 10.1016/j.celrep.2017.06.085
   Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JM, 1999, J VIROL, V73, P9555, DOI 10.1128/JVI.73.11.9555-9567.1999
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mackenzie JS, 2002, CURR TOP MICROBIOL, V267, P1
   Makhluf H, 2015, CRIT REV IMMUNOL, V35, P253, DOI 10.1615/CritRevImmunol.2015014251
   Malim MH, 2009, PHILOS T R SOC B, V364, P675, DOI 10.1098/rstb.2008.0185
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Manzano M, 2011, J BIOL CHEM, V286, P22521, DOI 10.1074/jbc.M111.234302
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   MARKOFF L, 1989, J VIROL, V63, P3345, DOI 10.1128/JVI.63.8.3345-3352.1989
   Martin-Acebes MA, 2016, J LIPID RES, V57, P422, DOI 10.1194/jlr.M064212
   Martinez-Gutierrez M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087412
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Matusan AE, 2001, J VIROL, V75, P9633, DOI 10.1128/JVI.75.20.9633-9643.2001
   Mauger DM, 2015, P NATL ACAD SCI USA, V112, P3692, DOI 10.1073/pnas.1416266112
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   MCGAVRAN MH, 1964, AM J PATHOL, V45, P501
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Meier KC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000614
   Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09
   Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miller S, 2006, J BIOL CHEM, V281, P8854, DOI 10.1074/jbc.M512697200
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   Miorin L, 2012, VIRUS RES, V163, P660, DOI 10.1016/j.virusres.2011.11.020
   Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Nag DK, 2012, VIRUS RES, V165, P103, DOI 10.1016/j.virusres.2012.01.009
   Naik NG, 2015, J VIROL, V89, P6746, DOI 10.1128/JVI.00423-15
   Nawa M, 1998, ARCH VIROL, V143, P1555, DOI 10.1007/s007050050398
   Ng KYB, 2018, HUM REPROD UPDATE, V24, P15, DOI 10.1093/humupd/dmx028
   NG ML, 1983, ARCH VIROL, V78, P177
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oliveira ERA, 2017, J COMPUT AID MOL DES, V31, P1009, DOI 10.1007/s10822-017-0076-8
   Ong C C, 1998, Malays J Pathol, V20, P11
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   PEIRIS JSM, 1979, NATURE, V282, P509, DOI 10.1038/282509a0
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Perera N, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12734
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Perera R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002584
   PERRY RP, 1974, CELL, V1, P37, DOI 10.1016/0092-8674(74)90153-6
   Perry ST, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001297
   Perry ST, 2009, J VIROL, V83, P8276, DOI 10.1128/JVI.00365-09
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Pfeffer S, 2016, BBA-GEN SUBJECTS, V1860, P2122, DOI 10.1016/j.bbagen.2016.06.024
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pijlman GP, 2006, J VIROL, V80, P11255, DOI 10.1128/JVI.01559-06
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Polacek C, 2009, J GEN VIROL, V90, P687, DOI 10.1099/vir.0.007021-0
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Proutski V, 1997, NUCLEIC ACIDS RES, V25, P1194, DOI 10.1093/nar/25.6.1194
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006
   Ramirez JL, 2010, DEV COMP IMMUNOL, V34, P625, DOI 10.1016/j.dci.2010.01.006
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Reddy T, 2016, STRUCTURE, V24, P375, DOI 10.1016/j.str.2015.12.011
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Reid DW, 2015, SCIENCE, V348, DOI 10.1126/science.aaa7257
   Reid DW, 2015, NAT REV MOL CELL BIO, V16, P221, DOI 10.1038/nrm3958
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rossini Giada, 2013, World J Virol, V2, P49, DOI 10.5501/wjv.v2.i2.49
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   RUIZLINARES A, 1989, J VIROL, V63, P4199, DOI 10.1128/JVI.63.10.4199-4209.1989
   Saez-Llorens X, 2018, LANCET INFECT DIS, V18, P162, DOI 10.1016/S1473-3099(17)30632-1
   Sakai M, 2015, VIRUS RES, V203, P36, DOI 10.1016/j.virusres.2015.03.006
   Sakai M, 2014, J GEN VIROL, V95, P823, DOI 10.1099/vir.0.060046-0
   Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283
   SalasBenito JS, 1997, J VIROL, V71, P7246, DOI 10.1128/JVI.71.10.7246-7252.1997
   Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175
   Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Schwartz M, 2002, MOL CELL, V9, P505, DOI 10.1016/S1097-2765(02)00474-4
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   SHATKIN AJ, 1976, CELL, V9, P645, DOI 10.1016/0092-8674(76)90128-8
   Shi PY, 2014, SCIENCE, V343, P849, DOI 10.1126/science.1251249
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Spitale RC, 2013, NAT CHEM BIOL, V9, P18, DOI [10.1038/NCHEMBIO.1131, 10.1038/nchembio.1131]
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Staples JE, 2008, JAMA-J AM MED ASSOC, V300, P960, DOI 10.1001/jama.300.8.960
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Stiasny K, 2003, J VIROL, V77, P7856, DOI 10.1128/JVI.77.14.7856-7862.2003
   SVITKIN YV, 1984, VIROLOGY, V135, P536, DOI 10.1016/0042-6822(84)90207-1
   Sztuba-Solinska J, 2013, NUCLEIC ACIDS RES, V41, P5075, DOI 10.1093/nar/gkt203
   Ta M, 2000, J VIROL, V74, P5108, DOI 10.1128/JVI.74.11.5108-5115.2000
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tajima S, 2011, ARCH VIROL, V156, P63, DOI 10.1007/s00705-010-0816-8
   Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang XF, 2017, J CLIN INVEST, V127, P4314, DOI 10.1172/JCI94152
   Tanji T, 2007, MOL CELL BIOL, V27, P4578, DOI 10.1128/MCB.01814-06
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Tay MYF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005886
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Tilgner M, 2005, VIROLOGY, V331, P375, DOI 10.1016/j.virol.2004.07.022
   Tilgner M, 2004, J VIROL, V78, P8159, DOI 10.1128/JVI.78.15.8159-8171.2004
   Tricou Vianney, 2010, PLoS Negl Trop Dis, V4, pe785, DOI 10.1371/journal.pntd.0000785
   Troupin A, 2016, BBA-GEN SUBJECTS, V1860, P1898, DOI 10.1016/j.bbagen.2016.05.033
   Tsai YT, 2009, CELL MICROBIOL, V11, P604, DOI 10.1111/j.1462-5822.2008.01277.x
   Tuplin A, 2012, NUCLEIC ACIDS RES, V40, P6908, DOI 10.1093/nar/gks370
   Umareddy I, 2006, J GEN VIROL, V87, P2605, DOI 10.1099/vir.0.81844-0
   Valle JRD, 2005, J VIROL, V79, P4557, DOI 10.1128/JVI.79.8.4557-4567.2005
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859
   Vashist S, 2011, DNA CELL BIOL, V30, P339, DOI 10.1089/dna.2010.1114
   Vashist S, 2009, J GEN VIROL, V90, P1343, DOI 10.1099/vir.0.010850-0
   Viktorovskaya OV, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004921
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093
   Wang SB, 2016, VIROLOGY, V498, P116, DOI 10.1016/j.virol.2016.08.013
   Ward AM, 2014, METHODS MOL BIOL, V1138, P253, DOI 10.1007/978-1-4939-0348-1_16
   Ward AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep34379
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WEI CM, 1975, NATURE, V257, P251, DOI 10.1038/257251a0
   WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0
   WEI CM, 1975, P NATL ACAD SCI USA, V72, P318, DOI 10.1073/pnas.72.1.318
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587
   WENGLER G, 1978, VIROLOGY, V89, P423, DOI 10.1016/0042-6822(78)90185-X
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Whitehorn J, 2016, CLIN INFECT DIS, V62, P468, DOI 10.1093/cid/civ949
   WHO, 2016, WORLD HLTH STAT 2016, P7
   [WHO] World Health Organization, 2010, WHO MOD LIST ESS MED, P4
   Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xie XP, 2011, J VIROL, V85, P11183, DOI 10.1128/JVI.05468-11
   Xu QQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45375
   Yangchao D., 2015, INT J MOL MED, V35, P1683
   Yeh SC, 2018, DNA CELL BIOL, V37, P154, DOI 10.1089/dna.2017.4059
   Yi ZG, 2012, J VIROL, V86, P11815, DOI 10.1128/JVI.01022-12
   Yi ZG, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001255
   Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042
   Yocupicio-Monroy RME, 2003, J VIROL, V77, P3067, DOI 10.1128/JVI.77.5.3067-3076.2003
   Yoshii K, 2014, J VIROL, V88, P5406, DOI 10.1128/JVI.00421-14
   You S, 1999, J BIOL CHEM, V274, P33714, DOI 10.1074/jbc.274.47.33714
   Youn S, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-339
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yutin N, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-25
   ZHANG LW, 1992, J VIROL, V66, P7549, DOI 10.1128/JVI.66.12.7549-7554.1992
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 492
TC 29
Z9 30
U1 10
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0009-2665
EI 1520-6890
J9 CHEM REV
JI Chem. Rev.
PD APR 25
PY 2018
VL 118
IS 8
SI SI
BP 4448
EP 4482
DI 10.1021/acs.chemrev.7b00719
PG 35
WC Chemistry, Multidisciplinary
SC Chemistry
GA GE3DY
UT WOS:000431095200009
PM 29652486
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Hamon, N
   Kaci, M
   Uttaro, JP
   Perigaud, C
   Mathe, C
AF Hamon, Nadege
   Kaci, Malika
   Uttaro, Jean-Pierre
   Perigaud, Christian
   Mathe, Christophe
TI Synthesis of 3 '-halo-5 '-norcarbocyclic nucleoside phosphonates as
   potent anti-HIV agents
SO EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
DE Antiviral; HIV; Nucleoside analogues; Carbocycle; Phosphonates
ID ANALOGS
AB The synthesis and the antiviral evaluation of 3'-halo (iodo and fluoro) 5'-norcarbocyclic nucleoside phosphonates is described. No antiviral activity was observed against Zika virus, Dengue virus 2, HSV-1, HSV-2 and Chikungunya virus. In contrast, some of the synthesized compounds are potent inhibitors of the replication of HIV-1, comparatively to (R)-PMPA, with no concomitant cytotoxicity. (C) 2018 Elsevier Masson SAS. All rights reserved.
C1 [Hamon, Nadege; Kaci, Malika; Uttaro, Jean-Pierre; Perigaud, Christian; Mathe, Christophe] Univ Montpellier, IBMM, UMR 5247, CNRS,ENSCM, Cc 1705,Site Triolet,Pl Eugene Bataillon, F-34095 Montpellier 5, France.
RP Mathe, C (corresponding author), Univ Montpellier, IBMM, UMR 5247, CNRS,ENSCM, Cc 1705,Site Triolet,Pl Eugene Bataillon, F-34095 Montpellier 5, France.
EM christophe.mathe@umontpellier.fr
RI Mathe, Christophe/B-9293-2019
OI Mathe, Christophe/0000-0003-3114-9361
FU Universite de Montpellier; SATT AxLR, Languedoc - Roussillon
FX N. H. and M. K. are particularly grateful to the Universite de
   Montpellier for doctoral fellowship. We gratefully acknowledge SATT
   AxLR, Languedoc - Roussillon for financial support and Dr. P. Clayette
   (Laboratory Oncodesign biotechnology) for the biological results.
CR BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183
   Curran TT, 1997, TETRAHEDRON, V53, P1983, DOI 10.1016/S0040-4020(96)01169-6
   De Clercq E, 2009, REV MED VIROL, V19, P287, DOI 10.1002/rmv.624
   DYATKINA NB, 1995, TETRAHEDRON, V51, P761, DOI 10.1016/0040-4020(94)00986-5
   GEMAL AL, 1981, J AM CHEM SOC, V103, P5454, DOI 10.1021/ja00408a029
   HOLY A, 1982, COLLECT CZECH CHEM C, V47, P3447, DOI 10.1135/cccc19823447
   JOHNSON CR, 1993, J AM CHEM SOC, V115, P11014, DOI 10.1021/ja00076a079
   JOHNSON CR, 1992, TETRAHEDRON LETT, V33, P917, DOI 10.1016/S0040-4039(00)91575-2
   Mehellou Y, 2010, J MED CHEM, V53, P521, DOI 10.1021/jm900492g
   MITSUNOBU O, 1981, SYNTHESIS-STUTTGART, P1, DOI 10.1055/s-1981-29317
   Moon HR, 2004, BIOORG MED CHEM LETT, V14, P5641, DOI 10.1016/j.bmcl.2004.08.047
   Ren K, 2015, J ORG CHEM, V80, P12572, DOI 10.1021/acs.joc.5b02519
   Soorukram D, 2007, ORG LETT, V9, P1021, DOI 10.1021/ol063052n
   Stolk LML, 2004, PHARM WORLD SCI, V26, P133, DOI 10.1023/B:PHAR.0000026815.44214.83
   Takahashi K, 2012, ORG LETT, V14, P1644, DOI 10.1021/ol300431n
   Tanaka K, 2007, BIOORGAN MED CHEM, V15, P1615, DOI 10.1016/j.bmc.2006.12.023
   Uttaro J.-P., 2017, WO patent, Patent No. [W02017/109388, 2017109388]
   Uttaro JP, 2013, TETRAHEDRON, V69, P2131, DOI 10.1016/j.tet.2013.01.011
NR 18
TC 2
Z9 2
U1 1
U2 4
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI ISSY-LES-MOULINEAUX
PA 65 RUE CAMILLE DESMOULINS, CS50083, 92442 ISSY-LES-MOULINEAUX, FRANCE
SN 0223-5234
EI 1768-3254
J9 EUR J MED CHEM
JI Eur. J. Med. Chem.
PD APR 25
PY 2018
VL 150
BP 642
EP 654
DI 10.1016/j.ejmech.2018.03.038
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GE0GF
UT WOS:000430891400045
PM 29558735
DA 2020-07-08
ER

PT J
AU Schmidt, CA
   Comeau, G
   Monaghan, AJ
   Williamson, DJ
   Ernst, KC
AF Schmidt, Chris A.
   Comeau, Genevieve
   Monaghan, Andrew J.
   Williamson, Daniel J.
   Ernst, Kacey C.
TI Effects of desiccation stress on adult female longevity in Aedes aegypti
   and Ae. albopictus (Diptera: Culicidae): results of a systematic review
   and pooled survival analysis
SO PARASITES & VECTORS
LA English
DT Review
DE Aedes aegypti; Aedes albopictus; Longevity; Survival; Humidity; Vapor
   pressure; Temperature; Review; Pooled analysis
ID LIFE TABLE CHARACTERISTICS; DENGUE VIRUS TRANSMISSION; AGENT-BASED
   MODEL; POPULATION-DYNAMICS; GLOBAL DISTRIBUTION; INVASIVE MOSQUITO;
   STEGOMYIA AEGYPTI; TEMPERATURE-FLUCTUATIONS; RELATIVE-HUMIDITY; CLIMATE
   VARIABLES
AB Background: Transmission dynamics of mosquito-borne viruses such as dengue, Zika and chikungunya are affected by the longevity of the adult female mosquito. Environmental conditions influence the survival of adult female Aedes mosquitoes, the primary vectors of these viruses. While the association of temperature with Aedes mortality has been relatively well-explored, the role of humidity is less established. The current study's goals were to compile knowledge of the influence of humidity on adult survival in the important vector species Aedes aegypti and Ae. albopictus, and to quantify this relationship while accounting for the modifying effect of temperature.
   Methods: We performed a systematic literature review to identify studies reporting experimental results informing the relationships among temperature, humidity and adult survival in Ae. aegypti and Ae. albopictus. Using a novel simulation approach to harmonize disparate survival data, we conducted pooled survival analyses via stratified and mixed effects Cox regression to estimate temperature-dependent associations between humidity and mortality risk for these species across a broad range of temperatures and vapor pressure deficits.
   Results: After screening 1517 articles, 17 studies (one in semi-field and 16 in laboratory settings) met inclusion criteria and collectively reported results for 192 survival experiments. We review and synthesize relevant findings from these studies. Our stratified model estimated a strong temperature-dependent association of humidity with mortality in both species, though associations were not significant for Ae. albopictus in the mixed effects model. Lowest mortality risks were estimated around 27.5 degrees C and 21.5 degrees C for Ae. aegypti and Ae. albopictus, respectively, and mortality increased non-linearly with decreasing humidity. Aedes aegypti had a survival advantage relative to Ae. albopictus in the stratified model under most conditions, but species differences were not significant in the mixed effects model.
   Conclusions: Humidity is associated with mortality risk in adult female Ae. aegypti in controlled settings. Data are limited at low humidities, temperature extremes, and for Ae. albopictus, and further studies should be conducted to reduce model uncertainty in these contexts. Desiccation is likely an important factor in Aedes population dynamics and viral transmission in arid regions. Models of Aedes-borne virus transmission may be improved by more comprehensively representing humidity effects.
C1 [Schmidt, Chris A.; Ernst, Kacey C.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, 1295 N Martin Ave, Tucson, AZ 85724 USA.
   [Schmidt, Chris A.; Monaghan, Andrew J.] Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.
   [Comeau, Genevieve; Williamson, Daniel J.; Ernst, Kacey C.] Univ Arizona, Dept Entomol, Coll Agr & Life Sci, POB 210036, Tucson, AZ 85721 USA.
RP Schmidt, CA (corresponding author), Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Dept Epidemiol & Biostat, 1295 N Martin Ave, Tucson, AZ 85724 USA.; Schmidt, CA (corresponding author), Natl Ctr Atmospher Res, POB 3000, Boulder, CO 80307 USA.
EM cschmidt@email.arizona.edu
FU NIH/NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01 AI091843-02]; National Aeronautics and
   Space AdministrationNational Aeronautics & Space Administration (NASA)
   [NNX16AO98G]; National Science FoundationNational Science Foundation
   (NSF)
FX This study was funded with support from NIH/NIAID R01 AI091843-02 and
   National Aeronautics and Space Administration grant NNX16AO98G to KE and
   AM. The National Center for Atmospheric Research is sponsored by the
   National Science Foundation.
CR Adams DK, 1997, B AM METEOROL SOC, V78, P2197, DOI 10.1175/1520-0477(1997)078<2197:TNAM>2.0.CO;2
   Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688
   Alto BW, 2015, J MED ENTOMOL, V52, P163, DOI 10.1093/jme/tju062
   Alto BW, 2001, J MED ENTOMOL, V38, P646, DOI 10.1603/0022-2585-38.5.646
   Anderson DB, 1936, ECOLOGY, V17, P277, DOI 10.2307/1931468
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859
   Ashkar F, 2006, J HYDROL, V328, P694, DOI 10.1016/j.jhydrol.2006.01.014
   Bagny Beilhe L, 2013, MED VET ENTOMOL, V27, P387, DOI 10.1111/j.1365-2915.2012.01062.x
   BAR-ZEEV MICHA, 1958, BULL ENT RES, V49, P157, DOI 10.1017/S0007485300053499
   BAR-ZEEV MICHA, 1957, BULL ENT RES, V48, P593, DOI 10.1017/S0007485300002765
   Bara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126703
   Beebe NW, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000429
   BEEUWKES HENRY, 1933, TRANS ROY SOC TROP MED AND HYG [LONDON], V26, P425, DOI 10.1016/S0035-9203(33)90103-0
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benoit JB, 2010, J INSECT PHYSIOL, V56, P151, DOI 10.1016/j.jinsphys.2009.09.012
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Briegel H, 2001, J VECTOR ECOL, V26, P21
   Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P93, DOI 10.1590/S0085-56262002000100011
   Canyon DV, 2013, TROP BIOMED, V30, P1
   Canyon DV, 1999, J INSECT PHYSIOL, V45, P959, DOI 10.1016/S0022-1910(99)00085-2
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   CGIAR, 2017, WORLDS DRY AR
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chown S. L., 2004, INSECT PHYSL ECOLOGY
   Christophers S., 1960, AEDES AEGYPTI L YELL
   CLEMENTS AN, 1981, J APPL ECOL, V18, P373, DOI 10.2307/2402401
   Colinet H, 2015, ANNU REV ENTOMOL, V60, P123, DOI 10.1146/annurev-ento-010814-021017
   CROVELLO TJ, 1972, EVOLUTION, V26, P185, DOI 10.1111/j.1558-5646.1972.tb00186.x
   Davis RE, 2016, ENVIRON RES, V144, P106, DOI 10.1016/j.envres.2015.10.014
   de Almeida SJ, 2010, ENVIRON MODELL SOFTW, V25, P1490, DOI 10.1016/j.envsoft.2010.04.021
   Degallier N, 2012, J VECTOR ECOL, V37, P428, DOI 10.1111/j.1948-7134.2012.00247.x
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103
   Dommar CJ, 2014, ACTA TROP, V129, P61, DOI 10.1016/j.actatropica.2013.08.004
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516
   Endersby NM, 2011, J MED ENTOMOL, V48, P999, DOI 10.1603/ME10264
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   GAO JZ, 1984, ACTA ENTOMOL SINICA, V27, P182
   Gharbi M, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-166
   Goindin D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135489
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   HARRELL F, 2001, REGRESSION MODELING
   Harrington LC, 2008, J MED ENTOMOL, V45, P307, DOI 10.1603/0022-2585(2008)45[307:ASOTDV]2.0.CO;2
   Harrington LC, 2001, J MED ENTOMOL, V38, P537, DOI 10.1603/0022-2585-38.4.537
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   HAUFE W. O., 1964, INT J BIOMETEOROL, V7, P245, DOI 10.1007/BF02187457
   Hayden MH, 2010, ECOHEALTH, V7, P64, DOI 10.1007/s10393-010-0288-z
   Higgins RW, 1997, J CLIMATE, V10, P2600, DOI 10.1175/1520-0442(1997)010<2600:IOTNAM>2.0.CO;2
   HO BC, 1971, B WORLD HEALTH ORGAN, V44, P635
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Hosmer Jr David W., 2008, APPL SURVIVAL ANAL
   HYLTON AR, 1969, J MED ENTOMOL, V6, P147, DOI 10.1093/jmedent/6.2.147
   Isidoro C, 2009, LECT NOTES ARTIF INT, V5816, P53, DOI 10.1007/978-3-642-04686-5_5
   Johansson MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104915
   Johnson N., 1994, CONTINUOUS UNIVARIAT, V1
   Johnson TL, 2017, J MED ENTOMOL, V54, P1605, DOI 10.1093/jme/tjx163
   Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009
   JULIANO SA, 1994, OECOLOGIA, V97, P369, DOI 10.1007/BF00317327
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Karim MN, 2012, INDIAN J MED RES, V136, P32
   Kearney M, 2009, FUNCT ECOL, V23, P528, DOI 10.1111/j.1365-2435.2008.01538.x
   Kessler S, 2008, J VECTOR ECOL, V33, P145, DOI 10.3376/1081-1710(2008)33[145:ROAGAS]2.0.CO;2
   Khormi HM, 2013, J EARTH SCI CLIM CH, V5, P168
   KLOWDEN MJ, 1992, J MED ENTOMOL, V29, P467, DOI 10.1093/jmedent/29.3.467
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2015, CURR OPIN VIROL, V15, P112, DOI 10.1016/j.coviro.2015.10.003
   LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Landau KI, 2012, J VECTOR ECOL, V37, P407, DOI 10.1111/j.1948-7134.2012.00245.x
   LANSDOWNE C, 1975, J MED ENTOMOL, V11, P723, DOI 10.1093/jmedent/11.6.723
   Lega J, 2017, J MED ENTOMOL, V54, P1375, DOI 10.1093/jme/tjx077
   Lewis D. J., 1933, Bulletin of Entomological Research London, V24, P363, DOI 10.1017/S0007485300031692
   Li C F, 1985, Southeast Asian J Trop Med Public Health, V16, P560
   Liberati A, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000100
   Lounibos LP, 2010, ANN ENTOMOL SOC AM, V103, P757, DOI 10.1603/AN09142
   Lounibos LP, 2016, J MED ENTOMOL, V53, P1385, DOI 10.1093/jme/tjw122
   Lozano-Fuentes S, 2014, J MED ENTOMOL, V51, P742, DOI 10.1603/ME14015
   Lucio PS, 2013, J VECTOR ECOL, V38, P20, DOI 10.1111/j.1948-7134.2013.12005.x
   MacDONALD G., 1956, BULL WORLD HEALTH ORGAN, V15, P369
   MACHADOA, 1972, ANN ENTOMOL SOC AM, V65, P542, DOI 10.1093/aesa/65.3.542
   Maciel-De-Freitas R, 2007, MED VET ENTOMOL, V21, P284, DOI 10.1111/j.1365-2915.2007.00694.x
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Manore CA, 2015, J BIOL DYNAM, V9, P52, DOI 10.1080/17513758.2015.1005698
   Mayer H, 2003, THEOR APPL CLIMATOL, V76, P165, DOI 10.1007/s00704-003-0010-y
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x
   Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Mogi M, 2017, J MED ENTOMOL, V54, P1615, DOI 10.1093/jme/tjx156
   MOGI M, 1988, MED VET ENTOMOL, V2, P319, DOI 10.1111/j.1365-2915.1988.tb00203.x
   Mogi M, 1996, J MED ENTOMOL, V33, P53, DOI 10.1093/jmedent/33.1.53
   Mogi M, 2015, J MED ENTOMOL, V52, P647, DOI 10.1093/jme/tjv038
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Monaghan AJ, 2015, TICKS TICK-BORNE DIS, V6, P615, DOI 10.1016/j.ttbdis.2015.05.005
   MOORE CG, 1978, AM J TROP MED HYG, V27, P1225, DOI 10.4269/ajtmh.1978.27.1225
   Moore CG, 1985, EC MOSQ P WORKSH
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Morin CW, 2013, ENVIRON HEALTH PERSP, V121, P1264, DOI 10.1289/ehp.1306556
   Morin CW, 2010, INT J BIOMETEOROL, V54, P517, DOI 10.1007/s00484-010-0349-6
   Murray F.W., 1967, J APPL METEOROL, V6, P203, DOI DOI 10.1175/1520-0450(1967)006<0203:OTCOSV>2.0.CO;2
   Naish S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-167
   Neto PL, 2004, NEOTROP ENTOMOL, V33, P29, DOI 10.1590/S1519-566X2004000100006
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Pinto E, 2011, INT J ENVIRON HEAL R, V21, P415, DOI 10.1080/09603123.2011.572279
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   R Development Core Team, 2016, R LANG ENV STAT COMP
   Reiskind MH, 2009, MED VET ENTOMOL, V23, P62, DOI 10.1111/j.1365-2915.2008.00782.x
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Sawabe K, 1999, J MED ENTOMOL, V36, P101, DOI 10.1093/jmedent/36.1.101
   Scott TW, 1997, AM J TROP MED HYG, V57, P235, DOI 10.4269/ajtmh.1997.57.235
   Simoes TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064773
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Steinhoff DF, 2016, EARTH INTERACT, V20, P1, DOI 10.1175/EI-D-15-0048.1
   Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Therneau TM, 2000, STAT BIOL HEALTH
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Trenberth KE, 2005, CLIM DYNAM, V24, P741, DOI 10.1007/s00382-005-0017-4
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   Urdaneta-Marquez L, 2011, INFECT GENET EVOL, V11, P253, DOI 10.1016/j.meegid.2010.11.020
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Walker KR, 2011, J AM MOSQUITO CONTR, V27, P135, DOI 10.2987/10-6078.1
   Wang JH, 2016, J CLIMATE, V29, P5205, DOI 10.1175/JCLI-D-15-0485.1
   Wang P K, 2013, PHYS DYNAMICS CLOUDS
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Wong PPY, 2016, BUILD ENVIRON, V95, P199, DOI 10.1016/j.buildenv.2015.09.024
   Xu CG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000830
   Xu HY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002805
   Yang HM, 2009, EPIDEMIOL INFECT, V137, P1188, DOI 10.1017/S0950268809002040
   Yang HM, 2011, BIOSYSTEMS, V103, P360, DOI 10.1016/j.biosystems.2010.11.002
   Yee DA, 2016, J MED ENTOMOL, V53, P1002, DOI 10.1093/jme/tjw046
NR 152
TC 6
Z9 6
U1 0
U2 15
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 25
PY 2018
VL 11
AR 267
DI 10.1186/s13071-018-2808-6
PG 21
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GD9GC
UT WOS:000430820100002
PM 29695282
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hall-Mendelin, S
   Pyke, AT
   Moore, PR
   Ritchie, SA
   Moore, FAJ
   van den Hurk, AF
AF Hall-Mendelin, Sonja
   Pyke, Alyssa T.
   Moore, Peter R.
   Ritchie, Scott A.
   Moore, Frederick A. J.
   van den Hurk, Andrew F.
TI Characterization of a Western Pacific Zika Virus Strain in Australian
   Aedes aegypti
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Zika virus; mosquito(es); Aedes aegypti; transmission; Australia
ID SUSCEPTIBILITY; TRANSMISSION; POPULATIONS; ARBOVIRUSES; AMERICA
AB Zika virus (ZIKV) is a globally emerging arbovirus responsible for widespread epidemics in the western Pacific, the Americas, and Asia. The virus predominately circulates in urban transmission cycles between Aedes aegypti and humans. Australia is considered at risk to outbreaks of ZIKV due to the presence of A. aegypti populations in northern areas of the state of Queensland. Furthermore, close proximity to epidemic regions has led to almost 50% of imported cases reported since 2012 originating in the Pacific region. We conducted the first vector competence experiments with A. aegypti from three Australian populations for a western Pacific strain of ZIKV. When exposed to bloodmeals containing between 10(5) and 10(8) tissue culture infectious dose (TCID)(50)/mL of virus, infection, dissemination, and transmission, rates were <10%. In comparison to using frozen virus stock, exposing mosquitoes to freshly cultured virus also did not increase infection or transmission rates. It was only when bloodmeal titers exceeded 10(8) TCID50/mL that infection rates approached 50% and transmission rates increased to >20%. However, this concentration of virus is considerably higher than levels previously reported in blood samples from viremic humans. The Australian A. aegypti tested appear to express a midgut barrier to ZIKV infection, as 50% of mosquitoes that became infected developed a disseminated infection, and 50% of those mosquitoes transmitted the virus. Overall, these results suggest that while Australian A. aegypti strains are able to transmit the western Pacific ZIKV strain, they are relatively inefficient vectors of the virus.
C1 [Hall-Mendelin, Sonja; Pyke, Alyssa T.; Moore, Peter R.; Moore, Frederick A. J.; van den Hurk, Andrew F.] Queensland Govt, Publ Hlth Virol Forens & Sci Serv, Dept Hlth, Coopers Plains, Australia.
   [Ritchie, Scott A.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Cairns, Australia.
RP van den Hurk, AF (corresponding author), Queensland Govt, Publ Hlth Virol Forens & Sci Serv, Dept Hlth, POB 594, Archerfield, Qld 4108, Australia.
EM andrew.vandenhurk@health.qld.gov.au
RI van den Hurk, Andrew/X-9831-2019
OI van den Hurk, Andrew/0000-0001-6262-831X; Pyke,
   Alyssa/0000-0003-3512-4321
FU internal Forensic and Scientific Services Research and Development Grant
   [RSS17-005]; National Health and Medical Research CouncilNational Health
   and Medical Research Council of Australia [1044698]
FX The authors wish to thank Helle Bielefeldt-Ohmann for early discussions
   regarding the study. They also thank Matt Bradford, Caleb Anning, Ben
   Purcel, and Di Morris of CSIRO for assisting in the collection of
   F<INF>0</INF> A. aegypti eggs from Innisfail, and Chris Paton (JCU),
   Sandy Taylor (CSIRO), and Jason Anderson (CSIRO) for providing the
   subsequent colony eggs used in this study. The authors also thank Bruce
   Harrower, Peter Burtonclay, and Tanya Constantino for cell culture
   maintenance. Funding for this study was provided by an internal Forensic
   and Scientific Services Research and Development Grant (Project number
   RSS17-005). S. Ritchie is supported by National Health and Medical
   Research Council Senior Research Fellowship 1044698.
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Australian Government Department of Health, SUMM INF OV ACQ VECT
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Black WC, 2002, ARCH MED RES, V33, P379, DOI 10.1016/S0188-4409(02)00373-9
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Goo L, 2016, MBIO, V7, DOI [10.1128/mBio.01396-16, 10.1128/mbio.01396-16]
   Hall-Mendelin S, 2017, AM J TROP MED HYG, V96, P1241, DOI 10.4269/ajtmh.16-0981
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ministry of Health, 2016, UPD ZIK VIRUSTONGA
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Pyke AT, 2016, PLOS CURR, V7, P8
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Ritchie SA, 2001, J AM MOSQUITO CONTR, V17, P206
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Ye YXH, 2014, AM J TROP MED HYG, V90, P422, DOI 10.4269/ajtmh.13-0186
NR 28
TC 4
Z9 4
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JUN
PY 2018
VL 18
IS 6
BP 317
EP 322
DI 10.1089/vbz.2017.2232
EA APR 2018
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GI5BA
UT WOS:000430989900001
PM 29694294
DA 2020-07-08
ER

PT J
AU Magnani, DM
   Rogers, TF
   Maness, NJ
   Grubaugh, ND
   Beutler, N
   Bailey, VK
   Gonzalez-Nieto, L
   Gutman, MJ
   Pedreno-Lopez, N
   Kwal, JM
   Ricciardi, MJ
   Myers, TA
   Julander, JG
   Bohm, RP
   Gilbert, MH
   Schiro, F
   Aye, PP
   Blair, RV
   Martins, MA
   Falkenstein, KP
   Kaur, A
   Curry, CL
   Kallas, EG
   Desrosiers, RC
   Goldschmidt-Clermont, PJ
   Whitehead, SS
   Andersen, KG
   Bonaldo, MC
   Lackner, AA
   Panganiban, AT
   Burton, DR
   Watkins, DI
AF Magnani, Diogo M.
   Rogers, Thomas F.
   Maness, Nicholas J.
   Grubaugh, Nathan D.
   Beutler, Nathan
   Bailey, Varian K.
   Gonzalez-Nieto, Lucas
   Gutman, Martin J.
   Pedreno-Lopez, Nuria
   Kwal, Jaclyn M.
   Ricciardi, Michael J.
   Myers, Tereance A.
   Julander, Justin G.
   Bohm, Rudolf P.
   Gilbert, Margaret H.
   Schiro, Faith
   Aye, Pyone P.
   Blair, Robert V.
   Martins, Mauricio A.
   Falkenstein, Kathrine P.
   Kaur, Amitinder
   Curry, Christine L.
   Kallas, Esper G.
   Desrosiers, Ronald C.
   Goldschmidt-Clermont, Pascal J.
   Whitehead, Stephen S.
   Andersen, Kristian G.
   Bonaldo, Myrna C.
   Lackner, Andrew A.
   Panganiban, Antonito T.
   Burton, Dennis R.
   Watkins, David I.
TI Fetal demise and failed antibody therapy during Zika virus infection of
   pregnant macaques
SO NATURE COMMUNICATIONS
LA English
DT Article
ID NONHUMAN PRIMATE; DENGUE VIRUSES; BIRTH-DEFECTS; UNITED-STATES; SEQUENCE
   DATA; MODEL; BRAZIL; EXPOSURE; JANUARY; MALARIA
AB Zika virus (ZIKV) infection of pregnant women is associated with pathologic complications of fetal development. Here, we infect pregnant rhesus macaques (Macaca mulatta) with a minimally passaged ZIKV isolate from Rio de Janeiro, where a high rate of fetal development complications was observed. The infection of pregnant macaques with this virus results in maternal viremia, virus crossing into the amniotic fluid (AF), and in utero fetal deaths. We also treated three additional ZIKV-infected pregnant macaques with a cocktail of ZIKV-neutralizing human monoclonal antibodies (nmAbs) at peak viremia. While the nmAbs can be effective in clearing the virus from the maternal sera of treated monkeys, it is not sufficient to clear ZIKV from AF. Our report suggests that ZIKV from Brazil causes fetal demise in non-human primates (NHPs) without additional mutations or confounding co-factors. Treatment with a neutralizing anti-ZIKV nmAb cocktail is insufficient to fully stop vertical transmission.
C1 [Magnani, Diogo M.; Bailey, Varian K.; Gonzalez-Nieto, Lucas; Gutman, Martin J.; Pedreno-Lopez, Nuria; Kwal, Jaclyn M.; Ricciardi, Michael J.; Martins, Mauricio A.; Desrosiers, Ronald C.; Watkins, David I.] Univ Miami, Leonard M Miller Sch Med, Dept Pathol, 1951 NW 7th Ave,Room 2340, Miami, FL 33136 USA.
   [Rogers, Thomas F.; Grubaugh, Nathan D.; Beutler, Nathan; Andersen, Kristian G.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, 3215 Merryfield Row Immunol 308, San Diego, CA 92121 USA.
   [Maness, Nicholas J.; Myers, Tereance A.; Bohm, Rudolf P.; Gilbert, Margaret H.; Schiro, Faith; Aye, Pyone P.; Blair, Robert V.; Falkenstein, Kathrine P.; Kaur, Amitinder; Lackner, Andrew A.; Panganiban, Antonito T.] Tulane Natl Primate Res Ctr, 18703 Three Rivers Rd, Covington, LA 70433 USA.
   [Julander, Justin G.] Utah State Univ, Inst Antiviral Res, 5600 Old Main Hill, Logan, UT 84322 USA.
   [Curry, Christine L.] Univ Miami, Leonard M Miller Sch Med, Dept Obstet & Gynecol, CRB 11th Floor, Miami, FL 33136 USA.
   [Kallas, Esper G.] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Av Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.
   [Goldschmidt-Clermont, Pascal J.] Univ Miami, Dept Med, Leonard M Miller Sch Med, 1600 NW 10th Ave 1140, Miami, FL USA.
   [Whitehead, Stephen S.] NIAID, NIH, Lab Infect Dis, Bldg 33,Room 3W10A,33 North Dr,MSC 3210, Bethesda, MD 20892 USA.
   [Andersen, Kristian G.] Scripps Translat Sci Inst, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Andersen, Kristian G.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, 10550 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Bonaldo, Myrna C.] Fiocruz MS, Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, Ave Brasil,4365 Manguinhos, BR-21040360 Rio De Janeiro, RJ, Brazil.
   [Burton, Dennis R.] Harvard Med Sch, Ragon Inst, 400 Technol Sq, Boston, MA 02139 USA.
RP Watkins, DI (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Pathol, 1951 NW 7th Ave,Room 2340, Miami, FL 33136 USA.; Burton, DR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, 3215 Merryfield Row Immunol 308, San Diego, CA 92121 USA.; Burton, DR (corresponding author), Harvard Med Sch, Ragon Inst, 400 Technol Sq, Boston, MA 02139 USA.
EM burton@scripps.edu; dwatkins@med.miami.edu
RI Whitehead, Stephen/AAG-2787-2019; amsalu, ribka/G-8780-2019
OI Beutler, Nathan/0000-0003-3240-9524; Kallas, Esper/0000-0003-2026-6925;
   Martins, Mauricio/0000-0001-8336-216X; Magnani,
   Diogo/0000-0002-1773-2406; Grubaugh, Nathan/0000-0003-2031-1933
FU Bill and Melinda Gates FoundationGates Foundation [OPP1152818]; National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [4P01AI094420-05];
   Wallace H. Coulter Center for Translational Research at the University
   of Miami; Miami Clinical and Translational Science Institute (CTSI);
   Jacobson Jewish Community Foundation; Clarence Wolf Jr & Alma B Wolf
   Foundation; National Institute of Allergy and Infectious Diseases,
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); NIHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [P51 OD011104,
   P30AI073961]; Defense Advanced Research Projects Agency (DARPA)
   Autonomous Diagnostics to Enable Prevention and Therapeutics:
   Prophylactic Options to Environmental and Contagious Threats
   (ADEPT-PROTECT) program [W31P4Q-13-1-0011]
FX This work was supported by the Bill and Melinda Gates Foundation
   (OPP1152818), the National Institutes of Health (NIH) grant
   4P01AI094420-05, the Wallace H. Coulter Center for Translational
   Research at the University of Miami, the Miami Clinical and
   Translational Science Institute (CTSI), the Jacobson Jewish Community
   Foundation and Clarence Wolf Jr & Alma B Wolf Foundation, and the
   Intramural Research Program of the National Institute of Allergy and
   Infectious Diseases, NIH. This work was in part supported by NIH grant
   P51 OD011104 to the TNPRC, the NIH grant P30AI073961 to the Miami Center
   for AIDS Research, as well as the Defense Advanced Research Projects
   Agency (DARPA) Autonomous Diagnostics to Enable Prevention and
   Therapeutics: Prophylactic Options to Environmental and Contagious
   Threats (ADEPT-PROTECT) program (W31P4Q-13-1-0011). The funders had no
   role in the study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Aliota MT, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006964
   Barry PA, 2006, ILAR J, V47, P49, DOI 10.1093/ilar.47.1.49
   Bialas KM, 2015, P NATL ACAD SCI USA, V112, P13645, DOI 10.1073/pnas.1511526112
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002
   Davison BB, 1998, AM J TROP MED HYG, V59, P189, DOI 10.4269/ajtmh.1998.59.189
   Davison BB, 2000, AM J TROP MED HYG, V63, P158, DOI 10.4269/ajtmh.2000.63.158
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DeSesso JM, 2012, CRIT REV TOXICOL, V42, P185, DOI 10.3109/10408444.2011.653487
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rath T, 2015, CRIT REV BIOTECHNOL, V35, P235, DOI 10.3109/07388551.2013.834293
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
NR 35
TC 22
Z9 22
U1 0
U2 8
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 24
PY 2018
VL 9
AR 1624
DI 10.1038/s41467-018-04056-4
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD7EU
UT WOS:000430674000013
PM 29691387
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Siraj, AS
   Rodriguez-Barraquer, I
   Barker, CM
   Tejedor-Garavito, N
   Harding, D
   Lorton, C
   Lukacevic, D
   Oates, G
   Espana, G
   Kraemer, MUG
   Manore, C
   Johansson, MA
   Tatem, AJ
   Reiner, RC
   Perkins, TA
AF Siraj, Amir S.
   Rodriguez-Barraquer, Isabel
   Barker, Christopher M.
   Tejedor-Garavito, Natalia
   Harding, Dennis
   Lorton, Christopher
   Lukacevic, Dejan
   Oates, Gene
   Espana, Guido
   Kraemer, Moritz U. G.
   Manore, Carrie
   Johansson, Michael A.
   Tatem, Andrew J.
   Reiner, Robert C.
   Perkins, T. Alex
TI Spatiotemporal incidence of Zika and associated environmental drivers
   for the 2015-2016 epidemic in Colombia
SO SCIENTIFIC DATA
LA English
DT Article; Data Paper
ID VIRUS OUTBREAK; TRANSMISSION; STATES; WOMEN; MODEL
AB Despite a long history of mosquito-borne virus epidemics in the Americas, the impact of the Zika virus (ZIKV) epidemic of 2015-2016 was unexpected. The need for scientifically informed decision-making is driving research to understand the emergence and spread of ZIKV. To support that research, we assembled a data set of key covariates for modeling ZIKV transmission dynamics in Colombia, where ZIKV transmission was widespread and the government made incidence data publically available. On a weekly basis between January 1, 2014 and October 1, 2016 at three administrative levels, we collated spatiotemporal Zika incidence data, nine environmental variables, and demographic data into a single downloadable database. These new datasets and those we identified, processed, and assembled at comparable spatial and temporal resolutions will save future researchers considerable time and effort in performing these data processing steps, enabling them to focus instead on extracting epidemiological insights from this important data set. Similar approaches could prove useful for filling data gaps to enable epidemiological analyses of future disease emergence events.
C1 [Siraj, Amir S.; Espana, Guido; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, 345 Galvin Hall, Notre Dame, IN 46556 USA.
   [Siraj, Amir S.; Espana, Guido; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, 345 Galvin Hall, Notre Dame, IN 46556 USA.
   [Rodriguez-Barraquer, Isabel] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St, Baltimore, MD 21205 USA.
   [Barker, Christopher M.] Univ Calif Davis, Dept Pathol Microbiol & Immunol, 5329 Vet Med 3A, Davis, CA 95616 USA.
   [Tejedor-Garavito, Natalia; Tatem, Andrew J.] Univ Southampton, Dept Geog & Environm, WorldPop, Univ Rd, Southampton SO17 1BJ, Hants, England.
   [Tejedor-Garavito, Natalia; Tatem, Andrew J.] Flowminder Fdn, Roslagsgatan 17, SE-11355 Stockholm, Sweden.
   [Harding, Dennis; Lorton, Christopher; Lukacevic, Dejan; Oates, Gene] Inst Dis Modeling, 3150 139th Ave SE, Bellevue, WA 31509 USA.
   [Kraemer, Moritz U. G.] Univ Oxford, Dept Zool, Spatial Ecol & Epidemiol Grp, South Parks Rd, Oxford OX1 3PS, England.
   [Kraemer, Moritz U. G.] Harvard Med Sch, 10 Shattuck St, Boston, MA 02115 USA.
   [Kraemer, Moritz U. G.] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA 02115 USA.
   [Manore, Carrie] Los Alamos Natl Lab, Theoret Biol & Biophys Grp, Los Alamos, NM 87545 USA.
   [Johansson, Michael A.] Ctr Dis Control & Prevent, 1324 Calle Canada, San Juan, PR 00920 USA.
   [Johansson, Michael A.] Harvard TH Chan Sch Publ Hlth, Ctr Communicable Dis Dynam, 677 Huntington Ave,Suite 506, Boston, MA 02115 USA.
   [Reiner, Robert C.] Univ Washington, Dept Global Hlth, 2301 Fifth Ave,Suite 600, Seattle, WA 98121 USA.
   [Reiner, Robert C.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 Fifth Ave,Suite 600, Seattle, WA 98121 USA.
RP Siraj, AS; Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, 345 Galvin Hall, Notre Dame, IN 46556 USA.; Siraj, AS; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, 345 Galvin Hall, Notre Dame, IN 46556 USA.
EM asiraj@nd.edu; taperkins@nd.edu
RI Barker, Christopher/K-1415-2018; Tejedor, Natalia/A-5601-2012
OI Barker, Christopher/0000-0002-7941-346X; Siraj,
   Amir/0000-0002-9275-0380; Johansson, Michael/0000-0002-5090-7722;
   Camargo Espana, guido/0000-0002-9915-8056; Rodriguez-Barraquer,
   Isabel/0000-0001-6784-1021; Tejedor, Natalia/0000-0002-1140-6263
FU RAPID award from the National Science Foundation [DEB 1641130]
FX This research was supported by a RAPID award from the National Science
   Foundation (DEB 1641130).
CR Alduchov OA, 1996, J APPL METEOROL, V35, P601, DOI 10.1175/1520-0450(1996)035<0601:IMFAOS>2.0.CO;2
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Banerjee S., 2014, HIERARCHICAL MODELIN
   Bellan SE, 2015, LANCET INFECT DIS, V15, P703, DOI 10.1016/S1473-3099(15)70139-8
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Center for International Earth Science Information Network, 2017, GRIDD POP WORLD VERS
   Centers for Disease Control and Prevention, 2017, ZIK VIR
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chretien JP, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002109
   CHRISTOPHERS SR, 1960, AEDES AEGYPTI YELLOW
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fan Y, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008470
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Geographic Information System for Territorial Planning, 2016, PRED THEM MAPS NAT
   Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657
   Hay SI, 1997, T ROY SOC TROP MED H, V91, P105, DOI 10.1016/S0035-9203(97)90186-3
   Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276
   Kraemer MUG, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0468
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   National Administrative Department of Statistics, 2016, GEOP
   National Administrative Department of Statistics, 2016, POP FERT IND
   National Institute of Health, 2016, NUMB CONF SUSP ZIK C
   National Oceanic and Atmospheric Research Center for Satellite Applications and Research, 2017, SAT RAINF EST 24 HOU
   Nelson A, 2017, ESTIMATED TRAVEL TIM
   Nordhaus WD, 2006, P NATL ACAD SCI USA, V103, P3510, DOI 10.1073/pnas.0509842103
   Nychka D., 2016, FIELDS TOOLS SPATIAL
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Parham PE, 2010, ENVIRON HEALTH PERSP, V118, P620, DOI 10.1289/ehp.0901256
   Perkins TA, 2017, P NATL ACAD SCI USA, V114, P5558, DOI 10.1073/pnas.1705969114
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Perkins T Alex, 2015, PLoS Curr, V7, DOI 10.1371/currents.outbreaks.a4c7b6ac10e0420b1788c9767946d1fc
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   R Core Team, 2016, R LANG ENV STAT COMP
   Reiner RC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0921
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Ribeiro J. R, 2001, J GEOR PACKAGE GEOST
   Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003
   Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003
   Siraj A. S, 2017, SPATIOTEMPORAL INCID
   Thomson MC, 1999, AM J TROP MED HYG, V61, P2, DOI 10.4269/ajtmh.1999.61.2
   United Nation, 2015, WORLD POP PROSP 2015
   United States Geological Survey, 2016, GLOB 30 ARC 2 EL
   WorldPop, 2016, POP IND COUNTR
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
   Zhang ZJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-11
NR 52
TC 5
Z9 5
U1 1
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2052-4463
J9 SCI DATA
JI Sci. Data
PD APR 24
PY 2018
VL 5
AR 180073
DI 10.1038/sdata.2018.73
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD7KN
UT WOS:000430690900001
PM 29688216
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Huang, YL
   Li, YJ
   Zhang, HN
   Zhao, RZ
   Jing, R
   Xu, YH
   He, M
   Peer, J
   Kim, YC
   Luo, JT
   Tong, ZH
   Zheng, JL
AF Huang, Yunlong
   Li, Yuju
   Zhang, Hainan
   Zhao, Runze
   Jing, Ran
   Xu, Yinghua
   He, Miao
   Peer, Justin
   Kim, Yeong C.
   Luo, Jiangtao
   Tong, Zenghan
   Zheng, Jialin
TI Zika virus propagation and release in human fetal astrocytes can be
   suppressed by neutral sphingomyelinase-2 inhibitor GW4869
SO CELL DISCOVERY
LA English
DT Article
ID EXTRACELLULAR VESICLES; NEURAL PROGENITORS; CELLS; MICROVESICLES;
   MICROGLIA; BRAIN; TRANSMISSION; MACROPHAGES; DIFFERENTIATION; MECHANISMS
AB Zika virus (ZIKV) is a neurotrophic flavivirus that is capable of infecting humans, leading to brain abnormalities during fetal development. The ZIKV infectivity in neural target cells remains poorly understood. Here, we found that ZIKV specifically infected glial fibrillary acidic protein-and S100B-positive primary human astrocytes derived from fetal brains. In contrast, neuron-specific Class III beta-tubulin (TuJ1)-positive neurons in the astrocyte cultures and SOX2-positive neural progenitor cells derived from the fetal brains were less susceptible to ZIKV infection compared with astrocytes. The infected astrocytes released competent viral particles and manifested programmed cell death with a progressive cytopathic effect. Interestingly, ZIKV infection in human fetal astrocytes induced a significant increase of extracellular vesicles (EVs). Treatment with GW4869, a specific inhibitor of neutral sphingomyelinase-2, decreased EV levels, suppressed ZIKV propagation, and reduced the release of infectious virions in astrocytes. Therefore, ZIKV infects primary human fetal astrocytes and the infection can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. Further investigation into sphingomyelin metabolism and EVs may provide insights to the therapeutic treatment of ZIKV infection.
C1 [Huang, Yunlong; Li, Yuju; Tong, Zenghan; Zheng, Jialin] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Translat Neurodegenerat & Regenerat Therapy, Shanghai, Peoples R China.
   [Huang, Yunlong; Li, Yuju; Zhang, Hainan; Zhao, Runze; Jing, Ran; Xu, Yinghua; He, Miao; Peer, Justin; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Kim, Yeong C.] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Coll Med, Omaha, NE 68198 USA.
   [Luo, Jiangtao] Univ Nebraska Med Ctr, Dept Biostat, Coll Publ Hlth, Omaha, NE 68198 USA.
RP Huang, YL; Zheng, JL (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Ctr Translat Neurodegenerat & Regenerat Therapy, Shanghai, Peoples R China.; Huang, YL; Zheng, JL (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Zheng, JL (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
EM yhuan1@unmc.edu; jialinzheng@tongji.edu.cn
RI Huang, Yunlong/J-6554-2015
OI Huang, Yunlong/0000-0002-3328-1924; Rao, Yanxia/0000-0001-5292-2056
FU Nebraska Research Initiative; Fred and Pamela Buffett Cancer Center
   Support Grant [P30CA036727]; Institutional Development Award (IDeA) from
   the NIGMS of the NIH [P30GM106397]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [S10RR027301]; Nebraska Research Initiative (NRI); University of
   Nebraska Foundation; National Key Basic Research Program of China
   (973Program)National Basic Research Program of China [2014CB965000];
   National Key Basic Research Program of ChinaNational Basic Research
   Program of China [2014CB965001, 2014CB965003]; Innovative Research
   Groups of the National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81221001]; Joint Research Fund for
   Overseas Chinese, Hong Kong and Macao Young Scientists of the National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81329002]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [2R56NS041858-15A1, 1R01NS097195-01, R03 NS094071-01]
FX We kindly thank Dr. Chantey Morris, Dr. Santhi Gorantla, Dr. Beiqing Wu,
   Dr. Kaihong Su, Dr. Yi Wang, and Ms. Li Wu for technical support; Lenal
   Bottoms and Dr. Matthew Mitchell for reviewing the manuscript. We thank
   Janice A. Taylor and James R. Talaska of the Advanced Microscopy Core
   Facility for providing assistance with confocal microscopy. Support for
   the UNMC Advanced Microscopy CORE Facility was provided by the Nebraska
   Research Initiative, the Fred and Pamela Buffett Cancer Center Support
   Grant (P30CA036727), an Institutional Development Award (IDeA) from the
   NIGMS of the NIH (P30GM106397), and NIH S10RR027301 for the LSM 710
   Zeiss Confocal Microscope. We also would like to thank Tom Bargar and
   Nicholas Conoan of the Electron Microscopy Core Facility (EMCF) at the
   University of Nebraska Medical Center for technical assistance. The EMCF
   is supported by state funds from the Nebraska Research Initiative (NRI)
   and the University of Nebraska Foundation, and institutionally by the
   Office of the Vice Chancellor for Research. This work was supported by
   grants from National Key Basic Research Program of China (973Program
   Grant No. 2014CB965000, project 1 No. 2014CB965001 and project 3 No.
   2014CB965003), Innovative Research Groups of the National Natural
   Science Foundation of China (#81221001 to J.Z.), and Joint Research Fund
   for Overseas Chinese, Hong Kong and Macao Young Scientists of the
   National Natural Science Foundation of China (#81329002 to J.Z.);
   National Institutes of Health: 2R56NS041858-15A1 (J.Z.), 1R01NS097195-01
   (J.Z.), and R03 NS094071-01 (Y.H.).
CR Allen NJ, 2014, ANNU REV CELL DEV BI, V30, P439, DOI 10.1146/annurev-cellbio-100913-013053
   Altan-Bonnet N, 2016, CURR OPIN MICROBIOL, V32, P77, DOI 10.1016/j.mib.2016.05.004
   Anderson MR, 2016, NEUROTHERAPEUTICS, V13, P535, DOI 10.1007/s13311-016-0450-6
   Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Colombo M, 2013, J CELL SCI, V126, P5553, DOI 10.1242/jcs.128868
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cui M, 2011, GLIA, V59, P641, DOI 10.1002/glia.21134
   Darios F, 2009, NEURON, V62, P683, DOI 10.1016/j.neuron.2009.04.024
   ELDER GA, 1988, DEV BRAIN RES, V42, P146, DOI 10.1016/0165-3806(88)90211-8
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fruhbeis C, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00182
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Ghorpade A, 2003, J NEUROIMMUNOL, V141, P141, DOI 10.1016/S0165-5728(03)00222-4
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Huang YL, 2011, J NEUROSCI, V31, P15195, DOI 10.1523/JNEUROSCI.2051-11.2011
   Joshi P, 2014, CELL DEATH DIFFER, V21, P582, DOI 10.1038/cdd.2013.180
   Kadiu I, 2012, J IMMUNOL, V189, P744, DOI 10.4049/jimmunol.1102244
   Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li B, 2012, ONCOGENE, V31, P4740, DOI 10.1038/onc.2011.636
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Peng H, 2006, GLIA, V54, P619, DOI 10.1002/glia.20409
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445
   Raymond AD, 2011, AIDS RES HUM RETROV, V27, P167, DOI 10.1089/aid.2009.0170
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rowitch DH, 2010, NATURE, V468, P214, DOI 10.1038/nature09611
   Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0
   Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124
   Wang DD, 2008, PROG NEUROBIOL, V86, P342, DOI 10.1016/j.pneurobio.2008.09.015
   Wang Y, 2014, STEM CELLS DEV, V23, P2782, DOI 10.1089/scd.2014.0022
   Whitney NP, 2008, FASEB J, V22, P2888, DOI 10.1096/fj.07-104661
   Wu BQ, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0058-z
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zheng JC, 2008, J NEUROIMMUNOL, V200, P100, DOI 10.1016/j.jneuroim.2008.06.015
   Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1
   Zhu B, 2012, STEM CELLS, V30, P2571, DOI 10.1002/stem.1239
   Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304
NR 62
TC 18
Z9 18
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD APR 24
PY 2018
VL 4
AR 19
DI 10.1038/s41421-018-0017-2
PG 16
WC Cell Biology
SC Cell Biology
GA GD8UH
UT WOS:000430787100001
PM 29707233
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Khandia, R
   Munjal, A
   Dhama, K
   Karthik, K
   Tiwari, R
   Malik, YS
   Singh, RK
   Chaicumpa, W
AF Khandia, Rekha
   Munjal, Ashok
   Dhama, Kuldeep
   Karthik, Kumaragurubaran
   Tiwari, Ruchi
   Malik, Yashpal Singh
   Singh, Raj Kumar
   Chaicumpa, Wanpen
TI Modulation of Dengue/Zika Virus Pathogenicity by Antibody-Dependent
   Enhancement and Strategies to Protect Against Enhancement in Zika Virus
   Infection
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE antibody-dependent enhancement; Dengue virus; Zika virus; pathogenesis;
   counteracting strategies; engineered antibodies
ID NEUTRALIZING HUMAN-ANTIBODIES; HUMAN MONOCLONAL-ANTIBODIES; CD8(+)
   T-CELLS; FC-GAMMA-R; HEMORRHAGIC-FEVER; HUMAN IGG1; HUMAN MACROPHAGES;
   CROSS-REACTIVITY; STRUCTURAL BASIS; DOWN-REGULATION
AB Antibody-dependent enhancement (ADE) is a phenomenon in which preexisting poorly neutralizing antibodies leads to enhanced infection. It is a serious concern with mosquito-borne flaviviruses such as Dengue virus (DENV) and Zika virus (ZIKV). In vitro experimental evidences have indicated the preventive, as well as a pathogenicity-enhancing role, of preexisting DENV antibodies in ZIKV infections. ADE has been confirmed in DENV but not ZIKV infections. Principally, the Fc region of the anti-DENV antibody binds with the fragment crystallizable gamma receptor (Fc gamma R), and subsequent C1q interactions and immune effector functions are responsible for the ADE. In contrast to normal DENV infections, with ADE in DENV infections, inhibition of STAT1 phosphorylation and a reduction in IRF-1 gene expression, NOS2 levels, and RIG-1 and MDA-5 expression levels occurs. Fc gamma RIIA is the most permissive Fc gamma R for DENV-ADE, and under hypoxic conditions, hypoxia-inducible factor-1 alpha transcriptionally enhances expression levels of Fc gamma RIIA, which further enhances ADE. To produce therapeutic antibodies with broad reactivity to different DENV serotypes, as well as to ZIKV, bispecific antibodies, Fc region mutants, modified Fc regions, and anti-idiotypic antibodies may be engineered. An in-depth understanding of the immunological and molecular mechanisms of DENV-ADE of ZIKV pathogenicity will be useful for the design of common and safe therapeutics and prophylactics against both viral pathogens. The present review discusses the role of DENV antibodies in modulating DENV/ZIKV pathogenicity/infection and strategies to counter ADE to protect against Zika infection.
C1 [Khandia, Rekha; Munjal, Ashok] Barkatullah Univ, Dept Biochem & Genet, Bhopal, India.
   [Dhama, Kuldeep] ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
   [Karthik, Kumaragurubaran] Tamil Nadu Vet & Anim Sci Univ, Cent Univ Lab, Madras, Tamil Nadu, India.
   [Tiwari, Ruchi] Uttar Pradesh Pandit Deen Dayal Upadhyaya Pashu C, Dept Vet Microbiol & Immunol, Coll Vet Sci, Mathura, India.
   [Malik, Yashpal Singh] ICAR Indian Vet Res Inst, Div Biol Standardizat, Bareilly, Uttar Pradesh, India.
   [Singh, Raj Kumar] ICAR Indian Vet Res Inst, Bareilly, Uttar Pradesh, India.
   [Chaicumpa, Wanpen] Mahidol Univ, Fac Med, Dept Parasitol,Siriraj Hosp, Ctr Res Excellence Therapeut Prot & Antibody Engn, Bangkok, Thailand.
RP Munjal, A (corresponding author), Barkatullah Univ, Dept Biochem & Genet, Bhopal, India.; Dhama, K (corresponding author), ICAR Indian Vet Res Inst, Div Pathol, Bareilly, Uttar Pradesh, India.
EM ashokmunjal70@yahoo.co.in; kdhama@rediffmail.com
RI Malik, Yashpal Singh/AAI-2259-2019; Dhama, Kuldeep/B-7852-2015
OI Dhama, Kuldeep/0000-0001-7469-4752
CR Armour KL, 1999, EUR J IMMUNOL, V29, P2613, DOI 10.1002/(SICI)1521-4141(199908)29:08<2613::AID-IMMU2613>3.0.CO;2-J
   Ayala-Nunez NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep28768
   Aye KS, 2014, HUM PATHOL, V45, P1221, DOI 10.1016/j.humpath.2014.01.022
   Baek S, 2013, BIOMOL THER, V21, P42, DOI 10.4062/biomolther.2012.082
   Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Bosco MC, 2011, BLOOD, V117, P2625, DOI 10.1182/blood-2010-06-292136
   Bournazos S, 2015, IMMUNOL REV, V268, P88, DOI 10.1111/imr.12343
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Carreau A, 2011, J CELL MOL MED, V15, P1239, DOI 10.1111/j.1582-4934.2011.01258.x
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chaichana P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092173
   Chareonsirisuthigul T, 2007, J GEN VIROL, V88, P365, DOI 10.1099/vir.0.82537-0
   Charles Anu Susan, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.4ab8bc87c945eb41cd8a49e127082620
   Chong LD, 2016, SCIENCE, V353, P787, DOI [10.1126/science.353.6301.787-b, DOI 10.1126/SCIENCE.353.6301.787-B]
   Chung KM, 2006, J VIROL, V80, P1340, DOI 10.1128/JVI.80.3.1340-1351.2006
   Clark KB, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00305
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dhama K, 2018, J EXP BIOL AGRIC SCI, V6, P1, DOI 10.18006/2018.6(1).1.31
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Fang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110655
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   Fink AL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005721
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Gan ES, 2017, EMBO J, V36, P1348, DOI 10.15252/embj.201695642
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gibbons RV, 2007, AM J TROP MED HYG, V77, P910, DOI 10.4269/ajtmh.2007.77.910
   GOLLINS SW, 1985, J GEN VIROL, V66, P1969, DOI 10.1099/0022-1317-66-9-1969
   Gomez-Villamandos JC, 2003, DEUT TIERARZTL WOCH, V110, P165
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Green S, 1999, J MED VIROL, V59, P329, DOI 10.1002/(SICI)1096-9071(199911)59:3&lt;329::AID-JMV12&gt;3.0.CO;2-G
   Guzmán María G., 2002, Rev Panam Salud Publica, V11, P223, DOI 10.1590/S1020-49892002000400003
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1982, PROG ALLERGY, V31, P301
   HALSTEAD SB, 1977, J EXP MED, V146, P218, DOI 10.1084/jem.146.1.218
   HALSTEAD SB, 1973, NATURE-NEW BIOL, V243, P24
   HALSTEAD SB, 1967, JPN J MED SCI BIOL, VS 20, P96
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350
   Halstead SB, 2017, LANCET INFECT DIS, V17, pE378, DOI 10.1016/S1473-3099(17)30362-6
   Halstead SB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00075
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HAWKES RA, 1964, AUST J EXP BIOL MED, V42, P465
   Huang XW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22303
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Hunter S, 1998, BLOOD, V91, P1762, DOI 10.1182/blood.V91.5.1762.1762_1762_1768
   Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178
   Jefferis R, 2002, IMMUNOL LETT, V82, P57, DOI 10.1016/S0165-2478(02)00019-6
   Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104
   Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   KANNO H, 1993, J VIROL, V67, P7017, DOI 10.1128/JVI.67.12.7017-7024.1993
   KARP CL, 1993, J CLIN INVEST, V91, P1644, DOI 10.1172/JCI116372
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   KLIKS SC, 1980, NATURE, V285, P504, DOI 10.1038/285504a0
   KLIKS SC, 1983, J VIROL, V46, P394, DOI 10.1128/JVI.46.2.394-404.1983
   Kubagawa H, 2014, J CLIN IMMUNOL, V34, pS35, DOI 10.1007/s10875-014-0022-7
   Kudchodkar SB, 2009, REV MED VIROL, V19, P359, DOI 10.1002/rmv.630
   Kyle JL, 2007, J INFECT DIS, V195, P1808, DOI 10.1086/518007
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LARSSON A, 1993, POULTRY SCI, V72, P1807, DOI 10.3382/ps.0721807
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lee YR, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-65
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171
   Lim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145381
   Lin JC, 2014, J IMMUNOL, V193, P1258, DOI 10.4049/jimmunol.1302675
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Mahalingam S, 2017, LANCET INFECT DIS, V17, P686, DOI 10.1016/S1473-3099(17)30340-7
   MARCHETTE NJ, 1976, J INFECT DIS, V133, P274, DOI 10.1093/infdis/133.3.274
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   MDURVWA EG, 1994, VET RES COMMUN, V18, P483, DOI 10.1007/BF01839425
   Mero P, 2006, J BIOL CHEM, V281, P33242, DOI 10.1074/jbc.M605372200
   Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Moi ML, 2014, ARCH VIROL, V159, P103, DOI 10.1007/s00705-013-1787-3
   Moi ML, 2010, J VIROL METHODS, V163, P205, DOI 10.1016/j.jviromet.2009.09.018
   Moi ML, 2010, J GEN VIROL, V91, P103, DOI 10.1099/vir.0.014829-0
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Munjal A, 2017, INT J PHARMACOL, V13, P667, DOI 10.3923/ijp.2017.667.676
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Noisakran S, 2010, ADV VIROL, V2010, DOI 10.1155/2010/164878
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Perez AB, 2004, J MED VIROL, V73, P230, DOI 10.1002/jmv.20080
   Pipiya T, 2005, GENE THER, V12, P911, DOI 10.1038/sj.gt.3302459
   Prestwood TR, 2012, J VIROL, V86, P12138, DOI 10.1128/JVI.00375-12
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0
   Raabe ML, 1999, VIROLOGY, V259, P416, DOI 10.1006/viro.1999.9772
   Rajamanonmani R, 2009, J GEN VIROL, V90, P799, DOI 10.1099/vir.0.006874-0
   Ramadhany R, 2015, ANTIVIR RES, V124, P61, DOI 10.1016/j.antiviral.2015.10.012
   Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342
   Riedinger HJ, 1999, J VIROL, V73, P2243, DOI 10.1128/JVI.73.3.2243-2252.1999
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rolph MS, 2011, J INFECT DIS, V204, P489, DOI 10.1093/infdis/jir271
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sasaki T, 2013, ANTIVIR RES, V98, P423, DOI 10.1016/j.antiviral.2013.03.018
   Sauter P, 2009, MICROBES INFECT, V11, P1219, DOI 10.1016/j.micinf.2009.09.011
   Schlothauer T, 2016, PROTEIN ENG DES SEL, V29, P457, DOI 10.1093/protein/gzw040
   Shi X, 2016, MABS-AUSTIN, V8, P574, DOI 10.1080/19420862.2016.1148850
   Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Suzuki T, 2006, BIOL PHARM BULL, V29, P1538, DOI 10.1248/bpb.29.1538
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Takada A, 2003, J VIROL, V77, P7539, DOI 10.1128/JVI.77.13.7539-7544.2003
   Takhampunya R, 2006, J GEN VIROL, V87, P3003, DOI 10.1099/vir.0.81880-0
   Tang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014207
   TAO MH, 1989, J IMMUNOL, V143, P2595
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Tsunoda Ikuo, 2016, Acta Med Kinki Univ, V41, P37
   Ubol S, 2010, CLIN VACCINE IMMUNOL, V17, P1829, DOI 10.1128/CVI.00316-10
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Unkeless J C, 1995, Semin Immunol, V7, P37, DOI 10.1016/1044-5323(95)90006-3
   Vassilaki N, 2013, J VIROL, V87, P2935, DOI 10.1128/JVI.02534-12
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00157
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   WEISS RC, 1981, COMP IMMUNOL MICROB, V4, P175, DOI 10.1016/0147-9571(81)90003-5
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Willey S, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-16
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Wong YH, 2017, J VIROL, V91, DOI [10.1128/JVI.00406-17, 10.1128/jvi.00406-17]
   Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266
   Xu HC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-499
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yeh WT, 2006, FEMS IMMUNOL MED MIC, V48, P84, DOI 10.1111/j.1574-695X.2006.00127.x
   Yoneyama M, 2015, CURR OPIN IMMUNOL, V32, P48, DOI 10.1016/j.coi.2014.12.012
   Yoon KJ, 1996, VIRAL IMMUNOL, V9, P51, DOI 10.1089/vim.1996.9.51
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
   Zellweger RM, 2014, J IMMUNOL, V193, P4117, DOI 10.4049/jimmunol.1401597
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zompi S, 2012, VIRUSES-BASEL, V4, P62, DOI 10.3390/v4010062
NR 164
TC 20
Z9 20
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 23
PY 2018
VL 9
AR 597
DI 10.3389/fimmu.2018.00597
PG 17
WC Immunology
SC Immunology
GA GD5RQ
UT WOS:000430564700001
PM 29740424
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, SS
   Zeng, Y
   Lerner, A
   Gao, B
   Law, M
AF Wu, Shanshan
   Zeng, Yu
   Lerner, Alexander
   Gao, Bo
   Law, Meng
TI Nervous System Injury and Neuroimaging of Zika Virus Infection
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE Zika virus; central nervous system infection; microcephaly;
   Guillain-Barre syndrome; neuroimaging
ID GUILLAIN-BARRE-SYNDROME; SEXUAL TRANSMISSION; PATHOLOGY
AB In 2016, World Health Organization announced Zika virus infection and its neurological sequalae are a public health emergency of global scope. Preliminary studies have confirmed a relationship between Zika virus infection and certain neurological disorders, including microcephaly and Guillain-Barre syndrome (GBS). The neuroimaging features of microcephaly secondary to Zika virus infection include calcifications at the junction of gray-white matter and subcortical white matter with associated cortical abnormalities, diminution of white matter, large ventricles with or without hydrocephalus, cortical malformations, hypoplasia of cerebellum and brainstem, and enlargement of cerebellomedullary cistern. Contrast enhancement of the cauda equine nerve roots is the typical neuroimaging finding of GBS associated with Zika virus. This review describes the nervous system disorders and associated imaging findings seen in Zika virus infection, with the aim to improve the understanding of this disease. Imaging plays a key role on accurate diagnosis and prognostic evaluation of this disease.
C1 [Wu, Shanshan; Zeng, Yu] Guizhou Med Univ, Dept Radiol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China.
   [Wu, Shanshan; Gao, Bo] Yantai Yuhuangding Hosp, Dept Radiol, Yantai, Peoples R China.
   [Lerner, Alexander; Law, Meng] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA USA.
RP Gao, B (corresponding author), Yantai Yuhuangding Hosp, Dept Radiol, Yantai, Peoples R China.
EM gygb2004@163.com
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [81471645]
FX The authors would like to thank Lara Brandao MD, Rio De Janeiro, Brazil
   for his assistance of the figures and thank Guiquan Shen for help in
   writing. This study was granted from National Natural Science Foundation
   of China (NSFC, Grant No. 81471645).
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Bierlaire D, 2017, TRANSFUSION, V57, P729, DOI 10.1111/trf.14028
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cavalheiro S, 2016, CHILD NERV SYST, V32, P1057, DOI 10.1007/s00381-016-3074-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Joob B, 2016, INT MARIT HEALTH, V67, P260, DOI 10.5603/IMH.2016.0046
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Li L, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000009884
   Livingston JH, 2014, DEV MED CHILD NEUROL, V56, P612, DOI 10.1111/dmcn.12359
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   MATTUCCI KF, 1970, EYE EAR NOSE THROAT, V49, P318
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Ribeiro BG, 2017, RADIOGRAPHICS, V37, P1840, DOI 10.1148/rg.2017170023
   Scholl T, 2017, BRAIN PATHOL, V27, P770, DOI 10.1111/bpa.12452
   Tarrant A, 2009, PEDIATR RADIOL, V39, P772, DOI 10.1007/s00247-009-1266-x
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Werner H, 2014, ULTRASOUND Q, V30, P69, DOI 10.1097/RUQ.0000000000000048
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wu J, 2016, CHINESE MED J-PEKING, V129, P2347, DOI 10.4103/0366-6999.190672
NR 38
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD APR 23
PY 2018
VL 9
AR 227
DI 10.3389/fneur.2018.00227
PG 6
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GD5UN
UT WOS:000430572300001
PM 29740383
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Loconsole, D
   Metallo, A
   De Robertis, AL
   Morea, A
   Quarto, M
   Chironna, M
AF Loconsole, Daniela
   Metallo, Angela
   De Robertis, Anna Lisa
   Morea, Anna
   Quarto, Michele
   Chironna, Maria
TI Seroprevalence of Dengue Virus, West Nile Virus, Chikungunya Virus, and
   Zika Virus in International Travelers Attending a Travel and Migration
   Center in 2015-2017, Southern Italy
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE travelers; Dengue Virus; West Nile Virus; Chikungunya Virus; Zika Virus;
   seroprevalence
AB International travelers to areas endemic for vector-borne diseases (VBDs) may be at risk of contracting and spreading these diseases. The aim of this study was to evaluate the prevalence of immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies that are specific for Dengue Virus (DV), West Nile Virus (WNV), Chikungunya Virus (CHIKV), or Zika Virus (ZV) in a cohort of international travelers. The study enrolled travelers who attended the Travel Medicine and Migration outpatient service of Local Health Unit of Bari, Italy, in March 2015-June 2017 for counseling and vaccine prophylaxis before travel. After receiving informed consent, post-travel blood samples were tested for IgM and IgG antibodies specific for DV, WNV, CHIKV, and ZV. Of the 207 travelers attending the vaccine service, 156 (75%) were enrolled. Of the 156 subjects, 23 (14.7%) had IgM and/or IgG antibodies specific for at least one VBD. Of these, 12 (52%) were asymptomatic. Nineteen (12.2% of the whole cohort), nine (5.8%), nine (5.8%), and two (1.3%) subjects had IgM and/or IgG antibodies specific for DV, WNV, CHIKV, and ZV, respectively. Ten subjects (6.4%) harbored antibodies that were specific for more than one VBD. A significant number of the international travelers were DV-positive. Our findings suggest that international travelers should undergo serological surveillance, particularly those who travel frequently and for long periods to areas that are endemic for hemorrhagic dengue. Due to a possible risk of introducing VBDs into nonendemic areas, increased awareness among physicians and travelers and appropriate laboratory detection are crucial. There are currently no licensed vaccines for these VBDs in Italy or other European countries; the main preventive measures are protection from mosquito bites and vector control.
C1 [Loconsole, Daniela; Metallo, Angela; De Robertis, Anna Lisa; Morea, Anna; Quarto, Michele; Chironna, Maria] Univ Bari, Sect Hyg, Dept Biomed Sci & Human Oncol, Piazza G Cesare 11, I-70124 Bari, Italy.
RP Chironna, M (corresponding author), Univ Bari, Sect Hyg, Dept Biomed Sci & Human Oncol, Piazza G Cesare 11, I-70124 Bari, Italy.
EM maria.chironna@uniba.it
OI De Robertis, Anna Lisa/0000-0002-1679-5368; Loconsole,
   Daniela/0000-0003-2057-9745; MOREA, ANNA/0000-0002-3692-864X; chironna,
   maria/0000-0002-1043-1256
CR Ayukekbong James Ayukepi, 2017, World J Virol, V6, P9, DOI 10.5501/wjv.v6.i1.9
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Confalonieri U., 2007, CLIMATE CHANGE 2007, P391, DOI DOI 10.1016/J.JHYDR0L.2011.05.013
   ECDC, 2017, RAP RISK ASS CLUST A
   Leder K, 2013, TRAVEL MED INFECT DI, V11, P210, DOI 10.1016/j.tmaid.2013.06.008
   Negev M, 2015, INT J ENV RES PUB HE, V12, P6745, DOI 10.3390/ijerph120606745
   Quam MB, 2015, J TRAVEL MED, V22, P186, DOI 10.1111/jtm.12192
   Venturi G, 2017, EUROSURVEILLANCE, V22, P39, DOI [DOI 10.2807/1560-7917.ES.2017.22.39.17-00646, 10.2807/1560-7917.ES.2017.22.39.17-00646]
   Wilder-Smith A, 2012, PAEDIATR INT CHILD H, V32, P28, DOI 10.1179/2046904712Z.00000000050
   World Health Organization, 2014, VECT BORN DIS
NR 10
TC 4
Z9 4
U1 0
U2 0
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD JUN
PY 2018
VL 18
IS 6
BP 331
EP 334
DI 10.1089/vbz.2017.2260
EA APR 2018
PG 4
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GI5BA
UT WOS:000430623000001
PM 29683399
OA Green Published
DA 2020-07-08
ER

PT J
AU Ruggiero, E
   Richter, SN
AF Ruggiero, Emanuela
   Richter, Sara N.
TI G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral
   therapy
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID TELOMERIC G-QUADRUPLEX; DNA G-QUADRUPLEX; LONG TERMINAL REPEAT;
   STRUCTURE-BASED DESIGN; INHIBITS TUMOR-GROWTH; VIRUS IMMUNE EVASION;
   HYBRID G-QUADRUPLEX; HUMAN GENOME; STRUCTURAL BASIS; IN-VIVO
AB G-quadruplexes (G4s) are non-canonical nucleic acids secondary structures that form within guaninerich strands of regulatory genomic regions. G4s have been extensively described in the human genome, especially in telomeres and oncogene promoters; in recent years the presence of G4s in viruses has attracted increasing interest. Indeed, G4s have been reported in several viruses, including those involved in recent epidemics, such as the Zika and Ebola viruses. Viral G4s are usually located in regulatory regions of the genome and implicated in the control of key viral processes; in some cases, they have been involved also in viral latency. In this context, G4 ligands have been developed and tested both as tools to study the complexity of G4-mediated mechanisms in the viral life cycle, and as therapeutic agents. In general, G4 ligands showed promising antiviral activity, with G4-mediated mechanisms of action both at the genome and transcript level. This review aims to provide an updated close-up of the literature on G4s in viruses. The current state of the art of G4 ligands in antiviral research is also reported, with particular focus on the structural and physicochemical requirements for optimal biological activity. The achievements and the to-dos in the field are discussed.
C1 [Ruggiero, Emanuela; Richter, Sara N.] Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
RP Richter, SN (corresponding author), Univ Padua, Dept Mol Med, I-35121 Padua, Italy.
EM sara.richter@unipd.it
RI Richter, Sara/A-5578-2012
OI Richter, Sara/0000-0002-5446-9029; Ruggiero,
   Emanuela/0000-0003-0989-4074
FU Bill and Melinda Gates Foundation (GCE) [OPP1035881, OPP1097238];
   European Research Council (ERC)European Research Council (ERC) [615879];
   Bill and Melinda Gates FoundationGates Foundation [OPP1097238]
FX Bill and Melinda Gates Foundation (GCE) [OPP1035881, OPP1097238];
   European Research Council (ERC Consolidator) [615879]. Funding for open
   access charge: Bill and Melinda Gates Foundation [OPP1097238].
CR AIKEN C, 1995, J VIROL, V69, P5048, DOI 10.1128/JVI.69.8.5048-5056.1995
   Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c
   Arbuckle JH, 2010, P NATL ACAD SCI USA, V107, P5563, DOI 10.1073/pnas.0913586107
   Artusi S, 2016, NUCLEIC ACIDS RES, V44, P10343, DOI 10.1093/nar/gkw968
   Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016
   Balasubramanian S, 2011, NAT REV DRUG DISCOV, V10, P261, DOI 10.1038/nrd3428
   Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071
   Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006
   Bidzinska J, 2013, MOLECULES, V18, P12368, DOI 10.3390/molecules181012368
   Biffi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102711
   Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/nchem.1548, 10.1038/NCHEM.1548]
   Biswas B, 2017, NUCLEIC ACIDS RES, V45, P11268, DOI 10.1093/nar/gkx823
   Biswas B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3282-1
   Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x
   Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655
   Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910
   Callegaro S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02667-3
   Campbell NH, 2008, J AM CHEM SOC, V130, P6722, DOI 10.1021/ja8016973
   Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295
   Chen BJ, 2014, INT J BIOL SCI, V10, P1084, DOI 10.7150/ijbs.10190
   Chung WJ, 2014, ANGEW CHEM INT EDIT, V53, P999, DOI 10.1002/anie.201308063
   Cogoi S, 2016, BBA-GENE REGUL MECH, V1859, P663, DOI 10.1016/j.bbagrm.2016.02.002
   Collie GW, 2012, J AM CHEM SOC, V134, P2723, DOI 10.1021/ja2102423
   Cuenca F, 2008, BIOORG MED CHEM LETT, V18, P1668, DOI 10.1016/j.bmcl.2008.01.050
   Daelemans D, 2011, NAT PROTOC, V6, P925, DOI 10.1038/nprot.2011.330
   De Cian A, 2007, P NATL ACAD SCI USA, V104, P17347, DOI 10.1073/pnas.0707365104
   De Cian A, 2007, J AM CHEM SOC, V129, P1856, DOI 10.1021/ja067352b
   De Nicola B, 2016, NUCLEIC ACIDS RES, V44, P6442, DOI 10.1093/nar/gkw432
   Di Antonio M, 2009, J AM CHEM SOC, V131, P13132, DOI 10.1021/ja904876q
   Doria F, 2007, J MED CHEM, V50, P6570, DOI 10.1021/jm070828x
   Doria F, 2013, CHEM-EUR J, V19, P78, DOI 10.1002/chem.201203097
   Doria F, 2012, ORG BIOMOL CHEM, V10, P2798, DOI 10.1039/c2ob06816h
   Duan WH, 2001, MOL CANCER THER, V1, P103
   Dunmire SK, 2015, CURR TOP MICROBIOL, V390, P211, DOI 10.1007/978-3-319-22822-8_9
   Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529
   Everly D, 2012, CURR CANCER RES, P133, DOI 10.1007/978-1-4614-0016-5_7
   Fay MM, 2017, J MOL BIOL, V429, P2127, DOI 10.1016/j.jmb.2017.05.017
   Fedoroff OY, 1998, BIOCHEMISTRY-US, V37, P12367, DOI 10.1021/bi981330n
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Gilbert-Girard S, 2017, J VIROL, V91, DOI 10.1128/JVI.00402-17
   Goncalves PH, 2017, CURR OPIN HIV AIDS, V12, P47, DOI 10.1097/COH.0000000000000330
   Gowan SM, 2002, MOL PHARMACOL, V61, P1154, DOI 10.1124/mol.61.5.1154
   Grand CL, 2002, MOL CANCER THER, V1, P565
   Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4
   Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m
   Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662
   Harris LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004562
   Harrison RJ, 1999, BIOORG MED CHEM LETT, V9, P2463, DOI 10.1016/S0960-894X(99)00394-7
   Harrison RJ, 2003, J MED CHEM, V46, P4463, DOI 10.1021/jm0308693
   Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957
   Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986
   Hill JA, 2014, CURR OPIN VIROL, V9, P53, DOI 10.1016/j.coviro.2014.09.006
   Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609
   Huppert JL, 2010, FEBS J, V277, P3452, DOI 10.1111/j.1742-4658.2010.07758.x
   Huppert JL, 2008, CHEM SOC REV, V37, P1375, DOI 10.1039/b702491f
   Islam MK, 2016, FUTURE MED CHEM, V8, P1259, DOI 10.4155/fmc-2015-0017
   Izbicka E, 1999, CANCER RES, V59, P639
   Juranek SA, 2012, CURR PHARM DESIGN, V18, P1867
   Kerkour A, 2017, J BIOL CHEM, V292, P8082, DOI 10.1074/jbc.M117.781906
   Knipe DM, 2008, NAT REV MICROBIOL, V6, P211, DOI 10.1038/nrmicro1794
   Knipe DM, 2013, VIROLOGY, V435, P141, DOI 10.1016/j.virol.2012.09.023
   Kouzine F, 2017, CELL SYST, V4, P344, DOI 10.1016/j.cels.2017.01.013
   Krafcikova P., 2016, BIOCHIM BIOPHYS ACTA, V1861, P1321
   Kudlicki AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146174
   Kusov Y, 2015, VIROLOGY, V484, P313, DOI 10.1016/j.virol.2015.06.016
   Kwok CK, 2017, TRENDS BIOTECHNOL, V35, P997, DOI 10.1016/j.tibtech.2017.06.012
   Laguerre A, 2015, J AM CHEM SOC, V137, P8521, DOI 10.1021/jacs.5b03413
   Lista MJ, 2017, MICROB CELL, V4, P305, DOI 10.15698/mic2017.09.590
   Lista MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16043
   Lyonnais S, 2002, NUCLEIC ACIDS RES, V30, P5276, DOI 10.1093/nar/gkf644
   Madireddy A, 2016, NUCLEIC ACIDS RES, V44, P3675, DOI 10.1093/nar/gkw038
   Marchetti C, 2018, J MED CHEM, V61, P2500, DOI 10.1021/acs.jmedchem.7b01781
   Martino L, 2009, J PHYS CHEM B, V113, P14779, DOI 10.1021/jp9066394
   Marusic M., 2016, BIOCHIM BIOPHYS ACTA, V1861, P1229
   Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999
   Micco M, 2013, J MED CHEM, V56, P2959, DOI 10.1021/jm301899y
   MILLER MD, 1994, J EXP MED, V179, P101, DOI 10.1084/jem.179.1.101
   Muller S, 2012, ORG BIOMOL CHEM, V10, P6537, DOI 10.1039/c2ob25830g
   Muller S, 2010, NAT CHEM, V2, P1095, DOI [10.1038/nchem.842, 10.1038/NCHEM.842]
   Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/NCHEMBIO.1479, 10.1038/nchembio.1479]
   Musumeci D, 2015, MOLECULES, V20, P17511, DOI 10.3390/molecules200917511
   Nadai M, 2011, BIOCHIMIE, V93, P1328, DOI 10.1016/j.biochi.2011.06.015
   Neidle S, 2017, NAT REV CHEM, V1, DOI 10.1038/s41570-017-0041
   Neidle S, 2016, J MED CHEM, V59, P5987, DOI 10.1021/acs.jmedchem.5b01835
   Neidle S, 2010, FEBS J, V277, P1118, DOI 10.1111/j.1742-4658.2009.07463.x
   Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09
   Ohnmacht SA, 2015, SCI REP-UK, V5, DOI 10.1038/srep11385
   Ou TM, 2008, CHEMMEDCHEM, V3, P690, DOI 10.1002/cmdc.200700300
   Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350
   Parkinson GN, 2007, BIOCHEMISTRY-US, V46, P2390, DOI 10.1021/bi062244n
   Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755
   Parrotta L, 2014, EXPERT OPIN DRUG DIS, V9, P1167, DOI 10.1517/17460441.2014.941353
   Perrone R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05867-z
   Perrone R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02291-1
   Perrone R, 2015, J MED CHEM, V58, P9639, DOI 10.1021/acs.jmedchem.5b01283
   Perrone R, 2014, J ANTIMICROB CHEMOTH, V69, P3248, DOI 10.1093/jac/dku280
   Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121
   Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r
   Perry PJ, 1998, J MED CHEM, V41, P4873, DOI 10.1021/jm981067o
   Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706
   Piekna-Przybylska D, 2017, CELL CYCLE, V16, P968, DOI 10.1080/15384101.2017.1312225
   Piekna-Przybylska D, 2013, J BIOL CHEM, V288, P24140, DOI 10.1074/jbc.M113.477265
   Platella C, 2017, BBA-GEN SUBJECTS, V1861, P1429, DOI 10.1016/j.bbagen.2016.11.027
   Raiber EA, 2012, NUCLEIC ACIDS RES, V40, P1499, DOI 10.1093/nar/gkr882
   Read M, 2001, P NATL ACAD SCI USA, V98, P4844, DOI 10.1073/pnas.081560598
   Read MA, 1999, J MED CHEM, V42, P4538, DOI 10.1021/jm990287e
   Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862
   Richter SN, 2004, J AM CHEM SOC, V126, P13973, DOI 10.1021/ja047655a
   Rigo R, 2017, BBA-GEN SUBJECTS, V1861, P1399, DOI 10.1016/j.bbagen.2016.12.024
   Riou JF, 2002, P NATL ACAD SCI USA, V99, P2672, DOI 10.1073/pnas.052698099
   Rodriguez R, 2008, J AM CHEM SOC, V130, P15758, DOI 10.1021/ja805615w
   Samudrala R, 2007, BIOORGAN MED CHEM, V15, P186, DOI 10.1016/j.bmc.2006.09.075
   Satkunanathan S, 2017, VIROLOGY, V510, P46, DOI 10.1016/j.virol.2017.07.007
   Sauerbrei A, 2016, EUR J CLIN MICROBIOL, V35, P723, DOI 10.1007/s10096-016-2605-0
   Scalabrin M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45244
   Shen W, 2011, J BIOL CHEM, V286, P29838, DOI 10.1074/jbc.M111.262352
   Simone R, 2018, EMBO MOL MED, V10, P22, DOI 10.15252/emmm.201707850
   Sissi C, 2007, BIOORGAN MED CHEM, V15, P555, DOI 10.1016/j.bmc.2006.09.029
   Sissi C, 2014, CURR PHARM DESIGN, V20, P6489, DOI 10.2174/1381612820666140630094300
   Smargiasso N, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-362
   Sun DY, 1997, J MED CHEM, V40, P2113, DOI 10.1021/jm970199z
   SUNDQUIST WI, 1993, P NATL ACAD SCI USA, V90, P3393, DOI 10.1073/pnas.90.8.3393
   Taetz S, 2006, PHARM RES-DORDR, V23, P1031, DOI 10.1007/s11095-006-0026-y
   Taka T, 2013, BIOORGAN MED CHEM, V21, P883, DOI 10.1016/j.bmc.2012.12.020
   Tan JZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000428
   Tan Z, 2015, CURR TOP MED CHEM, V15, P1940, DOI 10.2174/1568026615666150515145552
   Tellam JT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004423
   Tesini BL, 2014, CURR OPIN VIROL, V9, P91, DOI 10.1016/j.coviro.2014.09.013
   Thellman NM, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6030028
   Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g
   Todd AK, 2008, NUCLEIC ACIDS RES, V36, P2700, DOI 10.1093/nar/gkn078
   Tosoni E, 2015, NUCLEIC ACIDS RES, V43, P8884, DOI 10.1093/nar/gkv897
   Verma A, 2008, J MED CHEM, V51, P5641, DOI 10.1021/jm800448a
   Wang SR, 2016, CELL CHEM BIOL, V23, P1113, DOI 10.1016/j.chembiol.2016.07.019
   Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535
   Wheelhouse RT, 1998, J AM CHEM SOC, V120, P3261, DOI 10.1021/ja973792e
   Wu RY, 2015, ANGEW CHEM INT EDIT, V54, P2447, DOI 10.1002/anie.201408719
   Zhang SL, 2014, CHEMMEDCHEM, V9, P899, DOI 10.1002/cmdc.201300566
   Zheng KW, 2013, NUCLEIC ACIDS RES, V41, P5533, DOI 10.1093/nar/gkt264
NR 139
TC 69
Z9 70
U1 10
U2 57
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD APR 20
PY 2018
VL 46
IS 7
BP 3270
EP 3283
DI 10.1093/nar/gky187
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA GE3UH
UT WOS:000431137900008
PM 29554280
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Klug, KE
   Reynolds, KA
   Yoon, JY
AF Klug, Katherine E.
   Reynolds, Kelly A.
   Yoon, Jeong-Yeol
TI A Capillary Flow Dynamics-Based Sensing Modality for Direct
   Environmental Pathogen Monitoring
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE aggregation; biosensors; capillary; microfluidic device; pathogens
ID FIELD WATER SAMPLES; PAPER MICROFLUIDICS; ANALYTICAL DEVICES; RAPID
   DETECTION; DISPERSIONS; DIAGNOSTICS; SALMONELLA; BIOSENSORS; VISCOSITY
AB Toward ultra-simple and field-ready biosensors, we demonstrate a novel assay transducer mechanism based on interfacial property changes and capillary flow dynamics in antibody-conjugated submicron particle suspensions. Differential capillary flow is tunable, allowing pathogen quantification as a function of flow rate through a paper-based microfluidic device. Flow models based on interfacial and rheological properties indicate a significant relationship between the flow rate and the interfacial effects caused by target-particle aggregation. This mechanism is demonstrated for assays of Escherichia coli K12 in water samples and Zika virus (ZIKV) in blood serum. These assays achieved very low limits of detection compared with other demonstrated methods (1 log CFU/mL E. coli and 20 pg/mL ZIKV whole virus) with an operating time of 30 s, showing promise for environmental and health monitoring.
C1 [Klug, Katherine E.; Yoon, Jeong-Yeol] Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.
   [Reynolds, Kelly A.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ 85724 USA.
   [Yoon, Jeong-Yeol] Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
RP Yoon, JY (corresponding author), Univ Arizona, Dept Agr & Biosyst Engn, Tucson, AZ 85721 USA.; Yoon, JY (corresponding author), Univ Arizona, Dept Biomed Engn, Tucson, AZ 85721 USA.
EM jyyoon@email.arizona.edu
OI Reynolds, Kelly/0000-0003-4682-8359
FU BIO5 Institute, The University of Arizona; U.S. National Science
   Foundation (NSF) Water, Environment and Technology (WET) Center
   [IIP-1361815]; Tucson Water; NSFNational Science Foundation (NSF)
   [DGE-1143953]
FX Funding was provided by BIO5 Institute, The University of Arizona, with
   support from the U.S. National Science Foundation (NSF) Water,
   Environment and Technology (WET) Center (IIP-1361815) and Tucson Water.
   KEK is grateful to Trinny Tat, Veronica Paz, and support from the NSF
   Graduate Research Fellowship (DGE-1143953). Any opinion, findings, and
   conclusions or recommendations expressed are those of the author(s) and
   do not necessarily reflect the views of the NSF.
CR Ahmadivand A, 2017, ACS SENSORS, V2, P1359, DOI 10.1021/acssensors.7b00478
   Angus SV, 2012, J ENVIRON MONITOR, V14, P3295, DOI 10.1039/c2em30700f
   Cate DM, 2013, LAB CHIP, V13, P2397, DOI 10.1039/c3lc50072a
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Choi JR, 2016, BIOSENS BIOELECTRON, V79, P98, DOI 10.1016/j.bios.2015.12.005
   Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827
   DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0
   DHAENE P, 1994, RHEOL ACTA, V33, P165, DOI 10.1007/BF00437301
   Fronczek CF, 2013, BIOSENS BIOELECTRON, V40, P342, DOI 10.1016/j.bios.2012.07.076
   Gamelas JAF, 2013, CELLULOSE, V20, P2675, DOI 10.1007/s10570-013-0066-5
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Greenwood R, 1998, COLLOID SURFACE A, V144, P139, DOI 10.1016/S0927-7757(98)00409-9
   Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699
   Hyvaluoma J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.036705
   Li KW, 2015, SCI REP-UK, V5, DOI 10.1038/srep14085
   Lutz BR, 2011, LAB CHIP, V11, P4274, DOI 10.1039/c1lc20758j
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Martic G, 2002, LANGMUIR, V18, P7971, DOI 10.1021/la020068n
   Martinez AW, 2010, ANAL CHEM, V82, P3, DOI 10.1021/ac9013989
   McCracken KE, 2016, SCI REP-UK, V6, DOI 10.1038/srep27529
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Noh N, 2010, ANAL CHEM, V82, P4181, DOI 10.1021/ac100431y
   Park TS, 2015, IEEE SENS J, V15, P1902, DOI 10.1109/JSEN.2014.2367039
   Park TS, 2013, LAB CHIP, V13, P4832, DOI 10.1039/c3lc50976a
   PROBSTEIN RF, 1994, J RHEOL, V38, P811, DOI 10.1122/1.550594
   Songjaroen T, 2012, LAB CHIP, V12, P3392, DOI 10.1039/c2lc21299d
   Urdea Mickey, 2006, Nature, V444 Suppl 1, P73, DOI 10.1038/nature05448
   Washburn EW, 1921, PHYS REV, V17, P273, DOI 10.1103/PhysRev.17.273
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   You DJ, 2011, BIOSENS BIOELECTRON, V28, P399, DOI 10.1016/j.bios.2011.07.055
NR 30
TC 3
Z9 3
U1 3
U2 13
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PD APR 20
PY 2018
VL 24
IS 23
BP 6025
EP 6029
DI 10.1002/chem.201800085
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA GD4HV
UT WOS:000430465100005
PM 29405456
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chuang, CH
   Chiou, SJ
   Cheng, TL
   Wang, YT
AF Chuang, Chih-Hung
   Chiou, Shean-jaw
   Cheng, Tian-Lu
   Wang, Yeng-Tseng
TI A molecular dynamics simulation study decodes the Zika virus NS5
   methyltransferase bound to SAH and RNA analogue
SO SCIENTIFIC REPORTS
LA English
DT Article
ID PROTEIN-COUPLED RECEPTORS; FREE-ENERGY CALCULATION
AB Since 2015, widespread Zika virus outbreaks in Central and South America have caused increases in microcephaly cases, and this acute problem requires urgent attention. We employed molecular dynamics and Gaussian accelerated molecular dynamics techniques to investigate the structure of Zika NS5 protein with S-adenosyl-L-homocysteine (SAH) and an RNA analogue, namely 7-methylguanosine 5'-triphosphate (m7GTP). For the binding motif of Zika virus NS5 protein and SAH, we suggest that the four Zika NS5 substructures (residue orders: 101-112, 54-86, 127-136 and 146-161) and the residues (Ser56, Gly81, Arg84, Trp87, Thr104, Gly106, Gly107, His110, Asp146, Ile147, and Gly148) might be responsible for the selectivity of the new Zika virus drugs. For the binding motif of Zika NS5 protein and m7GTP, we suggest that the three Zika NS5 substructures (residue orders: 11-31, 146-161 and 207218) and the residues (Asn17, Phe24, Lys28, Lys29, Ser150, Arg213, and Ser215) might be responsible for the selectivity of the new Zika virus drugs.
C1 [Chiou, Shean-jaw; Wang, Yeng-Tseng] Kaohsiung Med Univ, Coll Med, Sch Med, Dept Biochem, Kaohsiung, Taiwan.
   [Wang, Yeng-Tseng] Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.
   [Cheng, Tian-Lu; Wang, Yeng-Tseng] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.
   [Wang, Yeng-Tseng] Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.
   [Chuang, Chih-Hung; Cheng, Tian-Lu; Wang, Yeng-Tseng] Kaohsiung Med Univ Hosp, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.
RP Wang, YT (corresponding author), Kaohsiung Med Univ, Coll Med, Sch Med, Dept Biochem, Kaohsiung, Taiwan.; Wang, YT (corresponding author), Kaohsiung Med Univ, Ctr Biomarkers & Biotech Drugs, Kaohsiung, Taiwan.; Wang, YT (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.; Wang, YT (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Res, Kaohsiung, Taiwan.; Wang, YT (corresponding author), Kaohsiung Med Univ Hosp, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.
EM c00jsw00@kmu.edu.tw
OI Cheng, Tian-Lu/0000-0002-7263-2766; Wang,
   Yeng-Tseng/0000-0002-6159-2690; Wang, Yeng-Tseng/0000-0002-7575-4953
FU Kaohsiung Medical University "Aim for the Top 500 Universities Grant",
   Kaohsiung, Taiwan [KMU-TP105C06, KMU-TP105C14]; Republic of China;
   National Science Council of the Republic of China, TaiwanNational
   Science Council of Taiwan [105-2113-M-037-009-]
FX This work was supported by the Kaohsiung Medical University "Aim for the
   Top 500 Universities Grant" (KMU-TP105C06 and KMU-TP105C14), Kaohsiung,
   Taiwan. This work also supported by the Republic of China and the
   National Science Council of the Republic of China, Taiwan
   (105-2113-M-037-009-).
CR Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Ekins S., 2016, F1000RESEARCH, V5, P1
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grossfield A., 2017, WHAM IMPLEMENTATION
   Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432
   Johnston JM, 2011, CURR OPIN STRUC BIOL, V21, P552, DOI 10.1016/j.sbi.2011.06.008
   KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100
   Kappel K, 2015, Q REV BIOPHYS, V48, P479, DOI 10.1017/S0033583515000153
   Kobayashi C, 2017, J COMPUT CHEM, V38, P2193, DOI 10.1002/jcc.24874
   Markwick PRL, 2011, PHYS CHEM CHEM PHYS, V13, P20053, DOI 10.1039/c1cp22100k
   Markwick PRL, 2011, J PHYS CHEM LETT, V2, P158, DOI 10.1021/jz101462n
   Miao YL, 2015, J CHEM THEORY COMPUT, V11, P3584, DOI 10.1021/acs.jctc.5b00436
   Miao YL, 2015, J COMPUT CHEM, V36, P1536, DOI 10.1002/jcc.23964
   Miao YL, 2014, J CHEM THEORY COMPUT, V10, P2677, DOI 10.1021/ct500090q
   Miao YL, 2014, PHYS CHEM CHEM PHYS, V16, P6398, DOI 10.1039/c3cp53962h
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Pierce LCT, 2012, J CHEM THEORY COMPUT, V8, P2997, DOI 10.1021/ct300284c
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shen TY, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2944250
   Wang Y, 2011, J CHEM THEORY COMPUT, V7, P3199, DOI 10.1021/ct200430c
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 27
TC 3
Z9 3
U1 0
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 20
PY 2018
VL 8
AR 6336
DI 10.1038/s41598-018-24775-4
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD5HK
UT WOS:000430537800013
PM 29679079
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marabuto, E
   Rebelo, MT
AF Marabuto, Eduardo
   Rebelo, Maria Teresa
TI The Asian tiger mosquito, Aedes (Stegomyia) albopictus (Skuse), a vector
   of dengue, chikungunya and zika viruses, reaches Portugal (Diptera:
   Culicidae)
SO ZOOTAXA
LA English
DT Article
ID 1ST RECORD; ESTABLISHMENT; SPAIN
C1 [Marabuto, Eduardo] Univ Lisbon, Computat Biol & Populat Genom Grp, CE3c, Fac Ciencias, P-1749016 Lisbon, Portugal.
   [Rebelo, Maria Teresa] Univ Lisbon, CESAM Ctr Environm & Marine Studies, Fac Ciencias, P-1749016 Lisbon, Portugal.
RP Marabuto, E (corresponding author), Univ Lisbon, Computat Biol & Populat Genom Grp, CE3c, Fac Ciencias, P-1749016 Lisbon, Portugal.
EM eduardo.marabuto@gmail.com
RI Marabuto, Eduardo/B-7284-2013; Rebelo, MT/A-3772-2013
OI Marabuto, Eduardo/0000-0001-7017-8451; Rebelo, MT/0000-0002-2724-2195
FU FCT (Fundacao para a Ciencia e Tecnologia), PortugalPortuguese
   Foundation for Science and Technology [SFRH/BD/102801/2014]
FX We would like to thank all family members of the first author involved
   with finding of the mosquito and discussing aspects related to its
   occurrence, location and apprehension during the time-frame of the
   study, especially Manuel Marabuto for allowing females to be
   photographed while feeding. Finally, the authors are grateful to two
   anonymous referees and the editor who greatly enhanced the manuscript.
   The research was supported by a FCT (Fundacao para a Ciencia e
   Tecnologia), Portugal doctoral grant SFRH/BD/102801/2014 to the first
   author.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Almeida APG, 2007, EUROSURVEILLANCE, V12
   Alves M. J., 2016, REVIVE 2011 2015 CUL, P9
   Aranda C, 2006, MED VET ENTOMOL, V20, P150, DOI 10.1111/j.1365-2915.2006.00605.x
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Centro de Coordination de Alertas y Emergencias sanitarias (CCAES), 2016, EV RAP RIESG TRANSM
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Estrada-Franco J. G., 1995, PAN AM HLTH ORG, V42, P49
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Halasa YA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089221
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kutateladze T, 2016, J AM MOSQUITO CONTR, V32, P230, DOI 10.2987/16-6574.1
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Marabuto Eduardo, 2014, Biodivers Data J, pe4117, DOI 10.3897/BDJ.2.e4117
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 20
TC 0
Z9 0
U1 2
U2 10
PU MAGNOLIA PRESS
PI AUCKLAND
PA PO BOX 41383, AUCKLAND, ST LUKES 1030, NEW ZEALAND
SN 1175-5326
EI 1175-5334
J9 ZOOTAXA
JI Zootaxa
PD APR 20
PY 2018
VL 4413
IS 1
BP 197
EP 200
DI 10.11646/zootaxa.4413.1.10
PG 4
WC Zoology
SC Zoology
GA GD4GW
UT WOS:000430462600010
PM 29690129
DA 2020-07-08
ER

PT J
AU Guo, XG
   Zhou, YZ
   Li, Q
   Wang, W
   Wen, JZ
   Zheng, L
   Wang, Q
AF Guo, Xu-Guang
   Zhou, Yong-Zhuo
   Li, Qin
   Wang, Wei
   Wen, Jin-Zhou
   Zheng, Lei
   Wang, Qian
TI Rapid and reliable diagnostic method to detect Zika virus by real-time
   fluorescence reverse transcription loop-mediated isothermal
   amplification
SO AMB EXPRESS
LA English
DT Article
DE Zika virus; NS5 gene; LAMP; Loop-mediated isothermal amplification;
   Real-time fluorescence reverse transcription
ID MOLECULAR DIAGNOSIS; INFECTIOUS-DISEASES; LAMP
AB To detect Zika virus more rapidly and accurately, we developed a novel method that utilized a real-time fluorescence reverse transcription loop-mediated isothermal amplification (LAMP) technique. The NS5 gene was amplified by a set of six specific primers that recognized six distinct sequences. The amplification process, including 60 min of thermostatic reaction with Bst DNA polymerase following real-time fluorescence reverse transcriptase using genomic Zika virus standard strain (MR766), was conducted through fluorescent signaling. Among the six pairs of primers that we designate here, NS5 was the most efficient with a high sensitivity of up to 3.3 ng/mu l and reproducible specificity on eight pathogen samples that were used as negative controls. The real-time fluorescence reverse transcription LAMP detection process can be completed within 35 min. Our study demonstrated that real-time fluorescence reverse transcription LAMP could be highly beneficial and convenient clinical application to detect Zika virus due to its high specificity and stability.
C1 [Guo, Xu-Guang; Zheng, Lei; Wang, Qian] Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.
   [Guo, Xu-Guang] Guangzhou Med Univ, Dept Clin Lab Med, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China.
   [Zhou, Yong-Zhuo] Southern Med Univ, Dept Clin Lab Med, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China.
   [Li, Qin] Yale Univ, Yale Sch Med, Dept Med, Sect Pulm Crit Care & Sleep Med, New Haven, CT 06520 USA.
   [Wang, Wei] Shenzhen Univ, Dept Lab Med, Affiliated Hosp 1, Shenzhen 518035, Guangdong, Peoples R China.
   [Wang, Wei] Shenzhen Second Peoples Hosp, Dept Lab Med, Shenzhen 518035, Guangdong, Peoples R China.
   [Wen, Jin-Zhou] Ctr Dis Control & Prevent Chaozhou, Guangzhou 521000, Guangdong, Peoples R China.
RP Wang, Q (corresponding author), Southern Med Univ, Nanfang Hosp, Lab Med Ctr, Guangzhou 510515, Guangdong, Peoples R China.
EM wangqian@smu.edu.cn
FU General Research Projects of Medical and Health Sciences of Guangzhou
   City [20151A011083]; Bureau of Science, Technology and Information of
   Liwan District of Guangzhou [20151217081, 2016080067]; National Nature
   Science FoundationNational Natural Science Foundation of China
   [81700004]
FX This study was supported by the General Research Projects of Medical and
   Health Sciences of Guangzhou City (No. 20151A011083), the Bureau of
   Science, Technology and Information of Liwan District of Guangzhou (Nos.
   20151217081 and 2016080067), and the National Nature Science Foundation
   (No. 81700004).
CR Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004
   Ahmad F, 2012, ANAL CHIM ACTA, V733, P1, DOI 10.1016/j.aca.2012.04.031
   Asiello PJ, 2011, LAB CHIP, V11, P1420, DOI 10.1039/c0lc00666a
   Beck ET, 2010, FUTURE MICROBIOL, V5, P901, DOI 10.2217/FMB.10.48
   Chen HL, 2016, J CHIN MED ASSOC, V79, P174, DOI 10.1016/j.jcma.2016.03.001
   Deborggraeve S, 2012, EXPERT REV MOL DIAGN, V12, P719, DOI [10.1586/erm.12.72, 10.1586/ERM.12.72]
   Ebenezer V, 2012, MAR BIOTECHNOL, V14, P129, DOI 10.1007/s10126-011-9427-y
   Fu SJ, 2011, APPL BIOCHEM BIOTECH, V163, P845, DOI 10.1007/s12010-010-9088-8
   Gill P, 2008, NUCLEOS NUCLEOT NUCL, V27, P224, DOI 10.1080/15257770701845204
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1739
   Hattori T, 2016, TOHOKU J EXP MED, V238, P287, DOI 10.1620/tjem.238.287
   Interlandi Jeneen, 2016, Consum Rep, V81, P25
   Khan Md Gulam Musawwir, 2012, Parasit Vectors, V5, P280, DOI 10.1186/1756-3305-5-280
   Mansour SMG, 2015, ANIM HEALTH RES REV, V16, P89, DOI 10.1017/S1466252315000018
   Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9
   Njiru ZK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001572
   Walsh Bryan, 2016, Time, V187, P9
   Wilbe M, 2017, PRENATAL DIAG, V37, P1146, DOI 10.1002/pd.5156
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Worobey M, 2017, NATURE, V546, P355, DOI 10.1038/nature22495
   Xia Y, 2014, J THORAC DIS, V6, P1193, DOI 10.3978/j.issn.2072-1439.2014.07.29
   Zamani M, 2017, IRAN J PUBLIC HEALTH, V46, P1305
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 24
TC 5
Z9 5
U1 3
U2 10
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2191-0855
J9 AMB EXPRESS
JI AMB Express
PD APR 18
PY 2018
VL 8
AR 60
DI 10.1186/s13568-018-0591-6
PG 8
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA GD3XW
UT WOS:000430438100002
PM 29671176
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hackett, BA
   Cherry, S
AF Hackett, Brent A.
   Cherry, Sara
TI Flavivirus internalization is regulated by a size-dependent endocytic
   pathway
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE endocytosis; flavivirus; entry; virus; LY6E
ID VIRUS NS3 PROTEIN; ZIKA VIRUS; ENTRY; ASSOCIATION; MICROTUBULES;
   REPLICATION; INFECTION; EFFECTORS; CLIP-170; RNASEK
AB Flaviviruses enter host cells through the process of clathrin-mediated endocytosis, and the spectrum of host factors required for this process are incompletely understood. Here we found that lymphocyte antigen 6 locus E (LY6E) promotes the internalization of multiple flaviviruses, including West Nile virus, Zika virus, and dengue virus. Perhaps surprisingly, LY6E is dispensable for the internalization of the endogenous cargo transferrin, which is also dependent on clathrin-mediated endocytosis for uptake. Since viruses are substantially larger than transferrin, we reasoned that LY6E may be required for uptake of larger cargoes and tested this using transferrin-coated beads of similar size as flaviviruses. LY6E was indeed required for the internalization of transferrin-coated beads, suggesting that LY6E is selectively required for large cargo. Cell biological studies found that LY6E forms tubules upon viral infection and bead internalization, and we found that tubule formation was dependent on RNASEK, which is also required for flavivirus internalization, but not transferrin uptake. Indeed, we found that RNASEK is also required for the internalization of transferrin-coated beads, suggesting it functions upstream of LY6E. These LY6E tubules resembled microtubules, and we found that microtubule assembly was required for their formation and flavivirus uptake. Since microtubule end-binding proteins link microtubules to downstream activities, we screened the three end-binding proteins and found that EB3 promotes virus uptake and LY6E tubularization. Taken together, these results highlight a specialized pathway required for the uptake of large clathrin-dependent endocytosis cargoes, including flaviviruses.
C1 [Hackett, Brent A.; Cherry, Sara] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Cherry, S (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
EM cherrys@pennmedicine.upenn.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI074951, R01AI122749,
   R01AI095500]; Linda Montague Investigator Award; ITMAT Pilot; Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease
   AwardBurroughs Wellcome Fund
FX We thank members of the S.C. laboratory for technical support and
   advice; Julie To for IC<INF>50</INF> replicates, and Drs. David Schultz
   and Matthew Tudor for advice and IC<INF>50</INF> analysis. We thank Dr.
   Derek Walsh for advice on EBs. This work was supported by NIH Grants
   R01AI074951, R01AI122749, and R01AI095500, the Linda Montague
   Investigator Award, ITMAT Pilot, and the Burroughs Wellcome
   Investigators in the Pathogenesis of Infectious Disease Award (to S.C.).
CR Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369
   Bjelic S, 2012, J STRUCT BIOL, V177, P160, DOI 10.1016/j.jsb.2011.11.010
   Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Buey RM, 2011, MOL BIOL CELL, V22, P2912, DOI 10.1091/mbc.E11-01-0017
   CAMERON PL, 1991, J CELL BIOL, V115, P151, DOI 10.1083/jcb.115.1.151
   Chiou CT, 2003, J GEN VIROL, V84, P2795, DOI 10.1099/vir.0.19201-0
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Feng XB, 2006, ARTHRITIS RHEUM, V54, P2951, DOI 10.1002/art.22044
   Frost MJ, 2012, EMERG INFECT DIS, V18, P792, DOI 10.3201/eid1805.111720
   Goldspink DA, 2013, J CELL SCI, V126, P4000, DOI 10.1242/jcs.129759
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Jovasevic V, 2015, J CELL BIOL, V211, P323, DOI 10.1083/jcb.201505123
   Juwana JP, 1999, INT J CANCER, V81, P275, DOI 10.1002/(SICI)1097-0215(19990412)81:2<275::AID-IJC18>3.0.CO;2-Z
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Liu B, 2004, NAT IMMUNOL, V5, P891, DOI 10.1038/ni1104
   MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001
   McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   NG ML, 1989, ARCH VIROL, V106, P103, DOI 10.1007/BF01311042
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Petersen LR, 2002, NEW ENGL J MED, V347, P1225, DOI 10.1056/NEJMo020128
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Robinson MS, 2015, TRAFFIC, V16, P1210, DOI 10.1111/tra.12335
   Rothman AL, 2010, CURR TOP MICROBIOL, V338, P83, DOI 10.1007/978-3-642-02215-9_7
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Sabo Y, 2013, CELL HOST MICROBE, V14, P535, DOI 10.1016/j.chom.2013.10.012
   Schoggins JW, 2012, P NATL ACAD SCI USA, V109, P14610, DOI 10.1073/pnas.1212379109
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Sejvar JJ, 2003, EMERG INFECT DIS, V9, P788, DOI 10.3201/eid0907.030129
   Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006
NR 36
TC 27
Z9 27
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 17
PY 2018
VL 115
IS 16
BP 4246
EP 4251
DI 10.1073/pnas.1720032115
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GD0LI
UT WOS:000430191900080
PM 29610346
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Chien, LC
   Lin, RT
   Liao, YQ
   Sy, FS
   Perez, A
AF Chien, Lung-Chang
   Lin, Ro-Ting
   Liao, Yunqi
   Sy, Francisco S.
   Perez, Adriana
TI Surveillance on the endemic of Zika virus infection by meteorological
   factors in Colombia: a population-based spatial and temporal study
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus infection; Meteorological factor; Nonlinear lagged effect;
   Spatial analysis
ID REGION; TRANSMISSION; MODELS; HEALTH; BRAZIL
AB Background: Zika virus (ZIKV) infection is a pandemic and a public health emergency. It is transmitted by mosquitoes, primarily the Aedes genus. In light of no treatment currently, it is crucial to develop effective vector control programs to prevent the spread of ZIKV infection earlier when observing possible risk factors, such as weather conditions enhancing mosquito breeding and surviving.
   Methods: This study collected daily meteorological measurements and weekly ZIKV infectious cases among 32 departments of Colombia from January 2015-December 2016. This study applied the distributed lag nonlinear model to estimate the association between the number of ZIKA virus infection and meteorological measurements, controlling for spatial and temporal variations. We examined at most three meteorological factors with 20 lags in weeks in the model.
   Results: Average humidity, total rainfall, and maximum temperature were more predictable of ZIKV infection outbreaks than other meteorological factors. Our models can detect significantly lagged effects of average humidity, total rainfall, and maximum temperature on outbreaks up to 15, 14, and 20 weeks, respectively. The spatial analysis identified 12 departments with a significant threat of ZIKV, and eight of those high-risk departments were located between the Equator and 6 degrees N. The outbreak prediction also performed well in identified high-risk departments.
   Conclusion: Our results demonstrate that meteorological factors could be used for predicting ZIKV epidemics. Building an early warning surveillance system is important for preventing ZIKV infection, particularly in endemic areas.
C1 [Chien, Lung-Chang; Sy, Francisco S.] Univ Nevada, Sch Community Hlth Sci, Dept Environm & Occupat Hlth, 4505 S Maryland Pkwy, Las Vegas, NV 89154 USA.
   [Lin, Ro-Ting] China Med Univ, Dept Occupat Safety & Hlth, 91 Hsueh Shih Rd, Taichung 40402, Taiwan.
   [Liao, Yunqi] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biostat & Data Sci, Sch Publ Hlth, Houston Campus,1200 Pressler St, Houston, TX 77030 USA.
   [Perez, Adriana] Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biostat & Data Sci, Sch Publ Hlth, Austin Campus,1616 Guadalupe,Suite 6-300, Austin, TX 78071 USA.
RP Perez, A (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Dept Biostat & Data Sci, Sch Publ Hlth, Austin Campus,1616 Guadalupe,Suite 6-300, Austin, TX 78071 USA.
EM adriana.perez@uth.tmc.edu
OI Lin, Ro-Ting/0000-0002-2687-203X
FU University of Nevada, Las Vegas; University of Texas Health Science
   Center at Houston-UTHealth; Michael & Susan Dell Foundation [8075]
FX The study was supported by the University of Nevada, Las Vegas and The
   University of Texas Health Science Center at Houston-UTHealth, and the
   Michael & Susan Dell Foundation [Grant 8075] during the writing of this
   manuscript.
CR Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chien LC, 2018, J EXPO SCI ENV EPID, V28, P13, DOI 10.1038/jes.2016.62
   Chien LC, 2014, ENVIRON INT, V73, P46, DOI 10.1016/j.envint.2014.06.018
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940
   Kindermann R, 1980, MARKOV RANDOM FIELDS
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Li X, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2170-2
   Liang D, 2013, ATMOS ENVIRON, V72, P60, DOI 10.1016/j.atmosenv.2013.02.034
   Lin HH, 2017, J NURS RES, V25, P3, DOI 10.1097/jnr.0000000000000205
   Lourenco J, 2017, BIORXIV
   McGough SF, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005295
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phung D, 2016, TROP MED INT HEALTH, V21, P1324, DOI 10.1111/tmi.12754
   ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rodriguez-Morales AJ, 2016, INT J INFECT DIS, V48, P70, DOI 10.1016/j.ijid.2016.05.012
   Rodriguez-Morales Alfonso J, 2016, F1000Res, V5, P568, DOI 10.12688/f1000research.8436.1
   Rojas DP, 2016, EUROSURVEILLANCE, V21, DOI [10.2807/1560-7917.ES.2016.2821.2828.30283, DOI 10.2807/1560-7917.ES.2016.2821.2828.30283]
   Shi Y, 2016, ENVIRON HEALTH PERSP, V124, P1369, DOI 10.1289/ehp.1509981
   United Nations, 2019, WORLD POP PROSP
   Wang JF, 2010, INT J GEOGR INF SCI, V24, P107, DOI 10.1080/13658810802443457
   WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143
NR 33
TC 4
Z9 4
U1 2
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 17
PY 2018
VL 18
AR 180
DI 10.1186/s12879-018-3085-x
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA GE2OG
UT WOS:000431053900001
PM 29665783
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Thawani, A
   Sirohi, D
   Kuhn, RJ
   Fekete, DM
AF Thawani, Ankita
   Sirohi, Devika
   Kuhn, Richard J.
   Fekete, Donna M.
TI Zika Virus Can Strongly Infect and Disrupt Secondary Organizers in the
   Ventricular Zone of the Embryonic Chicken Brain
SO CELL REPORTS
LA English
DT Article
ID SONIC HEDGEHOG; NEURAL-TUBE; MOUSE; MICE; SPECIFICATION; LEADS
AB Zika virus (ZIKV) is associated with severe neurodevelopmental impairments in human fetuses, including microencephaly. Previous reports examining neural progenitor tropism of ZIKV in organoid and animal models did not address whether the virus infects all neural progenitors uniformly. To explore this, ZIKV was injected into the neural tube of 2-day-old chicken embryos, resulting in nonuniform periventricular infection 3 days later. Recurrent foci of intense infection were present at specific signaling centers that influence neuroepithelial patterning at a distance through secretion of morphogens. ZIKV infection reduced transcript levels for 3 morphogens, SHH, BMP7, and FGF8 expressed at the midbrain basal plate, hypothalamic floor plate, and isthmus, respectively. Levels of Patched1, a SHH-pathway downstream gene, were also reduced, and a SHH-dependent cell population in the ventral midbrain was shifted in position. Thus, the diminishment of signaling centers through ZIKV-mediated apoptosis may yield broader, non-cell-autonomous changes in brain patterning.
C1 [Thawani, Ankita; Sirohi, Devika; Kuhn, Richard J.; Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Thawani, Ankita; Fekete, Donna M.] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.
   [Thawani, Ankita; Sirohi, Devika; Kuhn, Richard J.; Fekete, Donna M.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Kuhn, Richard J.; Fekete, Donna M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.
RP Fekete, DM (corresponding author), Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.; Fekete, DM (corresponding author), Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.; Fekete, DM (corresponding author), Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.; Fekete, DM (corresponding author), Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.
EM dfekete@purdue.edu
RI Sirohi, Devika/I-7136-2019; Thawani, Ankita/G-3827-2018
OI Sirohi, Devika/0000-0001-8601-6211; Thawani, Ankita/0000-0002-4964-9789
FU Purdue University; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI073755,
   R01AI076331, R21DC016732]
FX Support for this study was provided by Purdue University (D. LaCount,
   D.M.F and R.J.K.), the NIH (R01AI073755 and R01AI076331, R.J.K.; and
   R21DC016732, D.M.F.). We thank D. Biesemeier, N.H.C. Sammudin, and S.
   Tola for technical support. PAX6 and NKX2.2 antibodies developed by A.
   Kawakami and T.M. Jessell/S. Brenner-Morton, respectively, were obtained
   from the Developmental Studies Hybridoma Bank, created by the NICHD of
   the NIH and maintained at the Department of Biology, University of Iowa
   (Iowa City, IA). Plasmids were from D.K. Wu (NIDCD; SHH, BMP7, and
   PTCH1) and the S. Noji lab (U. Tokushima, Japan; FGF8B). ZIKV cDNA was
   from Pei-Yong Shi (UTMB). Purdue Statistical Consulting Services helped
   design SAS codes.
CR Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Butler H, 1987, ATLAS STAGING MAMMAL
   Cavodeassi F, 2012, DEV NEUROBIOL, V72, P218, DOI 10.1002/dneu.20938
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Echevarria D, 2003, BRAIN RES REV, V43, P179, DOI 10.1016/j.brainresrev.2003.08.002
   Fair JM, 2011, POULTRY SCI, V90, P328, DOI 10.3382/ps.2010-00809
   Ferran JL, 2008, BRAIN RES BULL, V75, P295, DOI 10.1016/j.brainresbull.2007.10.039
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Garcia-Lopez R, 2009, DEV GROWTH DIFFER, V51, P145, DOI 10.1111/j.1440-169X.2009.01096.x
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104
   Langevin SA, 2001, EMERG INFECT DIS, V7, P726, DOI 10.3201/eid0704.010422
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Marigo V, 1996, P NATL ACAD SCI USA, V93, P9346, DOI 10.1073/pnas.93.18.9346
   Martinez-Lopez JE, 2015, FRONT NEUROANAT, V9, DOI [10.3389/fnen.2015.00012, 10.3389/fnana.2015.00012]
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Ohyama K, 2008, DEVELOPMENT, V135, P3325, DOI 10.1242/dev.027078
   Puelles L, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00027
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wurst W, 2001, NAT REV NEUROSCI, V2, P99, DOI 10.1038/35053516
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 34
TC 4
Z9 4
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 17
PY 2018
VL 23
IS 3
BP 692
EP 700
DI 10.1016/j.celrep.2018.03.080
PG 9
WC Cell Biology
SC Cell Biology
GA GD3EC
UT WOS:000430384900004
PM 29669275
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Fink, JJ
   Levine, ES
AF Fink, James J.
   Levine, Eric S.
TI Uncovering True Cellular Phenotypes: Using induced Pluripotent Stem
   Cell-Derived Neurons to Study early insults in Neurodevelopmental
   Disorders
SO FRONTIERS IN NEUROLOGY
LA English
DT Review
DE neurodevelopmental disorders; autism spectrum disorders;
   electrophysiology; synaptic transmission; induced pluripotent stem cells
ID FRAGILE-X-SYNDROME; AUTISM SPECTRUM DISORDERS; DEVELOPMENTAL
   NEUROPSYCHIATRIC DISORDERS; MODELING PSYCHIATRIC-DISORDERS; COPY-NUMBER
   VARIATION; ZIKA VIRUS-INFECTION; RETT-SYNDROME; ANGELMAN SYNDROME;
   CEREBRAL ORGANOIDS; SYNDROME PATIENT
AB Animal models of neurodevelopmental disorders have provided invaluable insights into the molecular-, cellular-, and circuit-level defects associated with a plethora of genetic disruptions. In many cases, these deficits have been linked to changes in disease-relevant behaviors, but very few of these findings have been translated to treatments for human disease. This may be due to significant species differences and the difficulty in modeling disorders that involve deletion or duplication of multiple genes. The identification of primary underlying pathophysiology in these models is confounded by the accumulation of secondary disease phenotypes in the mature nervous system, as well as potential compensatory mechanisms. The discovery of induced pluripotent stem cell technology now provides a tool to accurately model complex genetic neurogenetic disorders. Using this technique, patient-specific cell lines can be generated and differentiated into specific subtypes of neurons that can be used to identify primary cellular and molecular phenotypes. It is clear that impairments in synaptic structure and function are a common pathophysiology across neurodevelopmental disorders, and electrophysiological analysis at the earliest stages of neuronal development is critical for identifying changes in activity and excitability that can contribute to synaptic dysfunction and identify targets for disease-modifying therapies.
C1 [Fink, James J.; Levine, Eric S.] Univ Connecticut, Sch Med, Dept Neurosci, Farmington, CT 06030 USA.
RP Fink, JJ; Levine, ES (corresponding author), Univ Connecticut, Sch Med, Dept Neurosci, Farmington, CT 06030 USA.
EM james.j.fink1@gmail.com; eslevine@uchc.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS078753, MH09-4896]; Dup15q Alliance;
   Angelman Syndrome Foundation; CT Regenerative Medicine Research Fund
FX Support was provided by NIH Grants NS078753 and MH09-4896 (EL), the
   Dup15q Alliance (JF), the Angelman Syndrome Foundation (EL), and the CT
   Regenerative Medicine Research Fund (EL).
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Amenduni M, 2011, EUR J HUM GENET, V19, P1246, DOI 10.1038/ejhg.2011.131
   Ananiev G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025255
   Arber C, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0268-4
   Ardhanareeswaran K, 2017, NAT REV NEUROL, V13, P265, DOI 10.1038/nrneurol.2017.45
   Avaliani N, 2014, STEM CELLS, V32, P3088, DOI 10.1002/stem.1823
   Avior Y, 2016, NAT REV MOL CELL BIO, V17, P170, DOI 10.1038/nrm.2015.27
   Bardy C, 2016, MOL PSYCHIATR, V21, P1573, DOI 10.1038/mp.2016.158
   Bardy C, 2015, P NATL ACAD SCI USA, V112, pE2725, DOI 10.1073/pnas.1504393112
   Belinsky GS, 2014, STEM CELL RES, V12, P101, DOI 10.1016/j.scr.2013.09.014
   Belinsky GS, 2011, STEM CELLS DEV, V20, P1733, DOI 10.1089/scd.2010.0501
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bershteyn M, 2013, CELL, V155, P19, DOI 10.1016/j.cell.2013.09.010
   Bienvenu T, 2006, NAT REV GENET, V7, P415, DOI 10.1038/nrg1878
   Bourgeron T, 2009, CURR OPIN NEUROBIOL, V19, P231, DOI 10.1016/j.conb.2009.06.003
   Brennand KJ, 2012, MOL PSYCHIATR, V17, P1239, DOI 10.1038/mp.2012.20
   Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478
   Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chamberlain SJ, 2010, P NATL ACAD SCI USA, V107, P17668, DOI 10.1073/pnas.1004487107
   Chamberlain SJ, 2010, J NEUROSCI, V30, P9958, DOI 10.1523/JNEUROSCI.1728-10.2010
   Chamberlain SJ, 2010, NEUROBIOL DIS, V39, P13, DOI 10.1016/j.nbd.2010.03.011
   Chanda S, 2014, STEM CELL REP, V3, P282, DOI 10.1016/j.stemcr.2014.05.020
   Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018
   Chen PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep25368
   Chinchalongporn V, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0129-y
   Christensen DL, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6503a1
   Courchesne E, 2011, JAMA-J AM MED ASSOC, V306, P2001, DOI 10.1001/jama.2011.1638
   D'Hulst C, 2007, TRENDS NEUROSCI, V30, P425, DOI 10.1016/j.tins.2007.06.003
   Dana H, 2016, ELIFE, V5, DOI 10.7554/eLife.12727
   Delepine C, 2016, HUM MOL GENET, V25, P146, DOI 10.1093/hmg/ddv464
   Devlin AC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6999
   Djuric U, 2015, NEUROBIOL DIS, V76, P37, DOI 10.1016/j.nbd.2015.01.001
   Doers ME, 2014, STEM CELLS DEV, V23, P1777, DOI 10.1089/scd.2014.0030
   Ebert DH, 2013, NATURE, V493, P327, DOI 10.1038/nature11860
   Farra N, 2012, MOL PSYCHIATR, V17, P1261, DOI 10.1038/mp.2011.180
   Fink JJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15038
   Fink JJ, 2018, BIORXIV, DOI [10.1101/286336, DOI 10.1101/286336]
   Germain ND, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-44
   Geschwind DH, 2008, CELL, V135, P391, DOI 10.1016/j.cell.2008.10.016
   Griesi-Oliveira K, 2015, MOL PSYCHIATR, V20, P1350, DOI 10.1038/mp.2014.141
   Gunhanlar N, 2018, MOL PSYCHIATR, V23, P1336, DOI 10.1038/mp.2017.56
   Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121
   Haelterman NA, 2014, ANNU REV NEUROSCI, V37, P137, DOI 10.1146/annurev-neuro-071013-014317
   Halevy T, 2015, STEM CELL REP, V4, P37, DOI 10.1016/j.stemcr.2014.10.015
   Hiroi N, 2013, MOL PSYCHIATR, V18, P1153, DOI 10.1038/mp.2013.92
   Huguet G, 2013, ANNU REV GENOM HUM G, V14, P191, DOI 10.1146/annurev-genom-091212-153431
   Intoh A, 2016, HUM MOL GENET, V25, P1814, DOI 10.1093/hmg/ddw053
   Isshiki M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5742
   Jeste SS, 2014, NAT REV NEUROL, V10, P74, DOI 10.1038/nrneurol.2013.278
   Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014
   Jiang YH, 2013, NEURON, V78, P8, DOI 10.1016/j.neuron.2013.03.016
   Judson MC, 2016, NEURON, V90, P56, DOI 10.1016/j.neuron.2016.02.040
   Juopperi TA, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-17
   Kaiser T, 2015, NAT MED, V21, P979, DOI 10.1038/nm.3935
   Kalsner L, 2015, PEDIATR CLIN N AM, V62, P587, DOI 10.1016/j.pcl.2015.03.004
   Kang S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12452-x
   Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011
   Kim KY, 2011, P NATL ACAD SCI USA, V108, P14169, DOI 10.1073/pnas.1018979108
   Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004
   Krey JF, 2013, NAT NEUROSCI, V16, P201, DOI 10.1038/nn.3307
   Kumari D, 2015, STEM CELL TRANSL MED, V4, P800, DOI 10.5966/sctm.2014-0278
   Lam RS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169506
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lieberman R, 2017, PSYCHIAT RES, V247, P172, DOI 10.1016/j.psychres.2016.11.027
   Lieberman R, 2015, ALCOHOL CLIN EXP RES, V39, P1654, DOI 10.1111/acer.12807
   Lieberman R, 2012, ALCOHOL CLIN EXP RES, V36, P1678, DOI 10.1111/j.1530-0277.2012.01792.x
   Liu J, 2012, HUM MOL GENET, V21, P3795, DOI 10.1093/hmg/dds207
   Liu Y, 2013, ANN NEUROL, V74, P128, DOI 10.1002/ana.23897
   Livide G, 2015, EUR J HUM GENET, V23, P195, DOI 10.1038/ejhg.2014.81
   Luscher C, 2009, J PHYSIOL-LONDON, V587, P727, DOI 10.1113/jphysiol.2008.167742
   Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001
   Mabb AM, 2010, ANNU REV CELL DEV BI, V26, P179, DOI 10.1146/annurev-cellbio-100109-104129
   Maisano X, 2012, J NEUROSCI, V32, P46, DOI 10.1523/JNEUROSCI.2683-11.2012
   Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012
   Marchetto MC, 2017, MOL PSYCHIATR, V22, P820, DOI 10.1038/mp.2016.95
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Martins-Taylor K, 2014, HUM MOL GENET, V23, P2364, DOI 10.1093/hmg/ddt628
   McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71
   Merkle FT, 2015, DEVELOPMENT, V142, P633, DOI 10.1242/dev.117978
   Mertens J, 2016, NAT REV NEUROSCI, V17, P424, DOI 10.1038/nrn.2016.46
   Mertens J, 2015, NATURE, V527, P95, DOI 10.1038/nature15526
   Mistry AM, 2014, NEUROBIOL DIS, V65, P1, DOI 10.1016/j.nbd.2014.01.006
   Mitchell KJ, 2011, CURR OPIN NEUROBIOL, V21, P197, DOI 10.1016/j.conb.2010.08.009
   Monteiro P, 2017, NAT REV NEUROSCI, V18, P147, DOI 10.1038/nrn.2016.183
   Mullins C, 2016, NEURON, V89, P1131, DOI 10.1016/j.neuron.2016.02.017
   Nadadhur AG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178533
   Nageshappa S, 2016, MOL PSYCHIATR, V21, P178, DOI 10.1038/mp.2015.128
   Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024
   Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153
   O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909
   Odawara A, 2016, BIOCHEM BIOPH RES CO, V469, P856, DOI 10.1016/j.bbrc.2015.12.087
   Onder TT, 2012, CURR OPIN GENET DEV, V22, P500, DOI 10.1016/j.gde.2012.05.005
   Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003
   Pak C, 2015, CELL STEM CELL, V17, P316, DOI 10.1016/j.stem.2015.07.017
   Pankevich DE, 2014, NEURON, V84, P546, DOI 10.1016/j.neuron.2014.10.007
   Parent JM, 2015, NAT NEUROSCI, V18, P360, DOI 10.1038/nn.3944
   Park CY, 2015, CELL REP, V13, P234, DOI 10.1016/j.celrep.2015.08.084
   Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576
   Patriarchi T, 2016, EUR J HUM GENET, V24, P871, DOI 10.1038/ejhg.2015.216
   Patzke C, 2016, J EXP MED, V213, P499, DOI 10.1084/jem.20150951
   Patzke C, 2015, J CLIN INVEST, V125, P3560, DOI 10.1172/JCI78612
   Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249
   Pfeiffer BE, 2009, NEUROSCIENTIST, V15, P549, DOI 10.1177/1073858409333075
   Piochon C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6586
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Portera-Cailliau C, 2012, NEUROSCIENTIST, V18, P28, DOI 10.1177/1073858410395322
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2016, NAT MED, V22, P1220, DOI 10.1038/nm.4214
   Ricciardi S, 2012, NAT CELL BIOL, V14, P911, DOI 10.1038/ncb2566
   Sahin M, 2012, CURR OPIN NEUROBIOL, V22, P895, DOI 10.1016/j.conb.2012.04.008
   Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215
   Shcheglovitov A, 2013, NATURE, V503, P267, DOI 10.1038/nature12618
   Sheng M, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005777
   Sheridan SD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026203
   Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771
   Silva-Santos S, 2015, J CLIN INVEST, V125, P2069, DOI 10.1172/JCI80554
   Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627
   Stanurova J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30792
   Steinbeck JA, 2016, CELL STEM CELL, V18, P134, DOI 10.1016/j.stem.2015.10.002
   Steinbeck JA, 2015, NAT BIOTECHNOL, V33, P204, DOI 10.1038/nbt.3124
   Stern S, 2018, MOL PSYCHIATR, V23, P1453, DOI 10.1038/mp.2016.260
   Stoner R, 2014, NEW ENGL J MED, V370, P1209, DOI 10.1056/NEJMoa1307491
   Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tang X, 2016, P NATL ACAD SCI USA, V113, P751, DOI 10.1073/pnas.1524013113
   Tang X, 2013, STEM CELL RES, V11, P743, DOI 10.1016/j.scr.2013.05.002
   Telias M, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00121
   Telias M, 2015, J NEUROSCI, V35, P15295, DOI 10.1523/JNEUROSCI.0317-15.2015
   Tian Y, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0075-5
   Tropea D, 2009, P NATL ACAD SCI USA, V106, P2029, DOI 10.1073/pnas.0812394106
   Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736
   Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005
   Vadodaria KC, 2016, MOL PSYCHIATR, V21, P49, DOI 10.1038/mp.2015.161
   Veenstra-VanderWeele J, 2004, MOL PSYCHIATR, V9, P819, DOI 10.1038/sj.mp.4001505
   Verpelli C, 2012, CURR OPIN NEUROBIOL, V22, P530, DOI 10.1016/j.conb.2011.09.007
   Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797
   Volk L, 2015, ANNU REV NEUROSCI, V38, P127, DOI 10.1146/annurev-neuro-071714-033821
   Wallace ML, 2012, NEURON, V74, P793, DOI 10.1016/j.neuron.2012.03.036
   Wang P, 2015, MOL AUTISM, V6, DOI 10.1186/s13229-015-0048-6
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wen ZX, 2014, NATURE, V515, P414, DOI 10.1038/nature13716
   West AE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005744
   Williams EC, 2014, HUM MOL GENET, V23, P2968, DOI 10.1093/hmg/ddu008
   Xu JC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad0623
   Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/nmeth.4291, 10.1038/NMETH.4291]
   Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327
   Yi F, 2016, SCIENCE, V352, DOI 10.1126/science.aaf2669
   Young-Pearse TL, 2016, CURR OPIN NEUROBIOL, V36, P66, DOI 10.1016/j.conb.2015.10.006
   Yu DX, 2014, STEM CELL REP, V2, P295, DOI 10.1016/j.stemcr.2014.01.009
   Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754
   Yung JSY, 2013, EXP CELL RES, V319, P177, DOI 10.1016/j.yexcr.2012.11.007
   Zoghbi HY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009886
NR 157
TC 8
Z9 8
U1 0
U2 6
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-2295
J9 FRONT NEUROL
JI Front. Neurol.
PD APR 16
PY 2018
VL 9
AR 237
DI 10.3389/fneur.2018.00237
PG 15
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GC9JX
UT WOS:000430114400001
PM 29713304
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU King, JG
   Souto-Maior, C
   Sartori, LM
   Maciel-de-Freitas, R
   Gomes, MGM
AF King, Jessica G.
   Souto-Maior, Caetano
   Sartori, Larissa M.
   Maciel-de-Freitas, Rafael
   Gomes, M. Gabriela M.
TI Variation in Wolbachia effects on Aedes mosquitoes as a determinant of
   invasiveness and vectorial capacity
SO NATURE COMMUNICATIONS
LA English
DT Article
ID INFECTION; DENGUE; ESTABLISHMENT; CHIKUNGUNYA
AB Wolbachia has been introduced into Aedes aegypti mosquitoes to control the spread of arboviruses, such as dengue, chikungunya and Zika. Studies showed that certain Wolbachia strains (such as wMel) reduce replication of dengue viruses in the laboratory, prompting the release of mosquitoes carrying the bacterium into the field, where vectorial capacity can be realistically assessed in relation to native non-carriers. Here we apply a new analysis to two published datasets, and show that wMel increases the mean and the variance in Ae. aegypti susceptibility to dengue infection when introgressed into Brazil and Vietnam genetic backgrounds. In the absence of other processes, higher mean susceptibility should lead to enhanced viral transmission. The increase in variance, however, widens the basis for selection imposed by unexplored natural forces, retaining the potential for reducing transmission overall.
C1 [King, Jessica G.; Gomes, M. Gabriela M.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, P-4485661 Vairao, Portugal.
   [Souto-Maior, Caetano] Inst Gulbenkian Ciencias, P-2780156 Oeiras, Portugal.
   [Sartori, Larissa M.] Univ Sao Paulo, Inst Matemat & Estat, BR-05508090 Sao Paulo, Brazil.
   [Maciel-de-Freitas, Rafael] Fundacao Oswaldo Cruz, Lab Transmissores Hematozoarios, IOC, BR-21040900 Rio De Janeiro, Brazil.
   [Gomes, M. Gabriela M.] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
   [King, Jessica G.] Univ Edinburgh, Inst Evolutionary Biol, Sch Biol Sci, Edinburgh EH9 3FL, Midlothian, Scotland.
RP Gomes, MGM (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, P-4485661 Vairao, Portugal.; Gomes, MGM (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.
EM gabriela.gomes@lstmed.ac.uk
RI Gomes, Gabriela/H-7218-2014; Souto-Maior, Caetano/AAG-4111-2020
OI Gomes, Gabriela/0000-0002-1454-4979; Souto-Maior,
   Caetano/0000-0002-0271-2576
FU Portuguese FCTPortuguese Foundation for Science and Technology
   [IF/01346/2014]; Brazilian CAPESCAPES [0775/2014]; AXA Research Fund
FX We thank Ary Hoffmann, Isabel Labouriau and Luciano Moreira for valuable
   discussions. This research was funded by the Portuguese FCT
   (IF/01346/2014), Brazilian CAPES (0775/2014) and AXA Research Fund.
CR Ahmad NA, 2017, AM J TROP MED HYG, V96, P148, DOI 10.4269/ajtmh.16-0516
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079
   [Anonymous], 2017, XINHUA NEWS
   Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672
   Bhatt S., 2003, NATURE, V497, P504
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Dutra HLC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003689
   Dobson B. L., 2017, PLOS NEGLECT TROP D, V11
   Dobson B. L., 2014, PLOS NEGLECT TROP D, V8, pe2955
   Fenton A, 2011, AM NAT, V178, P333, DOI 10.1086/661247
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Gomes MGM, 2016, VACCINE, V34, P3007, DOI 10.1016/j.vaccine.2016.04.065
   Gomes MGM, 2016, J THEOR BIOL, V395, P97, DOI 10.1016/j.jtbi.2016.01.029
   Gomes MGM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003849
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Haas CN, 1999, QUANTITATIVE MICROBI
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hughes GL, 2012, APPL ENVIRON MICROB, V78, P1491, DOI 10.1128/AEM.06751-11
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Langwig KE, 2017, MBIO, V8, DOI 10.1128/mBio.00796-17
   Luz PM, 2009, TROP MED INT HEALTH, V14, P237, DOI 10.1111/j.1365-3156.2008.02203.x
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Nguyen TKT, 2010, T ROY SOC TROP MED H, V104, P592, DOI 10.1016/j.trstmh.2010.06.003
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Patil A, 2010, J STAT SOFTW, V35, P1
   Pessoa D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003773
   Roberts MG, 2003, P ROY SOC B-BIOL SCI, V270, P1359, DOI 10.1098/rspb.2003.2339
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Smith DL, 2005, NATURE, V438, P492, DOI 10.1038/nature04024
   Souto-Maior C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006339
   Souto-Maior C, 2015, THEOR ECOL-NETH, V8, P53, DOI 10.1007/s12080-014-0235-7
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO, 2015, GLOB HLTH OBS LIF EX
   Ypma RJF, 2013, EPIDEMIOLOGY, V24, P395, DOI 10.1097/EDE.0b013e3182878e19
NR 43
TC 20
Z9 20
U1 0
U2 18
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 16
PY 2018
VL 9
AR 1483
DI 10.1038/s41467-018-03981-8
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GC8PD
UT WOS:000430056700015
PM 29662096
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Barzon, L
   Percivalle, E
   Pacenti, M
   Rovida, F
   Zavattoni, M
   Del Bravo, P
   Cattelan, AM
   Palu, G
   Baldanti, F
AF Barzon, Luisa
   Percivalle, Elena
   Pacenti, Monia
   Rovida, Francesca
   Zavattoni, Maurizio
   Del Bravo, Paola
   Cattelan, Anna Maria
   Palu, Giorgio
   Baldanti, Fausto
TI Virus and Antibody Dynamics in Travelers With Acute Zika Virus Infection
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; semen; follow-up; persistence; clearance
ID LINKED IMMUNOSORBENT ASSAYS; WHOLE-BLOOD; DISEASE; VIREMIA; RNA;
   PATHOGENESIS; PERSISTENCE; RHESUS; ISRAEL; SALIVA
AB Background. To improve our understanding of the natural history of Zika virus (ZIKV) infection in humans, we described the dynamics of ZIKV RNA shedding in different body fluids and antibody responses in patients with acute infection.
   Methods. Twenty-nine adults with travel-associated infection and 1 case of sexual transmission were enrolled and followed up with weekly ZIKV RNA testing in blood, urine, saliva, and semen samples and antibody testing.
   Results. ZIKV RNA was detected in plasma, urine, and saliva of 57%, 93.1%, and 69.2% of participants, with estimated median times to clearance of 11.5 days (interquartile range [IQR] 6-24 days), 24 days (IQR, 17-34), and 14 days (IQR, 8-31), respectively. In 2 pregnant women, ZIKV RNA persisted in blood until delivery of apparently healthy infants. ZIKV RNA was detected in semen of 5 of 10 tested men; median time to clearance was 25 days (IQR 14-29), and the longest time of shedding in semen was 370 days. In flavivirus-naive patients, the median times to detection of ZIKV nonstructural protein 1 (NS1)-specific immunoglobulin M (IgM) and immunoglobulin G (IgG) antibodies were estimated as 8 days (IQR, 5-15 days) and 17 days (IQR, 12-26 days), respectively. ZIKV NS1 IgM antibodies were undetectable in patients with previous dengue.
   Conclusions. Prolonged viremia and ZIKV RNA shedding in urine, saliva, and semen occur frequently in patients with acute ZIKV infection. At the time of diagnosis, about half of patients are ZIKV IgM negative. ZIKV NS1 IgM antibodies remain undetectable in patients with previous dengue. Estimates of the times to viral clearance and seroconversion are useful to optimize diagnostic algorithms.
C1 [Barzon, Luisa; Palu, Giorgio] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
   [Barzon, Luisa; Palu, Giorgio] Padova Univ Hosp, Microbiol & Virol Unit, Padua, Italy.
   [Percivalle, Elena; Rovida, Francesca; Zavattoni, Maurizio; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Mol Virol Unit, Pavia, Italy.
   [Del Bravo, Paola] Verona Univ Hosp, Infect Dis Unit, Verona, Italy.
   [Cattelan, Anna Maria] Padova Univ Hosp, Infect Dis Unit, Padua, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, Pavia, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Rovida, Francesca/K-7984-2016; amsalu, ribka/G-8780-2019; CATTELAN, ANNA
   MARIA/AAL-3654-2020; percivalle, elena/K-7994-2016; Barzon,
   Luisa/K-7961-2016; Baldanti, Fausto/J-4924-2018
OI Rovida, Francesca/0000-0003-2345-2790; CATTELAN, ANNA
   MARIA/0000-0003-2869-2945; percivalle, elena/0000-0002-3355-1410;
   Barzon, Luisa/0000-0003-0720-8456; Baldanti, Fausto/0000-0002-3358-8969
FU Veneto Region; Lombardy Region
FX This work was supported by funds from Veneto Region and Lombardy Region.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Barzon L, 2017, LANCET INFECT DIS, V17, P1107, DOI 10.1016/S1473-3099(17)30495-4
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, CLIN MICROBIOL INFEC
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Percivalle E, 2017, NEW MICROBIOL, V40, P197
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
NR 33
TC 42
Z9 42
U1 0
U2 13
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2018
VL 66
IS 8
BP 1173
EP 1180
DI 10.1093/cid/cix967
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GC0BO
UT WOS:000429441600011
PM 29300893
OA Bronze
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   DeBiasi, RL
   du Plessis, AJ
AF Mulkey, Sarah B.
   DeBiasi, Roberta L.
   du Plessis, Adre J.
TI Cerebral infarction due to Zika virus
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Zika virus; Cerebral infarct; Fetal brain; Brain MRI; Vasculitis;
   Pediatric stroke
C1 [Mulkey, Sarah B.; du Plessis, Adre J.] Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
   [DeBiasi, Roberta L.] Childrens Natl Hlth Syst, Div Infect Dis, Washington, DC USA.
   [Mulkey, Sarah B.; DeBiasi, Roberta L.; du Plessis, Adre J.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Microbiol Immunol & Trop Med, Washington, DC 20052 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hlth Syst, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
OI Mulkey, Sarah/0000-0002-8084-526X
FU IKARIA fund
FX The study received support by the IKARIA fund.
CR Acevedo Nathalie, 2017, Front Microbiol, V8, P42, DOI 10.3389/fmicb.2017.00042
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Roach ES, 2012, PEDIATRIC STROKE AND CEREBROVASCULAR DISORDERS, THIRD EDITION, P131
NR 4
TC 2
Z9 2
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD APR 15
PY 2018
VL 387
BP 109
EP 110
DI 10.1016/j.jns.2018.01.032
PG 2
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA GD8PX
UT WOS:000430775700019
PM 29571844
DA 2020-07-08
ER

PT J
AU Tabata, T
   Petitt, M
   Puerta-Guanio, H
   Michlmayr, D
   Harris, E
   Pereira, L
AF Tabata, Takako
   Petitt, Matthew
   Puerta-Guanio, Henry
   Michlmayr, Daniela
   Harris, Eva
   Pereira, Lenore
TI Zika Virus Replicates in Proliferating Cells in Explants From
   First-Trimester Human Placentas, Potential Sites for Dissemination of
   Infection
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; placenta; decidua; congenital infection
ID HOFBAUER CELLS; CYTOMEGALOVIRUS-INFECTION; 1ST TRIMESTER; DENGUE VIRUS;
   ADHESION; CYTOTROPHOBLASTS; DIFFERENTIATION; ACTIVATION; EMERGENCE;
   TROPISM
AB Background. Maternal Zika virus (ZIKV) infection with prolonged viremia leads to fetal infection and congenital Zika syndrome. Previously, we reported that ZIKV infects primary cells from human placentas and fetal membranes. Here, we studied viral replication in numerous explants of anchoring villi and basal decidua from first-trimester human placentas and midgestation amniotic epithelial cells (AmEpCs).
   Methods. Explants and AmEpCs were infected with American and African ZIKV strains at low multiplicities, and ZIKV proteins were visualized by immunofluorescence. Titers of infectious progeny, cell proliferation, and invasiveness were quantified.
   Results. In anchoring villus, ZIKV replicated reproducibly in proliferating cytotrophoblasts in proximal cell columns, dividing Hofbauer cells in villus cores, and invasive cytotrophoblasts, but frequencies differed. Cytotrophoblasts in explants infected by Nicaraguan strains were invasive, whereas those infected by prototype MR766 largely remained in cell columns, and titers varied by donor and strain. In basal decidua, ZIKV replicated in glandular epithelium, decidual cells, and immune cells. ZIKV-infected AmEpCs frequently occurred in pairs and expressed Ki67 and phosphohistone H3, indicating replication in dividing cells.
   Conclusions. ZIKV infection in early pregnancy could target proliferating cell column cytotrophoblasts and Hofbauer cells, amplifying infection in basal decidua and chorionic villi and enabling transplacental transmission.
C1 [Tabata, Takako; Petitt, Matthew; Pereira, Lenore] Univ Calif San Francisco, Sch Dent, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
   [Puerta-Guanio, Henry; Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
RP Pereira, L (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.
EM lenore.pereira@ucsf.edu
RI Michlmayr, Daniela/Q-1216-2018
FU NIH Institute for Allergy and Infectious Diseases [RO1AI04667, R21
   AI129508, RO1AI124493]
FX This work was supported by grants from the NIH Institute for Allergy and
   Infectious Diseases: RO1AI04667 (L. P.), R21 AI129508 (L. P., E. H.),
   and RO1AI124493 (E. H.).
CR Anteby EY, 2005, PLACENTA, V26, P476, DOI 10.1016/j.placenta.2004.08.008
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Castellucci M, 2000, HUM REPROD UPDATE, V6, P485, DOI 10.1093/humupd/6.5.485
   CASTELLUCCI M, 1987, PLACENTA, V8, P65, DOI 10.1016/0143-4004(87)90040-3
   Copeman J, 2000, BIOL REPROD, V62, P1543, DOI 10.1095/biolreprod62.6.1543
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   DAMSKY CH, 1992, J CLIN INVEST, V89, P210, DOI 10.1172/JCI115565
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Genbacev O, 2015, PLACENTA, V36, P716, DOI 10.1016/j.placenta.2015.05.002
   Genbacev OD, 2003, SCIENCE, V299, P405, DOI 10.1126/science.1079546
   Genbacev O, 2011, STEM CELLS, V29, P1427, DOI 10.1002/stem.686
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Ingman K, 2010, PLACENTA, V31, P535, DOI 10.1016/j.placenta.2010.03.003
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LIBRACH CL, 1991, J CELL BIOL, V113, P437, DOI 10.1083/jcb.113.2.437
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MCMASTER MT, 1995, J IMMUNOL, V154, P3771
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nozawa N, 2009, J CLIN VIROL, V46, pS58, DOI 10.1016/j.jcv.2009.10.004
   Ornelas AMM, 2017, ANN NEUROL, V81, P152, DOI 10.1002/ana.24839
   Pereira L, 2014, J INFECT DIS, V209, P1573, DOI 10.1093/infdis/jiu019
   Prakobphol A, 2006, DEV BIOL, V298, P107, DOI 10.1016/j.ydbio.2006.06.020
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Seval Y, 2007, PLACENTA, V28, P841, DOI 10.1016/j.placenta.2007.01.010
   Tabata T, 2007, PLACENTA, V28, P527, DOI 10.1016/j.placenta.2006.05.006
   Tabata T, 2008, AM J PATHOL, V172, P1127, DOI 10.2353/ajpath.2008.070448
   Tabata T, 2016, AM J PATHOL, V186, P2970, DOI 10.1016/j.ajpath.2016.07.016
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Tabata T, 2012, AM J PATHOL, V181, P1540, DOI 10.1016/j.ajpath.2012.08.003
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weisblum Y, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01905-16
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Yamamoto-Tabata T, 2004, J VIROL, V78, P2831, DOI 10.1128/JVI.78.6.2831-2840.2004
   Young OM, 2015, AM J REPROD IMMUNOL, V73, P22, DOI 10.1111/aji.12336
   Zhou Y, 1997, J CLIN INVEST, V99, P2139, DOI 10.1172/JCI119387
NR 49
TC 16
Z9 16
U1 1
U2 7
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 15
PY 2018
VL 217
IS 8
BP 1202
EP 1213
DI 10.1093/infdis/jix552
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GD7YG
UT WOS:000430728700006
PM 29106643
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Munoz
AF Munoz
TI Neurological Implications of Zika Virus in the Adult Population (vol
   216, pg S897, 2017)
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Correction
CR Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
NR 1
TC 0
Z9 0
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 15
PY 2018
VL 217
IS 8
BP 1334
EP 1334
DI 10.1093/infdis/jix691
PG 1
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GD7YG
UT WOS:000430728700021
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Simmons, G
   Stone, M
   Busch, MP
AF Simmons, Graham
   Stone, Mars
   Busch, Michael P.
TI Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus
   Vaccination and Zika Virus Epidemics
SO CLINICAL INFECTIOUS DISEASES
LA English
DT Editorial Material
DE dengue; Zika; diagnostics; serology; arbovirus
ID INFECTION; IMMUNOASSAYS; ANTIBODIES; RNA
C1 [Simmons, Graham; Stone, Mars; Busch, Michael P.] Univ Calif San Francisco, Blood Syst Res Inst, San Francisco, CA 94143 USA.
   [Simmons, Graham; Stone, Mars; Busch, Michael P.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.
RP Busch, MP (corresponding author), Blood Syst Res Inst, 270 Masonic Ave, San Francisco, CA 94118 USA.
EM mbusch@bloodsystems.org
RI Simmons, Graham/G-3523-2012
OI Simmons, Graham/0000-0002-9615-7023; Stone, Mars/0000-0001-5619-2767
FU Grifols; National Heart, Lung, and Blood Institute Recipient
   Epidemiology and Donor Evaluation Study-III [HHSN268201100001I]; Roche
   Diagnostics
FX All authors received financial support from Grifols and Roche
   Diagnostics and nonfinancial support from Abbott Diagnostics related to
   the contents of this article. The authors Zika virus and Dengue virus
   research is supported by the National Heart, Lung, and Blood Institute
   Recipient Epidemiology and Donor Evaluation Study-III contract
   HHSN268201100001I.
CR Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Coloma J, 2015, NAT IMMUNOL, V16, P135, DOI 10.1038/ni.3081
   Hunsperger EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005719
   Kochel TJ, 2005, J INFECT DIS, V191, P1000, DOI 10.1086/427511
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lustig Y, 2016, EURO SURVEILL, V21
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tsai WY, 2017, CLIN INFECT DIS
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 19
TC 3
Z9 3
U1 1
U2 5
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1058-4838
EI 1537-6591
J9 CLIN INFECT DIS
JI Clin. Infect. Dis.
PD APR 15
PY 2018
VL 66
IS 8
BP 1181
EP 1183
DI 10.1093/cid/cix972
PG 3
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA GC0BO
UT WOS:000429441600012
PM 29301009
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Shah, SK
   Kimmelman, J
   Lyerly, AD
   Lynch, HF
   Miller, FG
   Palacios, R
   Pardo, CA
   Zorrilla, C
AF Shah, S. K.
   Kimmelman, J.
   Lyerly, A. D.
   Lynch, H. F.
   Miller, F. G.
   Palacios, R.
   Pardo, C. A.
   Zorrilla, C.
TI Bystander risk, social value, and ethics of human research
SO SCIENCE
LA English
DT Editorial Material
ID NOVEMBER 2016; ZIKA VIRUS
C1 [Shah, S. K.] Univ Washington, Seattle, WA 98195 USA.
   [Shah, S. K.] Seattle Childrens Res Inst, Seattle, WA 98101 USA.
   [Kimmelman, J.] McGill Univ, Montreal, PQ, Canada.
   [Lyerly, A. D.] Univ North Carolina Chapel Hill, Chapel Hill, NC USA.
   [Lynch, H. F.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA.
   [Miller, F. G.] Weill Cornell Med Coll, New York, NY USA.
   [Palacios, R.] Inst Butantan, Sao Paulo, Brazil.
   [Pardo, C. A.] Johns Hopkins Univ, Baltimore, MD USA.
   [Zorrilla, C.] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA.
RP Shah, SK (corresponding author), Univ Washington, Seattle, WA 98195 USA.; Shah, SK (corresponding author), Seattle Childrens Res Inst, Seattle, WA 98101 USA.
EM shahsk@uw.edu
RI Pardo, Carlos A./A-5192-2008; Palacios, Ricardo/AAN-7606-2020
OI Pardo, Carlos A./0000-0002-4128-5335; Palacios,
   Ricardo/0000-0002-1410-8579
CR Abbott L, 2011, J EMPIR RES HUM RES, V6, P3, DOI 10.1525/jer.2011.6.1.3
   Bambery B, 2016, PUBLIC HEALTH ETH-UK, V9, P92, DOI 10.1093/phe/phv026
   Beavogui AH, 2016, CLIN TRIALS, V13, P73, DOI 10.1177/1740774515619877
   Etienne C, 2017, AM J TROP MED HYG, V97, P16, DOI 10.4269/ajtmh.17-0207
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Hooker C, 2017, PUBLIC HEALTH RES PR, V27, DOI 10.17061/phrp2711709
   Institute of Medicine, 2005, ETH CONS RES HOUS RE, P132
   Kimmelman J, 2007, CAMB Q HEALTHC ETHIC, V16, P483, DOI 10.1017/S0963180107070648
   Lawrence D, 2017, J VIRUS ERAD, V3, P69
   Lo B, 2009, JAMA-J AM MED ASSOC, V302, P2697, DOI 10.1001/jama.2009.1917
   Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203
   National Academies of Sciences Engineering and Medicine, 2016, MIT REPL TECHN ETH S
   Shah SK, 2017, ETHICAL CONSIDERATIO
NR 14
TC 12
Z9 12
U1 0
U2 12
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
EI 1095-9203
J9 SCIENCE
JI Science
PD APR 13
PY 2018
VL 360
IS 6385
BP 158
EP 159
DI 10.1126/science.aaq0917
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GC5DK
UT WOS:000429805400029
PM 29650663
DA 2020-07-08
ER

PT J
AU He, M
   Zhang, HN
   Li, YJ
   Wang, GS
   Tang, BS
   Zhao, J
   Huang, YL
   Zheng, JL
AF He, Miao
   Zhang, Hainan
   Li, Yuju
   Wang, Guangshun
   Tang, Beisha
   Zhao, Jeffrey
   Huang, Yunlong
   Zheng, Jialin
TI Cathelicidin-Derived Antimicrobial Peptides Inhibit Zika Virus Through
   Direct Inactivation and Interferon Pathway
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE antimicrobial peptides; Zika virus; innate immunity; cathelicidins;
   plaque-forming assays
ID GUILLAIN-BARRE-SYNDROME; SMALL-MOLECULE INHIBITORS;
   HERPES-SIMPLEX-VIRUS; ANTIVIRAL ACTIVITY; IN-VITRO; LL-37;
   IDENTIFICATION; INFECTION; MECHANISMS; VACCINE
AB Zika virus (ZIKV) is a neurotrophic flavivirus that is able to infect pregnant women and cause fetal brain abnormalities. Although there is a significant effort in identifying anti-ZIKV strategies, currently no vaccines or specific therapies are available to treat ZIKV infection. Antimicrobial peptides, which are potent host defense molecules in nearly all forms of life, have been found to be effective against several types of viruses such as HIV-1 and influenza A. However, they have not been tested in ZIKV infection. To determine whether antimicrobial peptides have anti-ZIKV effects, we used nine peptides mostly derived from human and bovine cathelicidins. Two peptides, GF-17 and BMAP-18, were found to have strong anti-ZIKV activities and little toxicity at 10 mu M in an African green monkey kidney cell line. We further tested GF-17 and BMAP-18 in human fetal astrocytes, a known susceptible cell type for ZIKV, and found that GF-17 and BMAP-18 effectively inhibited ZIKV regardless of whether peptides were added before or after ZIKV infection. Interestingly, inhibition of type-I interferon signaling resulted in higher levels of ZIKV infection as measured by viral RNA production and partially reversed GF-17-mediated viral inhibition. More importantly, pretreatment with GF-17 and BMAP-18 did not affect viral attachment but reduced viral RNA early in the infection course. Direct incubation with GF-17 for 1 to 4 h specifically reduced the number of infectious Zika virions in the inoculum. In conclusion, these findings suggest that cathelicidin-derived antimicrobial peptides inhibit ZIKV through direct inactivation of the virus and via the interferon pathway. Strategies that harness antimicrobial peptides might be useful in halting ZIKV infection.
C1 [He, Miao; Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.
   [He, Miao; Zhang, Hainan; Li, Yuju; Zhao, Jeffrey; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Zhang, Hainan] Cent S Univ, Xiangya Hosp 2, Dept Neurol, Changsha, Hunan, Peoples R China.
   [Li, Yuju; Huang, Yunlong; Zheng, Jialin] Tongji Univ, Shanghai Peoples Hosp 10, Ctr Translat Neurodegenerat & Regenerat Therapy, Sch Med, Shanghai, Peoples R China.
   [Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
   [Tang, Beisha] Natl Clin Res Ctr Geriatr Dis, Changsha, Hunan, Peoples R China.
   [Tang, Beisha] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China.
RP Huang, YL; Zheng, JL (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.; Huang, YL; Zheng, JL (corresponding author), Tongji Univ, Shanghai Peoples Hosp 10, Ctr Translat Neurodegenerat & Regenerat Therapy, Sch Med, Shanghai, Peoples R China.; Zheng, JL (corresponding author), Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE 68198 USA.
EM yhuan1@unmc.edu; jialinzheng@tongji.edu.cn
RI Huang, Yunlong/J-6554-2015
OI Huang, Yunlong/0000-0002-3328-1924
FU National Key Basic Research Program of China (973Program)National Basic
   Research Program of China [2014CB-965000, 2014CB965001, 2014C-B965003];
   National Key Plan for Scientific Research and development of China
   [2016YFC1306000]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81430023]; Innovative Research
   Groups of the National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81221001]; Joint Research Fund for
   Overseas Chinese, Hong Kong and Macao Young Scientists of the National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81329002]; National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [R01 AI105147, 2R56-NS041858-15A1, 1R01NS097195-01, R03
   NS094071-01]
FX This work was supported by grants from National Key Basic Research
   Program of China (973Program Grant No. 2014CB-965000, project 1 No.
   2014CB965001, and project 3No. 2014CB-965003 to JZ); National Key Plan
   for Scientific Research and development of China (2016YFC1306000 to BT);
   National Natural Science Foundation of China (81430023 to BT);
   Innovative Research Groups of the National Natural Science Foundation of
   China (#81221001 to JZ); Joint Research Fund for Overseas Chinese, Hong
   Kong and Macao Young Scientists of the National Natural Science
   Foundation of China (#81329002 to JZ); and National Institutes of
   Health: R01 AI105147 (to GW), 2R56-NS041858-15A1 (to JZ),
   1R01NS097195-01 (to JZ), and R03 NS094071-01 (to YH).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   [Anonymous], 2017, ZIK VIR COUNTR CLASS
   Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baxter AA, 2017, CELL MOL LIFE SCI, V74, P3809, DOI 10.1007/s00018-017-2604-z
   Belaid A, 2002, J MED VIROL, V66, P229, DOI 10.1002/jmv.2134
   Benincasa M, 2003, PEPTIDES, V24, P1723, DOI 10.1016/j.peptides.2003.07.025
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Currie SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073659
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gazit E, 1996, J MOL BIOL, V258, P860, DOI 10.1006/jmbi.1996.0293
   Ghorpade A, 2003, J NEUROIMMUNOL, V141, P141, DOI 10.1016/S0165-5728(03)00222-4
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Gudmundsson GH, 1996, EUR J BIOCHEM, V238, P325, DOI 10.1111/j.1432-1033.1996.0325z.x
   Hou M, 2013, CELL PHYSIOL BIOCHEM, V32, P614, DOI 10.1159/000354465
   Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763
   Huang YL, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0017-2
   Huang YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005397
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Li X, 2006, J AM CHEM SOC, V128, P5776, DOI 10.1021/ja0584875
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lorin C, 2005, VIROLOGY, V334, P264, DOI 10.1016/j.virol.2005.02.002
   Matanic VCA, 2004, INT J ANTIMICROB AG, V23, P382, DOI 10.1016/j.ijantimicag.2003.07.022
   Menousek J, 2012, INT J ANTIMICROB AG, V39, P402, DOI 10.1016/j.ijantimicag.2012.02.003
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pan American Health Organization World Health Organization, 2016, EP UPD NEUR SYNDR CO
   Pardi N, 2017, METHODS MOL BIOL, V1499, P109, DOI 10.1007/978-1-4939-6481-9_6
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Skerlavaj B, 1996, J BIOL CHEM, V271, P28375, DOI 10.1074/jbc.271.45.28375
   Tripathi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124706
   Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wang GS, 2008, J BIOL CHEM, V283, P32637, DOI 10.1074/jbc.M805533200
   Wang GS, 2008, ANTIMICROB AGENTS CH, V52, P3438, DOI 10.1128/AAC.00452-08
   Wang GS, 2016, NUCLEIC ACIDS RES, V44, pD1087, DOI 10.1093/nar/gkv1278
   Wang GS, 2014, ACS CHEM BIOL, V9, P1997, DOI 10.1021/cb500475y
   Wang GS, 2014, PHARMACEUTICALS, V7, P545, DOI 10.3390/ph7050545
   Wang GS, 2012, ANTIMICROB AGENTS CH, V56, P845, DOI 10.1128/AAC.05637-11
   Wang GS, 2010, ANTIMICROB AGENTS CH, V54, P1343, DOI 10.1128/AAC.01448-09
   Wang XQ, 2018, ADV BIOSYST, V2, DOI 10.1002/adbi.201700259
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457
   Zanetti M, 1997, ANN NY ACAD SCI, V832, P147, DOI 10.1111/j.1749-6632.1997.tb46244.x
   Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a
   Zheng JL, 1999, J NEUROIMMUNOL, V98, P185, DOI 10.1016/S0165-5728(99)00049-1
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 72
TC 21
Z9 21
U1 1
U2 10
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 12
PY 2018
VL 9
AR 722
DI 10.3389/fimmu.2018.00722
PG 12
WC Immunology
SC Immunology
GA GC5HZ
UT WOS:000429819500001
PM 29706959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mead, PS
   Duggal, NK
   Hook, SA
   Delorey, M
   Fischer, M
   McGuire, DO
   Becksted, H
   Max, RJ
   Anishchenko, M
   Schwartz, AM
   Tzeng, WP
   Nelson, CA
   McDonald, EM
   Brooks, JT
   Brault, AC
   Hinckley, AF
AF Mead, Paul S.
   Duggal, Nisha K.
   Hook, Sarah A.
   Delorey, Mark
   Fischer, Marc
   McGuire, Dana Olzenak
   Becksted, Heidi
   Max, Ryan J.
   Anishchenko, Michael
   Schwartz, Amy M.
   Tzeng, Wen-Pin
   Nelson, Christina A.
   McDonald, Erin M.
   Brooks, John T.
   Brault, Aaron C.
   Hinckley, Alison F.
TI Zika Virus Shedding in Semen of Symptomatic Infected Men
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Article
ID MALE SEXUAL TRANSMISSION; UPDATE INTERIM GUIDANCE; UNITED-STATES; RNA;
   PERSISTENCE; PREVENTION
AB BACKGROUND
   Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has been linked to adverse birth outcomes. Previous reports have shown that person-to-person transmission can occur by means of sexual contact.
   METHODS
   We conducted a prospective study involving men with symptomatic ZIKV infection to determine the frequency and duration of ZIKV shedding in semen and urine and to identify risk factors for prolonged shedding in these fluids. Specimens were obtained twice per month for 6 months after illness onset and were tested by real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay for ZIKV RNA and by Vero cell culture and plaque assay for infectious ZIKV.
   RESULTS
   A total of 1327 semen samples from 184 men and 1038 urine samples from 183 men were obtained 14 to 304 days after illness onset. ZIKV RNA was detected in the urine of 7 men (4%) and in the semen of 60 (33%), including in semen samples from 22 of 36 men (61%) who were tested within 30 days after illness onset. ZIKV RNA shedding in semen decreased substantially during the 3 months after illness onset but continued for 281 days in 1 man (1%). Factors that were independently associated with prolonged RNA shedding included older age, less frequent ejaculation, and the presence of certain symptoms at the time of initial illness. Infectious ZIKV was isolated from 3 of 78 semen samples with detectable ZIKV RNA, all obtained within 30 days after illness onset and all with at least 7.0 log 10 ZIKV RNA copies per milliliter of semen.
   CONCLUSIONS
   ZIKV RNA was commonly present in the semen of men with symptomatic ZIKV infection and persisted in some men for more than 6 months. In contrast, shedding of infectious ZIKV appeared to be much less common and was limited to the first few weeks after illness onset.
C1 [Mead, Paul S.; Duggal, Nisha K.; Hook, Sarah A.; Delorey, Mark; Fischer, Marc; Becksted, Heidi; Max, Ryan J.; Anishchenko, Michael; Schwartz, Amy M.; Tzeng, Wen-Pin; Nelson, Christina A.; McDonald, Erin M.; Brault, Aaron C.; Hinckley, Alison F.] Ctr Dis Control & Prevent CDC, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA.
   [McGuire, Dana Olzenak] CDC Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA.
   [Brooks, John T.] CDC Natl Ctr HIV AIDS Viral Hepatitis STD & TB Pr, Atlanta, GA USA.
RP Mead, PS (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, 3156 Rampart Rd, Ft Collins, CO 80521 USA.
EM pmead@cdc.gov
FU Centers for Disease Control and PreventionUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX Funded by the Centers for Disease Control and Prevention.
CR [Anonymous], 2016, ZIK VIR DIS NONC INF
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frank C, 2016, EUROPEAN COMMUNICABL, V2016, P21, DOI DOI 10.2807/1560-7917
   Freour T, 2016, EUROSURVEILLANCE, V21, P23
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Jang HC, 2016, J KOREAN MED SCI, V31, P1173, DOI 10.3346/jkms.2016.31.7.1173
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P323, DOI 10.15585/mmwr.mm6512e3
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rowland A, 2016, J ASSIST REPROD GEN, V33, P435, DOI 10.1007/s10815-016-0684-6
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.00172-17
   WHO, 2017, SIT REP
   WHO, 2016, PREV SEX TRANSM ZIK
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 38
TC 59
Z9 61
U1 2
U2 5
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 12
PY 2018
VL 378
IS 15
BP 1377
EP 1385
DI 10.1056/NEJMoa1711038
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA GC3YA
UT WOS:000429718500004
PM 29641964
OA Bronze
DA 2020-07-08
ER

PT J
AU Tsujimoto, H
   Anderson, MAE
   Myles, KM
   Adelman, ZN
AF Tsujimoto, Hitoshi
   Anderson, Michelle A. E.
   Myles, Kevin M.
   Adelman, Zach N.
TI Identification of Candidate Iron Transporters From the ZIP/ZnT Gene
   Families in the Mosquito Aedes aegypti
SO FRONTIERS IN PHYSIOLOGY
LA English
DT Article
DE Aedes; iron transporter; ZIP; ZnT; ferritin
ID MALPIGHIAN TUBULES; DROSOPHILA-MELANOGASTER; NATURAL-RESISTANCE;
   MALVOLIO; HOMOLOG; PROTEIN; INSECT; NRAMP; HOMEOSTASIS; INFECTION
AB Mosquito-transmitted viral pathogens, such as dengue and Zika, afflict tens of thousands of people every year. These viruses are transmitted during the blood-feeding process that is required for mosquito reproduction, the most important vector being Aedes aegypti. While vertebrate blood is rich in protein, its high iron content is potentially toxic to mosquitoes. Although iron transport and sequestration are essential in the reproduction of vector mosquitoes, we discovered that culicine mosquitoes lack homologs of the common iron transporter NRAMP. Using a novel cell-based screen, we identified two ZIP and one ZnT genes as candidate iron transporters in the mosquito A. aegypti, the vector of dengue, Zika, and chikungunya. We determined the organ-specific expression pattern of these genes at critical time points in early reproduction. The result indicates modulation of these genes upon blood feeding, especially a ZIP13 homolog that is highly up-regulated after blood feeding, suggesting its importance in iron mobilization during blood digestion and reproduction. Gene silencing resulted in differential iron accumulation in the midgut and ovaries. This study sets a foundation for further investigation of iron transport and control strategies of this viral vector.
C1 [Tsujimoto, Hitoshi; Myles, Kevin M.; Adelman, Zach N.] Texas A&M Univ, Dept Entomol & Agrilife Res, College Stn, TX 77843 USA.
   [Anderson, Michelle A. E.] Virginia Tech, Dept Entomol, Blacksburg, VA USA.
   [Anderson, Michelle A. E.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA USA.
RP Adelman, ZN (corresponding author), Texas A&M Univ, Dept Entomol & Agrilife Res, College Stn, TX 77843 USA.
EM zachadel@tamu.edu
FU National Institute of Allergies and Infectious Diseases of the National
   Institutes of Health [AI115138]
FX This study was supported by the National Institute of Allergies and
   Infectious Diseases of the National Institutes of Health under award
   number AI115138.
CR Ben-Shahar Y, 2004, J EXP BIOL, V207, P3281, DOI 10.1242/jeb.01151
   Beyenbach KW, 2010, ANNU REV ENTOMOL, V55, P351, DOI 10.1146/annurev-ento-112408-085512
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cabrera AR, 2014, ARCH INSECT BIOCHEM, V85, P61, DOI 10.1002/arch.21143
   Chintapalli V. R., 2010, RE FLYATLAS SURVEY A
   Folwell JL, 2006, J EXP BIOL, V209, P1988, DOI 10.1242/jeb.02193
   Fretz M, 2006, J CONTROL RELEASE, V116, P247, DOI 10.1016/j.jconrel.2006.07.009
   Garrick MD, 2011, GENES NUTR, V6, P45, DOI 10.1007/s12263-010-0184-8
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Haac ME, 2015, NUCLEIC ACIDS RES, V43, P3688, DOI 10.1093/nar/gkv152
   Hennessey M., 2015, CTR DIS CONTROL PREV, V65, P55, DOI DOI 10.15585/MMWR.MM6503E1
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Li YY, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00283
   Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530
   Lye JC, 2012, J EXP BIOL, V215, P3254, DOI 10.1242/jeb.069260
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Martinez-Barnetche J, 2007, INSECT BIOCHEM MOLEC, V37, P532, DOI 10.1016/j.ibmb.2007.02.009
   Mehlferber EC, 2017, G3-GENES GENOM GENET, V7, P3393, DOI 10.1534/g3.117.300183
   Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105
   Navarro JA, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00223
   Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007
   Orgad S, 1998, J EXP BIOL, V201, P115
   Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037
   Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004
   Pham DQD, 2005, INSECT MOL BIOL, V14, P263, DOI 10.1111/j.1365-2583.2005.00556.x
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Richards CD, 2016, ARCH BIOCHEM BIOPHYS, V611, P142, DOI 10.1016/j.abb.2016.07.015
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Southon A, 2008, J EXP BIOL, V211, P709, DOI 10.1242/jeb.014159
   Sovik E, 2017, GENES BRAIN BEHAV, V16, P506, DOI 10.1111/gbb.12375
   Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197
   Tang XN, 2013, IUBMB LIFE, V65, P863, DOI 10.1002/iub.1211
   Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596
   VIDAL SM, 1993, CELL, V73, P469, DOI 10.1016/0092-8674(93)90135-D
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xiao GR, 2014, ELIFE, V3, DOI 10.7554/eLife.03191
   Yu Y, 2013, J NUTR BIOCHEM, V24, P1697, DOI 10.1016/j.jnutbio.2013.02.010
   Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009
NR 40
TC 5
Z9 5
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-042X
J9 FRONT PHYSIOL
JI Front. Physiol.
PD APR 12
PY 2018
VL 9
AR 380
DI 10.3389/fphys.2018.00380
PG 10
WC Physiology
SC Physiology
GA GC5LV
UT WOS:000429830000002
PM 29706902
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Feldmann, H
AF Feldmann, Heinz
TI Virus in Semen and the Risk of Sexual Transmission
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Editorial Material
ID ZIKA VIRUS; EBOLA
C1 [Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.
RP Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT 59840 USA.
FU Intramural NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [Z99 AI999999]
CR Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Caswell RJ, 2017, INT J STD AIDS, V28, P1352, DOI 10.1177/0956462417703572
   Fischer WA, 2016, CLIN INFECT DIS, V62, P1272, DOI 10.1093/cid/ciw123
   Kainulainen MH, 2017, J INFECT DIS, V216, P1380, DOI 10.1093/infdis/jix486
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Raabe VN, 2017, CLIN INFECT DIS, V65, P855, DOI 10.1093/cid/cix406
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   WHO, 2016, INT ADV SEX TRANSM E
   WHO, 2016, PREV SEX TRANSM ZIK
NR 10
TC 7
Z9 7
U1 0
U2 8
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 12
PY 2018
VL 378
IS 15
BP 1440
EP 1441
DI 10.1056/NEJMe1803212
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA GC3YA
UT WOS:000429718500009
PM 29641967
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Desclaux, A
   de Lamballerie, X
   Leparc-Goffart, I
   Vilain-Parce, A
   Coatleven, F
   Fleury, H
   Malvy, D
AF Desclaux, Arnaud
   de lamballerie, Xavier
   Leparc-Goffart, Isabelle
   Vilain-Parce, Alice
   Coatleven, Frederic
   Fleury, Herve
   Malvy, Denis
TI Probable Sexually Transmitted Zika Virus Infection in a Pregnant Woman
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Letter
ID VIREMIA
C1 [Desclaux, Arnaud; Vilain-Parce, Alice; Coatleven, Frederic; Fleury, Herve; Malvy, Denis] Bordeaux Univ Hosp, Bordeaux, France.
   [de lamballerie, Xavier] Univ Aix Marseille, Marseille, France.
   [Leparc-Goffart, Isabelle] French Armed Forces Biomed Res Inst, Marseille, France.
RP Malvy, D (corresponding author), Bordeaux Univ Hosp, Bordeaux, France.
EM denis.malvy@chu-bordeaux.fr
RI MALVY, Denis/T-7930-2019
CR Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
NR 5
TC 11
Z9 11
U1 0
U2 0
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD APR 12
PY 2018
VL 378
IS 15
BP 1458
EP 1460
DI 10.1056/NEJMc1710453
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA GC3YA
UT WOS:000429718500014
PM 29641959
OA Bronze
DA 2020-07-08
ER

PT J
AU Melo, CFOR
   Navarro, LC
   de Oliveira, DN
   Guerreiro, TM
   Lima, ED
   Delafiori, J
   Dabaja, MZ
   Ribeiro, MD
   de Menezes, M
   Rodrigues, RGM
   Morishita, KN
   Esteves, CZ
   de Amorim, ALL
   Aoyagui, CT
   Parise, PL
   Milanez, GP
   do Nascimento, GM
   Freitas, ARR
   Angerami, R
   Costa, FTM
   Arns, CW
   Resende, MR
   Amaral, E
   Passini, R
   Ribeiro-do-Valle, CC
   Milanez, H
   Moretti, ML
   Proenca-Modena, JL
   Avila, S
   Rocha, A
   Catharino, RR
AF Odir Rodrigues Melo, Carlos Fernando
   Navarro, Luiz Claudio
   de Oliveira, Diogo Noin
   Guerreiro, Tatiane Melina
   Lima, Estela de Oliveira
   Delafiori, Jeany
   Dabaja, Mohamed Ziad
   Ribeiro, Marta da Silva
   de Menezes, Maico
   Martins Rodrigues, Rafael Gustavo
   Morishita, Karen Noda
   Esteves, Cibele Zanardi
   Lucas de Amorim, Aline Lopes
   Aoyagui, Caroline Tiemi
   Parise, Pierina Lorencini
   Milanez, Guilherme Paier
   do Nascimento, Gabriela Mansano
   Ribas Freitas, Andre Ricardo
   Angerami, Rodrigo
   Maranhao Costa, Fabio Trindade
   Arns, Clarice Weis
   Resende, Mariangela Ribeiro
   Amaral, Eliana
   Passini Junior, Renato
   Ribeiro-do-Valle, Carolina C.
   Milanez, Helaine
   Moretti, Maria Luiza
   Proenca-Modena, Jose Luiz
   Avila, Sandra
   Rocha, Anderson
   Catharino, Rodrigo Ramos
CA Zika-Unicamp Network
TI A Machine Learning Application Based in Random Forest for Integrating
   Mass Spectrometry-Based Metabolomic Data: A Simple Screening Method for
   Patients With Zika Virus
SO FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
LA English
DT Article
AB Recent Zika outbreaks in South America, accompanied by unexpectedly severe clinical complications have brought much interest in fast and reliable screening methods for ZIKV (Zika virus) identification. Reverse-transcriptase polymerase chain reaction (RT-PCR) is currently the method of choice to detect ZIKV in biological samples. This approach, none-theless, demands a considerable amount of time and resources such as kits and reagents that, in endemic areas, may result in a substantial financial burden over affected individuals and health services veering away from RT-PCR analysis. This study presents a powerful combination of high-resolution mass spectrometry and a machine-learning prediction model for data analysis to assess the existence of ZIKV infection across a series of patients that bear similar symptomatic conditions, but not necessarily are infected with the disease. By using mass spectrometry data that are inputted wrth the developed decision-making algorithm, we were able to provide a set of features that work as a "fingerprint" for this specific pathophysiological condition, even after the acute phase of infection. Since both mass spectrometry and machine learning approaches are well-established and have largely utilized tools within their respective fields, this combination of methods emerges as a distinct alternative for clinical applications, providing a diagnostic screening-faster and more accurate-with improved cost-effectiveness when compared to existing technologies.
C1 [Odir Rodrigues Melo, Carlos Fernando; de Oliveira, Diogo Noin; Guerreiro, Tatiane Melina; Lima, Estela de Oliveira; Delafiori, Jeany; Dabaja, Mohamed Ziad; Ribeiro, Marta da Silva; de Menezes, Maico; Martins Rodrigues, Rafael Gustavo; Morishita, Karen Noda; Esteves, Cibele Zanardi; Lucas de Amorim, Aline Lopes; Aoyagui, Caroline Tiemi; Catharino, Rodrigo Ramos] Univ Estadual Campinas, Sch Phannaceut Sci FCF, Innovate Biomarkers Lab, Campinas, SP, Brazil.
   [Navarro, Luiz Claudio; Avila, Sandra; Rocha, Anderson] Univ Estadual Campinas, IC, RECOD Lab, Campinas, SP, Brazil.
   [Parise, Pierina Lorencini; Milanez, Guilherme Paier; do Nascimento, Gabriela Mansano; Maranhao Costa, Fabio Trindade; Arns, Clarice Weis; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Biol Inst, Dept Genet Evolut Microbiol & Immunol, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Campinas Dept Publ Hlth Surveillance, Campinas, SP, Brazil.
   [Ribas Freitas, Andre Ricardo] Sao Leopoldo Mandic Inst & Res Ctr, Campinas, SP, Brazil.
   [Angerami, Rodrigo; Resende, Mariangela Ribeiro; Moretti, Maria Luiza] Univ Estadual Campinas, Sch Med Sci, Clin Pathol Dept, Campinas, SP, Brazil.
   [Amaral, Eliana; Passini Junior, Renato; Ribeiro-do-Valle, Carolina C.; Milanez, Helaine] Univ Campinas Campinas, Sch Med Sci, Obstet & Gynecol Dept, Campinas, SP, Brazil.
RP Catharino, RR (corresponding author), Univ Estadual Campinas, Sch Phannaceut Sci FCF, Innovate Biomarkers Lab, Campinas, SP, Brazil.
EM rrc@g.unicamp.br
RI de Oliveira Lima, Estela/G-7375-2015; de Souza Barnabe, Ana
   Caroline/AAJ-9487-2020; Resende, Mariangela/U-9938-2019; Angerami,
   Rodrigo Nogueira/A-8926-2013; Freitas, Andre Ricardo Ribas/L-1969-2016;
   de Oliveira, Diogo Noin/C-3939-2013; Lima, Estela/W-5105-2019; Modena,
   Jose Luiz Proenca/C-8231-2014; Milanez, Guilherme/G-6457-2016; Judice,
   Carla/P-4738-2014
OI de Oliveira Lima, Estela/0000-0003-0479-0364; de Souza Barnabe, Ana
   Caroline/0000-0002-8481-8226; Angerami, Rodrigo
   Nogueira/0000-0002-4976-9238; Freitas, Andre Ricardo
   Ribas/0000-0003-0291-7771; de Oliveira, Diogo Noin/0000-0002-2725-476X;
   Lima, Estela/0000-0003-0479-0364; Modena, Jose Luiz
   Proenca/0000-0002-4996-3153; Milanez, Guilherme/0000-0002-8599-1098;
   Judice, Carla/0000-0003-1839-053X; Vinolo, Marco
   Aurelio/0000-0003-1335-760X; Navarro, Luiz C./0000-0002-8041-8743; Melo,
   Carlos/0000-0003-0334-1065; Avila, Sandra/0000-0001-9068-938X;
   Guerreiro, Tatiane/0000-0002-4114-1243
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [16/17066-2, 14/00302-0, 2017/12646-3,
   11/50400-0, 15/06809-1, 17/20614-4]; CAPESCAPES [PNPD 1578388, PROEX
   1489740]; Plano Nacional de Enfrentamento ao Aedes aegypti e
   Microcefalia from the Brazilian Ministry of Health
   [88887.137889/2017-00]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [304472/2015-8]
FX The authors would like to thank the Sao Paulo Research Foundation
   (FAPESP) for the fellowships of CM (16/17066-2), CE (14/00302-0), and AR
   (2017/12646-3), and the grants for RC (11/50400-0, 15/06809-1, and
   17/20614-4). We also acknowledge CAPES for the scholarships for EL (PNPD
   1578388) and TG (PROEX 1489740). DO acknowledges the Plano Nacional de
   Enfrentamento ao Aedes aegypti e Microcefalia from the Brazilian
   Ministry of Health for the fellowship (88887.137889/2017-00). AR thanks
   CNPq for his grant No. 304472/2015-8.
CR Acharjee A, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1292-2
   Altmann A, 2010, BIOINFORMATICS, V26, P1340, DOI 10.1093/bioinformatics/btq134
   Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L, 1996, TECH REP
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Caruana R., 2006, P 23 INT C MACH LEAR, V2006, P161, DOI DOI 10.1145/1143844.1143865
   Criminisil A, 2011, FOUND TRENDS COMPUT, V7, P81, DOI [10.1561/0600000035, 10.1501/0000000035]
   Deng L, 2017, METABOLITES, V7, DOI 10.3390/metabo7030032
   Diakopoulos N., 2017, TECH REP
   Eiras MM, 2014, ANAL METHODS-UK, V6, P1350, DOI 10.1039/c3ay41632a
   Eltzov E, 2010, NATO SCI PEACE SEC A, P275, DOI 10.1007/978-90-481-8544-3_12
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fernandez-Delgado M, 2014, J MACH LEARN RES, V15, P3133
   Gromski PS, 2015, ANAL CHIM ACTA, V879, P10, DOI 10.1016/j.aca.2015.02.012
   Johnson CH, 2015, ANAL CHEM, V87, P147, DOI 10.1021/ac5040693
   Kind T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39227
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lima ED, 2015, ANAL CHEM, V87, P3585, DOI 10.1021/acs.analchem.5b00097
   Louppe G, 2013, ADV NEURAL INFORM PR, V2013, P431
   MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095
   Melo CFOR, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01954
   MILLER LH, 1956, J AM STAT ASSOC, V51, P111, DOI 10.2307/2280807
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murphy KP, 2012, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE, P543
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shotton J, 2013, COMMUN ACM, V56, P116, DOI 10.1145/2398356.2398381
   Smith R, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S9
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Suna G., 2017, INT J PERFORMABILITY, V13, P446, DOI [DOI 10.23940/IJPE.17.04.P12.446457, 10.23940/ijpe.17.04.p12.446457]
   Sylvester EVA, 2018, EVOL APPL, V11, P153, DOI 10.1111/eva.12524
   Takayama T, 2016, CLIN CHIM ACTA, V452, P18, DOI 10.1016/j.cca.2015.10.032
   To KKW, 2015, J INFECTION, V70, P433, DOI 10.1016/j.jinf.2015.02.011
   van der Maaten L, 2008, J MACH LEARN RES, V9, P2579
   Vinaixa M, 2016, TRAC-TREND ANAL CHEM, V78, P23, DOI 10.1016/j.trac.2015.09.005
   Zheng BC, 2014, EXPERT SYST APPL, V41, P1476, DOI 10.1016/j.eswa.2013.08.044
NR 41
TC 5
Z9 5
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-4185
J9 FRONT BIOENG BIOTECH
JI Front. Bioeng. Biotechnol.
PD APR 11
PY 2018
VL 6
AR 31
DI 10.3389/fbioe.2018.00031
PG 11
WC Biotechnology & Applied Microbiology; Multidisciplinary Sciences
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA GO7QT
UT WOS:000440267300001
PM 29696139
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Santiago, GA
   Vazquez, J
   Courtney, S
   Matias, KY
   Andersen, LE
   Colon, C
   Butler, AE
   Roulo, R
   Bowzard, J
   Villanueva, JM
   Munoz-Jordan, JL
AF Santiago, Gilberto A.
   Vazquez, Jesus
   Courtney, Sean
   Matias, Katia Y.
   Andersen, Lauren E.
   Colon, Candimar
   Butler, Angela E.
   Roulo, Rebecca
   Bowzard, John
   Villanueva, Julie M.
   Munoz-Jordan, Jorge L.
TI Performance of the Trioplex real-time RT-PCR assay for detection of
   Zika, dengue, and chikungunya viruses
SO NATURE COMMUNICATIONS
LA English
DT Article
ID REVERSE TRANSCRIPTION-PCR; WHOLE-BLOOD SPECIMENS; SEXUAL TRANSMISSION;
   MOLECULAR-DETECTION; RNA; INFECTION; TRAVELERS; URINE; MICRONESIA;
   OUTBREAK
AB The emergence and spread of Zika virus (ZIKV) presented a challenge to the diagnosis of ZIKV infections in areas with transmission of dengue (DENV) and chikungunya (CHIKV) viruses. To facilitate detection of ZIKV infections, and differentiate these infections from DENV and CHIKV, we developed the Trioplex real-time RT-PCR assay (Trioplex assay). Here, we describe the optimization of multiplex and singleplex formats of the assay for a variety of chemistries and instruments to facilitate global standardization and implementation. We evaluated the analytical performance of all Trioplex modalities for detection of these three pathogens in serum and whole blood, and for ZIKV in urine. The limit of detection for the three viruses and in different RNA-extraction modalities is near 103 genome copy equivalents per milliliter (GCE/mL). Simultaneous testing of more than one specimen type from each patient provides a 6.4% additional diagnostic sensitivity. Overall, the high sensitivity of the Trioplex assay demonstrates the utility of this assay ascertaining Zika cases.
C1 [Santiago, Gilberto A.; Vazquez, Jesus; Matias, Katia Y.; Colon, Candimar; Munoz-Jordan, Jorge L.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, Natl Ctr Emerging & Zoonot Infect Dis, San Juan, PR 00920 USA.
   [Courtney, Sean; Andersen, Lauren E.; Butler, Angela E.; Roulo, Rebecca; Bowzard, John; Villanueva, Julie M.] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP Munoz-Jordan, JL (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Dengue Branch, Natl Ctr Emerging & Zoonot Infect Dis, San Juan, PR 00920 USA.
EM JMunoz@cdc.gov
FU CDC Office of Public Health Preparedness and Response [14379]
FX We thank Dr. Robert Lanciotti for designing some of the Trioplex primers
   and probes. Laura Rose and Neal Satterly are thanked for their valuable
   data assessments and regulatory expertize. We thank Drs. Dean Erdman and
   Brett Whitaker from the CDC for the use of the NucliSENS (R) easyMag (R)
   instrument and technical assistance. We thank Dr. Kirsten St. George and
   team from the Wadsworth Center, New York Department of Health, for their
   work with the NucliSENS (R) easyMag (R) protocols and evaluations. We
   also thank Drs. Michael Busch and Mars Stone from the Blood Systems
   Research Institute for the collection and donation of whole blood. This
   project was funded in part by the CDC Office of Public Health
   Preparedness and Response, August 2015, project # 14379.
CR [Anonymous], 2017, Am J Transplant, V17, P572, DOI 10.1111/ajt.14179
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2016, DIAGN TEST ZIK VIR T
   Chotiwan N, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag0538
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Frankel MB, 2017, J VIROL METHODS, V246, P117, DOI 10.1016/j.jviromet.2017.05.002
   Ginier M, 2016, TRAVEL MED INFECT DI, V14, P16, DOI 10.1016/j.tmaid.2016.01.012
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Johnson BW, 2005, J CLIN MICROBIOL, V43, P4977, DOI 10.1128/JCM.43.10.4977-4983.2005
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Meaney-Delman D, 2016, MMWR-MORBID MORTAL W, V65, P211, DOI 10.15585/mmwr.mm6508e1
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pan American Health Organization, 2017, REG ZIK EP UPD AM
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Puerto Rico Department of Health, 2017, ZIK SURV WEEKL UPD W
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   St George K, 2017, J CLIN MICROBIOL, V55, P535, DOI 10.1128/JCM.01232-16
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tan SK, 2017, J VIROL METHODS, V248, P66, DOI 10.1016/j.jviromet.2017.04.018
   U.S. Food and Drug Administration, 2016, EM US AUTH TRIOPL RE
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
NR 42
TC 43
Z9 43
U1 2
U2 20
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD APR 11
PY 2018
VL 9
AR 1391
DI 10.1038/s41467-018-03772-1
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GC3NC
UT WOS:000429689800014
PM 29643334
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marzi, A
   Emanuel, J
   Callison, J
   McNally, KL
   Arndt, N
   Chadinha, S
   Martellaro, C
   Rosenke, R
   Scott, DP
   Safronetz, D
   Whitehead, SS
   Best, SM
   Feldmann, H
AF Marzi, Andrea
   Emanuel, Jackson
   Callison, Julie
   McNally, Kristin L.
   Arndt, Nicolette
   Chadinha, Spencer
   Martellaro, Cynthia
   Rosenke, Rebecca
   Scott, Dana P.
   Safronetz, David
   Whitehead, Stephen S.
   Best, Sonja M.
   Feldmann, Heinz
TI Lethal Zika Virus Disease Models in Young and Older Interferon
   alpha/beta Receptor Knock Out Mice
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Article
DE Zika virus; strains; pathogenesis; animal model; IFNAR(-/-) mice;
   uniform lethality; countermeasures
ID SEXUAL TRANSMISSION; PATHOGENESIS; INFECTION; MOSQUITOS
AB The common small animal disease models for Zika virus (ZIKV) are mice lacking the interferon responses, but infection of interferon receptor alpha/beta knock out (IFNAR(-/-)) mice is not uniformly lethal particularly in older animals. Here we sought to advance this model in regard to lethality for future countermeasure efficacy testing against more recent ZIKV strains from the Asian lineage, preferably the American sublineage. We first infected IFNAR(-/-) mice subcutaneously with the contemporary ZIKV-Paraiba strain resulting in predominantly neurological disease with similar to 50% lethality. Infection with ZIKV-Paraiba by different routes established a uniformly lethal model only in young mice (4-week old) upon intraperitoneal infection. However, intraperitoneal inoculation of ZIKV-French Polynesia resulted in uniform lethality in older IFNAR(-/-) mice (10-12-weeks old). In conclusion, we have established uniformly lethal mouse disease models for efficacy testing of antivirals and vaccines against recent ZIKV strains representing the Asian lineage.
C1 [Marzi, Andrea; Emanuel, Jackson; Callison, Julie; McNally, Kristin L.; Chadinha, Spencer; Martellaro, Cynthia; Best, Sonja M.; Feldmann, Heinz] NIAID, Lab Virol, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT 59840 USA.
   [Arndt, Nicolette; Rosenke, Rebecca; Scott, Dana P.] NIAID, Rocky Mt Vet Branch, Div Intramural Res, NIH, Hamilton, MT USA.
   [Safronetz, David] Publ Hlth Agcy Canada, Natl Microbiol Lab, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Whitehead, Stephen S.] NIAID, Infect Dis Lab, Div Intramural Res, NIH, Bldg 10, Bethesda, MD 20892 USA.
RP Marzi, A (corresponding author), NIAID, Lab Virol, Rocky Mt Labs, Div Intramural Res,NIH, Hamilton, MT 59840 USA.
EM marzia@niaid.nih.gov
RI Whitehead, Stephen/AAG-2787-2019
FU Division of Intramural Research, NIAID, NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
FX This work was funded by the Division of Intramural Research, NIAID, NIH.
   Opinions, interpretations, conclusions, and recommendations are those of
   the authors and are not necessarily endorsed by the NIH.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   BEARCROFT W. G. C., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P442, DOI 10.1016/0035-9203(56)90090-6
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Frank C, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.23.30252
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hinkula J, 2017, J VIROL, V91, DOI [10.1128/JVI.02076-16, 10.1128/jvi.02076-16]
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 36
TC 9
Z9 9
U1 0
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD APR 11
PY 2018
VL 8
AR 117
DI 10.3389/fcimb.2018.00117
PG 10
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GC3FN
UT WOS:000429669800001
PM 29696134
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Acosta-Ampudia, Y
   Monsalve, DM
   Castillo-Medina, LF
   Rodriguez, Y
   Pacheco, Y
   Halstead, S
   Willison, HJ
   Anaya, JM
   Ramirez-Santana, C
AF Acosta-Ampudia, Yeny
   Monsalve, Diana M.
   Castillo-Medina, Luis F.
   Rodriguez, Yhojan
   Pacheco, Yovana
   Halstead, Susan
   Willison, Hugh J.
   Anaya, Juan-Manuel
   Ramirez-Santana, Carolina
TI Autoimmune Neurological Conditions Associated With Zika Virus Infection
SO FRONTIERS IN MOLECULAR NEUROSCIENCE
LA English
DT Review
DE Zika virus; autoimmunity; Guillain-Barre syndrome; Transverse myelitis;
   molecular mimicry
ID GUILLAIN-BARRE-SYNDROME; ACUTE TRANSVERSE MYELITIS;
   CENTRAL-NERVOUS-SYSTEM; AUTONOMIC DYSFUNCTION; NEUROMYELITIS-OPTICA;
   MULTIPLE-SCLEROSIS; ACUTE MYELOPATHIES; DENGUE VIRUS; CELLS; DIAGNOSIS
AB Zika virus (ZIKV) is an emerging flavivirus rapidly spreading throughout the tropical Americas. Aedes mosquitoes is the principal way of transmission of the virus to humans. ZIKV can be spread by transplacental, perinatal, and body fluids. ZIKV infection is often asymptomatic and those with symptoms present minor illness after 3 to 12 days of incubation, characterized by a mild and self-limiting disease with low-grade fever, conjunctivitis, widespread pruritic maculopapular rash, arthralgia and myalgia. ZIKV has been linked to a number of central and peripheral nervous system injuries such as Guillain-Barre syndrome (GBS), transverse myelitis (TM), meningoencephalitis, ophthalmological manifestations, and other neurological complications. Nevertheless, mechanisms of host-pathogen neuro-immune interactions remain incompletely elucidated. This review provides a critical discussion about the possible mechanisms underlying the development of autoimmune neurological conditions associated with Zika virus infection.
C1 [Acosta-Ampudia, Yeny; Monsalve, Diana M.; Castillo-Medina, Luis F.; Rodriguez, Yhojan; Pacheco, Yovana; Anaya, Juan-Manuel; Ramirez-Santana, Carolina] Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res, Bogota, Colombia.
   [Halstead, Susan; Willison, Hugh J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland.
RP Ramirez-Santana, C (corresponding author), Univ Rosario, Sch Med & Hlth Sci, Ctr Autoimmune Dis Res, Bogota, Colombia.
EM heily.ramirez@urosario.edu.co
RI ; Ramirez-Santana, Carolina/J-2363-2016; Monsalve, Diana M./J-2374-2016;
   Pacheco Nieva, Yovana/J-2932-2018; Anaya, Juan-Manuel/J-1960-2016;
   Acosta-Ampudia, Yeny/J-2401-2016
OI Halstead, Susan/0000-0001-7396-8969; Ramirez-Santana,
   Carolina/0000-0003-2137-4899; Monsalve, Diana M./0000-0002-1145-1312;
   Pacheco Nieva, Yovana/0000-0002-0722-546X; Anaya,
   Juan-Manuel/0000-0002-6444-1249; Acosta-Ampudia,
   Yeny/0000-0001-8491-9134
FU Universidad del Rosario [ABN011]; Colciencias, Bogota,
   ColombiaDepartamento Administrativo de Ciencia, Tecnologia e Innovacion
   Colciencias [747-2016]
FX This work was supported by Universidad del Rosario (ABN011) and
   Colciencias (747-2016), Bogota, Colombia.
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alhomoud IA, 2009, SAUDI MED J, V30, P1067
   Alirezaei M, 2009, AUTOPHAGY, V5, P152, DOI 10.4161/auto.5.2.7348
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Barnes G, 2002, NEUROLOGY, V59, P499, DOI 10.1212/wnl.59.4.499
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beh SC, 2013, NEUROL CLIN, V31, P79, DOI 10.1016/j.ncl.2012.09.008
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   BERMAN M, 1981, NEUROLOGY, V31, P969
   Bhat A, 2010, AUTOIMMUN REV, V9, pA395, DOI 10.1016/j.autrev.2009.12.007
   Borchers AT, 2012, AUTOIMMUN REV, V11, P231, DOI 10.1016/j.autrev.2011.05.018
   Brannagan TH, 2003, J NEUROL SCI, V208, P39, DOI 10.1016/S0022-510X(02)00418-5
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   CHRISTENSEN PB, 1990, ACTA NEUROL SCAND, V81, P431
   Cree BAC, 2005, NEUROLOGY, V65, P1857, DOI 10.1212/01.wnl.0000194615.51750.f8
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dagklis IE, 2016, CASE REP NEUROL MED, DOI 10.1155/2016/3431849
   Dalakas MC, 2015, BBA-MOL BASIS DIS, V1852, P658, DOI 10.1016/j.bbadis.2014.06.013
   Dar WR, 2015, NEUROL INDIA, V63, P986, DOI 10.4103/0028-3886.170077
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   de Seze J, 2001, BRAIN, V124, P1509, DOI 10.1093/brain/124.8.1509
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Gerardin P, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30014-4
   Gonzalez P, 2016, NEUROLOGIA, V31, P389, DOI 10.1016/j.nrl.2014.09.004
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Israeli E, 2012, CLIN REV ALLERG IMMU, V42, P121, DOI 10.1007/s12016-010-8213-3
   Ito M, 2008, J NEUROL, V255, P674, DOI 10.1007/s00415-008-0775-0
   Jacob A, 2008, SEMIN NEUROL, V28, P105, DOI 10.1055/s-2007-1019132
   Carod-Artal FJ, 2018, CLIN AUTON RES, V28, P161, DOI 10.1007/s10286-018-0516-0
   JEFFERY DR, 1993, ARCH NEUROL-CHICAGO, V50, P532, DOI 10.1001/archneur.1993.00540050074019
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kaplin AI, 2005, NEUROLOGIST, V11, P2, DOI 10.1097/01.nrl.0000149975.39201.0b
   Katz JD, 2000, ARCH NEUROL-CHICAGO, V57, P355, DOI 10.1001/archneur.57.3.355
   Kerr DA, 2002, CURR OPIN NEUROL, V15, P339, DOI 10.1097/00019052-200206000-00019
   Krassioukov AV, 2007, J REHABIL RES DEV, V44, P103, DOI 10.1682/JRRD.2005.10.0159
   Krishnan C, 2004, FRONT BIOSCI-LANDMRK, V9, P1483, DOI 10.2741/1351
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0750-4
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Leis A Arturo, 2012, Front Neurol, V3, P37, DOI 10.3389/fneur.2012.00037
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lin N, 2017, PROTEIN PEPTIDE LETT, V24, P245, DOI 10.2174/0929866524666170110150436
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lozier M., 2017, OPEN FORUM INFECT DI, V4, pS56, DOI [10.1093/ofid/ofx162.133, DOI 10.1093/OFID/OFX162.133]
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Mahecha MP, 2017, IMMUNOL RES, V65, P72, DOI 10.1007/s12026-016-8816-8
   Maramattom BV, 2014, ANN INDIAN ACAD NEUR, V17, P85, DOI 10.4103/0972-2327.128561
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mok CC, 1998, J RHEUMATOL, V25, P467
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Monsalve DM, 2017, AUTOIMMUN REV, V16, P1237, DOI 10.1016/j.autrev.2017.10.008
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Neal JW, 2014, J INFECTION, V69, P203, DOI 10.1016/j.jinf.2014.05.010
   Nicastri E, 2016, EMERG INFECT DIS, V22, P2228, DOI 10.3201/eid2212.161280
   Oehler E., 2014, Eurosurveillance, V19, P20720
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200
   PAHO WHO, 2016, ZIK CUM CAS 25 AUG 2
   Palacios E, 2019, NEUROLOGIA, V34, P204, DOI 10.1016/j.nrl.2016.08.006
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pidcock FS, 2007, NEUROLOGY, V68, P1474, DOI 10.1212/01.wnl.0000260609.11357.6f
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Prineas JW, 2018, MULT SCLER J, V24, P610, DOI 10.1177/1352458517706037
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   Rodriguez Y, 2018, CLIN AUTON RES, V28, P211, DOI 10.1007/s10286-018-0515-1
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sejvar J, 2014, HAND CLINIC, V123, P719, DOI 10.1016/B978-0-444-53488-0.00038-9
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Shoenfeld Y, 1996, INT ARCH ALLERGY IMM, V109, P318, DOI 10.1159/000237258
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Suzuki Y, 2017, J VIROL, V91, DOI [10.1128/JVI.00571-17, 10.1128/jvi.00571-17]
   Swartwout BK, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040049
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Vatti A, 2017, J AUTOIMMUN, V83, P12, DOI 10.1016/j.jaut.2017.04.008
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019575
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Yoshikura N, 2017, J NEUROIMMUNOL, V310, P150, DOI 10.1016/j.jneuroim.2017.07.006
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
NR 117
TC 8
Z9 9
U1 0
U2 5
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5099
J9 FRONT MOL NEUROSCI
JI Front. Molec. Neurosci.
PD APR 11
PY 2018
VL 11
AR 116
DI 10.3389/fnmol.2018.00116
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA GC3TE
UT WOS:000429705800001
PM 29695953
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU da Maia, JTS
   Vidal, SJA
   Mendes, TV
   Lins, MG
   Zacarkim, MR
   Rolim, DD
   Aronoff, DM
   LaBeaud, AD
   Neto, NNM
AF da Maia, Jessika T. S.
   Alves Vidal, Sebastiana Jayne
   Mendes, Tatyana Vidal
   Lins, Maria Goretti
   Zacarkim, Marcelo Rodrigues
   Rolim, Daniel Duarte
   Aronoff, David M.
   LaBeaud, Angelle Desiree
   Mendes Neto, Nilson N.
TI Perinatal Case Fatality Rate in Cases of Congenital Zika Syndrome: a
   Cross-Sectional Study
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY APR 21-27, 2018
CL Los Angeles, CA
SP Amer Acad Neurol
C1 [da Maia, Jessika T. S.] Univ Potiguar, Sch Med, Natal, RN, Brazil.
   [Alves Vidal, Sebastiana Jayne] SES RN, Natal, RN, Brazil.
   [Mendes, Tatyana Vidal] SMS Cajazeiras, Cajazeiras, PB, Brazil.
   [Lins, Maria Goretti] Varela Santiago Children Hosp, Pediat Infect Dis, Natal, RN, Brazil.
   [Zacarkim, Marcelo Rodrigues] Harvard Med Sch, Boston, MA USA.
   [Rolim, Daniel Duarte] FCM, Campina Grande, Brazil.
   [Aronoff, David M.] Vanderbilt Univ, Infect Dis, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [LaBeaud, Angelle Desiree] Stanford Univ, Infect Dis, Stanford, CA 94305 USA.
   [Mendes Neto, Nilson N.] Univ Calif Davis, Extens Ctr, Davis, CA 95616 USA.
RI Neto, Nilson Nogueira Mendes/V-6717-2019
OI Neto, Nilson Nogueira Mendes/0000-0002-3626-189X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 10
PY 2018
VL 90
SU 15
MA P5.160
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA HE2FF
UT WOS:000453090804009
DA 2020-07-08
ER

PT J
AU De Alcantara, T
   LaBeaud, AD
   Aronoff, D
   Zacarkim, MR
   Maia, JTD
   Fernandes, KE
   Neto, NNM
AF De Alcantara, Tabata
   LaBeaud, Angelle Desiree
   Aronoff, David
   Zacarkim, Marcelo Rodrigues
   da Silva Maia, Jessika Thais
   Fernandes, Kalyana E.
   Neto, Nilson N. Mendes
TI CT Scan Findings in Microcephaly Cases During 2015-2016 Zika Outbreak: A
   Cohort Study
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY APR 21-27, 2018
CL Los Angeles, CA
SP Amer Acad Neurol
C1 [De Alcantara, Tabata; Fernandes, Kalyana E.] CRI RN, Natal, RN, Brazil.
   [LaBeaud, Angelle Desiree] Stanford Univ, Stanford, CA 94305 USA.
   [Aronoff, David] Vanderbilt Univ, Infect Dis, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Zacarkim, Marcelo Rodrigues] Harvard Med Sch, Boston, MA USA.
   [da Silva Maia, Jessika Thais] Univ Potiguar, Natal, RN, Brazil.
   [Neto, Nilson N. Mendes] Univ Calif Davis, Extens Ctr, Miami Beach, FL USA.
RI Neto, Nilson Nogueira Mendes/V-6717-2019
OI Neto, Nilson Nogueira Mendes/0000-0002-3626-189X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 10
PY 2018
VL 90
SU 15
MA P2.310
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA HE2FF
UT WOS:000453090801282
DA 2020-07-08
ER

PT J
AU De Alcantara, T
   Maia, JTD
   Aronoff, D
   Rolim, DD
   Zacarkim, MR
   LaBeaud, AD
   Fernandes, KE
   Neto, NNM
AF De Alcantara, Tabata
   da Silva Maia, Jessika Thais
   Aronoff, David
   Rolim, Daniel Duarte
   Zacarkim, Marcelo Rodrigues
   LaBeaud, Angelle Desiree
   Fernandes, Kalyana E.
   Neto, Nilson Nogueira Mendes
TI Radiological Findings and Neurological Disorders in Microcephaly Cases
   Related to Zika Virus: A Cohort Study
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY APR 21-27, 2018
CL Los Angeles, CA
SP Amer Acad Neurol
C1 [De Alcantara, Tabata; Fernandes, Kalyana E.] CRI RN, Natal, RN, Brazil.
   [da Silva Maia, Jessika Thais] Univ Potiguar, Natal, RN, Brazil.
   [Aronoff, David] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA.
   [Rolim, Daniel Duarte] FCM, Campina Grande, Brazil.
   [Zacarkim, Marcelo Rodrigues] Harvard Med Sch, Boston, MA USA.
   [LaBeaud, Angelle Desiree] Stanford Univ, Stanford, CA 94305 USA.
   [Neto, Nilson Nogueira Mendes] Univ Calif Davis, Miami Beach, FL USA.
RI Neto, Nilson Nogueira Mendes/V-6717-2019
OI Neto, Nilson Nogueira Mendes/0000-0002-3626-189X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 10
PY 2018
VL 90
SU 15
MA P2.314
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA HE2FF
UT WOS:000453090801286
DA 2020-07-08
ER

PT J
AU Ferreira, JM
   dos Santos, PP
   Pagliarini, LF
   Macedo, P
   Da Silva, I
   Hygino, C
   Andorinho, AC
   Bittar, C
   Moreira, P
   Pupe, C
   Nascimento, O
AF Ferreira, Joao Marcos
   dos Santos, Pamela Passos
   Pagliarini, Luiz Felipe
   Macedo, Pedro
   Da Silva, Ivan
   Hygino, Celso
   Andorinho, Ana Carolina
   Bittar, Caroline
   Moreira Filho, Pedro
   Pupe, Camila
   Nascimento, Osvaldo
TI Subacute ZIKA Virus encephalitis in Rio de Janeiro
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY APR 21-27, 2018
CL Los Angeles, CA
SP Amer Acad Neurol
C1 [Ferreira, Joao Marcos; dos Santos, Pamela Passos; Pagliarini, Luiz Felipe; Macedo, Pedro; Andorinho, Ana Carolina; Bittar, Caroline; Moreira Filho, Pedro; Pupe, Camila; Nascimento, Osvaldo] Fluminense Fed Univ, Rio De Janeiro, Brazil.
   [Da Silva, Ivan] Rush Univ, Med Ctr, Rio De Janeiro, Brazil.
   [Hygino, Celso] CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 10
PY 2018
VL 90
SU 15
MA P5.111
PG 3
WC Clinical Neurology
SC Neurosciences & Neurology
GA HE2FF
UT WOS:000453090803430
DA 2020-07-08
ER

PT J
AU Macedo, P
   Pagliarini, LFD
   Ferreira, JM
   dos Santos, PP
   Andorinho, AC
   Davidovich, E
   Da Silva, I
   Hygino, C
   Pupe, C
   Nascimento, O
AF Macedo, Pedro
   Dantas Pagliarini, Luiz Felipe
   Ferreira, Joao Marcos
   dos Santos, Pamela Passos
   Andorinho, Ana Carolina
   Davidovich, Eduardo
   Da Silva, Ivan
   Hygino, Celso
   Pupe, Camila
   Nascimento, Osvaldo
TI Image studies in Zika Virus neurological complications
SO NEUROLOGY
LA English
DT Meeting Abstract
CT 70th Annual Meeting of the American-Academy-of-Neurology (AAN)
CY APR 21-27, 2018
CL Los Angeles, CA
SP Amer Acad Neurol
C1 [Macedo, Pedro; Dantas Pagliarini, Luiz Felipe; Ferreira, Joao Marcos; dos Santos, Pamela Passos; Andorinho, Ana Carolina; Davidovich, Eduardo; Pupe, Camila; Nascimento, Osvaldo] Fluminense Fed Univ, Rio De Janeiro, Brazil.
   [Da Silva, Ivan] Rush Univ, Med Ctr, Rio De Janeiro, Brazil.
   [Hygino, Celso] CDPI, Rio De Janeiro, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0028-3878
EI 1526-632X
J9 NEUROLOGY
JI Neurology
PD APR 10
PY 2018
VL 90
SU 15
MA P5.149
PG 2
WC Clinical Neurology
SC Neurosciences & Neurology
GA HE2FF
UT WOS:000453090803462
DA 2020-07-08
ER

PT J
AU Gupta, S
   Agarwal, A
   Kumar, A
   Biswas, D
AF Gupta, Sudheer
   Agarwal, Ankita
   Kumar, Amod
   Biswas, Debasis
TI Genome-Wide Analysis to Identify HLA Factors Potentially Associated With
   Severe Dengue
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE dengue hemorrhagic fever; epitope variants; HLA association; severe
   dengue; GWASIN
ID T-CELL RESPONSES; HEMORRHAGIC-FEVER; VIRUS-INFECTION; DISEASE SEVERITY;
   EPITOPES; PATHOGENESIS; THAILAND; ALLELE; RISK; GENE
AB The pathogenesis of dengue hemorrhagic fever (DHF), following dengue virus (DENV) infection, is a complex and poorly understood phenomenon. In view of the clinical need of identifying patients with higher likelihood of developing this severe outcome, we undertook a comparative genome-wide association analysis of epitope variants from sequences available in the ViPR database that have been reported to be differentially related to dengue fever and DHF. Having enumerated the incriminated epitope variants, we determined the corresponding HLA alleles in the context of which DENV infection could potentially precipitate DHF. Our analysis considered the development of DHF in three different perspectives: (a) as a consequence of primary DENV infection, (b) following secondary DENV infection with a heterologous serotype, (c) as a result of DENV infection following infection with related flaviviruses like Zika virus, Japanese Encephalitis virus, West Nile virus, etc. Subject to experimental validation, these viral and host markers would be valuable in triaging DENV-infected patients for closer supervision owing to the relatively higher risk of poor prognostic outcome and also for the judicious allocation of scarce institutional resources during large outbreaks.
C1 [Gupta, Sudheer; Agarwal, Ankita; Kumar, Amod; Biswas, Debasis] All India Inst Med Sci Bhopal, Dept Microbiol, Reg Virol Lab, Bhopal, India.
RP Biswas, D (corresponding author), All India Inst Med Sci Bhopal, Dept Microbiol, Reg Virol Lab, Bhopal, India.
EM debasis.microbiology@aiimsbhopal.edu.in
OI Gupta, Sudheer/0000-0002-6836-6696; Kumar, Amod/0000-0002-7531-574X
CR Anantapreecha S, 2005, EPIDEMIOL INFECT, V133, P503, DOI 10.1017/S0950268804003541
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Appanna R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013029
   CDC, 2016, CDC
   Cohen J, 2017, SCIENCE, V355, P1362, DOI 10.1126/science.355.6332.1362
   Costa VV, 2013, AM J PATHOL, V182, P1950, DOI 10.1016/j.ajpath.2013.02.027
   Duan ZL, 2015, J MED VIROL, V87, P1077, DOI 10.1002/jmv.24167
   de Alencar LXE, 2013, J TROP MED-US, V2013, DOI 10.1155/2013/648475
   Fleri W, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00278
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0
   Gupta S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0928-3
   Khurram M, 2014, J INFECT PUBLIC HEAL, V7, P489, DOI 10.1016/j.jiph.2014.05.005
   KURANE I, 1995, J GEN VIROL, V76, P2243, DOI 10.1099/0022-1317-76-9-2243
   Li CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep36288
   Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320
   Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mathew A, 1998, J VIROL, V72, P3999, DOI 10.1128/JVI.72.5.3999-4004.1998
   Mercado ES, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115619
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Monteiro SP, 2012, MEM I OSWALDO CRUZ, V107, P224, DOI 10.1590/S0074-02762012000200012
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005
   Stephens HAF, 2010, CURR TOP MICROBIOL, V338, P99, DOI 10.1007/978-3-642-02215-9_8
   STREATFIELD R, 1993, LANCET, V342, P560, DOI 10.1016/0140-6736(93)91692-F
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Vejbaesya S, 2009, J INFECT DIS, V199, P1442, DOI 10.1086/597422
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   WHO, 2013, DENGUE
   Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959
NR 34
TC 3
Z9 3
U1 0
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 10
PY 2018
VL 9
AR 728
DI 10.3389/fimmu.2018.00728
PG 9
WC Immunology
SC Immunology
GA GC1ZV
UT WOS:000429582700001
PM 29692780
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Molton, JS
   Low, I
   Choy, MMJ
   Aw, PPK
   Hibberd, ML
   Tambyah, PA
   Wilder-Smith, A
AF Molton, James S.
   Low, Isaac
   Choy, Milly Ming Ju
   Aw, Pauline Poh Kim
   Hibberd, Martin L.
   Tambyah, Paul A.
   Wilder-Smith, Annelies
TI Dengue virus not detected in human semen
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE dengue; semen; sexual transmission; zika
ID TRANSMISSION
AB Zika and Ebola viruses can persist in semen and pose a risk for sexual transmission. To determine if dengue virus, another flavivirus, is similarly detectable in semen, we performed dengue PCR on semen in five patients with acute dengue virus infection. All five tested negative, suggesting that dengue does not pose a risk for sexual transmission.
C1 [Molton, James S.; Low, Isaac; Tambyah, Paul A.] Natl Univ Hlth Syst, Univ Med Cluster, Singapore, Singapore.
   [Molton, James S.; Tambyah, Paul A.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore.
   [Choy, Milly Ming Ju; Aw, Pauline Poh Kim; Hibberd, Martin L.] A STAR Genome Inst Singapore, GIS Efficient Rapid Microbial Sequencing Platform, Singapore, Singapore.
   [Wilder-Smith, Annelies] Tan Tock Seng Hosp, Travellers Hlth & Vaccinat Clin, Singapore, Singapore.
   [Wilder-Smith, Annelies] Nanyang Technol Univ, Lee Kong Chian Sch Med, Singapore, Singapore.
RP Molton, JS (corresponding author), Natl Univ Hlth Syst, Univ Med Cluster, Div Infect Dis, 1E Kent Ridge Rd,NUHS Tower Block,Level 10, Singapore 119228, Singapore.
EM james_steven_molton@nuhs.edu.sg
OI Hibberd, Martin/0000-0001-8587-1849
FU National University Hospital, Singapore's Global Health Fund
FX This work was supported by an unrestricted grant from the National
   University Hospital, Singapore's Global Health Fund.
CR [Anonymous], 2014, QIAMMP VIR RNA MIN H
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Clark BM, 2012, J CLIN VIROL, V54, P376, DOI 10.1016/j.jcv.2012.04.012
   Fischer WA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx155
   Fischer WA, 2016, CLIN INFECT DIS, V62, P1272, DOI 10.1093/cid/ciw123
   Guljit K, 2014, J OBSTET GYN INDIA, V64, P1, DOI 10.1007/s13224-012-0253-6
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Iannetta M, 2017, EURO SURVEILL, V22
   Jentes ES, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/taw062
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oh HB, 2015, TRANSFUSION, V55, P1655, DOI 10.1111/trf.13054
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Wilder-Smith A, 2009, EMERG INFECT DIS, V15, P8, DOI 10.3201/eid1501.071097
   World Health Organization, INT ADV SEX TRANSM E
NR 14
TC 8
Z9 8
U1 0
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD APR 9
PY 2018
VL 25
AR tay023
DI 10.1093/jtm/tay023
PG 3
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0WV
UT WOS:000451521500001
PM 29672710
OA Bronze
DA 2020-07-08
ER

PT J
AU Griffiths, KM
   Savini, H
   Brouqui, P
   Simon, F
   Parola, P
   Gautret, P
AF Griffiths, Karolina M.
   Savini, Helene
   Brouqui, Philippe
   Simon, Fabrice
   Parola, Philippe
   Gautret, Philippe
TI Surveillance of travel-associated diseases at two referral centres in
   Marseille, France: a 12-year survey
SO JOURNAL OF TRAVEL MEDICINE
LA English
DT Article
DE Travel medicine; sentinel surveillance; malaria
ID FRENCH PILGRIMS; VIRUS; INFECTIONS; EXPOSURE; ILLNESS; COMOROS; MALARIA;
   TRENDS; DENGUE; ZIKA
AB Background: With increasing international travel and historically high numbers of residents visiting friends and relatives overseas, travel-associated illnesses are frequent in Marseille, France. We report the changing epidemiology of travel-related illnesses over a 12-year period.
   Methods: A single site GeoSentinel surveillance analysis was undertaken for 3460 ill returned travellers presenting to two public hospitals in Marseille, France from March 2003 to October 2015, with travel-related illnesses. Demographic characteristics, travel history, presenting symptoms and information on pre-travel consultations were collected.
   Results: There was a predominance of travel to sub-Saharan Africa, in particular to Comoros archipelago. Tourism was the main reason for travel (1591/3460, 46%), followed by visiting friends or relatives (VFR) (895/3460, 26%), with a mean duration of 29 days; 35% (1212/3460) of travellers reported a pre-travel health consultation. The most common syndromic diagnoses were febrile systemic illness (1343, 39%), dermatologic (716, 21%), gastrointestinal (340, 10%) and respiratory/ear-nose-throat (331, ENT) (10%). Hospitalization rates were highest amongst travellers from sub-Saharan Africa (858/1632, 53%), and VFR (573/895, 64%, P < 0.001). Frequent diagnoses included malaria (797, 23%), dengue (96, 2.77%) and chikungunya (75, 2.17%), reflecting global trends. Comparison of two periods (2003-10 to 2011-15) demonstrated an increase in chikungunya and decrease in malaria and influenza-like illness. We report an increase in ill travellers from the Caribbean, Middle East and South-East Asia.
   Conclusion: Surveillance of travellers provides relevant sentinel information on the changing epidemiology of infectious diseases across the globe, most notably for malaria, dengue and chikungunya. We demonstrate the use of travel surveillance in improving pre-travel consultation needs and to address autochthonous vector-borne viral risks.
C1 [Griffiths, Karolina M.; Brouqui, Philippe; Parola, Philippe; Gautret, Philippe] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
   [Savini, Helene; Simon, Fabrice] Laveran Mil Teaching Hosp, Dept Trop Med & Infect Dis, Marseille, France.
RP Gautret, P (corresponding author), Inst Hosp Univ Mediterranee Infect, VITROME, 19-21 Blvd Jean Moulin, F-13385 Marseille 05, France.
EM philippe.gautret@club-internet.fr
FU Centres for Disease Control and Prevention [U50CK00189]; International
   Society of Travel Medicine (ISTM); ISTM; Public Health Agency of Canada;
   Agence Nationale de la Recherche "Investissements d'avenir"
   (Mediterranee Infection) [10-IAHU-03]
FX GeoSentinel is supported by a cooperative agreement (U50CK00189) between
   the Centres for Disease Control and Prevention and the International
   Society of Travel Medicine (ISTM) and by funding from the ISTM and the
   Public Health Agency of Canada. Mediterranee Infection is funded by the
   Agence Nationale de la Recherche "Investissements d'avenir"
   (Mediterranee Infection 10-IAHU-03).
CR Aubry C, 2012, EURO SURVEILL B EUR, V17, P1
   Bertoncello B, 1999, REV EUROPEENNE MIGRA, V15, P177, DOI DOI 10.3406/remi.1999.1697
   Centre National de Reference du Paludisme, 2015, RAPP ACT 2015
   Cotteaux-Lautard C, 2013, J AM MOSQUITO CONTR, V29, P81, DOI 10.2987/12-6288R.1
   Delord M, 2014, TRAVEL MED INFECT DI, V12, P443, DOI 10.1016/j.tmaid.2014.08.006
   Dia A, 2010, J TRAVEL MED, V17, P296, DOI 10.1111/j.1708-8305.2010.00439.x
   Direction Generale des Entreprises, 2016, ET EC
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Gautret P, 2010, EUROSURVEILLANCE, V15, P2
   Gautret P, 2010, EURO SURVEILL B EUR, V15
   Gautret P, 2015, TRAVEL MED INFECT DI, V13, P485, DOI 10.1016/j.tmaid.2015.09.008
   Gautret P, 2015, EMERG INFECT DIS, V21, P569, DOI 10.3201/eid2104.141479
   Gautret P, 2009, J TRAVEL MED, V16, P377, DOI 10.1111/j.1708-8305.2009.00358.x
   Gharbi M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-35
   Griffiths K, 2016, TRAVEL MED INFECT DI, V14, P414, DOI 10.1016/j.tmaid.2016.05.002
   Hagmann SHF, 2014, FAM PRACT, V31, P678, DOI 10.1093/fampra/cmu063
   Hamer DH, 2017, ANN INTERN MED, V166, P99, DOI 10.7326/M16-1842
   Harvey K, 2013, MMWR SURVEILL SUMM, V62, P1
   Kassim S A, 2016, SAMJ, S. Afr. med. j., V106, P709, DOI [10.7196/samj.2016.v106i7.10902, 10.7196/SAMJ.2016.v106i7.10902]
   Leder K, 2011, TRAVEL MED INFECT DI, V9, P258, DOI 10.1016/j.tmaid.2011.09.002
   Leder K, 2013, EMERG INFECT DIS, V19, P1049, DOI 10.3201/eid1907.121573
   Marks M, 2016, T ROY SOC TROP MED H, V110, P456, DOI 10.1093/trstmh/trw053
   Neumayr A, 2017, EUROSURVEILLANCE, V22, P39, DOI 10.2807/1560-7917.ES.2017.22.1.30433
   Newman RD, 2004, ANN INTERN MED, V141, P547, DOI 10.7326/0003-4819-141-7-200410050-00012
   Ninove L, 2009, EMERG INFECT DIS, V15, P1871, DOI 10.3201/eid1511.081736
   Nutt C, 2017, LANCET, V389, P1595, DOI 10.1016/S0140-6736(17)31051-6
   Parola P, 2004, J TRAVEL MED, V11, P184, DOI 10.2310/7060.2004.18470
   Parola Philippe, 2006, Travel Med Infect Dis, V4, P61, DOI 10.1016/j.tmaid.2005.01.002
   Rapp C, 2014, TRAVEL MED INFECT DI, V12, P355, DOI 10.1016/j.tmaid.2014.03.005
   Savini H, 2013, EMERG INFECT DIS, V19, P1297, DOI 10.3201/eid1908.121739
   Seale H, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1479-1
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Zhou S, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1093-0
NR 33
TC 5
Z9 5
U1 0
U2 3
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1195-1982
EI 1708-8305
J9 J TRAVEL MED
JI J. Travel Med.
PD APR 9
PY 2018
VL 25
AR tay007
DI 10.1093/jtm/tay007
PG 9
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Medicine, General & Internal
SC Public, Environmental & Occupational Health; Infectious Diseases;
   General & Internal Medicine
GA HC0QD
UT WOS:000451503300001
PM 29672709
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Morris, JK
   Springett, AL
   Greenlees, R
   Loane, M
   Addor, MC
   Arriola, L
   Barisic, I
   Bergmann, JEH
   Csaky-Szunyogh, M
   Dias, C
   Draper, ES
   Garne, E
   Gatt, M
   Khoshnood, B
   Klungsoyr, K
   Lynch, C
   McDonnell, R
   Nelen, V
   Neville, AJ
   O'Mahony, M
   Pierini, A
   Queisser-Luft, A
   Randrianaivo, H
   Rankin, J
   Rissmann, A
   Kurinczuk, J
   Tucker, D
   Verellen-Dumoulin, C
   Wellesley, D
   Dolk, H
AF Morris, Joan K.
   Springett, Anna L.
   Greenlees, Ruth
   Loane, Maria
   Addor, Marie-Claude
   Arriola, Larraitz
   Barisic, Ingeborg
   Bergmann, Jorieke E. H.
   Csaky-Szunyogh, Melinda
   Dias, Carlos
   Draper, Elizabeth S.
   Garne, Ester
   Gatt, Miriam
   Khoshnood, Babak
   Klungsoyr, Kari
   Lynch, Catherine
   McDonnell, Robert
   Nelen, Vera
   Neville, Amanda J.
   O'Mahony, Mary
   Pierini, Anna
   Queisser-Luft, Annette
   Randrianaivo, Hanitra
   Rankin, Judith
   Rissmann, Anke
   Kurinczuk, Jennifer
   Tucker, David
   Verellen-Dumoulin, Christine
   Wellesley, Diana
   Dolk, Helen
TI Trends in congenital anomalies in Europe from 1980 to 2012
SO PLOS ONE
LA English
DT Article
ID NEURAL-TUBE DEFECTS; FOLIC-ACID FORTIFICATION; POPULATION-BASED
   EVALUATION; ZIKA VIRUS-INFECTION; HEART-DEFECTS; PREVALENCE; RISK;
   ASSOCIATION; REDUCTION; EUROCAT
AB Background
   Surveillance of congenital anomalies is important to identify potential teratogens.
   Methods
   This study analysed the prevalence of 61 congenital anomaly subgroups (excluding chromosomal) in 25 population-based EUROCAT registries (1980-2012). Live births, fetal deaths and terminations of pregnancy for fetal anomaly were analysed with multilevel random-effects Poisson regression models.
   Results
   Seventeen anomaly subgroups had statistically significant trends from 2003-2012; 12 increasing and 5 decreasing.
   Conclusions
   The annual increasing prevalence of severe congenital heart defects, single ventricle, atrioventricular septal defects and tetralogy of Fallot of 1.4% (95% CI: 0.7% to 2.0%), 4.6% (1.0% to 8.2%), 3.4% (1.3% to 5.5%) and 4.1% (2.4% to 5.7%) respectively may reflect increases in maternal obesity and diabetes (known risk factors). The increased prevalence of cystic adenomatous malformation of the lung [6.5% (3.5% to 9.4%)] and decreased prevalence of limb reduction defects [-2.8% (-4.2% to -1.5%)] are unexplained. For renal dysplasia and maternal infections, increasing trends may be explained by increased screening, and deceases in patent ductus arteriosus at term and increases in craniosynostosis, by improved follow up period after birth and improved diagnosis. For oesophageal atresia, duodenal atresia/stenosis and ano-rectal atresia/stenosis recent changes in prevalence appeared incidental when compared with larger long term fluctuations. For microcephaly and congenital hydronephrosis trends could not be interpreted due to discrepancies in diagnostic criteria. The trends for club foot and syndactyly disappeared once registries with disparate results were excluded. No decrease in neural tube defects was detected, despite efforts at prevention through folic acid supplementation.
C1 [Morris, Joan K.; Springett, Anna L.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.
   [Greenlees, Ruth; Loane, Maria; Dolk, Helen] Univ Ulster, Fac Life & Hlth Sci, Newtownabbey, North Ireland.
   [Addor, Marie-Claude] Univ Hosp Ctr CHUV, Dept Woman Mother Child, Lausanne, Switzerland.
   [Arriola, Larraitz] Biodonostia Res Inst, Publ Hlth Div, San Sebastian, Spain.
   [Barisic, Ingeborg] Univ Zagreb, Med Sch, Childrens Hosp Zagreb, Dept Med Genet & Reprod Hlth, Zagreb, Croatia.
   [Bergmann, Jorieke E. H.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.
   [Csaky-Szunyogh, Melinda] Hungarian Congenital Abnormal Registry, Natl Publ Hlth & Med Officer Serv, Budapest, Hungary.
   [Dias, Carlos] Ctr Estudos & Registo AC, Lisbon, Portugal.
   [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.
   [Garne, Ester] Hosp Lillebaelt, Paediat Dept, Kolding, Denmark.
   [Gatt, Miriam] Directorate Hlth Informat & Res, Guardamangia, Malta.
   [Khoshnood, Babak] Paris Descartes Univ, Obstetr Perinatal & Pediat Epidemiol Res Team, Sorbonne Paris Cite,INSERM,UMR 1153, Ctr Epidemiol & Stat,Paris Registry Congenital An, Paris, France.
   [Klungsoyr, Kari] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway.
   [Klungsoyr, Kari] Norwegian Inst Publ Hlth, Div Mental & Phys Hlth, Bergen, Norway.
   [Lynch, Catherine] Hlth Serv Execut, Dept Publ Hlth, Kilkenny, Ireland.
   [McDonnell, Robert] Hlth Serv Execut, Dept Publ Hlth, Dublin, Ireland.
   [Nelen, Vera] Prov Inst Hyg, Antwerp, Belgium.
   [Neville, Amanda J.] Univ Ferrara, Ctr Clin & Epidemiol Res, IMER Registry, Ferrara, Italy.
   [Neville, Amanda J.] Azienda Osped Univ Ferrara, Ferrara, Italy.
   [O'Mahony, Mary] Hlth Serv Execut, Dept Publ Hlth, Cork, Ireland.
   [Pierini, Anna] CNR, Inst Clin Physiol, Pisa, Italy.
   [Queisser-Luft, Annette] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Ctr Child & Adolescence Med, Mainz, Germany.
   [Randrianaivo, Hanitra] Registre Malformat Congenit Reun, St Pierre, St Pierre & Miq, France.
   [Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England.
   [Rissmann, Anke] Otto von Guericke Univ, Malformat Monitoring Ctr Saxony Anhalt, Magdeburg, Germany.
   [Kurinczuk, Jennifer] Univ Oxford, Natl Perinatal & Epidemiol Unit, Oxford, England.
   [Tucker, David] Publ Hlth Wales, Swansea, W Glam, Wales.
   [Verellen-Dumoulin, Christine] Ctr Human Genet, Inst Pathol Genet, Charleroi, Belgium.
   [Wellesley, Diana] Univ Southampton, Southampton, Hants, England.
   [Wellesley, Diana] Wessex Clin Genet Serv, Southampton, Hants, England.
RP Morris, JK (corresponding author), Queen Mary Univ London, Wolfson Inst Prevent Med, London, England.
EM j.k.morris@qmul.ac.uk
RI Draper, Elizabeth S/I-6304-2018; Draper, Elizabeth/S-6874-2019;
   Khoshnood, Babak/N-9096-2017; Pierini, Anna/A-9622-2013; Matias Dias,
   Carlos/I-6335-2012
OI Draper, Elizabeth S/0000-0001-9340-8176; Draper,
   Elizabeth/0000-0001-9340-8176; Pierini, Anna/0000-0003-3321-9343; Matias
   Dias, Carlos/0000-0002-0206-5874; Klungsoyr, Kari/0000-0003-2482-1690;
   Morris, Joan/0000-0002-7164-612X; Loane, Maria/0000-0002-1206-3637;
   Rankin, Judith/0000-0001-5355-454X
FU European UnionEuropean Union (EU)
FX This work was supported by the European Union in the framework of the
   Health Programme (2008-2013) to all authors. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.r We thank the many people throughout
   Europe involved in providing and processing information, including
   affected families, clinicians, health professionals, medical records
   clerks and registry staff. This work was supported by funding from the
   European Union in the framework of the Health Programme (2008-2013)
CR Bell R, 2012, DIABETOLOGIA, V55, P936, DOI 10.1007/s00125-012-2455-y
   Botting J, 2002, DRUG NEWS PERSPECT, V15, P604, DOI 10.1358/dnp.2002.15.9.840066
   Boyd PA, 2011, BIRTH DEFECTS RES A, V91, pS2, DOI 10.1002/bdra.20780
   Collins JS, 2001, J PEDIAT, V159, P143
   COOPER LZ, 1985, REV INFECT DIS, V7, pS2
   De Wals P, 2007, NEW ENGL J MED, V357, P135, DOI 10.1056/NEJMoa067103
   Dolk H, 2005, ARCH DIS CHILD-FETAL, V90, pF355, DOI 10.1136/adc.2004.062810
   Dolk H, 2015, EUR J EPIDEMIOL, V30, P1153, DOI 10.1007/s10654-015-0012-y
   Dolk H, 2011, CIRCULATION, V123, P841, DOI 10.1161/CIRCULATIONAHA.110.958405
   EUROCAT, 2015, EUROCAT STAT MON REP
   EUROCAT, 2005, EUROCAT GUID 1 3 INS
   EUROCAT, 2009, EUROCAT SPEC REP PRE
   EUROCAT, 2014, EUROCAT STAT MON PRO
   FIRTH HV, 1991, LANCET, V337, P762, DOI 10.1016/0140-6736(91)91374-4
   Greenlees R, 2011, BIRTH DEFECTS RES A, V91, pS51, DOI 10.1002/bdra.20775
   Hackshaw A, 2011, HUM REPROD UPDATE, V17, P589, DOI 10.1093/humupd/dmr022
   Jenkins KJ, 2007, CIRCULATION, V115, P2995, DOI 10.1161/CIRCULATIONAHA.106.183216
   Khoshnood B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5949
   Khoshnood B, 2013, J PEDIATR-US, V162, P108, DOI 10.1016/j.jpeds.2012.06.035
   Lisowski LA, 2010, HERZ, V35, P19, DOI 10.1007/s00059-010-3244-3
   Liu SL, 2013, CIRCULATION, V128, P583, DOI 10.1161/CIRCULATIONAHA.112.001054
   Loane M, 2013, EUR J HUM GENET, V21, P27, DOI 10.1038/ejhg.2012.94
   Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778
   Lopez-Camelo JS, 2005, AM J MED GENET A, V135A, P120, DOI 10.1002/ajmg.a.30651
   MASTROIACOVO P, 1991, LANCET, V337, P1091, DOI 10.1016/0140-6736(91)91735-D
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sayed AR, 2008, BIRTH DEFECTS RES A, V82, P211, DOI 10.1002/bdra.20442
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113
   Tararbit K, 2013, HUM REPROD, V28, P367, DOI 10.1093/humrep/des400
   Tararbit K, 2011, EUR HEART J, V32, P500, DOI 10.1093/eurheartj/ehq440
   Taruscio D, 2014, PUBLIC HEALTH GENOM, V17, P115, DOI 10.1159/000360602
   WHO, 2011, DIAB EP EUR
NR 35
TC 20
Z9 21
U1 0
U2 9
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2018
VL 13
IS 4
AR e0194986
DI 10.1371/journal.pone.0194986
PG 18
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GB6TQ
UT WOS:000429206800031
PM 29621304
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Ranjard, L
   Wong, TKF
   Rodrigo, AG
AF Ranjard, Louis
   Wong, Thomas K. F.
   Rodrigo, Allen G.
TI Reassembling haplotypes in a mixture of pooled amplicons when the
   relative concentrations are known: A proof-of-concept study on the
   efficient design of next-generation sequencing strategies
SO PLOS ONE
LA English
DT Article
ID MITOCHONDRIAL GENOMES; ZIKA
AB Next-generation sequencing can be costly and labour intensive. Usually, the sequencing cost per sample is reduced by pooling amplified DNA = amplicons) derived from different individuals on the same sequencing lane. Barcodes unique to each amplicon permit short-read sequences to be assigned appropriately. However, the cost of the library preparation increases with the number of barcodes used. We propose an alternative to barcoding: by using different known proportions of individually-derived amplicons in a pooled sample, each is characterised a priori by an expected depth of coverage. We have developed a Hidden Markov Model that uses these expected proportions to reconstruct the input sequences. We apply this method to pools of mitochondrial DNA amplicons extracted from kangaroo meat, genus Macropus. Our experiments indicate that the sequence coverage can be efficiently used to index the short-reads and that we can reassemble the input haplotypes when secondary factors impacting the coverage are controlled. We therefore demonstrate that, by combining our approach with standard barcoding, the cost of the library preparation is reduced to a third.
C1 [Ranjard, Louis; Wong, Thomas K. F.; Rodrigo, Allen G.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.
RP Ranjard, L (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.
EM louis.ranjard@anu.edu.au
RI Rodrigo, Allen/E-8905-2015; Ranjard, Louis/M-4525-2015
OI Rodrigo, Allen/0000-0002-8327-7317; Ranjard, Louis/0000-0002-7622-4823
FU Australian Research CouncilAustralian Research Council [DP160103474]
FX This research was supported by the Australian Research Council Discovery
   Project Grant #DP160103474.
CR Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18
   [Anonymous], MATLAB BIOINF TOOLB
   Chen YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062856
   Dodt WG, 2016, MITOCHONDRIAL DNA A, V27, P1366, DOI 10.3109/19401736.2014.947583
   Ekblom R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-467
   Ferretti L, 2013, MOL ECOL, V22, P5561, DOI 10.1111/mec.12522
   Futschik A, 2010, NEXT GENERATION MOLE, V218, P207
   GARRISON E, 2012, GENOMICS, V1207, P3907, DOI DOI 10.1101/1207.3907
   Gautier M, 2013, MOL ECOL, V22, P3766, DOI 10.1111/mec.12360
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leguia M, 2017, J VIROL METHODS, V248, P77, DOI 10.1016/j.jviromet.2017.06.005
   Mariac C, 2014, MOL ECOL RESOUR, V14, P1103, DOI 10.1111/1755-0998.12258
   McComish BJ, 2010, GENOME BIOL EVOL, V2, P410, DOI 10.1093/gbe/evq029
   Minoche AE, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r112
   Nilsson MA, 2003, J MOL EVOL, V57, pS3, DOI 10.1007/s00239-003-0001-8
   O'Neill EM, 2013, MOL ECOL, V22, P111, DOI 10.1111/mec.12049
   Penalba JV, 2014, MOL ECOL RESOUR, V14, P1000, DOI 10.1111/1755-0998.12249
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Schlotterer C, 2014, NAT REV GENET, V15, P749, DOI 10.1038/nrg3803
   Sham P, 2002, NAT REV GENET, V3, P862, DOI 10.1038/nrg930
   State of New South Wales and Office of Environment and Heritage, 2017, 2016 ANN REP
   Van den Hoecke S, 2016, SCI REP-UK, V6, DOI 10.1038/srep26314
   VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010
   Wu SH, 2017, BIOINFORMATICS, V266, P554
   Zhou H, 2017, MATLAB MGLM TOOLBOX
NR 26
TC 2
Z9 2
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 5
PY 2018
VL 13
IS 4
AR e0195090
DI 10.1371/journal.pone.0195090
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GB6TQ
UT WOS:000429206800036
PM 29621260
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mavigner, M
   Raper, J
   Kovacs-Balint, Z
   Gumber, S
   O'Neal, JT
   Bhaumik, SK
   Zhang, XD
   Habib, J
   Mattingly, C
   McDonald, CE
   Avanzato, V
   Burke, MW
   Magnani, DM
   Bailey, VK
   Watkins, DI
   Vanderford, TH
   Fair, D
   Earl, E
   Feczko, E
   Styner, M
   Jean, SM
   Cohen, JK
   Silvestri, G
   Johnson, RP
   O'Connor, DH
   Wrammert, J
   Suthar, MS
   Sanchez, MM
   Alvarado, MC
   Chahroudi, A
AF Mavigner, Maud
   Raper, Jessica
   Kovacs-Balint, Zsofia
   Gumber, Sanjeev
   O'Neal, Justin T.
   Bhaumik, Siddhartha K.
   Zhang, Xiaodong
   Habib, Jakob
   Mattingly, Cameron
   McDonald, Circe E.
   Avanzato, Victoria
   Burke, Mark W.
   Magnani, Diogo M.
   Bailey, Varian K.
   Watkins, David I.
   Vanderford, Thomas H.
   Fair, Damien
   Earl, Eric
   Feczko, Eric
   Styner, Martin
   Jean, Sherrie M.
   Cohen, Joyce K.
   Silvestri, Guido
   Johnson, R. Paul
   O'Connor, David H.
   Wrammert, Jens
   Suthar, Mehul S.
   Sanchez, Mar M.
   Alvarado, Maria C.
   Chahroudi, Ann
TI Postnatal Zika virus infection is associated with persistent
   abnormalities in brain structure, function, and behavior in infant
   macaques
SO SCIENCE TRANSLATIONAL MEDICINE
LA English
DT Article
ID RECOGNITION MEMORY; NEONATAL AMYGDALA; NEUROIMAGING FINDINGS; PREFRONTAL
   CORTEX; RHESUS MACAQUES; SOCIAL-BEHAVIOR; MACACA-MULATTA; HIPPOCAMPUS;
   LESIONS; RESPONSES
AB The Zika virus (ZIKV) epidemic is associated with fetal brain lesions and other serious birth defects classified as congenital ZIKV syndrome. Postnatal ZIKV infection in infants and children has been reported; however, data on brain anatomy, function, and behavioral outcomes following infection are absent. We show that postnatal ZIKV infection of infant rhesus macaques (RMs) results in persistent structural and functional alterations of the central nervous system compared to age-matched controls. We demonstrate ZIKV lymphoid tropism and neurotropism in infant RMs and histopathologic abnormalities in the peripheral and central nervous systems including inflammatory infiltrates, astrogliosis, and Wallerian degeneration. Structural and resting-state functional magnetic resonance imaging (MRI/rs-fMRI) show persistent enlargement of lateral ventricles, maturational changes in specific brain regions, and altered functional connectivity (FC) between brain areas involved in emotional behavior and arousal functions, including weakened amygdala-hippocampal connectivity in two of two ZIKV-infected infant RMs several months after clearance of ZIKV RNA from peripheral blood. ZIKV infection also results in distinct alterations in the species-typical emotional reactivity to acute stress, which were predicted by the weak amygdala-hippocampal FC. We demonstrate that postnatal ZIKV infection of infants in this model affects neurodevelopment, suggesting that long-term clinical monitoring of pediatric cases is warranted.
C1 [Mavigner, Maud; Bhaumik, Siddhartha K.; Habib, Jakob; Mattingly, Cameron; Avanzato, Victoria; Wrammert, Jens; Suthar, Mehul S.; Chahroudi, Ann] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.
   [Raper, Jessica; Kovacs-Balint, Zsofia; Gumber, Sanjeev; Zhang, Xiaodong; Vanderford, Thomas H.; Jean, Sherrie M.; Cohen, Joyce K.; Silvestri, Guido; Johnson, R. Paul; Sanchez, Mar M.; Alvarado, Maria C.; Chahroudi, Ann] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.
   [O'Neal, Justin T.; McDonald, Circe E.; Suthar, Mehul S.] Emory Vaccine Ctr, Atlanta, GA 30329 USA.
   [Burke, Mark W.] Howard Univ, Dept Physiol & Biophys, Washington, DC 20060 USA.
   [Magnani, Diogo M.; Bailey, Varian K.; Watkins, David I.] Univ Miami, Dept Pathol, Miami, FL 33146 USA.
   [Fair, Damien; Earl, Eric; Feczko, Eric] Oregon Hlth & Sci Univ, Portland, OR 97239 USA.
   [Styner, Martin] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27599 USA.
   [Silvestri, Guido] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.
   [O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.
   [Sanchez, Mar M.; Alvarado, Maria C.] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA 30322 USA.
   [Chahroudi, Ann] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.
RP Chahroudi, A (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.; Chahroudi, A (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.; Chahroudi, A (corresponding author), Childrens Healthcare Atlanta, Atlanta, GA 30322 USA.
EM achahro@emory.edu
RI Raper, Jessica/J-6355-2019
OI Raper, Jessica/0000-0002-0964-9944; Gumber, Sanjeev/0000-0001-9048-2717;
   Alvarado, Maria C./0000-0001-8858-6373; Magnani,
   Diogo/0000-0002-1773-2406; Mavigner, Maud/0000-0001-9898-317X
FU Pilot Grant Program of the YNPRC [P51 OD011132]; Emory Center for
   Childhood Infections and Vaccines, and Children's Healthcare of Atlanta;
   National Library of Medicine of the NIH [T15LM007088]
FX This work was supported by the Pilot Grant Program of the YNPRC (P51
   OD011132), as well as funding from the Emory Center for Childhood
   Infections and Vaccines, and Children's Healthcare of Atlanta (all to
   A.C.). Research reported in this publication was supported by the
   National Library of Medicine of the NIH under award number T15LM007088
   (to E.F.).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alvarado MC, 2017, BRIT J ANAESTH, V119, P517, DOI 10.1093/bja/aew473
   Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Beauregard M, 1996, CAN J PSYCHIAT, V41, P446, DOI 10.1177/070674379604100710
   Bechara A, 2004, INT REV NEUROBIOL, V62, P159, DOI 10.1016/S0074-7742(04)62006-X
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bianchi S, 2013, P NATL ACAD SCI USA, V110, P10395, DOI 10.1073/pnas.1301224110
   Bliss-Moreau E, 2017, BEHAV BRAIN RES, V322, P123, DOI 10.1016/j.bbr.2016.11.052
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064
   Buchanan TW, 2004, BIOL PSYCHIAT, V56, P651, DOI 10.1016/j.biopsych.2004.08.014
   Burbacher TM, 2012, NEUROTOXICOL TERATOL, V34, P473, DOI 10.1016/j.ntt.2012.06.003
   Centers for Disease Control and Prevention, ZIK INF CHILDR
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Coleman K, 2014, ILAR J, V55, P333, DOI 10.1093/ilar/ilu019
   Cooper ER, 1998, J PEDIATR-US, V132, P808, DOI 10.1016/S0022-3476(98)70308-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Dudley D. M., 2018, SCI TRANSL MED, V10
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   EPSTEIN LG, 1988, ANN NEUROL, V23, pS19, DOI 10.1002/ana.410230709
   FAGAN JF, 1970, J EXP CHILD PSYCHOL, V9, P217, DOI 10.1016/0022-0965(70)90087-1
   Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104
   Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381
   FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Glantz LA, 2007, NEUROSCIENCE, V149, P582, DOI 10.1016/j.neuroscience.2007.06.036
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013
   Gottlieb DH, 2013, AM J PRIMATOL, V75, P314, DOI 10.1002/ajp.22107
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043
   Hamprecht K, 2017, CLIN PERINATOL, V44, P121, DOI 10.1016/j.clp.2016.11.012
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hunsaker MR, 2014, HIPPOCAMPUS, V24, P794, DOI 10.1002/hipo.22271
   Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058
   Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z
   Iyer SP, 2013, NEUROIMAGE, V75, P165, DOI 10.1016/j.neuroimage.2013.02.054
   KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713
   KALIN NH, 1989, SCIENCE, V243, P1718, DOI 10.1126/science.2564702
   Karere GM, 2009, BIOL PSYCHIAT, V65, P770, DOI 10.1016/j.biopsych.2008.11.004
   Knickmeyer RC, 2010, CEREB CORTEX, V20, P1053, DOI 10.1093/cercor/bhp166
   Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lavenex P, 2007, DEV NEUROSCI-BASEL, V29, P179, DOI 10.1159/000096222
   Lewis JW, 2000, J COMP NEUROL, V428, P112, DOI 10.1002/1096-9861(20001204)428:1<112::AID-CNE8>3.0.CO;2-9
   Li CX, 2013, NEUROSCI LETT, V541, P58, DOI 10.1016/j.neulet.2013.02.007
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270
   McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003
   McLaren DG, 2009, NEUROIMAGE, V45, P52, DOI 10.1016/j.neuroimage.2008.10.058
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P89, DOI 10.1007/s11604-016-0609-4
   Miller DJ, 2012, P NATL ACAD SCI USA, V109, P16480, DOI 10.1073/pnas.1117943109
   Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moadab G, 2017, BEHAV NEUROSCI, V131, P68, DOI 10.1037/bne0000181
   Moadab G, 2015, BEHAV NEUROSCI, V129, P339, DOI 10.1037/bne0000062
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Murray EA, 2010, CURR OPIN NEUROBIOL, V20, P212, DOI 10.1016/j.conb.2010.02.001
   National Institutes of Health, 2017, STUD EX EFF ZIK INF
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Paxinos G, 1999, RHESUS MONKEY BRAIN
   Payne C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081825
   Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688
   Paz-Bailey G, 2017, N ENGL J MED
   Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048
   Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Raper J, 2017, PSYCHONEUROENDOCRINO, V76, P57, DOI 10.1016/j.psyneuen.2016.11.018
   Raper J, 2015, ANESTHESIOLOGY, V123, P1084, DOI 10.1097/ALN.0000000000000851
   Raper J, 2013, PSYCHONEUROENDOCRINO, V38, P1021, DOI 10.1016/j.psyneuen.2012.10.008
   Raper J, 2013, HORM BEHAV, V63, P646, DOI 10.1016/j.yhbeh.2013.01.010
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Saleem K. S., 2012, COMBINED MRI HISTOLO
   Shi YD, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00617
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Styner M, 2007, PROC SPIE, V6512, DOI 10.1117/12.710027
   Tang CY, 2016, INT ANESTHESIOL CLIN, V54, P129, DOI 10.1097/AIA.0000000000000081
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Zeamer A, 2010, J NEUROSCI, V30, P9157, DOI 10.1523/JNEUROSCI.0022-10.2010
NR 104
TC 27
Z9 27
U1 0
U2 14
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1946-6234
EI 1946-6242
J9 SCI TRANSL MED
JI Sci. Transl. Med.
PD APR 4
PY 2018
VL 10
IS 435
AR eaao6975
DI 10.1126/scitranslmed.aao6975
PG 15
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA GB5IW
UT WOS:000429098800006
PM 29618564
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Schwartz, KL
   Chan, T
   Rai, N
   Murphy, KE
   Whittle, W
   Drebot, MA
   Gubbay, J
   Boggild, AK
AF Schwartz, Kevin L.
   Chan, Tiffany
   Rai, Nanky
   Murphy, Kellie E.
   Whittle, Wendy
   Drebot, Michael A.
   Gubbay, Jonathan
   Boggild, Andrea K.
TI Zika virus infection in a pregnant Canadian traveler with congenital
   fetal malformations noted by ultrasonography at 14-weeks gestation
SO TROPICAL DISEASES TRAVEL MEDICINE AND VACCINES
LA English
DT Article
DE Arbovirus; Congenital infections; Fetal sonography; Pregnancy and
   travel; Zika virus
ID UPDATE INTERIM GUIDANCE; BIRTH-DEFECTS; UNITED-STATES; FETUSES;
   EPIDEMIC; INFANTS; SALIVA; WOMEN; RNA
AB Background Following emergence of Zika virus in the Americas, a devastating new congenital syndrome has been documented, leading to significant morbidity among Zika-infected fetuses and neonates. Case presentation A 29-year-old pregnant woman infected with Zika virus at 9-weeks gestation in Trinidad presented with one-month of fever, headache, and myalgia with persistent viremia. Significant fetal abnormalities were identified at 14-week ultrasound, which is the earliest ultrasound to describe a severely affected fetus following Zika virus infection to our knowledge. Conclusions We discuss the implications of prolonged maternal viremia and the spectrum of congenital Zika syndrome detectable by fetal ultrasound.
C1 [Schwartz, Kevin L.; Gubbay, Jonathan; Boggild, Andrea K.] Publ Hlth Ontario, Toronto, ON, Canada.
   [Schwartz, Kevin L.] St Josephs Hlth Sci Ctr, Toronto, ON, Canada.
   [Schwartz, Kevin L.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Chan, Tiffany; Gubbay, Jonathan; Boggild, Andrea K.] Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
   [Rai, Nanky] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada.
   [Murphy, Kellie E.; Whittle, Wendy] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON, Canada.
   [Whittle, Wendy] Sinai Hlth Syst, Toronto, ON, Canada.
   [Drebot, Michael A.] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.
   [Gubbay, Jonathan] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.
   [Boggild, Andrea K.] Toronto Gen Hosp, Trop Dis Unit, 200 Elizabeth St,13EN-218, Toronto, ON M5G 2C4, Canada.
RP Boggild, AK (corresponding author), Publ Hlth Ontario, Toronto, ON, Canada.; Boggild, AK (corresponding author), Univ Toronto, Dept Med, Div Infect Dis, Toronto, ON, Canada.
EM kevin.schwartz@oahpp.ca; tiffany.chan1@medportal.ca; RaiN@smh.ca;
   kellie.murphy@sinaihealthsystem.ca; wendy.whittle@sinaihealthsystem.ca;
   mike.drebot@phac-aspc.gc.ca; jonathan.gubbay@oahpp.ca;
   andrea.boggild@utoronto.ca
CR Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   GOAR EL, 1945, T AM OPHTHAL SOC, V43, P135
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Riley HD, 1997, SOUTH MED J, V90, P184, DOI 10.1097/00007611-199702000-00004
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Zika Working Group, 2016, Can Commun Dis Rep, V42, P101
NR 27
TC 1
Z9 1
U1 0
U2 0
PU SPRINGERNATURE
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2055-0936
J9 TROP DIS TRAVEL MED
JI Trop. Dis. Travel Med. Vaccines
PD APR 4
PY 2018
VL 4
IS 1
AR UNSP 2
DI 10.1186/s40794-018-0062-8
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
SC Public, Environmental & Occupational Health; Infectious Diseases;
   Tropical Medicine
GA LE5SD
UT WOS:000526777900001
PM 29632700
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ahlers, LRH
   Goodman, AG
AF Ahlers, Laura R. H.
   Goodman, Alan G.
TI The Immune Responses of the Animal Hosts of West Nile Virus: A
   Comparison of Insects, Birds, and Mammals
SO FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY
LA English
DT Review
DE innate immunity; West Nile virus; Culex; host response; vector-borne
   disease
ID INTERFERON REGULATORY FACTOR-3; VECTOR COMPETENCE; CULEX MOSQUITOS;
   HEALTHY-ADULTS; CLIMATE-CHANGE; FEEDING PATTERNS; WOLBACHIA STRAIN;
   NORTH-AMERICA; NEUTRALIZING ANTIBODY; ENCEPHALITIS-VIRUS
AB Vector-borne diseases including-arbovirues, pose a serious threat to public health worldwide. Arboviruses of U is Ilavivirus genus, such as Zika virus (ZIKV), dengue virus, yellow fever virus (YFV), and West Nile virus, (WNV), are transmitted to humans from insect vectors and can cause serious disease. In 2017. over 2.000 reported cases of WNV virus infection occurred in the United States, with two-thirds of cases classified as neuroirwasive. WNV transmission cycles through two different animal populations: birds and mosquitoes. Mammals, particularly humans and horses, can become infected through mosquito bites and represent dead-end hosts of WNV infection. Because WNV can infect diverse species. research on this arbovirus has Investigated the host response in mosquitoes, birds. humans. and horses. With the growing geographical range of the WNV mosquito vector and increased hurnan exposure. Improved surveilance and treatment of the infection will enhance public health in areas where WNV is endemic. In this review. wo survey the bionomics of mosquito species involved in Noarctic WNV transmission. Subsequently, we describe the known immune response pathways that counter WNV infection in insects. birds, and mammals. as well as the mechanisms known to curb viral infection. Moreover. we discuss the bacterium wolbacrila and Its Involvement in reducing flavivIrus titer In insects. Finally. we highlight the similarities of the known Immune pathways and identify potential targets for future studies aimed at improving antiviral therapeutic and vaccination design.
C1 [Ahlers, Laura R. H.; Goodman, Alan G.] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.
   [Goodman, Alan G.] Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
RP Goodman, AG (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.; Goodman, AG (corresponding author), Washington State Univ, Coll Vet Med, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
EM alan.goodman@wsu.edu
RI Goodman, Alan/AAQ-1108-2020
OI Goodman, Alan/0000-0001-6394-332X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21 AI128103]; NIH/NIGMSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [T32
   GM008336]; Poncin Fellowship; Stanley L. Adler Research Fund; Mary V.
   Schindler Equine Research Endowment
FX Research in the Goodman lab is supported by NIH Grant R21 AI128103 to
   AG, NIH/NIGMS funded pre-doctoral fellowship T32 GM008336 and a Poncin
   Fellowship to LA, the Stanley L. Adler Research Fund, and the Mary V.
   Schindler Equine Research Endowment.
CR Ahlers LRH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166088
   Andersen LK, 2017, INT J DERMATOL, V56, P252, DOI 10.1111/ijd.13438
   Arroyo J, 2004, J VIROL, V78, P12497, DOI 10.1128/JVI.78.22.12497-12507.2004
   Baitchman EJ, 2007, J ZOO WILDLIFE MED, V38, P337, DOI 10.1638/1042-7260(2007)038[0337:PTOMAT]2.0.CO;2
   Balasuriya U, 2015, AAEP VACCINATION GUI
   BARR AR, 1957, AM J TROP MED HYG, V6, P153, DOI 10.4269/ajtmh.1957.6.153
   Benitez AA, 2015, CELL REP, V13, P1456, DOI 10.1016/j.celrep.2015.10.020
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Bielefeldt-Ohmann H, 2017, MICROB PATHOGENESIS, V103, P71, DOI 10.1016/j.micpath.2016.12.018
   Bigham AW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024745
   Bourgeois MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024371
   Brackney DE, 2015, J VIROL, V89, P4035, DOI 10.1128/JVI.02612-14
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352
   Chang GJJ, 2007, VACCINE, V25, P2325, DOI 10.1016/j.vaccine.2006.11.056
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chen CC, 2013, INT J ENV RES PUB HE, V10, P3052, DOI 10.3390/ijerph10073052
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Ciota Alexander T., 2011, BMC Ecology, V11, P23, DOI 10.1186/1472-6785-11-23
   Clarke P, 2014, J VIROL, V88, P1080, DOI 10.1128/JVI.02944-13
   Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189
   Daffis S, 2010, NATURE, V468, P452, DOI 10.1038/nature09489
   Darsie Jr R. F., 2005, IDENTIFICATION GEOGR
   Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522
   Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640
   Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064
   Fang Y, 2006, AM J TROP MED HYG, V75, P480, DOI 10.4269/ajtmh.2006.75.480
   Farkas JZ, 2017, J MATH BIOL, V75, P621, DOI 10.1007/s00285-017-1096-7
   Fish I, 2016, INFECT GENET EVOL, V44, P341, DOI 10.1016/j.meegid.2016.07.005
   Fredericksen BL, 2006, J VIROL, V80, P2913, DOI 10.1128/JVI.80.6.2913-2923.2006
   Fredericksen BL, 2004, J VIROL, V78, P7737, DOI 10.1128/JVI.78.14.7737-7747.2004
   Fredericksen BL, 2008, J VIROL, V82, P609, DOI 10.1128/JVI.01305-07
   Gibbs SEJ, 2005, CLIN DIAGN LAB IMMUN, V12, P665, DOI 10.1128/CDLI.12.5.665-667.2005
   Giordano D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006743
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hahn DC, 2006, AVIAN DIS, V50, P454, DOI 10.1637/7509-012606R1.1
   Hertig M, 1924, J MED RES, V44, P329
   Hongoh V, 2012, APPL GEOGR, V33, P53, DOI 10.1016/j.apgeog.2011.05.015
   Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Janssen N, 2015, TROP MED INT HEALTH, V20, P1488, DOI 10.1111/tmi.12587
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Johnson BJ, 2015, INFECT GENET EVOL, V31, P40, DOI 10.1016/j.meegid.2015.01.007
   Johnson KN, 2015, VIRUSES-BASEL, V7, P5705, DOI 10.3390/v7112903
   Jones CI, 2012, WIRES RNA, V3, P455, DOI 10.1002/wrna.1109
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005
   Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lubick KJ, 2015, CELL HOST MICROBE, V18, P61, DOI 10.1016/j.chom.2015.06.007
   Lujan DA, 2014, J MED ENTOMOL, V51, P264, DOI 10.1603/ME13163
   Mackay AJ, 2010, J MED ENTOMOL, V47, P238, DOI 10.1603/ME09168
   Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650
   McMeniman CJ, 2008, APPL ENVIRON MICROB, V74, P6963, DOI 10.1128/AEM.01038-08
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Molaei G, 2006, EMERG INFECT DIS, V12, P468, DOI 10.3201/eid1203.051004
   Monath TP, 2006, P NATL ACAD SCI USA, V103, P6694, DOI 10.1073/pnas.0601932103
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morin CW, 2013, P NATL ACAD SCI USA, V110, P15620, DOI 10.1073/pnas.1307135110
   Morrison J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003265
   Nemeth NM, 2009, AM J TROP MED HYG, V80, P864, DOI 10.4269/ajtmh.2009.80.864
   Nemeth NM, 2008, ECOHEALTH, V5, P298, DOI 10.1007/s10393-008-0183-z
   Olson KE, 2015, CURR OPIN VIROL, V15, P119, DOI 10.1016/j.coviro.2015.10.001
   Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9
   Paradkar PN, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002823
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Rainey SM, 2014, J GEN VIROL, V95, P517, DOI 10.1099/vir.0.057422-0
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rasgon JL, 2004, J MED ENTOMOL, V41, P255, DOI 10.1603/0022-2585-41.2.255
   Reed Kurt D, 2003, Clin Med Res, V1, P5
   Reisen WK, 2012, J AM MOSQUITO CONTR, V28, P82, DOI 10.2987/8756-971X-28.4.82
   Rios JJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-313
   Rios JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010537
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Samuel MA, 2007, J VIROL, V81, P2614, DOI 10.1128/JVI.02311-06
   Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Schuler LA, 2004, JAVMA-J AM VET MED A, V225, P1084, DOI 10.2460/javma.2004.225.1084
   Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07
   Styer LM, 2007, J MED ENTOMOL, V44, P1074, DOI 10.1603/0022-2585(2007)44[1074:WNVIDF]2.0.CO;2
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Szretter KJ, 2011, J VIROL, V85, P11557, DOI 10.1128/JVI.05519-11
   Tag-El-Din-Hassan HT, 2012, JPN J VET RES, V60, P95
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Turell MJ, 2002, VECTOR-BORNE ZOONOT, V2, P193, DOI 10.1089/15303660260613756
   Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130
   USDA APHIS, 2017, W NIL VIR MAPS STAT
   Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y
   Vandergaast R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045800
   Voronin D, 2012, P NATL ACAD SCI USA, V109, pE1638, DOI 10.1073/pnas.1203519109
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wilkins PA, 2006, J VET INTERN MED, V20, P1045, DOI 10.1892/0891-6640(2006)20[1045:PTONAS]2.0.CO;2
   Woolfit M, 2013, GENOME BIOL EVOL, V5, P2189, DOI 10.1093/gbe/evt169
   Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 109
TC 5
Z9 5
U1 4
U2 30
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2235-2988
J9 FRONT CELL INFECT MI
JI Front. Cell. Infect. Microbiol.
PD APR 3
PY 2018
VL 8
AR 96
DI 10.3389/fcimb.2018.00096
PG 9
WC Immunology; Microbiology
SC Immunology; Microbiology
GA GB4RK
UT WOS:000429048200001
PM 29666784
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Song, JZ
   Pandian, V
   Mauk, MG
   Bau, HH
   Cherry, S
   Tisi, LC
   Liu, CC
AF Song, Jinzhao
   Pandian, Vikram
   Mauk, Michael G.
   Bau, Haim H.
   Cherry, Sara
   Tisi, Laurence C.
   Liu, Changchun
TI Smartphone-Based Mobile Detection Platform for Molecular Diagnostics and
   Spatiotemporal Disease Mapping
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID MEDIATED ISOTHERMAL AMPLIFICATION; TIME QUANTITATIVE PCR; ZIKA VIRUS;
   ENZYMATIC AMPLIFICATION; INFECTIOUS-DISEASES; MEDICAL INTERNET;
   NUCLEIC-ACIDS; HEALTH-CARE; THINGS; URINE
AB Rapid and quantitative molecular diagnostics in the field, at home, and at remote clinics is essential for evidence-based disease management, control, and prevention. Conventional molecular diagnostics requires extensive sample preparation, relatively sophisticated instruments, and trained personnel, restricting its use to centralized laboratories. To overcome these limitations, we designed a simple, inexpensive, hand-held, smartphone-based mobile detection platform, dubbed "smart-connected cup" (SCC), for rapid, connected, and quantitative molecular diagnostics. Our platform combines bioluminescent assay in real-time and loop-mediated isothermal amplification (BART-LAMP) technology with smartphone-based detection, eliminating the need for an excitation source and optical filters that are essential in fluorescent-based detection. The incubation heating for the isothermal amplification is provided, electricity-free, with an exothermic chemical reaction, and incubation temperature is regulated with a phase change material. A custom Android App was developed for bioluminescent signal monitoring and analysis, target quantification, data sharing, and spatiotemporal mapping of disease. SCC's utility is demonstrated by quantitative detection of Zika virus (ZIKV) in urine and saliva and HIV in blood within 45 min. We demonstrate SCC's connectivity for disease spatiotemporal mapping with a custom-designed website. Such a smart- and connected-diagnostic system does not require any lab facilities and is suitable for use at home, in the field, in the clinic, and particularly in resource-limited settings in the context of Internet of Medical Things (IoMT).
C1 [Song, Jinzhao; Pandian, Vikram; Mauk, Michael G.; Bau, Haim H.; Liu, Changchun] Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
   [Cherry, Sara] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.
   [Tisi, Laurence C.] ERBA Mol, Ely CB7 4EA, Cambs, England.
RP Liu, CC (corresponding author), Univ Penn, Dept Mech Engn & Appl Mech, Philadelphia, PA 19104 USA.
EM lchangc@seas.upenn.edu
RI Bau, Haim H/D-1161-2009
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01CA214072, R01EB023607, R21DE026700,
   1R21AI128059-A1, R21TW010625]; NAS [AID-OAA-A-11-00012]
FX This work was partially supported by NIH Grants R01CA214072,
   R01EB023607, R21DE026700, 1R21AI128059-A1, R21TW010625, and NAS
   AID-OAA-A-11-00012.
CR Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen DF, 2010, BIOMED MICRODEVICES, V12, P705, DOI 10.1007/s10544-010-9423-4
   Chen W, 2000, ANAL BIOCHEM, V280, P166, DOI 10.1006/abio.2000.4518
   Chen WL, 2017, ANAL CHEM, V89, P11219, DOI 10.1021/acs.analchem.7b02478
   Chen X, 2007, ANAL CHIM ACTA, V584, P237, DOI 10.1016/j.aca.2006.11.057
   Chin CD, 2011, NAT MED, V17, P1015, DOI 10.1038/nm.2408
   Damhorst GL, 2015, ENGINEERING-PRC, V1, P324, DOI 10.15302/J-ENG-2015072
   Dimitrov DV, 2016, HEALTHC INFORM RES, V22, P156, DOI 10.4258/hir.2016.22.3.156
   Dimov IK, 2011, LAB CHIP, V11, P4279
   Easley CJ, 2006, P NATL ACAD SCI USA, V103, P19272, DOI 10.1073/pnas.0604663103
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Gandelman OA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014155
   Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1080-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haghi M, 2017, HEALTHC INFORM RES, V23, P4, DOI 10.4258/hir.2017.23.1.4
   Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986
   Jayakumar P, 2016, SOUTH MED J, V109, P697, DOI 10.14423/SMJ.0000000000000550
   Klein D, 2002, TRENDS MOL MED, V8, P257, DOI 10.1016/S1471-4914(02)02355-9
   Konstantinidis EI, 2015, STUD HEALTH TECHNOL, V210, P587, DOI 10.3233/978-1-61499-512-8-587
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liao SC, 2016, SENSOR ACTUAT B-CHEM, V229, P232, DOI 10.1016/j.snb.2016.01.073
   Liu CC, 2016, LAB CHIP, V16, P553, DOI 10.1039/c5lc01235j
   Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a
   Liu CC, 2009, LAB CHIP, V9, P768, DOI 10.1039/b814322f
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Machouf N, 2006, J MED VIROL, V78, P608, DOI 10.1002/jmv.20582
   Mauk M, 2017, LAB CHIP, V17, P382, DOI 10.1039/c6lc01239f
   Miyamoto S, 2015, ANAL BIOCHEM, V473, P28, DOI 10.1016/j.ab.2014.12.016
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Ozcan A, 2014, LAB CHIP, V14, P3187, DOI 10.1039/c4lc00010b
   Park SY, 2010, APPL MICROBIOL BIOT, V85, P807, DOI 10.1007/s00253-009-2314-z
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Qiu XB, 2011, BIOMED MICRODEVICES, V13, P809, DOI 10.1007/s10544-011-9551-5
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Sieverink F, 2016, STUD HEALTH TECHNOL, V221, P129, DOI 10.3233/978-1-61499-633-0-129
   Song JZ, 2018, ANAL CHEM, V90, P1209, DOI 10.1021/acs.analchem.7b03834
   Song JZ, 2017, CLIN CHEM, V63, P714, DOI 10.1373/clinchem.2016.263665
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Steinhubl SR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3487
   Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996
   Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064
   Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8
NR 44
TC 23
Z9 24
U1 27
U2 87
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD APR 3
PY 2018
VL 90
IS 7
BP 4823
EP 4831
DI 10.1021/acs.analchem.8b00283
PG 9
WC Chemistry, Analytical
SC Chemistry
GA GB9HV
UT WOS:000429385800080
PM 29542319
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Li, Y
   Zhang, ZZ
   Phoo, WW
   Loh, YR
   Li, R
   Yang, HY
   Jansson, AE
   Hill, J
   Keller, TH
   Nacro, K
   Luo, DH
   Kang, CB
AF Li, Yan
   Zhang, Zhenzhen
   Phoo, Wint Wint
   Loh, Ying Ru
   Li, Rong
   Yang, Hai Yan
   Jansson, Anna E.
   Hill, Jeffrey
   Keller, Thomas H.
   Nacro, Kassoum
   Luo, Dahai
   Kang, CongBao
TI Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease
   by a Small-Molecule Inhibitor
SO STRUCTURE
LA English
DT Article
ID CRYSTAL-STRUCTURE; DRUG DISCOVERY; NS3 PROTEASE; DENGUE; PROTEINASE;
   REFINEMENT; ACTIVATION; INTERFACE; PROGRESS; DESIGN
AB Zika virus (ZIKV) infection has become a global public health concern. The viral NS2B-NS3 protease is an attractive antiviral target because of its role in maturation of viral non-structural proteins. Substrate-derived protease inhibitors have been investigated, but it remains challenging to develop them into drugs. Small-molecule inhibitors are of great interest in antiviral drug development. Here we report the structure and dynamics of ZIKV NS2B-NS3 protease covalently bound to a small-molecule inhibitor. Our crystallographic and NMR studies demonstrate that the inhibitor further stabilizes the closed conformation of ZIKV protease. Upon hydrolysis in situ into two fragments, the benzoyl group of the inhibitor forms a covalent bond with the side chain of catalytic residue S135, whereas the second fragment exhibits no obvious molecular interactions with the protease. This study provides a detailed mechanism of action for a covalent inhibitor, which will guide further development of ZIKV protease inhibitors.
C1 [Li, Yan; Loh, Ying Ru; Li, Rong; Yang, Hai Yan; Jansson, Anna E.; Hill, Jeffrey; Keller, Thomas H.; Nacro, Kassoum; Kang, CongBao] ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.
   [Zhang, Zhenzhen; Phoo, Wint Wint; Nacro, Kassoum; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Zhang, Zhenzhen; Phoo, Wint Wint; Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
   [Phoo, Wint Wint] Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 636921, Singapore.
RP Nacro, K; Kang, CB (corresponding author), ASTAR, Expt Therapeut Ctr, 31 Biopolis Way,Nanos 03-01, Singapore 138669, Singapore.; Nacro, K; Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Luo, DH (corresponding author), Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
EM knacro@etc.a-star.edu.sg; luodahai@ntu.edu.sg; cbkang@etc.a-star.edu.sg
RI Kang, Congbao/AAP-7572-2020; Li, Yan/G-4642-2013
OI Kang, Congbao/0000-0002-9886-9374; Li, Yan/0000-0003-1963-839X; Keller,
   Thomas/0000-0002-7553-6235
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Baronti C, 2014, GENOME ANNOUNC, V2
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Deng J, 2012, J MED CHEM, V55, P6278, DOI 10.1021/jm300146f
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X
   Gayen S, 2011, PROTEINS, V79, P2557, DOI 10.1002/prot.23089
   Goddard T. D., 2008, SPARKY 3
   Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101
   Jones CL, 2015, NAT REV DRUG DISCOV, V14, P442, DOI 10.1038/nrd4001-c1
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Keller R. L. J., 2004, THESIS
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Nitsche C, 2012, ANTIVIR RES, V94, P72, DOI 10.1016/j.antiviral.2012.02.008
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585
   Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z
   Sidique S, 2009, BIOORG MED CHEM LETT, V19, P5773, DOI 10.1016/j.bmcl.2009.07.150
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yin Z, 2006, BIOORG MED CHEM LETT, V16, P36, DOI 10.1016/j.bmcl.2005.09.062
   Zhang LN, 2017, ADVANCED ENGINEERING AND TECHNOLOGY III, P25
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 53
TC 24
Z9 25
U1 2
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD APR 3
PY 2018
VL 26
IS 4
BP 555
EP +
DI 10.1016/j.str.2018.02.005
PG 13
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA GB6DK
UT WOS:000429158900006
PM 29526431
OA Green Accepted, Bronze
DA 2020-07-08
ER

PT J
AU Kumar, A
   Jovel, J
   Lopez-Orozco, J
   Limonta, D
   Airo, AM
   Hou, SM
   Stryapunina, I
   Fibke, C
   Moore, RB
   Hobman, TC
AF Kumar, Anil
   Jovel, Juan
   Lopez-Orozco, Joaquin
   Limonta, Daniel
   Airo, Adriana M.
   Hou, Shangmei
   Stryapunina, Iryna
   Fibke, Chad
   Moore, Ronald B.
   Hobman, Tom C.
TI Human Sertoli cells support high levels of Zika virus replication and
   persistence
SO SCIENTIFIC REPORTS
LA English
DT Article
ID SEXUAL TRANSMISSION; SELF-RENEWAL; INFECTION; SPERMATOGENESIS;
   ACTIVATION; APOPTOSIS; BIOLOGY; ENTRY
AB Zika virus is a teratogenic mosquito-transmitted flavivirus that is associated with birth defects in newborns and Guillain-Barre syndrome in adults. The virus can also be sexually transmitted, but currently, very little is known about the cell types supporting virus replication and persistence in human testes. Using primary cell cultures, we observed that Sertoli but not Leydig cells are highly susceptible to Zika virus infection, a process that is dependent on the TAM family receptor Axl. In cell culture, Sertoli cells could be productively infected with Zika virus for at least 6-weeks. Infection of Sertoli cells resulted in dramatic changes to the transcriptional profile of these cells. The most upregulated mRNA in infected cells was basic fibroblast growth factor (FGF2), a cytokine that was found to enhance Zika virus replication and support viral persistence. Together these findings provide key insights into understanding how Zika virus persists in the male reproductive tract and in turn may aid in developing antiviral therapies or strategies to minimize sexual transmission of this pathogen.
C1 [Kumar, Anil; Lopez-Orozco, Joaquin; Limonta, Daniel; Hou, Shangmei; Stryapunina, Iryna; Hobman, Tom C.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.
   [Airo, Adriana M.; Fibke, Chad; Hobman, Tom C.] Univ Alberta, Dept Med Microbiol, Edmonton, AB, Canada.
   [Airo, Adriana M.; Fibke, Chad; Hobman, Tom C.] Univ Alberta, Dept Immunol, Edmonton, AB, Canada.
   [Jovel, Juan] Univ Alberta, Dept Med, Edmonton, AB, Canada.
   [Moore, Ronald B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada.
   [Hobman, Tom C.] Li Ka Shing Inst Virol, Edmonton, AB, Canada.
   [Hobman, Tom C.] Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
RP Hobman, TC (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Univ Alberta, Dept Med Microbiol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Univ Alberta, Dept Immunol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Li Ka Shing Inst Virol, Edmonton, AB, Canada.; Hobman, TC (corresponding author), Women & Childrens Hlth Res Inst, Edmonton, AB, Canada.
EM tom.hobman@ualberta.ca
OI Kumar, Anil/0000-0002-6179-4516; Fibke, Chad/0000-0002-5536-5547
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); Li Ka Shing Institute of Virology; Women &
   Children's Health Research Institute; Alberta Innovates-Health
   Solutions; CIHRCanadian Institutes of Health Research (CIHR)
FX The authors thank Valeria Mancinelli, Eileen Reklow and Sandra O'Keefe
   for technical support. This work was funded by the grants from the
   Canadian Institutes of Health Research (CIHR), the Li Ka Shing Institute
   of Virology and the Women & Children's Health Research Institute to
   T.C.H.; A.K. and D.L. are funded by postdoctoral fellowships from the
   Alberta Innovates-Health Solutions. A.A. is the recipient of a Doctoral
   scholarship from CIHR. T.C.H. holds a Canada Research Chair in RNA virus
   host interactions.
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Bray NL, 2016, NAT BIOTECHNOL, V34, P525, DOI 10.1038/nbt.3519
   Bryckaert M, 1999, ONCOGENE, V18, P7584, DOI 10.1038/sj.onc.1203200
   Chen HL, 2009, MOL CELL ENDOCRINOL, V306, P9, DOI 10.1016/j.mce.2009.01.023
   Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dimitriadis F, 2015, HORM-INT J ENDOCRINO, V14, P479, DOI 10.14310/horm.2002.1633
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca LR, 2016, ANDROLOGY-US, V4, P189, DOI 10.1111/andr.12165
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Guo Y, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0101-2
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kaur G, 2014, SEMIN CELL DEV BIOL, V30, P36, DOI 10.1016/j.semcdb.2014.02.011
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Li B, 2013, BIOCHEM J, V452, P139, DOI 10.1042/BJ20121671
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pimentel H, 2016, BIORXIV
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Takashima S, 2015, STEM CELL REP, V4, P489, DOI 10.1016/j.stemcr.2015.01.010
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Twyffels L, 2011, FEBS J, V278, P3246, DOI 10.1111/j.1742-4658.2011.08274.x
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 38
TC 25
Z9 26
U1 0
U2 5
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 3
PY 2018
VL 8
AR 5477
DI 10.1038/s41598-018-23899-x
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GB3ZK
UT WOS:000428999200013
PM 29615760
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vielle, NJ
   Zumkehr, B
   Garcia-Nicolas, O
   Blank, F
   Stojanov, M
   Musso, D
   Baud, D
   Summerfield, A
   Alves, MP
AF Vielle, Nathalie J.
   Zumkehr, Beatrice
   Garcia-Nicolas, Obdulio
   Blank, Fabian
   Stojanov, Milos
   Musso, Didier
   Baud, David
   Summerfield, Artur
   Alves, Marco P.
TI Silent infection of human dendritic cells by African and Asian strains
   of Zika virus
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ADAPTIVE IMMUNITY; DENGUE VIRUS; PRODUCTIVE INFECTION; NEURAL
   PROGENITORS; VIRAL-INFECTION; INNATE; INTERFERON; EXPRESSION;
   FLAVIVIRUSES; REPLICATION
AB While Zika virus (ZIKV) circulated for decades (African lineage strains) without report of outbreaks and severe complications, its emergence in French Polynesia and subsequently in the Americas (Asian lineage strains) was associated with description of severe neurological defects in newborns/neonates and adults. With the aim to identify virus lineage-dependent factors, we compared cell susceptibility, virus replication, cell death and innate immune responses following infection with two African and three contemporary Asian lineage strains of ZIKV. To this end, we used green monkey Vero and Aedes albopictus C6/36 cells and human monocyte-derived dendritic cells (DCs). The latter are involved in the pathogenesis of several mosquito-borne Flavivirus infections. In Vero and C6/36 cells, we observed strain-but not lineage-dependent differences in infection profiles. Nevertheless, in human DCs, no significant differences in susceptibility and virus replication were found between lineages and strains. ZIKV induced antiviral interferon type I/III in a limited fashion, with the exception of one African strain. None of the strains induced cell death or DC maturation in terms of MHC II, CD40, CD80/86 or CCR7 expression. Taken together, our data suggest that a large collection of virus isolates needs to be investigated before conclusions on lineage differences can be made.
C1 [Vielle, Nathalie J.; Zumkehr, Beatrice; Garcia-Nicolas, Obdulio; Summerfield, Artur; Alves, Marco P.] Inst Virol & Immunol, Fed Dept Home Affairs, Mittelhausern, Switzerland.
   [Vielle, Nathalie J.] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland.
   [Blank, Fabian] Univ Bern, Bern Univ Hosp, Dept Clin Res, Resp Med, Bern, Switzerland.
   [Stojanov, Milos; Baud, David] Lausanne Univ Hosp, Dept Woman Mother Child, Materno Fetal & Obstet Res Unit, Lausanne, Switzerland.
   [Musso, Didier] Inst Louis Malarde, Unit Emerging Infect Dis, Tahiti, French Polynesi, France.
   [Summerfield, Artur; Alves, Marco P.] Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
   [Musso, Didier] Aix Marseille Univ, IRD, AP HM, SSA,VITROME,IHU Mediterranee Infect, Marseille, France.
RP Alves, MP (corresponding author), Inst Virol & Immunol, Fed Dept Home Affairs, Mittelhausern, Switzerland.; Alves, MP (corresponding author), Univ Bern, Vetsuisse Fac, Dept Infect Dis & Pathobiol, Bern, Switzerland.
EM marco.alves@vetsuisse.unibe.ch
RI Summerfield, Artur/H-6025-2019; Musso, Didier/P-7809-2016; Musso,
   Didier/AAO-8178-2020; Stojanov, Milos/G-4396-2015
OI Summerfield, Artur/0000-0001-8292-4634; Musso,
   Didier/0000-0002-9226-0971; Musso, Didier/0000-0002-9226-0971; Blank,
   Fabian/0000-0002-3374-0414; Baud, David/0000-0001-9914-6496; Stojanov,
   Milos/0000-0002-5166-5841
CR Baud D, 2017, LANCET
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Coccia EM, 2004, EUR J IMMUNOL, V34, P796, DOI 10.1002/eji.200324610
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dar HA, 2017, INFECT GENET EVOL, V51, P143, DOI 10.1016/j.meegid.2017.03.027
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hou WQ, 2012, BLOOD, V119, P3128, DOI 10.1182/blood-2011-09-379479
   Hsu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24530
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Iversen MB, 2010, J VIROL, V84, P4579, DOI 10.1128/JVI.02591-09
   Iwasaki A, 2010, SCIENCE, V327, P291, DOI 10.1126/science.1183021
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4304
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Robertson SJ, 2014, J IMMUNOL, V192, P2744, DOI 10.4049/jimmunol.1302110
   Schlitzer A, 2015, SEMIN CELL DEV BIOL, V41, P9, DOI 10.1016/j.semcdb.2015.03.011
   Schmid MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00647
   Schogler A, 2015, EUR RESPIR J, V45, P428, DOI 10.1183/09031936.00102014
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Simonin Y, 2016, EBIOMEDICINE
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017
   Steinman RM, 2006, CURR TOP MICROBIOL, V311, P17
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Wira CR, 2005, IMMUNOL REV, V206, P306, DOI 10.1111/j.0105-2896.2005.00287.x
NR 55
TC 13
Z9 13
U1 0
U2 7
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD APR 3
PY 2018
VL 8
AR 5440
DI 10.1038/s41598-018-23734-3
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GB3XP
UT WOS:000428994100033
PM 29615676
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pomerantz, A
   Penafiel, N
   Arteaga, A
   Bustamante, L
   Pichardo, F
   Coloma, LA
   Barrio-Amoros, CL
   Salazar-Valenzuela, D
   Prost, S
AF Pomerantz, Aaron
   Penafiel, Nicolaa
   Arteaga, Alejandro
   Bustamante, Lucas
   Pichardo, Frank
   Coloma, Luis A.
   Barrio-Amoros, Cesar L.
   Salazar-Valenzuela, David
   Prost, Stefan
TI Real-time DNA barcoding in a rainforest using nanopore sequencing:
   opportunities for rapid biodiversity assessments and local capacity
   building
SO GIGASCIENCE
LA English
DT Article
DE nanopore sequencing; portable; DNA barcoding; biodiversity; field-based;
   real-time
ID ZIKA VIRUS; CONSERVATION; BUFONIDAE; MINION; EARTHS
AB Background: Advancements in portable scientific instruments provide promising avenues to expedite field work in order to understand the diverse array of organisms that inhabit our planet. Here, we tested the feasibility for in situ molecular analyses of endemic fauna using a portable laboratory fitting within a single backpack in one of the world's most imperiled biodiversity hotspots, the Ecuadorian Choco rainforest. We used portable equipment, including the MinION nanopore sequencer (Oxford Nanopore Technologies) and the miniPCR (miniPCR), to perform DNA extraction, polymerase chain reaction amplification, and real-time DNA barcoding of reptile specimens in the field. Findings: We demonstrate that nanopore sequencing can be implemented in a remote tropical forest to quickly and accurately identify species using DNA barcoding, as we generated consensus sequences for species resolution with an accuracy of >99% in less than 24 hours after collecting specimens. The flexibility of our mobile laboratory further allowed us to generate sequence information at the Universidad Tecnologica Indoamerica in Quito for rare, endangered, and undescribed species. This includes the recently rediscovered Jambato toad, which was thought to be extinct for 28 years. Sequences generated on the MinION required as few as 30 reads to achieve high accuracy relative to Sanger sequencing, and with further multiplexing of samples, nanopore sequencing can become a cost-effective approach for rapid and portable DNA barcoding. Conclusions: Overall, we establish how mobile laboratories and nanopore sequencing can help to accelerate species identification in remote areas to aid in conservation efforts and be applied to research facilities in developing countries. This opens up possibilities for biodiversity studies by promoting local research capacity building, teaching nonspecialists and students about the environment, tackling wildlife crime, and promoting conservation via research-focused ecotourism.
C1 [Pomerantz, Aaron; Prost, Stefan] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
   [Penafiel, Nicolaa; Salazar-Valenzuela, David] Univ Tecnol Indoamer, Fac Ciencias Medio Ambiente, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Machala, Quito, Ecuador.
   [Penafiel, Nicolaa; Salazar-Valenzuela, David] Univ Tecnol Indoamer, Fac Ciencias Medio Ambiente, Ctr Invest Biodiversidad & Cambio Climat BioCamb, Sabanilla, Quito, Ecuador.
   [Arteaga, Alejandro] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA.
   [Arteaga, Alejandro] Amer Museum Nat Hist, Dept Herpetol, New York, NY 10024 USA.
   [Arteaga, Alejandro; Bustamante, Lucas; Pichardo, Frank] Trop Herping, Quito, Ecuador.
   [Coloma, Luis A.] Fdn Otonga, Ctr Jambatu Invest & Conservac Anfibios, Quito, Ecuador.
   [Barrio-Amoros, Cesar L.] Doc Frog Expedit, Uvita, Costa Rica.
   [Prost, Stefan] Stanford Univ, Program Conservat Genom, Dept Biol, Stanford, CA 94305 USA.
RP Pomerantz, A (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.
EM pomerantz_aaron@berkeley.edu; stefanprost.research@protonmail.com
RI Coloma, Luis/AAO-3956-2020; Salazar-Valenzuela, David/C-6525-2016;
   Arteaga, Alejandro/AAL-3432-2020
OI Coloma, Luis/0000-0003-0158-2455; Salazar-Valenzuela,
   David/0000-0002-3874-7690; Arteaga, Alejandro/0000-0002-0014-3728;
   Prost, Stefan/0000-0002-6229-3596; Pomerantz, Aaron/0000-0002-6412-9001
FU National Geographic Society/Waitt grantNational Geographic Society
   [W412-15]; Program of Conservation Genomics at Stanford University;
   Tropical Herping and Universidad Tecnologica Indoamerica
FX Fieldwork for this project was made possible with the support of
   Tropical Herping and Universidad Tecnologica Indoamerica. For granting
   access to the Canande reserve, we are grateful to Martin Schaefer of
   Fundacion Jocotoco. Funding for equipment and reagents was supported by
   the National Geographic Society/Waitt grant (W412-15). Travel funding
   for Stefan Prost was provided by the Program of Conservation Genomics at
   Stanford University. Laboratory work was carried out at Universidad
   Tecnologica Indoamerica in Quito. Research and collection permits were
   issued by the Ministerio del Ambiente de Ecuador (MAE-DNB-CM-2015-0017).
   The Jambato toad tissue was provided by the Museum of Centro Jambatu
   under the Ministerio del Ambiente de Ecuador project "Conservation of
   Ecuadorian amphibian diversity and sustainable use of its genetic
   resources." We thank Oxford Nanopore Technologies for providing
   technical support, making the offline MinKNOW software available, and
   for providing two free flow cells. We also thank Hitomi Asahara and the
   UC Berkeley DNA Sequencing Facility for lending the bench-top centrifuge
   used in this study; Jared Simpson, Sergey Koren, and Adam Phillippy for
   very helpful advice and discussion on the bioinformatic pipeline; and
   Ellie E. Armstrong for valuable input on the manuscript.
CR Ayub M, 2013, NANO LETT, V13, P6144, DOI 10.1021/nl403469r
   Barley AJ, 2013, EVOLUTION, V67, P3556, DOI 10.1111/evo.12219
   Bhamla MS, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-016-0009
   Bik HM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002231
   Canier L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-405
   Carstens BC, 2013, MOL ECOL, V22, P4369, DOI 10.1111/mec.12413
   Castro-Wallace SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18364-0
   Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114
   Centeno-Cuadros A, 2017, MOL ECOL RESOUR, V17, P153, DOI 10.1111/1755-0998.12540
   Chandler Jodie, 2017, F1000Res, V6, P56, DOI 10.12688/f1000research.10545.1
   Coloma LA, 2016, JAMBATO NEGRO PARAMO
   Coloma Luis A., 2010, Zootaxa, V2574, P1
   Cuesta Francisco, 2017, Neotropical Biodiversity, V3, P93, DOI 10.1080/23766808.2017.1295705
   Dinerstein E., 1995, CONSERVATION ASSESSM, Vxvii, P129
   Edwards A., 2016, EXTREME METAGENOMICS, DOI [10.1101/073965, DOI 10.1101/073965]
   Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035
   ERWIN T L, 1982, Coleopterists Bulletin, V36, P74
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Fernandez F, 2011, CALDASIA, V33, P665
   Garalde DR, 2018, NAT METHODS, V15, P201, DOI [10.1038/NMETH.4577, 10.1038/nmeth.4577]
   Gascon C, 2015, CURR BIOL, V25, pR431, DOI 10.1016/j.cub.2015.03.041
   Gilbert N, 2010, NATURE, V463, P598, DOI 10.1038/463598a
   Glenn TC, 2011, MOL ECOL RESOUR, V11, P759, DOI 10.1111/j.1755-0998.2011.03024.x
   Guevara EE, 2018, CONSERV GENET RESOUR, V10, P119, DOI 10.1007/s12686-017-0758-5
   Hargreaves AD, 2015, PEERJ, V3, DOI 10.7717/peerj.1441
   Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218
   Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886
   Hebert PDN, 2017, 191619 BIORXIV, DOI [10.1101/191619, DOI 10.1101/191619]
   Howson ELA, 2017, TRANSBOUND EMERG DIS, V64, P861, DOI 10.1111/tbed.12451
   Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715
   Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009
   Kiesecker JM, 2011, ECOL RES, V26, P897, DOI 10.1007/s11284-010-0702-6
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Laver T, 2015, Biomol Detect Quantif, V3, P1
   Lips KR, 2008, PLOS BIOL, V6, P441, DOI 10.1371/journal.pbio.0060072
   Liu S. M., 2017, CHINA ADV METEOROLOG, V2017, P1, DOI DOI 10.1016/J.S0LENER.2017.01.019
   Lotters S, 2011, SYST BIODIVERS, V9, P45, DOI 10.1080/14772000.2011.557403
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   Marx V, 2015, NAT METHODS, V12, P393, DOI 10.1038/nmeth.3369
   Meier R, 2016, CLADISTICS, V32, P100, DOI 10.1111/cla.12115
   Menegon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184741
   Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422
   Mikheyev AS, 2014, MOL ECOL RESOUR, V14, P1097, DOI 10.1111/1755-0998.12324
   Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501
   Olson DM, 1998, CONSERV BIOL, V12, P502, DOI 10.1046/j.1523-1739.1998.012003502.x
   Parker J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08461-5
   Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752
   Pomerantz A, 2018, GIGASCIENCE DATABASE, DOI [10.5524/100426, DOI 10.5524/100426]
   Pounds AJ, 2008, NAT REP CLIM CHANGE, V2, P57, DOI DOI 10.1038/CLIMATE.2008.37
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306
   Ron S, 2004, IUCN RED LIST THREAT
   Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730
   Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008
   Sierra R, 2002, LANDSCAPE URBAN PLAN, V59, P95, DOI 10.1016/S0169-2046(02)00006-3
   Nguyen SH, 2017, BIOINFORMATICS, V33, P3988, DOI 10.1093/bioinformatics/btx537
   STORK NE, 1993, BIODIVERS CONSERV, V2, P215, DOI 10.1007/BF00056669
   Tapia Elicio Eladio, 2017, Neotropical Biodiversity, V3, P157, DOI 10.1080/23766808.2017.1327000
   Weldon C, 2004, EMERG INFECT DIS, V10, P2100, DOI 10.3201/eid1012.030804
   Wick RR, 2017, MICROB GENOMICS, V3, DOI 10.1099/mgen.0.000132
   Zeng Y, 2017, 227439 BIORXIV
NR 62
TC 35
Z9 36
U1 1
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 2047-217X
J9 GIGASCIENCE
JI GigaScience
PD APR 2
PY 2018
VL 7
IS 4
AR giy033
DI 10.1093/gigascience/giy033
PG 14
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA GH0AP
UT WOS:000433064100001
PM 29617771
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Brahma, R
   Gurumayum, S
   Naorem, LD
   Muthaiyan, M
   Gopal, J
   Venkatesan, A
AF Brahma, Rahul
   Gurumayum, Sanathoi
   Naorem, Leimarembi Devi
   Muthaiyan, Mathavan
   Gopal, Jeyakodi
   Venkatesan, Amouda
TI Identification of Hub Genes and Pathways in Zika Virus Infection Using
   RNA-Seq Data: A Network-Based Computational Approach
SO VIRAL IMMUNOLOGY
LA English
DT Article
DE Zika virus; RNA sequencing; biological network; hub genes; pathways
ID APOPTOSIS; CELLS; PHOSPHORYLATION; VISUALIZATION; EXPRESSION; COMPLEXES;
   SYSTEM; GROWTH
AB Zika virus (ZIKV), a single-strand RNA flavivirus, is transmitted primarily through Aedes aegypti. The recent outbreaks in America and unexpected association between ZIKV infection and birth defects have triggered the global attention. This vouches to understand the molecular mechanisms of ZIKV infection to develop effective drug therapy. A systems-level understanding of biological process affected by ZIKV infection in fetal brain sample led us to identify the candidate genes for pharmaceutical intervention and potential biomarkers for diagnosis. To identify the key genes, transcriptomics data (RNA-Seq) with GSE93385 of ZIKV (Strain: MR766) infected human fetal neural stem cell are analyzed. In total, 1,084 differentially expressed genes (DEGs) are identified, that is, 471 upregulated and 613 downregulated genes. Further analysis such as the gene ontology term suggested that the downregulated genes are mostly enriched in defense response to virus, receptor binding, laminin binding, extracellular matrix, endoplasmic reticulum, and for upregulated DEGs: translation initiation, RNA binding, cytosol, and nucleosome are enriched. And through pathway analysis, systemic lupus erythematosus (SLE) is found to be the most enriched pathway. Protein-protein interaction (PPI) network is constructed to find the hub genes using STRING database. The seven key genes namely cyclin-dependent kinase 1 (CDK1), cyclin B1 (CCNB1), histone cluster 1 H2B family member K, (HIST1H2BK) histone cluster 1 H2B family member O (HIST1H2BO), and histone cluster 1 H2B family member B (HIST1H2BB), polo-like kinase 1 (PLK1), and cell division cycle 20 (CDC20) with highest degree are found to be hub genes using Centiscape, a Cytoscape plugin. The modules of PPI network using Molecular Complex Detection plugin are found significant in structural constituent of ribosome, defense response to virus, nucleosome, SLE, extracellular region, and regulation of gene silencing. Thus, identified key hub genes and pathways shed light on molecular mechanism that may contribute to the discovery of novel therapeutic targets and development of new strategies for the intervention of ZIKV disease.
C1 [Brahma, Rahul; Gurumayum, Sanathoi; Naorem, Leimarembi Devi; Muthaiyan, Mathavan; Venkatesan, Amouda] Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Kalapet 605014, Puducherry, India.
   [Gopal, Jeyakodi] Vector Control Res Ctr, Biomed Informat Ctr, Pondicherry, India.
RP Venkatesan, A (corresponding author), Pondicherry Univ, Sch Life Sci, Ctr Bioinformat, Kalapet 605014, Puducherry, India.
EM amouda@yahoo.com
RI Brahma, Rahul/M-3084-2019; muthaiyan, mathavan/J-3202-2016; Brahma,
   Rahul/J-7752-2018
OI Brahma, Rahul/0000-0003-1802-3430; muthaiyan,
   mathavan/0000-0002-4885-203X; Brahma, Rahul/0000-0003-1802-3430; devi,
   naorem leimarembi/0000-0002-2454-2862; Gurumayum,
   Sanathoi/0000-0002-6295-6783
CR Ajiro K, 2000, J BIOL CHEM, V275, P439, DOI 10.1074/jbc.275.1.439
   Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Andrews S., 2010, BABRAHAM BIOINFORM
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos RK, 2017, J VIROL, V91, DOI 10.1128/JVI.01706-16
   Castedo M, 2002, CELL DEATH DIFFER, V9, P1287, DOI 10.1038/sj.cdd.4401130
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Dieker J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165373
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fang YF, 2014, CANCER BIOL THER, V15, P1268, DOI 10.4161/cbt.29691
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He XL, 2006, PLOS GENET, V2, P826, DOI 10.1371/journal.pgen.0020088
   Ji X, 2016, CELL STEM CELL, V18, P262, DOI 10.1016/j.stem.2015.11.007
   Kaleem Afshan, 2006, Pakistan Journal of Zoology, V38, P305
   Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a
   Leffler J, 2014, ANN RHEUM DIS, V73, P1601, DOI 10.1136/annrheumdis-2014-205287
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Martin C, 2011, THESIS
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mok CC, 2003, J CLIN PATHOL, V56, P481, DOI 10.1136/jcp.56.7.481
   Nair J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094328
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pathan M, 2015, PROTEOMICS, V15, P2597, DOI 10.1002/pmic.201400515
   Qin XF, 2016, SCI CHINA LIFE SCI, V59, P737, DOI 10.1007/s11427-016-5069-7
   RStudio Team, 2016, RSTUDIO INT DEV R
   Sakai D, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002566
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scardoni G, 2012, BIOINFORMATICS, V28, P1178
   Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Slomnicki LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16952-8
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Terrano DT, 2010, MOL CELL BIOL, V30, P640, DOI 10.1128/MCB.00882-09
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016
   van Bavel CC, 2009, MOL IMMUNOL, V47, P511, DOI 10.1016/j.molimm.2009.08.009
   van Hemert F, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0551-1
   von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034
   Wan LX, 2014, DEV CELL, V29, P377, DOI 10.1016/j.devcel.2014.04.022
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475
NR 56
TC 4
Z9 4
U1 0
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
PD MAY
PY 2018
VL 31
IS 4
BP 321
EP 332
DI 10.1089/vim.2017.0116
EA APR 2018
PG 12
WC Immunology; Virology
SC Immunology; Virology
GA GE7NM
UT WOS:000428858500002
PM 29608426
DA 2020-07-08
ER

PT J
AU Rocker, AE
   Muller, JA
   Dietzel, E
   Harms, M
   Kruger, F
   Heid, C
   Sowislok, A
   Riber, CF
   Kupke, A
   Lippold, S
   von Einem, J
   Beer, J
   Knoll, B
   Becker, S
   Schmidt-Chanasit, J
   Otto, M
   Vapalahti, O
   Zelikin, AN
   Bitan, G
   Schrader, T
   Munch, J
AF Roecker, Annika E.
   Mueller, Janis A.
   Dietzel, Erik
   Harms, Mirja
   Krueger, Franziska
   Heid, Christian
   Sowislok, Andrea
   Riber, Camilla Frich
   Kupke, Alexandra
   Lippold, Sina
   von Einem, Jens
   Beer, Judith
   Knoell, Bernd
   Becker, Stephan
   Schmidt-Chanasit, Jonas
   Otto, Markus
   Vapalahti, Olli
   Zelikin, Alexander N.
   Bitan, Gal
   Schrader, Thomas
   Muench, Jan
TI The molecular tweezer CLR01 inhibits Ebola and Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika virus; Ebola virus; Broadly active antiviral agents; Virus
   inactivation; Lipid rafts
ID SEXUAL TRANSMISSION; LYSINE; MEMBRANE; TOXICITY; BRAIN; RAFT
AB Ebola (EBOV) and Zika viruses (ZIKV) are responsible for recent global health threats. As no preventive vaccines or antiviral drugs against these two re-emerging pathogens are available, we evaluated whether the molecular tweezer CLR01 may inhibit EBOV and ZIKV infection. This small molecule has previously been shown to inactivate HIV-1 and herpes viruses through a selective interaction with lipid-raft-rich regions in the viral envelope, which results in membrane disruption and loss of infectivity. We found that CLR01 indeed blocked infection of EBOV and ZIKV in a dose-dependent manner. The tweezer inhibited infection of epidemic ZIKV strains in cells derived from the anogenital tract and the central nervous system, and remained antivirally active in the presence of semen, saliva, urine and cerebrospinal fluid. Our findings show that CLR01 is a broad-spectrum inhibitor of enveloped viruses with prospects as a preventative microbicide or antiviral agent.
C1 [Roecker, Annika E.; Mueller, Janis A.; Harms, Mirja; Krueger, Franziska; Muench, Jan] Ulm Univ, Med Ctr, Inst Mol Virol, D-89081 Ulm, Germany.
   [Dietzel, Erik; Kupke, Alexandra; Becker, Stephan] Philipps Univ Marburg, Inst Virol, D-35043 Marburg, Germany.
   [Dietzel, Erik; Kupke, Alexandra; Becker, Stephan] German Ctr Infect Res DZIF, Partner Site Giessen Marburg Langen, D-35043 Marburg, Germany.
   [Heid, Christian; Sowislok, Andrea; Schrader, Thomas] Univ Duisburg Essen, Fac Chem, D-45117 Essen, Germany.
   [Lippold, Sina; von Einem, Jens] Univ Ulm, Med Ctr, Inst Virol, D-89081 Ulm, Germany.
   [Beer, Judith; Knoell, Bernd] Univ Ulm, Inst Physiol Chem, D-89081 Ulm, Germany.
   [Schmidt-Chanasit, Jonas] Bernhard Nocht Inst Tropenmed, D-20359 Hamburg, Germany.
   [Schmidt-Chanasit, Jonas] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel, D-20359 Hamburg, Germany.
   [Otto, Markus] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
   [Vapalahti, Olli] Univ Helsinki, Dept Virol & Immunol, Helsinki 00014, Finland.
   [Vapalahti, Olli] Helsinki Univ Hosp, Helsinki 00014, Finland.
   [Vapalahti, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki 00014, Finland.
   [Bitan, Gal] Univ Calif Los Angeles, Brain Res Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Bitan, Gal] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.
   [Muench, Jan] Ulm Univ, U PEP, D-89081 Ulm, Germany.
   [Muench, Jan] Ulm Univ, Core Facil Funct Peptid, D-89081 Ulm, Germany.
RP Munch, J (corresponding author), Ulm Univ, Med Ctr, Inst Mol Virol, D-89081 Ulm, Germany.
EM jan.muench@uni-ulm.de
RI Otto, Markus/F-4304-2015; Bitan, Gal/U-2204-2019; Zelikin,
   Alexander/J-3659-2012
OI Otto, Markus/0000-0003-4273-4267; Bitan, Gal/0000-0001-7046-3754; Jan,
   Munch/0000-0001-7316-7141; Zelikin, Alexander/0000-0002-9864-321X;
   Frich, Camilla Kaas/0000-0002-9664-3830; Vapalahti,
   Olli/0000-0003-2270-6824
FU DFGGerman Research Foundation (DFG) [CRC1279, CRC1921, CRC1093];
   Baden-Wurttemberg Stiftung
FX J.M., T.S. and S.B. acknowledge DFG funding (CRC1279, CRC1921 and
   CRC1093, respectively). J.A.M. acknowledges funding by the
   Baden-Wurttemberg Stiftung.
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Attar A, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-23
   Attar A, 2012, BRAIN, V135, P3735, DOI 10.1093/brain/aws289
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bavari S, 2002, J EXP MED, V195, P593, DOI 10.1084/jem.20011500
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103
   Buschmann H., 2017, DRUG SELECTIVITY EVO
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CDC, 2016, 2014 EB OUTBR W AFR
   Chan R, 2008, J VIROL, V82, P11228, DOI 10.1128/JVI.00981-08
   Chazal N, 2003, MICROBIOL MOL BIOL R, V67, P226, DOI 10.1128/MMBR.67.2.226-237.2003
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deen GF, 2017, NEW ENGL J MED, V377, P1428, DOI 10.1056/NEJMoa1511410
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ebihara H, 2007, J INFECT DIS, V196, pS313, DOI 10.1086/520590
   *FDA, 2006, GUID IND ANT PROD DE
   Ferreira N, 2014, NEUROTHERAPEUTICS, V11, P450, DOI 10.1007/s13311-013-0256-8
   Fokkens M, 2005, J AM CHEM SOC, V127, P14415, DOI 10.1021/ja052806a
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hoenen T, 2013, ANTIVIR RES, V99, P207, DOI 10.1016/j.antiviral.2013.05.017
   Hu S, 2006, PROTEOMICS, V6, P6326, DOI 10.1002/pmic.200600284
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lopes DHJ, 2015, ACS CHEM BIOL, V10, P1555, DOI 10.1021/acschembio.5b00146
   Lorizate M, 2013, CELL MICROBIOL, V15, P292, DOI 10.1111/cmi.12101
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Lulla A., 2016, NEUROTOXICITY PARKIN
   Lump E, 2015, ELIFE, V4, DOI 10.7554/eLife.05397
   Malik R., 2017, METHODS MOL IN PRESS
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Muller JA, 2017, MED MICROBIOL IMMUN, V206, P175, DOI 10.1007/s00430-017-0493-2
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prabhudesai S, 2012, NEUROTHERAPEUTICS, V9, P464, DOI 10.1007/s13311-012-0105-1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richter F., 2017, NEUROTHERAPEUTICS, P1
   Schandock F., 2017, ADV HEALTHC MATER, V6
   Schrader T, 2016, CHEM COMMUN, V52, P11318, DOI 10.1039/c6cc04640a
   Sharma R, 2017, J CLIN DIAGN RES, V11, DOI 10.7860/JCDR/2017/22184.9863
   Shuaib W, 2016, AM J MED, V129, DOI 10.1016/j.amjmed.2016.02.027
   Sinha S, 2011, J AM CHEM SOC, V133, P16958, DOI 10.1021/ja206279b
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Talbiersky P, 2008, J AM CHEM SOC, V130, P9824, DOI 10.1021/ja801441j
   Usmani SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4508
   Vibhakar PA, 2013, INT J ORAL MAXILLOF, V4, P13
   Xu N, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006182
   Zhu JD, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00517
NR 55
TC 12
Z9 12
U1 1
U2 19
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2018
VL 152
BP 26
EP 35
DI 10.1016/j.antiviral.2018.02.003
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA GB9ML
UT WOS:000429397800004
PM 29428508
OA Green Published
DA 2020-07-08
ER

PT J
AU Li, T
   Zhao, Q
   Yang, XY
   Chen, C
   Yang, KL
   Wu, C
   Zhang, TQ
   Duan, YK
   Xue, XY
   Mi, KX
   Ji, XY
   Wang, ZF
   Yang, HT
AF Li, Ting
   Zhao, Qi
   Yang, Xiaoyun
   Chen, Cheng
   Yang, Kailin
   Wu, Chen
   Zhang, Tianqing
   Duan, Yinkai
   Xue, Xiaoyu
   Mi, Kaixia
   Ji, Xiaoyun
   Wang, Zefang
   Yang, Haitao
TI Structural insight into the Zika virus capsid encapsulating the viral
   genome
SO CELL RESEARCH
LA English
DT Letter
ID CORE PROTEIN; DRUG DESIGN; RNA
C1 [Li, Ting; Yang, Xiaoyun; Chen, Cheng; Wu, Chen; Zhang, Tianqing; Duan, Yinkai; Wang, Zefang; Yang, Haitao] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.
   [Li, Ting; Yang, Haitao] Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
   [Zhao, Qi; Xue, Xiaoyu] Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.
   [Yang, Kailin] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44195 USA.
   [Mi, Kaixia] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.
   [Ji, Xiaoyun] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China.
RP Yang, HT (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Yang, HT (corresponding author), Tianjin Int Joint Acad Biotechnol & Med, Tianjin 300457, Peoples R China.
EM yanght@tju.edu.cn
OI Ji, Xiaoyun/0000-0002-0801-8825
FU National Key Basic Research Program of China (973 program)National Basic
   Research Program of China [2015CB859800]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [81772204, 31528006]; National Key Research Program of China
   [2016YFD0500300]
FX We thank Wen Cui and Hongliang Tian for data collection at beamline
   BL17U1 and BL18U1 of the Shanghai Synchrotron Radiation Facility (SSRF);
   Jun Li for data collection at beamline I04 of DIAMOND Synchrotron
   Radiation Facility (Britain); Xia Chen for technical support; Michael
   Rossmann, Lei Sun, and Erin Weber for discussion and advice. This work
   was supported by the National Key Basic Research Program of China (973
   program; 2015CB859800), the National Natural Science Foundation of China
   (81772204 and 31528006), and the National Key Research Program of China
   (2016YFD0500300).
CR Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Jones CT, 2003, J VIROL, V77, P7143, DOI 10.1128/JVI.77.12.7143-7149.2003
   Khromykh AA, 1996, ARCH VIROL, V141, P685, DOI 10.1007/BF01718326
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Samuel GH, 2016, P NATL ACAD SCI USA, V113, P13863, DOI 10.1073/pnas.1600544113
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tseng HN, 2007, VIRUS GENES, V35, P483, DOI 10.1007/s11262-006-0075-7
NR 12
TC 9
Z9 9
U1 2
U2 16
PU INST BIOCHEMISTRY & CELL BIOLOGY
PI SHANGHAI
PA SIBS, CAS, 319 YUEYANG ROAD, SHANGHAI, 200031, PEOPLES R CHINA
SN 1001-0602
EI 1748-7838
J9 CELL RES
JI Cell Res.
PD APR
PY 2018
VL 28
IS 4
BP 497
EP 499
DI 10.1038/s41422-018-0007-9
PG 3
WC Cell Biology
SC Cell Biology
GA GF5SO
UT WOS:000432028300013
PM 29467384
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Ramani, S
   Crawford, SE
   Blutt, SE
   Estes, MK
AF Ramani, Sasirekha
   Crawford, Sue E.
   Blutt, Sarah E.
   Estes, Mary K.
TI Human organoid cultures: transformative new tools for human virus
   studies
SO CURRENT OPINION IN VIROLOGY
LA English
DT Article
ID HUMAN INTESTINAL ENTEROIDS; ZIKA-VIRUS; ROTAVIRUS INFECTION; IN-VITRO;
   NEURAL PROGENITORS; CEREBRAL ORGANOIDS; MODEL; CELLS; GASTROENTERITIS;
   REPLICATION
AB Studies of human infectious diseases have been limited by the paucity of functional models that mimic normal human physiology and pathophysiology. Recent advances in the development of multicellular, physiologically active organotypic cultures produced from embryonic and pluripotent stem cells, as well as from stem cells isolated from biopsies and surgical specimens are allowing unprecedented new studies and discoveries about host-microbe interactions. Here, we summarize recent developments in the use of organoids for studying human viral pathogens, including intestinal infections with human rotavirus, norovirus, enteroviruses and adenoviruses (intestinal organoids and enteroids), neuronal infections with Zika virus (cerebral organoids) and respiratory infections with respiratory syncytial virus in (lung bud organoids). Biologic discovery of host-specific genetic and epigenetic factors affecting infection, and responses to infection that lead to disease are possible with the use of organoid cultures. Continued development to increase the complexity of these cultures by including components of the normal host tissue microenvironment such as immune cells, blood vessels and microbiome, will facilitate studies on human viral pathogenesis, and advance the development of platforms for pre-clinical evaluation of vaccines, antivirals and therapeutics.
C1 [Ramani, Sasirekha; Crawford, Sue E.; Blutt, Sarah E.; Estes, Mary K.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Estes, Mary K.] Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
RP Estes, MK (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.; Estes, MK (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.
EM mestes@bcm.tmc.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U18-TR000552,
   UH3-TR00003, U19-AI116497, R01-AI080656, R01-AI105101, P30-DK56338];
   Food Research Initiative Competitive grant from the CS Department of
   Agriculture, National Institute of Food and Agriculture
   [2011-68003-30395]
FX The authors would like to acknowledge support from grants U18-TR000552,
   UH3-TR00003, U19-AI116497, R01-AI080656, R01-AI105101, P30-DK56338 from
   the National Institutes of Health and the Food Research Initiative
   Competitive grant 2011-68003-30395 from the CS Department of
   Agriculture, National Institute of Food and Agriculture.
CR Ahmed SM, 2014, LANCET INFECT DIS, V14, P725, DOI 10.1016/S1473-3099(14)70767-4
   Alge CS, 2006, J PROTEOME RES, V5, P862, DOI 10.1021/pr050420t
   Blutt SE, 2018, CELL MOL GASTROENTER, V5, P241, DOI 10.1016/j.jcmgh.2017.12.001
   Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981
   Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510
   Chen Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187880
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Drummond CG, 2017, P NATL ACAD SCI USA, V114, P1672, DOI 10.1073/pnas.1617363114
   Dutta D, 2017, TRENDS MOL MED, V23, P393, DOI 10.1016/j.molmed.2017.02.007
   Duttal D, 2017, CURR OPIN IMMUNOL, V48, P15, DOI 10.1016/j.coi.2017.07.012
   Ettayebi K, 2016, SCIENCE, V353, P1387, DOI 10.1126/science.aaf5211
   Fatehullah A, 2016, NAT CELL BIOL, V18, P246, DOI 10.1038/ncb3312
   Finkbeiner SR, 2015, STEM CELL REP
   Finkbeiner SR, 2012, MBIO, V3, DOI 10.1128/mBio.00159-12
   Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047
   Frias AH, 2012, INNATE IMMUN-LONDON, V18, P294, DOI 10.1177/1753425911401930
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Harris KG, 2013, CYTOKINE, V63, P230, DOI 10.1016/j.cyto.2013.05.007
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hill DR, 2017, CELL MOL GASTROENTER, V3, P138, DOI 10.1016/j.jcmgh.2016.11.007
   Holly MK, 2018, J VIROL, V92, DOI 10.1128/JVI.00250-18
   Janssens S, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00210-17
   Jonesteller CL, 2017, CLIN INFECT DIS, V65, P840, DOI 10.1093/cid/cix369
   Kambhampati A, 2016, CLIN INFECT DIS, V62, P11, DOI 10.1093/cid/civ873
   Kasendra M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21201-7
   Koo Hoonmo L, 2013, J Pediatric Infect Dis Soc, V2, P57, DOI 10.1093/jpids/pis070
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lanik WE, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030124
   Lee B, 2018, J INFECT DIS
   Mak IWY, 2014, AM J TRANSL RES, V6, P114
   Martic-Kehl MI, 2012, EUR J NUCL MED MOL I, V39, P1492, DOI 10.1007/s00259-012-2175-z
   Noel G, 2017, GUT MICROBES
   NOEL G, 2017, SCI REP, V7
   Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005
   Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200
   Payne DC, 2013, NEW ENGL J MED, V368, P1121, DOI 10.1056/NEJMsa1206589
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rajan A, 2018, MBIO, V9, DOI 10.1128/mBio.02419-17
   Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050
   Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935
   Saxena K, 2017, P NATL ACAD SCI USA, V114, pE570, DOI 10.1073/pnas.1615422114
   Saxena K, 2016, J VIROL, V90, P43, DOI 10.1128/JVI.01930-15
   Simonin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005821
   Spence JR, 2011, NATURE, V470, P105, DOI 10.1038/nature09691
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stelzner M, 2012, AM J PHYSIOL-GASTR L, V302, pG1359, DOI 10.1152/ajpgi.00493.2011
   Sun DX, 2002, PHARMACEUT RES, V19, P1400, DOI 10.1023/A:1020483911355
   Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013
   VanDussen KL, 2015, GUT, V64, P911, DOI 10.1136/gutjnl-2013-306651
   Wang YL, 2017, BIOMATERIALS, V128, P44, DOI 10.1016/j.biomaterials.2017.03.005
   Warren HS, 2015, P NATL ACAD SCI USA, V112, pE345, DOI 10.1073/pnas.1414857111
   Wold W. S. M., 2013, FIELDS VIROLOGY
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yin YB, 2016, ANTIVIR RES, V133, P41, DOI 10.1016/j.antiviral.2016.07.017
   Yin YB, 2015, ANTIVIR RES, V123, P120, DOI 10.1016/j.antiviral.2015.09.010
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zachos NC, 2016, J BIOL CHEM, V291, P3759, DOI 10.1074/jbc.R114.635995
   Zheng YT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005415
   Zou WY, 2017, METHODS MOL BIOL
NR 62
TC 13
Z9 13
U1 5
U2 17
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1879-6257
J9 CURR OPIN VIROL
JI Curr. Opin. Virol.
PD APR
PY 2018
VL 29
BP 79
EP 86
DI 10.1016/j.coviro.2018.04.001
PG 8
WC Virology
SC Virology
GA GG7LT
UT WOS:000432880400012
PM 29656244
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Benelli, G
   Maggi, F
   Pavela, R
   Murugan, K
   Govindarajan, M
   Vaseeharan, B
   Petrelli, R
   Cappellacci, L
   Kumar, S
   Hofer, A
   Youssefi, MR
   Alarfaj, AA
   Hwang, JS
   Higuchi, A
AF Benelli, Giovanni
   Maggi, Filippo
   Pavela, Roman
   Murugan, Kadarkarai
   Govindarajan, Marimuthu
   Vaseeharan, Baskaralingam
   Petrelli, Riccardo
   Cappellacci, Loredana
   Kumar, Suresh
   Hofer, Anders
   Youssefi, Mohammad Reza
   Alarfaj, Abdullah A.
   Hwang, Jiang-Shiou
   Higuchi, Akon
TI Mosquito control with green nanopesticides: towards the One Health
   approach? A review of non-target effects
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Review
DE Arbovirus; Biosafety; Dengue; Genotoxicity; Japanese encephalitis;
   Malaria; Nanosynthesis; West Nile virus; Zika virus
ID SYNTHESIZED SILVER NANOPARTICLES; VECTOR ANOPHELES-STEPHENSI;
   TITANIUM-DIOXIDE NANOPARTICLES; RHIPICEPHALUS BOOPHILUS MICROPLUS;
   AEGYPTI DIPTERA-CULICIDAE; ASIAN TIGER MOSQUITO; CULEX-QUINQUEFASCIATUS
   SAY; PEDICULUS-HUMANUS-CAPITIS; STERILE INSECT TECHNIQUE; ONE-POT
   FABRICATION
AB The rapid spread of highly aggressive arboviruses, parasites, and bacteria along with the development of resistance in the pathogens and parasites, as well as in their arthropod vectors, represents a huge challenge in modern parasitology and tropical medicine. Eco-friendly vector control programs are crucial to fight, besides malaria, the spread of dengue, West Nile, chikungunya, and Zika virus, as well as other arboviruses such as St. Louis encephalitis and Japanese encephalitis. However, research efforts on the control of mosquito vectors are experiencing a serious lack of eco-friendly and highly effective pesticides, as well as the limited success of most biocontrol tools currently applied. Most importantly, a cooperative interface between the two disciplines is still lacking. To face this challenge, we have reviewed a wide number of promising results in the field of green-fabricated pesticides tested against mosquito vectors, outlining several examples of synergy with classic biological control tools. The non-target effects of green-fabricated nanopesticides, including acute toxicity, genotoxicity, and impact on behavioral traits of mosquito predators, have been critically discussed. In the final section, we have identified several key challenges at the interface between "green" nanotechnology and classic biological control, which deserve further research attention.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Maggi, Filippo; Petrelli, Riccardo; Cappellacci, Loredana] Univ Camerino, Sch Pharm, Via St Agostino 1, I-62032 Camerino, Italy.
   [Pavela, Roman] Crop Res Inst, Drnovska 507, Prague 16106 6, Czech Republic.
   [Murugan, Kadarkarai] Thiruvalluvar Univ, Dept Biotechnol, Vellore 632115, Tamil Nadu, India.
   [Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Vaseeharan, Baskaralingam] Alagappa Univ, Dept Anim Hlth & Management, Biomat & Biotechnol Anim Hlth Lab, Nanobiosci & Nanopharmacol Div, Karaikkudi 630004, Tamil Nadu, India.
   [Kumar, Suresh] Dept Med Microbiol & Parasitol, Serdang 43400, Malaysia.
   [Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, Umea, Sweden.
   [Youssefi, Mohammad Reza] Islamic Azad Univ, Babol Branch, Dept Vet Parasitol, Babol Sar, Iran.
   [Alarfaj, Abdullah A.] King Saud Univ, Dept Bot & Microbiol, Coll Sci, Riyadh 11451, Saudi Arabia.
   [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.
   [Higuchi, Akon] Natl Cent Univ, Dept Chem & Mat Engn, Taoyuan 32001, Taiwan.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
EM benelli.giovanni@gmail.com
RI Higuchi, Akon/AAA-9711-2019; GOVINDARAJAN, MARIMUTHU/A-8070-2019;
   Alarfaj, Abdullah/AAA-2018-2019; Murugan, Kadarkarai/AAP-3937-2020;
   Benelli, Giovanni/A-9100-2013; Pavela, Roman/Q-8647-2016; Youssefi,
   Mohammad Reza/G-2832-2012; Kumar S, Suresh/J-2423-2017
OI GOVINDARAJAN, MARIMUTHU/0000-0002-4662-8931; Benelli,
   Giovanni/0000-0001-8971-6010; Youssefi, Mohammad
   Reza/0000-0002-8606-2266; Pavela, Roman/0000-0001-7866-4278; Kumar S,
   Suresh/0000-0002-0505-7554
FU International Scientific Partnership Program ISPP at King Saud
   University [0062]; Ministry of Science and Technology of TaiwanMinistry
   of Science and Technology, Taiwan [NSC98-2621-B-019-001-MY3,
   NSC101-2621-B-019-002, NSC102-2923-B-019-001-MY3]; Technology Agency of
   the CR [TA04020103]; National Science Council of TaiwanNational Science
   Council of Taiwan [MOST-104-2221-E-008-107-MY3,
   MOST-105-2119-M-008-006]; Ministry of Education, Culture, Sports,
   Science, and Technology of JapanMinistry of Education, Culture, Sports,
   Science and Technology, Japan (MEXT) [15K06591]; University of Camerino
   [FAR 2014/15, FPI000044]; International High Cited Research Group
   (IHCRG), Deanship of Scientific Research, King Saud University, Riyadh,
   Kingdom of Saudi Arabia [14-104]
FX The Authors extend our appreciation to the International Scientific
   Partnership Program ISPP at King Saud University for funding through
   ISPP no. 0062. J.-S. Hwang thanks the Ministry of Science and Technology
   of Taiwan (grant no. NSC98-2621-B-019-001-MY3, NSC101-2621-B-019-002,
   and NSC102-2923-B-019-001-MY3) for the financial support. R. Pavela
   would like to thank the Technology Agency of the CR (Project no.
   TA04020103). A. Higuchi is grateful to the National Science Council of
   Taiwan under Grant no. MOST-104-2221-E-008-107-MY3 and
   MOST-105-2119-M-008-006, as well as to a Grant-in-Aid for Scientific
   Research (15K06591) from the Ministry of Education, Culture, Sports,
   Science, and Technology of Japan. F. Maggi, R. Petrelli, and L.
   Cappellacci would like to thank University of Camerino (FAR 2014/15,
   FPI000044) for the financial support. A. Hofer thanks the Swedish
   Research Council (2012-1932) and the Kempe Foundation. Lastly, we
   acknowledge the International High Cited Research Group (IHCRG no.
   14-104), Deanship of Scientific Research, King Saud University, Riyadh,
   Kingdom of Saudi Arabia. Funders had no role in the study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abdel-Ghaffar F, 2015, PARASITOL RES, V114, P3041, DOI 10.1007/s00436-015-4506-z
   Al-Fatimi M, 2007, J ETHNOPHARMACOL, V111, P657, DOI 10.1016/j.jep.2007.01.018
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Amerasan D, 2016, J PEST SCI, V89, P249, DOI 10.1007/s10340-015-0675-x
   Anbu P, 2016, NAT PROD RES, V30, P2077, DOI 10.1080/14786419.2015.1114935
   Anjali CH, 2012, PEST MANAG SCI, V68, P158, DOI 10.1002/ps.2233
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Azarudeen RMST, 2017, J CLUST SCI, V28, P369, DOI 10.1007/s10876-016-1103-y
   Azarudeen RMST, 2017, J CLUST SCI, V28, P179, DOI 10.1007/s10876-016-1067-y
   Azarudeen RMST, 2016, RSC ADV, V6, P96573, DOI 10.1039/c6ra23208f
   Banumathi B, 2017, J CLUST SCI, V28, P2027, DOI 10.1007/s10876-017-1201-5
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Banumathi B, 2016, VET PARASITOL, V216, P93, DOI 10.1016/j.vetpar.2015.12.003
   Barik TK, 2012, PARASITOL RES, V111, P1075, DOI 10.1007/s00436-012-2934-6
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker Norbert, 2012, P31
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10228, DOI 10.1007/s11356-017-8482-y
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2017, PARASITOL INT, V66, P166, DOI 10.1016/j.parint.2017.01.012
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BHANDARY MJ, 1995, J ETHNOPHARMACOL, V47, P149, DOI 10.1016/0378-8741(95)01274-H
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blanco E, 1999, J ETHNOPHARMACOL, V65, P113, DOI 10.1016/S0378-8741(98)00178-0
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Botha CJ, 2008, J ETHNOPHARMACOL, V119, P549, DOI 10.1016/j.jep.2008.07.022
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bouvard V, 2012, LANCET ONCOL, V13, P339, DOI 10.1016/S1470-2045(12)70125-0
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Breman JG, 2001, AM J TROP MED HYG, V64, P1
   Callaway E, 2015, NATURE, V526, P174, DOI 10.1038/nature.2015.18507
   Cano JH, 2004, J ETHNOPHARMACOL, V90, P293, DOI 10.1016/j.jep.2003.10.012
   Carlton JM, 2008, TRENDS PARASITOL, V24, P545, DOI 10.1016/j.pt.2008.09.003
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   Chandramohan B, 2016, PARASITOL RES, V115, P1015, DOI 10.1007/s00436-015-4829-9
   Chung SK, 2013, J FOOD SCI, V78, pE709, DOI 10.1111/1750-3841.12111
   Cohen J, 2011, PARASITOL RES MG, V2, P121, DOI 10.1007/978-3-642-21396-0_7
   Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1
   Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003
   Day MJ, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-49
   Dinesh D, 2015, PARASITOL RES, V114, P1519, DOI 10.1007/s00436-015-4336-z
   Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382
   Esha R. T., 2012, American-Eurasian Journal of Sustainable Agriculture, V6, P74
   European Centre for Disease Prevention and Control, 2015, MICR BRAZ POT LINK Z
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   Franco AO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101699
   Fu LM, 2003, J COLLOID INTERF SCI, V258, P266, DOI 10.1016/S0021-9797(02)00078-4
   Garima Mishra, 2010, International Journal of PharmTech Research, V2, P1298
   GOODSELL DS, 2004, BIONANOTECHNOLOGY LE
   Govindarajan M, 2017, J APPL BIOMED, V15, P87, DOI 10.1016/j.jab.2016.10.004
   Govindarajan M, 2017, ARTIF CELL NANOMED B, V45, P1317, DOI 10.1080/21691401.2016.1228664
   Govindarajan M, 2016, ENZYME MICROB TECH, V95, P155, DOI 10.1016/j.enzmictec.2016.05.005
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V162, P646, DOI 10.1016/j.jphotobiol.2016.07.036
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V161, P482, DOI 10.1016/j.jphotobiol.2016.06.016
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P925, DOI 10.1007/s00436-015-4817-0
   Grzywacz D, 2014, FOOD SECUR, V6, P71, DOI 10.1007/s12571-013-0313-5
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hamza OJM, 2006, J ETHNOPHARMACOL, V108, P124, DOI 10.1016/j.jep.2006.04.026
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Heng MY, 2013, TRAC-TREND ANAL CHEM, V50, P1, DOI 10.1016/j.trac.2013.03.012
   Idolo M, 2010, J ETHNOPHARMACOL, V127, P379, DOI 10.1016/j.jep.2009.10.027
   Ishwarya R, 2017, J CLUST SCI, V28, P519, DOI 10.1007/s10876-016-1126-4
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005
   Jaganathan A, 2016, PARASITOL INT, V65, P276, DOI 10.1016/j.parint.2016.02.003
   Jensen M, 2009, PARASITOL RES, V105, P609, DOI 10.1007/s00436-009-1524-8
   Johansson O, 2017, PARASITOL RES, V116, P1, DOI 10.1007/s00436-016-5272-2
   Joseph JM, 2010, J ETHNOPHARMACOL, V131, P216, DOI 10.1016/j.jep.2010.06.010
   Kalimuthu K, 2017, HYDROBIOLOGIA, V785, P359, DOI 10.1007/s10750-016-2943-z
   Kamaraj C, 2017, J CLUST SCI, DOI [10.1007/s10876-017-1180-1186, DOI 10.1007/S10876-017-1180-1186]
   Kannan RRR, 2013, FOOD CHEM, V136, P1484, DOI 10.1016/j.foodchem.2012.09.006
   Kirthi AV, 2011, PARASITOL RES, V109, P461, DOI 10.1007/s00436-011-2277-8
   Kovendan K, 2016, J ASIA-PAC ENTOMOL, V19, P1001, DOI 10.1016/j.aspen.2016.09.001
   Kumar C. S., 2011, International Research Journal of Pharmaceutical and Applied Sciences, V1, P105
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   Kumar S, 2015, NANOMEDICINE-UK, V10, P2451, DOI [10.2217/NNM.15.112, 10.2217/nnm.15.112]
   Laphookhieo S, 2004, J NAT PROD, V67, P886, DOI 10.1021/np0305122
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lees RS, 2014, ACTA TROP, V132, pS2, DOI 10.1016/j.actatropica.2013.11.005
   Li JA, 2010, J ETHNOPHARMACOL, V129, P350, DOI 10.1016/j.jep.2010.03.033
   Lubbe A, 2012, J ETHNOPHARMACOL, V141, P854, DOI 10.1016/j.jep.2012.03.024
   Madhiyazhagan P, 2017, J APPL PHYCOL, V29, P649, DOI 10.1007/s10811-016-0953-x
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Marimuthu S, 2013, ASIAN PAC J TROP MED, V6, P682, DOI 10.1016/S1995-7645(13)60118-2
   Marimuthu S, 2012, PARASITOL RES, V111, P2023, DOI 10.1007/s00436-011-2667-y
   Marimuthu S, 2011, PARASITOL RES, V108, P1541, DOI 10.1007/s00436-010-2212-4
   Mehlhorn H., 2012, PARASITOL RES MONOGR, V3
   Mehlhorn H., 2016, PARASITOL RES MONOGR, V8
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002
   Mohan V. R., 2010, Journal of Economic and Taxonomic Botany, V34, P639
   Moo-Puc R, 2008, J ETHNOPHARMACOL, V120, P92, DOI 10.1016/j.jep.2008.07.035
   Mueller MS, 2000, J ETHNOPHARMACOL, V73, P487, DOI 10.1016/S0378-8741(00)00289-0
   Murthy BK, 2004, J ETHNOPHARMACOL, V91, P95, DOI 10.1016/j.jep.2003.12.010
   Murugan K, 2017, J CLUST SCI, V28, P393, DOI 10.1007/s10876-016-1107-7
   Murugan K, 2017, J CLUST SCI, V28, P437, DOI 10.1007/s10876-016-1115-7
   Murugan K, 2017, J CLUST SCI, V28, P529, DOI 10.1007/s10876-016-1129-1
   Murugan K, 2017, PARASITOL RES, V116, P495, DOI 10.1007/s00436-016-5310-0
   Murugan K, 2016, ENVIRON SCI POLLUT R, V23, P16671, DOI 10.1007/s11356-016-6832-9
   Murugan K, 2016, ECOTOX ENVIRON SAFE, V132, P318, DOI 10.1016/j.ecoenv.2016.06.021
   Murugan K, 2016, RES VET SCI, V106, P14, DOI 10.1016/j.rvsc.2016.03.001
   Murugan K, 2016, PARASITOL RES, V115, P1071, DOI 10.1007/s00436-015-4837-9
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, PARASITOL RES, V114, P4645, DOI 10.1007/s00436-015-4710-x
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Murugan K, 2015, PARASITOL RES, V114, P3601, DOI 10.1007/s00436-015-4582-0
   Murugan K, 2015, PARASITOL RES, V114, P2243, DOI 10.1007/s00436-015-4417-z
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Natarajan K, 2010, DIG J NANOMATER BIOS, V5, P135
   Nathan SS, 2005, ACTA TROP, V96, P47, DOI 10.1016/j.actatropica.2005.07.002
   Negrelle R. R. B., 2007, Revista Brasileira de Plantas Medicinais, V9, P80
   Newmaster AF, 2011, J ETHNOBIOL ETHNOMED, V7, DOI 10.1186/1746-4269-7-37
   Oehler E., 2014, Eurosurveillance, V19, P20720
   ORABI KY, 1991, J NAT PROD, V54, P856, DOI 10.1021/np50075a017
   Panneerselvam C, 2016, PARASITOL RES, V115, P997, DOI 10.1007/s00436-015-4828-x
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Patil D. A., 2010, Journal of Phytology, V2, P22
   Pattanaik C, 2008, INDIAN J TRADIT KNOW, V7, P598
   Pavela R, 2017, IND CROP PROD, V97, P338, DOI 10.1016/j.indcrop.2016.12.046
   Pavela R, 2016, RES VET SCI, V109, P1, DOI 10.1016/j.rvsc.2016.09.001
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, CURR ORG CHEM, V20, P2674, DOI 10.2174/1385272820666151026231851
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Ponnusamy Y, 2015, J ETHNOPHARMACOL, V168, P305, DOI 10.1016/j.jep.2015.03.062
   Priya SP, 2017, ACTA TROP, V171, P213, DOI 10.1016/j.actatropica.2017.04.010
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Rajakumar G, 2012, RES VET SCI, V93, P303, DOI 10.1016/j.rvsc.2011.08.001
   Rajakumar G, 2015, PARASITOL RES, V114, P571, DOI 10.1007/s00436-014-4219-8
   Rajakumar G, 2014, PARASITOL RES, V113, P469, DOI 10.1007/s00436-013-3676-9
   Rajakumar G, 2013, VET PARASITOL, V191, P332, DOI 10.1016/j.vetpar.2012.08.028
   Rajan R, 2015, IND CROP PROD, V70, P356, DOI 10.1016/j.indcrop.2015.03.015
   Rajesh, 2002, J ETHNOPHARMACOL, V80, P193, DOI 10.1016/S0378-8741(02)00036-3
   Ramanibai R, 2015, RES VET SCI, V98, P82, DOI 10.1016/j.rvsc.2014.11.009
   Ramyadevi J, 2011, PARASITOL RES, V109, P1403, DOI 10.1007/s00436-011-2387-3
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Costa CARD, 2011, J ETHNOPHARMACOL, V137, P828, DOI 10.1016/j.jep.2011.07.003
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Ruiz L, 2011, J ETHNOPHARMACOL, V133, P917, DOI 10.1016/j.jep.2010.10.039
   Santhoshkumar T, 2012, EXP PARASITOL, V132, P156, DOI 10.1016/j.exppara.2012.06.009
   Sanz-Biset J, 2009, J ETHNOPHARMACOL, V122, P333, DOI 10.1016/j.jep.2008.12.009
   Sekhar J., 2011, LIFE SCI LEAFLLETS, V12, P368
   Semmler M, 2014, PARASITOL RES, V113, P185, DOI 10.1007/s00436-013-3641-7
   Semmler M, 2009, PARASITOL RES, V105, P1483, DOI 10.1007/s00436-009-1634-3
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Son YO, 2003, FOOD CHEM TOXICOL, V41, P1421, DOI 10.1016/S0278-6915(03)00161-3
   Soni N, 2014, PARASITOL RES, V113, P4015, DOI 10.1007/s00436-014-4069-4
   Srinivasan D, 2001, J ETHNOPHARMACOL, V74, P217, DOI 10.1016/S0378-8741(00)00345-7
   Srivastava S. K., 2007, Natural Product Sciences, V13, P27
   Steenkamp V, 2003, J ETHNOPHARMACOL, V86, P97, DOI 10.1016/S0378-8741(03)00053-9
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Subramaniam J, 2017, J CLUST SCI, V28, P413, DOI 10.1007/s10876-016-1113-9
   Subramaniam J, 2016, ENVIRON SCI POLLUT R, V23, P7543, DOI 10.1007/s11356-015-6007-0
   Subramaniam J, 2015, ENVIRON SCI POLLUT R, V22, P20067, DOI 10.1007/s11356-015-5253-5
   Sujitha V, 2017, AQUAT TOXICOL, V188, P100, DOI 10.1016/j.aquatox.2017.04.015
   Sujitha V, 2015, PARASITOL RES, V114, P3315, DOI 10.1007/s00436-015-4556-2
   Sundararajan B, 2017, J TRACE ELEM MED BIO, V43, P187, DOI 10.1016/j.jtemb.2017.03.008
   Suresh U, 2018, PHYSIOL MOL PLANT P, V101, P225, DOI 10.1016/j.pmpp.2017.01.002
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Theerthagiri J, 2017, J CLUST SCI, V28, P581, DOI 10.1007/s10876-016-1128-2
   Thiengsusuk A, 2013, PARASITOL RES, V112, P1475, DOI 10.1007/s00436-013-3294-6
   Tona L, 1998, J ETHNOPHARMACOL, V61, P57, DOI 10.1016/S0378-8741(98)00015-4
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   Turek C, 2013, COMPR REV FOOD SCI F, V12, P40, DOI 10.1111/1541-4337.12006
   Upadhya V, 2012, J ETHNOPHARMACOL, V142, P557, DOI 10.1016/j.jep.2012.05.051
   Vadivalagan C, 2017, ACTA TROP, V169, P43, DOI 10.1016/j.actatropica.2017.01.020
   Veerakumar K, 2014, PARASITOL RES, V113, P4567, DOI 10.1007/s00436-014-4147-7
   Veerakumar K, 2014, PARASITOL RES, V113, P4085, DOI 10.1007/s00436-014-4077-4
   Velayutham K, 2012, PARASITOL RES, V111, P2329, DOI 10.1007/s00436-011-2676-x
   Villasenor IM, 2006, J ETHNOPHARMACOL, V104, P129, DOI 10.1016/j.jep.2005.08.067
   Vincent S, 2017, J CLUST SCI, V28, P37, DOI 10.1007/s10876-016-1038-3
   Wahab A, 2009, PHYTOTHER RES, V23, P153, DOI 10.1002/ptr.2548
   Ward M, 2017, PARASITOL RES, V116, P839, DOI 10.1007/s00436-016-5352-3
   Webster JP, 2016, EVOL APPL, V9, P313, DOI 10.1111/eva.12341
   White NJ, 2015, NEW ENGL J MED, V373, P1670, DOI 10.1056/NEJMe1511278
   White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297
   WHO, 2015, WHO UPD ART RES
   World Health Organization, 2015, FACT SHEET WORLD MAL
   World Health Organization, 2012, HDB INT VECT MAN
   Yamany AS, 2012, PARASITOL RES, V111, P1315, DOI 10.1007/s00436-012-2967-x
   Zahir AA, 2012, VET PARASITOL, V187, P511, DOI 10.1016/j.vetpar.2012.02.001
   Zirihi GN, 2005, J ETHNOPHARMACOL, V98, P281, DOI 10.1016/j.jep.2005.01.004
NR 201
TC 14
Z9 14
U1 3
U2 75
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10184
EP 10206
DI 10.1007/s11356-017-9752-4
PG 23
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200004
PM 28755145
DA 2020-07-08
ER

PT J
AU Benelli, G
   Rajeswary, M
   Govindarajan, M
AF Benelli, Giovanni
   Rajeswary, Mohan
   Govindarajan, Marimuthu
TI Towards green oviposition deterrents? Effectiveness of Syzygium
   lanceolatum (Myrtaceae) essential oil against six mosquito vectors and
   impact on four aquatic biological control agents
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Biosafety; Dengue; Filariasis; Japanese encephalitis; Larvicides;
   Malaria; Zika virus
ID ECO-FRIENDLY LARVICIDES; ALBOPICTUS DIPTERA-CULICIDAE; ASIAN TIGER
   MOSQUITO; AEDES-ALBOPICTUS; CHEMICAL-COMPOSITION; INSECTICIDE
   RESISTANCE; CINNAMOMUM-OSMOPHLOEUM; ANOPHELES-STEPHENSI; BORNE DISEASES;
   ACUTE TOXICITY
AB Essential oils (EOs) from plants may be alternative sources of molecules toxic against mosquito vectors of public health relevance. Most of researches in this field focused on EOs as larvicides or ovicides, while limited efforts focused on the exploitation of EOs as oviposition deterrents. In the present study, the larvicidal and oviposition deterrent activity of Syzygium lanceolatum leaf EO was evaluated against six mosquito species, Anopheles stephensi, An. subpictus, Aedes aegypti, Ae. albopictus, Culex quinquefasciatus, and Cx. tritaeniorhynchus. The chemical composition of the S. lanceolatum EO was analyzed by GC-MS analysis, showing the presence of phenyl propanal, beta-caryophyllene, alpha-humulene, and caryophyllene oxide as major constituents. S. lanceolatum EO showed high acute toxicity on An. stephensi (LC50 = 51.20 mu g/ml), Ae. aegypti (LC50 = 55.11 mu g/ml), Cx. quinquefasciatus (LC50 = 60.01 mu g/ml), An. subpictus (LC50 = 61.34 mu g/ml), Ae. albopictus (LC50 = 66.71 mu g/ml), and Cx. tritaeniorhynchus (LC50 = 72.24 mu g/ml) larvae. Furthermore, the EO was effective as oviposition deterrent against the six tested mosquito species, with OAI on An. stephensi, An. subpictus, Ae. aegypti, Ae. albopictus, Cx. quinquefasciatus, and Cx. tritaeniorhynchus reaching -0.83, -0.81, -0.84, -0.83, -0.84, and -0.86, respectively. The toxicity of S. lanceolatum EO against several biological control agents of mosquitoes, including water bugs (Anisops bouvieri and Diplonychus indicus) and fishes (Gambusia affinis and Poecilia reticulata), was extremely low, with LC50 ranging between 4148 and 15,762 mu g/ml. Overall, our results pointed out the promising potential of the S. lanceolatum leaf EO as a source of environmental-friendly oviposition deterrents and larvicides effective against a wide number of mosquito species of importance for parasitology.
C1 [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Rajeswary, Mohan; Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.; Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
EM benelli.giovanni@gmail.com; drgovind1979@gmail.com
RI Benelli, Giovanni/A-9100-2013; GOVINDARAJAN, MARIMUTHU/A-8070-2019
OI Benelli, Giovanni/0000-0001-8971-6010; GOVINDARAJAN,
   MARIMUTHU/0000-0002-4662-8931
FU PROAPI [PRAF 2015]; University of Pisa, Department of Agriculture, Food
   and Environment [COFIN2015_22]
FX G. Benelli is sponsored by PROAPI (PRAF 2015) and University of Pisa,
   Department of Agriculture, Food and Environment (Grant ID:
   COFIN2015_22). Funders had no role in the study design, data collection
   and analyses, decision to publish, or preparation of the manuscript.
CR Adams R.P., 2007, IDENTIFICATION ESSEN
   Ahmed F, 2009, J YOUNG PHARM, V1, P317, DOI 10.4103/0975-1483.59320
   Autran ES, 2009, BIORESOURCE TECHNOL, V100, P2284, DOI 10.1016/j.biortech.2008.10.055
   Ayyanar Muniappan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P240, DOI 10.1016/S2221-1691(12)60050-1
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P468, DOI 10.1016/j.apjtb.2016.03.012
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P887, DOI 10.1007/s00436-014-4252-7
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Benelli G, 2012, B INSECTOL, V65, P177
   Bezerra-Silva PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150008
   Bhuiyan N., 2010, AFR J PLANT SCI, V4, P451
   Boulos L., 1983, MED PLANTS N AFRICA
   Chaubey M. K., 2012, Herba Polonica, V58, P33
   Cheng SS, 2009, BIORESOURCE TECHNOL, V100, P457, DOI 10.1016/j.biortech.2008.02.030
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Conti B, 2010, PARASITOL RES, V107, P1455, DOI 10.1007/s00436-010-2018-4
   de Mendonca FAC, 2005, FITOTERAPIA, V76, P629, DOI 10.1016/j.fitote.2005.06.013
   DEO P G, 1988, International Pest Control, V30, P118
   Elango G, 2010, PARASITOL RES, V107, P167, DOI 10.1007/s00436-010-1856-4
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Gamble JS, 1923, FLORA PRESIDENCY MAD, VI-III, P1915
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Govindarajan M, 2016, COMB CHEM HIGH T SCR, V19, P565, DOI 10.2174/1386207319666160506123520
   Govindarajan M, 2016, PARASITOL RES, V115, P2771, DOI 10.1007/s00436-016-5025-2
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470
   Khandagle AJ, 2011, PARASITOL RES, V109, P339, DOI 10.1007/s00436-011-2261-3
   Kim HJ, 2004, J AGR FOOD CHEM, V52, P2849, DOI 10.1021/jf035377d
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412
   KRAMER WL, 1979, ENVIRON ENTOMOL, V8, P1111, DOI 10.1093/ee/8.6.1111
   Lee SeongWei, 2009, Frontiers of Agriculture in China, V3, P332, DOI 10.1007/s11703-009-0052-8
   MABBERLY DJ, 1997, PLANT BOOK PORTABLE
   Mahmoud II, 2001, PHYTOCHEMISTRY, V58, P1239, DOI 10.1016/S0031-9422(01)00365-X
   Maisuthisakul P, 2007, FOOD CHEM, V100, P1409, DOI 10.1016/j.foodchem.2005.11.032
   Mehlhorn H., 2015, ENCY PARASITOLOGY, P893
   Milet-Pinheiro P, 2015, PLOS ONE, V9, P1
   Morais F.D., 2010, PEST MANAG SCI, V5, P965
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nassar M. I., 2007, Revista Latinoamericana de Quimica, V35, P47
   Noudogbessi JP, 2008, REC NAT PROD, V2, P33
   Pavela R, 2016, RES VET SCI, V109, P1, DOI 10.1016/j.rvsc.2016.09.001
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Raina VK, 2001, FLAVOUR FRAG J, V16, P334, DOI 10.1002/ffj.1005
   Rajaganesh R, 2016, RES VET SCI, V109, P40, DOI 10.1016/j.rvsc.2016.09.012
   Reynertson K. A., 2005, Ethnobotany Research and Applications, V3, P25
   da Silva MFR, 2016, EXP PARASITOL, V165, P64, DOI 10.1016/j.exppara.2016.03.017
   Santos GKN, 2012, IND CROP PROD, V40, P254, DOI 10.1016/j.indcrop.2012.03.020
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Stalin N, 2013, J ESSENT OIL BEAR P1, V17, P371
   STASI LC, 2002, PLANTAS MED AMAZONIA
   WHO, 2005, WHOCDSWHOPESGCDPP13
   Wong K. C., 1996, Flavour and Fragrance Journal, V11, P61, DOI [10.1002/(SICI)1099-1026(199601)11:1<61::AID-FFJ539>3.0.CO;2-1, 10.1002/(SICI)1099-1026(199601)11:1&lt;61::AID-FFJ539&gt;3.0.CO;2-1]
   Xue RD, 2001, MED VET ENTOMOL, V15, P126, DOI 10.1046/j.0269-283x.2001.00301.x
NR 64
TC 16
Z9 16
U1 3
U2 51
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD APR
PY 2018
VL 25
IS 11
SI SI
BP 10218
EP 10227
DI 10.1007/s11356-016-8146-3
PG 10
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA GC5FC
UT WOS:000429810200006
PM 27921244
DA 2020-07-08
ER

PT J
AU Talero-Gutierrez, C
   Rivera-Molina, A
   Perez-Pavajeau, C
   Ossa-Ospina, I
   Santos-Garcia, C
   Rojas-Anaya, MC
   de-la-Torre, A
AF Talero-Gutierrez, C.
   Rivera-Molina, A.
   Perez-Pavajeau, C.
   Ossa-Ospina, I.
   Santos-Garcia, C.
   Rojas-Anaya, M. C.
   de-la-Torre, A.
TI Zika virus epidemiology: from Uganda to world pandemic, an update
SO EPIDEMIOLOGY AND INFECTION
LA English
DT Review
DE Epidemiology; Public Health; Zika
ID SEXUAL TRANSMISSION; OUTBREAK; INFECTION; HISTORY; MANIFESTATIONS;
   COLOMBIA; BRAZIL; STATE; RNA
AB Zika virus (ZIKV) infection is an emergent worldwide public health problem. Historically, 84 countries have reported vector-borne ZIKV transmission, 61 of which report on-going transmission. It is a Flavivirus transmitted through arthropods belonging to the Aedes genus. Since 2015, ZIKV infections have increased dramatically; with 1.3 million people infected during 2015 in Brazil alone. This paper's objective is to highlight the conjectural epidemiological points of the virus' dissemination. The digital archives Pubmed, MEDLINE, EMBASE and Cochrane were searched for papers that assessed aspects of ZIKV transmission and epidemiology. The first isolation occurred in Uganda in 1947. Since then, important outbreaks were documented globally. Consequently, an emergent public health problem arose from a rapidly increasing incidence and its association with the development of neurological diseases such as microcephaly and Guillain-Barre syndrome. Key factors in the successful containment of outbreaks include surveillance of mosquitos in the neighbourhood, an early mosquito control treatment, an assertive information campaign, and the involvement of the local population and healthcare workers. As such, while ZIKV seems to be spreading globally in a similar manner to other arboviruses, such as Dengue and Chikungunya viruses, it can also be rapidly contained due to the pre-existing availability of necessary resources and regulatory tools as control measures. This review aims to provide a description of those characteristics of ZIKV infection that may be useful in the construction of effective outbreak control strategies.
C1 [Talero-Gutierrez, C.] Univ Rosario, Neurosci Unit, Escuela Med & Ciencias Salud, Neurosci Res Grp NeURos, Bogota 111211, Colombia.
   [Rivera-Molina, A.; Perez-Pavajeau, C.; Ossa-Ospina, I.; Santos-Garcia, C.; Rojas-Anaya, M. C.] Univ Rosario, Neurosci Undergrad Res Grp NeURos, Escuela Med & Ciencias Salud, Bogota, Colombia.
   [de-la-Torre, A.] Univ Rosario, Immunol Dept, Escuela Med & Ciencias Salud, Neurosci Res Grp NeURos, Bogota, Colombia.
RP Talero-Gutierrez, C (corresponding author), Univ Rosario, Neurosci Unit, Escuela Med & Ciencias Salud, Neurosci Res Grp NeURos, Bogota 111211, Colombia.
EM claudia.talero@urosario.edu.co
RI de-la-Torre, Alejandra/N-2757-2019; Talero-Gutierrez,
   Claudia/I-7078-2016
OI de-la-Torre, Alejandra/0000-0003-0684-1989; Perez pavajeau, Maria
   Carolina/0000-0001-5598-5554; Talero-Gutierrez,
   Claudia/0000-0003-1601-5015
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bierle CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187720
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2014, ZIK VIR TRANSM RISKS
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Del Carpio-Orantes Luis, 2016, Rev Med Inst Mex Seguro Soc, V54, P540
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, AM J TROP MED HYG, V97, P1410, DOI 10.4269/ajtmh.17-0263
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   European Centre for Disease Prevention and Control, 2016, PREP ZIK EU, DOI [10.2900/624835, DOI 10.2900/624835]
   European Centre for Disease Prevention and Control, 2017, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, COMM DIS THREAT REP
   European Centre for Disease Prevention and Control, 2016, RAP RISK ASS ZIK VIR
   European Centre for Disease Prevention and Control, 2016, EP UPD OUTBR ZIK VIR
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Karam E, 2017, J NEUROVIROL, V23, P932, DOI 10.1007/s13365-017-0585-1
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leal Mariana de Carvalho, 2016, Braz J Otorhinolaryngol, DOI 10.1016/j.bjorl.2016.06.001
   Lee Hee -Jung, 2017, Journal of Bacteriology and Virology, V47, P1, DOI 10.4167/jbv.2017.47.1.1
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Li R, 2017, RADIOL INFECT DIS, V4, P88, DOI [10.1016/j.jrid.2017.01.002, DOI 10.1016/J.JRID.2017.01.002]
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Marini G, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.37.30612
   Massad E, 2017, EPIDEMIOL INFECT, V145, P2303, DOI 10.1017/S0950268817001200
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Meaney-Delman D, 2016, OBSTET GYNECOL, V128, P724, DOI 10.1097/AOG.0000000000001625
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moghadam SRJ, 2016, ASIAN PAC J TROP BIO, V6, P989, DOI 10.1016/j.apjtb.2016.09.007
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muller JA, 2016, EMERG INFECT DIS, V22, P1685, DOI 10.3201/eid2209.160664
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nunes ML, 2016, J PEDIAT-BRAZIL, V92, P230, DOI 10.1016/j.jped.2016.02.009
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Panamerican Health Organization, 2012, SIT ACT DENG INF PRO, P31
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Report S, 2017, ZIK VIR MICR GUILL B
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Shankar A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01761
   Sharma S, 2017, J MED VIROL, V89, P1693, DOI 10.1002/jmv.24822
   Slavov SN, 2017, TRANSFUSION, V57, P2897, DOI 10.1111/trf.14322
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Vogel G, 2016, SCIENCE, V351, P1377, DOI 10.1126/science.351.6280.1377
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   World Health Organization, WHO STAT 1 M INT HLT
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
NR 79
TC 4
Z9 4
U1 0
U2 12
PU CAMBRIDGE UNIV PRESS
PI NEW YORK
PA 32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA
SN 0950-2688
EI 1469-4409
J9 EPIDEMIOL INFECT
JI Epidemiol. Infect.
PD APR
PY 2018
VL 146
IS 6
BP 673
EP 679
DI 10.1017/S0950268818000419
PG 7
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA GD0KK
UT WOS:000430189500002
PM 29536828
OA Bronze
DA 2020-07-08
ER

PT J
AU Aneja, S
AF Aneja, Satinder
TI Zika Virus Infection and Microcephaly in Infants: Is the Association
   Casual or Causal?
SO INDIAN PEDIATRICS
LA English
DT Editorial Material
ID BRAZIL; SURVEILLANCE; TERRITORIES; PREVALENCE; STANDARDS; CHILDREN;
   OUTCOMES; JANUARY; HEALTH; STATES
C1 [Aneja, Satinder] Sharda Univ, Sch Med Sci & Res, Dept Pediat, Greater Noida, Uttar Pradesh, India.
RP Aneja, S (corresponding author), Sharda Univ, Sch Med Sci & Res, Dept Pediat, Greater Noida, Uttar Pradesh, India.
EM drsaneja@gmail.com
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Auger N, 2018, ARCH DIS CHILD-FETAL, V103, pF167, DOI 10.1136/archdischild-2016-311199
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bautista LE, 2018, ANN EPIDEMIOL, V28, P111, DOI 10.1016/j.annepidem.2017.11.010
   Bhardwaj S, 2017, INDIAN J MED RES, V146, P572, DOI 10.4103/ijmr.IJMR_1160_17
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Magalhaes-Barbosa MC, 2017, ARCH DIS CHILD, V102, P728, DOI 10.1136/archdischild-2016-311541
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Hoyt AT, 2018, BIRTH DEFECTS RES, V110, P395, DOI 10.1002/bdr2.1164
   Indian Council of Medical Research, 2018, ZIK VIR PREP RESP
   KOZAK RA, 2017, VIRUSES-BASEL, V9, DOI DOI 10.3390/V9100297
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Liuzzi G, 2016, NEW MICROBIOL, V39, P83
   McCloskey B, 2017, PUBLIC HEALTH, V150, P87, DOI 10.1016/j.puhe.2017.05.008
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   de Albuquerque MDPM, 2016, MEM I OSWALDO CRUZ, V111, P774, DOI 10.1590/0074-02760160291
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   ORIOLI IM, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5018
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Possas C, 2017, MEM I OSWALDO CRUZ, V112, P319, DOI 10.1590/0074-02760160510
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Ribeiro IG, 2018, EPIDEMIOL SERV SAUDE, V27, DOI 10.5123/S1679-49742018000100002
   Ronchetti R, 2016, EPIDEMIOL PREV, V40, P466, DOI 10.19191/EP16.6.P466.128
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Souza AD, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00064615
   Villar J, 2015, LANCET GLOB HEALTH, V3, pE681, DOI 10.1016/S2214-109X(15)00163-1
   World Health Organization, 2016, SCREEN ASS MAN NEON
NR 39
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-6061
EI 0974-7559
J9 INDIAN PEDIATR
JI Indian Pediatrics
PD APR
PY 2018
VL 55
IS 4
BP 326
EP 334
DI 10.1016/S2352-4642(18)30020-8
PG 9
WC Pediatrics
SC Pediatrics
GA GE5OH
UT WOS:000431271400011
OA Bronze
DA 2020-07-08
ER

PT J
AU Prakalapakorn, SG
   Rasmussen, SA
AF Prakalapakorn, S. Grace
   Rasmussen, Sonja A.
TI THE EYES AS A WINDOW TO IMPROVED UNDERSTANDING OF THE PRENATAL EFFECTS
   OF ZIKA VIRUS INFECTION Reply
SO JOURNAL OF AAPOS
LA English
DT Letter
ID INFANTS; UPDATE
C1 [Prakalapakorn, S. Grace] Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.
   [Rasmussen, Sonja A.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Prakalapakorn, SG (corresponding author), Duke Univ, Dept Ophthalmol, Durham, NC 27708 USA.
OI Rasmussen, Sonja/0000-0002-0574-4928; Prakalapakorn,
   Sasapin/0000-0001-6788-7425
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Prakalapakorn SG, 2017, J AAPOS, V21, P259, DOI 10.1016/j.jaapos.2017.07.001
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
NR 4
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD APR
PY 2018
VL 22
IS 2
BP 166
EP 166
DI 10.1016/j.jaapos.2018.02.002
PG 1
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA GE5TM
UT WOS:000431285000028
PM 29574136
OA Bronze
DA 2020-07-08
ER

PT J
AU Koo, B
   Jin, CE
   Park, SY
   Lee, TY
   Nam, J
   Jang, YR
   Kim, SM
   Kim, JY
   Kim, SH
   Shin, Y
AF Koo, Bonhan
   Jin, Choong Eun
   Park, Se Yoon
   Lee, Tae Yoon
   Nam, Jeonghun
   Jang, Young-Rock
   Kim, Sun Mi
   Kim, Ji Yeun
   Kim, Sung-Han
   Shin, Yong
TI A rapid bio-optical sensor for diagnosing Q fever in clinical specimens
SO JOURNAL OF BIOPHOTONICS
LA English
DT Article
DE bio-optical sensor; clinical specimens; isothermal DNA amplification; Q
   fever; zoonosis
ID RECOMBINASE POLYMERASE AMPLIFICATION; SILICON MICRORING RESONATORS;
   COXIELLA-BURNETII; LABEL-FREE; BLADDER-CANCER; UNKNOWN ORIGIN; DNA; PCR;
   EXTRACTION; BIOSENSOR
AB Recent zoonotic outbreaks, such as Zika, Middle East respiratory syndrome and Ebola, have highlighted the need for rapid and accurate diagnostic assays that can be used to aid pathogen control. Q fever is a zoonotic disease caused by the transmission of Coxiella burnetii that can cause serious illness in humans through aerosols and is considered a potential bioterrorism agent. However, the existing assays are not suitable for the detection of this pathogen due to its low levels in real samples. We here describe a rapid bio-optical sensor for the accurate detection of Q fever and validate its clinical utility. By combining a bio-optical sensor, that transduces the presence of the target DNA based on binding-induced changes in the refractive index on the waveguide surface in a label-free and real-time manner, with isothermal DNA amplification, this new diagnostic tool offers a rapid (<20min), 1-step DNA amplification/detection method. We confirmed the clinical sensitivity (>90%) of the bio-optical sensor by detecting C. burnetii in 11 formalin-fixed, paraffin-embedded liver biopsy samples from acute Q fever hepatitis patients and in 16 blood plasma samples from patients in which Q fever is the cause of fever of unknown origin.
C1 [Koo, Bonhan; Jin, Choong Eun; Shin, Yong] Univ Ulsan, Dept Convergence Med, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul, South Korea.
   [Koo, Bonhan; Jin, Choong Eun; Shin, Yong] Asan Inst Life Sci, Biomed Engn Res Ctr, 88 Olymp Ro 43 Gil, Seoul, South Korea.
   [Park, Se Yoon] Soonchunhyang Univ, Div Infect Dis, Dept Internal Med, Coll Med, 59 Daesangwan Ro, Seoul, South Korea.
   [Lee, Tae Yoon] Chungnam Natl Univ, Dept Technol Educ, Daejeon 34134, South Korea.
   [Nam, Jeonghun] Korea Univ, Sch Med, Dept Lab Med, 145 Anam Ro, Seoul, South Korea.
   [Jang, Young-Rock; Kim, Sun Mi; Kim, Ji Yeun; Kim, Sung-Han] Univ Ulsan, Dept Infect Dis, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul, South Korea.
   [Jang, Young-Rock] Gachon Univ, Div Infect Dis, Dept Internal Med, Coll Med,Gil Med Ctr, 21 Namdong Daero 774 Beon Gil, Incheon, South Korea.
RP Shin, Y (corresponding author), Univ Ulsan, Dept Convergence Med, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul, South Korea.; Shin, Y (corresponding author), Asan Inst Life Sci, Biomed Engn Res Ctr, 88 Olymp Ro 43 Gil, Seoul, South Korea.; Kim, SH (corresponding author), Univ Ulsan, Dept Infect Dis, Asan Med Ctr, Coll Med, 88 Olymp Ro 43 Gil, Seoul, South Korea.
EM kimsunghanmd@hotmail.com; shinyongno1@gmail.com
OI Lee, Tae Yoon/0000-0003-1139-6269; Jin, Choong Eun/0000-0002-4462-2333;
   Nam, Jeonghun/0000-0002-0591-7745
FU Ministry of Health & Welfare, Republic of KoreaMinistry of Health &
   Welfare, Republic of Korea [HI16C-0272-010016]
FX Ministry of Health & Welfare, Republic of Korea, Grant/Award number:
   HI16C-0272-010016
CR Aguilar-Olivos N, 2013, ANN HEPATOL, V12, P138, DOI 10.1016/S1665-2681(19)31396-1
   Blow N, 2007, NATURE, V448, P959, DOI 10.1038/448959a
   Bogaerts W, 2012, LASER PHOTONICS REV, V6, P47, DOI 10.1002/lpor.201100017
   Chen HW, 2014, J MICROBIOL METH, V107, P176, DOI 10.1016/j.mimet.2014.07.039
   Chien YL, 2017, J MICROBIOL IMMUNOL, V50, P893, DOI 10.1016/j.jmii.2015.08.007
   Cunha BA, 2007, INFECT DIS CLIN N AM, V21, P867, DOI 10.1016/j.idc.2007.09.002
   Cunha BA, 2015, AM J MED, V128, DOI 10.1016/j.amjmed.2015.06.001
   de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11
   de Rooij MMT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151281
   De Vos K, 2007, OPT EXPRESS, V15, P7610, DOI 10.1364/OE.15.007610
   De Vos K, 2009, BIOSENS BIOELECTRON, V24, P2528, DOI 10.1016/j.bios.2009.01.009
   Drancourt M, 2005, NAT REV MICROBIOL, V3, P23, DOI 10.1038/nrmicro1063
   Duron O, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv132
   Elsa Jourdain, 2015, Infection Ecology & Epidemiology, V5, P29230, DOI 10.3402/iee.v5.29230
   Euler M, 2012, J CLIN VIROL, V54, P308, DOI 10.1016/j.jcv.2012.05.006
   Field PR, 2000, J CLIN MICROBIOL, V38, P1645, DOI 10.1128/JCM.38.4.1645-1647.2000
   Hamzic S., 2008, ACTA INFORM MED, V16, P86
   Hatchette TF, 2001, CLIN INFECT DIS, V33, P1347, DOI 10.1086/323031
   Hong CC, 2016, BIOSENS BIOELECTRON, V86, P623, DOI 10.1016/j.bios.2016.07.032
   Hubalek Z, 2003, EMERG INFECT DIS, V9, P403, DOI 10.3201/eid0903.020208
   Hussain M, 2015, BIOSENS BIOELECTRON, V66, P579, DOI 10.1016/j.bios.2014.12.003
   Iqbal M, 2010, IEEE J SEL TOP QUANT, V16, P654, DOI 10.1109/JSTQE.2009.2032510
   Jaton K, 2013, New Microbes New Infect, V1, P6, DOI 10.1002/2052-2975.8
   Kargar M, 2015, ZJRMS, V17, P29
   Kersh GJ, 2010, APPL ENVIRON MICROB, V76, P4469, DOI 10.1128/AEM.00042-10
   Kim KW, 2013, BIOSENS BIOELECTRON, V45, P152, DOI 10.1016/j.bios.2013.02.001
   Kim SH, 2016, CLIN INFECT DIS, V63, P363, DOI 10.1093/cid/ciw239
   Klee SR, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-2
   Kokkat TJ, 2013, BIOPRESERV BIOBANK, V11, P101, DOI 10.1089/bio.2012.0052
   Lin JH, 2009, ANAL BIOCHEM, V395, P265, DOI 10.1016/j.ab.2009.08.016
   Liu Q, 2013, SENSOR ACTUAT B-CHEM, V188, P681, DOI 10.1016/j.snb.2013.07.053
   Lorenz H, 1998, APPL ENVIRON MICROB, V64, P4234
   Lutz S, 2010, LAB CHIP, V10, P887, DOI 10.1039/b921140c
   Marmion BP, 2005, QJM-INT J MED, V98, P7, DOI 10.1093/qjmed/hci009
   Meekelenkamp JCE, 2012, EUR J CLIN MICROBIOL, V31, P1267, DOI 10.1007/s10096-011-1438-0
   Mares-Guia MAMD, 2014, REV SOC BRAS MED TRO, V47, P231, DOI 10.1590/0037-8682-0076-2013
   Mtshali K, 2015, J VET MED SCI, V77, P1573, DOI 10.1292/jvms.15-0170
   Nouvellet P, 2015, NATURE, V528, pS109, DOI 10.1038/nature16041
   Panning M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-77
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Park MK, 2013, SENSOR ACTUAT B-CHEM, V176, P552, DOI 10.1016/j.snb.2012.08.078
   Pearson T, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw088
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k
   Rolain J. M., 2005, J MED, V98, P615
   Schrader C, 2012, J APPL MICROBIOL, V113, P1014, DOI 10.1111/j.1365-2672.2012.05384.x
   Scicchitano MS, 2009, J HISTOCHEM CYTOCHEM, V57, P849, DOI 10.1369/jhc.2009.953497
   Seo MG, 2016, EMERG INFECT DIS, V22, P2192, DOI 10.3201/eid2212.161236
   Seshadri R, 2003, P NATL ACAD SCI USA, V100, P5455, DOI 10.1073/pnas.0931379100
   Shen F, 2011, ANAL CHEM, V83, P3533, DOI 10.1021/ac200247e
   Shin Y, 2013, SENSOR ACTUAT B-CHEM, V177, P404, DOI 10.1016/j.snb.2012.11.058
   Shrivastava A., 2011, CHRON YOUNG SCI, V2, P21, DOI [10.4103/2229-5186.79345, DOI 10.4103/2229-5186.79345]
   Slaba K, 2005, ACTA VIROL, V49, P123
   Streicker DG, 2013, SCIENCE, V342, P1185, DOI [10.1126/Science.1247566, 10.1126/science.1247566]
   Wang XH, 2010, BIOSENS BIOELECTRON, V26, P404, DOI 10.1016/j.bios.2010.07.121
   Zhang Z, 2010, J MOL DIAGN, V12, P152, DOI 10.2353/jmoldx.2010.090070
NR 56
TC 2
Z9 2
U1 2
U2 16
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1864-063X
EI 1864-0648
J9 J BIOPHOTONICS
JI J. Biophotonics
PD APR
PY 2018
VL 11
IS 4
AR UNSP e201700167
DI 10.1002/jbio.201700167
PG 9
WC Biochemical Research Methods; Biophysics; Optics
SC Biochemistry & Molecular Biology; Biophysics; Optics
GA GD0GE
UT WOS:000430178100011
PM 29024445
DA 2020-07-08
ER

PT J
AU Goncalves, A
   Peeling, RW
   Chu, MC
   Gubler, DJ
   de Silva, AM
   Harris, E
   Murtagh, M
   Chua, A
   Rodriguez, W
   Kelly, C
   Wilder-Smith, A
AF Goncalves, Adriana
   Peeling, Rosanna W.
   Chu, May C.
   Gubler, Duane J.
   de Silva, Aravinda M.
   Harris, Eva
   Murtagh, Maurine
   Chua, Arlene
   Rodriguez, William
   Kelly, Cassandra
   Wilder-Smith, Annelies
TI Innovative and New Approaches to Laboratory Diagnosis of Zika and
   Dengue: A Meeting Report
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Dengue; Zika; flavivirus; arbovirus; laboratory; diagnostics; serology;
   surveillance
ID POLYMERASE-CHAIN-REACTION; VIRUS-INFECTION; NEUTRALIZING ANTIBODIES;
   CROSS-REACTIVITY; RAPID DETECTION; CHIKUNGUNYA; PLATFORM; VACCINE; POINT
AB Epidemics of dengue, Zika, and other arboviral diseases are increasing in frequency and severity. Current efforts to rapidly identify and manage these epidemics are limited by the short diagnostic window in acute infection, the extensive serologic cross-reactivity among flaviviruses, and the lack of point-of-care diagnostic tools to detect these viral species in primary care settings. The Partnership for Dengue Control organized a workshop to review the current landscape of Flavivirus diagnostic tools, identified current gaps, and developed strategies to accelerate the adoption of promising novel technologies into national programs. The rate-limiting step to bringing new diagnostic tools to the market is access to reference materials and well-characterized clinical samples to facilitate performance evaluation. We suggest the creation of an international laboratory-response consortium for flaviviruses with a decentralized biobank of well-characterized samples to facilitate assay validation. Access to proficiency panels are needed to ensure quality control, in additional to in-country capacity building.
C1 [Goncalves, Adriana; Peeling, Rosanna W.] London Sch Hyg & Trop Med, London, England.
   [Chu, May C.] Univ Colorado, Dept Epidemiol, Colorado Sch Publ Hlth, Anschutz Med Ctr, Aurora, CO USA.
   [de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC USA.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Murtagh, Maurine] Murtagh Grp, Palo Alto, CA USA.
   [Gubler, Duane J.] Duke NUS Med Sch, Emerging Infect Dis Program, Singapore, Singapore.
   [Wilder-Smith, Annelies] Lee Kong Chian Sch Med, Singapore, Singapore.
   [Chua, Arlene] WHO, Geneva, Switzerland.
   [Rodriguez, William; Kelly, Cassandra] Fdn Innovat New Diagnost, Geneva, Switzerland.
   [Wilder-Smith, Annelies] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.
   [Wilder-Smith, Annelies] Univ Umea, Dept Global Hlth & Epidemiol, Umea, Sweden.
RP Wilder-Smith, A (corresponding author), Lee Kong Chian Sch Med, Singapore, Singapore.; Wilder-Smith, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany.; Wilder-Smith, A (corresponding author), Univ Umea, Dept Global Hlth & Epidemiol, Umea, Sweden.
EM anneliesws@gmail.com
FU Gates FoundationGates Foundation; European Union's Research and
   Innovation Programme, through the ZikaPLAN consortium [734584]; PSRC IRC
   in Early-Warning Sensing Systems for Infectious Diseases [EP/K031953/1];
   bioMerieux; Sanofi Pasteur; TakedaTakeda Pharmaceutical Company Ltd;
   Foundation for Innovative and New Diagnostics; World Health Organization
   (WHO) Special Program for Research and Training in Tropical Diseases;
   WHO RD Blueprint
FX This work was supported by the Gates Foundation; the European Union's
   2020 Research and Innovation Programme, through the ZikaPLAN consortium
   (grant 734584); the EPSRC IRC in Early-Warning Sensing Systems for
   Infectious Diseases (EP/K031953/1); bioMerieux (unrestricted grant);
   Sanofi Pasteur (unrestricted grant); Takeda (unrestricted grant); the
   Foundation for Innovative and New Diagnostics (in-kind support); the
   World Health Organization (WHO) Special Program for Research and
   Training in Tropical Diseases (in-kind support); and the WHO R&D
   Blueprint (in-kind support).
CR Abd El Wahed Ahmed, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.a7f1db2c7d66c3fc0ea0a774305d319e
   Andrade DV, 2018, VIRUS RES, V254, P27, DOI 10.1016/j.virusres.2017.06.019
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bedin F, 2017, J MED VIROL, V89, P1520, DOI 10.1002/jmv.24806
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Gubler DJ, 2015, VACCINE, V33, P1233, DOI 10.1016/j.vaccine.2015.01.002
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   HOTTA S, 1952, J INFECT DIS, V90, P1, DOI 10.1093/infdis/90.1.1
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lee D, 2016, ANAL CHEM, V88, P12272, DOI 10.1021/acs.analchem.6b03460
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Niwa K, 2014, ANAL BIOCHEM, V464, P12, DOI 10.1016/j.ab.2014.07.010
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Patel B, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005554
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Rose N, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0314-5
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Special Program for Research and Training in Tropical Diseases, 2006, SPEC PROGR RES TRAIN
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Teoh BT, 2015, J CLIN MICROBIOL, V53, P830, DOI 10.1128/JCM.02648-14
   Teoh EP, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003888
   Trosemeier JH, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00917-16
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilder-Smith A, 2017, LANCET INFECT DIS, V17, P1109, DOI 10.1016/S1473-3099(17)30494-2
   Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341
   World Health Organization, R D BLUEPR
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 49
TC 26
Z9 26
U1 1
U2 18
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD APR 1
PY 2018
VL 217
IS 7
BP 1060
EP 1068
DI 10.1093/infdis/jix678
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA FZ8GM
UT WOS:000427845800007
PM 29294035
OA Bronze, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Hobbins, JC
   Platt, LD
   Copel, JA
   Euser, AG
   Afshar, Y
   Irani, RA
   Levine, D
   Cortes, MS
   Abuhamad, A
   Gaw, SL
   Harris, K
   Herrera, M
   Lynch, L
   Melo, A
   Noguchi, L
   Aguiar, R
   Sheffield, JS
   Minton, KK
AF Hobbins, John C.
   Platt, Lawrence D.
   Copel, Joshua A.
   Euser, Anna G.
   Afshar, Yalda
   Irani, Roxanna A.
   Levine, Deborah
   Cortes, Magda Sanz
   Abuhamad, Alfred
   Gaw, Stephanie L.
   Harris, Karen
   Herrera, Mauricio
   Lynch, Lauren
   Melo, Adriana
   Noguchi, Lisa
   Aguiar, Renato
   Sheffield, Jeanne S.
   Minton, Katherine K.
TI Gottesfeld-Hohler Memorial Foundation Zika Virus Think Tank Summary
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID PROTECTION; INFECTION; FETUSES; WOMEN
AB At a think tank bringing together experts on fetal neuroimaging, obstetric infectious diseases, and public health, we discussed trends in all of these areas for Zika virus. There is a wide variety of imaging findings in affected fetuses, influenced by timing of infection and probably host factors. The resources for diagnosis and interventions also vary by location with the hardest hit areas often having the fewest resources. We identified potential areas for both research and clinical collaboration as the Zika virus epidemic continues to evolve.
C1 Univ Colorado Denver, Sch Med, Dept Obstet & Gynecol, Aurora, CO USA.
   Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT USA.
   Yale Sch Med, Dept Pediat, New Haven, CT USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA.
   Harvard Med Sch, Brigham & Womens Hosp, Dept Radiol, Boston, MA USA.
   Texas Childrens Hosp, Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.
   Eastern Virginia Med Sch, Maternal Fetal Med, Norfolk, VA 23501 USA.
   Univ Calif San Francisco, Obstet & Gynecol, San Francisco, CA 94143 USA.
   North Florida Womens Phys, Gainesville, FL USA.
   Columbia Univ Clin, Maternal Fetal Med Dept, Colsanitas Clin, Bogota, Colombia.
   Prof Joaquim Amorim Neto Res Inst, Campina Grande, Brazil.
   Johns Hopkins Univ Jhpiego, Baltimore, MD USA.
   Johns Hopkins Univ, Dept Obstet & Gynecol, Baltimore, MD USA.
   Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   Amer Inst Ultrasound Med, Laurel, MD USA.
RP Hobbins, JC (corresponding author), Platte River Perinatal Ctr, 1772 Platte St, Denver, CO 80202 USA.
EM john.hobbins@ucdenver.edu
RI Gaw, Stephanie/K-4592-2019; Aguiar, Renato S/G-3542-2015; Melo, Adriana
   S O/H-5650-2016
OI Gaw, Stephanie/0000-0003-0891-6964; Aguiar, Renato
   S/0000-0001-5180-3717; Afshar, Yalda/0000-0003-3807-7022
FU Gottesfeld-Hohler Memorial Foundation
FX The manuscript was produced from a Think Tank organized by The
   Gottesfeld-Hohler Memorial Foundation and held in Ft. Lauderdale,
   Florida, June 2- 4, 2017. Costs of the meeting were underwritten by the
   Foundation with no commercial support.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2017, ZIK VIR CAS COUNTS 2
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Levine D, 2003, RADIOLOGY, V229, P51, DOI 10.1148/radiol.2291020770
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pan-American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Paz-Bailey G, 2017, N ENGL J MED
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Timor-Tritsch IE, 2012, ULTRASONOGRAPHY PREN
   WHO, 2017, ZIK SIT REP
NR 23
TC 1
Z9 1
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2018
VL 131
IS 4
BP 661
EP 665
DI 10.1097/AOG.0000000000002538
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GQ0YP
UT WOS:000441347800010
PM 29528928
DA 2020-07-08
ER

PT J
AU Vissoci, JRN
   Rocha, TAH
   da Silva, NC
   Queiroz, RCD
   Thomaz, EBAF
   Amaral, PVM
   Lein, A
   Branco, MDFC
   Aquino, J
   Rodrigues, ZMR
   da Silva, AAM
   Staton, C
AF Vissoci, Joao Ricardo Nickenig
   Hernandes Rocha, Thiago Augusto
   da Silva, Nubia Cristina
   de Sousa Queiroz, Rejane Christine
   Abreu Fonseca Thomaz, Erika Barbara
   Maia Amaral, Pedro Vasconcelos
   Lein, Adriana
   Freitas Carvalho Branco, Maria dos Remedios
   Aquino Junior, Jose
   Ribeiro Rodrigues, Zulimar Marita
   Moura da Silva, Antonio Augusto
   Staton, Catherine
TI Zika virus infection and microcephaly: Evidence regarding geospatial
   associations
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID SPATIAL ASSOCIATION; SEXUAL TRANSMISSION; BRAZIL; DISEASE; HEALTH
AB Background
   Although the Zika virus (ZIKV) epidemic ceased to be a public health emergency by the end of 2016, studies to improve knowledge about this emerging disease are still needed, especially those investigating a causal relationship between ZIKV in pregnant women and microcephaly in neonates. However, there are still many challenges in describing the relationship between ZIKV and microcephaly. The few studies focusing on the epidemiological profile of ZIKV and its changes over time are largely limited to systematic reviews of case reports and dispersal mapping of ZIKV spread over time without quantitative methods to analyze patterns and their covariates. Since Brazil has been at the epicenter of the ZIKV epidemic, this study examines the geospatial association between ZIKV and microcephaly in Brazil.
   Methods
   Our study is categorized as a retrospective, ecological study based on secondary databases. Data were obtained from January to December 2016, from the following data sources: Brazilian System for Epidemiological Surveillance, Disease Notification System, System for Specialized Management Support, and Brazilian Institute of Geography and Statistics. Data were aggregated by municipality. Incidence rates were estimated per 100,000 inhabitants. Analyses consisted of mapping the aggregated incidence rates of ZIKV and microcephaly, followed by a Getis-Ord-Gi spatial cluster analysis and a Bivariate Local Moran's I analysis.
   Results
   The incidence of ZIKV cases is changing the virus's spatial pattern, shifting from Brazil's Northeast region to the Midwest and North regions. The number of municipalities in clusters of microcephaly incidence is also shifting from the Northeast region to the Midwest and North, after a time lag is considered. Our findings suggest an increase in microcephaly incidence in the Midwest and North regions, associated with high levels of ZIKV infection months before.
   Conclusion
   The greatest burden of microcephaly shifted from the Northeast to other Brazilian regions at the beginning of 2016. Brazil's Midwest region experienced an increase in microcephaly incidence associated with ZIKV incidence. This finding highlights an association between an increase in ZIKV infection with a rise in microcephaly cases after approximately three months.
C1 [Vissoci, Joao Ricardo Nickenig; Lein, Adriana; Staton, Catherine] Duke Univ, Duke Global Hlth Inst, Durham, NC USA.
   [Vissoci, Joao Ricardo Nickenig; Staton, Catherine] Duke Univ Hlth Syst, Div Emergency Med, Dept Surg, Durham, NC USA.
   [Hernandes Rocha, Thiago Augusto] Univ Fed Minas Gerais, Sch Econ, Ctr Postgrad & Res Adm, Belo Horizonte, MG, Brazil.
   [da Silva, Nubia Cristina] Univ Fed Minas Gerais, Fac Econ, Observ Human Resources Hlth, Belo Horizonte, MG, Brazil.
   [de Sousa Queiroz, Rejane Christine; Abreu Fonseca Thomaz, Erika Barbara; Moura da Silva, Antonio Augusto] Univ Fed Maranhao, Dept Publ Hlth, Sao Luis, Maranhao, Brazil.
   [Maia Amaral, Pedro Vasconcelos] Univ Fed Minas Gerais, Ctr Dev & Reg Planning, Belo Horizonte, MG, Brazil.
   [Freitas Carvalho Branco, Maria dos Remedios] Univ Fed Maranhao, Dept Pathol, Sao Luis, Maranhao, Brazil.
   [Aquino Junior, Jose; Ribeiro Rodrigues, Zulimar Marita] Univ Fed Maranhao, Dept Geosci, Sao Luis, Maranhao, Brazil.
RP Vissoci, JRN (corresponding author), Duke Univ, Duke Global Hlth Inst, Durham, NC USA.; Vissoci, JRN (corresponding author), Duke Univ Hlth Syst, Div Emergency Med, Dept Surg, Durham, NC USA.
EM jnv4@duke.edu
RI Silva, Antonio A M/B-5410-2009
OI Silva, Antonio A M/0000-0003-4968-5138; Queiroz,
   Rejane/0000-0003-4019-2011; Rocha, Thiago/0000-0002-6262-3276; Silva
   Rocha, Nubia/0000-0002-0809-2152; Freitas Carvalho Branco, Maria dos
   Remedios/0000-0002-3537-0840
FU Fogarty International Center (Staton) [K01 TW010000-01A1]; Brazil's
   Ministry of Science, Technology, Innovation, and Communication-CNPq
   (MCTIC/FNDCT - CNPq / MEC-CAPES / MS-Decit) [311835/2016-3]; Foundation
   for Research and Scientific and Technological Development of
   Maranhao-FAPEMA
FX The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. Dr. Staton would
   like to acknowledge salary support funding from the Fogarty
   International Center (Staton, K01 TW010000-01A1). The authors would like
   to acknowledge the funding support by Brazil's Ministry of Science,
   Technology, Innovation, and Communication-CNPq (MCTIC/FNDCT - CNPq /
   MEC-CAPES / MS-Decit # 14/2016 / CNPq-PQ # 311835/2016-3) and the
   Foundation for Research and Scientific and Technological Development of
   Maranhao-FAPEMA, for publication and productivity scholarship support.
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   Anselin L, 2006, GEOGR ANAL, V38, P5, DOI 10.1111/j.0016-7363.2005.00671.x
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Arbex AK, 2016, SCI RES PUBL, V8, P711, DOI [10.4236/health.2016.87074, DOI 10.4236/HEALTH.2016.87074]
   Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Barreto ML, 2016, LANCET, V387, P919, DOI 10.1016/S0140-6736(16)00545-6
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil, 2015, INF SAUD TABNET
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2016, INCR REP PREV MICR I
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Cunha Antonio Jose Ledo Alves da, 2017, Pediatr Infect Dis J, V36, P528, DOI 10.1097/INF.0000000000001486
   Da Silva NC, 2014, EQUIDADE ATENC HER A, V38, P243
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Environmental Systems Research Institute (ESRI), 2014, ARCGIS DESKT REL 10
   Evans Roger, 2014, Nurs Stand, V29, P30, DOI 10.7748/ns.29.9.30.s34
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Hartfield M, 2014, AM NAT, V183, pE105, DOI 10.1086/674795
   IBGE, 2016, I BRAS GEOGR EST
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Laguardia J, 2004, EPIDEMIOL SERV SAUDE, V13, P135, DOI DOI 10.5123/S1679-49742004000300002
   Macintyre S, 2002, SOC SCI MED, V55, P125, DOI 10.1016/S0277-9536(01)00214-3
   Ministerio da Saude, 2017, VIR ZIK BRAS REP SUS
   Ministry of Health, 2017, B EP
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nsoesie EO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003977
   Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Registry USZP, 2017, VITAL SIGNS UPDATE Z, V66, P366, DOI [10.15585/mmwr.mm6613e1, DOI 10.15585/MMWR.MM6613E1]
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   United Nations, 2016, UN MILL DEV GOALS
   Villamil-Gomez WE, 2016, INT J INFECT DIS, V51, P135, DOI 10.1016/j.ijid.2016.07.017
   World Bank, 2017, GROSS DOM PROD RANK
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization (WHO), 2016, ZIK VIR COMPL 2016 P
   Xavier DR, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00186615, 10.1590/0102-311x00186615]
   Zinszer K, 2017, EMERG INFECT DIS, V23, P92, DOI 10.3201/eid2301.161274
NR 52
TC 5
Z9 5
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD APR
PY 2018
VL 12
IS 4
AR e0006392
DI 10.1371/journal.pntd.0006392
PG 16
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA GH5QP
UT WOS:000433487700032
PM 29694351
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rueda, AG
   Otero, ALC
   Duque, JE
   Kouznetsov, VV
AF Rueda, Andres G.
   Carreno Otero, Aurora L.
   Duque, Jonny E.
   Kouznetsov, Vladimir V.
TI Synthesis of new alpha-amino nitriles with insecticidal action on Aedes
   aegypti (Diptera: Culicidae)
SO REVISTA BRASILEIRA DE ENTOMOLOGIA
LA English
DT Article
DE Arthropod-borne diseases; Girgensohnine analogs; Strecker reaction;
   Insecticidal activity; Vector control
ID ZIKA VIRUS; CHIKUNGUNYA VIRUS; RESISTANCE
AB Aedes aegypti is the principal vector of arboviral pathogens that may cause diseases as dengue fever, chikungunya and zika. The harmful environmental effects of commercial pesticides coalesced with the development of insecticide-resistant populations encourage the discovery and generation of new alternative products as a tool to reduce the incidence of vector-borne diseases. In this work, through the classic three component Strecker reaction of commercial benzaldehydes, cyclic secondary amines and KCN, a new series of nine alpha-amino nitriles, girgensohnine analogs, has been synthetized and screened for larvicide and adulticide properties against A. aegypti, one of the dominant vectors of dengue, chikungunya and zika in tropical and subtropical areas all over the world. Molecules 3 and 4 were identified as potential larvicidal agents with LC50 values of 50.55 and 69.59 ppm, respectively. Molecule 3 showed 100% of mortality after 2 h of treatment when a concentration of 30 ppm in adulticidal assays was evaluated. Additionally, in order to elucidate the mode of action of these molecules, their acetylcholinesterase (AChE) inhibitory properties were evaluated using the Ellman assay. It was found that the molecules possess a weak AChE inhibitory activity with IC50 values between 148.80 and 259.40 mu M, indicating that AChE could not be a principal target for insecticide activity. (C) 2018 Sociedade Brasileira de Entomologia. Published by Elsevier Editora Ltda.
C1 [Rueda, Andres G.; Carreno Otero, Aurora L.; Kouznetsov, Vladimir V.] Univ Ind Santander, Lab Quim Organ & Biomol, Escuela Quim, Santander, Colombia.
   [Duque, Jonny E.] Univ Ind Santander, Ctr Invest Enfermedades Trop, Escuela Med, Santander, Colombia.
RP Kouznetsov, VV (corresponding author), Univ Ind Santander, Lab Quim Organ & Biomol, Escuela Quim, Santander, Colombia.; Duque, JE (corresponding author), Univ Ind Santander, Ctr Invest Enfermedades Trop, Escuela Med, Santander, Colombia.
EM jonedulu@uis.edu.co; kouznet@uis.edu.co
OI Duque, Jonny Edward/0000-0003-2245-0558
FU Departamento Administrativo de Ciencia, Tecnologia e Innovacion de
   Colombia; COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia
   e Innovacion Colciencias; Patrimonio Autonomo, Fondo Nacional de
   Financiamiento para la Ciencia, Francisco Jose de Caldas [110265740528,
   624-2014]; COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia
   e Innovacion Colciencias [567/2012]
FX This work was supported by the Research program: "Financial support from
   Departamento Administrativo de Ciencia, Tecnologia e Innovacion de
   Colombia, COLCIENCIAS and Patrimonio Autonomo, Fondo Nacional de
   Financiamiento para la Ciencia, Francisco Jose de Caldas", contracts
   code 110265740528 (grant 624-2014). A.L.C.O. thanks COLCIENCIAS for the
   fellowship No. 567/2012 to carry out doctoral studies.
CR Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   ASHFORD JR, 1970, BIOMETRICS, V26, P535, DOI 10.2307/2529107
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   Brahmachari G, 2016, CHEM REC, V16, P98, DOI 10.1002/tcr.201500229
   Brogdon W. G., 2005, SE ASIAN J TROP MED, V36, P417
   Cao-Lormeau V. -M., 2016, GUILLAIN BARRE SYNDR
   Carreno Otero A. L., 2018, OIL COMP BIOCH PHY C
   Otero ALC, 2014, EUR J MED CHEM, V78, P392, DOI 10.1016/j.ejmech.2014.03.067
   Dalla Bona AC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1634-y
   Dias CN, 2014, PARASITOL RES, V113, P565, DOI 10.1007/s00436-013-3687-6
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Erturk E, 2012, TETRAHEDRON, V68, P6463, DOI 10.1016/j.tet.2012.05.116
   Grisales N, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002438
   Guedes RNC, 2017, CURR OPIN INSECT SCI, V21, P47, DOI 10.1016/j.cois.2017.04.010
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Hemingway J., 2005, GUIDELINES LAB FIELD
   Flores-Conde MI, 2012, INT J MOL SCI, V13, P2590, DOI 10.3390/ijms13032590
   Instituto Nacional de Salud INS, 2017, B EP SEM
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kawada H., 2014, PARAS VECTORS, V7, P1
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0
   Lipinski CA, 2000, J PHARMACOL TOXICOL, V44, P235, DOI 10.1016/S1056-8719(00)00107-6
   Liu XC, 2016, MOLECULES, V21, DOI 10.3390/molecules21121665
   Low V. L., 2015, 1 MOL GENOTYPING A30
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NAHRSTEDT A, 1993, PHYTOCHEMISTRY, V33, P847, DOI 10.1016/0031-9422(93)85288-3
   Otto N, 2014, CHEM-EUR J, V20, P13064, DOI 10.1002/chem.201403956
   Pacelli G., 2013, PARASITOL RES
   Pang YP, 2014, ADV INSECT PHYSIOL, V46, P435, DOI 10.1016/B978-0-12-417010-0.00006-9
   Prajapati V., 2005, BIORESOUR TECHNOL
   Rashad AA, 2014, J MED CHEM, V57, P1147, DOI 10.1021/jm400460d
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Russell RJ, 2004, PESTIC BIOCHEM PHYS, V79, P84, DOI 10.1016/j.pestbp.2004.03.002
   Seo SM, 2015, J AGR FOOD CHEM, V63, P9977, DOI 10.1021/acs.jafc.5b03586
   Shafer TJ, 2005, ENVIRON HEALTH PERSP, V113, P123, DOI 10.1289/ehp.7254
   Shafran Y. M., 1989, RUSS CHEM REV, V58, P148
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Smith L. B., 2016, PESTIC BIOCHEM
   Sparks TC, 2015, PESTIC BIOCHEM PHYS, V121, P122, DOI 10.1016/j.pestbp.2014.11.014
   Staples JE, 2014, NEW ENGL J MED, V371, P887, DOI 10.1056/NEJMp1407698
   Stevens AJ, 2009, J MED CHEM, V52, P7911, DOI 10.1021/jm900652e
   Strecker A., 1850, LIEBIGS ANN CHEM, V75, P27, DOI DOI 10.1002/JLAC.18500750103
   Mendez LYV, 2013, CURR ORG SYNTH, V10, P969
   Wang J, 2011, CHEM REV, V111, P6947, DOI 10.1021/cr200057t
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   World Health Organization, 2012, REP WHO TECHN WORK G
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 54
TC 3
Z9 3
U1 0
U2 0
PU SOC BRASILEIRA ENTOMOLOGIA
PI CURITIBA
PA CAIXA POSTAL 19030, CURITIBA, PR 81531-980, BRAZIL
SN 0085-5626
EI 1806-9665
J9 REV BRAS ENTOMOL
JI Rev. Bras. Entomol.
PD APR-JUN
PY 2018
VL 62
IS 2
BP 112
EP 118
DI 10.1016/j.rbe.2018.01.004
PG 7
WC Entomology
SC Entomology
GA GL3HG
UT WOS:000437021700006
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Figueiredo, LTM
AF Moraes Figueiredo, Luiz Tadeu
TI Has the threat of Zika virus outbreaks come to an end?
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Editorial Material
C1 [Moraes Figueiredo, Luiz Tadeu] Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, SP, Brazil.
RP Figueiredo, LTM (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Ctr Pesquisa Virol, Ribeirao Preto, SP, Brazil.
EM ltmfigue@fmrp.usp.br
CR Butler Declan, 2016, Nature, V530, P13, DOI 10.1038/nature.2016.19259
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Meltzer E, 2012, INFECT DIS CLIN N AM, V26, P479, DOI 10.1016/j.idc.2012.02.003
   Figueiredo LTM, 2015, REV SOC BRAS MED TRO, V48, P233, DOI 10.1590/0037-8682-0179-2015
   Proenca-Modena JL, 2018, MICROBES INFECT
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
NR 6
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD APR-JUN
PY 2018
VL 51
IS 3
BP 259
EP 260
DI 10.1590/0037-8682-0247-2018
PG 2
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GL3IM
UT WOS:000437026000001
PM 29972553
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dias, IKR
   Sobreira, CLD
   Martins, RMG
   Santana, KFS
   Lopes, MDV
   Joventino, ES
   Viana, MCA
AF Rodrigues Dias, Itala Keane
   da Silva Sobreira, Cicera Luciana
   Grangeiro Martins, Rosa Maria
   Silva Santana, Kelly Fernanda
   Vieira Lopes, Maria do Socorro
   Joventino, Emanuella Silva
   Amaral Viana, Maria Corina
TI Zika virus: - a review of the main aspects of this type of arbovirosis
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Review
DE Zika virus; Arbovirus infections; Tropical Medicine; Aedes; Public
   health
ID GUILLAIN-BARRE-SYNDROME; UNITED-STATES; SEXUAL TRANSMISSION; GLOBAL
   THREAT; BRAZIL; EPIDEMIOLOGY; PREVENTION; MECHANISMS; INFECTION;
   OUTBREAK
AB The objective of this study was to integrate findings related to Zika virus from the scientific literature. An integrative review of Medline was conducted, and data search was performed using the Health Sciences Descriptor Zika virus and the following filters: full texts available; studies in humans; full articles; and publications in Portuguese, French, English, and Spanish. After application of the filters, followed by reading of the titles, abstracts, and full texts, 44 studies were included in the review, for which content analysis was performed. A large part of the literature comprised review articles (84%; N=37); the majority was in English (95%, N=42). In 2016, 84% (N=37) of our sample articles was published, while in 2017, 16% (N=7) was published. The main form of viral transmission was thorough the mosquito Aedes aegypti (N=30). In addition, sexual transmission (N=09), transmission through blood transfusion (N=16), vertical transmission (N=21) and transmission from occupational activities (N=03) occurred. It was possible to diagnose the disease by testing blood (N=22), urine (N=14), saliva (N=06), semen/sperm (N=03), cerebrospinal and amniotic fluid, and other tissues (N=02). Symptomatology occurred in 1-5 people (N=10) between 3 and 7 days after a mosquito bite (N=09). Complications observed were Guillain Barre syndrome (N=27); neurological Zika syndrome (N=27); meningitis, meningoencephalitis, and myelitis (N=07); deaths and/or newborns (N=03). The review provides scientific evidence that contributes to the care, planning and implementation of public policies.
C1 [Rodrigues Dias, Itala Keane; da Silva Sobreira, Cicera Luciana; Silva Santana, Kelly Fernanda] Univ Reg Cariri, Programa Posgrad Stricto Sensu Enfermagem, Crato, CE, Brazil.
   [Grangeiro Martins, Rosa Maria] Univ Reg Cariri, Programa Posgrad Stricto Sensu Saude Familia, Crato, CE, Brazil.
   [Vieira Lopes, Maria do Socorro; Amaral Viana, Maria Corina] Univ Reg Cariri, Dept Enfermagem, Crato, CE, Brazil.
   [Joventino, Emanuella Silva] Univ Integracao Int Lusofonia Afro Brasileira, Dept Enfermagem, Redencao, CE, Brazil.
RP Dias, IKR (corresponding author), Univ Reg Cariri, Programa Posgrad Stricto Sensu Enfermagem, Crato, CE, Brazil.
EM itala_keany@hotmail.com
CR Ahmad SSY, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1062
   de Brito CAA, 2016, REV SOC BRAS MED TRO, V49, P537, DOI 10.1590/0037-8682-0328-2016
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Borchardt RA, 2016, JAAPA-J AM ACAD PHYS, V29, P48, DOI 10.1097/01.JAA.0000481413.11539.b1
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   da Silva LRC, 2016, REV SOC BRAS MED TRO, V49, P267, DOI 10.1590/0037-8682-0150-2016
   Centers for Disease Control and Prevention, REV DIAGN TEST ZIK C
   de Carvalho NS, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12616
   de Souza MT, 2010, EINSTEIN-SAO PAULO, V8, P102, DOI 10.1590/S1679-45082010RW1134
   Dirlikov E, 2017, EMERG INFECT DIS, V23, P134, DOI 10.3201/eid2301.161290
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faizan MI, 2016, INTERVIROLOGY, V59, P152, DOI 10.1159/000452950
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fellner Chris, 2016, P T, V41, P242
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Fuwa K, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12605
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hajra A, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12607
   Hajra A, 2016, N AM J MED SCI, V8, DOI 10.4103/1947-2714.179112
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Jin J., 2016, JAMA-J AM MED ASSOC, V315, P2373
   Kwak-Kim J, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12606
   Laval F, 2016, MED SANTE TROP, V26, P145
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Macfadden DR, 2016, CMAJ, V188, P311
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P95, DOI 10.2450/2015.0066-15
   de Salazar PM, 2016, ENFERM INFEC MICR CL, V34, P247, DOI 10.1016/j.eimc.2016.02.016
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Mendes Karina Dal Sasso, 2008, Texto contexto - enferm., V17, P758, DOI 10.1590/S0104-07072008000400018
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   Murray JS, 2017, J SPEC PEDIATR NURS, V22, DOI 10.1111/jspn.12164
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olson CK, 2016, MMWR-MORBID MORTAL W, V65, P290, DOI 10.15585/mmwr.mm6511e3
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seley Celeste M., 2009, Prensa Medica Argentina, V96, P395
   Simoes R, 2016, REV ASSOC MED BRAS, V62, P108, DOI [10.1590/1806-9282.62.02.106, 10.1590/1806-9282.62.02.108]
   Slenczka W, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0019-2016
   Soares Cassia Baldini, 2014, Rev. esc. enferm. USP, V48, P335, DOI 10.1590/S0080-6234201400002000020
   Toresdahl BG, 2016, SPORTS HEALTH, V8, P438, DOI 10.1177/1941738116659060
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Walker WL, 2016, MMWR-MORBID MORTAL W, V65, P983, DOI 10.15585/mmwr.mm6536e5
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 57
TC 3
Z9 3
U1 1
U2 7
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD APR-JUN
PY 2018
VL 51
IS 3
BP 261
EP 269
DI 10.1590/0037-8682-0130-2018
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GL3IM
UT WOS:000437026000002
PM 29972554
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU de Azevedo, MB
   Coutinho, MSC
   da Silva, MA
   Arduini, DB
   Lima, JDV
   Monteiro, R
   Mendes, BNB
   Lemos, MCF
   Noronha, CP
   Saraceni, V
AF de Azevedo, Marina Baptista
   Coelho Coutinho, Marcia Sandre
   da Silva, Monica Agostinho
   Arduini, Denise Bastos
   Vieira Lima, Juliana Dias
   Monteiro, Rosangela
   Bahia Mendes, Barbara Nicacio
   Ferreira Lemos, Maria Cristina
   Noronha, Claudio Pompeiano
   Saraceni, Valeria
TI Neurologic manifestations in emerging arboviral diseases in Rio de
   Janeiro City, Brazil, 2015-2016
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Neurologic disorder; Arbovirus; Emerging infectious disease
ID GUILLAIN-BARRE-SYNDROME; ZIKA VIRUS; COMPLICATIONS; CHIKUNGUNYA;
   INFECTION
AB Introduction: Dengue has affected Rio de Janeiro City since the 1980s. The sequential Zika and chikungunya virus introductions during 2015 aggravated the health scenario, with 97,241 cases of arboviral diseases reported in 2015-2016, some with neurological disorders. Methods: Arbovirus-related neurologic cases were descriptively analyzed, including neurological syndromes and laboratory results. Results: In total, 112 cases with non-congenital neurologic manifestations (Guillain-Barre syndrome, 64.3%; meningoencephalitis, 24.1%; acute demyelinating encephalomyelitis, 8%) were arbovirus-related; 43.7% were laboratory-confirmed, of which 57.1% were chikungunya-positive. Conclusions: Emerging arbovirus infections brought opportunities to study atypical, severe manifestations. Surveillance responses optimized case identification and better clinical approaches.
C1 [de Azevedo, Marina Baptista; Coelho Coutinho, Marcia Sandre; da Silva, Monica Agostinho; Arduini, Denise Bastos; Vieira Lima, Juliana Dias; Monteiro, Rosangela; Bahia Mendes, Barbara Nicacio; Ferreira Lemos, Maria Cristina; Noronha, Claudio Pompeiano; Saraceni, Valeria] Secretaria Municipal Saude Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
RP Saraceni, V (corresponding author), Secretaria Municipal Saude Rio de Janeiro, Rio De Janeiro, RJ, Brazil.
EM valsaraceni@gmail.com
CR Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carod-Artal FJ, 2016, REV NEUROLOGIA, V62, P317, DOI 10.33588/rn.6207.2016152
   Cerny T, 2017, NEUROCRIT CARE, V27, P447, DOI 10.1007/s12028-017-0413-8
   Chandak NH, 2009, NEUROL INDIA, V57, P177, DOI 10.4103/0028-3886.51289
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   PAHO/WHO, 2016, EP UPD NEUR SYNDR CO
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 17
TC 2
Z9 2
U1 0
U2 3
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD APR-JUN
PY 2018
VL 51
IS 3
BP 347
EP 351
DI 10.1590/0037-8682-0327-2017
PG 5
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GL3IM
UT WOS:000437026000014
PM 29972566
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Vieira, MADES
   Castro, AAD
   Henriques, DF
   da Silva, EVP
   Tavares, FN
   Martins, LC
   Guimaraes, LM
   Monteiro, TAF
   Azevedo, RDD
   Cruz, ACR
   Vasconcelos, PFD
AF da Cunha e Silva Vieira, Marcelo Adriano
   de Sousa Castro, Alzira Almeida
   Henriques, Daniele Freitas
   Pinto da Silva, Eliana Vieira
   Tavares, Fernando Neto
   Martins, Livia Caricio
   Guimaraes, Lucas Melo
   Furtado Monteiro, Talita Antonia
   da Silva Azevedo, Raimunda do Socorro
   Ribeiro Cruz, Ana Cecilia
   da Costa Vasconcelos, Pedro Fernando
TI Encephalitis associated with Zika virus infection and reactivation of
   the varicella-zoster virus in a Brazilian child
SO REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL
LA English
DT Article
DE Encephalitis; Human herpesvirus 3; Zika virus infection
ID PCR
AB We report a case of encephalitis associated with Zika virus infection and reactivation of varicella-zoster virus in the central nervous system of a Brazilian child. This case raises the possibility that reactivation of the latent varicella-zoster virus may be a mechanism of neurological impairment induced by acquired Zika virus infection.
C1 [da Cunha e Silva Vieira, Marcelo Adriano] Secretaria Estado Saude Piaui, Inst Doencas Trop Natan Portella, Teresina, PI, Brazil.
   [da Cunha e Silva Vieira, Marcelo Adriano] Fundacao Municipal Saude Teresina, Diretoria Vigilancia Saude, Teresina, PI, Brazil.
   [da Cunha e Silva Vieira, Marcelo Adriano; Furtado Monteiro, Talita Antonia] Inst Evandro Chagas, Programa Posgrad Virol, Ananindeua, PA, Brazil.
   [de Sousa Castro, Alzira Almeida] Secretaria Estado Saude Piaui, Hosp Infantil Lucidio Portella, Teresina, PI, Brazil.
   [Henriques, Daniele Freitas; Pinto da Silva, Eliana Vieira; Martins, Livia Caricio; da Silva Azevedo, Raimunda do Socorro; Ribeiro Cruz, Ana Cecilia; da Costa Vasconcelos, Pedro Fernando] Inst Evandro Chagas, Secao Arbovirol & Febres Hemorrag, Ananindeua, PA, Brazil.
   [Tavares, Fernando Neto; Furtado Monteiro, Talita Antonia] Inst Evandro Chagas, Secao Virol Geral, Ananindeua, PA, Brazil.
   [Guimaraes, Lucas Melo] Fundacao Municipal Saude Teresina, Hosp Urgencias Teresina Dr Zenon Rocha Filho, Teresina, PI, Brazil.
RP Vieira, MADES (corresponding author), Secretaria Estado Saude Piaui, Inst Doencas Trop Natan Portella, Teresina, PI, Brazil.; Vieira, MADES (corresponding author), Fundacao Municipal Saude Teresina, Diretoria Vigilancia Saude, Teresina, PI, Brazil.; Vieira, MADES (corresponding author), Inst Evandro Chagas, Programa Posgrad Virol, Ananindeua, PA, Brazil.
EM macsvieira@superig.com.br
RI Vasconcelos, Pedro/AAH-3142-2019; Azevedo, Raimunda/T-4656-2019; Cruz,
   Ana Cecilia Ribeiro/V-9276-2019
OI Azevedo, Raimunda/0000-0003-1932-9976; 
FU Evandro Chagas Institute; CAPES (Zika fast track grant); CNPqNational
   Council for Scientific and Technological Development (CNPq)
   [303999/2016-0, 439971/2016-0, 440405/2016-5];  [301641/2010-2]
FX This study was partially supported by The Evandro Chagas Institute. The
   Evandro Chagas Institute provided a grant for this study, as well as
   CAPES (Zika fast track grant); CNPq (grants, 303999/2016-0,
   439971/2016-0 and 440405/2016-5). Pedro F. C. Vasconcelos is fellow of
   the CNPq and supported by the above grants and plus grant 301641/2010-2.
CR Azevedo RSS, 2016, J CLIN VIROL, V85, P56, DOI 10.1016/j.jcv.2016.10.024
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Franceschetti S, 2014, NEUROLOGY, V82, P405, DOI 10.1212/WNL.0000000000000077
   Hertzog J, 2018, EUR J IMMUNOL, P1
   Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013
   Lowenstein DH, 2014, EPILEPSY CURR, V14, P43, DOI 10.5698/1535-7511-14.s2.43
   Markoulatos P, 2001, J CLIN MICROBIOL, V39, P4426, DOI 10.1128/JCM.39.12.4426-4432.2001
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nagel MA, 2013, CURR TREAT OPTION NE, V15, P439, DOI 10.1007/s11940-013-0246-5
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
NR 12
TC 0
Z9 2
U1 0
U2 5
PU SOC BRASILEIRA MEDICINA TROPICAL
PI BRASILIA
PA UNIV BRASILIA, NUCLEO MEDICINA TROPICAL E NUTRICAO, CAIXA POSTAL 4356,
   BRASILIA, DF 70919-970, BRAZIL
SN 0037-8682
J9 REV SOC BRAS MED TRO
JI Rev. Soc. Bras. Med. Trop.
PD APR-JUN
PY 2018
VL 51
IS 3
BP 390
EP 392
DI 10.1590/0037-8682-0447-2017
PG 3
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA GL3IM
UT WOS:000437026000024
PM 29972576
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Elgner, F
   Sabino, C
   Basic, M
   Ploen, D
   Grunweller, A
   Hildt, E
AF Elgner, Fabian
   Sabino, Catarina
   Basic, Michael
   Ploen, Daniela
   Gruenweller, Arnold
   Hildt, Eberhard
TI Inhibition of Zika Virus Replication by Silvestrol
SO VIRUSES-BASEL
LA English
DT Article
DE Ziks virus; silvestrol; antiviral; eIF4A; hepatocytes
ID IN-VITRO; TRANSLATION; RNA; MODULATION; APOPTOSIS; LEUKEMIA; CELLS
AB The Zika virus (ZIKV) outbreak in 2016 in South America with specific pathogenic outcomes highlighted the need for new antiviral substances with broad-spectrum activities to react quickly to unexpected outbreaks of emerging viral pathogens. Very recently, the natural compound silvestrol isolated from the plant Aglaia foveolata was found to have very potent antiviral effects against the (-)-strand RNA-virus Ebola virus as well as against Corona-and Picornaviruses with a (+)-strand RNA-genome. This antiviral activity is based on the impaired translation of viral RNA by the inhibition of the DEAD-box RNA helicase eukaryotic initiation factor-4A (eIF4A) which is required to unwind structured 5'-untranslated regions (5'-UTRs) of several proto-oncogenes and thereby facilitate their translation. Zika virus is a flavivirus with a positive-stranded RNA-genome harboring a 5'-capped UTR with distinct secondary structure elements. Therefore, we investigated the effects of silvestrol on ZIKV replication in A549 cells and primary human hepatocytes. Two different ZIKV strains were used. In both infected A549 cells and primary human hepatocytes, silvestrol has the potential to exert a significant inhibition of ZIKV replication for both analyzed strains, even though the ancestor strain from Uganda is less sensitive to silvestrol. Our data might contribute to identify host factors involved in the control of ZIKV infection and help to develop antiviral concepts that can be used to treat a variety of viral infections without the risk of resistances because a host protein is targeted.
C1 [Elgner, Fabian; Sabino, Catarina; Basic, Michael; Ploen, Daniela; Hildt, Eberhard] Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.
   [Gruenweller, Arnold] Philipps Univ Marburg, Pharmazeut Chem, D-35037 Marburg, Germany.
   [Hildt, Eberhard] German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
RP Hildt, E (corresponding author), Paul Ehrlich Inst, Dept Virol, D-63225 Langen, Germany.; Hildt, E (corresponding author), German Ctr Infect Res DZIF, D-38124 Braunschweig, Germany.
EM fabian.elgner@pei.de; catarina.sabino@pei.de; michel.basic@pei.de;
   daniela.ploen@pei.de; amold.gruenweller@staff.uni-marburg.de;
   eberhard.hildt@pei.de
RI Hildt, Eberhard/A-1040-2015
OI Basic, Michael/0000-0001-6339-1262; Bender, Daniela/0000-0002-8991-126X;
   Sabino, Catarina/0000-0002-0586-1235
FU European Virus Archive goes Global (EVAg) project that has received
   funding from the European Union's Horizon 2020 research and innovation
   program [653316]; EVAg [976]; Federal Ministry of Health (BMG); LOEWE
   Center DRUID (Novel Drug Targets against Poverty-Related and Neglected
   Tropical Infectious Diseases)
FX The authors thank Gert Carra for his excellent technical support and
   Dagmar Fecht-Schwarz for her critical reading of the manuscript.
   Moreover, the authors thank the PHH Core Facility of Florian Vondran at
   the Medizinische Hochschule Hannover for isolating and sharing the PHHs.
   We thank Didier Musso (Director of the Research and Diagnosis
   Laboratory, Institute Louis Malarde in Papeete, Tahiti) for donating the
   ZIKV Polynesia strain (PF 13/251013-18). This publication was supported
   by the European Virus Archive goes Global (EVAg) project that has
   received funding from the European Union's Horizon 2020 research and
   innovation program under grant agreement No 653316. Based on this
   funding, EVAg provided the ZIKV strain Uganda (strain 976). This work
   was supported by a grant from the Federal Ministry of Health (BMG) to
   E.H. A.G. and E.H. obtained funding from the LOEWE Center DRUID (Novel
   Drug Targets against Poverty-Related and Neglected Tropical Infectious
   Diseases).
CR Baronti C, 2014, GENOME ANNOUNC, V2
   Biedenkopf N, 2017, ANTIVIR RES, V137, P76, DOI 10.1016/j.antiviral.2016.11.011
   Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753
   Burckstummer T, 2006, FEBS LETT, V580, P575, DOI 10.1016/j.febslet.2005.12.071
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cencic R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005223
   Chu J, 2016, CELL REP, V15, P2340, DOI 10.1016/j.celrep.2016.05.005
   Chu J, 2015, BBA-GENE REGUL MECH, V1849, P781, DOI 10.1016/j.bbagrm.2014.09.006
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Elgner F, 2016, J VIROL, V90, P11181, DOI 10.1128/JVI.01053-16
   Goertz GP, 2017, VIRUS RES, V254, P41
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Himmelsbach K, 2009, GUT, V58, P1644, DOI 10.1136/gut.2009.182212
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868
   Kim S, 2007, ANTICANCER RES, V27, P2175
   Kogure T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076136
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Liu S, 2012, HEPATOLOGY, V56, P57, DOI 10.1002/hep.25642
   Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430
   Masoudi S, 2014, VACCINE, V32, P2980, DOI 10.1016/j.vaccine.2014.03.085
   Muller C, 2018, ANTIVIR RES, V150, P123, DOI 10.1016/j.antiviral.2017.12.010
   MUTHUKRISHNAN S, 1975, NATURE, V255, P33, DOI 10.1038/255033a0
   Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789
   Ploen D, 2013, J HEPATOL, V58, P1081, DOI 10.1016/j.jhep.2013.01.022
   Rubio CA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0476-1
   Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t
   Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846
   Su BN, 2006, BIOORGAN MED CHEM, V14, P960, DOI 10.1016/j.bmc.2005.09.012
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Weiss TS, 2003, J HEPATOL, V38, P476, DOI 10.1016/S0168-8278(02)00454-3
   Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485
   Zhu JY, 2007, INT J CANCER, V121, P1839, DOI 10.1002/ijc.22883
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 36
TC 15
Z9 15
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2018
VL 10
IS 4
AR 149
DI 10.3390/v10040149
PG 14
WC Virology
SC Virology
GA GJ3HZ
UT WOS:000435184400010
PM 29584632
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haviernik, J
   Stefanik, M
   Fojtikova, M
   Kali, S
   Tordo, N
   Rudolf, I
   Hubalek, Z
   Eyer, L
   Ruzek, D
AF Haviernik, Jan
   Stefanik, Michal
   Fojtikova, Martina
   Kali, Sabrina
   Tordo, Noel
   Rudolf, Ivo
   Hubalek, Zdenek
   Eyer, Ludek
   Ruzek, Daniel
TI Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits
   Medically Important Arthropod-Borne Flaviviruses
SO VIRUSES-BASEL
LA English
DT Article
DE flavivirus; arbidol; umifenovir; antiviral activity; cytotoxicity;
   cell-type dependent antiviral effect
ID NUCLEOSIDE INHIBITORS; ZIKA VIRUS; IN-VITRO; EFFICACY; SOFOSBUVIR;
   MECHANISM; COMPOUND; CULTURE; MODEL
AB Arthropod-borne flaviviruses are human pathogens of global medical importance, against which no effective small molecule-based antiviral therapy has currently been reported. Arbidol (umifenovir) is a broad-spectrum antiviral compound approved in Russia and China for prophylaxis and treatment of influenza. This compound shows activities against numerous DNA and RNA viruses. The mode of action is based predominantly on impairment of critical steps in virus-cell interactions. Here we demonstrate that arbidol possesses micromolar-level anti-viral effects (EC50 values ranging from 10.57 +/- 0.74 to 19.16 +/- 0.29 mu M) in Vero cells infected with Zika virus, West Nile virus, and tick-borne encephalitis virus, three medically important representatives of the arthropod-borne flaviviruses. Interestingly, no antiviral effects of arbidol are observed in virus infected porcine stable kidney cells (PS), human neuroblastoma cells (UKF-NB-4), and human hepatoma cells (Huh-7 cells) indicating that the antiviral effect of arbidol is strongly cell-type dependent. Arbidol shows increasing cytotoxicity when tested in various cell lines, in the order: Huh-7 < HBCA < PS < UKF-NB-4 < Vero with CC50 values ranging from 18.69 +/- 0.1 to 89.72 +/- 0.19 mu M. Antiviral activities and acceptable cytotoxicity profiles suggest that arbidol could be a promising candidate for further investigation as a potential therapeutic agent in selective treatment of flaviviral infections.
C1 [Haviernik, Jan; Stefanik, Michal; Fojtikova, Martina; Eyer, Ludek; Ruzek, Daniel] Vet Res Inst, Dept Virol, Hudcova 70, CZ-62100 Brno, Czech Republic.
   [Kali, Sabrina; Tordo, Noel] Inst Pasteur, Unit Antiviral Strategies, 25 Dr Roux, F-75724 Paris 15, France.
   [Tordo, Noel] Inst Pasteur Guinee, Route Donka, Conakry, Guinea.
   [Rudolf, Ivo; Hubalek, Zdenek] Czech Acad Sci, Inst Vertebrate Biol, Kvetna 8, CZ-60365 Brno, Czech Republic.
   [Eyer, Ludek; Ruzek, Daniel] Czech Acad Sci, Biol Ctr, Inst Parasitol, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
RP Ruzek, D (corresponding author), Vet Res Inst, Dept Virol, Hudcova 70, CZ-62100 Brno, Czech Republic.; Ruzek, D (corresponding author), Czech Acad Sci, Biol Ctr, Inst Parasitol, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
EM haviernik@vri.cz; stefanik@vri.cz; fojtikova@vri.cz;
   sabrina.kali@pasteur.fr; ntordo@pasteur.fr; rudolf@ivb.cz;
   zhubalek@brno.cas.cz; eyer@vri.cz; ruzekd@paru.cas.cz
RI Hubalek, Zdenek/AAF-8071-2019; Ruzek, Daniel/G-9275-2014; Hubalek,
   Zdenek/G-1111-2014; Rudolf, Ivo/G-1112-2014; Eyer, Ludek/U-4883-2018
OI Ruzek, Daniel/0000-0003-4655-2380; Hubalek, Zdenek/0000-0003-4732-0987;
   Rudolf, Ivo/0000-0001-6602-2905; Eyer, Ludek/0000-0001-7761-0702
FU European Union's Horizon 2020 research and innovation program [653316]
FX We thank Carla Torres Braconi and Paolo M. de A. Zanotto (University of
   Sao Paolo) for providing us with the ZIKV strain Paraiba 01, and the
   European Virus Archive Goes Global project (which has received funding
   from the European Union's Horizon 2020 research and innovation program
   (Grant 653316)) for providing us with ZIKV stran MR766. We also thank
   Andrew D. Miller (Veterinary Research Institute, Brno, Czech Republic)
   for language correction of the manuscript.
CR Baier A., 2011, FLAVIVIRUS ENCEPHALI, P89
   Becher F, 2004, AIDS, V18, P181, DOI 10.1097/00002030-200401230-00006
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Boriskin YS, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-56
   Chapel C, 2006, FUTURE VIROL, V1, P197, DOI 10.2217/17460794.1.2.197
   Delogu I, 2011, ANTIVIR RES, V90, P99, DOI 10.1016/j.antiviral.2011.03.182
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Deng HY, 2009, ACTA PHARMACOL SIN, V30, P1015, DOI 10.1038/aps.2009.53
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   GAO WY, 1993, J CLIN INVEST, V91, P2326, DOI 10.1172/JCI116463
   Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   KOZUCH O, 1975, ACTA VIROL, V19, P498
   Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Leneva IA, 2005, TERAPEVT ARKH, V77, P84
   Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009
   Liu Q, 2013, ACTA PHARMACOL SIN, V34, P1075, DOI 10.1038/aps.2013.54
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Oestereich L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002804
   PANISHEVA EK, 1988, KHIM FARM ZH+, V22, P1455
   Pecheur EI, 2007, BIOCHEMISTRY-US, V46, P6050, DOI 10.1021/bi700181j
   Pecheur EI, 2016, J VIROL, V90, P3086, DOI 10.1128/JVI.02077-15
   Peterson LW, 2009, EXPERT OPIN DRUG DEL, V6, P405, DOI [10.1517/17425240902824808, 10.1517/17425240902824808 ]
   Ruzek D, 2009, J GEN VIROL, V90, P1649, DOI 10.1099/vir.0.010058-0
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06
   Shi L, 2007, ARCH VIROL, V152, P1447, DOI 10.1007/s00705-007-0974-5
   Villalain J, 2010, J PHYS CHEM B, V114, P8544, DOI 10.1021/jp102619w
NR 33
TC 22
Z9 22
U1 3
U2 10
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2018
VL 10
IS 4
AR 184
DI 10.3390/v10040184
PG 8
WC Virology
SC Virology
GA GJ3HZ
UT WOS:000435184400045
PM 29642580
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Herrlinger, SA
   Shao, Q
   Ma, L
   Brindley, M
   Chen, JF
AF Herrlinger, Stephanie A.
   Shao, Qiang
   Ma, Li
   Brindley, Melinda
   Chen, Jian-Fu
TI Establishing Mouse Models for Zika Virus-induced Neurological Disorders
   Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Neuroscience; Issue 134; Zika; microcephaly; mouse; intracerebral
   inoculation; embryo; adult; confocal imaging
ID INFECTION; BRAIN; DEFECTS; WDR62
AB The Zika virus (ZIKV) is a flavivirus currently endemic in North, Central, and South America. It is now established that the ZIKV can cause microcephaly and additional brain abnormalities. However, the mechanism underlying the pathogenesis of ZIKV in the developing brain remains unclear. Intracerebral surgical methods are frequently used in neuroscience research to address questions about both normal and abnormal brain development and brain function. This protocol utilizes classical surgical techniques and describes methods that allow one to model ZIKV-associated human neurological disease in the mouse nervous system. While direct brain inoculation does not model the normal mode of virus transmission, the method allows investigators to ask targeted questions concerning the consequence after ZIKV infection of the developing brain. This protocol describes embryonic, neonatal, and adult stages of intraventricular inoculation of ZIKV. Once mastered, this method can become a straightforward and reproducible technique that only takes a few hours to perform.
C1 [Herrlinger, Stephanie A.] Univ Georgia, Biomed & Hlth Sci Inst, Athens, GA 30602 USA.
   [Shao, Qiang; Ma, Li; Chen, Jian-Fu] Univ Southern Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA USA.
   [Brindley, Melinda] Univ Georgia, Coll Vet Med, Dept Infect Dis, Athens, GA 30602 USA.
RP Chen, JF (corresponding author), Univ Southern Calif, Ctr Craniofacial Mol Biol, Los Angeles, CA USA.
EM jianfu@usc.edu
OI Shao, Qiang/0000-0001-5307-8264
FU Advancement for Research College Scientists (ARCS) foundation; NIH
   (NINDS)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01NS096176-02, R01NS097231-01,
   F99NS105187-01]
FX The authors would like to acknowledge Dr. Abdellatif Benraiss at the
   University of Rochester for his mentorship and discussions relevant to
   learning the adult surgical and neonate techniques. The authors would
   also like to acknowledge Dr. James Lauderdale at UGA for the use of his
   stereotaxic equipment and discussions related to setting up the
   methodology for this technique, and the Advancement for Research College
   Scientists (ARCS) foundation for their support and our NIH support
   (NINDS grants R01NS096176-02, R01NS097231-01, & F99NS105187-01).
CR Abuelo Dianne, 2007, Semin Pediatr Neurol, V14, P118, DOI 10.1016/j.spen.2007.07.003
   Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3
   Cragan JD, 2017, MMWR-MORBID MORTAL W, V66, P19, DOI 10.15585/mmwr.mm6608a4
   Cragan JD, 2016, BIRTH DEFECTS RES A, V106, P972, DOI 10.1002/bdra.23587
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dreher AM, 2014, J PEDIATR-US, V164, P855, DOI 10.1016/j.jpeds.2013.12.007
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Goodfellow F., 2016, STEM CELLS DEV, V25, P1
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Lanzieri T. M., 2017, J PERINATOL
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   MIKI T, 1995, NEUROSCI RES, V23, P241, DOI 10.1016/0168-0102(95)00947-7
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Naseer MI, 2017, ANN SAUDI MED, V37, P148, DOI 10.5144/0256-4947.2017.148
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001
   Shao Q., 2017, DEVELOPMENT
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
NR 21
TC 1
Z9 1
U1 2
U2 2
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2018
IS 134
AR e56486
DI 10.3791/56486
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS9OW
UT WOS:000444051300011
PM 29757270
OA Green Published
DA 2020-07-08
ER

PT J
AU Valiant, WG
   Mattapallil, JJ
AF Valiant, William G.
   Mattapallil, Joseph J.
TI A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody
   Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent
   Serum
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Immunology and Infection; Issue 134; Zika virus; Dengue virus; Antibody
   dependent enhancement; Reporter viral particles; convalescent serum;
   Flavivirus
ID FC RECEPTOR; HUMAN-IGG; INFECTION; SPECIFICITY; RESPONSES; K562
AB Antibody dependent enhancement of infection has been shown to play a major role in Dengue viral pathogenesis. Traditional assays that measure the capacity of antibodies or serum to enhance infection in impermissible cell lines have relied on using viral output in the media followed by plaque assays to quantify infection. More recently, these assays have examined Dengue virus (DENV) infection in the cell lines using fluorescently labeled antibodies. Both these approaches have limitations that restrict the widespread use of these techniques. Here, we describe a simple in vitro assay using Dengue virus reporter viral particles (RVPs) that express green fluorescent protein and K562 cells to examine antibody dependent enhancement (ADE) of DENV infection using serum that was obtained from rhesus macaques 16 weeks after infection with Zika virus (ZIKV). This technique is reliable, involves minimal manipulation of cells, does not involve the use of live replication competent virus, and can be performed in a high throughput format to get a quantitative readout using flow cytometry. Additionally, this assay can be easily adapted to examine antibody dependent enhancement (ADE) of other flavivirus infections such as Yellow Fever virus (YFV), Japanese Equine Encephalitis virus (JEEV), West Nile virus (WNV) etc. where RVPs are available. The ease of setting up the assay, analyzing the data, and interpreting results makes it highly amenable to most laboratory settings.
C1 [Valiant, William G.; Mattapallil, Joseph J.] Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.
RP Mattapallil, JJ (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Microbiol & Immunol, Bethesda, MD 20814 USA.
EM joseph.mattapallil@usuhs.edu
OI Mattapallil, Joseph/0000-0002-7412-9507
FU Uniformed Services University of the Health Sciences
FX The described project was supported by funds from the Uniformed Services
   University of the Health Sciences to JJM. The opinions or assertions
   contained herein are the private ones of the authors and are not to be
   construed as official or reflecting the views of the Department of
   Defense, the Uniformed Services University of the Health Sciences or any
   other agency of the U.S. Government.
CR CHIOFALO MS, 1988, CELL IMMUNOL, V114, P272, DOI 10.1016/0008-8749(88)90321-8
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   KLEIN E, 1976, INT J CANCER, V18, P421, DOI 10.1002/ijc.2910180405
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   LITTAUA R, 1990, J IMMUNOL, V144, P3183
   Mattia K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027252
   MORENS DM, 1990, J GEN VIROL, V71, P2909, DOI 10.1099/0022-1317-71-12-2909
   Perfetto SP, 2006, J IMMUNOL METHODS, V313, P199, DOI 10.1016/j.jim.2006.04.007
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
NR 14
TC 3
Z9 3
U1 0
U2 1
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD APR
PY 2018
IS 134
AR e57371
DI 10.3791/57371
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA GS9OW
UT WOS:000444051300078
PM 29708542
OA Green Published
DA 2020-07-08
ER

PT J
AU Dran, J
AF Dran, Jenna
TI A Unique Institutional Response to the Zika Virus Epidemic
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
AB In 2015, Zika virus rapidly emerged as a concern for obstetric patients and health care providers as the disease spread geographically and it was discovered that Zika virus infection had the potential to cause devastating birth defects. Essentially overnight, obstetric care providers were faced with an influx of rapidly evolving information and an increased workload. New systems, workflows, and personnel were needed to effectively address the new patient care needs fueled by the burgeoning Zika virus epidemic. The University of California, San Francisco responded by filling a Zika Response Nurse Coordinator position to take on tasks necessary to design a systematic approach for Zika virus management. The Zika Response Coordinator at the University of California, San Francisco serves as a subject matter expert who counsels patients and health care providers, arranges testing and follow-up care after potential Zika virus exposure, and helps design the screening tools, protocols, and educational material needed to manage the evolving Zika virus response. The position has enabled a Zika virus response that has been tightly coordinated, consistent, and thorough without overburdening health care providers. The Zika Response Nurse Coordinator Role serves as a template for how institutions can model coordinated Zika virus care and prepare for future threats that will necessitate a focused and rapid response. Timely institutional financial support is critical for an appropriate response to emerging diseases for not only Zika virus but future epidemics as well.
C1 [Dran, Jenna] Univ Calif San Francisco, Dept Obstet & Perinatal Med, San Francisco, CA 94143 USA.
RP Dran, J (corresponding author), 1825 Fourth St,3rd Floor, San Francisco, CA 94143 USA.
EM Jenna.dran@ucsf.edu
CR American College of Obstetricians and Gynecologists Society for Maternal-Fetal Medicine, PRACT ADV INT GUID C
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
NR 3
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD APR
PY 2018
VL 131
IS 4
BP 666
EP 670
DI 10.1097/AOG.0000000000002532
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GQ0YP
UT WOS:000441347800011
PM 29528929
DA 2020-07-08
ER

PT J
AU Diaz-Quijano, FA
   Pelissari, DM
   Chiavegatto, ADP
AF Diaz-Quijano, Fredi Alexander
   Pelissari, Daniele Maria
   Porto Chiavegatto Filho, Alexandre Dias
TI Zika-Associated Microcephaly Epidemic and Birth Rate Reduction in
   Brazilian Cities
SO AMERICAN JOURNAL OF PUBLIC HEALTH
LA English
DT Article
AB Objectives. To estimate birth reduction potentially in response to Zika virus-associated microcephaly among the 36 largest Brazilian cities.
   Methods. We analyzed the number of live births per month on the basis of information on approximately 8.2 million births from all of Brazil's state capitals and cities that had more than 10 000 annual births.
   Results. In the second half of 2016, the live birth rate was reduced by 7.78% (95% confidence interval [CI] = 6.64%, 8.89%; P< .001). This reduction was correlated with the Zika virus-associated microcephaly rate. In the cities with the highest microcephaly rate in 2015 (> 1 case per 1000 live births), the reduction in the live birth rate was 10.84% (95% CI = 8.58%, 13.04%).
   Conclusions. The birth rate in the largest Brazilian cities during the second half of 2016 was significantly reduced, which is potentially the effect of a birth control recommendation prompted by an epidemiological alert.
   Public Health Implications. The effects of population-based interventions should be weighed by considering the actual risk of disease and the sociodemographic impact of strategies such as birth control.
C1 [Diaz-Quijano, Fredi Alexander; Porto Chiavegatto Filho, Alexandre Dias] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil.
   [Pelissari, Daniele Maria] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Epidemiol, Sao Paulo, Brazil.
RP Diaz-Quijano, FA (corresponding author), Univ Sao Paulo, Fac Saude Publ, Av Arnaldo 715, BR-01246904 Sao Paulo, SP, Brazil.
EM frediazq@msn.com
RI Diaz-Quijano, Fredi Alexander/I-3740-2012
OI Diaz-Quijano, Fredi Alexander/0000-0002-1134-1930; Pelissari, Daniele
   Maria/0000-0002-0760-1875
CR Aguiar R, 2016, REV ELETRON COMUN IN, V10, P1
   Ahrens KA, 2017, MATERN CHILD HLTH J, V21, P982, DOI 10.1007/s10995-017-2275-2
   Awadh A, 2017, PLOS CURR, V9
   Bahamondes L, 2016, HUM REPROD, V32, P88
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Diaz-Quijano FA, 2017, ANN EPIDEMIOL, V27, P616, DOI 10.1016/j.annepidem.2017.08.009
   Dubaut JP, 2017, J ASSIST REPROD GEN, V34, P1237, DOI 10.1007/s10815-017-0988-1
   Eboli E, 2015, MICROCEFALIA FRENTE
   Lenharo M, 2017, DADOS SUGEREM QUEDA
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P286, DOI 10.1016/j.tmaid.2016.03.018
NR 12
TC 4
Z9 4
U1 0
U2 1
PU AMER PUBLIC HEALTH ASSOC INC
PI WASHINGTON
PA 800 I STREET, NW, WASHINGTON, DC 20001-3710 USA
SN 0090-0036
EI 1541-0048
J9 AM J PUBLIC HEALTH
JI Am. J. Public Health
PD APR
PY 2018
VL 108
IS 4
BP 514
EP 516
DI 10.2105/AJPH.2017.304260
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GO7MM
UT WOS:000440250600045
PM 29470110
OA Green Published
DA 2020-07-08
ER

PT J
AU Nardeli, JV
   Arakaki, AH
   Colman, TAD
   Cabrini, I
   Teixeira, JA
   de Carvalho, CT
   de Arruda, EJ
AF Nardeli, Jessica Verger
   Arakaki, Andrea Haruko
   Denck Colman, Tiago Andre
   Cabrini, Isaias
   Teixeira, Jose Augusto
   de Carvalho, Claudio Teodoro
   de Arruda, Eduardo Jose
TI Synthesis and Biological Activity of Fe (III) Acetate for Microbial
   Control at Breeding Sites of Aedes aegypti (Diptera: Culicidae)
SO ORBITAL-THE ELECTRONIC JOURNAL OF CHEMISTRY
LA English
DT Article
DE acetate; bactericidal; metallo-organic pesticides; mosquitoes; zika
ID PERITROPHIC MATRIX; ANOPHELES-STEPHENSI; IRON; BACTERIA; MOSQUITOS;
   GAMBIAE; HEALTH
AB Unconventional approaches can be used control populations of disease-carrying insect to improve health, economic, social, and environmental standards. There is a need for prolonged reduction of vector populations, using low-toxicity and low-cost products in domestic settings. Metals such copper and iron have shown to be toxic to insect larvae, with a delay in reproduction, damage to the cells of the digestive system and the production of free radicals and oxidant species, resulting in tissue damage and death. To control insect breeding, we synthesized and characterized Fe (III) acetate via carbonate. Fe (III) acetate showed no toxic effect on mosquito larvae up to 1.000 mg L-1, but was bactericidal for Gram-positive and Gram-negative bacteria, mainly due to the action of Fe (III) acetate.
C1 [Nardeli, Jessica Verger; Teixeira, Jose Augusto] Sao Paulo State Univ, Inst Chem, BR-14800060 Araraquara, SP, Brazil.
   [Arakaki, Andrea Haruko] Univ Fed Mato Grosso do Sul, Inst Chem, BR-79074460 Campo Grande, MS, Brazil.
   [Denck Colman, Tiago Andre; Cabrini, Isaias; de Carvalho, Claudio Teodoro; de Arruda, Eduardo Jose] Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dept Chem, Dourados Itahum Highway 12 Km,POB 533, BR-79804970 Dourados, MS, Brazil.
   [Cabrini, Isaias] Univ Estadual Campinas, Inst Biol, Dept Anim Biol, POB 6109,Monteiro Lobato St, BR-13083862 Campinas, SP, Brazil.
RP de Arruda, EJ (corresponding author), Fed Univ Grande Dourados, Fac Exact Sci & Technol, Dept Chem, Dourados Itahum Highway 12 Km,POB 533, BR-79804970 Dourados, MS, Brazil.
EM ejarruda@gmail.com
RI de Arruda, Eduardo Jose/AAJ-9834-2020; Carvalho, Claudio T./E-7421-2014;
   Nardeli, Jessica Verger/T-7233-2019; Teixeira, Jose Augusto/L-7021-2016;
   Colman, Tiago Andre Denck/B-3580-2015; de Carvalho, Claudio
   Teodoro/Y-2772-2019; Teixeira, Jose Augusto/N-5742-2019
OI de Arruda, Eduardo Jose/0000-0002-9835-467X; Carvalho, Claudio
   T./0000-0002-8081-4287; Nardeli, Jessica Verger/0000-0003-4240-3863;
   Teixeira, Jose Augusto/0000-0002-6557-9557; Colman, Tiago Andre
   Denck/0000-0003-1405-4571; de Carvalho, Claudio
   Teodoro/0000-0002-8081-4287; Teixeira, Jose Augusto/0000-0002-6557-9557
CR Albeny-Simoes D, 2014, OECOLOGIA, V175, P481, DOI 10.1007/s00442-014-2910-1
   Arduino Marylene de Brito, 2015, Revista de Patologia Tropical, V44, P89, DOI 10.5216/rpt.v44i1.34801
   Arruda E. J., 2011, BRAZ ARCH BIOL TECHN, V54, P509
   Bratby J., 2006, COAGULATION FLOCCULA, P47
   Carvalho CB, 2006, THESIS
   Chaparro CM, 2008, J NUTR, V138, P2529
   Lima-Camara Tamara Nunes de, 2006, Cad. Saúde Pública, V22, P2079, DOI 10.1590/S0102-311X2006001000013
   DeMaio J, 1996, AM J TROP MED HYG, V54, P219, DOI 10.4269/ajtmh.1996.54.219
   Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2
   DREW WL, 1972, APPL MICROBIOL, V24, P240, DOI 10.1128/AEM.24.2.240-247.1972
   Fares RCG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/321873
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Gonzalez-Ceron L, 2003, J MED ENTOMOL, V40, P371, DOI 10.1603/0022-2585-40.3.371
   HASSELSCHWERT D, 1988, GREAT LAKES ENTOMOL, V21, P163
   Hell R, 2003, PLANTA, V216, P541, DOI 10.1007/s00425-002-0920-4
   Hughes S, 2006, PARASITE IMMUNOL, V28, P577, DOI 10.1111/j.1365-3024.2006.00897.x
   ITO K, 1956, CAN J CHEM, V34, P170, DOI 10.1139/v56-021
   Jordao R. E., 2009, REV PAUL PEDIATR, V27, P98
   LADEIRA A. C. Q., 2014, CAD TEM QUIM NOVA ES, V8, P18
   Laurikenas A, 2016, LITH J PHYS, V56, P35
   Legrand D, 2006, BIOCHEM CELL BIOL, V84, P282, DOI 10.1139/O06-045
   Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005
   Lozoff B, 2006, ARCH PEDIAT ADOL MED, V160, P1108, DOI 10.1001/archpedi.160.11.1108
   Marenco RA, 2005, FISIOLOGIA VEGETAL F
   Marten J. E., 2000, J INSECT PHYSIOL, V46, P1313
   Moskalyk LA, 1996, INSECT MOL BIOL, V5, P261, DOI 10.1111/j.1365-2583.1996.tb00100.x
   Nakamoto K., 1997, INFRARED RAMAN SPE B
   Nardeli JV, 2014, ORBITAL, V6, P122
   NRC-National Research Council, 2000, DIET REF INT APPL DI
   Nyakeriga AM, 2004, J INFECT DIS, V190, P439, DOI 10.1086/422331
   Oliver SV, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151049
   PAHO-WHO, 2016, STRAT ENH NAT CAP RE
   Pascoa V, 2002, INSECT BIOCHEM MOLEC, V32, P517, DOI 10.1016/S0965-1748(01)00130-8
   Pidiyar VJ, 2004, AM J TROP MED HYG, V70, P597, DOI 10.4269/ajtmh.2004.70.597
   Pinto G. M., 2008, REV MED MG, V18, P191
   Ponnusamy L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024409
   Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96
   Rayms-Keller A, 1998, ECOTOX ENVIRON SAFE, V39, P41, DOI 10.1006/eesa.1997.1605
   Ribeiro GS, 2016, REV SOC BRAS MED TRO, V49, P1, DOI 10.1590/0037-8682-0036-2016
   Salvador M., 2004, RADICAIS LIVRES RESP, P13
   Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2
   Silva MRL, 2012, TROP PLANT PATHOL, V37, P65, DOI 10.1590/S1982-56762012000100008
   Souza A. O., 2014, QUIM NOVA, V37, P1132
   Turte KI, 2002, J STRUCT CHEM+, V43, P108, DOI 10.1023/A:1016082018299
   Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829
   Villalon JM, 2003, J INSECT PHYSIOL, V49, P891, DOI 10.1016/S0022-1910(03)00135-5
   WHO, 2016, ON YEAR ZIK OUTBR OB
   Yi Y, 1996, PLANT J, V10, P835, DOI 10.1046/j.1365-313X.1996.10050835.x
   Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009
   Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x
NR 50
TC 0
Z9 0
U1 0
U2 0
PU UNIV FEDERAL MATO GROSSO SUL, DEPT QUIMICA
PI CAMPO GRANDE
PA AV SENADOR FILINTO MULLER 1555, CAMPO GRANDE, MS 79074-460, BRAZIL
SN 1984-6428
J9 ORBITAL
JI Orbital
PD APR-JUN
PY 2018
VL 10
IS 5
BP 407
EP 417
DI 10.17807/orbital.v10i5.1135
PG 11
WC Chemistry, Multidisciplinary
SC Chemistry
GA GN5FN
UT WOS:000439075500006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Brown, IAM
   DeLalio, LJ
   Liu, SF
   Isakson, BE
   Wang, TT
AF Brown, Isola A. M.
   DeLalio, Leon J.
   Liu, Shufeng
   Isakson, Brant E.
   Wang, Tony T.
TI Vascular Localization of Zika Virus Following in vivo Infection
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 902.8
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2WL
UT WOS:000436986703013
DA 2020-07-08
ER

PT J
AU DeLaat, A
   Rakotondraibe, HL
   Piermarini, P
AF DeLaat, Andrew
   Rakotondraibe, Harinantenaina Liva
   Piermarini, Peter
TI The effects of natural products from a medicinal plant (Cinnamosma
   fragrans) on contractions of a visceral muscle in the Zika vector Aedes
   aegypti
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 21-25, 2018
CL San Diego, CA
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI129951]
FX Supported by NIH grant R21AI129951.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 770.5
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2WL
UT WOS:000436986705436
DA 2020-07-08
ER

PT J
AU Khachatoorian, R
   Micewicz, ED
   Buzzanco, AS
   Riahi, R
   Jin, D
   Ruchala, P
   French, SW
AF Khachatoorian, Ronik
   Micewicz, Ewa D.
   Buzzanco, Anthony S.
   Riahi, Rana
   Jin, Daphne
   Ruchala, Piotr
   French, Samuel W.
TI Identification/Optimization of Novel Small Molecule Inhibitors of Zika
   Virus Infection
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Experimental Biology Meeting
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
NR 0
TC 0
Z9 0
U1 0
U2 2
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 828.2
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2WL
UT WOS:000436986700057
DA 2020-07-08
ER

PT J
AU Crane, AT
   Shiao, M
   Voth, JP
   Sipe, C
   Vaid, S
   Bierle, CJ
   Schleiss, MR
   Krishna, VD
   Cheeran, MC
   Low, WC
AF Crane, A. T.
   Shiao, M.
   Voth, J. P.
   Sipe, C.
   Vaid, S.
   Bierle, C. J.
   Schleiss, M. R.
   Krishna, V. D.
   Cheeran, M. C.
   Low, W. C.
TI Zika Virus as an Oncolytic Agent in Human and Murine Malignant Gliomas
SO CELL TRANSPLANTATION
LA English
DT Meeting Abstract
CT Annual Meeting of the American-Society-for-Neural-Therapy-and-Repair
   (ASNTR)
CY APR 25-29, 2018
CL Clearwater Beach, FL
SP Amer Soc Neural Therapy & Repair
C1 [Crane, A. T.] Univ Minnesota, Minnesota Craniofacial Res Training Program, Minneapolis, MN USA.
   [Crane, A. T.; Shiao, M.; Voth, J. P.; Sipe, C.; Vaid, S.; Low, W. C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.
   [Bierle, C. J.; Schleiss, M. R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.
   [Krishna, V. D.; Cheeran, M. C.] Univ Minnesota, Dept Vet Populat Med, Minneapolis, MN USA.
   [Low, W. C.] Univ Minnesota, Stem Cell Inst, Minneapolis, MN USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0963-6897
EI 1555-3892
J9 CELL TRANSPLANT
JI Cell Transplant.
PD APR
PY 2018
VL 27
IS 4
SI SI
BP 687
EP 688
PG 2
WC Cell & Tissue Engineering; Medicine, Research & Experimental;
   Transplantation
SC Cell Biology; Research & Experimental Medicine; Transplantation
GA GM9IE
UT WOS:000438559500023
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Figueredo, LF
   Franco-Zuluaga, JA
   Carrere-Rivera, C
   Rodriguez-Silva, DS
   Akle, V
AF Figueredo, Luisa Fernanda
   Franco-Zuluaga, Jorge Andres
   Carrere-Rivera, Camille
   Rodriguez-Silva, Daniela Sofia
   Akle, Veronica
TI Anatomical Findings of fetuses Vertically-infected with Zika Virus
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of Amer-Assoc-of-Anatomists (AAA), Amer-Physiol-Soc
   (APS), Amer-Soc-for-Biochemistry-and-Mol-Biol (ASBMB),
   Amer-Soc-for-Investigat-Pathol (ASIP),
   Amer-Soc-for-Pharmacol-and-Experimental-Therapeut (ASPET) on
   Experimental Biology (EB)
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
RI akle, veronica/AAD-7577-2019
FU School of Medicine. Universidad de los Andes. Bogota - Colombia
FX School of Medicine. Universidad de los Andes. Bogota - Colombia
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 819.12
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2VX
UT WOS:000436985005283
DA 2020-07-08
ER

PT J
AU Khachatoorian, R
   Buzzanco, AS
   Waring, A
   Riahi, R
   Jin, D
   Dasgupta, A
   Arumugaswami, V
   Ruchala, P
   French, SW
AF Khachatoorian, Ronik
   Buzzanco, Anthony S.
   Waring, Alan
   Riahi, Rana
   Jin, Daphne
   Dasgupta, Asim
   Arumugaswami, Vaithilingaraja
   Ruchala, Piotr
   French, Samuel W.
TI Identification of Potential Broad-Spectrum Peptidomimetic Antivirals
   Active Against Zika Virus
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of Amer-Assoc-of-Anatomists (AAA), Amer-Physiol-Soc
   (APS), Amer-Soc-for-Biochemistry-and-Mol-Biol (ASBMB),
   Amer-Soc-for-Investigat-Pathol (ASIP),
   Amer-Soc-for-Pharmacol-and-Experimental-Therapeut (ASPET) on
   Experimental Biology (EB)
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 819.18
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2VX
UT WOS:000436985005288
DA 2020-07-08
ER

PT J
AU Lai, YC
AF Lai, Yen-Chung
TI Contribution of Zika Virus Envelop Protein-Induced Autoantibodies in
   Neuropathy
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of Amer-Assoc-of-Anatomists (AAA), Amer-Physiol-Soc
   (APS), Amer-Soc-for-Biochemistry-and-Mol-Biol (ASBMB),
   Amer-Soc-for-Investigat-Pathol (ASIP),
   Amer-Soc-for-Pharmacol-and-Experimental-Therapeut (ASPET) on
   Experimental Biology (EB)
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 819.3
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2VX
UT WOS:000436985005292
DA 2020-07-08
ER

PT J
AU Lawrence, J
   Parcells, MS
   Schwarz, J
AF Lawrence, Jennifer
   Parcells, Mark S.
   Schwarz, Jaclyn
TI An Investigation into the Microglial Response to Neonatal ZIKV Infection
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of Amer-Assoc-of-Anatomists (AAA), Amer-Physiol-Soc
   (APS), Amer-Soc-for-Biochemistry-and-Mol-Biol (ASBMB),
   Amer-Soc-for-Investigat-Pathol (ASIP),
   Amer-Soc-for-Pharmacol-and-Experimental-Therapeut (ASPET) on
   Experimental Biology (EB)
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 805.8
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2VX
UT WOS:000436985003270
DA 2020-07-08
ER

PT J
AU Song, G
   Lee, E
   Pan, JB
   Xu, M
   Rho, HS
   Cheng, YC
   Whitt, N
   Yang, S
   Kouznetsova, J
   Klumpp-Thomas, C
   Michael, SG
   Simeonov, A
   Huang, WW
   Xia, MH
   Huang, RL
   Lal-Nag, M
   Zhu, H
   Tang, HL
   Zheng, W
AF Song, Guang
   Lee, Emily
   Pan, Jianbo
   Xu, Miao
   Rho, Hee-Sool
   Cheng, Yichen
   Whitt, Nadia
   Yang, Shu
   Kouznetsova, Jennifer
   Klumpp-Thomas, Carleen
   Michael, Samuel G.
   Simeonov, Anton
   Huang, Wenwei
   Xia, Menghang
   Huang, Ruili
   Lal-Nag, Madhu
   Zhu, Heng
   Tang, Hengli
   Zheng, Wei
TI An Integrated System Approach Identified the Human Proteasome as a
   Conserved Critical Machinery for ZIKV and DENV Replication
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of Amer-Assoc-of-Anatomists (AAA), Amer-Physiol-Soc
   (APS), Amer-Soc-for-Biochemistry-and-Mol-Biol (ASBMB),
   Amer-Soc-for-Investigat-Pathol (ASIP),
   Amer-Soc-for-Pharmacol-and-Experimental-Therapeut (ASPET) on
   Experimental Biology (EB)
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
FU National Center for Advancing Translational Sciences, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Center for
   Advancing Translational Sciences (NCATS); NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R01GM111514, U19AI131130, R35NS097370, R37NS047344]; FSU Zika seed
   funding
FX This work was supported by the Intramural Research Program of the
   National Center for Advancing Translational Sciences, National
   Institutes of Health (W.Z.) and partially supported by NIH grants
   R01GM111514 (to H.Z & J.Q.), U19AI131130 (to G-l.M, & H.T.), R35NS097370
   (to G-l.M.), R37NS047344 (to H-j.S.), and FSU Zika seed funding (to
   H.T.).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 669.3
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2VX
UT WOS:000436985003199
DA 2020-07-08
ER

PT J
AU Wells, GS
   Bernatchez, J
   Coste, M
   Luna, L
   Neto, JS
   Purse, B
   Sohl, CS
AF Wells, Grace S.
   Bernatchez, Jean
   Coste, Michael
   Luna, Lucas
   Neto, Jair Siqueira
   Purse, Byron
   Sohl, Christal State
TI Zika Viral Polymerase: a promising therapeutic target
SO FASEB JOURNAL
LA English
DT Meeting Abstract
CT Annual Meeting of Amer-Assoc-of-Anatomists (AAA), Amer-Physiol-Soc
   (APS), Amer-Soc-for-Biochemistry-and-Mol-Biol (ASBMB),
   Amer-Soc-for-Investigat-Pathol (ASIP),
   Amer-Soc-for-Pharmacol-and-Experimental-Therapeut (ASPET) on
   Experimental Biology (EB)
CY APR 21-25, 2018
CL Amer Assoc Anatomists, San Diego, CA
SP Amer Physiol Soc, Amer Soc Biochemistry & Mol Biol, Amer Soc Investigat Pathol, Amer Soc Pharmacol & Experimental Therapeut
HO Amer Assoc Anatomists
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD APR
PY 2018
VL 32
IS 1
SU S
MA 650.2
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA GL2VX
UT WOS:000436985004189
DA 2020-07-08
ER

PT J
AU Lippi, CA
   Stewart-Ibarra, AM
   Munoz, AG
   Borbor-Cordova, MJ
   Mejia, R
   Rivero, K
   Castillo, K
   Cardenas, WB
   Ryan, SJ
AF Lippi, Catherine A.
   Stewart-Ibarra, Anna M.
   Munoz, Angel G.
   Borbor-Cordova, Mercy J.
   Mejia, Rani
   Rivero, Keytia
   Castillo, Katty
   Cardenas, Washington B.
   Ryan, Sadie J.
TI The Social and Spatial Ecology of Dengue Presence and Burden during an
   Outbreak in Guayaquil, Ecuador, 2012
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE dengue fever; geography; ecology; risk factors; climate; spatial
   analysis; temporal; Ecuador
ID AEDES-AEGYPTI; HUMAN MOVEMENT; URBAN AREA; ZIKA VIRUS; SAO-PAULO;
   THAILAND; FEVER; TRANSMISSION; CIRCULATION; ENVIRONMENT
AB Dengue fever, a mosquito-borne arbovirus, is a major public health concern in Ecuador. In this study, we aimed to describe the spatial distribution of dengue risk and identify local social-ecological factors associated with an outbreak of dengue fever in the city of Guayaquil, Ecuador. We examined georeferenced dengue cases (n = 4248) and block-level census data variables to identify social-ecological risk factors associated with the presence/absence and burden of dengue in Guayaquil in 2012. Local Indicators of Spatial Association (LISA), specifically Anselin's Local Moran's I, and Moran's I tests were used to locate hotspots of dengue transmission, and multimodel selection was used to identify covariates associated with dengue presence and burden at the census block level. We identified significant dengue transmission hotspots near the North Central and Southern portions of Guayaquil. Significant risk factors for presence of dengue included poor housing conditions, access to paved roads, and receipt of remittances. Counterintuitive positive correlations with dengue presence were observed with several municipal services such as garbage collection and access to piped water. Risk factors for increased burden of dengue included poor housing conditions, garbage collection, receipt of remittances, and sharing a property with more than one household. Social factors such as education and household demographics were negatively correlated with increased dengue burden. These findings elucidate underlying differences with dengue presence versus burden, and suggest that vulnerability and risk maps could be developed to inform dengue prevention and control; this is information that is also relevant for emerging epidemics of chikungunya and Zika viruses.
C1 [Lippi, Catherine A.; Ryan, Sadie J.] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab, Gainesville, FL 32611 USA.
   [Lippi, Catherine A.; Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32608 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Ctr Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Munoz, Angel G.] Princeton Univ, Atmospher & Ocean Sci AOS, Princeton, NJ 08540 USA.
   [Munoz, Angel G.] Columbia Univ, Int Res Inst Climate & Soc IRI, Earth Inst, New York, NY 10964 USA.
   [Borbor-Cordova, Mercy J.] Escuela Super Politecn Litoral ESPOL, Guayaquil 09015863, Ecuador.
   [Mejia, Rani; Rivero, Keytia] Natl Inst Meteorol & Hydrol INAMHI, Quito 170135, Ecuador.
   [Castillo, Katty] Inst Biometr & Epidemiol, Aufm Hennekamp 65, D-40225 Dusseldorf, Germany.
   [Cardenas, Washington B.] Escuela Super Politecn Litoral ESPOL, Lab Biomed, FCV, Guayaquil 09015863, Ecuador.
RP Ryan, SJ (corresponding author), Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat Lab, Gainesville, FL 32611 USA.; Ryan, SJ (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32608 USA.
EM clippi@ufl.edu; stewarta@upstate.edu; agmunoz@iri.columbia.edu;
   meborbor@espol.edu.ec; rmejia@inamhi.gob.ec; keytiar@gmail.com;
   katty.castillo@ddz.uni-duesseldorf.de; wbcarden@espol.edu.ec;
   sjryan@ufl.edu
RI Ryan, Sadie Jane/H-7488-2019; Cardenas, Washington B./AAG-2327-2020
OI Ryan, Sadie Jane/0000-0002-4308-6321; Cardenas, Washington
   B./0000-0001-6829-1295; Stewart-Ibarra, Anna/0000-0002-3383-4672;
   Borbor, Mercy/0000-0002-7418-141X; Lippi, Catherine/0000-0002-7988-0324
FU NSFNational Science Foundation (NSF) [DEB EEID 1518681, DEB RAPID
   1641145]; National Secretary of Higher Education, Science, Technology
   and Innovation of Ecuador (SENESCYT)
FX C.A.L., S.J.R., A.M.S.I. were supported on NSF DEB EEID 1518681, and
   S.J.R. and A.M.S. were also supported on NSF DEB RAPID 1641145. This
   work was additionally funded by the National Secretary of Higher
   Education, Science, Technology and Innovation of Ecuador (SENESCYT),
   grant to INAMHI for the project "Surveillance and climate modeling to
   predict dengue in urban centers (Guayaquil, Huaquillas, Portovelo,
   Machala)". Many thanks to colleagues at the Ministry of Health and
   INAMHI-the National Institute of Meteorology and Hydrology-for
   supporting ongoing climate-health initiatives in Ecuador. A.G.M. used
   computational resources from the Observatorio Latinoamericano de Eventos
   Extraordinarios (www.ole2.org) and Centro de Modelado Cientifico (CMC),
   Universidad del Zulia.
CR Alava A., 2005, REV ECUAT HIG MED TR, V42, P11
   [Anonymous], 2015, GADM DAT GLOB ADM AR
   ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x
   Banaitiene N., 2012, RISK MANAGEMENT CURR
   Bertoli S, 2014, J DEV STUD, V50, P1067, DOI 10.1080/00220388.2014.919382
   Bertoli S, 2011, WORLD BANK ECON REV, V25, P57, DOI 10.1093/wber/lhr004
   Borbor-Cordova MJ, 2006, BIOGEOCHEMISTRY, V79, P135, DOI 10.1007/s10533-006-9009-7
   Bradley J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080626
   Burnham K. P, 2002, MODEL SELECTION MULT, P2
   Calcagno V, 2010, J STAT SOFTW, V34, P1
   Castillo K., 2011, THESIS
   Castillo KC, 2011, PROCEDIA ENVIRON SCI, V7, P188, DOI 10.1016/j.proenv.2011.07.033
   Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106
   Cummings DAT, 2004, NATURE, V427, P344, DOI 10.1038/nature02225
   de Almeida AS, 2009, REV SAUDE PUBL, V43, P666, DOI 10.1590/s0034-89102009000400013
   Almeida MCD, 2007, J URBAN HEALTH, V84, P334, DOI 10.1007/s11524-006-9154-2
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   ESRI, 2016, ARCGIS 10 3 1
   Galli B, 2008, REV SAUDE PUBL, V42, P656, DOI [10.1590/S0034-89102008005000032, 10.1590/s0034-89102008000400011]
   Hartter J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001634
   Hiscox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062769
   Huang BY, 2015, J CLIMATE, V28, P911, DOI 10.1175/JCLI-D-14-00006.1
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   INEC, 2010, CENS POBL VIV
   Jokisch B, 2002, INT MIGR, V40, P75, DOI 10.1111/1468-2435.00206
   Kanamitsu M, 2002, B AM METEOROL SOC, V83, P1631, DOI 10.1175/Bams-83-11-1631
   KUHN K, 2005, USING CLIMATE PREDIC
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Ministerio de Salud Publica, 2013, B EP SIT DENG EC
   Mondini A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000448
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Munoz A.G., 2013, TECHNICAL REPORT
   Munoz AG, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0146-1
   Oliveira Maria Aparecida de, 2013, Rev. bras. epidemiol., V16, P907, DOI 10.1590/S1415-790X2013000400011
   Padmanabha H, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001799
   Pan American Health Organization, 2016, ZIK SUSP CONF CAS RE
   Real J, 2012, DETECCION VIRUS DENG
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Rodrigues MD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0703-y
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Ibarra AMS, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1135
   Stewart-Ibarra AM, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0610-4
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Teixeira MD, 2002, TROP MED INT HEALTH, V7, P757, DOI 10.1046/j.1365-3156.2002.00930.x
   Thomson M.C., 2008, SEASONAL FORECASTS C
   US Military Department of Defense (all branches), 1992, DIG CHART WORLD DCW
   Van Benthem BHB, 2005, AM J TROP MED HYG, V72, P201, DOI 10.4269/ajtmh.2005.72.201
   van Benthem BHB, 2002, TROP MED INT HEALTH, V7, P993, DOI 10.1046/j.1365-3156.2002.00950.x
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000920
   Vazquez-Prokopec GM, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-68
   World Helth Organization, GLOB STRAT DENG PREV
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
   Zambrano H, 2016, AM J TROP MED HYG, V95, P894, DOI 10.4269/ajtmh.16-0323
NR 54
TC 10
Z9 10
U1 1
U2 7
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2018
VL 15
IS 4
AR 827
DI 10.3390/ijerph15040827
PG 15
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GI9TK
UT WOS:000434868800266
PM 29690593
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Osorio, HC
   Ze-Ze, L
   Neto, M
   Silva, S
   Marques, F
   Silva, AS
   Alves, MJ
AF Osorio, Hugo Costa
   Ze-Ze, Libia
   Neto, Maria
   Silva, Silvia
   Marques, Fatima
   Silva, Ana Sofia
   Alves, Maria Joao
TI Detection of the Invasive Mosquito Species Aedes (Stegomyia) albopictus
   (Diptera: Culicidae) in Portugal
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Aedes albopictus; invasive mosquito species; DNA barcoding; REVIVE;
   arboviruses; Portugal
ID SPREAD; SKUSE; TIGER
AB The Asian tiger mosquito Aedes albopictus is an invasive mosquito originating from the Asia-Pacific region. This species is of major concern to public and veterinary health because of its vector role in the transmission of several pathogens, such as chikungunya, dengue, and Zika viruses. In Portugal, a National Vector Surveillance Network (REde de Vlgilancia de VEctores REVIVE) is responsible for the surveillance of autochthonous, but also invasive, mosquito species at points of entry, such as airports, ports, storage areas, and specific border regions with Spain. At these locations, networks of mosquito traps are set and maintained under surveillance throughout the year. In September 2017, Ae. albopictus was detected for the first time in a tyre company located in the North of Portugal. Molecular typing was performed, and a preliminary phylogenetic analysis indicated a high similarity with sequences of Ae. albopictus collected in Europe. A prompt surveillance response was locally implemented to determine its dispersal and abundance, and adult mosquitoes were screened for the presence of arboviral RNA. A total of 103 specimens, 52 immatures and 51 adults, were collected. No pathogenic viruses were detected. Despite the obtained results suggest low abundance of the population locally introduced, the risk of dispersal and potential establishment of Ae. albopictus in Portugal has raised concern for autochthonous mosquito-borne disease outbreaks.
C1 [Osorio, Hugo Costa; Ze-Ze, Libia; Alves, Maria Joao] Ctr Vectors & Infect Dis Res, Natl Inst Hlth Doutor Ricardo Jorge, Ave Liberdade 5, P-2965575 Aguas De Moura, Portugal.
   [Osorio, Hugo Costa; Alves, Maria Joao] Univ Lisbon, Fac Med, Inst Saude Ambiental, Ave Prof Egas Moniz,Ed Egas Moniz,Piso 0,Ala C, P-1649028 Lisbon, Portugal.
   [Ze-Ze, Libia] Biosyst & Integrat Sci Inst BioISI, Edificio TecLabs,Campus FCUL, P-1749016 Lisbon, Portugal.
   [Neto, Maria; Silva, Silvia] Adm Reg Saude Norte IP, Dept Saude Publ, Rua Anselmo Braamcamp 144, P-4000078 Porto, Portugal.
   [Marques, Fatima; Silva, Ana Sofia] Agrupamento Ctr Saude Vale de Sousa Sul, Unidade Saude Publ, Ave Comendador Abilio Seabra 104, P-4580029 Paredes, Portugal.
RP Osorio, HC (corresponding author), Ctr Vectors & Infect Dis Res, Natl Inst Hlth Doutor Ricardo Jorge, Ave Liberdade 5, P-2965575 Aguas De Moura, Portugal.; Osorio, HC (corresponding author), Univ Lisbon, Fac Med, Inst Saude Ambiental, Ave Prof Egas Moniz,Ed Egas Moniz,Piso 0,Ala C, P-1649028 Lisbon, Portugal.
EM hugo.osorio@insa.min-saude.pt; libia.zeze@insa.min-saude.pt;
   mneto@arsnorte.min-saude.pt; scsilva@arsnorte.min-saude.pt;
   asparedes@csparedes.min-saude.pt; asgrmsilva@arsnorte.min-saude.pt;
   m.joao.alves@insa.min-saude.pt
RI Osorio, Hugo/V-9073-2019
OI Osorio, Hugo/0000-0001-6704-740X; Ze-Ze, Libia/0000-0001-7258-1439;
   Alves, Maria Joao/0000-0003-0065-9000
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Angelini R, 2007, Euro Surveill, V12
   Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Briese T, 2002, EMERG INFECT DIS, V8, P528, DOI 10.3201/eid0805.010324
   Briese T, 1999, LANCET, V354, P1261, DOI 10.1016/S0140-6736(99)04576-6
   Calba C, 2017, EURO SURVEILL, V22
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Collantes F, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1262-y
   ECDC, 2012, GUID SURV INV MOSQ E
   European Centre for Disease Prevention and Control (ECDC), 2009, DEV AED ALB RISK MAP
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Hall T.A., 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Manica M., 2017, EURO SURVEILL, V22
   Margarita Y, 2006, ACTA PARASITOL, V1, P59
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Osorio HC, 2014, INT J ENV RES PUB HE, V11, P11583, DOI 10.3390/ijerph111111583
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Ribeiro Henrique, 1999, European Mosquito Bulletin, V3, P1
   Romi R, 1999, J AM MOSQUITO CONTR, V15, P425
   SABATANI A, 1990, Parassitologia (Rome), V32, P301
   Schaffner F, 2001, MOSQUITOES EUROPE ID
   Scholte EJ, 2007, ECOL CONT VECTOR-BOR, V1, P241
   WHO World Health Organization, CHIK IT
NR 26
TC 5
Z9 5
U1 0
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD APR
PY 2018
VL 15
IS 4
AR 820
DI 10.3390/ijerph15040820
PG 9
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA GI9TK
UT WOS:000434868800259
PM 29690531
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Usman, S
   Naz, Z
   Saleem, K
   Bashir, H
   Bilal, M
   Sumrin, A
AF Usman, Sana
   Naz, Zara
   Saleem, Komal
   Bashir, Hamid
   Bilal, Muhammad
   Sumrin, Aleena
TI The countermeasure for Zika virus: a hard nut to be cracked
SO FUTURE VIROLOGY
LA English
DT Review
DE BCX4430; CPE; monoclonal antibodies; nanchangmycin; NITD008; NSC; T705;
   7DMA
ID ADENOSINE ANALOG NITD008; VACCINE DEVELOPMENT; PROTECTION; FLAVIVIRUSES;
   INHIBITORS; INFECTION; OUTBREAK; EFFICACY; BCX4430; DENGUE
AB The emergence of Zika virus (ZIKV) infection in America has caused a new threat worldwide, as it is linked with the increased incidence of congenital microcephaly in neonates and development of Guillain-Barr'e syndrome. A number of potential antiviral drugs such as sofosbuvir, BCX4430, NITD008 and 7-DMA have shown activity against ZIKV both in vitro and in vivo. Similarly, different research organizations and academic institutions are trying hard to develop a vaccine against the ZIKV. Some of these groups have received approval from the US FDA to start Phase I clinical trials. Immuno-based treatment strategies, such as use of humanized monoclonal antibodies (hE16 and CR4373) have also entered clinical trials. However, a licensed vaccine is still a long way off and efforts should be made to accelerate the evaluation procedures while minimizing the delay in licensing.
C1 [Usman, Sana; Naz, Zara; Saleem, Komal; Bashir, Hamid; Bilal, Muhammad; Sumrin, Aleena] Univ Punjab, Ctr Appl Mol Biol, 87 West Canal,Bank Rd, Lahore 53700, Pakistan.
RP Bashir, H (corresponding author), Univ Punjab, Ctr Appl Mol Biol, 87 West Canal,Bank Rd, Lahore 53700, Pakistan.
EM hamid.camb@pu.edu.pk
RI Bilal, Muhammad/AAF-3102-2019
OI Bilal, Muhammad/0000-0003-2546-1199
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Crance JM, 2003, ANTIVIR RES, V58, P73, DOI 10.1016/S0166-3542(02)00185-7
   Deng CL, 2014, J VIROL, V88, P11915, DOI 10.1128/JVI.01207-14
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Dikhit MR, 2016, INFECT GENET EVOL, V45, P187, DOI 10.1016/j.meegid.2016.08.037
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin AP, 2016, SEMIN REPROD MED, V34, P299, DOI 10.1055/s-0036-1592070
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kim E, 2016, EBIOMEDICINE, V13, P315, DOI 10.1016/j.ebiom.2016.09.028
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lo MK, 2016, ANTIVIR RES, V130, P46, DOI 10.1016/j.antiviral.2016.03.013
   Mumtaz N, 2016, CURR TREAT OPTIONS I, V8, P208, DOI [10.1007/s40506-016-0083-7, DOI 10.1007/S40506-016-0083-7]
   Onorati M, 2016, CELL REP, V16, P2576, DOI 10.1016/j.celrep.2016.08.038
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   WHO, 2017, WHO VACC PIP TRACK
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 40
TC 0
Z9 0
U1 0
U2 3
PU FUTURE MEDICINE LTD
PI LONDON
PA UNITEC HOUSE, 3RD FLOOR, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON, N3
   1QB, ENGLAND
SN 1746-0794
EI 1746-0808
J9 FUTURE VIROL
JI Future Virol.
PD APR
PY 2018
VL 13
IS 5
BP 361
EP 369
DI 10.2217/fvl-2018-0018
PG 9
WC Virology
SC Virology
GA GK7UK
UT WOS:000436415400009
DA 2020-07-08
ER

PT J
AU Nguyen, DT
   Do, HT
   Le, HX
   Le, NT
   Vien, MQ
   Nguyen, TB
   Phan, LT
   Nguyen, TV
   Luong, QC
   Phan, HC
   Diep, HT
   Pham, QD
   Nguyen, TV
   Huynh, LKT
   Nguyen, DCT
   Pham, HTT
   Ly, KKH
   Tran, HNLT
   Tran, PD
   Dang, TQ
   Pham, H
   Vu, LN
   Mounts, A
   Balajee, SA
   Nolen, LD
AF Nguyen, Dong T.
   Do, Hung T.
   Le, Huy X.
   Le, Nghia T.
   Vien, Mai Q.
   Nguyen, Trieu B.
   Phan, Lan T.
   Nguyen, Thuong V.
   Luong, Quang C.
   Phan, Hung C.
   Diep, Hai T.
   Pham, Quang D.
   Nguyen, Thinh V.
   Huynh, Loan K. T.
   Nguyen, Dung C. T.
   Pham, Hang T. T.
   Ly, Khanh K. H.
   Tran, Huong N. L. T.
   Tran, Phu D.
   Dang, Tan Q.
   Pham, Hung
   Vu, Long N.
   Mounts, Anthony
   Balajee, S. Arunmozhi
   Nolen, Leisha D.
TI Zika preparedness and response in Viet Nam
SO WESTERN PACIFIC SURVEILLANCE AND RESPONSE
LA English
DT Editorial Material
C1 [Nguyen, Dong T.; Do, Hung T.; Le, Huy X.; Le, Nghia T.; Vien, Mai Q.; Nguyen, Trieu B.] Pasteur Inst, Nha Trang, Vietnam.
   [Phan, Lan T.; Nguyen, Thuong V.; Luong, Quang C.; Phan, Hung C.; Diep, Hai T.; Pham, Quang D.; Nguyen, Thinh V.; Huynh, Loan K. T.; Nguyen, Dung C. T.; Pham, Hang T. T.; Ly, Khanh K. H.; Tran, Huong N. L. T.] Pasteur Inst, Ho Chi Minh City, Vietnam.
   [Tran, Phu D.; Dang, Tan Q.; Pham, Hung; Vu, Long N.] Gen Dept Prevent Med, Hanoi, Vietnam.
   [Mounts, Anthony; Balajee, S. Arunmozhi] Ctr Dis Control & Prevent, Div Global Hlth Protect, Atlanta, GA USA.
   [Nolen, Leisha D.] Ctr Dis Control & Prevent, Arctic Invest Program, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Anchorage, AK 99508 USA.
RP Nolen, LD (corresponding author), Ctr Dis Control & Prevent, Arctic Invest Program, Div Preparedness & Emerging Infect, Natl Ctr Emerging & Zoonot Infect Dis, Anchorage, AK 99508 USA.
EM xdf8@cdc.gov
CR [Anonymous], 2016, ZIK VIR INF VIET NAM
   Balajee SA, 2016, HEALTH SECUR, V14, P424, DOI 10.1089/hs.2015.0062
   Katz R, 2014, BIOSECUR BIOTERROR, V12, P231, DOI 10.1089/bsp.2014.0038
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
NR 5
TC 0
Z9 0
U1 0
U2 1
PU WORLD HEALTH ORGANIZATION, REGIONAL OFFICE WESTERN PACIFIC
PI MANILA
PA PO BOX 2932, MANILA, 1000, PHILIPPINES
SN 2094-7321
EI 2094-7313
J9 WEST PAC SURVEILL RE
JI West. Pa. Surveill. Response
PD APR-JUN
PY 2018
VL 9
IS 2
DI 10.5365/wpsar.2018.9.1.002
PG 3
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA GL3KO
UT WOS:000437033400004
PM 30057851
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nayyer, F
   Tariq, I
   Ejaz, A
AF Nayyer, Faiqua
   Tariq, Iqra
   Ejaz, Amina
TI ANTECEDENTS OF DENGUE VIRUS DURING THE CLINICAL INVESTIGATIONS IN
   FAISALABAD
SO INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES
LA English
DT Article
DE Classic dengue outbreak; dengue virus; molecular typing; RT-PCR; RSS-PCR
ID ZIKA VIRUS
AB Background: Dengue is the most important viral mutagenic disease in public health, caused by one of the four serotypes (DEN-1, 2, 3 and 4) of the dengue virus, a positive chain RNA virus of the Flaviviridae family, which produces a spectrum of illness ranging from dengue fever to dengue hemorrhagic fever / shock syndrome (shock) due to dengue, the latter a serious infection with vascular and haemostatic abnormality that can lead to death. Objectives: To identify by reverse transcription-polymerase chain reaction (RT-PCR) and specific restriction sites - polymerase chain reaction (RSS-PCR) to the causative agent of the epidemic outbreak presented in the district of Faisalabad in April 2017.
   Materials and methods: twenty serum samples collected during the dengue outbreak were processed by RT-PCR to determine the serotype; this technique was performed in one step. The RSS-PCR technique was then applied to identify the circulating genotype and the results were subsequently corroborated with viral isolation and sequencing.
   Results: The analysis of the RTPCR of the RNA extracted from the samples presented an amplified product of 290pb corresponding to the dengue serotype. The analysis of the RSS-PCR products of RNA extracted from dengue isolates corresponded to pattern C, included in genotype III. The isolations of the dengue virus in C6 / 36 cell lines, typed by IFI and the genetic sequencing confirmed the results obtained by the tests previously described. Conclusion: During the classic dengue epidemic outbreak in Lima, genotype III of the dengue virus circulated.
C1 [Nayyer, Faiqua] BHU Rasul, Mandi Bahu Din, Pakistan.
   [Tariq, Iqra; Ejaz, Amina] Maryam Mem Hosp, WMO, Rawalpindi, Pakistan.
RP Nayyer, F (corresponding author), BHU Rasul, Mandi Bahu Din, Pakistan.
CR Bett A., 2018, DENGUE VIRUS VACCINE
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Hafirassou ML, 2018, CELL REP, V22, P1364, DOI 10.1016/j.celrep.2018.01.038
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Lai H., 2018, VACCINE
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Reyes-Ruiz JM, 2018, VIROLOGY, V515, P74, DOI 10.1016/j.virol.2017.12.014
   Schuler-Faccini L, 2018, MOL NEUROBIOL, V55, P1551, DOI 10.1007/s12035-017-0429-2
   Song G, 2018, MOL CELL PROTEOMICS, V17, P349, DOI 10.1074/mcp.RA117.000310
   Tsai JJ, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.01865-17, 10.1128/JCM.01865-17]
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Wahab N., 2018, J FUNDAMENTAL APPL S, V10, P580
   York A., 2018, NATURE REV MICROBIOL
NR 14
TC 0
Z9 0
U1 0
U2 0
PU SSJ COLL PHARMACY-SSJCP
PI NAGPUR
PA 125B-125 SANTRANJIPURA, TLIPHONE EXCHANGE RD, NAGPUR, 440001, INDIA
SN 2349-7750
J9 INDO AM J PHARM SCI
JI Indo Am. J. Pharm. Sci.
PD APR
PY 2018
VL 5
IS 4
BP 2458
EP 2461
DI 10.5281/zenodo.1218651
PG 4
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA GI5FX
UT WOS:000434397500057
DA 2020-07-08
ER

PT J
AU Giles, AB
AF Giles, Amber B.
TI A Travel Medicine Primer for the Pharmacist
SO US PHARMACIST
LA English
DT Article
ID DISEASES; DIARRHEA
AB With international travel increasing in past decades, pharmacists should be informed and stay up-to-date on the most pertinent travel-health information available. Preventive measures including prescriptions and other nonpharmacologic therapies are available to reduce the risk of acquiring an infectious disease while traveling internationally. Pharmacists in the community may be the last line of medication information and counseling available to the patient before travel, and they may be asked for recommendations about medications and OTC products to prevent travel-related illnesses such as traveler's diarrhea, cholera, typhoid fever, malaria, and Zika.
C1 [Giles, Amber B.] Presbyterian Coll Sch Pharm, Pharm Practice, Clinton, SC 29325 USA.
RP Giles, AB (corresponding author), Presbyterian Coll Sch Pharm, Pharm Practice, Clinton, SC 29325 USA.
CR Advisory Committee on Immunization Practices, 2016, SUMM REP
   Arguin PM, TRAVELERS HLTH YELLO
   Averhoff F., TRAVELERS HLTH YELLO
   Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009
   CDC, 2015, MMWR
   CDC, SEARCH YELL FEV VACC
   CDC, MAL DIAGN TREATM US
   Chen LH, TRAVELERS HLTH YELLO
   Chen T, TRAVELERS HLTH YELLO
   Connor BA, TRAVELERS HLTH YELLO
   Fitzgerald B, 2018, JAMA
   Gershman MD, TRAVELERS HLTH YELLO
   Hills SL, TRAVELERS HLTH YELLO
   International Society of Travel Medicine, ONL CLIN DIR
   Judd MC, TRAVELERS HLTH YELLO
   Kroger AT, TRAVELERS HLTH YELLO
   MacNeil JR, TRAVELERS HLTH YELLO
   Morof DF, TRAVELERS HLTH YELLO
   Mutebi J, TRAVELERS HLTH YELLO
   National Travel and Tourism Office, 2017, 2016 OUTB AN
   Nelson NP, TRAVELERS HLTH YELLO
   Petersen BW, TRAVELERS HLTH YELLO
   Shane AL, 2017, CLIN INFECT DIS, V65, pE45, DOI 10.1093/cid/cix669
   Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006
   Wong KK, TRAVELERS HLTH YELLO
NR 25
TC 0
Z9 0
U1 0
U2 0
PU JOBSON PUBLISHING LLC
PI NEW YORK
PA 100 AVE OF THE AMERICAS, NEW YORK, NY 10013-1678 USA
SN 0148-4818
EI 2331-3501
J9 US PHARM
JI US Pharm.
PD APR
PY 2018
VL 43
IS 4
BP 19
EP 26
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA GK5DD
UT WOS:000436191700006
DA 2020-07-08
ER

PT J
AU Gaudry, A
   Bos, S
   Viranaicken, W
   Roche, M
   Krejbich-Trotot, P
   Gadea, G
   Despres, P
   El-Kalamouni, C
AF Gaudry, Arnaud
   Bos, Sandra
   Viranaicken, Wildriss
   Roche, Marjolaine
   Krejbich-Trotot, Pascale
   Gadea, Gilles
   Despres, Philippe
   El-Kalamouni, Chaker
TI The Flavonoid Isoquercitrin Precludes Initiation of Zika Virus Infection
   in Human Cells
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE Zika virus; flavivirus; antiviral activity; natural compounds;
   nutraceutical; polyphenols; flavonoids; isoquercitrin
ID DENGUE VIRUS; SEXUAL TRANSMISSION; ANTIVIRAL ACTIVITY; INFLUENZA-VIRUS;
   INHIBITS ZIKA; REPLICATION; BIOLOGY; ENTRY; QUERCETIN; EPIDEMIC
AB The medical importance of Zika virus (ZIKV) was fully highlighted during the recent epidemics in South Pacific islands and Americas due to ZIKV association with severe damage to fetal brain development and neurological complications in adult patients. A worldwide research effort has been undertaken to identify effective compounds to prevent or treat ZIKV infection. Fruits and vegetables may be sources of compounds with medicinal properties. Flavonoids are one class of plant compounds that emerge as promising antiviral molecules against ZIKV. In the present study, we demonstrated that flavonoid isoquercitrin exerts antiviral activity against African historical and Asian epidemic strains of ZIKV in human hepatoma, epithelial, and neuroblastoma cell lines. Time-of-drug addition assays showed that isoquercitrin acts on ZIKV entry by preventing the internalisation of virus particles into the host cell. Our data also suggest that the glycosylated moiety of isoquercitrin might play a role in the antiviral effect of the flavonoid against ZIKV. Our results highlight the importance of isoquercitrin as a promising natural antiviral compound to prevent ZIKV infection.
C1 [Gaudry, Arnaud; Bos, Sandra; Viranaicken, Wildriss; Roche, Marjolaine; Krejbich-Trotot, Pascale; Gadea, Gilles; Despres, Philippe; El-Kalamouni, Chaker] Univ La Reunion, INSERM U1187, CNRS UMR 9192,Plateforme Technol CYROI, IRD UMR 249,Unite Mixte Proc Infect Milieu Insula, F-94791 St Clotilde, Reunion, France.
   [Gaudry, Arnaud] Univ Geneva, Univ Lausanne, EPGL, Sch Pharmaceut Sci, Quai Ernest Ansermet 30, CH-1211 Geneva 4, Switzerland.
RP Despres, P; El-Kalamouni, C (corresponding author), Univ La Reunion, INSERM U1187, CNRS UMR 9192,Plateforme Technol CYROI, IRD UMR 249,Unite Mixte Proc Infect Milieu Insula, F-94791 St Clotilde, Reunion, France.
EM arnaud.gaudry@etu.unige.ch; sandrabos.lab@gmail.com;
   wildriss.viranaicken@univ-reunion.fr; marjolaine.roche@univ-reunion.fr;
   pascale.krejbich@univ-reunion.fr; gilles.gadea@inserm.fr;
   philippe.despres@univ-reunion.fr; chaker.el-kalamouni@univ-reunion.fr
RI Gilles, Gadea/M-9966-2015
OI Gilles, Gadea/0000-0001-6325-4866; El Kalamouni,
   Chaker/0000-0003-4673-6614; BOS, Sandra/0000-0001-5036-0336; Gaudry,
   Arnaud/0000-0002-3648-7362; Krejbich Trotot, Pascale/0000-0001-7329-1716
FU INSERM-Transfert [R16029FS]; ZIKAlert project [SYNERGY: RE0001902];
   Swiss-European Mobility program from University of Geneva (Switzerland);
   La Reunion Island University (Ecole Doctorale STS) - French ministry
   MEESR
FX We gratefully thank Patrick Mavingui and Andrea Koishi for helpful
   discussions. This work was supported by INSERM-Transfert (project No.
   R16029FS) and ZIKAlert project (No. SYNERGY: RE0001902). Arnaud Gaudry
   has a Master degree scholarship from Swiss-European Mobility program
   from University of Geneva (Switzerland). Sandra Bos has PhD degree
   scholarship from La Reunion Island University (Ecole Doctorale STS),
   funded by French ministry MEESR.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Calland N, 2015, J VIROL, V89, P10053, DOI 10.1128/JVI.01473-15
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Cotin S, 2012, ANTIVIR RES, V96, P181, DOI 10.1016/j.antiviral.2012.09.010
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dayem AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121610
   dos Santos AE, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-130
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Estoppey D, 2017, CELL REP, V19, P451, DOI 10.1016/j.celrep.2017.03.071
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Giovanetti M, 2016, ASIAN PAC J TROP MED, V9, P445, DOI 10.1016/j.apjtm.2016.03.028
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grienke U, 2016, SCI REP-UK, V6, DOI 10.1038/srep27156
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Khachatoorian R, 2012, VIROLOGY, V433, P346, DOI 10.1016/j.virol.2012.08.029
   Kim YJ, 2010, ANTIVIR RES, V88, P227, DOI 10.1016/j.antiviral.2010.08.016
   Koishi AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051089
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lin LT, 2011, J VIROL, V85, P4386, DOI 10.1128/JVI.01492-10
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lulu SS, 2016, NAT PROD RES, V30, P464, DOI 10.1080/14786419.2015.1020490
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Martin KW, 2003, ANTIVIR THER, V8, P77
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Qiu XG, 2016, ANTIMICROB AGENTS CH, V60, P5182, DOI 10.1128/AAC.00307-16
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saiz J.C., 2017, ANTIMICROB AGENTS CH, V61
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Talarico LB, 2005, ANTIVIR RES, V66, P103, DOI 10.1016/j.antiviral.2005.02.001
   Valentova K, 2014, FOOD CHEM TOXICOL, V68, P267, DOI 10.1016/j.fct.2014.03.018
   Verri WA, 2012, STUD NAT PROD CHEM, V36, P297, DOI 10.1016/B978-0-444-53836-9.00026-8
   Viranaicken W, 2017, BIOCHIMIE, V142, P179, DOI 10.1016/j.biochi.2017.09.011
   Jaime MFV, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-245
   Wong G, 2017, VIROL SIN, V32, P545, DOI 10.1007/s12250-017-4057-9
NR 47
TC 17
Z9 17
U1 0
U2 6
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2018
VL 19
IS 4
AR 1093
DI 10.3390/ijms19041093
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA GJ0XU
UT WOS:000434978700172
PM 29621184
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kong, LY
   Libman, MD
   Yansouni, CP
AF Kong, Ling Yuan
   Libman, Michael D.
   Yansouni, Cedric P.
TI Travel-Related Infections Among Pregnant Travellers to the Tropics: An
   Overview
SO JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA
LA English
DT Article
DE Travel; pregnancy; infectious diseases; Zika; malaria
ID ZIKA VIRUS-INFECTION; MALARIA; SCHISTOSOMIASIS; EFFICACY
AB Infectious diseases acquired during travel pose a significant health risk to pregnant travellers, who are more susceptible to both acquiring certain infections and developing severe complications. A review of the literature focusing on recent evidence-based guidelines was conducted with attention to tropical infections in the pregnant patient. A summary meant to serve as a succinct reference for health care professionals caring for pregnant women is presented. Magnitude of risk, clinical features, management, and preventive strategies of major travel-acquired infections of pertinence to the pregnant traveller are summarized, including malaria, arboviral infections, foodborne infections, helminthic infections, and influenza. Tables with details on specific infections within each group and guidance for reducing travel-related health risks in the pregnant patient are presented.
C1 [Kong, Ling Yuan; Libman, Michael D.; Yansouni, Cedric P.] McGill Univ, Hlth Ctr, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada.
RP Kong, LY (corresponding author), McGill Univ, Hlth Ctr, Div Infect Dis, JD MacLean Ctr Trop Dis, Montreal, PQ, Canada.; Kong, LY (corresponding author), McGill Univ, Hlth Ctr, Dept Microbiol, Montreal, PQ, Canada.
EM ling.kong@mail.mcgill.ca
OI /0000-0002-4765-3469
CR Antony KM, 2017, OBSTET GYNECOL SURV, V72, P97, DOI 10.1097/OGX.0000000000000398
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Blackwell AD, 2016, IN J WOMENS HEALTH, V8, P651, DOI 10.2147/IJWH.S103529
   Boggild Andrea K, 2016, CMAJ Open, V4, pE352
   Boggild Andrea K, 2014, Open Med, V8, pe20
   Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291
   Buresch AM, 2015, OBSTET GYNECOL, V126, P87, DOI 10.1097/AOG.0000000000000676
   Centers for Disease Control and Prevention, WORLD MAP AR RISK ZI
   Chahroudi A., 2017, NEUROLOGIC CONSEQUEN
   Chaudhry SA, 2015, CAN FAM PHYSICIAN, V61, P963
   Chaudhry SA, 2015, CAN FAM PHYSICIAN, V61, P607
   Committee to Advise on Tropical Medicine and Travel (CATMAT), 2010, CAN COMMUN DIS REP, V36, P1
   Committee to Advise on Tropical Medicine and Travel (CATMAT), 2012, CANADA COMMUNICABLE, V38, P1
   Committee to Advise on Tropical Medicine and Travel (CATMAT), 2015, STAT TRAV DIARRH ADV
   Committee to Advise on Tropical Medicine and Travel (CATMAT), 2014, CAN COMMUN DIS REP, V40
   Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1
   D'Cruz RF, 2016, OXF MED CASE REP, P138, DOI 10.1093/omcr/omw019
   Dellicour S, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002290
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Folgori L, 2017, CURR OPIN INFECT DIS, V30, P281, DOI 10.1097/QCO.0000000000000371
   Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226
   Friedman JF, 2007, TRENDS PARASITOL, V23, P159, DOI 10.1016/j.pt.2007.02.006
   Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277
   Government of Canada, SURV ZIK VIR
   Gyorkos TW, 2011, TROP MED INT HEALTH, V16, P531, DOI 10.1111/j.1365-3156.2011.02727.x
   Kaser AK, 2015, TRAVEL MED INFECT DI, V13, P300, DOI 10.1016/j.tmaid.2015.06.011
   Keiser J, 2008, JAMA-J AM MED ASSOC, V299, P1937, DOI 10.1001/jama.299.16.1937
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Lenglet Y, 2006, J Gynecol Obstet Biol Reprod (Paris), V35, P578
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Libman M., 2016, CDC HLTH INFORM INT
   Luteijn JM, 2014, HUM REPROD, V29, P809, DOI 10.1093/humrep/det455
   McGovern LM, 2007, J TRAVEL MED, V14, P117, DOI 10.1111/j.1708-8305.2006.00093.x
   Mclean ARD, 2015, PARASITOLOGY, V142, P999, DOI 10.1017/S0031182015000074
   Mehrjardi MZ, 2016, JPN J RADIOL, V34, P765, DOI 10.1007/s11604-016-0588-5
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Olveda RM, 2016, LANCET INFECT DIS, V16, P199, DOI 10.1016/S1473-3099(15)00345-X
   Petdachai Witaya, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P403
   Public Health Agency of Canada, 2014, COMM ADV TROP MED TR
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Riddle MS, 2017, J TRAVEL MED, V24, pS63, DOI 10.1093/jtm/tax026
   Ryan ET, 2002, NEW ENGL J MED, V347, P505, DOI 10.1056/NEJMra020118
   Salam RA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005547.pub3
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shah OJ, 2005, WORLD J SURG, V29, P1294, DOI 10.1007/s00268-005-0015-z
   Shapiro-Mendoza CK, 2016, PREGNANCY OUTCOMES M
   Statistics Canada, 2017, TRAV CAN OTH COUNTR
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   WHO, 2015, GUID TREATM MAL
   World Health Organization, 2017, INF TRAV VIS ZIK AFF
   World Health Organization, 2017, DEW PREGN
   Wylie BJ, 2016, OBSTET GYNECOL, V128, P1111, DOI 10.1097/AOG.0000000000001685
   Zika Working Group, 2016, Can Commun Dis Rep, V42, P101
NR 55
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER INC
PI SAN DIEGO
PA 525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1701-2163
J9 J OBSTET GYNAECOL CA
JI J. Obstet. Gynaecol. Can.
PD APR
PY 2018
VL 40
IS 4
BP 460
EP 472
DI 10.1016/j.jogc.2017.08.006
PG 13
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GJ2BG
UT WOS:000435071200022
PM 29307707
DA 2020-07-08
ER

PT J
AU Lindsey, ARI
   Bhattacharya, T
   Newton, ILG
   Hardy, RW
AF Lindsey, Amelia R. I.
   Bhattacharya, Tamanash
   Newton, Irene L. G.
   Hardy, Richard W.
TI Conflict in the Intracellular Lives of Endosymbionts and Viruses: A
   Mechanistic Look at Wolbachia-Mediated Pathogen-blocking
SO VIRUSES-BASEL
LA English
DT Review
DE vector control; antiviral; symbiosis; endosymbiont; arbovirus;
   Drosophila; Aedes
ID SEMLIKI-FOREST-VIRUS; AEDES-AEGYPTI MOSQUITOS; LIFE-SHORTENING
   WOLBACHIA; DOUBLE-STRANDED-RNA; INDUCED CYTOPLASMIC INCOMPATIBILITY;
   SIGNAL-REGULATED KINASE; INNATE IMMUNE-RESPONSES; HOST GENE-EXPRESSION;
   JAK-STAT PATHWAY; DENGUE VIRUS
AB At the forefront of vector control efforts are strategies that leverage host-microbe associations to reduce vectorial capacity. The most promising of these efforts employs Wolbachia, a maternally transmitted endosymbiotic bacterium naturally found in 40% of insects. Wolbachia can spread through a population of insects while simultaneously inhibiting the replication of viruses within its host. Despite successes in using Wolbachia-transfected mosquitoes to limit dengue, Zika, and chikungunya transmission, the mechanisms behind pathogen-blocking have not been fully characterized. Firstly, we discuss how Wolbachia and viruses both require specific host-derived structures, compounds, and processes to initiate and maintain infection. There is significant overlap in these requirements, and infection with either microbe often manifests as cellular stress, which may be a key component of Wolbachia's anti-viral effect. Secondly, we discuss the current understanding of pathogen-blocking through this lens of cellular stress and develop a comprehensive view of how the lives of Wolbachia and viruses are fundamentally in conflict with each other. A thorough understanding of the genetic and cellular determinants of pathogen-blocking will significantly enhance the ability of vector control programs to deploy and maintain effective Wolbachia-mediated control measures.
C1 [Lindsey, Amelia R. I.; Bhattacharya, Tamanash; Newton, Irene L. G.; Hardy, Richard W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.
RP Newton, ILG (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.
EM amlind@indiana.edu; tamanash@umail.iu.edu; imewton@indiana.edu;
   rwhardy@indiana.edu
RI Newton, Irene/H-5939-2019
OI Newton, Irene/0000-0002-7118-0374; Lindsey, Amelia/0000-0003-3354-7419
FU National Institute of Allergy and Infectious Disease (NIH)United States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [R21 A1121849]
FX This work was supported by the National Institute of Allergy and
   Infectious Disease (NIH R21 A1121849 to ILGN and RWH). We thank Eric A.
   Smith and two anonymous reviewers for feedback on earlier drafts of the
   manuscript.
CR Ahlquist P, 2006, NAT REV MICROBIOL, V4, P371, DOI 10.1038/nrmicro1389
   Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   [Anonymous], 2017, SYMBIOSIS
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Arjona A, 2007, J IMMUNOL, V179, P8403, DOI 10.4049/jimmunol.179.12.8403
   Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Barillas-Mury C, 1999, EMBO J, V18, P959, DOI 10.1093/emboj/18.4.959
   BARTON DJ, 1991, J VIROL, V65, P1496, DOI 10.1128/JVI.65.3.1496-1506.1991
   Beckham CJ, 2008, CELL HOST MICROBE, V3, P206, DOI 10.1016/j.chom.2008.03.004
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Belov GA, 2014, CURR OPIN VIROL, V9, P19, DOI 10.1016/j.coviro.2014.08.007
   Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073
   Bernard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011479
   Bhattacharya B, 2010, VIRUSES-BASEL, V2, P1218, DOI 10.3390/v2051218
   Bhattacharya T., 2017, ENV MICROBIOL
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002250
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blair CD, 2015, VIRUSES-BASEL, V7, P820, DOI 10.3390/v7020820
   Bordenstein SR, 2001, NATURE, V409, P707, DOI 10.1038/35055543
   Bost AG, 2003, J VIROL, V77, P4401, DOI 10.1128/JVI.77.7.4401-4408.2003
   Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502
   Brennan LJ, 2012, INSECT MOL BIOL, V21, P510, DOI 10.1111/j.1365-2583.2012.01155.x
   Brennan LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002083
   BRINTON MA, 1988, VIROLOGY, V162, P290, DOI 10.1016/0042-6822(88)90468-0
   Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368
   Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003
   Bull James J., 2013, Evolution Medicine and Public Health, P197, DOI 10.1093/emph/eot018
   Caragata EP, 2014, MICROB ECOL, V67, P205, DOI 10.1007/s00248-013-0339-4
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Chandran K, 2002, J VIROL, V76, P9920, DOI 10.1128/JVI.76.19.9920-9933.2002
   Cho KO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022703
   Chrostek E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099025
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Clyde K, 2006, J VIROL, V80, P2170, DOI 10.1128/JVI.80.5.2170-2182.2006
   Costa A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007436
   Cristea IM, 2010, J VIROL, V84, P6720, DOI 10.1128/JVI.01983-09
   Danthi P, 2008, J VIROL, V82, P161, DOI 10.1128/JVI.01739-07
   Dean MD, 2006, P ROY SOC B-BIOL SCI, V273, P1415, DOI 10.1098/rspb.2005.3453
   Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   DUBIN DT, 1977, VIROLOGY, V77, P457, DOI 10.1016/0042-6822(77)90471-8
   Durdevic Z, 2013, CELL REP, V4, P931, DOI 10.1016/j.celrep.2013.07.046
   Durdevic Z, 2013, EMBO REP, V14, P269, DOI 10.1038/embor.2013.3
   Ferree PM, 2005, PLOS PATHOG, V1, P111, DOI 10.1371/journal.ppat.0010014
   Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507
   Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0
   Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frolov I, 2001, RNA, V7, P1638, DOI 10.1017/S135583820101010X
   Fros JJ, 2012, J VIROL, V86, P10873, DOI 10.1128/JVI.01506-12
   Gale M, 2000, MICROBIOL MOL BIOL R, V64, P239, DOI 10.1128/MMBR.64.2.239-280.2000
   Garcia-Moreno M, 2013, CELL MICROBIOL, V15, P823, DOI 10.1111/cmi.12079
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gerth M, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.241
   Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Glaser RL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011977
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976
   Graham RI, 2012, ECOL LETT, V15, P993, DOI 10.1111/j.1461-0248.2012.01820.x
   Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727
   Hamm CA, 2014, MOL ECOL, V23, P4871, DOI 10.1111/mec.12901
   Han YH, 2011, J VIROL, V85, P13153, DOI 10.1128/JVI.05518-11
   Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9
   Harley D, 2001, CLIN MICROBIOL REV, V14, P909, DOI 10.1128/CMR.14.4.909-932.2001
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hedges LM, 2012, APPL ENVIRON MICROB, V78, P6773, DOI 10.1128/AEM.01650-12
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   HOFFMANN AA, 1990, GENETICS, V126, P933
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Huang ZJ, 2013, J VIROL, V87, P4272, DOI 10.1128/JVI.03360-12
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001296
   Hurst GDD, 1999, P ROY SOC B-BIOL SCI, V266, P735, DOI 10.1098/rspb.1999.0698
   Hussain M, 2011, P NATL ACAD SCI USA, V108, P9250, DOI 10.1073/pnas.1105469108
   Issac THK, 2014, J PROTEOMICS, V108, P445, DOI 10.1016/j.jprot.2014.06.003
   Jaenike J, 2006, PLOS BIOL, V4, P1852, DOI 10.1371/journal.pbio.0040325
   Jansen CC, 2010, MICROBES INFECT, V12, P272, DOI 10.1016/j.micinf.2009.12.011
   Joubert DA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005275
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   JUNKERNIEPMANN M, 1990, EMBO J, V9, P3389, DOI 10.1002/j.1460-2075.1990.tb07540.x
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kaneko T, 2005, CELL MICROBIOL, V7, P461, DOI 10.1111/j.1462-5822.2005.00504.x
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   KIELIAN MC, 1984, J VIROL, V52, P281, DOI 10.1128/JVI.52.1.281-283.1984
   Kim DY, 2011, J VIROL, V85, P8022, DOI 10.1128/JVI.00644-11
   Kingsolver MB, 2013, J MOL BIOL, V425, P4921, DOI 10.1016/j.jmb.2013.10.006
   Kondo N, 2005, BIOL LETTERS, V1, P488, DOI 10.1098/rsbl.2005.0340
   Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220
   Kremer N, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S7
   Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630
   Kujala P, 2001, J VIROL, V75, P3873, DOI 10.1128/JVI.75.8.3873-3884.2001
   Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08
   Landmann F, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000343
   Lassy CW, 1996, MECH DEVELOP, V57, P47, DOI 10.1016/0925-4773(96)00527-8
   LAVEN H, 1967, NATURE, V216, P383, DOI 10.1038/216383a0
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Lee JS, 2012, AM J TRANSL RES, V4, P102
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   LePage DP, 2014, PEERJ, V2, DOI 10.7717/peerj.678
   Libert S, 2006, AGING CELL, V5, P533, DOI 10.1111/j.1474-9726.2006.00251.x
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lim DH, 2011, FEBS LETT, V585, P3079, DOI 10.1016/j.febslet.2011.08.034
   Lindsey ARI, 2018, GENOME BIOL EVOL, V10, P434, DOI 10.1093/gbe/evy012
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Makungu C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2056-9
   Marhold J, 2004, INSECT MOL BIOL, V13, P117, DOI 10.1111/j.0962-1075.2004.00466.x
   Martinez J., 2017, MOL ECOL
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Martinez-Gutierrez M, 2011, INTERVIROLOGY, V54, P202, DOI 10.1159/000321892
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   McGraw EA, 2002, P NATL ACAD SCI USA, V99, P2918, DOI 10.1073/pnas.052466499
   McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124
   McIntyre W., 2018, NUCL ACIDS RES
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mercot H, 2004, GENETICA, V120, P51, DOI 10.1023/B:GENE.0000017629.31383.8f
   Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a
   Micieli MV, 2014, J MED ENTOMOL, V51, P189, DOI 10.1603/ME13152
   Milligan SA, 1998, ARCH BIOCHEM BIOPHYS, V352, P255, DOI 10.1006/abbi.1998.0603
   Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792
   Molloy JC, 2016, APPL ENVIRON MICROB, V82, P3109, DOI 10.1128/AEM.00275-16
   Moreau J, 2001, J EVOLUTION BIOL, V14, P388, DOI 10.1046/j.1420-9101.2001.00292.x
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Morrison J, 2012, VIRUSES-BASEL, V4, P397, DOI 10.3390/v4030397
   Mosavi LK, 2004, PROTEIN SCI, V13, P1435, DOI 10.1110/ps.03554604
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Moya A, 2004, NAT REV MICROBIOL, V2, P279, DOI 10.1038/nrmicro863
   Muller JM, 1997, EUR J BIOCHEM, V244, P45, DOI 10.1111/j.1432-1033.1997.00045.x
   Negri H, 2009, P ROY SOC B-BIOL SCI, V276, P2485, DOI 10.1098/rspb.2009.0324
   Newton ILG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004798
   Ng CG, 2008, P NATL ACAD SCI USA, V105, P16326, DOI 10.1073/pnas.0808720105
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Osei-Amo S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050049
   Ote M, 2016, CURR BIOL, V26, P2223, DOI 10.1016/j.cub.2016.06.054
   Pager CT, 2013, VIROLOGY, V435, P472, DOI 10.1016/j.virol.2012.10.027
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Panas MD, 2012, MOL BIOL CELL, V23, P4701, DOI 10.1091/mbc.E12-08-0619
   Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Pietri JE, 2016, MICROBIOLOGYOPEN, V5, P923, DOI 10.1002/mbo3.390
   Pinto SB, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S11
   Poh MK, 2012, ANTIVIR RES, V93, P191, DOI 10.1016/j.antiviral.2011.11.014
   Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583
   Radtke K, 2006, CELL MICROBIOL, V8, P387, DOI 10.1111/j.1462-5822.2005.00679.x
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rathore APS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-36
   Rice DW, 2017, GENOME BIOL EVOL, V9, P1925, DOI 10.1093/gbe/evx139
   RIGAUD T, 1993, GENETICS, V133, P247
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Ryman KD, 2008, IMMUNOL REV, V225, P27, DOI 10.1111/j.1600-065X.2008.00670.x
   Salonen A, 2003, J VIROL, V77, P1691, DOI 10.1128/JVI.77.3.1691-1702.2003
   Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010
   SASAO F, 1980, MICROBIOL IMMUNOL, V24, P915, DOI 10.1111/j.1348-0421.1980.tb02897.x
   Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710
   Schaefer M, 2010, CHROMOSOMA, V119, P35, DOI 10.1007/s00412-009-0240-6
   Schnettler E, 2016, J GEN VIROL, V97, P3024, DOI 10.1099/jgv.0.000617
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Serbus LR, 2008, ANNU REV GENET, V42, P683, DOI 10.1146/annurev.genet.41.110306.130354
   Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005
   Sheehan KB, 2016, MBIO, V7, DOI 10.1128/mBio.00622-16
   Sinkins SP, 2004, INSECT BIOCHEM MOLEC, V34, P723, DOI 10.1016/j.ibmb.2004.03.025
   Siu RWC, 2011, J VIROL, V85, P2907, DOI 10.1128/JVI.02052-10
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   STOUTHAMER R, 1993, NATURE, V361, P66, DOI 10.1038/361066a0
   STOUTHAMER R, 1993, ENTOMOL EXP APPL, V67, P183, DOI 10.1007/BF02386524
   STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424
   Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tassetto M, 2017, CELL, V169, P314, DOI 10.1016/j.cell.2017.03.033
   Taylor MP, 2008, AUTOPHAGY, V4, P286, DOI 10.4161/auto.5377
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Terradas G, 2017, SCI REP-UK, V7, DOI 10.1038/srep43847
   Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005
   Thiagarajan D, 2011, EPIGENETICS-US, V6, P103, DOI 10.4161/epi.6.1.13418
   Tram U, 2002, SCIENCE, V296, P1124, DOI 10.1126/science.1070536
   TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0
   TURELLI M, 1994, EVOLUTION, V48, P1500, DOI 10.1111/j.1558-5646.1994.tb02192.x
   TURELLI M, 1995, GENETICS, V140, P1319
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Van Wynsberghe PM, 2009, J VIROL, V83, P2976, DOI 10.1128/JVI.02040-08
   Vasquez CJ, 2011, BIOL CONTROL, V58, P192, DOI 10.1016/j.biocontrol.2011.06.006
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596
   White PM, 2017, GENETICS, V205, P1473, DOI 10.1534/genetics.116.198903
   Wong ZS, 2016, J GEN VIROL, V97, P1446, DOI 10.1099/jgv.0.000456
   Wong ZS, 2015, APPL ENVIRON MICROB, V81, P3001, DOI 10.1128/AEM.03847-14
   Wong ZS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025430
   Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069
   Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098
   Xi ZY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-1
   Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002
   Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110
   Ye YXH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066482
   Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58
   YEN JH, 1971, NATURE, V232, P657, DOI 10.1038/232657a0
   Yixin H.Y., 2015, PLOS NEGLECT TROP D, V9
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yoshii K, 2008, J GEN VIROL, V89, P200, DOI 10.1099/vir.0.82824-0
   Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zheng Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-595
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 228
TC 17
Z9 17
U1 2
U2 14
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2018
VL 10
IS 4
AR 141
DI 10.3390/v10040141
PG 29
WC Virology
SC Virology
GA GJ3HZ
UT WOS:000435184400002
PM 29561780
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sakkas, H
   Bozidis, P
   Franks, A
   Papadopoulou, C
AF Sakkas, Hercules
   Bozidis, Petros
   Franks, Ashley
   Papadopoulou, Chrissanthy
TI Oropouche Fever: A Review
SO VIRUSES-BASEL
LA English
DT Review
DE Oropouche virus; OROV disease; arbovirus; Culicoides; Amazon
ID CULICOIDES BITING MIDGES; CENTRAL-NERVOUS-SYSTEM; VIRUS-INFECTION;
   DIPTERA-CERATOPOGONIDAE; CULEX-QUINQUEFASCIATUS; ARBOVIRAL DISEASES;
   PUBLIC-HEALTH; MATO-GROSSO; IN-VITRO; ORTHOBUNYAVIRUS
AB Oropouche fever is an emerging zoonotic disease caused by Oropouche virus (OROV), an arthropod transmitted Orthobunyavirus circulating in South and Central America. During the last 60 years, more than 30 epidemics and over half a million clinical cases attributed to OROV infection have been reported in Brazil, Peru, Panama, Trinidad and Tobago. OROV fever is considered the second most frequent arboviral febrile disease in Brazil after dengue fever. OROV is transmitted through both urban and sylvatic transmission cycles, with the primary vector in the urban cycle being the anthropophilic biting midge Culicoides paraensis. Currently, there is no evidence of direct human-to-human OROV transmission. OROV fever is usually either undiagnosed due to its mild, self-limited manifestations or misdiagnosed because its clinical characteristics are similar to dengue, chikungunya, Zika and yellow fever, including malaria as well. At present, there is no specific antiviral treatment, and in the absence of a vaccine for effective prophylaxis of human populations in endemic areas, the disease prevention relies solely on vector control strategies and personal protection measures. OROV fever is considered to have the potential to spread across the American continent and under favorable climatic conditions may expand its geographic distribution to other continents. In view of OROV's emergence, increased interest for formerly neglected tropical diseases and within the One Health concept, the existing knowledge and gaps of knowledge on OROV fever are reviewed.
C1 [Sakkas, Hercules; Bozidis, Petros; Papadopoulou, Chrissanthy] Univ Ioannina, Sch Hlth Sci, Fac Med, Dept Microbiol, GR-45110 Ioannina, Greece.
   [Sakkas, Hercules; Franks, Ashley] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia.
RP Sakkas, H (corresponding author), Univ Ioannina, Sch Hlth Sci, Fac Med, Dept Microbiol, GR-45110 Ioannina, Greece.; Sakkas, H (corresponding author), La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic 3086, Australia.
EM isakkas@uoi.gr; pbozidis@cc.uoi.gr; A.Franks@latrobe.edu.au;
   cpapadop@cc.uoi.gr
RI Sakkas, Hercules/AAH-8344-2019; Papadopoulou, Chrissanthy/AAC-2390-2019;
   Bozidis, Petros/AAC-8283-2019
OI Papadopoulou, Chrissanthy/0000-0002-1628-1009; Sakkas,
   Hercules/0000-0002-2495-8374; Franks, Ashley/0000-0003-1664-6060
CR Acrani GO, 2015, J GEN VIROL, V96, P513, DOI 10.1099/jgv.0.000005
   Acrani GO, 2010, VIRUS RES, V149, P56, DOI 10.1016/j.virusres.2009.12.013
   Adams MJ, 2017, ARCH VIROL, V162, P2505, DOI 10.1007/s00705-017-3358-5
   Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Alencar J, 2011, REV SOC BRAS MED TRO, V44, P247, DOI 10.1590/S0037-86822011000200023
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Araujo R, 1978, Rev Inst Med Trop Sao Paulo, V20, P45
   Augot D, 2017, PEERJ, V5, DOI 10.7717/peerj.3478
   Augot D, 2017, PARASITE, V24, DOI 10.1051/parasite/2017020
   Baisley KJ, 1998, AM J TROP MED HYG, V59, P710, DOI 10.4269/ajtmh.1998.59.710
   Bastos MD, 2012, AM J TROP MED HYG, V86, P732, DOI 10.4269/ajtmh.2012.11-0485
   Bastos MS, 2014, J MED VIROL, V86, P1522, DOI 10.1002/jmv.23953
   Batista PM, 2013, REV SOC BRAS MED TRO, V46, P684, DOI 10.1590/0037-8682-0181-2013
   Benelli G, 2017, RES VET SCI, V115, P263, DOI 10.1016/j.rvsc.2017.05.023
   Bhattacharya Sajal, 2016, Journal of Entomology and Zoology Studies, V4, P73
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Cardoso JD, 2010, EMERG INFECT DIS, V16, P1918, DOI 10.3201/eid1612.100608
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Carpenter S, 2013, ANTIVIR RES, V100, P102, DOI 10.1016/j.antiviral.2013.07.020
   CHAVEZ R, 1992, REV FARMACOL TERAP L, V2, P12
   Culquichicon Carlos, 2017, F1000Res, V6, P194, DOI 10.12688/f1000research.10936.1
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Luna LKD, 2017, J MED VIROL, V89, P1108, DOI 10.1002/jmv.24722
   DIXON KE, 1981, AM J TROP MED HYG, V30, P161, DOI 10.4269/ajtmh.1981.30.161
   Elliott RM, 2011, BUNYAVIRIDAE: MOLECULAR AND CELLULAR BIOLOGY, P1
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Gibrail MM, 2016, REV SOC BRAS MED TRO, V49, P357, DOI 10.1590/0037-8682-0425-2015
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Gonzalez M, 2016, VET PARASITOL, V226, P44, DOI 10.1016/j.vetpar.2016.06.020
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hang Jun, 2012, J Biomol Tech, V23, P4, DOI 10.7171/jbt.12-2301-001
   Hoch A.L., 1986, Bulletin of the Pan American Health Organization, V20, P284
   Ladner JT, 2014, J GEN VIROL, V95, P1055, DOI 10.1099/vir.0.061309-0
   Lassen SB, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-143
   Livonesi MC, 2006, AM J TROP MED HYG, V75, P1011, DOI 10.4269/ajtmh.2006.75.1011
   Livonesi MC, 2007, ANTIVIR RES, V75, P121, DOI 10.1016/j.antiviral.2007.01.158
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307
   Mercer DR, 2003, J MED ENTOMOL, V40, P807, DOI 10.1603/0022-2585-40.6.807
   Figueiredo LTM, 2007, REV SOC BRAS MED TRO, V40, P224, DOI 10.1590/S0037-86822007000200016
   Moreli ML, 2002, J MED VIROL, V66, P139, DOI 10.1002/jmv.2122
   Mourao MPG, 2009, EMERG INFECT DIS, V15, P2063, DOI 10.3201/eid1512.090917
   Navarro JC, 2016, AM J TROP MED HYG, V95, P328, DOI 10.4269/ajtmh.15-0679
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   PINHEIRO F P, 1981, American Journal of Tropical Medicine and Hygiene, V30, P149
   Pinheiro F P, 1982, Rev Inst Med Trop Sao Paulo, V24, P246
   PINHEIRO FP, 1976, TROPENMED PARASITOL, V27, P213
   PINHEIRO FP, 1982, SCIENCE, V215, P1251, DOI 10.1126/science.6800036
   Proenca-Modena JL, 2016, J VIROL, V90, P189, DOI 10.1128/JVI.02276-15
   Proenca-Modena JL, 2015, J VIROL, V89, P4720, DOI 10.1128/JVI.00077-15
   PULZOVA L, 2009, PATHOG DIS, V57, P203, DOI DOI 10.1111/J.1574-695X.2009.00594.X
   Purse BV, 2015, ANNU REV ENTOMOL, V60, P373, DOI 10.1146/annurev-ento-010814-020614
   ROBERTS DR, 1981, AM J TROP MED HYG, V30, P165, DOI 10.4269/ajtmh.1981.30.165
   Robin M, 2016, EQUINE VET J, V48, P659, DOI 10.1111/evj.12600
   Rodrigues AH, 2011, VIRUS RES, V155, P35, DOI 10.1016/j.virusres.2010.08.009
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   Romero-Alvarez D, 2017, MEM I OSWALDO CRUZ, V112, P292, DOI 10.1590/0074-02760160415
   Rosa A P, 1996, Rev Soc Bras Med Trop, V29, P537, DOI 10.1590/S0037-86821996000600002
   Saeed MF, 2001, J CLIN MICROBIOL, V39, P2445, DOI 10.1128/JCM.39.7.2445-2452.2001
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Santos RI, 2014, VIRUSES-BASEL, V6, P3827, DOI 10.3390/v6103827
   Santos RI, 2012, VIRUS RES, V170, P25, DOI 10.1016/j.virusres.2012.07.006
   Schnettler E, 2013, J VIROL, V87, P2441, DOI 10.1128/JVI.02848-12
   Temmam S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030077
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   TESH RB, 1994, ANN NY ACAD SCI, V740, P129, DOI 10.1111/j.1749-6632.1994.tb19863.x
   Tilston-Lunel NL, 2016, J VIROL, V90, P2616, DOI 10.1128/JVI.02849-15
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   VASCONCELOS PFD, 1989, REV INST MED TROP SP, V31, P271, DOI 10.1590/S0036-46651989000400011
   Aybar CAV, 2010, MED VET ENTOMOL, V24, P95, DOI 10.1111/j.1365-2915.2009.00846.x
   Aybar CAV, 2012, J INSECT SCI, V12, P1, DOI 10.1673/031.012.14501
   Aybar CAV, 2011, J AM MOSQUITO CONTR, V27, P306, DOI 10.2987/10-6059.1
   Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148
   Weidmann M, 2003, J CLIN MICROBIOL, V41, P3299, DOI 10.1128/JCM.41.7.3299-3305.2003
   WIRTH WW, 1989, MEM I OSWALDO CRUZ, V84, P551, DOI 10.1590/S0074-02761989000800096
NR 81
TC 19
Z9 19
U1 2
U2 5
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2018
VL 10
IS 4
AR 175
DI 10.3390/v10040175
PG 16
WC Virology
SC Virology
GA GJ3HZ
UT WOS:000435184400036
PM 29617280
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stassen, L
   Armitage, CW
   van der Heide, DJ
   Beagley, KW
   Frentiu, FD
AF Stassen, Liesel
   Armitage, Charles W.
   van der Heide, David J.
   Beagley, Kenneth W.
   Frentiu, Francesca D.
TI Zika Virus in the Male Reproductive Tract
SO VIRUSES-BASEL
LA English
DT Review
DE flavivirus; arbovirus; Zika; sexual transmission; testis; prostate
ID MALE SEXUAL TRANSMISSION; SERTOLI-CELLS; BODY-FLUIDS; INFECTION; SEMEN;
   RNA; REPLICATION; PERSISTENCE; ANTIBODIES; KINETICS
AB Arthropod-borne viruses (arboviruses) are resurging across the globe. Zika virus (ZIKV) has caused significant concern in recent years because it can lead to congenital malformations in babies and Guillain-Barre syndrome in adults. Unlike other arboviruses, ZIKV can be sexually transmitted and may persist in the male reproductive tract. There is limited information regarding the impact of ZIKV on male reproductive health and fertility. Understanding the mechanisms that underlie persistent ZIKV infections in men is critical to developing effective vaccines and therapies. Mouse and macaque models have begun to unravel the pathogenesis of ZIKV infection in the male reproductive tract, with the testes and prostate gland implicated as potential reservoirs for persistent ZIKV infection. Here, we summarize current knowledge regarding the pathogenesis of ZIKV in the male reproductive tract, the development of animal models to study ZIKV infection at this site, and prospects for vaccines and therapeutics against persistent ZIKV infection.
C1 [Frentiu, Francesca D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4006, Australia.
   Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld 4006, Australia.
RP Frentiu, FD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld 4006, Australia.
EM liesel.stassen@qut.edu.au; charles.armitage@qut.edu.au;
   d.vanderheide@qut.edu.au; k2.beagley@qut.edu.au;
   francesca.frentiu@qut.edu.au
RI ; Beagley, Ken/J-1129-2012
OI Armitage, Charles/0000-0002-3859-5172; Frentiu,
   Francesca/0000-0001-8628-4216; Beagley, Ken/0000-0003-3112-6557
FU Queensland University of Technology Institute for Health and Biomedical
   Innovation Mid-Career Researcher Development grant
FX This collaborative review was facilitated by a Queensland University of
   Technology Institute for Health and Biomedical Innovation Mid-Career
   Researcher Development grant awarded to Francesca D. Frentiu in 2017.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chammard TB, 2017, EMERG INFECT DIS, V23, P696, DOI 10.3201/eid2304.161967
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   de Laval F, 2017, NEW ENGL J MED, V377, P697, DOI 10.1056/NEJMc1612600
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Dejucq-Rainsford N, 2004, CURR PHARM DESIGN, V10, P557, DOI 10.2174/1381612043453225
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hedger MP, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1195
   Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Huits R.M.H.G., 2016, B WHO
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jenabian MA, 2016, AIDS, V30, P2777, DOI 10.1097/QAD.0000000000001282
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Kamiyama N, 2017, ANTIVIR RES, V146, P1, DOI 10.1016/j.antiviral.2017.08.007
   Kawiecki AB, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0749-x
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mruk DD, 2015, ENDOCR REV, V36, P564, DOI [10.1210/er.2014-1101, 10.1210/er.2015-1127]
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   O'Meara CP, 2016, MUCOSAL IMMUNOL, V9, P1076, DOI 10.1038/mi.2015.125
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Pacheco O, 2016, N ENGL J MED
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Revenig L, 2014, TRANSL ANDROL UROL, V3, P41, DOI 10.3978/j.issn.2223-4683.2014.02.02
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Siddharthan V, 2017, VIROLOGY, V507, P89, DOI 10.1016/j.virol.2017.04.013
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Stein DR, 2017, ANTIVIR RES, V146, P164, DOI 10.1016/j.antiviral.2017.09.005
   Tebas P, 2017, N ENGL J MED
   Torres JR, 2016, INT J INFECT DIS, V51, P127, DOI 10.1016/j.ijid.2016.08.025
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
   Vinhaes ES, 2017, CLIN INFECT DIS, V64, P675, DOI 10.1093/cid/ciw770
   Visseaux B, 2016, LANCET INFECT DIS, V16, P1220, DOI 10.1016/S1473-3099(16)30387-5
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wahid B, 2017, EUR J INTERN MED, V44, P12, DOI 10.1016/j.ejim.2017.08.001
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang HZ, 2005, J HISTOCHEM CYTOCHEM, V53, P1355, DOI 10.1369/jhc.5A6637.2005
   Watrin L, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003257
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Yakob L, 2016, LANCET INFECT DIS, V16, P1100, DOI 10.1016/S1473-3099(16)30324-3
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 110
TC 17
Z9 17
U1 0
U2 3
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
SN 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2018
VL 10
IS 4
AR 198
DI 10.3390/v10040198
PG 15
WC Virology
SC Virology
GA GJ3HZ
UT WOS:000435184400059
PM 29659541
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bhagat, R
   Seth, P
AF Bhagat, Reshma
   Seth, Pankaj
TI Zika Virus E protein alters properties of human fetal neural stem cells
   by disruption of microRNA circuitry
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Bhagat, Reshma; Seth, Pankaj] Natl Brain Res Ctr, Gurgaon, Haryana, India.
EM reshuubhagat@gmail.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P19
BP S6
EP S6
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400020
DA 2020-07-08
ER

PT J
AU Bidokhti, M
   Dutta, D
   Madduri, L
   Knight, L
   Giavedoni, L
   Byrareddy, S
AF Bidokhti, Mehdi
   Dutta, Debashis
   Madduri, Lepakshe
   Knight, Lindsey
   Giavedoni, Luis
   Byrareddy, Siddappa
TI Rhesus Macaque Model of Zika and SIV/HIV Co-infection
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Bidokhti, Mehdi; Dutta, Debashis; Madduri, Lepakshe; Knight, Lindsey; Byrareddy, Siddappa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.
   [Giavedoni, Luis] Texas Biomed Res Inst, San Antonio, TX 78245 USA.
EM mehdi.bidokhti@unmc.edu
RI Dutta, Debashis/L-4685-2019
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P22
BP S7
EP S7
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400023
DA 2020-07-08
ER

PT J
AU Caobi, A
   Yndart, A
   El-Hage, N
   Nair, M
   Raymond, A
AF Caobi, Allen
   Yndart, Adriana
   El-Hage, Nazira
   Nair, Madhavan
   Raymond, Andrea
TI Pathogenic strains of ZIKV induce gene expression promoting inflammation
   and apoptosis in primary human placental trophoblasts
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Caobi, Allen; Yndart, Adriana; El-Hage, Nazira; Nair, Madhavan; Raymond, Andrea] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA.
EM adraymon@fiu.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P40
BP S12
EP S12
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400041
DA 2020-07-08
ER

PT J
AU Cicalese, S
   Donadoni, M
   Sariyer, I
AF Cicalese, Stephanie
   Donadoni, Martina
   Sariyer, Ilker
TI Regulation of ZIKV infection by SRSF1 and IFN-gamma in human astrocytes
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Cicalese, Stephanie; Donadoni, Martina; Sariyer, Ilker] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.
EM isariyer@temple.edu
RI Sariyer, Ilker/AAE-7677-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P56
BP S16
EP S17
PG 2
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400057
DA 2020-07-08
ER

PT J
AU Cisneros, I
   Dineley, K
   Paessler, S
AF Cisneros, Irma
   Dineley, Kelly
   Paessler, Slobodan
TI Cocaine promotes astrocyte mitochondrial toxicity to regulate activation
   of antiviral innate immune responses to HIV-1 and Zika virus
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Cisneros, Irma; Dineley, Kelly] Univ Texas Med Branch, Dept Pathol, Ctr Addict Res, Galveston, TX 77555 USA.
   [Paessler, Slobodan] Univ Texas Med Branch, Dept Pathol, Inst Human Infect & Immun, Galveston Natl Lab, Galveston, TX 77555 USA.
EM ircisner@utmb.edu
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P58
BP S17
EP S17
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400059
DA 2020-07-08
ER

PT J
AU GeurtsvanKessel, C
   Islam, Z
   Islam, MB
   Kamga, S
   Koopmans, M
   Jacobs, B
   Endtz, H
AF GeurtsvanKessel, Corine
   Islam, Zhahirul
   Islam, Md. Badrul
   Kamga, Sandra
   Koopmans, Marion
   Jacobs, Bart
   Endtz, Hubert
TI Zika virus infection and Guillain-Barre syndrome in Bangladesh: a
   prospective case-control study
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [GeurtsvanKessel, Corine; Kamga, Sandra; Koopmans, Marion] Erasmus MC, Dept Virosci, Rotterdam, Netherlands.
   [Islam, Zhahirul] Int Ctr Diarrhoeal Dis Res Icddr B, Lab Sci & Serv Div 2, Dhaka, Bangladesh.
   [Jacobs, Bart] Erasmus MC, Dept Neurol, Rotterdam, Netherlands.
   [Jacobs, Bart] Erasmus MC, Dept Immunol, Rotterdam, Netherlands.
   [Endtz, Hubert] Fdn Merieux, Lyon, France.
   [Endtz, Hubert] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.
EM c.geurtsvankessel@erasmusmc.nl
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P101
BP S30
EP S30
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400102
DA 2020-07-08
ER

PT J
AU He, M
   Zhang, HN
   Li, YJ
   Wang, GS
   Tang, BS
   Zhao, J
   Huang, YL
   Zheng, JL
AF He, Miao
   Zhang, Hainan
   Li, Yuju
   Wang, Guangshun
   Tang, Beisha
   Zhao, Jeffrey
   Huang, Yunlong
   Zheng, Jialin
TI Cathelicidin-derived antimicrobial peptides suppress Zika virus through
   direct inactivation and interferon pathway
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [He, Miao; Zhang, Hainan; Li, Yuju; Zhao, Jeffrey; Huang, Yunlong; Zheng, Jialin] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA.
   [Wang, Guangshun] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA.
   [Tang, Beisha] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.
EM yhuan1@unmc.edu
RI Huang, Yunlong/J-6554-2015
OI Huang, Yunlong/0000-0002-3328-1924
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P117
BP S34
EP S34
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400118
DA 2020-07-08
ER

PT J
AU Jimenez, O
   Narasipura, S
   Al-Harthi, L
AF Jimenez, Oscar
   Narasipura, Srinivas
   Al-Harthi, Lena
TI Zika virus, in a strain specificmanner, induces human fetal astrocyte
   cell death through beta-catenin inhibition
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Meeting Abstract
CT Joint Meeting of the International-Society-for-NeuroVirology (ISNV) and
   the Society-on-NeuroImmune-Pharmacology (SNIP)
CY APR 10-14, 2018
CL Chicago, IL
SP Int Soc NeuroVirol, Soc NeuroImmune Pharmacol
C1 [Jimenez, Oscar; Narasipura, Srinivas; Al-Harthi, Lena] Rush Univ, Coll Med, Dept Microbial Pathogens & Immun, Chicago, IL 60612 USA.
EM oscar_a_jimenez@rush.edu
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
PD APR
PY 2018
VL 24
SU 1
MA P134
BP S39
EP S39
PG 1
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA GI8ES
UT WOS:000434755400135
DA 2020-07-08
ER

EF